{"GPL17586": [{"GSM1308838": [{"title": "human_monocytes_0day in DC culture"}, {"type": "RNA"}, {"source_name_ch1": "human monocyte derived cells"}, {"characteristics_ch1": "in vitro culture: 0day in GMCSF/IL4 DC culture"}]}, {"GSM1308839": [{"title": "human_cells_1day in DC culture"}, {"type": "RNA"}, {"source_name_ch1": "human monocyte derived cells"}, {"characteristics_ch1": "in vitro culture: 1day in GMCSF/IL4 DC culture"}]}, {"GSM1308840": [{"title": "human_cells_2day in DC culture"}, {"type": "RNA"}, {"source_name_ch1": "human monocyte derived cells"}, {"characteristics_ch1": "in vitro culture: 2day in GMCSF/IL4 DC culture"}]}, {"GSM1308841": [{"title": "human_cells_3day in DC culture"}, {"type": "RNA"}, {"source_name_ch1": "human monocyte derived cells"}, {"characteristics_ch1": "in vitro culture: 3day in GMCSF/IL4 DC culture"}]}, {"GSM1308842": [{"title": "human_cells_5day in DC culture"}, {"type": "RNA"}, {"source_name_ch1": "human monocyte derived cells"}, {"characteristics_ch1": "in vitro culture: 5day in GMCSF/IL4 DC culture"}]}, {"GSM1308843": [{"title": "human_dendritic cells_7day in DC culture"}, {"type": "RNA"}, {"source_name_ch1": "human monocyte derived cells"}, {"characteristics_ch1": "in vitro culture: 7day in GMCSF/IL4 DC culture"}]}, {"GSM1308844": [{"title": "LV control_rep1"}, {"type": "RNA"}, {"source_name_ch1": "human monocyte derived cells"}, {"characteristics_ch1": "in vitro culture: 5day in GMCSF/IL4 DC culture with control lentivirus infection at day0"}]}, {"GSM1308845": [{"title": "LV control_rep2"}, {"type": "RNA"}, {"source_name_ch1": "human monocyte derived cells"}, {"characteristics_ch1": "in vitro culture: 5day in GMCSF/IL4 DC culture with control lentivirus infection at day0"}]}, {"GSM1308846": [{"title": "LV linc-DC RNAi_rep1"}, {"type": "RNA"}, {"source_name_ch1": "human monocyte derived cells"}, {"characteristics_ch1": "in vitro culture: 5day in GMCSF/IL4 DC culture with linc-DC RNAi lentivirus infection at day0"}]}, {"GSM1308847": [{"title": "LV linc-DC RNAi_rep2"}, {"type": "RNA"}, {"source_name_ch1": "human monocyte derived cells"}, {"characteristics_ch1": "in vitro culture: 5day in GMCSF/IL4 DC culture with linc-DC RNAi lentivirus infection at day0"}]}, {"GSM1308848": [{"title": "DMSO_rep1"}, {"type": "RNA"}, {"source_name_ch1": "human monocyte derived cells"}, {"characteristics_ch1": "in vitro culture: 5day in GMCSF/IL4 DC culture supplemented with DMSO"}]}, {"GSM1308849": [{"title": "DMSO_rep2"}, {"type": "RNA"}, {"source_name_ch1": "human monocyte derived cells"}, {"characteristics_ch1": "in vitro culture: 5day in GMCSF/IL4 DC culture supplemented with DMSO"}]}, {"GSM1308850": [{"title": "STAT3 inhibition _rep1"}, {"type": "RNA"}, {"source_name_ch1": "human monocyte derived cells"}, {"characteristics_ch1": "in vitro culture: 5day in GMCSF/IL4 DC culture supplemented with STAT3 inhibitor S3I-201(200uM)"}]}, {"GSM1308851": [{"title": "STAT3 inhibition _rep2"}, {"type": "RNA"}, {"source_name_ch1": "human monocyte derived cells"}, {"characteristics_ch1": "in vitro culture: 5day in GMCSF/IL4 DC culture supplemented with STAT3 inhibitor S3I-201(200uM)"}]}, {"GSM1326801": [{"title": "TRIBAL rep1"}, {"type": "RNA"}, {"source_name_ch1": "TRIBAL, HepG2"}, {"characteristics_ch1": "cell line: HepG2 Hepatoma cells;\tgenotype/variation: TRIBAL overexpression"}]}, {"GSM1326802": [{"title": "TRIBAL rep2"}, {"type": "RNA"}, {"source_name_ch1": "TRIBAL, HepG2"}, {"characteristics_ch1": "cell line: HepG2 Hepatoma cells;\tgenotype/variation: TRIBAL overexpression"}]}, {"GSM1326803": [{"title": "TRIBAL rep3"}, {"type": "RNA"}, {"source_name_ch1": "TRIBAL, HepG2"}, {"characteristics_ch1": "cell line: HepG2 Hepatoma cells;\tgenotype/variation: TRIBAL overexpression"}]}, {"GSM1326804": [{"title": "CONTROL rep1"}, {"type": "RNA"}, {"source_name_ch1": "CONTROL, HepG2"}, {"characteristics_ch1": "cell line: HepG2 Hepatoma cells;\tgenotype/variation: control"}]}, {"GSM1326805": [{"title": "CONTROL rep2"}, {"type": "RNA"}, {"source_name_ch1": "CONTROL, HepG2"}, {"characteristics_ch1": "cell line: HepG2 Hepatoma cells;\tgenotype/variation: control"}]}, {"GSM1326806": [{"title": "CONTROL rep3"}, {"type": "RNA"}, {"source_name_ch1": "CONTROL, HepG2"}, {"characteristics_ch1": "cell line: HepG2 Hepatoma cells;\tgenotype/variation: control"}]}, {"GSM1388395": [{"title": "Normal symmetry, class II, open bite, rep 1"}, {"type": "RNA"}, {"source_name_ch1": "subject 35_right_ normal facial symmetry; J CRANIOFAC SURG_7"}, {"characteristics_ch1": "subject id: Orthognathic surgical subject 35;\trace/ethnicity: French caucasian;\tgender: Female;\tage: 15;\tfacial symmetry: normal facial symmetry;\tmalocclusion classification: class II open bite;\ttissue: masseter muscle"}]}, {"GSM1388396": [{"title": "Normal symmetry, class II , open bite, rep 2"}, {"type": "RNA"}, {"source_name_ch1": "subject 3_right_normal facial symmetry; J CRANIOFAC SURG_8"}, {"characteristics_ch1": "subject id: Orthognathic surgical subject 3;\trace/ethnicity: French caucasian;\tgender: Female;\tage: 17;\tfacial symmetry: normal facial symmetry;\tmalocclusion classification: class II  open bite;\ttissue: masseter muscle"}]}, {"GSM1388397": [{"title": "Normal symmetry, sleep apnea, class II, open bite"}, {"type": "RNA"}, {"source_name_ch1": "subject 4_left_normal facial symmetry_sleep apnea"}, {"characteristics_ch1": "subject id: Orthognathic surgical subject 4;\trace/ethnicity: French caucasian;\tgender: Female;\tage: 41;\tfacial symmetry: normal facial symmetry;\tmalocclusion classification: class II open bite;\ttissue: masseter muscle"}]}, {"GSM1388398": [{"title": "Normal symmetry, class III, open bite, rep 2"}, {"type": "RNA"}, {"source_name_ch1": "subject 36_right_normal facial symmetry; J CRANIOFAC SURG_6"}, {"characteristics_ch1": "subject id: Orthognathic surgical subject 36;\trace/ethnicity: French caucasian;\tgender: Female;\tage: 16;\tfacial symmetry: normal facial symmetry;\tmalocclusion classification: class III open bite;\ttissue: masseter muscle"}]}, {"GSM1388399": [{"title": "Normal symmetry, class II, deep bite, rep 4"}, {"type": "RNA"}, {"source_name_ch1": "subject 10_left_normal facial symmetry; J CRANIOFAC SURG_10"}, {"characteristics_ch1": "subject id: Orthognathic surgical subject 10;\trace/ethnicity: French caucasian;\tgender: Female;\tage: 24;\tfacial symmetry: normal facial symmetry;\tmalocclusion classification: class II deep bite;\ttissue: masseter muscle"}]}, {"GSM1388400": [{"title": "Normal symmetry, class II, deep bite, rep 2"}, {"type": "RNA"}, {"source_name_ch1": "subject 11_left_normal facial symmetry; J CRANIOFAC SURG_5"}, {"characteristics_ch1": "subject id: Orthognathic surgical subject 11;\trace/ethnicity: French caucasian;\tgender: Female;\tage: 47;\tfacial symmetry: normal facial symmetry;\tmalocclusion classification: class II deep bite;\ttissue: masseter muscle"}]}, {"GSM1388401": [{"title": "Normal symmetry, class II, deep bite, rep 3"}, {"type": "RNA"}, {"source_name_ch1": "subject 12_left_normal facial symmetry; J CRANIOFAC SURG_9"}, {"characteristics_ch1": "subject id: Orthognathic surgical subject 12;\trace/ethnicity: French caucasian;\tgender: Male;\tage: 17;\tfacial symmetry: normal facial symmetry;\tmalocclusion classification: class II deep bite;\ttissue: masseter muscle"}]}, {"GSM1388402": [{"title": "Normal symmetry, class II, deep bite, rep 1"}, {"type": "RNA"}, {"source_name_ch1": "subject 19_right_normal facial symmetry; J CRANIOFAC SURG_3"}, {"characteristics_ch1": "subject id: Orthognathic surgical subject 19;\trace/ethnicity: French caucasian;\tgender: Female;\tage: 34;\tfacial symmetry: normal facial symmetry;\tmalocclusion classification: class II deep bite;\ttissue: masseter muscle"}]}, {"GSM1388403": [{"title": "Posterior facial asymmetry, class III, open bite"}, {"type": "RNA"}, {"source_name_ch1": "subject 5_left_posterior facial asymmetry; J CRANIOFAC SURG_2"}, {"characteristics_ch1": "subject id: Orthognathic surgical subject 5;\trace/ethnicity: French caucasian;\tgender: Female;\tage: 53;\tfacial symmetry: posterior facial asymmetry;\tmalocclusion classification: class III open bite;\ttissue: masseter muscle"}]}, {"GSM1388404": [{"title": "Normal symmetry, class III, open bite, rep 1"}, {"type": "RNA"}, {"source_name_ch1": "subject 6_left_normal facial symmetry; J CRANIOFAC SURG_4"}, {"characteristics_ch1": "subject id: Orthognathic surgical subject 6;\trace/ethnicity: North African;\tgender: Female;\tage: 18;\tfacial symmetry: normal facial symmetry;\tmalocclusion classification: class III open bite;\ttissue: masseter muscle"}]}, {"GSM1388405": [{"title": "Posterior facial asymmetry, class II, open bite"}, {"type": "RNA"}, {"source_name_ch1": "subject 38_right_posterior facial asymmetry; J CRANIOFAC SURG_1"}, {"characteristics_ch1": "subject id: Orthognathic surgical subject 38;\trace/ethnicity: French caucasian;\tgender: Female;\tage: 41;\tfacial symmetry: posterior facial asymmetry;\tmalocclusion classification: class II open bite;\ttissue: masseter muscle"}]}, {"GSM1421099": [{"title": "DMSO-DMEM-1"}, {"type": "RNA"}, {"source_name_ch1": "Human Heptoma (HepG2)"}, {"characteristics_ch1": "cell line: HepG2;\ttreatment: control-complete medium"}]}, {"GSM1421100": [{"title": "DMSO-DMEM-2"}, {"type": "RNA"}, {"source_name_ch1": "Human Heptoma (HepG2)"}, {"characteristics_ch1": "cell line: HepG2;\ttreatment: control-complete medium"}]}, {"GSM1421101": [{"title": "DMSO-DMEM-3"}, {"type": "RNA"}, {"source_name_ch1": "Human Heptoma (HepG2)"}, {"characteristics_ch1": "cell line: HepG2;\ttreatment: control-complete medium"}]}, {"GSM1421102": [{"title": "DMSO-DMEM-4"}, {"type": "RNA"}, {"source_name_ch1": "Human Heptoma (HepG2)"}, {"characteristics_ch1": "cell line: HepG2;\ttreatment: control-complete medium"}]}, {"GSM1421103": [{"title": "DMSO-His-1"}, {"type": "RNA"}, {"source_name_ch1": "Human Heptoma (HepG2)"}, {"characteristics_ch1": "cell line: HepG2;\ttreatment: control-depleted for Histidine"}]}, {"GSM1421104": [{"title": "DMSO-His-2"}, {"type": "RNA"}, {"source_name_ch1": "Human Heptoma (HepG2)"}, {"characteristics_ch1": "cell line: HepG2;\ttreatment: control-depleted for Histidine"}]}, {"GSM1421105": [{"title": "DMSO-His-3"}, {"type": "RNA"}, {"source_name_ch1": "Human Heptoma (HepG2)"}, {"characteristics_ch1": "cell line: HepG2;\ttreatment: control-depleted for Histidine"}]}, {"GSM1421106": [{"title": "DMSO-His-4"}, {"type": "RNA"}, {"source_name_ch1": "Human Heptoma (HepG2)"}, {"characteristics_ch1": "cell line: HepG2;\ttreatment: control-depleted for Histidine"}]}, {"GSM1421107": [{"title": "PD-DMEM-1"}, {"type": "RNA"}, {"source_name_ch1": "Human Heptoma (HepG2)"}, {"characteristics_ch1": "cell line: HepG2;\ttreatment: 2.5M PD98059-complete medium"}]}, {"GSM1421108": [{"title": "PD-DMEM-2"}, {"type": "RNA"}, {"source_name_ch1": "Human Heptoma (HepG2)"}, {"characteristics_ch1": "cell line: HepG2;\ttreatment: 2.5M PD98059-complete medium"}]}, {"GSM1421109": [{"title": "PD-DMEM-3"}, {"type": "RNA"}, {"source_name_ch1": "Human Heptoma (HepG2)"}, {"characteristics_ch1": "cell line: HepG2;\ttreatment: 2.5M PD98059-complete medium"}]}, {"GSM1421110": [{"title": "PD-DMEM-4"}, {"type": "RNA"}, {"source_name_ch1": "Human Heptoma (HepG2)"}, {"characteristics_ch1": "cell line: HepG2;\ttreatment: 2.5M PD98059-complete medium"}]}, {"GSM1421111": [{"title": "PD-His-1"}, {"type": "RNA"}, {"source_name_ch1": "Human Heptoma (HepG2)"}, {"characteristics_ch1": "cell line: HepG2;\ttreatment: 2.5M PD98059-depleted for Histidine"}]}, {"GSM1421112": [{"title": "PD-His-2"}, {"type": "RNA"}, {"source_name_ch1": "Human Heptoma (HepG2)"}, {"characteristics_ch1": "cell line: HepG2;\ttreatment: 2.5M PD98059-depleted for Histidine"}]}, {"GSM1421113": [{"title": "PD-His-3"}, {"type": "RNA"}, {"source_name_ch1": "Human Heptoma (HepG2)"}, {"characteristics_ch1": "cell line: HepG2;\ttreatment: 2.5M PD98059-depleted for Histidine"}]}, {"GSM1421114": [{"title": "PD-His-4"}, {"type": "RNA"}, {"source_name_ch1": "Human Heptoma (HepG2)"}, {"characteristics_ch1": "cell line: HepG2;\ttreatment: 2.5M PD98059-depleted for Histidine"}]}, {"GSM1435446": [{"title": "MCF7-F, ethanol treated, replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "MCF7 cells cultured in normal FBS"}, {"characteristics_ch1": "cell type: MCF7;\ttreatment: ethanol treated"}]}, {"GSM1435447": [{"title": "MCF7-F, ethanol treated, replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "MCF7 cells cultured in normal FBS"}, {"characteristics_ch1": "cell type: MCF7;\ttreatment: ethanol treated"}]}, {"GSM1435448": [{"title": "MCF7-F, estradiol treated, replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "MCF7 cells cultured in normal FBS"}, {"characteristics_ch1": "cell type: MCF7;\ttreatment: estradiol treated"}]}, {"GSM1435449": [{"title": "MCF7-F, estradiol treated, replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "MCF7 cells cultured in normal FBS"}, {"characteristics_ch1": "cell type: MCF7;\ttreatment: estradiol treated"}]}, {"GSM1435450": [{"title": "MCF7-B, ethanol treated, replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "MCF7 cells chronically cultured in BPA"}, {"characteristics_ch1": "cell type: MCF7;\ttreatment: ethanol treated"}]}, {"GSM1435451": [{"title": "MCF7-B, ethanol treated, replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "MCF7 cells chronically cultured in BPA"}, {"characteristics_ch1": "cell type: MCF7;\ttreatment: ethanol treated"}]}, {"GSM1435452": [{"title": "MCF7-B, estradiol treated, replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "MCF7 cells chronically cultured in BPA"}, {"characteristics_ch1": "cell type: MCF7;\ttreatment: estradiol treated"}]}, {"GSM1435453": [{"title": "MCF7-B, estradiol treated, replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "MCF7 cells chronically cultured in BPA"}, {"characteristics_ch1": "cell type: MCF7;\ttreatment: estradiol treated"}]}, {"GSM1435454": [{"title": "MCF7-G, ethanol treated, replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "MCF7 cells chronically cultured in GEN"}, {"characteristics_ch1": "cell type: MCF7;\ttreatment: ethanol treated"}]}, {"GSM1435455": [{"title": "MCF7-G, ethanol treated, replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "MCF7 cells chronically cultured in GEN"}, {"characteristics_ch1": "cell type: MCF7;\ttreatment: ethanol treated"}]}, {"GSM1435456": [{"title": "MCF7-G, estradiol treated, replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "MCF7 cells chronically cultured in GEN"}, {"characteristics_ch1": "cell type: MCF7;\ttreatment: estradiol treated"}]}, {"GSM1435457": [{"title": "MCF7-G, estradiol treated, replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "MCF7 cells chronically cultured in GEN"}, {"characteristics_ch1": "cell type: MCF7;\ttreatment: estradiol treated"}]}, {"GSM1502840": [{"title": "human iPSC line 3"}, {"type": "RNA"}, {"source_name_ch1": "human iPSC line 3"}, {"characteristics_ch1": "cell line: human iPSC line 3"}]}, {"GSM1502841": [{"title": "human iPSC line 5"}, {"type": "RNA"}, {"source_name_ch1": "human iPSC line 5"}, {"characteristics_ch1": "cell line: human iPSC line 5"}]}, {"GSM1502842": [{"title": "human iPSC line 6"}, {"type": "RNA"}, {"source_name_ch1": "human iPSC line 6"}, {"characteristics_ch1": "cell line: human iPSC line 6"}]}, {"GSM1502843": [{"title": "human NPC ax0013, derived from line 3"}, {"type": "RNA"}, {"source_name_ch1": "human NPC ax0013, derived from line 3"}, {"characteristics_ch1": "cell line: human NPC ax0013, derived from line 3"}]}, {"GSM1502844": [{"title": "human NPC ax0015, derived from line 5"}, {"type": "RNA"}, {"source_name_ch1": "human NPC ax0015, derived from line 5"}, {"characteristics_ch1": "cell line: human NPC ax0015, derived from line 5"}]}, {"GSM1502845": [{"title": "human NPC ax0016, derived from line 6"}, {"type": "RNA"}, {"source_name_ch1": "human NPC ax0016, derived from line 6"}, {"characteristics_ch1": "cell line: human NPC ax0016, derived from line 6"}]}, {"GSM1474239": [{"title": "C1"}, {"type": "RNA"}, {"source_name_ch1": "control"}, {"characteristics_ch1": "cell type: H tert Fibroblasts"}]}, {"GSM1474240": [{"title": "C6"}, {"type": "RNA"}, {"source_name_ch1": "control"}, {"characteristics_ch1": "cell type: H tert Fibroblasts"}]}, {"GSM1474241": [{"title": "C16"}, {"type": "RNA"}, {"source_name_ch1": "control"}, {"characteristics_ch1": "cell type: H tert Fibroblasts"}]}, {"GSM1474242": [{"title": "P1"}, {"type": "RNA"}, {"source_name_ch1": "ISG15 deficient patient"}, {"characteristics_ch1": "cell type: H tert Fibroblasts"}]}, {"GSM1474243": [{"title": "P2"}, {"type": "RNA"}, {"source_name_ch1": "ISG15 deficient patient"}, {"characteristics_ch1": "cell type: H tert Fibroblasts"}]}, {"GSM1474244": [{"title": "P3"}, {"type": "RNA"}, {"source_name_ch1": "ISG15 deficient patient"}, {"characteristics_ch1": "cell type: H tert Fibroblasts"}]}, {"GSM1474245": [{"title": "C1 plus IFNa"}, {"type": "RNA"}, {"source_name_ch1": "control plus IFNa"}, {"characteristics_ch1": "cell type: H tert Fibroblasts"}]}, {"GSM1474246": [{"title": "C6 plus IFNa"}, {"type": "RNA"}, {"source_name_ch1": "control plus IFNa"}, {"characteristics_ch1": "cell type: H tert Fibroblasts"}]}, {"GSM1474247": [{"title": "C16 plus IFNa"}, {"type": "RNA"}, {"source_name_ch1": "control plus IFNa"}, {"characteristics_ch1": "cell type: H tert Fibroblasts"}]}, {"GSM1474248": [{"title": "P1 plus IFNa"}, {"type": "RNA"}, {"source_name_ch1": "ISG15 deficient patient plus IFNa"}, {"characteristics_ch1": "cell type: H tert Fibroblasts"}]}, {"GSM1474249": [{"title": "P2 plus IFNa"}, {"type": "RNA"}, {"source_name_ch1": "ISG15 deficient patient plus IFNa"}, {"characteristics_ch1": "cell type: H tert Fibroblasts"}]}, {"GSM1474250": [{"title": "P3 plus IFNa"}, {"type": "RNA"}, {"source_name_ch1": "ISG15 deficient patient plus IFNa"}, {"characteristics_ch1": "cell type: H tert Fibroblasts"}]}, {"GSM1495295": [{"title": "revertant-iPSC-FB (P9), technical rep 1"}, {"type": "RNA"}, {"source_name_ch1": "revertant-iPSC-FB from patient EB026-01"}, {"characteristics_ch1": "cell type: revertant-iPSC-FB"}]}, {"GSM1495296": [{"title": "revertant-iPSC-FB (P9), technical rep 2"}, {"type": "RNA"}, {"source_name_ch1": "revertant-iPSC-FB from patient EB026-01"}, {"characteristics_ch1": "cell type: revertant-iPSC-FB"}]}, {"GSM1495297": [{"title": "revertant-iPSC-FB (P9), technical rep 3"}, {"type": "RNA"}, {"source_name_ch1": "revertant-iPSC-FB from patient EB026-01"}, {"characteristics_ch1": "cell type: revertant-iPSC-FB"}]}, {"GSM1495298": [{"title": "normal FB (P4), technical rep 1"}, {"type": "RNA"}, {"source_name_ch1": "normal fibroblasts from healthy control"}, {"characteristics_ch1": "cell type: normal human fibroblasts"}]}, {"GSM1495299": [{"title": "normal FB (P4), technical rep 2"}, {"type": "RNA"}, {"source_name_ch1": "normal fibroblasts from healthy control"}, {"characteristics_ch1": "cell type: normal human fibroblasts"}]}, {"GSM1495300": [{"title": "revertant-iPS-KC (P1)"}, {"type": "RNA"}, {"source_name_ch1": "revertant-iPSC-KC from patient EB026-01"}, {"characteristics_ch1": "cell type: revertant-iPSC-KC"}]}, {"GSM1495301": [{"title": "original revertant keratinocytes (P3)"}, {"type": "RNA"}, {"source_name_ch1": "original revertant keratinocytes from patient EB026-01"}, {"characteristics_ch1": "cell type: revertant keratinocytes"}]}, {"GSM1495302": [{"title": "revertant-iPSCs (P21)"}, {"type": "RNA"}, {"source_name_ch1": "revertant-iPSCs from patient EB026-01"}, {"characteristics_ch1": "cell type: revertant-iPSCs"}]}, {"GSM1410416": [{"title": "HCT116_ASO_SC_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HCT116, 5FU, 12h"}, {"characteristics_ch1": "cell line: HCT116;\ttransfection: 100nM ASOs (siRNA-scramble);\ttreatment: 5 FU for 12h;\tpassages: 8-10passeges"}]}, {"GSM1410417": [{"title": "HCT116_ASO_SC_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HCT116, 5FU, 12h"}, {"characteristics_ch1": "cell line: HCT116;\ttransfection: 100nM ASOs (siRNA-scramble);\ttreatment: 5 FU for 12h;\tpassages: 8-10passeges"}]}, {"GSM1410418": [{"title": "HCT116_ASO_SC_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HCT116, 5FU, 12h"}, {"characteristics_ch1": "cell line: HCT116;\ttransfection: 100nM ASOs (siRNA-scramble);\ttreatment: 5 FU for 12h;\tpassages: 8-10passeges"}]}, {"GSM1410419": [{"title": "HCT116_ASO_lncRNA-1_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HCT116, 5FU, 12h"}, {"characteristics_ch1": "cell line: HCT116;\ttransfection: 100nM ASOs (target one of the candidate lncRNA for depletion);\ttreatment: 5 FU for 12h;\tpassages: 8-10passeges"}]}, {"GSM1410420": [{"title": "HCT116_ASO_lncRNA-1_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HCT116, 5FU, 12h"}, {"characteristics_ch1": "cell line: HCT116;\ttransfection: 100nM ASOs (target one of the candidate lncRNA for depletion);\ttreatment: 5 FU for 12h;\tpassages: 8-10passeges"}]}, {"GSM1410421": [{"title": "HCT116_ASO_lncRNA-1_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HCT116, 5FU, 12h"}, {"characteristics_ch1": "cell line: HCT116;\ttransfection: 100nM ASOs (target one of the candidate lncRNA for depletion);\ttreatment: 5 FU for 12h;\tpassages: 8-10passeges"}]}, {"GSM1410422": [{"title": "HCT116_ASO_unassigned-1_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HCT116, 5FU, 12h"}, {"characteristics_ch1": "cell line: HCT116;\ttransfection: 100nM ASOs (target one new region non-coding);\ttreatment: 5 FU for 12h;\tpassages: 8-10passeges"}]}, {"GSM1410423": [{"title": "HCT116_ASO_unassigned-1_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HCT116, 5FU, 12h"}, {"characteristics_ch1": "cell line: HCT116;\ttransfection: 100nM ASOs (target one new region non-coding);\ttreatment: 5 FU for 12h;\tpassages: 8-10passeges"}]}, {"GSM1410424": [{"title": "HCT116_ASO_unassigned-1_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HCT116, 5FU, 12h"}, {"characteristics_ch1": "cell line: HCT116;\ttransfection: 100nM ASOs (target one new region non-coding);\ttreatment: 5 FU for 12h;\tpassages: 8-10passeges"}]}, {"GSM1593835": [{"title": "HaCaT wild type control sodium concentration_1"}, {"type": "RNA"}, {"source_name_ch1": "keratinocyte cell line"}, {"characteristics_ch1": "gender: female;\ttissue: skin epithelium;\tcell line: HaCaT;\tgenotype/variation: wild type;\ttreatment: control;\ttime: control"}]}, {"GSM1593836": [{"title": "HaCaT wild type control sodium concentration_2"}, {"type": "RNA"}, {"source_name_ch1": "keratinocyte cell line"}, {"characteristics_ch1": "gender: female;\ttissue: skin epithelium;\tcell line: HaCaT;\tgenotype/variation: wild type;\ttreatment: control;\ttime: control"}]}, {"GSM1593837": [{"title": "HaCaT wild type control sodium concentration_3"}, {"type": "RNA"}, {"source_name_ch1": "keratinocyte cell line"}, {"characteristics_ch1": "gender: female;\ttissue: skin epithelium;\tcell line: HaCaT;\tgenotype/variation: wild type;\ttreatment: control;\ttime: control"}]}, {"GSM1593838": [{"title": "HaCaT wild type control sodium concentration_5"}, {"type": "RNA"}, {"source_name_ch1": "keratinocyte cell line"}, {"characteristics_ch1": "gender: female;\ttissue: skin epithelium;\tcell line: HaCaT;\tgenotype/variation: wild type;\ttreatment: control;\ttime: control"}]}, {"GSM1593839": [{"title": "HaCaT wild type control sodium concentration_6"}, {"type": "RNA"}, {"source_name_ch1": "keratinocyte cell line"}, {"characteristics_ch1": "gender: female;\ttissue: skin epithelium;\tcell line: HaCaT;\tgenotype/variation: wild type;\ttreatment: control;\ttime: control"}]}, {"GSM1593840": [{"title": "HaCaT wild type high sodium concentration 4 hour stimulation_1"}, {"type": "RNA"}, {"source_name_ch1": "keratinocyte cell line"}, {"characteristics_ch1": "gender: female;\ttissue: skin epithelium;\tcell line: HaCaT;\tgenotype/variation: wild type;\ttreatment: high sodium concentration;\ttime: 4 hour"}]}, {"GSM1593841": [{"title": "HaCaT wild type high sodium concentration 4 hour stimulation_3"}, {"type": "RNA"}, {"source_name_ch1": "keratinocyte cell line"}, {"characteristics_ch1": "gender: female;\ttissue: skin epithelium;\tcell line: HaCaT;\tgenotype/variation: wild type;\ttreatment: high sodium concentration;\ttime: 4 hour"}]}, {"GSM1593842": [{"title": "HaCaT wild type high sodium concentration 4 hour stimulation_4"}, {"type": "RNA"}, {"source_name_ch1": "keratinocyte cell line"}, {"characteristics_ch1": "gender: female;\ttissue: skin epithelium;\tcell line: HaCaT;\tgenotype/variation: wild type;\ttreatment: high sodium concentration;\ttime: 4 hour"}]}, {"GSM1593843": [{"title": "HaCaT wild type high sodium concentration 4 hour stimulation_7"}, {"type": "RNA"}, {"source_name_ch1": "keratinocyte cell line"}, {"characteristics_ch1": "gender: female;\ttissue: skin epithelium;\tcell line: HaCaT;\tgenotype/variation: wild type;\ttreatment: high sodium concentration;\ttime: 4 hour"}]}, {"GSM1593844": [{"title": "HaCaT wild type high sodium concentration 4 hour stimulation_8"}, {"type": "RNA"}, {"source_name_ch1": "keratinocyte cell line"}, {"characteristics_ch1": "gender: female;\ttissue: skin epithelium;\tcell line: HaCaT;\tgenotype/variation: wild type;\ttreatment: high sodium concentration;\ttime: 4 hour"}]}, {"GSM1593845": [{"title": "HaCaT wild type high sodium concentration 16 hour stimulation_1"}, {"type": "RNA"}, {"source_name_ch1": "keratinocyte cell line"}, {"characteristics_ch1": "gender: female;\ttissue: skin epithelium;\tcell line: HaCaT;\tgenotype/variation: wild type;\ttreatment: high sodium concentration;\ttime: 16 hour"}]}, {"GSM1593846": [{"title": "HaCaT wild type high sodium concentration 16 hour stimulation_3"}, {"type": "RNA"}, {"source_name_ch1": "keratinocyte cell line"}, {"characteristics_ch1": "gender: female;\ttissue: skin epithelium;\tcell line: HaCaT;\tgenotype/variation: wild type;\ttreatment: high sodium concentration;\ttime: 16 hour"}]}, {"GSM1593847": [{"title": "HaCaT wild type high sodium concentration 16 hour stimulation_4"}, {"type": "RNA"}, {"source_name_ch1": "keratinocyte cell line"}, {"characteristics_ch1": "gender: female;\ttissue: skin epithelium;\tcell line: HaCaT;\tgenotype/variation: wild type;\ttreatment: high sodium concentration;\ttime: 16 hour"}]}, {"GSM1593848": [{"title": "HaCaT wild type high sodium concentration 16 hour stimulation_5"}, {"type": "RNA"}, {"source_name_ch1": "keratinocyte cell line"}, {"characteristics_ch1": "gender: female;\ttissue: skin epithelium;\tcell line: HaCaT;\tgenotype/variation: wild type;\ttreatment: high sodium concentration;\ttime: 16 hour"}]}, {"GSM1593849": [{"title": "HaCaT wild type high sodium concentration 16 hour stimulation_8"}, {"type": "RNA"}, {"source_name_ch1": "keratinocyte cell line"}, {"characteristics_ch1": "gender: female;\ttissue: skin epithelium;\tcell line: HaCaT;\tgenotype/variation: wild type;\ttreatment: high sodium concentration;\ttime: 16 hour"}]}, {"GSM1593850": [{"title": "Nax knockdown HaCaT control sodium concentration_2"}, {"type": "RNA"}, {"source_name_ch1": "keratinocyte cell line"}, {"characteristics_ch1": "gender: female;\ttissue: skin epithelium;\tcell line: HaCaT;\tgenotype/variation: Nax knockdown;\ttreatment: control;\ttime: control"}]}, {"GSM1593851": [{"title": "Nax knockdown HaCaT control sodium concentration_3"}, {"type": "RNA"}, {"source_name_ch1": "keratinocyte cell line"}, {"characteristics_ch1": "gender: female;\ttissue: skin epithelium;\tcell line: HaCaT;\tgenotype/variation: Nax knockdown;\ttreatment: control;\ttime: control"}]}, {"GSM1593852": [{"title": "Nax knockdown HaCaT control sodium concentration_4"}, {"type": "RNA"}, {"source_name_ch1": "keratinocyte cell line"}, {"characteristics_ch1": "gender: female;\ttissue: skin epithelium;\tcell line: HaCaT;\tgenotype/variation: Nax knockdown;\ttreatment: control;\ttime: control"}]}, {"GSM1593853": [{"title": "Nax knockdown HaCaT control sodium concentration_6"}, {"type": "RNA"}, {"source_name_ch1": "keratinocyte cell line"}, {"characteristics_ch1": "gender: female;\ttissue: skin epithelium;\tcell line: HaCaT;\tgenotype/variation: Nax knockdown;\ttreatment: control;\ttime: control"}]}, {"GSM1593854": [{"title": "Nax knockdown HaCaT control sodium concentration_8"}, {"type": "RNA"}, {"source_name_ch1": "keratinocyte cell line"}, {"characteristics_ch1": "gender: female;\ttissue: skin epithelium;\tcell line: HaCaT;\tgenotype/variation: Nax knockdown;\ttreatment: control;\ttime: control"}]}, {"GSM1593855": [{"title": "Nax knockdown HaCaT high sodium concentration 4 hour stimulation_1"}, {"type": "RNA"}, {"source_name_ch1": "keratinocyte cell line"}, {"characteristics_ch1": "gender: female;\ttissue: skin epithelium;\tcell line: HaCaT;\tgenotype/variation: Nax knockdown;\ttreatment: high sodium concentration;\ttime: 4 hour"}]}, {"GSM1593856": [{"title": "Nax knockdown HaCaT high sodium concentration 4 hour stimulation_2"}, {"type": "RNA"}, {"source_name_ch1": "keratinocyte cell line"}, {"characteristics_ch1": "gender: female;\ttissue: skin epithelium;\tcell line: HaCaT;\tgenotype/variation: Nax knockdown;\ttreatment: high sodium concentration;\ttime: 4 hour"}]}, {"GSM1593857": [{"title": "Nax knockdown HaCaT high sodium concentration 4 hour stimulation_5"}, {"type": "RNA"}, {"source_name_ch1": "keratinocyte cell line"}, {"characteristics_ch1": "gender: female;\ttissue: skin epithelium;\tcell line: HaCaT;\tgenotype/variation: Nax knockdown;\ttreatment: high sodium concentration;\ttime: 4 hour"}]}, {"GSM1593858": [{"title": "Nax knockdown HaCaT high sodium concentration 4 hour stimulation_6"}, {"type": "RNA"}, {"source_name_ch1": "keratinocyte cell line"}, {"characteristics_ch1": "gender: female;\ttissue: skin epithelium;\tcell line: HaCaT;\tgenotype/variation: Nax knockdown;\ttreatment: high sodium concentration;\ttime: 4 hour"}]}, {"GSM1593859": [{"title": "Nax knockdown HaCaT high sodium concentration 4 hour stimulation_7"}, {"type": "RNA"}, {"source_name_ch1": "keratinocyte cell line"}, {"characteristics_ch1": "gender: female;\ttissue: skin epithelium;\tcell line: HaCaT;\tgenotype/variation: Nax knockdown;\ttreatment: high sodium concentration;\ttime: 4 hour"}]}, {"GSM1593860": [{"title": "Nax knockdown HaCaT high sodium concentration 16 hour stimulation_1"}, {"type": "RNA"}, {"source_name_ch1": "keratinocyte cell line"}, {"characteristics_ch1": "gender: female;\ttissue: skin epithelium;\tcell line: HaCaT;\tgenotype/variation: Nax knockdown;\ttreatment: high sodium concentration;\ttime: 16 hour"}]}, {"GSM1593861": [{"title": "Nax knockdown HaCaT high sodium concentration 16 hour stimulation_2"}, {"type": "RNA"}, {"source_name_ch1": "keratinocyte cell line"}, {"characteristics_ch1": "gender: female;\ttissue: skin epithelium;\tcell line: HaCaT;\tgenotype/variation: Nax knockdown;\ttreatment: high sodium concentration;\ttime: 16 hour"}]}, {"GSM1593862": [{"title": "Nax knockdown HaCaT high sodium concentration 16 hour stimulation_3"}, {"type": "RNA"}, {"source_name_ch1": "keratinocyte cell line"}, {"characteristics_ch1": "gender: female;\ttissue: skin epithelium;\tcell line: HaCaT;\tgenotype/variation: Nax knockdown;\ttreatment: high sodium concentration;\ttime: 16 hour"}]}, {"GSM1593863": [{"title": "Nax knockdown HaCaT high sodium concentration 16 hour stimulation_5"}, {"type": "RNA"}, {"source_name_ch1": "keratinocyte cell line"}, {"characteristics_ch1": "gender: female;\ttissue: skin epithelium;\tcell line: HaCaT;\tgenotype/variation: Nax knockdown;\ttreatment: high sodium concentration;\ttime: 16 hour"}]}, {"GSM1593864": [{"title": "Nax knockdown HaCaT high sodium concentration 16 hour stimulation_6"}, {"type": "RNA"}, {"source_name_ch1": "keratinocyte cell line"}, {"characteristics_ch1": "gender: female;\ttissue: skin epithelium;\tcell line: HaCaT;\tgenotype/variation: Nax knockdown;\ttreatment: high sodium concentration;\ttime: 16 hour"}]}, {"GSM1369898": [{"title": "MDA-MB-231 DMSO, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "Human breast cancer cell line MDA-MB-231 treated with DMSO"}, {"characteristics_ch1": "tissue: Cultured breast cancer cells;\tcell line: MDA-MB-231"}]}, {"GSM1369899": [{"title": "MDA-MB-231 DMSO, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "Human breast cancer cell line MDA-MB-231 treated with DMSO"}, {"characteristics_ch1": "tissue: Cultured breast cancer cells;\tcell line: MDA-MB-231"}]}, {"GSM1369900": [{"title": "MDA-MB-231 DMSO, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "Human breast cancer cell line MDA-MB-231 treated with DMSO"}, {"characteristics_ch1": "tissue: Cultured breast cancer cells;\tcell line: MDA-MB-231"}]}, {"GSM1369901": [{"title": "MDA-MB-231 UF010, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "Human breast cancer cell line MDA-MB-231 treated with UF010"}, {"characteristics_ch1": "tissue: Cultured breast cancer cells;\tcell line: MDA-MB-231"}]}, {"GSM1369902": [{"title": "MDA-MB-231 UF010, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "Human breast cancer cell line MDA-MB-231 treated with UF010"}, {"characteristics_ch1": "tissue: Cultured breast cancer cells;\tcell line: MDA-MB-231"}]}, {"GSM1369903": [{"title": "MDA-MB-231 UF010, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "Human breast cancer cell line MDA-MB-231 treated with UF010"}, {"characteristics_ch1": "tissue: Cultured breast cancer cells;\tcell line: MDA-MB-231"}]}, {"GSM1505559": [{"title": "NT_rep1"}, {"type": "RNA"}, {"source_name_ch1": "Control Knock-down"}, {"characteristics_ch1": "cell type: Primary Hepatocytes plated on collagen"}]}, {"GSM1505560": [{"title": "NT_rep2"}, {"type": "RNA"}, {"source_name_ch1": "Control Knock-down"}, {"characteristics_ch1": "cell type: Primary Hepatocytes plated on collagen"}]}, {"GSM1505561": [{"title": "NT_rep3"}, {"type": "RNA"}, {"source_name_ch1": "Control Knock-down"}, {"characteristics_ch1": "cell type: Primary Hepatocytes plated on collagen"}]}, {"GSM1505562": [{"title": "TRIB1_rep1"}, {"type": "RNA"}, {"source_name_ch1": "TRIB1 knock-down"}, {"characteristics_ch1": "cell type: Primary Hepatocytes plated on collagen"}]}, {"GSM1505563": [{"title": "TRIB1_rep2"}, {"type": "RNA"}, {"source_name_ch1": "TRIB1 knock-down"}, {"characteristics_ch1": "cell type: Primary Hepatocytes plated on collagen"}]}, {"GSM1505564": [{"title": "TRIB1_rep3"}, {"type": "RNA"}, {"source_name_ch1": "TRIB1 knock-down"}, {"characteristics_ch1": "cell type: Primary Hepatocytes plated on collagen"}]}, {"GSM1539076": [{"title": "1.NB4-VEC"}, {"type": "RNA"}, {"source_name_ch1": "NB4 cell line"}, {"characteristics_ch1": "disease state: acute promyelocytic leukemia (APL);\tcell line: NB4;\ttreatment: transfected with the empty vector"}]}, {"GSM1539077": [{"title": "2.NB4-TETON.377"}, {"type": "RNA"}, {"source_name_ch1": "NB4 cell line"}, {"characteristics_ch1": "disease state: acute promyelocytic leukemia (APL);\tcell line: NB4;\ttreatment: transfected with Pin1 KD (TET-ON)"}]}, {"GSM1539078": [{"title": "3.NB4-DMSO"}, {"type": "RNA"}, {"source_name_ch1": "NB4 cell line"}, {"characteristics_ch1": "disease state: acute promyelocytic leukemia (APL);\tcell line: NB4;\ttreatment: treated with DMSO"}]}, {"GSM1539079": [{"title": "4.NB4-ATRA"}, {"type": "RNA"}, {"source_name_ch1": "NB4 cell line"}, {"characteristics_ch1": "disease state: acute promyelocytic leukemia (APL);\tcell line: NB4;\ttreatment: treated with ATRA"}]}, {"GSM1561370": [{"title": "shFOXM1"}, {"type": "RNA"}, {"source_name_ch1": "GBM patient derived GSCs"}, {"characteristics_ch1": "cell type: glioma stem cells;\tcell line: GBM83;\ttransfection: pLKO 1.0- shFoxm1"}]}, {"GSM1561371": [{"title": "shFOXM1+EZH2 OE"}, {"type": "RNA"}, {"source_name_ch1": "GBM patient derived GSCs"}, {"characteristics_ch1": "cell type: glioma stem cells;\tcell line: GBM83;\ttransfection: pLKO 1.0- shFoxm1+ EZH2 Overexpression vector"}]}, {"GSM1561372": [{"title": "shMELK"}, {"type": "RNA"}, {"source_name_ch1": "GBM patient derived GSCs"}, {"characteristics_ch1": "cell type: glioma stem cells;\tcell line: GBM83;\ttransfection: pLKO 1.0- shMELK"}]}, {"GSM1561373": [{"title": "shMELK+EZH2 OE"}, {"type": "RNA"}, {"source_name_ch1": "GBM patient derived GSCs"}, {"characteristics_ch1": "cell type: glioma stem cells;\tcell line: GBM83;\ttransfection: pLKO 1.0- shMELK+EZH2 overexpression vector"}]}, {"GSM1561374": [{"title": "shNT"}, {"type": "RNA"}, {"source_name_ch1": "GBM patient derived GSCs"}, {"characteristics_ch1": "cell type: glioma stem cells;\tcell line: GBM83;\ttransfection: pLKO 1.0- shNon-targeting vector"}]}, {"GSM1487516": [{"title": "HeLa_WildType_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HeLa_no-treatment (NT)"}, {"characteristics_ch1": "cell line: HeLa;\ttreated with: deionized H2O for 36 days (NT)"}]}, {"GSM1487517": [{"title": "HeLa_WildType_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HeLa_no-treatment (NT)"}, {"characteristics_ch1": "cell line: HeLa;\ttreated with: deionized H2O for 36 days (NT)"}]}, {"GSM1487518": [{"title": "HeLa_Treated_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HeLa_1 uM arsenite (iAs-T) for 36 d"}, {"characteristics_ch1": "cell line: HeLa;\ttreated with: 1 uM of sodium arsenite (iAs-T) for 36 days"}]}, {"GSM1487519": [{"title": "HeLa_Treated_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HeLa_1 uM arsenite (iAs-T) for 36 d"}, {"characteristics_ch1": "cell line: HeLa;\ttreated with: 1 uM of sodium arsenite (iAs-T) for 36 days"}]}, {"GSM1487520": [{"title": "HeLa_Reversed_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HeLa_1 uM arsenite for 26 days_removal of arsenite for 10 days (iAs-Rev)"}, {"characteristics_ch1": "cell line: HeLa;\ttreated with: 1 uM sodium arsenite for 26 days followed by removal of sodium arsenite for 10 days (measured at day 36)"}]}, {"GSM1487521": [{"title": "HeLa_Reversed_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HeLa_1 uM arsenite for 26 days_removal of arsenite for 10 days (iAs-Rev)"}, {"characteristics_ch1": "cell line: HeLa;\ttreated with: 1 uM sodium arsenite for 26 days followed by removal of sodium arsenite for 10 days (measured at day 36)"}]}, {"GSM1487522": [{"title": "HeLa_ReversedTreated_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HeLa_1 uM arsenite for 26 days_removal of arsenite for 10 days_1uM arsenite for 10 days (iAs-Rev-T)"}, {"characteristics_ch1": "cell line: HeLa;\ttreated with: 1 uM sodium arsenite for 26 days,  followed by removal of sodium arsenite for 10 days, followed by 1uM sodium arsenite treatment for 10 days  (measured at day 46)"}]}, {"GSM1487523": [{"title": "HeLa_ReversedTreated_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HeLa_1 uM arsenite for 26 days_removal of arsenite for 10 days_1uM arsenite for 10 days (iAs-Rev-T)"}, {"characteristics_ch1": "cell line: HeLa;\ttreated with: 1 uM sodium arsenite for 26 days,  followed by removal of sodium arsenite for 10 days, followed by 1uM sodium arsenite treatment for 10 days  (measured at day 46)"}]}, {"GSM1541092": [{"title": "SH-SY5Y cells with Control shRNA replicate1"}, {"type": "RNA"}, {"source_name_ch1": "Human SH-SY5Y cells"}, {"characteristics_ch1": "cell line: SH-SY5Y;\ttransfection: control shRNA"}]}, {"GSM1541093": [{"title": "SH-SY5Y cells with Control shRNA replicate2"}, {"type": "RNA"}, {"source_name_ch1": "Human SH-SY5Y cells"}, {"characteristics_ch1": "cell line: SH-SY5Y;\ttransfection: control shRNA"}]}, {"GSM1541094": [{"title": "SH-SY5Y cells with LSD1+8a shRNA replicate1"}, {"type": "RNA"}, {"source_name_ch1": "Human SH-SY5Y cells"}, {"characteristics_ch1": "cell line: SH-SY5Y;\ttransfection: LSD1+8a shRNA"}]}, {"GSM1541095": [{"title": "SH-SY5Y cells with LSD1+8a shRNA replicate2"}, {"type": "RNA"}, {"source_name_ch1": "Human SH-SY5Y cells"}, {"characteristics_ch1": "cell line: SH-SY5Y;\ttransfection: LSD1+8a shRNA"}]}, {"GSM1598917": [{"title": "Patient-06.pre"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: none;\tpre or post treatment: pre"}]}, {"GSM1598918": [{"title": "Patient-13.pre"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: none;\tpre or post treatment: pre"}]}, {"GSM1598919": [{"title": "Patient-14.pre"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: none;\tpre or post treatment: pre"}]}, {"GSM1598920": [{"title": "Patient-15.pre-BR"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: none;\tpre or post treatment: pre"}]}, {"GSM1598921": [{"title": "Patient-15.pre"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: none;\tpre or post treatment: pre"}]}, {"GSM1598922": [{"title": "Patient-19.pre"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: none;\tpre or post treatment: pre"}]}, {"GSM1598923": [{"title": "Patient-22.pre"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: none;\tpre or post treatment: pre"}]}, {"GSM1598924": [{"title": "Patient-30.pre"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: none;\tpre or post treatment: pre"}]}, {"GSM1598925": [{"title": "Patient-32.pre"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: none;\tpre or post treatment: pre"}]}, {"GSM1598926": [{"title": "Patient-32.pre-BR"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: none;\tpre or post treatment: pre"}]}, {"GSM1598927": [{"title": "Patient-06.post"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: 15 Gy;\tpre or post treatment: post"}]}, {"GSM1598928": [{"title": "Patient-13.post"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: 18 Gy;\tpre or post treatment: post"}]}, {"GSM1598929": [{"title": "Patient-14.post"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: 18 Gy;\tpre or post treatment: post"}]}, {"GSM1598930": [{"title": "Patient-15.post-BR"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: 18 Gy;\tpre or post treatment: post"}]}, {"GSM1598931": [{"title": "Patient-15.post"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: 18 Gy;\tpre or post treatment: post"}]}, {"GSM1598932": [{"title": "Patient-22.post"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: 21Gy;\tpre or post treatment: post"}]}, {"GSM1598933": [{"title": "Patient-30.post"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: 21Gy;\tpre or post treatment: post"}]}, {"GSM1598934": [{"title": "Patient-32.post"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: 21Gy;\tpre or post treatment: post"}]}, {"GSM1598935": [{"title": "Patient-32.post-BR"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: 21Gy;\tpre or post treatment: post"}]}, {"GSM1598936": [{"title": "Patient-01.pre"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: none;\tpre or post treatment: pre"}]}, {"GSM1598937": [{"title": "Patient-04.pre"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: none;\tpre or post treatment: pre"}]}, {"GSM1598938": [{"title": "Patient-05.pre"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: none;\tpre or post treatment: pre"}]}, {"GSM1598939": [{"title": "Patient-07.pre"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: none;\tpre or post treatment: pre"}]}, {"GSM1598940": [{"title": "Patient-08.pre"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: none;\tpre or post treatment: pre"}]}, {"GSM1598941": [{"title": "Patient-09.pre"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: none;\tpre or post treatment: pre"}]}, {"GSM1598942": [{"title": "Patient-10.pre"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: none;\tpre or post treatment: pre"}]}, {"GSM1598943": [{"title": "Patient-11.pre"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: none;\tpre or post treatment: pre"}]}, {"GSM1598944": [{"title": "Patient-16.pre"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: none;\tpre or post treatment: pre"}]}, {"GSM1598945": [{"title": "Patient-17.pre"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: none;\tpre or post treatment: pre"}]}, {"GSM1598946": [{"title": "Patient-18.pre"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: none;\tpre or post treatment: pre"}]}, {"GSM1598947": [{"title": "Patient-20.pre"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: none;\tpre or post treatment: pre"}]}, {"GSM1598948": [{"title": "Patient-21.pre"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: none;\tpre or post treatment: pre"}]}, {"GSM1598949": [{"title": "Patient-23.pre"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: none;\tpre or post treatment: pre"}]}, {"GSM1598950": [{"title": "Patient-26.pre"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: none;\tpre or post treatment: pre"}]}, {"GSM1598951": [{"title": "Patient-27.pre"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: none;\tpre or post treatment: pre"}]}, {"GSM1598952": [{"title": "Patient-28.pre"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: none;\tpre or post treatment: pre"}]}, {"GSM1598953": [{"title": "Patient-29.pre"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: none;\tpre or post treatment: pre"}]}, {"GSM1598954": [{"title": "Patient-31.pre"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: none;\tpre or post treatment: pre"}]}, {"GSM1598955": [{"title": "Patient-31.pre-BR"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: none;\tpre or post treatment: pre"}]}, {"GSM1598956": [{"title": "Patient-01.post"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: 15 Gy;\tpre or post treatment: post"}]}, {"GSM1598957": [{"title": "Patient-04.post"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: 15 Gy;\tpre or post treatment: post"}]}, {"GSM1598958": [{"title": "Patient-05.post"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: 15 Gy;\tpre or post treatment: post"}]}, {"GSM1598959": [{"title": "Patient-07.post"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: 15 Gy;\tpre or post treatment: post"}]}, {"GSM1598960": [{"title": "Patient-08.post"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: 15 Gy;\tpre or post treatment: post"}]}, {"GSM1598961": [{"title": "Patient-09.post"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: 18 Gy;\tpre or post treatment: post"}]}, {"GSM1598962": [{"title": "Patient-09.post-BR"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: 18 Gy;\tpre or post treatment: post"}]}, {"GSM1598963": [{"title": "Patient-10.post"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: 18 Gy;\tpre or post treatment: post"}]}, {"GSM1598964": [{"title": "Patient-11.post"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: 18 Gy;\tpre or post treatment: post"}]}, {"GSM1598965": [{"title": "Patient-16.post"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: 18 Gy;\tpre or post treatment: post"}]}, {"GSM1598966": [{"title": "Patient-17.post"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: 21Gy;\tpre or post treatment: post"}]}, {"GSM1598967": [{"title": "Patient-18.post"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: 21Gy;\tpre or post treatment: post"}]}, {"GSM1598968": [{"title": "Patient-20.post"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: 21Gy;\tpre or post treatment: post"}]}, {"GSM1598969": [{"title": "Patient-20.post-BR"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: 21Gy;\tpre or post treatment: post"}]}, {"GSM1598970": [{"title": "Patient-21.post"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: 21Gy;\tpre or post treatment: post"}]}, {"GSM1598971": [{"title": "Patient-23.post"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: 21Gy;\tpre or post treatment: post"}]}, {"GSM1598972": [{"title": "Patient-26.post"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: 21Gy;\tpre or post treatment: post"}]}, {"GSM1598973": [{"title": "Patient-27.post"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: 21Gy;\tpre or post treatment: post"}]}, {"GSM1598974": [{"title": "Patient-28.post"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: 21Gy;\tpre or post treatment: post"}]}, {"GSM1598975": [{"title": "Patient-29.post"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: 21Gy;\tpre or post treatment: post"}]}, {"GSM1598976": [{"title": "Patient-29.post-BR"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: 21Gy;\tpre or post treatment: post"}]}, {"GSM1598977": [{"title": "Patient-31.post"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: 21Gy;\tpre or post treatment: post"}]}, {"GSM1598978": [{"title": "Patient-31.post-BR"}, {"type": "RNA"}, {"source_name_ch1": "breast cancer"}, {"characteristics_ch1": "tissue: breast cancer;\tdose: 21Gy;\tpre or post treatment: post"}]}, {"GSM1536272": [{"title": "Control siRNA 1  [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Control siRNA treatment of activated CD4 T cells"}, {"characteristics_ch1": "cell type: Primary CD4 T cells;\tpretreated with: Control siRNA for 24hrs;\tactivated with: anti-CD3/CD26 activator beads for 24 h;\tpassages: 7-8"}]}, {"GSM1536273": [{"title": "Control siRNA 2 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Control siRNA treatment of activated CD4 T cells"}, {"characteristics_ch1": "cell type: Primary CD4 T cells;\tpretreated with: Control siRNA for 24hrs;\tactivated with: anti-CD3/CD26 activator beads for 24 h;\tpassages: 7-8"}]}, {"GSM1536274": [{"title": "Control siRNA 3 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Control siRNA treatment of activated CD4 T cells"}, {"characteristics_ch1": "cell type: Primary CD4 T cells;\tpretreated with: Control siRNA for 24hrs;\tactivated with: anti-CD3/CD26 activator beads for 24 h;\tpassages: 7-8"}]}, {"GSM1536275": [{"title": "U2AF1 siRNA 1 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "U2AF1 siRNA treatment of activated CD4 T cells"}, {"characteristics_ch1": "cell type: Primary CD4 T cells;\tpretreated with: U2AF1 siRNA for 24hrs;\tactivated with: anti-CD3/CD26 activator beads for 24 h;\tpassages: 7-8"}]}, {"GSM1536276": [{"title": "U2AF1 siRNA 2 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "U2AF1 siRNA treatment of activated CD4 T cells"}, {"characteristics_ch1": "cell type: Primary CD4 T cells;\tpretreated with: U2AF1 siRNA for 24hrs;\tactivated with: anti-CD3/CD26 activator beads for 24 h;\tpassages: 7-8"}]}, {"GSM1536277": [{"title": "U2AF1 siRNA 3 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "U2AF1 siRNA treatment of activated CD4 T cells"}, {"characteristics_ch1": "cell type: Primary CD4 T cells;\tpretreated with: U2AF1 siRNA for 24hrs;\tactivated with: anti-CD3/CD26 activator beads for 24 h;\tpassages: 7-8"}]}, {"GSM1536278": [{"title": "SYNCRIP siRNA 1 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "SYNCRIP siRNA treatment of activated CD4 T cells"}, {"characteristics_ch1": "cell type: Primary CD4 T cells;\tpretreated with: SYNCRIP siRNA for 24hrs;\tactivated with: anti-CD3/CD26 activator beads for 24 h;\tpassages: 7-8"}]}, {"GSM1536279": [{"title": "SYNCRIP siRNA 2 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "SYNCRIP siRNA treatment of activated CD4 T cells"}, {"characteristics_ch1": "cell type: Primary CD4 T cells;\tpretreated with: SYNCRIP siRNA for 24hrs;\tactivated with: anti-CD3/CD26 activator beads for 24 h;\tpassages: 7-8"}]}, {"GSM1536280": [{"title": "SYNCRIP siRNA 3 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "SYNCRIP siRNA treatment of activated CD4 T cells"}, {"characteristics_ch1": "cell type: Primary CD4 T cells;\tpretreated with: SYNCRIP siRNA for 24hrs;\tactivated with: anti-CD3/CD26 activator beads for 24 h;\tpassages: 7-8"}]}, {"GSM1536281": [{"title": "Control siRNA 4 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Control siRNA treatment of activated CD4 T cells"}, {"characteristics_ch1": "cell type: Primary CD4 T cells;\tpretreated with: Control siRNA for 24hrs;\tactivated with: anti-CD3/CD26 activator beads for 24 h;\tpassages: 7-8"}]}, {"GSM1536282": [{"title": "Control siRNA 5 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Control siRNA treatment of activated CD4 T cells"}, {"characteristics_ch1": "cell type: Primary CD4 T cells;\tpretreated with: Control siRNA for 24hrs;\tactivated with: anti-CD3/CD26 activator beads for 24 h;\tpassages: 7-8"}]}, {"GSM1536283": [{"title": "Control siRNA 6 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Control siRNA treatment of activated CD4 T cells"}, {"characteristics_ch1": "cell type: Primary CD4 T cells;\tpretreated with: Control siRNA for 24hrs;\tactivated with: anti-CD3/CD26 activator beads for 24 h;\tpassages: 7-8"}]}, {"GSM1536284": [{"title": "SYNCRIP siRNA 4 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "SYNCRIP siRNA treatment of activated CD4 T cells"}, {"characteristics_ch1": "cell type: Primary CD4 T cells;\tpretreated with: SYNCRIP siRNA for 24hrs;\tactivated with: anti-CD3/CD26 activator beads for 24 h;\tpassages: 7-8"}]}, {"GSM1536285": [{"title": "SYNCRIP siRNA 5 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "SYNCRIP siRNA treatment of activated CD4 T cells"}, {"characteristics_ch1": "cell type: Primary CD4 T cells;\tpretreated with: SYNCRIP siRNA for 24hrs;\tactivated with: anti-CD3/CD26 activator beads for 24 h;\tpassages: 7-8"}]}, {"GSM1536286": [{"title": "SYNCRIP siRNA 6 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "SYNCRIP siRNA treatment of activated CD4 T cells"}, {"characteristics_ch1": "cell type: Primary CD4 T cells;\tpretreated with: SYNCRIP siRNA for 24hrs;\tactivated with: anti-CD3/CD26 activator beads for 24 h;\tpassages: 7-8"}]}, {"GSM1536287": [{"title": "ILF2 siRNA 1 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "ILF2 siRNA treatment of activated CD4 T cells"}, {"characteristics_ch1": "cell type: Primary CD4 T cells;\tpretreated with: ILF2 siRNA for 24hrs;\tactivated with: anti-CD3/CD26 activator beads for 24 h;\tpassages: 7-8"}]}, {"GSM1536288": [{"title": "ILF2 siRNA 2 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "ILF2 siRNA treatment of activated CD4 T cells"}, {"characteristics_ch1": "cell type: Primary CD4 T cells;\tpretreated with: ILF2 siRNA for 24hrs;\tactivated with: anti-CD3/CD26 activator beads for 24 h;\tpassages: 7-8"}]}, {"GSM1536289": [{"title": "ILF2 siRNA 3 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "ILF2 siRNA treatment of activated CD4 T cells"}, {"characteristics_ch1": "cell type: Primary CD4 T cells;\tpretreated with: ILF2 siRNA for 24hrs;\tactivated with: anti-CD3/CD26 activator beads for 24 h;\tpassages: 7-8"}]}, {"GSM1536290": [{"title": "SRRM2 siRNA 1 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "SRRM2 siRNA treatment of activated CD4 T cells"}, {"characteristics_ch1": "cell type: Primary CD4 T cells;\tpretreated with: SRRM2 siRNA for 24hrs;\tactivated with: anti-CD3/CD26 activator beads for 24 h;\tpassages: 7-8"}]}, {"GSM1536291": [{"title": "SRRM2 siRNA 2 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "SRRM2 siRNA treatment of activated CD4 T cells"}, {"characteristics_ch1": "cell type: Primary CD4 T cells;\tpretreated with: SRRM2 siRNA for 24hrs;\tactivated with: anti-CD3/CD26 activator beads for 24 h;\tpassages: 7-8"}]}, {"GSM1536292": [{"title": "SRRM2 siRNA 3 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "SRRM2 siRNA treatment of activated CD4 T cells"}, {"characteristics_ch1": "cell type: Primary CD4 T cells;\tpretreated with: SRRM2 siRNA for 24hrs;\tactivated with: anti-CD3/CD26 activator beads for 24 h;\tpassages: 7-8"}]}, {"GSM1536305": [{"title": "U2AF2 RIP Control siRNA 1 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "U2AF2 RIP from Control siRNA treatment of activated CD4 T cells"}, {"characteristics_ch1": "cell type: Primary CD4 T cells;\tpretreated with: Control siRNA for 24hrs;\tactivated with: anti-CD3/CD26 activator beads for 24 h;\tpassages: 7-8;\trip antibody: U2AF2 antibody;\trip antibody vendor: Sigma;\trip antibody cat. #: U4758;\trip antibody lot #: 034K4841;\tmolecule subtype: U2AF2 RIP RNA"}]}, {"GSM1536306": [{"title": "U2AF2 RIP Control siRNA 2 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "U2AF2 RIP from Control siRNA treatment of activated CD4 T cells"}, {"characteristics_ch1": "cell type: Primary CD4 T cells;\tpretreated with: Control siRNA for 24hrs;\tactivated with: anti-CD3/CD26 activator beads for 24 h;\tpassages: 7-8;\trip antibody: U2AF2 antibody;\trip antibody vendor: Sigma;\trip antibody cat. #: U4758;\trip antibody lot #: 034K4841;\tmolecule subtype: U2AF2 RIP RNA"}]}, {"GSM1536307": [{"title": "U2AF2 RIP Control siRNA 3 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "U2AF2 RIP from Control siRNA treatment of activated CD4 T cells"}, {"characteristics_ch1": "cell type: Primary CD4 T cells;\tpretreated with: Control siRNA for 24hrs;\tactivated with: anti-CD3/CD26 activator beads for 24 h;\tpassages: 7-8;\trip antibody: U2AF2 antibody;\trip antibody vendor: Sigma;\trip antibody cat. #: U4758;\trip antibody lot #: 034K4841;\tmolecule subtype: U2AF2 RIP RNA"}]}, {"GSM1536308": [{"title": "U2AF2 RIP U2AF1 siRNA 1 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "U2AF2 RIP from U2AF1 siRNA treatment of activated CD4 T cells"}, {"characteristics_ch1": "cell type: Primary CD4 T cells;\tpretreated with: U2AF1 siRNA for 24hrs;\tactivated with: anti-CD3/CD26 activator beads for 24 h;\tpassages: 7-8;\trip antibody: U2AF2 antibody;\trip antibody vendor: Sigma;\trip antibody cat. #: U4758;\trip antibody lot #: 034K4841;\tmolecule subtype: U2AF2 RIP RNA"}]}, {"GSM1536309": [{"title": "U2AF2 RIP U2AF1 siRNA 2 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "U2AF2 RIP from U2AF1 siRNA treatment of activated CD4 T cells"}, {"characteristics_ch1": "cell type: Primary CD4 T cells;\tpretreated with: U2AF1 siRNA for 24hrs;\tactivated with: anti-CD3/CD26 activator beads for 24 h;\tpassages: 7-8;\trip antibody: U2AF2 antibody;\trip antibody vendor: Sigma;\trip antibody cat. #: U4758;\trip antibody lot #: 034K4841;\tmolecule subtype: U2AF2 RIP RNA"}]}, {"GSM1536310": [{"title": "U2AF2 RIP U2AF1 siRNA 3 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "U2AF2 RIP from U2AF1 siRNA treatment of activated CD4 T cells"}, {"characteristics_ch1": "cell type: Primary CD4 T cells;\tpretreated with: U2AF1 siRNA for 24hrs;\tactivated with: anti-CD3/CD26 activator beads for 24 h;\tpassages: 7-8;\trip antibody: U2AF2 antibody;\trip antibody vendor: Sigma;\trip antibody cat. #: U4758;\trip antibody lot #: 034K4841;\tmolecule subtype: U2AF2 RIP RNA"}]}, {"GSM1536311": [{"title": "U2AF2 RIP Control siRNA 4 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "U2AF2 RIP from Control siRNA treatment of activated CD4 T cells"}, {"characteristics_ch1": "cell type: Primary CD4 T cells;\tpretreated with: Control siRNA for 24hrs;\tactivated with: anti-CD3/CD26 activator beads for 24 h;\tpassages: 7-8;\trip antibody: U2AF2 antibody;\trip antibody vendor: Sigma;\trip antibody cat. #: U4758;\trip antibody lot #: 034K4841;\tmolecule subtype: U2AF2 RIP RNA"}]}, {"GSM1536312": [{"title": "U2AF2 RIP Control siRNA 5 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "U2AF2 RIP from Control siRNA treatment of activated CD4 T cells"}, {"characteristics_ch1": "cell type: Primary CD4 T cells;\tpretreated with: Control siRNA for 24hrs;\tactivated with: anti-CD3/CD26 activator beads for 24 h;\tpassages: 7-8;\trip antibody: U2AF2 antibody;\trip antibody vendor: Sigma;\trip antibody cat. #: U4758;\trip antibody lot #: 034K4841;\tmolecule subtype: U2AF2 RIP RNA"}]}, {"GSM1536313": [{"title": "U2AF2 RIP Control siRNA 6 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "U2AF2 RIP from Control siRNA treatment of activated CD4 T cells"}, {"characteristics_ch1": "cell type: Primary CD4 T cells;\tpretreated with: Control siRNA for 24hrs;\tactivated with: anti-CD3/CD26 activator beads for 24 h;\tpassages: 7-8;\trip antibody: U2AF2 antibody;\trip antibody vendor: Sigma;\trip antibody cat. #: U4758;\trip antibody lot #: 034K4841;\tmolecule subtype: U2AF2 RIP RNA"}]}, {"GSM1536314": [{"title": "U2AF2 RIP SYNCRIP siRNA 1 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "U2AF2 RIP from SYNCRIP siRNA treatment of activated CD4 T cells"}, {"characteristics_ch1": "cell type: Primary CD4 T cells;\tpretreated with: SYNCRIP siRNA for 24hrs;\tactivated with: anti-CD3/CD26 activator beads for 24 h;\tpassages: 7-8;\trip antibody: U2AF2 antibody;\trip antibody vendor: Sigma;\trip antibody cat. #: U4758;\trip antibody lot #: 034K4841;\tmolecule subtype: U2AF2 RIP RNA"}]}, {"GSM1536315": [{"title": "U2AF2 RIP SYNCRIP siRNA 2 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "U2AF2 RIP from SYNCRIP siRNA treatment of activated CD4 T cells"}, {"characteristics_ch1": "cell type: Primary CD4 T cells;\tpretreated with: SYNCRIP siRNA for 24hrs;\tactivated with: anti-CD3/CD26 activator beads for 24 h;\tpassages: 7-8;\trip antibody: U2AF2 antibody;\trip antibody vendor: Sigma;\trip antibody cat. #: U4758;\trip antibody lot #: 034K4841;\tmolecule subtype: U2AF2 RIP RNA"}]}, {"GSM1536316": [{"title": "U2AF2 RIP SYNCRIP siRNA 3 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "U2AF2 RIP from SYNCRIP siRNA treatment of activated CD4 T cells"}, {"characteristics_ch1": "cell type: Primary CD4 T cells;\tpretreated with: SYNCRIP siRNA for 24hrs;\tactivated with: anti-CD3/CD26 activator beads for 24 h;\tpassages: 7-8;\trip antibody: U2AF2 antibody;\trip antibody vendor: Sigma;\trip antibody cat. #: U4758;\trip antibody lot #: 034K4841;\tmolecule subtype: U2AF2 RIP RNA"}]}, {"GSM1545195": [{"title": "EGFP-expressing cells, biological rep 1"}, {"type": "RNA"}, {"source_name_ch1": "GBM primary culture G514NS_EGFP"}, {"characteristics_ch1": "cell type: glioblastoma (GBM) primary culture;\tgenotype/variation: EGFP-expressing;\ttime point: 72 h post-transfection"}]}, {"GSM1545196": [{"title": "EGFP-expressing cells, biological rep 2"}, {"type": "RNA"}, {"source_name_ch1": "GBM primary culture G514NS_EGFP"}, {"characteristics_ch1": "cell type: glioblastoma (GBM) primary culture;\tgenotype/variation: EGFP-expressing;\ttime point: 72 h post-transfection"}]}, {"GSM1545197": [{"title": "EGFP-expressing cells, biological rep 3"}, {"type": "RNA"}, {"source_name_ch1": "GBM primary culture G514NS_EGFP"}, {"characteristics_ch1": "cell type: glioblastoma (GBM) primary culture;\tgenotype/variation: EGFP-expressing;\ttime point: 72 h post-transfection"}]}, {"GSM1545198": [{"title": "ER-overexpressing cells, biological rep 1"}, {"type": "RNA"}, {"source_name_ch1": "GBM primary culture G514NS_MLL5"}, {"characteristics_ch1": "cell type: glioblastoma (GBM) primary culture;\tgenotype/variation: MLL5-overexpressing;\ttime point: 72 h post-transfection"}]}, {"GSM1545199": [{"title": "ER-overexpressing cells, biological rep 2"}, {"type": "RNA"}, {"source_name_ch1": "GBM primary culture G514NS_MLL5"}, {"characteristics_ch1": "cell type: glioblastoma (GBM) primary culture;\tgenotype/variation: MLL5-overexpressing;\ttime point: 72 h post-transfection"}]}, {"GSM1545200": [{"title": "ER-overexpressing cells, biological rep 3"}, {"type": "RNA"}, {"source_name_ch1": "GBM primary culture G514NS_MLL5"}, {"characteristics_ch1": "cell type: glioblastoma (GBM) primary culture;\tgenotype/variation: MLL5-overexpressing;\ttime point: 72 h post-transfection"}]}, {"GSM1559599": [{"title": "UD, biological rep1 (gene level)"}, {"type": "RNA"}, {"source_name_ch1": "Undifferentiated CESCs"}, {"characteristics_ch1": "cell type: Undifferentiated CESCs"}]}, {"GSM1559601": [{"title": "CD, biological rep1 (gene level)"}, {"type": "RNA"}, {"source_name_ch1": "Chondrogenic differentiation of CESCs"}, {"characteristics_ch1": "cell type: Chondrogenic differentiation of CESCs"}]}, {"GSM1559603": [{"title": "OD, biological rep1 (gene level)"}, {"type": "RNA"}, {"source_name_ch1": "Osteogenic differentiation"}, {"characteristics_ch1": "cell type: Osteogenic differentiation"}]}, {"GSM1602156": [{"title": "Homo_G1-1"}, {"type": "RNA"}, {"source_name_ch1": "Glioblastoma tissue"}, {"characteristics_ch1": "individual: patient 1;\ttissue: Glioblastoma tissue;\tgender: male;\tage(years): 59"}]}, {"GSM1602158": [{"title": "Homo_N1-1"}, {"type": "RNA"}, {"source_name_ch1": "Adjacent normal brain tissue"}, {"characteristics_ch1": "individual: patient 1;\ttissue: Adjacent normal brain tissue;\tgender: male;\tage(years): 59"}]}, {"GSM1602160": [{"title": "Homo_G2-1"}, {"type": "RNA"}, {"source_name_ch1": "Glioblastoma tissue"}, {"characteristics_ch1": "individual: patient 2;\ttissue: Glioblastoma tissue;\tgender: male;\tage(years): 42"}]}, {"GSM1602162": [{"title": "Homo_N2-1"}, {"type": "RNA"}, {"source_name_ch1": "Adjacent normal brain tissue"}, {"characteristics_ch1": "individual: patient 2;\ttissue: Adjacent normal brain tissue;\tgender: male;\tage(years): 42"}]}, {"GSM1602164": [{"title": "Homo_G3-1"}, {"type": "RNA"}, {"source_name_ch1": "Glioblastoma tissue"}, {"characteristics_ch1": "individual: patient 3;\ttissue: Glioblastoma tissue;\tgender: male;\tage(years): 49"}]}, {"GSM1602166": [{"title": "Homo_N3-1"}, {"type": "RNA"}, {"source_name_ch1": "Adjacent normal brain tissue"}, {"characteristics_ch1": "individual: patient 3;\ttissue: Adjacent normal brain tissue;\tgender: male;\tage(years): 49"}]}, {"GSM1625016": [{"title": "CD3-CD56dimCD57brightNKG2A-NKG2C-, biological replicate1"}, {"type": "RNA"}, {"source_name_ch1": "CD3-CD56dimCD57brightNKG2A-NKG2C-"}, {"characteristics_ch1": "donor id: donor 1;\ttissue: PBMC;\tcell subset: CD57brightNKG2A-NKG2C-"}]}, {"GSM1625017": [{"title": "CD3-CD56dimCD57-NKG2A-NKG2C-, biological replicate1"}, {"type": "RNA"}, {"source_name_ch1": "CD3-CD56dimCD57-NKG2A-NKG2C-"}, {"characteristics_ch1": "donor id: donor 1;\ttissue: PBMC;\tcell subset: CD57-NKG2A-NKG2C-"}]}, {"GSM1625018": [{"title": "CD3-CD56dimCD57brightNKG2A-NKG2C+, biological replicate1"}, {"type": "RNA"}, {"source_name_ch1": "CD3-CD56dimCD57brightNKG2A-NKG2C+"}, {"characteristics_ch1": "donor id: donor 1;\ttissue: PBMC;\tcell subset: CD57brightNKG2A-NKG2C+"}]}, {"GSM1625019": [{"title": "CD3-CD56dimCD57-NKG2A+, biological replicate1"}, {"type": "RNA"}, {"source_name_ch1": "CD3-CD56dimCD57-NKG2A+"}, {"characteristics_ch1": "donor id: donor 1;\ttissue: PBMC;\tcell subset: CD57-NKG2A+"}]}, {"GSM1625020": [{"title": "CD3-CD56dimCD57brightNKG2A-NKG2C-, biological replicate2"}, {"type": "RNA"}, {"source_name_ch1": "CD3-CD56dimCD57brightNKG2A-NKG2C-"}, {"characteristics_ch1": "donor id: donor 2;\ttissue: PBMC;\tcell subset: CD57brightNKG2A-NKG2C-"}]}, {"GSM1625021": [{"title": "CD3-CD56dimCD3-CD56dimCD57-NKG2A-NKG2C-, biological replicate2"}, {"type": "RNA"}, {"source_name_ch1": "CD3-CD56dimCD3-CD56dimCD57-NKG2A-NKG2C-"}, {"characteristics_ch1": "donor id: donor 2;\ttissue: PBMC;\tcell subset: CD57-NKG2A-NKG2C-"}]}, {"GSM1625022": [{"title": "CD3-CD56dimCD57brightNKG2A-NKG2C+, biological replicate2"}, {"type": "RNA"}, {"source_name_ch1": "CD3-CD56dimCD57brightNKG2A-NKG2C+"}, {"characteristics_ch1": "donor id: donor 2;\ttissue: PBMC;\tcell subset: CD57brightNKG2A-NKG2C+"}]}, {"GSM1625023": [{"title": "CD3-CD56dimCD57-NKG2A+, biological replicate2"}, {"type": "RNA"}, {"source_name_ch1": "CD3-CD56dimCD57-NKG2A+"}, {"characteristics_ch1": "donor id: donor 2;\ttissue: PBMC;\tcell subset: CD57-NKG2A+"}]}, {"GSM1625024": [{"title": "CD3-CD56dimCD57brightNKG2A-NKG2C-, biological replicate3"}, {"type": "RNA"}, {"source_name_ch1": "CD3-CD56dimCD57brightNKG2A-NKG2C-"}, {"characteristics_ch1": "donor id: donor 3;\ttissue: PBMC;\tcell subset: CD57brightNKG2A-NKG2C-"}]}, {"GSM1625025": [{"title": "CD3-CD56dimCD57-NKG2A-NKG2C-, biological replicate3"}, {"type": "RNA"}, {"source_name_ch1": "CD3-CD56dimCD57-NKG2A-NKG2C-"}, {"characteristics_ch1": "donor id: donor 3;\ttissue: PBMC;\tcell subset: CD57-NKG2A-NKG2C-"}]}, {"GSM1625026": [{"title": "CD3-CD56dimCD57brightNKG2A-NKG2C+, biological replicate3"}, {"type": "RNA"}, {"source_name_ch1": "CD3-CD56dimCD57brightNKG2A-NKG2C+"}, {"characteristics_ch1": "donor id: donor 3;\ttissue: PBMC;\tcell subset: CD57brightNKG2A-NKG2C+"}]}, {"GSM1625027": [{"title": "CD3-CD56dimCD57-NKG2A+, biological replicate3"}, {"type": "RNA"}, {"source_name_ch1": "CD3-CD56dimCD57-NKG2A+"}, {"characteristics_ch1": "donor id: donor 3;\ttissue: PBMC;\tcell subset: CD57-NKG2A+"}]}, {"GSM1625028": [{"title": "CD3-CD56dimCD57brightNKG2A-NKG2C-, biological replicate4"}, {"type": "RNA"}, {"source_name_ch1": "CD3-CD56dimCD57brightNKG2A-NKG2C-"}, {"characteristics_ch1": "donor id: donor 4;\ttissue: PBMC;\tcell subset: CD57brightNKG2A-NKG2C-"}]}, {"GSM1625029": [{"title": "CD3-CD56dimCD57-NKG2A-NKG2C-, biological replicate4"}, {"type": "RNA"}, {"source_name_ch1": "CD3-CD56dimCD57-NKG2A-NKG2C-"}, {"characteristics_ch1": "donor id: donor 4;\ttissue: PBMC;\tcell subset: CD57-NKG2A-NKG2C-"}]}, {"GSM1625030": [{"title": "CD3-CD56dimCD57-NKG2A+, biological replicate4"}, {"type": "RNA"}, {"source_name_ch1": "CD3-CD56dimCD57-NKG2A+"}, {"characteristics_ch1": "donor id: donor 4;\ttissue: PBMC;\tcell subset: CD57-NKG2A+"}]}, {"GSM1626751": [{"title": "CP70-Vector-1"}, {"type": "RNA"}, {"source_name_ch1": "CP70 cells transfected with empty vector, clone-1"}, {"characteristics_ch1": "cell line: ovarian cancer cell line A2780-CP70;\tprotocol: control"}]}, {"GSM1626752": [{"title": "CP70-Vector-3"}, {"type": "RNA"}, {"source_name_ch1": "CP70 cells transfected with empty vector, clone-2"}, {"characteristics_ch1": "cell line: ovarian cancer cell line A2780-CP70;\tprotocol: control"}]}, {"GSM1626753": [{"title": "CP70-DDB2-1"}, {"type": "RNA"}, {"source_name_ch1": "CP70 cells transfected with DDB2-expressing vector, clone-1"}, {"characteristics_ch1": "cell line: ovarian cancer cell line A2780-CP70;\tprotocol: DDB2-overexpression"}]}, {"GSM1626754": [{"title": "CP70-DDB2-2"}, {"type": "RNA"}, {"source_name_ch1": "CP70 cells transfected with DDB2-expressing vector, clone-2"}, {"characteristics_ch1": "cell line: ovarian cancer cell line A2780-CP70;\tprotocol: DDB2-overexpression"}]}, {"GSM1626755": [{"title": "CP70-DDB2-3"}, {"type": "RNA"}, {"source_name_ch1": "CP70 cells transfected with DDB2-expressing vector, clone-3"}, {"characteristics_ch1": "cell line: ovarian cancer cell line A2780-CP70;\tprotocol: DDB2-overexpression"}]}, {"GSM1627004": [{"title": "AGO_1 (gene)"}, {"type": "RNA"}, {"source_name_ch1": "Original Agilent Human Universal Reference RNA"}, {"characteristics_ch1": "sample type: pure reference RNA (AGO)"}]}, {"GSM1627005": [{"title": "AG1BM4_1 (gene)"}, {"type": "RNA"}, {"source_name_ch1": "Mixed RNA of both (1:4)"}, {"characteristics_ch1": "sample type: 1:4 mixture of AGO and BMO"}]}, {"GSM1627006": [{"title": "AG1BM16_1 (gene)"}, {"type": "RNA"}, {"source_name_ch1": "Mixed RNA of both (1:16)"}, {"characteristics_ch1": "sample type: 1:16 mixture of AGO and BMO"}]}, {"GSM1627007": [{"title": "AG1BM64_1 (gene)"}, {"type": "RNA"}, {"source_name_ch1": "Mixed RNA of both (1:64)"}, {"characteristics_ch1": "sample type: 1:64 mixture of AGO and BMO"}]}, {"GSM1627008": [{"title": "BMO_1 (gene)"}, {"type": "RNA"}, {"source_name_ch1": "Original Bone Marrow RNA"}, {"characteristics_ch1": "sample type: pure bone marrow RNA (BMO)"}]}, {"GSM1627009": [{"title": "AGO_2 (gene)"}, {"type": "RNA"}, {"source_name_ch1": "Original Agilent Human Universal Reference RNA"}, {"characteristics_ch1": "sample type: pure reference RNA (AGO)"}]}, {"GSM1627010": [{"title": "AG1BM4_2 (gene)"}, {"type": "RNA"}, {"source_name_ch1": "Mixed RNA of both (1:4)"}, {"characteristics_ch1": "sample type: 1:4 mixture of AGO and BMO"}]}, {"GSM1627011": [{"title": "AG1BM16_2 (gene)"}, {"type": "RNA"}, {"source_name_ch1": "Mixed RNA of both (1:16)"}, {"characteristics_ch1": "sample type: 1:16 mixture of AGO and BMO"}]}, {"GSM1627012": [{"title": "AG1BM64_2 (gene)"}, {"type": "RNA"}, {"source_name_ch1": "Mixed RNA of both (1:64)"}, {"characteristics_ch1": "sample type: 1:64 mixture of AGO and BMO"}]}, {"GSM1627013": [{"title": "BMO_2 (gene)"}, {"type": "RNA"}, {"source_name_ch1": "Original Bone Marrow RNA"}, {"characteristics_ch1": "sample type: pure bone marrow RNA (BMO)"}]}, {"GSM1635554": [{"title": "im-DC"}, {"type": "RNA"}, {"source_name_ch1": "immature dendritic cells"}, {"characteristics_ch1": "cell type: immature dendritic cells;\ttissue: hematopoietic tissue"}]}, {"GSM1635555": [{"title": "m-DC"}, {"type": "RNA"}, {"source_name_ch1": "mature dendritic cells"}, {"characteristics_ch1": "cell type: mature dendritic cells;\ttissue: hematopoietic tissue"}]}, {"GSM1635556": [{"title": "im-DC_A"}, {"type": "RNA"}, {"source_name_ch1": "immature dendritic cells + 1mM acetate"}, {"characteristics_ch1": "cell type: immature dendritic cells;\ttreatment: 1mM acetate;\ttissue: hematopoietic tissue"}]}, {"GSM1635557": [{"title": "im-DC_B"}, {"type": "RNA"}, {"source_name_ch1": "immature dendritic cells + 1mM butyrate"}, {"characteristics_ch1": "cell type: immature dendritic cells;\ttreatment: 1mM butyrate;\ttissue: hematopoietic tissue"}]}, {"GSM1635558": [{"title": "im-DC_P"}, {"type": "RNA"}, {"source_name_ch1": "immature dendritic cells + 1mM propionate"}, {"characteristics_ch1": "cell type: immature dendritic cells;\ttreatment: 1mM propionate;\ttissue: hematopoietic tissue"}]}, {"GSM1635559": [{"title": "m-DC_A"}, {"type": "RNA"}, {"source_name_ch1": "mature dendritic cells + 1mM acetate"}, {"characteristics_ch1": "cell type: mature dendritic cells;\ttreatment: 1mM acetate;\ttissue: hematopoietic tissue"}]}, {"GSM1635560": [{"title": "m-DC_B"}, {"type": "RNA"}, {"source_name_ch1": "mature dendritic cells + 1mM butyrate"}, {"characteristics_ch1": "cell type: mature dendritic cells;\ttreatment: 1mM butyrate;\ttissue: hematopoietic tissue"}]}, {"GSM1635561": [{"title": "m-DC_P"}, {"type": "RNA"}, {"source_name_ch1": "mature dendritic cells + 1mM propionate"}, {"characteristics_ch1": "cell type: mature dendritic cells;\ttreatment: 1mM propionate;\ttissue: hematopoietic tissue"}]}, {"GSM1638615": [{"title": "YDFR.CB3, DMSO, rep 1"}, {"type": "RNA"}, {"source_name_ch1": "YDFR-human melanoma cells macro-metastasis to brain"}, {"characteristics_ch1": "cell type: YDFR.CB3;\ttreatment: 1\u2009\u00b5M DMSO;\tmalignancy stage: brain macro-metastasis"}]}, {"GSM1638616": [{"title": "YDFR.CB3, Vemurafenib, rep1"}, {"type": "RNA"}, {"source_name_ch1": "YDFR-human melanoma cells macro-metastasis to brain"}, {"characteristics_ch1": "cell type: YDFR.CB3;\ttreatment: 1\u2009\u00b5M PLX-4032 (Vemurafenib);\tmalignancy stage: brain macro-metastasis"}]}, {"GSM1638617": [{"title": "YDFR.SB3, DMSO, rep 1"}, {"type": "RNA"}, {"source_name_ch1": "YDFR-human melanoma cells micro-metastasis to brain"}, {"characteristics_ch1": "cell type: YDFR.SB3;\ttreatment: 1\u2009\u00b5M DMSO;\tmalignancy stage: brain micro-metastasis"}]}, {"GSM1638618": [{"title": "YDFR.SB3, Vemurafenib, rep 1"}, {"type": "RNA"}, {"source_name_ch1": "YDFR-human melanoma cells micro-metastasis to brain"}, {"characteristics_ch1": "cell type: YDFR.SB3;\ttreatment: 1\u2009\u00b5M PLX-4032 (Vemurafenib);\tmalignancy stage: brain micro-metastasis"}]}, {"GSM1638619": [{"title": "YDFR.SL3, DMSO, rep 1"}, {"type": "RNA"}, {"source_name_ch1": "YDFR-human melanoma cells micro-metastasis to lung"}, {"characteristics_ch1": "cell type: YDFR.SL3;\ttreatment: 1\u2009\u00b5M DMSO;\tmalignancy stage: lung micro-metastasis"}]}, {"GSM1638620": [{"title": "YDFR.SL3, Vemurafenib, rep 1"}, {"type": "RNA"}, {"source_name_ch1": "YDFR-human melanoma cells micro-metastasis to lung"}, {"characteristics_ch1": "cell type: YDFR.SL3;\ttreatment: 1\u2009\u00b5M PLX-4032 (Vemurafenib);\tmalignancy stage: lung micro-metastasis"}]}, {"GSM1644002": [{"title": "MHCC97Hshv"}, {"type": "RNA"}, {"source_name_ch1": "MHCC97H control cell"}, {"characteristics_ch1": "cell line: liver cancer cell line MHCC97H;\tgenotype/variation: control"}]}, {"GSM1644003": [{"title": "MHCC97HshGP73"}, {"type": "RNA"}, {"source_name_ch1": "GP73 knock down MHCC97H cell"}, {"characteristics_ch1": "cell line: liver cancer cell line MHCC97H;\tgenotype/variation: GP73 knockdown"}]}, {"GSM1648339": [{"title": "Huvecs, Untreated, 24h, Biological Rep 1"}, {"type": "RNA"}, {"source_name_ch1": "Huvecs under normal growth conditions after 24h"}, {"characteristics_ch1": "tissue: Human Umbilical Vein;\ttreatment: under normal growth conditions after 24h"}]}, {"GSM1648340": [{"title": "Huvecs, Untreated, 24h, Biological Rep 2"}, {"type": "RNA"}, {"source_name_ch1": "Huvecs under normal growth conditions after 24h"}, {"characteristics_ch1": "tissue: Human Umbilical Vein;\ttreatment: under normal growth conditions after 24h"}]}, {"GSM1648341": [{"title": "Huvecs, Untreated, 24h, Biological Rep 3"}, {"type": "RNA"}, {"source_name_ch1": "Huvecs under normal growth conditions after 24h"}, {"characteristics_ch1": "tissue: Human Umbilical Vein;\ttreatment: under normal growth conditions after 24h"}]}, {"GSM1648342": [{"title": "Huvecs, Cold Control, 24h, Biological Rep1"}, {"type": "RNA"}, {"source_name_ch1": "Huvecs exposed to 4\u00b0C for 2hours while perfused with LM5 and then left to incubate under normal growth conditions for 24h"}, {"characteristics_ch1": "tissue: Human Umbilical Vein;\ttreatment: exposed to 4\u00b0C for 2hours while perfused with LM5 and then left to incubate under normal growth conditions for 24h"}]}, {"GSM1648343": [{"title": "Huvecs, Cold Control, 24h, Biological Rep2"}, {"type": "RNA"}, {"source_name_ch1": "Huvecs exposed to 4\u00b0C for 2hours while perfused with LM5 and then left to incubate under normal growth conditions for 24h"}, {"characteristics_ch1": "tissue: Human Umbilical Vein;\ttreatment: exposed to 4\u00b0C for 2hours while perfused with LM5 and then left to incubate under normal growth conditions for 24h"}]}, {"GSM1648344": [{"title": "Huvecs, Cold Control, 24h, Biological Rep3"}, {"type": "RNA"}, {"source_name_ch1": "Huvecs exposed to 4\u00b0C for 2hours while perfused with LM5 and then left to incubate under normal growth conditions for 24h"}, {"characteristics_ch1": "tissue: Human Umbilical Vein;\ttreatment: exposed to 4\u00b0C for 2hours while perfused with LM5 and then left to incubate under normal growth conditions for 24h"}]}, {"GSM1648345": [{"title": "Huvecs, EG treated, 24h, Biological Rep1"}, {"type": "RNA"}, {"source_name_ch1": "Huvecs exposed to 4\u00b0C for 2hours while perfused with LM5 and increasing concentrations of Ethylene Glycol and then left to incubate under normal growth conditions for 24h"}, {"characteristics_ch1": "tissue: Human Umbilical Vein;\ttreatment: exposed to 4\u00b0C for 2hours while perfused with LM5 and increasing concentrations of Ethylene Glycol and then left to incubate under normal growth conditions for 24h"}]}, {"GSM1648346": [{"title": "Huvecs, EG treated, 24h, Biological Rep2"}, {"type": "RNA"}, {"source_name_ch1": "Huvecs exposed to 4\u00b0C for 2hours while perfused with LM5 and increasing concentrations of Ethylene Glycol and then left to incubate under normal growth conditions for 24h"}, {"characteristics_ch1": "tissue: Human Umbilical Vein;\ttreatment: exposed to 4\u00b0C for 2hours while perfused with LM5 and increasing concentrations of Ethylene Glycol and then left to incubate under normal growth conditions for 24h"}]}, {"GSM1648347": [{"title": "Huvecs, EG treated, 24h, Biological Rep3"}, {"type": "RNA"}, {"source_name_ch1": "Huvecs exposed to 4\u00b0C for 2hours while perfused with LM5 and increasing concentrarions of Ethylene Glycol and then left to incubate under normal growth conditions for 24h"}, {"characteristics_ch1": "tissue: Human Umbilical Vein;\ttreatment: exposed to 4\u00b0C for 2hours while perfused with LM5 and increasing concentrarions of Ethylene Glycol and then left to incubate under normal growth conditions for 24h"}]}, {"GSM1648348": [{"title": "Huvecs, Untreated, 72h, Biological Rep 1"}, {"type": "RNA"}, {"source_name_ch1": "Huvecs under normal growth conditions after 72h"}, {"characteristics_ch1": "tissue: Human Umbilical Vein;\ttreatment: exposed to 4\u00b0C for 2hours while perfused with LM5 and increasing concentrations of Ethylene Glycol and then left to incubate under normal growth conditions for 24h;\ttissue: Human Umbilical Vein;\ttreatment: under normal growth conditions after 72h"}]}, {"GSM1648349": [{"title": "Huvecs, Untreated, 72h, Biological Rep 2"}, {"type": "RNA"}, {"source_name_ch1": "Huvecs under normal growth conditions after 72h"}, {"characteristics_ch1": "tissue: Human Umbilical Vein;\ttreatment: under normal growth conditions after 72h"}]}, {"GSM1648350": [{"title": "Huvecs, Untreated, 72h, Biological Rep 3"}, {"type": "RNA"}, {"source_name_ch1": "Huvecs under normal growth conditions after 72h"}, {"characteristics_ch1": "tissue: Human Umbilical Vein;\ttreatment: under normal growth conditions after 72h"}]}, {"GSM1648351": [{"title": "Huvecs, Cold Control, 72h, Biological Rep1"}, {"type": "RNA"}, {"source_name_ch1": "Huvecs exposed to 4\u00b0C for 2hours while perfused with LM5 and then left to incubate under normal growth conditions for 72h"}, {"characteristics_ch1": "tissue: Human Umbilical Vein;\ttreatment: exposed to 4\u00b0C for 2hours while perfused with LM5 and then left to incubate under normal growth conditions for 72h"}]}, {"GSM1648352": [{"title": "Huvecs, Cold Control, 72h, Biological Rep2"}, {"type": "RNA"}, {"source_name_ch1": "Huvecs exposed to 4\u00b0C for 2hours while perfused with LM5 and then left to incubate under normal growth conditions for 72h"}, {"characteristics_ch1": "tissue: Human Umbilical Vein;\ttreatment: exposed to 4\u00b0C for 2hours while perfused with LM5 and then left to incubate under normal growth conditions for 72h"}]}, {"GSM1648353": [{"title": "Huvecs, Cold Control, 72h, Biological Rep3"}, {"type": "RNA"}, {"source_name_ch1": "Huvecs exposed to 4\u00b0C for 2hours while perfused with LM5 and then left to incubate under normal growth conditions for 72h"}, {"characteristics_ch1": "tissue: Human Umbilical Vein;\ttreatment: exposed to 4\u00b0C for 2hours while perfused with LM5 and then left to incubate under normal growth conditions for 72h"}]}, {"GSM1648354": [{"title": "Huvecs, EG treated, 72h, Biological Rep1"}, {"type": "RNA"}, {"source_name_ch1": "Huvecs exposed to 4\u00b0C for 2hours while perfused with LM5 and increasing concentrations of Ethylene Glycol and then left to incubate under normal growth conditions for 72h"}, {"characteristics_ch1": "tissue: Human Umbilical Vein;\ttreatment: exposed to 4\u00b0C for 2hours while perfused with LM5 and increasing concentrations of Ethylene Glycol and then left to incubate under normal growth conditions for 72h"}]}, {"GSM1648355": [{"title": "Huvecs, EG treated, 72h, Biological Rep2"}, {"type": "RNA"}, {"source_name_ch1": "Huvecs exposed to 4\u00b0C for 2hours while perfused with LM5 and increasing concentrations of Ethylene Glycol and then left to incubate under normal growth conditions for 72h"}, {"characteristics_ch1": "tissue: Human Umbilical Vein;\ttreatment: exposed to 4\u00b0C for 2hours while perfused with LM5 and increasing concentrations of Ethylene Glycol and then left to incubate under normal growth conditions for 72h"}]}, {"GSM1648356": [{"title": "Huvecs, EG treated, 72h, Biological Rep3"}, {"type": "RNA"}, {"source_name_ch1": "Huvecs exposed to 4\u00b0C for 2hours while perfused with LM5 and increasing concentrations of Ethylene Glycol and then left to incubate under normal growth conditions for 72h"}, {"characteristics_ch1": "tissue: Human Umbilical Vein;\ttreatment: exposed to 4\u00b0C for 2hours while perfused with LM5 and increasing concentrations of Ethylene Glycol and then left to incubate under normal growth conditions for 72h"}]}, {"GSM1660248": [{"title": "Patient1"}, {"type": "RNA"}, {"source_name_ch1": "ER/HER2 Pos Breast Tumor"}, {"characteristics_ch1": "tissue: Breast tumor;\ter2 status: Positive;\ther status: Positive;\tneoadjuvant chemotherapy response: no pCR"}]}, {"GSM1660249": [{"title": "Patient2"}, {"type": "RNA"}, {"source_name_ch1": "ER/HER2 Pos Breast Tumor"}, {"characteristics_ch1": "tissue: Breast tumor;\ter2 status: Positive;\ther status: Positive;\tneoadjuvant chemotherapy response: pCR"}]}, {"GSM1660250": [{"title": "Patient3"}, {"type": "RNA"}, {"source_name_ch1": "ER/HER2 Pos Breast Tumor"}, {"characteristics_ch1": "tissue: Breast tumor;\ter2 status: Positive;\ther status: Positive;\tneoadjuvant chemotherapy response: no pCR"}]}, {"GSM1660251": [{"title": "Patient4"}, {"type": "RNA"}, {"source_name_ch1": "ER/HER2 Pos Breast Tumor"}, {"characteristics_ch1": "tissue: Breast tumor;\ter2 status: Positive;\ther status: Positive;\tneoadjuvant chemotherapy response: no pCR"}]}, {"GSM1660252": [{"title": "Patient5"}, {"type": "RNA"}, {"source_name_ch1": "ER/HER2 Pos Breast Tumor"}, {"characteristics_ch1": "tissue: Breast tumor;\ter2 status: Positive;\ther status: Positive;\tneoadjuvant chemotherapy response: pCR"}]}, {"GSM1660253": [{"title": "Patient6"}, {"type": "RNA"}, {"source_name_ch1": "ER/HER2 Pos Breast Tumor"}, {"characteristics_ch1": "tissue: Breast tumor;\ter2 status: Positive;\ther status: Positive;\tneoadjuvant chemotherapy response: no pCR"}]}, {"GSM1660254": [{"title": "Patient7"}, {"type": "RNA"}, {"source_name_ch1": "ER/HER2 Pos Breast Tumor"}, {"characteristics_ch1": "tissue: Breast tumor;\ter2 status: Positive;\ther status: Positive;\tneoadjuvant chemotherapy response: pCR"}]}, {"GSM1660255": [{"title": "Patient8"}, {"type": "RNA"}, {"source_name_ch1": "ER/HER2 Pos Breast Tumor"}, {"characteristics_ch1": "tissue: Breast tumor;\ter2 status: Positive;\ther status: Positive;\tneoadjuvant chemotherapy response: no pCR"}]}, {"GSM1660256": [{"title": "Patient9"}, {"type": "RNA"}, {"source_name_ch1": "ER/HER2 Pos Breast Tumor"}, {"characteristics_ch1": "tissue: Breast tumor;\ter2 status: Positive;\ther status: Positive;\tneoadjuvant chemotherapy response: no pCR"}]}, {"GSM1660257": [{"title": "Patient10"}, {"type": "RNA"}, {"source_name_ch1": "ER/HER2 Pos Breast Tumor"}, {"characteristics_ch1": "tissue: Breast tumor;\ter2 status: Positive;\ther status: Positive;\tneoadjuvant chemotherapy response: pCR"}]}, {"GSM1660258": [{"title": "Patient11"}, {"type": "RNA"}, {"source_name_ch1": "ER/HER2 Pos Breast Tumor"}, {"characteristics_ch1": "tissue: Breast tumor;\ter2 status: Positive;\ther status: Positive;\tneoadjuvant chemotherapy response: pCR"}]}, {"GSM1696185": [{"title": "INA-6 treated with control UNC2400, biological rep 1"}, {"type": "RNA"}, {"source_name_ch1": "Mature Plasma cells"}, {"characteristics_ch1": "cell line: INA-6;\tagent: UNC2400"}]}, {"GSM1696186": [{"title": "INA-6 treated with control UNC2400, biological rep 2"}, {"type": "RNA"}, {"source_name_ch1": "Mature Plasma cells"}, {"characteristics_ch1": "cell line: INA-6;\tagent: UNC2400"}]}, {"GSM1696187": [{"title": "INA-6 treated with control UNC2400, biological rep 3"}, {"type": "RNA"}, {"source_name_ch1": "Mature Plasma cells"}, {"characteristics_ch1": "cell line: INA-6;\tagent: UNC2400"}]}, {"GSM1696188": [{"title": "INA-6 treated with EZH2 inhibitor UNC1999, biological rep 1"}, {"type": "RNA"}, {"source_name_ch1": "Mature Plasma cells"}, {"characteristics_ch1": "cell line: INA-6;\tagent: UNC1999"}]}, {"GSM1696189": [{"title": "INA-6 treated with EZH2 inhibitor UNC1999, biological rep 2"}, {"type": "RNA"}, {"source_name_ch1": "Mature Plasma cells"}, {"characteristics_ch1": "cell line: INA-6;\tagent: UNC1999"}]}, {"GSM1696190": [{"title": "INA-6 treated with EZH2 inhibitor UNC1999, biological rep 3"}, {"type": "RNA"}, {"source_name_ch1": "Mature Plasma cells"}, {"characteristics_ch1": "cell line: INA-6;\tagent: UNC1999"}]}, {"GSM1697484": [{"title": "HCT_Control1"}, {"type": "RNA"}, {"source_name_ch1": "HCT-shSLBP"}, {"characteristics_ch1": "cell line: HCT-shSLBP derived from HCT116;\tcell type: colon cancer"}]}, {"GSM1697485": [{"title": "HCT_Control2"}, {"type": "RNA"}, {"source_name_ch1": "HCT-shSLBP"}, {"characteristics_ch1": "cell line: HCT-shSLBP derived from HCT116;\tcell type: colon cancer"}]}, {"GSM1697486": [{"title": "HCT_Control3"}, {"type": "RNA"}, {"source_name_ch1": "HCT-shSLBP"}, {"characteristics_ch1": "cell line: HCT-shSLBP derived from HCT116;\tcell type: colon cancer"}]}, {"GSM1697487": [{"title": "HCT_Dox1"}, {"type": "RNA"}, {"source_name_ch1": "HCT-shSLBP + DOX"}, {"characteristics_ch1": "cell line: HCT-shSLBP derived from HCT116;\tcell type: colon cancer"}]}, {"GSM1697488": [{"title": "HCT_Dox2"}, {"type": "RNA"}, {"source_name_ch1": "HCT-shSLBP + DOX"}, {"characteristics_ch1": "cell line: HCT-shSLBP derived from HCT116;\tcell type: colon cancer"}]}, {"GSM1697489": [{"title": "HCT_Dox3"}, {"type": "RNA"}, {"source_name_ch1": "HCT-shSLBP + DOX"}, {"characteristics_ch1": "cell line: HCT-shSLBP derived from HCT116;\tcell type: colon cancer"}]}, {"GSM1706509": [{"title": "MIR204WT, biological rep 4"}, {"type": "RNA"}, {"source_name_ch1": "SH-SY5Y cells overexpressing wild type MIR204 gene"}, {"characteristics_ch1": "cell line: SH-SY5Y;\tgenotype: MIR204 with rs7861254 genotype CC"}]}, {"GSM1706510": [{"title": "MIR204WT, biological rep 5"}, {"type": "RNA"}, {"source_name_ch1": "SH-SY5Y cells overexpressing wild type MIR204 gene"}, {"characteristics_ch1": "cell line: SH-SY5Y;\tgenotype: MIR204 with rs7861254 genotype CC"}]}, {"GSM1706511": [{"title": "MIR204SNP, biological rep 4"}, {"type": "RNA"}, {"source_name_ch1": "SH-SY5Y cells stably overexpressing mutant MIR204 gene"}, {"characteristics_ch1": "cell line: SH-SY5Y;\tgenotype: MIR204 with rs7861254 genotype TT"}]}, {"GSM1706512": [{"title": "MIR204SNP, biological rep 5"}, {"type": "RNA"}, {"source_name_ch1": "SH-SY5Y cells stably overexpressing mutant MIR204 gene"}, {"characteristics_ch1": "cell line: SH-SY5Y;\tgenotype: MIR204 with rs7861254 genotype TT"}]}, {"GSM1706513": [{"title": "MIR204SNP, biological rep 6"}, {"type": "RNA"}, {"source_name_ch1": "SH-SY5Y cells stably overexpressing mutant MIR204 gene"}, {"characteristics_ch1": "cell line: SH-SY5Y;\tgenotype: MIR204 with rs7861254 genotype TT"}]}, {"GSM1706514": [{"title": "MIR618WT, biological rep 1"}, {"type": "RNA"}, {"source_name_ch1": "SH-SY5Y cells overexpressing wild type MIR618 gene"}, {"characteristics_ch1": "cell line: SH-SY5Y;\tgenotype: MIR618 with rs2682818 genotype AA"}]}, {"GSM1706515": [{"title": "MIR618WT, biological rep 2"}, {"type": "RNA"}, {"source_name_ch1": "SH-SY5Y cells overexpressing wild type MIR618 gene"}, {"characteristics_ch1": "cell line: SH-SY5Y;\tgenotype: MIR618 with rs2682818 genotype AA"}]}, {"GSM1706516": [{"title": "MIR618WT, biological rep 3"}, {"type": "RNA"}, {"source_name_ch1": "SH-SY5Y cells overexpressing wild type MIR618 gene"}, {"characteristics_ch1": "cell line: SH-SY5Y;\tgenotype: MIR618 with rs2682818 genotype AA"}]}, {"GSM1706517": [{"title": "MIR618SNP1, biological rep 1"}, {"type": "RNA"}, {"source_name_ch1": "SH-SY5Y cells stably overexpressing mutant MIR618 gene"}, {"characteristics_ch1": "cell line: SH-SY5Y;\tgenotype: MIR618 with rs2682818 genotype CC"}]}, {"GSM1706518": [{"title": "MIR618SNP1, biological rep 2"}, {"type": "RNA"}, {"source_name_ch1": "SH-SY5Y cells stably overexpressing mutant MIR618 gene"}, {"characteristics_ch1": "cell line: SH-SY5Y;\tgenotype: MIR618 with rs2682818 genotype CC"}]}, {"GSM1706519": [{"title": "MIR618SNP1, biological rep 3"}, {"type": "RNA"}, {"source_name_ch1": "SH-SY5Y cells stably overexpressing mutant MIR618 gene"}, {"characteristics_ch1": "cell line: SH-SY5Y;\tgenotype: MIR618 with rs2682818 genotype CC"}]}, {"GSM1923245": [{"title": "GES-1 cells_noninfected_24h_rep1"}, {"type": "RNA"}, {"source_name_ch1": "Human gastric epithelial cell"}, {"characteristics_ch1": "cell type: Human gastric epithelial cell, GES-1 cell line"}]}, {"GSM1923246": [{"title": "GES-1 cells_noninfected_24h_rep2"}, {"type": "RNA"}, {"source_name_ch1": "Human gastric epithelial cell"}, {"characteristics_ch1": "cell type: Human gastric epithelial cell, GES-1 cell line"}]}, {"GSM1923247": [{"title": "GES-1 cells_noninfected_24h_rep3"}, {"type": "RNA"}, {"source_name_ch1": "Human gastric epithelial cell"}, {"characteristics_ch1": "cell type: Human gastric epithelial cell, GES-1 cell line"}]}, {"GSM1923248": [{"title": "GES-1 cells_hp26695_24h_rep1"}, {"type": "RNA"}, {"source_name_ch1": "Human gastric epithelial cell"}, {"characteristics_ch1": "cell type: Human gastric epithelial cell, GES-1 cell line"}]}, {"GSM1923249": [{"title": "GES-1 cells_hp26695_24h_rep2"}, {"type": "RNA"}, {"source_name_ch1": "Human gastric epithelial cell"}, {"characteristics_ch1": "cell type: Human gastric epithelial cell, GES-1 cell line"}]}, {"GSM1923250": [{"title": "GES-1 cells_hp26695_24h_rep3"}, {"type": "RNA"}, {"source_name_ch1": "Human gastric epithelial cell"}, {"characteristics_ch1": "cell type: Human gastric epithelial cell, GES-1 cell line"}]}, {"GSM1929754": [{"title": "stool_109A, replicate A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.246;\tgender: M;\tage (month): 47.01"}]}, {"GSM1929755": [{"title": "stool_316B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.348;\tgender: M;\tage (month): 26.73"}]}, {"GSM1929756": [{"title": "stool_022A, replicate A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.379;\tgender: M;\tage (month): 41.82"}]}, {"GSM1929757": [{"title": "stool_007A, replicate A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.258;\tgender: F;\tage (month): 43.59"}]}, {"GSM1929758": [{"title": "stool_134B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.188;\tgender: M;\tage (month): 48.82"}]}, {"GSM1929759": [{"title": "stool_168A, replicate A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.636;\tgender: M;\tage (month): 32.61"}]}, {"GSM1929760": [{"title": "stool_004A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.556;\tgender: F;\tage (month): 40.15"}]}, {"GSM1929761": [{"title": "stool_008A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.237;\tgender: M;\tage (month): 39.39"}]}, {"GSM1929762": [{"title": "stool_010A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.699;\tgender: F;\tage (month): 50.17"}]}, {"GSM1929763": [{"title": "stool_025B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.105;\tgender: F;\tage (month): 49.81"}]}, {"GSM1929764": [{"title": "stool_054A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.15;\tgender: M;\tage (month): 55.56"}]}, {"GSM1929765": [{"title": "stool_060A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.258;\tgender: F;\tage (month): 55.4"}]}, {"GSM1929766": [{"title": "stool_071B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.31;\tgender: M;\tage (month): 49.31"}]}, {"GSM1929767": [{"title": "stool_079B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.436;\tgender: F;\tage (month): 43.46"}]}, {"GSM1929768": [{"title": "stool_098A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.298;\tgender: F;\tage (month): 42.87"}]}, {"GSM1929769": [{"title": "stool_118B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.501;\tgender: F;\tage (month): 38.43"}]}, {"GSM1929770": [{"title": "stool_127A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.665;\tgender: M;\tage (month): 39.19"}]}, {"GSM1929771": [{"title": "stool_149B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.47;\tgender: F;\tage (month): 38.07"}]}, {"GSM1929772": [{"title": "stool_160B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.289;\tgender: M;\tage (month): 36.14"}]}, {"GSM1929773": [{"title": "stool_205A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.182;\tgender: F;\tage (month): 34.75"}]}, {"GSM1929774": [{"title": "stool_219A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.205;\tgender: M;\tage (month): 36.2"}]}, {"GSM1929775": [{"title": "stool_221B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.403;\tgender: M;\tage (month): 36.9"}]}, {"GSM1929776": [{"title": "stool_278B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.333;\tgender: F;\tage (month): 41.33"}]}, {"GSM1929777": [{"title": "stool_294A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.154;\tgender: M;\tage (month): 35.41"}]}, {"GSM1929778": [{"title": "stool_201"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.196;\tgender: M;\tage (month): 23.79"}]}, {"GSM1929779": [{"title": "stool_219"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.5;\tgender: F;\tage (month): 15.08"}]}, {"GSM1929780": [{"title": "stool_188"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.361;\tgender: M;\tage (month): 18.56"}]}, {"GSM1929781": [{"title": "stool_123"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.942;\tgender: F;\tage (month): 18.63"}]}, {"GSM1929782": [{"title": "stool_232"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.521;\tgender: M;\tage (month): 18.99"}]}, {"GSM1929783": [{"title": "stool_250"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.265;\tgender: F;\tage (month): 20.01"}]}, {"GSM1929784": [{"title": "stool_21"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.118;\tgender: M;\tage (month): 12.22"}]}, {"GSM1929785": [{"title": "stool_120"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.314;\tgender: M;\tage (month): 17.68"}]}, {"GSM1929786": [{"title": "stool_198"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.301;\tgender: M;\tage (month): 15.41"}]}, {"GSM1929787": [{"title": "stool_97"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.339;\tgender: F;\tage (month): 19.22"}]}, {"GSM1929788": [{"title": "stool_223"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 1.192;\tgender: M;\tage (month): 20.83"}]}, {"GSM1929789": [{"title": "stool_115"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.668;\tgender: M;\tage (month): 18.1"}]}, {"GSM1929790": [{"title": "stool_192"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.131;\tgender: M;\tage (month): 27.04"}]}, {"GSM1929791": [{"title": "stool_134"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.334;\tgender: M;\tage (month): 15.18"}]}, {"GSM1929792": [{"title": "stool_168"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.075;\tgender: M;\tage (month): 14.95"}]}, {"GSM1929793": [{"title": "stool_131"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.32;\tgender: F;\tage (month): 13.57"}]}, {"GSM1929794": [{"title": "stool_16"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.088;\tgender: M;\tage (month): 18.1"}]}, {"GSM1929795": [{"title": "stool_94"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.477;\tgender: F;\tage (month): 15.41"}]}, {"GSM1929796": [{"title": "stool_238"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.752;\tgender: F;\tage (month): 14.62"}]}, {"GSM1929797": [{"title": "stool_156"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.329;\tgender: M;\tage (month): 12.58"}]}, {"GSM1929798": [{"title": "stool_208"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.176;\tgender: F;\tage (month): 23.56"}]}, {"GSM1929799": [{"title": "stool_1"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.309;\tgender: M;\tage (month): 22.7"}]}, {"GSM1929800": [{"title": "stool_59"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.89;\tgender: M;\tage (month): 23.49"}]}, {"GSM1929801": [{"title": "stool_37"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.279;\tgender: M;\tage (month): 18.27"}]}, {"GSM1929802": [{"title": "stool_133"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.213;\tgender: F;\tage (month): 16.3"}]}, {"GSM1929803": [{"title": "stool_4"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.137;\tgender: F;\tage (month): 17.02"}]}, {"GSM1929804": [{"title": "stool_50"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.343;\tgender: M;\tage (month): 16.59"}]}, {"GSM1929805": [{"title": "stool_27"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.408;\tgender: F;\tage (month): 20.57"}]}, {"GSM1929806": [{"title": "stool_209"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.159;\tgender: F;\tage (month): 14.95"}]}, {"GSM1929807": [{"title": "stool_51"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.257;\tgender: F;\tage (month): 13.54"}]}, {"GSM1929808": [{"title": "stool_14"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.255;\tgender: F;\tage (month): 15.61"}]}, {"GSM1929809": [{"title": "stool_164"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.289;\tgender: F;\tage (month): 21.19"}]}, {"GSM1929810": [{"title": "stool_5"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.214;\tgender: F;\tage (month): 19.81"}]}, {"GSM1929811": [{"title": "stool_127"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.494;\tgender: M;\tage (month): 19.55"}]}, {"GSM1929812": [{"title": "stool_96"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.337;\tgender: M;\tage (month): 15.47"}]}, {"GSM1929813": [{"title": "stool_80"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.213;\tgender: F;\tage (month): 13.77"}]}, {"GSM1929814": [{"title": "stool_199"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.072;\tgender: F;\tage (month): 17.02"}]}, {"GSM1929815": [{"title": "stool_81"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.084;\tgender: F;\tage (month): 14.46"}]}, {"GSM1929816": [{"title": "stool_98"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.183;\tgender: F;\tage (month): 22.74"}]}, {"GSM1929817": [{"title": "stool_170"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.309;\tgender: F;\tage (month): 17.94"}]}, {"GSM1929818": [{"title": "stool_172"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.292;\tgender: M;\tage (month): 19.38"}]}, {"GSM1929819": [{"title": "stool_165"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.159;\tgender: F;\tage (month): 14.78"}]}, {"GSM1929820": [{"title": "stool_LNS20"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.613;\tgender: M;\tage (month): 38.86"}]}, {"GSM1929822": [{"title": "stool_LNS48"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.746;\tgender: M;\tage (month): 18.67"}]}, {"GSM1929825": [{"title": "stool_LNS114"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.284;\tgender: F;\tage (month): 29.65"}]}, {"GSM1929828": [{"title": "stool_144B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.25;\tgender: M;\tage (month): 46.16"}]}, {"GSM1929830": [{"title": "stool_089B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.302;\tgender: F;\tage (month): 57.34"}]}, {"GSM1929832": [{"title": "stool_LNS8"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.82;\tgender: M;\tage (month): 22.82"}]}, {"GSM1929834": [{"title": "stool_LNS161"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.47;\tgender: M;\tage (month): 25.91"}]}, {"GSM1929837": [{"title": "stool_321A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.178;\tgender: F;\tage (month): 25.97"}]}, {"GSM1929842": [{"title": "stool_LNS98"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.874;\tgender: M;\tage (month): 19.04"}]}, {"GSM1929844": [{"title": "stool_LNS39"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.684;\tgender: M;\tage (month): 25.78"}]}, {"GSM1929846": [{"title": "stool_LNS232"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.123;\tgender: F;\tage (month): 25.35"}]}, {"GSM1929848": [{"title": "stool_LNS226"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.47;\tgender: M;\tage (month): 33.14"}]}, {"GSM1929851": [{"title": "stool_276A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.21;\tgender: F;\tage (month): 29.33"}]}, {"GSM1929852": [{"title": "stool_270A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.416;\tgender: F;\tage (month): 32.45"}]}, {"GSM1929855": [{"title": "stool_LNS142"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.263;\tgender: F;\tage (month): 15.65"}]}, {"GSM1929857": [{"title": "stool_141A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.2;\tgender: M;\tage (month): 36.53"}]}, {"GSM1929858": [{"title": "stool_LNS56"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.601;\tgender: M;\tage (month): 16.57"}]}, {"GSM1929859": [{"title": "stool_LNS53"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.235;\tgender: F;\tage (month): 23.01"}]}, {"GSM1929860": [{"title": "stool_LNS19"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 1.221;\tgender: F;\tage (month): 26.89"}]}, {"GSM1929861": [{"title": "stool_LNS87"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.659;\tgender: M;\tage (month): 32.98"}]}, {"GSM1929862": [{"title": "stool_LNS73"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.621;\tgender: M;\tage (month): 28.04"}]}, {"GSM1929863": [{"title": "stool_LNS137"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 1.037;\tgender: F;\tage (month): 21.6"}]}, {"GSM1929864": [{"title": "stool_LNS149"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.385;\tgender: M;\tage (month): 27.09"}]}, {"GSM1929865": [{"title": "stool_LNS148"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.378;\tgender: F;\tage (month): 23.41"}]}, {"GSM1929866": [{"title": "stool_LNS192"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.403;\tgender: M;\tage (month): 23.08"}]}, {"GSM1929867": [{"title": "stool_LNS198"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.31;\tgender: M;\tage (month): 21.6"}]}, {"GSM1929868": [{"title": "stool_LNS228"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.503;\tgender: M;\tage (month): 12.36"}]}, {"GSM1929869": [{"title": "stool_LNS50"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.502;\tgender: F;\tage (month): 26.01"}]}, {"GSM1929870": [{"title": "stool_291B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.107;\tgender: F;\tage (month): 32.19"}]}, {"GSM1929871": [{"title": "stool_149A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.709;\tgender: M;\tage (month): 38.07"}]}, {"GSM1929872": [{"title": "stool_LNS247"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 1.743;\tgender: F;\tage (month): 28.7"}]}, {"GSM1929873": [{"title": "stool_050B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.373;\tgender: F;\tage (month): 43.07"}]}, {"GSM1929874": [{"title": "stool_LNS119"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.209;\tgender: F;\tage (month): 28.67"}]}, {"GSM1929875": [{"title": "stool_150A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.236;\tgender: M;\tage (month): 45.24"}]}, {"GSM1929876": [{"title": "stool_099B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.549;\tgender: M;\tage (month): 39.65"}]}, {"GSM1929877": [{"title": "stool_LNS25"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.222;\tgender: F;\tage (month): 22.09"}]}, {"GSM1929878": [{"title": "stool_LNS138"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.738;\tgender: M;\tage (month): 19.99"}]}, {"GSM1929879": [{"title": "stool_044B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.165;\tgender: F;\tage (month): 59.04"}]}, {"GSM1929880": [{"title": "stool_LNS108"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.34;\tgender: F;\tage (month): 23.54"}]}, {"GSM1929881": [{"title": "stool_LNS124"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.297;\tgender: F;\tage (month): 26.6"}]}, {"GSM1929882": [{"title": "stool_LNS155"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.32;\tgender: M;\tage (month): 22.09"}]}, {"GSM1929883": [{"title": "stool_LNS134"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 1.509;\tgender: M;\tage (month): 18.61"}]}, {"GSM1929884": [{"title": "stool_LNS135"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.59;\tgender: F;\tage (month): 13.35"}]}, {"GSM1929885": [{"title": "stool_LNS203"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 1.188;\tgender: M;\tage (month): 26.2"}]}, {"GSM1929886": [{"title": "stool_LNS92"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.582;\tgender: F;\tage (month): 28.6"}]}, {"GSM1929887": [{"title": "stool_LNS237"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.556;\tgender: M;\tage (month): 19.63"}]}, {"GSM1929888": [{"title": "stool_LNS21"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.284;\tgender: M;\tage (month): 24.56"}]}, {"GSM1929889": [{"title": "stool_LNS130"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.955;\tgender: F;\tage (month): 27.32"}]}, {"GSM1929890": [{"title": "stool_LNS201"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.614;\tgender: F;\tage (month): 16.57"}]}, {"GSM1929891": [{"title": "stool_LNS99"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 1.074;\tgender: M;\tage (month): 27.45"}]}, {"GSM1929892": [{"title": "stool_LNS183"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.349;\tgender: F;\tage (month): 26.4"}]}, {"GSM1929893": [{"title": "stool_LNS146"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.381;\tgender: M;\tage (month): 22.55"}]}, {"GSM1929894": [{"title": "stool_LNS42"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.412;\tgender: F;\tage (month): 28.8"}]}, {"GSM1929895": [{"title": "stool_LNS209"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.326;\tgender: M;\tage (month): 19.4"}]}, {"GSM1929896": [{"title": "stool_LNS174"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.417;\tgender: M;\tage (month): 25.18"}]}, {"GSM1929897": [{"title": "stool_200A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.474;\tgender: M;\tage (month): 32.05"}]}, {"GSM1929898": [{"title": "stool_LNS212"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.658;\tgender: M;\tage (month): 14.07"}]}, {"GSM1929899": [{"title": "stool_148B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.748;\tgender: F;\tage (month): 37.22"}]}, {"GSM1929900": [{"title": "stool_LNS15"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.341;\tgender: M;\tage (month): 14.27"}]}, {"GSM1929901": [{"title": "stool_289A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.29;\tgender: F;\tage (month): 35.68"}]}, {"GSM1929902": [{"title": "stool_180A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.182;\tgender: M;\tage (month): 34.65"}]}, {"GSM1929903": [{"title": "stool_231A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.2;\tgender: F;\tage (month): 31.07"}]}, {"GSM1929904": [{"title": "stool_182A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.124;\tgender: F;\tage (month): 35.54"}]}, {"GSM1929905": [{"title": "stool_253A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.653;\tgender: M;\tage (month): 34.65"}]}, {"GSM1929906": [{"title": "stool_103A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.122;\tgender: F;\tage (month): 47.15"}]}, {"GSM1929907": [{"title": "stool_218B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.538;\tgender: F;\tage (month): 31.56"}]}, {"GSM1929908": [{"title": "stool_146B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.287;\tgender: F;\tage (month): 49.08"}]}, {"GSM1929909": [{"title": "stool_LNS7"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 1.086;\tgender: F;\tage (month): 15.78"}]}, {"GSM1929910": [{"title": "stool_LNS46"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.42;\tgender: M;\tage (month): 26.79"}]}, {"GSM1929911": [{"title": "stool_196B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.181;\tgender: M;\tage (month): 32.88"}]}, {"GSM1929912": [{"title": "stool_LNS105"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.572;\tgender: F;\tage (month): 35.08"}]}, {"GSM1929913": [{"title": "stool_LNS179"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.416;\tgender: M;\tage (month): 17"}]}, {"GSM1929914": [{"title": "stool_LNS18"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.457;\tgender: M;\tage (month): 31.56"}]}, {"GSM1929915": [{"title": "stool_018A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.22;\tgender: F;\tage (month): 42.02"}]}, {"GSM1929916": [{"title": "stool_LNS241"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.518;\tgender: F;\tage (month): 24.33"}]}, {"GSM1929917": [{"title": "stool_LNS208"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.416;\tgender: M;\tage (month): 28.7"}]}, {"GSM1929918": [{"title": "stool_LNS242"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.402;\tgender: M;\tage (month): 34.75"}]}, {"GSM1929919": [{"title": "stool_177A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.172;\tgender: M;\tage (month): 36.04"}]}, {"GSM1929920": [{"title": "stool_LNS213"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.558;\tgender: F;\tage (month): 13.18"}]}, {"GSM1929921": [{"title": "stool_209A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.156;\tgender: F;\tage (month): 34.85"}]}, {"GSM1929922": [{"title": "stool_LNS88"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.351;\tgender: M;\tage (month): 35.61"}]}, {"GSM1929923": [{"title": "stool_LNS75"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.515;\tgender: F;\tage (month): 23.9"}]}, {"GSM1929924": [{"title": "stool_LNS110"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 1.405;\tgender: M;\tage (month): 21.3"}]}, {"GSM1929925": [{"title": "stool_LNS205"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 1.162;\tgender: F;\tage (month): 26.79"}]}, {"GSM1929926": [{"title": "stool_LNS36"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.959;\tgender: F;\tage (month): 31.5"}]}, {"GSM1929927": [{"title": "stool_LNS51"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 1.152;\tgender: M;\tage (month): 26.83"}]}, {"GSM1929928": [{"title": "stool_LNS214"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.445;\tgender: M;\tage (month): 13.18"}]}, {"GSM1929929": [{"title": "stool_138B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.733;\tgender: M;\tage (month): 43.92"}]}, {"GSM1929930": [{"title": "stool_LNS112"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.676;\tgender: M;\tage (month): 18.71"}]}, {"GSM1929931": [{"title": "stool_LNS200"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.372;\tgender: M;\tage (month): 24.36"}]}, {"GSM1929932": [{"title": "stool_182B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.175;\tgender: M;\tage (month): 35.54"}]}, {"GSM1929933": [{"title": "stool_137A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.175;\tgender: M;\tage (month): 42.48"}]}, {"GSM1929934": [{"title": "stool_273B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.713;\tgender: F;\tage (month): 37.59"}]}, {"GSM1929935": [{"title": "stool_279A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.415;\tgender: M;\tage (month): 35.8"}]}, {"GSM1929936": [{"title": "stool_LNS153"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.472;\tgender: M;\tage (month): 33.44"}]}, {"GSM1929937": [{"title": "stool_169A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.262;\tgender: F;\tage (month): 32.85"}]}, {"GSM1929938": [{"title": "stool_LNS219"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.473;\tgender: M;\tage (month): 24.85"}]}, {"GSM1929939": [{"title": "stool_LNS111"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 1.193;\tgender: M;\tage (month): 35.9"}]}, {"GSM1929940": [{"title": "stool_LNS79"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.64;\tgender: F;\tage (month): 35.8"}]}, {"GSM1929941": [{"title": "stool_LNS231"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.925;\tgender: M;\tage (month): 32.75"}]}, {"GSM1929942": [{"title": "stool_207B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.112;\tgender: M;\tage (month): 45.86"}]}, {"GSM1929943": [{"title": "stool_308A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.158;\tgender: F;\tage (month): 26.02"}]}, {"GSM1929944": [{"title": "stool_014B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.112;\tgender: M;\tage (month): 49.41"}]}, {"GSM1929945": [{"title": "stool_153A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.153;\tgender: M;\tage (month): 53.79"}]}, {"GSM1929946": [{"title": "stool_295B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.359;\tgender: M;\tage (month): 29.19"}]}, {"GSM1929947": [{"title": "stool_LNS60"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 1.051;\tgender: M;\tage (month): 29.23"}]}, {"GSM1929948": [{"title": "stool_LNS156"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.545;\tgender: M;\tage (month): 35.87"}]}, {"GSM1929949": [{"title": "stool_LNS89"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.405;\tgender: F;\tage (month): 12.92"}]}, {"GSM1929950": [{"title": "stool_LNS49"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.219;\tgender: F;\tage (month): 21.83"}]}, {"GSM1929951": [{"title": "stool_LNS12"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.592;\tgender: M;\tage (month): 19.99"}]}, {"GSM1929952": [{"title": "stool_LNS141"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.216;\tgender: F;\tage (month): 21.6"}]}, {"GSM1929953": [{"title": "stool_LNS246"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.805;\tgender: F;\tage (month): 21.24"}]}, {"GSM1929954": [{"title": "stool_019A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.373;\tgender: F;\tage (month): 48.66"}]}, {"GSM1929955": [{"title": "stool_201A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.513;\tgender: M;\tage (month): 32.05"}]}, {"GSM1929956": [{"title": "stool_085A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.291;\tgender: M;\tage (month): 42.21"}]}, {"GSM1929957": [{"title": "stool_087B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.136;\tgender: F;\tage (month): 46.88"}]}, {"GSM1929958": [{"title": "stool_241B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.342;\tgender: F;\tage (month): 44.81"}]}, {"GSM1929959": [{"title": "stool_186C"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.541;\tgender: M;\tage (month): 54.58"}]}, {"GSM1929960": [{"title": "stool_256A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.322;\tgender: M;\tage (month): 31"}]}, {"GSM1929961": [{"title": "stool_091B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.207;\tgender: F;\tage (month): 52.01"}]}, {"GSM1929962": [{"title": "stool_288A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.329;\tgender: M;\tage (month): 32.55"}]}, {"GSM1929963": [{"title": "stool_020A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.268;\tgender: M;\tage (month): 41.88"}]}, {"GSM1929964": [{"title": "stool_LNS191"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.422;\tgender: M;\tage (month): 24.3"}]}, {"GSM1929965": [{"title": "stool_LNS160"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 1.165;\tgender: M;\tage (month): 20.09"}]}, {"GSM1929966": [{"title": "stool_LNS173"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.106;\tgender: F;\tage (month): 29.46"}]}, {"GSM1929967": [{"title": "stool_LNS71"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.364;\tgender: F;\tage (month): 32.81"}]}, {"GSM1929968": [{"title": "stool_LNS101"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.491;\tgender: M;\tage (month): 18.25"}]}, {"GSM1929969": [{"title": "stool_LNS217"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 1.182;\tgender: M;\tage (month): 22.72"}]}, {"GSM1929970": [{"title": "stool_LNS28"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.907;\tgender: F;\tage (month): 25.02"}]}, {"GSM1929971": [{"title": "stool_LNS177"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.166;\tgender: M;\tage (month): 16.11"}]}, {"GSM1929972": [{"title": "stool_014A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.196;\tgender: F;\tage (month): 49.41"}]}, {"GSM1929973": [{"title": "stool_260B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.126;\tgender: M;\tage (month): 36.9"}]}, {"GSM1929974": [{"title": "stool_202A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.115;\tgender: M;\tage (month): 34.55"}]}, {"GSM1929975": [{"title": "stool_136A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.376;\tgender: F;\tage (month): 37.87"}]}, {"GSM1929976": [{"title": "stool_097A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.191;\tgender: F;\tage (month): 49.78"}]}, {"GSM1929977": [{"title": "stool_282B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.43;\tgender: F;\tage (month): 35.08"}]}, {"GSM1929978": [{"title": "stool_114A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.173;\tgender: F;\tage (month): 52.14"}]}, {"GSM1929979": [{"title": "stool_304A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.495;\tgender: M;\tage (month): 27.53"}]}, {"GSM1929980": [{"title": "stool_240B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.547;\tgender: M;\tage (month): 32.35"}]}, {"GSM1929981": [{"title": "stool_LNS29"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.914;\tgender: M;\tage (month): 31.86"}]}, {"GSM1929982": [{"title": "stool_LNS165"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.269;\tgender: F;\tage (month): 15.45"}]}, {"GSM1929983": [{"title": "stool_059A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.258;\tgender: F;\tage (month): 44.05"}]}, {"GSM1929984": [{"title": "stool_319A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.772;\tgender: M;\tage (month): 25.64"}]}, {"GSM1929985": [{"title": "stool_078A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.178;\tgender: M;\tage (month): 47.11"}]}, {"GSM1929986": [{"title": "stool_LNS243"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 1.021;\tgender: M;\tage (month): 23.77"}]}, {"GSM1929987": [{"title": "stool_203B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.287;\tgender: F;\tage (month): 35.44"}]}, {"GSM1929988": [{"title": "stool_LNS94"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 1.359;\tgender: F;\tage (month): 23.38"}]}, {"GSM1929989": [{"title": "stool_LNS27"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.497;\tgender: F;\tage (month): 32.94"}]}, {"GSM1929990": [{"title": "stool_157A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.116;\tgender: M;\tage (month): 36.23"}]}, {"GSM1929991": [{"title": "stool_238A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.086;\tgender: F;\tage (month): 33.34"}]}, {"GSM1929992": [{"title": "stool_106B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.168;\tgender: F;\tage (month): 43.73"}]}, {"GSM1929993": [{"title": "stool_049B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.564;\tgender: F;\tage (month): 42.67"}]}, {"GSM1929994": [{"title": "stool_206A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.005;\tgender: M;\tage (month): 38.01"}]}, {"GSM1929995": [{"title": "stool_060B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.224;\tgender: F;\tage (month): 55.4"}]}, {"GSM1929996": [{"title": "stool_126B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.183;\tgender: M;\tage (month): 40.21"}]}, {"GSM1929997": [{"title": "stool_243B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.098;\tgender: F;\tage (month): 33.86"}]}, {"GSM1929998": [{"title": "stool_088A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.092;\tgender: F;\tage (month): 40.31"}]}, {"GSM1929999": [{"title": "stool_152B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.133;\tgender: F;\tage (month): 37.52"}]}, {"GSM1930000": [{"title": "stool_117A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.14;\tgender: F;\tage (month): 52.6"}]}, {"GSM1930001": [{"title": "stool_112A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.1;\tgender: M;\tage (month): 43.53"}]}, {"GSM1930002": [{"title": "stool_258A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.021;\tgender: M;\tage (month): 42.15"}]}, {"GSM1930003": [{"title": "stool_079A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.474;\tgender: M;\tage (month): 43.46"}]}, {"GSM1930004": [{"title": "stool_314A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.709;\tgender: M;\tage (month): 26.33"}]}, {"GSM1930005": [{"title": "stool_311A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.363;\tgender: F;\tage (month): 26.07"}]}, {"GSM1930006": [{"title": "stool_248A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.471;\tgender: F;\tage (month): 33.17"}]}, {"GSM1930007": [{"title": "stool_273A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.483;\tgender: F;\tage (month): 37.59"}]}, {"GSM1930008": [{"title": "stool_LNS189"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.571;\tgender: F;\tage (month): 13.97"}]}, {"GSM1930009": [{"title": "stool_LNS196"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.274;\tgender: F;\tage (month): 20.88"}]}, {"GSM1930010": [{"title": "stool_LNS38"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.738;\tgender: M;\tage (month): 22.62"}]}, {"GSM1930011": [{"title": "stool_LNS40"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.347;\tgender: F;\tage (month): 25.55"}]}, {"GSM1930012": [{"title": "stool_LNS67"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 1.579;\tgender: M;\tage (month): 23.11"}]}, {"GSM1930013": [{"title": "stool_LNS210"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.363;\tgender: F;\tage (month): 25.71"}]}, {"GSM1930014": [{"title": "stool_LNS35"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.338;\tgender: M;\tage (month): 21.57"}]}, {"GSM1930015": [{"title": "stool_LNS133"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.807;\tgender: M;\tage (month): 19.46"}]}, {"GSM1930016": [{"title": "stool_LNS52"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 1.444;\tgender: F;\tage (month): 35.93"}]}, {"GSM1930017": [{"title": "stool_309A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.194;\tgender: M;\tage (month): 27.66"}]}, {"GSM1930018": [{"title": "stool_168B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.162;\tgender: M;\tage (month): 32.61"}]}, {"GSM1930019": [{"title": "stool_LNS102"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.296;\tgender: F;\tage (month): 23.11"}]}, {"GSM1930020": [{"title": "stool_LNS235"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.273;\tgender: F;\tage (month): 17"}]}, {"GSM1930021": [{"title": "stool_186A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.391;\tgender: M;\tage (month): 54.58"}]}, {"GSM1930022": [{"title": "stool_LNS122"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.883;\tgender: F;\tage (month): 32.35"}]}, {"GSM1930023": [{"title": "stool_LNS229"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.467;\tgender: F;\tage (month): 19.53"}]}, {"GSM1930024": [{"title": "stool_142A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.287;\tgender: M;\tage (month): 45.44"}]}, {"GSM1930025": [{"title": "stool_LNS188"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.437;\tgender: F;\tage (month): 28.37"}]}, {"GSM1930026": [{"title": "stool_LNS24"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 1.508;\tgender: M;\tage (month): 24.33"}]}, {"GSM1930027": [{"title": "stool_294B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.119;\tgender: M;\tage (month): 35.41"}]}, {"GSM1930028": [{"title": "stool_180B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.148;\tgender: M;\tage (month): 34.63"}]}, {"GSM1930029": [{"title": "stool_023A"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.232;\tgender: F;\tage (month): 44.32"}]}, {"GSM1930030": [{"title": "stool_080B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.199;\tgender: F;\tage (month): 47.61"}]}, {"GSM1930031": [{"title": "stool_021B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.508;\tgender: M;\tage (month): 38.83"}]}, {"GSM1930032": [{"title": "stool_LNS225"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.188;\tgender: F;\tage (month): 34.95"}]}, {"GSM1930033": [{"title": "stool_LNS68"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.31;\tgender: M;\tage (month): 30.35"}]}, {"GSM1930034": [{"title": "stool_142B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.191;\tgender: F;\tage (month): 45.47"}]}, {"GSM1930035": [{"title": "stool_109A, replicate B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.246;\tgender: M;\tage (month): 47.01"}]}, {"GSM1930036": [{"title": "stool_022A, replicate B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.379;\tgender: M;\tage (month): 41.82"}]}, {"GSM1930037": [{"title": "stool_007A, replicate B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.258;\tgender: F;\tage (month): 43.59"}]}, {"GSM1930038": [{"title": "stool_168A, replicate B"}, {"type": "RNA"}, {"source_name_ch1": "fecal total RNA from study subject"}, {"characteristics_ch1": "sample type: stool;\tdisease state: environmental enteric dysfunction;\tpercent lactulose in urine: 0.636;\tgender: M;\tage (month): 32.61"}]}, {"GSM1930652": [{"title": "KYSE150_control_rep1"}, {"type": "RNA"}, {"source_name_ch1": "KYSE150 human esophageal cancer cell lines"}, {"characteristics_ch1": "cell line: KYSE150;\ttransfection: control"}]}, {"GSM1930653": [{"title": "KYSE150_knockdown lncRNA625_rep1"}, {"type": "RNA"}, {"source_name_ch1": "KYSE150 human esophageal cancer cell lines"}, {"characteristics_ch1": "cell line: KYSE150;\ttransfection: knockdown lncRNA625"}]}, {"GSM1931614": [{"title": "KYSE150_scramble_control_rep1"}, {"type": "RNA"}, {"source_name_ch1": "KYSE150 cells"}, {"characteristics_ch1": "transfection: control"}]}, {"GSM1931615": [{"title": "KYSE150_knockdown EP300_rep1"}, {"type": "RNA"}, {"source_name_ch1": "KYSE150 cells"}, {"characteristics_ch1": "transfection: knockdown EP300"}]}, {"GSM1970166": [{"title": "U937-negative control-rep1"}, {"type": "RNA"}, {"source_name_ch1": "U937 cells, transfected by negative control virus"}, {"characteristics_ch1": "cell line: U937"}]}, {"GSM1970167": [{"title": "U937-negative control-rep2"}, {"type": "RNA"}, {"source_name_ch1": "U937 cells, transfected by negative control virus"}, {"characteristics_ch1": "cell line: U937"}]}, {"GSM1970168": [{"title": "U937-negative control-rep3"}, {"type": "RNA"}, {"source_name_ch1": "U937 cells, transfected by negative control virus"}, {"characteristics_ch1": "cell line: U937"}]}, {"GSM1970169": [{"title": "U937-has-miR-608 inhibitor-rep1"}, {"type": "RNA"}, {"source_name_ch1": "U937 cells, transfected by has-miR-608 inhibitor virus"}, {"characteristics_ch1": "cell line: U937"}]}, {"GSM1970170": [{"title": "U937-has-miR-608 inhibitor-rep2"}, {"type": "RNA"}, {"source_name_ch1": "U937 cells, transfected by has-miR-608 inhibitor virus"}, {"characteristics_ch1": "cell line: U937"}]}, {"GSM1970171": [{"title": "U937-has-miR-608 inhibitor-rep3"}, {"type": "RNA"}, {"source_name_ch1": "U937 cells, transfected by has-miR-608 inhibitor virus"}, {"characteristics_ch1": "cell line: U937"}]}, {"GSM1973227": [{"title": "1_195011"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 70;\ter (allred score): 4.5;\tpr (allred score): 3.8;\tki67 (%): 19;\ther2: 3"}]}, {"GSM1973228": [{"title": "2_184003"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 58;\ter (allred score): 8;\tpr (allred score): 0;\tki67 (%): 15;\ther2: 0"}]}, {"GSM1973229": [{"title": "3_184004"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 56;\ter (allred score): 8;\tpr (allred score): 8;\tki67 (%): 11;\ther2: 0"}]}, {"GSM1973230": [{"title": "4_184006"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 68;\ter (allred score): 5.5;\tpr (allred score): 5.3;\tki67 (%): 10;\ther2: 3"}]}, {"GSM1973231": [{"title": "5_184009"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 68;\ter (allred score): 3;\tpr (allred score): 5.5;\tki67 (%): 21;\ther2: 0"}]}, {"GSM1973232": [{"title": "6_184010"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 74;\ter (allred score): 3.5;\tpr (allred score): 0.8;\tki67 (%): 7;\ther2: 0"}]}, {"GSM1973233": [{"title": "7_14004"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 67;\ter (allred score): 8;\tpr (allred score): 0;\tki67 (%): 6;\ther2: 0"}]}, {"GSM1973234": [{"title": "8_140005"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 58;\ter (allred score): 2;\tpr (allred score): 2;\tki67 (%): 2;\ther2: 2"}]}, {"GSM1973235": [{"title": "9_140006"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 73;\ter (allred score): 8;\tpr (allred score): 6;\tki67 (%): 40;\ther2: 0"}]}, {"GSM1973236": [{"title": "10_140003"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 69;\ter (allred score): 8;\tpr (allred score): 8;\tki67 (%): 32;\ther2: 0"}]}, {"GSM1973237": [{"title": "11_184012"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 75;\ter (allred score): 0;\tpr (allred score): 0;\tki67 (%): 9;\ther2: 0"}]}, {"GSM1973238": [{"title": "12_184014"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 72;\ter (allred score): 8;\tpr (allred score): 0;\tki67 (%): 41;\ther2: 0"}]}, {"GSM1973239": [{"title": "13_184015"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 66;\ter (allred score): 7;\tpr (allred score): 8;\tki67 (%): 17;\ther2: 0"}]}, {"GSM1973240": [{"title": "14_184021"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 68;\ter (allred score): 8;\tpr (allred score): 7.7;\tki67 (%): 13;\ther2: 0"}]}, {"GSM1973241": [{"title": "15_184022"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 75;\ter (allred score): 7;\tpr (allred score): 5.5;\tki67 (%): 44;\ther2: 0"}]}, {"GSM1973242": [{"title": "16_184025"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 73;\ter (allred score): 8;\tpr (allred score): 0;\tki67 (%): 18;\ther2: 0"}]}, {"GSM1973243": [{"title": "17_184027"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 54;\ter (allred score): 7;\tpr (allred score): 6.3;\tki67 (%): 41;\ther2: 0"}]}, {"GSM1973244": [{"title": "18_184030"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 81;\ter (allred score): 8;\tpr (allred score): 6.8;\tki67 (%): 49;\ther2: 3"}]}, {"GSM1973245": [{"title": "19_184034"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 68;\ter (allred score): 8;\tpr (allred score): 3.8;\tki67 (%): 8;\ther2: 0"}]}, {"GSM1973246": [{"title": "20_184035"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 78;\ter (allred score): 6.7;\tpr (allred score): 6;\tki67 (%): 22;\ther2: 0"}]}, {"GSM1973247": [{"title": "22_184038"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 52;\ter (allred score): 5.3;\tpr (allred score): 0;\tki67 (%): 9;\ther2: 0"}]}, {"GSM1973248": [{"title": "23_184039"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 65;\ter (allred score): 2.7;\tpr (allred score): 0;\tki67 (%): 25;\ther2: 0"}]}, {"GSM1973249": [{"title": "24_184041"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 68;\ter (allred score): 8;\tpr (allred score): 5.5;\tki67 (%): 24;\ther2: 0"}]}, {"GSM1973250": [{"title": "25_184042"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 56;\ter (allred score): 8;\tpr (allred score): 5.5;\tki67 (%): 8;\ther2: 1"}]}, {"GSM1973251": [{"title": "26_184045"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 43;\ter (allred score): 4.8;\tpr (allred score): 0;\tki67 (%): 19;\ther2: 1"}]}, {"GSM1973252": [{"title": "27_184046"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 55;\ter (allred score): 8;\tpr (allred score): 3.5;\tki67 (%): 18;\ther2: 0"}]}, {"GSM1973253": [{"title": "28_184048"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 72;\ter (allred score): 8;\tpr (allred score): 2;\tki67 (%): 19;\ther2: 1"}]}, {"GSM1973254": [{"title": "29_184051"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 69;\ter (allred score): 4;\tpr (allred score): 7;\tki67 (%): 7;\ther2: 3"}]}, {"GSM1973255": [{"title": "30_184052"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 76;\ter (allred score): 5.5;\tpr (allred score): 0;\tki67 (%): 45;\ther2: 1"}]}, {"GSM1973256": [{"title": "31_182006"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 68;\ter (allred score): 5.5;\tpr (allred score): 5.3;\tki67 (%): 10;\ther2: 3"}]}, {"GSM1973257": [{"title": "32_235001"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 62;\ter (allred score): 5.5;\tpr (allred score): 5;\tki67 (%): 18;\ther2: 0"}]}, {"GSM1973258": [{"title": "33_235002"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 69;\ter (allred score): 8;\tpr (allred score): 5.8;\tki67 (%): 21;\ther2: 2"}]}, {"GSM1973259": [{"title": "34_235003"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 63;\ter (allred score): 8;\tpr (allred score): 2.7;\tki67 (%): 22;\ther2: 0"}]}, {"GSM1973260": [{"title": "35_290002"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 52;\ter (allred score): 0;\tpr (allred score): 0;\tki67 (%): 5;\ther2: 3"}]}, {"GSM1973261": [{"title": "36_290003"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 55;\ter (allred score): 4;\tpr (allred score): 3;\tki67 (%): 2;\ther2: 0"}]}, {"GSM1973262": [{"title": "37_290007"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 59;\ter (allred score): 3;\tpr (allred score): 5.3;\tki67 (%): 4;\ther2: 0"}]}, {"GSM1973263": [{"title": "1_124001"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 58;\ter (allred score): 4;\tpr (allred score): 2.5;\tki67 (%): 0;\ther2: 3"}]}, {"GSM1973264": [{"title": "4_113001"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 68;\ter (allred score): 8;\tpr (allred score): 4;\tki67 (%): 30;\ther2: 0"}]}, {"GSM1973265": [{"title": "5_116005"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 60;\ter (allred score): 7.3;\tpr (allred score): 6.3;\tki67 (%): 26;\ther2: 0"}]}, {"GSM1973266": [{"title": "6_121001"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 57;\ter (allred score): 7.3;\tpr (allred score): 0;\tki67 (%): 13.2;\ther2: 0"}]}, {"GSM1973267": [{"title": "7_121005"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 77;\ter (allred score): 6.3;\tpr (allred score): 5.8;\tki67 (%): 8;\ther2: 0"}]}, {"GSM1973268": [{"title": "9_121008"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 59;\ter (allred score): 6;\tpr (allred score): 2.5;\tki67 (%): 11;\ther2: 0"}]}, {"GSM1973269": [{"title": "12_121002"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 76;\ter (allred score): 7;\tpr (allred score): 4.3;\tki67 (%): 0;\ther2: 0"}]}, {"GSM1973270": [{"title": "10_121009"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 68;\ter (allred score): 6.8;\tpr (allred score): 8;\tki67 (%): 9;\ther2: 0"}]}, {"GSM1973271": [{"title": "11_124003"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 43;\ter (allred score): 4;\tpr (allred score): 8;\tki67 (%): 24;\ther2: 0"}]}, {"GSM1973272": [{"title": "13_125001"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 58;\ter (allred score): 6.7;\tpr (allred score): 3.7;\tki67 (%): 27;\ther2: 0"}]}, {"GSM1973273": [{"title": "14_180008"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 41;\ter (allred score): 0;\tpr (allred score): 0.5;\tki67 (%): 92;\ther2: 0"}]}, {"GSM1973274": [{"title": "15_185001"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 58;\ter (allred score): 0;\tpr (allred score): 0;\tki67 (%): 52;\ther2: 0"}]}, {"GSM1973275": [{"title": "17_185007"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 69;\ter (allred score): 8;\tpr (allred score): 2;\tki67 (%): 0;\ther2: 1"}]}, {"GSM1973276": [{"title": "18_185008"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 65;\ter (allred score): 8;\tpr (allred score): 6.3;\tki67 (%): 24;\ther2: 3"}]}, {"GSM1973277": [{"title": "20_185023"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 42;\ter (allred score): 7;\tpr (allred score): 4.5;\tki67 (%): 33;\ther2: 0"}]}, {"GSM1973278": [{"title": "21_185025"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 45;\ter (allred score): 7;\tpr (allred score): 8;\tki67 (%): 16;\ther2: 0"}]}, {"GSM1973279": [{"title": "22_187001"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 52;\ter (allred score): 8;\tpr (allred score): 8;\tki67 (%): 12;\ther2: 1"}]}, {"GSM1973280": [{"title": "23_187003"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 57;\ter (allred score): 6;\tpr (allred score): 3;\tki67 (%): 35;\ther2: 0"}]}, {"GSM1973281": [{"title": "25_187009"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 31;\ter (allred score): 7;\tpr (allred score): 6.7;\tki67 (%): 10;\ther2: 1"}]}, {"GSM1973282": [{"title": "26_244001"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 60;\ter (allred score): 8;\tpr (allred score): 4;\tki67 (%): 2;\ther2: 0"}]}, {"GSM1973283": [{"title": "29_244008"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 66;\ter (allred score): 0;\tpr (allred score): 0;\tki67 (%): 0;\ther2: 0"}]}, {"GSM1973284": [{"title": "30_247001"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 62;\ter (allred score): 0;\tpr (allred score): 0;\tki67 (%): 58;\ther2: 3"}]}, {"GSM1973285": [{"title": "32_247003"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 76;\ter (allred score): 7;\tpr (allred score): 8;\tki67 (%): 15;\ther2: 0"}]}, {"GSM1973286": [{"title": "33_247004"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 64;\ter (allred score): 7;\tpr (allred score): 0;\tki67 (%): 5;\ther2: 1"}]}, {"GSM1973287": [{"title": "34_272001"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 66;\ter (allred score): 5.8;\tpr (allred score): 2;\tki67 (%): 0;\ther2: 0"}]}, {"GSM1973288": [{"title": "35_130004"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 77;\ter (allred score): 7;\tpr (allred score): 1;\tki67 (%): 16;\ther2: 1"}]}, {"GSM1973289": [{"title": "36_246002"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 40;\ter (allred score): 5;\tpr (allred score): 8;\tki67 (%): 17;\ther2: 0"}]}, {"GSM1973290": [{"title": "37_127001"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 61;\ter (allred score): 3.5;\tpr (allred score): 5;\tki67 (%): 2;\ther2: 0"}]}, {"GSM1973291": [{"title": "38_127009"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 67;\ter (allred score): 7.3;\tpr (allred score): 0;\tki67 (%): 5;\ther2: 0"}]}, {"GSM1973292": [{"title": "39_127005"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 57;\ter (allred score): 6;\tpr (allred score): 7;\tki67 (%): 4;\ther2: 0"}]}, {"GSM1973293": [{"title": "41_127007"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 40;\ter (allred score): 8;\tpr (allred score): 8;\tki67 (%): 51;\ther2: 0"}]}, {"GSM1973294": [{"title": "42_127008"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 59;\ter (allred score): 4;\tpr (allred score): 7.8;\tki67 (%): 11;\ther2: 0"}]}, {"GSM1973295": [{"title": "44_127012"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 73;\ter (allred score): 7.5;\tpr (allred score): 7.8;\tki67 (%): 10;\ther2: 0"}]}, {"GSM1973296": [{"title": "45_127013"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 59;\ter (allred score): 0;\tpr (allred score): 0;\tki67 (%): 0;\ther2: 0"}]}, {"GSM1973297": [{"title": "46_127015"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 47;\ter (allred score): 4.5;\tpr (allred score): 0;\tki67 (%): 6.8;\ther2: 0"}]}, {"GSM1973298": [{"title": "47_127016"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 64;\ter (allred score): 8;\tpr (allred score): 5.5;\tki67 (%): 40;\ther2: 0"}]}, {"GSM1973299": [{"title": "48_243002"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 64;\ter (allred score): 6.3;\tpr (allred score): 5;\tki67 (%): 12;\ther2: 0"}]}, {"GSM1973300": [{"title": "49_243003"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 62;\ter (allred score): 7;\tpr (allred score): 0;\tki67 (%): 7;\ther2: 0"}]}, {"GSM1973301": [{"title": "50_243007"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 58;\ter (allred score): 1.8;\tpr (allred score): 8;\tki67 (%): 22;\ther2: 0"}]}, {"GSM1973302": [{"title": "52_243008"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 52;\ter (allred score): 5.3;\tpr (allred score): 3.7;\tki67 (%): 3;\ther2: 0"}]}, {"GSM1973303": [{"title": "53_243009"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 42;\ter (allred score): 7;\tpr (allred score): 0;\tki67 (%): 17;\ther2: 1"}]}, {"GSM1973304": [{"title": "54_243010"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 56;\ter (allred score): 8;\tpr (allred score): 6.7;\tki67 (%): 4;\ther2: 0"}]}, {"GSM1973305": [{"title": "56_243014"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 63;\ter (allred score): 4.5;\tpr (allred score): 8;\tki67 (%): 6;\ther2: 0"}]}, {"GSM1973306": [{"title": "57_243016"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 71;\ter (allred score): 6;\tpr (allred score): 6;\tki67 (%): 16;\ther2: 0"}]}, {"GSM1973307": [{"title": "58_243018"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 79;\ter (allred score): 7;\tpr (allred score): 0;\tki67 (%): 19;\ther2: 3"}]}, {"GSM1973308": [{"title": "60_150002"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 72;\ter (allred score): 8;\tpr (allred score): 7;\tki67 (%): 21;\ther2: 0"}]}, {"GSM1973309": [{"title": "62_161003"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 69;\ter (allred score): 0;\tpr (allred score): 0.7;\tki67 (%): 1;\ther2: 0"}]}, {"GSM1973310": [{"title": "63_231001"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 66;\ter (allred score): 1;\tpr (allred score): 6.5;\tki67 (%): 5;\ther2: 0"}]}, {"GSM1973311": [{"title": "64_145002A"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 50;\ter (allred score): 6.4;\tpr (allred score): 1.6;\tki67 (%): 43;\ther2: 0"}]}, {"GSM1973312": [{"title": "67_161004"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 78;\ter (allred score): 8;\tpr (allred score): 0;\tki67 (%): 0;\ther2: 2"}]}, {"GSM1973313": [{"title": "68_161009"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 65;\ter (allred score): 8;\tpr (allred score): 3;\tki67 (%): 2;\ther2: 1"}]}, {"GSM1973314": [{"title": "69_126003"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 78;\ter (allred score): 8;\tpr (allred score): 5;\tki67 (%): 17;\ther2: 1"}]}, {"GSM1973315": [{"title": "70_126004"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 62;\ter (allred score): 6.5;\tpr (allred score): 8;\tki67 (%): 20;\ther2: 3"}]}, {"GSM1973316": [{"title": "71_126005"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 66;\ter (allred score): 8;\tpr (allred score): 3;\tki67 (%): 20;\ther2: 0"}]}, {"GSM1973317": [{"title": "72_126006"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 76;\ter (allred score): 8;\tpr (allred score): 0;\tki67 (%): 20;\ther2: 0"}]}, {"GSM1973318": [{"title": "73_126007"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 63;\ter (allred score): 8;\tpr (allred score): 2.3;\tki67 (%): 3;\ther2: 0"}]}, {"GSM1973319": [{"title": "74_126008"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 46;\ter (allred score): 1.3;\tpr (allred score): 0;\tki67 (%): 0;\ther2: 0"}]}, {"GSM1973320": [{"title": "75_126012A"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 54;\ter (allred score): 7.3;\tpr (allred score): 1.2;\tki67 (%): 62;\ther2: 3"}]}, {"GSM1973321": [{"title": "79_126015"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 70;\ter (allred score): 8;\tpr (allred score): 3.3;\tki67 (%): 32;\ther2: 1"}]}, {"GSM1973322": [{"title": "80_126016"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 51;\ter (allred score): 4;\tpr (allred score): 4.5;\tki67 (%): 30;\ther2: 0"}]}, {"GSM1973323": [{"title": "81_126018"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 76;\ter (allred score): 7;\tpr (allred score): 2;\tki67 (%): 3;\ther2: 0"}]}, {"GSM1973324": [{"title": "82_126019"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 49;\ter (allred score): 8;\tpr (allred score): 8;\tki67 (%): 22;\ther2: 0"}]}, {"GSM1973325": [{"title": "83_126020"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 57;\ter (allred score): 8;\tpr (allred score): 8;\tki67 (%): 8;\ther2: 0"}]}, {"GSM1973326": [{"title": "84_126022"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 56;\ter (allred score): 8;\tpr (allred score): 0.5;\tki67 (%): 26;\ther2: 1"}]}, {"GSM1973327": [{"title": "86_242001"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 78;\ter (allred score): 6.5;\tpr (allred score): 0;\tki67 (%): 8;\ther2: 0"}]}, {"GSM1973328": [{"title": "87_242003"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 62;\ter (allred score): 7;\tpr (allred score): 0;\tki67 (%): 7;\ther2: 0"}]}, {"GSM1973329": [{"title": "88_242005"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 62;\ter (allred score): 4;\tpr (allred score): 6.3;\tki67 (%): 0;\ther2: 0"}]}, {"GSM1973330": [{"title": "89_242006"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 77;\ter (allred score): 4;\tpr (allred score): 3.3;\tki67 (%): 13;\ther2: 0"}]}, {"GSM1973331": [{"title": "91_160002"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 82;\ter (allred score): 8;\tpr (allred score): 8;\tki67 (%): 8;\ther2: 0"}]}, {"GSM1973332": [{"title": "92_160003"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 63;\ter (allred score): 7.8;\tpr (allred score): 6.5;\tki67 (%): 2;\ther2: 0"}]}, {"GSM1973333": [{"title": "93_195001"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 48;\ter (allred score): 1;\tpr (allred score): 2.5;\tki67 (%): 1;\ther2: 0"}]}, {"GSM1973334": [{"title": "94_195004"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 64;\ter (allred score): 8;\tpr (allred score): 7.3;\tki67 (%): 40;\ther2: 1"}]}, {"GSM1973335": [{"title": "95_195009"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 44;\ter (allred score): 4.5;\tpr (allred score): 8;\tki67 (%): 4;\ther2: 1"}]}, {"GSM1973336": [{"title": "2_103001"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 63;\ter (allred score): 7.8;\tpr (allred score): 6.8;\tki67 (%): 18;\ther2: 1"}]}, {"GSM1973337": [{"title": "8_121007"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 65;\ter (allred score): 3;\tpr (allred score): 8;\tki67 (%): 27;\ther2: 0"}]}, {"GSM1973338": [{"title": "16_185002"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 65;\ter (allred score): 8;\tpr (allred score): 2;\tki67 (%): 41;\ther2: 3"}]}, {"GSM1973339": [{"title": "43_127009"}, {"type": "RNA"}, {"source_name_ch1": "primary breast cancer from post menopausal patients that developed metastatic disease"}, {"characteristics_ch1": "tissue: primary breast cancer;\tage: 67;\ter (allred score): 7.3;\tpr (allred score): 0;\tki67 (%): 5;\ther2: 0"}]}, {"GSM1977646": [{"title": "cancer [1253]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 41;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 4;\ttumor grade: 3;\tpositive lymph nodes: 1;\tki67(%): 15;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977647": [{"title": "cancer [1268]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 59;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 1.5;\ttumor grade: 2;\tpositive lymph nodes: 0;\tki67(%): 95;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977648": [{"title": "cancer [1271]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 83;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 3;\ttumor grade: 0;\tpositive lymph nodes: 12;\tki67(%): 95;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977649": [{"title": "cancer [1302]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 66;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 2.5;\ttumor grade: 3;\tpositive lymph nodes: 3;\tki67(%): 0;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977650": [{"title": "cancer [1303]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 69;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 3;\ttumor grade: 3;\tpositive lymph nodes: 2;\tki67(%): 5;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977651": [{"title": "cancer [1304]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 63;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 4.5;\ttumor grade: 2;\tpositive lymph nodes: 0;\tki67(%): 20;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977652": [{"title": "cancer [1355]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 83;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 2;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 15;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977653": [{"title": "cancer [1365]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 61;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 3;\ttumor grade: 2;\tpositive lymph nodes: 2;\tki67(%): 5;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977654": [{"title": "cancer [1503]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 45;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 2.5;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 75;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977655": [{"title": "cancer [1507]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 74;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 2.6;\ttumor grade: 2;\tpositive lymph nodes: 3;\tki67(%): 5;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977656": [{"title": "cancer [1545]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 69;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 3.5;\ttumor grade: 2;\tpositive lymph nodes: 0;\tki67(%): 5;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977657": [{"title": "cancer [1709]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 55;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 2.8;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 60;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977658": [{"title": "cancer [1723]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 55;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 2.2;\ttumor grade: 2;\tpositive lymph nodes: 0;\tki67(%): 90;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977659": [{"title": "cancer [1758]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 43;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 2.2;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 25;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977660": [{"title": "cancer [1777]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 64;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 2.5;\ttumor grade: 2;\tpositive lymph nodes: 0;\tki67(%): 30;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977661": [{"title": "cancer [1803]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 46;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 3;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 40;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977662": [{"title": "cancer [1814]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 55;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 2.6;\ttumor grade: 3;\tpositive lymph nodes: 2;\tki67(%): 20;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977663": [{"title": "cancer [2084]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 42;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 2.5;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 50;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977664": [{"title": "cancer [2093]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 70;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 3;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 20;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977665": [{"title": "cancer [2095]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 64;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 2.5;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 40;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977666": [{"title": "cancer [2110]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 68;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 2.5;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 15;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977667": [{"title": "cancer [2111]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 65;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 2.3;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 30;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977668": [{"title": "cancer [2139]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 27;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 3;\ttumor grade: 3;\tpositive lymph nodes: 1;\tki67(%): 70;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977669": [{"title": "cancer [2170]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 56;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 3;\ttumor grade: 0;\tpositive lymph nodes: 0;\tki67(%): 20;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977670": [{"title": "cancer [2204]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 54;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 2;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 50;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977671": [{"title": "cancer [2272]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 43;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 3;\ttumor grade: 3;\tpositive lymph nodes: 8;\tki67(%): 20;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977672": [{"title": "cancer [2285]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 33;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 0;\ttumor grade: 0;\tpositive lymph nodes: 0;\tki67(%): 50;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977673": [{"title": "cancer [2361]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 57;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 1;\ttumor grade: 2;\tpositive lymph nodes: 0;\tki67(%): 10;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977674": [{"title": "cancer [2392]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 43;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 3.5;\ttumor grade: 3;\tpositive lymph nodes: 3;\tki67(%): 70;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977675": [{"title": "cancer [2433]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 70;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 1.2;\ttumor grade: 2;\tpositive lymph nodes: 1;\tki67(%): 20;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977676": [{"title": "cancer [2445]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 54;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 2.5;\ttumor grade: 3;\tpositive lymph nodes: 5;\tki67(%): 30;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977677": [{"title": "cancer [2508]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 50;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 3;\ttumor grade: 3;\tpositive lymph nodes: 18;\tki67(%): 50;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977678": [{"title": "cancer [2522]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 51;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 4.5;\ttumor grade: 2;\tpositive lymph nodes: 2;\tki67(%): 40;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977679": [{"title": "cancer [2526]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 41;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 3;\ttumor grade: 2;\tpositive lymph nodes: 14;\tki67(%): 25;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977680": [{"title": "cancer [2548]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 53;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 2;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 30;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977681": [{"title": "cancer [2557]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 50;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 2;\ttumor grade: 3;\tpositive lymph nodes: 2;\tki67(%): 30;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977682": [{"title": "cancer [2585]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 44;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 4;\ttumor grade: 2;\tpositive lymph nodes: 11;\tki67(%): 40;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977683": [{"title": "cancer [2587]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 35;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 4;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 60;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977684": [{"title": "cancer [2590]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 49;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 3;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 70;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977685": [{"title": "cancer [2617]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 52;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 1.7;\ttumor grade: 3;\tpositive lymph nodes: 4;\tki67(%): 80;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977686": [{"title": "cancer [2625]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 59;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 2;\ttumor grade: 2;\tpositive lymph nodes: 0;\tki67(%): 60;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977687": [{"title": "cancer [2630]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 62;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 2.3;\ttumor grade: 2;\tpositive lymph nodes: 0;\tki67(%): 25;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977688": [{"title": "cancer [2669]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 36;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 2;\ttumor grade: 2;\tpositive lymph nodes: 2;\tki67(%): 60;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977689": [{"title": "cancer [2682]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 48;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 1.9;\ttumor grade: 2;\tpositive lymph nodes: 0;\tki67(%): 50;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977690": [{"title": "cancer [2688]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 49;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 3.2;\ttumor grade: 3;\tpositive lymph nodes: 2;\tki67(%): 80;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977691": [{"title": "cancer [2695]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 45;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 1;\ttumor grade: 2;\tpositive lymph nodes: 0;\tki67(%): 50;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977692": [{"title": "cancer [2729]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 64;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 1.5;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 70;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977693": [{"title": "cancer [2742]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 61;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 2.5;\ttumor grade: 3;\tpositive lymph nodes: 4;\tki67(%): 40;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977694": [{"title": "cancer [2752]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 64;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 3.5;\ttumor grade: 2;\tpositive lymph nodes: 1;\tki67(%): 30;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977695": [{"title": "cancer [2789]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 50;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 1.4;\ttumor grade: 3;\tpositive lymph nodes: 4;\tki67(%): 60;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977696": [{"title": "cancer [2792]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 58;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 2.8;\ttumor grade: 0;\tpositive lymph nodes: 14;\tki67(%): 60;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977697": [{"title": "cancer [2916]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 44;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 1.2;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 60;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977698": [{"title": "cancer [2963]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 74;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 2.5;\ttumor grade: 2;\tpositive lymph nodes: 0;\tki67(%): 40;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977699": [{"title": "cancer [2965]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 65;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 2.5;\ttumor grade: 2;\tpositive lymph nodes: 0;\tki67(%): 50;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977700": [{"title": "cancer [3032]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 59;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 3;\ttumor grade: 0;\tpositive lymph nodes: 13;\tki67(%): 70;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977701": [{"title": "cancer [3055]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 59;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 1.5;\ttumor grade: 2;\tpositive lymph nodes: 0;\tki67(%): 60;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977702": [{"title": "cancer [3059]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 49;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 2.5;\ttumor grade: 0;\tpositive lymph nodes: 0;\tki67(%): 30;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977703": [{"title": "cancer [3083]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 66;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 1.5;\ttumor grade: 0;\tpositive lymph nodes: 0;\tki67(%): 10;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977704": [{"title": "cancer [3085]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 58;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 2.7;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 60;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977705": [{"title": "cancer [3109]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 59;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 1.2;\ttumor grade: 2;\tpositive lymph nodes: 2;\tki67(%): 40;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977706": [{"title": "cancer [3113]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 52;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 1.5;\ttumor grade: 2;\tpositive lymph nodes: 0;\tki67(%): 70;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977707": [{"title": "cancer [3118]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 39;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 2.8;\ttumor grade: 3;\tpositive lymph nodes: 6;\tki67(%): 60;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977708": [{"title": "cancer [3119]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 58;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 3;\ttumor grade: 3;\tpositive lymph nodes: 1;\tki67(%): 70;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977709": [{"title": "cancer [3131]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 42;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 3.3;\ttumor grade: 3;\tpositive lymph nodes: 5;\tki67(%): 50;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977710": [{"title": "cancer [3145]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 56;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 1.5;\ttumor grade: 0;\tpositive lymph nodes: 0;\tki67(%): 10;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977711": [{"title": "cancer [3162]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 63;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 3.5;\tpositive lymph nodes: 0;\tki67(%): 80;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977712": [{"title": "cancer [3169]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 35;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 2;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 70;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977713": [{"title": "cancer [3180]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977714": [{"title": "cancer [3183]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 36;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 4;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 50;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977715": [{"title": "cancer [3191]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 42;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 2.5;\tpositive lymph nodes: 12;\tki67(%): 10;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977716": [{"title": "cancer [3205]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 57;\tmenopause status (0=pre, 1=post): 0;\tpositive lymph nodes: 0;\tki67(%): 50;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977717": [{"title": "cancer [3209]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 47;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 3;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 60;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977718": [{"title": "cancer [3222]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977719": [{"title": "cancer [3241]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 56;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 2.7;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 50;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977720": [{"title": "cancer [3262]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 47;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 3;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 50;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977721": [{"title": "cancer [3263]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 56;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 1.5;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 90;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977722": [{"title": "cancer [3266]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 49;\tmenopause status (0=pre, 1=post): 0;\tpositive lymph nodes: 2;\tki67(%): 70;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977723": [{"title": "cancer [3283]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 55;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 2.2;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 70;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977724": [{"title": "cancer [3292]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 58;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 3;\tpositive lymph nodes: 1;\tki67(%): 30;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977725": [{"title": "cancer [3297]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 50;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 2.5;\ttumor grade: 2;\tpositive lymph nodes: 1;\tki67(%): 20;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977726": [{"title": "cancer [3310]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 52;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 2;\ttumor grade: 3;\tpositive lymph nodes: 1;\tki67(%): 60;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977727": [{"title": "cancer [3314]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 49;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 1;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 80;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977728": [{"title": "cancer [3336]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 45;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 3.2;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 60;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977729": [{"title": "cancer [3366]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 41;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 13;\ttumor grade: 3;\tpositive lymph nodes: 4;\tki67(%): 70;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977730": [{"title": "cancer [3383]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 30;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 2.5;\ttumor grade: 0;\tpositive lymph nodes: 0;\tki67(%): 40;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977731": [{"title": "cancer [3392]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 42;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 2.5;\ttumor grade: 3;\tpositive lymph nodes: 18;\tki67(%): 80;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977732": [{"title": "cancer [3398]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 41;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 2;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 70;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977733": [{"title": "cancer [3400]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 65;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 2;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 50;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977734": [{"title": "cancer [3405]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 35;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 0.5;\ttumor grade: 3;\tpositive lymph nodes: 5;\tki67(%): 50;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977735": [{"title": "cancer [3415]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 76;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 2.5;\ttumor grade: 2;\tpositive lymph nodes: 1;\tki67(%): 15;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977736": [{"title": "cancer [3419]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 42;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 1;\ttumor grade: 3;\tpositive lymph nodes: 1;\tki67(%): 70;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977737": [{"title": "cancer [3420]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 59;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 3;\ttumor grade: 2;\tpositive lymph nodes: 1;\tki67(%): 70;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977738": [{"title": "cancer [3431]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 55;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 3.5;\ttumor grade: 2;\tpositive lymph nodes: 27;\tki67(%): 60;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977739": [{"title": "cancer [3479]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 29;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 5.5;\ttumor grade: 0;\tpositive lymph nodes: 0;\tki67(%): 70;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977740": [{"title": "cancer [3508]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 52;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 2.5;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 80;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977741": [{"title": "cancer [3533]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 62;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 5.5;\ttumor grade: 0;\tpositive lymph nodes: 0;\tki67(%): 5;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977742": [{"title": "cancer [3538]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 57;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 2;\ttumor grade: 2;\tpositive lymph nodes: 0;\tki67(%): 20;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977743": [{"title": "cancer [3595]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 65;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 2.5;\ttumor grade: 3;\tpositive lymph nodes: 2;\tki67(%): 70;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977744": [{"title": "cancer [3621]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 69;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 1.5;\ttumor grade: 2;\tpositive lymph nodes: 0;\tki67(%): 50;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977745": [{"title": "cancer [3622]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977746": [{"title": "cancer [3626]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 50;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 2.5;\ttumor grade: 0;\tpositive lymph nodes: 0;\tki67(%): 20;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977747": [{"title": "cancer [3637]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 57;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 2;\ttumor grade: 0;\tpositive lymph nodes: 0;\tki67(%): 50;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977748": [{"title": "cancer [3673]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 48;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 1.3;\ttumor grade: 3;\tpositive lymph nodes: 22;\tki67(%): 60;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977749": [{"title": "cancer [3889]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 42;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 2;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 90;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977750": [{"title": "cancer [3897]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 41;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 2.6;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 80;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977751": [{"title": "cancer [3976]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 54;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 2.5;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 70;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977752": [{"title": "cancer [3979]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 49;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 2;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 80;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977753": [{"title": "cancer [3983]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 69;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 3;\ttumor grade: 0;\tpositive lymph nodes: 16;\tki67(%): 20;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977754": [{"title": "cancer [3984+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 69;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 3;\ttumor grade: 3;\tpositive lymph nodes: 16;\tki67(%): 20;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977755": [{"title": "cancer [3995+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 57;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 4.5;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 50;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977756": [{"title": "cancer [4054+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 49;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 3;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 80;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977757": [{"title": "cancer [4075+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 58;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 2.2;\ttumor grade: 3;\tpositive lymph nodes: 17;\tki67(%): 30;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977758": [{"title": "cancer [4076+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 49;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 3;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 75;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977759": [{"title": "cancer [4083+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 53;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 1.2;\ttumor grade: 2;\tpositive lymph nodes: 1;\tki67(%): 80;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977760": [{"title": "cancer [4119+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 50;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 1.1;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 50;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977761": [{"title": "cancer [4132+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 52;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 2;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 80;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977762": [{"title": "cancer [4136+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 48;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 3;\ttumor grade: 3;\tpositive lymph nodes: 3;\tki67(%): 90;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977763": [{"title": "cancer [4143+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 62;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 3.5;\ttumor grade: 0;\tpositive lymph nodes: 0;\tki67(%): 50;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977764": [{"title": "cancer [4155+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 44;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 2.8;\ttumor grade: 3;\tpositive lymph nodes: 1;\tki67(%): 90;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977765": [{"title": "cancer [4160+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 67;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 2;\ttumor grade: 3;\tpositive lymph nodes: 1;\tki67(%): 70;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977766": [{"title": "cancer [4162+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 69;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 2;\ttumor grade: 3;\tpositive lymph nodes: 17;\tki67(%): 70;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977767": [{"title": "cancer [4167+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 56;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 3;\ttumor grade: 3;\tpositive lymph nodes: 1;\tki67(%): 60;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977768": [{"title": "cancer [4170+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 64;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 4.5;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 80;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977769": [{"title": "cancer [4232+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977770": [{"title": "cancer [4252+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 57;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 2.5;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 80;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977771": [{"title": "cancer [4267+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 33;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 1.5;\ttumor grade: 3;\tpositive lymph nodes: 2;\tki67(%): 80;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977772": [{"title": "cancer [4311+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 41;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 3;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 80;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977773": [{"title": "cancer [4318+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 64;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 2;\ttumor grade: 3;\tpositive lymph nodes: 1;\tki67(%): 50;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977774": [{"title": "cancer [4346+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 62;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 3.2;\ttumor grade: 3;\tpositive lymph nodes: 2;\tki67(%): 60;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977775": [{"title": "cancer [4366+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 47;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 2.7;\ttumor grade: 3;\tpositive lymph nodes: 1;\tki67(%): 90;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977776": [{"title": "cancer [4367+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 58;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 1.5;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 40;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977777": [{"title": "cancer [4412+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 54;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 3;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 90;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977778": [{"title": "cancer [4439+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 36;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 2.2;\ttumor grade: 3;\tpositive lymph nodes: 12;\tki67(%): 40;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977779": [{"title": "cancer [4442+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 43;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 4;\ttumor grade: 2;\tpositive lymph nodes: 22;\tki67(%): 80;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977780": [{"title": "cancer [4448+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 64;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 3.5;\ttumor grade: 3;\tpositive lymph nodes: 6;\tki67(%): 80;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977781": [{"title": "cancer [4467+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 61;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 1.5;\ttumor grade: 3;\tpositive lymph nodes: 2;\tki67(%): 60;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977782": [{"title": "cancer [4474+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 43;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 2;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 90;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977783": [{"title": "cancer [4483+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 50;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 3.3;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 90;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977784": [{"title": "cancer [4557+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 44;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 2.5;\ttumor grade: 3;\tpositive lymph nodes: 28;\tki67(%): 80;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977785": [{"title": "cancer [4559+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 55;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 0.8;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 70;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977786": [{"title": "cancer [4563+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 78;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 2.5;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 30;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977787": [{"title": "cancer [4584+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 38;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 3;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 80;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977788": [{"title": "cancer [4591+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 45;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 2.7;\ttumor grade: 3;\tpositive lymph nodes: 1;\tki67(%): 70;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977789": [{"title": "cancer [4601+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 58;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 2;\ttumor grade: 2;\tpositive lymph nodes: 1;\tki67(%): 20;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977790": [{"title": "cancer [4603+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 50;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 3;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 60;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977791": [{"title": "cancer [4624+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 35;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 2.5;\ttumor grade: 0;\tpositive lymph nodes: 0;\tki67(%): 70;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977792": [{"title": "cancer [4638+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 54;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 2.6;\ttumor grade: 0;\tpositive lymph nodes: 0;\tki67(%): 60;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977793": [{"title": "cancer [4639+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 56;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 1.8;\ttumor grade: 0;\tpositive lymph nodes: 0;\tki67(%): 70;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977794": [{"title": "cancer [4659+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 63;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 2.5;\ttumor grade: 2;\tpositive lymph nodes: 0;\tki67(%): 20;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977795": [{"title": "cancer [4660+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 46;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 4;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 40;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977796": [{"title": "cancer [4700+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 57;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 1.8;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 70;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977797": [{"title": "cancer [4702+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 50;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 1.5;\tpositive lymph nodes: 1;\tki67(%): 60;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977798": [{"title": "cancer [4708+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 55;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 2;\ttumor grade: 2;\tpositive lymph nodes: 1;\tki67(%): 20;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977799": [{"title": "cancer [4714+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 52;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 0.8;\ttumor grade: 2;\tpositive lymph nodes: 0;\tki67(%): 25;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977800": [{"title": "cancer [4736+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 27;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 1.5;\ttumor grade: 3;\tpositive lymph nodes: 2;\tki67(%): 90;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977801": [{"title": "cancer [4737+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 49;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 2;\ttumor grade: 2;\tpositive lymph nodes: 6;\tki67(%): 90;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977802": [{"title": "cancer [4747+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 57;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 2;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 70;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977803": [{"title": "cancer [4769+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 58;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 2.5;\ttumor grade: 3;\tpositive lymph nodes: 6;\tki67(%): 70;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977804": [{"title": "cancer [4773+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 55;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 2;\ttumor grade: 3;\tpositive lymph nodes: 6;\tki67(%): 30;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977805": [{"title": "cancer [4783+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 61;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 1.7;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 60;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977806": [{"title": "cancer [4791+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 50;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 2;\ttumor grade: 0;\tpositive lymph nodes: 0;\tki67(%): 25;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977807": [{"title": "cancer [4793+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 68;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 2.8;\ttumor grade: 3;\tpositive lymph nodes: 4;\tki67(%): 40;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977808": [{"title": "cancer [4799+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 65;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 2;\ttumor grade: 3;\tpositive lymph nodes: 0;\tki67(%): 55;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977809": [{"title": "cancer [4803+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 46;\tmenopause status (0=pre, 1=post): 0;\tsize (cm): 3.5;\ttumor grade: 3;\tpositive lymph nodes: 8;\tki67(%): 75;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977810": [{"title": "cancer [4827+]"}, {"type": "RNA"}, {"source_name_ch1": "breast_TNBC"}, {"characteristics_ch1": "gender: female;\tage (yrs): 64;\tmenopause status (0=pre, 1=post): 1;\tsize (cm): 2.2;\ttumor grade: 3;\tpositive lymph nodes: 2;\tki67(%): 75;\ttissue type: triple negative breast cancer (TNBC)"}]}, {"GSM1977811": [{"title": "adjacent cancer [4803-]"}, {"type": "RNA"}, {"source_name_ch1": "breast_normal tissue"}, {"characteristics_ch1": "gender: female;\ttissue type: normal breast tissue"}]}, {"GSM1977812": [{"title": "adjacent cancer [4474-]"}, {"type": "RNA"}, {"source_name_ch1": "breast_normal tissue"}, {"characteristics_ch1": "gender: female;\ttissue type: normal breast tissue"}]}, {"GSM1977813": [{"title": "adjacent cancer [4162-]"}, {"type": "RNA"}, {"source_name_ch1": "breast_normal tissue"}, {"characteristics_ch1": "gender: female;\ttissue type: normal breast tissue"}]}, {"GSM1977814": [{"title": "adjacent cancer [4119-]"}, {"type": "RNA"}, {"source_name_ch1": "breast_normal tissue"}, {"characteristics_ch1": "gender: female;\ttissue type: normal breast tissue"}]}, {"GSM1977815": [{"title": "adjacent cancer [4448-]"}, {"type": "RNA"}, {"source_name_ch1": "breast_normal tissue"}, {"characteristics_ch1": "gender: female;\ttissue type: normal breast tissue"}]}, {"GSM1977816": [{"title": "adjacent cancer [4346-]"}, {"type": "RNA"}, {"source_name_ch1": "breast_normal tissue"}, {"characteristics_ch1": "gender: female;\ttissue type: normal breast tissue"}]}, {"GSM1977817": [{"title": "adjacent cancer [4318-]"}, {"type": "RNA"}, {"source_name_ch1": "breast_normal tissue"}, {"characteristics_ch1": "gender: female;\ttissue type: normal breast tissue"}]}, {"GSM1977818": [{"title": "adjacent cancer [4559-]"}, {"type": "RNA"}, {"source_name_ch1": "breast_normal tissue"}, {"characteristics_ch1": "gender: female;\ttissue type: normal breast tissue"}]}, {"GSM1977819": [{"title": "adjacent cancer [4638-]"}, {"type": "RNA"}, {"source_name_ch1": "breast_normal tissue"}, {"characteristics_ch1": "gender: female;\ttissue type: normal breast tissue"}]}, {"GSM1977820": [{"title": "adjacent cancer [4083-]"}, {"type": "RNA"}, {"source_name_ch1": "breast_normal tissue"}, {"characteristics_ch1": "gender: female;\ttissue type: normal breast tissue"}]}, {"GSM1977821": [{"title": "adjacent cancer [4467-]"}, {"type": "RNA"}, {"source_name_ch1": "breast_normal tissue"}, {"characteristics_ch1": "gender: female;\ttissue type: normal breast tissue"}]}, {"GSM1977822": [{"title": "adjacent cancer [4603-]"}, {"type": "RNA"}, {"source_name_ch1": "breast_normal tissue"}, {"characteristics_ch1": "gender: female;\ttissue type: normal breast tissue"}]}, {"GSM1977823": [{"title": "adjacent cancer [4136-]"}, {"type": "RNA"}, {"source_name_ch1": "breast_normal tissue"}, {"characteristics_ch1": "gender: female;\ttissue type: normal breast tissue"}]}, {"GSM1977824": [{"title": "adjacent cancer [4232-]"}, {"type": "RNA"}, {"source_name_ch1": "breast_normal tissue"}, {"characteristics_ch1": "gender: female;\ttissue type: normal breast tissue"}]}, {"GSM1977825": [{"title": "adjacent cancer [4442-]"}, {"type": "RNA"}, {"source_name_ch1": "breast_normal tissue"}, {"characteristics_ch1": "gender: female;\ttissue type: normal breast tissue"}]}, {"GSM1977826": [{"title": "adjacent cancer [4737-]"}, {"type": "RNA"}, {"source_name_ch1": "breast_normal tissue"}, {"characteristics_ch1": "gender: female;\ttissue type: normal breast tissue"}]}, {"GSM1977827": [{"title": "adjacent cancer [4783-]"}, {"type": "RNA"}, {"source_name_ch1": "breast_normal tissue"}, {"characteristics_ch1": "gender: female;\ttissue type: normal breast tissue"}]}, {"GSM1977828": [{"title": "adjacent cancer [4659-]"}, {"type": "RNA"}, {"source_name_ch1": "breast_normal tissue"}, {"characteristics_ch1": "gender: female;\ttissue type: normal breast tissue"}]}, {"GSM1977829": [{"title": "adjacent cancer [4143-]"}, {"type": "RNA"}, {"source_name_ch1": "breast_normal tissue"}, {"characteristics_ch1": "gender: female;\ttissue type: normal breast tissue"}]}, {"GSM1977830": [{"title": "adjacent cancer [4252-]"}, {"type": "RNA"}, {"source_name_ch1": "breast_normal tissue"}, {"characteristics_ch1": "gender: female;\ttissue type: normal breast tissue"}]}, {"GSM1977831": [{"title": "adjacent cancer [4483-]"}, {"type": "RNA"}, {"source_name_ch1": "breast_normal tissue"}, {"characteristics_ch1": "gender: female;\ttissue type: normal breast tissue"}]}, {"GSM1977832": [{"title": "adjacent cancer [4439-]"}, {"type": "RNA"}, {"source_name_ch1": "breast_normal tissue"}, {"characteristics_ch1": "gender: female;\ttissue type: normal breast tissue"}]}, {"GSM1977833": [{"title": "adjacent cancer [4132-]"}, {"type": "RNA"}, {"source_name_ch1": "breast_normal tissue"}, {"characteristics_ch1": "gender: female;\ttissue type: normal breast tissue"}]}, {"GSM1977834": [{"title": "adjacent cancer [3995-2]"}, {"type": "RNA"}, {"source_name_ch1": "breast_normal tissue"}, {"characteristics_ch1": "gender: female;\ttissue type: normal breast tissue"}]}, {"GSM1977835": [{"title": "adjacent cancer [4311-]"}, {"type": "RNA"}, {"source_name_ch1": "breast_normal tissue"}, {"characteristics_ch1": "gender: female;\ttissue type: normal breast tissue"}]}, {"GSM1977836": [{"title": "adjacent cancer [4660-]"}, {"type": "RNA"}, {"source_name_ch1": "breast_normal tissue"}, {"characteristics_ch1": "gender: female;\ttissue type: normal breast tissue"}]}, {"GSM1977837": [{"title": "adjacent cancer [4160-]"}, {"type": "RNA"}, {"source_name_ch1": "breast_normal tissue"}, {"characteristics_ch1": "gender: female;\ttissue type: normal breast tissue"}]}, {"GSM1977838": [{"title": "adjacent cancer [4700-]"}, {"type": "RNA"}, {"source_name_ch1": "breast_normal tissue"}, {"characteristics_ch1": "gender: female;\ttissue type: normal breast tissue"}]}, {"GSM1977839": [{"title": "adjacent cancer [4557-]"}, {"type": "RNA"}, {"source_name_ch1": "breast_normal tissue"}, {"characteristics_ch1": "gender: female;\ttissue type: normal breast tissue"}]}, {"GSM1977840": [{"title": "adjacent cancer [4366-]"}, {"type": "RNA"}, {"source_name_ch1": "breast_normal tissue"}, {"characteristics_ch1": "gender: female;\ttissue type: normal breast tissue"}]}, {"GSM1977841": [{"title": "adjacent cancer [4367-]"}, {"type": "RNA"}, {"source_name_ch1": "breast_normal tissue"}, {"characteristics_ch1": "gender: female;\ttissue type: normal breast tissue"}]}, {"GSM1977842": [{"title": "adjacent cancer [4155-]"}, {"type": "RNA"}, {"source_name_ch1": "breast_normal tissue"}, {"characteristics_ch1": "gender: female;\ttissue type: normal breast tissue"}]}, {"GSM1977843": [{"title": "adjacent cancer [4563-]"}, {"type": "RNA"}, {"source_name_ch1": "breast_normal tissue"}, {"characteristics_ch1": "gender: female;\ttissue type: normal breast tissue"}]}, {"GSM2024737": [{"title": "SW1990_Ctrl"}, {"type": "RNA"}, {"source_name_ch1": "SW1990 cells infected with empty control lentiviral particles"}, {"characteristics_ch1": "cell line: SW1990 (human pancreatic cancer cell line);\ttreatment: infected with empty control lentiviral particles and followed by puromycin selection;\tgenotype/variation: control"}]}, {"GSM2024738": [{"title": "SW1990_Fbw7"}, {"type": "RNA"}, {"source_name_ch1": "SW1990 cells stably overexpressing Fbw7"}, {"characteristics_ch1": "cell line: SW1990 (human pancreatic cancer cell line);\ttreatment: infected with Fbw7 expressing lentiviral particles and followed by puromycin selection;\tgenotype/variation: Fbw7 over-expression"}]}, {"GSM2039069": [{"title": "Medullary carcinoma_1"}, {"type": "RNA"}, {"source_name_ch1": "Medullary carcinoma"}, {"characteristics_ch1": "tissue: colon;\tdisease state: Colon Cancer"}]}, {"GSM2039070": [{"title": "Medullary carcinoma_2"}, {"type": "RNA"}, {"source_name_ch1": "Medullary carcinoma"}, {"characteristics_ch1": "tissue: colon;\tdisease state: Colon Cancer"}]}, {"GSM2039071": [{"title": "Medullary carcinoma_3"}, {"type": "RNA"}, {"source_name_ch1": "Medullary carcinoma"}, {"characteristics_ch1": "tissue: colon;\tdisease state: Colon Cancer"}]}, {"GSM2039072": [{"title": "Medullary carcinoma_4"}, {"type": "RNA"}, {"source_name_ch1": "Medullary carcinoma"}, {"characteristics_ch1": "tissue: colon;\tdisease state: Colon Cancer"}]}, {"GSM2039073": [{"title": "Medullary carcinoma_5"}, {"type": "RNA"}, {"source_name_ch1": "Medullary carcinoma"}, {"characteristics_ch1": "tissue: colon;\tdisease state: Colon Cancer"}]}, {"GSM2039074": [{"title": "Medullary carcinoma_6"}, {"type": "RNA"}, {"source_name_ch1": "Medullary carcinoma"}, {"characteristics_ch1": "tissue: colon;\tdisease state: Colon Cancer"}]}, {"GSM2039075": [{"title": "Adjacent normal colonic mucosa_1"}, {"type": "RNA"}, {"source_name_ch1": "Adjacent normal colonic mucosa"}, {"characteristics_ch1": "tissue: colon;\tdisease state: Normal tissue"}]}, {"GSM2039076": [{"title": "Adjacent normal colonic mucosa_2"}, {"type": "RNA"}, {"source_name_ch1": "Adjacent normal colonic mucosa"}, {"characteristics_ch1": "tissue: colon;\tdisease state: Normal tissue"}]}, {"GSM2039077": [{"title": "Adjacent normal colonic mucosa_3"}, {"type": "RNA"}, {"source_name_ch1": "Adjacent normal colonic mucosa"}, {"characteristics_ch1": "tissue: colon;\tdisease state: Normal tissue"}]}, {"GSM2039078": [{"title": "Adjacent normal colonic mucosa_4"}, {"type": "RNA"}, {"source_name_ch1": "Adjacent normal colonic mucosa"}, {"characteristics_ch1": "tissue: colon;\tdisease state: Normal tissue"}]}, {"GSM2039079": [{"title": "Adjacent normal colonic mucosa_5"}, {"type": "RNA"}, {"source_name_ch1": "Adjacent normal colonic mucosa"}, {"characteristics_ch1": "tissue: colon;\tdisease state: Normal tissue"}]}, {"GSM2039080": [{"title": "Adjacent normal colonic mucosa_6"}, {"type": "RNA"}, {"source_name_ch1": "Adjacent normal colonic mucosa"}, {"characteristics_ch1": "tissue: colon;\tdisease state: Normal tissue"}]}, {"GSM2039126": [{"title": "HC-1"}, {"type": "RNA"}, {"source_name_ch1": "trophoblasts from placenta villi tissue of healthy controls"}, {"characteristics_ch1": "tissue: placenta villi;\tsample type: healthy control;\tdevelopmental stage: early pregnancy"}]}, {"GSM2039127": [{"title": "HC-2"}, {"type": "RNA"}, {"source_name_ch1": "trophoblasts from placenta villi tissue of healthy controls"}, {"characteristics_ch1": "tissue: placenta villi;\tsample type: healthy control;\tdevelopmental stage: early pregnancy"}]}, {"GSM2039128": [{"title": "HC-3"}, {"type": "RNA"}, {"source_name_ch1": "trophoblasts from placenta villi tissue of healthy controls"}, {"characteristics_ch1": "tissue: placenta villi;\tsample type: healthy control;\tdevelopmental stage: early pregnancy"}]}, {"GSM2039129": [{"title": "RM-1"}, {"type": "RNA"}, {"source_name_ch1": "trophoblasts from placenta villi tissue of patients with recurrent miscarriage"}, {"characteristics_ch1": "tissue: placenta villi;\tsample type: recurrent miscarriage;\tdevelopmental stage: early pregnancy"}]}, {"GSM2039130": [{"title": "RM-2"}, {"type": "RNA"}, {"source_name_ch1": "trophoblasts from placenta villi tissue of patients with recurrent miscarriage"}, {"characteristics_ch1": "tissue: placenta villi;\tsample type: recurrent miscarriage;\tdevelopmental stage: early pregnancy"}]}, {"GSM2039131": [{"title": "RM-3"}, {"type": "RNA"}, {"source_name_ch1": "trophoblasts from placenta villi tissue of patients with recurrent miscarriage"}, {"characteristics_ch1": "tissue: placenta villi;\tsample type: recurrent miscarriage;\tdevelopmental stage: early pregnancy"}]}, {"GSM2040281": [{"title": "HUMAN-PVs-CON-MALE [4945331_(HTA-2_0)]"}, {"type": "RNA"}, {"source_name_ch1": "myocardial sleeves of pulmonary veins in non-AF"}, {"characteristics_ch1": "gender: MALE"}]}, {"GSM2040282": [{"title": "HUMAN-PVs-CON-MALE [4958228_(HTA-2_0)]"}, {"type": "RNA"}, {"source_name_ch1": "myocardial sleeves of pulmonary veins in non-AF"}, {"characteristics_ch1": "gender: MALE"}]}, {"GSM2040283": [{"title": "HUMAN-PVs-CON-MALE [711814_(HTA-2_0)]"}, {"type": "RNA"}, {"source_name_ch1": "myocardial sleeves of pulmonary veins in non-AF"}, {"characteristics_ch1": "gender: MALE"}]}, {"GSM2040284": [{"title": "HUMAN-PVs-AF-MALE [1000663180_(HTA-2_0)]"}, {"type": "RNA"}, {"source_name_ch1": "myocardial sleeves of pulmonary veins in AF"}, {"characteristics_ch1": "gender: MALE"}]}, {"GSM2040285": [{"title": "HUMAN-PVs-AF-MALE [477405_(HTA-2_0)]"}, {"type": "RNA"}, {"source_name_ch1": "myocardial sleeves of pulmonary veins in AF"}, {"characteristics_ch1": "gender: MALE"}]}, {"GSM2040286": [{"title": "HUMAN-PVs-AF-MALE [4779897_(HTA-2_0)]"}, {"type": "RNA"}, {"source_name_ch1": "myocardial sleeves of pulmonary veins in AF"}, {"characteristics_ch1": "gender: MALE"}]}, {"GSM2040287": [{"title": "HUMAN-PVs-CON-FEMALE [502821_(HTA-2_0)]"}, {"type": "RNA"}, {"source_name_ch1": "myocardial sleeves of pulmonary veins in non-AF"}, {"characteristics_ch1": "gender: FEMALE"}]}, {"GSM2040288": [{"title": "HUMAN-PVs-CON-FEMALE [711269_(HTA-2_0)]"}, {"type": "RNA"}, {"source_name_ch1": "myocardial sleeves of pulmonary veins in non-AF"}, {"characteristics_ch1": "gender: FEMALE"}]}, {"GSM2040289": [{"title": "HUMAN-PVs-CON-FEMALE [711470_(HTA-2_0)]"}, {"type": "RNA"}, {"source_name_ch1": "myocardial sleeves of pulmonary veins in non-AF"}, {"characteristics_ch1": "gender: FEMALE"}]}, {"GSM2040290": [{"title": "HUMAN-PVs-AF-FEMALE [706696_(HTA-2_0)]"}, {"type": "RNA"}, {"source_name_ch1": "myocardial sleeves of pulmonary veins in AF"}, {"characteristics_ch1": "gender: FEMALE"}]}, {"GSM2040291": [{"title": "HUMAN-PVs-AF-FEMALE [1001252643_(HTA-2_0)]"}, {"type": "RNA"}, {"source_name_ch1": "myocardial sleeves of pulmonary veins in AF"}, {"characteristics_ch1": "gender: FEMALE"}]}, {"GSM2040292": [{"title": "HUMAN-PVs-AF-FEMALE [1002131318_(HTA-2_0)]"}, {"type": "RNA"}, {"source_name_ch1": "myocardial sleeves of pulmonary veins in AF"}, {"characteristics_ch1": "gender: FEMALE"}]}, {"GSM2045723": [{"title": "AP-UT-69"}, {"type": "RNA"}, {"source_name_ch1": "CML-69"}, {"characteristics_ch1": "disease state: CML;\ttissue: Blood;\tphase: Accelerated Phase;\ttreatment: Under Treatment Imatinib treated 3 months;\tage: 40 years;\tgender: female"}]}, {"GSM2045724": [{"title": "AP-UT-70"}, {"type": "RNA"}, {"source_name_ch1": "CML-70"}, {"characteristics_ch1": "disease state: CML;\ttissue: Blood;\tphase: Accelerated Phase;\ttreatment: Under Treatment Imatinib and Nilotinib treated 1 year;\tage: 30 years;\tgender: male"}]}, {"GSM2045725": [{"title": "CP-UT-71"}, {"type": "RNA"}, {"source_name_ch1": "CML-71"}, {"characteristics_ch1": "disease state: CML;\ttissue: Blood;\tphase: Chronic Phase;\ttreatment: Under Treatment-Initially Hydab, Uridrea and since october 2012 Imatinib 8.1 years;\tage: 52 years;\tgender: male"}]}, {"GSM2045726": [{"title": "AP-UT-72"}, {"type": "RNA"}, {"source_name_ch1": "CML-72"}, {"characteristics_ch1": "disease state: CML;\ttissue: Blood;\tphase: Accelerated Phase;\ttreatment: Under Treatment Imatinib and Nilotinib treated 6 months;\tage: 45 years;\tgender: male"}]}, {"GSM2045727": [{"title": "AP-NEW-73"}, {"type": "RNA"}, {"source_name_ch1": "CML-73"}, {"characteristics_ch1": "disease state: CML;\ttissue: Blood;\tphase: Chronic Phase;\ttreatment: NEW;\tage: 50 years;\tgender: male"}]}, {"GSM2045728": [{"title": "CP-NEW-83"}, {"type": "RNA"}, {"source_name_ch1": "CML-83"}, {"characteristics_ch1": "disease state: CML;\ttissue: Blood;\tphase: Chronic Phase;\ttreatment: NEW;\tage: 70 years;\tgender: male"}]}, {"GSM2045729": [{"title": "AP-UT-1"}, {"type": "RNA"}, {"source_name_ch1": "CML-86"}, {"characteristics_ch1": "disease state: CML;\ttissue: Blood;\tphase: Accelerated Phase;\ttreatment: Under Treatment- Imatinib for 1.8 years;\tage: 35 years;\tgender: male"}]}, {"GSM2045730": [{"title": "AP-UT-86"}, {"type": "RNA"}, {"source_name_ch1": "CML-1"}, {"characteristics_ch1": "disease state: CML;\ttissue: Blood;\tphase: Accerelated Phase;\ttreatment: Under Treatment Imatinib and Nilotinib for 5 months;\tage: 49 years;\tgender: male"}]}, {"GSM2045731": [{"title": "CP-NEW-10"}, {"type": "RNA"}, {"source_name_ch1": "CML-10"}, {"characteristics_ch1": "disease state: CML;\ttissue: Blood;\tphase: Chronic Phase;\ttreatment: NEW;\tage: 46 years;\tgender: male"}]}, {"GSM2045732": [{"title": "B-NEW-11"}, {"type": "RNA"}, {"source_name_ch1": "CML-11"}, {"characteristics_ch1": "disease state: CML;\ttissue: Blood;\tphase: Blast;\ttreatment: NEW;\tage: 20 years;\tgender: male"}]}, {"GSM2045733": [{"title": "CP-UT-13"}, {"type": "RNA"}, {"source_name_ch1": "CML-13"}, {"characteristics_ch1": "disease state: CML;\ttissue: Blood;\tphase: Chronic Phase;\ttreatment: Under Treatment-Droxygel (Antacid), Unidrea and Imatinib treated for 7.1 years;\tage: 50 years;\tgender: male"}]}, {"GSM2045734": [{"title": "CP-NEW-14"}, {"type": "RNA"}, {"source_name_ch1": "CML-14"}, {"characteristics_ch1": "disease state: CML;\ttissue: Blood;\tphase: Chronic Phase;\ttreatment: NEW;\tage: 35 years;\tgender: female"}]}, {"GSM2045735": [{"title": "B-NEW-19"}, {"type": "RNA"}, {"source_name_ch1": "CML-19"}, {"characteristics_ch1": "disease state: CML;\ttissue: Blood;\tphase: Blast;\ttreatment: NEW;\tage: 28 years;\tgender: male"}]}, {"GSM2045736": [{"title": "CP-UT-20"}, {"type": "RNA"}, {"source_name_ch1": "CML-20"}, {"characteristics_ch1": "disease state: CML;\ttissue: Blood;\tphase: Chronic Phase;\ttreatment: Under Treatment Imatinib one month;\tage: 33 years;\tgender: female"}]}, {"GSM2045737": [{"title": "CP-UT-21"}, {"type": "RNA"}, {"source_name_ch1": "CML-21"}, {"characteristics_ch1": "disease state: CML;\ttissue: Blood;\tphase: Chronic Phase;\ttreatment: Under Treatment-Droxygel (Antacid), Unidrea and Imatinib treated for 3.8 years;\tage: 60 years;\tgender: male"}]}, {"GSM2045738": [{"title": "CP-UT-2"}, {"type": "RNA"}, {"source_name_ch1": "CML-2"}, {"characteristics_ch1": "disease state: CML;\ttissue: Blood;\tphase: Chronic Phase;\ttreatment: Under Treatment-Droxygel (Antacid), Unidrea and Imatinib treated;\tage: 50 years;\tgender: male"}]}, {"GSM2045739": [{"title": "AP-UT-32"}, {"type": "RNA"}, {"source_name_ch1": "CML-32"}, {"characteristics_ch1": "disease state: CML;\ttissue: Blood;\tphase: Accelerated Phase;\ttreatment: Under Treatment-Initially treated with Myeleron, Hydab irocos, Zyloric since may 2005 on Imatinib treated for 15 years;\tage: 27 years;\tgender: female"}]}, {"GSM2045740": [{"title": "B-NEW-34"}, {"type": "RNA"}, {"source_name_ch1": "CML-34"}, {"characteristics_ch1": "disease state: CML;\ttissue: Blood;\tphase: Blast;\ttreatment: NEW;\tage: 24 years;\tgender: male"}]}, {"GSM2045741": [{"title": "CP-UT-36"}, {"type": "RNA"}, {"source_name_ch1": "CML-36"}, {"characteristics_ch1": "disease state: CML;\ttissue: Blood;\tphase: Chronic Phase;\ttreatment: Under Treatment-Hydab and Imatinib treated for 6.10 years;\tage: 23 years;\tgender: male"}]}, {"GSM2045742": [{"title": "CP-UT-55"}, {"type": "RNA"}, {"source_name_ch1": "CML-55"}, {"characteristics_ch1": "disease state: CML;\ttissue: Blood;\tphase: Chronic Phase;\ttreatment: Under Treatment-Imatinib treated for 3 months;\tage: 60 years;\tgender: male"}]}, {"GSM2045743": [{"title": "CP-UT-56"}, {"type": "RNA"}, {"source_name_ch1": "CML-56"}, {"characteristics_ch1": "disease state: CML;\ttissue: Blood;\tphase: Chronic Phase;\ttreatment: Under Treatment-Hydroxyurea , Zyloric and  Imatinib treated one year;\tage: 43 years;\tgender: female"}]}, {"GSM2045744": [{"title": "CP-UT-58"}, {"type": "RNA"}, {"source_name_ch1": "CML-58"}, {"characteristics_ch1": "disease state: CML;\ttissue: Blood;\tphase: Chronic Phase;\ttreatment: Under Treatment-Hydroxyurea , Zyloric and  Imatinib treated nine months;\tage: 32 years;\tgender: female"}]}, {"GSM2045745": [{"title": "AP-UT-59"}, {"type": "RNA"}, {"source_name_ch1": "CML-59"}, {"characteristics_ch1": "disease state: CML;\ttissue: Blood;\tphase: Chronic Phase;\ttreatment: Under Treatment-Hydroxyurea , Zyloric and Imatinib treated 3months;\tage: 15 years;\tgender: female"}]}, {"GSM2045746": [{"title": "CP-UT-6"}, {"type": "RNA"}, {"source_name_ch1": "CML-6"}, {"characteristics_ch1": "disease state: CML;\ttissue: Blood;\tphase: Chronic Phase;\ttreatment: Under Treatment-Imatinib treated 7 months;\tage: 24 years;\tgender: male"}]}, {"GSM2045747": [{"title": "CP-UT-87"}, {"type": "RNA"}, {"source_name_ch1": "CML-87"}, {"characteristics_ch1": "disease state: CML;\ttissue: Blood;\tphase: Chronic Phase;\ttreatment: Under Treatment- Imatinib treated 2.9 years;\tage: 45 years;\tgender: female"}]}, {"GSM2045748": [{"title": "CP-NEW-9"}, {"type": "RNA"}, {"source_name_ch1": "CML-9"}, {"characteristics_ch1": "disease state: CML;\ttissue: Blood;\tphase: Chronic Phase;\ttreatment: NEW;\tage: 46 years;\tgender: male"}]}, {"GSM2045749": [{"title": "CP-UT-4"}, {"type": "RNA"}, {"source_name_ch1": "CML-4"}, {"characteristics_ch1": "disease state: CML;\ttissue: Blood;\tphase: Chronic Phase;\ttreatment: Under Treatment-Imatinib 10 months;\tage: 14 years;\tgender: male"}]}, {"GSM2045750": [{"title": "CP-UT-57"}, {"type": "RNA"}, {"source_name_ch1": "CML-57"}, {"characteristics_ch1": "disease state: CML;\ttissue: Blood;\tphase: Chronic Phase;\ttreatment: Under Treatment-Hydroxyurea, Zyloric and Imatinib treated;\tage: 42 years;\tgender: male"}]}, {"GSM2045751": [{"title": "CP"}, {"type": "RNA"}, {"source_name_ch1": "CML-60"}, {"characteristics_ch1": "disease state: CML;\ttissue: Blood;\tphase: Chronic Phase;\ttreatment: N/A;\tage: N/A;\tgender: N/A"}]}, {"GSM2045752": [{"title": "CP-UT-7"}, {"type": "RNA"}, {"source_name_ch1": "CML-7"}, {"characteristics_ch1": "disease state: CML;\ttissue: Blood;\tphase: Chronic Phase;\ttreatment: Under Treatment-Imatinib for 7.2 years;\tage: 41 years;\tgender: male"}]}, {"GSM2045753": [{"title": "AP-UT-62"}, {"type": "RNA"}, {"source_name_ch1": "CML-62"}, {"characteristics_ch1": "disease state: CML;\ttissue: Blood;\tphase: Accelerated Phase;\ttreatment: Under Treatment-Uridrea, Imatinib and since February 2014 Nilotinib treated for 4.4 years;\tage: 42 years;\tgender: male"}]}, {"GSM2045754": [{"title": "CP-UT-63"}, {"type": "RNA"}, {"source_name_ch1": "CML-63"}, {"characteristics_ch1": "disease state: CML;\ttissue: Blood;\tphase: Chronic Phase;\ttreatment: Under Treatment-Imatinib for 7 months;\tage: 37 years;\tgender: male"}]}, {"GSM2045755": [{"title": "CP-UT-65"}, {"type": "RNA"}, {"source_name_ch1": "CML-65"}, {"characteristics_ch1": "disease state: CML;\ttissue: Blood;\tphase: Chronic Phase;\ttreatment: Under Treatment-Imatinib for 7.9 years;\tage: 43 years;\tgender: male"}]}, {"GSM2045756": [{"title": "CP-UT-68"}, {"type": "RNA"}, {"source_name_ch1": "CML-68"}, {"characteristics_ch1": "disease state: CML;\ttissue: Blood;\tphase: Chronic Phase;\ttreatment: Under Treatment-Imatinib for 4 months;\tage: 28 years;\tgender: male"}]}, {"GSM2045757": [{"title": "CP-UT-91"}, {"type": "RNA"}, {"source_name_ch1": "CML-91"}, {"characteristics_ch1": "disease state: CML;\ttissue: Blood;\tphase: Chronic Phase;\ttreatment: Under Treatment-Imatinib 6 months;\tage: 66 years;\tgender: female"}]}, {"GSM2045758": [{"title": "CP-UT-93"}, {"type": "RNA"}, {"source_name_ch1": "CML-93"}, {"characteristics_ch1": "disease state: CML;\ttissue: Blood;\tphase: Chronic Phase;\ttreatment: Under Treatment-Imatinib for 11 months;\tage: 60 years;\tgender: male"}]}, {"GSM2045759": [{"title": "CON-M-1"}, {"type": "RNA"}, {"source_name_ch1": "Control M-1"}, {"characteristics_ch1": "disease state: Control;\ttissue: Blood;\tphase: CONTROL;\ttreatment: N/A;\tage: N/A;\tgender: male"}]}, {"GSM2045760": [{"title": "CON-F-1"}, {"type": "RNA"}, {"source_name_ch1": "Control F-1"}, {"characteristics_ch1": "disease state: Control;\ttissue: Blood;\tphase: CONTROL;\ttreatment: N/A;\tage: N/A;\tgender: female"}]}, {"GSM2045761": [{"title": "CON-F-2"}, {"type": "RNA"}, {"source_name_ch1": "Control F-2"}, {"characteristics_ch1": "disease state: Control;\ttissue: Blood;\tphase: CONTROL;\ttreatment: N/A;\tage: N/A;\tgender: female"}]}, {"GSM2045762": [{"title": "CON-M-2"}, {"type": "RNA"}, {"source_name_ch1": "Control M-2"}, {"characteristics_ch1": "disease state: Control;\ttissue: Blood;\tphase: CONTROL;\ttreatment: N/A;\tage: N/A;\tgender: male"}]}, {"GSM2053564": [{"title": "FFPE specimen of NFPA, biological rep1 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "obtained from archived tissue samples derived from patients with NFPA"}, {"characteristics_ch1": "gender: female;\ttissue: pituitary;\tage: 49 years old"}]}, {"GSM2053565": [{"title": "FFPE specimen of NFPA, biological rep2 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "obtained from archived tissue samples derived from patients with NFPA"}, {"characteristics_ch1": "gender: male;\ttissue: pituitary;\tage: 36 years old"}]}, {"GSM2053566": [{"title": "FFPE specimen of NFPA, biological rep3 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "obtained from archived tissue samples derived from patients with NFPA"}, {"characteristics_ch1": "gender: male;\ttissue: pituitary;\tage: 58 years old"}]}, {"GSM2053567": [{"title": "FFPE specimen of NFPA, biological rep4 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "obtained from archived tissue samples derived from patients with NFPA"}, {"characteristics_ch1": "gender: female;\ttissue: pituitary;\tage: 48 years old"}]}, {"GSM2053568": [{"title": "FFPE specimen of NFPA, biological rep5 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "obtained from archived tissue samples derived from patients with NFPA"}, {"characteristics_ch1": "gender: female;\ttissue: pituitary;\tage: 60 years old"}]}, {"GSM2053569": [{"title": "FFPE specimen of NP, biological rep1 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "obtained from autopsy without PA"}, {"characteristics_ch1": "gender: female;\ttissue: pituitary;\tage: 33 years old"}]}, {"GSM2053570": [{"title": "FFPE specimen of NP, biological rep2 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "obtained from autopsy without PA"}, {"characteristics_ch1": "gender: female;\ttissue: pituitary;\tage: 55 years old"}]}, {"GSM2053571": [{"title": "FFPE specimen of NP, biological rep3 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "obtained from autopsy without PA"}, {"characteristics_ch1": "gender: male;\ttissue: pituitary;\tage: 60 years old"}]}, {"GSM2053572": [{"title": "FFPE specimen of NP, biological rep4 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "obtained from autopsy without PA"}, {"characteristics_ch1": "gender: female;\ttissue: pituitary;\tage: 28 years old"}]}, {"GSM2053573": [{"title": "FFPE specimen of NP, biological rep5 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "obtained from autopsy without PA"}, {"characteristics_ch1": "gender: female;\ttissue: pituitary;\tage: 30 years old"}]}, {"GSM2054570": [{"title": "MDA-MB-453_NC_48h"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-453, untreated"}, {"characteristics_ch1": "cell line: MDA-MB-453;\tgender: female;\tcell type: breast carcinoma;\tage: 48 years adult;\tethnicity: Caucasian"}]}, {"GSM2054571": [{"title": "MDA-MB-453_sulforaphene_48h"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-453, sulforaphene"}, {"characteristics_ch1": "cell line: MDA-MB-453;\tgender: female;\tcell type: breast carcinoma;\tage: 48 years adult;\tethnicity: Caucasian"}]}, {"GSM2059950": [{"title": "22Rv1-SSX2 Knockdown-1"}, {"type": "RNA"}, {"source_name_ch1": "22Rv1 Cells-SSX2 Knockdown"}, {"characteristics_ch1": "ssx expression: none;\tcell line: 22Rv1"}]}, {"GSM2059951": [{"title": "22Rv1-SSX2 Knockdown-2"}, {"type": "RNA"}, {"source_name_ch1": "22Rv1 Cells-SSX2 Knockdown"}, {"characteristics_ch1": "ssx expression: none;\tcell line: 22Rv1"}]}, {"GSM2059952": [{"title": "22Rv1-SSX2 Knockdown-3"}, {"type": "RNA"}, {"source_name_ch1": "22Rv1 Cells-SSX2 Knockdown"}, {"characteristics_ch1": "ssx expression: none;\tcell line: 22Rv1"}]}, {"GSM2059953": [{"title": "22Rv1-scramble shRNA control-1"}, {"type": "RNA"}, {"source_name_ch1": "22Rv1 Cells- shRNA scramble control"}, {"characteristics_ch1": "ssx expression: High (scramble control);\tcell line: 22Rv1"}]}, {"GSM2059954": [{"title": "22Rv1-scramble shRNA control-2"}, {"type": "RNA"}, {"source_name_ch1": "22Rv1 Cells- shRNA scramble control"}, {"characteristics_ch1": "ssx expression: High (scramble control);\tcell line: 22Rv1"}]}, {"GSM2059955": [{"title": "22Rv1-scramble shRNA control-3"}, {"type": "RNA"}, {"source_name_ch1": "22Rv1 Cells- shRNA scramble control"}, {"characteristics_ch1": "ssx expression: High (scramble control);\tcell line: 22Rv1"}]}, {"GSM2059956": [{"title": "22Rv1-Wildtype untransfected-1"}, {"type": "RNA"}, {"source_name_ch1": "22Rv1 Cells- Wildtype"}, {"characteristics_ch1": "ssx expression: High (wildtype);\tcell line: 22Rv1"}]}, {"GSM2059957": [{"title": "22Rv1-Wildtype untransfected-2"}, {"type": "RNA"}, {"source_name_ch1": "22Rv1 Cells- Wildtype"}, {"characteristics_ch1": "ssx expression: High (wildtype);\tcell line: 22Rv1"}]}, {"GSM2059958": [{"title": "22Rv1-Wildtype untransfected-3"}, {"type": "RNA"}, {"source_name_ch1": "22Rv1 Cells- Wildtype"}, {"characteristics_ch1": "ssx expression: High (wildtype);\tcell line: 22Rv1"}]}, {"GSM2081545": [{"title": "Control, rep 1"}, {"type": "RNA"}, {"source_name_ch1": "Caco2 cells treated with vehicle control (DMSO) for 48h"}, {"characteristics_ch1": "cell type: Colorectal cancer cell line;\tcell line: Caco2"}]}, {"GSM2081546": [{"title": "Control, rep 2"}, {"type": "RNA"}, {"source_name_ch1": "Caco2 cells treated with vehicle control (DMSO) for 48h"}, {"characteristics_ch1": "cell type: Colorectal cancer cell line;\tcell line: Caco2"}]}, {"GSM2081547": [{"title": "Cudraflavone C, rep1"}, {"type": "RNA"}, {"source_name_ch1": "Caco2 cells treated with 10uM Cidraflavone C for 48h"}, {"characteristics_ch1": "cell type: Colorectal cancer cell line;\tcell line: Caco2"}]}, {"GSM2081548": [{"title": "Cudraflavone C, rep2"}, {"type": "RNA"}, {"source_name_ch1": "Caco2 cells treated with 10uM Cidraflavone C for 48h"}, {"characteristics_ch1": "cell type: Colorectal cancer cell line;\tcell line: Caco2"}]}, {"GSM2090208": [{"title": "LIMM-3"}, {"type": "RNA"}, {"source_name_ch1": "colorectal liver metastasis patient with decreased systemic CCL2 levels following EPA-FFA treatment"}, {"characteristics_ch1": "tissue: colorectal liver metastasis;\ttreatment: EPA-FFA 2g/day"}]}, {"GSM2090209": [{"title": "LIMM-4"}, {"type": "RNA"}, {"source_name_ch1": "colorectal liver metastasis patient with increased systemic CCL2 levels following EPA-FFA treatment"}, {"characteristics_ch1": "tissue: colorectal liver metastasis;\ttreatment: EPA-FFA 2g/day"}]}, {"GSM2090210": [{"title": "LIMM-7"}, {"type": "RNA"}, {"source_name_ch1": "colorectal liver metastasis patient with decreased systemic CCL2 levels following EPA-FFA treatment"}, {"characteristics_ch1": "tissue: colorectal liver metastasis;\ttreatment: EPA-FFA 2g/day"}]}, {"GSM2090211": [{"title": "LIMM-9"}, {"type": "RNA"}, {"source_name_ch1": "colorectal liver metastasis patient with decreased systemic CCL2 levels following EPA-FFA treatment"}, {"characteristics_ch1": "tissue: colorectal liver metastasis;\ttreatment: EPA-FFA 2g/day"}]}, {"GSM2090212": [{"title": "LIMM-10"}, {"type": "RNA"}, {"source_name_ch1": "colorectal liver metastasis patient with increased systemic CCL2 levels following EPA-FFA treatment"}, {"characteristics_ch1": "tissue: colorectal liver metastasis;\ttreatment: EPA-FFA 2g/day"}]}, {"GSM2090213": [{"title": "LIMM-15"}, {"type": "RNA"}, {"source_name_ch1": "colorectal liver metastasis patient with decreased systemic CCL2 levels following EPA-FFA treatment"}, {"characteristics_ch1": "tissue: colorectal liver metastasis;\ttreatment: EPA-FFA 2g/day"}]}, {"GSM2090214": [{"title": "LIMM-17"}, {"type": "RNA"}, {"source_name_ch1": "colorectal liver metastasis patient with decreased systemic CCL2 levels following EPA-FFA treatment"}, {"characteristics_ch1": "tissue: colorectal liver metastasis;\ttreatment: EPA-FFA 2g/day"}]}, {"GSM2090215": [{"title": "LIMM-19"}, {"type": "RNA"}, {"source_name_ch1": "colorectal liver metastasis patient with increased systemic CCL2 levels following EPA-FFA treatment"}, {"characteristics_ch1": "tissue: colorectal liver metastasis;\ttreatment: EPA-FFA 2g/day"}]}, {"GSM2090216": [{"title": "LIMM-20"}, {"type": "RNA"}, {"source_name_ch1": "colorectal liver metastasis patient with decreased systemic CCL2 levels following EPA-FFA treatment"}, {"characteristics_ch1": "tissue: colorectal liver metastasis;\ttreatment: EPA-FFA 2g/day"}]}, {"GSM2090217": [{"title": "LIMM-21"}, {"type": "RNA"}, {"source_name_ch1": "colorectal liver metastasis patient with decreased systemic CCL2 levels following EPA-FFA treatment"}, {"characteristics_ch1": "tissue: colorectal liver metastasis;\ttreatment: EPA-FFA 2g/day"}]}, {"GSM2090218": [{"title": "LIMM-24"}, {"type": "RNA"}, {"source_name_ch1": "colorectal liver metastasis patient with decreased systemic CCL2 levels following EPA-FFA treatment"}, {"characteristics_ch1": "tissue: colorectal liver metastasis;\ttreatment: EPA-FFA 2g/day"}]}, {"GSM2090219": [{"title": "LIMM-26"}, {"type": "RNA"}, {"source_name_ch1": "colorectal liver metastasis patient with increased systemic CCL2 levels following EPA-FFA treatment"}, {"characteristics_ch1": "tissue: colorectal liver metastasis;\ttreatment: EPA-FFA 2g/day"}]}, {"GSM2090220": [{"title": "LIMM-30"}, {"type": "RNA"}, {"source_name_ch1": "colorectal liver metastasis patient with decreased systemic CCL2 levels following EPA-FFA treatment"}, {"characteristics_ch1": "tissue: colorectal liver metastasis;\ttreatment: EPA-FFA 2g/day"}]}, {"GSM2090221": [{"title": "LIMM-32"}, {"type": "RNA"}, {"source_name_ch1": "colorectal liver metastasis patient with decreased systemic CCL2 levels following EPA-FFA treatment"}, {"characteristics_ch1": "tissue: colorectal liver metastasis;\ttreatment: EPA-FFA 2g/day"}]}, {"GSM2090222": [{"title": "LIMM-36"}, {"type": "RNA"}, {"source_name_ch1": "colorectal liver metastasis patient with decreased systemic CCL2 levels following EPA-FFA treatment"}, {"characteristics_ch1": "tissue: colorectal liver metastasis;\ttreatment: EPA-FFA 2g/day"}]}, {"GSM1722134": [{"title": "HL60 leukemic cell line treated with DMSO replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "HL60 cell line treated with DMSO replicate 1"}, {"characteristics_ch1": "drug: DMSO;\tcell line: HL60"}]}, {"GSM1722135": [{"title": "HL60 leukemic cell line treated with DMSO replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "HL60 cell line treated with DMSO replicate 2"}, {"characteristics_ch1": "drug: DMSO;\tcell line: HL60"}]}, {"GSM1722136": [{"title": "HL60 leukemic cell line treated with DMSO replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "HL60 cell line treated with DMSO replicate 3"}, {"characteristics_ch1": "drug: DMSO;\tcell line: HL60"}]}, {"GSM1722137": [{"title": "HL60 leukemic cell line treated with JQ1 replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "HL60 cell line treated with JQ1 replicate 1"}, {"characteristics_ch1": "drug: JQ1;\tcell line: HL60"}]}, {"GSM1722138": [{"title": "HL60 leukemic cell line treated with JQ1 replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "HL60 cell line treated with JQ1 replicate 2"}, {"characteristics_ch1": "drug: JQ1;\tcell line: HL60"}]}, {"GSM1722139": [{"title": "HL60 leukemic cell line treated with JQ1 replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "HL60 cell line treated with JQ1 replicate 3"}, {"characteristics_ch1": "drug: JQ1;\tcell line: HL60"}]}, {"GSM1722140": [{"title": "HL60 leukemic cell line treated with OTX replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "HL60 cell line treated with OTX replicate 1"}, {"characteristics_ch1": "drug: OTX;\tcell line: HL60"}]}, {"GSM1722141": [{"title": "HL60 leukemic cell line treated with OTX replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "HL60 cell line treated with OTX replicate 2"}, {"characteristics_ch1": "drug: OTX;\tcell line: HL60"}]}, {"GSM1722142": [{"title": "HL60 leukemic cell line treated with OTX replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "HL60 cell line treated with OTX replicate 3"}, {"characteristics_ch1": "drug: OTX;\tcell line: HL60"}]}, {"GSM1722143": [{"title": "K562 leukemic cell line treated with DMSO replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "K562 cell line treated with DMSO replicate 1"}, {"characteristics_ch1": "drug: DMSO;\tcell line: K562"}]}, {"GSM1722144": [{"title": "K562 leukemic cell line treated with DMSO replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "K562 cell line treated with DMSO replicate 2"}, {"characteristics_ch1": "drug: DMSO;\tcell line: K562"}]}, {"GSM1722145": [{"title": "K562 leukemic cell line treated with DMSO replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "K562 cell line treated with DMSO replicate 3"}, {"characteristics_ch1": "drug: DMSO;\tcell line: K562"}]}, {"GSM1722146": [{"title": "K562 leukemic cell line treated with JQ1 replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "K562 cell line treated with JQ1 replicate 1"}, {"characteristics_ch1": "drug: JQ1;\tcell line: K562"}]}, {"GSM1722147": [{"title": "K562 leukemic cell line treated with JQ1 replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "K562 cell line treated with JQ1 replicate 2"}, {"characteristics_ch1": "drug: JQ1;\tcell line: K562"}]}, {"GSM1722148": [{"title": "K562 leukemic cell line treated with OTX replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "K562 cell line treated with OTX replicate 1"}, {"characteristics_ch1": "drug: OTX;\tcell line: K562"}]}, {"GSM1722149": [{"title": "K562 leukemic cell line treated with OTX replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "K562 cell line treated with OTX replicate 2"}, {"characteristics_ch1": "drug: OTX;\tcell line: K562"}]}, {"GSM1722150": [{"title": "K562 leukemic cell line treated with OTX replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "K562 cell line treated with OTX replicate 3"}, {"characteristics_ch1": "drug: OTX;\tcell line: K562"}]}, {"GSM1722151": [{"title": "KG1A leukemic cell line treated with DMSO replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "KG1A cell line treated with DMSO replicate 1"}, {"characteristics_ch1": "drug: DMSO;\tcell line: KG1a"}]}, {"GSM1722152": [{"title": "KG1A leukemic cell line treated with DMSO replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "KG1A cell line treated with DMSO replicate 2"}, {"characteristics_ch1": "drug: DMSO;\tcell line: KG1a"}]}, {"GSM1722153": [{"title": "KG1A leukemic cell line treated with DMSO replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "KG1A cell line treated with DMSO replicate 3"}, {"characteristics_ch1": "drug: DMSO;\tcell line: KG1a"}]}, {"GSM1722154": [{"title": "KG1A leukemic cell line treated with JQ1 replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "KG1A cell line treated with JQ1 replicate 1"}, {"characteristics_ch1": "drug: JQ1;\tcell line: KG1a"}]}, {"GSM1722155": [{"title": "KG1A leukemic cell line treated with JQ1 replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "KG1A cell line treated with JQ1 replicate 2"}, {"characteristics_ch1": "drug: JQ1;\tcell line: KG1a"}]}, {"GSM1722156": [{"title": "KG1A leukemic cell line treated with JQ1 replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "KG1A cell line treated with JQ1 replicate 3"}, {"characteristics_ch1": "drug: JQ1;\tcell line: KG1a"}]}, {"GSM1722157": [{"title": "KG1A leukemic cell line treated with OTX replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "KG1A cell line treated with OTX replicate 1"}, {"characteristics_ch1": "drug: OTX;\tcell line: KG1a"}]}, {"GSM1722158": [{"title": "KG1A leukemic cell line treated with OTX replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "KG1A cell line treated with OTX replicate 2"}, {"characteristics_ch1": "drug: OTX;\tcell line: KG1a"}]}, {"GSM1722159": [{"title": "KG1A leukemic cell line treated with OTX replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "KG1A cell line treated with OTX replicate 3"}, {"characteristics_ch1": "drug: OTX;\tcell line: KG1a"}]}, {"GSM1722160": [{"title": "NOMO-1 leukemic cell line treated with DMSO replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "NOMO-1 cell line treated with DMSO replicate 1"}, {"characteristics_ch1": "drug: DMSO;\tcell line: NOMO-1"}]}, {"GSM1722161": [{"title": "NOMO-1 leukemic cell line treated with DMSO replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "NOMO-1 cell line treated with DMSO replicate 2"}, {"characteristics_ch1": "drug: DMSO;\tcell line: NOMO-1"}]}, {"GSM1722162": [{"title": "NOMO-1 leukemic cell line treated with DMSO replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "NOMO-1 cell line treated with DMSO replicate 3"}, {"characteristics_ch1": "drug: DMSO;\tcell line: NOMO-1"}]}, {"GSM1722163": [{"title": "NOMO-1 leukemic cell line treated with JQ1 replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "NOMO-1 cell line treated with JQ1 replicate 1"}, {"characteristics_ch1": "drug: JQ1;\tcell line: NOMO-1"}]}, {"GSM1722164": [{"title": "NOMO-1 leukemic cell line treated with JQ1 replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "NOMO-1 cell line treated with JQ1 replicate 2"}, {"characteristics_ch1": "drug: JQ1;\tcell line: NOMO-1"}]}, {"GSM1722165": [{"title": "NOMO-1 leukemic cell line treated with JQ1 replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "NOMO-1 cell line treated with JQ1 replicate 3"}, {"characteristics_ch1": "drug: JQ1;\tcell line: NOMO-1"}]}, {"GSM1722166": [{"title": "NOMO-1 leukemic cell line treated with OTX replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "NOMO-1 cell line treated with OTX replicate 1"}, {"characteristics_ch1": "drug: OTX;\tcell line: NOMO-1"}]}, {"GSM1722167": [{"title": "NOMO-1 leukemic cell line treated with OTX replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "NOMO-1 cell line treated with OTX replicate 2"}, {"characteristics_ch1": "drug: OTX;\tcell line: NOMO-1"}]}, {"GSM1722168": [{"title": "NOMO-1 leukemic cell line treated with OTX replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "NOMO-1 cell line treated with OTX replicate 3"}, {"characteristics_ch1": "drug: OTX;\tcell line: NOMO-1"}]}, {"GSM1722169": [{"title": "OCI-AML3 leukemic cell line treated with DMSO replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "OCI-AML3 cell line treated with DMSO replicate 1"}, {"characteristics_ch1": "drug: DMSO;\tcell line: OCI-AML3"}]}, {"GSM1722170": [{"title": "OCI-AML3 leukemic cell line treated with DMSO replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "OCI-AML3 cell line treated with DMSO replicate 2"}, {"characteristics_ch1": "drug: DMSO;\tcell line: OCI-AML3"}]}, {"GSM1722171": [{"title": "OCI-AML3 leukemic cell line treated with DMSO replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "OCI-AML3 cell line treated with DMSO replicate 3"}, {"characteristics_ch1": "drug: DMSO;\tcell line: OCI-AML3"}]}, {"GSM1722172": [{"title": "OCI-AML3 leukemic cell line treated with JQ1 replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "OCI-AML3 cell line treated with JQ1 replicate 1"}, {"characteristics_ch1": "drug: JQ1;\tcell line: OCI-AML3"}]}, {"GSM1722173": [{"title": "OCI-AML3 leukemic cell line treated with OTX replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "OCI-AML3 cell line treated with OTX replicate 1"}, {"characteristics_ch1": "drug: OTX;\tcell line: OCI-AML3"}]}, {"GSM1722174": [{"title": "OCI-AML3 leukemic cell line treated with OTX replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "OCI-AML3 cell line treated with OTX replicate 2"}, {"characteristics_ch1": "drug: OTX;\tcell line: OCI-AML3"}]}, {"GSM1722175": [{"title": "OCI-AML3 leukemic cell line treated with OTX replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "OCI-AML3 cell line treated with OTX replicate 3"}, {"characteristics_ch1": "drug: OTX;\tcell line: OCI-AML3"}]}, {"GSM1724248": [{"title": "iPSC with a RPS19 muation, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "iPSC with a RPS19 muation"}, {"characteristics_ch1": "subject status: DBA patients carrying RPS19 mutation;\tcell type: induced pluripotent stem cells;\tgenotype/variation: RPS19 mutant;\tpassage: Passage 27"}]}, {"GSM1724249": [{"title": "iPSC with a RPS19 muation, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "iPSC with a RPS19 muation"}, {"characteristics_ch1": "subject status: DBA patients carrying RPS19 mutation;\tcell type: induced pluripotent stem cells;\tgenotype/variation: RPS19 mutant;\tpassage: Passage 28"}]}, {"GSM1724250": [{"title": "Corrected RPS19 mutant iPSC, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "Corrected RPS19 mutant iPSC"}, {"characteristics_ch1": "subject status: DBA patients carrying RPS19 mutation;\tcell type: induced pluripotent stem cells;\tgenotype/variation: corrected RPS19 mutant (with a wildtype cDNA of RPS19);\tpassage: Passage 27"}]}, {"GSM1724251": [{"title": "Corrected RPS19 mutant iPSC, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "Corrected RPS19 mutant iPSC"}, {"characteristics_ch1": "subject status: DBA patients carrying RPS19 mutation;\tcell type: induced pluripotent stem cells;\tgenotype/variation: corrected RPS19 mutant (with a wildtype cDNA of RPS19);\tpassage: Passage 28"}]}, {"GSM1724252": [{"title": "wild type 1 iPSC, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "wild type 1 iPSC"}, {"characteristics_ch1": "subject status: DBA patients;\tcell type: induced pluripotent stem cells;\tgenotype/variation: wild type;\tpassage: Passage 27"}]}, {"GSM1724253": [{"title": "wild type 1 iPSC, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "wild type 1 iPSC"}, {"characteristics_ch1": "subject status: DBA patients;\tcell type: induced pluripotent stem cells;\tgenotype/variation: wild type;\tpassage: Passage 28"}]}, {"GSM1724254": [{"title": "wild type 2 iPSC, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "wild type 2 iPSC"}, {"characteristics_ch1": "subject status: DBA patients;\tcell type: induced pluripotent stem cells;\tgenotype/variation: wild type;\tpassage: Passage 27"}]}, {"GSM1724255": [{"title": "wild type 2 iPSC, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "wild type 2 iPSC"}, {"characteristics_ch1": "subject status: DBA patients;\tcell type: induced pluripotent stem cells;\tgenotype/variation: wild type;\tpassage: Passage 28"}]}, {"GSM1784987": [{"title": "Placenta_GDM_Yes_ID10_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: Yes"}]}, {"GSM1784988": [{"title": "Placenta_GDM_Yes_ID17_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: Yes"}]}, {"GSM1784989": [{"title": "Placenta_GDM_Yes_ID26_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: Yes"}]}, {"GSM1784990": [{"title": "Placenta_GDM_No_ID35_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: No"}]}, {"GSM1784991": [{"title": "Placenta_GDM_Yes_ID49_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: Yes"}]}, {"GSM1784993": [{"title": "Placenta_GDM_No_ID18_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: No"}]}, {"GSM1784994": [{"title": "Placenta_GDM_Yes_ID27_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: Yes"}]}, {"GSM1784995": [{"title": "Placenta_GDM_Yes_ID43_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: Yes"}]}, {"GSM1784996": [{"title": "Placenta_GDM_Yes_ID50_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: Yes"}]}, {"GSM1784997": [{"title": "Placenta_GDM_Yes_ID2_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: Yes"}]}, {"GSM1784998": [{"title": "Placenta_GDM_No_ID3_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: No"}]}, {"GSM1784999": [{"title": "Placenta_GDM_Yes_ID11_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: Yes"}]}, {"GSM1785000": [{"title": "Placenta_GDM_Yes_ID19_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: Yes"}]}, {"GSM1785001": [{"title": "Placenta_GDM_No_ID28_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: No"}]}, {"GSM1785003": [{"title": "Placenta_GDM_No_ID36_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: No"}]}, {"GSM1785004": [{"title": "Placenta_GDM_No_ID8_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: No"}]}, {"GSM1785005": [{"title": "Placenta_GDM_No_ID44_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: No"}]}, {"GSM1785006": [{"title": "Placenta_GDM_No_ID53_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: No"}]}, {"GSM1785007": [{"title": "Placenta_GDM_Yes_ID4_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: Yes"}]}, {"GSM1785008": [{"title": "Placenta_GDM_Yes_ID9_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: Yes"}]}, {"GSM1785009": [{"title": "Placenta_GDM_Yes_ID20_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: Yes"}]}, {"GSM1785011": [{"title": "Placenta_GDM_Yes_ID29_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: Yes"}]}, {"GSM1785012": [{"title": "Placenta_GDM_Yes_ID51_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: Yes"}]}, {"GSM1785013": [{"title": "Placenta_GDM_No_ID16_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: No"}]}, {"GSM1785014": [{"title": "Placenta_GDM_No_ID53_rep 1_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: No"}]}, {"GSM1785015": [{"title": "Placenta_GDM_Yes_ID13_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: Yes"}]}, {"GSM1785016": [{"title": "Placenta_GDM_Yes_ID21_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: Yes"}]}, {"GSM1785017": [{"title": "Placenta_GDM_No_ID37_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: No"}]}, {"GSM1785018": [{"title": "Placenta_GDM_Yes_ID45_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: Yes"}]}, {"GSM1785020": [{"title": "Placenta_GDM_No_ID53_rep 2_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: No"}]}, {"GSM1785021": [{"title": "Placenta_GDM_No_ID52_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: No"}]}, {"GSM1785022": [{"title": "Placenta_GDM_No_ID12_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: No"}]}, {"GSM1785023": [{"title": "Placenta_GDM_Yes_ID46_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: Yes"}]}, {"GSM1785024": [{"title": "Placenta_GDM_No_ID52_rep 1_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: No"}]}, {"GSM1785025": [{"title": "Placenta_GDM_No_ID52_rep 2_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: No"}]}, {"GSM1785027": [{"title": "Placenta_GDM_No_ID5_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: No"}]}, {"GSM1785028": [{"title": "Placenta_GDM_No_ID15_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: No"}]}, {"GSM1785029": [{"title": "Placenta_GDM_No_ID33_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: No"}]}, {"GSM1785030": [{"title": "Placenta_GDM_Yes_ID30_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: Yes"}]}, {"GSM1785031": [{"title": "Placenta_GDM_No_ID38_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: No"}]}, {"GSM1785032": [{"title": "Placenta_GDM_Yes_ID54_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: Yes"}]}, {"GSM1785033": [{"title": "Placenta_GDM_No_ID23_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: No"}]}, {"GSM1785035": [{"title": "Placenta_GDM_No_ID31_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: No"}]}, {"GSM1785036": [{"title": "Placenta_GDM_No_ID40_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: No"}]}, {"GSM1785037": [{"title": "Placenta_GDM_No_ID42_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: No"}]}, {"GSM1785038": [{"title": "Placenta_GDM_No_ID47_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: No"}]}, {"GSM1785039": [{"title": "Placenta_GDM_Yes_ID55_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: Yes"}]}, {"GSM1785040": [{"title": "Placenta_GDM_Yes_ID6_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: Yes"}]}, {"GSM1785041": [{"title": "Placenta_GDM_Yes_ID14_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: Yes"}]}, {"GSM1785042": [{"title": "Placenta_GDM_Yes_ID22_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: Yes"}]}, {"GSM1785044": [{"title": "Placenta_GDM_No_ID32_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: No"}]}, {"GSM1785045": [{"title": "Placenta_GDM_Yes_ID39_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: Yes"}]}, {"GSM1785046": [{"title": "Placenta_GDM_Yes_ID24_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: Yes"}]}, {"GSM1785047": [{"title": "Placenta_GDM_Yes_ID34_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: Yes"}]}, {"GSM1785048": [{"title": "Placenta_GDM_Yes_ID41_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: Yes"}]}, {"GSM1785049": [{"title": "Placenta_GDM_No_ID7_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: No"}]}, {"GSM1785050": [{"title": "Placenta_GDM_No_ID1_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: No"}]}, {"GSM1785052": [{"title": "Placenta_GDM_Yes_ID25_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: Yes"}]}, {"GSM1785053": [{"title": "Placenta_GDM_No_ID48_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: No"}]}, {"GSM1785054": [{"title": "Placenta_GDM_No_ID1_rep 1_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: No"}]}, {"GSM1785055": [{"title": "Placenta_GDM_Yes_ID55_rep 1_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: Yes"}]}, {"GSM1785056": [{"title": "Placenta_GDM_No_ID1_rep 2_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: No"}]}, {"GSM1785057": [{"title": "Placenta_GDM_Yes_ID55_rep 2_expression"}, {"type": "RNA"}, {"source_name_ch1": "Placenta tissue from the maternal (decidual basalis) side near the umbilical cord"}, {"characteristics_ch1": "tissue: placenta;\tgestational diabetes: Yes"}]}, {"GSM1820071": [{"title": "human myofubes, aldosterone treated, biological rep 1"}, {"type": "RNA"}, {"source_name_ch1": "normal primary human myotubes"}, {"characteristics_ch1": "Sex: male;\tagent: aldosterone"}]}, {"GSM1820072": [{"title": "human myofubes, aldosterone treated, biological rep 2"}, {"type": "RNA"}, {"source_name_ch1": "normal primary human myotubes"}, {"characteristics_ch1": "Sex: male;\tagent: aldosterone"}]}, {"GSM1820073": [{"title": "human myofubes, aldosterone treated, biological rep 3"}, {"type": "RNA"}, {"source_name_ch1": "normal primary human myotubes"}, {"characteristics_ch1": "Sex: male;\tagent: aldosterone"}]}, {"GSM1820074": [{"title": "human myofubes, spironolactone treated, biological rep 1"}, {"type": "RNA"}, {"source_name_ch1": "normal primary human myotubes"}, {"characteristics_ch1": "Sex: male;\tagent: spironolactone"}]}, {"GSM1820075": [{"title": "human myofubes, spironolactone treated, biological rep 2"}, {"type": "RNA"}, {"source_name_ch1": "normal primary human myotubes"}, {"characteristics_ch1": "Sex: male;\tagent: spironolactone"}]}, {"GSM1820076": [{"title": "human myofubes, spironolactone treated, biological rep 3"}, {"type": "RNA"}, {"source_name_ch1": "normal primary human myotubes"}, {"characteristics_ch1": "Sex: male;\tagent: spironolactone"}]}, {"GSM1820077": [{"title": "human myofubes, untreated/vehicle-treated, biological rep 1"}, {"type": "RNA"}, {"source_name_ch1": "normal primary human myotubes"}, {"characteristics_ch1": "Sex: male;\tagent: untreated/vehicle"}]}, {"GSM1820078": [{"title": "human myofubes, untreated/vehicle-treated, biological rep 2"}, {"type": "RNA"}, {"source_name_ch1": "normal primary human myotubes"}, {"characteristics_ch1": "Sex: male;\tagent: untreated/vehicle"}]}, {"GSM1820079": [{"title": "human myofubes, untreated/vehicle-treated, biological rep 3"}, {"type": "RNA"}, {"source_name_ch1": "normal primary human myotubes"}, {"characteristics_ch1": "Sex: male;\tagent: untreated/vehicle"}]}, {"GSM1825679": [{"title": "Control"}, {"type": "RNA"}, {"source_name_ch1": "Vector were transfected into gastric cancer cell"}, {"characteristics_ch1": "cell line: MKN45;\ttreatment: cell transfected with vector"}]}, {"GSM1825680": [{"title": "DNMT3A"}, {"type": "RNA"}, {"source_name_ch1": "DNMT3A construct were transfected into gastric cancer cell"}, {"characteristics_ch1": "cell line: MKN45;\ttreatment: cell transfected with DNMT3A"}]}, {"GSM1833026": [{"title": "AC16-CONTROL-6HOUR-REP1"}, {"type": "RNA"}, {"source_name_ch1": "AC16 human adult ventricular cardiomyocyte cells cultured at 37 \u00b0C with 5% CO2 for 6 hours"}, {"characteristics_ch1": "cell line: AC16 human adult ventricular cardiomyocyte cells"}]}, {"GSM1833027": [{"title": "AC16-CONTROL-6HOUR-REP2"}, {"type": "RNA"}, {"source_name_ch1": "AC16 human adult ventricular cardiomyocyte cells cultured at 37 \u00b0C with 5% CO2 for 6 hours"}, {"characteristics_ch1": "cell line: AC16 human adult ventricular cardiomyocyte cells"}]}, {"GSM1833028": [{"title": "AC16-CONTROL-6HOUR-REP3"}, {"type": "RNA"}, {"source_name_ch1": "AC16 human adult ventricular cardiomyocyte cells cultured at 37 \u00b0C with 5% CO2 for 6 hours"}, {"characteristics_ch1": "cell line: AC16 human adult ventricular cardiomyocyte cells"}]}, {"GSM1833029": [{"title": "AC16-HYPOTHERMIA-6HOUR-REP1"}, {"type": "RNA"}, {"source_name_ch1": "AC16 human adult ventricular cardiomyocyte cells cultured at 28 \u00b0C with 5% CO2 for 6 hours"}, {"characteristics_ch1": "cell line: AC16 human adult ventricular cardiomyocyte cells"}]}, {"GSM1833030": [{"title": "AC16-HYPOTHERMIA-6HOUR-REP2"}, {"type": "RNA"}, {"source_name_ch1": "AC16 human adult ventricular cardiomyocyte cells cultured at 28 \u00b0C with 5% CO2 for 6 hours"}, {"characteristics_ch1": "cell line: AC16 human adult ventricular cardiomyocyte cells"}]}, {"GSM1833031": [{"title": "AC16-HYPOTHERMIA-6HOUR-REP3"}, {"type": "RNA"}, {"source_name_ch1": "AC16 human adult ventricular cardiomyocyte cells cultured at 28 \u00b0C with 5% CO2 for 6 hours"}, {"characteristics_ch1": "cell line: AC16 human adult ventricular cardiomyocyte cells"}]}, {"GSM1847831": [{"title": "MDAMB231.Control.Replicate1"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-231 breast cancer cells, control treatment"}, {"characteristics_ch1": "cell line: MDA-MB-231;\ttreatment: control"}]}, {"GSM1847832": [{"title": "MDAMB231.Control.Replicate2"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-231 breast cancer cells, control treatment"}, {"characteristics_ch1": "cell line: MDA-MB-231;\ttreatment: control"}]}, {"GSM1847833": [{"title": "MDAMB231.Control.Replicate3"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-231 breast cancer cells, control treatment"}, {"characteristics_ch1": "cell line: MDA-MB-231;\ttreatment: control"}]}, {"GSM1847834": [{"title": "MDAMB231.miR_183_5p_0_0.Replicate1"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-231 breast cancer cells, treatment with the miR-183-5p|0|0| isomiR"}, {"characteristics_ch1": "cell line: MDA-MB-231;\ttreatment: miR-183-5p|0|0| isomiR"}]}, {"GSM1847835": [{"title": "MDAMB231.miR_183_5p_0_0.Replicate2"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-231 breast cancer cells, treatment with the miR-183-5p|0|0| isomiR"}, {"characteristics_ch1": "cell line: MDA-MB-231;\ttreatment: miR-183-5p|0|0| isomiR"}]}, {"GSM1847836": [{"title": "MDAMB231.miR_183_5p_0_0.Replicate3"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-231 breast cancer cells, treatment with the miR-183-5p|0|0| isomiR"}, {"characteristics_ch1": "cell line: MDA-MB-231;\ttreatment: miR-183-5p|0|0| isomiR"}]}, {"GSM1847837": [{"title": "MDAMB231.miR_183_5p_minus2_minus2.Replicate1"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-231 breast cancer cells, treatment with the miR-183-5p|-2|-2| isomiR"}, {"characteristics_ch1": "cell line: MDA-MB-231;\ttreatment: miR-183-5p|-2|-2| isomiR"}]}, {"GSM1847838": [{"title": "MDAMB231.miR_183_5p_minus2_minus2.Replicate2"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-231 breast cancer cells, treatment with the miR-183-5p|-2|-2| isomiR"}, {"characteristics_ch1": "cell line: MDA-MB-231;\ttreatment: miR-183-5p|-2|-2| isomiR"}]}, {"GSM1847839": [{"title": "MDAMB231.miR_183_5p_minus2_minus2.Replicate3"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-231 breast cancer cells, treatment with the miR-183-5p|-2|-2| isomiR"}, {"characteristics_ch1": "cell line: MDA-MB-231;\ttreatment: miR-183-5p|-2|-2| isomiR"}]}, {"GSM1847840": [{"title": "MDAMB231.miR_183_5p_plus2_plus2.Replicate1"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-231 breast cancer cells, treatment with the miR-183-5p|+2|+2| isomiR"}, {"characteristics_ch1": "cell line: MDA-MB-231;\ttreatment: miR-183-5p|+2|+2| isomiR"}]}, {"GSM1847841": [{"title": "MDAMB231.miR_183_5p_plus2_plus2.Replicate2"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-231 breast cancer cells, treatment with the miR-183-5p|+2|+2| isomiR"}, {"characteristics_ch1": "cell line: MDA-MB-231;\ttreatment: miR-183-5p|+2|+2| isomiR"}]}, {"GSM1847842": [{"title": "MDAMB231.miR_183_5p_plus2_plus2.Replicate3"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-231 breast cancer cells, treatment with the miR-183-5p|+2|+2| isomiR"}, {"characteristics_ch1": "cell line: MDA-MB-231;\ttreatment: miR-183-5p|+2|+2| isomiR"}]}, {"GSM1854182": [{"title": "IPF patient 1"}, {"type": "RNA"}, {"source_name_ch1": "lung tissues"}, {"characteristics_ch1": "disease: Idiopathic pulmonary fibrosis;\ttissue: lung"}]}, {"GSM1854183": [{"title": "IPF patient 2"}, {"type": "RNA"}, {"source_name_ch1": "lung tissues"}, {"characteristics_ch1": "disease: Idiopathic pulmonary fibrosis;\ttissue: lung"}]}, {"GSM1854184": [{"title": "IPF patient 3"}, {"type": "RNA"}, {"source_name_ch1": "lung tissues"}, {"characteristics_ch1": "disease: Idiopathic pulmonary fibrosis;\ttissue: lung"}]}, {"GSM1854185": [{"title": "IPF patient 4"}, {"type": "RNA"}, {"source_name_ch1": "lung tissues"}, {"characteristics_ch1": "disease: Idiopathic pulmonary fibrosis;\ttissue: lung"}]}, {"GSM1854186": [{"title": "IPF patient 5"}, {"type": "RNA"}, {"source_name_ch1": "lung tissues"}, {"characteristics_ch1": "disease: Idiopathic pulmonary fibrosis;\ttissue: lung"}]}, {"GSM1854187": [{"title": "patients with primary spontaneous pneumothorax 1"}, {"type": "RNA"}, {"source_name_ch1": "lung tissues"}, {"characteristics_ch1": "disease: primary spontaneous pneumothorax);\ttissue: lung"}]}, {"GSM1854188": [{"title": "patients with primary spontaneous pneumothorax 2"}, {"type": "RNA"}, {"source_name_ch1": "lung tissues"}, {"characteristics_ch1": "disease: primary spontaneous pneumothorax);\ttissue: lung"}]}, {"GSM1854189": [{"title": "patients with primary spontaneous pneumothorax 3"}, {"type": "RNA"}, {"source_name_ch1": "lung tissues"}, {"characteristics_ch1": "disease: primary spontaneous pneumothorax);\ttissue: lung"}]}, {"GSM1857830": [{"title": "Explanted cells-U3020-rep1"}, {"type": "RNA"}, {"source_name_ch1": "U3020, explanted cells"}, {"characteristics_ch1": "sample type: U3020, explanted cells"}]}, {"GSM1857831": [{"title": "Explanted cells-U3020-rep2"}, {"type": "RNA"}, {"source_name_ch1": "U3020, explanted cells"}, {"characteristics_ch1": "sample type: U3020, explanted cells"}]}, {"GSM1857832": [{"title": "Explanted cells-U3065-rep1"}, {"type": "RNA"}, {"source_name_ch1": "U3065, explanted cells"}, {"characteristics_ch1": "sample type: U3065, explanted cells"}]}, {"GSM1857833": [{"title": "Explanted cells-U3065-rep2"}, {"type": "RNA"}, {"source_name_ch1": "U3065, explanted cells"}, {"characteristics_ch1": "sample type: U3065, explanted cells"}]}, {"GSM1857834": [{"title": "Explanted cells-U3047-rep1"}, {"type": "RNA"}, {"source_name_ch1": "U3047, explanted cells"}, {"characteristics_ch1": "sample type: U3047, explanted cells"}]}, {"GSM1857835": [{"title": "Explanted cells-U3047-rep2"}, {"type": "RNA"}, {"source_name_ch1": "U3047, explanted cells"}, {"characteristics_ch1": "sample type: U3047, explanted cells"}]}, {"GSM1857836": [{"title": "Tumor-U3020-rep1"}, {"type": "RNA"}, {"source_name_ch1": "U3020, tumor"}, {"characteristics_ch1": "sample type: U3020, tumor"}]}, {"GSM1857837": [{"title": "Tumor-U3020-rep2"}, {"type": "RNA"}, {"source_name_ch1": "U3020, tumor"}, {"characteristics_ch1": "sample type: U3020, tumor"}]}, {"GSM1857838": [{"title": "Tumor-U3065-rep1"}, {"type": "RNA"}, {"source_name_ch1": "U3065, tumor"}, {"characteristics_ch1": "sample type: U3065, tumor"}]}, {"GSM1857839": [{"title": "Tumor-U3065-rep2"}, {"type": "RNA"}, {"source_name_ch1": "U3065, tumor"}, {"characteristics_ch1": "sample type: U3065, tumor"}]}, {"GSM1857840": [{"title": "Tumor-U3047-rep1"}, {"type": "RNA"}, {"source_name_ch1": "U3047, tumor"}, {"characteristics_ch1": "sample type: U3047, tumor"}]}, {"GSM1857841": [{"title": "Tumor-U3047-rep2"}, {"type": "RNA"}, {"source_name_ch1": "U3047, tumor"}, {"characteristics_ch1": "sample type: U3047, tumor"}]}, {"GSM1857842": [{"title": "U3020"}, {"type": "RNA"}, {"source_name_ch1": "U3020"}, {"characteristics_ch1": "sample type: U3020"}]}, {"GSM1857843": [{"title": "U3047"}, {"type": "RNA"}, {"source_name_ch1": "U3047"}, {"characteristics_ch1": "sample type: U3047"}]}, {"GSM1857844": [{"title": "U3065"}, {"type": "RNA"}, {"source_name_ch1": "U3065"}, {"characteristics_ch1": "sample type: U3065"}]}, {"GSM1859144": [{"title": "Control sample from pediatric patient with epilepsy [Ast_15Agosto2014_1_(HTA-2_0)] gene-level"}, {"type": "RNA"}, {"source_name_ch1": "Control sample"}, {"characteristics_ch1": "tissue: glia tissue;\ttumor grade: Control Tissue"}]}, {"GSM1859145": [{"title": "Control sample from pediatric patient with epilepsy [Ast_15Agosto2014_2_(HTA-2_0)] gene-level"}, {"type": "RNA"}, {"source_name_ch1": "Control sample"}, {"characteristics_ch1": "tissue: glia tissue;\ttumor grade: Control Tissue"}]}, {"GSM1859146": [{"title": "Low grade tumor sample [Ast_15Agosto2014_4_(HTA-2_0)] gene-level"}, {"type": "RNA"}, {"source_name_ch1": "Tumor sample"}, {"characteristics_ch1": "tissue: glia tissue;\ttumor grade: Pilocitic astrocitoma"}]}, {"GSM1859147": [{"title": "Low grade tumor sample [Ast_15Agosto2014_5_(HTA-2_0)] gene-level"}, {"type": "RNA"}, {"source_name_ch1": "Tumor sample"}, {"characteristics_ch1": "tissue: glia tissue;\ttumor grade: Pilocitic astrocitoma"}]}, {"GSM1859148": [{"title": "Low grade tumor sample [CAR_Ast_23072014_(HTA-2_0)] gene-level"}, {"type": "RNA"}, {"source_name_ch1": "Tumor sample"}, {"characteristics_ch1": "tissue: glia tissue;\ttumor grade: Pilocitic astrocitoma"}]}, {"GSM1859149": [{"title": "High grade tumor sample [ARI_Ast_23072014_(HTA-2_0)] gene-level"}, {"type": "RNA"}, {"source_name_ch1": "Tumor sample"}, {"characteristics_ch1": "tissue: glia tissue;\ttumor grade: GBM"}]}, {"GSM1859150": [{"title": "High grade tumor sample [CVA_Ast_23072014_(HTA-2_0)] gene-level"}, {"type": "RNA"}, {"source_name_ch1": "Tumor sample"}, {"characteristics_ch1": "tissue: glia tissue;\ttumor grade: GBM"}]}, {"GSM1859151": [{"title": "High grade tumor sample [Ast_15Agosto2014_3_(HTA-2_0)] gene-level"}, {"type": "RNA"}, {"source_name_ch1": "Tumor sample"}, {"characteristics_ch1": "tissue: glia tissue;\ttumor grade: GBM"}]}, {"GSM1859152": [{"title": "High grade tumor sample [Ast_15agosto2014_6_(HTA-2_0)] gene-level"}, {"type": "RNA"}, {"source_name_ch1": "Tumor sample"}, {"characteristics_ch1": "tissue: glia tissue;\ttumor grade: GBM"}]}, {"GSM1884953": [{"title": "Patient 1, CD4+ cells, before first dose of fingolimod [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD4+ cells"}, {"characteristics_ch1": "patient identifier: QSCV-8684;\tgender: Female;\tage in years: 43;\tdisease duration in years: 20;\tprevious treatment: Interferon-beta-1a subcutaneous;\ttreatment gap in months: 38;\tedss at baseline: 4.0;\tedss after 12 months: 3.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM1884954": [{"title": "Patient 1, CD4+ cells, before second dose of fingolimod [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD4+ cells"}, {"characteristics_ch1": "patient identifier: QSCV-8684;\tgender: Female;\tage in years: 43;\tdisease duration in years: 20;\tprevious treatment: Interferon-beta-1a subcutaneous;\ttreatment gap in months: 38;\tedss at baseline: 4.0;\tedss after 12 months: 3.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM1884955": [{"title": "Patient 1, CD4+ cells, after 3 months of fingolimod treatment [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD4+ cells"}, {"characteristics_ch1": "patient identifier: QSCV-8684;\tgender: Female;\tage in years: 43;\tdisease duration in years: 20;\tprevious treatment: Interferon-beta-1a subcutaneous;\ttreatment gap in months: 38;\tedss at baseline: 4.0;\tedss after 12 months: 3.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM1884956": [{"title": "Patient 2, CD4+ cells, before first dose of fingolimod [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD4+ cells"}, {"characteristics_ch1": "patient identifier: ANRT-6851;\tgender: Female;\tage in years: 26;\tdisease duration in years: 3;\tprevious treatment: Interferon-beta-1b subcutaneous;\ttreatment gap in months: 1;\tedss at baseline: 1.5;\tedss after 12 months: 2.0;\trelapses during 12 months prior fingolimod: 2;\trelapses during 12-month follow-up: 0"}]}, {"GSM1884957": [{"title": "Patient 2, CD4+ cells, before second dose of fingolimod [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD4+ cells"}, {"characteristics_ch1": "patient identifier: ANRT-6851;\tgender: Female;\tage in years: 26;\tdisease duration in years: 3;\tprevious treatment: Interferon-beta-1b subcutaneous;\ttreatment gap in months: 1;\tedss at baseline: 1.5;\tedss after 12 months: 2.0;\trelapses during 12 months prior fingolimod: 2;\trelapses during 12-month follow-up: 0"}]}, {"GSM1884958": [{"title": "Patient 2, CD4+ cells, after 3 months of fingolimod treatment [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD4+ cells"}, {"characteristics_ch1": "patient identifier: ANRT-6851;\tgender: Female;\tage in years: 26;\tdisease duration in years: 3;\tprevious treatment: Interferon-beta-1b subcutaneous;\ttreatment gap in months: 1;\tedss at baseline: 1.5;\tedss after 12 months: 2.0;\trelapses during 12 months prior fingolimod: 2;\trelapses during 12-month follow-up: 0"}]}, {"GSM1884959": [{"title": "Patient 3, CD4+ cells, before first dose of fingolimod [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD4+ cells"}, {"characteristics_ch1": "patient identifier: YHCG-2832;\tgender: Female;\tage in years: 29;\tdisease duration in years: 5;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: <1;\tedss at baseline: 2.5;\tedss after 12 months: 1.5;\trelapses during 12 months prior fingolimod: 3;\trelapses during 12-month follow-up: 0"}]}, {"GSM1884960": [{"title": "Patient 3, CD4+ cells, before second dose of fingolimod [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD4+ cells"}, {"characteristics_ch1": "patient identifier: YHCG-2832;\tgender: Female;\tage in years: 29;\tdisease duration in years: 5;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: <1;\tedss at baseline: 2.5;\tedss after 12 months: 1.5;\trelapses during 12 months prior fingolimod: 3;\trelapses during 12-month follow-up: 0"}]}, {"GSM1884961": [{"title": "Patient 3, CD4+ cells, after 3 months of fingolimod treatment [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD4+ cells"}, {"characteristics_ch1": "patient identifier: YHCG-2832;\tgender: Female;\tage in years: 29;\tdisease duration in years: 5;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: <1;\tedss at baseline: 2.5;\tedss after 12 months: 1.5;\trelapses during 12 months prior fingolimod: 3;\trelapses during 12-month follow-up: 0"}]}, {"GSM1884962": [{"title": "Patient 4, CD4+ cells, before first dose of fingolimod [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD4+ cells"}, {"characteristics_ch1": "patient identifier: WKSB-4693;\tgender: Female;\tage in years: 43;\tdisease duration in years: 1;\tprevious treatment: Interferon-beta-1a intramuscular;\ttreatment gap in months: 1;\tedss at baseline: 4.0;\tedss after 12 months: 3.5;\trelapses during 12 months prior fingolimod: 2;\trelapses during 12-month follow-up: 0"}]}, {"GSM1884963": [{"title": "Patient 4, CD4+ cells, before second dose of fingolimod [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD4+ cells"}, {"characteristics_ch1": "patient identifier: WKSB-4693;\tgender: Female;\tage in years: 43;\tdisease duration in years: 1;\tprevious treatment: Interferon-beta-1a intramuscular;\ttreatment gap in months: 1;\tedss at baseline: 4.0;\tedss after 12 months: 3.5;\trelapses during 12 months prior fingolimod: 2;\trelapses during 12-month follow-up: 0"}]}, {"GSM1884964": [{"title": "Patient 4, CD4+ cells, after 3 months of fingolimod treatment [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD4+ cells"}, {"characteristics_ch1": "patient identifier: WKSB-4693;\tgender: Female;\tage in years: 43;\tdisease duration in years: 1;\tprevious treatment: Interferon-beta-1a intramuscular;\ttreatment gap in months: 1;\tedss at baseline: 4.0;\tedss after 12 months: 3.5;\trelapses during 12 months prior fingolimod: 2;\trelapses during 12-month follow-up: 0"}]}, {"GSM1884965": [{"title": "Patient 5, CD4+ cells, before first dose of fingolimod [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD4+ cells"}, {"characteristics_ch1": "patient identifier: SSBZ-7676;\tgender: Female;\tage in years: 45;\tdisease duration in years: 12;\tprevious treatment: Interferon-beta-1a intramuscular;\ttreatment gap in months: 2;\tedss at baseline: 3.0;\tedss after 12 months: 3.0;\trelapses during 12 months prior fingolimod: 3;\trelapses during 12-month follow-up: 0"}]}, {"GSM1884966": [{"title": "Patient 5, CD4+ cells, before second dose of fingolimod [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD4+ cells"}, {"characteristics_ch1": "patient identifier: SSBZ-7676;\tgender: Female;\tage in years: 45;\tdisease duration in years: 12;\tprevious treatment: Interferon-beta-1a intramuscular;\ttreatment gap in months: 2;\tedss at baseline: 3.0;\tedss after 12 months: 3.0;\trelapses during 12 months prior fingolimod: 3;\trelapses during 12-month follow-up: 0"}]}, {"GSM1884967": [{"title": "Patient 5, CD4+ cells, after 3 months of fingolimod treatment [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD4+ cells"}, {"characteristics_ch1": "patient identifier: SSBZ-7676;\tgender: Female;\tage in years: 45;\tdisease duration in years: 12;\tprevious treatment: Interferon-beta-1a intramuscular;\ttreatment gap in months: 2;\tedss at baseline: 3.0;\tedss after 12 months: 3.0;\trelapses during 12 months prior fingolimod: 3;\trelapses during 12-month follow-up: 0"}]}, {"GSM1884968": [{"title": "Patient 6, CD4+ cells, before first dose of fingolimod [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD4+ cells"}, {"characteristics_ch1": "patient identifier: ESRN-3798;\tgender: Female;\tage in years: 33;\tdisease duration in years: 2;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: <1;\tedss at baseline: 2.5;\tedss after 12 months: 5.5;\trelapses during 12 months prior fingolimod: 2;\trelapses during 12-month follow-up: 2"}]}, {"GSM1884969": [{"title": "Patient 6, CD4+ cells, before second dose of fingolimod [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD4+ cells"}, {"characteristics_ch1": "patient identifier: ESRN-3798;\tgender: Female;\tage in years: 33;\tdisease duration in years: 2;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: <1;\tedss at baseline: 2.5;\tedss after 12 months: 5.5;\trelapses during 12 months prior fingolimod: 2;\trelapses during 12-month follow-up: 2"}]}, {"GSM1884970": [{"title": "Patient 6, CD4+ cells, after 3 months of fingolimod treatment [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD4+ cells"}, {"characteristics_ch1": "patient identifier: ESRN-3798;\tgender: Female;\tage in years: 33;\tdisease duration in years: 2;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: <1;\tedss at baseline: 2.5;\tedss after 12 months: 5.5;\trelapses during 12 months prior fingolimod: 2;\trelapses during 12-month follow-up: 2"}]}, {"GSM1884971": [{"title": "Patient 7, CD4+ cells, before first dose of fingolimod [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD4+ cells"}, {"characteristics_ch1": "patient identifier: DMPU-9668;\tgender: Female;\tage in years: 46;\tdisease duration in years: 9;\tprevious treatment: Interferon-beta-1b subcutaneous;\ttreatment gap in months: <1;\tedss at baseline: 4.0;\tedss after 12 months: 4.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM1884972": [{"title": "Patient 7, CD4+ cells, before second dose of fingolimod [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD4+ cells"}, {"characteristics_ch1": "patient identifier: DMPU-9668;\tgender: Female;\tage in years: 46;\tdisease duration in years: 9;\tprevious treatment: Interferon-beta-1b subcutaneous;\ttreatment gap in months: <1;\tedss at baseline: 4.0;\tedss after 12 months: 4.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM1884973": [{"title": "Patient 7, CD4+ cells, after 3 months of fingolimod treatment [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD4+ cells"}, {"characteristics_ch1": "patient identifier: DMPU-9668;\tgender: Female;\tage in years: 46;\tdisease duration in years: 9;\tprevious treatment: Interferon-beta-1b subcutaneous;\ttreatment gap in months: <1;\tedss at baseline: 4.0;\tedss after 12 months: 4.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM1884974": [{"title": "Patient 8, CD4+ cells, before first dose of fingolimod [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD4+ cells"}, {"characteristics_ch1": "patient identifier: CFMJ-5805;\tgender: Male;\tage in years: 33;\tdisease duration in years: 4;\tprevious treatment: Interferon-beta-1a subcutaneous;\ttreatment gap in months: <1;\tedss at baseline: 3.0;\tedss after 12 months: 6.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 3"}]}, {"GSM1884975": [{"title": "Patient 8, CD4+ cells, before second dose of fingolimod [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD4+ cells"}, {"characteristics_ch1": "patient identifier: CFMJ-5805;\tgender: Male;\tage in years: 33;\tdisease duration in years: 4;\tprevious treatment: Interferon-beta-1a subcutaneous;\ttreatment gap in months: <1;\tedss at baseline: 3.0;\tedss after 12 months: 6.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 3"}]}, {"GSM1884976": [{"title": "Patient 8, CD4+ cells, after 3 months of fingolimod treatment [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD4+ cells"}, {"characteristics_ch1": "patient identifier: CFMJ-5805;\tgender: Male;\tage in years: 33;\tdisease duration in years: 4;\tprevious treatment: Interferon-beta-1a subcutaneous;\ttreatment gap in months: <1;\tedss at baseline: 3.0;\tedss after 12 months: 6.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 3"}]}, {"GSM1884977": [{"title": "Patient 9, CD4+ cells, before first dose of fingolimod [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD4+ cells"}, {"characteristics_ch1": "patient identifier: RBTM-1672;\tgender: Male;\tage in years: 46;\tdisease duration in years: 15;\tprevious treatment: Interferon-beta-1b subcutaneous;\ttreatment gap in months: <1;\tedss at baseline: 3.5;\tedss after 12 months: 2.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM1884978": [{"title": "Patient 9, CD4+ cells, before second dose of fingolimod [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD4+ cells"}, {"characteristics_ch1": "patient identifier: RBTM-1672;\tgender: Male;\tage in years: 46;\tdisease duration in years: 15;\tprevious treatment: Interferon-beta-1b subcutaneous;\ttreatment gap in months: <1;\tedss at baseline: 3.5;\tedss after 12 months: 2.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM1884979": [{"title": "Patient 9, CD4+ cells, after 3 months of fingolimod treatment [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD4+ cells"}, {"characteristics_ch1": "patient identifier: RBTM-1672;\tgender: Male;\tage in years: 46;\tdisease duration in years: 15;\tprevious treatment: Interferon-beta-1b subcutaneous;\ttreatment gap in months: <1;\tedss at baseline: 3.5;\tedss after 12 months: 2.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM1884980": [{"title": "Patient 10, CD4+ cells, before first dose of fingolimod [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD4+ cells"}, {"characteristics_ch1": "patient identifier: FCCI-7765;\tgender: Male;\tage in years: 37;\tdisease duration in years: 9;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: 1;\tedss at baseline: 5.5;\tedss after 12 months: 4.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM1884981": [{"title": "Patient 10, CD4+ cells, before second dose of fingolimod [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD4+ cells"}, {"characteristics_ch1": "patient identifier: FCCI-7765;\tgender: Male;\tage in years: 37;\tdisease duration in years: 9;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: 1;\tedss at baseline: 5.5;\tedss after 12 months: 4.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM1884982": [{"title": "Patient 10, CD4+ cells, after 3 months of fingolimod treatment [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD4+ cells"}, {"characteristics_ch1": "patient identifier: FCCI-7765;\tgender: Male;\tage in years: 37;\tdisease duration in years: 9;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: 1;\tedss at baseline: 5.5;\tedss after 12 months: 4.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM1885013": [{"title": "Patient 1, CD8+ cells, before first dose of fingolimod [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD8+ cells"}, {"characteristics_ch1": "patient identifier: QSCV-8684;\tgender: Female;\tage in years: 43;\tdisease duration in years: 20;\tprevious treatment: Interferon-beta-1a subcutaneous;\ttreatment gap in months: 38;\tedss at baseline: 4.0;\tedss after 12 months: 3.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM1885014": [{"title": "Patient 1, CD8+ cells, before second dose of fingolimod [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD8+ cells"}, {"characteristics_ch1": "patient identifier: QSCV-8684;\tgender: Female;\tage in years: 43;\tdisease duration in years: 20;\tprevious treatment: Interferon-beta-1a subcutaneous;\ttreatment gap in months: 38;\tedss at baseline: 4.0;\tedss after 12 months: 3.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM1885015": [{"title": "Patient 1, CD8+ cells, after 3 months of fingolimod treatment [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD8+ cells"}, {"characteristics_ch1": "patient identifier: QSCV-8684;\tgender: Female;\tage in years: 43;\tdisease duration in years: 20;\tprevious treatment: Interferon-beta-1a subcutaneous;\ttreatment gap in months: 38;\tedss at baseline: 4.0;\tedss after 12 months: 3.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM1885016": [{"title": "Patient 2, CD8+ cells, before first dose of fingolimod [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD8+ cells"}, {"characteristics_ch1": "patient identifier: YHCG-2832;\tgender: Female;\tage in years: 29;\tdisease duration in years: 5;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: <1;\tedss at baseline: 2.5;\tedss after 12 months: 1.5;\trelapses during 12 months prior fingolimod: 3;\trelapses during 12-month follow-up: 0"}]}, {"GSM1885017": [{"title": "Patient 2, CD8+ cells, before second dose of fingolimod [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD8+ cells"}, {"characteristics_ch1": "patient identifier: YHCG-2832;\tgender: Female;\tage in years: 29;\tdisease duration in years: 5;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: <1;\tedss at baseline: 2.5;\tedss after 12 months: 1.5;\trelapses during 12 months prior fingolimod: 3;\trelapses during 12-month follow-up: 0"}]}, {"GSM1885018": [{"title": "Patient 2, CD8+ cells, after 3 months of fingolimod treatment [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD8+ cells"}, {"characteristics_ch1": "patient identifier: YHCG-2832;\tgender: Female;\tage in years: 29;\tdisease duration in years: 5;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: <1;\tedss at baseline: 2.5;\tedss after 12 months: 1.5;\trelapses during 12 months prior fingolimod: 3;\trelapses during 12-month follow-up: 0"}]}, {"GSM1885019": [{"title": "Patient 3, CD8+ cells, before first dose of fingolimod [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD8+ cells"}, {"characteristics_ch1": "patient identifier: WKSB-4693;\tgender: Female;\tage in years: 43;\tdisease duration in years: 1;\tprevious treatment: Interferon-beta-1a intramuscular;\ttreatment gap in months: 1;\tedss at baseline: 4.0;\tedss after 12 months: 3.5;\trelapses during 12 months prior fingolimod: 2;\trelapses during 12-month follow-up: 0"}]}, {"GSM1885020": [{"title": "Patient 3, CD8+ cells, before second dose of fingolimod [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD8+ cells"}, {"characteristics_ch1": "patient identifier: WKSB-4693;\tgender: Female;\tage in years: 43;\tdisease duration in years: 1;\tprevious treatment: Interferon-beta-1a intramuscular;\ttreatment gap in months: 1;\tedss at baseline: 4.0;\tedss after 12 months: 3.5;\trelapses during 12 months prior fingolimod: 2;\trelapses during 12-month follow-up: 0"}]}, {"GSM1885021": [{"title": "Patient 3, CD8+ cells, after 3 months of fingolimod treatment [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD8+ cells"}, {"characteristics_ch1": "patient identifier: WKSB-4693;\tgender: Female;\tage in years: 43;\tdisease duration in years: 1;\tprevious treatment: Interferon-beta-1a intramuscular;\ttreatment gap in months: 1;\tedss at baseline: 4.0;\tedss after 12 months: 3.5;\trelapses during 12 months prior fingolimod: 2;\trelapses during 12-month follow-up: 0"}]}, {"GSM1885022": [{"title": "Patient 4, CD8+ cells, before first dose of fingolimod [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD8+ cells"}, {"characteristics_ch1": "patient identifier: SSBZ-7676;\tgender: Female;\tage in years: 45;\tdisease duration in years: 12;\tprevious treatment: Interferon-beta-1a intramuscular;\ttreatment gap in months: 2;\tedss at baseline: 3.0;\tedss after 12 months: 3.0;\trelapses during 12 months prior fingolimod: 3;\trelapses during 12-month follow-up: 0"}]}, {"GSM1885023": [{"title": "Patient 4, CD8+ cells, before second dose of fingolimod [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD8+ cells"}, {"characteristics_ch1": "patient identifier: SSBZ-7676;\tgender: Female;\tage in years: 45;\tdisease duration in years: 12;\tprevious treatment: Interferon-beta-1a intramuscular;\ttreatment gap in months: 2;\tedss at baseline: 3.0;\tedss after 12 months: 3.0;\trelapses during 12 months prior fingolimod: 3;\trelapses during 12-month follow-up: 0"}]}, {"GSM1885024": [{"title": "Patient 4, CD8+ cells, after 3 months of fingolimod treatment [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD8+ cells"}, {"characteristics_ch1": "patient identifier: SSBZ-7676;\tgender: Female;\tage in years: 45;\tdisease duration in years: 12;\tprevious treatment: Interferon-beta-1a intramuscular;\ttreatment gap in months: 2;\tedss at baseline: 3.0;\tedss after 12 months: 3.0;\trelapses during 12 months prior fingolimod: 3;\trelapses during 12-month follow-up: 0"}]}, {"GSM1885025": [{"title": "Patient 5, CD8+ cells, before first dose of fingolimod [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD8+ cells"}, {"characteristics_ch1": "patient identifier: XBOH-5819;\tgender: Male;\tage in years: 31;\tdisease duration in years: 7;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: <1;\tedss at baseline: 3.5;\tedss after 12 months: 2.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM1885026": [{"title": "Patient 5, CD8+ cells, before second dose of fingolimod [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD8+ cells"}, {"characteristics_ch1": "patient identifier: XBOH-5819;\tgender: Male;\tage in years: 31;\tdisease duration in years: 7;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: <1;\tedss at baseline: 3.5;\tedss after 12 months: 2.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM1885027": [{"title": "Patient 5, CD8+ cells, after 3 months of fingolimod treatment [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD8+ cells"}, {"characteristics_ch1": "patient identifier: XBOH-5819;\tgender: Male;\tage in years: 31;\tdisease duration in years: 7;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: <1;\tedss at baseline: 3.5;\tedss after 12 months: 2.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM1885028": [{"title": "Patient 6, CD8+ cells, before first dose of fingolimod [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD8+ cells"}, {"characteristics_ch1": "patient identifier: ESRN-3798;\tgender: Female;\tage in years: 33;\tdisease duration in years: 2;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: <1;\tedss at baseline: 2.5;\tedss after 12 months: 5.5;\trelapses during 12 months prior fingolimod: 2;\trelapses during 12-month follow-up: 2"}]}, {"GSM1885029": [{"title": "Patient 6, CD8+ cells, before second dose of fingolimod [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD8+ cells"}, {"characteristics_ch1": "patient identifier: ESRN-3798;\tgender: Female;\tage in years: 33;\tdisease duration in years: 2;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: <1;\tedss at baseline: 2.5;\tedss after 12 months: 5.5;\trelapses during 12 months prior fingolimod: 2;\trelapses during 12-month follow-up: 2"}]}, {"GSM1885030": [{"title": "Patient 6, CD8+ cells, after 3 months of fingolimod treatment [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD8+ cells"}, {"characteristics_ch1": "patient identifier: ESRN-3798;\tgender: Female;\tage in years: 33;\tdisease duration in years: 2;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: <1;\tedss at baseline: 2.5;\tedss after 12 months: 5.5;\trelapses during 12 months prior fingolimod: 2;\trelapses during 12-month follow-up: 2"}]}, {"GSM1885031": [{"title": "Patient 7, CD8+ cells, before first dose of fingolimod [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD8+ cells"}, {"characteristics_ch1": "patient identifier: DMPU-9668;\tgender: Female;\tage in years: 46;\tdisease duration in years: 9;\tprevious treatment: Interferon-beta-1b subcutaneous;\ttreatment gap in months: <1;\tedss at baseline: 4.0;\tedss after 12 months: 4.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM1885032": [{"title": "Patient 7, CD8+ cells, before second dose of fingolimod [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD8+ cells"}, {"characteristics_ch1": "patient identifier: DMPU-9668;\tgender: Female;\tage in years: 46;\tdisease duration in years: 9;\tprevious treatment: Interferon-beta-1b subcutaneous;\ttreatment gap in months: <1;\tedss at baseline: 4.0;\tedss after 12 months: 4.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM1885033": [{"title": "Patient 7, CD8+ cells, after 3 months of fingolimod treatment [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD8+ cells"}, {"characteristics_ch1": "patient identifier: DMPU-9668;\tgender: Female;\tage in years: 46;\tdisease duration in years: 9;\tprevious treatment: Interferon-beta-1b subcutaneous;\ttreatment gap in months: <1;\tedss at baseline: 4.0;\tedss after 12 months: 4.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM1885034": [{"title": "Patient 8, CD8+ cells, before first dose of fingolimod [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD8+ cells"}, {"characteristics_ch1": "patient identifier: CFMJ-5805;\tgender: Male;\tage in years: 33;\tdisease duration in years: 4;\tprevious treatment: Interferon-beta-1a subcutaneous;\ttreatment gap in months: <1;\tedss at baseline: 3.0;\tedss after 12 months: 6.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 3"}]}, {"GSM1885035": [{"title": "Patient 8, CD8+ cells, before second dose of fingolimod [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD8+ cells"}, {"characteristics_ch1": "patient identifier: CFMJ-5805;\tgender: Male;\tage in years: 33;\tdisease duration in years: 4;\tprevious treatment: Interferon-beta-1a subcutaneous;\ttreatment gap in months: <1;\tedss at baseline: 3.0;\tedss after 12 months: 6.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 3"}]}, {"GSM1885036": [{"title": "Patient 8, CD8+ cells, after 3 months of fingolimod treatment [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD8+ cells"}, {"characteristics_ch1": "patient identifier: CFMJ-5805;\tgender: Male;\tage in years: 33;\tdisease duration in years: 4;\tprevious treatment: Interferon-beta-1a subcutaneous;\ttreatment gap in months: <1;\tedss at baseline: 3.0;\tedss after 12 months: 6.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 3"}]}, {"GSM1885037": [{"title": "Patient 9, CD8+ cells, before first dose of fingolimod [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD8+ cells"}, {"characteristics_ch1": "patient identifier: RBTM-1672;\tgender: Male;\tage in years: 46;\tdisease duration in years: 15;\tprevious treatment: Interferon-beta-1b subcutaneous;\ttreatment gap in months: <1;\tedss at baseline: 3.5;\tedss after 12 months: 2.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM1885038": [{"title": "Patient 9, CD8+ cells, before second dose of fingolimod [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD8+ cells"}, {"characteristics_ch1": "patient identifier: RBTM-1672;\tgender: Male;\tage in years: 46;\tdisease duration in years: 15;\tprevious treatment: Interferon-beta-1b subcutaneous;\ttreatment gap in months: <1;\tedss at baseline: 3.5;\tedss after 12 months: 2.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM1885039": [{"title": "Patient 9, CD8+ cells, after 3 months of fingolimod treatment [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD8+ cells"}, {"characteristics_ch1": "patient identifier: RBTM-1672;\tgender: Male;\tage in years: 46;\tdisease duration in years: 15;\tprevious treatment: Interferon-beta-1b subcutaneous;\ttreatment gap in months: <1;\tedss at baseline: 3.5;\tedss after 12 months: 2.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM1885040": [{"title": "Patient 10, CD8+ cells, before first dose of fingolimod [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD8+ cells"}, {"characteristics_ch1": "patient identifier: FCCI-7765;\tgender: Male;\tage in years: 37;\tdisease duration in years: 9;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: 1;\tedss at baseline: 5.5;\tedss after 12 months: 4.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM1885041": [{"title": "Patient 10, CD8+ cells, before second dose of fingolimod [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD8+ cells"}, {"characteristics_ch1": "patient identifier: FCCI-7765;\tgender: Male;\tage in years: 37;\tdisease duration in years: 9;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: 1;\tedss at baseline: 5.5;\tedss after 12 months: 4.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM1885042": [{"title": "Patient 10, CD8+ cells, after 3 months of fingolimod treatment [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD8+ cells"}, {"characteristics_ch1": "patient identifier: FCCI-7765;\tgender: Male;\tage in years: 37;\tdisease duration in years: 9;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: 1;\tedss at baseline: 5.5;\tedss after 12 months: 4.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM1888875": [{"title": "Hep3B_scr1"}, {"type": "RNA"}, {"source_name_ch1": "Human HCC Hep3B cells treated with scrambled siRNA for 48hrs"}, {"characteristics_ch1": "cell type: primary HCC cells"}]}, {"GSM1888876": [{"title": "Hep3B_scr2"}, {"type": "RNA"}, {"source_name_ch1": "Human HCC Hep3B cells treated with scrambled siRNA for 48hrs"}, {"characteristics_ch1": "cell type: primary HCC cells"}]}, {"GSM1888877": [{"title": "Hep3B_scr3"}, {"type": "RNA"}, {"source_name_ch1": "Human HCC Hep3B cells treated with scrambled siRNA for 48hrs"}, {"characteristics_ch1": "cell type: primary HCC cells"}]}, {"GSM1888878": [{"title": "Hep3B_RDBP1"}, {"type": "RNA"}, {"source_name_ch1": "Human HCC Hep3B cells treated with RDBP siRNA for 48hrs"}, {"characteristics_ch1": "cell type: primary HCC cells"}]}, {"GSM1888879": [{"title": "Hep3B_RDBP2"}, {"type": "RNA"}, {"source_name_ch1": "Human HCC Hep3B cells treated with RDBP siRNA for 48hrs"}, {"characteristics_ch1": "cell type: primary HCC cells"}]}, {"GSM1888880": [{"title": "Hep3B_RDBP3"}, {"type": "RNA"}, {"source_name_ch1": "Human HCC Hep3B cells treated with RDBP siRNA for 48hrs"}, {"characteristics_ch1": "cell type: primary HCC cells"}]}, {"GSM1888881": [{"title": "Huh1_scr1"}, {"type": "RNA"}, {"source_name_ch1": "Human HCC Huh1 cells treated with scrambled siRNA for 48hrs"}, {"characteristics_ch1": "cell type: primary HCC cells"}]}, {"GSM1888882": [{"title": "Huh1_scr2"}, {"type": "RNA"}, {"source_name_ch1": "Human HCC Huh1 cells treated with scrambled siRNA for 48hrs"}, {"characteristics_ch1": "cell type: primary HCC cells"}]}, {"GSM1888883": [{"title": "Huh1_scr3"}, {"type": "RNA"}, {"source_name_ch1": "Human HCC Huh1 cells treated with scrambled siRNA for 48hrs"}, {"characteristics_ch1": "cell type: primary HCC cells"}]}, {"GSM1888884": [{"title": "Huh1_RDBP1"}, {"type": "RNA"}, {"source_name_ch1": "Human HCC Huh1 cells treated with RDBP siRNA for 48hrs"}, {"characteristics_ch1": "cell type: primary HCC cells"}]}, {"GSM1888885": [{"title": "Huh1_RDBP2"}, {"type": "RNA"}, {"source_name_ch1": "Human HCC Huh1 cells treated with RDBP siRNA for 48hrs"}, {"characteristics_ch1": "cell type: primary HCC cells"}]}, {"GSM1888886": [{"title": "Huh1_RDBP3"}, {"type": "RNA"}, {"source_name_ch1": "Human HCC Huh1 cells treated with RDBP siRNA for 48hrs"}, {"characteristics_ch1": "cell type: primary HCC cells"}]}, {"GSM1892385": [{"title": "Cells without differentiation, biological replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "pre-adipocytes from human vascular progenitors"}, {"characteristics_ch1": "cell type: pre-adipocytes from human vascular progenitors"}]}, {"GSM1892386": [{"title": "Cells without differentiation, biological replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "pre-adipocytes from human vascular progenitors"}, {"characteristics_ch1": "cell type: pre-adipocytes from human vascular progenitors"}]}, {"GSM1892387": [{"title": "Cells without differentation, biological replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "pre-adipocytes from human vascular progenitors"}, {"characteristics_ch1": "cell type: pre-adipocytes from human vascular progenitors"}]}, {"GSM1892388": [{"title": "Cells after adipogenic differentation with MDI, biological replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "adipocytes from human vascular progenitors"}, {"characteristics_ch1": "cell type: adipocytes from human vascular progenitors"}]}, {"GSM1892389": [{"title": "Cells after adipogenic differentation with MDI, biological replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "adipocytes from human vascular progenitors"}, {"characteristics_ch1": "cell type: adipocytes from human vascular progenitors"}]}, {"GSM1892390": [{"title": "Cells after adipogenic differentation with MDI, biological replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "adipocytes from human vascular progenitors"}, {"characteristics_ch1": "cell type: adipocytes from human vascular progenitors"}]}, {"GSM1892391": [{"title": "Cells after adipogenic differentation with MDI, treated with forskolin, biological replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "adipocytes from human vascular progenitors treated with forskolin"}, {"characteristics_ch1": "cell type: adipocytes from human vascular progenitors;\ttreatment: forskolin"}]}, {"GSM1892392": [{"title": "Cells after adipogenic differentation with MDI, treated with forskolin, biological replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "adipocytes from human vascular progenitors treated with forskolin"}, {"characteristics_ch1": "cell type: adipocytes from human vascular progenitors;\ttreatment: forskolin"}]}, {"GSM1892393": [{"title": "Cells after adipogenic differentation with MDI, treated with forskolin, biological replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "adipocytes from human vascular progenitors treated with forskolin"}, {"characteristics_ch1": "cell type: adipocytes from human vascular progenitors;\ttreatment: forskolin"}]}, {"GSM1892412": [{"title": "Dox_10_nM_E2_1_05012014_(HTA-2.0)"}, {"type": "RNA"}, {"source_name_ch1": "MCF7_Dox_10_nM_E2"}, {"characteristics_ch1": "cell line: MCF7;\tcell type: breast cancer cell line;\tgenotype/variation: MCF7-tet-on-shCtr9;\tpre-treated with: 500 ng/ml Dox;\ttreated with: 10 nM E2 for 4 hrs"}]}, {"GSM1892413": [{"title": "Dox_10_nM_E2_2_05012014_(HTA-2.0)"}, {"type": "RNA"}, {"source_name_ch1": "MCF7_Dox_10_nM_E2"}, {"characteristics_ch1": "cell line: MCF7;\tcell type: breast cancer cell line;\tgenotype/variation: MCF7-tet-on-shCtr9;\tpre-treated with: 500 ng/ml Dox;\ttreated with: 10 nM E2 for 4 hrs"}]}, {"GSM1892414": [{"title": "Dox_10_nM_E2_3_05012014_(HTA-2.0)"}, {"type": "RNA"}, {"source_name_ch1": "MCF7_Dox_10_nM_E2"}, {"characteristics_ch1": "cell line: MCF7;\tcell type: breast cancer cell line;\tgenotype/variation: MCF7-tet-on-shCtr9;\tpre-treated with: 500 ng/ml Dox;\ttreated with: 10 nM E2 for 4 hrs"}]}, {"GSM1892415": [{"title": "Dox_DMSO_1_05012014_(HTA-2.0)"}, {"type": "RNA"}, {"source_name_ch1": "MCF7_Dox_DMSO"}, {"characteristics_ch1": "cell line: MCF7;\tcell type: breast cancer cell line;\tgenotype/variation: MCF7-tet-on-shCtr9;\tpre-treated with: 500 ng/ml Dox;\ttreated with: DMSO for 4 hrs"}]}, {"GSM1892416": [{"title": "Dox_DMSO_2_05012014_(HTA-2.0)"}, {"type": "RNA"}, {"source_name_ch1": "MCF7_Dox_DMSO"}, {"characteristics_ch1": "cell line: MCF7;\tcell type: breast cancer cell line;\tgenotype/variation: MCF7-tet-on-shCtr9;\tpre-treated with: 500 ng/ml Dox;\ttreated with: DMSO for 4 hrs"}]}, {"GSM1892417": [{"title": "Dox_DMSO_3_05012014_(HTA-2.0)"}, {"type": "RNA"}, {"source_name_ch1": "MCF7_Dox_DMSO"}, {"characteristics_ch1": "cell line: MCF7;\tcell type: breast cancer cell line;\tgenotype/variation: MCF7-tet-on-shCtr9;\tpre-treated with: 500 ng/ml Dox;\ttreated with: DMSO for 4 hrs"}]}, {"GSM1892418": [{"title": "Vehicle_10_nM_E2_1_05012014_(HTA-2.0)"}, {"type": "RNA"}, {"source_name_ch1": "MCF7_Vehicle_10_nM_E2"}, {"characteristics_ch1": "cell line: MCF7;\tcell type: breast cancer cell line;\tgenotype/variation: MCF7-tet-on-shCtr9;\tpre-treated with: none (absence of Dox);\ttreated with: 10 nM E2 for 4 hrs"}]}, {"GSM1892419": [{"title": "Vehicle_10_nM_E2_2_05012014_(HTA-2.0)"}, {"type": "RNA"}, {"source_name_ch1": "MCF7_Vehicle_10_nM_E2"}, {"characteristics_ch1": "cell line: MCF7;\tcell type: breast cancer cell line;\tgenotype/variation: MCF7-tet-on-shCtr9;\tpre-treated with: none (absence of Dox);\ttreated with: 10 nM E2 for 4 hrs"}]}, {"GSM1892420": [{"title": "Vehicle_10_nM_E2_3_05012014_(HTA-2.0)"}, {"type": "RNA"}, {"source_name_ch1": "MCF7_Vehicle_10_nM_E2"}, {"characteristics_ch1": "cell line: MCF7;\tcell type: breast cancer cell line;\tgenotype/variation: MCF7-tet-on-shCtr9;\tpre-treated with: none (absence of Dox);\ttreated with: 10 nM E2 for 4 hrs"}]}, {"GSM1892421": [{"title": "Vehicle_DMSO_1_05012014_(HTA-2.0)"}, {"type": "RNA"}, {"source_name_ch1": "MCF7_Vehicle_DMSO"}, {"characteristics_ch1": "cell line: MCF7;\tcell type: breast cancer cell line;\tgenotype/variation: MCF7-tet-on-shCtr9;\tpre-treated with: none (absence of Dox);\ttreated with: DMSO for 4 hrs"}]}, {"GSM1892422": [{"title": "Vehicle_DMSO_2_05012014_(HTA-2.0)"}, {"type": "RNA"}, {"source_name_ch1": "MCF7_Vehicle_DMSO"}, {"characteristics_ch1": "cell line: MCF7;\tcell type: breast cancer cell line;\tgenotype/variation: MCF7-tet-on-shCtr9;\tpre-treated with: none (absence of Dox);\ttreated with: DMSO for 4 hrs"}]}, {"GSM1892423": [{"title": "Vehicle_DMSO_3_05012014_(HTA-2.0)"}, {"type": "RNA"}, {"source_name_ch1": "MCF7_Vehicle_DMSO"}, {"characteristics_ch1": "cell line: MCF7;\tcell type: breast cancer cell line;\tgenotype/variation: MCF7-tet-on-shCtr9;\tpre-treated with: none (absence of Dox);\ttreated with: DMSO for 4 hrs"}]}, {"GSM1902294": [{"title": "C33-A transfected with HPV16 variant AAa (1)"}, {"type": "RNA"}, {"source_name_ch1": "C33-A transfected with AAa variant"}, {"characteristics_ch1": "cell line: cervical carcinoma cell line C33-A;\ttransfection: AAa"}]}, {"GSM1902295": [{"title": "C33-A transfected with HPV16 variant AAa (2)"}, {"type": "RNA"}, {"source_name_ch1": "C33-A transfected with AAa variant"}, {"characteristics_ch1": "cell line: cervical carcinoma cell line C33-A;\ttransfection: AAa"}]}, {"GSM1902296": [{"title": "C33-A transfected with HPV16 variant AAc (1)"}, {"type": "RNA"}, {"source_name_ch1": "C33-A transfected with AAc variant"}, {"characteristics_ch1": "cell line: cervical carcinoma cell line C33-A;\ttransfection: AAc"}]}, {"GSM1902297": [{"title": "C33-A transfected with HPV16 variant AAc (2)"}, {"type": "RNA"}, {"source_name_ch1": "C33-A transfected with AAc variant"}, {"characteristics_ch1": "cell line: cervical carcinoma cell line C33-A;\ttransfection: AAc"}]}, {"GSM1902298": [{"title": "C33-A WT (1)"}, {"type": "RNA"}, {"source_name_ch1": "C33-A wt"}, {"characteristics_ch1": "cell line: cervical carcinoma cell line C33-A;\ttransfection: WT- No tranfection"}]}, {"GSM1902299": [{"title": "C33-A WT (2)"}, {"type": "RNA"}, {"source_name_ch1": "C33-A wt"}, {"characteristics_ch1": "cell line: cervical carcinoma cell line C33-A;\ttransfection: WT- No tranfection"}]}, {"GSM1902300": [{"title": "C33-A transfected with HPV16 variant E-A176/G350 (1)"}, {"type": "RNA"}, {"source_name_ch1": "C33-A transfected with E-A176/G350 variant"}, {"characteristics_ch1": "cell line: cervical carcinoma cell line C33-A;\ttransfection: E-A176/G350"}]}, {"GSM1902301": [{"title": "C33-A transfected with HPV16 variant E-A176/G350 (2)"}, {"type": "RNA"}, {"source_name_ch1": "C33-A transfected with E-A176/G350 variant"}, {"characteristics_ch1": "cell line: cervical carcinoma cell line C33-A;\ttransfection: E-A176/G350"}]}, {"GSM1902302": [{"title": "C33-A transfected with HPV16 variant E-C188/G350 (1)"}, {"type": "RNA"}, {"source_name_ch1": "C33-A transfected with E-C188/G350 variant"}, {"characteristics_ch1": "cell line: cervical carcinoma cell line C33-A;\ttransfection: E-C188/G350"}]}, {"GSM1902303": [{"title": "C33-A transfected with HPV16 variant E-C188/G350 (2)"}, {"type": "RNA"}, {"source_name_ch1": "C33-A transfected with E-C188/G350 variant"}, {"characteristics_ch1": "cell line: cervical carcinoma cell line C33-A;\ttransfection: E-C188/G350"}]}, {"GSM1902304": [{"title": "C33-A transfected with HPV16 variant G350 (1)"}, {"type": "RNA"}, {"source_name_ch1": "C33-A transfected with G350 variant"}, {"characteristics_ch1": "cell line: cervical carcinoma cell line C33-A;\ttransfection: E-G350"}]}, {"GSM1902305": [{"title": "C33-A transfected with HPV16 variant G350 (2)"}, {"type": "RNA"}, {"source_name_ch1": "C33-A transfected with G350 variant"}, {"characteristics_ch1": "cell line: cervical carcinoma cell line C33-A;\ttransfection: E-G350"}]}, {"GSM1902306": [{"title": "C33-A transfected with HPV16 E-protype (1)"}, {"type": "RNA"}, {"source_name_ch1": "C33-A transfected with E-protype"}, {"characteristics_ch1": "cell line: cervical carcinoma cell line C33-A;\ttransfection: E-prototype (E-A176)"}]}, {"GSM1902307": [{"title": "C33-A transfected with HPV16 E-protype (2)"}, {"type": "RNA"}, {"source_name_ch1": "C33-A transfected with E-protype"}, {"characteristics_ch1": "cell line: cervical carcinoma cell line C33-A;\ttransfection: E-prototype (E-A176)"}]}, {"GSM1902308": [{"title": "C33-A transfected with mock (1)"}, {"type": "RNA"}, {"source_name_ch1": "C33-A transfected with mock"}, {"characteristics_ch1": "cell line: cervical carcinoma cell line C33-A;\ttransfection: Mock"}]}, {"GSM1902309": [{"title": "C33-A transfected with mock (2)"}, {"type": "RNA"}, {"source_name_ch1": "C33-A transfected with mock"}, {"characteristics_ch1": "cell line: cervical carcinoma cell line C33-A;\ttransfection: Mock"}]}, {"GSM1903858": [{"title": "PBMC CD4&CD8 T cells-GVHD.1"}, {"type": "RNA"}, {"source_name_ch1": "PBMC CD4&CD8 T cells from patient with GVHD"}, {"characteristics_ch1": "batch: 1;\tday_post_hct: 28;\tpatient_id: UM1;\thx_of_gvhd: Yes;\tgroup: GVHD;\tcell type: PBMC CD4&CD8 T cells"}]}, {"GSM1903859": [{"title": "PBMC CD4&CD8 T cells-GVHD.10"}, {"type": "RNA"}, {"source_name_ch1": "PBMC CD4&CD8 T cells from patient with GVHD"}, {"characteristics_ch1": "batch: 1;\tday_post_hct: 28;\tpatient_id: UM10;\thx_of_gvhd: Yes;\tgroup: GVHD;\tcell type: PBMC CD4&CD8 T cells"}]}, {"GSM1903860": [{"title": "PBMC CD4&CD8 T cells-GVHD.11"}, {"type": "RNA"}, {"source_name_ch1": "PBMC CD4&CD8 T cells from patient with GVHD"}, {"characteristics_ch1": "batch: 2;\tday_post_hct: 83;\tpatient_id: ABA-001-008;\thx_of_gvhd: Yes;\tgroup: GVHD;\tcell type: PBMC CD4&CD8 T cells"}]}, {"GSM1903861": [{"title": "PBMC CD4&CD8 T cells-GVHD.2"}, {"type": "RNA"}, {"source_name_ch1": "PBMC CD4&CD8 T cells from patient with GVHD"}, {"characteristics_ch1": "batch: 3;\tday_post_hct: 28;\tpatient_id: UM2;\thx_of_gvhd: Yes;\tgroup: GVHD;\tcell type: PBMC CD4&CD8 T cells"}]}, {"GSM1903862": [{"title": "PBMC CD4&CD8 T cells-GVHD.3"}, {"type": "RNA"}, {"source_name_ch1": "PBMC CD4&CD8 T cells from patient with GVHD"}, {"characteristics_ch1": "batch: 1;\tday_post_hct: 60;\tpatient_id: UM3;\thx_of_gvhd: Yes;\tgroup: GVHD;\tcell type: PBMC CD4&CD8 T cells"}]}, {"GSM1903863": [{"title": "PBMC CD4&CD8 T cells-GVHD.4"}, {"type": "RNA"}, {"source_name_ch1": "PBMC CD4&CD8 T cells from patient with GVHD"}, {"characteristics_ch1": "batch: 1;\tday_post_hct: 60;\tpatient_id: UM4;\thx_of_gvhd: Yes;\tgroup: GVHD;\tcell type: PBMC CD4&CD8 T cells"}]}, {"GSM1903864": [{"title": "PBMC CD4&CD8 T cells-GVHD.5"}, {"type": "RNA"}, {"source_name_ch1": "PBMC CD4&CD8 T cells from patient with GVHD"}, {"characteristics_ch1": "batch: 1;\tday_post_hct: 28;\tpatient_id: UM5;\thx_of_gvhd: Yes;\tgroup: GVHD;\tcell type: PBMC CD4&CD8 T cells"}]}, {"GSM1903865": [{"title": "PBMC CD4&CD8 T cells-GVHD.6"}, {"type": "RNA"}, {"source_name_ch1": "PBMC CD4&CD8 T cells from patient with GVHD"}, {"characteristics_ch1": "batch: 1;\tday_post_hct: 60;\tpatient_id: UM6;\thx_of_gvhd: Yes;\tgroup: GVHD;\tcell type: PBMC CD4&CD8 T cells"}]}, {"GSM1903866": [{"title": "PBMC CD4&CD8 T cells-GVHD.7"}, {"type": "RNA"}, {"source_name_ch1": "PBMC CD4&CD8 T cells from patient with GVHD"}, {"characteristics_ch1": "batch: 1;\tday_post_hct: 28;\tpatient_id: UM7;\thx_of_gvhd: Yes;\tgroup: GVHD;\tcell type: PBMC CD4&CD8 T cells"}]}, {"GSM1903867": [{"title": "PBMC CD4&CD8 T cells-GVHD.8"}, {"type": "RNA"}, {"source_name_ch1": "PBMC CD4&CD8 T cells from patient with GVHD"}, {"characteristics_ch1": "batch: 1;\tday_post_hct: 28;\tpatient_id: UM8;\thx_of_gvhd: Yes;\tgroup: GVHD;\tcell type: PBMC CD4&CD8 T cells"}]}, {"GSM1903868": [{"title": "PBMC CD4&CD8 T cells-GVHD.9"}, {"type": "RNA"}, {"source_name_ch1": "PBMC CD4&CD8 T cells from patient with GVHD"}, {"characteristics_ch1": "batch: 1;\tday_post_hct: 60;\tpatient_id: UM9;\thx_of_gvhd: Yes;\tgroup: GVHD;\tcell type: PBMC CD4&CD8 T cells"}]}, {"GSM1903869": [{"title": "PBMC CD4&CD8 T cells-No GVHD.1"}, {"type": "RNA"}, {"source_name_ch1": "PBMC CD4&CD8 T cells from patient with No GVHD"}, {"characteristics_ch1": "batch: 1;\tday_post_hct: 28;\tpatient_id: UM11;\thx_of_gvhd: No;\tgroup: No GVHD;\tcell type: PBMC CD4&CD8 T cells"}]}, {"GSM1903870": [{"title": "PBMC CD4&CD8 T cells-No GVHD.10"}, {"type": "RNA"}, {"source_name_ch1": "PBMC CD4&CD8 T cells from patient with No GVHD"}, {"characteristics_ch1": "batch: 1;\tday_post_hct: 28;\tpatient_id: UM20;\thx_of_gvhd: No;\tgroup: No GVHD;\tcell type: PBMC CD4&CD8 T cells"}]}, {"GSM1903871": [{"title": "PBMC CD4&CD8 T cells-No GVHD.11"}, {"type": "RNA"}, {"source_name_ch1": "PBMC CD4&CD8 T cells from patient with No GVHD"}, {"characteristics_ch1": "batch: 1;\tday_post_hct: 176;\tpatient_id: ABA-004-001;\thx_of_gvhd: No;\tgroup: No GVHD;\tcell type: PBMC CD4&CD8 T cells"}]}, {"GSM1903872": [{"title": "PBMC CD4&CD8 T cells-No GVHD.12"}, {"type": "RNA"}, {"source_name_ch1": "PBMC CD4&CD8 T cells from patient with No GVHD"}, {"characteristics_ch1": "batch: 1;\tday_post_hct: 28;\tpatient_id: ABA-001-001;\thx_of_gvhd: No;\tgroup: No GVHD;\tcell type: PBMC CD4&CD8 T cells"}]}, {"GSM1903873": [{"title": "PBMC CD4&CD8 T cells-No GVHD.13"}, {"type": "RNA"}, {"source_name_ch1": "PBMC CD4&CD8 T cells from patient with No GVHD"}, {"characteristics_ch1": "batch: 1;\tday_post_hct: 28;\tpatient_id: ABA-001-002;\thx_of_gvhd: No;\tgroup: No GVHD;\tcell type: PBMC CD4&CD8 T cells"}]}, {"GSM1903874": [{"title": "PBMC CD4&CD8 T cells-No GVHD.2"}, {"type": "RNA"}, {"source_name_ch1": "PBMC CD4&CD8 T cells from patient with No GVHD"}, {"characteristics_ch1": "batch: 1;\tday_post_hct: 28;\tpatient_id: UM12;\thx_of_gvhd: No;\tgroup: No GVHD;\tcell type: PBMC CD4&CD8 T cells"}]}, {"GSM1903875": [{"title": "PBMC CD4&CD8 T cells-No GVHD.3"}, {"type": "RNA"}, {"source_name_ch1": "PBMC CD4&CD8 T cells from patient with No GVHD"}, {"characteristics_ch1": "batch: 1;\tday_post_hct: 60;\tpatient_id: UM13;\thx_of_gvhd: No;\tgroup: No GVHD;\tcell type: PBMC CD4&CD8 T cells"}]}, {"GSM1903876": [{"title": "PBMC CD4&CD8 T cells-No GVHD.4"}, {"type": "RNA"}, {"source_name_ch1": "PBMC CD4&CD8 T cells from patient with No GVHD"}, {"characteristics_ch1": "batch: 1;\tday_post_hct: 60;\tpatient_id: UM14;\thx_of_gvhd: No;\tgroup: No GVHD;\tcell type: PBMC CD4&CD8 T cells"}]}, {"GSM1903877": [{"title": "PBMC CD4&CD8 T cells-No GVHD.5"}, {"type": "RNA"}, {"source_name_ch1": "PBMC CD4&CD8 T cells from patient with No GVHD"}, {"characteristics_ch1": "batch: 1;\tday_post_hct: 28;\tpatient_id: UM15;\thx_of_gvhd: No;\tgroup: No GVHD;\tcell type: PBMC CD4&CD8 T cells"}]}, {"GSM1903878": [{"title": "PBMC CD4&CD8 T cells-No GVHD.6"}, {"type": "RNA"}, {"source_name_ch1": "PBMC CD4&CD8 T cells from patient with No GVHD"}, {"characteristics_ch1": "batch: 3;\tday_post_hct: 60;\tpatient_id: UM16;\thx_of_gvhd: No;\tgroup: No GVHD;\tcell type: PBMC CD4&CD8 T cells"}]}, {"GSM1903879": [{"title": "PBMC CD4&CD8 T cells-No GVHD.7"}, {"type": "RNA"}, {"source_name_ch1": "PBMC CD4&CD8 T cells from patient with No GVHD"}, {"characteristics_ch1": "batch: 2;\tday_post_hct: 28;\tpatient_id: UM17;\thx_of_gvhd: No;\tgroup: No GVHD;\tcell type: PBMC CD4&CD8 T cells"}]}, {"GSM1903880": [{"title": "PBMC CD4&CD8 T cells-No GVHD.8"}, {"type": "RNA"}, {"source_name_ch1": "PBMC CD4&CD8 T cells from patient with No GVHD"}, {"characteristics_ch1": "batch: 1;\tday_post_hct: 28;\tpatient_id: UM18;\thx_of_gvhd: No;\tgroup: No GVHD;\tcell type: PBMC CD4&CD8 T cells"}]}, {"GSM1903881": [{"title": "PBMC CD4&CD8 T cells-No GVHD.9"}, {"type": "RNA"}, {"source_name_ch1": "PBMC CD4&CD8 T cells from patient with No GVHD"}, {"characteristics_ch1": "batch: 1;\tday_post_hct: 60;\tpatient_id: UM19;\thx_of_gvhd: No;\tgroup: No GVHD;\tcell type: PBMC CD4&CD8 T cells"}]}, {"GSM1907996": [{"title": "undifferentiated H9 hESCs, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "undifferentiated H9 hESCs"}, {"characteristics_ch1": "gender: female;\tcell line: H9 ESC;\tprotocol: undifferentiated;\ttime: control"}]}, {"GSM1907997": [{"title": "undifferentiated H9 hESCs, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "undifferentiated H9 hESCs"}, {"characteristics_ch1": "gender: female;\tcell line: H9 ESC;\tprotocol: undifferentiated;\ttime: control"}]}, {"GSM1907998": [{"title": "undifferentiated H9 hESCs, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "undifferentiated H9 hESCs"}, {"characteristics_ch1": "gender: female;\tcell line: H9 ESC;\tprotocol: undifferentiated;\ttime: control"}]}, {"GSM1907999": [{"title": "H9 hESCs differentiated for 8hrs, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "H9 hESCs differentiated for 8hrs"}, {"characteristics_ch1": "gender: female;\tcell line: H9 ESC;\tprotocol: differentiated;\ttime: 8hrs"}]}, {"GSM1908000": [{"title": "H9 hESCs differentiated for 8hrs, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "H9 hESCs differentiated for 8hrs"}, {"characteristics_ch1": "gender: female;\tcell line: H9 ESC;\tprotocol: differentiated;\ttime: 8hrs"}]}, {"GSM1908001": [{"title": "H9 hESCs differentiated for 8hrs, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "H9 hESCs differentiated for 8hrs"}, {"characteristics_ch1": "gender: female;\tcell line: H9 ESC;\tprotocol: differentiated;\ttime: 8hrs"}]}, {"GSM1908002": [{"title": "H9 hESCs differentiated for 24hrs, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "H9 hESCs differentiated for 24hrs"}, {"characteristics_ch1": "gender: female;\tcell line: H9 ESC;\tprotocol: differentiated;\ttime: 24hrs"}]}, {"GSM1908003": [{"title": "H9 hESCs differentiated for 24hrs, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "H9 hESCs differentiated for 24hrs"}, {"characteristics_ch1": "gender: female;\tcell line: H9 ESC;\tprotocol: differentiated;\ttime: 24hrs"}]}, {"GSM1908004": [{"title": "H9 hESCs differentiated for 24hrs, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "H9 hESCs differentiated for 24hrs"}, {"characteristics_ch1": "gender: female;\tcell line: H9 ESC;\tprotocol: differentiated;\ttime: 24hrs"}]}, {"GSM1908005": [{"title": "H9 hESCs differentiated for 72hrs, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "H9 hESCs differentiated for 72hrs"}, {"characteristics_ch1": "gender: female;\tcell line: H9 ESC;\tprotocol: differentiated;\ttime: 72 hrs"}]}, {"GSM1908006": [{"title": "H9 hESCs differentiated for 72hrs, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "H9 hESCs differentiated for 72hrs"}, {"characteristics_ch1": "gender: female;\tcell line: H9 ESC;\tprotocol: differentiated;\ttime: 72 hrs"}]}, {"GSM1908007": [{"title": "H9 hESCs differentiated for 72hrs, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "H9 hESCs differentiated for 72hrs"}, {"characteristics_ch1": "gender: female;\tcell line: H9 ESC;\tprotocol: differentiated;\ttime: 72 hrs"}]}, {"GSM2124147": [{"title": "Control-1"}, {"type": "RNA"}, {"source_name_ch1": "erlotinib resistance PC9 NSCLC cells, no treatment (control)"}, {"characteristics_ch1": "tissue: Lung;\tcell type: epithelial cell;\tgenotype: EGFR exon 19 deletion, activating mutation;\tdisease: Carcinoma;\ttreatment: none"}]}, {"GSM2124148": [{"title": "Control-2"}, {"type": "RNA"}, {"source_name_ch1": "erlotinib resistance PC9 NSCLC cells, no treatment (control)"}, {"characteristics_ch1": "tissue: Lung;\tcell type: epithelial cell;\tgenotype: EGFR exon 19 deletion, activating mutation;\tdisease: Carcinoma;\ttreatment: none"}]}, {"GSM2124149": [{"title": "Control-3"}, {"type": "RNA"}, {"source_name_ch1": "erlotinib resistance PC9 NSCLC cells, no treatment (control)"}, {"characteristics_ch1": "tissue: Lung;\tcell type: epithelial cell;\tgenotype: EGFR exon 19 deletion, activating mutation;\tdisease: Carcinoma;\ttreatment: none"}]}, {"GSM2124150": [{"title": "Combination-1"}, {"type": "RNA"}, {"source_name_ch1": "erlotinib resistance PC9 NSCLC cells,5\u03bcM erlotinib+0.2\u03bcM YF454A"}, {"characteristics_ch1": "tissue: Lung;\tcell type: epithelial cell;\tgenotype: EGFR exon 19 deletion, activating mutation;\tdisease: Carcinoma;\ttreatment: 5\u03bcM erlotinib and 0.2\u03bcM YF454A"}]}, {"GSM2124151": [{"title": "Combination-2"}, {"type": "RNA"}, {"source_name_ch1": "erlotinib resistance PC9 NSCLC cells,5\u03bcM erlotinib+0.2\u03bcM YF454A"}, {"characteristics_ch1": "tissue: Lung;\tcell type: epithelial cell;\tgenotype: EGFR exon 19 deletion, activating mutation;\tdisease: Carcinoma;\ttreatment: 5\u03bcM erlotinib and 0.2\u03bcM YF454A"}]}, {"GSM2124152": [{"title": "Combination-3"}, {"type": "RNA"}, {"source_name_ch1": "erlotinib resistance PC9 NSCLC cells,5\u03bcM erlotinib+0.2\u03bcM YF454A"}, {"characteristics_ch1": "tissue: Lung;\tcell type: epithelial cell;\tgenotype: EGFR exon 19 deletion, activating mutation;\tdisease: Carcinoma;\ttreatment: 5\u03bcM erlotinib and 0.2\u03bcM YF454A"}]}, {"GSM2124153": [{"title": "Erlotinib-1"}, {"type": "RNA"}, {"source_name_ch1": "erlotinib resistance PC9 NSCLC cells,5\u03bcM erlotinib"}, {"characteristics_ch1": "tissue: Lung;\tcell type: epithelial cell;\tgenotype: EGFR exon 19 deletion, activating mutation;\tdisease: Carcinoma;\ttreatment: 5\u03bcM erlotinib"}]}, {"GSM2124154": [{"title": "Erlotinib-2"}, {"type": "RNA"}, {"source_name_ch1": "erlotinib resistance PC9 NSCLC cells,5\u03bcM erlotinib"}, {"characteristics_ch1": "tissue: Lung;\tcell type: epithelial cell;\tgenotype: EGFR exon 19 deletion, activating mutation;\tdisease: Carcinoma;\ttreatment: 5\u03bcM erlotinib"}]}, {"GSM2124155": [{"title": "Erlotinib-3"}, {"type": "RNA"}, {"source_name_ch1": "erlotinib resistance PC9 NSCLC cells,5\u03bcM erlotinib"}, {"characteristics_ch1": "tissue: Lung;\tcell type: epithelial cell;\tgenotype: EGFR exon 19 deletion, activating mutation;\tdisease: Carcinoma;\ttreatment: 5\u03bcM erlotinib"}]}, {"GSM2124156": [{"title": "YF454A-1"}, {"type": "RNA"}, {"source_name_ch1": "erlotinib resistance PC9 NSCLC cells,0.2\u03bcM YF454A"}, {"characteristics_ch1": "tissue: Lung;\tcell type: epithelial cell;\tgenotype: EGFR exon 19 deletion, activating mutation;\tdisease: Carcinoma;\ttreatment: 0.2\u03bcM YF454A"}]}, {"GSM2124157": [{"title": "YF454A-2"}, {"type": "RNA"}, {"source_name_ch1": "erlotinib resistance PC9 NSCLC cells,0.2\u03bcM YF454A"}, {"characteristics_ch1": "tissue: Lung;\tcell type: epithelial cell;\tgenotype: EGFR exon 19 deletion, activating mutation;\tdisease: Carcinoma;\ttreatment: 0.2\u03bcM YF454A"}]}, {"GSM2124158": [{"title": "YF454A-3"}, {"type": "RNA"}, {"source_name_ch1": "erlotinib resistance PC9 NSCLC cells,0.2\u03bcM YF454A"}, {"characteristics_ch1": "tissue: Lung;\tcell type: epithelial cell;\tgenotype: EGFR exon 19 deletion, activating mutation;\tdisease: Carcinoma;\ttreatment: 0.2\u03bcM YF454A"}]}, {"GSM1684739": [{"title": "endometrium in the proliferative phase_A1"}, {"type": "RNA"}, {"source_name_ch1": "eutopic endometrium in the proliferative phase of adenomyosis"}, {"characteristics_ch1": "gender: female;\tage: 44 years old;\tdisease state: adenomyosis;\ttissue: endometrium;\ttissue phase: proliferative"}]}, {"GSM1684740": [{"title": "endometrium in the secretory phase_A2"}, {"type": "RNA"}, {"source_name_ch1": "eutopic endometrium in the secretory phase of adenomyosis"}, {"characteristics_ch1": "gender: female;\tage: 43 years old;\tdisease state: adenomyosis;\ttissue: endometrium;\ttissue phase: secretory"}]}, {"GSM1684741": [{"title": "endometrium in the secretory phase_A3"}, {"type": "RNA"}, {"source_name_ch1": "eutopic endometrium in the secretory phase of adenomyosis"}, {"characteristics_ch1": "gender: female;\tage: 41 years old;\tdisease state: adenomyosis;\ttissue: endometrium;\ttissue phase: secretory"}]}, {"GSM1684742": [{"title": "endometrium in the proliferative phase_A4"}, {"type": "RNA"}, {"source_name_ch1": "eutopic endometrium in the proliferative phase of adenomyosis"}, {"characteristics_ch1": "gender: female;\tage: 50 years old;\tdisease state: adenomyosis;\ttissue: endometrium;\ttissue phase: proliferative"}]}, {"GSM1684743": [{"title": "endometrium in the secretory phase_C1"}, {"type": "RNA"}, {"source_name_ch1": "normal endometrium in the secretory phase"}, {"characteristics_ch1": "gender: female;\tage: 42 years old;\tdisease state: control;\ttissue: endometrium;\ttissue phase: secretory"}]}, {"GSM1684744": [{"title": "endometrium in the proliferative phase_C2"}, {"type": "RNA"}, {"source_name_ch1": "normal endometrium in the proliferative phase"}, {"characteristics_ch1": "gender: female;\tage: 39 years old;\tdisease state: control;\ttissue: endometrium;\ttissue phase: proliferative"}]}, {"GSM1684745": [{"title": "endometrium in the proliferative phase_C3"}, {"type": "RNA"}, {"source_name_ch1": "normal endometrium in the proliferative phase"}, {"characteristics_ch1": "gender: female;\tage: 47 years old;\tdisease state: control;\ttissue: endometrium;\ttissue phase: proliferative"}]}, {"GSM1684746": [{"title": "endometrium in the secretory phase_C4"}, {"type": "RNA"}, {"source_name_ch1": "normal endometrium in the secretory phase"}, {"characteristics_ch1": "gender: female;\tage: 51 years old;\tdisease state: control;\ttissue: endometrium;\ttissue phase: secretory"}]}, {"GSM1701910": [{"title": "miR-138 group"}, {"type": "RNA"}, {"source_name_ch1": "Human H1299 cells"}, {"characteristics_ch1": "cell line: H1299;\ttransfection: miR-138"}]}, {"GSM1701911": [{"title": "NC mimic group"}, {"type": "RNA"}, {"source_name_ch1": "Human H1299 cells"}, {"characteristics_ch1": "cell line: H1299;\ttransfection: NC mimics"}]}, {"GSM2094166": [{"title": "Caco-2 human epithelial colorectal adenocarcinoma cells, mRNA, anaerobic control, rep1"}, {"type": "RNA"}, {"source_name_ch1": "Caco-2 human epithelial colorectal adenocarcinoma cells, mRNA, anaerobic control, rep1"}, {"characteristics_ch1": "tissue: Caco-2 human epithelial colorectal adenocarcinoma cells;\ttreatment: control"}]}, {"GSM2094167": [{"title": "Caco-2 human epithelial colorectal adenocarcinoma cells, mRNA, anaerobic control, rep2"}, {"type": "RNA"}, {"source_name_ch1": "Caco-2 human epithelial colorectal adenocarcinoma cells, mRNA, anaerobic control, rep2"}, {"characteristics_ch1": "tissue: Caco-2 human epithelial colorectal adenocarcinoma cells;\ttreatment: control"}]}, {"GSM2094168": [{"title": "Caco-2 human epithelial colorectal adenocarcinoma cells, mRNA, anaerobic control, rep3"}, {"type": "RNA"}, {"source_name_ch1": "Caco-2 human epithelial colorectal adenocarcinoma cells, mRNA, anaerobic control, rep3"}, {"characteristics_ch1": "tissue: Caco-2 human epithelial colorectal adenocarcinoma cells;\ttreatment: control"}]}, {"GSM2094169": [{"title": "Caco-2 human epithelial colorectal adenocarcinoma cells, mRNA, anaerobic co-culture (LGG), rep1"}, {"type": "RNA"}, {"source_name_ch1": "Caco-2 human epithelial colorectal adenocarcinoma cells, mRNA, anaerobic co-culture (LGG), rep1"}, {"characteristics_ch1": "tissue: Caco-2 human epithelial colorectal adenocarcinoma cells;\ttreatment: co-culture (LGG)"}]}, {"GSM2094170": [{"title": "Caco-2 human epithelial colorectal adenocarcinoma cells, mRNA, anaerobic co-culture (LGG), rep2"}, {"type": "RNA"}, {"source_name_ch1": "Caco-2 human epithelial colorectal adenocarcinoma cells, mRNA, anaerobic co-culture (LGG), rep2"}, {"characteristics_ch1": "tissue: Caco-2 human epithelial colorectal adenocarcinoma cells;\ttreatment: co-culture (LGG)"}]}, {"GSM2094171": [{"title": "Caco-2 human epithelial colorectal adenocarcinoma cells, mRNA, anaerobic co-culture (LGG), rep3"}, {"type": "RNA"}, {"source_name_ch1": "Caco-2 human epithelial colorectal adenocarcinoma cells, mRNA, anaerobic co-culture (LGG), rep3"}, {"characteristics_ch1": "tissue: Caco-2 human epithelial colorectal adenocarcinoma cells;\ttreatment: co-culture (LGG)"}]}, {"GSM2094172": [{"title": "Caco-2 human epithelial colorectal adenocarcinoma cells, mRNA, anaerobic co-culture (LGG+B.caccae), rep1"}, {"type": "RNA"}, {"source_name_ch1": "Caco-2 human epithelial colorectal adenocarcinoma cells, mRNA, anaerobic co-culture (LGG+B.caccae), rep1"}, {"characteristics_ch1": "tissue: Caco-2 human epithelial colorectal adenocarcinoma cells;\ttreatment: co-culture (LGG+B.caccae)"}]}, {"GSM2094173": [{"title": "Caco-2 human epithelial colorectal adenocarcinoma cells, mRNA, anaerobic co-culture (LGG+B.caccae), rep2"}, {"type": "RNA"}, {"source_name_ch1": "Caco-2 human epithelial colorectal adenocarcinoma cells, mRNA, anaerobic co-culture (LGG+B.caccae), rep2"}, {"characteristics_ch1": "tissue: Caco-2 human epithelial colorectal adenocarcinoma cells;\ttreatment: co-culture (LGG+B.caccae)"}]}, {"GSM2094174": [{"title": "Caco-2 human epithelial colorectal adenocarcinoma cells, mRNA, anaerobic co-culture (LGG+B.caccae), rep3"}, {"type": "RNA"}, {"source_name_ch1": "Caco-2 human epithelial colorectal adenocarcinoma cells, mRNA, anaerobic co-culture (LGG+B.caccae), rep3"}, {"characteristics_ch1": "tissue: Caco-2 human epithelial colorectal adenocarcinoma cells;\ttreatment: co-culture (LGG+B.caccae)"}]}, {"GSM1520869": [{"title": "Saos2-p21WAF1/Cip1 Tet-ON_rep1"}, {"type": "RNA"}, {"source_name_ch1": "Saos2-p21WAF1/Cip1 Tet-ON"}, {"characteristics_ch1": "cell line: Saos2;\tcell type: human osteosarcoma;\tgenotype/variation: p21WAF1/Cip1"}]}, {"GSM1520870": [{"title": "Saos2-p21WAF1/Cip1 Tet-ON_rep2"}, {"type": "RNA"}, {"source_name_ch1": "Saos2-p21WAF1/Cip1 Tet-ON"}, {"characteristics_ch1": "cell line: Saos2;\tcell type: human osteosarcoma;\tgenotype/variation: p21WAF1/Cip1"}]}, {"GSM1520871": [{"title": "Saos2-p21WAF1/Cip1 Tet-ON_rep3"}, {"type": "RNA"}, {"source_name_ch1": "Saos2-p21WAF1/Cip1 Tet-ON"}, {"characteristics_ch1": "cell line: Saos2;\tcell type: human osteosarcoma;\tgenotype/variation: p21WAF1/Cip1"}]}, {"GSM1520872": [{"title": "Saos2-p21WAF1/Cip1 Tet-ON_rep4"}, {"type": "RNA"}, {"source_name_ch1": "Saos2-p21WAF1/Cip1 Tet-ON"}, {"characteristics_ch1": "cell line: Saos2;\tcell type: human osteosarcoma;\tgenotype/variation: p21WAF1/Cip1"}]}, {"GSM1520873": [{"title": "Saos2-p21WAF1/Cip1 Tet-OFF_rep1"}, {"type": "RNA"}, {"source_name_ch1": "Saos2-p21WAF1/Cip1 Tet-OFF"}, {"characteristics_ch1": "cell line: Saos2;\tcell type: human osteosarcoma;\tgenotype/variation: p21WAF1/Cip1"}]}, {"GSM1520874": [{"title": "Saos2-p21WAF1/Cip1 Tet-OFF_rep2"}, {"type": "RNA"}, {"source_name_ch1": "Saos2-p21WAF1/Cip1 Tet-OFF"}, {"characteristics_ch1": "cell line: Saos2;\tcell type: human osteosarcoma;\tgenotype/variation: p21WAF1/Cip1"}]}, {"GSM1520875": [{"title": "Saos2-p21WAF1/Cip1 Tet-OFF_rep4"}, {"type": "RNA"}, {"source_name_ch1": "Saos2-p21WAF1/Cip1 Tet-OFF"}, {"characteristics_ch1": "cell line: Saos2;\tcell type: human osteosarcoma;\tgenotype/variation: p21WAF1/Cip1"}]}, {"GSM2157794": [{"title": "Patient 1, CD14+ cells, before first dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD14+ cells"}, {"characteristics_ch1": "patient identifier: QSCV-8684;\tgender: Female;\tage in years: 43;\tdisease duration in years: 20;\tprevious treatment: Interferon-beta-1a subcutaneous;\ttreatment gap in months: 38;\tedss at baseline: 4.0;\tedss after 12 months: 3.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM2157795": [{"title": "Patient 1, CD14+ cells, before second dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD14+ cells"}, {"characteristics_ch1": "patient identifier: QSCV-8684;\tgender: Female;\tage in years: 43;\tdisease duration in years: 20;\tprevious treatment: Interferon-beta-1a subcutaneous;\ttreatment gap in months: 38;\tedss at baseline: 4.0;\tedss after 12 months: 3.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM2157796": [{"title": "Patient 1, CD14+ cells, after 3 months of fingolimod treatment"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD14+ cells"}, {"characteristics_ch1": "patient identifier: QSCV-8684;\tgender: Female;\tage in years: 43;\tdisease duration in years: 20;\tprevious treatment: Interferon-beta-1a subcutaneous;\ttreatment gap in months: 38;\tedss at baseline: 4.0;\tedss after 12 months: 3.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM2157797": [{"title": "Patient 2, CD14+ cells, before first dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD14+ cells"}, {"characteristics_ch1": "patient identifier: ANRT-6851;\tgender: Female;\tage in years: 26;\tdisease duration in years: 3;\tprevious treatment: Interferon-beta-1b subcutaneous;\ttreatment gap in months: 1;\tedss at baseline: 1.5;\tedss after 12 months: 2.0;\trelapses during 12 months prior fingolimod: 2;\trelapses during 12-month follow-up: 0"}]}, {"GSM2157798": [{"title": "Patient 2, CD14+ cells, before second dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD14+ cells"}, {"characteristics_ch1": "patient identifier: ANRT-6851;\tgender: Female;\tage in years: 26;\tdisease duration in years: 3;\tprevious treatment: Interferon-beta-1b subcutaneous;\ttreatment gap in months: 1;\tedss at baseline: 1.5;\tedss after 12 months: 2.0;\trelapses during 12 months prior fingolimod: 2;\trelapses during 12-month follow-up: 0"}]}, {"GSM2157799": [{"title": "Patient 2, CD14+ cells, after 3 months of fingolimod treatment"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD14+ cells"}, {"characteristics_ch1": "patient identifier: ANRT-6851;\tgender: Female;\tage in years: 26;\tdisease duration in years: 3;\tprevious treatment: Interferon-beta-1b subcutaneous;\ttreatment gap in months: 1;\tedss at baseline: 1.5;\tedss after 12 months: 2.0;\trelapses during 12 months prior fingolimod: 2;\trelapses during 12-month follow-up: 0"}]}, {"GSM2157800": [{"title": "Patient 3, CD14+ cells, before first dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD14+ cells"}, {"characteristics_ch1": "patient identifier: YHCG-2832;\tgender: Female;\tage in years: 29;\tdisease duration in years: 5;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: <1;\tedss at baseline: 2.5;\tedss after 12 months: 1.5;\trelapses during 12 months prior fingolimod: 3;\trelapses during 12-month follow-up: 0"}]}, {"GSM2157801": [{"title": "Patient 3, CD14+ cells, before second dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD14+ cells"}, {"characteristics_ch1": "patient identifier: YHCG-2832;\tgender: Female;\tage in years: 29;\tdisease duration in years: 5;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: <1;\tedss at baseline: 2.5;\tedss after 12 months: 1.5;\trelapses during 12 months prior fingolimod: 3;\trelapses during 12-month follow-up: 0"}]}, {"GSM2157802": [{"title": "Patient 3, CD14+ cells, after 3 months of fingolimod treatment"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD14+ cells"}, {"characteristics_ch1": "patient identifier: YHCG-2832;\tgender: Female;\tage in years: 29;\tdisease duration in years: 5;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: <1;\tedss at baseline: 2.5;\tedss after 12 months: 1.5;\trelapses during 12 months prior fingolimod: 3;\trelapses during 12-month follow-up: 0"}]}, {"GSM2157803": [{"title": "Patient 4, CD14+ cells, before first dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD14+ cells"}, {"characteristics_ch1": "patient identifier: WKSB-4693;\tgender: Female;\tage in years: 43;\tdisease duration in years: 1;\tprevious treatment: Interferon-beta-1a intramuscular;\ttreatment gap in months: 1;\tedss at baseline: 4.0;\tedss after 12 months: 3.5;\trelapses during 12 months prior fingolimod: 2;\trelapses during 12-month follow-up: 0"}]}, {"GSM2157804": [{"title": "Patient 4, CD14+ cells, before second dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD14+ cells"}, {"characteristics_ch1": "patient identifier: WKSB-4693;\tgender: Female;\tage in years: 43;\tdisease duration in years: 1;\tprevious treatment: Interferon-beta-1a intramuscular;\ttreatment gap in months: 1;\tedss at baseline: 4.0;\tedss after 12 months: 3.5;\trelapses during 12 months prior fingolimod: 2;\trelapses during 12-month follow-up: 0"}]}, {"GSM2157805": [{"title": "Patient 4, CD14+ cells, after 3 months of fingolimod treatment"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD14+ cells"}, {"characteristics_ch1": "patient identifier: WKSB-4693;\tgender: Female;\tage in years: 43;\tdisease duration in years: 1;\tprevious treatment: Interferon-beta-1a intramuscular;\ttreatment gap in months: 1;\tedss at baseline: 4.0;\tedss after 12 months: 3.5;\trelapses during 12 months prior fingolimod: 2;\trelapses during 12-month follow-up: 0"}]}, {"GSM2157806": [{"title": "Patient 5, CD14+ cells, before first dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD14+ cells"}, {"characteristics_ch1": "patient identifier: SSBZ-7676;\tgender: Female;\tage in years: 45;\tdisease duration in years: 12;\tprevious treatment: Interferon-beta-1a intramuscular;\ttreatment gap in months: 2;\tedss at baseline: 3.0;\tedss after 12 months: 3.0;\trelapses during 12 months prior fingolimod: 3;\trelapses during 12-month follow-up: 0"}]}, {"GSM2157807": [{"title": "Patient 5, CD14+ cells, before second dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD14+ cells"}, {"characteristics_ch1": "patient identifier: SSBZ-7676;\tgender: Female;\tage in years: 45;\tdisease duration in years: 12;\tprevious treatment: Interferon-beta-1a intramuscular;\ttreatment gap in months: 2;\tedss at baseline: 3.0;\tedss after 12 months: 3.0;\trelapses during 12 months prior fingolimod: 3;\trelapses during 12-month follow-up: 0"}]}, {"GSM2157808": [{"title": "Patient 5, CD14+ cells, after 3 months of fingolimod treatment"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD14+ cells"}, {"characteristics_ch1": "patient identifier: SSBZ-7676;\tgender: Female;\tage in years: 45;\tdisease duration in years: 12;\tprevious treatment: Interferon-beta-1a intramuscular;\ttreatment gap in months: 2;\tedss at baseline: 3.0;\tedss after 12 months: 3.0;\trelapses during 12 months prior fingolimod: 3;\trelapses during 12-month follow-up: 0"}]}, {"GSM2157809": [{"title": "Patient 6, CD14+ cells, before first dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD14+ cells"}, {"characteristics_ch1": "patient identifier: ESRN-3798;\tgender: Female;\tage in years: 33;\tdisease duration in years: 2;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: <1;\tedss at baseline: 2.5;\tedss after 12 months: 5.5;\trelapses during 12 months prior fingolimod: 2;\trelapses during 12-month follow-up: 2"}]}, {"GSM2157810": [{"title": "Patient 6, CD14+ cells, before second dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD14+ cells"}, {"characteristics_ch1": "patient identifier: ESRN-3798;\tgender: Female;\tage in years: 33;\tdisease duration in years: 2;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: <1;\tedss at baseline: 2.5;\tedss after 12 months: 5.5;\trelapses during 12 months prior fingolimod: 2;\trelapses during 12-month follow-up: 2"}]}, {"GSM2157811": [{"title": "Patient 6, CD14+ cells, after 3 months of fingolimod treatment"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD14+ cells"}, {"characteristics_ch1": "patient identifier: ESRN-3798;\tgender: Female;\tage in years: 33;\tdisease duration in years: 2;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: <1;\tedss at baseline: 2.5;\tedss after 12 months: 5.5;\trelapses during 12 months prior fingolimod: 2;\trelapses during 12-month follow-up: 2"}]}, {"GSM2157812": [{"title": "Patient 7, CD14+ cells, before first dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD14+ cells"}, {"characteristics_ch1": "patient identifier: DMPU-9668;\tgender: Female;\tage in years: 46;\tdisease duration in years: 9;\tprevious treatment: Interferon-beta-1b subcutaneous;\ttreatment gap in months: <1;\tedss at baseline: 4.0;\tedss after 12 months: 4.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM2157813": [{"title": "Patient 7, CD14+ cells, before second dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD14+ cells"}, {"characteristics_ch1": "patient identifier: DMPU-9668;\tgender: Female;\tage in years: 46;\tdisease duration in years: 9;\tprevious treatment: Interferon-beta-1b subcutaneous;\ttreatment gap in months: <1;\tedss at baseline: 4.0;\tedss after 12 months: 4.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM2157814": [{"title": "Patient 7, CD14+ cells, after 3 months of fingolimod treatment"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD14+ cells"}, {"characteristics_ch1": "patient identifier: DMPU-9668;\tgender: Female;\tage in years: 46;\tdisease duration in years: 9;\tprevious treatment: Interferon-beta-1b subcutaneous;\ttreatment gap in months: <1;\tedss at baseline: 4.0;\tedss after 12 months: 4.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM2157815": [{"title": "Patient 8, CD14+ cells, before first dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD14+ cells"}, {"characteristics_ch1": "patient identifier: CFMJ-5805;\tgender: Male;\tage in years: 33;\tdisease duration in years: 4;\tprevious treatment: Interferon-beta-1a subcutaneous;\ttreatment gap in months: <1;\tedss at baseline: 3.0;\tedss after 12 months: 6.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 3"}]}, {"GSM2157816": [{"title": "Patient 8, CD14+ cells, before second dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD14+ cells"}, {"characteristics_ch1": "patient identifier: CFMJ-5805;\tgender: Male;\tage in years: 33;\tdisease duration in years: 4;\tprevious treatment: Interferon-beta-1a subcutaneous;\ttreatment gap in months: <1;\tedss at baseline: 3.0;\tedss after 12 months: 6.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 3"}]}, {"GSM2157817": [{"title": "Patient 8, CD14+ cells, after 3 months of fingolimod treatment"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD14+ cells"}, {"characteristics_ch1": "patient identifier: CFMJ-5805;\tgender: Male;\tage in years: 33;\tdisease duration in years: 4;\tprevious treatment: Interferon-beta-1a subcutaneous;\ttreatment gap in months: <1;\tedss at baseline: 3.0;\tedss after 12 months: 6.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 3"}]}, {"GSM2157818": [{"title": "Patient 9, CD14+ cells, before first dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD14+ cells"}, {"characteristics_ch1": "patient identifier: RBTM-1672;\tgender: Male;\tage in years: 46;\tdisease duration in years: 15;\tprevious treatment: Interferon-beta-1b subcutaneous;\ttreatment gap in months: <1;\tedss at baseline: 3.5;\tedss after 12 months: 2.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM2157819": [{"title": "Patient 9, CD14+ cells, before second dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD14+ cells"}, {"characteristics_ch1": "patient identifier: RBTM-1672;\tgender: Male;\tage in years: 46;\tdisease duration in years: 15;\tprevious treatment: Interferon-beta-1b subcutaneous;\ttreatment gap in months: <1;\tedss at baseline: 3.5;\tedss after 12 months: 2.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM2157820": [{"title": "Patient 9, CD14+ cells, after 3 months of fingolimod treatment"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD14+ cells"}, {"characteristics_ch1": "patient identifier: RBTM-1672;\tgender: Male;\tage in years: 46;\tdisease duration in years: 15;\tprevious treatment: Interferon-beta-1b subcutaneous;\ttreatment gap in months: <1;\tedss at baseline: 3.5;\tedss after 12 months: 2.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM2157821": [{"title": "Patient 10, CD14+ cells, before first dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD14+ cells"}, {"characteristics_ch1": "patient identifier: FCCI-7765;\tgender: Male;\tage in years: 37;\tdisease duration in years: 9;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: 1;\tedss at baseline: 5.5;\tedss after 12 months: 4.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM2157822": [{"title": "Patient 10, CD14+ cells, before second dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD14+ cells"}, {"characteristics_ch1": "patient identifier: FCCI-7765;\tgender: Male;\tage in years: 37;\tdisease duration in years: 9;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: 1;\tedss at baseline: 5.5;\tedss after 12 months: 4.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM2157823": [{"title": "Patient 10, CD14+ cells, after 3 months of fingolimod treatment"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD14+ cells"}, {"characteristics_ch1": "patient identifier: FCCI-7765;\tgender: Male;\tage in years: 37;\tdisease duration in years: 9;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: 1;\tedss at baseline: 5.5;\tedss after 12 months: 4.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM2157869": [{"title": "Patient 1, CD19+ cells, before first dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD19+ cells"}, {"characteristics_ch1": "patient identifier: QSCV-8684;\tgender: Female;\tage in years: 43;\tdisease duration in years: 20;\tprevious treatment: Interferon-beta-1a subcutaneous;\ttreatment gap in months: 38;\tedss at baseline: 4.0;\tedss after 12 months: 3.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM2157870": [{"title": "Patient 1, CD19+ cells, before second dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD19+ cells"}, {"characteristics_ch1": "patient identifier: QSCV-8684;\tgender: Female;\tage in years: 43;\tdisease duration in years: 20;\tprevious treatment: Interferon-beta-1a subcutaneous;\ttreatment gap in months: 38;\tedss at baseline: 4.0;\tedss after 12 months: 3.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM2157871": [{"title": "Patient 1, CD19+ cells, after 3 months of fingolimod treatment"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD19+ cells"}, {"characteristics_ch1": "patient identifier: QSCV-8684;\tgender: Female;\tage in years: 43;\tdisease duration in years: 20;\tprevious treatment: Interferon-beta-1a subcutaneous;\ttreatment gap in months: 38;\tedss at baseline: 4.0;\tedss after 12 months: 3.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM2157872": [{"title": "Patient 2, CD19+ cells, before first dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD19+ cells"}, {"characteristics_ch1": "patient identifier: ANRT-6851;\tgender: Female;\tage in years: 26;\tdisease duration in years: 3;\tprevious treatment: Interferon-beta-1b subcutaneous;\ttreatment gap in months: 1;\tedss at baseline: 1.5;\tedss after 12 months: 2.0;\trelapses during 12 months prior fingolimod: 2;\trelapses during 12-month follow-up: 0"}]}, {"GSM2157873": [{"title": "Patient 2, CD19+ cells, before second dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD19+ cells"}, {"characteristics_ch1": "patient identifier: ANRT-6851;\tgender: Female;\tage in years: 26;\tdisease duration in years: 3;\tprevious treatment: Interferon-beta-1b subcutaneous;\ttreatment gap in months: 1;\tedss at baseline: 1.5;\tedss after 12 months: 2.0;\trelapses during 12 months prior fingolimod: 2;\trelapses during 12-month follow-up: 0"}]}, {"GSM2157874": [{"title": "Patient 2, CD19+ cells, after 3 months of fingolimod treatment"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD19+ cells"}, {"characteristics_ch1": "patient identifier: ANRT-6851;\tgender: Female;\tage in years: 26;\tdisease duration in years: 3;\tprevious treatment: Interferon-beta-1b subcutaneous;\ttreatment gap in months: 1;\tedss at baseline: 1.5;\tedss after 12 months: 2.0;\trelapses during 12 months prior fingolimod: 2;\trelapses during 12-month follow-up: 0"}]}, {"GSM2157875": [{"title": "Patient 3, CD19+ cells, before first dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD19+ cells"}, {"characteristics_ch1": "patient identifier: YHCG-2832;\tgender: Female;\tage in years: 29;\tdisease duration in years: 5;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: <1;\tedss at baseline: 2.5;\tedss after 12 months: 1.5;\trelapses during 12 months prior fingolimod: 3;\trelapses during 12-month follow-up: 0"}]}, {"GSM2157876": [{"title": "Patient 3, CD19+ cells, before second dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD19+ cells"}, {"characteristics_ch1": "patient identifier: YHCG-2832;\tgender: Female;\tage in years: 29;\tdisease duration in years: 5;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: <1;\tedss at baseline: 2.5;\tedss after 12 months: 1.5;\trelapses during 12 months prior fingolimod: 3;\trelapses during 12-month follow-up: 0"}]}, {"GSM2157877": [{"title": "Patient 3, CD19+ cells, after 3 months of fingolimod treatment"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD19+ cells"}, {"characteristics_ch1": "patient identifier: YHCG-2832;\tgender: Female;\tage in years: 29;\tdisease duration in years: 5;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: <1;\tedss at baseline: 2.5;\tedss after 12 months: 1.5;\trelapses during 12 months prior fingolimod: 3;\trelapses during 12-month follow-up: 0"}]}, {"GSM2157878": [{"title": "Patient 4, CD19+ cells, before first dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD19+ cells"}, {"characteristics_ch1": "patient identifier: WKSB-4693;\tgender: Female;\tage in years: 43;\tdisease duration in years: 1;\tprevious treatment: Interferon-beta-1a intramuscular;\ttreatment gap in months: 1;\tedss at baseline: 4.0;\tedss after 12 months: 3.5;\trelapses during 12 months prior fingolimod: 2;\trelapses during 12-month follow-up: 0"}]}, {"GSM2157879": [{"title": "Patient 4, CD19+ cells, before second dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD19+ cells"}, {"characteristics_ch1": "patient identifier: WKSB-4693;\tgender: Female;\tage in years: 43;\tdisease duration in years: 1;\tprevious treatment: Interferon-beta-1a intramuscular;\ttreatment gap in months: 1;\tedss at baseline: 4.0;\tedss after 12 months: 3.5;\trelapses during 12 months prior fingolimod: 2;\trelapses during 12-month follow-up: 0"}]}, {"GSM2157880": [{"title": "Patient 4, CD19+ cells, after 3 months of fingolimod treatment"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD19+ cells"}, {"characteristics_ch1": "patient identifier: WKSB-4693;\tgender: Female;\tage in years: 43;\tdisease duration in years: 1;\tprevious treatment: Interferon-beta-1a intramuscular;\ttreatment gap in months: 1;\tedss at baseline: 4.0;\tedss after 12 months: 3.5;\trelapses during 12 months prior fingolimod: 2;\trelapses during 12-month follow-up: 0"}]}, {"GSM2157881": [{"title": "Patient 5, CD19+ cells, before first dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD19+ cells"}, {"characteristics_ch1": "patient identifier: SSBZ-7676;\tgender: Female;\tage in years: 45;\tdisease duration in years: 12;\tprevious treatment: Interferon-beta-1a intramuscular;\ttreatment gap in months: 2;\tedss at baseline: 3.0;\tedss after 12 months: 3.0;\trelapses during 12 months prior fingolimod: 3;\trelapses during 12-month follow-up: 0"}]}, {"GSM2157882": [{"title": "Patient 5, CD19+ cells, before second dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD19+ cells"}, {"characteristics_ch1": "patient identifier: SSBZ-7676;\tgender: Female;\tage in years: 45;\tdisease duration in years: 12;\tprevious treatment: Interferon-beta-1a intramuscular;\ttreatment gap in months: 2;\tedss at baseline: 3.0;\tedss after 12 months: 3.0;\trelapses during 12 months prior fingolimod: 3;\trelapses during 12-month follow-up: 0"}]}, {"GSM2157883": [{"title": "Patient 5, CD19+ cells, after 3 months of fingolimod treatment"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD19+ cells"}, {"characteristics_ch1": "patient identifier: SSBZ-7676;\tgender: Female;\tage in years: 45;\tdisease duration in years: 12;\tprevious treatment: Interferon-beta-1a intramuscular;\ttreatment gap in months: 2;\tedss at baseline: 3.0;\tedss after 12 months: 3.0;\trelapses during 12 months prior fingolimod: 3;\trelapses during 12-month follow-up: 0"}]}, {"GSM2157884": [{"title": "Patient 6, CD19+ cells, before first dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD19+ cells"}, {"characteristics_ch1": "patient identifier: ESRN-3798;\tgender: Female;\tage in years: 33;\tdisease duration in years: 2;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: <1;\tedss at baseline: 2.5;\tedss after 12 months: 5.5;\trelapses during 12 months prior fingolimod: 2;\trelapses during 12-month follow-up: 2"}]}, {"GSM2157885": [{"title": "Patient 6, CD19+ cells, before second dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD19+ cells"}, {"characteristics_ch1": "patient identifier: ESRN-3798;\tgender: Female;\tage in years: 33;\tdisease duration in years: 2;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: <1;\tedss at baseline: 2.5;\tedss after 12 months: 5.5;\trelapses during 12 months prior fingolimod: 2;\trelapses during 12-month follow-up: 2"}]}, {"GSM2157886": [{"title": "Patient 6, CD19+ cells, after 3 months of fingolimod treatment"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD19+ cells"}, {"characteristics_ch1": "patient identifier: ESRN-3798;\tgender: Female;\tage in years: 33;\tdisease duration in years: 2;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: <1;\tedss at baseline: 2.5;\tedss after 12 months: 5.5;\trelapses during 12 months prior fingolimod: 2;\trelapses during 12-month follow-up: 2"}]}, {"GSM2157887": [{"title": "Patient 7, CD19+ cells, before first dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD19+ cells"}, {"characteristics_ch1": "patient identifier: DMPU-9668;\tgender: Female;\tage in years: 46;\tdisease duration in years: 9;\tprevious treatment: Interferon-beta-1b subcutaneous;\ttreatment gap in months: <1;\tedss at baseline: 4.0;\tedss after 12 months: 4.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM2157888": [{"title": "Patient 7, CD19+ cells, before second dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD19+ cells"}, {"characteristics_ch1": "patient identifier: DMPU-9668;\tgender: Female;\tage in years: 46;\tdisease duration in years: 9;\tprevious treatment: Interferon-beta-1b subcutaneous;\ttreatment gap in months: <1;\tedss at baseline: 4.0;\tedss after 12 months: 4.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM2157889": [{"title": "Patient 7, CD19+ cells, after 3 months of fingolimod treatment"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD19+ cells"}, {"characteristics_ch1": "patient identifier: DMPU-9668;\tgender: Female;\tage in years: 46;\tdisease duration in years: 9;\tprevious treatment: Interferon-beta-1b subcutaneous;\ttreatment gap in months: <1;\tedss at baseline: 4.0;\tedss after 12 months: 4.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM2157890": [{"title": "Patient 8, CD19+ cells, before first dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD19+ cells"}, {"characteristics_ch1": "patient identifier: CFMJ-5805;\tgender: Male;\tage in years: 33;\tdisease duration in years: 4;\tprevious treatment: Interferon-beta-1a subcutaneous;\ttreatment gap in months: <1;\tedss at baseline: 3.0;\tedss after 12 months: 6.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 3"}]}, {"GSM2157891": [{"title": "Patient 8, CD19+ cells, before second dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD19+ cells"}, {"characteristics_ch1": "patient identifier: CFMJ-5805;\tgender: Male;\tage in years: 33;\tdisease duration in years: 4;\tprevious treatment: Interferon-beta-1a subcutaneous;\ttreatment gap in months: <1;\tedss at baseline: 3.0;\tedss after 12 months: 6.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 3"}]}, {"GSM2157892": [{"title": "Patient 8, CD19+ cells, after 3 months of fingolimod treatment"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD19+ cells"}, {"characteristics_ch1": "patient identifier: CFMJ-5805;\tgender: Male;\tage in years: 33;\tdisease duration in years: 4;\tprevious treatment: Interferon-beta-1a subcutaneous;\ttreatment gap in months: <1;\tedss at baseline: 3.0;\tedss after 12 months: 6.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 3"}]}, {"GSM2157893": [{"title": "Patient 9, CD19+ cells, before first dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD19+ cells"}, {"characteristics_ch1": "patient identifier: RBTM-1672;\tgender: Male;\tage in years: 46;\tdisease duration in years: 15;\tprevious treatment: Interferon-beta-1b subcutaneous;\ttreatment gap in months: <1;\tedss at baseline: 3.5;\tedss after 12 months: 2.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM2157894": [{"title": "Patient 9, CD19+ cells, before second dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD19+ cells"}, {"characteristics_ch1": "patient identifier: RBTM-1672;\tgender: Male;\tage in years: 46;\tdisease duration in years: 15;\tprevious treatment: Interferon-beta-1b subcutaneous;\ttreatment gap in months: <1;\tedss at baseline: 3.5;\tedss after 12 months: 2.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM2157895": [{"title": "Patient 9, CD19+ cells, after 3 months of fingolimod treatment"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD19+ cells"}, {"characteristics_ch1": "patient identifier: RBTM-1672;\tgender: Male;\tage in years: 46;\tdisease duration in years: 15;\tprevious treatment: Interferon-beta-1b subcutaneous;\ttreatment gap in months: <1;\tedss at baseline: 3.5;\tedss after 12 months: 2.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM2157896": [{"title": "Patient 10, CD19+ cells, before first dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD19+ cells"}, {"characteristics_ch1": "patient identifier: FCCI-7765;\tgender: Male;\tage in years: 37;\tdisease duration in years: 9;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: 1;\tedss at baseline: 5.5;\tedss after 12 months: 4.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM2157897": [{"title": "Patient 10, CD19+ cells, before second dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD19+ cells"}, {"characteristics_ch1": "patient identifier: FCCI-7765;\tgender: Male;\tage in years: 37;\tdisease duration in years: 9;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: 1;\tedss at baseline: 5.5;\tedss after 12 months: 4.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM2157898": [{"title": "Patient 10, CD19+ cells, after 3 months of fingolimod treatment"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD19+ cells"}, {"characteristics_ch1": "patient identifier: FCCI-7765;\tgender: Male;\tage in years: 37;\tdisease duration in years: 9;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: 1;\tedss at baseline: 5.5;\tedss after 12 months: 4.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM2159232": [{"title": "Patient 1, CD56+ cells, before first dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD56+ cells"}, {"characteristics_ch1": "patient identifier: QSCV-8684;\tgender: Female;\tage in years: 43;\tdisease duration in years: 20;\tprevious treatment: Interferon-beta-1a subcutaneous;\ttreatment gap in months: 38;\tedss at baseline: 4.0;\tedss after 12 months: 3.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM2159233": [{"title": "Patient 1, CD56+ cells, before second dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD56+ cells"}, {"characteristics_ch1": "patient identifier: QSCV-8684;\tgender: Female;\tage in years: 43;\tdisease duration in years: 20;\tprevious treatment: Interferon-beta-1a subcutaneous;\ttreatment gap in months: 38;\tedss at baseline: 4.0;\tedss after 12 months: 3.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM2159234": [{"title": "Patient 1, CD56+ cells, after 3 months of fingolimod treatment"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD56+ cells"}, {"characteristics_ch1": "patient identifier: QSCV-8684;\tgender: Female;\tage in years: 43;\tdisease duration in years: 20;\tprevious treatment: Interferon-beta-1a subcutaneous;\ttreatment gap in months: 38;\tedss at baseline: 4.0;\tedss after 12 months: 3.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM2159236": [{"title": "Patient 2, CD56+ cells, before first dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD56+ cells"}, {"characteristics_ch1": "patient identifier: ANRT-6851;\tgender: Female;\tage in years: 26;\tdisease duration in years: 3;\tprevious treatment: Interferon-beta-1b subcutaneous;\ttreatment gap in months: 1;\tedss at baseline: 1.5;\tedss after 12 months: 2.0;\trelapses during 12 months prior fingolimod: 2;\trelapses during 12-month follow-up: 0"}]}, {"GSM2159237": [{"title": "Patient 2, CD56+ cells, before second dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD56+ cells"}, {"characteristics_ch1": "patient identifier: ANRT-6851;\tgender: Female;\tage in years: 26;\tdisease duration in years: 3;\tprevious treatment: Interferon-beta-1b subcutaneous;\ttreatment gap in months: 1;\tedss at baseline: 1.5;\tedss after 12 months: 2.0;\trelapses during 12 months prior fingolimod: 2;\trelapses during 12-month follow-up: 0"}]}, {"GSM2159239": [{"title": "Patient 2, CD56+ cells, after 3 months of fingolimod treatment"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD56+ cells"}, {"characteristics_ch1": "patient identifier: ANRT-6851;\tgender: Female;\tage in years: 26;\tdisease duration in years: 3;\tprevious treatment: Interferon-beta-1b subcutaneous;\ttreatment gap in months: 1;\tedss at baseline: 1.5;\tedss after 12 months: 2.0;\trelapses during 12 months prior fingolimod: 2;\trelapses during 12-month follow-up: 0"}]}, {"GSM2159241": [{"title": "Patient 3, CD56+ cells, before first dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD56+ cells"}, {"characteristics_ch1": "patient identifier: YHCG-2832;\tgender: Female;\tage in years: 29;\tdisease duration in years: 5;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: <1;\tedss at baseline: 2.5;\tedss after 12 months: 1.5;\trelapses during 12 months prior fingolimod: 3;\trelapses during 12-month follow-up: 0"}]}, {"GSM2159242": [{"title": "Patient 3, CD56+ cells, before second dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD56+ cells"}, {"characteristics_ch1": "patient identifier: YHCG-2832;\tgender: Female;\tage in years: 29;\tdisease duration in years: 5;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: <1;\tedss at baseline: 2.5;\tedss after 12 months: 1.5;\trelapses during 12 months prior fingolimod: 3;\trelapses during 12-month follow-up: 0"}]}, {"GSM2159244": [{"title": "Patient 3, CD56+ cells, after 3 months of fingolimod treatment"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD56+ cells"}, {"characteristics_ch1": "patient identifier: YHCG-2832;\tgender: Female;\tage in years: 29;\tdisease duration in years: 5;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: <1;\tedss at baseline: 2.5;\tedss after 12 months: 1.5;\trelapses during 12 months prior fingolimod: 3;\trelapses during 12-month follow-up: 0"}]}, {"GSM2159246": [{"title": "Patient 4, CD56+ cells, before first dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD56+ cells"}, {"characteristics_ch1": "patient identifier: WKSB-4693;\tgender: Female;\tage in years: 43;\tdisease duration in years: 1;\tprevious treatment: Interferon-beta-1a intramuscular;\ttreatment gap in months: 1;\tedss at baseline: 4.0;\tedss after 12 months: 3.5;\trelapses during 12 months prior fingolimod: 2;\trelapses during 12-month follow-up: 0"}]}, {"GSM2159247": [{"title": "Patient 4, CD56+ cells, before second dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD56+ cells"}, {"characteristics_ch1": "patient identifier: WKSB-4693;\tgender: Female;\tage in years: 43;\tdisease duration in years: 1;\tprevious treatment: Interferon-beta-1a intramuscular;\ttreatment gap in months: 1;\tedss at baseline: 4.0;\tedss after 12 months: 3.5;\trelapses during 12 months prior fingolimod: 2;\trelapses during 12-month follow-up: 0"}]}, {"GSM2159249": [{"title": "Patient 4, CD56+ cells, after 3 months of fingolimod treatment"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD56+ cells"}, {"characteristics_ch1": "patient identifier: WKSB-4693;\tgender: Female;\tage in years: 43;\tdisease duration in years: 1;\tprevious treatment: Interferon-beta-1a intramuscular;\ttreatment gap in months: 1;\tedss at baseline: 4.0;\tedss after 12 months: 3.5;\trelapses during 12 months prior fingolimod: 2;\trelapses during 12-month follow-up: 0"}]}, {"GSM2159250": [{"title": "Patient 5, CD56+ cells, before first dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD56+ cells"}, {"characteristics_ch1": "patient identifier: SSBZ-7676;\tgender: Female;\tage in years: 45;\tdisease duration in years: 12;\tprevious treatment: Interferon-beta-1a intramuscular;\ttreatment gap in months: 2;\tedss at baseline: 3.0;\tedss after 12 months: 3.0;\trelapses during 12 months prior fingolimod: 3;\trelapses during 12-month follow-up: 0"}]}, {"GSM2159252": [{"title": "Patient 5, CD56+ cells, before second dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD56+ cells"}, {"characteristics_ch1": "patient identifier: SSBZ-7676;\tgender: Female;\tage in years: 45;\tdisease duration in years: 12;\tprevious treatment: Interferon-beta-1a intramuscular;\ttreatment gap in months: 2;\tedss at baseline: 3.0;\tedss after 12 months: 3.0;\trelapses during 12 months prior fingolimod: 3;\trelapses during 12-month follow-up: 0"}]}, {"GSM2159253": [{"title": "Patient 5, CD56+ cells, after 3 months of fingolimod treatment"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD56+ cells"}, {"characteristics_ch1": "patient identifier: SSBZ-7676;\tgender: Female;\tage in years: 45;\tdisease duration in years: 12;\tprevious treatment: Interferon-beta-1a intramuscular;\ttreatment gap in months: 2;\tedss at baseline: 3.0;\tedss after 12 months: 3.0;\trelapses during 12 months prior fingolimod: 3;\trelapses during 12-month follow-up: 0"}]}, {"GSM2159255": [{"title": "Patient 6, CD56+ cells, before first dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD56+ cells"}, {"characteristics_ch1": "patient identifier: XBOH-5819;\tgender: Male;\tage in years: 31;\tdisease duration in years: 7;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: <1;\tedss at baseline: 3.5;\tedss after 12 months: 2.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM2159257": [{"title": "Patient 6, CD56+ cells, before second dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD56+ cells"}, {"characteristics_ch1": "patient identifier: XBOH-5819;\tgender: Male;\tage in years: 31;\tdisease duration in years: 7;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: <1;\tedss at baseline: 3.5;\tedss after 12 months: 2.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM2159259": [{"title": "Patient 6, CD56+ cells, after 3 months of fingolimod treatment"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD56+ cells"}, {"characteristics_ch1": "patient identifier: XBOH-5819;\tgender: Male;\tage in years: 31;\tdisease duration in years: 7;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: <1;\tedss at baseline: 3.5;\tedss after 12 months: 2.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM2159260": [{"title": "Patient 7, CD56+ cells, before first dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD56+ cells"}, {"characteristics_ch1": "patient identifier: ESRN-3798;\tgender: Female;\tage in years: 33;\tdisease duration in years: 2;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: <1;\tedss at baseline: 2.5;\tedss after 12 months: 5.5;\trelapses during 12 months prior fingolimod: 2;\trelapses during 12-month follow-up: 2"}]}, {"GSM2159262": [{"title": "Patient 7, CD56+ cells, before second dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD56+ cells"}, {"characteristics_ch1": "patient identifier: ESRN-3798;\tgender: Female;\tage in years: 33;\tdisease duration in years: 2;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: <1;\tedss at baseline: 2.5;\tedss after 12 months: 5.5;\trelapses during 12 months prior fingolimod: 2;\trelapses during 12-month follow-up: 2"}]}, {"GSM2159264": [{"title": "Patient 7, CD56+ cells, after 3 months of fingolimod treatment"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD56+ cells"}, {"characteristics_ch1": "patient identifier: ESRN-3798;\tgender: Female;\tage in years: 33;\tdisease duration in years: 2;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: <1;\tedss at baseline: 2.5;\tedss after 12 months: 5.5;\trelapses during 12 months prior fingolimod: 2;\trelapses during 12-month follow-up: 2"}]}, {"GSM2159265": [{"title": "Patient 8, CD56+ cells, before first dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD56+ cells"}, {"characteristics_ch1": "patient identifier: CFMJ-5805;\tgender: Male;\tage in years: 33;\tdisease duration in years: 4;\tprevious treatment: Interferon-beta-1a subcutaneous;\ttreatment gap in months: <1;\tedss at baseline: 3.0;\tedss after 12 months: 6.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 3"}]}, {"GSM2159267": [{"title": "Patient 8, CD56+ cells, before second dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD56+ cells"}, {"characteristics_ch1": "patient identifier: CFMJ-5805;\tgender: Male;\tage in years: 33;\tdisease duration in years: 4;\tprevious treatment: Interferon-beta-1a subcutaneous;\ttreatment gap in months: <1;\tedss at baseline: 3.0;\tedss after 12 months: 6.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 3"}]}, {"GSM2159268": [{"title": "Patient 8, CD56+ cells, after 3 months of fingolimod treatment"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD56+ cells"}, {"characteristics_ch1": "patient identifier: CFMJ-5805;\tgender: Male;\tage in years: 33;\tdisease duration in years: 4;\tprevious treatment: Interferon-beta-1a subcutaneous;\ttreatment gap in months: <1;\tedss at baseline: 3.0;\tedss after 12 months: 6.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 3"}]}, {"GSM2159270": [{"title": "Patient 9, CD56+ cells, before first dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD56+ cells"}, {"characteristics_ch1": "patient identifier: RBTM-1672;\tgender: Male;\tage in years: 46;\tdisease duration in years: 15;\tprevious treatment: Interferon-beta-1b subcutaneous;\ttreatment gap in months: <1;\tedss at baseline: 3.5;\tedss after 12 months: 2.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM2159272": [{"title": "Patient 9, CD56+ cells, before second dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD56+ cells"}, {"characteristics_ch1": "patient identifier: RBTM-1672;\tgender: Male;\tage in years: 46;\tdisease duration in years: 15;\tprevious treatment: Interferon-beta-1b subcutaneous;\ttreatment gap in months: <1;\tedss at baseline: 3.5;\tedss after 12 months: 2.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM2159273": [{"title": "Patient 9, CD56+ cells, after 3 months of fingolimod treatment"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD56+ cells"}, {"characteristics_ch1": "patient identifier: RBTM-1672;\tgender: Male;\tage in years: 46;\tdisease duration in years: 15;\tprevious treatment: Interferon-beta-1b subcutaneous;\ttreatment gap in months: <1;\tedss at baseline: 3.5;\tedss after 12 months: 2.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM2159275": [{"title": "Patient 10, CD56+ cells, before first dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD56+ cells"}, {"characteristics_ch1": "patient identifier: FCCI-7765;\tgender: Male;\tage in years: 37;\tdisease duration in years: 9;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: 1;\tedss at baseline: 5.5;\tedss after 12 months: 4.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM2159276": [{"title": "Patient 10, CD56+ cells, before second dose of fingolimod"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD56+ cells"}, {"characteristics_ch1": "patient identifier: FCCI-7765;\tgender: Male;\tage in years: 37;\tdisease duration in years: 9;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: 1;\tedss at baseline: 5.5;\tedss after 12 months: 4.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM2159278": [{"title": "Patient 10, CD56+ cells, after 3 months of fingolimod treatment"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood CD56+ cells"}, {"characteristics_ch1": "patient identifier: FCCI-7765;\tgender: Male;\tage in years: 37;\tdisease duration in years: 9;\tprevious treatment: Glatiramer acetate;\ttreatment gap in months: 1;\tedss at baseline: 5.5;\tedss after 12 months: 4.0;\trelapses during 12 months prior fingolimod: 1;\trelapses during 12-month follow-up: 0"}]}, {"GSM2081399": [{"title": "colonic mucosa from control group 1"}, {"type": "RNA"}, {"source_name_ch1": "Control_human colonic mucosa"}, {"characteristics_ch1": "subject group: control patient group;\ttissue: colon biopsies from endoscopy"}]}, {"GSM2081400": [{"title": "colonic mucosa from control group 2"}, {"type": "RNA"}, {"source_name_ch1": "Control_human colonic mucosa"}, {"characteristics_ch1": "subject group: control patient group;\ttissue: colon biopsies from endoscopy"}]}, {"GSM2081401": [{"title": "colonic mucosa from control group 3"}, {"type": "RNA"}, {"source_name_ch1": "Control_human colonic mucosa"}, {"characteristics_ch1": "subject group: control patient group;\ttissue: colon biopsies from endoscopy"}]}, {"GSM2081402": [{"title": "colonic mucosa from control group 4"}, {"type": "RNA"}, {"source_name_ch1": "Control_human colonic mucosa"}, {"characteristics_ch1": "subject group: control patient group;\ttissue: colon biopsies from endoscopy"}]}, {"GSM2081403": [{"title": "colonic mucosa from control group 5"}, {"type": "RNA"}, {"source_name_ch1": "Control_human colonic mucosa"}, {"characteristics_ch1": "subject group: control patient group;\ttissue: colon biopsies from endoscopy"}]}, {"GSM2081404": [{"title": "colonic mucosa from MC group 1"}, {"type": "RNA"}, {"source_name_ch1": "MC patient_human colonic mucosa"}, {"characteristics_ch1": "subject group: melanosis coli (MC) patient group;\ttissue: colon biopsies from endoscopy"}]}, {"GSM2081405": [{"title": "colonic mucosa from MC group 2"}, {"type": "RNA"}, {"source_name_ch1": "MC patient_human colonic mucosa"}, {"characteristics_ch1": "subject group: melanosis coli (MC) patient group;\ttissue: colon biopsies from endoscopy"}]}, {"GSM2081406": [{"title": "colonic mucosa from MC group 3"}, {"type": "RNA"}, {"source_name_ch1": "MC patient_human colonic mucosa"}, {"characteristics_ch1": "subject group: melanosis coli (MC) patient group;\ttissue: colon biopsies from endoscopy"}]}, {"GSM2081407": [{"title": "colonic mucosa from MC group 4"}, {"type": "RNA"}, {"source_name_ch1": "MC patient_human colonic mucosa"}, {"characteristics_ch1": "subject group: melanosis coli (MC) patient group;\ttissue: colon biopsies from endoscopy"}]}, {"GSM2081408": [{"title": "colonic mucosa from MC group 5"}, {"type": "RNA"}, {"source_name_ch1": "MC patient_human colonic mucosa"}, {"characteristics_ch1": "subject group: melanosis coli (MC) patient group;\ttissue: colon biopsies from endoscopy"}]}, {"GSM2182800": [{"title": "BeasSiNPs-P40, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "Beas-2B cells treated with 5 \u03bcg/mL amorphous silica nanoparticles for 40 passages"}, {"characteristics_ch1": "cell line: Beas-2B"}]}, {"GSM2182801": [{"title": "BeasSiNPs-P40, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "Beas-2B cells treated with 5 \u03bcg/mL amorphous silica nanoparticles for 40 passages"}, {"characteristics_ch1": "cell line: Beas-2B"}]}, {"GSM2182802": [{"title": "BeasSiNPs-P40, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "Beas-2B cells treated with 5 \u03bcg/mL amorphous silica nanoparticles for 40 passages"}, {"characteristics_ch1": "cell line: Beas-2B"}]}, {"GSM2182803": [{"title": "Beas-P40, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "The passage-matched control Beas-2B cells without amorphous silica nanoparticles treatment"}, {"characteristics_ch1": "cell line: Beas-2B"}]}, {"GSM2182804": [{"title": "Beas-P40, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "The passage-matched control Beas-2B cells without amorphous silica nanoparticles treatment"}, {"characteristics_ch1": "cell line: Beas-2B"}]}, {"GSM2182805": [{"title": "Beas-P40, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "The passage-matched control Beas-2B cells without amorphous silica nanoparticles treatment"}, {"characteristics_ch1": "cell line: Beas-2B"}]}, {"GSM1865817": [{"title": "Cord Tissue_Patient D"}, {"type": "RNA"}, {"source_name_ch1": "CT_MSCs"}, {"characteristics_ch1": "patient id: Patient D;\ttissue: Cord tissue (CT);\tcell type: mesenchymal stem cells (MSCs)"}]}, {"GSM1865818": [{"title": "Cord Tissue_Patient E"}, {"type": "RNA"}, {"source_name_ch1": "CT_MSCs"}, {"characteristics_ch1": "patient id: Patient E;\ttissue: Cord tissue (CT);\tcell type: mesenchymal stem cells (MSCs)"}]}, {"GSM1865819": [{"title": "Cord Tissue_Patient F"}, {"type": "RNA"}, {"source_name_ch1": "CT_MSCs"}, {"characteristics_ch1": "patient id: Patient F;\ttissue: Cord tissue (CT);\tcell type: mesenchymal stem cells (MSCs)"}]}, {"GSM1865820": [{"title": "Cord-placenta junction_Patient E"}, {"type": "RNA"}, {"source_name_ch1": "CPJ_MSCs"}, {"characteristics_ch1": "patient id: Patient E;\ttissue: Cord-placenta junction (CPJ);\tcell type: mesenchymal stem cells (MSCs)"}]}, {"GSM1865821": [{"title": "Cord-placenta junction_Patient G"}, {"type": "RNA"}, {"source_name_ch1": "CPJ_MSCs"}, {"characteristics_ch1": "patient id: Patient G;\ttissue: Cord-placenta junction (CPJ);\tcell type: mesenchymal stem cells (MSCs)"}]}, {"GSM1865822": [{"title": "Wharton's jelly_Patient E"}, {"type": "RNA"}, {"source_name_ch1": "WJ_MSCs"}, {"characteristics_ch1": "patient id: Patient E;\ttissue: Wharton's jelly (WJ);\tcell type: mesenchymal stem cells (MSCs)"}]}, {"GSM1865823": [{"title": "Wharton's jelly_Patient G"}, {"type": "RNA"}, {"source_name_ch1": "WJ_MSCs"}, {"characteristics_ch1": "patient id: Patient G;\ttissue: Wharton's jelly (WJ);\tcell type: mesenchymal stem cells (MSCs)"}]}, {"GSM1979343": [{"title": "Cord Tissue_Early Passage 1"}, {"type": "RNA"}, {"source_name_ch1": "Cord tissue"}, {"characteristics_ch1": "tissue: Cord tissue;\tpassage: Early"}]}, {"GSM1979344": [{"title": "Cord Tissue_Early Passage 2"}, {"type": "RNA"}, {"source_name_ch1": "Cord tissue"}, {"characteristics_ch1": "tissue: Cord tissue;\tpassage: Early"}]}, {"GSM1979345": [{"title": "Cord Tissue_Early Passage 3"}, {"type": "RNA"}, {"source_name_ch1": "Cord tissue"}, {"characteristics_ch1": "tissue: Cord tissue;\tpassage: Early"}]}, {"GSM1979346": [{"title": "Cord-placenta junction_Early Passage 1"}, {"type": "RNA"}, {"source_name_ch1": "Cord-placenta junction"}, {"characteristics_ch1": "tissue: Cord-placenta junction;\tpassage: Early"}]}, {"GSM1979347": [{"title": "Cord-placenta junction_Early Passage 2"}, {"type": "RNA"}, {"source_name_ch1": "Cord-placenta junction"}, {"characteristics_ch1": "tissue: Cord-placenta junction;\tpassage: Early"}]}, {"GSM1979348": [{"title": "Wharton's jelly_Early Passage 1"}, {"type": "RNA"}, {"source_name_ch1": "Wharton's jelly"}, {"characteristics_ch1": "tissue: Wharton's jelly;\tpassage: Early"}]}, {"GSM1979349": [{"title": "Wharton's jelly_Early Passage 2"}, {"type": "RNA"}, {"source_name_ch1": "Wharton's jelly"}, {"characteristics_ch1": "tissue: Wharton's jelly;\tpassage: Early"}]}, {"GSM1979350": [{"title": "Cord-placenta junction_Late Passage 1"}, {"type": "RNA"}, {"source_name_ch1": "Cord-placenta junction"}, {"characteristics_ch1": "tissue: Cord-placenta junction;\tpassage: Late"}]}, {"GSM1979351": [{"title": "Cord-placenta junction_Late Passage 2"}, {"type": "RNA"}, {"source_name_ch1": "Cord-placenta junction"}, {"characteristics_ch1": "tissue: Cord-placenta junction;\tpassage: Late"}]}, {"GSM1979352": [{"title": "Cord-placenta junction_Late Passage 3"}, {"type": "RNA"}, {"source_name_ch1": "Cord-placenta junction"}, {"characteristics_ch1": "tissue: Cord-placenta junction;\tpassage: Late"}]}, {"GSM1979353": [{"title": "Cord Tissue_Late Passage 1"}, {"type": "RNA"}, {"source_name_ch1": "Cord tissue"}, {"characteristics_ch1": "tissue: Cord tissue;\tpassage: Late"}]}, {"GSM1979354": [{"title": "Cord Tissue_Late Passage 2"}, {"type": "RNA"}, {"source_name_ch1": "Cord tissue"}, {"characteristics_ch1": "tissue: Cord tissue;\tpassage: Late"}]}, {"GSM1979355": [{"title": "Cord Tissue_Late Passage 3"}, {"type": "RNA"}, {"source_name_ch1": "Cord tissue"}, {"characteristics_ch1": "tissue: Cord tissue;\tpassage: Late"}]}, {"GSM1979356": [{"title": "Wharton's jelly_Late Passage 1"}, {"type": "RNA"}, {"source_name_ch1": "Wharton's jelly"}, {"characteristics_ch1": "tissue: Wharton's jelly;\tpassage: Late"}]}, {"GSM1979357": [{"title": "Wharton's jelly_Late Passage 2"}, {"type": "RNA"}, {"source_name_ch1": "Wharton's jelly"}, {"characteristics_ch1": "tissue: Wharton's jelly;\tpassage: Late"}]}, {"GSM1979358": [{"title": "Wharton's jelly_Late Passage 3"}, {"type": "RNA"}, {"source_name_ch1": "Wharton's jelly"}, {"characteristics_ch1": "tissue: Wharton's jelly;\tpassage: Late"}]}, {"GSM2198194": [{"title": "CESCs cultured in osteogenic induction medium under hypoxia"}, {"type": "RNA"}, {"source_name_ch1": "Osteogenic differentiated CESCs under hypoxia"}, {"characteristics_ch1": "cell type: Osteogenic differentiated CESCs"}]}, {"GSM2198195": [{"title": "CESCs cultured in osteogenic induction medium under normoxia"}, {"type": "RNA"}, {"source_name_ch1": "Osteogenic differentiated CESCs under normoxia"}, {"characteristics_ch1": "cell type: Osteogenic differentiated CESCs"}]}, {"GSM2199910": [{"title": "RNA GUCY1B3 overexpression stable U87 MG  Rep1"}, {"type": "RNA"}, {"source_name_ch1": "GUCY1B3 overexpression stable U87 MG cells"}, {"characteristics_ch1": "cell line: glioblastoma cancer cell line U87;\tgenotype/variation: GUCY1B3 overexpression"}]}, {"GSM2199911": [{"title": "RNA GUCY1B3 overexpression stable U87 MG  Rep2"}, {"type": "RNA"}, {"source_name_ch1": "GUCY1B3 overexpression stable U87 MG cells"}, {"characteristics_ch1": "cell line: glioblastoma cancer cell line U87;\tgenotype/variation: GUCY1B3 overexpression"}]}, {"GSM2199912": [{"title": "RNA GUCY1B3 overexpression stable U87 MG  Rep3"}, {"type": "RNA"}, {"source_name_ch1": "GUCY1B3 overexpression stable U87 MG cells"}, {"characteristics_ch1": "cell line: glioblastoma cancer cell line U87;\tgenotype/variation: GUCY1B3 overexpression"}]}, {"GSM2199913": [{"title": "RNA U87 MG  Rep1"}, {"type": "RNA"}, {"source_name_ch1": "U87 MG cells"}, {"characteristics_ch1": "cell line: glioblastoma cancer cell line U87;\tgenotype/variation: control"}]}, {"GSM2199914": [{"title": "RNA U87 MG  Rep2"}, {"type": "RNA"}, {"source_name_ch1": "U87 MG cells"}, {"characteristics_ch1": "cell line: glioblastoma cancer cell line U87;\tgenotype/variation: control"}]}, {"GSM2199915": [{"title": "RNA U87 MG  Rep3"}, {"type": "RNA"}, {"source_name_ch1": "U87 MG cells"}, {"characteristics_ch1": "cell line: glioblastoma cancer cell line U87;\tgenotype/variation: control"}]}, {"GSM1955456": [{"title": "Primary AML patient 01"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M2;\tc/ebpsigma quartile: Q1;\tkaryotypic aberration: t(8;21) RUNX1/RUNX1T1"}]}, {"GSM1955457": [{"title": "Primary AML patient 02"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M2;\tc/ebpsigma quartile: Q1;\tkaryotypic aberration: t(8;21) RUNX1/RUNX1T1"}]}, {"GSM1955458": [{"title": "Primary AML patient 03"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M2;\tc/ebpsigma quartile: Q1;\tkaryotypic aberration: t(8;21) RUNX1/RUNX1T1"}]}, {"GSM1955459": [{"title": "Primary AML patient 04"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M2;\tc/ebpsigma quartile: Q3;\tkaryotypic aberration: t(8;21) RUNX1/RUNX1T1"}]}, {"GSM1955460": [{"title": "Primary AML patient 05"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: N/A;\tc/ebpsigma quartile: Q1;\tkaryotypic aberration: t(8;21) RUNX1/RUNX1T1"}]}, {"GSM1955461": [{"title": "Primary AML patient 06"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M4;\tc/ebpsigma quartile: Q3;\tkaryotypic aberration: t(8;21) RUNX1/RUNX1T1"}]}, {"GSM1955462": [{"title": "Primary AML patient 07"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M2;\tc/ebpsigma quartile: Q3;\tkaryotypic aberration: t(8;21) RUNX1/RUNX1T1"}]}, {"GSM1955463": [{"title": "Primary AML patient 08"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M2;\tc/ebpsigma quartile: Q1;\tkaryotypic aberration: t(8;21) RUNX1/RUNX1T1"}]}, {"GSM1955464": [{"title": "Primary AML patient 09"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M2;\tc/ebpsigma quartile: Q1;\tkaryotypic aberration: t(8;21) RUNX1/RUNX1T1"}]}, {"GSM1955465": [{"title": "Primary AML patient 10"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M1;\tc/ebpsigma quartile: Q3;\tkaryotypic aberration: t(8;21) RUNX1/RUNX1T1"}]}, {"GSM1955466": [{"title": "Primary AML patient 11"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M2;\tc/ebpsigma quartile: Q2;\tkaryotypic aberration: t(8;21) RUNX1/RUNX1T1"}]}, {"GSM1955467": [{"title": "Primary AML patient 12"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M1;\tc/ebpsigma quartile: Q2;\tkaryotypic aberration: t(8;21) RUNX1/RUNX1T1"}]}, {"GSM1955468": [{"title": "Primary AML patient 13"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M4;\tc/ebpsigma quartile: Q1;\tkaryotypic aberration: t(8;21) RUNX1/RUNX1T1"}]}, {"GSM1955469": [{"title": "Primary AML patient 14"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M2;\tc/ebpsigma quartile: Q2;\tkaryotypic aberration: t(8;21) RUNX1/RUNX1T1"}]}, {"GSM1955470": [{"title": "Primary AML patient 15"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M2;\tc/ebpsigma quartile: Q3;\tkaryotypic aberration: t(8;21) RUNX1/RUNX1T1"}]}, {"GSM1955471": [{"title": "Primary AML patient 16"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M2;\tc/ebpsigma quartile: Q4;\tkaryotypic aberration: t(8;21) RUNX1/RUNX1T1"}]}, {"GSM1955472": [{"title": "Primary AML patient 17"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M1;\tc/ebpsigma quartile: Q3;\tkaryotypic aberration: t(11;17)NUP98-PHF23"}]}, {"GSM1955473": [{"title": "Primary AML patient 18"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M7;\tc/ebpsigma quartile: Q4;\tkaryotypic aberration: t(11;21)NUP98-JARID1A"}]}, {"GSM1955474": [{"title": "Primary AML patient 26"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M1;\tc/ebpsigma quartile: Q2;\tkaryotypic aberration: t(2;11) NUP98/HOXD13"}]}, {"GSM1955475": [{"title": "Primary AML patient 27"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M1;\tc/ebpsigma quartile: Q2;\tkaryotypic aberration: t(5;11)NUP98/NSD1"}]}, {"GSM1955476": [{"title": "Primary AML patient 28"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M1;\tc/ebpsigma quartile: Q3;\tkaryotypic aberration: t(5;11)NUP98/NSD1"}]}, {"GSM1955477": [{"title": "Primary AML patient 29"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M2;\tc/ebpsigma quartile: Q4;\tkaryotypic aberration: t(5;11)NUP98/NSD1"}]}, {"GSM1955478": [{"title": "Primary AML patient 32"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M2;\tc/ebpsigma quartile: Q2;\tkaryotypic aberration: t(9;11)NUP98-LEDGF"}]}, {"GSM1955479": [{"title": "Primary AML patient 36"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: N/A;\tc/ebpsigma quartile: Q3;\tkaryotypic aberration: t(5;11)NUP98/NSD1"}]}, {"GSM1955480": [{"title": "Primary AML patient 39"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: N/A;\tc/ebpsigma quartile: Q2;\tkaryotypic aberration: t(5;11)NUP98/NSD1"}]}, {"GSM1955481": [{"title": "Primary AML patient 40"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M5;\tc/ebpsigma quartile: Q3;\tkaryotypic aberration: t(5;11)NUP98/NSD1"}]}, {"GSM1955482": [{"title": "Primary AML patient 42"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: N/A;\tc/ebpsigma quartile: Q2;\tkaryotypic aberration: t(5;11)NUP98/NSD1"}]}, {"GSM1955483": [{"title": "Primary AML patient 83"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M4;\tc/ebpsigma quartile: Q3;\tkaryotypic aberration: t(11;17)NUP98-PHF23"}]}, {"GSM1955484": [{"title": "Primary AML patient 84"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: N/A;\tc/ebpsigma quartile: Q3;\tkaryotypic aberration: inv(11) NUP98/DDX10"}]}, {"GSM1955485": [{"title": "Primary AML patient 85"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M7;\tc/ebpsigma quartile: Q4;\tkaryotypic aberration: t(11;21)NUP98-JARID1A"}]}, {"GSM1955486": [{"title": "Primary AML patient 96"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M0;\tc/ebpsigma quartile: Q1;\tkaryotypic aberration: t(11;17)NUP98-PHF23"}]}, {"GSM1955487": [{"title": "Primary AML patient 20"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M7;\tc/ebpsigma quartile: Q4;\tkaryotypic aberration: NEG"}]}, {"GSM1955488": [{"title": "Primary AML patient 21"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M5;\tc/ebpsigma quartile: Q3;\tkaryotypic aberration: NEG"}]}, {"GSM1955489": [{"title": "Primary AML patient 22"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M1;\tc/ebpsigma quartile: Q3;\tkaryotypic aberration: NEG"}]}, {"GSM1955490": [{"title": "Primary AML patient 23"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M2;\tc/ebpsigma quartile: Q1;\tkaryotypic aberration: NEG"}]}, {"GSM1955491": [{"title": "Primary AML patient 24"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M1;\tc/ebpsigma quartile: Q4;\tkaryotypic aberration: NEG"}]}, {"GSM1955492": [{"title": "Primary AML patient 31"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M1;\tc/ebpsigma quartile: Q4;\tkaryotypic aberration: NEG"}]}, {"GSM1955493": [{"title": "Primary AML patient 33"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M7;\tc/ebpsigma quartile: Q2;\tkaryotypic aberration: NEG"}]}, {"GSM1955494": [{"title": "Primary AML patient 34"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M2;\tc/ebpsigma quartile: Q3;\tkaryotypic aberration: NEG"}]}, {"GSM1955495": [{"title": "Primary AML patient 35"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M7;\tc/ebpsigma quartile: Q4;\tkaryotypic aberration: NEG"}]}, {"GSM1955496": [{"title": "Primary AML patient 41"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M1;\tc/ebpsigma quartile: Q1;\tkaryotypic aberration: NEG"}]}, {"GSM1955497": [{"title": "Primary AML patient 55"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M5;\tc/ebpsigma quartile: Q4;\tkaryotypic aberration: NEG"}]}, {"GSM1955498": [{"title": "Primary AML patient 62"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M1;\tc/ebpsigma quartile: Q3;\tkaryotypic aberration: NEG"}]}, {"GSM1955499": [{"title": "Primary AML patient 63"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: N/A;\tc/ebpsigma quartile: Q4;\tkaryotypic aberration: NEG"}]}, {"GSM1955500": [{"title": "Primary AML patient 66"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M5;\tc/ebpsigma quartile: Q2;\tkaryotypic aberration: NEG"}]}, {"GSM1955501": [{"title": "Primary AML patient 87"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: N/A;\tc/ebpsigma quartile: Q4;\tkaryotypic aberration: NEG"}]}, {"GSM1955502": [{"title": "Primary AML patient 43"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M0;\tc/ebpsigma quartile: Q4;\tkaryotypic aberration: MLL-t"}]}, {"GSM1955503": [{"title": "Primary AML patient 44"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M5;\tc/ebpsigma quartile: Q2;\tkaryotypic aberration: MLL-t"}]}, {"GSM1955504": [{"title": "Primary AML patient 45"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: N/A;\tc/ebpsigma quartile: Q3;\tkaryotypic aberration: MLL-t"}]}, {"GSM1955505": [{"title": "Primary AML patient 46"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: N/A;\tc/ebpsigma quartile: Q2;\tkaryotypic aberration: MLL-t"}]}, {"GSM1955506": [{"title": "Primary AML patient 47"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M7;\tc/ebpsigma quartile: Q4;\tkaryotypic aberration: MLL-t"}]}, {"GSM1955507": [{"title": "Primary AML patient 48"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: N/A;\tc/ebpsigma quartile: Q3;\tkaryotypic aberration: MLL-t"}]}, {"GSM1955508": [{"title": "Primary AML patient 49"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M5;\tc/ebpsigma quartile: Q3;\tkaryotypic aberration: MLL-t"}]}, {"GSM1955509": [{"title": "Primary AML patient 52"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: N/A;\tc/ebpsigma quartile: Q4;\tkaryotypic aberration: NEG"}]}, {"GSM1955510": [{"title": "Primary AML patient 60"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M4;\tc/ebpsigma quartile: Q1;\tkaryotypic aberration: inv(16) CBFB/MYH11"}]}, {"GSM1955511": [{"title": "Primary AML patient 67"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: N/A;\tc/ebpsigma quartile: Q2;\tkaryotypic aberration: inv(16) CBFB/MYH11"}]}, {"GSM1955512": [{"title": "Primary AML patient 68"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: N/A;\tc/ebpsigma quartile: Q2;\tkaryotypic aberration: inv(16) CBFB/MYH11"}]}, {"GSM1955513": [{"title": "Primary AML patient 69"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: N/A;\tc/ebpsigma quartile: Q1;\tkaryotypic aberration: inv(16) CBFB/MYH11"}]}, {"GSM1955514": [{"title": "Primary AML patient 70"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M5;\tc/ebpsigma quartile: Q1;\tkaryotypic aberration: t(6;9) DEK/NUP214"}]}, {"GSM1955515": [{"title": "Primary AML patient 71"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M2;\tc/ebpsigma quartile: Q1;\tkaryotypic aberration: t(6;9) DEK/NUP214"}]}, {"GSM1955516": [{"title": "Primary AML patient 72"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: N/A;\tc/ebpsigma quartile: Q2;\tkaryotypic aberration: t(6;9) DEK/NUP214"}]}, {"GSM1955517": [{"title": "Primary AML patient 73"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: N/A;\tc/ebpsigma quartile: Q1;\tkaryotypic aberration: t(6;9) DEK/NUP214"}]}, {"GSM1955518": [{"title": "Primary AML patient 82"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M2;\tc/ebpsigma quartile: Q1;\tkaryotypic aberration: t(6;9) DEK/NUP214"}]}, {"GSM1955519": [{"title": "Primary AML patient 78"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M1;\tc/ebpsigma quartile: Q4;\tkaryotypic aberration: NEG"}]}, {"GSM1955520": [{"title": "Primary AML patient 80"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M6;\tc/ebpsigma quartile: Q2;\tkaryotypic aberration: NEG"}]}, {"GSM1955521": [{"title": "Primary AML patient 86"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M2;\tc/ebpsigma quartile: Q4;\tkaryotypic aberration: NEG"}]}, {"GSM1955522": [{"title": "Primary AML patient 88"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M2;\tc/ebpsigma quartile: Q2;\tkaryotypic aberration: NEG"}]}, {"GSM1955523": [{"title": "Primary AML patient 89"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: N/A;\tc/ebpsigma quartile: Q1;\tkaryotypic aberration: NEG"}]}, {"GSM1955524": [{"title": "Primary AML patient 95"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M2;\tc/ebpsigma quartile: Q2;\tkaryotypic aberration: NEG"}]}, {"GSM1955525": [{"title": "Primary AML patient 93"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M1;\tc/ebpsigma quartile: Q4;\tkaryotypic aberration: NEG"}]}, {"GSM1955526": [{"title": "Primary AML patient 94"}, {"type": "RNA"}, {"source_name_ch1": "AML BM"}, {"characteristics_ch1": "tissue: Bone Marrow;\tfab: M2;\tc/ebpsigma quartile: Q3;\tkaryotypic aberration: NEG"}]}, {"GSM1964911": [{"title": "HMVEC-L_Control_Replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "HMVEC-L, Control"}, {"characteristics_ch1": "cell line: HMVEC-L;\tcell type: Primary culture of microvascular endothelial cells;\tpassage #: 2;\ttreatment: Control"}]}, {"GSM1964912": [{"title": "HMVEC-L_Control_Replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "HMVEC-L, Control"}, {"characteristics_ch1": "cell line: HMVEC-L;\tcell type: Primary culture of microvascular endothelial cells;\tpassage #: 2;\ttreatment: Control"}]}, {"GSM1964913": [{"title": "HMVEC-L_Control_Replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "HMVEC-L, Control"}, {"characteristics_ch1": "cell line: HMVEC-L;\tcell type: Primary culture of microvascular endothelial cells;\tpassage #: 2;\ttreatment: Control"}]}, {"GSM1964914": [{"title": "HMVEC-L_Control_Replicate 4"}, {"type": "RNA"}, {"source_name_ch1": "HMVEC-L, Control"}, {"characteristics_ch1": "cell line: HMVEC-L;\tcell type: Primary culture of microvascular endothelial cells;\tpassage #: 2;\ttreatment: Control"}]}, {"GSM1964915": [{"title": "HMVEC-L_10ng CTSL_4hr_Replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "HMVEC-L, 10ng CTSL"}, {"characteristics_ch1": "cell line: HMVEC-L;\tcell type: Primary culture of microvascular endothelial cells;\tpassage #: 2;\ttreatment: CTSL"}]}, {"GSM1964916": [{"title": "HMVEC-L_10ng CTSL_4hr_Replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "HMVEC-L, 10ng CTSL"}, {"characteristics_ch1": "cell line: HMVEC-L;\tcell type: Primary culture of microvascular endothelial cells;\tpassage #: 2;\ttreatment: CTSL"}]}, {"GSM1964917": [{"title": "HMVEC-L_10ng CTSL_4hr_Replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "HMVEC-L, 10ng CTSL"}, {"characteristics_ch1": "cell line: HMVEC-L;\tcell type: Primary culture of microvascular endothelial cells;\tpassage #: 2;\ttreatment: CTSL"}]}, {"GSM1964918": [{"title": "HMVEC-L_10ng CTSL_4hr_Replicate 4"}, {"type": "RNA"}, {"source_name_ch1": "HMVEC-L, 10ng CTSL"}, {"characteristics_ch1": "cell line: HMVEC-L;\tcell type: Primary culture of microvascular endothelial cells;\tpassage #: 2;\ttreatment: CTSL"}]}, {"GSM1862914": [{"title": "Baseline_rep2"}, {"type": "RNA"}, {"source_name_ch1": "Muscle biopsy before intervention derived from subject 2"}, {"characteristics_ch1": "insulin sensitivity: non-responder;\ttissue: muscle"}]}, {"GSM1862915": [{"title": "Baseline_rep3"}, {"type": "RNA"}, {"source_name_ch1": "Muscle biopsy before intervention derived from subject 3"}, {"characteristics_ch1": "insulin sensitivity: high-responder;\ttissue: muscle"}]}, {"GSM1862916": [{"title": "Baseline_rep4"}, {"type": "RNA"}, {"source_name_ch1": "Muscle biopsy before intervention derived from subject 4"}, {"characteristics_ch1": "insulin sensitivity: high-responder;\ttissue: muscle"}]}, {"GSM1862917": [{"title": "Baseline_rep5"}, {"type": "RNA"}, {"source_name_ch1": "Muscle biopsy before intervention derived from subject 5"}, {"characteristics_ch1": "insulin sensitivity: non-responder;\ttissue: muscle"}]}, {"GSM1862918": [{"title": "Baseline_rep6"}, {"type": "RNA"}, {"source_name_ch1": "Muscle biopsy before intervention derived from subject 6"}, {"characteristics_ch1": "insulin sensitivity: non-responder;\ttissue: muscle"}]}, {"GSM1862919": [{"title": "Baseline_rep7"}, {"type": "RNA"}, {"source_name_ch1": "Muscle biopsy before intervention derived from subject 7"}, {"characteristics_ch1": "insulin sensitivity: non-responder;\ttissue: muscle"}]}, {"GSM1862920": [{"title": "Baseline_rep8"}, {"type": "RNA"}, {"source_name_ch1": "Muscle biopsy before intervention derived from subject 8"}, {"characteristics_ch1": "insulin sensitivity: non-responder;\ttissue: muscle"}]}, {"GSM1862921": [{"title": "Baseline_rep9"}, {"type": "RNA"}, {"source_name_ch1": "Muscle biopsy before intervention derived from subject 9"}, {"characteristics_ch1": "insulin sensitivity: non-responder;\ttissue: muscle"}]}, {"GSM1862922": [{"title": "Baseline_rep10"}, {"type": "RNA"}, {"source_name_ch1": "Muscle biopsy before intervention derived from subject 10"}, {"characteristics_ch1": "insulin sensitivity: low-responder;\ttissue: muscle"}]}, {"GSM1862923": [{"title": "Baseline_rep11"}, {"type": "RNA"}, {"source_name_ch1": "Muscle biopsy before intervention derived from subject 11"}, {"characteristics_ch1": "insulin sensitivity: low-responder;\ttissue: muscle"}]}, {"GSM1862924": [{"title": "Baseline_rep12"}, {"type": "RNA"}, {"source_name_ch1": "Muscle biopsy before intervention derived from subject 12"}, {"characteristics_ch1": "insulin sensitivity: high-responder;\ttissue: muscle"}]}, {"GSM1862925": [{"title": "Baseline_rep13"}, {"type": "RNA"}, {"source_name_ch1": "Muscle biopsy before intervention derived from subject 13"}, {"characteristics_ch1": "insulin sensitivity: low-responder;\ttissue: muscle"}]}, {"GSM1862926": [{"title": "Baseline_rep14"}, {"type": "RNA"}, {"source_name_ch1": "Muscle biopsy before intervention derived from subject 14"}, {"characteristics_ch1": "insulin sensitivity: high-responder;\ttissue: muscle"}]}, {"GSM1862927": [{"title": "Baseline_rep16"}, {"type": "RNA"}, {"source_name_ch1": "Muscle biopsy before intervention derived from subject 16"}, {"characteristics_ch1": "insulin sensitivity: high-responder;\ttissue: muscle"}]}, {"GSM1862928": [{"title": "Baseline_rep17"}, {"type": "RNA"}, {"source_name_ch1": "Muscle biopsy before intervention derived from subject 17"}, {"characteristics_ch1": "insulin sensitivity: non-responder;\ttissue: muscle"}]}, {"GSM1862929": [{"title": "Baseline_rep18"}, {"type": "RNA"}, {"source_name_ch1": "Muscle biopsy before intervention derived from subject 18"}, {"characteristics_ch1": "insulin sensitivity: high-responder;\ttissue: muscle"}]}, {"GSM1862930": [{"title": "Baseline_rep19"}, {"type": "RNA"}, {"source_name_ch1": "Muscle biopsy before intervention derived from subject 19"}, {"characteristics_ch1": "insulin sensitivity: high-responder;\ttissue: muscle"}]}, {"GSM1862931": [{"title": "Baseline_rep20"}, {"type": "RNA"}, {"source_name_ch1": "Muscle biopsy before intervention derived from subject 20"}, {"characteristics_ch1": "insulin sensitivity: low-responder;\ttissue: muscle"}]}, {"GSM1862932": [{"title": "Post_intervention_2"}, {"type": "RNA"}, {"source_name_ch1": "Muscle biopsy after an eight weeks endurance training intervention derived from subject 2"}, {"characteristics_ch1": "insulin sensitivity: non-responder;\ttissue: muscle"}]}, {"GSM1862933": [{"title": "Post_intervention_3"}, {"type": "RNA"}, {"source_name_ch1": "Muscle biopsy after an eight weeks endurance training intervention derived from subject 3"}, {"characteristics_ch1": "insulin sensitivity: high-responder;\ttissue: muscle"}]}, {"GSM1862934": [{"title": "Post_intervention_4"}, {"type": "RNA"}, {"source_name_ch1": "Muscle biopsy after an eight weeks endurance training intervention derived from subject 4"}, {"characteristics_ch1": "insulin sensitivity: high-responder;\ttissue: muscle"}]}, {"GSM1862935": [{"title": "Post_intervention_5"}, {"type": "RNA"}, {"source_name_ch1": "Muscle biopsy after an eight weeks endurance training intervention derived from subject 5"}, {"characteristics_ch1": "insulin sensitivity: non-responder;\ttissue: muscle"}]}, {"GSM1862936": [{"title": "Post_intervention_6"}, {"type": "RNA"}, {"source_name_ch1": "Muscle biopsy after an eight weeks endurance training intervention derived from subject 6"}, {"characteristics_ch1": "insulin sensitivity: non-responder;\ttissue: muscle"}]}, {"GSM1862937": [{"title": "Post_intervention_7"}, {"type": "RNA"}, {"source_name_ch1": "Muscle biopsy after an eight weeks endurance training intervention derived from subject 7"}, {"characteristics_ch1": "insulin sensitivity: non-responder;\ttissue: muscle"}]}, {"GSM1862938": [{"title": "Post_intervention_8"}, {"type": "RNA"}, {"source_name_ch1": "Muscle biopsy after an eight weeks endurance training intervention derived from subject 8"}, {"characteristics_ch1": "insulin sensitivity: non-responder;\ttissue: muscle"}]}, {"GSM1862939": [{"title": "Post_intervention_9"}, {"type": "RNA"}, {"source_name_ch1": "Muscle biopsy after an eight weeks endurance training intervention derived from subject 9"}, {"characteristics_ch1": "insulin sensitivity: non-responder;\ttissue: muscle"}]}, {"GSM1862940": [{"title": "Post_intervention_10"}, {"type": "RNA"}, {"source_name_ch1": "Muscle biopsy after an eight weeks endurance training intervention derived from subject 10"}, {"characteristics_ch1": "insulin sensitivity: low-responder;\ttissue: muscle"}]}, {"GSM1862941": [{"title": "Post_intervention_11"}, {"type": "RNA"}, {"source_name_ch1": "Muscle biopsy after an eight weeks endurance training intervention derived from subject 11"}, {"characteristics_ch1": "insulin sensitivity: low-responder;\ttissue: muscle"}]}, {"GSM1862942": [{"title": "Post_intervention_12"}, {"type": "RNA"}, {"source_name_ch1": "Muscle biopsy after an eight weeks endurance training intervention derived from subject 12"}, {"characteristics_ch1": "insulin sensitivity: high-responder;\ttissue: muscle"}]}, {"GSM1862943": [{"title": "Post_intervention_13"}, {"type": "RNA"}, {"source_name_ch1": "Muscle biopsy after an eight weeks endurance training intervention derived from subject 13"}, {"characteristics_ch1": "insulin sensitivity: low-responder;\ttissue: muscle"}]}, {"GSM1862944": [{"title": "Post_intervention_14"}, {"type": "RNA"}, {"source_name_ch1": "Muscle biopsy after an eight weeks endurance training intervention derived from subject 14"}, {"characteristics_ch1": "insulin sensitivity: high-responder;\ttissue: muscle"}]}, {"GSM1862945": [{"title": "Post_intervention_16"}, {"type": "RNA"}, {"source_name_ch1": "Muscle biopsy after an eight weeks endurance training intervention derived from subject 16"}, {"characteristics_ch1": "insulin sensitivity: high-responder;\ttissue: muscle"}]}, {"GSM1862946": [{"title": "Post_intervention_17"}, {"type": "RNA"}, {"source_name_ch1": "Muscle biopsy after an eight weeks endurance training intervention derived from subject 17"}, {"characteristics_ch1": "insulin sensitivity: non-responder;\ttissue: muscle"}]}, {"GSM1862947": [{"title": "Post_intervention_18"}, {"type": "RNA"}, {"source_name_ch1": "Muscle biopsy after an eight weeks endurance training intervention derived from subject 18"}, {"characteristics_ch1": "insulin sensitivity: high-responder;\ttissue: muscle"}]}, {"GSM1862948": [{"title": "Post_intervention_19"}, {"type": "RNA"}, {"source_name_ch1": "Muscle biopsy after an eight weeks endurance training intervention derived from subject 19"}, {"characteristics_ch1": "insulin sensitivity: high-responder;\ttissue: muscle"}]}, {"GSM1862949": [{"title": "Post_intervention_20"}, {"type": "RNA"}, {"source_name_ch1": "Muscle biopsy after an eight weeks endurance training intervention derived from subject 20"}, {"characteristics_ch1": "insulin sensitivity: low-responder;\ttissue: muscle"}]}, {"GSM1912865": [{"title": "Primary AML patient 25"}, {"type": "RNA"}, {"source_name_ch1": "FLT3-ITD AML BM"}, {"characteristics_ch1": "fab: M5;\tc/ebpsigma quartile: Q1;\ttissue: Bone Marrow;\tmutation: FLT3-ITD;\tdiagnosis: acute myeloid leukemia;\tkaryotypic aberration: t(5;11)NUP98/NSD1"}]}, {"GSM1912866": [{"title": "Primary AML patient 30"}, {"type": "RNA"}, {"source_name_ch1": "FLT3-ITD AML BM"}, {"characteristics_ch1": "fab: M5;\tc/ebpsigma quartile: Q2;\ttissue: Bone Marrow;\tmutation: FLT3-ITD;\tdiagnosis: acute myeloid leukemia;\tkaryotypic aberration: t(5;11)NUP98/NSD1"}]}, {"GSM1912867": [{"title": "Primary AML patient 37"}, {"type": "RNA"}, {"source_name_ch1": "FLT3-ITD AML BM"}, {"characteristics_ch1": "fab: M4;\tc/ebpsigma quartile: Q1;\ttissue: Bone Marrow;\tmutation: FLT3-ITD;\tdiagnosis: acute myeloid leukemia;\tkaryotypic aberration: t(5;11)NUP98/NSD1"}]}, {"GSM1912868": [{"title": "Primary AML patient 38"}, {"type": "RNA"}, {"source_name_ch1": "FLT3-ITD AML BM"}, {"characteristics_ch1": "fab: M5;\tc/ebpsigma quartile: Q2;\ttissue: Bone Marrow;\tmutation: FLT3-ITD;\tdiagnosis: acute myeloid leukemia;\tkaryotypic aberration: t(5;11)NUP98/NSD1"}]}, {"GSM1912869": [{"title": "Primary AML patient 50"}, {"type": "RNA"}, {"source_name_ch1": "FLT3-ITD AML BM"}, {"characteristics_ch1": "fab: M4;\tc/ebpsigma quartile: Q1;\ttissue: Bone Marrow;\tmutation: FLT3-ITD;\tdiagnosis: acute myeloid leukemia;\tkaryotypic aberration: NEG"}]}, {"GSM1912870": [{"title": "Primary AML patient 51"}, {"type": "RNA"}, {"source_name_ch1": "FLT3-ITD AML BM"}, {"characteristics_ch1": "fab: M1;\tc/ebpsigma quartile: Q3;\ttissue: Bone Marrow;\tmutation: FLT3-ITD;\tdiagnosis: acute myeloid leukemia;\tkaryotypic aberration: NEG"}]}, {"GSM1912871": [{"title": "Primary AML patient 53"}, {"type": "RNA"}, {"source_name_ch1": "FLT3-ITD AML BM"}, {"characteristics_ch1": "fab: M0;\tc/ebpsigma quartile: Q4;\ttissue: Bone Marrow;\tmutation: FLT3-ITD;\tdiagnosis: acute myeloid leukemia;\tkaryotypic aberration: NEG"}]}, {"GSM1912872": [{"title": "Primary AML patient 54"}, {"type": "RNA"}, {"source_name_ch1": "FLT3-ITD AML BM"}, {"characteristics_ch1": "fab: M2;\tc/ebpsigma quartile: Q4;\ttissue: Bone Marrow;\tmutation: FLT3-ITD;\tdiagnosis: acute myeloid leukemia;\tkaryotypic aberration: NEG"}]}, {"GSM1912873": [{"title": "Primary AML patient 56"}, {"type": "RNA"}, {"source_name_ch1": "FLT3-ITD AML BM"}, {"characteristics_ch1": "fab: M1;\tc/ebpsigma quartile: Q2;\ttissue: Bone Marrow;\tmutation: FLT3-ITD;\tdiagnosis: acute myeloid leukemia;\tkaryotypic aberration: NEG"}]}, {"GSM1912874": [{"title": "Primary AML patient 57"}, {"type": "RNA"}, {"source_name_ch1": "FLT3-ITD AML BM"}, {"characteristics_ch1": "fab: M5;\tc/ebpsigma quartile: Q3;\ttissue: Bone Marrow;\tmutation: FLT3-ITD;\tdiagnosis: acute myeloid leukemia;\tkaryotypic aberration: NEG"}]}, {"GSM1912875": [{"title": "Primary AML patient 58"}, {"type": "RNA"}, {"source_name_ch1": "FLT3-ITD AML BM"}, {"characteristics_ch1": "fab: M2;\tc/ebpsigma quartile: Q4;\ttissue: Bone Marrow;\tmutation: FLT3-ITD;\tdiagnosis: acute myeloid leukemia;\tkaryotypic aberration: NEG"}]}, {"GSM1912876": [{"title": "Primary AML patient 74"}, {"type": "RNA"}, {"source_name_ch1": "FLT3-ITD AML BM"}, {"characteristics_ch1": "fab: M1;\tc/ebpsigma quartile: Q1;\ttissue: Bone Marrow;\tmutation: FLT3-ITD;\tdiagnosis: acute myeloid leukemia;\tkaryotypic aberration: t(6;9) DEK/NUP214"}]}, {"GSM1912877": [{"title": "Primary AML patient 75"}, {"type": "RNA"}, {"source_name_ch1": "FLT3-ITD AML BM"}, {"characteristics_ch1": "fab: M4;\tc/ebpsigma quartile: Q1;\ttissue: Bone Marrow;\tmutation: FLT3-ITD;\tdiagnosis: acute myeloid leukemia;\tkaryotypic aberration: t(6;9) DEK/NUP214"}]}, {"GSM1912878": [{"title": "Primary AML patient 81"}, {"type": "RNA"}, {"source_name_ch1": "FLT3-ITD AML BM"}, {"characteristics_ch1": "fab: M4;\tc/ebpsigma quartile: Q4;\ttissue: Bone Marrow;\tmutation: FLT3-ITD;\tdiagnosis: acute myeloid leukemia;\tkaryotypic aberration: NEG"}]}, {"GSM2237842": [{"title": "CESCs cultured under hypoxia [gene]"}, {"type": "RNA"}, {"source_name_ch1": "CESCs cultured under hypoxia for 21 days"}, {"characteristics_ch1": "cell: Cartilage endplate-derived stem cells (CESCs)"}]}, {"GSM2237843": [{"title": "CESCs cultured under normoxia [gene]"}, {"type": "RNA"}, {"source_name_ch1": "CESCs cultured under normoxia for 21 days"}, {"characteristics_ch1": "cell: Cartilage endplate-derived stem cells (CESCs)"}]}, {"GSM1832978": [{"title": "xenograft tissue_PC9_Sh KDM1A, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "Mouse xenograft derived from human PC9 cells expressing stable ShRNA KDM1A"}, {"characteristics_ch1": "cell type: NSCLC cells;\tmouse strain: BALB/C;\tinjection position: the right axillary;\tshRNA: KDM1A"}]}, {"GSM1832979": [{"title": "xenograft tissue_PC9_Sh KDM1A, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "Mouse xenograft derived from human PC9 cells expressing stable ShRNA KDM1A"}, {"characteristics_ch1": "cell type: NSCLC cells;\tmouse strain: BALB/C;\tinjection position: the right axillary;\tshRNA: KDM1A"}]}, {"GSM1832980": [{"title": "xenograft tissue_PC9_Sh KDM1A, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "Mouse xenograft derived from human PC9 cells expressing stable ShRNA KDM1A"}, {"characteristics_ch1": "cell type: NSCLC cells;\tmouse strain: BALB/C;\tinjection position: the right axillary;\tshRNA: KDM1A"}]}, {"GSM1832981": [{"title": "xenograft tissue_PC9_Sh control, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "Mouse xenograft derived from human PC9 cells expressing stable ShRNA control"}, {"characteristics_ch1": "cell type: NSCLC cells;\tmouse strain: BALB/C;\tinjection position: the right axillary;\tshRNA: control"}]}, {"GSM1832982": [{"title": "xenograft tissue_PC9_Sh control, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "Mouse xenograft derived from human PC9 cells expressing stable ShRNA control"}, {"characteristics_ch1": "cell type: NSCLC cells;\tmouse strain: BALB/C;\tinjection position: the right axillary;\tshRNA: control"}]}, {"GSM1832983": [{"title": "xenograft tissue_PC9_Sh control, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "Mouse xenograft derived from human PC9 cells expressing stable ShRNA control"}, {"characteristics_ch1": "cell type: NSCLC cells;\tmouse strain: BALB/C;\tinjection position: the right axillary;\tshRNA: control"}]}, {"GSM2252633": [{"title": "x-MV3-L1CAM_01"}, {"type": "RNA"}, {"source_name_ch1": "MV3_L1CAM"}, {"characteristics_ch1": "origin: Xenograft;\tknockdown: L1CAM;\tcell line: MV3"}]}, {"GSM2252634": [{"title": "x-MV3-L1CAM_02"}, {"type": "RNA"}, {"source_name_ch1": "MV3_L1CAM"}, {"characteristics_ch1": "origin: Xenograft;\tknockdown: L1CAM;\tcell line: MV3"}]}, {"GSM2252635": [{"title": "x-MV3-L1CAM_03"}, {"type": "RNA"}, {"source_name_ch1": "MV3_L1CAM"}, {"characteristics_ch1": "origin: Xenograft;\tknockdown: L1CAM;\tcell line: MV3"}]}, {"GSM2252636": [{"title": "x-MV3-L1CAM_04"}, {"type": "RNA"}, {"source_name_ch1": "MV3_L1CAM"}, {"characteristics_ch1": "origin: Xenograft;\tknockdown: L1CAM;\tcell line: MV3"}]}, {"GSM2252637": [{"title": "x-MV3-luc_01"}, {"type": "RNA"}, {"source_name_ch1": "MV3_luc"}, {"characteristics_ch1": "origin: Xenograft;\tknockdown: luc;\tcell line: MV3"}]}, {"GSM2252638": [{"title": "x-MV3-luc_02"}, {"type": "RNA"}, {"source_name_ch1": "MV3_luc"}, {"characteristics_ch1": "origin: Xenograft;\tknockdown: luc;\tcell line: MV3"}]}, {"GSM2252639": [{"title": "x-MV3-luc_03"}, {"type": "RNA"}, {"source_name_ch1": "MV3_luc"}, {"characteristics_ch1": "origin: Xenograft;\tknockdown: luc;\tcell line: MV3"}]}, {"GSM2252640": [{"title": "x-MV3-luc_04"}, {"type": "RNA"}, {"source_name_ch1": "MV3_luc"}, {"characteristics_ch1": "origin: Xenograft;\tknockdown: luc;\tcell line: MV3"}]}, {"GSM2252641": [{"title": "x-MeWo-luc_01"}, {"type": "RNA"}, {"source_name_ch1": "MeWo_luc"}, {"characteristics_ch1": "origin: Xenograft;\tknockdown: luc;\tcell line: MeWo"}]}, {"GSM2252642": [{"title": "x-MeWo-luc_02"}, {"type": "RNA"}, {"source_name_ch1": "MeWo_luc"}, {"characteristics_ch1": "origin: Xenograft;\tknockdown: luc;\tcell line: MeWo"}]}, {"GSM2252643": [{"title": "x-MeWo-luc_03"}, {"type": "RNA"}, {"source_name_ch1": "MeWo_luc"}, {"characteristics_ch1": "origin: Xenograft;\tknockdown: luc;\tcell line: MeWo"}]}, {"GSM2252644": [{"title": "x-MeWo-luc_04"}, {"type": "RNA"}, {"source_name_ch1": "MeWo_luc"}, {"characteristics_ch1": "origin: Xenograft;\tknockdown: luc;\tcell line: MeWo"}]}, {"GSM2252645": [{"title": "x-MeWo-luc_05"}, {"type": "RNA"}, {"source_name_ch1": "MeWo_luc"}, {"characteristics_ch1": "origin: Xenograft;\tknockdown: luc;\tcell line: MeWo"}]}, {"GSM2252646": [{"title": "x-MeWo-luc_06"}, {"type": "RNA"}, {"source_name_ch1": "MeWo_luc"}, {"characteristics_ch1": "origin: Xenograft;\tknockdown: luc;\tcell line: MeWo"}]}, {"GSM2252647": [{"title": "x-MeWo-luc_07"}, {"type": "RNA"}, {"source_name_ch1": "MeWo_luc"}, {"characteristics_ch1": "origin: Xenograft;\tknockdown: luc;\tcell line: MeWo"}]}, {"GSM2252648": [{"title": "x-MeWo-luc_08"}, {"type": "RNA"}, {"source_name_ch1": "MeWo_luc"}, {"characteristics_ch1": "origin: Xenograft;\tknockdown: luc;\tcell line: MeWo"}]}, {"GSM2252649": [{"title": "x-MeWo-L1CAM_01"}, {"type": "RNA"}, {"source_name_ch1": "MeWo_L1CAM"}, {"characteristics_ch1": "origin: Xenograft;\tknockdown: L1CAM;\tcell line: MeWo"}]}, {"GSM2252650": [{"title": "x-MeWo-L1CAM_02"}, {"type": "RNA"}, {"source_name_ch1": "MeWo_L1CAM"}, {"characteristics_ch1": "origin: Xenograft;\tknockdown: L1CAM;\tcell line: MeWo"}]}, {"GSM2252651": [{"title": "x-MeWo-L1CAM_03"}, {"type": "RNA"}, {"source_name_ch1": "MeWo_L1CAM"}, {"characteristics_ch1": "origin: Xenograft;\tknockdown: L1CAM;\tcell line: MeWo"}]}, {"GSM2252652": [{"title": "x-MeWo-L1CAM_04"}, {"type": "RNA"}, {"source_name_ch1": "MeWo_L1CAM"}, {"characteristics_ch1": "origin: Xenograft;\tknockdown: L1CAM;\tcell line: MeWo"}]}, {"GSM2252653": [{"title": "x-MeWo-L1CAM_05"}, {"type": "RNA"}, {"source_name_ch1": "MeWo_L1CAM"}, {"characteristics_ch1": "origin: Xenograft;\tknockdown: L1CAM;\tcell line: MeWo"}]}, {"GSM2252654": [{"title": "x-MeWo-L1CAM_06"}, {"type": "RNA"}, {"source_name_ch1": "MeWo_L1CAM"}, {"characteristics_ch1": "origin: Xenograft;\tknockdown: L1CAM;\tcell line: MeWo"}]}, {"GSM1841212": [{"title": "skeletal muscle, PLA_ t3, p42_rep1"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_PLA_after intervention"}, {"characteristics_ch1": "treatment: placebo;\ttime point: after intervention;\tgender: female;\ttissue: vastus lateralis muscle;\tage: 50;\tbmi: 28.4"}]}, {"GSM1841213": [{"title": "skeletal muscle, INTV_t3, p5_rep1"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_INTV_after intervention"}, {"characteristics_ch1": "treatment: Epigallocatechin-gallate (E, 282 mg/d) and Resveratrol (R; 80 mg/d);\ttime point: after intervention;\tgender: male;\ttissue: vastus lateralis muscle;\tage: 47;\tbmi: 34.3"}]}, {"GSM1841214": [{"title": "skeletal muscle, PLA_t0, p2_rep2"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_PLA_before intervention"}, {"characteristics_ch1": "treatment: placebo;\ttime point: before intervention;\tgender: male;\ttissue: vastus lateralis muscle;\tage: 48;\tbmi: 28.3"}]}, {"GSM1841215": [{"title": "skeletal muscle, PLA_t0, p33_rep3"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_PLA_before intervention"}, {"characteristics_ch1": "treatment: placebo;\ttime point: before intervention;\tgender: female;\ttissue: vastus lateralis muscle;\tage: 45;\tbmi: 27.0"}]}, {"GSM1841216": [{"title": "skeletal muscle, INTV_t0, p29_rep2"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_INTV_before intervention"}, {"characteristics_ch1": "treatment: Epigallocatechin-gallate (E, 282 mg/d) and Resveratrol (R; 80 mg/d);\ttime point: before intervention;\tgender: female;\ttissue: vastus lateralis muscle;\tage: 23;\tbmi: 26.0"}]}, {"GSM1841217": [{"title": "skeletal muscle, PLA_t3, p10_rep4"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_PLA_after intervention"}, {"characteristics_ch1": "treatment: placebo;\ttime point: after intervention;\tgender: male;\ttissue: vastus lateralis muscle;\tage: 46;\tbmi: 27.6"}]}, {"GSM1841218": [{"title": "skeletal muscle, INTV_t0, p38_rep3"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_INTV_before intervention"}, {"characteristics_ch1": "treatment: Epigallocatechin-gallate (E, 282 mg/d) and Resveratrol (R; 80 mg/d);\ttime point: before intervention;\tgender: female;\ttissue: vastus lateralis muscle;\tage: 47;\tbmi: 30.4"}]}, {"GSM1841219": [{"title": "skeletal muscle, PLA_t0, p15_rep5"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_PLA_before intervention"}, {"characteristics_ch1": "treatment: placebo;\ttime point: before intervention;\tgender: male;\ttissue: vastus lateralis muscle;\tage: 39;\tbmi: 29.5"}]}, {"GSM1841220": [{"title": "skeletal muscle, INTV_t0, p24_rep4"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_INTV_before intervention"}, {"characteristics_ch1": "treatment: Epigallocatechin-gallate (E, 282 mg/d) and Resveratrol (R; 80 mg/d);\ttime point: before intervention;\tgender: female;\ttissue: vastus lateralis muscle;\tage: 23;\tbmi: 30.1"}]}, {"GSM1841221": [{"title": "skeletal muscle, PLA_t3, p39_rep6"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_PLA_after intervention"}, {"characteristics_ch1": "treatment: placebo;\ttime point: after intervention;\tgender: female;\ttissue: vastus lateralis muscle;\tage: 44;\tbmi: 27.9"}]}, {"GSM1841222": [{"title": "skeletal muscle, INTV_t3, p41_rep5"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_INTV_after intervention"}, {"characteristics_ch1": "treatment: Epigallocatechin-gallate (E, 282 mg/d) and Resveratrol (R; 80 mg/d);\ttime point: after intervention;\tgender: female;\ttissue: vastus lateralis muscle;\tage: 45;\tbmi: 31.7"}]}, {"GSM1841223": [{"title": "skeletal muscle, INTV_t0, p5_rep1"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_INTV_before intervention"}, {"characteristics_ch1": "treatment: Epigallocatechin-gallate (E, 282 mg/d) and Resveratrol (R; 80 mg/d);\ttime point: before intervention;\tgender: male;\ttissue: vastus lateralis muscle;\tage: 47;\tbmi: 34.3"}]}, {"GSM1841224": [{"title": "skeletal muscle, PLA_t0, p14_rep7"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_PLA_before intervention"}, {"characteristics_ch1": "treatment: placebo;\ttime point: before intervention;\tgender: male;\ttissue: vastus lateralis muscle;\tage: 38;\tbmi: 26.8"}]}, {"GSM1841225": [{"title": "skeletal muscle, PLA_t3, p15_rep5"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_PLA_after intervention"}, {"characteristics_ch1": "treatment: placebo;\ttime point: after intervention;\tgender: male;\ttissue: vastus lateralis muscle;\tage: 39;\tbmi: 29.5"}]}, {"GSM1841226": [{"title": "skeletal muscle, PLA_t0, p3_rep8"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_PLA_before intervention"}, {"characteristics_ch1": "treatment: placebo;\ttime point: before intervention;\tgender: male;\ttissue: vastus lateralis muscle;\tage: 52;\tbmi: 27.0"}]}, {"GSM1841227": [{"title": "skeletal muscle, PLA_t3, p14_rep7"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_PLA_after intervention"}, {"characteristics_ch1": "treatment: placebo;\ttime point: after intervention;\tgender: male;\ttissue: vastus lateralis muscle;\tage: 38;\tbmi: 26.8"}]}, {"GSM1841228": [{"title": "skeletal muscle, PLA_t3, p2_rep2"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_PLA_after intervention"}, {"characteristics_ch1": "treatment: placebo;\ttime point: after intervention;\tgender: male;\ttissue: vastus lateralis muscle;\tage: 48;\tbmi: 28.3"}]}, {"GSM1841229": [{"title": "skeletal muscle, INTV_t3, p35_rep6"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_INTV_after intervention"}, {"characteristics_ch1": "treatment: Epigallocatechin-gallate (E, 282 mg/d) and Resveratrol (R; 80 mg/d);\ttime point: after intervention;\tgender: female;\ttissue: vastus lateralis muscle;\tage: 21;\tbmi: 26.1"}]}, {"GSM1841230": [{"title": "skeletal muscle, INTV_t3, p11_rep7"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_INTV_after intervention"}, {"characteristics_ch1": "treatment: Epigallocatechin-gallate (E, 282 mg/d) and Resveratrol (R; 80 mg/d);\ttime point: after intervention;\tgender: male;\ttissue: vastus lateralis muscle;\tage: 19;\tbmi: 30.8"}]}, {"GSM1841231": [{"title": "skeletal muscle, PLA_t0, p42_rep1"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_PLA_before intervention"}, {"characteristics_ch1": "treatment: placebo;\ttime point: before intervention;\tgender: female;\ttissue: vastus lateralis muscle;\tage: 50;\tbmi: 28.4"}]}, {"GSM1841232": [{"title": "skeletal muscle, INTV_t3, p18_rep8"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_INTV_after intervention"}, {"characteristics_ch1": "treatment: Epigallocatechin-gallate (E, 282 mg/d) and Resveratrol (R; 80 mg/d);\ttime point: after intervention;\tgender: male;\ttissue: vastus lateralis muscle;\tage: 48;\tbmi: 32.9"}]}, {"GSM1841233": [{"title": "skeletal muscle, INTV_t0, p4_rep9"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_INTV_before intervention"}, {"characteristics_ch1": "treatment: Epigallocatechin-gallate (E, 282 mg/d) and Resveratrol (R; 80 mg/d);\ttime point: before intervention;\tgender: male;\ttissue: vastus lateralis muscle;\tage: 43;\tbmi: 28.7"}]}, {"GSM1841234": [{"title": "skeletal muscle, PLA_t0, p39_rep6"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_PLA_before intervention"}, {"characteristics_ch1": "treatment: placebo;\ttime point: before intervention;\tgender: female;\ttissue: vastus lateralis muscle;\tage: 44;\tbmi: 27.9"}]}, {"GSM1841235": [{"title": "skeletal muscle, INTV_t0, p35_rep6"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_INTV_before intervention"}, {"characteristics_ch1": "treatment: Epigallocatechin-gallate (E, 282 mg/d) and Resveratrol (R; 80 mg/d);\ttime point: before intervention;\tgender: female;\ttissue: vastus lateralis muscle;\tage: 21;\tbmi: 26.1"}]}, {"GSM1841236": [{"title": "skeletal muscle, PLA_t0, p17_rep9"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_PLA_before intervention"}, {"characteristics_ch1": "treatment: placebo;\ttime point: before intervention;\tgender: male;\ttissue: vastus lateralis muscle;\tage: 46;\tbmi: 38.5"}]}, {"GSM1841237": [{"title": "skeletal muscle, PLA_t3, p33_rep3"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_PLA_after intervention"}, {"characteristics_ch1": "treatment: placebo;\ttime point: after intervention;\tgender: female;\ttissue: vastus lateralis muscle;\tage: 45;\tbmi: 27.0"}]}, {"GSM1841238": [{"title": "skeletal muscle, INTV_t3, p36_rep10"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_INTV_after intervention"}, {"characteristics_ch1": "treatment: Epigallocatechin-gallate (E, 282 mg/d) and Resveratrol (R; 80 mg/d);\ttime point: after intervention;\tgender: female;\ttissue: vastus lateralis muscle;\tage: 42;\tbmi: 28.2"}]}, {"GSM1841239": [{"title": "skeletal muscle, INTV_t0, p16_rep11"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_INTV_before intervention"}, {"characteristics_ch1": "treatment: Epigallocatechin-gallate (E, 282 mg/d) and Resveratrol (R; 80 mg/d);\ttime point: before intervention;\tgender: male;\ttissue: vastus lateralis muscle;\tage: 41;\tbmi: 27.0"}]}, {"GSM1841240": [{"title": "skeletal muscle, PLA_t3, p3_rep8"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_PLA_after intervention"}, {"characteristics_ch1": "treatment: placebo;\ttime point: after intervention;\tgender: male;\ttissue: vastus lateralis muscle;\tage: 52;\tbmi: 27.0"}]}, {"GSM1841241": [{"title": "skeletal muscle, INTV_t0, p41_rep5"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_INTV_before intervention"}, {"characteristics_ch1": "treatment: Epigallocatechin-gallate (E, 282 mg/d) and Resveratrol (R; 80 mg/d);\ttime point: before intervention;\tgender: female;\ttissue: vastus lateralis muscle;\tage: 45;\tbmi: 31.7"}]}, {"GSM1841242": [{"title": "skeletal muscle, INTV_t3, p9_rep12"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_INTV_after intervention"}, {"characteristics_ch1": "treatment: Epigallocatechin-gallate (E, 282 mg/d) and Resveratrol (R; 80 mg/d);\ttime point: after intervention;\tgender: male;\ttissue: vastus lateralis muscle;\tage: 28;\tbmi: 33.3"}]}, {"GSM1841243": [{"title": "skeletal muscle, INTV_t3, p29_rep2"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_INTV_after intervention"}, {"characteristics_ch1": "treatment: Epigallocatechin-gallate (E, 282 mg/d) and Resveratrol (R; 80 mg/d);\ttime point: after intervention;\tgender: female;\ttissue: vastus lateralis muscle;\tage: 23;\tbmi: 26.0"}]}, {"GSM1841244": [{"title": "skeletal muscle, PLA_t3, p37_rep10"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_PLA_after intervention"}, {"characteristics_ch1": "treatment: placebo;\ttime point: after intervention;\tgender: female;\ttissue: vastus lateralis muscle;\tage: 21;\tbmi: 29.1"}]}, {"GSM1841245": [{"title": "skeletal muscle, INTV_t0, p11_rep7"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_INTV_before intervention"}, {"characteristics_ch1": "treatment: Epigallocatechin-gallate (E, 282 mg/d) and Resveratrol (R; 80 mg/d);\ttime point: before intervention;\tgender: male;\ttissue: vastus lateralis muscle;\tage: 19;\tbmi: 30.8"}]}, {"GSM1841246": [{"title": "skeletal muscle, PLA_t0, p37_rep10"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_PLA_before intervention"}, {"characteristics_ch1": "treatment: placebo;\ttime point: before intervention;\tgender: female;\ttissue: vastus lateralis muscle;\tage: 21;\tbmi: 29.1"}]}, {"GSM1841247": [{"title": "skeletal muscle, PLA_t0, p19_rep11"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_PLA_before intervention"}, {"characteristics_ch1": "treatment: placebo;\ttime point: before intervention;\tgender: male;\ttissue: vastus lateralis muscle;\tage: 47;\tbmi: 29.2"}]}, {"GSM1841248": [{"title": "skeletal muscle, INTV_t3, p24_rep4"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_INTV_after intervention"}, {"characteristics_ch1": "treatment: Epigallocatechin-gallate (E, 282 mg/d) and Resveratrol (R; 80 mg/d);\ttime point: after intervention;\tgender: female;\ttissue: vastus lateralis muscle;\tage: 23;\tbmi: 30.1"}]}, {"GSM1841249": [{"title": "skeletal muscle, INTV_t3, p16_rep11"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_INTV_after intervention"}, {"characteristics_ch1": "treatment: Epigallocatechin-gallate (E, 282 mg/d) and Resveratrol (R; 80 mg/d);\ttime point: after intervention;\tgender: male;\ttissue: vastus lateralis muscle;\tage: 41;\tbmi: 27.0"}]}, {"GSM1841250": [{"title": "skeletal muscle, PLA_t3, p19_rep11"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_PLA_after intervention"}, {"characteristics_ch1": "treatment: placebo;\ttime point: after intervention;\tgender: male;\ttissue: vastus lateralis muscle;\tage: 47;\tbmi: 29.2"}]}, {"GSM1841252": [{"title": "skeletal muscle, PLA_t0, p20_rep12"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_PLA_before intervention"}, {"characteristics_ch1": "treatment: placebo;\ttime point: before intervention;\tgender: male;\ttissue: vastus lateralis muscle;\tage: 43;\tbmi: 25.3"}]}, {"GSM1841253": [{"title": "skeletal muscle, INTV_t0, p36_rep10"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_INTV_before intervention"}, {"characteristics_ch1": "treatment: Epigallocatechin-gallate (E, 282 mg/d) and Resveratrol (R; 80 mg/d);\ttime point: before intervention;\tgender: female;\ttissue: vastus lateralis muscle;\tage: 42;\tbmi: 28.2"}]}, {"GSM1841254": [{"title": "skeletal muscle, PLA_t3, p20_rep12"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_PLA_after intervention"}, {"characteristics_ch1": "treatment: placebo;\ttime point: after intervention;\tgender: male;\ttissue: vastus lateralis muscle;\tage: 43;\tbmi: 25.3"}]}, {"GSM1841255": [{"title": "skeletal muscle, PLA_t3, p8_rep13"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_PLA_after intervention"}, {"characteristics_ch1": "treatment: placebo;\ttime point: after intervention;\tgender: male;\ttissue: vastus lateralis muscle;\tage: 23;\tbmi: 25.6"}]}, {"GSM1841256": [{"title": "skeletal muscle, PLA_t0, p8_rep13"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_PLA_before intervention"}, {"characteristics_ch1": "treatment: placebo;\ttime point: before intervention;\tgender: male;\ttissue: vastus lateralis muscle;\tage: 23;\tbmi: 25.6"}]}, {"GSM1841257": [{"title": "skeletal muscle, PLA_t0, p10_rep4"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_PLA_before intervention"}, {"characteristics_ch1": "treatment: placebo;\ttime point: before intervention;\tgender: male;\ttissue: vastus lateralis muscle;\tage: 46;\tbmi: 27.6"}]}, {"GSM1841258": [{"title": "skeletal muscle, INTV_t3, p4_rep9"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_INTV_after intervention"}, {"characteristics_ch1": "treatment: Epigallocatechin-gallate (E, 282 mg/d) and Resveratrol (R; 80 mg/d);\ttime point: after intervention;\tgender: male;\ttissue: vastus lateralis muscle;\tage: 43;\tbmi: 28.7"}]}, {"GSM1841260": [{"title": "skeletal muscle, PLA_t0, p6_rep14"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_PLA_before intervention"}, {"characteristics_ch1": "treatment: placebo;\ttime point: before intervention;\tgender: male;\ttissue: vastus lateralis muscle;\tage: 38;\tbmi: 30.0"}]}, {"GSM1841262": [{"title": "skeletal muscle, PLA_t3, p6_rep14"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_PLA_after intervention"}, {"characteristics_ch1": "treatment: placebo;\ttime point: after intervention;\tgender: male;\ttissue: vastus lateralis muscle;\tage: 38;\tbmi: 30.0"}]}, {"GSM1841264": [{"title": "skeletal muscle, INTV_t0, p9_rep12"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_INTV_before intervention"}, {"characteristics_ch1": "treatment: Epigallocatechin-gallate (E, 282 mg/d) and Resveratrol (R; 80 mg/d);\ttime point: before intervention;\tgender: male;\ttissue: vastus lateralis muscle;\tage: 28;\tbmi: 33.3"}]}, {"GSM1841265": [{"title": "skeletal muscle, PLA_t3, p17_rep9"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_PLA_after intervention"}, {"characteristics_ch1": "treatment: placebo;\ttime point: after intervention;\tgender: male;\ttissue: vastus lateralis muscle;\tage: 46;\tbmi: 38.5"}]}, {"GSM1841267": [{"title": "skeletal muscle, INTV_t0, p40_rep13"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_INTV_before intervention"}, {"characteristics_ch1": "treatment: Epigallocatechin-gallate (E, 282 mg/d) and Resveratrol (R; 80 mg/d);\ttime point: before intervention;\tgender: female;\ttissue: vastus lateralis muscle;\tage: 28;\tbmi: 26.5"}]}, {"GSM1841269": [{"title": "skeletal muscle, INTV_t0, p18_rep8"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_INTV_before intervention"}, {"characteristics_ch1": "treatment: Epigallocatechin-gallate (E, 282 mg/d) and Resveratrol (R; 80 mg/d);\ttime point: before intervention;\tgender: male;\ttissue: vastus lateralis muscle;\tage: 48;\tbmi: 32.9"}]}, {"GSM1841271": [{"title": "skeletal muscle, INTV_t3, p38_rep3"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_INTV_after intervention"}, {"characteristics_ch1": "treatment: Epigallocatechin-gallate (E, 282 mg/d) and Resveratrol (R; 80 mg/d);\ttime point: after intervention;\tgender: female;\ttissue: vastus lateralis muscle;\tage: 47;\tbmi: 30.4"}]}, {"GSM1841272": [{"title": "skeletal muscle, INTV_t3, p40_rep13"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis muscle_INTV_after intervention"}, {"characteristics_ch1": "treatment: Epigallocatechin-gallate (E, 282 mg/d) and Resveratrol (R; 80 mg/d);\ttime point: after intervention;\tgender: female;\ttissue: vastus lateralis muscle;\tage: 28;\tbmi: 26.5"}]}, {"GSM2157824": [{"title": "siRNA_CONCR_REP1"}, {"type": "RNA"}, {"source_name_ch1": "A549 cells_siRNA_CONCR"}, {"characteristics_ch1": "cell line: A549"}]}, {"GSM2157825": [{"title": "siRNA_CONCR_REP2"}, {"type": "RNA"}, {"source_name_ch1": "A549 cells_siRNA_CONCR"}, {"characteristics_ch1": "cell line: A549"}]}, {"GSM2157826": [{"title": "siRNA_CONCR_REP3"}, {"type": "RNA"}, {"source_name_ch1": "A549 cells_siRNA_CONCR"}, {"characteristics_ch1": "cell line: A549"}]}, {"GSM2157827": [{"title": "siRNA_Control_REP1"}, {"type": "RNA"}, {"source_name_ch1": "A549 cells_siRNA_control"}, {"characteristics_ch1": "cell line: A549"}]}, {"GSM2157828": [{"title": "siRNA_Control_REP2"}, {"type": "RNA"}, {"source_name_ch1": "A549 cells_siRNA_control"}, {"characteristics_ch1": "cell line: A549"}]}, {"GSM2157829": [{"title": "siRNA_Control_REP3"}, {"type": "RNA"}, {"source_name_ch1": "A549 cells_siRNA_control"}, {"characteristics_ch1": "cell line: A549"}]}, {"GSM2267450": [{"title": "HUVECs as control, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "HUVECs"}, {"characteristics_ch1": "cell type: HUVECs"}]}, {"GSM2267451": [{"title": "HUVECs as control, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "HUVECs"}, {"characteristics_ch1": "cell type: HUVECs"}]}, {"GSM2267452": [{"title": "HUVECs as control, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "HUVECs"}, {"characteristics_ch1": "cell type: HUVECs"}]}, {"GSM2267453": [{"title": "HUVECs treated with PM2.5, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "HUVECs"}, {"characteristics_ch1": "cell type: HUVECs"}]}, {"GSM2267454": [{"title": "HUVECs treated with PM2.5, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "HUVECs"}, {"characteristics_ch1": "cell type: HUVECs"}]}, {"GSM2267455": [{"title": "HUVECs treated with PM2.5, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "HUVECs"}, {"characteristics_ch1": "cell type: HUVECs"}]}, {"GSM2233143": [{"title": "cultured PBMCs_no YM treatment_rep1"}, {"type": "RNA"}, {"source_name_ch1": "PHA-stimulated PBMCs"}, {"characteristics_ch1": "tissue: PBMCs;\tgender: male"}]}, {"GSM2233144": [{"title": "cultured PBMCs_no YM treatment_rep2"}, {"type": "RNA"}, {"source_name_ch1": "PHA-stimulated PBMCs"}, {"characteristics_ch1": "tissue: PBMCs;\tgender: male"}]}, {"GSM2233145": [{"title": "cultured PBMCs_100 ug/ml YM treatment_rep1"}, {"type": "RNA"}, {"source_name_ch1": "PHA-stimulated PBMCs 100 ug/ml YM"}, {"characteristics_ch1": "tissue: PBMCs;\tgender: male"}]}, {"GSM2233146": [{"title": "cultured PBMCs_100 ug/ml YM treatment_rep2"}, {"type": "RNA"}, {"source_name_ch1": "PHA-stimulated PBMCs 100 ug/ml YM"}, {"characteristics_ch1": "tissue: PBMCs;\tgender: male"}]}, {"GSM2286763": [{"title": "hiPSCs-rep1"}, {"type": "RNA"}, {"source_name_ch1": "human induced Pluripotent Stem Cells"}, {"characteristics_ch1": "cell type: induced Pluripotent Stem Cells"}]}, {"GSM2286764": [{"title": "hiPSCs-rep2"}, {"type": "RNA"}, {"source_name_ch1": "human induced Pluripotent Stem Cells"}, {"characteristics_ch1": "cell type: induced Pluripotent Stem Cells"}]}, {"GSM2286765": [{"title": "hESCs-rep1"}, {"type": "RNA"}, {"source_name_ch1": "human Embryonic Stem Cells"}, {"characteristics_ch1": "cell type: Embryonic Stem Cells"}]}, {"GSM2286766": [{"title": "hESCs-rep2"}, {"type": "RNA"}, {"source_name_ch1": "human Embryonic Stem Cells"}, {"characteristics_ch1": "cell type: Embryonic Stem Cells"}]}, {"GSM2286767": [{"title": "human Urine-Derived Cells-rep1"}, {"type": "RNA"}, {"source_name_ch1": "human Urine-Derived Cells"}, {"characteristics_ch1": "cell type: Urine-Derived Cells"}]}, {"GSM2286768": [{"title": "human Urine-Derived Cells-rep2"}, {"type": "RNA"}, {"source_name_ch1": "human Urine-Derived Cells"}, {"characteristics_ch1": "cell type: Urine-Derived Cells"}]}, {"GSM2286818": [{"title": "Neurons, derived from ax0016 (line 6)"}, {"type": "RNA"}, {"source_name_ch1": "iPSC-derived Neural Stem Cells"}, {"characteristics_ch1": "gender: Female;\thla serotype: A3 A33, B7(Bw6) B7(Bw6), Cw7 Cw7;\tgenetic modification: None;\tstarting material: Cord blood CD34+ cells"}]}, {"GSM2287822": [{"title": "HEK293_Tet-on G0(+)_1"}, {"type": "RNA"}, {"source_name_ch1": "HEK293 Tet-on APOL1 G0 cells w/  Dox induction"}, {"characteristics_ch1": "cell type: embyronic kidney cell"}]}, {"GSM2287823": [{"title": "HEK293_Tet-on G0(+)_3"}, {"type": "RNA"}, {"source_name_ch1": "HEK293 Tet-on APOL1 G0 cells w/  Dox induction"}, {"characteristics_ch1": "cell type: embyronic kidney cell"}]}, {"GSM2287824": [{"title": "HEK293_Tet-on G1(+)_1"}, {"type": "RNA"}, {"source_name_ch1": "HEK293 Tet-on APOL1 G1 cells w/  Dox induction"}, {"characteristics_ch1": "cell type: embyronic kidney cell"}]}, {"GSM2287825": [{"title": "HEK293_Tet-on G1(+)_3"}, {"type": "RNA"}, {"source_name_ch1": "HEK293 Tet-on APOL1 G1 cells w/  Dox induction"}, {"characteristics_ch1": "cell type: embyronic kidney cell"}]}, {"GSM2287826": [{"title": "HEK293_Tet-on G2(+)_1"}, {"type": "RNA"}, {"source_name_ch1": "HEK293 Tet-on APOL1 G2 cells w/  Dox induction"}, {"characteristics_ch1": "cell type: embyronic kidney cell"}]}, {"GSM2287827": [{"title": "HEK293_Tet-on G2(+)_3"}, {"type": "RNA"}, {"source_name_ch1": "HEK293 Tet-on APOL1 G2 cells w/  Dox induction"}, {"characteristics_ch1": "cell type: embyronic kidney cell"}]}, {"GSM2287828": [{"title": "African American primary proximal tubule cells K10015"}, {"type": "RNA"}, {"source_name_ch1": "African American primary proximal tubule cells"}, {"characteristics_ch1": "apol1 genotype: G0G0;\tcell type: primary proximal tubule cells"}]}, {"GSM2287829": [{"title": "African American primary proximal tubule cells K10023"}, {"type": "RNA"}, {"source_name_ch1": "African American primary proximal tubule cells"}, {"characteristics_ch1": "apol1 genotype: G0G0;\tcell type: primary proximal tubule cells"}]}, {"GSM2287830": [{"title": "African American primary proximal tubule cells K10053"}, {"type": "RNA"}, {"source_name_ch1": "African American primary proximal tubule cells"}, {"characteristics_ch1": "apol1 genotype: G0G0;\tcell type: primary proximal tubule cells"}]}, {"GSM2287831": [{"title": "African American primary proximal tubule cells K10056"}, {"type": "RNA"}, {"source_name_ch1": "African American primary proximal tubule cells"}, {"characteristics_ch1": "apol1 genotype: G0G0;\tcell type: primary proximal tubule cells"}]}, {"GSM2287832": [{"title": "African American primary proximal tubule cells K10075"}, {"type": "RNA"}, {"source_name_ch1": "African American primary proximal tubule cells"}, {"characteristics_ch1": "apol1 genotype: G0G0;\tcell type: primary proximal tubule cells"}]}, {"GSM2287833": [{"title": "African American primary proximal tubule cells K10095"}, {"type": "RNA"}, {"source_name_ch1": "African American primary proximal tubule cells"}, {"characteristics_ch1": "apol1 genotype: G0G0;\tcell type: primary proximal tubule cells"}]}, {"GSM2287834": [{"title": "African American primary proximal tubule cells K10101"}, {"type": "RNA"}, {"source_name_ch1": "African American primary proximal tubule cells"}, {"characteristics_ch1": "apol1 genotype: G0G0;\tcell type: primary proximal tubule cells"}]}, {"GSM2287835": [{"title": "African American primary proximal tubule cells K10102"}, {"type": "RNA"}, {"source_name_ch1": "African American primary proximal tubule cells"}, {"characteristics_ch1": "apol1 genotype: G0G0;\tcell type: primary proximal tubule cells"}]}, {"GSM2287836": [{"title": "African American primary proximal tubule cells K10109"}, {"type": "RNA"}, {"source_name_ch1": "African American primary proximal tubule cells"}, {"characteristics_ch1": "apol1 genotype: G0G0;\tcell type: primary proximal tubule cells"}]}, {"GSM2287837": [{"title": "African American primary proximal tubule cells K10110"}, {"type": "RNA"}, {"source_name_ch1": "African American primary proximal tubule cells"}, {"characteristics_ch1": "apol1 genotype: G0G0;\tcell type: primary proximal tubule cells"}]}, {"GSM2287838": [{"title": "African American primary proximal tubule cells K10111"}, {"type": "RNA"}, {"source_name_ch1": "African American primary proximal tubule cells"}, {"characteristics_ch1": "apol1 genotype: G0G0;\tcell type: primary proximal tubule cells"}]}, {"GSM2287839": [{"title": "African American primary proximal tubule cells K10133"}, {"type": "RNA"}, {"source_name_ch1": "African American primary proximal tubule cells"}, {"characteristics_ch1": "apol1 genotype: G0G0;\tcell type: primary proximal tubule cells"}]}, {"GSM2287840": [{"title": "African American primary proximal tubule cells K10135"}, {"type": "RNA"}, {"source_name_ch1": "African American primary proximal tubule cells"}, {"characteristics_ch1": "apol1 genotype: G0G0;\tcell type: primary proximal tubule cells"}]}, {"GSM2287841": [{"title": "African American primary proximal tubule cells K10148"}, {"type": "RNA"}, {"source_name_ch1": "African American primary proximal tubule cells"}, {"characteristics_ch1": "apol1 genotype: G0G0;\tcell type: primary proximal tubule cells"}]}, {"GSM2287842": [{"title": "African American primary proximal tubule cells K10150"}, {"type": "RNA"}, {"source_name_ch1": "African American primary proximal tubule cells"}, {"characteristics_ch1": "apol1 genotype: G0G0;\tcell type: primary proximal tubule cells"}]}, {"GSM2287843": [{"title": "African American primary proximal tubule cells K10159"}, {"type": "RNA"}, {"source_name_ch1": "African American primary proximal tubule cells"}, {"characteristics_ch1": "apol1 genotype: G0G0;\tcell type: primary proximal tubule cells"}]}, {"GSM2287844": [{"title": "African American primary proximal tubule cells K10160"}, {"type": "RNA"}, {"source_name_ch1": "African American primary proximal tubule cells"}, {"characteristics_ch1": "apol1 genotype: G0G0;\tcell type: primary proximal tubule cells"}]}, {"GSM2287845": [{"title": "African American primary proximal tubule cells K10165"}, {"type": "RNA"}, {"source_name_ch1": "African American primary proximal tubule cells"}, {"characteristics_ch1": "apol1 genotype: G0G0;\tcell type: primary proximal tubule cells"}]}, {"GSM2287846": [{"title": "African American primary proximal tubule cells K10188"}, {"type": "RNA"}, {"source_name_ch1": "African American primary proximal tubule cells"}, {"characteristics_ch1": "apol1 genotype: G0G0;\tcell type: primary proximal tubule cells"}]}, {"GSM2287847": [{"title": "African American primary proximal tubule cells K10210"}, {"type": "RNA"}, {"source_name_ch1": "African American primary proximal tubule cells"}, {"characteristics_ch1": "apol1 genotype: G0G0;\tcell type: primary proximal tubule cells"}]}, {"GSM2287848": [{"title": "African American primary proximal tubule cells K10211"}, {"type": "RNA"}, {"source_name_ch1": "African American primary proximal tubule cells"}, {"characteristics_ch1": "apol1 genotype: G0G0;\tcell type: primary proximal tubule cells"}]}, {"GSM2287849": [{"title": "African American primary proximal tubule cells K10214"}, {"type": "RNA"}, {"source_name_ch1": "African American primary proximal tubule cells"}, {"characteristics_ch1": "apol1 genotype: G0G0;\tcell type: primary proximal tubule cells"}]}, {"GSM2287850": [{"title": "African American primary proximal tubule cells K10217"}, {"type": "RNA"}, {"source_name_ch1": "African American primary proximal tubule cells"}, {"characteristics_ch1": "apol1 genotype: G0G0;\tcell type: primary proximal tubule cells"}]}, {"GSM2287851": [{"title": "African American primary proximal tubule cells K10219"}, {"type": "RNA"}, {"source_name_ch1": "African American primary proximal tubule cells"}, {"characteristics_ch1": "apol1 genotype: G0G0;\tcell type: primary proximal tubule cells"}]}, {"GSM2287852": [{"title": "African American primary proximal tubule cells K10222"}, {"type": "RNA"}, {"source_name_ch1": "African American primary proximal tubule cells"}, {"characteristics_ch1": "apol1 genotype: G0G0;\tcell type: primary proximal tubule cells"}]}, {"GSM2287853": [{"title": "African American primary proximal tubule cells K10073"}, {"type": "RNA"}, {"source_name_ch1": "African American primary proximal tubule cells"}, {"characteristics_ch1": "apol1 genotype: G1G1;\tcell type: primary proximal tubule cells"}]}, {"GSM2287854": [{"title": "African American primary proximal tubule cells K10203"}, {"type": "RNA"}, {"source_name_ch1": "African American primary proximal tubule cells"}, {"characteristics_ch1": "apol1 genotype: G1G1;\tcell type: primary proximal tubule cells"}]}, {"GSM2287855": [{"title": "African American primary proximal tubule cells K10018"}, {"type": "RNA"}, {"source_name_ch1": "African American primary proximal tubule cells"}, {"characteristics_ch1": "apol1 genotype: G1G2;\tcell type: primary proximal tubule cells"}]}, {"GSM2287856": [{"title": "African American primary proximal tubule cells K10182"}, {"type": "RNA"}, {"source_name_ch1": "African American primary proximal tubule cells"}, {"characteristics_ch1": "apol1 genotype: G1G2;\tcell type: primary proximal tubule cells"}]}, {"GSM2287857": [{"title": "African American primary proximal tubule cells K10202"}, {"type": "RNA"}, {"source_name_ch1": "African American primary proximal tubule cells"}, {"characteristics_ch1": "apol1 genotype: G1G2;\tcell type: primary proximal tubule cells"}]}, {"GSM2293538": [{"title": "hUCBCD34+_DMSO_444_Biological replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "Umbilical Cord CD34+"}, {"characteristics_ch1": "umbilical cord blood: CD34+;\ttreatment: DMSO"}]}, {"GSM2293539": [{"title": "hUCBCD34+_DMSO_394_Biological replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "Umbilical Cord CD34+"}, {"characteristics_ch1": "umbilical cord blood: CD34+;\ttreatment: DMSO"}]}, {"GSM2293540": [{"title": "hUCBCD34+_1,25(OH)D3_444_Biological replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "Umbilical Cord CD34+"}, {"characteristics_ch1": "umbilical cord blood: CD34+;\ttreatment: 1,25(OH)D3 1mM"}]}, {"GSM2293541": [{"title": "hUCBCD34+_1,25(OH)D3_394_Biological replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "Umbilical Cord CD34+"}, {"characteristics_ch1": "umbilical cord blood: CD34+;\ttreatment: 1,25(OH)D3 1mM"}]}, {"GSM2211051": [{"title": "242A 1 Replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 3;\tlentivirus: CONTROL(nontargeting1)"}]}, {"GSM2211052": [{"title": "242A 2 Replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 3;\tlentivirus: CONTROL(nontargeting2)"}]}, {"GSM2211053": [{"title": "242A 3 Replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 3;\tlentivirus: CONTROL(nontargeting3)"}]}, {"GSM2211054": [{"title": "242A 4 Replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 3;\tlentivirus: CONTROL(nontargeting4)"}]}, {"GSM2211055": [{"title": "242A 5 Replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 3;\tlentivirus: CONTROL(nontargeting5)"}]}, {"GSM2211056": [{"title": "242A 12 Replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 3;\tlentivirus: HI-LNC25sh1"}]}, {"GSM2211057": [{"title": "242A 16 Replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 3;\tlentivirus: CDSGliS3sh2"}]}, {"GSM2211058": [{"title": "242A 17 Replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 3;\tlentivirus: CDSGliS3sh4"}]}, {"GSM2211059": [{"title": "242A 38 Replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 3;\tlentivirus: HI-LNC70sh2"}]}, {"GSM2211060": [{"title": "242A 39 Replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 3;\tlentivirus: HI-LNC70sh2"}]}, {"GSM2211061": [{"title": "242A 43 Replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 3;\tlentivirus: CDS HNF1A_sh4"}]}, {"GSM2211062": [{"title": "245 UNT1 Replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 1;\tlentivirus: Untreatedcells"}]}, {"GSM2211063": [{"title": "245 UNT2 Replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 1;\tlentivirus: Untreatedcells"}]}, {"GSM2211064": [{"title": "245A 1 Replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 1;\tlentivirus: CONTROL(nontargeting1)"}]}, {"GSM2211065": [{"title": "245A 2 Replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 1;\tlentivirus: CONTROL(nontargeting2)"}]}, {"GSM2211066": [{"title": "245A 3 Replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 1;\tlentivirus: CONTROL(nontargeting3)"}]}, {"GSM2211067": [{"title": "245A 4 Replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 1;\tlentivirus: CONTROL(nontargeting4)"}]}, {"GSM2211068": [{"title": "245A 5 Replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 1;\tlentivirus: CONTROL(nontargeting5)"}]}, {"GSM2211069": [{"title": "245A 6 Replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 1;\tlentivirus: HI-LNC12sh3"}]}, {"GSM2211070": [{"title": "245A 7 Replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 1;\tlentivirus: HI-LNC12sh4"}]}, {"GSM2211071": [{"title": "245A 8 Replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 1;\tlentivirus: HI-LNC15sh2"}]}, {"GSM2211072": [{"title": "245A 9 Replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 1;\tlentivirus: HI-LNC15sh3"}]}, {"GSM2211073": [{"title": "245A 10 Replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 1;\tlentivirus: CDSNkx2.2sh1"}]}, {"GSM2211074": [{"title": "245A 11 Replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 1;\tlentivirus: CDSNKX2.2sh2"}]}, {"GSM2211075": [{"title": "245A 12 Replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 1;\tlentivirus: HI-LNCMAFBsh1"}]}, {"GSM2211076": [{"title": "245A 14 Replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 1;\tlentivirus: CDSMAFBsh3"}]}, {"GSM2211077": [{"title": "245A 15 Replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 1;\tlentivirus: CDSMAFBsh4"}]}, {"GSM2211078": [{"title": "245A 16 Replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 1;\tlentivirus: CDSGliS3sh2"}]}, {"GSM2211079": [{"title": "245A 17 Replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 1;\tlentivirus: CDSGliS3sh4"}]}, {"GSM2211080": [{"title": "245A 19 Replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 1;\tlentivirus: HI-HI-LNC71_sh4"}]}, {"GSM2211081": [{"title": "245A 19REP Replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 3;\tlentivirus: HI-HI-LNC71_sh4"}]}, {"GSM2211082": [{"title": "245A 20 Replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 1;\tlentivirus: CDSPDX1sh2"}]}, {"GSM2211083": [{"title": "245A 21 Replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 1;\tlentivirus: CDSPDX1sh5"}]}, {"GSM2211084": [{"title": "245A 22 Replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 1;\tlentivirus: CDSPDX1sh6"}]}, {"GSM2211085": [{"title": "245A 28 Replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 1;\tlentivirus: HI-LNC30sh3"}]}, {"GSM2211086": [{"title": "245A 29 Replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 1;\tlentivirus: HI-LNC30sh2"}]}, {"GSM2211087": [{"title": "245A 30 Replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 1;\tlentivirus: HI-LNC80sh2"}]}, {"GSM2211088": [{"title": "245A 31 Replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 1;\tlentivirus: HI-LNC80sh3"}]}, {"GSM2211089": [{"title": "245A 32 Replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 1;\tlentivirus: HI-LNC75sh2"}]}, {"GSM2211090": [{"title": "245A 33 Replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 1;\tlentivirus: HI-LNC75sh4"}]}, {"GSM2211091": [{"title": "245A 34 Replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 1;\tlentivirus: HI-LNC78sh1"}]}, {"GSM2211092": [{"title": "245A 35 Replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 1;\tlentivirus: HI-LNC78sh2"}]}, {"GSM2211093": [{"title": "245A 36 Replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 1;\tlentivirus: HI-LNC79sh3"}]}, {"GSM2211094": [{"title": "245A 42 Replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 1;\tlentivirus: CDSHNF1Ash1"}]}, {"GSM2211095": [{"title": "245A 43 Replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 1;\tlentivirus: CDSHNF1Ash4"}]}, {"GSM2211096": [{"title": "245A 43REP Replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 3;\tlentivirus: CDSHNF1Ash4"}]}, {"GSM2211097": [{"title": "245A 48 Replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 1;\tlentivirus: HI-LNC76sh2"}]}, {"GSM2211098": [{"title": "245A 49 Replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 1;\tlentivirus: HI-LNC76sh4"}]}, {"GSM2211099": [{"title": "245A 51 Replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 1;\tlentivirus: HI-LNC85sh2"}]}, {"GSM2211100": [{"title": "245B 1 Replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 2;\tlentivirus: CONTROL(nontargeting1)"}]}, {"GSM2211101": [{"title": "245B 2 Replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 2;\tlentivirus: CONTROL(nontargeting2)"}]}, {"GSM2211102": [{"title": "245B 3 Replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 2;\tlentivirus: CONTROL(nontargeting3)"}]}, {"GSM2211103": [{"title": "245B 4 Replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 2;\tlentivirus: CONTROL(nontargeting4)"}]}, {"GSM2211104": [{"title": "245B 5 Replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 2;\tlentivirus: CONTROL(nontargeting5)"}]}, {"GSM2211105": [{"title": "245B 6 Replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 2;\tlentivirus: HI-LNC12sh3"}]}, {"GSM2211106": [{"title": "245B 7 Replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 2;\tlentivirus: HI-LNC12sh4"}]}, {"GSM2211107": [{"title": "245B 8 Replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 2;\tlentivirus: HI-LNC15sh2"}]}, {"GSM2211108": [{"title": "245B 9 Replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 2;\tlentivirus: HI-LNC15sh3"}]}, {"GSM2211109": [{"title": "245B 10 Replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 2;\tlentivirus: CDSNkx2.2sh1"}]}, {"GSM2211110": [{"title": "245B 11 Replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 2;\tlentivirus: CDSNKX2.2sh2"}]}, {"GSM2211111": [{"title": "245B 12 Replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 2;\tlentivirus: HI-LNCMAFBsh1"}]}, {"GSM2211112": [{"title": "245B 14 Replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 2;\tlentivirus: CDSMAFBsh3"}]}, {"GSM2211113": [{"title": "245B 15 Replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 2;\tlentivirus: CDSMAFBsh4"}]}, {"GSM2211114": [{"title": "245B 16 Replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 2;\tlentivirus: CDSGliS3sh2"}]}, {"GSM2211115": [{"title": "245B 17 Replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 2;\tlentivirus: CDSGliS3sh4"}]}, {"GSM2211116": [{"title": "245B 19 Replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 2;\tlentivirus: ASPDX1sh4"}]}, {"GSM2211117": [{"title": "245B 20 Replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 2;\tlentivirus: CDSPDX1sh2"}]}, {"GSM2211118": [{"title": "245B 21 Replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 2;\tlentivirus: CDSPDX1sh5"}]}, {"GSM2211119": [{"title": "245B 22 Replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 2;\tlentivirus: CDSPDX1sh6"}]}, {"GSM2211120": [{"title": "245B 28 Replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 2;\tlentivirus: HI-LNC30sh3"}]}, {"GSM2211121": [{"title": "245B 29 Replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 2;\tlentivirus: HI-LNC30sh2"}]}, {"GSM2211122": [{"title": "245B 30 Replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 2;\tlentivirus: HI-LNC80sh2"}]}, {"GSM2211123": [{"title": "245B 31 Replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 2;\tlentivirus: HI-LNC80sh3"}]}, {"GSM2211124": [{"title": "245B 32 Replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 2;\tlentivirus: HI-LNC75sh2"}]}, {"GSM2211125": [{"title": "245B 33 Replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 2;\tlentivirus: HI-LNC75sh4"}]}, {"GSM2211126": [{"title": "245B 34 Replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 2;\tlentivirus: HI-LNC78sh1"}]}, {"GSM2211127": [{"title": "245B 35 Replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 2;\tlentivirus: HI-LNC78sh2"}]}, {"GSM2211128": [{"title": "245B 36 Replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 2;\tlentivirus: HI-LNC79sh3"}]}, {"GSM2211129": [{"title": "245B 37 Replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 3;\tlentivirus: HI-LNC79sh3"}]}, {"GSM2211130": [{"title": "245B 42 Replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 2;\tlentivirus: CDSHNF1Ash1"}]}, {"GSM2211131": [{"title": "245B 48 Replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 2;\tlentivirus: HI-LNC76sh2"}]}, {"GSM2211132": [{"title": "245B 49 Replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 2;\tlentivirus: HI-LNC76sh4"}]}, {"GSM2211133": [{"title": "245B 50 Replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 2;\tlentivirus: HI-LNC85sh2"}]}, {"GSM2211134": [{"title": "245B 51 Replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "EndoC-betaH1 cell line (human beta cell line)"}, {"characteristics_ch1": "cell line: EndoC-betaH1;\treplicate: Replicate 3;\tlentivirus: HI-LNC85sh2"}]}, {"GSM2301012": [{"title": "A375_replicate1"}, {"type": "RNA"}, {"source_name_ch1": "Human melanoma cell line"}, {"characteristics_ch1": "cell line: A375;\tcell type: Human melanoma cell line (A375) was derived from the skin of a 54 year-old female patient with malignant melanoma"}]}, {"GSM2301013": [{"title": "Hema_replicate1"}, {"type": "RNA"}, {"source_name_ch1": "Human melanocyte cell line"}, {"characteristics_ch1": "cell line: HeMa;\tcell type: Primary Human Epidermal Melanocytes (HeMa) were isolated from the skin of an adult donor"}]}, {"GSM2301014": [{"title": "M6_replicate1"}, {"type": "RNA"}, {"source_name_ch1": "Human melanoma cell line"}, {"characteristics_ch1": "cell line: A375-M6;\tcell type: A375-M6 melanoma cells (M6) were isolated from lung metastasis of SCID bg/bg mice i.v. injected with A375 human melanoma cell line"}]}, {"GSM2301015": [{"title": "A375_replicate2"}, {"type": "RNA"}, {"source_name_ch1": "Human melanoma cell line"}, {"characteristics_ch1": "cell line: A375;\tcell type: Human melanoma cell line (A375) was derived from the skin of a 54 year-old female patient with malignant melanoma"}]}, {"GSM2301016": [{"title": "Hema_replicate2"}, {"type": "RNA"}, {"source_name_ch1": "Human melanocyte cell line"}, {"characteristics_ch1": "cell line: HeMa;\tcell type: Primary Human Epidermal Melanocytes (HeMa) were isolated from the skin of an adult donor"}]}, {"GSM2301017": [{"title": "M6_replicate2"}, {"type": "RNA"}, {"source_name_ch1": "Human melanoma cell line"}, {"characteristics_ch1": "cell line: A375-M6;\tcell type: A375-M6 melanoma cells (M6) were isolated from lung metastasis of SCID bg/bg mice i.v. injected with A375 human melanoma cell line"}]}, {"GSM2301018": [{"title": "A375_replicate3"}, {"type": "RNA"}, {"source_name_ch1": "Human melanoma cell line"}, {"characteristics_ch1": "cell line: A375;\tcell type: Human melanoma cell line (A375) was derived from the skin of a 54 year-old female patient with malignant melanoma"}]}, {"GSM2301019": [{"title": "Hema_replicate3"}, {"type": "RNA"}, {"source_name_ch1": "Human melanocyte cell line"}, {"characteristics_ch1": "cell line: HeMa;\tcell type: Primary Human Epidermal Melanocytes (HeMa) were isolated from the skin of an adult donor"}]}, {"GSM2301020": [{"title": "M6_replicate3"}, {"type": "RNA"}, {"source_name_ch1": "Human melanoma cell line"}, {"characteristics_ch1": "cell line: A375-M6;\tcell type: A375-M6 melanoma cells (M6) were isolated from lung metastasis of SCID bg/bg mice i.v. injected with A375 human melanoma cell line"}]}, {"GSM1932967": [{"title": "20_SQ11-101T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 3;\tpt: 1b;\tpn: 0;\tpm: 0;\t7th pstage: IA;\tgender: Male;\tage: 57;\tsmoking status: Ever;\tpack-year: 56;\trelapse: not relapsed;\tdays before relapse/censor: 3156;\tdeath: alive;\tdays before death/censor: 3156"}]}, {"GSM1932968": [{"title": "78_SQ11-105T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 6;\tpt: 2b;\tpn: 1;\tpm: NA;\t7th pstage: IIB;\tgender: Male;\tage: 69;\tsmoking status: Current;\tpack-year: 52;\trelapse: relapsed;\tdays before relapse/censor: 564;\tdeath: dead;\tdays before death/censor: 754"}]}, {"GSM1932969": [{"title": "79_SQ11-109T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 0.9;\tpt: 1a;\tpn: 1;\tpm: 0;\t7th pstage: IIA;\tgender: Male;\tage: 59;\tsmoking status: Current;\tpack-year: 38;\trelapse: not relapsed;\tdays before relapse/censor: 1402;\tdeath: alive;\tdays before death/censor: 1402"}]}, {"GSM1932970": [{"title": "54_SQ11-10T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 2.5;\tpt: 3;\tpn: 0;\tpm: 0;\t7th pstage: IIB;\tgender: Male;\tage: 60;\tsmoking status: Current;\tpack-year: 44;\trelapse: not relapsed;\tdays before relapse/censor: 1362;\tdeath: dead;\tdays before death/censor: 1489"}]}, {"GSM1932971": [{"title": "80_SQ11-110T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 4;\tpt: 2a;\tpn: 1;\tpm: 0;\t7th pstage: IIA;\tgender: Female;\tage: 66;\tsmoking status: Current;\tpack-year: 35;\trelapse: relapsed;\tdays before relapse/censor: 1991;\tdeath: dead;\tdays before death/censor: 2008"}]}, {"GSM1932972": [{"title": "21_SQ11-111T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 3.3;\tpt: 2a;\tpn: 0;\tpm: 0;\t7th pstage: IB;\tgender: Male;\tage: 60;\tsmoking status: Current;\tpack-year: 100;\trelapse: not relapsed;\tdays before relapse/censor: 3254;\tdeath: alive;\tdays before death/censor: 3254"}]}, {"GSM1932973": [{"title": "22_SQ11-113T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 3.5;\tpt: 2a;\tpn: 0;\tpm: 0;\t7th pstage: IB;\tgender: Male;\tage: 57;\tsmoking status: Ever;\tpack-year: 111;\trelapse: not relapsed;\tdays before relapse/censor: 2043;\tdeath: alive;\tdays before death/censor: 2043"}]}, {"GSM1932974": [{"title": "81_SQ11-114T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 3.5;\tpt: 3;\tpn: 0;\tpm: 0;\t7th pstage: IIB;\tgender: Male;\tage: 67;\tsmoking status: Ever;\tpack-year: 23;\trelapse: relapsed;\tdays before relapse/censor: 2419;\tdeath: dead;\tdays before death/censor: 2585"}]}, {"GSM1932975": [{"title": "23_SQ11-116T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 3.3;\tpt: 2a;\tpn: 0;\tpm: 0;\t7th pstage: IB;\tgender: Male;\tage: 65;\tsmoking status: Current;\tpack-year: 59;\trelapse: not relapsed;\tdays before relapse/censor: 2018;\tdeath: alive;\tdays before death/censor: 2018"}]}, {"GSM1932976": [{"title": "7_SQ11-11T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 2.5;\tpt: 1b;\tpn: 0;\tpm: 0;\t7th pstage: IA;\tgender: Male;\tage: 63;\tsmoking status: Ever;\tpack-year: 45;\trelapse: not relapsed;\tdays before relapse/censor: 4714;\tdeath: alive;\tdays before death/censor: 4714"}]}, {"GSM1932977": [{"title": "24_SQ11-120T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 2.8;\tpt: 2a;\tpn: 0;\tpm: 0;\t7th pstage: IB;\tgender: Male;\tage: 66;\tsmoking status: Ever;\tpack-year: 35;\trelapse: not relapsed;\tdays before relapse/censor: 4250;\tdeath: alive;\tdays before death/censor: 4250"}]}, {"GSM1932978": [{"title": "67_SQ11-121T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 11;\tpt: 3;\tpn: 0;\tpm: 0;\t7th pstage: IIB;\tgender: Male;\tage: 63;\tsmoking status: Current;\tpack-year: 43;\trelapse: relapsed;\tdays before relapse/censor: 315;\tdeath: dead;\tdays before death/censor: 981"}]}, {"GSM1932979": [{"title": "68_SQ11-123T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 6.5;\tpt: 2b;\tpn: 0;\tpm: 0;\t7th pstage: IIA;\tgender: Male;\tage: 67;\tsmoking status: Ever;\tpack-year: 32;\trelapse: not relapsed;\tdays before relapse/censor: 3102;\tdeath: alive;\tdays before death/censor: 3233"}]}, {"GSM1932980": [{"title": "69_SQ11-126T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 8;\tpt: 3;\tpn: 0;\tpm: 0;\t7th pstage: IIB;\tgender: Male;\tage: 69;\tsmoking status: Ever;\tpack-year: 45;\trelapse: not relapsed;\tdays before relapse/censor: 4110;\tdeath: alive;\tdays before death/censor: 4110"}]}, {"GSM1932981": [{"title": "82_SQ11-128T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 2.6;\tpt: 3;\tpn: 0;\tpm: 0;\t7th pstage: IIB;\tgender: Male;\tage: 54;\tsmoking status: Current;\tpack-year: 36;\trelapse: not relapsed;\tdays before relapse/censor: 3807;\tdeath: alive;\tdays before death/censor: 3807"}]}, {"GSM1932982": [{"title": "31_SQ13-9T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 3.2;\tpt: 2a;\tpn: 0;\tpm: 0;\t7th pstage: IB;\tgender: Female;\tage: 75;\tsmoking status: Ever;\tpack-year: 24;\trelapse: not relapsed;\tdays before relapse/censor: 2498;\tdeath: alive;\tdays before death/censor: 2498"}]}, {"GSM1932983": [{"title": "52_SQ13-10T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 2.8;\tpt: 2a;\tpn: 0;\tpm: 0;\t7th pstage: IB;\tgender: Male;\tage: 82;\tsmoking status: Ever;\tpack-year: 30;\trelapse: not relapsed;\tdays before relapse/censor: 914;\tdeath: dead;\tdays before death/censor: 914"}]}, {"GSM1932984": [{"title": "53_SQ13-11T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 4.5;\tpt: 2a;\tpn: 0;\tpm: 0;\t7th pstage: IB;\tgender: Male;\tage: 67;\tsmoking status: Current;\tpack-year: 49;\trelapse: not relapsed;\tdays before relapse/censor: 4169;\tdeath: alive;\tdays before death/censor: 4169"}]}, {"GSM1932985": [{"title": "83_SQ11-131T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 4.5;\tpt: 2a;\tpn: 1;\tpm: 0;\t7th pstage: IIA;\tgender: Female;\tage: 65;\tsmoking status: Ever;\tpack-year: 35;\trelapse: not relapsed;\tdays before relapse/censor: 3587;\tdeath: alive;\tdays before death/censor: 3587"}]}, {"GSM1932986": [{"title": "84_SQ11-132T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 7;\tpt: 3;\tpn: 0;\tpm: 0;\t7th pstage: IIB;\tgender: Male;\tage: 64;\tsmoking status: Current;\tpack-year: 42;\trelapse: not relapsed;\tdays before relapse/censor: 2876;\tdeath: alive;\tdays before death/censor: 3724"}]}, {"GSM1932987": [{"title": "85_SQ11-133T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 5;\tpt: 2a;\tpn: 1;\tpm: 0;\t7th pstage: IIA;\tgender: Male;\tage: 69;\tsmoking status: Ever;\tpack-year: 38;\trelapse: not relapsed;\tdays before relapse/censor: 3725;\tdeath: alive;\tdays before death/censor: 3725"}]}, {"GSM1932988": [{"title": "86_SQ11-134T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 4;\tpt: 2a;\tpn: 1;\tpm: 0;\t7th pstage: IIA;\tgender: Male;\tage: 58;\tsmoking status: Ever;\tpack-year: 36;\trelapse: not relapsed;\tdays before relapse/censor: 3621;\tdeath: alive;\tdays before death/censor: 3621"}]}, {"GSM1932989": [{"title": "87_SQ11-138T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 3.5;\tpt: 2a;\tpn: 1;\tpm: 0;\t7th pstage: IIA;\tgender: Male;\tage: 54;\tsmoking status: Current;\tpack-year: 34;\trelapse: not relapsed;\tdays before relapse/censor: 3940;\tdeath: alive;\tdays before death/censor: 3940"}]}, {"GSM1932990": [{"title": "25_SQ11-143T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 3.3;\tpt: 2a;\tpn: 0;\tpm: 0;\t7th pstage: IB;\tgender: Male;\tage: 67;\tsmoking status: Ever;\tpack-year: 48;\trelapse: relapsed;\tdays before relapse/censor: 2605;\tdeath: dead;\tdays before death/censor: 2687"}]}, {"GSM1932991": [{"title": "51_SQ11-144T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 2.2;\tpt: 1b;\tpn: 0;\tpm: 0;\t7th pstage: IA;\tgender: Male;\tage: 61;\tsmoking status: Ever;\tpack-year: 100;\trelapse: not relapsed;\tdays before relapse/censor: 3391;\tdeath: alive;\tdays before death/censor: 3391"}]}, {"GSM1932992": [{"title": "88_SQ11-146T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 7.4;\tpt: 3;\tpn: 0;\tpm: 0;\t7th pstage: IIB;\tgender: Female;\tage: 52;\tsmoking status: Current;\tpack-year: 36;\trelapse: not relapsed;\tdays before relapse/censor: 2463;\tdeath: alive;\tdays before death/censor: 3862"}]}, {"GSM1932993": [{"title": "26_SQ11-148T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 1.8;\tpt: 2a;\tpn: 0;\tpm: 0;\t7th pstage: IB;\tgender: Male;\tage: 62;\tsmoking status: Current;\tpack-year: 32;\trelapse: not relapsed;\tdays before relapse/censor: 1889;\tdeath: alive;\tdays before death/censor: 1889"}]}, {"GSM1932994": [{"title": "89_SQ11-149T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 6.1;\tpt: 2b;\tpn: 1;\tpm: 0;\t7th pstage: IIB;\tgender: Male;\tage: 60;\tsmoking status: Current;\tpack-year: 41;\trelapse: not relapsed;\tdays before relapse/censor: 3707;\tdeath: alive;\tdays before death/censor: 3707"}]}, {"GSM1932995": [{"title": "8_SQ11-14T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 5;\tpt: 2a;\tpn: 0;\tpm: 0;\t7th pstage: IB;\tgender: Male;\tage: 71;\tsmoking status: Current;\tpack-year: 84;\trelapse: not relapsed;\tdays before relapse/censor: 1665;\tdeath: dead;\tdays before death/censor: 1931"}]}, {"GSM1932996": [{"title": "90_SQ11-152T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 5.4;\tpt: 2b;\tpn: 0;\tpm: 0;\t7th pstage: IIA;\tgender: Male;\tage: 65;\tsmoking status: Ever;\tpack-year: 42;\trelapse: relapsed;\tdays before relapse/censor: 638;\tdeath: dead;\tdays before death/censor: 947"}]}, {"GSM1932997": [{"title": "28_SQ11-153T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 4.1;\tpt: 2a;\tpn: 0;\tpm: 0;\t7th pstage: IB;\tgender: Male;\tage: 62;\tsmoking status: Ever;\tpack-year: 62;\trelapse: relapsed;\tdays before relapse/censor: 587;\tdeath: dead;\tdays before death/censor: 1397"}]}, {"GSM1932998": [{"title": "91_SQ11-154T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 6.4;\tpt: 2b;\tpn: 1;\tpm: 0;\t7th pstage: IIB;\tgender: Male;\tage: 58;\tsmoking status: Current;\tpack-year: 40;\trelapse: not relapsed;\tdays before relapse/censor: 1889;\tdeath: dead;\tdays before death/censor: 1889"}]}, {"GSM1932999": [{"title": "29_SQ11-155T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 1.3;\tpt: 1a;\tpn: NA;\tpm: 0;\t7th pstage: IA;\tgender: Male;\tage: 67;\tsmoking status: Ever;\tpack-year: 66;\trelapse: not relapsed;\tdays before relapse/censor: 3191;\tdeath: alive;\tdays before death/censor: 3191"}]}, {"GSM1933000": [{"title": "30_SQ11-156T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 2.6;\tpt: 2a;\tpn: 0;\tpm: 0;\t7th pstage: IB;\tgender: Male;\tage: 59;\tsmoking status: Current;\tpack-year: 35;\trelapse: relapsed;\tdays before relapse/censor: 760;\tdeath: dead;\tdays before death/censor: 1245"}]}, {"GSM1933001": [{"title": "92_SQ11-158T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 4;\tpt: 2a;\tpn: 1;\tpm: 0;\t7th pstage: IIA;\tgender: Male;\tage: 67;\tsmoking status: Current;\tpack-year: 50;\trelapse: not relapsed;\tdays before relapse/censor: 1217;\tdeath: dead;\tdays before death/censor: 1551"}]}, {"GSM1933002": [{"title": "93_SQ11-159T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 6.7;\tpt: 2b;\tpn: 0;\tpm: 0;\t7th pstage: IIA;\tgender: Male;\tage: 69;\tsmoking status: Ever;\tpack-year: 42;\trelapse: relapsed;\tdays before relapse/censor: 1493;\tdeath: dead;\tdays before death/censor: 1717"}]}, {"GSM1933003": [{"title": "33_SQ11-161T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 3.6;\tpt: 2a;\tpn: 0;\tpm: 0;\t7th pstage: IB;\tgender: Male;\tage: 68;\tsmoking status: Ever;\tpack-year: 47;\trelapse: not relapsed;\tdays before relapse/censor: 1345;\tdeath: dead;\tdays before death/censor: 1531"}]}, {"GSM1933004": [{"title": "34_SQ11-165T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 2.2;\tpt: 2a;\tpn: 0;\tpm: 0;\t7th pstage: IB;\tgender: Male;\tage: 62;\tsmoking status: Ever;\tpack-year: 74;\trelapse: relapsed;\tdays before relapse/censor: 349;\tdeath: dead;\tdays before death/censor: 554"}]}, {"GSM1933005": [{"title": "32_SQ11-167T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 1.5;\tpt: 1a;\tpn: 0;\tpm: 0;\t7th pstage: IA;\tgender: Male;\tage: 52;\tsmoking status: Ever;\tpack-year: 30;\trelapse: not relapsed;\tdays before relapse/censor: 2829;\tdeath: alive;\tdays before death/censor: 2829"}]}, {"GSM1933006": [{"title": "94_SQ11-168T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 3.9;\tpt: 3;\tpn: 0;\tpm: 0;\t7th pstage: IIB;\tgender: Male;\tage: 64;\tsmoking status: Ever;\tpack-year: 40;\trelapse: not relapsed;\tdays before relapse/censor: 3042;\tdeath: alive;\tdays before death/censor: 3042"}]}, {"GSM1933007": [{"title": "95_SQ11-169T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 7;\tpt: 2b;\tpn: 1;\tpm: 0;\t7th pstage: IIB;\tgender: Male;\tage: 63;\tsmoking status: Current;\tpack-year: 44;\trelapse: relapsed;\tdays before relapse/censor: 174;\tdeath: dead;\tdays before death/censor: 399"}]}, {"GSM1933008": [{"title": "96_SQ11-172T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 3.8;\tpt: 2a;\tpn: 1;\tpm: 0;\t7th pstage: IIA;\tgender: Male;\tage: 64;\tsmoking status: Ever;\tpack-year: 25;\trelapse: not relapsed;\tdays before relapse/censor: 1961;\tdeath: alive;\tdays before death/censor: 1961"}]}, {"GSM1933009": [{"title": "27_SQ11-173T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 3.8;\tpt: 2a;\tpn: 0;\tpm: 0;\t7th pstage: IB;\tgender: Male;\tage: 67;\tsmoking status: Current;\tpack-year: 71;\trelapse: not relapsed;\tdays before relapse/censor: 951;\tdeath: dead;\tdays before death/censor: 1897"}]}, {"GSM1933010": [{"title": "97_SQ11-174T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 10;\tpt: 3;\tpn: 0;\tpm: 0;\t7th pstage: IIB;\tgender: Male;\tage: 53;\tsmoking status: Current;\tpack-year: 33;\trelapse: not relapsed;\tdays before relapse/censor: 2080;\tdeath: alive;\tdays before death/censor: 2080"}]}, {"GSM1933011": [{"title": "35_SQ11-179T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 2.7;\tpt: 2a;\tpn: 0;\tpm: 0;\t7th pstage: IB;\tgender: Male;\tage: 67;\tsmoking status: Current;\tpack-year: 74;\trelapse: relapsed;\tdays before relapse/censor: 463;\tdeath: dead;\tdays before death/censor: 1264"}]}, {"GSM1933012": [{"title": "98_SQ11-180T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 5;\tpt: 2a;\tpn: 1;\tpm: 0;\t7th pstage: IIA;\tgender: Male;\tage: 55;\tsmoking status: Current;\tpack-year: 35;\trelapse: not relapsed;\tdays before relapse/censor: 1896;\tdeath: alive;\tdays before death/censor: 1896"}]}, {"GSM1933013": [{"title": "99_SQ11-181T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 3.8;\tpt: 3;\tpn: 0;\tpm: 0;\t7th pstage: IIB;\tgender: Male;\tage: 64;\tsmoking status: Ever;\tpack-year: 39;\trelapse: not relapsed;\tdays before relapse/censor: 3083;\tdeath: alive;\tdays before death/censor: 3083"}]}, {"GSM1933014": [{"title": "100_SQ11-183T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 4.2;\tpt: 2a;\tpn: 1;\tpm: 0;\t7th pstage: IIA;\tgender: Male;\tage: 65;\tsmoking status: Ever;\tpack-year: 47;\trelapse: not relapsed;\tdays before relapse/censor: 3095;\tdeath: alive;\tdays before death/censor: 3095"}]}, {"GSM1933015": [{"title": "36_SQ11-190T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 1.6;\tpt: 2a;\tpn: 0;\tpm: 0;\t7th pstage: IB;\tgender: Male;\tage: 64;\tsmoking status: Ever;\tpack-year: 35;\trelapse: not relapsed;\tdays before relapse/censor: 1776;\tdeath: alive;\tdays before death/censor: 1776"}]}, {"GSM1933016": [{"title": "37_SQ11-193T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 3.5;\tpt: 2a;\tpn: 0;\tpm: 0;\t7th pstage: IB;\tgender: Male;\tage: 69;\tsmoking status: Ever;\tpack-year: 40;\trelapse: relapsed;\tdays before relapse/censor: 367;\tdeath: dead;\tdays before death/censor: 497"}]}, {"GSM1933017": [{"title": "101_SQ11-196T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 4.5;\tpt: 2a;\tpn: 1;\tpm: 0;\t7th pstage: IIA;\tgender: Male;\tage: 59;\tsmoking status: Current;\tpack-year: 39;\trelapse: not relapsed;\tdays before relapse/censor: 2605;\tdeath: alive;\tdays before death/censor: 2605"}]}, {"GSM1933018": [{"title": "38_SQ11-198T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 3.6;\tpt: 2a;\tpn: 0;\tpm: 0;\t7th pstage: IB;\tgender: Male;\tage: 69;\tsmoking status: Ever;\tpack-year: 28;\trelapse: not relapsed;\tdays before relapse/censor: 920;\tdeath: alive;\tdays before death/censor: 920"}]}, {"GSM1933019": [{"title": "1_SQ11-1T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 5;\tpt: 2a;\tpn: 0;\tpm: 0;\t7th pstage: IB;\tgender: Male;\tage: 66;\tsmoking status: Current;\tpack-year: 41;\trelapse: relapsed;\tdays before relapse/censor: 126;\tdeath: alive;\tdays before death/censor: 126"}]}, {"GSM1933020": [{"title": "39_SQ11-201T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 2.5;\tpt: 1b;\tpn: 0;\tpm: 0;\t7th pstage: IA;\tgender: Male;\tage: 62;\tsmoking status: Ever;\tpack-year: 41;\trelapse: not relapsed;\tdays before relapse/censor: 1454;\tdeath: dead;\tdays before death/censor: 2164"}]}, {"GSM1933021": [{"title": "40_SQ11-203T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 2;\tpt: 1a;\tpn: 0;\tpm: 0;\t7th pstage: IA;\tgender: Male;\tage: 66;\tsmoking status: Ever;\tpack-year: 60;\trelapse: not relapsed;\tdays before relapse/censor: 2605;\tdeath: alive;\tdays before death/censor: 2605"}]}, {"GSM1933022": [{"title": "41_SQ11-207T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 2;\tpt: 1a;\tpn: 0;\tpm: 0;\t7th pstage: IA;\tgender: Male;\tage: 68;\tsmoking status: Ever;\tpack-year: 44;\trelapse: not relapsed;\tdays before relapse/censor: 1419;\tdeath: alive;\tdays before death/censor: 1419"}]}, {"GSM1933023": [{"title": "42_SQ11-209T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 4.2;\tpt: 2a;\tpn: 0;\tpm: 0;\t7th pstage: IB;\tgender: Male;\tage: 67;\tsmoking status: Ever;\tpack-year: 80;\trelapse: not relapsed;\tdays before relapse/censor: 2131;\tdeath: alive;\tdays before death/censor: 2131"}]}, {"GSM1933024": [{"title": "43_SQ11-211T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 1.7;\tpt: 1a;\tpn: 0;\tpm: 0;\t7th pstage: IA;\tgender: Male;\tage: 59;\tsmoking status: Current;\tpack-year: 39;\trelapse: not relapsed;\tdays before relapse/censor: 2158;\tdeath: alive;\tdays before death/censor: 2158"}]}, {"GSM1933025": [{"title": "102_SQ11-214T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 6.5;\tpt: 2b;\tpn: 1;\tpm: 0;\t7th pstage: IIB;\tgender: Male;\tage: 63;\tsmoking status: Current;\tpack-year: 43;\trelapse: not relapsed;\tdays before relapse/censor: 1310;\tdeath: alive;\tdays before death/censor: 1310"}]}, {"GSM1933026": [{"title": "103_SQ11-215T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 3.2;\tpt: 2a;\tpn: 1;\tpm: 0;\t7th pstage: IIA;\tgender: Female;\tage: 67;\tsmoking status: Never;\tpack-year: 0;\trelapse: not relapsed;\tdays before relapse/censor: 2241;\tdeath: alive;\tdays before death/censor: 2241"}]}, {"GSM1933027": [{"title": "44_SQ11-216T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 2;\tpt: 1a;\tpn: 0;\tpm: 0;\t7th pstage: IA;\tgender: Female;\tage: 62;\tsmoking status: Current;\tpack-year: 27;\trelapse: not relapsed;\tdays before relapse/censor: 2280;\tdeath: alive;\tdays before death/censor: 2280"}]}, {"GSM1933028": [{"title": "55_SQ11-21T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 6.5;\tpt: 3;\tpn: 0;\tpm: 0;\t7th pstage: IIB;\tgender: Male;\tage: 72;\tsmoking status: Current;\tpack-year: 47;\trelapse: relapsed;\tdays before relapse/censor: 433;\tdeath: dead;\tdays before death/censor: 1156"}]}, {"GSM1933029": [{"title": "104_SQ11-220T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 5.6;\tpt: 2b;\tpn: 0;\tpm: 0;\t7th pstage: IIA;\tgender: Male;\tage: 68;\tsmoking status: Current;\tpack-year: 51;\trelapse: not relapsed;\tdays before relapse/censor: 2241;\tdeath: alive;\tdays before death/censor: 2241"}]}, {"GSM1933030": [{"title": "45_SQ11-221T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 4.7;\tpt: 2a;\tpn: 0;\tpm: 0;\t7th pstage: IB;\tgender: Male;\tage: 67;\tsmoking status: Current;\tpack-year: 47;\trelapse: not relapsed;\tdays before relapse/censor: 2378;\tdeath: alive;\tdays before death/censor: 2378"}]}, {"GSM1933031": [{"title": "105_SQ11-223T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 5.4;\tpt: 3;\tpn: 0;\tpm: 0;\t7th pstage: IIB;\tgender: Male;\tage: 52;\tsmoking status: Current;\tpack-year: 33;\trelapse: relapsed;\tdays before relapse/censor: 415;\tdeath: alive;\tdays before death/censor: 2422"}]}, {"GSM1933032": [{"title": "106_SQ11-228T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 6.3;\tpt: 2b;\tpn: 1;\tpm: 0;\t7th pstage: IIB;\tgender: Male;\tage: 67;\tsmoking status: Ever;\tpack-year: 45;\trelapse: not relapsed;\tdays before relapse/censor: 2190;\tdeath: alive;\tdays before death/censor: 2190"}]}, {"GSM1933033": [{"title": "46_SQ11-229T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 2.6;\tpt: 2a;\tpn: 0;\tpm: 0;\t7th pstage: IB;\tgender: Male;\tage: 56;\tsmoking status: Ever;\tpack-year: 72;\trelapse: not relapsed;\tdays before relapse/censor: 2033;\tdeath: alive;\tdays before death/censor: 2033"}]}, {"GSM1933034": [{"title": "47_SQ11-230T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 2.7;\tpt: 1b;\tpn: 0;\tpm: 0;\t7th pstage: IA;\tgender: Female;\tage: 56;\tsmoking status: Current;\tpack-year: 60;\trelapse: not relapsed;\tdays before relapse/censor: 1973;\tdeath: alive;\tdays before death/censor: 1973"}]}, {"GSM1933035": [{"title": "48_SQ11-232T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 2.8;\tpt: 1b;\tpn: 0;\tpm: 0;\t7th pstage: IA;\tgender: Male;\tage: 69;\tsmoking status: Ever;\tpack-year: 130;\trelapse: relapsed;\tdays before relapse/censor: 728;\tdeath: alive;\tdays before death/censor: 1309"}]}, {"GSM1933036": [{"title": "107_SQ11-235T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 4.5;\tpt: 2a;\tpn: 1;\tpm: 0;\t7th pstage: IIA;\tgender: Male;\tage: 61;\tsmoking status: Current;\tpack-year: 41;\trelapse: not relapsed;\tdays before relapse/censor: 1817;\tdeath: alive;\tdays before death/censor: 1817"}]}, {"GSM1933037": [{"title": "56_SQ11-23T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 5.5;\tpt: 2b;\tpn: 1;\tpm: 0;\t7th pstage: IIB;\tgender: Male;\tage: 66;\tsmoking status: Current;\tpack-year: 46;\trelapse: relapsed;\tdays before relapse/censor: 377;\tdeath: dead;\tdays before death/censor: 718"}]}, {"GSM1933038": [{"title": "57_SQ11-24T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 6;\tpt: 2b;\tpn: 1;\tpm: 0;\t7th pstage: IIB;\tgender: Male;\tage: 78;\tsmoking status: Current;\tpack-year: 60;\trelapse: relapsed;\tdays before relapse/censor: 828;\tdeath: dead;\tdays before death/censor: 912"}]}, {"GSM1933039": [{"title": "58_SQ11-27T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 4.5;\tpt: 2a;\tpn: 1;\tpm: 0;\t7th pstage: IIA;\tgender: Female;\tage: 72;\tsmoking status: Ever;\tpack-year: 20;\trelapse: not relapsed;\tdays before relapse/censor: 2536;\tdeath: alive;\tdays before death/censor: 5028"}]}, {"GSM1933040": [{"title": "59_SQ11-28T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 3.7;\tpt: 2a;\tpn: 1;\tpm: 0;\t7th pstage: IIA;\tgender: Male;\tage: 58;\tsmoking status: Ever;\tpack-year: 34;\trelapse: not relapsed;\tdays before relapse/censor: 1049;\tdeath: dead;\tdays before death/censor: 1049"}]}, {"GSM1933041": [{"title": "9_SQ11-29T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 2.5;\tpt: 1b;\tpn: 0;\tpm: 0;\t7th pstage: IA;\tgender: Male;\tage: 83;\tsmoking status: Ever;\tpack-year: 42;\trelapse: relapsed;\tdays before relapse/censor: 3007;\tdeath: alive;\tdays before death/censor: 3185"}]}, {"GSM1933042": [{"title": "2_SQ11-2T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 3;\tpt: 1b;\tpn: 0;\tpm: 0;\t7th pstage: IA;\tgender: Male;\tage: 66;\tsmoking status: Current;\tpack-year: 92;\trelapse: not relapsed;\tdays before relapse/censor: 4507;\tdeath: dead;\tdays before death/censor: 4615"}]}, {"GSM1933043": [{"title": "10_SQ11-30T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 3;\tpt: 1b;\tpn: 0;\tpm: 0;\t7th pstage: IA;\tgender: Male;\tage: 74;\tsmoking status: Current;\tpack-year: 43;\trelapse: not relapsed;\tdays before relapse/censor: 2716;\tdeath: alive;\tdays before death/censor: 3195"}]}, {"GSM1933044": [{"title": "60_SQ11-37T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 6;\tpt: 3;\tpn: 0;\tpm: 0;\t7th pstage: IIB;\tgender: Male;\tage: 78;\tsmoking status: Ever;\tpack-year: 20;\trelapse: relapsed;\tdays before relapse/censor: 163;\tdeath: dead;\tdays before death/censor: 248"}]}, {"GSM1933045": [{"title": "3_SQ11-3T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 5;\tpt: 2a;\tpn: 0;\tpm: 0;\t7th pstage: IB;\tgender: Female;\tage: 73;\tsmoking status: Never;\tpack-year: 0;\trelapse: not relapsed;\tdays before relapse/censor: 3588;\tdeath: alive;\tdays before death/censor: 3588"}]}, {"GSM1933046": [{"title": "61_SQ11-40T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 5;\tpt: 3;\tpn: 0;\tpm: 0;\t7th pstage: IIB;\tgender: Male;\tage: 70;\tsmoking status: Ever;\tpack-year: 47;\trelapse: relapsed;\tdays before relapse/censor: 1994;\tdeath: dead;\tdays before death/censor: 3031"}]}, {"GSM1933047": [{"title": "62_SQ11-42T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 3.5;\tpt: 2a;\tpn: 1;\tpm: 0;\t7th pstage: IIA;\tgender: Male;\tage: 56;\tsmoking status: Current;\tpack-year: 36;\trelapse: relapsed;\tdays before relapse/censor: 475;\tdeath: dead;\tdays before death/censor: 965"}]}, {"GSM1933048": [{"title": "66_SQ11-46T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 5;\tpt: 2a;\tpn: 0;\tpm: 0;\t7th pstage: IB;\tgender: Male;\tage: 64;\tsmoking status: Current;\tpack-year: 161;\trelapse: not relapsed;\tdays before relapse/censor: 2192;\tdeath: dead;\tdays before death/censor: 2903"}]}, {"GSM1933049": [{"title": "63_SQ11-48T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 3;\tpt: 1b;\tpn: 1;\tpm: 0;\t7th pstage: IIA;\tgender: Male;\tage: 59;\tsmoking status: Current;\tpack-year: 39;\trelapse: not relapsed;\tdays before relapse/censor: 1983;\tdeath: alive;\tdays before death/censor: 1983"}]}, {"GSM1933050": [{"title": "4_SQ11-4T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 3.2;\tpt: 2a;\tpn: 0;\tpm: 0;\t7th pstage: IB;\tgender: Male;\tage: 70;\tsmoking status: Ever;\tpack-year: 38;\trelapse: not relapsed;\tdays before relapse/censor: 782;\tdeath: alive;\tdays before death/censor: 782"}]}, {"GSM1933051": [{"title": "64_SQ11-54T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 7;\tpt: 3;\tpn: 0;\tpm: 0;\t7th pstage: IIB;\tgender: Male;\tage: 69;\tsmoking status: Never;\tpack-year: 0;\trelapse: not relapsed;\tdays before relapse/censor: 2919;\tdeath: alive;\tdays before death/censor: 2919"}]}, {"GSM1933052": [{"title": "11_SQ11-56T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 4;\tpt: 2a;\tpn: 0;\tpm: 0;\t7th pstage: IB;\tgender: Male;\tage: 60;\tsmoking status: Current;\tpack-year: 53;\trelapse: not relapsed;\tdays before relapse/censor: 2922;\tdeath: dead;\tdays before death/censor: 3087"}]}, {"GSM1933053": [{"title": "65_SQ11-57T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 3.5;\tpt: 2a;\tpn: 1;\tpm: 0;\t7th pstage: IIA;\tgender: Female;\tage: 72;\tsmoking status: Ever;\tpack-year: 52;\trelapse: not relapsed;\tdays before relapse/censor: 1778;\tdeath: dead;\tdays before death/censor: 3848"}]}, {"GSM1933054": [{"title": "49_SQ13-5T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 4.5;\tpt: 2a;\tpn: 0;\tpm: 0;\t7th pstage: IB;\tgender: Male;\tage: 62;\tsmoking status: Current;\tpack-year: 28;\trelapse: not relapsed;\tdays before relapse/censor: 792;\tdeath: dead;\tdays before death/censor: 1706"}]}, {"GSM1933055": [{"title": "12_SQ11-62T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 1.8;\tpt: 1a;\tpn: 0;\tpm: 0;\t7th pstage: IA;\tgender: Male;\tage: 66;\tsmoking status: Ever;\tpack-year: 60;\trelapse: not relapsed;\tdays before relapse/censor: 3148;\tdeath: alive;\tdays before death/censor: 3148"}]}, {"GSM1933056": [{"title": "70_SQ11-63T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 7;\tpt: 2b;\tpn: 1;\tpm: 0;\t7th pstage: IIB;\tgender: Male;\tage: 64;\tsmoking status: Current;\tpack-year: 44;\trelapse: not relapsed;\tdays before relapse/censor: 2010;\tdeath: alive;\tdays before death/censor: 2010"}]}, {"GSM1933057": [{"title": "13_SQ11-66T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 1.8;\tpt: 1a;\tpn: 0;\tpm: 0;\t7th pstage: IA;\tgender: Female;\tage: 72;\tsmoking status: Current;\tpack-year: 21;\trelapse: not relapsed;\tdays before relapse/censor: 2293;\tdeath: alive;\tdays before death/censor: 2293"}]}, {"GSM1933058": [{"title": "71_SQ11-67T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 3.2;\tpt: 2a;\tpn: 1;\tpm: 0;\t7th pstage: IIA;\tgender: Male;\tage: 61;\tsmoking status: Current;\tpack-year: 45;\trelapse: relapsed;\tdays before relapse/censor: 687;\tdeath: dead;\tdays before death/censor: 832"}]}, {"GSM1933059": [{"title": "14_SQ11-69T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 3.1;\tpt: 2a;\tpn: 0;\tpm: 0;\t7th pstage: IB;\tgender: Male;\tage: 77;\tsmoking status: Current;\tpack-year: 52;\trelapse: not relapsed;\tdays before relapse/censor: 2969;\tdeath: alive;\tdays before death/censor: 2969"}]}, {"GSM1933060": [{"title": "72_SQ11-71T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 6.5;\tpt: 3;\tpn: 0;\tpm: 0;\t7th pstage: IIB;\tgender: Male;\tage: 49;\tsmoking status: Current;\tpack-year: 29;\trelapse: not relapsed;\tdays before relapse/censor: 822;\tdeath: dead;\tdays before death/censor: 1428"}]}, {"GSM1933061": [{"title": "15_SQ11-72T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 2.8;\tpt: 1b;\tpn: NA;\tpm: 0;\t7th pstage: IA;\tgender: Male;\tage: 73;\tsmoking status: Current;\tpack-year: 89;\trelapse: not relapsed;\tdays before relapse/censor: 1715;\tdeath: dead;\tdays before death/censor: 1787"}]}, {"GSM1933062": [{"title": "73_SQ11-77T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 3.5;\tpt: 2a;\tpn: 1;\tpm: 0;\t7th pstage: IIA;\tgender: Male;\tage: 56;\tsmoking status: Current;\tpack-year: 33;\trelapse: not relapsed;\tdays before relapse/censor: 4649;\tdeath: alive;\tdays before death/censor: 4649"}]}, {"GSM1933063": [{"title": "5_SQ11-7T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 5;\tpt: 2a;\tpn: 0;\tpm: 0;\t7th pstage: IB;\tgender: Male;\tage: 60;\tsmoking status: Ever;\tpack-year: 36;\trelapse: not relapsed;\tdays before relapse/censor: 2671;\tdeath: alive;\tdays before death/censor: 2671"}]}, {"GSM1933064": [{"title": "74_SQ11-80T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 4.8;\tpt: 2a;\tpn: 1;\tpm: 0;\t7th pstage: IIA;\tgender: Male;\tage: 61;\tsmoking status: Ever;\tpack-year: 21;\trelapse: relapsed;\tdays before relapse/censor: 265;\tdeath: dead;\tdays before death/censor: 491"}]}, {"GSM1933065": [{"title": "75_SQ11-81T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 2.3;\tpt: 1b;\tpn: 1;\tpm: 0;\t7th pstage: IIA;\tgender: Male;\tage: 66;\tsmoking status: Ever;\tpack-year: 39;\trelapse: not relapsed;\tdays before relapse/censor: 4127;\tdeath: alive;\tdays before death/censor: 4127"}]}, {"GSM1933066": [{"title": "16_SQ11-83T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 2;\tpt: 1a;\tpn: 0;\tpm: 0;\t7th pstage: IA;\tgender: Male;\tage: 50;\tsmoking status: Current;\tpack-year: 64;\trelapse: not relapsed;\tdays before relapse/censor: 2368;\tdeath: alive;\tdays before death/censor: 2368"}]}, {"GSM1933067": [{"title": "50_SQ13-8T_2"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 2.8;\tpt: 1b;\tpn: 0;\tpm: 0;\t7th pstage: IA;\tgender: Male;\tage: 75;\tsmoking status: Ever;\tpack-year: 52;\trelapse: relapsed;\tdays before relapse/censor: 1758;\tdeath: dead;\tdays before death/censor: 1842"}]}, {"GSM1933068": [{"title": "76_SQ11-90T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 5;\tpt: 2a;\tpn: 1;\tpm: 0;\t7th pstage: IIA;\tgender: Male;\tage: 52;\tsmoking status: Ever;\tpack-year: 29;\trelapse: relapsed;\tdays before relapse/censor: 123;\tdeath: dead;\tdays before death/censor: 357"}]}, {"GSM1933069": [{"title": "17_SQ11-91T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 1.9;\tpt: 1a;\tpn: 0;\tpm: 0;\t7th pstage: IA;\tgender: Male;\tage: 65;\tsmoking status: Ever;\tpack-year: 27;\trelapse: not relapsed;\tdays before relapse/censor: 4640;\tdeath: alive;\tdays before death/censor: 4640"}]}, {"GSM1933070": [{"title": "18_SQ11-92T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 2;\tpt: 1a;\tpn: 0;\tpm: 0;\t7th pstage: IA;\tgender: Male;\tage: 67;\tsmoking status: Current;\tpack-year: 47;\trelapse: not relapsed;\tdays before relapse/censor: 1836;\tdeath: dead;\tdays before death/censor: 4075"}]}, {"GSM1933071": [{"title": "19_SQ11-98T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 3.9;\tpt: 2a;\tpn: 0;\tpm: 0;\t7th pstage: IB;\tgender: Male;\tage: 70;\tsmoking status: Current;\tpack-year: 77;\trelapse: not relapsed;\tdays before relapse/censor: 2543;\tdeath: dead;\tdays before death/censor: 3038"}]}, {"GSM1933072": [{"title": "77_SQ11-99T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 2.2;\tpt: 2a;\tpn: 1;\tpm: 0;\t7th pstage: IIA;\tgender: Male;\tage: 63;\tsmoking status: Current;\tpack-year: 43;\trelapse: relapsed;\tdays before relapse/censor: 232;\tdeath: dead;\tdays before death/censor: 274"}]}, {"GSM1933073": [{"title": "6_SQ11-9T"}, {"type": "RNA"}, {"source_name_ch1": "lung SCC"}, {"characteristics_ch1": "tissue: lung squamous cell carcinoma;\ttumor size(cm): 3;\tpt: 1b;\tpn: 0;\tpm: 0;\t7th pstage: IA;\tgender: Male;\tage: 80;\tsmoking status: Ever;\tpack-year: 50;\trelapse: not relapsed;\tdays before relapse/censor: 2821;\tdeath: alive;\tdays before death/censor: 2821"}]}, {"GSM1897470": [{"title": "SD0017-Tumour-copy number 1"}, {"type": "RNA"}, {"source_name_ch1": "Primary breast cancer"}, {"characteristics_ch1": "gender: female;\tage (year): 54;\tStage: 2a;\tt: 2;\tn: 0;\tm: 0;\tgrade: 2;\tsize (cm): 2.5;\tsite: right;\thistology: intraductal carcinoma;\tgermline apobec3b copy number: 1"}]}, {"GSM1897471": [{"title": "SD0020-Tumour-copy number 2"}, {"type": "RNA"}, {"source_name_ch1": "Primary breast cancer"}, {"characteristics_ch1": "gender: female;\tage (year): 50;\tStage: 2a;\tt: 2;\tn: 0;\tm: 0;\tgrade: 2;\tsize (cm): 2.5;\tsite: left;\thistology: mucinous;\tgermline apobec3b copy number: 2"}]}, {"GSM1897472": [{"title": "SD0028-Tumour-copy number 0"}, {"type": "RNA"}, {"source_name_ch1": "Primary breast cancer"}, {"characteristics_ch1": "gender: female;\tage (year): 64;\tStage: 3b;\tt: 1;\tn: 2;\tm: 0;\tgrade: 3;\tsize (cm): 2;\tsite: left;\thistology: intraductal carcinoma;\tgermline apobec3b copy number: 0"}]}, {"GSM1897473": [{"title": "SD0029-Tumour-copy number 1"}, {"type": "RNA"}, {"source_name_ch1": "Primary breast cancer"}, {"characteristics_ch1": "gender: female;\tage (year): 69;\tStage: 3c;\tt: 2;\tn: 3;\tm: 0;\tgrade: 3;\tsize (cm): 4.3;\tsite: left;\thistology: intraductal carcinoma;\tgermline apobec3b copy number: 1"}]}, {"GSM1897474": [{"title": "SD0037-Tumour-copy number 0"}, {"type": "RNA"}, {"source_name_ch1": "Primary breast cancer"}, {"characteristics_ch1": "gender: female;\tage (year): 64;\tStage: 4;\tt: 3;\tn: 3;\tm: 1;\tgrade: 2;\tsize (cm): 3.5;\tsite: left;\thistology: intraductal carcinoma;\tgermline apobec3b copy number: 0"}]}, {"GSM1897475": [{"title": "SD0044-Tumour-copy number 0"}, {"type": "RNA"}, {"source_name_ch1": "Primary breast cancer"}, {"characteristics_ch1": "gender: female;\tage (year): 68;\tStage: 3c;\tt: 4;\tn: 3;\tm: 0;\tgrade: 2;\tsize (cm): 4;\tsite: right;\thistology: intraductal carcinoma;\tgermline apobec3b copy number: 0"}]}, {"GSM1897476": [{"title": "SD0045-Tumour-copy number 2"}, {"type": "RNA"}, {"source_name_ch1": "Primary breast cancer"}, {"characteristics_ch1": "gender: female;\tage (year): 42;\tStage: 2a;\tt: 1;\tn: 1;\tm: 0;\tgrade: 1;\tsize (cm): 1;\tsite: left;\thistology: intraductal carcinoma;\tgermline apobec3b copy number: 2"}]}, {"GSM1897477": [{"title": "SD0048-Tumour-copy number 0"}, {"type": "RNA"}, {"source_name_ch1": "Primary breast cancer"}, {"characteristics_ch1": "gender: female;\tage (year): 66;\tStage: 3c;\tt: 2;\tn: 3;\tm: 0;\tgrade: 2;\tsize (cm): 4;\tsite: right;\thistology: intraductal carcinoma;\tgermline apobec3b copy number: 0"}]}, {"GSM1897478": [{"title": "SD0066-Tumour-copy number 1"}, {"type": "RNA"}, {"source_name_ch1": "Primary breast cancer"}, {"characteristics_ch1": "gender: female;\tage (year): 41;\tStage: 1;\tt: 1;\tn: 0;\tm: 0;\tgrade: 3;\tsize (cm): 1.2;\tsite: left;\thistology: intraductal carcinoma;\tgermline apobec3b copy number: 1"}]}, {"GSM1897479": [{"title": "SD0072-Tumour-copy number 0"}, {"type": "RNA"}, {"source_name_ch1": "Primary breast cancer"}, {"characteristics_ch1": "gender: female;\tage (year): 55;\tStage: 3c;\tt: 4;\tn: 2;\tm: 0;\tgrade: 2;\tsize (cm): 2;\tsite: right;\thistology: intraductal carcinoma;\tgermline apobec3b copy number: 0"}]}, {"GSM1897480": [{"title": "SD0081-Tumour-copy number 2"}, {"type": "RNA"}, {"source_name_ch1": "Primary breast cancer"}, {"characteristics_ch1": "gender: female;\tage (year): 56;\tStage: 2a;\tt: 2;\tn: 0;\tm: 0;\tgrade: 2;\tsize (cm): 2.6;\tsite: left;\thistology: intraductal carcinoma;\tgermline apobec3b copy number: 2"}]}, {"GSM1897481": [{"title": "SD0096-Tumour-copy number 0"}, {"type": "RNA"}, {"source_name_ch1": "Primary breast cancer"}, {"characteristics_ch1": "gender: female;\tage (year): 63;\tStage: 2a;\tt: 1;\tn: 1;\tm: 0;\tgrade: 2;\tsize (cm): 1.5;\tsite: right;\thistology: intraductal carcinoma;\tgermline apobec3b copy number: 0"}]}, {"GSM1897482": [{"title": "SD0124-Tumour-copy number 2"}, {"type": "RNA"}, {"source_name_ch1": "Primary breast cancer"}, {"characteristics_ch1": "gender: female;\tage (year): 62;\tStage: 3c;\tt: 2;\tn: 3;\tm: 0;\tgrade: 3;\tsize (cm): 7.6;\tsite: left;\thistology: intraductal carcinoma;\tgermline apobec3b copy number: 2"}]}, {"GSM1897483": [{"title": "SD0129-Tumour-copy number 1"}, {"type": "RNA"}, {"source_name_ch1": "Primary breast cancer"}, {"characteristics_ch1": "gender: female;\tage (year): 45;\tStage: 2a;\tt: 2;\tn: 0;\tm: 0;\tgrade: 3;\tsize (cm): 2.8;\tsite: left;\thistology: intraductal carcinoma;\tgermline apobec3b copy number: 1"}]}, {"GSM1897484": [{"title": "SD0131-Tumour-copy number 0"}, {"type": "RNA"}, {"source_name_ch1": "Primary breast cancer"}, {"characteristics_ch1": "gender: female;\tage (year): 47;\tStage: 2b;\tt: 2;\tn: 1;\tm: 0;\tgrade: 2;\tsize (cm): 2.3;\tsite: right;\thistology: intraductal carcinoma;\tgermline apobec3b copy number: 0"}]}, {"GSM1897485": [{"title": "SD0133-Tumour-copy number 2"}, {"type": "RNA"}, {"source_name_ch1": "Primary breast cancer"}, {"characteristics_ch1": "gender: female;\tage (year): 45;\tStage: 3a;\tt: 2;\tn: 2;\tm: 0;\tgrade: 2;\tsize (cm): 2.5;\tsite: left;\thistology: intralobular carcinoma;\tgermline apobec3b copy number: 2"}]}, {"GSM1897486": [{"title": "SD0158-Tumour-copy number 2"}, {"type": "RNA"}, {"source_name_ch1": "Primary breast cancer"}, {"characteristics_ch1": "gender: female;\tage (year): 65;\tStage: 2a;\tt: 2;\tn: 0;\tm: 0;\tgrade: 2;\tsize (cm): 2.2;\tsite: right;\thistology: intraductal carcinoma;\tgermline apobec3b copy number: 2"}]}, {"GSM1897487": [{"title": "SD0214-Tumour-copy number 0"}, {"type": "RNA"}, {"source_name_ch1": "Primary breast cancer"}, {"characteristics_ch1": "gender: female;\tage (year): 44;\tStage: 2a;\tt: 1;\tn: 1;\tm: 0;\tgrade: 2;\tsize (cm): 1.2;\tsite: right;\thistology: intraductal carcinoma;\tgermline apobec3b copy number: 0"}]}, {"GSM1897488": [{"title": "SD0268-Tumour-copy number 0"}, {"type": "RNA"}, {"source_name_ch1": "Primary breast cancer"}, {"characteristics_ch1": "gender: female;\tage (year): 51;\tStage: 2b;\tt: 2;\tn: 1;\tm: 0;\tgrade: 2;\tsize (cm): 2.5;\tsite: left;\thistology: intralobular carcinoma;\tgermline apobec3b copy number: 0"}]}, {"GSM1897489": [{"title": "SD0350-Tumour-copy number 1"}, {"type": "RNA"}, {"source_name_ch1": "Primary breast cancer"}, {"characteristics_ch1": "gender: female;\tage (year): 64;\tStage: 2a;\tt: 2;\tn: 0;\tm: 0;\tgrade: 2;\tsize (cm): 3.4;\tsite: right;\thistology: intraductal carcinoma;\tgermline apobec3b copy number: 1"}]}, {"GSM1897490": [{"title": "SD0356-Tumour-copy number 1"}, {"type": "RNA"}, {"source_name_ch1": "Primary breast cancer"}, {"characteristics_ch1": "gender: female;\tage (year): 45;\tStage: 2a;\tt: 2;\tn: 0;\tm: 0;\tgrade: 2;\tsize (cm): 4;\tsite: right;\thistology: intraductal carcinoma;\tgermline apobec3b copy number: 1"}]}, {"GSM1897491": [{"title": "SD0375-Tumour-copy number 0"}, {"type": "RNA"}, {"source_name_ch1": "Primary breast cancer"}, {"characteristics_ch1": "gender: female;\tage (year): 47;\tStage: 2a;\tt: 2;\tn: 0;\tm: 0;\tgrade: 3;\tsize (cm): 3.5;\tsite: right;\thistology: intraductal carcinoma;\tgermline apobec3b copy number: 0"}]}, {"GSM1897492": [{"title": "SD0386-Tumour-copy number 1"}, {"type": "RNA"}, {"source_name_ch1": "Primary breast cancer"}, {"characteristics_ch1": "gender: female;\tage (year): 65;\tStage: 3b;\tt: 2;\tn: 2;\tm: 0;\tgrade: 2;\tsize (cm): 5;\tsite: left;\thistology: intraductal carcinoma;\tgermline apobec3b copy number: 1"}]}, {"GSM1897493": [{"title": "SD0389-Tumour-copy number 1"}, {"type": "RNA"}, {"source_name_ch1": "Primary breast cancer"}, {"characteristics_ch1": "gender: female;\tage (year): 46;\tStage: 2b;\tt: 2;\tn: 1;\tm: 0;\tgrade: 2;\tsize (cm): 5;\tsite: left;\thistology: intraductal carcinoma;\tgermline apobec3b copy number: 1"}]}, {"GSM1897494": [{"title": "SD0433-Tumour-copy number 2"}, {"type": "RNA"}, {"source_name_ch1": "Primary breast cancer"}, {"characteristics_ch1": "gender: female;\tage (year): 41;\tStage: 1;\tt: 1;\tn: 0;\tm: 0;\tgrade: 2;\tsize (cm): 0.6;\tsite: right;\thistology: intraductal carcinoma;\tgermline apobec3b copy number: 2"}]}, {"GSM1897495": [{"title": "SD0459-Tumour-copy number 2"}, {"type": "RNA"}, {"source_name_ch1": "Primary breast cancer"}, {"characteristics_ch1": "gender: female;\tage (year): 56;\tStage: 2a;\tt: 1;\tn: 1;\tm: 0;\tgrade: 2;\tsize (cm): 2;\tsite: left;\thistology: intraductal carcinoma;\tgermline apobec3b copy number: 2"}]}, {"GSM1897496": [{"title": "SD0464-Tumour-copy number 0"}, {"type": "RNA"}, {"source_name_ch1": "Primary breast cancer"}, {"characteristics_ch1": "gender: female;\tage (year): 56;\tStage: 2a;\tt: 1;\tn: 1;\tm: 0;\tgrade: 2;\tsize (cm): 2;\tsite: left;\thistology: intraductal carcinoma;\tgermline apobec3b copy number: 0"}]}, {"GSM1897497": [{"title": "SD0482-Tumour-copy number 2"}, {"type": "RNA"}, {"source_name_ch1": "Primary breast cancer"}, {"characteristics_ch1": "gender: female;\tage (year): 62;\tStage: 3a;\tt: 2;\tn: 2;\tm: 0;\tgrade: 3;\tsize (cm): 4.5;\tsite: left;\thistology: intraductal carcinoma;\tgermline apobec3b copy number: 2"}]}, {"GSM1897498": [{"title": "SD0020-Normal-copy number 2"}, {"type": "RNA"}, {"source_name_ch1": "Normal breast tissue"}, {"characteristics_ch1": "gender: female;\tage (year): 50;\tsite: left;\tgermline apobec3b copy number: 2"}]}, {"GSM1897499": [{"title": "SD0072-Normal-copy number 0"}, {"type": "RNA"}, {"source_name_ch1": "Normal breast tissue"}, {"characteristics_ch1": "gender: female;\tage (year): 55;\tsite: right;\tgermline apobec3b copy number: 0"}]}, {"GSM1897500": [{"title": "SD0357-Normal-copy number 1"}, {"type": "RNA"}, {"source_name_ch1": "Normal breast tissue"}, {"characteristics_ch1": "gender: female;\tage (year): 49;\tsite: left;\tgermline apobec3b copy number: 1"}]}, {"GSM2331237": [{"title": "DLD1_si(-) (GAC-MO-D1)"}, {"type": "RNA"}, {"source_name_ch1": "DLD1_si(-)"}, {"characteristics_ch1": "cell line: DLD1 cell line;\ttreatment: control"}]}, {"GSM2331238": [{"title": "DLD1_siH19-1 (GAC-MO-D2)"}, {"type": "RNA"}, {"source_name_ch1": "DLD1_siH19-1"}, {"characteristics_ch1": "cell line: DLD1 cell line;\ttreatment: siH19-1"}]}, {"GSM2331239": [{"title": "DLD1_siH19-2 (GAC-MO-D3)"}, {"type": "RNA"}, {"source_name_ch1": "DLD1_siH19-2"}, {"characteristics_ch1": "cell line: DLD1 cell line;\ttreatment: siH19-2"}]}, {"GSM2331240": [{"title": "HCT116_si(-), biological rep1 (GAC-MO-1)"}, {"type": "RNA"}, {"source_name_ch1": "HCT116_si(-)"}, {"characteristics_ch1": "cell line: HCT116 cell line;\ttreatment: control"}]}, {"GSM2331241": [{"title": "HCT116_siCDK8, biological rep1 (GAC-MO-2)"}, {"type": "RNA"}, {"source_name_ch1": "HCT116_siCDK8"}, {"characteristics_ch1": "cell line: HCT116 cell line;\ttreatment: siCDK8"}]}, {"GSM2331242": [{"title": "HCT116_si(-), biological rep2 (GAC-MO-3)"}, {"type": "RNA"}, {"source_name_ch1": "HCT116_si(-)"}, {"characteristics_ch1": "cell line: HCT116 cell line;\ttreatment: control"}]}, {"GSM2331243": [{"title": "HCT116_siCDK8, biological rep2 (GAC-MO-4)"}, {"type": "RNA"}, {"source_name_ch1": "HCT116_siCDK8"}, {"characteristics_ch1": "cell line: HCT116 cell line;\ttreatment: siCDK8"}]}, {"GSM2331244": [{"title": "HCT116_si(-), biological rep1 (A_GAC-MO-A)"}, {"type": "RNA"}, {"source_name_ch1": "HCT116_si(-)"}, {"characteristics_ch1": "cell line: HCT116 cell line;\ttreatment: control"}]}, {"GSM2331245": [{"title": "HCT116_siCTNNB1, biological rep1 (B_GAC-MO-B)"}, {"type": "RNA"}, {"source_name_ch1": "HCT116_siCTNNB1"}, {"characteristics_ch1": "cell line: HCT116 cell line;\ttreatment: siCTNNB1"}]}, {"GSM2331246": [{"title": "HCT116_si(-), biological rep2 (E_GAC-MO-E)"}, {"type": "RNA"}, {"source_name_ch1": "HCT116_si(-)"}, {"characteristics_ch1": "cell line: HCT116 cell line;\ttreatment: control"}]}, {"GSM2331247": [{"title": "HCT116_siCTNNB1, biological rep2 (F_GAC-MO-F)"}, {"type": "RNA"}, {"source_name_ch1": "HCT116_siCTNNB1"}, {"characteristics_ch1": "cell line: HCT116 cell line;\ttreatment: siCTNNB1"}]}, {"GSM2331248": [{"title": "HCT116_si(-), biological rep1 (01_GAC-MO-1)"}, {"type": "RNA"}, {"source_name_ch1": "HCT116_si(-)"}, {"characteristics_ch1": "cell line: HCT116 cell line;\ttreatment: control"}]}, {"GSM2331249": [{"title": "HCT116_siH19-1, biological rep1 (02_GAC-MO-2)"}, {"type": "RNA"}, {"source_name_ch1": "HCT116_siH19-1"}, {"characteristics_ch1": "cell line: HCT116 cell line;\ttreatment: siH19-1"}]}, {"GSM2331250": [{"title": "HCT116_siH19-2, biological rep1 (03_GAC-MO-3)"}, {"type": "RNA"}, {"source_name_ch1": "HCT116_siH19-2"}, {"characteristics_ch1": "cell line: HCT116 cell line;\ttreatment: siH19-2"}]}, {"GSM2331251": [{"title": "HCT116_si(-), biological rep2 (04_GAC-MO-4)"}, {"type": "RNA"}, {"source_name_ch1": "HCT116_si(-)"}, {"characteristics_ch1": "cell line: HCT116 cell line;\ttreatment: control"}]}, {"GSM2331252": [{"title": "HCT116_siH19-1, biological rep2 (05_GAC-MO-5)"}, {"type": "RNA"}, {"source_name_ch1": "HCT116_siH19-1"}, {"characteristics_ch1": "cell line: HCT116 cell line;\ttreatment: siH19-1"}]}, {"GSM2331253": [{"title": "HCT116_siH19-2, biological rep2 (06_GAC-MO-6)"}, {"type": "RNA"}, {"source_name_ch1": "HCT116_siH19-2"}, {"characteristics_ch1": "cell line: HCT116 cell line;\ttreatment: siH19-2"}]}, {"GSM1618237": [{"title": "AB23_Day 0_CD34+"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 0_CD34+"}, {"characteristics_ch1": "days cultured: 0;\tsource: Adult PBMCs;\tpopulation: CD34+;\tmedia: N/A;\tenrichment method: Magnetic Beads;\tcell type: AB-EB"}]}, {"GSM1618238": [{"title": "AB24_Day 0_CD34+"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 0_CD34+"}, {"characteristics_ch1": "days cultured: 0;\tsource: Adult PBMCs;\tpopulation: CD34+;\tmedia: N/A;\tenrichment method: Magnetic Beads;\tcell type: AB-EB"}]}, {"GSM1618239": [{"title": "AB42_Day 0_CD34+"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 0_CD34+"}, {"characteristics_ch1": "days cultured: 0;\tsource: Adult PBMCs;\tpopulation: CD34+;\tmedia: N/A;\tenrichment method: Magnetic Beads;\tcell type: AB-EB"}]}, {"GSM1618240": [{"title": "AB16_Day 4_SEM-B_CD36+, CD71+, CD235a-"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 4_SEM-B"}, {"characteristics_ch1": "days cultured: 4;\tsource: Adult PBMCs;\tpopulation: CD36+,CD71+,CD235a-;\tmedia: SEM-B;\tenrichment method: Flow Cytometry;\tcell type: AB-EB"}]}, {"GSM1618241": [{"title": "AB17_Day 4_SEM-B_CD36+, CD71+, CD235a-"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 4_SEM-B_CD36+,CD71+,CD235a-"}, {"characteristics_ch1": "days cultured: 4;\tsource: Adult PBMCs;\tpopulation: CD36+,CD71+,CD235a-;\tmedia: SEM-B;\tenrichment method: Flow Cytometry;\tcell type: AB-EB"}]}, {"GSM1618242": [{"title": "AB8_Day 4_SEM-F_CD36+, CD71+, CD235a-"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 4_SEM-F_CD36+,CD71+,CD235a-"}, {"characteristics_ch1": "days cultured: 4;\tsource: Adult PBMCs;\tpopulation: CD36+,CD71+,CD235a-;\tmedia: SEM-F;\tenrichment method: Flow Cytometry;\tcell type: AB-EB"}]}, {"GSM1618243": [{"title": "AB9_Day 4_SEM-F_CD36+, CD71+, CD235a-"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 4_SEM-F_CD36+,CD71+,CD235a-"}, {"characteristics_ch1": "days cultured: 4;\tsource: Adult PBMCs;\tpopulation: CD36+,CD71+,CD235a-;\tmedia: SEM-F;\tenrichment method: Flow Cytometry;\tcell type: AB-EB"}]}, {"GSM1618244": [{"title": "AB11_Day 4_SEM-F_CD36+, CD71+, CD235a-"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 4_SEM-F_CD36+,CD71+,CD235a-"}, {"characteristics_ch1": "days cultured: 4;\tsource: Adult PBMCs;\tpopulation: CD36+,CD71+,CD235a-;\tmedia: SEM-F;\tenrichment method: Flow Cytometry;\tcell type: AB-EB"}]}, {"GSM1618245": [{"title": "AB21_Day 4_SEM-i_CD36+, CD71+, CD235a-"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 4_SEM-i_CD36+,CD71+,CD235a-"}, {"characteristics_ch1": "days cultured: 4;\tsource: Adult PBMCs;\tpopulation: CD36+,CD71+,CD235a-;\tmedia: SEM-i;\tenrichment method: Flow Cytometry;\tcell type: AB-EB"}]}, {"GSM1618246": [{"title": "AB22_Day 4_SEM-i_CD36+, CD71+, CD235a-"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 4_SEM-i_CD36+,CD71+,CD235a-"}, {"characteristics_ch1": "days cultured: 4;\tsource: Adult PBMCs;\tpopulation: CD36+,CD71+,CD235a-;\tmedia: SEM-i;\tenrichment method: Flow Cytometry;\tcell type: AB-EB"}]}, {"GSM1618247": [{"title": "AB28_Day 4_SEM-i_CD36+, CD71+, CD235a-"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 4_SEM-i_CD36+,CD71+,CD235a-"}, {"characteristics_ch1": "days cultured: 4;\tsource: Adult PBMCs;\tpopulation: CD36+,CD71+,CD235a-;\tmedia: SEM-i;\tenrichment method: Flow Cytometry;\tcell type: AB-EB"}]}, {"GSM1618248": [{"title": "AB18_Day 7_SEM-B_CD36+, CD71+, CD235a-"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 7_SEM-B_CD36+,CD71+,CD235a-"}, {"characteristics_ch1": "days cultured: 7;\tsource: Adult PBMCs;\tpopulation: CD36+,CD71+,CD235a-;\tmedia: SEM-B;\tenrichment method: Flow Cytometry;\tcell type: AB-EB"}]}, {"GSM1618249": [{"title": "AB19_Day 7_SEM-B_CD36+, CD71+, CD235a-"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 7_SEM-B_CD36+,CD71+,CD235a-"}, {"characteristics_ch1": "days cultured: 7;\tsource: Adult PBMCs;\tpopulation: CD36+,CD71+,CD235a-;\tmedia: SEM-B;\tenrichment method: Flow Cytometry;\tcell type: AB-EB"}]}, {"GSM1618250": [{"title": "AB20_Day 7_SEM-B_CD36+, CD71+, CD235a-"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 7_SEM-B_CD36+,CD71+,CD235a-"}, {"characteristics_ch1": "days cultured: 7;\tsource: Adult PBMCs;\tpopulation: CD36+,CD71+,CD235a-;\tmedia: SEM-B;\tenrichment method: Flow Cytometry;\tcell type: AB-EB"}]}, {"GSM1618251": [{"title": "AB18_Day 7_SEM-B_CD36+, CD71+, CD235a+"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 7_SEM-B_CD36+,CD71+,CD235a+"}, {"characteristics_ch1": "days cultured: 7;\tsource: Adult PBMCs;\tpopulation: CD36+,CD71+,CD235a+;\tmedia: SEM-B;\tenrichment method: Flow Cytometry;\tcell type: AB-EB"}]}, {"GSM1618252": [{"title": "AB19_Day 7_SEM-B_CD36+, CD71+, CD235a+"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 7_SEM-B_CD36+,CD71+,CD235a+"}, {"characteristics_ch1": "days cultured: 7;\tsource: Adult PBMCs;\tpopulation: CD36+,CD71+,CD235a+;\tmedia: SEM-B;\tenrichment method: Flow Cytometry;\tcell type: AB-EB"}]}, {"GSM1618253": [{"title": "AB20_Day 7_SEM-B_CD36+, CD71+, CD235a+"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 7_SEM-B_CD36+,CD71+,CD235a+"}, {"characteristics_ch1": "days cultured: 7;\tsource: Adult PBMCs;\tpopulation: CD36+,CD71+,CD235a+;\tmedia: SEM-B;\tenrichment method: Flow Cytometry;\tcell type: AB-EB"}]}, {"GSM1618254": [{"title": "AB7_Day 7_SEM-F_CD36+, CD71+, CD235a-"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 7_SEM-F_CD36+,CD71+,CD235a-"}, {"characteristics_ch1": "days cultured: 7;\tsource: Adult PBMCs;\tpopulation: CD36+,CD71+,CD235a-;\tmedia: SEM-F;\tenrichment method: Flow Cytometry;\tcell type: AB-EB"}]}, {"GSM1618255": [{"title": "AB18_Day 7_SEM-F_CD36+, CD71+, CD235a-"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 7_SEM-F_CD36+,CD71+,CD235a-"}, {"characteristics_ch1": "days cultured: 7;\tsource: Adult PBMCs;\tpopulation: CD36+,CD71+,CD235a-;\tmedia: SEM-F;\tenrichment method: Flow Cytometry;\tcell type: AB-EB"}]}, {"GSM1618256": [{"title": "AB19_Day 7_SEM-F_CD36+, CD71+, CD235a-"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 7_SEM-F_CD36+,CD71+,CD235a-"}, {"characteristics_ch1": "days cultured: 7;\tsource: Adult PBMCs;\tpopulation: CD36+,CD71+,CD235a-;\tmedia: SEM-F;\tenrichment method: Flow Cytometry;\tcell type: AB-EB"}]}, {"GSM1618257": [{"title": "AB7_Day 7_SEM-F_CD36+, CD71+, CD235a+"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 7_SEM-F_CD36+,CD71+,CD235a+"}, {"characteristics_ch1": "days cultured: 7;\tsource: Adult PBMCs;\tpopulation: CD36+,CD71+,CD235a+;\tmedia: SEM-F;\tenrichment method: Flow Cytometry;\tcell type: AB-EB"}]}, {"GSM1618258": [{"title": "AB18_Day 7_SEM-F_CD36+, CD71+, CD235a+"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 7_SEM-F_CD36+,CD71+,CD235a+"}, {"characteristics_ch1": "days cultured: 7;\tsource: Adult PBMCs;\tpopulation: CD36+,CD71+,CD235a+;\tmedia: SEM-F;\tenrichment method: Flow Cytometry;\tcell type: AB-EB"}]}, {"GSM1618259": [{"title": "AB20_Day 7_SEM-F_CD36+, CD71+, CD235a+"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 7_SEM-F_CD36+,CD71+,CD235a+"}, {"characteristics_ch1": "days cultured: 7;\tsource: Adult PBMCs;\tpopulation: CD36+,CD71+,CD235a+;\tmedia: SEM-F;\tenrichment method: Flow Cytometry;\tcell type: AB-EB"}]}, {"GSM1618260": [{"title": "AB32_Day 7_SEM-F_CD71+"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 7_SEM-F_CD71+"}, {"characteristics_ch1": "days cultured: 7;\tsource: Adult PBMCs;\tpopulation: CD71+;\tmedia: SEM-F;\tenrichment method: Magnetic Beads;\tcell type: AB-EB"}]}, {"GSM1618261": [{"title": "AB33_Day 7_SEM-F_CD71+"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 7_SEM-F_CD71+"}, {"characteristics_ch1": "days cultured: 7;\tsource: Adult PBMCs;\tpopulation: CD71+;\tmedia: SEM-F;\tenrichment method: Magnetic Beads;\tcell type: AB-EB"}]}, {"GSM1618262": [{"title": "AB35_Day 7_SEM-F_CD71+"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 7_SEM-F_CD71+"}, {"characteristics_ch1": "days cultured: 7;\tsource: Adult PBMCs;\tpopulation: CD71+;\tmedia: SEM-F;\tenrichment method: Magnetic Beads;\tcell type: AB-EB"}]}, {"GSM1618263": [{"title": "AB43_Day 7_SEM-F_CD71+"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 7_SEM-F_CD71+"}, {"characteristics_ch1": "days cultured: 7;\tsource: Adult PBMCs;\tpopulation: CD71+;\tmedia: SEM-F;\tenrichment method: Magnetic Beads;\tcell type: AB-EB"}]}, {"GSM1618264": [{"title": "AB45_Day 7_SEM-F_CD71+"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 7_SEM-F_CD71+"}, {"characteristics_ch1": "days cultured: 7;\tsource: Adult PBMCs;\tpopulation: CD71+;\tmedia: SEM-F;\tenrichment method: Magnetic Beads;\tcell type: AB-EB"}]}, {"GSM1618265": [{"title": "AB32_Day 7_SEM-i_CD71+"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 7_SEM-i_CD71+"}, {"characteristics_ch1": "days cultured: 7;\tsource: Adult PBMCs;\tpopulation: CD71+;\tmedia: SEM-i;\tenrichment method: Magnetic Beads;\tcell type: AB-EB"}]}, {"GSM1618266": [{"title": "AB35_Day 7_SEM-i_CD71+"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 7_SEM-i_CD71+"}, {"characteristics_ch1": "days cultured: 7;\tsource: Adult PBMCs;\tpopulation: CD71+;\tmedia: SEM-i;\tenrichment method: Magnetic Beads;\tcell type: AB-EB"}]}, {"GSM1618267": [{"title": "AB46_Day 7_SEM-i_CD71+"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 7_SEM-i_CD71+"}, {"characteristics_ch1": "days cultured: 7;\tsource: Adult PBMCs;\tpopulation: CD71+;\tmedia: SEM-i;\tenrichment method: Magnetic Beads;\tcell type: AB-EB"}]}, {"GSM1618268": [{"title": "AB47_Day 7_SEM-i_CD71+"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 7_SEM-i_CD71+"}, {"characteristics_ch1": "days cultured: 7;\tsource: Adult PBMCs;\tpopulation: CD71+;\tmedia: SEM-i;\tenrichment method: Magnetic Beads;\tcell type: AB-EB"}]}, {"GSM1618269": [{"title": "AB48_Day 7_SEM-i_CD71+"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 7_SEM-i_CD71+"}, {"characteristics_ch1": "days cultured: 7;\tsource: Adult PBMCs;\tpopulation: CD71+;\tmedia: SEM-i;\tenrichment method: Magnetic Beads;\tcell type: AB-EB"}]}, {"GSM1618270": [{"title": "AB49_Day 10_SEM-F_CD71+, CD235a+"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 10_SEM-F_CD71+,CD235a+"}, {"characteristics_ch1": "days cultured: 10;\tsource: Adult PBMCs;\tpopulation: CD71+,CD235a+;\tmedia: SEM-F;\tenrichment method: Flow Cytometry;\tcell type: AB-EB"}]}, {"GSM1618271": [{"title": "AB50_Day 10_SEM-F_CD71+, CD235a+"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 10_SEM-F_CD71+,CD235a+"}, {"characteristics_ch1": "days cultured: 10;\tsource: Adult PBMCs;\tpopulation: CD71+,CD235a+;\tmedia: SEM-F;\tenrichment method: Flow Cytometry;\tcell type: AB-EB"}]}, {"GSM1618272": [{"title": "AB51_Day 10_SEM-F_CD71+, CD235a+"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 10_SEM-F_CD71+,CD235a+"}, {"characteristics_ch1": "days cultured: 10;\tsource: Adult PBMCs;\tpopulation: CD71+,CD235a+;\tmedia: SEM-F;\tenrichment method: Flow Cytometry;\tcell type: AB-EB"}]}, {"GSM1618273": [{"title": "AB49_Day 12_SEM-F_CD71+, CD235a+"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 12_SEM-F_CD71+,CD235a+"}, {"characteristics_ch1": "days cultured: 12;\tsource: Adult PBMCs;\tpopulation: CD71+,CD235a+;\tmedia: SEM-F;\tenrichment method: Flow Cytometry;\tcell type: AB-EB"}]}, {"GSM1618274": [{"title": "AB50_Day 12_SEM-F_CD71+, CD235a+"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 12_SEM-F_CD71+,CD235a+"}, {"characteristics_ch1": "days cultured: 12;\tsource: Adult PBMCs;\tpopulation: CD71+,CD235a+;\tmedia: SEM-F;\tenrichment method: Flow Cytometry;\tcell type: AB-EB"}]}, {"GSM1618275": [{"title": "AB51_Day 12_SEM-F_CD71+, CD235a+"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 12_SEM-F_CD71+,CD235a+"}, {"characteristics_ch1": "days cultured: 12;\tsource: Adult PBMCs;\tpopulation: CD71+,CD235a+;\tmedia: SEM-F;\tenrichment method: Flow Cytometry;\tcell type: AB-EB"}]}, {"GSM1618276": [{"title": "AB15_Day 14_SEM-B_CD71+, CD235a+"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 14_SEM-B_CD71+,CD235a+"}, {"characteristics_ch1": "days cultured: 14;\tsource: Adult PBMCs;\tpopulation: CD71+,CD235a+;\tmedia: SEM-B;\tenrichment method: Flow Cytometry;\tcell type: AB-EB"}]}, {"GSM1618277": [{"title": "AB19_Day 14_SEM-B_CD71+, CD235a+"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 14_SEM-B_CD71+,CD235a+"}, {"characteristics_ch1": "days cultured: 14;\tsource: Adult PBMCs;\tpopulation: CD71+,CD235a+;\tmedia: SEM-B;\tenrichment method: Flow Cytometry;\tcell type: AB-EB"}]}, {"GSM1618278": [{"title": "AB20_Day 14_SEM-B_CD71+, CD235a+"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 14_SEM-B_CD71+,CD235a+"}, {"characteristics_ch1": "days cultured: 14;\tsource: Adult PBMCs;\tpopulation: CD71+,CD235a+;\tmedia: SEM-B;\tenrichment method: Flow Cytometry;\tcell type: AB-EB"}]}, {"GSM1618279": [{"title": "AB32_Day 14_SEM-F_CD235a+"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 14_SEM-F_CD235a+"}, {"characteristics_ch1": "days cultured: 14;\tsource: Adult PBMCs;\tpopulation: CD235a+;\tmedia: SEM-F;\tenrichment method: Magnetic Beads;\tcell type: AB-EB"}]}, {"GSM1618280": [{"title": "AB33_Day 14_SEM-F_CD235a+"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 14_SEM-F_CD235a+"}, {"characteristics_ch1": "days cultured: 14;\tsource: Adult PBMCs;\tpopulation: CD235a+;\tmedia: SEM-F;\tenrichment method: Magnetic Beads;\tcell type: AB-EB"}]}, {"GSM1618281": [{"title": "AB43_Day 14_SEM-F_CD235a+"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 14_SEM-F_CD235a+"}, {"characteristics_ch1": "days cultured: 14;\tsource: Adult PBMCs;\tpopulation: CD235a+;\tmedia: SEM-F;\tenrichment method: Magnetic Beads;\tcell type: AB-EB"}]}, {"GSM1618282": [{"title": "AB15_Day 14_SEM-F_CD71+, CD235a+"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 14_SEM-F_CD71+,CD235a+"}, {"characteristics_ch1": "days cultured: 14;\tsource: Adult PBMCs;\tpopulation: CD71+,CD235a+;\tmedia: SEM-F;\tenrichment method: Flow Cytometry;\tcell type: AB-EB"}]}, {"GSM1618283": [{"title": "AB19_Day 14_SEM-F_CD71+, CD235a+"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 14_SEM-F_CD71+,CD235a+"}, {"characteristics_ch1": "days cultured: 14;\tsource: Adult PBMCs;\tpopulation: CD71+,CD235a+;\tmedia: SEM-F;\tenrichment method: Flow Cytometry;\tcell type: AB-EB"}]}, {"GSM1618284": [{"title": "AB20_Day 14_SEM-F_CD71+, CD235a+"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 14_SEM-F_CD71+,CD235a+"}, {"characteristics_ch1": "days cultured: 14;\tsource: Adult PBMCs;\tpopulation: CD71+,CD235a+;\tmedia: SEM-F;\tenrichment method: Flow Cytometry;\tcell type: AB-EB"}]}, {"GSM1618285": [{"title": "AB32_Day 14_SEM-i_CD235a+"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 14_SEM-i_CD235a+"}, {"characteristics_ch1": "days cultured: 14;\tsource: Adult PBMCs;\tpopulation: CD235a+;\tmedia: SEM-i;\tenrichment method: Magnetic Beads;\tcell type: AB-EB"}]}, {"GSM1618286": [{"title": "AB33_Day 14_SEM-i_CD235a+"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 14_SEM-i_CD235a+"}, {"characteristics_ch1": "days cultured: 14;\tsource: Adult PBMCs;\tpopulation: CD235a+;\tmedia: SEM-i;\tenrichment method: Magnetic Beads;\tcell type: AB-EB"}]}, {"GSM1618287": [{"title": "AB35_Day 14_SEM-i_CD235a+"}, {"type": "RNA"}, {"source_name_ch1": "AB_Day 14_SEM-i_CD235a+"}, {"characteristics_ch1": "days cultured: 14;\tsource: Adult PBMCs;\tpopulation: CD235a+;\tmedia: SEM-i;\tenrichment method: Magnetic Beads;\tcell type: AB-EB"}]}, {"GSM1618288": [{"title": "CB_CB10_Day 0_CD34+"}, {"type": "RNA"}, {"source_name_ch1": "CB_Day 0_CD34+"}, {"characteristics_ch1": "days cultured: 0;\tsource: CB PBMCs;\tpopulation: CD34+;\tmedia: N/A;\tenrichment method: Magnetic Beads;\tcell type: CB-EB"}]}, {"GSM1618289": [{"title": "CB_CB11_Day 0_CD34+"}, {"type": "RNA"}, {"source_name_ch1": "CB_Day 0_CD34+"}, {"characteristics_ch1": "days cultured: 0;\tsource: CB PBMCs;\tpopulation: CD34+;\tmedia: N/A;\tenrichment method: Magnetic Beads;\tcell type: CB-EB"}]}, {"GSM1618290": [{"title": "CB_CB12_Day 0_CD34+"}, {"type": "RNA"}, {"source_name_ch1": "CB_Day 0_CD34+"}, {"characteristics_ch1": "days cultured: 0;\tsource: CB PBMCs;\tpopulation: CD34+;\tmedia: N/A;\tenrichment method: Magnetic Beads;\tcell type: CB-EB"}]}, {"GSM1618291": [{"title": "CB_CB1_Day 7_SEM-F_CD36+, CD71+, CD235a-"}, {"type": "RNA"}, {"source_name_ch1": "CB_Day 7_SEM-F_CD36+,CD71+,CD235a-"}, {"characteristics_ch1": "days cultured: 7;\tsource: CB PBMCs;\tpopulation: CD36+,CD71+,CD235a-;\tmedia: SEM-F;\tenrichment method: Flow Cytometry;\tcell type: CB-EB"}]}, {"GSM1618292": [{"title": "CB_CB2_Day 7_SEM-F_CD36+, CD71+, CD235a-"}, {"type": "RNA"}, {"source_name_ch1": "CB_Day 7_SEM-F_CD36+,CD71+,CD235a-"}, {"characteristics_ch1": "days cultured: 7;\tsource: CB PBMCs;\tpopulation: CD36+,CD71+,CD235a-;\tmedia: SEM-F;\tenrichment method: Flow Cytometry;\tcell type: CB-EB"}]}, {"GSM1618293": [{"title": "CB_CB13_Day 7_SEM-F_CD36+, CD71+, CD235a-"}, {"type": "RNA"}, {"source_name_ch1": "CB_Day 7_SEM-F_CD36+,CD71+,CD235a-"}, {"characteristics_ch1": "days cultured: 7;\tsource: CB PBMCs;\tpopulation: CD36+,CD71+,CD235a-;\tmedia: SEM-F;\tenrichment method: Flow Cytometry;\tcell type: CB-EB"}]}, {"GSM1618294": [{"title": "CB_CB2_Day 7_SEM-F_CD36+, CD71+, CD235a+"}, {"type": "RNA"}, {"source_name_ch1": "CB_Day 7_SEM-F_CD36+,CD71+,CD235a+"}, {"characteristics_ch1": "days cultured: 7;\tsource: CB PBMCs;\tpopulation: CD36+,CD71+,CD235a+;\tmedia: SEM-F;\tenrichment method: Flow Cytometry;\tcell type: CB-EB"}]}, {"GSM1618295": [{"title": "CB_CB13_Day 7_SEM-F_CD36+, CD71+, CD235a+"}, {"type": "RNA"}, {"source_name_ch1": "CB_Day 14_SEM-F_CD36+,CD71+,CD235a+"}, {"characteristics_ch1": "days cultured: 14;\tsource: CB PBMCs;\tpopulation: CD36+,CD71+,CD235a+;\tmedia: SEM-F;\tenrichment method: Flow Cytometry;\tcell type: CB-EB"}]}, {"GSM1618296": [{"title": "CB_CB8_Day 14_SEM-F_CD71+, CD235a+"}, {"type": "RNA"}, {"source_name_ch1": "CB_Day 14_SEM-F_CD71+,CD235a+"}, {"characteristics_ch1": "days cultured: 14;\tsource: CB PBMCs;\tpopulation: CD71+,CD235a+;\tmedia: SEM-F;\tenrichment method: Flow Cytometry;\tcell type: CB-EB"}]}, {"GSM1618297": [{"title": "CB_CB9_Day 14_SEM-F_CD71+, CD235a+"}, {"type": "RNA"}, {"source_name_ch1": "CB_Day 14_SEM-F_CD71+,CD235a+"}, {"characteristics_ch1": "days cultured: 14;\tsource: CB PBMCs;\tpopulation: CD71+,CD235a+;\tmedia: SEM-F;\tenrichment method: Flow Cytometry;\tcell type: CB-EB"}]}, {"GSM1618298": [{"title": "hiPSC_OC1_Day 0_CD31+"}, {"type": "RNA"}, {"source_name_ch1": "hiPSC_Day 0_CD31+"}, {"characteristics_ch1": "days cultured: 0;\tsource: hiPSCs;\tpopulation: CD31+;\tmedia: N/A;\tenrichment method: Magnetic Beads;\tcell type: hiPSC-EB"}]}, {"GSM1618299": [{"title": "hiPSC_OCE1-6_Day 0_CD31+"}, {"type": "RNA"}, {"source_name_ch1": "hiPSC_Day 0_CD31+"}, {"characteristics_ch1": "days cultured: 0;\tsource: hiPSCs;\tpopulation: CD31+;\tmedia: N/A;\tenrichment method: Magnetic Beads;\tcell type: hiPSC-EB"}]}, {"GSM1618300": [{"title": "hiPSC_OCE1-7_Day 0_CD31+"}, {"type": "RNA"}, {"source_name_ch1": "hiPSC_Day 0_CD31+"}, {"characteristics_ch1": "days cultured: 0;\tsource: hiPSCs;\tpopulation: CD31+;\tmedia: N/A;\tenrichment method: Magnetic Beads;\tcell type: hiPSC-EB"}]}, {"GSM1618301": [{"title": "hiPSC_iOCE1-1_Day 0_CD34+"}, {"type": "RNA"}, {"source_name_ch1": "hiPSC_Day 0_CD34+"}, {"characteristics_ch1": "days cultured: 0;\tsource: hiPSCs;\tpopulation: CD34+;\tmedia: N/A;\tenrichment method: Magnetic Beads;\tcell type: hiPSC-EB"}]}, {"GSM1618302": [{"title": "hiPSC_iOCE1-2_Day 0_CD34+"}, {"type": "RNA"}, {"source_name_ch1": "hiPSC_Day 0_CD34+"}, {"characteristics_ch1": "days cultured: 0;\tsource: hiPSCs;\tpopulation: CD34+;\tmedia: N/A;\tenrichment method: Magnetic Beads;\tcell type: hiPSC-EB"}]}, {"GSM1618303": [{"title": "hiPSC_iOCE1-3_Day 0_CD34+"}, {"type": "RNA"}, {"source_name_ch1": "hiPSC_Day 0_CD34+"}, {"characteristics_ch1": "days cultured: 0;\tsource: hiPSCs;\tpopulation: CD34+;\tmedia: N/A;\tenrichment method: Magnetic Beads;\tcell type: hiPSC-EB"}]}, {"GSM1618304": [{"title": "hiPSC_C18_Day 7_SEM-i_CD71+"}, {"type": "RNA"}, {"source_name_ch1": "hiPSC_Day 7_SEM-i_CD71+"}, {"characteristics_ch1": "days cultured: 7;\tsource: hiPSCs;\tpopulation: CD71+;\tmedia: SEM-i;\tenrichment method: Magnetic Beads;\tcell type: hiPSC-EB"}]}, {"GSM1618305": [{"title": "hiPSC_OC1_Day 7_SEM-i_CD71+"}, {"type": "RNA"}, {"source_name_ch1": "hiPSC_Day 7_SEM-i_CD71+"}, {"characteristics_ch1": "days cultured: 7;\tsource: hiPSCs;\tpopulation: CD71+;\tmedia: SEM-i;\tenrichment method: Magnetic Beads;\tcell type: hiPSC-EB"}]}, {"GSM1618306": [{"title": "hiPSC_iOCE1-4_Day 7_SEM-i_CD71+"}, {"type": "RNA"}, {"source_name_ch1": "hiPSC_Day 7_SEM-i_CD71+"}, {"characteristics_ch1": "days cultured: 7;\tsource: hiPSCs;\tpopulation: CD71+;\tmedia: SEM-i;\tenrichment method: Magnetic Beads;\tcell type: hiPSC-EB"}]}, {"GSM1618307": [{"title": "hiPSC_iOCE1-5_Day 7_SEM-i_CD71+"}, {"type": "RNA"}, {"source_name_ch1": "hiPSC_Day 7_SEM-i_CD71+"}, {"characteristics_ch1": "days cultured: 7;\tsource: hiPSCs;\tpopulation: CD71+;\tmedia: SEM-i;\tenrichment method: Magnetic Beads;\tcell type: hiPSC-EB"}]}, {"GSM1618308": [{"title": "hiPSC_C18_Day 14_SEM-i_CD235a+"}, {"type": "RNA"}, {"source_name_ch1": "hiPSC_Day 14_SEM-i_CD235a+"}, {"characteristics_ch1": "days cultured: 14;\tsource: hiPSCs;\tpopulation: CD235a+;\tmedia: SEM-i;\tenrichment method: Magnetic Beads;\tcell type: hiPSC-EB"}]}, {"GSM1618309": [{"title": "hiPSC_OC1_Day 14_SEM-i_CD235a+"}, {"type": "RNA"}, {"source_name_ch1": "hiPSC_Day 14_SEM-i_CD235a+"}, {"characteristics_ch1": "days cultured: 14;\tsource: hiPSCs;\tpopulation: CD235a+;\tmedia: SEM-i;\tenrichment method: Magnetic Beads;\tcell type: hiPSC-EB"}]}, {"GSM1618310": [{"title": "hiPSC_OCE1_Day 14_SEM-i_CD235a+"}, {"type": "RNA"}, {"source_name_ch1": "hiPSC_Day 14_SEM-i_CD235a+"}, {"characteristics_ch1": "days cultured: 14;\tsource: hiPSCs;\tpopulation: CD235a+;\tmedia: SEM-i;\tenrichment method: Magnetic Beads;\tcell type: hiPSC-EB"}]}, {"GSM2098893": [{"title": "Undifferentiated H9 hESCs infected with non-silencing shRNA, rep1"}, {"type": "RNA"}, {"source_name_ch1": "undifferentiated H9 hESCs infected with non-silencing shRNA"}, {"characteristics_ch1": "cell line: H9;\tcell type: female human embryonic stem cell (hESC) line;\tdifferentiation state: undifferentiated;\tshRNA: non-silencing"}]}, {"GSM2098894": [{"title": "Undifferentiated H9 hESCs infected with non-silencing shRNA, rep2"}, {"type": "RNA"}, {"source_name_ch1": "undifferentiated H9 hESCs infected with non-silencing shRNA"}, {"characteristics_ch1": "cell line: H9;\tcell type: female human embryonic stem cell (hESC) line;\tdifferentiation state: undifferentiated;\tshRNA: non-silencing"}]}, {"GSM2098895": [{"title": "Undifferentiated H9 hESCs infected with non-silencing shRNA, rep3"}, {"type": "RNA"}, {"source_name_ch1": "undifferentiated H9 hESCs infected with non-silencing shRNA"}, {"characteristics_ch1": "cell line: H9;\tcell type: female human embryonic stem cell (hESC) line;\tdifferentiation state: undifferentiated;\tshRNA: non-silencing"}]}, {"GSM2098896": [{"title": "H9 hESCs infected with non-silencing shRNA and differentiated for 8hrs, rep1"}, {"type": "RNA"}, {"source_name_ch1": "H9 hESCs infected with non-silencing shRNA and differentiated for 8hrs"}, {"characteristics_ch1": "cell line: H9;\tcell type: female human embryonic stem cell (hESC) line;\tdifferentiation state: 8 hrs FBS differentiated;\tshRNA: non-silencing"}]}, {"GSM2098897": [{"title": "H9 hESCs infected with non-silencing shRNA and differentiated for 8hrs, rep2"}, {"type": "RNA"}, {"source_name_ch1": "H9 hESCs infected with non-silencing shRNA and differentiated for 8hrs"}, {"characteristics_ch1": "cell line: H9;\tcell type: female human embryonic stem cell (hESC) line;\tdifferentiation state: 8 hrs FBS differentiated;\tshRNA: non-silencing"}]}, {"GSM2098898": [{"title": "H9 hESCs infected with non-silencing shRNA and differentiated for 8hrs, rep3"}, {"type": "RNA"}, {"source_name_ch1": "H9 hESCs infected with non-silencing shRNA and differentiated for 8hrs"}, {"characteristics_ch1": "cell line: H9;\tcell type: female human embryonic stem cell (hESC) line;\tdifferentiation state: 8 hrs FBS differentiated;\tshRNA: non-silencing"}]}, {"GSM2098899": [{"title": "H9 hESCs infected with non-silencing shRNA and differentiated for 24hrs, rep1"}, {"type": "RNA"}, {"source_name_ch1": "H9 hESCs infected with non-silencing shRNA and differentiated for 24hrs"}, {"characteristics_ch1": "cell line: H9;\tcell type: female human embryonic stem cell (hESC) line;\tdifferentiation state: 24 hrs FBS differentiated;\tshRNA: non-silencing"}]}, {"GSM2098900": [{"title": "H9 hESCs infected with non-silencing shRNA and differentiated for 24hrs, rep2"}, {"type": "RNA"}, {"source_name_ch1": "H9 hESCs infected with non-silencing shRNA and differentiated for 24hrs"}, {"characteristics_ch1": "cell line: H9;\tcell type: female human embryonic stem cell (hESC) line;\tdifferentiation state: 24 hrs FBS differentiated;\tshRNA: non-silencing"}]}, {"GSM2098901": [{"title": "H9 hESCs infected with non-silencing shRNA and differentiated for 24hrs, rep3"}, {"type": "RNA"}, {"source_name_ch1": "H9 hESCs infected with non-silencing shRNA and differentiated for 24hrs"}, {"characteristics_ch1": "cell line: H9;\tcell type: female human embryonic stem cell (hESC) line;\tdifferentiation state: 24 hrs FBS differentiated;\tshRNA: non-silencing"}]}, {"GSM2098902": [{"title": "H9 hESCs infected with non-silencing shRNA and differentiated for 72hrs, rep1"}, {"type": "RNA"}, {"source_name_ch1": "H9 hESCs infected with non-silencing shRNA and differentiated for 72hrs"}, {"characteristics_ch1": "cell line: H9;\tcell type: female human embryonic stem cell (hESC) line;\tdifferentiation state: 72 hrs FBS differentiated;\tshRNA: non-silencing"}]}, {"GSM2098903": [{"title": "H9 hESCs infected with non-silencing shRNA and differentiated for 72hrs, rep2"}, {"type": "RNA"}, {"source_name_ch1": "H9 hESCs infected with non-silencing shRNA and differentiated for 72hrs"}, {"characteristics_ch1": "cell line: H9;\tcell type: female human embryonic stem cell (hESC) line;\tdifferentiation state: 72 hrs FBS differentiated;\tshRNA: non-silencing"}]}, {"GSM2098904": [{"title": "H9 hESCs infected with non-silencing shRNA and differentiated for 72hrs, rep3"}, {"type": "RNA"}, {"source_name_ch1": "H9 hESCs infected with non-silencing shRNA and differentiated for 72hrs"}, {"characteristics_ch1": "cell line: H9;\tcell type: female human embryonic stem cell (hESC) line;\tdifferentiation state: 72 hrs FBS differentiated;\tshRNA: non-silencing"}]}, {"GSM2098905": [{"title": "Undifferentiated H9 hESCs infected with shRUNX1, rep1"}, {"type": "RNA"}, {"source_name_ch1": "undifferentiated H9 hESCs infected with shRUNX1"}, {"characteristics_ch1": "cell line: H9;\tcell type: female human embryonic stem cell (hESC) line;\tdifferentiation state: undifferentiated;\tshRNA: shRUNX1"}]}, {"GSM2098906": [{"title": "Undifferentiated H9 hESCs infected with shRUNX1, rep2"}, {"type": "RNA"}, {"source_name_ch1": "undifferentiated H9 hESCs infected with shRUNX1"}, {"characteristics_ch1": "cell line: H9;\tcell type: female human embryonic stem cell (hESC) line;\tdifferentiation state: undifferentiated;\tshRNA: shRUNX1"}]}, {"GSM2098907": [{"title": "Undifferentiated H9 hESCs infected with shRUNX1, rep3"}, {"type": "RNA"}, {"source_name_ch1": "undifferentiated H9 hESCs infected with shRUNX1"}, {"characteristics_ch1": "cell line: H9;\tcell type: female human embryonic stem cell (hESC) line;\tdifferentiation state: undifferentiated;\tshRNA: shRUNX1"}]}, {"GSM2098908": [{"title": "H9 hESCs infected with shRUNX1 and differentiated for 8hrs, rep1"}, {"type": "RNA"}, {"source_name_ch1": "H9 hESCs infected with shRUNX1 and differentiated for 8hrs"}, {"characteristics_ch1": "cell line: H9;\tcell type: female human embryonic stem cell (hESC) line;\tdifferentiation state: 8 hrs FBS differentiated;\tshRNA: shRUNX1"}]}, {"GSM2098909": [{"title": "H9 hESCs infected with shRUNX1 and differentiated for 8hrs, rep2"}, {"type": "RNA"}, {"source_name_ch1": "H9 hESCs infected with shRUNX1 and differentiated for 8hrs"}, {"characteristics_ch1": "cell line: H9;\tcell type: female human embryonic stem cell (hESC) line;\tdifferentiation state: 8 hrs FBS differentiated;\tshRNA: shRUNX1"}]}, {"GSM2098910": [{"title": "H9 hESCs infected with shRUNX1 and differentiated for 8hrs, rep3"}, {"type": "RNA"}, {"source_name_ch1": "H9 hESCs infected with shRUNX1 and differentiated for 8hrs"}, {"characteristics_ch1": "cell line: H9;\tcell type: female human embryonic stem cell (hESC) line;\tdifferentiation state: 8 hrs FBS differentiated;\tshRNA: shRUNX1"}]}, {"GSM2098911": [{"title": "H9 hESCs infected with shRUNX1 and differentiated for 24hrs, rep1"}, {"type": "RNA"}, {"source_name_ch1": "H9 hESCs infected with shRUNX1 and differentiated for 24hrs"}, {"characteristics_ch1": "cell line: H9;\tcell type: female human embryonic stem cell (hESC) line;\tdifferentiation state: 24 hrs FBS differentiated;\tshRNA: shRUNX1"}]}, {"GSM2098912": [{"title": "H9 hESCs infected with shRUNX1 and differentiated for 24hrs, rep2"}, {"type": "RNA"}, {"source_name_ch1": "H9 hESCs infected with shRUNX1 and differentiated for 24hrs"}, {"characteristics_ch1": "cell line: H9;\tcell type: female human embryonic stem cell (hESC) line;\tdifferentiation state: 24 hrs FBS differentiated;\tshRNA: shRUNX1"}]}, {"GSM2098913": [{"title": "H9 hESCs infected with shRUNX1 and differentiated for 24hrs, rep3"}, {"type": "RNA"}, {"source_name_ch1": "H9 hESCs infected with shRUNX1 and differentiated for 24hrs"}, {"characteristics_ch1": "cell line: H9;\tcell type: female human embryonic stem cell (hESC) line;\tdifferentiation state: 24 hrs FBS differentiated;\tshRNA: shRUNX1"}]}, {"GSM2098914": [{"title": "H9 hESCs infected with shRUNX1 and differentiated for 72hrs, rep1"}, {"type": "RNA"}, {"source_name_ch1": "H9 hESCs infected with shRUNX1 and differentiated for 72hrs"}, {"characteristics_ch1": "cell line: H9;\tcell type: female human embryonic stem cell (hESC) line;\tdifferentiation state: 72 hrs FBS differentiated;\tshRNA: shRUNX1"}]}, {"GSM2098915": [{"title": "H9 hESCs infected with shRUNX1 and differentiated for 72hrs, rep2"}, {"type": "RNA"}, {"source_name_ch1": "H9 hESCs infected with shRUNX1 and differentiated for 72hrs"}, {"characteristics_ch1": "cell line: H9;\tcell type: female human embryonic stem cell (hESC) line;\tdifferentiation state: 72 hrs FBS differentiated;\tshRNA: shRUNX1"}]}, {"GSM2098916": [{"title": "H9 hESCs infected with shRUNX1 and differentiated for 72hrs, rep3"}, {"type": "RNA"}, {"source_name_ch1": "H9 hESCs infected with shRUNX1 and differentiated for 72hrs"}, {"characteristics_ch1": "cell line: H9;\tcell type: female human embryonic stem cell (hESC) line;\tdifferentiation state: 72 hrs FBS differentiated;\tshRNA: shRUNX1"}]}, {"GSM2341100": [{"title": "Breast cancer tissue of Patient 2 (Technical replicate 1)"}, {"type": "RNA"}, {"source_name_ch1": "Cancer tissue"}, {"characteristics_ch1": "gender: female;\ttissue: Breast cancer tissue"}]}, {"GSM2341101": [{"title": "Breast cancer tissue of Patient 2 (Technical replicate 2)"}, {"type": "RNA"}, {"source_name_ch1": "Cancer tissue"}, {"characteristics_ch1": "gender: female;\ttissue: Breast cancer tissue"}]}, {"GSM2341102": [{"title": "Reference (Technical replicate 1)"}, {"type": "RNA"}, {"source_name_ch1": "Pool of 10 cell lines"}, {"characteristics_ch1": "tissue: Pool of 10 cell lines"}]}, {"GSM2341103": [{"title": "Reference (Technical replicate 2)"}, {"type": "RNA"}, {"source_name_ch1": "Pool of 10 cell lines"}, {"characteristics_ch1": "tissue: Pool of 10 cell lines"}]}, {"GSM2341911": [{"title": "A549 si-FAM210B, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "A549 si-FAM210B"}, {"characteristics_ch1": "cell line: A549"}]}, {"GSM2341912": [{"title": "A549 si-FAM210B, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "A549 si-FAM210B"}, {"characteristics_ch1": "cell line: A549"}]}, {"GSM2341913": [{"title": "A549 si-FAM210B, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "A549 si-FAM210B"}, {"characteristics_ch1": "cell line: A549"}]}, {"GSM2341914": [{"title": "A549 si-negative control, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "A549 si-negative control"}, {"characteristics_ch1": "cell line: A549"}]}, {"GSM2341915": [{"title": "A549 si-negative control, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "A549 si-negative control"}, {"characteristics_ch1": "cell line: A549"}]}, {"GSM2341916": [{"title": "A549 si-negative control, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "A549 si-negative control"}, {"characteristics_ch1": "cell line: A549"}]}, {"GSM2341917": [{"title": "A549 si-UQCRC2, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "A549 si-UQCRC2"}, {"characteristics_ch1": "cell line: A549"}]}, {"GSM2341918": [{"title": "A549 si-UQCRC2, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "A549 si-UQCRC2"}, {"characteristics_ch1": "cell line: A549"}]}, {"GSM2341919": [{"title": "A549 si-UQCRC2, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "A549 si-UQCRC2"}, {"characteristics_ch1": "cell line: A549"}]}, {"GSM2350024": [{"title": "Islet graft tissue_mRNA"}, {"type": "RNA"}, {"source_name_ch1": "Human islets into mouse xenotransplantation"}, {"characteristics_ch1": "tissue: pancreas;\tcell type: islets;\tcell compartment: whole cell"}]}, {"GSM2350025": [{"title": "Exosome profiles TISE_mRNA"}, {"type": "RNA"}, {"source_name_ch1": "Human islets into mouse xenotransplantation"}, {"characteristics_ch1": "tissue: pancreas;\tcell type: islets;\tcell compartment: exosome"}]}, {"GSM2350873": [{"title": "SUBJ.1307, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.1307;\ttime: baseline;\tgroup: Normal;\tbatch: Additional HCs;\trace: --;\tSex: Female;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350874": [{"title": "SUBJ.1378, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.1378;\ttime: baseline;\tgroup: Normal;\tbatch: ILLUMINATE-1;\trace: --;\tSex: --;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350875": [{"title": "SUBJ.1280, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.1280;\ttime: baseline;\tgroup: Normal;\tbatch: Additional HCs;\trace: --;\tSex: Female;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350876": [{"title": "SUBJ.0294, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.0294;\ttime: baseline;\tgroup: Normal;\tbatch: Additional HCs;\trace: --;\tSex: Female;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350877": [{"title": "SUBJ.1088, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.1088;\ttime: baseline;\tgroup: Normal;\tbatch: ILLUMINATE-1;\trace: --;\tSex: --;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350878": [{"title": "SUBJ.1412, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.1412;\ttime: baseline;\tgroup: Normal;\tbatch: ILLUMINATE-1;\trace: --;\tSex: --;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350879": [{"title": "SUBJ.1406, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.1406;\ttime: baseline;\tgroup: Normal;\tbatch: ILLUMINATE-2;\trace: --;\tSex: --;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350880": [{"title": "SUBJ.0073, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.0073;\ttime: baseline;\tgroup: Normal;\tbatch: ILLUMINATE-2;\trace: --;\tSex: --;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350881": [{"title": "SUBJ.0241, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.0241;\ttime: baseline;\tgroup: Normal;\tbatch: Additional HCs;\trace: --;\tSex: Female;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350882": [{"title": "SUBJ.0602, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.0602;\ttime: baseline;\tgroup: Normal;\tbatch: Additional HCs;\trace: --;\tSex: Female;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350883": [{"title": "SUBJ.0536, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.0536;\ttime: baseline;\tgroup: Normal;\tbatch: ILLUMINATE-2;\trace: --;\tSex: --;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350884": [{"title": "SUBJ.1618, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.1618;\ttime: baseline;\tgroup: Normal;\tbatch: Additional HCs;\trace: --;\tSex: Female;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350885": [{"title": "SUBJ.0044, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.0044;\ttime: baseline;\tgroup: Normal;\tbatch: Additional HCs;\trace: --;\tSex: Female;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350886": [{"title": "SUBJ.1648, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.1648;\ttime: baseline;\tgroup: Normal;\tbatch: ILLUMINATE-1;\trace: --;\tSex: --;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350887": [{"title": "SUBJ.0691, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.0691;\ttime: baseline;\tgroup: Normal;\tbatch: Additional HCs;\trace: --;\tSex: Female;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350888": [{"title": "SUBJ.0861, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.0861;\ttime: baseline;\tgroup: Normal;\tbatch: Additional HCs;\trace: --;\tSex: Female;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350889": [{"title": "SUBJ.1329, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.1329;\ttime: baseline;\tgroup: Normal;\tbatch: ILLUMINATE-1;\trace: --;\tSex: --;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350890": [{"title": "SUBJ.1703, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.1703;\ttime: baseline;\tgroup: Normal;\tbatch: ILLUMINATE-2;\trace: --;\tSex: --;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350891": [{"title": "SUBJ.0812, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.0812;\ttime: baseline;\tgroup: Normal;\tbatch: ILLUMINATE-2;\trace: --;\tSex: --;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350892": [{"title": "SUBJ.0744, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.0744;\ttime: baseline;\tgroup: Normal;\tbatch: ILLUMINATE-1;\trace: --;\tSex: --;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350893": [{"title": "SUBJ.0855, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.0855;\ttime: baseline;\tgroup: Normal;\tbatch: ILLUMINATE-1;\trace: --;\tSex: --;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350894": [{"title": "SUBJ.0866, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.0866;\ttime: baseline;\tgroup: Normal;\tbatch: Additional HCs;\trace: --;\tSex: Female;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350895": [{"title": "SUBJ.0255, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.0255;\ttime: baseline;\tgroup: Normal;\tbatch: ILLUMINATE-1;\trace: --;\tSex: --;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350896": [{"title": "SUBJ.1204, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.1204;\ttime: baseline;\tgroup: Normal;\tbatch: Additional HCs;\trace: --;\tSex: Female;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350897": [{"title": "SUBJ.0122, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.0122;\ttime: baseline;\tgroup: Normal;\tbatch: Additional HCs;\trace: --;\tSex: Female;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350898": [{"title": "SUBJ.0185, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.0185;\ttime: baseline;\tgroup: Normal;\tbatch: ILLUMINATE-1;\trace: --;\tSex: --;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350899": [{"title": "SUBJ.1619, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.1619;\ttime: baseline;\tgroup: Normal;\tbatch: Additional HCs;\trace: --;\tSex: Female;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350900": [{"title": "SUBJ.0087, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.0087;\ttime: baseline;\tgroup: Normal;\tbatch: Additional HCs;\trace: --;\tSex: Female;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350901": [{"title": "SUBJ.0106, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.0106;\ttime: baseline;\tgroup: Normal;\tbatch: ILLUMINATE-2;\trace: --;\tSex: --;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350902": [{"title": "SUBJ.0879, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.0879;\ttime: baseline;\tgroup: Normal;\tbatch: ILLUMINATE-2;\trace: --;\tSex: --;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350903": [{"title": "SUBJ.1561, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.1561;\ttime: baseline;\tgroup: Normal;\tbatch: ILLUMINATE-1;\trace: --;\tSex: --;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350904": [{"title": "SUBJ.0367, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.0367;\ttime: baseline;\tgroup: Normal;\tbatch: Additional HCs;\trace: --;\tSex: Female;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350905": [{"title": "SUBJ.0418, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.0418;\ttime: baseline;\tgroup: Normal;\tbatch: Additional HCs;\trace: --;\tSex: Female;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350906": [{"title": "SUBJ.1772, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.1772;\ttime: baseline;\tgroup: Normal;\tbatch: Additional HCs;\trace: --;\tSex: Female;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350907": [{"title": "SUBJ.0277, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.0277;\ttime: baseline;\tgroup: Normal;\tbatch: Additional HCs;\trace: --;\tSex: Female;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350908": [{"title": "SUBJ.0343, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.0343;\ttime: baseline;\tgroup: Normal;\tbatch: ILLUMINATE-2;\trace: --;\tSex: --;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350909": [{"title": "SUBJ.0130, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.0130;\ttime: baseline;\tgroup: Normal;\tbatch: Additional HCs;\trace: --;\tSex: Female;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350910": [{"title": "SUBJ.0070, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.0070;\ttime: baseline;\tgroup: Normal;\tbatch: ILLUMINATE-1;\trace: --;\tSex: --;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350911": [{"title": "SUBJ.0209, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.0209;\ttime: baseline;\tgroup: Normal;\tbatch: ILLUMINATE-1;\trace: --;\tSex: --;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350912": [{"title": "SUBJ.0467, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.0467;\ttime: baseline;\tgroup: Normal;\tbatch: ILLUMINATE-1;\trace: --;\tSex: --;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350913": [{"title": "SUBJ.1392, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.1392;\ttime: baseline;\tgroup: Normal;\tbatch: Additional HCs;\trace: --;\tSex: Female;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350914": [{"title": "SUBJ.0649, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.0649;\ttime: baseline;\tgroup: Normal;\tbatch: Additional HCs;\trace: --;\tSex: Female;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350915": [{"title": "SUBJ.0515, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.0515;\ttime: baseline;\tgroup: Normal;\tbatch: ILLUMINATE-1;\trace: --;\tSex: --;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350916": [{"title": "SUBJ.0256, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.0256;\ttime: baseline;\tgroup: Normal;\tbatch: ILLUMINATE-2;\trace: --;\tSex: --;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350917": [{"title": "SUBJ.0098, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.0098;\ttime: baseline;\tgroup: Normal;\tbatch: ILLUMINATE-2;\trace: --;\tSex: --;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350918": [{"title": "SUBJ.0055, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.0055;\ttime: baseline;\tgroup: Normal;\tbatch: ILLUMINATE-1;\trace: --;\tSex: --;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350919": [{"title": "SUBJ.1338, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.1338;\ttime: baseline;\tgroup: Normal;\tbatch: Additional HCs;\trace: --;\tSex: Female;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350920": [{"title": "SUBJ.1599, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.1599;\ttime: baseline;\tgroup: Normal;\tbatch: Additional HCs;\trace: --;\tSex: Female;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350921": [{"title": "SUBJ.0076, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.0076;\ttime: baseline;\tgroup: Normal;\tbatch: ILLUMINATE-1;\trace: --;\tSex: --;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350922": [{"title": "SUBJ.0388, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.0388;\ttime: baseline;\tgroup: Normal;\tbatch: ILLUMINATE-2;\trace: --;\tSex: --;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350923": [{"title": "SUBJ.0236, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.0236;\ttime: baseline;\tgroup: Normal;\tbatch: ILLUMINATE-1;\trace: --;\tSex: --;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350924": [{"title": "SUBJ.0952, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.0952;\ttime: baseline;\tgroup: Normal;\tbatch: Additional HCs;\trace: --;\tSex: Female;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350925": [{"title": "SUBJ.0825, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.0825;\ttime: baseline;\tgroup: Normal;\tbatch: Additional HCs;\trace: --;\tSex: Female;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350926": [{"title": "SUBJ.1353, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.1353;\ttime: baseline;\tgroup: Normal;\tbatch: Additional HCs;\trace: --;\tSex: Female;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350927": [{"title": "SUBJ.1216, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.1216;\ttime: baseline;\tgroup: Normal;\tbatch: Additional HCs;\trace: --;\tSex: Female;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350928": [{"title": "SUBJ.0620, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.0620;\ttime: baseline;\tgroup: Normal;\tbatch: Additional HCs;\trace: --;\tSex: Female;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350929": [{"title": "SUBJ.0016, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.0016;\ttime: baseline;\tgroup: Normal;\tbatch: Additional HCs;\trace: --;\tSex: Female;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350930": [{"title": "SUBJ.1403, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.1403;\ttime: baseline;\tgroup: Normal;\tbatch: ILLUMINATE-2;\trace: --;\tSex: --;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350931": [{"title": "SUBJ.1263, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.1263;\ttime: baseline;\tgroup: Normal;\tbatch: Additional HCs;\trace: --;\tSex: Female;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350932": [{"title": "SUBJ.0581, Normal, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from normal subject"}, {"characteristics_ch1": "subject_id: SUBJ.0581;\ttime: baseline;\tgroup: Normal;\tbatch: ILLUMINATE-2;\trace: --;\tSex: --;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2350933": [{"title": "SUBJ.1135, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1135;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 48.0438356164383;\tregion: europe;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 148;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.76;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.067;\ttissue: Blood"}]}, {"GSM2350934": [{"title": "SUBJ.0113, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0113;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 37.8551912568306;\tregion: mex_ca_sa;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.741;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.216;\ttissue: Blood"}]}, {"GSM2350935": [{"title": "SUBJ.0410, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0410;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 46.8904109589041;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.27;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.51;\ttissue: Blood"}]}, {"GSM2350936": [{"title": "SUBJ.0775, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0775;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 24.4712328767123;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.639;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.064;\ttissue: Blood"}]}, {"GSM2350937": [{"title": "SUBJ.1669, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1669;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 29.0876712328767;\tregion: rest_world;\tsledai_at_baseline: 17;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.535;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.095;\ttissue: Blood"}]}, {"GSM2350938": [{"title": "SUBJ.1446, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1446;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 46.2191780821917;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.795;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.092;\ttissue: Blood"}]}, {"GSM2350939": [{"title": "SUBJ.1589, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1589;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 51.6;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.51;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.305;\ttissue: Blood"}]}, {"GSM2350940": [{"title": "SUBJ.0737, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0737;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 47.6849315068493;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.17;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.261;\ttissue: Blood"}]}, {"GSM2350941": [{"title": "SUBJ.0544, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0544;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 43.4246575342465;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.472;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.086;\ttissue: Blood"}]}, {"GSM2350942": [{"title": "SUBJ.1764, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1764;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 51.9098360655737;\tregion: us_can;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 34;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.76;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.117;\ttissue: Blood"}]}, {"GSM2350943": [{"title": "SUBJ.0384, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0384;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 32.9917808219178;\tregion: rest_world;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 196;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.799;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.057;\ttissue: Blood"}]}, {"GSM2350944": [{"title": "SUBJ.0415, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0415;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 19.9123287671232;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.589;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.069;\ttissue: Blood"}]}, {"GSM2350945": [{"title": "SUBJ.1568, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1568;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 20.7814207650273;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.04;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.185;\ttissue: Blood"}]}, {"GSM2350946": [{"title": "SUBJ.1747, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1747;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 42.6794520547945;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.45;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.212;\ttissue: Blood"}]}, {"GSM2350947": [{"title": "SUBJ.1533, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1533;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 33.6027397260274;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.08;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.196;\ttissue: Blood"}]}, {"GSM2350948": [{"title": "SUBJ.0161, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0161;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 24.2931506849315;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 20;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.122;\ttissue: Blood"}]}, {"GSM2350949": [{"title": "SUBJ.0758, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0758;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 25.8082191780821;\tregion: mex_ca_sa;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.636;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.101;\ttissue: Blood"}]}, {"GSM2350950": [{"title": "SUBJ.0786, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0786;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Male;\tage_at_baseline: 34.545205479452;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.16;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.203;\ttissue: Blood"}]}, {"GSM2350951": [{"title": "SUBJ.1271, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1271;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 45.0383561643835;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 117;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.15;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.291;\ttissue: Blood"}]}, {"GSM2350952": [{"title": "SUBJ.0052, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0052;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 50.5479452054794;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.859;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.131;\ttissue: Blood"}]}, {"GSM2350953": [{"title": "SUBJ.0484, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0484;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 38.3424657534246;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 132;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.29;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.259;\ttissue: Blood"}]}, {"GSM2350954": [{"title": "SUBJ.1174, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1174;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: asian;\tSex: Female;\tage_at_baseline: 45.4767123287671;\tregion: rest_world;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.56;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.278;\ttissue: Blood"}]}, {"GSM2350955": [{"title": "SUBJ.1281, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1281;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 54.7431693989071;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.12;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.063;\ttissue: Blood"}]}, {"GSM2350956": [{"title": "SUBJ.1352, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1352;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 31.7890410958904;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 173;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.849;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.127;\ttissue: Blood"}]}, {"GSM2350957": [{"title": "SUBJ.0452, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0452;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 43.3342465753424;\tregion: europe;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 124;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.36;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.155;\ttissue: Blood"}]}, {"GSM2350958": [{"title": "SUBJ.1081, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1081;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 69.4575342465753;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.15;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.158;\ttissue: Blood"}]}, {"GSM2350959": [{"title": "SUBJ.0986, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0986;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 34.7404371584699;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.39;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.294;\ttissue: Blood"}]}, {"GSM2350960": [{"title": "SUBJ.0342, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0342;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 47.7732240437158;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 17;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.06;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.139;\ttissue: Blood"}]}, {"GSM2350961": [{"title": "SUBJ.0843, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0843;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 34.2986301369863;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.953;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.239;\ttissue: Blood"}]}, {"GSM2350962": [{"title": "SUBJ.0017, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0017;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 41.4191780821917;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 110;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.26;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.166;\ttissue: Blood"}]}, {"GSM2350963": [{"title": "SUBJ.0759, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0759;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 30.0273972602739;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 122;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.25;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.174;\ttissue: Blood"}]}, {"GSM2350964": [{"title": "SUBJ.0804, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0804;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 24.8606557377049;\tregion: europe;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 63;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.916;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.104;\ttissue: Blood"}]}, {"GSM2350965": [{"title": "SUBJ.1054, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1054;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 41.1068493150685;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.12;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.073;\ttissue: Blood"}]}, {"GSM2350966": [{"title": "SUBJ.0555, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0555;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 63.8360655737705;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 119;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.18;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.299;\ttissue: Blood"}]}, {"GSM2350967": [{"title": "SUBJ.0959, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0959;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 18.6739726027397;\tregion: us_can;\tsledai_at_baseline: 13;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.708;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.055;\ttissue: Blood"}]}, {"GSM2350968": [{"title": "SUBJ.0108, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0108;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 44.9480874316939;\tregion: europe;\tsledai_at_baseline: 4;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.36;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.357;\ttissue: Blood"}]}, {"GSM2350969": [{"title": "SUBJ.1118, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1118;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 51.2027397260274;\tregion: europe;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 19;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.29;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.231;\ttissue: Blood"}]}, {"GSM2350970": [{"title": "SUBJ.1546, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1546;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 29.2904109589041;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.757;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.192;\ttissue: Blood"}]}, {"GSM2350971": [{"title": "SUBJ.0210, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0210;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 47.775956284153;\tregion: mex_ca_sa;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.51;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.059;\ttissue: Blood"}]}, {"GSM2350972": [{"title": "SUBJ.1024, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1024;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 42.4767123287671;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 147;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.797;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.146;\ttissue: Blood"}]}, {"GSM2350973": [{"title": "SUBJ.1247, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1247;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 27.1835616438356;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.22;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.336;\ttissue: Blood"}]}, {"GSM2350974": [{"title": "SUBJ.0796, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0796;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 40.2383561643835;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 33;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.774;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2350975": [{"title": "SUBJ.1416, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1416;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 46.2410958904109;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 11;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.37;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.263;\ttissue: Blood"}]}, {"GSM2350976": [{"title": "SUBJ.1799, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1799;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 39.8907103825136;\tregion: rest_world;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.61;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.222;\ttissue: Blood"}]}, {"GSM2350977": [{"title": "SUBJ.1369, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1369;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 51.5150684931507;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 11;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.5;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.255;\ttissue: Blood"}]}, {"GSM2350978": [{"title": "SUBJ.0360, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0360;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 43.8876712328767;\tregion: mex_ca_sa;\tsledai_at_baseline: 22;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 98;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.667;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.149;\ttissue: Blood"}]}, {"GSM2350979": [{"title": "SUBJ.1635, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1635;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 60.5506849315068;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.72;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.512;\ttissue: Blood"}]}, {"GSM2350980": [{"title": "SUBJ.0211, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0211;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 33.6465753424657;\tregion: mex_ca_sa;\tsledai_at_baseline: 13;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 131;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.795;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.09;\ttissue: Blood"}]}, {"GSM2350981": [{"title": "SUBJ.0919, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0919;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 35.7397260273972;\tregion: us_can;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 34;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.59;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.575;\ttissue: Blood"}]}, {"GSM2350982": [{"title": "SUBJ.0999, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0999;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 45.6821917808219;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.7;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.4;\ttissue: Blood"}]}, {"GSM2350983": [{"title": "SUBJ.1119, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1119;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 25.8142076502732;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.22;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.219;\ttissue: Blood"}]}, {"GSM2350984": [{"title": "SUBJ.1404, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1404;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.8136986301369;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.899;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.222;\ttissue: Blood"}]}, {"GSM2350985": [{"title": "SUBJ.0787, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0787;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 28.811475409836;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.05;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.16;\ttissue: Blood"}]}, {"GSM2350986": [{"title": "SUBJ.1710, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1710;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 40.0767123287671;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.7;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.405;\ttissue: Blood"}]}, {"GSM2350987": [{"title": "SUBJ.0159, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0159;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 27.4575342465753;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 267;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.825;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.065;\ttissue: Blood"}]}, {"GSM2350988": [{"title": "SUBJ.0803, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0803;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 41.1534246575342;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.889;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.169;\ttissue: Blood"}]}, {"GSM2350989": [{"title": "SUBJ.1110, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1110;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Male;\tage_at_baseline: 25.0273972602739;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.292;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2350990": [{"title": "SUBJ.1816, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1816;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: multiple;\tSex: Female;\tage_at_baseline: 44.3342465753424;\tregion: rest_world;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.44;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.31;\ttissue: Blood"}]}, {"GSM2350991": [{"title": "SUBJ.1602, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1602;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 60.2986301369863;\tregion: europe;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.39;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.25;\ttissue: Blood"}]}, {"GSM2350992": [{"title": "SUBJ.0341, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0341;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 70.1205479452054;\tregion: us_can;\tsledai_at_baseline: 7;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.999;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.216;\ttissue: Blood"}]}, {"GSM2350993": [{"title": "SUBJ.0292, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0292;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 20.8821917808219;\tregion: us_can;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.27;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.221;\ttissue: Blood"}]}, {"GSM2350994": [{"title": "SUBJ.0969, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0969;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 48.5972602739726;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 160;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.639;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.067;\ttissue: Blood"}]}, {"GSM2350995": [{"title": "SUBJ.1554, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1554;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 47.6639344262295;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.854;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2350996": [{"title": "SUBJ.1391, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1391;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 59.9808219178082;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 31;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.811;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.068;\ttissue: Blood"}]}, {"GSM2350997": [{"title": "SUBJ.1502, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1502;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 51.1013698630137;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.14;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.2;\ttissue: Blood"}]}, {"GSM2350998": [{"title": "SUBJ.0035, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0035;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 38.1972602739726;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 21;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.32;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.375;\ttissue: Blood"}]}, {"GSM2350999": [{"title": "SUBJ.0047, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0047;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 60.0657534246575;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.39;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.163;\ttissue: Blood"}]}, {"GSM2351000": [{"title": "SUBJ.1341, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1341;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 26.186301369863;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 75;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.143;\ttissue: Blood"}]}, {"GSM2351001": [{"title": "SUBJ.0613, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0613;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 52.3917808219178;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.19;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.13;\ttissue: Blood"}]}, {"GSM2351002": [{"title": "SUBJ.0338, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0338;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 40.8743169398907;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 18;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.06;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.119;\ttissue: Blood"}]}, {"GSM2351003": [{"title": "SUBJ.1700, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1700;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 60.5808219178082;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 114;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.787;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.245;\ttissue: Blood"}]}, {"GSM2351004": [{"title": "SUBJ.0445, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0445;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 26.8986301369863;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 7;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.908;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.159;\ttissue: Blood"}]}, {"GSM2351005": [{"title": "SUBJ.1789, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1789;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 53.7486338797814;\tregion: rest_world;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 18;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.09;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.335;\ttissue: Blood"}]}, {"GSM2351006": [{"title": "SUBJ.1000, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1000;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 31.5616438356164;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 132;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.989;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.072;\ttissue: Blood"}]}, {"GSM2351007": [{"title": "SUBJ.0175, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0175;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 40.5506849315068;\tregion: mex_ca_sa;\tsledai_at_baseline: 13;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.678;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.106;\ttissue: Blood"}]}, {"GSM2351008": [{"title": "SUBJ.0440, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0440;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 22.8958904109589;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 49;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.234;\ttissue: Blood"}]}, {"GSM2351009": [{"title": "SUBJ.1058, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1058;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 53.1123287671233;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 16;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.078;\ttissue: Blood"}]}, {"GSM2351010": [{"title": "SUBJ.0214, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0214;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 34.6191780821917;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 124;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.17;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.174;\ttissue: Blood"}]}, {"GSM2351011": [{"title": "SUBJ.0827, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0827;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 22.8934426229508;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 182;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.913;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.197;\ttissue: Blood"}]}, {"GSM2351012": [{"title": "SUBJ.0345, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0345;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 75.4493150684931;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.963;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.194;\ttissue: Blood"}]}, {"GSM2351013": [{"title": "SUBJ.0039, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0039;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 24.117808219178;\tregion: rest_world;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.667;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.108;\ttissue: Blood"}]}, {"GSM2351014": [{"title": "SUBJ.1269, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1269;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 36.7349726775956;\tregion: mex_ca_sa;\tsledai_at_baseline: 13;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 108;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.792;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.109;\ttissue: Blood"}]}, {"GSM2351015": [{"title": "SUBJ.0978, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0978;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 59.5808219178082;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.876;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.138;\ttissue: Blood"}]}, {"GSM2351016": [{"title": "SUBJ.0375, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0375;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 41.1150684931506;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 22;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.33;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.242;\ttissue: Blood"}]}, {"GSM2351017": [{"title": "SUBJ.0815, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0815;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 45.5397260273972;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 156;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.29;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.131;\ttissue: Blood"}]}, {"GSM2351018": [{"title": "SUBJ.0670, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0670;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 30.8142076502732;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 150;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.821;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.093;\ttissue: Blood"}]}, {"GSM2351019": [{"title": "SUBJ.1207, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1207;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 31.5479452054794;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.83;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.105;\ttissue: Blood"}]}, {"GSM2351020": [{"title": "SUBJ.1537, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1537;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 58.8712328767123;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 96;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.35;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.251;\ttissue: Blood"}]}, {"GSM2351021": [{"title": "SUBJ.1432, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1432;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 23.8712328767123;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 138;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.738;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.086;\ttissue: Blood"}]}, {"GSM2351022": [{"title": "SUBJ.0622, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0622;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 32.1616438356164;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.93;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.133;\ttissue: Blood"}]}, {"GSM2351023": [{"title": "SUBJ.0105, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0105;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 30.1753424657534;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 16;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.619;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.082;\ttissue: Blood"}]}, {"GSM2351024": [{"title": "SUBJ.1745, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1745;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 51.8688524590164;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.909;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.158;\ttissue: Blood"}]}, {"GSM2351025": [{"title": "SUBJ.1171, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1171;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 44.2;\tregion: mex_ca_sa;\tsledai_at_baseline: 22;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 158;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.714;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.063;\ttissue: Blood"}]}, {"GSM2351026": [{"title": "SUBJ.0782, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0782;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: multiple;\tSex: Female;\tage_at_baseline: 22.8356164383561;\tregion: rest_world;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 125;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.16;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.143;\ttissue: Blood"}]}, {"GSM2351027": [{"title": "SUBJ.1011, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1011;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 56.0356164383561;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 17;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.16;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.37;\ttissue: Blood"}]}, {"GSM2351028": [{"title": "SUBJ.1686, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1686;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 37.7978142076502;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.673;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.112;\ttissue: Blood"}]}, {"GSM2351029": [{"title": "SUBJ.0480, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0480;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 62.7205479452054;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 38;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.49;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.175;\ttissue: Blood"}]}, {"GSM2351030": [{"title": "SUBJ.1235, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1235;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 55.758904109589;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 121;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.774;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2351031": [{"title": "SUBJ.1072, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1072;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Male;\tage_at_baseline: 23.3671232876712;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.07;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.206;\ttissue: Blood"}]}, {"GSM2351032": [{"title": "SUBJ.0633, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0633;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 43.2136986301369;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 10;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.898;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.155;\ttissue: Blood"}]}, {"GSM2351033": [{"title": "SUBJ.1036, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1036;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 67.8876712328767;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 31;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.28;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.464;\ttissue: Blood"}]}, {"GSM2351034": [{"title": "SUBJ.0466, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0466;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 23.6027397260274;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.879;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.197;\ttissue: Blood"}]}, {"GSM2351035": [{"title": "SUBJ.0583, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0583;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 51.2383561643835;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.24;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.217;\ttissue: Blood"}]}, {"GSM2351036": [{"title": "SUBJ.0735, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0735;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 31.8032786885245;\tregion: europe;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 39;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.807;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.176;\ttissue: Blood"}]}, {"GSM2351037": [{"title": "SUBJ.1522, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1522;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 35.775956284153;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.05;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.171;\ttissue: Blood"}]}, {"GSM2351038": [{"title": "SUBJ.1321, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1321;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 40.9342465753424;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.11;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.141;\ttissue: Blood"}]}, {"GSM2351039": [{"title": "SUBJ.0884, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0884;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 30.5616438356164;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.812;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.11;\ttissue: Blood"}]}, {"GSM2351040": [{"title": "SUBJ.1258, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1258;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 54.7972602739726;\tregion: us_can;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 188;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.918;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.199;\ttissue: Blood"}]}, {"GSM2351041": [{"title": "SUBJ.1448, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1448;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 45.6712328767123;\tregion: europe;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 113;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.804;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.123;\ttissue: Blood"}]}, {"GSM2351042": [{"title": "SUBJ.0405, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0405;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 34.7369863013698;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 24;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.03;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.176;\ttissue: Blood"}]}, {"GSM2351043": [{"title": "SUBJ.1389, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1389;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 20.4712328767123;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.505;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2351044": [{"title": "SUBJ.1018, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1018;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 38.6438356164383;\tregion: europe;\tsledai_at_baseline: 15;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 170;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.763;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.087;\ttissue: Blood"}]}, {"GSM2351045": [{"title": "SUBJ.1157, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1157;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 44.0876712328767;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 80;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.09;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.072;\ttissue: Blood"}]}, {"GSM2351046": [{"title": "SUBJ.1111, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1111;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.5616438356164;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 38;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.36;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.213;\ttissue: Blood"}]}, {"GSM2351047": [{"title": "SUBJ.1469, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1469;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 32.8602739726027;\tregion: us_can;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.852;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.186;\ttissue: Blood"}]}, {"GSM2351048": [{"title": "SUBJ.1678, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1678;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 37.2931506849315;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.05;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.244;\ttissue: Blood"}]}, {"GSM2351049": [{"title": "SUBJ.0499, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0499;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 35.8879781420765;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 133;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.351;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.134;\ttissue: Blood"}]}, {"GSM2351050": [{"title": "SUBJ.0019, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0019;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 70.5753424657534;\tregion: us_can;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.35;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.164;\ttissue: Blood"}]}, {"GSM2351051": [{"title": "SUBJ.1376, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1376;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 39.6164383561643;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 11;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.3;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.282;\ttissue: Blood"}]}, {"GSM2351052": [{"title": "SUBJ.0513, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0513;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 47.9616438356164;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 131;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.31;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.368;\ttissue: Blood"}]}, {"GSM2351053": [{"title": "SUBJ.0288, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0288;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 21.7349726775956;\tregion: mex_ca_sa;\tsledai_at_baseline: 24;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.09;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.131;\ttissue: Blood"}]}, {"GSM2351054": [{"title": "SUBJ.0011, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0011;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 64.0054794520548;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.887;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.175;\ttissue: Blood"}]}, {"GSM2351055": [{"title": "SUBJ.0244, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0244;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 35.7369863013698;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.37;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.205;\ttissue: Blood"}]}, {"GSM2351056": [{"title": "SUBJ.1471, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1471;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 55.3835616438356;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.513;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.055;\ttissue: Blood"}]}, {"GSM2351057": [{"title": "SUBJ.0941, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0941;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 46.0767123287671;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.21;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.269;\ttissue: Blood"}]}, {"GSM2351058": [{"title": "SUBJ.0760, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0760;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: asian;\tSex: Female;\tage_at_baseline: 57.9232876712328;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.958;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.179;\ttissue: Blood"}]}, {"GSM2351059": [{"title": "SUBJ.0089, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0089;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 57.9644808743169;\tregion: mex_ca_sa;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 73;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.801;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.107;\ttissue: Blood"}]}, {"GSM2351060": [{"title": "SUBJ.0465, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0465;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 53.131506849315;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 144;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.853;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.153;\ttissue: Blood"}]}, {"GSM2351061": [{"title": "SUBJ.0621, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0621;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 26.4684931506849;\tregion: rest_world;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.85;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.094;\ttissue: Blood"}]}, {"GSM2351062": [{"title": "SUBJ.0155, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0155;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 29.6465753424657;\tregion: us_can;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.529;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.133;\ttissue: Blood"}]}, {"GSM2351063": [{"title": "SUBJ.0818, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0818;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 63.1150684931507;\tregion: us_can;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.899;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.187;\ttissue: Blood"}]}, {"GSM2351064": [{"title": "SUBJ.1287, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1287;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 49.1260273972602;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 21;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.15;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.249;\ttissue: Blood"}]}, {"GSM2351065": [{"title": "SUBJ.0229, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0229;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: asian;\tSex: Female;\tage_at_baseline: 40.7459016393442;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.46;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.283;\ttissue: Blood"}]}, {"GSM2351066": [{"title": "SUBJ.0144, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0144;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 32.8794520547945;\tregion: us_can;\tsledai_at_baseline: 15;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.684;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.119;\ttissue: Blood"}]}, {"GSM2351067": [{"title": "SUBJ.1580, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1580;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 42.0273972602739;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.818;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.105;\ttissue: Blood"}]}, {"GSM2351068": [{"title": "SUBJ.1089, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1089;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 35.7698630136986;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.832;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.089;\ttissue: Blood"}]}, {"GSM2351069": [{"title": "SUBJ.0981, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0981;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 41.4712328767123;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 33;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.18;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.132;\ttissue: Blood"}]}, {"GSM2351070": [{"title": "SUBJ.0002, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0002;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 26.545205479452;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 70;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.931;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.115;\ttissue: Blood"}]}, {"GSM2351071": [{"title": "SUBJ.1653, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1653;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 57.5643835616438;\tregion: rest_world;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.37;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.253;\ttissue: Blood"}]}, {"GSM2351072": [{"title": "SUBJ.0449, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0449;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 35.4904109589041;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 227;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.09;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.155;\ttissue: Blood"}]}, {"GSM2351073": [{"title": "SUBJ.0198, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0198;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 52.9013698630137;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.998;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.181;\ttissue: Blood"}]}, {"GSM2351074": [{"title": "SUBJ.0837, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0837;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 40.4273972602739;\tregion: mex_ca_sa;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 132;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.847;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.104;\ttissue: Blood"}]}, {"GSM2351075": [{"title": "SUBJ.1708, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1708;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 38.6246575342465;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.804;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.129;\ttissue: Blood"}]}, {"GSM2351076": [{"title": "SUBJ.0276, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0276;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 23.9369863013698;\tregion: us_can;\tsledai_at_baseline: 22;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 229;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.98;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.058;\ttissue: Blood"}]}, {"GSM2351077": [{"title": "SUBJ.0282, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0282;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 58.317808219178;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.66;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.303;\ttissue: Blood"}]}, {"GSM2351078": [{"title": "SUBJ.0192, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0192;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 54.3205479452054;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 228;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.936;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.258;\ttissue: Blood"}]}, {"GSM2351079": [{"title": "SUBJ.1483, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1483;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 43.2054794520548;\tregion: us_can;\tsledai_at_baseline: 26;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): H;\tc3_at_baseline (g/l): 1.89;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.09;\ttissue: Blood"}]}, {"GSM2351080": [{"title": "SUBJ.1261, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1261;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 50.2465753424657;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 265;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.27;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.293;\ttissue: Blood"}]}, {"GSM2351081": [{"title": "SUBJ.1218, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1218;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 32.4904109589041;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 146;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.739;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.103;\ttissue: Blood"}]}, {"GSM2351082": [{"title": "SUBJ.1627, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1627;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 27.8821917808219;\tregion: rest_world;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 247;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.58;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.165;\ttissue: Blood"}]}, {"GSM2351083": [{"title": "SUBJ.1385, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1385;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 28.9698630136986;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.766;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.063;\ttissue: Blood"}]}, {"GSM2351084": [{"title": "SUBJ.1253, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1253;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 49.5479452054794;\tregion: europe;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 33;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.904;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.102;\ttissue: Blood"}]}, {"GSM2351085": [{"title": "SUBJ.1670, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1670;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 21.2821917808219;\tregion: mex_ca_sa;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 230;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.818;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.098;\ttissue: Blood"}]}, {"GSM2351086": [{"title": "SUBJ.0257, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0257;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 31.5424657534246;\tregion: rest_world;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 63;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.974;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.224;\ttissue: Blood"}]}, {"GSM2351087": [{"title": "SUBJ.0088, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0088;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 32.0109589041095;\tregion: mex_ca_sa;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.01;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.136;\ttissue: Blood"}]}, {"GSM2351088": [{"title": "SUBJ.1348, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1348;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 37.5643835616438;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 96;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.728;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.089;\ttissue: Blood"}]}, {"GSM2351089": [{"title": "SUBJ.1044, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1044;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 31.0246575342465;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 161;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.716;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.078;\ttissue: Blood"}]}, {"GSM2351090": [{"title": "SUBJ.1459, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1459;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 42.6602739726027;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.7;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.287;\ttissue: Blood"}]}, {"GSM2351091": [{"title": "SUBJ.0792, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0792;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 37.8989071038251;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 100;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.847;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.21;\ttissue: Blood"}]}, {"GSM2351092": [{"title": "SUBJ.0318, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0318;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 49.6857923497267;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.38;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.24;\ttissue: Blood"}]}, {"GSM2351093": [{"title": "SUBJ.0054, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0054;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 50.8657534246575;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 100;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.91;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.24;\ttissue: Blood"}]}, {"GSM2351094": [{"title": "SUBJ.1830, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1830;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 41.5643835616438;\tregion: europe;\tsledai_at_baseline: 13;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.696;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.123;\ttissue: Blood"}]}, {"GSM2351095": [{"title": "SUBJ.0822, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0822;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 43.9123287671232;\tregion: rest_world;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.46;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.506;\ttissue: Blood"}]}, {"GSM2351096": [{"title": "SUBJ.1519, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1519;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 51.7753424657534;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 14;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.3;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.343;\ttissue: Blood"}]}, {"GSM2351097": [{"title": "SUBJ.0426, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0426;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 35.1780821917808;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.31;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.246;\ttissue: Blood"}]}, {"GSM2351098": [{"title": "SUBJ.1574, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1574;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Male;\tage_at_baseline: 34.5698630136986;\tregion: us_can;\tsledai_at_baseline: 2;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.13;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.235;\ttissue: Blood"}]}, {"GSM2351099": [{"title": "SUBJ.1003, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1003;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 43.5972602739726;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.572;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2351100": [{"title": "SUBJ.0939, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0939;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 48.0465753424657;\tregion: us_can;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.782;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.275;\ttissue: Blood"}]}, {"GSM2351101": [{"title": "SUBJ.0050, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0050;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 41.7786885245901;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.803;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.131;\ttissue: Blood"}]}, {"GSM2351102": [{"title": "SUBJ.1252, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1252;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 32.7561643835616;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 256;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.839;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.092;\ttissue: Blood"}]}, {"GSM2351103": [{"title": "SUBJ.0890, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0890;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 37.0109589041095;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 71;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.118;\ttissue: Blood"}]}, {"GSM2351104": [{"title": "SUBJ.1243, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1243;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 25.8907103825136;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 83;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.947;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.185;\ttissue: Blood"}]}, {"GSM2351105": [{"title": "SUBJ.1117, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1117;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 25.172602739726;\tregion: rest_world;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.24;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.276;\ttissue: Blood"}]}, {"GSM2351106": [{"title": "SUBJ.1676, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1676;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 25.7978142076502;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 141;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.09;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.15;\ttissue: Blood"}]}, {"GSM2351107": [{"title": "SUBJ.0404, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0404;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 32.1616438356164;\tregion: rest_world;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 263;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.989;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.273;\ttissue: Blood"}]}, {"GSM2351108": [{"title": "SUBJ.1608, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1608;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 35.2739726027397;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 216;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.478;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.052;\ttissue: Blood"}]}, {"GSM2351109": [{"title": "SUBJ.0809, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0809;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 40.6356164383561;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 129;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.74;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.104;\ttissue: Blood"}]}, {"GSM2351110": [{"title": "SUBJ.1423, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1423;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 50.6465753424657;\tregion: rest_world;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 145;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.899;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.13;\ttissue: Blood"}]}, {"GSM2351111": [{"title": "SUBJ.0272, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0272;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 58.6602739726027;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.11;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.238;\ttissue: Blood"}]}, {"GSM2351112": [{"title": "SUBJ.0302, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0302;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 38.2712328767123;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.897;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.188;\ttissue: Blood"}]}, {"GSM2351113": [{"title": "SUBJ.1827, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1827;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 23.4136986301369;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 119;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.93;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.148;\ttissue: Blood"}]}, {"GSM2351114": [{"title": "SUBJ.1181, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1181;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 34.717808219178;\tregion: us_can;\tsledai_at_baseline: 13;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.373;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.056;\ttissue: Blood"}]}, {"GSM2351115": [{"title": "SUBJ.0817, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0817;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 53.9479452054794;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 108;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.851;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.223;\ttissue: Blood"}]}, {"GSM2351116": [{"title": "SUBJ.0689, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0689;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 27.5534246575342;\tregion: europe;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 199;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.759;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.064;\ttissue: Blood"}]}, {"GSM2351117": [{"title": "SUBJ.0351, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0351;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Male;\tage_at_baseline: 33.8688524590164;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 67;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.831;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.21;\ttissue: Blood"}]}, {"GSM2351118": [{"title": "SUBJ.1166, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1166;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 40.1260273972602;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.21;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.102;\ttissue: Blood"}]}, {"GSM2351119": [{"title": "SUBJ.1612, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1612;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 36.8333333333333;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.81;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.162;\ttissue: Blood"}]}, {"GSM2351120": [{"title": "SUBJ.0527, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0527;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 44.1479452054794;\tregion: us_can;\tsledai_at_baseline: 13;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 231;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.829;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.082;\ttissue: Blood"}]}, {"GSM2351121": [{"title": "SUBJ.0495, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0495;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 34;\tregion: rest_world;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 38;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.22;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.174;\ttissue: Blood"}]}, {"GSM2351122": [{"title": "SUBJ.0930, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0930;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 51.8551912568306;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 70;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.98;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.192;\ttissue: Blood"}]}, {"GSM2351123": [{"title": "SUBJ.1347, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1347;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 51.3041095890411;\tregion: us_can;\tsledai_at_baseline: 7;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.24;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.18;\ttissue: Blood"}]}, {"GSM2351124": [{"title": "SUBJ.0005, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0005;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: multiple;\tSex: Female;\tage_at_baseline: 42.2986301369863;\tregion: rest_world;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.567;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.117;\ttissue: Blood"}]}, {"GSM2351125": [{"title": "SUBJ.0142, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0142;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 50.5808219178082;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.39;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.167;\ttissue: Blood"}]}, {"GSM2351126": [{"title": "SUBJ.0742, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0742;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 37.8767123287671;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.858;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.15;\ttissue: Blood"}]}, {"GSM2351127": [{"title": "SUBJ.1779, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1779;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 60.2684931506849;\tregion: us_can;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.16;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.229;\ttissue: Blood"}]}, {"GSM2351128": [{"title": "SUBJ.1005, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1005;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 42.8931506849315;\tregion: europe;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.997;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.067;\ttissue: Blood"}]}, {"GSM2351129": [{"title": "SUBJ.1801, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1801;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 34.8169398907103;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 40;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.883;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.072;\ttissue: Blood"}]}, {"GSM2351130": [{"title": "SUBJ.0422, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0422;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 17.9808219178082;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 141;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.601;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.108;\ttissue: Blood"}]}, {"GSM2351131": [{"title": "SUBJ.1332, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1332;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 50.9753424657534;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.101;\ttissue: Blood"}]}, {"GSM2351132": [{"title": "SUBJ.1442, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1442;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 38.9424657534246;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 92;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.343;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.065;\ttissue: Blood"}]}, {"GSM2351133": [{"title": "SUBJ.1401, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1401;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 29.8054794520548;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.903;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.134;\ttissue: Blood"}]}, {"GSM2351134": [{"title": "SUBJ.0111, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0111;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 53.0301369863013;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.24;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.061;\ttissue: Blood"}]}, {"GSM2351135": [{"title": "SUBJ.0755, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0755;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 42.2602739726027;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 150;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.12;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.112;\ttissue: Blood"}]}, {"GSM2351136": [{"title": "SUBJ.0914, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0914;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 50.6;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.664;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.092;\ttissue: Blood"}]}, {"GSM2351137": [{"title": "SUBJ.0715, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0715;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 46.1616438356164;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 22;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.574;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.125;\ttissue: Blood"}]}, {"GSM2351138": [{"title": "SUBJ.1365, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1365;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 32.2821917808219;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 11;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.31;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.18;\ttissue: Blood"}]}, {"GSM2351139": [{"title": "SUBJ.0793, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0793;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 47.3397260273972;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.11;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.198;\ttissue: Blood"}]}, {"GSM2351140": [{"title": "SUBJ.1695, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1695;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 47.9698630136986;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.56;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.272;\ttissue: Blood"}]}, {"GSM2351141": [{"title": "SUBJ.1694, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1694;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 45.4630136986301;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.49;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.217;\ttissue: Blood"}]}, {"GSM2351142": [{"title": "SUBJ.1099, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1099;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 42.9424657534246;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 98;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.2;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.228;\ttissue: Blood"}]}, {"GSM2351143": [{"title": "SUBJ.1293, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1293;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 36.9150684931506;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.28;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.253;\ttissue: Blood"}]}, {"GSM2351144": [{"title": "SUBJ.1566, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1566;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 52.7950819672131;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.21;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.201;\ttissue: Blood"}]}, {"GSM2351145": [{"title": "SUBJ.1268, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1268;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 59.4301369863013;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 119;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.83;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.088;\ttissue: Blood"}]}, {"GSM2351146": [{"title": "SUBJ.0777, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0777;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 25.8986301369863;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 49;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.68;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.361;\ttissue: Blood"}]}, {"GSM2351147": [{"title": "SUBJ.0964, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0964;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: multiple;\tSex: Female;\tage_at_baseline: 31.1479452054794;\tregion: rest_world;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 19;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.11;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.075;\ttissue: Blood"}]}, {"GSM2351148": [{"title": "SUBJ.0641, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0641;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 25.4575342465753;\tregion: europe;\tsledai_at_baseline: 13;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 115;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.06;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.097;\ttissue: Blood"}]}, {"GSM2351149": [{"title": "SUBJ.0942, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0942;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 31.1698630136986;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 39;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.75;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.341;\ttissue: Blood"}]}, {"GSM2351150": [{"title": "SUBJ.1409, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1409;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 30.2739726027397;\tregion: europe;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 49;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.778;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.095;\ttissue: Blood"}]}, {"GSM2351151": [{"title": "SUBJ.1016, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1016;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 30.0986301369863;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 49;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.63;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.275;\ttissue: Blood"}]}, {"GSM2351152": [{"title": "SUBJ.0831, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0831;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 43.4054794520547;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 11;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.58;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.384;\ttissue: Blood"}]}, {"GSM2351153": [{"title": "SUBJ.0355, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0355;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 39.4328767123287;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 43;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.624;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.127;\ttissue: Blood"}]}, {"GSM2351154": [{"title": "SUBJ.0560, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0560;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 48.8961748633879;\tregion: us_can;\tsledai_at_baseline: 7;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.38;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.279;\ttissue: Blood"}]}, {"GSM2351155": [{"title": "SUBJ.0523, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0523;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 33.6493150684931;\tregion: us_can;\tsledai_at_baseline: 24;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.324;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.089;\ttissue: Blood"}]}, {"GSM2351156": [{"title": "SUBJ.1311, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1311;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 42.5397260273972;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.975;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.183;\ttissue: Blood"}]}, {"GSM2351157": [{"title": "SUBJ.0554, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0554;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 55.145205479452;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.57;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.234;\ttissue: Blood"}]}, {"GSM2351158": [{"title": "SUBJ.1020, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1020;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 50.5534246575342;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 120;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.161;\ttissue: Blood"}]}, {"GSM2351159": [{"title": "SUBJ.1415, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1415;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 58.4684931506849;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.39;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.351;\ttissue: Blood"}]}, {"GSM2351160": [{"title": "SUBJ.0417, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0417;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 22.8712328767123;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.368;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.093;\ttissue: Blood"}]}, {"GSM2351161": [{"title": "SUBJ.1495, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1495;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 59.7369863013698;\tregion: europe;\tsledai_at_baseline: 13;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 189;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.612;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.082;\ttissue: Blood"}]}, {"GSM2351162": [{"title": "SUBJ.0991, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0991;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 28.5260273972602;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.736;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.057;\ttissue: Blood"}]}, {"GSM2351163": [{"title": "SUBJ.1565, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1565;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 42.8054794520548;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 25;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.943;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.214;\ttissue: Blood"}]}, {"GSM2351164": [{"title": "SUBJ.0133, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0133;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 29.3397260273972;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.759;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.243;\ttissue: Blood"}]}, {"GSM2351165": [{"title": "SUBJ.0013, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0013;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 46.9616438356164;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 11;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.663;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.107;\ttissue: Blood"}]}, {"GSM2351166": [{"title": "SUBJ.1586, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1586;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 40.8465753424657;\tregion: us_can;\tsledai_at_baseline: 4;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.33;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.554;\ttissue: Blood"}]}, {"GSM2351167": [{"title": "SUBJ.0924, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0924;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 22.6383561643835;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 102;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.747;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.13;\ttissue: Blood"}]}, {"GSM2351168": [{"title": "SUBJ.0494, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0494;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 49.1890410958904;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.846;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.154;\ttissue: Blood"}]}, {"GSM2351169": [{"title": "SUBJ.1334, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1334;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 40.8551912568306;\tregion: europe;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.802;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.103;\ttissue: Blood"}]}, {"GSM2351170": [{"title": "SUBJ.1215, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1215;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 58.1287671232876;\tregion: us_can;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 110;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.87;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.164;\ttissue: Blood"}]}, {"GSM2351171": [{"title": "SUBJ.0813, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0813;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 44.1917808219178;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 13;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.834;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.18;\ttissue: Blood"}]}, {"GSM2351172": [{"title": "SUBJ.1480, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1480;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 52.6520547945205;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 64;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.2;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.166;\ttissue: Blood"}]}, {"GSM2351173": [{"title": "SUBJ.1624, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1624;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 55.7622950819672;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.14;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.352;\ttissue: Blood"}]}, {"GSM2351174": [{"title": "SUBJ.1419, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1419;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 46.972602739726;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 15;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): H;\tc3_at_baseline (g/l): 1.98;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.392;\ttissue: Blood"}]}, {"GSM2351175": [{"title": "SUBJ.0614, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0614;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.7753424657534;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 245;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.23;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.197;\ttissue: Blood"}]}, {"GSM2351176": [{"title": "SUBJ.0878, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0878;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 43.4575342465753;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.953;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.113;\ttissue: Blood"}]}, {"GSM2351177": [{"title": "SUBJ.0171, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0171;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 42.7972602739726;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.24;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.261;\ttissue: Blood"}]}, {"GSM2351178": [{"title": "SUBJ.1520, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1520;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 54.4383561643835;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.07;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.185;\ttissue: Blood"}]}, {"GSM2351179": [{"title": "SUBJ.1257, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1257;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 63.8770491803278;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 147;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.221;\ttissue: Blood"}]}, {"GSM2351180": [{"title": "SUBJ.1664, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1664;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 44.7616438356164;\tregion: rest_world;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 61;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.999;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.221;\ttissue: Blood"}]}, {"GSM2351181": [{"title": "SUBJ.0504, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0504;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 32.1698630136986;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.06;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.231;\ttissue: Blood"}]}, {"GSM2351182": [{"title": "SUBJ.1134, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1134;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Male;\tage_at_baseline: 42.8547945205479;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.05;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.195;\ttissue: Blood"}]}, {"GSM2351183": [{"title": "SUBJ.0326, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0326;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 33.0465753424657;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 159;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.687;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.158;\ttissue: Blood"}]}, {"GSM2351184": [{"title": "SUBJ.0659, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0659;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 37.758904109589;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 95;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.25;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.07;\ttissue: Blood"}]}, {"GSM2351185": [{"title": "SUBJ.1154, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1154;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 47.2191780821917;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 31;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): H;\tc3_at_baseline (g/l): 1.96;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.424;\ttissue: Blood"}]}, {"GSM2351186": [{"title": "SUBJ.0062, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0062;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 42.3643835616438;\tregion: europe;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.856;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.179;\ttissue: Blood"}]}, {"GSM2351187": [{"title": "SUBJ.0028, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0028;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 53.6830601092896;\tregion: us_can;\tsledai_at_baseline: 7;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 53;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.13;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.305;\ttissue: Blood"}]}, {"GSM2351188": [{"title": "SUBJ.0823, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0823;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 51.2958904109589;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 65;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.897;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.195;\ttissue: Blood"}]}, {"GSM2351189": [{"title": "SUBJ.1063, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1063;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 60.7123287671233;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.53;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.113;\ttissue: Blood"}]}, {"GSM2351190": [{"title": "SUBJ.0281, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0281;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 36.6410958904109;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 112;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.831;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.137;\ttissue: Blood"}]}, {"GSM2351191": [{"title": "SUBJ.1073, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1073;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 21.772602739726;\tregion: mex_ca_sa;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.53;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.052;\ttissue: Blood"}]}, {"GSM2351192": [{"title": "SUBJ.0658, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0658;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 37.9753424657534;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.802;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.096;\ttissue: Blood"}]}, {"GSM2351193": [{"title": "SUBJ.0092, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0092;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 42.1205479452054;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 16;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.03;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.107;\ttissue: Blood"}]}, {"GSM2351194": [{"title": "SUBJ.0481, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0481;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 31.1123287671232;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 13;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.607;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.148;\ttissue: Blood"}]}, {"GSM2351195": [{"title": "SUBJ.0379, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0379;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Male;\tage_at_baseline: 47.1205479452054;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 91;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.51;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2351196": [{"title": "SUBJ.0945, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0945;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 55.3150684931506;\tregion: rest_world;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.06;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.157;\ttissue: Blood"}]}, {"GSM2351197": [{"title": "SUBJ.1234, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1234;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 33.7479452054794;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.67;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.348;\ttissue: Blood"}]}, {"GSM2351198": [{"title": "SUBJ.1260, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1260;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 25.2931506849315;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.01;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.183;\ttissue: Blood"}]}, {"GSM2351199": [{"title": "SUBJ.0680, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0680;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 51.9506849315068;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.43;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.185;\ttissue: Blood"}]}, {"GSM2351200": [{"title": "SUBJ.1735, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1735;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 34.5123287671232;\tregion: europe;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.894;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.112;\ttissue: Blood"}]}, {"GSM2351201": [{"title": "SUBJ.1061, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1061;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 46.8164383561643;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.79;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.246;\ttissue: Blood"}]}, {"GSM2351202": [{"title": "SUBJ.1661, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1661;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 30.2958904109589;\tregion: us_can;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 96;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.699;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.122;\ttissue: Blood"}]}, {"GSM2351203": [{"title": "SUBJ.1211, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1211;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 51.3698630136986;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 10;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.14;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.201;\ttissue: Blood"}]}, {"GSM2351204": [{"title": "SUBJ.1009, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1009;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 32.9890410958904;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.46;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.195;\ttissue: Blood"}]}, {"GSM2351205": [{"title": "SUBJ.1264, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1264;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 21.7123287671232;\tregion: rest_world;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.458;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.075;\ttissue: Blood"}]}, {"GSM2351206": [{"title": "SUBJ.0860, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0860;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 37.0904109589041;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.03;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.222;\ttissue: Blood"}]}, {"GSM2351207": [{"title": "SUBJ.0923, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0923;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 50.558904109589;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 87;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.977;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.09;\ttissue: Blood"}]}, {"GSM2351208": [{"title": "SUBJ.1025, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1025;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 21.3753424657534;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.725;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.078;\ttissue: Blood"}]}, {"GSM2351209": [{"title": "SUBJ.1463, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1463;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 51.2164383561643;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.52;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.29;\ttissue: Blood"}]}, {"GSM2351210": [{"title": "SUBJ.1750, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1750;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 45.9808219178082;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 16;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.37;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.308;\ttissue: Blood"}]}, {"GSM2351211": [{"title": "SUBJ.1782, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1782;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 42.7213114754098;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 37;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.728;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.062;\ttissue: Blood"}]}, {"GSM2351212": [{"title": "SUBJ.1751, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1751;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 48.1616438356164;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 113;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.05;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.183;\ttissue: Blood"}]}, {"GSM2351213": [{"title": "SUBJ.0038, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0038;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 60.9616438356164;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.08;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.239;\ttissue: Blood"}]}, {"GSM2351214": [{"title": "SUBJ.1734, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1734;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 31.6967213114754;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.15;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2351215": [{"title": "SUBJ.0551, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0551;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 29.2794520547945;\tregion: mex_ca_sa;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 141;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.557;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2351216": [{"title": "SUBJ.0425, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0425;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 35.9890410958904;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.729;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.059;\ttissue: Blood"}]}, {"GSM2351217": [{"title": "SUBJ.1704, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1704;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 25.4712328767123;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.233;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.096;\ttissue: Blood"}]}, {"GSM2351218": [{"title": "SUBJ.0042, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0042;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 34.3479452054794;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.22;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.254;\ttissue: Blood"}]}, {"GSM2351219": [{"title": "SUBJ.0852, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0852;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 32.9616438356164;\tregion: europe;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.632;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.074;\ttissue: Blood"}]}, {"GSM2351220": [{"title": "SUBJ.0363, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0363;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 46.9561643835616;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.6;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.307;\ttissue: Blood"}]}, {"GSM2351221": [{"title": "SUBJ.0886, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0886;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 52.1945205479452;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.07;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.177;\ttissue: Blood"}]}, {"GSM2351222": [{"title": "SUBJ.1571, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1571;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 34.3397260273972;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.98;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.164;\ttissue: Blood"}]}, {"GSM2351223": [{"title": "SUBJ.1548, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1548;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 35.4493150684931;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 161;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.26;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.187;\ttissue: Blood"}]}, {"GSM2351224": [{"title": "SUBJ.0721, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0721;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 28.4438356164383;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.986;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.215;\ttissue: Blood"}]}, {"GSM2351225": [{"title": "SUBJ.1690, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1690;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 52.8931506849315;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 93;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.895;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.091;\ttissue: Blood"}]}, {"GSM2351226": [{"title": "SUBJ.0485, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0485;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 50.3479452054794;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 212;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.01;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2351227": [{"title": "SUBJ.1489, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1489;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 26.5095890410958;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 135;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.853;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.166;\ttissue: Blood"}]}, {"GSM2351228": [{"title": "SUBJ.0847, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0847;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 25.5616438356164;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 69;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.669;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.089;\ttissue: Blood"}]}, {"GSM2351229": [{"title": "SUBJ.1584, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1584;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 41.0602739726027;\tregion: us_can;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.921;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.251;\ttissue: Blood"}]}, {"GSM2351230": [{"title": "SUBJ.1173, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1173;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.1287671232876;\tregion: mex_ca_sa;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 11;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.83;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.227;\ttissue: Blood"}]}, {"GSM2351231": [{"title": "SUBJ.1476, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1476;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 41.3397260273972;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 20;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.4;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.343;\ttissue: Blood"}]}, {"GSM2351232": [{"title": "SUBJ.0706, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0706;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 19.5479452054794;\tregion: mex_ca_sa;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.537;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.059;\ttissue: Blood"}]}, {"GSM2351233": [{"title": "SUBJ.0525, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0525;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 51.7616438356164;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.27;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.313;\ttissue: Blood"}]}, {"GSM2351234": [{"title": "SUBJ.1538, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1538;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 54.5260273972602;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 31;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.21;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.257;\ttissue: Blood"}]}, {"GSM2351235": [{"title": "SUBJ.1517, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1517;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 34.0438356164383;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.64;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.257;\ttissue: Blood"}]}, {"GSM2351236": [{"title": "SUBJ.1813, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1813;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 28.8169398907103;\tregion: europe;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.32;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.331;\ttissue: Blood"}]}, {"GSM2351237": [{"title": "SUBJ.1820, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1820;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 44.8684931506849;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 7;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.64;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.22;\ttissue: Blood"}]}, {"GSM2351238": [{"title": "SUBJ.1223, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1223;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 36.6602739726027;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.13;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.231;\ttissue: Blood"}]}, {"GSM2351239": [{"title": "SUBJ.0464, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0464;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 37.9534246575342;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.28;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.309;\ttissue: Blood"}]}, {"GSM2351240": [{"title": "SUBJ.0390, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0390;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 56.1479452054794;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.15;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.264;\ttissue: Blood"}]}, {"GSM2351241": [{"title": "SUBJ.1328, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1328;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 34.8739726027397;\tregion: mex_ca_sa;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.988;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.163;\ttissue: Blood"}]}, {"GSM2351242": [{"title": "SUBJ.0572, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0572;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 51.9753424657534;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.36;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.275;\ttissue: Blood"}]}, {"GSM2351243": [{"title": "SUBJ.0129, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0129;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 32.4109589041095;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.973;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.206;\ttissue: Blood"}]}, {"GSM2351244": [{"title": "SUBJ.1093, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1093;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 29.8520547945205;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.782;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.174;\ttissue: Blood"}]}, {"GSM2351245": [{"title": "SUBJ.0128, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0128;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 47.9232876712328;\tregion: us_can;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.632;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.116;\ttissue: Blood"}]}, {"GSM2351246": [{"title": "SUBJ.1461, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1461;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 47.8328767123287;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 18;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.322;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2351247": [{"title": "SUBJ.1384, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1384;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 55.2164383561643;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 13;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.868;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.128;\ttissue: Blood"}]}, {"GSM2351248": [{"title": "SUBJ.1645, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1645;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 48.3616438356164;\tregion: europe;\tsledai_at_baseline: 13;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 12;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.09;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.188;\ttissue: Blood"}]}, {"GSM2351249": [{"title": "SUBJ.0895, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0895;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 23.0383561643835;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.06;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.059;\ttissue: Blood"}]}, {"GSM2351250": [{"title": "SUBJ.0756, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0756;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 40.3561643835616;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 20;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.182;\ttissue: Blood"}]}, {"GSM2351251": [{"title": "SUBJ.0535, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0535;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 52.7349726775956;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 7;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.955;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.156;\ttissue: Blood"}]}, {"GSM2351252": [{"title": "SUBJ.1595, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1595;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 35.8661202185792;\tregion: europe;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 87;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.52;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.181;\ttissue: Blood"}]}, {"GSM2351253": [{"title": "SUBJ.1395, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1395;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 66.0794520547945;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.07;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.196;\ttissue: Blood"}]}, {"GSM2351254": [{"title": "SUBJ.0578, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0578;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 41.7123287671232;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 13;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.23;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.201;\ttissue: Blood"}]}, {"GSM2351255": [{"title": "SUBJ.1788, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1788;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 52.4684931506849;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.39;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.28;\ttissue: Blood"}]}, {"GSM2351256": [{"title": "SUBJ.1592, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1592;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 38.4520547945205;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 183;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.684;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.137;\ttissue: Blood"}]}, {"GSM2351257": [{"title": "SUBJ.1394, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1394;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 28.6602739726027;\tregion: us_can;\tsledai_at_baseline: 26;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.03;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.092;\ttissue: Blood"}]}, {"GSM2351258": [{"title": "SUBJ.0968, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0968;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.3671232876712;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 7;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.2;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.235;\ttissue: Blood"}]}, {"GSM2351259": [{"title": "SUBJ.0354, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0354;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 42.6438356164383;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.72;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.419;\ttissue: Blood"}]}, {"GSM2351260": [{"title": "SUBJ.0149, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0149;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 44.4630136986301;\tregion: rest_world;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 222;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.54;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.476;\ttissue: Blood"}]}, {"GSM2351261": [{"title": "SUBJ.0381, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0381;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 25.3013698630137;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 10;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): H;\tc3_at_baseline (g/l): 2;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.4;\ttissue: Blood"}]}, {"GSM2351262": [{"title": "SUBJ.1819, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1819;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 19.7917808219178;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 34;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.13;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.148;\ttissue: Blood"}]}, {"GSM2351263": [{"title": "SUBJ.0331, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0331;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 34.7616438356164;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 15;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.906;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.169;\ttissue: Blood"}]}, {"GSM2351264": [{"title": "SUBJ.1048, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1048;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 62.8551912568306;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 76;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.188;\ttissue: Blood"}]}, {"GSM2351265": [{"title": "SUBJ.0301, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0301;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 43.7841530054644;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.633;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.194;\ttissue: Blood"}]}, {"GSM2351266": [{"title": "SUBJ.1667, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1667;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 21.3671232876712;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.802;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.088;\ttissue: Blood"}]}, {"GSM2351267": [{"title": "SUBJ.0842, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0842;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 23.4602739726027;\tregion: rest_world;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.21;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.14;\ttissue: Blood"}]}, {"GSM2351268": [{"title": "SUBJ.1613, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1613;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 42.5342465753424;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.05;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.108;\ttissue: Blood"}]}, {"GSM2351269": [{"title": "SUBJ.0921, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0921;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 23.3150684931506;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.08;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.08;\ttissue: Blood"}]}, {"GSM2351270": [{"title": "SUBJ.1129, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1129;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 34.2383561643835;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 56;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.918;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.164;\ttissue: Blood"}]}, {"GSM2351271": [{"title": "SUBJ.0442, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0442;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 36.9287671232876;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.01;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.207;\ttissue: Blood"}]}, {"GSM2351272": [{"title": "SUBJ.0877, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0877;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 27.8169398907103;\tregion: rest_world;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 11;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.12;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.152;\ttissue: Blood"}]}, {"GSM2351273": [{"title": "SUBJ.0493, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0493;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 20.7506849315068;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.689;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.068;\ttissue: Blood"}]}, {"GSM2351274": [{"title": "SUBJ.1427, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1427;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 32.3890410958904;\tregion: rest_world;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 181;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.743;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.057;\ttissue: Blood"}]}, {"GSM2351275": [{"title": "SUBJ.0524, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0524;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 30.6219178082191;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 143;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.796;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.095;\ttissue: Blood"}]}, {"GSM2351276": [{"title": "SUBJ.0041, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0041;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 67.2246575342465;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 31;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.45;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.355;\ttissue: Blood"}]}, {"GSM2351277": [{"title": "SUBJ.0972, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0972;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 36.3616438356164;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.739;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.086;\ttissue: Blood"}]}, {"GSM2351278": [{"title": "SUBJ.0663, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0663;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 62.2767123287671;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.959;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2351279": [{"title": "SUBJ.0587, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0587;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 53.158904109589;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 7;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.22;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.182;\ttissue: Blood"}]}, {"GSM2351280": [{"title": "SUBJ.0807, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0807;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 72.4383561643835;\tregion: us_can;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.42;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.264;\ttissue: Blood"}]}, {"GSM2351281": [{"title": "SUBJ.0740, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0740;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 18.7342465753424;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.34;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.214;\ttissue: Blood"}]}, {"GSM2351282": [{"title": "SUBJ.1141, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1141;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 56.4109589041096;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.656;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.087;\ttissue: Blood"}]}, {"GSM2351283": [{"title": "SUBJ.0638, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0638;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 52.186301369863;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.695;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.18;\ttissue: Blood"}]}, {"GSM2351284": [{"title": "SUBJ.1327, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1327;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 20.7013698630137;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 141;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.855;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.11;\ttissue: Blood"}]}, {"GSM2351285": [{"title": "SUBJ.1360, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1360;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 33.2958904109589;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.08;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.147;\ttissue: Blood"}]}, {"GSM2351286": [{"title": "SUBJ.0487, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0487;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 51.3890410958904;\tregion: rest_world;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.76;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.618;\ttissue: Blood"}]}, {"GSM2351287": [{"title": "SUBJ.0770, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0770;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 46.7972602739726;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 76;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.28;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.35;\ttissue: Blood"}]}, {"GSM2351288": [{"title": "SUBJ.0188, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0188;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 25.1068493150685;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 31;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.3;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.132;\ttissue: Blood"}]}, {"GSM2351289": [{"title": "SUBJ.0955, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0955;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 37.1945205479452;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.04;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.111;\ttissue: Blood"}]}, {"GSM2351290": [{"title": "SUBJ.1397, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1397;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 39.8547945205479;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 23;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.71;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.151;\ttissue: Blood"}]}, {"GSM2351291": [{"title": "SUBJ.0065, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0065;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 52.7185792349726;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.897;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.159;\ttissue: Blood"}]}, {"GSM2351292": [{"title": "SUBJ.0026, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0026;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 47.0876712328767;\tregion: rest_world;\tsledai_at_baseline: 15;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 13;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.25;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.077;\ttissue: Blood"}]}, {"GSM2351293": [{"title": "SUBJ.0888, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0888;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 47.5835616438356;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.734;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.1;\ttissue: Blood"}]}, {"GSM2351294": [{"title": "SUBJ.0871, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0871;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 52.8465753424657;\tregion: rest_world;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.33;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.306;\ttissue: Blood"}]}, {"GSM2351295": [{"title": "SUBJ.0661, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0661;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 48.8383561643835;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 22;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.66;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.079;\ttissue: Blood"}]}, {"GSM2351296": [{"title": "SUBJ.1689, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1689;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 36.9726775956284;\tregion: us_can;\tsledai_at_baseline: 7;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 117;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.958;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.148;\ttissue: Blood"}]}, {"GSM2351297": [{"title": "SUBJ.0225, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0225;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 49.2438356164383;\tregion: us_can;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.803;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.189;\ttissue: Blood"}]}, {"GSM2351298": [{"title": "SUBJ.1398, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1398;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Male;\tage_at_baseline: 26.8931506849315;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 261;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.942;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.154;\ttissue: Blood"}]}, {"GSM2351299": [{"title": "SUBJ.1447, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1447;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 42.6273972602739;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.57;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.14;\ttissue: Blood"}]}, {"GSM2351300": [{"title": "SUBJ.0669, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0669;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 58.5342465753424;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 13;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.844;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.125;\ttissue: Blood"}]}, {"GSM2351301": [{"title": "SUBJ.1037, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1037;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 39.4246575342465;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.746;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.106;\ttissue: Blood"}]}, {"GSM2351302": [{"title": "SUBJ.1660, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1660;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 24.2931506849315;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.726;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.074;\ttissue: Blood"}]}, {"GSM2351303": [{"title": "SUBJ.0901, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0901;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 62.7978142076502;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 143;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.11;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.232;\ttissue: Blood"}]}, {"GSM2351304": [{"title": "SUBJ.1563, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1563;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 46.2931506849315;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 202;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.977;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.258;\ttissue: Blood"}]}, {"GSM2351305": [{"title": "SUBJ.1184, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1184;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 48.5068493150685;\tregion: rest_world;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.13;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.094;\ttissue: Blood"}]}, {"GSM2351306": [{"title": "SUBJ.1067, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1067;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 34.8606557377049;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 132;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.14;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.105;\ttissue: Blood"}]}, {"GSM2351307": [{"title": "SUBJ.0907, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0907;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 51.5835616438356;\tregion: mex_ca_sa;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 129;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.09;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.232;\ttissue: Blood"}]}, {"GSM2351308": [{"title": "SUBJ.0874, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0874;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 46.2767123287671;\tregion: us_can;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.39;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.305;\ttissue: Blood"}]}, {"GSM2351309": [{"title": "SUBJ.0644, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0644;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 45.8136986301369;\tregion: mex_ca_sa;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.335;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2351310": [{"title": "SUBJ.0446, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0446;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 45.5479452054794;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.24;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.246;\ttissue: Blood"}]}, {"GSM2351311": [{"title": "SUBJ.0797, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0797;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 56.0219178082191;\tregion: rest_world;\tsledai_at_baseline: 23;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.06;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.395;\ttissue: Blood"}]}, {"GSM2351312": [{"title": "SUBJ.0101, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0101;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 61.9506849315068;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.804;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.178;\ttissue: Blood"}]}, {"GSM2351313": [{"title": "SUBJ.1060, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1060;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 56.1041095890411;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.06;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.13;\ttissue: Blood"}]}, {"GSM2351314": [{"title": "SUBJ.0967, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0967;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: multiple;\tSex: Female;\tage_at_baseline: 57.4904109589041;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.26;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.408;\ttissue: Blood"}]}, {"GSM2351315": [{"title": "SUBJ.0286, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0286;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 43.4493150684931;\tregion: mex_ca_sa;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.06;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.368;\ttissue: Blood"}]}, {"GSM2351316": [{"title": "SUBJ.1304, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1304;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 59.3287671232876;\tregion: rest_world;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.19;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.3;\ttissue: Blood"}]}, {"GSM2351317": [{"title": "SUBJ.0429, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0429;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 47.8520547945205;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 114;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.744;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.113;\ttissue: Blood"}]}, {"GSM2351318": [{"title": "SUBJ.0733, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0733;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: multiple;\tSex: Female;\tage_at_baseline: 40.0328767123287;\tregion: rest_world;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.13;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.19;\ttissue: Blood"}]}, {"GSM2351319": [{"title": "SUBJ.0079, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0079;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 25.6775956284153;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 145;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.778;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.081;\ttissue: Blood"}]}, {"GSM2351320": [{"title": "SUBJ.0872, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0872;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 47.545205479452;\tregion: europe;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 115;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.35;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.262;\ttissue: Blood"}]}, {"GSM2351321": [{"title": "SUBJ.1582, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1582;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 25.7622950819672;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 147;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.806;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.12;\ttissue: Blood"}]}, {"GSM2351322": [{"title": "SUBJ.0584, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0584;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 38.7213114754098;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 15;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.54;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.285;\ttissue: Blood"}]}, {"GSM2351323": [{"title": "SUBJ.0757, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0757;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 50.9616438356164;\tregion: us_can;\tsledai_at_baseline: 22;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 48;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.987;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.102;\ttissue: Blood"}]}, {"GSM2351324": [{"title": "SUBJ.1367, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1367;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 27.172602739726;\tregion: rest_world;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 31;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.06;\ttissue: Blood"}]}, {"GSM2351325": [{"title": "SUBJ.0206, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0206;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 43.6410958904109;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.115;\ttissue: Blood"}]}, {"GSM2351326": [{"title": "SUBJ.0126, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0126;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 32.1506849315068;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 127;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.55;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.213;\ttissue: Blood"}]}, {"GSM2351327": [{"title": "SUBJ.0377, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0377;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 34.1041095890411;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 172;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.748;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.102;\ttissue: Blood"}]}, {"GSM2351328": [{"title": "SUBJ.0747, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0747;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 63.8136986301369;\tregion: rest_world;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 146;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.41;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.306;\ttissue: Blood"}]}, {"GSM2351329": [{"title": "SUBJ.0885, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0885;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: multiple;\tSex: Female;\tage_at_baseline: 19.4328767123287;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 190;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.03;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.191;\ttissue: Blood"}]}, {"GSM2351330": [{"title": "SUBJ.1494, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1494;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.9506849315068;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.793;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.235;\ttissue: Blood"}]}, {"GSM2351331": [{"title": "SUBJ.1748, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1748;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 22.2246575342465;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 152;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.691;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.063;\ttissue: Blood"}]}, {"GSM2351332": [{"title": "SUBJ.0430, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0430;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 49.1780821917808;\tregion: europe;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.777;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.132;\ttissue: Blood"}]}, {"GSM2351333": [{"title": "SUBJ.0821, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0821;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 53.2082191780822;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 11;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.663;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.104;\ttissue: Blood"}]}, {"GSM2351334": [{"title": "SUBJ.0008, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0008;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 36.1013698630137;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.24;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.2;\ttissue: Blood"}]}, {"GSM2351335": [{"title": "SUBJ.0811, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0811;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: --;\tSex: --;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2351336": [{"title": "SUBJ.0532, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0532;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 31.8934426229508;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 54;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.07;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.128;\ttissue: Blood"}]}, {"GSM2351337": [{"title": "SUBJ.0174, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0174;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 65.7095890410959;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.08;\ttissue: Blood"}]}, {"GSM2351338": [{"title": "SUBJ.1506, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1506;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 31.3753424657534;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.799;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.162;\ttissue: Blood"}]}, {"GSM2351339": [{"title": "SUBJ.0703, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0703;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 37.8360655737704;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 12;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.41;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.283;\ttissue: Blood"}]}, {"GSM2351340": [{"title": "SUBJ.1790, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1790;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 46.3917808219178;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.176;\ttissue: Blood"}]}, {"GSM2351341": [{"title": "SUBJ.0015, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0015;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 59.9534246575342;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.802;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.147;\ttissue: Blood"}]}, {"GSM2351342": [{"title": "SUBJ.0746, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0746;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 25.8849315068493;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.04;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.195;\ttissue: Blood"}]}, {"GSM2351343": [{"title": "SUBJ.1116, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1116;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 47.931506849315;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 98;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.085;\ttissue: Blood"}]}, {"GSM2351344": [{"title": "SUBJ.1191, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1191;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 65.7267759562841;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.24;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.257;\ttissue: Blood"}]}, {"GSM2351345": [{"title": "SUBJ.1721, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1721;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 41.9123287671232;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 139;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.689;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.201;\ttissue: Blood"}]}, {"GSM2351346": [{"title": "SUBJ.0690, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0690;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 63.1917808219178;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.42;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.282;\ttissue: Blood"}]}, {"GSM2351347": [{"title": "SUBJ.0409, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0409;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 45.9616438356164;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.05;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.181;\ttissue: Blood"}]}, {"GSM2351348": [{"title": "SUBJ.1701, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1701;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 62.6830601092896;\tregion: europe;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 12;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.39;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.155;\ttissue: Blood"}]}, {"GSM2351349": [{"title": "SUBJ.1043, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1043;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 60.7424657534246;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.979;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.163;\ttissue: Blood"}]}, {"GSM2351350": [{"title": "SUBJ.0624, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0624;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 75.0712328767123;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.61;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.248;\ttissue: Blood"}]}, {"GSM2351351": [{"title": "SUBJ.0398, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0398;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 44.6575342465753;\tregion: rest_world;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.4;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.198;\ttissue: Blood"}]}, {"GSM2351352": [{"title": "SUBJ.0067, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0067;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 30.6520547945205;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 83;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.854;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.155;\ttissue: Blood"}]}, {"GSM2351353": [{"title": "SUBJ.0824, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0824;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 52.8465753424657;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 141;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.2;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.193;\ttissue: Blood"}]}, {"GSM2351354": [{"title": "SUBJ.1626, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1626;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 20.3534246575342;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 238;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.444;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2351355": [{"title": "SUBJ.0434, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0434;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 35.9506849315068;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.24;\ttissue: Blood"}]}, {"GSM2351356": [{"title": "SUBJ.0227, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0227;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 53.9479452054794;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 190;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.653;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.087;\ttissue: Blood"}]}, {"GSM2351357": [{"title": "SUBJ.1344, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1344;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 41.0849315068493;\tregion: us_can;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 81;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.41;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.175;\ttissue: Blood"}]}, {"GSM2351358": [{"title": "SUBJ.1724, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1724;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 51.8383561643835;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 52;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.44;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.278;\ttissue: Blood"}]}, {"GSM2351359": [{"title": "SUBJ.0267, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0267;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 35.4520547945205;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.16;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.293;\ttissue: Blood"}]}, {"GSM2351360": [{"title": "SUBJ.0806, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0806;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 46.8958904109589;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 38;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.97;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.337;\ttissue: Blood"}]}, {"GSM2351361": [{"title": "SUBJ.0539, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0539;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 46.0684931506849;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 96;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.912;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.137;\ttissue: Blood"}]}, {"GSM2351362": [{"title": "SUBJ.0903, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0903;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: multiple;\tSex: Female;\tage_at_baseline: 59.6739726027397;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.54;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.491;\ttissue: Blood"}]}, {"GSM2351363": [{"title": "SUBJ.1564, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1564;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 42.3260273972602;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.73;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.129;\ttissue: Blood"}]}, {"GSM2351364": [{"title": "SUBJ.1720, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1720;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 49.6438356164383;\tregion: us_can;\tsledai_at_baseline: 4;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 99;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.918;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2351365": [{"title": "SUBJ.1478, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1478;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 22.5095890410958;\tregion: mex_ca_sa;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 162;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.8;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.181;\ttissue: Blood"}]}, {"GSM2351366": [{"title": "SUBJ.0114, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0114;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.6602739726027;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.08;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.211;\ttissue: Blood"}]}, {"GSM2351367": [{"title": "SUBJ.1439, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1439;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 25.4712328767123;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.57;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.356;\ttissue: Blood"}]}, {"GSM2351368": [{"title": "SUBJ.1800, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1800;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 29.3753424657534;\tregion: europe;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 14;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.14;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.207;\ttissue: Blood"}]}, {"GSM2351369": [{"title": "SUBJ.0031, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0031;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 29.7369863013698;\tregion: europe;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 84;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.616;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.051;\ttissue: Blood"}]}, {"GSM2351370": [{"title": "SUBJ.0506, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0506;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 29.5616438356164;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 23;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.783;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.135;\ttissue: Blood"}]}, {"GSM2351371": [{"title": "SUBJ.1682, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1682;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 44.8958904109589;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 12;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.6;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.565;\ttissue: Blood"}]}, {"GSM2351372": [{"title": "SUBJ.0120, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0120;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 39.0849315068493;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 13;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.24;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.149;\ttissue: Blood"}]}, {"GSM2351373": [{"title": "SUBJ.1508, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1508;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 40.5260273972602;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 180;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.839;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.139;\ttissue: Blood"}]}, {"GSM2351374": [{"title": "SUBJ.0561, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0561;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 39.5917808219178;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.35;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.232;\ttissue: Blood"}]}, {"GSM2351375": [{"title": "SUBJ.0297, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0297;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 38.9371584699453;\tregion: europe;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 157;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.645;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.134;\ttissue: Blood"}]}, {"GSM2351376": [{"title": "SUBJ.1727, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1727;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 54.4547945205479;\tregion: us_can;\tsledai_at_baseline: 22;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.583;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.072;\ttissue: Blood"}]}, {"GSM2351377": [{"title": "SUBJ.0805, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0805;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 61.6054794520548;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.38;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.162;\ttissue: Blood"}]}, {"GSM2351378": [{"title": "SUBJ.0164, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0164;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 54.6328767123287;\tregion: rest_world;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.42;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.313;\ttissue: Blood"}]}, {"GSM2351379": [{"title": "SUBJ.0141, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0141;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 35.9672131147541;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 130;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.25;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.115;\ttissue: Blood"}]}, {"GSM2351380": [{"title": "SUBJ.1168, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1168;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 46.5287671232876;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 19;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.04;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.235;\ttissue: Blood"}]}, {"GSM2351381": [{"title": "SUBJ.1544, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1544;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 30.811475409836;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.958;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.059;\ttissue: Blood"}]}, {"GSM2351382": [{"title": "SUBJ.1127, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1127;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 32.1041095890411;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.09;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.315;\ttissue: Blood"}]}, {"GSM2351383": [{"title": "SUBJ.1742, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1742;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 37.6438356164383;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.93;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.145;\ttissue: Blood"}]}, {"GSM2351384": [{"title": "SUBJ.0932, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0932;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 27.9098360655737;\tregion: europe;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 159;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.953;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.227;\ttissue: Blood"}]}, {"GSM2351385": [{"title": "SUBJ.0976, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0976;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 49.5424657534246;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 12;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.11;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.322;\ttissue: Blood"}]}, {"GSM2351386": [{"title": "SUBJ.1167, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1167;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 50.9698630136986;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 166;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.25;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.338;\ttissue: Blood"}]}, {"GSM2351387": [{"title": "SUBJ.1783, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1783;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 24.2739726027397;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 120;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.666;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.104;\ttissue: Blood"}]}, {"GSM2351388": [{"title": "SUBJ.0637, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0637;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 43.6666666666666;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 10;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.4;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.22;\ttissue: Blood"}]}, {"GSM2351389": [{"title": "SUBJ.1617, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1617;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 46.6986301369863;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.964;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.243;\ttissue: Blood"}]}, {"GSM2351390": [{"title": "SUBJ.0631, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0631;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 21.8770491803278;\tregion: mex_ca_sa;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 72;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.961;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.196;\ttissue: Blood"}]}, {"GSM2351391": [{"title": "SUBJ.1756, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1756;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 33.1616438356164;\tregion: rest_world;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 153;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.08;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.316;\ttissue: Blood"}]}, {"GSM2351392": [{"title": "SUBJ.1792, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1792;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 35.7917808219178;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.601;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.055;\ttissue: Blood"}]}, {"GSM2351393": [{"title": "SUBJ.1295, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1295;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 23.8219178082191;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 83;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.58;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.302;\ttissue: Blood"}]}, {"GSM2351394": [{"title": "SUBJ.0673, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0673;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 33.8849315068493;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.56;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.432;\ttissue: Blood"}]}, {"GSM2351395": [{"title": "SUBJ.1814, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1814;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 29.572602739726;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.618;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.086;\ttissue: Blood"}]}, {"GSM2351396": [{"title": "SUBJ.0226, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0226;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 23.5698630136986;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 16;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.28;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.225;\ttissue: Blood"}]}, {"GSM2351397": [{"title": "SUBJ.0374, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0374;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 50.1013698630137;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.23;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.222;\ttissue: Blood"}]}, {"GSM2351398": [{"title": "SUBJ.1069, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1069;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 36.7049180327868;\tregion: rest_world;\tsledai_at_baseline: 22;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.669;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.059;\ttissue: Blood"}]}, {"GSM2351399": [{"title": "SUBJ.0470, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0470;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 70.4493150684931;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 40;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.21;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.243;\ttissue: Blood"}]}, {"GSM2351400": [{"title": "SUBJ.1473, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1473;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 36.3698630136986;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 44;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.03;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.172;\ttissue: Blood"}]}, {"GSM2351401": [{"title": "SUBJ.1725, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1725;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 37.331506849315;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 123;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.966;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.088;\ttissue: Blood"}]}, {"GSM2351402": [{"title": "SUBJ.0435, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0435;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 30.6054794520548;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.785;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.3;\ttissue: Blood"}]}, {"GSM2351403": [{"title": "SUBJ.0749, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0749;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 25.9917808219178;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.39;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.142;\ttissue: Blood"}]}, {"GSM2351404": [{"title": "SUBJ.1797, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1797;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 35.7732240437158;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 22;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.04;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.137;\ttissue: Blood"}]}, {"GSM2351405": [{"title": "SUBJ.0709, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0709;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 33.9508196721311;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 15;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.03;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.111;\ttissue: Blood"}]}, {"GSM2351406": [{"title": "SUBJ.0385, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0385;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 58.0684931506849;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 96;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.55;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.219;\ttissue: Blood"}]}, {"GSM2351407": [{"title": "SUBJ.0618, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0618;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 42.0273972602739;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.38;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.226;\ttissue: Blood"}]}, {"GSM2351408": [{"title": "SUBJ.0218, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0218;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 39.586301369863;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.938;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.181;\ttissue: Blood"}]}, {"GSM2351409": [{"title": "SUBJ.0014, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0014;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 55.2602739726027;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 176;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.09;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.164;\ttissue: Blood"}]}, {"GSM2351410": [{"title": "SUBJ.0033, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0033;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 40.3369863013698;\tregion: us_can;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 230;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.874;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.183;\ttissue: Blood"}]}, {"GSM2351411": [{"title": "SUBJ.1467, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1467;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 41.1643835616438;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.171;\ttissue: Blood"}]}, {"GSM2351412": [{"title": "SUBJ.0859, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0859;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: multiple;\tSex: Female;\tage_at_baseline: 44.8770491803278;\tregion: mex_ca_sa;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.17;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.245;\ttissue: Blood"}]}, {"GSM2351413": [{"title": "SUBJ.0337, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0337;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 33.545205479452;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 181;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.07;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.179;\ttissue: Blood"}]}, {"GSM2351414": [{"title": "SUBJ.0234, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0234;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 36.8630136986301;\tregion: us_can;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.671;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.089;\ttissue: Blood"}]}, {"GSM2351415": [{"title": "SUBJ.0453, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0453;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 44.5753424657534;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.58;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.243;\ttissue: Blood"}]}, {"GSM2351416": [{"title": "SUBJ.1038, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1038;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 69.6191780821917;\tregion: europe;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.19;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.094;\ttissue: Blood"}]}, {"GSM2351417": [{"title": "SUBJ.1082, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1082;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 32.8524590163934;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 148;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.747;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.168;\ttissue: Blood"}]}, {"GSM2351418": [{"title": "SUBJ.1242, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1242;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 36.9890410958904;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.562;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.079;\ttissue: Blood"}]}, {"GSM2351419": [{"title": "SUBJ.1322, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1322;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 32.7185792349726;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 89;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.072;\ttissue: Blood"}]}, {"GSM2351420": [{"title": "SUBJ.0678, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0678;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 57.5917808219178;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.68;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.425;\ttissue: Blood"}]}, {"GSM2351421": [{"title": "SUBJ.1187, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1187;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 36.731506849315;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.63;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.266;\ttissue: Blood"}]}, {"GSM2351422": [{"title": "SUBJ.1529, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1529;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 24.1616438356164;\tregion: rest_world;\tsledai_at_baseline: 15;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.446;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.051;\ttissue: Blood"}]}, {"GSM2351423": [{"title": "SUBJ.1826, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1826;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 28.8931506849315;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 22;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.732;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.056;\ttissue: Blood"}]}, {"GSM2351424": [{"title": "SUBJ.0626, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0626;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 42.3808219178082;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 48;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.22;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.343;\ttissue: Blood"}]}, {"GSM2351425": [{"title": "SUBJ.1769, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1769;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 38.8328767123287;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 131;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.857;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.183;\ttissue: Blood"}]}, {"GSM2351426": [{"title": "SUBJ.1021, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1021;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 48.0602739726027;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.12;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.123;\ttissue: Blood"}]}, {"GSM2351427": [{"title": "SUBJ.0057, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0057;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 45.8169398907103;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.65;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2351428": [{"title": "SUBJ.0086, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0086;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 29.0657534246575;\tregion: us_can;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.492;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.064;\ttissue: Blood"}]}, {"GSM2351429": [{"title": "SUBJ.0612, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0612;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 38.2547945205479;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 31;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.01;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.108;\ttissue: Blood"}]}, {"GSM2351430": [{"title": "SUBJ.0373, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0373;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 37.7232876712328;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.662;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.09;\ttissue: Blood"}]}, {"GSM2351431": [{"title": "SUBJ.0305, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0305;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 51.117808219178;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 18;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.34;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.318;\ttissue: Blood"}]}, {"GSM2351432": [{"title": "SUBJ.1203, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1203;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 18.7377049180327;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.775;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.088;\ttissue: Blood"}]}, {"GSM2351433": [{"title": "SUBJ.0951, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0951;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 36.372602739726;\tregion: europe;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.814;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.104;\ttissue: Blood"}]}, {"GSM2351434": [{"title": "SUBJ.0395, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0395;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 48.9371584699453;\tregion: us_can;\tsledai_at_baseline: 13;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.663;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.097;\ttissue: Blood"}]}, {"GSM2351435": [{"title": "SUBJ.0127, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0127;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 45.7814207650273;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 102;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.796;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.186;\ttissue: Blood"}]}, {"GSM2351436": [{"title": "SUBJ.0714, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0714;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 56.6082191780822;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 97;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.23;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.368;\ttissue: Blood"}]}, {"GSM2351437": [{"title": "SUBJ.0151, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0151;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 45.2520547945205;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.68;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.328;\ttissue: Blood"}]}, {"GSM2351438": [{"title": "SUBJ.1746, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1746;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 74.158904109589;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 16;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.17;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.29;\ttissue: Blood"}]}, {"GSM2351439": [{"title": "SUBJ.1318, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1318;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 36.0876712328767;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.417;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2351440": [{"title": "SUBJ.1306, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1306;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 27.1205479452054;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 140;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.801;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.163;\ttissue: Blood"}]}, {"GSM2351441": [{"title": "SUBJ.0834, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0834;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 30.3287671232876;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 99;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.04;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.204;\ttissue: Blood"}]}, {"GSM2351442": [{"title": "SUBJ.0788, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0788;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 33.2164383561643;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 223;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.77;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.287;\ttissue: Blood"}]}, {"GSM2351443": [{"title": "SUBJ.1470, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1470;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 23.5232876712328;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.969;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.089;\ttissue: Blood"}]}, {"GSM2351444": [{"title": "SUBJ.1806, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1806;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 51.7404371584699;\tregion: us_can;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 24;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.17;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.171;\ttissue: Blood"}]}, {"GSM2351445": [{"title": "SUBJ.0169, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0169;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 38.4246575342465;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.983;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.172;\ttissue: Blood"}]}, {"GSM2351446": [{"title": "SUBJ.1420, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1420;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 28.6410958904109;\tregion: europe;\tsledai_at_baseline: 15;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 101;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.749;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.063;\ttissue: Blood"}]}, {"GSM2351447": [{"title": "SUBJ.1639, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1639;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 18.8931506849315;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 51;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.04;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.216;\ttissue: Blood"}]}, {"GSM2351448": [{"title": "SUBJ.0814, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0814;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 46.331506849315;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.96;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.131;\ttissue: Blood"}]}, {"GSM2351449": [{"title": "SUBJ.0259, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0259;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 23.7540983606557;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 54;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.886;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.114;\ttissue: Blood"}]}, {"GSM2351450": [{"title": "SUBJ.0867, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0867;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 49.1835616438356;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.05;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.184;\ttissue: Blood"}]}, {"GSM2351451": [{"title": "SUBJ.1316, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1316;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 25.6246575342465;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 12;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.829;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.231;\ttissue: Blood"}]}, {"GSM2351452": [{"title": "SUBJ.0009, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0009;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 43.0849315068493;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 106;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.971;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.183;\ttissue: Blood"}]}, {"GSM2351453": [{"title": "SUBJ.1809, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1809;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 33.4246575342465;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.839;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.178;\ttissue: Blood"}]}, {"GSM2351454": [{"title": "SUBJ.1101, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1101;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 53.2054794520548;\tregion: europe;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 107;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.682;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.073;\ttissue: Blood"}]}, {"GSM2351455": [{"title": "SUBJ.1051, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1051;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 45.775956284153;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 13;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.24;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.148;\ttissue: Blood"}]}, {"GSM2351456": [{"title": "SUBJ.1834, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1834;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 29.3287671232876;\tregion: us_can;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.83;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.085;\ttissue: Blood"}]}, {"GSM2351457": [{"title": "SUBJ.0993, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0993;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 40.2575342465753;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 103;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.32;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.214;\ttissue: Blood"}]}, {"GSM2351458": [{"title": "SUBJ.0785, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0785;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 30.0301369863013;\tregion: mex_ca_sa;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 160;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.822;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.14;\ttissue: Blood"}]}, {"GSM2351459": [{"title": "SUBJ.1499, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1499;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 28.7814207650273;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 238;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.631;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.078;\ttissue: Blood"}]}, {"GSM2351460": [{"title": "SUBJ.0263, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0263;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 34.4273972602739;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 218;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.748;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.118;\ttissue: Blood"}]}, {"GSM2351461": [{"title": "SUBJ.1598, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1598;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 31.9205479452054;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.066;\ttissue: Blood"}]}, {"GSM2351462": [{"title": "SUBJ.0816, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0816;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 42.4958904109589;\tregion: us_can;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.831;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.112;\ttissue: Blood"}]}, {"GSM2351463": [{"title": "SUBJ.0994, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0994;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 58.6958904109589;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.77;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.414;\ttissue: Blood"}]}, {"GSM2351464": [{"title": "SUBJ.0001, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0001;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 22.7671232876712;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 233;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.961;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.098;\ttissue: Blood"}]}, {"GSM2351465": [{"title": "SUBJ.0443, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0443;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 51.2821917808219;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 7;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.657;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.1;\ttissue: Blood"}]}, {"GSM2351466": [{"title": "SUBJ.0564, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0564;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 61.358904109589;\tregion: europe;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.715;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.093;\ttissue: Blood"}]}, {"GSM2351467": [{"title": "SUBJ.0066, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0066;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 31.9071038251366;\tregion: europe;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 158;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.983;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.185;\ttissue: Blood"}]}, {"GSM2351468": [{"title": "SUBJ.0437, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0437;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 55.9698630136986;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 38;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.721;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.102;\ttissue: Blood"}]}, {"GSM2351469": [{"title": "SUBJ.0913, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0913;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 52.9699453551912;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 174;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.91;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.115;\ttissue: Blood"}]}, {"GSM2351470": [{"title": "SUBJ.1556, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1556;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 45.8986301369863;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.2;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.299;\ttissue: Blood"}]}, {"GSM2351471": [{"title": "SUBJ.0863, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0863;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 36.7369863013698;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.543;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.067;\ttissue: Blood"}]}, {"GSM2351472": [{"title": "SUBJ.0386, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0386;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 55.1643835616438;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.39;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.292;\ttissue: Blood"}]}, {"GSM2351473": [{"title": "SUBJ.1128, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1128;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 36.8191780821917;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.45;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.273;\ttissue: Blood"}]}, {"GSM2351474": [{"title": "SUBJ.1120, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1120;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 25.2191780821917;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 12;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.04;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.088;\ttissue: Blood"}]}, {"GSM2351475": [{"title": "SUBJ.1345, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1345;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 47.5150684931506;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.74;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.326;\ttissue: Blood"}]}, {"GSM2351476": [{"title": "SUBJ.0849, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0849;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 48.4082191780822;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 38;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.18;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.209;\ttissue: Blood"}]}, {"GSM2351477": [{"title": "SUBJ.0110, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0110;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 30.7205479452054;\tregion: us_can;\tsledai_at_baseline: 7;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.32;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.271;\ttissue: Blood"}]}, {"GSM2351478": [{"title": "SUBJ.0250, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0250;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 47.6775956284153;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.48;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.2;\ttissue: Blood"}]}, {"GSM2351479": [{"title": "SUBJ.1616, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1616;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 51.983606557377;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 37;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.55;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.359;\ttissue: Blood"}]}, {"GSM2351480": [{"title": "SUBJ.1150, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1150;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 40.2986301369863;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.689;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2351481": [{"title": "SUBJ.0053, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0053;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 46.7753424657534;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.983;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.256;\ttissue: Blood"}]}, {"GSM2351482": [{"title": "SUBJ.0186, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0186;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 71.6136986301369;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.2;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.06;\ttissue: Blood"}]}, {"GSM2351483": [{"title": "SUBJ.0966, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0966;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 21.8356164383561;\tregion: us_can;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 163;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.51;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.23;\ttissue: Blood"}]}, {"GSM2351484": [{"title": "SUBJ.0916, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0916;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: multiple;\tSex: Female;\tage_at_baseline: 41.1041095890411;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.15;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.144;\ttissue: Blood"}]}, {"GSM2351485": [{"title": "SUBJ.1572, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1572;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: asian;\tSex: Female;\tage_at_baseline: 35.5835616438356;\tregion: rest_world;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.26;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.35;\ttissue: Blood"}]}, {"GSM2351486": [{"title": "SUBJ.0314, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0314;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 54.331506849315;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.15;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.138;\ttissue: Blood"}]}, {"GSM2351487": [{"title": "SUBJ.1201, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1201;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 50.7698630136986;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.47;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.284;\ttissue: Blood"}]}, {"GSM2351488": [{"title": "SUBJ.0667, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0667;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 32.7561643835616;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.28;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.231;\ttissue: Blood"}]}, {"GSM2351489": [{"title": "SUBJ.0340, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0340;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 44.558904109589;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.575;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.097;\ttissue: Blood"}]}, {"GSM2351490": [{"title": "SUBJ.0115, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0115;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: asian;\tSex: Female;\tage_at_baseline: 25.4520547945205;\tregion: rest_world;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.9;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.086;\ttissue: Blood"}]}, {"GSM2351491": [{"title": "SUBJ.0707, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0707;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 36.9287671232876;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 130;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.818;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.193;\ttissue: Blood"}]}, {"GSM2351492": [{"title": "SUBJ.0454, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0454;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 30.6994535519125;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 150;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.521;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.123;\ttissue: Blood"}]}, {"GSM2351493": [{"title": "SUBJ.1514, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1514;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 35.0301369863013;\tregion: mex_ca_sa;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.787;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.123;\ttissue: Blood"}]}, {"GSM2351494": [{"title": "SUBJ.1755, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1755;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 59.986301369863;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 74;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.43;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.242;\ttissue: Blood"}]}, {"GSM2351495": [{"title": "SUBJ.1146, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1146;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 33.4273972602739;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 93;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.979;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.18;\ttissue: Blood"}]}, {"GSM2351496": [{"title": "SUBJ.1382, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1382;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 32.5287671232876;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 144;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.4;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.189;\ttissue: Blood"}]}, {"GSM2351497": [{"title": "SUBJ.1741, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1741;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.8879781420765;\tregion: mex_ca_sa;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 254;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.695;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.095;\ttissue: Blood"}]}, {"GSM2351498": [{"title": "SUBJ.1773, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1773;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 62.5917808219178;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.06;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.16;\ttissue: Blood"}]}, {"GSM2351499": [{"title": "SUBJ.1346, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1346;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 54.5479452054794;\tregion: rest_world;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 7;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.43;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.214;\ttissue: Blood"}]}, {"GSM2351500": [{"title": "SUBJ.1702, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1702;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 51.2547945205479;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.08;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.188;\ttissue: Blood"}]}, {"GSM2351501": [{"title": "SUBJ.1754, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1754;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 52.7568306010929;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.17;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.194;\ttissue: Blood"}]}, {"GSM2351502": [{"title": "SUBJ.1575, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1575;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 50.3479452054794;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 226;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.643;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.094;\ttissue: Blood"}]}, {"GSM2351503": [{"title": "SUBJ.0022, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0022;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 28.6575342465753;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 270;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.371;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2351504": [{"title": "SUBJ.1631, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1631;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.9342465753424;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 38;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.36;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.266;\ttissue: Blood"}]}, {"GSM2351505": [{"title": "SUBJ.0235, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0235;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 33.0438356164383;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 193;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.492;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.122;\ttissue: Blood"}]}, {"GSM2351506": [{"title": "SUBJ.1355, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1355;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 42.6794520547945;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 107;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.05;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.216;\ttissue: Blood"}]}, {"GSM2351507": [{"title": "SUBJ.1357, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1357;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 24.6219178082191;\tregion: rest_world;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 10;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.848;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.115;\ttissue: Blood"}]}, {"GSM2351508": [{"title": "SUBJ.1274, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1274;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 43.8602739726027;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.22;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.224;\ttissue: Blood"}]}, {"GSM2351509": [{"title": "SUBJ.0201, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0201;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: multiple;\tSex: Female;\tage_at_baseline: 23.3068493150684;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 181;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.979;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.132;\ttissue: Blood"}]}, {"GSM2351510": [{"title": "SUBJ.0726, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0726;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.8715846994535;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.862;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.138;\ttissue: Blood"}]}, {"GSM2351511": [{"title": "SUBJ.0593, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0593;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 43.1068493150685;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 99;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.09;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.083;\ttissue: Blood"}]}, {"GSM2351512": [{"title": "SUBJ.1824, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1824;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 39.3561643835616;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 20;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.05;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.149;\ttissue: Blood"}]}, {"GSM2351513": [{"title": "SUBJ.0040, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0040;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: asian;\tSex: Male;\tage_at_baseline: 24.5972602739726;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.55;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.373;\ttissue: Blood"}]}, {"GSM2351514": [{"title": "SUBJ.0349, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0349;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 38.1041095890411;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 111;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.2;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.135;\ttissue: Blood"}]}, {"GSM2351515": [{"title": "SUBJ.0431, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0431;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 36.3561643835616;\tregion: europe;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.779;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.118;\ttissue: Blood"}]}, {"GSM2351516": [{"title": "SUBJ.0024, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0024;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 25.1123287671232;\tregion: us_can;\tsledai_at_baseline: 21;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.567;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.057;\ttissue: Blood"}]}, {"GSM2351517": [{"title": "SUBJ.0563, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0563;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 35.7049180327868;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 59;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.721;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.216;\ttissue: Blood"}]}, {"GSM2351518": [{"title": "SUBJ.1601, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1601;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 53.1616438356164;\tregion: europe;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.925;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.18;\ttissue: Blood"}]}, {"GSM2351519": [{"title": "SUBJ.1492, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1492;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.6191780821917;\tregion: europe;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.15;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.159;\ttissue: Blood"}]}, {"GSM2351520": [{"title": "SUBJ.0799, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0799;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 28.9890410958904;\tregion: rest_world;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 140;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.982;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.224;\ttissue: Blood"}]}, {"GSM2351521": [{"title": "SUBJ.0231, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0231;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 24.6602739726027;\tregion: us_can;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 102;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.19;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.24;\ttissue: Blood"}]}, {"GSM2351522": [{"title": "SUBJ.0247, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0247;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 40.5424657534246;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 23;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.27;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.223;\ttissue: Blood"}]}, {"GSM2351523": [{"title": "SUBJ.1147, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1147;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 26.3068493150685;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 37;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.66;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.255;\ttissue: Blood"}]}, {"GSM2351524": [{"title": "SUBJ.0154, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0154;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 55.4246575342465;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 47;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.912;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.159;\ttissue: Blood"}]}, {"GSM2351525": [{"title": "SUBJ.0996, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0996;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 46.4657534246575;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.607;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.074;\ttissue: Blood"}]}, {"GSM2351526": [{"title": "SUBJ.0723, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0723;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 33.9424657534246;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.12;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.201;\ttissue: Blood"}]}, {"GSM2351527": [{"title": "SUBJ.1029, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1029;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 62.531506849315;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 44;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.52;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.239;\ttissue: Blood"}]}, {"GSM2351528": [{"title": "SUBJ.0636, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0636;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 19.317808219178;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 11;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.11;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.103;\ttissue: Blood"}]}, {"GSM2351529": [{"title": "SUBJ.0845, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0845;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 46.0109589041095;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 41;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.956;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.248;\ttissue: Blood"}]}, {"GSM2351530": [{"title": "SUBJ.0071, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0071;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 24.3753424657534;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 59;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.748;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.093;\ttissue: Blood"}]}, {"GSM2351531": [{"title": "SUBJ.0698, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0698;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 52.5506849315068;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.608;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.059;\ttissue: Blood"}]}, {"GSM2351532": [{"title": "SUBJ.1723, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1723;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 46.4082191780821;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.16;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.181;\ttissue: Blood"}]}, {"GSM2351533": [{"title": "SUBJ.0034, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0034;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 40.8164383561643;\tregion: us_can;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.421;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.065;\ttissue: Blood"}]}, {"GSM2351534": [{"title": "SUBJ.0846, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0846;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 49.7158469945355;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 19;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.2;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.139;\ttissue: Blood"}]}, {"GSM2351535": [{"title": "SUBJ.0909, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0909;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 46.2986301369863;\tregion: us_can;\tsledai_at_baseline: 22;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.06;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.218;\ttissue: Blood"}]}, {"GSM2351536": [{"title": "SUBJ.1705, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1705;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 35.7568306010929;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.934;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.086;\ttissue: Blood"}]}, {"GSM2351537": [{"title": "SUBJ.0252, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0252;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 59.8438356164383;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 61;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.29;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.283;\ttissue: Blood"}]}, {"GSM2351538": [{"title": "SUBJ.0794, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0794;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 48.6657534246575;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.41;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.16;\ttissue: Blood"}]}, {"GSM2351539": [{"title": "SUBJ.0841, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0841;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: asian;\tSex: Female;\tage_at_baseline: 24.8164383561643;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 236;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.681;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.124;\ttissue: Blood"}]}, {"GSM2351540": [{"title": "SUBJ.1372, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1372;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 33.9644808743169;\tregion: europe;\tsledai_at_baseline: 15;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.471;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.108;\ttissue: Blood"}]}, {"GSM2351541": [{"title": "SUBJ.0857, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0857;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 39.7342465753424;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.65;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.449;\ttissue: Blood"}]}, {"GSM2351542": [{"title": "SUBJ.1159, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1159;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 31.6164383561643;\tregion: mex_ca_sa;\tsledai_at_baseline: 15;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 32;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.836;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.134;\ttissue: Blood"}]}, {"GSM2351543": [{"title": "SUBJ.1288, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1288;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 52.8657534246575;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.49;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.256;\ttissue: Blood"}]}, {"GSM2351544": [{"title": "SUBJ.1206, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1206;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 42.0273972602739;\tregion: us_can;\tsledai_at_baseline: 13;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 254;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.777;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.164;\ttissue: Blood"}]}, {"GSM2351545": [{"title": "SUBJ.1581, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1581;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: asian;\tSex: Female;\tage_at_baseline: 57.2986301369863;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 11;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.854;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.191;\ttissue: Blood"}]}, {"GSM2351546": [{"title": "SUBJ.1096, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1096;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 21.2438356164383;\tregion: us_can;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 240;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.797;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.141;\ttissue: Blood"}]}, {"GSM2351547": [{"title": "SUBJ.0158, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0158;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 46.9397260273972;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.32;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.153;\ttissue: Blood"}]}, {"GSM2351548": [{"title": "SUBJ.1136, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1136;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 36.7568306010929;\tregion: rest_world;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 23;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.46;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.395;\ttissue: Blood"}]}, {"GSM2351549": [{"title": "SUBJ.0424, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0424;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 54.9041095890411;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.226;\ttissue: Blood"}]}, {"GSM2351550": [{"title": "SUBJ.0131, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0131;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 35.775956284153;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.19;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.221;\ttissue: Blood"}]}, {"GSM2351551": [{"title": "SUBJ.1285, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1285;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 67.2876712328767;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 24;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.2;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.27;\ttissue: Blood"}]}, {"GSM2351552": [{"title": "SUBJ.1784, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1784;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 47.7972602739726;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.46;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.311;\ttissue: Blood"}]}, {"GSM2351553": [{"title": "SUBJ.1233, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1233;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 79.8493150684931;\tregion: rest_world;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.964;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.187;\ttissue: Blood"}]}, {"GSM2351554": [{"title": "SUBJ.1104, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1104;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 47.572602739726;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 211;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.643;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.089;\ttissue: Blood"}]}, {"GSM2351555": [{"title": "SUBJ.1666, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1666;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 47.9424657534246;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.03;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.151;\ttissue: Blood"}]}, {"GSM2351556": [{"title": "SUBJ.0180, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0180;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 33.2356164383561;\tregion: europe;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 100;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.664;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.086;\ttissue: Blood"}]}, {"GSM2351557": [{"title": "SUBJ.0140, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0140;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 37.6027397260274;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.04;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.252;\ttissue: Blood"}]}, {"GSM2351558": [{"title": "SUBJ.0505, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0505;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 65.1479452054794;\tregion: us_can;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.27;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.297;\ttissue: Blood"}]}, {"GSM2351559": [{"title": "SUBJ.1780, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1780;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 33.0219178082191;\tregion: rest_world;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 47;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.834;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.103;\ttissue: Blood"}]}, {"GSM2351560": [{"title": "SUBJ.1092, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1092;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 44.0301369863013;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 136;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.6;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.286;\ttissue: Blood"}]}, {"GSM2351561": [{"title": "SUBJ.1744, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1744;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 43.8712328767123;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.37;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.277;\ttissue: Blood"}]}, {"GSM2351562": [{"title": "SUBJ.0473, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0473;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 29.7397260273972;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.738;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.071;\ttissue: Blood"}]}, {"GSM2351563": [{"title": "SUBJ.1672, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1672;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 25.3506849315068;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 146;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.422;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.096;\ttissue: Blood"}]}, {"GSM2351564": [{"title": "SUBJ.0963, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0963;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 40.4904109589041;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 217;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.674;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.088;\ttissue: Blood"}]}, {"GSM2351565": [{"title": "SUBJ.1712, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1712;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 51.0876712328767;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.22;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.217;\ttissue: Blood"}]}, {"GSM2351566": [{"title": "SUBJ.1429, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1429;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 44.4301369863013;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 41;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.667;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.184;\ttissue: Blood"}]}, {"GSM2351567": [{"title": "SUBJ.0490, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0490;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 52.7431693989071;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.8;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.257;\ttissue: Blood"}]}, {"GSM2351568": [{"title": "SUBJ.1765, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1765;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 42.5643835616438;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.985;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.139;\ttissue: Blood"}]}, {"GSM2351569": [{"title": "SUBJ.1377, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1377;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 45.9098360655737;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 11;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.953;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.232;\ttissue: Blood"}]}, {"GSM2351570": [{"title": "SUBJ.0195, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0195;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: --;\tSex: --;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2351571": [{"title": "SUBJ.0482, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0482;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 37.0164383561643;\tregion: us_can;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 127;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.851;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.227;\ttissue: Blood"}]}, {"GSM2351572": [{"title": "SUBJ.0196, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0196;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 30.8;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 60;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.26;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.258;\ttissue: Blood"}]}, {"GSM2351573": [{"title": "SUBJ.1753, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1753;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 57.0904109589041;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 149;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.03;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.185;\ttissue: Blood"}]}, {"GSM2351574": [{"title": "SUBJ.0732, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0732;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 25.1780821917808;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 35;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.75;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.065;\ttissue: Blood"}]}, {"GSM2351575": [{"title": "SUBJ.0477, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0477;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 36.3205479452054;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.24;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.369;\ttissue: Blood"}]}, {"GSM2351576": [{"title": "SUBJ.0004, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0004;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 20.6547945205479;\tregion: us_can;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 168;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.598;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.062;\ttissue: Blood"}]}, {"GSM2351577": [{"title": "SUBJ.0655, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0655;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 46.8383561643835;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 60;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.17;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.248;\ttissue: Blood"}]}, {"GSM2351578": [{"title": "SUBJ.1593, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1593;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 44.9917808219178;\tregion: us_can;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.27;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.33;\ttissue: Blood"}]}, {"GSM2351579": [{"title": "SUBJ.1719, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1719;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 47.7890410958904;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.67;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.373;\ttissue: Blood"}]}, {"GSM2351580": [{"title": "SUBJ.0683, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0683;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 49.5397260273972;\tregion: mex_ca_sa;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.998;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.181;\ttissue: Blood"}]}, {"GSM2351581": [{"title": "SUBJ.0421, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0421;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 44.7021857923497;\tregion: europe;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.877;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.204;\ttissue: Blood"}]}, {"GSM2351582": [{"title": "SUBJ.0688, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0688;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 31.9480874316939;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 63;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.36;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.258;\ttissue: Blood"}]}, {"GSM2351583": [{"title": "SUBJ.0347, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0347;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 57.9890410958904;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.13;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.151;\ttissue: Blood"}]}, {"GSM2351584": [{"title": "SUBJ.0306, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0306;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 28.6639344262295;\tregion: mex_ca_sa;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.612;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2351585": [{"title": "SUBJ.0750, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0750;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 20.4082191780821;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 52;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.15;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.162;\ttissue: Blood"}]}, {"GSM2351586": [{"title": "SUBJ.0615, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0615;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 23.4301369863013;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.727;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.149;\ttissue: Blood"}]}, {"GSM2351587": [{"title": "SUBJ.0217, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0217;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 71.9890410958904;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 24;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.04;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.16;\ttissue: Blood"}]}, {"GSM2351588": [{"title": "SUBJ.0835, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0835;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 52.6054794520548;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.213;\ttissue: Blood"}]}, {"GSM2351589": [{"title": "SUBJ.0137, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0137;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 46.5945205479452;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.14;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.194;\ttissue: Blood"}]}, {"GSM2351590": [{"title": "SUBJ.0238, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0238;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 28.7185792349726;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.2;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.228;\ttissue: Blood"}]}, {"GSM2351591": [{"title": "SUBJ.0550, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0550;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 39.8136986301369;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.992;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.277;\ttissue: Blood"}]}, {"GSM2351592": [{"title": "SUBJ.1013, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1013;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 48.6383561643835;\tregion: us_can;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 98;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.23;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.37;\ttissue: Blood"}]}, {"GSM2351593": [{"title": "SUBJ.0917, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0917;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 34.3342465753424;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 187;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.06;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.143;\ttissue: Blood"}]}, {"GSM2351594": [{"title": "SUBJ.1214, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1214;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 24.317808219178;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 151;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.877;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.148;\ttissue: Blood"}]}, {"GSM2351595": [{"title": "SUBJ.1015, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1015;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 25.8360655737704;\tregion: mex_ca_sa;\tsledai_at_baseline: 24;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 145;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.729;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.103;\ttissue: Blood"}]}, {"GSM2351596": [{"title": "SUBJ.0928, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0928;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 27.8849315068493;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.883;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.128;\ttissue: Blood"}]}, {"GSM2351597": [{"title": "SUBJ.0208, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0208;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 24.1013698630137;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 187;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.431;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2351598": [{"title": "SUBJ.0382, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0382;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 53.2246575342465;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.19;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.078;\ttissue: Blood"}]}, {"GSM2351599": [{"title": "SUBJ.1319, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1319;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 30.8715846994535;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 62;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.758;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.157;\ttissue: Blood"}]}, {"GSM2351600": [{"title": "SUBJ.0790, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0790;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 48.2191780821917;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.648;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2351601": [{"title": "SUBJ.0529, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0529;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 20.0438356164383;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 121;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.6;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.102;\ttissue: Blood"}]}, {"GSM2351602": [{"title": "SUBJ.0353, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0353;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 39.6712328767123;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.09;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.195;\ttissue: Blood"}]}, {"GSM2351603": [{"title": "SUBJ.1778, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1778;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 44.7841530054644;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 147;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.3;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.393;\ttissue: Blood"}]}, {"GSM2351604": [{"title": "SUBJ.0651, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0651;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 31.5972602739726;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 16;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.758;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.142;\ttissue: Blood"}]}, {"GSM2351605": [{"title": "SUBJ.0606, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0606;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 45.2958904109589;\tregion: us_can;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 126;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.857;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.093;\ttissue: Blood"}]}, {"GSM2351606": [{"title": "SUBJ.1070, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1070;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 34.3698630136986;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.98;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.252;\ttissue: Blood"}]}, {"GSM2351607": [{"title": "SUBJ.0336, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0336;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 59.8904109589041;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 7;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.62;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.438;\ttissue: Blood"}]}, {"GSM2351608": [{"title": "SUBJ.0896, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0896;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 58.145205479452;\tregion: us_can;\tsledai_at_baseline: 4;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.33;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.217;\ttissue: Blood"}]}, {"GSM2351609": [{"title": "SUBJ.0183, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0183;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 28.5808219178082;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 20;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.891;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.149;\ttissue: Blood"}]}, {"GSM2351610": [{"title": "SUBJ.1611, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1611;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 44.8931506849315;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 15;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.855;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.122;\ttissue: Blood"}]}, {"GSM2351611": [{"title": "SUBJ.0585, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0585;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 52.945205479452;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 134;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.498;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.158;\ttissue: Blood"}]}, {"GSM2351612": [{"title": "SUBJ.0179, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0179;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 31.8142076502732;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.53;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.293;\ttissue: Blood"}]}, {"GSM2351613": [{"title": "SUBJ.1387, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1387;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 34.1945205479452;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 82;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.191;\ttissue: Blood"}]}, {"GSM2351614": [{"title": "SUBJ.0189, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0189;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 36.158904109589;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.524;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2351615": [{"title": "SUBJ.1091, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1091;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 58.131506849315;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 180;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.03;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.17;\ttissue: Blood"}]}, {"GSM2351616": [{"title": "SUBJ.1587, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1587;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 36.8438356164383;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 104;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.836;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.104;\ttissue: Blood"}]}, {"GSM2351617": [{"title": "SUBJ.0992, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0992;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Male;\tage_at_baseline: 30.1808219178082;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 129;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.86;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.098;\ttissue: Blood"}]}, {"GSM2351618": [{"title": "SUBJ.0315, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0315;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 45.8246575342465;\tregion: us_can;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 193;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.74;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.11;\ttissue: Blood"}]}, {"GSM2351619": [{"title": "SUBJ.0056, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0056;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 28.1616438356164;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 97;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.01;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.163;\ttissue: Blood"}]}, {"GSM2351620": [{"title": "SUBJ.1336, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1336;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 62.1945205479452;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 39;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.23;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.176;\ttissue: Blood"}]}, {"GSM2351621": [{"title": "SUBJ.0528, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0528;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 58.7232876712328;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.84;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2351622": [{"title": "SUBJ.0023, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0023;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 20.7917808219178;\tregion: europe;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.628;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.061;\ttissue: Blood"}]}, {"GSM2351623": [{"title": "SUBJ.1610, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1610;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.7021857923497;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 147;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.816;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.18;\ttissue: Blood"}]}, {"GSM2351624": [{"title": "SUBJ.1795, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1795;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 50.9753424657534;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.18;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.281;\ttissue: Blood"}]}, {"GSM2351625": [{"title": "SUBJ.1388, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1388;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 56.8931506849315;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 61;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.03;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.158;\ttissue: Blood"}]}, {"GSM2351626": [{"title": "SUBJ.1177, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1177;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 50.0465753424657;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): H;\tc3_at_baseline (g/l): 1.92;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.364;\ttissue: Blood"}]}, {"GSM2351627": [{"title": "SUBJ.1337, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1337;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 43.8821917808219;\tregion: us_can;\tsledai_at_baseline: 15;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 37;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.653;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.082;\ttissue: Blood"}]}, {"GSM2351628": [{"title": "SUBJ.0647, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0647;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 52.2630136986301;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.32;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.227;\ttissue: Blood"}]}, {"GSM2351629": [{"title": "SUBJ.1569, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1569;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 23.5698630136986;\tregion: us_can;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.735;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.07;\ttissue: Blood"}]}, {"GSM2351630": [{"title": "SUBJ.0509, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0509;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: multiple;\tSex: Female;\tage_at_baseline: 30.4684931506849;\tregion: mex_ca_sa;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 32;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.076;\ttissue: Blood"}]}, {"GSM2351631": [{"title": "SUBJ.1490, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1490;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 27.1780821917808;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 42;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.556;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2351632": [{"title": "SUBJ.1543, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1543;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 47.6082191780822;\tregion: us_can;\tsledai_at_baseline: 13;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 74;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.03;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.38;\ttissue: Blood"}]}, {"GSM2351633": [{"title": "SUBJ.0562, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0562;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 38.2191780821917;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.74;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.316;\ttissue: Blood"}]}, {"GSM2351634": [{"title": "SUBJ.0312, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0312;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 27.0821917808219;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.925;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.136;\ttissue: Blood"}]}, {"GSM2351635": [{"title": "SUBJ.0021, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0021;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 48.7213114754098;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.55;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.176;\ttissue: Blood"}]}, {"GSM2351636": [{"title": "SUBJ.0934, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0934;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 55.6657534246575;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.35;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.307;\ttissue: Blood"}]}, {"GSM2351637": [{"title": "SUBJ.1513, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1513;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 32.9780821917808;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.45;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.239;\ttissue: Blood"}]}, {"GSM2351638": [{"title": "SUBJ.0401, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0401;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 25.6191780821917;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 191;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.755;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.094;\ttissue: Blood"}]}, {"GSM2351639": [{"title": "SUBJ.1366, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1366;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 55.6383561643835;\tregion: europe;\tsledai_at_baseline: 17;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 23;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.21;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.18;\ttissue: Blood"}]}, {"GSM2351640": [{"title": "SUBJ.1831, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1831;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 23.2547945205479;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.15;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.06;\ttissue: Blood"}]}, {"GSM2351641": [{"title": "SUBJ.1550, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1550;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 32.1945205479452;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 106;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.22;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.318;\ttissue: Blood"}]}, {"GSM2351642": [{"title": "SUBJ.1787, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1787;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 26.0876712328767;\tregion: europe;\tsledai_at_baseline: 22;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 72;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.897;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.066;\ttissue: Blood"}]}, {"GSM2351643": [{"title": "SUBJ.1246, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1246;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 29.8931506849315;\tregion: us_can;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 105;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.571;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2351644": [{"title": "SUBJ.0540, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0540;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 39.6684931506849;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.836;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.132;\ttissue: Blood"}]}, {"GSM2351645": [{"title": "SUBJ.1498, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1498;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 38.7972602739726;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 65;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.614;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.143;\ttissue: Blood"}]}, {"GSM2351646": [{"title": "SUBJ.1552, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1552;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 48.0849315068493;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): H;\tc3_at_baseline (g/l): 1.89;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.427;\ttissue: Blood"}]}, {"GSM2351647": [{"title": "SUBJ.0118, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0118;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Male;\tage_at_baseline: 33.3835616438356;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 13;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.06;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.244;\ttissue: Blood"}]}, {"GSM2351648": [{"title": "SUBJ.1317, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1317;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 38.1232876712328;\tregion: rest_world;\tsledai_at_baseline: 23;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 128;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.541;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2351649": [{"title": "SUBJ.1087, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1087;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 47.6639344262295;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 57;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.275;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2351650": [{"title": "SUBJ.1815, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1815;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 53.8958904109589;\tregion: rest_world;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 23;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.44;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.248;\ttissue: Blood"}]}, {"GSM2351651": [{"title": "SUBJ.0828, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0828;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 38.5945205479452;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.807;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.172;\ttissue: Blood"}]}, {"GSM2351652": [{"title": "SUBJ.1131, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1131;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Male;\tage_at_baseline: 49.8684931506849;\tregion: us_can;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.23;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.215;\ttissue: Blood"}]}, {"GSM2351653": [{"title": "SUBJ.1668, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1668;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 29.4273972602739;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.769;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.061;\ttissue: Blood"}]}, {"GSM2351654": [{"title": "SUBJ.1125, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1125;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 31.386301369863;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.421;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.157;\ttissue: Blood"}]}, {"GSM2351655": [{"title": "SUBJ.0471, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0471;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 38.358904109589;\tregion: rest_world;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.471;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.062;\ttissue: Blood"}]}, {"GSM2351656": [{"title": "SUBJ.1213, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1213;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 30.9125683060109;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.832;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.15;\ttissue: Blood"}]}, {"GSM2351657": [{"title": "SUBJ.1732, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1732;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 30.4493150684931;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.36;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.307;\ttissue: Blood"}]}, {"GSM2351658": [{"title": "SUBJ.0719, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0719;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 23.3890410958904;\tregion: us_can;\tsledai_at_baseline: 22;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.458;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.055;\ttissue: Blood"}]}, {"GSM2351659": [{"title": "SUBJ.0798, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0798;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 24.2383561643835;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 63;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.693;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.058;\ttissue: Blood"}]}, {"GSM2351660": [{"title": "SUBJ.1740, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1740;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 38.7786885245901;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 103;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.714;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.141;\ttissue: Blood"}]}, {"GSM2351661": [{"title": "SUBJ.1290, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1290;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 61.0438356164383;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 24;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.802;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2351662": [{"title": "SUBJ.0731, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0731;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 36.6054794520548;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 208;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.06;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.16;\ttissue: Blood"}]}, {"GSM2351663": [{"title": "SUBJ.1835, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1835;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 42.5424657534246;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.095;\ttissue: Blood"}]}, {"GSM2351664": [{"title": "SUBJ.1743, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1743;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 49.4219178082191;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 11;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.906;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.201;\ttissue: Blood"}]}, {"GSM2351665": [{"title": "SUBJ.0882, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0882;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 55.6739726027397;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 36;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.25;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.164;\ttissue: Blood"}]}, {"GSM2351666": [{"title": "SUBJ.1677, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1677;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 51.0904109589041;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 46;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.6;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.178;\ttissue: Blood"}]}, {"GSM2351667": [{"title": "SUBJ.0530, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0530;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 53.3561643835616;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.16;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.192;\ttissue: Blood"}]}, {"GSM2351668": [{"title": "SUBJ.0543, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0543;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 49.0794520547945;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.41;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.291;\ttissue: Blood"}]}, {"GSM2351669": [{"title": "SUBJ.1512, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1512;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 48.2739726027397;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.25;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.216;\ttissue: Blood"}]}, {"GSM2351670": [{"title": "SUBJ.1399, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1399;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 34.4109589041095;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.705;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.13;\ttissue: Blood"}]}, {"GSM2351671": [{"title": "SUBJ.1466, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1466;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 45.317808219178;\tregion: us_can;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 100;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.169;\ttissue: Blood"}]}, {"GSM2351672": [{"title": "SUBJ.0406, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0406;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 40.9095890410958;\tregion: mex_ca_sa;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 50;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.526;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.098;\ttissue: Blood"}]}, {"GSM2351673": [{"title": "SUBJ.0165, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0165;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 25.1397260273972;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 124;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.766;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.098;\ttissue: Blood"}]}, {"GSM2351674": [{"title": "SUBJ.0416, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0416;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 63.4657534246575;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.945;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.248;\ttissue: Blood"}]}, {"GSM2351675": [{"title": "SUBJ.0502, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0502;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 32.4356164383561;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 64;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.643;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.065;\ttissue: Blood"}]}, {"GSM2351676": [{"title": "SUBJ.0864, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0864;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 57.186301369863;\tregion: europe;\tsledai_at_baseline: 13;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 157;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.15;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.118;\ttissue: Blood"}]}, {"GSM2351677": [{"title": "SUBJ.1308, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1308;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 34.4109589041095;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 66;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.896;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.124;\ttissue: Blood"}]}, {"GSM2351678": [{"title": "SUBJ.0428, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0428;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 39.2767123287671;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 184;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.63;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.074;\ttissue: Blood"}]}, {"GSM2351679": [{"title": "SUBJ.0166, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0166;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 23.6639344262295;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 53;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.581;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2351680": [{"title": "SUBJ.0595, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0595;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 38.6602739726027;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 44;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.11;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.114;\ttissue: Blood"}]}, {"GSM2351681": [{"title": "SUBJ.1172, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1172;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 28.3369863013698;\tregion: europe;\tsledai_at_baseline: 22;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.723;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.075;\ttissue: Blood"}]}, {"GSM2351682": [{"title": "SUBJ.0577, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0577;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 45.5808219178082;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 7;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.23;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.266;\ttissue: Blood"}]}, {"GSM2351683": [{"title": "SUBJ.1823, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1823;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 24.2904109589041;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.06;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.183;\ttissue: Blood"}]}, {"GSM2351684": [{"title": "SUBJ.0125, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0125;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 43.9780821917808;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 23;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.47;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.319;\ttissue: Blood"}]}, {"GSM2351685": [{"title": "SUBJ.0153, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0153;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 34.8684931506849;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 37;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.899;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.172;\ttissue: Blood"}]}, {"GSM2351686": [{"title": "SUBJ.0061, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0061;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: asian;\tSex: Female;\tage_at_baseline: 61.0328767123287;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 47;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.24;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.286;\ttissue: Blood"}]}, {"GSM2351687": [{"title": "SUBJ.1224, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1224;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 44.6803278688524;\tregion: us_can;\tsledai_at_baseline: 19;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 42;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.2;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.239;\ttissue: Blood"}]}, {"GSM2351688": [{"title": "SUBJ.1057, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1057;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Male;\tage_at_baseline: 45.0794520547945;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.751;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.102;\ttissue: Blood"}]}, {"GSM2351689": [{"title": "SUBJ.1450, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1450;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 41.3397260273972;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 31;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.293;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.066;\ttissue: Blood"}]}, {"GSM2351690": [{"title": "SUBJ.1570, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1570;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 40.4876712328767;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.845;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.119;\ttissue: Blood"}]}, {"GSM2351691": [{"title": "SUBJ.0262, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0262;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 36.4356164383561;\tregion: us_can;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.729;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.065;\ttissue: Blood"}]}, {"GSM2351692": [{"title": "SUBJ.0181, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0181;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 32.1890410958904;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2351693": [{"title": "SUBJ.1356, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1356;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 34.8164383561643;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.785;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.159;\ttissue: Blood"}]}, {"GSM2351694": [{"title": "SUBJ.0640, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0640;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 45.0931506849315;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 61;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.685;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.1;\ttissue: Blood"}]}, {"GSM2351695": [{"title": "SUBJ.1482, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1482;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 23.6767123287671;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.53;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.111;\ttissue: Blood"}]}, {"GSM2351696": [{"title": "SUBJ.0780, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0780;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 19.8876712328767;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.175;\ttissue: Blood"}]}, {"GSM2351697": [{"title": "SUBJ.0568, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0568;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: multiple;\tSex: Male;\tage_at_baseline: 19.6739726027397;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 42;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.268;\ttissue: Blood"}]}, {"GSM2351698": [{"title": "SUBJ.1609, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1609;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 46.8849315068493;\tregion: rest_world;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 68;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.818;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.149;\ttissue: Blood"}]}, {"GSM2351699": [{"title": "SUBJ.1083, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1083;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 38.7978142076502;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.74;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.155;\ttissue: Blood"}]}, {"GSM2351700": [{"title": "SUBJ.1738, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1738;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 61.358904109589;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.909;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2351701": [{"title": "SUBJ.0608, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0608;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 62.2356164383561;\tregion: europe;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 245;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.2;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.237;\ttissue: Blood"}]}, {"GSM2351702": [{"title": "SUBJ.1050, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1050;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 25.2547945205479;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 78;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.844;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.194;\ttissue: Blood"}]}, {"GSM2351703": [{"title": "SUBJ.0359, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0359;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 38.8169398907103;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.05;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.284;\ttissue: Blood"}]}, {"GSM2351704": [{"title": "SUBJ.1275, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1275;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 49.7808219178082;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.511;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.105;\ttissue: Blood"}]}, {"GSM2351705": [{"title": "SUBJ.0503, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0503;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 65.0301369863013;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 256;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.476;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.05;\ttissue: Blood"}]}, {"GSM2351706": [{"title": "SUBJ.0844, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0844;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 49.9260273972602;\tregion: mex_ca_sa;\tsledai_at_baseline: 15;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.719;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.111;\ttissue: Blood"}]}, {"GSM2351707": [{"title": "SUBJ.0283, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0283;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 57.9095890410959;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.19;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.35;\ttissue: Blood"}]}, {"GSM2351708": [{"title": "SUBJ.1526, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1526;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 38.9698630136986;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 7;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.848;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.194;\ttissue: Blood"}]}, {"GSM2351709": [{"title": "SUBJ.0329, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0329;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 33.2246575342465;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 41;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.926;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.187;\ttissue: Blood"}]}, {"GSM2351710": [{"title": "SUBJ.0397, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0397;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 25.6219178082191;\tregion: europe;\tsledai_at_baseline: 13;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 99;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.723;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.056;\ttissue: Blood"}]}, {"GSM2351711": [{"title": "SUBJ.1425, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1425;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 27.0986301369863;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 21;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.823;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.103;\ttissue: Blood"}]}, {"GSM2351712": [{"title": "SUBJ.0712, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0712;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 65.2164383561644;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 12;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.45;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.227;\ttissue: Blood"}]}, {"GSM2351713": [{"title": "SUBJ.0609, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0609;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 25.4136986301369;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.883;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.13;\ttissue: Blood"}]}, {"GSM2351714": [{"title": "SUBJ.0548, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0548;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 47.1561643835616;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.04;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.2;\ttissue: Blood"}]}, {"GSM2351715": [{"title": "SUBJ.0773, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0773;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 46.3479452054794;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 45;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.678;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.132;\ttissue: Blood"}]}, {"GSM2351716": [{"title": "SUBJ.0291, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0291;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 34.775956284153;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.36;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.154;\ttissue: Blood"}]}, {"GSM2351717": [{"title": "SUBJ.1730, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1730;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 34.8054794520548;\tregion: us_can;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 134;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.761;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.128;\ttissue: Blood"}]}, {"GSM2351718": [{"title": "SUBJ.0400, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0400;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 47.6630136986301;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 82;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.25;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.4;\ttissue: Blood"}]}, {"GSM2351719": [{"title": "SUBJ.0653, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0653;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: asian;\tSex: Female;\tage_at_baseline: 27.0328767123287;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.644;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.081;\ttissue: Blood"}]}, {"GSM2351720": [{"title": "SUBJ.1001, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1001;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 59.5753424657534;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.08;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.235;\ttissue: Blood"}]}, {"GSM2351721": [{"title": "SUBJ.0521, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0521;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 34.9534246575342;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.59;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.453;\ttissue: Blood"}]}, {"GSM2351722": [{"title": "SUBJ.1158, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1158;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 25.2794520547945;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.971;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.052;\ttissue: Blood"}]}, {"GSM2351723": [{"title": "SUBJ.0573, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0573;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 38.7568306010929;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 234;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.88;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.108;\ttissue: Blood"}]}, {"GSM2351724": [{"title": "SUBJ.0051, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0051;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 60.986301369863;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.861;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.205;\ttissue: Blood"}]}, {"GSM2351725": [{"title": "SUBJ.0692, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0692;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 54.1013698630137;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 86;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.953;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.149;\ttissue: Blood"}]}, {"GSM2351726": [{"title": "SUBJ.1726, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1726;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 34.0684931506849;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 46;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.556;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.076;\ttissue: Blood"}]}, {"GSM2351727": [{"title": "SUBJ.1386, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1386;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 26.4849315068493;\tregion: rest_world;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.743;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.178;\ttissue: Blood"}]}, {"GSM2351728": [{"title": "SUBJ.1793, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1793;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.1671232876712;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.71;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.295;\ttissue: Blood"}]}, {"GSM2351729": [{"title": "SUBJ.1381, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1381;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 45.4602739726027;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.24;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.237;\ttissue: Blood"}]}, {"GSM2351730": [{"title": "SUBJ.0868, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0868;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 21.6465753424657;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.331;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.071;\ttissue: Blood"}]}, {"GSM2351731": [{"title": "SUBJ.1630, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1630;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 29.2739726027397;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 65;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.846;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.11;\ttissue: Blood"}]}, {"GSM2351732": [{"title": "SUBJ.1094, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1094;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 42.8356164383561;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.797;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.155;\ttissue: Blood"}]}, {"GSM2351733": [{"title": "SUBJ.0858, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0858;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 33.8767123287671;\tregion: us_can;\tsledai_at_baseline: 15;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.848;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.133;\ttissue: Blood"}]}, {"GSM2351734": [{"title": "SUBJ.0474, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0474;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 37.9344262295082;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 10;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.13;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.205;\ttissue: Blood"}]}, {"GSM2351735": [{"title": "SUBJ.0138, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0138;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 39.9506849315068;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.77;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.204;\ttissue: Blood"}]}, {"GSM2351736": [{"title": "SUBJ.1802, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1802;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 58.6684931506849;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): H;\tc3_at_baseline (g/l): 1.84;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.226;\ttissue: Blood"}]}, {"GSM2351737": [{"title": "SUBJ.1414, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1414;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 34.6219178082191;\tregion: us_can;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): H;\tc3_at_baseline (g/l): 1.84;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.375;\ttissue: Blood"}]}, {"GSM2351738": [{"title": "SUBJ.1272, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1272;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 36.4136986301369;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 58;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.26;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.32;\ttissue: Blood"}]}, {"GSM2351739": [{"title": "SUBJ.0741, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0741;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 55.2109589041096;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): H;\tc3_at_baseline (g/l): 1.84;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.157;\ttissue: Blood"}]}, {"GSM2351740": [{"title": "SUBJ.1468, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1468;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 42.9890710382513;\tregion: mex_ca_sa;\tsledai_at_baseline: 4;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 7;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.03;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.292;\ttissue: Blood"}]}, {"GSM2351741": [{"title": "SUBJ.0173, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0173;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 58.9424657534246;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 18;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.857;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.194;\ttissue: Blood"}]}, {"GSM2351742": [{"title": "SUBJ.1665, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1665;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 21.931506849315;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.28;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.24;\ttissue: Blood"}]}, {"GSM2351743": [{"title": "SUBJ.1219, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1219;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 62.945205479452;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.45;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.344;\ttissue: Blood"}]}, {"GSM2351744": [{"title": "SUBJ.1488, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1488;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 30.5643835616438;\tregion: mex_ca_sa;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.755;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.29;\ttissue: Blood"}]}, {"GSM2351745": [{"title": "SUBJ.0476, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0476;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 43.5835616438356;\tregion: us_can;\tsledai_at_baseline: 15;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.751;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.052;\ttissue: Blood"}]}, {"GSM2351746": [{"title": "SUBJ.1477, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1477;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 27.8904109589041;\tregion: mex_ca_sa;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 131;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.905;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.162;\ttissue: Blood"}]}, {"GSM2351747": [{"title": "SUBJ.0894, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0894;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 48.9506849315068;\tregion: europe;\tsledai_at_baseline: 7;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 149;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.521;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.05;\ttissue: Blood"}]}, {"GSM2351748": [{"title": "SUBJ.0203, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0203;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 34.4520547945205;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.14;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.187;\ttissue: Blood"}]}, {"GSM2351749": [{"title": "SUBJ.0074, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0074;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 48.613698630137;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 95;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.65;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.117;\ttissue: Blood"}]}, {"GSM2351750": [{"title": "SUBJ.0710, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0710;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 65.6602739726027;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 49;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.887;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.165;\ttissue: Blood"}]}, {"GSM2351751": [{"title": "SUBJ.0619, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0619;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 18.4109589041095;\tregion: mex_ca_sa;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 90;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.14;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.216;\ttissue: Blood"}]}, {"GSM2351752": [{"title": "SUBJ.1449, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1449;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 28.811475409836;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.09;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.095;\ttissue: Blood"}]}, {"GSM2351753": [{"title": "SUBJ.1270, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1270;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: multiple;\tSex: Female;\tage_at_baseline: 31.158904109589;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 53;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.13;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.167;\ttissue: Blood"}]}, {"GSM2351754": [{"title": "SUBJ.0117, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0117;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 24.7808219178082;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 57;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.862;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.071;\ttissue: Blood"}]}, {"GSM2351755": [{"title": "SUBJ.1766, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1766;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 86.6967213114754;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 11;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.206;\ttissue: Blood"}]}, {"GSM2351756": [{"title": "SUBJ.1359, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1359;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 33.5342465753424;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 120;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.608;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.089;\ttissue: Blood"}]}, {"GSM2351757": [{"title": "SUBJ.0176, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0176;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 48.2520547945205;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 75;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.36;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.329;\ttissue: Blood"}]}, {"GSM2351758": [{"title": "SUBJ.1699, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1699;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 34.5945205479452;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.05;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.18;\ttissue: Blood"}]}, {"GSM2351759": [{"title": "SUBJ.0501, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0501;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 83.2246575342465;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 150;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.242;\ttissue: Blood"}]}, {"GSM2351760": [{"title": "SUBJ.1452, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1452;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 26.7732240437158;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 16;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.763;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.104;\ttissue: Blood"}]}, {"GSM2351761": [{"title": "SUBJ.1241, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1241;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 62.6082191780822;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 10;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.63;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.436;\ttissue: Blood"}]}, {"GSM2351762": [{"title": "SUBJ.1139, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1139;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 48.5150684931507;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 13;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.13;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.366;\ttissue: Blood"}]}, {"GSM2351763": [{"title": "SUBJ.0990, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0990;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 30.2027397260274;\tregion: europe;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 160;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.143;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2351764": [{"title": "SUBJ.0496, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0496;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 59.0767123287671;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.958;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.165;\ttissue: Blood"}]}, {"GSM2351765": [{"title": "SUBJ.0060, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0060;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 41.6775956284153;\tregion: mex_ca_sa;\tsledai_at_baseline: 7;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 23;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.27;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.232;\ttissue: Blood"}]}, {"GSM2351766": [{"title": "SUBJ.1715, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1715;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 38.0410958904109;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.099;\ttissue: Blood"}]}, {"GSM2351767": [{"title": "SUBJ.0366, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0366;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 46.5890410958904;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 12;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.265;\ttissue: Blood"}]}, {"GSM2351768": [{"title": "SUBJ.0043, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0043;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 67.0082191780822;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 7;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.13;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.158;\ttissue: Blood"}]}, {"GSM2351769": [{"title": "SUBJ.0873, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0873;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 25.9123287671232;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.749;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.126;\ttissue: Blood"}]}, {"GSM2351770": [{"title": "SUBJ.0960, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0960;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 40.8520547945205;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 54;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.206;\ttissue: Blood"}]}, {"GSM2351771": [{"title": "SUBJ.1297, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1297;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 69.2794520547945;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.34;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.282;\ttissue: Blood"}]}, {"GSM2351772": [{"title": "SUBJ.0522, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0522;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 48.7753424657534;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 27;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.22;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.127;\ttissue: Blood"}]}, {"GSM2351773": [{"title": "SUBJ.0679, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0679;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 42.7185792349726;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.36;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.196;\ttissue: Blood"}]}, {"GSM2351774": [{"title": "SUBJ.0830, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0830;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 37.8301369863013;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.864;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.128;\ttissue: Blood"}]}, {"GSM2351775": [{"title": "SUBJ.0163, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0163;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 55.772602739726;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2351776": [{"title": "SUBJ.1590, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1590;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Male;\tage_at_baseline: 59.7890410958904;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 21;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.907;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.318;\ttissue: Blood"}]}, {"GSM2351777": [{"title": "SUBJ.1004, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1004;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 26.9863387978142;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.823;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.205;\ttissue: Blood"}]}, {"GSM2351778": [{"title": "SUBJ.0339, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0339;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 30.3013698630137;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.55;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.246;\ttissue: Blood"}]}, {"GSM2351779": [{"title": "SUBJ.1189, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1189;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 33.5232876712328;\tregion: rest_world;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.23;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.143;\ttissue: Blood"}]}, {"GSM2351780": [{"title": "SUBJ.0269, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0269;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 36.5150684931506;\tregion: rest_world;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 121;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.16;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.192;\ttissue: Blood"}]}, {"GSM2351781": [{"title": "SUBJ.0954, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0954;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 56.9397260273972;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.08;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.197;\ttissue: Blood"}]}, {"GSM2351782": [{"title": "SUBJ.1810, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1810;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 60.758904109589;\tregion: us_can;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 89;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.868;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.183;\ttissue: Blood"}]}, {"GSM2351783": [{"title": "SUBJ.0705, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0705;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 44.2219178082191;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 16;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.963;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.122;\ttissue: Blood"}]}, {"GSM2351784": [{"title": "SUBJ.1282, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1282;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.9945355191256;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 14;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.74;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.409;\ttissue: Blood"}]}, {"GSM2351785": [{"title": "SUBJ.1807, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1807;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 48.213698630137;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.6;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.209;\ttissue: Blood"}]}, {"GSM2351786": [{"title": "SUBJ.1335, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1335;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: multiple;\tSex: Female;\tage_at_baseline: 18.1753424657534;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.864;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.099;\ttissue: Blood"}]}, {"GSM2351787": [{"title": "SUBJ.0574, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0574;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 26.4520547945205;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.12;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.201;\ttissue: Blood"}]}, {"GSM2351788": [{"title": "SUBJ.0789, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0789;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 21.345205479452;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.21;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.273;\ttissue: Blood"}]}, {"GSM2351789": [{"title": "SUBJ.0808, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0808;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 42.9424657534246;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.667;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.126;\ttissue: Blood"}]}, {"GSM2351790": [{"title": "SUBJ.0983, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0983;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 28.9041095890411;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.641;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.078;\ttissue: Blood"}]}, {"GSM2351791": [{"title": "SUBJ.1633, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1633;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: asian;\tSex: Male;\tage_at_baseline: 31.972602739726;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 92;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.752;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.168;\ttissue: Blood"}]}, {"GSM2351792": [{"title": "SUBJ.0875, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0875;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 29.9098360655737;\tregion: mex_ca_sa;\tsledai_at_baseline: 22;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.87;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.146;\ttissue: Blood"}]}, {"GSM2351793": [{"title": "SUBJ.0686, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0686;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 27.8904109589041;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 18;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.91;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.125;\ttissue: Blood"}]}, {"GSM2351794": [{"title": "SUBJ.0279, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0279;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 58.1917808219178;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 220;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.01;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.082;\ttissue: Blood"}]}, {"GSM2351795": [{"title": "SUBJ.0498, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0498;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 29.2602739726027;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 36;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.28;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.164;\ttissue: Blood"}]}, {"GSM2351796": [{"title": "SUBJ.1808, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1808;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 36.9424657534246;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 170;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.573;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.114;\ttissue: Blood"}]}, {"GSM2351797": [{"title": "SUBJ.1736, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1736;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 40.5260273972602;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 7;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.752;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.122;\ttissue: Blood"}]}, {"GSM2351798": [{"title": "SUBJ.1303, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1303;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 60.0493150684931;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.16;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.328;\ttissue: Blood"}]}, {"GSM2351799": [{"title": "SUBJ.0069, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0069;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 43.9753424657534;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.779;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.074;\ttissue: Blood"}]}, {"GSM2351800": [{"title": "SUBJ.1265, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1265;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 51.5260273972602;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 60;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.532;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2351801": [{"title": "SUBJ.1195, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1195;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 35.0931506849315;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 77;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.712;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.158;\ttissue: Blood"}]}, {"GSM2351802": [{"title": "SUBJ.0517, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0517;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 29.6465753424657;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.12;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.14;\ttissue: Blood"}]}, {"GSM2351803": [{"title": "SUBJ.1501, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1501;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 54.2082191780822;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 177;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.46;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.226;\ttissue: Blood"}]}, {"GSM2351804": [{"title": "SUBJ.0265, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0265;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 40.972602739726;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 16;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.04;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.145;\ttissue: Blood"}]}, {"GSM2351805": [{"title": "SUBJ.0278, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0278;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 47.2904109589041;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.59;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.08;\ttissue: Blood"}]}, {"GSM2351806": [{"title": "SUBJ.0221, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0221;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 48.1479452054794;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.737;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.223;\ttissue: Blood"}]}, {"GSM2351807": [{"title": "SUBJ.0979, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0979;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 40.8958904109589;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 52;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.169;\ttissue: Blood"}]}, {"GSM2351808": [{"title": "SUBJ.1697, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1697;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 27.9095890410958;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 144;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.83;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.2;\ttissue: Blood"}]}, {"GSM2351809": [{"title": "SUBJ.1680, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1680;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 59.5123287671233;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.08;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.289;\ttissue: Blood"}]}, {"GSM2351810": [{"title": "SUBJ.1030, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1030;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 28.7753424657534;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.18;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.256;\ttissue: Blood"}]}, {"GSM2351811": [{"title": "SUBJ.0049, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0049;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 29.7978142076502;\tregion: europe;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.473;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2351812": [{"title": "SUBJ.0104, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0104;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 53.9397260273972;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.25;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.142;\ttissue: Blood"}]}, {"GSM2351813": [{"title": "SUBJ.0500, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0500;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 42.558904109589;\tregion: rest_world;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): H;\tc3_at_baseline (g/l): 1.84;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.352;\ttissue: Blood"}]}, {"GSM2351814": [{"title": "SUBJ.1301, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1301;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 23.8273972602739;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 21;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.854;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.166;\ttissue: Blood"}]}, {"GSM2351815": [{"title": "SUBJ.1364, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1364;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 46.0219178082191;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.01;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.224;\ttissue: Blood"}]}, {"GSM2351816": [{"title": "SUBJ.0566, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0566;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 24.6136986301369;\tregion: europe;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.548;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.08;\ttissue: Blood"}]}, {"GSM2351817": [{"title": "SUBJ.1102, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1102;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 19.6520547945205;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 222;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.874;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.15;\ttissue: Blood"}]}, {"GSM2351818": [{"title": "SUBJ.0889, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0889;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 43.9672131147541;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.23;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.201;\ttissue: Blood"}]}, {"GSM2351819": [{"title": "SUBJ.0369, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0369;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 28.531506849315;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 50;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.946;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.194;\ttissue: Blood"}]}, {"GSM2351820": [{"title": "SUBJ.1014, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1014;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 52.4657534246575;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 97;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.267;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2351821": [{"title": "SUBJ.1162, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1162;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 32.5479452054794;\tregion: rest_world;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 14;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.63;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.422;\ttissue: Blood"}]}, {"GSM2351822": [{"title": "SUBJ.1396, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1396;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 28.6301369863013;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.532;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.061;\ttissue: Blood"}]}, {"GSM2351823": [{"title": "SUBJ.1504, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1504;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 45.6739726027397;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.33;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.212;\ttissue: Blood"}]}, {"GSM2351824": [{"title": "SUBJ.1443, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1443;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 28.0301369863013;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 128;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.868;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.142;\ttissue: Blood"}]}, {"GSM2351825": [{"title": "SUBJ.1286, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1286;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 39.0876712328767;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.903;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.143;\ttissue: Blood"}]}, {"GSM2351826": [{"title": "SUBJ.0795, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0795;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 56.9342465753424;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.92;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.069;\ttissue: Blood"}]}, {"GSM2351827": [{"title": "SUBJ.1521, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1521;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: multiple;\tSex: Female;\tage_at_baseline: 52.2767123287671;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 20;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.977;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.345;\ttissue: Blood"}]}, {"GSM2351828": [{"title": "SUBJ.0590, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0590;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 61.0410958904109;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.45;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.314;\ttissue: Blood"}]}, {"GSM2351829": [{"title": "SUBJ.0324, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0324;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 29.772602739726;\tregion: rest_world;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 14;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.09;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.176;\ttissue: Blood"}]}, {"GSM2351830": [{"title": "SUBJ.0364, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0364;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 20.3917808219178;\tregion: us_can;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.03;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.088;\ttissue: Blood"}]}, {"GSM2351831": [{"title": "SUBJ.0905, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0905;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 26.0849315068493;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.663;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.144;\ttissue: Blood"}]}, {"GSM2351832": [{"title": "SUBJ.0284, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0284;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 54.2027397260274;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.896;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.106;\ttissue: Blood"}]}, {"GSM2351833": [{"title": "SUBJ.0323, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0323;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 46.9095890410958;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 142;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.39;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.232;\ttissue: Blood"}]}, {"GSM2351834": [{"title": "SUBJ.1578, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1578;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 39.8164383561643;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.28;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.226;\ttissue: Blood"}]}, {"GSM2351835": [{"title": "SUBJ.0643, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0643;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 21.9287671232876;\tregion: europe;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.768;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.053;\ttissue: Blood"}]}, {"GSM2351836": [{"title": "SUBJ.0182, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0182;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 55.7479452054794;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 13;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.57;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.357;\ttissue: Blood"}]}, {"GSM2351837": [{"title": "SUBJ.1804, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1804;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 46.4547945205479;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 31;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.08;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.117;\ttissue: Blood"}]}, {"GSM2351838": [{"title": "SUBJ.1284, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1284;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 49.0520547945205;\tregion: us_can;\tsledai_at_baseline: 30;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.358;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2351839": [{"title": "SUBJ.1068, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1068;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 31.0657534246575;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 64;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.03;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.08;\ttissue: Blood"}]}, {"GSM2351840": [{"title": "SUBJ.0989, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0989;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 34.172602739726;\tregion: rest_world;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 83;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.28;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.258;\ttissue: Blood"}]}, {"GSM2351841": [{"title": "SUBJ.0458, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0458;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 35.2904109589041;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 114;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.159;\ttissue: Blood"}]}, {"GSM2351842": [{"title": "SUBJ.0779, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0779;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 29.0547945205479;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.861;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.215;\ttissue: Blood"}]}, {"GSM2351843": [{"title": "SUBJ.0200, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0200;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 32.8715846994535;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 36;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.18;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.251;\ttissue: Blood"}]}, {"GSM2351844": [{"title": "SUBJ.1059, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1059;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 34.4520547945205;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.155;\ttissue: Blood"}]}, {"GSM2351845": [{"title": "SUBJ.1634, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1634;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 18.7158469945355;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 122;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.455;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.08;\ttissue: Blood"}]}, {"GSM2351846": [{"title": "SUBJ.0222, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0222;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 48.1616438356164;\tregion: mex_ca_sa;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 31;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.05;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.23;\ttissue: Blood"}]}, {"GSM2351847": [{"title": "SUBJ.0722, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0722;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 73.931506849315;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.03;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.235;\ttissue: Blood"}]}, {"GSM2351848": [{"title": "SUBJ.0237, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0237;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 24.7021857923497;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 62;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.821;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.149;\ttissue: Blood"}]}, {"GSM2351849": [{"title": "SUBJ.0545, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0545;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 42.4712328767123;\tregion: europe;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 121;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.886;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.077;\ttissue: Blood"}]}, {"GSM2351850": [{"title": "SUBJ.1407, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1407;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 47.6054794520548;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 72;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.24;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.342;\ttissue: Blood"}]}, {"GSM2351851": [{"title": "SUBJ.0881, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0881;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 64.6639344262295;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 112;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.12;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.188;\ttissue: Blood"}]}, {"GSM2351852": [{"title": "SUBJ.1248, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1248;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 48.8524590163934;\tregion: us_can;\tsledai_at_baseline: 7;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.21;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.15;\ttissue: Blood"}]}, {"GSM2351853": [{"title": "SUBJ.0762, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0762;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.0849315068493;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.29;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.234;\ttissue: Blood"}]}, {"GSM2351854": [{"title": "SUBJ.0197, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0197;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: asian;\tSex: Male;\tage_at_baseline: 33.7397260273972;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.96;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.218;\ttissue: Blood"}]}, {"GSM2351855": [{"title": "SUBJ.0162, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0162;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 36.0328767123287;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.29;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.261;\ttissue: Blood"}]}, {"GSM2351856": [{"title": "SUBJ.1628, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1628;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: multiple;\tSex: Female;\tage_at_baseline: 20.0684931506849;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.651;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.15;\ttissue: Blood"}]}, {"GSM2351857": [{"title": "SUBJ.1579, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1579;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 37.9344262295082;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.37;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.359;\ttissue: Blood"}]}, {"GSM2351858": [{"title": "SUBJ.0399, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0399;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 53.3397260273972;\tregion: us_can;\tsledai_at_baseline: 13;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 46;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.05;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.075;\ttissue: Blood"}]}, {"GSM2351859": [{"title": "SUBJ.0003, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0003;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 45.3534246575342;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 18;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.28;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.253;\ttissue: Blood"}]}, {"GSM2351860": [{"title": "SUBJ.1531, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1531;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 46.945205479452;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 186;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.935;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2351861": [{"title": "SUBJ.1240, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1240;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 49.6273972602739;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.37;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.375;\ttissue: Blood"}]}, {"GSM2351862": [{"title": "SUBJ.0212, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0212;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 63.4164383561643;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.56;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.332;\ttissue: Blood"}]}, {"GSM2351863": [{"title": "SUBJ.1413, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1413;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 30.6109589041095;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 14;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.815;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.229;\ttissue: Blood"}]}, {"GSM2351864": [{"title": "SUBJ.0611, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0611;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 51.2164383561643;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 42;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.06;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.188;\ttissue: Blood"}]}, {"GSM2351865": [{"title": "SUBJ.0708, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0708;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 68.0301369863013;\tregion: rest_world;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 136;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.576;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2351866": [{"title": "SUBJ.1239, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1239;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 48.0547945205479;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 97;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.691;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.163;\ttissue: Blood"}]}, {"GSM2351867": [{"title": "SUBJ.0240, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0240;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 52.3698630136986;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 11;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.764;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2351868": [{"title": "SUBJ.0935, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0935;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 29.2931506849315;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 164;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.14;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.214;\ttissue: Blood"}]}, {"GSM2351869": [{"title": "SUBJ.1507, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1507;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 43.775956284153;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 21;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.903;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.122;\ttissue: Blood"}]}, {"GSM2351870": [{"title": "SUBJ.1164, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1164;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 30.1945205479452;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 181;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.2;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.079;\ttissue: Blood"}]}, {"GSM2351871": [{"title": "SUBJ.1237, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1237;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 29.3972602739726;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 265;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.656;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.106;\ttissue: Blood"}]}, {"GSM2351872": [{"title": "SUBJ.1614, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1614;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 32.1232876712328;\tregion: mex_ca_sa;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 27;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.11;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.09;\ttissue: Blood"}]}, {"GSM2351873": [{"title": "SUBJ.1472, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1472;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 25.8876712328767;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 168;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.14;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.165;\ttissue: Blood"}]}, {"GSM2351874": [{"title": "SUBJ.0332, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0332;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 65.6136986301369;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.68;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.149;\ttissue: Blood"}]}, {"GSM2351875": [{"title": "SUBJ.1696, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1696;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 29.0273972602739;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.951;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.143;\ttissue: Blood"}]}, {"GSM2351876": [{"title": "SUBJ.0160, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0160;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 52.4109589041096;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.37;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.339;\ttissue: Blood"}]}, {"GSM2351877": [{"title": "SUBJ.1716, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1716;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: multiple;\tSex: Female;\tage_at_baseline: 35.145205479452;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.93;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.113;\ttissue: Blood"}]}, {"GSM2351878": [{"title": "SUBJ.0984, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0984;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 23.8579234972677;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 49;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.997;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.096;\ttissue: Blood"}]}, {"GSM2351879": [{"title": "SUBJ.0537, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0537;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 43.558904109589;\tregion: rest_world;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 74;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.25;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.137;\ttissue: Blood"}]}, {"GSM2351880": [{"title": "SUBJ.0261, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0261;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 56.0986301369863;\tregion: rest_world;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.881;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.076;\ttissue: Blood"}]}, {"GSM2351881": [{"title": "SUBJ.1625, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1625;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 42.0465753424657;\tregion: europe;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.973;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.269;\ttissue: Blood"}]}, {"GSM2351882": [{"title": "SUBJ.0702, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0702;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 59.2;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 20;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.51;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.3;\ttissue: Blood"}]}, {"GSM2351883": [{"title": "SUBJ.0937, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0937;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: multiple;\tSex: Female;\tage_at_baseline: 62.8;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.18;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.237;\ttissue: Blood"}]}, {"GSM2351884": [{"title": "SUBJ.0316, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0316;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 30.7397260273972;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 40;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.26;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.17;\ttissue: Blood"}]}, {"GSM2351885": [{"title": "SUBJ.1220, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1220;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 37.3972602739726;\tregion: europe;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 15;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.956;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.201;\ttissue: Blood"}]}, {"GSM2351886": [{"title": "SUBJ.1074, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1074;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 52.6438356164383;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 10;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.869;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.06;\ttissue: Blood"}]}, {"GSM2351887": [{"title": "SUBJ.1444, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1444;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 27.2794520547945;\tregion: us_can;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.457;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.067;\ttissue: Blood"}]}, {"GSM2351888": [{"title": "SUBJ.0654, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0654;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 28.0684931506849;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 129;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.03;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.149;\ttissue: Blood"}]}, {"GSM2351889": [{"title": "SUBJ.0287, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0287;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 41.8712328767123;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 143;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): H;\tc3_at_baseline (g/l): 2.07;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.418;\ttissue: Blood"}]}, {"GSM2351890": [{"title": "SUBJ.1662, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1662;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 37.1424657534246;\tregion: us_can;\tsledai_at_baseline: 28;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 77;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.603;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2351891": [{"title": "SUBJ.0402, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0402;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 39.6602739726027;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 41;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.769;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.098;\ttissue: Blood"}]}, {"GSM2351892": [{"title": "SUBJ.0761, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0761;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 64.7950819672131;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.44;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.445;\ttissue: Blood"}]}, {"GSM2351893": [{"title": "SUBJ.1361, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1361;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 55.6739726027397;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.892;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.181;\ttissue: Blood"}]}, {"GSM2351894": [{"title": "SUBJ.0977, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0977;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 42.9424657534246;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.616;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.103;\ttissue: Blood"}]}, {"GSM2351895": [{"title": "SUBJ.0479, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0479;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 43.8328767123287;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.08;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.125;\ttissue: Blood"}]}, {"GSM2351896": [{"title": "SUBJ.1430, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1430;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 51.2219178082191;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 46;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.29;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.169;\ttissue: Blood"}]}, {"GSM2351897": [{"title": "SUBJ.0441, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0441;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 19.9561643835616;\tregion: us_can;\tsledai_at_baseline: 7;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 211;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.626;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.077;\ttissue: Blood"}]}, {"GSM2351898": [{"title": "SUBJ.1428, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1428;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 47.8657534246575;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.07;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.157;\ttissue: Blood"}]}, {"GSM2351899": [{"title": "SUBJ.1333, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1333;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 28.372602739726;\tregion: rest_world;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.985;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.325;\ttissue: Blood"}]}, {"GSM2351900": [{"title": "SUBJ.1259, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1259;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 43.9754098360655;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.957;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.191;\ttissue: Blood"}]}, {"GSM2351901": [{"title": "SUBJ.1320, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1320;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 55.4712328767123;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): H;\tc3_at_baseline (g/l): 1.9;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.399;\ttissue: Blood"}]}, {"GSM2351902": [{"title": "SUBJ.1380, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1380;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 26.372602739726;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 11;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.27;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.18;\ttissue: Blood"}]}, {"GSM2351903": [{"title": "SUBJ.1144, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1144;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 50.1506849315068;\tregion: us_can;\tsledai_at_baseline: 4;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 11;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2351904": [{"title": "SUBJ.1400, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1400;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 20.931693989071;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 264;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.17;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.134;\ttissue: Blood"}]}, {"GSM2351905": [{"title": "SUBJ.0307, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0307;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 56.8657534246575;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 22;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.26;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.403;\ttissue: Blood"}]}, {"GSM2351906": [{"title": "SUBJ.0526, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0526;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 49.7568306010929;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 14;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.991;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.16;\ttissue: Blood"}]}, {"GSM2351907": [{"title": "SUBJ.0184, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0184;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 25.9095890410958;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 124;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.932;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.222;\ttissue: Blood"}]}, {"GSM2351908": [{"title": "SUBJ.0177, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0177;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 35.7643835616438;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 23;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.65;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.183;\ttissue: Blood"}]}, {"GSM2351909": [{"title": "SUBJ.1731, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1731;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: multiple;\tSex: Female;\tage_at_baseline: 38.558904109589;\tregion: rest_world;\tsledai_at_baseline: 7;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.08;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.395;\ttissue: Blood"}]}, {"GSM2351910": [{"title": "SUBJ.1557, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1557;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 26.3287671232876;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.304;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2351911": [{"title": "SUBJ.0478, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0478;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 29.8688524590164;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 23;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.04;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.198;\ttissue: Blood"}]}, {"GSM2351912": [{"title": "SUBJ.0739, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0739;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 52.6054794520548;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 166;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.12;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.467;\ttissue: Blood"}]}, {"GSM2351913": [{"title": "SUBJ.0010, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0010;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 36.9123287671232;\tregion: europe;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.133;\ttissue: Blood"}]}, {"GSM2351914": [{"title": "SUBJ.1636, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1636;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 28.4575342465753;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.172;\ttissue: Blood"}]}, {"GSM2351915": [{"title": "SUBJ.1833, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1833;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 58.9369863013698;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 37;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.64;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.269;\ttissue: Blood"}]}, {"GSM2351916": [{"title": "SUBJ.0552, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0552;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 31.972602739726;\tregion: us_can;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.883;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.132;\ttissue: Blood"}]}, {"GSM2351917": [{"title": "SUBJ.1180, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1180;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 40.9643835616438;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.01;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.275;\ttissue: Blood"}]}, {"GSM2351918": [{"title": "SUBJ.1196, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1196;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 45.0054794520548;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.877;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.085;\ttissue: Blood"}]}, {"GSM2351919": [{"title": "SUBJ.1255, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1255;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 39.2547945205479;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.37;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.185;\ttissue: Blood"}]}, {"GSM2351920": [{"title": "SUBJ.1363, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1363;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 62.4410958904109;\tregion: rest_world;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.948;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.161;\ttissue: Blood"}]}, {"GSM2351921": [{"title": "SUBJ.0285, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0285;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Male;\tage_at_baseline: 38.8739726027397;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 89;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.099;\ttissue: Blood"}]}, {"GSM2351922": [{"title": "SUBJ.0616, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0616;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 45.6191780821917;\tregion: mex_ca_sa;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 196;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.596;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2351923": [{"title": "SUBJ.0274, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0274;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 59.4712328767123;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.69;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.26;\ttissue: Blood"}]}, {"GSM2351924": [{"title": "SUBJ.0630, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0630;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 47.8306010928961;\tregion: rest_world;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 14;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.42;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.246;\ttissue: Blood"}]}, {"GSM2351925": [{"title": "SUBJ.0765, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0765;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 27.7568306010929;\tregion: europe;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 143;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.129;\ttissue: Blood"}]}, {"GSM2351926": [{"title": "SUBJ.0853, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0853;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 33.9123287671232;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 14;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.08;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.208;\ttissue: Blood"}]}, {"GSM2351927": [{"title": "SUBJ.0436, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0436;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 36.6273972602739;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.57;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.223;\ttissue: Blood"}]}, {"GSM2351928": [{"title": "SUBJ.0898, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0898;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 65.6246575342465;\tregion: europe;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 143;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.15;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.183;\ttissue: Blood"}]}, {"GSM2351929": [{"title": "SUBJ.1179, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1179;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 54.3150684931506;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.42;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.274;\ttissue: Blood"}]}, {"GSM2351930": [{"title": "SUBJ.0507, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0507;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 46.8109589041095;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.63;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.333;\ttissue: Blood"}]}, {"GSM2351931": [{"title": "SUBJ.1230, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1230;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 34.2520547945205;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.41;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.177;\ttissue: Blood"}]}, {"GSM2351932": [{"title": "SUBJ.1379, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1379;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 33.1616438356164;\tregion: europe;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 40;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.71;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.125;\ttissue: Blood"}]}, {"GSM2351933": [{"title": "SUBJ.1683, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1683;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 47.3506849315068;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 12;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.33;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.222;\ttissue: Blood"}]}, {"GSM2351934": [{"title": "SUBJ.1114, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1114;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 47.9342465753424;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.25;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.228;\ttissue: Blood"}]}, {"GSM2351935": [{"title": "SUBJ.0020, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0020;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 42.5095890410959;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 153;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.17;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.145;\ttissue: Blood"}]}, {"GSM2351936": [{"title": "SUBJ.0488, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0488;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 29.4684931506849;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 16;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.712;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.183;\ttissue: Blood"}]}, {"GSM2351937": [{"title": "SUBJ.0090, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0090;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 37.7732240437158;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 57;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.735;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.062;\ttissue: Blood"}]}, {"GSM2351938": [{"title": "SUBJ.1160, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1160;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 64.7835616438356;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.33;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.21;\ttissue: Blood"}]}, {"GSM2351939": [{"title": "SUBJ.0862, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0862;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 41.8273972602739;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 130;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.678;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.111;\ttissue: Blood"}]}, {"GSM2351940": [{"title": "SUBJ.0687, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0687;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 46.8169398907103;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 139;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.572;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2351941": [{"title": "SUBJ.0625, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0625;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 50.0273972602739;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 86;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.11;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.143;\ttissue: Blood"}]}, {"GSM2351942": [{"title": "SUBJ.0334, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0334;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Male;\tage_at_baseline: 36.0328767123287;\tregion: us_can;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 148;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.37;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.32;\ttissue: Blood"}]}, {"GSM2351943": [{"title": "SUBJ.1052, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1052;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 32.6967213114754;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.31;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.354;\ttissue: Blood"}]}, {"GSM2351944": [{"title": "SUBJ.1812, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1812;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 41.5123287671232;\tregion: europe;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 16;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.995;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.192;\ttissue: Blood"}]}, {"GSM2351945": [{"title": "SUBJ.0258, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0258;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 32.5260273972602;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 78;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.34;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.204;\ttissue: Blood"}]}, {"GSM2351946": [{"title": "SUBJ.0579, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0579;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 39.6639344262295;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 197;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.823;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.13;\ttissue: Blood"}]}, {"GSM2351947": [{"title": "SUBJ.0048, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0048;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 51.731506849315;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.31;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.191;\ttissue: Blood"}]}, {"GSM2351948": [{"title": "SUBJ.0325, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0325;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 41.0547945205479;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.32;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.181;\ttissue: Blood"}]}, {"GSM2351949": [{"title": "SUBJ.1426, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1426;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 25.8931506849315;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.08;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.141;\ttissue: Blood"}]}, {"GSM2351950": [{"title": "SUBJ.0220, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0220;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 25.8547945205479;\tregion: rest_world;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 108;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.03;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.095;\ttissue: Blood"}]}, {"GSM2351951": [{"title": "SUBJ.1615, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1615;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 79.3561643835616;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.09;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.272;\ttissue: Blood"}]}, {"GSM2351952": [{"title": "SUBJ.1711, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1711;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 72.9424657534246;\tregion: mex_ca_sa;\tsledai_at_baseline: 7;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.22;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.255;\ttissue: Blood"}]}, {"GSM2351953": [{"title": "SUBJ.1713, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1713;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 50.9150684931506;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 19;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.924;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.079;\ttissue: Blood"}]}, {"GSM2351954": [{"title": "SUBJ.0299, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0299;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 26.6602739726027;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 127;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.898;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.158;\ttissue: Blood"}]}, {"GSM2351955": [{"title": "SUBJ.0304, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0304;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 30.2164383561643;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.837;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.09;\ttissue: Blood"}]}, {"GSM2351956": [{"title": "SUBJ.1205, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1205;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 46.0465753424657;\tregion: us_can;\tsledai_at_baseline: 13;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.7;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.067;\ttissue: Blood"}]}, {"GSM2351957": [{"title": "SUBJ.1133, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1133;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 26.6575342465753;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 10;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.98;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.186;\ttissue: Blood"}]}, {"GSM2351958": [{"title": "SUBJ.1098, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1098;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 61.5808219178082;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 116;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.88;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.335;\ttissue: Blood"}]}, {"GSM2351959": [{"title": "SUBJ.0538, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0538;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.4520547945205;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.32;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.239;\ttissue: Blood"}]}, {"GSM2351960": [{"title": "SUBJ.1424, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1424;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 43.0219178082191;\tregion: rest_world;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.31;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.127;\ttissue: Blood"}]}, {"GSM2351961": [{"title": "SUBJ.1760, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1760;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 19.5890410958904;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.32;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.15;\ttissue: Blood"}]}, {"GSM2351962": [{"title": "SUBJ.0327, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0327;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 53.3287671232876;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 11;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.75;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.088;\ttissue: Blood"}]}, {"GSM2351963": [{"title": "SUBJ.0906, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0906;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 34.9726775956284;\tregion: us_can;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 26;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.07;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.135;\ttissue: Blood"}]}, {"GSM2351964": [{"title": "SUBJ.1047, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1047;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 36.5260273972602;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 16;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.43;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.477;\ttissue: Blood"}]}, {"GSM2351965": [{"title": "SUBJ.1759, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1759;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 56.9508196721311;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 43;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.27;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.303;\ttissue: Blood"}]}, {"GSM2351966": [{"title": "SUBJ.0132, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0132;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 37.4273972602739;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 252;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.81;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.13;\ttissue: Blood"}]}, {"GSM2351967": [{"title": "SUBJ.0102, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0102;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 46.2739726027397;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.388;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.065;\ttissue: Blood"}]}, {"GSM2351968": [{"title": "SUBJ.1155, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1155;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 56.1424657534246;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 215;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.07;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.145;\ttissue: Blood"}]}, {"GSM2351969": [{"title": "SUBJ.1817, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1817;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 51.5397260273972;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.175;\ttissue: Blood"}]}, {"GSM2351970": [{"title": "SUBJ.1022, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1022;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 34.9232876712328;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.858;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.111;\ttissue: Blood"}]}, {"GSM2351971": [{"title": "SUBJ.1124, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1124;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 33.317808219178;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 43;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.981;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.118;\ttissue: Blood"}]}, {"GSM2351972": [{"title": "SUBJ.0791, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0791;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 59.8301369863013;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.52;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.31;\ttissue: Blood"}]}, {"GSM2351973": [{"title": "SUBJ.0693, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0693;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 38.0958904109589;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 122;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.525;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.1;\ttissue: Blood"}]}, {"GSM2351974": [{"title": "SUBJ.0145, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0145;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 77.4438356164383;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 11;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.25;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.233;\ttissue: Blood"}]}, {"GSM2351975": [{"title": "SUBJ.0037, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0037;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 28.4109589041095;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.09;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.353;\ttissue: Blood"}]}, {"GSM2351976": [{"title": "SUBJ.1079, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1079;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 35.531506849315;\tregion: europe;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.649;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.099;\ttissue: Blood"}]}, {"GSM2351977": [{"title": "SUBJ.1152, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1152;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 67.9945205479452;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.22;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.431;\ttissue: Blood"}]}, {"GSM2351978": [{"title": "SUBJ.0308, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0308;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 32.3095890410958;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.66;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.315;\ttissue: Blood"}]}, {"GSM2351979": [{"title": "SUBJ.0497, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0497;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 30.3095890410958;\tregion: mex_ca_sa;\tsledai_at_baseline: 22;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 111;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.76;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.061;\ttissue: Blood"}]}, {"GSM2351980": [{"title": "SUBJ.1278, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1278;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 50.9125683060109;\tregion: mex_ca_sa;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 15;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.707;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.135;\ttissue: Blood"}]}, {"GSM2351981": [{"title": "SUBJ.0293, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0293;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 20.5342465753424;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.42;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.224;\ttissue: Blood"}]}, {"GSM2351982": [{"title": "SUBJ.1032, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1032;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 46.2958904109589;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 34;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.14;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.155;\ttissue: Blood"}]}, {"GSM2351983": [{"title": "SUBJ.1331, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1331;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 38.1479452054794;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 142;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.999;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.126;\ttissue: Blood"}]}, {"GSM2351984": [{"title": "SUBJ.1183, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1183;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 42.6967213114754;\tregion: europe;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 132;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.816;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.118;\ttissue: Blood"}]}, {"GSM2351985": [{"title": "SUBJ.0940, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0940;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 38.0575342465753;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.37;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.122;\ttissue: Blood"}]}, {"GSM2351986": [{"title": "SUBJ.0233, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0233;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 46.8164383561643;\tregion: us_can;\tsledai_at_baseline: 23;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.478;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2351987": [{"title": "SUBJ.1588, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1588;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 41.6493150684931;\tregion: mex_ca_sa;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 250;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.23;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.198;\ttissue: Blood"}]}, {"GSM2351988": [{"title": "SUBJ.1559, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1559;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 37.4904109589041;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 37;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.23;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.142;\ttissue: Blood"}]}, {"GSM2351989": [{"title": "SUBJ.1273, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1273;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 30.9013698630137;\tregion: us_can;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.19;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.136;\ttissue: Blood"}]}, {"GSM2351990": [{"title": "SUBJ.1105, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1105;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 50.9453551912568;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 110;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.589;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.088;\ttissue: Blood"}]}, {"GSM2351991": [{"title": "SUBJ.0771, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0771;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 49.983606557377;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.759;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.06;\ttissue: Blood"}]}, {"GSM2351992": [{"title": "SUBJ.1046, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1046;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 47.2739726027397;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 160;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.01;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.126;\ttissue: Blood"}]}, {"GSM2351993": [{"title": "SUBJ.0851, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0851;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 46.3753424657534;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 68;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.03;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.114;\ttissue: Blood"}]}, {"GSM2351994": [{"title": "SUBJ.1457, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1457;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 40.2438356164383;\tregion: europe;\tsledai_at_baseline: 13;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 184;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.967;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.064;\ttissue: Blood"}]}, {"GSM2351995": [{"title": "SUBJ.1254, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1254;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 53.5506849315068;\tregion: europe;\tsledai_at_baseline: 24;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 37;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.08;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.234;\ttissue: Blood"}]}, {"GSM2351996": [{"title": "SUBJ.0248, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0248;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 37.7342465753424;\tregion: us_can;\tsledai_at_baseline: 15;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 86;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.14;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.218;\ttissue: Blood"}]}, {"GSM2351997": [{"title": "SUBJ.0246, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0246;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 46.2054794520548;\tregion: europe;\tsledai_at_baseline: 17;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.419;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2351998": [{"title": "SUBJ.0883, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0883;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 26.5260273972602;\tregion: europe;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.39;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2351999": [{"title": "SUBJ.0533, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0533;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 27.8005464480874;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 138;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.65;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.068;\ttissue: Blood"}]}, {"GSM2352000": [{"title": "SUBJ.1453, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1453;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 32.6164383561643;\tregion: rest_world;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.467;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.05;\ttissue: Blood"}]}, {"GSM2352001": [{"title": "SUBJ.1465, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1465;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 25.7150684931506;\tregion: mex_ca_sa;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 268;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.712;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.077;\ttissue: Blood"}]}, {"GSM2352002": [{"title": "SUBJ.1251, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1251;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 39.9123287671232;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 149;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.809;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.076;\ttissue: Blood"}]}, {"GSM2352003": [{"title": "SUBJ.1511, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1511;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 56.586301369863;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 38;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.771;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.094;\ttissue: Blood"}]}, {"GSM2352004": [{"title": "SUBJ.0348, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0348;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: multiple;\tSex: Female;\tage_at_baseline: 40.7808219178082;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.53;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.458;\ttissue: Blood"}]}, {"GSM2352005": [{"title": "SUBJ.1654, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1654;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: asian;\tSex: Female;\tage_at_baseline: 52.0876712328767;\tregion: rest_world;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.34;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.213;\ttissue: Blood"}]}, {"GSM2352006": [{"title": "SUBJ.1305, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1305;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 32.3753424657534;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 14;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.778;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.135;\ttissue: Blood"}]}, {"GSM2352007": [{"title": "SUBJ.1232, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1232;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 46.8630136986301;\tregion: us_can;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 12;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.744;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.237;\ttissue: Blood"}]}, {"GSM2352008": [{"title": "SUBJ.0836, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0836;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 46.4520547945205;\tregion: europe;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.43;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.217;\ttissue: Blood"}]}, {"GSM2352009": [{"title": "SUBJ.1503, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1503;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 30.0575342465753;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.29;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.276;\ttissue: Blood"}]}, {"GSM2352010": [{"title": "SUBJ.0095, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0095;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 43.1643835616438;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.946;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.147;\ttissue: Blood"}]}, {"GSM2352011": [{"title": "SUBJ.1249, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1249;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 52.1808219178082;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.22;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.316;\ttissue: Blood"}]}, {"GSM2352012": [{"title": "SUBJ.1481, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1481;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 45.1972602739726;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 270;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.944;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.117;\ttissue: Blood"}]}, {"GSM2352013": [{"title": "SUBJ.0112, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0112;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 41.7267759562841;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 106;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.07;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.136;\ttissue: Blood"}]}, {"GSM2352014": [{"title": "SUBJ.1370, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1370;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 31.4465753424657;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.492;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2352015": [{"title": "SUBJ.0598, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0598;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 32.8306010928961;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.44;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.28;\ttissue: Blood"}]}, {"GSM2352016": [{"title": "SUBJ.1534, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1534;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 40.811475409836;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 7;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.07;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.232;\ttissue: Blood"}]}, {"GSM2352017": [{"title": "SUBJ.0027, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0027;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 45.5397260273972;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 11;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.898;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.166;\ttissue: Blood"}]}, {"GSM2352018": [{"title": "SUBJ.1749, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1749;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 55.6493150684931;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 13;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.33;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.197;\ttissue: Blood"}]}, {"GSM2352019": [{"title": "SUBJ.1541, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1541;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 39.2931506849315;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 23;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.29;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.315;\ttissue: Blood"}]}, {"GSM2352020": [{"title": "SUBJ.1785, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1785;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 40.6273972602739;\tregion: europe;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.948;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.16;\ttissue: Blood"}]}, {"GSM2352021": [{"title": "SUBJ.1687, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1687;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 45.724043715847;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.4;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.231;\ttissue: Blood"}]}, {"GSM2352022": [{"title": "SUBJ.1108, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1108;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 55.811475409836;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.25;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.255;\ttissue: Blood"}]}, {"GSM2352023": [{"title": "SUBJ.0520, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0520;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 50.9041095890411;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.26;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.222;\ttissue: Blood"}]}, {"GSM2352024": [{"title": "SUBJ.0187, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0187;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 30.5479452054794;\tregion: rest_world;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 254;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.451;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.081;\ttissue: Blood"}]}, {"GSM2352025": [{"title": "SUBJ.1198, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1198;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 30.9480874316939;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 36;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.531;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.098;\ttissue: Blood"}]}, {"GSM2352026": [{"title": "SUBJ.0394, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0394;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 62.6994535519125;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.988;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.211;\ttissue: Blood"}]}, {"GSM2352027": [{"title": "SUBJ.0063, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0063;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 42.8497267759562;\tregion: europe;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 50;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.772;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.203;\ttissue: Blood"}]}, {"GSM2352028": [{"title": "SUBJ.0310, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0310;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 30.6803278688524;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.17;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.169;\ttissue: Blood"}]}, {"GSM2352029": [{"title": "SUBJ.1266, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1266;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 44.3369863013698;\tregion: us_can;\tsledai_at_baseline: 22;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 35;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.636;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.106;\ttissue: Blood"}]}, {"GSM2352030": [{"title": "SUBJ.1622, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1622;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 34.0602739726027;\tregion: europe;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 183;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.791;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.115;\ttissue: Blood"}]}, {"GSM2352031": [{"title": "SUBJ.1326, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1326;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 46.0219178082191;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 96;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.869;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.159;\ttissue: Blood"}]}, {"GSM2352032": [{"title": "SUBJ.0699, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0699;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 40.7561643835616;\tregion: rest_world;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.778;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.102;\ttissue: Blood"}]}, {"GSM2352033": [{"title": "SUBJ.1655, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1655;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 25.8770491803278;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.842;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.108;\ttissue: Blood"}]}, {"GSM2352034": [{"title": "SUBJ.0753, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0753;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 32.545205479452;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.863;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.155;\ttissue: Blood"}]}, {"GSM2352035": [{"title": "SUBJ.0802, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0802;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 38.3342465753424;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 12;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.28;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.142;\ttissue: Blood"}]}, {"GSM2352036": [{"title": "SUBJ.0642, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0642;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 36.9890710382513;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.26;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.246;\ttissue: Blood"}]}, {"GSM2352037": [{"title": "SUBJ.0929, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0929;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 42.7732240437158;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 211;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.896;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.109;\ttissue: Blood"}]}, {"GSM2352038": [{"title": "SUBJ.0319, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0319;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 30.4520547945205;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 12;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.41;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.279;\ttissue: Blood"}]}, {"GSM2352039": [{"title": "SUBJ.1641, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1641;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 52.0876712328767;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.834;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.191;\ttissue: Blood"}]}, {"GSM2352040": [{"title": "SUBJ.0772, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0772;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 57.4191780821917;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.25;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.162;\ttissue: Blood"}]}, {"GSM2352041": [{"title": "SUBJ.1594, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1594;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 37.9424657534246;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 70;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.29;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.192;\ttissue: Blood"}]}, {"GSM2352042": [{"title": "SUBJ.1055, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1055;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 42.8684931506849;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.832;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.187;\ttissue: Blood"}]}, {"GSM2352043": [{"title": "SUBJ.0438, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0438;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 22.9506849315068;\tregion: us_can;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.04;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.16;\ttissue: Blood"}]}, {"GSM2352044": [{"title": "SUBJ.0303, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0303;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 25.4684931506849;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 29;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.783;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.107;\ttissue: Blood"}]}, {"GSM2352045": [{"title": "SUBJ.1706, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1706;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 39.1671232876712;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.51;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.112;\ttissue: Blood"}]}, {"GSM2352046": [{"title": "SUBJ.1510, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1510;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 34.3424657534246;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.999;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.054;\ttissue: Blood"}]}, {"GSM2352047": [{"title": "SUBJ.1084, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1084;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 46.3534246575342;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.26;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.264;\ttissue: Blood"}]}, {"GSM2352048": [{"title": "SUBJ.0701, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0701;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 41.9726775956284;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 126;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.03;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.135;\ttissue: Blood"}]}, {"GSM2352049": [{"title": "SUBJ.1525, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1525;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 64.4301369863013;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 150;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.25;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.151;\ttissue: Blood"}]}, {"GSM2352050": [{"title": "SUBJ.1596, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1596;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 64.4520547945205;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 23;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.32;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.227;\ttissue: Blood"}]}, {"GSM2352051": [{"title": "SUBJ.0170, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0170;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 24.8109589041095;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 84;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.62;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.119;\ttissue: Blood"}]}, {"GSM2352052": [{"title": "SUBJ.0634, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0634;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 45.3342465753424;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 32;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.111;\ttissue: Blood"}]}, {"GSM2352053": [{"title": "SUBJ.0949, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0949;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 31.7123287671232;\tregion: europe;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 215;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.856;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2352054": [{"title": "SUBJ.1250, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1250;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 44.4547945205479;\tregion: us_can;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.619;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.187;\ttissue: Blood"}]}, {"GSM2352055": [{"title": "SUBJ.1573, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1573;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 20.2;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 180;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.622;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.134;\ttissue: Blood"}]}, {"GSM2352056": [{"title": "SUBJ.0729, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0729;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 54.9287671232876;\tregion: europe;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 7;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.13;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.261;\ttissue: Blood"}]}, {"GSM2352057": [{"title": "SUBJ.0290, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0290;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 55.3698630136986;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.866;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.178;\ttissue: Blood"}]}, {"GSM2352058": [{"title": "SUBJ.0648, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0648;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 44.331506849315;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 185;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.968;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.105;\ttissue: Blood"}]}, {"GSM2352059": [{"title": "SUBJ.1770, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1770;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 53.1013698630137;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.225;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2352060": [{"title": "SUBJ.0982, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0982;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 39.5808219178082;\tregion: rest_world;\tsledai_at_baseline: 7;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 7;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.06;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.175;\ttissue: Blood"}]}, {"GSM2352061": [{"title": "SUBJ.0313, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0313;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 42.2438356164383;\tregion: europe;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.32;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.293;\ttissue: Blood"}]}, {"GSM2352062": [{"title": "SUBJ.1692, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1692;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 48.9698630136986;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.16;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.195;\ttissue: Blood"}]}, {"GSM2352063": [{"title": "SUBJ.0344, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0344;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 65.811475409836;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.134;\ttissue: Blood"}]}, {"GSM2352064": [{"title": "SUBJ.0147, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0147;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 50.9753424657534;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 217;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.77;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.077;\ttissue: Blood"}]}, {"GSM2352065": [{"title": "SUBJ.1080, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1080;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 61.3506849315068;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.23;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.192;\ttissue: Blood"}]}, {"GSM2352066": [{"title": "SUBJ.0639, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0639;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 51.117808219178;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 75;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.04;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.214;\ttissue: Blood"}]}, {"GSM2352067": [{"title": "SUBJ.1175, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1175;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 28.4301369863013;\tregion: mex_ca_sa;\tsledai_at_baseline: 15;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.733;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.112;\ttissue: Blood"}]}, {"GSM2352068": [{"title": "SUBJ.1062, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1062;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 37.9125683060109;\tregion: mex_ca_sa;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 24;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.803;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.209;\ttissue: Blood"}]}, {"GSM2352069": [{"title": "SUBJ.0391, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0391;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 43.9123287671232;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 15;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.808;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.222;\ttissue: Blood"}]}, {"GSM2352070": [{"title": "SUBJ.0876, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0876;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 70.4904109589041;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.085;\ttissue: Blood"}]}, {"GSM2352071": [{"title": "SUBJ.1549, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1549;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 59.545205479452;\tregion: mex_ca_sa;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.34;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.344;\ttissue: Blood"}]}, {"GSM2352072": [{"title": "SUBJ.0025, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0025;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 38.7923497267759;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 17;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.801;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.078;\ttissue: Blood"}]}, {"GSM2352073": [{"title": "SUBJ.0289, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0289;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 34.6082191780822;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 34;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.118;\ttissue: Blood"}]}, {"GSM2352074": [{"title": "SUBJ.1132, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1132;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 28.1013698630137;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.099;\ttissue: Blood"}]}, {"GSM2352075": [{"title": "SUBJ.0300, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0300;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 46.7808219178082;\tregion: us_can;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.68;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.206;\ttissue: Blood"}]}, {"GSM2352076": [{"title": "SUBJ.0766, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0766;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 31.986301369863;\tregion: mex_ca_sa;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 76;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.462;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.101;\ttissue: Blood"}]}, {"GSM2352077": [{"title": "SUBJ.1500, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1500;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 23.931506849315;\tregion: mex_ca_sa;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.569;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.056;\ttissue: Blood"}]}, {"GSM2352078": [{"title": "SUBJ.0531, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0531;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 50.4465753424657;\tregion: mex_ca_sa;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 117;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.47;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.283;\ttissue: Blood"}]}, {"GSM2352079": [{"title": "SUBJ.0936, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0936;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 19.3890410958904;\tregion: mex_ca_sa;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 246;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.697;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.064;\ttissue: Blood"}]}, {"GSM2352080": [{"title": "SUBJ.0461, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0461;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 47.2027397260274;\tregion: europe;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 12;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.846;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.138;\ttissue: Blood"}]}, {"GSM2352081": [{"title": "SUBJ.0751, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0751;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 53.7185792349726;\tregion: us_can;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 144;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.66;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.34;\ttissue: Blood"}]}, {"GSM2352082": [{"title": "SUBJ.1256, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1256;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 26.8356164383561;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 175;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.65;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.067;\ttissue: Blood"}]}, {"GSM2352083": [{"title": "SUBJ.1351, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1351;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 48.8849315068493;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 10;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.38;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.234;\ttissue: Blood"}]}, {"GSM2352084": [{"title": "SUBJ.0365, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0365;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 67.8524590163934;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 39;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): H;\tc3_at_baseline (g/l): 1.88;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.333;\ttissue: Blood"}]}, {"GSM2352085": [{"title": "SUBJ.0119, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0119;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 38.8684931506849;\tregion: europe;\tsledai_at_baseline: 22;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.714;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.117;\ttissue: Blood"}]}, {"GSM2352086": [{"title": "SUBJ.1227, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1227;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: --;\tSex: --;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2352087": [{"title": "SUBJ.1656, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1656;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Male;\tage_at_baseline: 51.2958904109589;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.912;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.207;\ttissue: Blood"}]}, {"GSM2352088": [{"title": "SUBJ.0704, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0704;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 34.7486338797814;\tregion: rest_world;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 203;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.17;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.199;\ttissue: Blood"}]}, {"GSM2352089": [{"title": "SUBJ.1458, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1458;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 51.8109589041096;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 70;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.466;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.13;\ttissue: Blood"}]}, {"GSM2352090": [{"title": "SUBJ.0432, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0432;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 48.0493150684931;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 31;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.93;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.114;\ttissue: Blood"}]}, {"GSM2352091": [{"title": "SUBJ.0018, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0018;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 24.6803278688524;\tregion: europe;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 120;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.769;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.108;\ttissue: Blood"}]}, {"GSM2352092": [{"title": "SUBJ.1339, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1339;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 48.0657534246575;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.31;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.279;\ttissue: Blood"}]}, {"GSM2352093": [{"title": "SUBJ.1411, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1411;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 50.7506849315068;\tregion: rest_world;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 113;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.18;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.249;\ttissue: Blood"}]}, {"GSM2352094": [{"title": "SUBJ.1374, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1374;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 43.5506849315068;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 7;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.66;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.242;\ttissue: Blood"}]}, {"GSM2352095": [{"title": "SUBJ.1375, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1375;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 23.1616438356164;\tregion: us_can;\tsledai_at_baseline: 7;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.478;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2352096": [{"title": "SUBJ.0116, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0116;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 50.8142076502732;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 7;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.04;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.137;\ttissue: Blood"}]}, {"GSM2352097": [{"title": "SUBJ.1728, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1728;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 33.7808219178082;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.19;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.096;\ttissue: Blood"}]}, {"GSM2352098": [{"title": "SUBJ.1796, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1796;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 23.8082191780821;\tregion: rest_world;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 90;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.062;\ttissue: Blood"}]}, {"GSM2352099": [{"title": "SUBJ.0736, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0736;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 52.8931506849315;\tregion: us_can;\tsledai_at_baseline: 7;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 13;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.31;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.212;\ttissue: Blood"}]}, {"GSM2352100": [{"title": "SUBJ.1623, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1623;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 42.9180327868852;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.651;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.067;\ttissue: Blood"}]}, {"GSM2352101": [{"title": "SUBJ.0084, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0084;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 36.8712328767123;\tregion: europe;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.892;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.11;\ttissue: Blood"}]}, {"GSM2352102": [{"title": "SUBJ.1733, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1733;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 38.3287671232876;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.53;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.36;\ttissue: Blood"}]}, {"GSM2352103": [{"title": "SUBJ.0456, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0456;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 57.9479452054794;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 13;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.644;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.096;\ttissue: Blood"}]}, {"GSM2352104": [{"title": "SUBJ.0933, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0933;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 19.1671232876712;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.383;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2352105": [{"title": "SUBJ.1208, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1208;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 26.0575342465753;\tregion: us_can;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.872;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.079;\ttissue: Blood"}]}, {"GSM2352106": [{"title": "SUBJ.1143, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1143;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 21.9068493150684;\tregion: mex_ca_sa;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.496;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2352107": [{"title": "SUBJ.0152, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0152;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 50.5095890410959;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 148;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.37;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.278;\ttissue: Blood"}]}, {"GSM2352108": [{"title": "SUBJ.1354, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1354;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 34.5506849315068;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 109;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.44;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.166;\ttissue: Blood"}]}, {"GSM2352109": [{"title": "SUBJ.0970, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0970;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 24.2958904109589;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 40;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.728;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.155;\ttissue: Blood"}]}, {"GSM2352110": [{"title": "SUBJ.0610, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0610;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 53.8547945205479;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 227;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.16;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.257;\ttissue: Blood"}]}, {"GSM2352111": [{"title": "SUBJ.0094, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0094;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 25.3671232876712;\tregion: rest_world;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 154;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.04;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.244;\ttissue: Blood"}]}, {"GSM2352112": [{"title": "SUBJ.0168, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0168;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 46.2;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.04;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.203;\ttissue: Blood"}]}, {"GSM2352113": [{"title": "SUBJ.0491, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0491;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 53.9342465753424;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.73;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.471;\ttissue: Blood"}]}, {"GSM2352114": [{"title": "SUBJ.0376, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0376;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 68.3753424657534;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.44;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.287;\ttissue: Blood"}]}, {"GSM2352115": [{"title": "SUBJ.0557, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0557;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 42.8387978142076;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 39;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.12;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.14;\ttissue: Blood"}]}, {"GSM2352116": [{"title": "SUBJ.0224, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0224;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 23.9289617486338;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.786;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.153;\ttissue: Blood"}]}, {"GSM2352117": [{"title": "SUBJ.0273, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0273;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 52.9071038251366;\tregion: europe;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 162;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.8;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.211;\ttissue: Blood"}]}, {"GSM2352118": [{"title": "SUBJ.0965, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0965;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 20.1972602739726;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 96;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.03;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.114;\ttissue: Blood"}]}, {"GSM2352119": [{"title": "SUBJ.1436, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1436;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 41.0054794520548;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 111;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.851;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.102;\ttissue: Blood"}]}, {"GSM2352120": [{"title": "SUBJ.1679, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1679;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 26.0438356164383;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 54;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.37;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.246;\ttissue: Blood"}]}, {"GSM2352121": [{"title": "SUBJ.0420, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0420;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 43.9232876712328;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.11;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.151;\ttissue: Blood"}]}, {"GSM2352122": [{"title": "SUBJ.1445, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1445;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 28.0931506849315;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.01;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.073;\ttissue: Blood"}]}, {"GSM2352123": [{"title": "SUBJ.0356, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0356;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 40.7814207650273;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 55;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.95;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.142;\ttissue: Blood"}]}, {"GSM2352124": [{"title": "SUBJ.0321, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0321;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 38.9534246575342;\tregion: rest_world;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 11;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.13;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.248;\ttissue: Blood"}]}, {"GSM2352125": [{"title": "SUBJ.0083, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0083;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 32.9260273972602;\tregion: rest_world;\tsledai_at_baseline: 7;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.46;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.466;\ttissue: Blood"}]}, {"GSM2352126": [{"title": "SUBJ.1289, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1289;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 47.7213114754098;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.297;\ttissue: Blood"}]}, {"GSM2352127": [{"title": "SUBJ.0486, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0486;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 31.9808743169398;\tregion: europe;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.77;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2352128": [{"title": "SUBJ.0915, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0915;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 41.6164383561643;\tregion: europe;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 41;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.07;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.151;\ttissue: Blood"}]}, {"GSM2352129": [{"title": "SUBJ.0121, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0121;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 52.7534246575342;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.01;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.188;\ttissue: Blood"}]}, {"GSM2352130": [{"title": "SUBJ.1637, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1637;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 18.5616438356164;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.591;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2352131": [{"title": "SUBJ.1640, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1640;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 40.0301369863013;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 43;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.651;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.134;\ttissue: Blood"}]}, {"GSM2352132": [{"title": "SUBJ.0380, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0380;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 38.9150684931506;\tregion: us_can;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 227;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.14;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.235;\ttissue: Blood"}]}, {"GSM2352133": [{"title": "SUBJ.0682, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0682;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 55.117808219178;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 48;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.03;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.154;\ttissue: Blood"}]}, {"GSM2352134": [{"title": "SUBJ.1075, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1075;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 35.8164383561643;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 12;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.01;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.167;\ttissue: Blood"}]}, {"GSM2352135": [{"title": "SUBJ.1781, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1781;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 62.7616438356164;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.273;\ttissue: Blood"}]}, {"GSM2352136": [{"title": "SUBJ.0407, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0407;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 31.9232876712328;\tregion: europe;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.947;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.115;\ttissue: Blood"}]}, {"GSM2352137": [{"title": "SUBJ.0623, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0623;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 39.2027397260274;\tregion: rest_world;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 164;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.13;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.232;\ttissue: Blood"}]}, {"GSM2352138": [{"title": "SUBJ.1151, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1151;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 23.8082191780821;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.3;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.224;\ttissue: Blood"}]}, {"GSM2352139": [{"title": "SUBJ.0763, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0763;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 58.317808219178;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 23;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.17;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.443;\ttissue: Blood"}]}, {"GSM2352140": [{"title": "SUBJ.0870, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0870;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 26.386301369863;\tregion: mex_ca_sa;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.684;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.089;\ttissue: Blood"}]}, {"GSM2352141": [{"title": "SUBJ.1536, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1536;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 36.8082191780821;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.39;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.248;\ttissue: Blood"}]}, {"GSM2352142": [{"title": "SUBJ.0413, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0413;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 43.2465753424657;\tregion: rest_world;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.918;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2352143": [{"title": "SUBJ.1418, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1418;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 44.1068493150685;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 56;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.828;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.166;\ttissue: Blood"}]}, {"GSM2352144": [{"title": "SUBJ.0135, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0135;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 38.3561643835616;\tregion: us_can;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.4;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.315;\ttissue: Blood"}]}, {"GSM2352145": [{"title": "SUBJ.0228, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0228;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 53.5479452054794;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 102;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.21;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.094;\ttissue: Blood"}]}, {"GSM2352146": [{"title": "SUBJ.0403, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0403;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 25.0684931506849;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 148;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.889;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.181;\ttissue: Blood"}]}, {"GSM2352147": [{"title": "SUBJ.0082, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0082;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 28.4493150684931;\tregion: europe;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.773;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.075;\ttissue: Blood"}]}, {"GSM2352148": [{"title": "SUBJ.0330, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0330;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 39.5671232876712;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 149;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.586;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.079;\ttissue: Blood"}]}, {"GSM2352149": [{"title": "SUBJ.0362, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0362;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 22.7123287671232;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.756;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.119;\ttissue: Blood"}]}, {"GSM2352150": [{"title": "SUBJ.0357, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0357;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 55.213698630137;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 88;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.974;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.152;\ttissue: Blood"}]}, {"GSM2352151": [{"title": "SUBJ.1090, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1090;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 46.5287671232876;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.2;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.166;\ttissue: Blood"}]}, {"GSM2352152": [{"title": "SUBJ.1591, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1591;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 55.2739726027397;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.787;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.066;\ttissue: Blood"}]}, {"GSM2352153": [{"title": "SUBJ.0178, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0178;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 56.0767123287671;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.44;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.358;\ttissue: Blood"}]}, {"GSM2352154": [{"title": "SUBJ.0389, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0389;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 40.4164383561643;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 145;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.07;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.242;\ttissue: Blood"}]}, {"GSM2352155": [{"title": "SUBJ.0910, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0910;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 27.6383561643835;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.01;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.171;\ttissue: Blood"}]}, {"GSM2352156": [{"title": "SUBJ.1825, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1825;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 45.7342465753424;\tregion: rest_world;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 35;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.851;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.155;\ttissue: Blood"}]}, {"GSM2352157": [{"title": "SUBJ.0899, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0899;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 38.1068493150685;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 13;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.61;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.475;\ttissue: Blood"}]}, {"GSM2352158": [{"title": "SUBJ.1803, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1803;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 46.6630136986301;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.51;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.518;\ttissue: Blood"}]}, {"GSM2352159": [{"title": "SUBJ.0570, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0570;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 35.9508196721311;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.71;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.084;\ttissue: Blood"}]}, {"GSM2352160": [{"title": "SUBJ.0662, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0662;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 49.7835616438356;\tregion: us_can;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): H;\tc3_at_baseline (g/l): 2.3;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.454;\ttissue: Blood"}]}, {"GSM2352161": [{"title": "SUBJ.1454, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1454;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Male;\tage_at_baseline: 51.6410958904109;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.01;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.101;\ttissue: Blood"}]}, {"GSM2352162": [{"title": "SUBJ.0230, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0230;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 38.4191780821917;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.998;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.305;\ttissue: Blood"}]}, {"GSM2352163": [{"title": "SUBJ.0383, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0383;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 31.172602739726;\tregion: rest_world;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 94;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.26;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.371;\ttissue: Blood"}]}, {"GSM2352164": [{"title": "SUBJ.0109, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0109;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 46.0931506849315;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 143;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.964;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.186;\ttissue: Blood"}]}, {"GSM2352165": [{"title": "SUBJ.1791, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1791;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 39.3150684931506;\tregion: europe;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.877;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.177;\ttissue: Blood"}]}, {"GSM2352166": [{"title": "SUBJ.1663, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1663;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Male;\tage_at_baseline: 33.75956284153;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.13;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.212;\ttissue: Blood"}]}, {"GSM2352167": [{"title": "SUBJ.0734, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0734;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 39.2027397260274;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.29;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.262;\ttissue: Blood"}]}, {"GSM2352168": [{"title": "SUBJ.1086, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1086;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Male;\tage_at_baseline: 32.386301369863;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 51;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.31;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.223;\ttissue: Blood"}]}, {"GSM2352169": [{"title": "SUBJ.0838, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0838;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 48.1506849315068;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 77;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.56;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.275;\ttissue: Blood"}]}, {"GSM2352170": [{"title": "SUBJ.1673, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1673;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: --;\tSex: --;\tage_at_baseline: --;\tregion: --;\tsledai_at_baseline: --;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): --;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2352171": [{"title": "SUBJ.1236, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1236;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 49.7732240437158;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 114;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.07;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.183;\ttissue: Blood"}]}, {"GSM2352172": [{"title": "SUBJ.1768, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1768;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 18.7377049180327;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 127;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.861;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.104;\ttissue: Blood"}]}, {"GSM2352173": [{"title": "SUBJ.1123, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1123;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 29.0301369863013;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.928;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.179;\ttissue: Blood"}]}, {"GSM2352174": [{"title": "SUBJ.1408, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1408;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 36.0657534246575;\tregion: us_can;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 100;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.13;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.156;\ttissue: Blood"}]}, {"GSM2352175": [{"title": "SUBJ.0591, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0591;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 43.8109589041095;\tregion: rest_world;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 148;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.839;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.143;\ttissue: Blood"}]}, {"GSM2352176": [{"title": "SUBJ.1393, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1393;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 27.0821917808219;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 135;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.04;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.114;\ttissue: Blood"}]}, {"GSM2352177": [{"title": "SUBJ.1681, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1681;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 49.7561643835616;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 34;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.861;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.122;\ttissue: Blood"}]}, {"GSM2352178": [{"title": "SUBJ.1033, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1033;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 51.372602739726;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.23;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.315;\ttissue: Blood"}]}, {"GSM2352179": [{"title": "SUBJ.0350, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0350;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 28.2630136986301;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.43;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.136;\ttissue: Blood"}]}, {"GSM2352180": [{"title": "SUBJ.1085, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1085;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 27.572602739726;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.31;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.243;\ttissue: Blood"}]}, {"GSM2352181": [{"title": "SUBJ.0893, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0893;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Male;\tage_at_baseline: 42.6410958904109;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 23;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.858;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.078;\ttissue: Blood"}]}, {"GSM2352182": [{"title": "SUBJ.1607, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1607;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 56.2958904109589;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.32;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.238;\ttissue: Blood"}]}, {"GSM2352183": [{"title": "SUBJ.0444, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0444;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 25.5616438356164;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 49;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.901;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.108;\ttissue: Blood"}]}, {"GSM2352184": [{"title": "SUBJ.0948, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0948;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 49.517808219178;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.242;\ttissue: Blood"}]}, {"GSM2352185": [{"title": "SUBJ.1228, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1228;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: multiple;\tSex: Female;\tage_at_baseline: 33.9972602739726;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 17;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.01;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.272;\ttissue: Blood"}]}, {"GSM2352186": [{"title": "SUBJ.1642, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1642;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 27.3123287671232;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 199;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.694;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2352187": [{"title": "SUBJ.0514, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0514;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 30.172602739726;\tregion: rest_world;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 55;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.188;\ttissue: Blood"}]}, {"GSM2352188": [{"title": "SUBJ.0275, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0275;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 44.3123287671232;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.775;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.138;\ttissue: Blood"}]}, {"GSM2352189": [{"title": "SUBJ.0309, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0309;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 44.8196721311475;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 69;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.38;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.348;\ttissue: Blood"}]}, {"GSM2352190": [{"title": "SUBJ.0219, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0219;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 59.2383561643835;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.65;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.139;\ttissue: Blood"}]}, {"GSM2352191": [{"title": "SUBJ.1113, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1113;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: multiple;\tSex: Female;\tage_at_baseline: 37.8657534246575;\tregion: rest_world;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 32;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.788;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.152;\ttissue: Blood"}]}, {"GSM2352192": [{"title": "SUBJ.1153, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1153;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 48.3287671232876;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 195;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.907;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.119;\ttissue: Blood"}]}, {"GSM2352193": [{"title": "SUBJ.0199, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0199;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 38.558904109589;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.05;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2352194": [{"title": "SUBJ.1629, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1629;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 50.0219178082191;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 18;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.954;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.141;\ttissue: Blood"}]}, {"GSM2352195": [{"title": "SUBJ.0534, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0534;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 60.5890410958904;\tregion: europe;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.764;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.113;\ttissue: Blood"}]}, {"GSM2352196": [{"title": "SUBJ.1212, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1212;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 26.9260273972602;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 56;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.676;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.101;\ttissue: Blood"}]}, {"GSM2352197": [{"title": "SUBJ.0962, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0962;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 40.1616438356164;\tregion: us_can;\tsledai_at_baseline: 15;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 146;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.62;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.225;\ttissue: Blood"}]}, {"GSM2352198": [{"title": "SUBJ.0492, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0492;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 23.4684931506849;\tregion: rest_world;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.01;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.103;\ttissue: Blood"}]}, {"GSM2352199": [{"title": "SUBJ.1017, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1017;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 42.6639344262295;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 40;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.926;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.1;\ttissue: Blood"}]}, {"GSM2352200": [{"title": "SUBJ.1553, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1553;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 29.6803278688524;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.891;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.231;\ttissue: Blood"}]}, {"GSM2352201": [{"title": "SUBJ.0242, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0242;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 58.1013698630137;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 11;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.16;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.254;\ttissue: Blood"}]}, {"GSM2352202": [{"title": "SUBJ.1097, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1097;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 36.8497267759562;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.914;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.11;\ttissue: Blood"}]}, {"GSM2352203": [{"title": "SUBJ.1515, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1515;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 40.6493150684931;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 54;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.807;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.099;\ttissue: Blood"}]}, {"GSM2352204": [{"title": "SUBJ.0296, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0296;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 67.6219178082191;\tregion: us_can;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 132;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.838;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.209;\ttissue: Blood"}]}, {"GSM2352205": [{"title": "SUBJ.0191, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0191;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: asian;\tSex: Male;\tage_at_baseline: 34.5424657534246;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.693;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2352206": [{"title": "SUBJ.0783, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0783;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 52.0273972602739;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.05;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.176;\ttissue: Blood"}]}, {"GSM2352207": [{"title": "SUBJ.1138, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1138;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 50.2301369863013;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): H;\tc3_at_baseline (g/l): 2.29;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.519;\ttissue: Blood"}]}, {"GSM2352208": [{"title": "SUBJ.1217, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1217;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 43.731506849315;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 23;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.971;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.201;\ttissue: Blood"}]}, {"GSM2352209": [{"title": "SUBJ.1652, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1652;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 38.972602739726;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 89;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.664;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.08;\ttissue: Blood"}]}, {"GSM2352210": [{"title": "SUBJ.1112, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1112;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 34.1616438356164;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.32;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.262;\ttissue: Blood"}]}, {"GSM2352211": [{"title": "SUBJ.1324, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1324;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 35.8328767123287;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.705;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.121;\ttissue: Blood"}]}, {"GSM2352212": [{"title": "SUBJ.0511, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0511;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 61.5205479452054;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 41;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.935;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.232;\ttissue: Blood"}]}, {"GSM2352213": [{"title": "SUBJ.0671, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0671;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 38.0547945205479;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 233;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.583;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.104;\ttissue: Blood"}]}, {"GSM2352214": [{"title": "SUBJ.0668, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0668;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 55.1260273972602;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 58;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.798;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.169;\ttissue: Blood"}]}, {"GSM2352215": [{"title": "SUBJ.1523, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1523;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 41.0739726027397;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 48;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.976;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.208;\ttissue: Blood"}]}, {"GSM2352216": [{"title": "SUBJ.1714, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1714;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 51.2547945205479;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.34;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.174;\ttissue: Blood"}]}, {"GSM2352217": [{"title": "SUBJ.1487, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1487;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: native_hw_pac_island;\tSex: Female;\tage_at_baseline: 36.3342465753424;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 11;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.12;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.111;\ttissue: Blood"}]}, {"GSM2352218": [{"title": "SUBJ.1283, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1283;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 45.5506849315068;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 154;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.981;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.233;\ttissue: Blood"}]}, {"GSM2352219": [{"title": "SUBJ.0295, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0295;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 52.9699453551912;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.37;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.195;\ttissue: Blood"}]}, {"GSM2352220": [{"title": "SUBJ.0950, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0950;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 43.8328767123287;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.41;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.359;\ttissue: Blood"}]}, {"GSM2352221": [{"title": "SUBJ.0666, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0666;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 24.8142076502732;\tregion: europe;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.664;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.124;\ttissue: Blood"}]}, {"GSM2352222": [{"title": "SUBJ.1474, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1474;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 62.717808219178;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 17;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.09;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.105;\ttissue: Blood"}]}, {"GSM2352223": [{"title": "SUBJ.1023, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1023;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 31.358904109589;\tregion: rest_world;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 52;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.05;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.192;\ttissue: Blood"}]}, {"GSM2352224": [{"title": "SUBJ.0695, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0695;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 42.3917808219178;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 128;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.01;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.191;\ttissue: Blood"}]}, {"GSM2352225": [{"title": "SUBJ.1603, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1603;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 34.1287671232876;\tregion: us_can;\tsledai_at_baseline: 19;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 18;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.782;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.087;\ttissue: Blood"}]}, {"GSM2352226": [{"title": "SUBJ.1197, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1197;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 33.1534246575342;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.7;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.374;\ttissue: Blood"}]}, {"GSM2352227": [{"title": "SUBJ.0093, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0093;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 59.5424657534246;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.648;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.119;\ttissue: Blood"}]}, {"GSM2352228": [{"title": "SUBJ.1737, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1737;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 53.1013698630137;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.11;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.185;\ttissue: Blood"}]}, {"GSM2352229": [{"title": "SUBJ.1604, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1604;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 40.1424657534246;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 250;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.795;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.174;\ttissue: Blood"}]}, {"GSM2352230": [{"title": "SUBJ.0571, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0571;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 25.7021857923497;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.9;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.089;\ttissue: Blood"}]}, {"GSM2352231": [{"title": "SUBJ.0891, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0891;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 42.5479452054794;\tregion: europe;\tsledai_at_baseline: 40;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.428;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2352232": [{"title": "SUBJ.0134, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0134;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 55.8465753424657;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.26;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.268;\ttissue: Blood"}]}, {"GSM2352233": [{"title": "SUBJ.0869, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0869;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 36.4;\tregion: europe;\tsledai_at_baseline: 15;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 63;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.801;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.063;\ttissue: Blood"}]}, {"GSM2352234": [{"title": "SUBJ.0450, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0450;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 43.6639344262295;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 7;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.26;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.221;\ttissue: Blood"}]}, {"GSM2352235": [{"title": "SUBJ.1007, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1007;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 44.2027397260274;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.953;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.159;\ttissue: Blood"}]}, {"GSM2352236": [{"title": "SUBJ.1053, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1053;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 22.3671232876712;\tregion: rest_world;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.07;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.269;\ttissue: Blood"}]}, {"GSM2352237": [{"title": "SUBJ.1535, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1535;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 57.6904109589041;\tregion: europe;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 138;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.136;\ttissue: Blood"}]}, {"GSM2352238": [{"title": "SUBJ.0518, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0518;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 36.2356164383561;\tregion: europe;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 55;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.663;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.057;\ttissue: Blood"}]}, {"GSM2352239": [{"title": "SUBJ.0072, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0072;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.7972602739726;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.677;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.088;\ttissue: Blood"}]}, {"GSM2352240": [{"title": "SUBJ.1122, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1122;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 40.2602739726027;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.06;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.248;\ttissue: Blood"}]}, {"GSM2352241": [{"title": "SUBJ.0232, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0232;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 41.7917808219178;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 7;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.54;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.22;\ttissue: Blood"}]}, {"GSM2352242": [{"title": "SUBJ.1156, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1156;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 30.9534246575342;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 109;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.82;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.138;\ttissue: Blood"}]}, {"GSM2352243": [{"title": "SUBJ.0096, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0096;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 42.0849315068493;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.999;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.269;\ttissue: Blood"}]}, {"GSM2352244": [{"title": "SUBJ.0900, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0900;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 28.9041095890411;\tregion: rest_world;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 132;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.2;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.136;\ttissue: Blood"}]}, {"GSM2352245": [{"title": "SUBJ.0627, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0627;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: multiple;\tSex: Female;\tage_at_baseline: 30.6602739726027;\tregion: rest_world;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 55;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.15;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.431;\ttissue: Blood"}]}, {"GSM2352246": [{"title": "SUBJ.1225, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1225;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 46.8684931506849;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.4;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.233;\ttissue: Blood"}]}, {"GSM2352247": [{"title": "SUBJ.0617, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0617;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 56.2383561643835;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 14;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.26;\ttissue: Blood"}]}, {"GSM2352248": [{"title": "SUBJ.1210, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1210;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 55.6;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 14;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.34;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.284;\ttissue: Blood"}]}, {"GSM2352249": [{"title": "SUBJ.0820, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0820;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 46.7616438356164;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 62;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.17;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.104;\ttissue: Blood"}]}, {"GSM2352250": [{"title": "SUBJ.0264, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0264;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 33.931506849315;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.61;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.283;\ttissue: Blood"}]}, {"GSM2352251": [{"title": "SUBJ.0012, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0012;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 22.0273972602739;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 37;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.445;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.225;\ttissue: Blood"}]}, {"GSM2352252": [{"title": "SUBJ.0239, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0239;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.811475409836;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 188;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.673;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.097;\ttissue: Blood"}]}, {"GSM2352253": [{"title": "SUBJ.0472, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0472;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 68.7205479452054;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 11;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.56;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.295;\ttissue: Blood"}]}, {"GSM2352254": [{"title": "SUBJ.1485, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1485;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 47.3890410958904;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 140;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.23;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.14;\ttissue: Blood"}]}, {"GSM2352255": [{"title": "SUBJ.1638, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1638;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 22.9068493150684;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.45;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.41;\ttissue: Blood"}]}, {"GSM2352256": [{"title": "SUBJ.0768, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0768;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 44.3506849315068;\tregion: rest_world;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 150;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.679;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.11;\ttissue: Blood"}]}, {"GSM2352257": [{"title": "SUBJ.1292, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1292;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 62.0301369863013;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 46;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.37;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.163;\ttissue: Blood"}]}, {"GSM2352258": [{"title": "SUBJ.0677, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0677;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 45.2821917808219;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.755;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.15;\ttissue: Blood"}]}, {"GSM2352259": [{"title": "SUBJ.0961, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0961;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 25.9424657534246;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.525;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.06;\ttissue: Blood"}]}, {"GSM2352260": [{"title": "SUBJ.1222, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1222;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 66.7622950819672;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 18;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.967;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.189;\ttissue: Blood"}]}, {"GSM2352261": [{"title": "SUBJ.1342, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1342;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 36.9125683060109;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 145;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.05;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.295;\ttissue: Blood"}]}, {"GSM2352262": [{"title": "SUBJ.0549, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0549;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 49.7431693989071;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 162;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.527;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.084;\ttissue: Blood"}]}, {"GSM2352263": [{"title": "SUBJ.1505, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1505;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 70.8715846994535;\tregion: mex_ca_sa;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.22;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.229;\ttissue: Blood"}]}, {"GSM2352264": [{"title": "SUBJ.0207, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0207;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 46.8794520547945;\tregion: us_can;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 7;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.32;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.311;\ttissue: Blood"}]}, {"GSM2352265": [{"title": "SUBJ.1562, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1562;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 44.4383561643835;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 15;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.44;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.203;\ttissue: Blood"}]}, {"GSM2352266": [{"title": "SUBJ.0064, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0064;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 36.775956284153;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 189;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.789;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.081;\ttissue: Blood"}]}, {"GSM2352267": [{"title": "SUBJ.1606, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1606;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 43.1232876712328;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 145;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.969;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.129;\ttissue: Blood"}]}, {"GSM2352268": [{"title": "SUBJ.0036, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0036;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.5671232876712;\tregion: us_can;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 50;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.627;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.117;\ttissue: Blood"}]}, {"GSM2352269": [{"title": "SUBJ.1071, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1071;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 21.8688524590163;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.68;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.115;\ttissue: Blood"}]}, {"GSM2352270": [{"title": "SUBJ.0081, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0081;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 34.8273972602739;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.11;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.257;\ttissue: Blood"}]}, {"GSM2352271": [{"title": "SUBJ.0674, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0674;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 46.6109589041095;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.818;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.161;\ttissue: Blood"}]}, {"GSM2352272": [{"title": "SUBJ.1479, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1479;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 36.7049180327868;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 33;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.642;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.117;\ttissue: Blood"}]}, {"GSM2352273": [{"title": "SUBJ.0887, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0887;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 33.1205479452054;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.531;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.059;\ttissue: Blood"}]}, {"GSM2352274": [{"title": "SUBJ.0320, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0320;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 57.0191780821917;\tregion: mex_ca_sa;\tsledai_at_baseline: 17;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 255;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.506;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.067;\ttissue: Blood"}]}, {"GSM2352275": [{"title": "SUBJ.0565, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0565;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 41.9671232876712;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.598;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.057;\ttissue: Blood"}]}, {"GSM2352276": [{"title": "SUBJ.0271, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0271;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 40.2136986301369;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 23;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.58;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.152;\ttissue: Blood"}]}, {"GSM2352277": [{"title": "SUBJ.1422, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1422;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 54.2054794520548;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.25;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.216;\ttissue: Blood"}]}, {"GSM2352278": [{"title": "SUBJ.0599, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0599;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 53.5698630136986;\tregion: us_can;\tsledai_at_baseline: 13;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 40;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.38;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.362;\ttissue: Blood"}]}, {"GSM2352279": [{"title": "SUBJ.0245, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0245;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 28.9369863013698;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 10;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.35;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.226;\ttissue: Blood"}]}, {"GSM2352280": [{"title": "SUBJ.0897, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0897;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 25.3780821917808;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.09;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.362;\ttissue: Blood"}]}, {"GSM2352281": [{"title": "SUBJ.1794, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1794;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 26.2438356164383;\tregion: rest_world;\tsledai_at_baseline: 15;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 144;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.838;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.133;\ttissue: Blood"}]}, {"GSM2352282": [{"title": "SUBJ.1130, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1130;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 54.5808219178082;\tregion: rest_world;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.14;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.172;\ttissue: Blood"}]}, {"GSM2352283": [{"title": "SUBJ.0007, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0007;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 39.8082191780821;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.79;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.743;\ttissue: Blood"}]}, {"GSM2352284": [{"title": "SUBJ.1671, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1671;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 20.8306010928961;\tregion: rest_world;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 147;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.03;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.253;\ttissue: Blood"}]}, {"GSM2352285": [{"title": "SUBJ.1039, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1039;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 31.931506849315;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 16;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.16;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.229;\ttissue: Blood"}]}, {"GSM2352286": [{"title": "SUBJ.1323, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1323;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 49.5561643835616;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 16;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.85;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.069;\ttissue: Blood"}]}, {"GSM2352287": [{"title": "SUBJ.0832, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0832;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 63.1095890410959;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.22;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.316;\ttissue: Blood"}]}, {"GSM2352288": [{"title": "SUBJ.1178, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1178;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 31.8739726027397;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.411;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2352289": [{"title": "SUBJ.0378, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0378;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 37.1671232876712;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.39;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.268;\ttissue: Blood"}]}, {"GSM2352290": [{"title": "SUBJ.1161, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1161;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 22.6027397260274;\tregion: europe;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 117;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.45;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.234;\ttissue: Blood"}]}, {"GSM2352291": [{"title": "SUBJ.0971, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0971;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 49.4383561643835;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 12;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.894;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.207;\ttissue: Blood"}]}, {"GSM2352292": [{"title": "SUBJ.0439, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0439;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 49.2410958904109;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.168;\ttissue: Blood"}]}, {"GSM2352293": [{"title": "SUBJ.0938, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0938;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 37.6748633879781;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.924;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.152;\ttissue: Blood"}]}, {"GSM2352294": [{"title": "SUBJ.0774, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0774;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 41.2109589041095;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.916;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.1;\ttissue: Blood"}]}, {"GSM2352295": [{"title": "SUBJ.0559, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0559;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 71.6939890710382;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.23;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.228;\ttissue: Blood"}]}, {"GSM2352296": [{"title": "SUBJ.1693, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1693;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 73.531506849315;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 141;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.23;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.202;\ttissue: Blood"}]}, {"GSM2352297": [{"title": "SUBJ.1121, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1121;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 48.6054794520548;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 120;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.15;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.235;\ttissue: Blood"}]}, {"GSM2352298": [{"title": "SUBJ.0558, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0558;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 56.7068493150685;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.34;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.112;\ttissue: Blood"}]}, {"GSM2352299": [{"title": "SUBJ.1169, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1169;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 47.7896174863388;\tregion: rest_world;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.26;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.283;\ttissue: Blood"}]}, {"GSM2352300": [{"title": "SUBJ.0769, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0769;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 22.3397260273972;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 126;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.776;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.131;\ttissue: Blood"}]}, {"GSM2352301": [{"title": "SUBJ.0254, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0254;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 47.2027397260274;\tregion: us_can;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 129;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.12;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.155;\ttissue: Blood"}]}, {"GSM2352302": [{"title": "SUBJ.0908, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0908;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 30.5643835616438;\tregion: mex_ca_sa;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 13;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.25;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.168;\ttissue: Blood"}]}, {"GSM2352303": [{"title": "SUBJ.0091, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0091;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 24.3479452054794;\tregion: rest_world;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.08;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.295;\ttissue: Blood"}]}, {"GSM2352304": [{"title": "SUBJ.0781, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0781;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 52.945205479452;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.26;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.287;\ttissue: Blood"}]}, {"GSM2352305": [{"title": "SUBJ.1126, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1126;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 61.731506849315;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 17;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.05;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.164;\ttissue: Blood"}]}, {"GSM2352306": [{"title": "SUBJ.0801, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0801;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 33.9071038251366;\tregion: europe;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.701;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.145;\ttissue: Blood"}]}, {"GSM2352307": [{"title": "SUBJ.0510, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0510;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 21.3150684931506;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.998;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.333;\ttissue: Blood"}]}, {"GSM2352308": [{"title": "SUBJ.1028, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1028;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 46.8551912568306;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 38;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.231;\ttissue: Blood"}]}, {"GSM2352309": [{"title": "SUBJ.1644, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1644;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 31.2;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.47;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.341;\ttissue: Blood"}]}, {"GSM2352310": [{"title": "SUBJ.1621, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1621;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 56.8465753424657;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.36;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.351;\ttissue: Blood"}]}, {"GSM2352311": [{"title": "SUBJ.1199, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1199;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 25.3616438356164;\tregion: europe;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.611;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.07;\ttissue: Blood"}]}, {"GSM2352312": [{"title": "SUBJ.0006, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0006;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 68.4328767123287;\tregion: rest_world;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 24;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.948;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.238;\ttissue: Blood"}]}, {"GSM2352313": [{"title": "SUBJ.0725, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0725;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 27.0109589041095;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 176;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.956;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.099;\ttissue: Blood"}]}, {"GSM2352314": [{"title": "SUBJ.0764, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0764;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 30.1780821917808;\tregion: mex_ca_sa;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.878;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.15;\ttissue: Blood"}]}, {"GSM2352315": [{"title": "SUBJ.0469, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0469;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 56.9369863013698;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.47;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.27;\ttissue: Blood"}]}, {"GSM2352316": [{"title": "SUBJ.0833, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0833;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 40.131506849315;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.809;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.404;\ttissue: Blood"}]}, {"GSM2352317": [{"title": "SUBJ.0371, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0371;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 57.6666666666666;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.962;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.253;\ttissue: Blood"}]}, {"GSM2352318": [{"title": "SUBJ.0681, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0681;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 52.4931506849315;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.42;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.339;\ttissue: Blood"}]}, {"GSM2352319": [{"title": "SUBJ.1451, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1451;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 26.2931506849315;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.81;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2352320": [{"title": "SUBJ.1518, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1518;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 73.9369863013698;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.26;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.178;\ttissue: Blood"}]}, {"GSM2352321": [{"title": "SUBJ.1042, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1042;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 54.9945205479452;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 65;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.27;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.099;\ttissue: Blood"}]}, {"GSM2352322": [{"title": "SUBJ.0448, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0448;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 24.6383561643835;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.41;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.087;\ttissue: Blood"}]}, {"GSM2352323": [{"title": "SUBJ.1190, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1190;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 81.0328767123287;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.52;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.213;\ttissue: Blood"}]}, {"GSM2352324": [{"title": "SUBJ.1685, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1685;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 38.572602739726;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.68;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.431;\ttissue: Blood"}]}, {"GSM2352325": [{"title": "SUBJ.0580, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0580;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 42.7917808219178;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.863;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.078;\ttissue: Blood"}]}, {"GSM2352326": [{"title": "SUBJ.0519, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0519;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 59.7232876712328;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 41;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.35;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.27;\ttissue: Blood"}]}, {"GSM2352327": [{"title": "SUBJ.0172, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0172;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 55.4712328767123;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 54;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.25;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.186;\ttissue: Blood"}]}, {"GSM2352328": [{"title": "SUBJ.0589, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0589;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 35.2136986301369;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 47;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.73;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.092;\ttissue: Blood"}]}, {"GSM2352329": [{"title": "SUBJ.1142, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1142;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 51.8082191780822;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.01;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.055;\ttissue: Blood"}]}, {"GSM2352330": [{"title": "SUBJ.1312, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1312;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 49.1150684931507;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.03;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.235;\ttissue: Blood"}]}, {"GSM2352331": [{"title": "SUBJ.1315, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1315;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 53.4575342465753;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.18;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.217;\ttissue: Blood"}]}, {"GSM2352332": [{"title": "SUBJ.0097, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0097;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 39.958904109589;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.77;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.307;\ttissue: Blood"}]}, {"GSM2352333": [{"title": "SUBJ.0754, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0754;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 36.1835616438356;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.26;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.177;\ttissue: Blood"}]}, {"GSM2352334": [{"title": "SUBJ.0311, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0311;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 44.7917808219178;\tregion: mex_ca_sa;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 90;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.987;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.215;\ttissue: Blood"}]}, {"GSM2352335": [{"title": "SUBJ.1299, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1299;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 53.0739726027397;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 251;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.83;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.103;\ttissue: Blood"}]}, {"GSM2352336": [{"title": "SUBJ.1221, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1221;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 51.8219178082191;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.36;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.163;\ttissue: Blood"}]}, {"GSM2352337": [{"title": "SUBJ.0973, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0973;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 44.2986301369863;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.947;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.163;\ttissue: Blood"}]}, {"GSM2352338": [{"title": "SUBJ.0865, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0865;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: multiple;\tSex: Female;\tage_at_baseline: 50.3534246575342;\tregion: rest_world;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 147;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.906;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.119;\ttissue: Blood"}]}, {"GSM2352339": [{"title": "SUBJ.0922, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0922;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 42.7013698630137;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 139;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.38;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.259;\ttissue: Blood"}]}, {"GSM2352340": [{"title": "SUBJ.1583, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1583;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Male;\tage_at_baseline: 24.2219178082191;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.519;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.096;\ttissue: Blood"}]}, {"GSM2352341": [{"title": "SUBJ.1527, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1527;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 32.4301369863013;\tregion: rest_world;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 84;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.976;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.167;\ttissue: Blood"}]}, {"GSM2352342": [{"title": "SUBJ.0925, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0925;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 27.0082191780822;\tregion: mex_ca_sa;\tsledai_at_baseline: 7;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 17;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.57;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.176;\ttissue: Blood"}]}, {"GSM2352343": [{"title": "SUBJ.1717, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1717;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 63.6465753424657;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.823;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.138;\ttissue: Blood"}]}, {"GSM2352344": [{"title": "SUBJ.1188, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1188;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 44.9972602739726;\tregion: rest_world;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 154;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.881;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.197;\ttissue: Blood"}]}, {"GSM2352345": [{"title": "SUBJ.0985, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0985;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Male;\tage_at_baseline: 33.2958904109589;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 15;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.751;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.127;\ttissue: Blood"}]}, {"GSM2352346": [{"title": "SUBJ.1771, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1771;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 54.2904109589041;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 72;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.26;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.22;\ttissue: Blood"}]}, {"GSM2352347": [{"title": "SUBJ.1106, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1106;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 60.6246575342465;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.47;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.267;\ttissue: Blood"}]}, {"GSM2352348": [{"title": "SUBJ.1148, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1148;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 68.7041095890411;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.23;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.204;\ttissue: Blood"}]}, {"GSM2352349": [{"title": "SUBJ.0029, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0029;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 43.9808219178082;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 127;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.15;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.176;\ttissue: Blood"}]}, {"GSM2352350": [{"title": "SUBJ.0605, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0605;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 30.7568306010929;\tregion: rest_world;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 79;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.504;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.073;\ttissue: Blood"}]}, {"GSM2352351": [{"title": "SUBJ.1441, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1441;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 64.8383561643835;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.873;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2352352": [{"title": "SUBJ.0880, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0880;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 52.0684931506849;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.926;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.149;\ttissue: Blood"}]}, {"GSM2352353": [{"title": "SUBJ.0414, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0414;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 42.8931506849315;\tregion: rest_world;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 158;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.41;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.277;\ttissue: Blood"}]}, {"GSM2352354": [{"title": "SUBJ.1170, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1170;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 54.0082191780822;\tregion: europe;\tsledai_at_baseline: 23;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.799;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.127;\ttissue: Blood"}]}, {"GSM2352355": [{"title": "SUBJ.0412, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0412;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 49.6602739726027;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.21;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.173;\ttissue: Blood"}]}, {"GSM2352356": [{"title": "SUBJ.0988, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0988;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 51.4712328767123;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.5;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.132;\ttissue: Blood"}]}, {"GSM2352357": [{"title": "SUBJ.1140, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1140;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 59.8931506849315;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.936;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.184;\ttissue: Blood"}]}, {"GSM2352358": [{"title": "SUBJ.0068, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0068;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 44.1041095890411;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 95;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.832;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.136;\ttissue: Blood"}]}, {"GSM2352359": [{"title": "SUBJ.1822, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1822;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 36.4602739726027;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.2;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.264;\ttissue: Blood"}]}, {"GSM2352360": [{"title": "SUBJ.0268, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0268;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Male;\tage_at_baseline: 42.4493150684931;\tregion: us_can;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 16;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.13;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.376;\ttissue: Blood"}]}, {"GSM2352361": [{"title": "SUBJ.0592, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0592;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 46.5506849315068;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.782;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.162;\ttissue: Blood"}]}, {"GSM2352362": [{"title": "SUBJ.1200, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1200;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 23.2383561643835;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 84;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.973;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.188;\ttissue: Blood"}]}, {"GSM2352363": [{"title": "SUBJ.0370, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0370;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 48.2602739726027;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 20;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.896;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.135;\ttissue: Blood"}]}, {"GSM2352364": [{"title": "SUBJ.0995, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0995;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: multiple;\tSex: Female;\tage_at_baseline: 37.2520547945205;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.85;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.124;\ttissue: Blood"}]}, {"GSM2352365": [{"title": "SUBJ.0727, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0727;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 68.6547945205479;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 158;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.774;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.077;\ttissue: Blood"}]}, {"GSM2352366": [{"title": "SUBJ.1109, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1109;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 50.3917808219178;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.882;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.105;\ttissue: Blood"}]}, {"GSM2352367": [{"title": "SUBJ.1828, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1828;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 25.5753424657534;\tregion: europe;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 108;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.629;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.117;\ttissue: Blood"}]}, {"GSM2352368": [{"title": "SUBJ.1358, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1358;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 34.0027397260274;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 63;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.346;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.063;\ttissue: Blood"}]}, {"GSM2352369": [{"title": "SUBJ.0652, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0652;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 37.4164383561643;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.659;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.11;\ttissue: Blood"}]}, {"GSM2352370": [{"title": "SUBJ.0457, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0457;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 39.2986301369863;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 118;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.09;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.179;\ttissue: Blood"}]}, {"GSM2352371": [{"title": "SUBJ.0547, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0547;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 52.8169398907103;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.44;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.249;\ttissue: Blood"}]}, {"GSM2352372": [{"title": "SUBJ.1373, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1373;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 30.0657534246575;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.24;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.194;\ttissue: Blood"}]}, {"GSM2352373": [{"title": "SUBJ.1390, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1390;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 34.7123287671232;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.45;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.278;\ttissue: Blood"}]}, {"GSM2352374": [{"title": "SUBJ.0468, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0468;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: multiple;\tSex: Female;\tage_at_baseline: 59.1808219178082;\tregion: rest_world;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.951;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.167;\ttissue: Blood"}]}, {"GSM2352375": [{"title": "SUBJ.1577, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1577;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 31.345205479452;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.13;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.216;\ttissue: Blood"}]}, {"GSM2352376": [{"title": "SUBJ.0190, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0190;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 42.4136986301369;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 45;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.9;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.143;\ttissue: Blood"}]}, {"GSM2352377": [{"title": "SUBJ.1763, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1763;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 38.0931506849315;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.825;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.155;\ttissue: Blood"}]}, {"GSM2352378": [{"title": "SUBJ.0720, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0720;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 25.9753424657534;\tregion: us_can;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 111;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.706;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.158;\ttissue: Blood"}]}, {"GSM2352379": [{"title": "SUBJ.1231, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1231;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 69.9232876712328;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.614;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.088;\ttissue: Blood"}]}, {"GSM2352380": [{"title": "SUBJ.1383, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1383;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 62.7978142076502;\tregion: rest_world;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.786;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.136;\ttissue: Blood"}]}, {"GSM2352381": [{"title": "SUBJ.0730, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0730;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 31.6602739726027;\tregion: mex_ca_sa;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.03;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.234;\ttissue: Blood"}]}, {"GSM2352382": [{"title": "SUBJ.0664, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0664;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: multiple;\tSex: Female;\tage_at_baseline: 30.2712328767123;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.43;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.219;\ttissue: Blood"}]}, {"GSM2352383": [{"title": "SUBJ.0460, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0460;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 59.7978142076502;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.49;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.266;\ttissue: Blood"}]}, {"GSM2352384": [{"title": "SUBJ.1064, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1064;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 35.317808219178;\tregion: europe;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 42;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.809;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.052;\ttissue: Blood"}]}, {"GSM2352385": [{"title": "SUBJ.1798, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1798;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: multiple;\tSex: Female;\tage_at_baseline: 24.5808219178082;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 84;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.89;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.125;\ttissue: Blood"}]}, {"GSM2352386": [{"title": "SUBJ.1031, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1031;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.9287671232876;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.05;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.164;\ttissue: Blood"}]}, {"GSM2352387": [{"title": "SUBJ.0711, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0711;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 35.9453551912568;\tregion: europe;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 198;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.844;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.063;\ttissue: Blood"}]}, {"GSM2352388": [{"title": "SUBJ.1330, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1330;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 30.8821917808219;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 34;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.03;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.198;\ttissue: Blood"}]}, {"GSM2352389": [{"title": "SUBJ.0317, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0317;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 45.4191780821917;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.855;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.128;\ttissue: Blood"}]}, {"GSM2352390": [{"title": "SUBJ.0745, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0745;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 29.4383561643835;\tregion: us_can;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 10;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.23;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.318;\ttissue: Blood"}]}, {"GSM2352391": [{"title": "SUBJ.1524, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1524;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 54.7780821917808;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 44;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.25;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.209;\ttissue: Blood"}]}, {"GSM2352392": [{"title": "SUBJ.1464, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1464;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 23.7377049180327;\tregion: us_can;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 40;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.1;\ttissue: Blood"}]}, {"GSM2352393": [{"title": "SUBJ.0423, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0423;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Male;\tage_at_baseline: 31.931506849315;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.14;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.42;\ttissue: Blood"}]}, {"GSM2352394": [{"title": "SUBJ.0143, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0143;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 48.7561643835616;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 124;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.156;\ttissue: Blood"}]}, {"GSM2352395": [{"title": "SUBJ.0080, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0080;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 37.3205479452054;\tregion: us_can;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.469;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.068;\ttissue: Blood"}]}, {"GSM2352396": [{"title": "SUBJ.1496, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1496;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 46.7185792349726;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 125;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.902;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.101;\ttissue: Blood"}]}, {"GSM2352397": [{"title": "SUBJ.1658, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1658;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 21.4575342465753;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.719;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.075;\ttissue: Blood"}]}, {"GSM2352398": [{"title": "SUBJ.1202, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1202;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 29.5698630136986;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.21;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.204;\ttissue: Blood"}]}, {"GSM2352399": [{"title": "SUBJ.0542, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0542;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 35.4876712328767;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.07;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.151;\ttissue: Blood"}]}, {"GSM2352400": [{"title": "SUBJ.1684, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1684;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 33.5643835616438;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.01;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.119;\ttissue: Blood"}]}, {"GSM2352401": [{"title": "SUBJ.1722, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1722;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: asian;\tSex: Female;\tage_at_baseline: 31.8333333333333;\tregion: us_can;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 135;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.878;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.222;\ttissue: Blood"}]}, {"GSM2352402": [{"title": "SUBJ.1576, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1576;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 18.7049180327868;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.12;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.094;\ttissue: Blood"}]}, {"GSM2352403": [{"title": "SUBJ.1402, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1402;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 24.1835616438356;\tregion: rest_world;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.26;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.435;\ttissue: Blood"}]}, {"GSM2352404": [{"title": "SUBJ.1774, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1774;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 40.945205479452;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 79;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.17;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.153;\ttissue: Blood"}]}, {"GSM2352405": [{"title": "SUBJ.1410, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1410;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 51.0383561643835;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.21;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.261;\ttissue: Blood"}]}, {"GSM2352406": [{"title": "SUBJ.1302, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1302;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 53.3232876712328;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.812;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.067;\ttissue: Blood"}]}, {"GSM2352407": [{"title": "SUBJ.1107, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1107;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: multiple;\tSex: Female;\tage_at_baseline: 35.8054794520548;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 57;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.11;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.208;\ttissue: Blood"}]}, {"GSM2352408": [{"title": "SUBJ.0107, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0107;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 25.7232876712328;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.899;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.106;\ttissue: Blood"}]}, {"GSM2352409": [{"title": "SUBJ.0697, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0697;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 34.4575342465753;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 18;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.11;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.199;\ttissue: Blood"}]}, {"GSM2352410": [{"title": "SUBJ.0346, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0346;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 41.7459016393442;\tregion: mex_ca_sa;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 163;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.972;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.061;\ttissue: Blood"}]}, {"GSM2352411": [{"title": "SUBJ.0100, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0100;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 47.4356164383561;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.26;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.21;\ttissue: Blood"}]}, {"GSM2352412": [{"title": "SUBJ.1077, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1077;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 52.8;\tregion: us_can;\tsledai_at_baseline: 7;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.975;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.153;\ttissue: Blood"}]}, {"GSM2352413": [{"title": "SUBJ.0997, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0997;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 41.7322404371584;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 241;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.584;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.051;\ttissue: Blood"}]}, {"GSM2352414": [{"title": "SUBJ.1431, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1431;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 59.6246575342465;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.941;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.156;\ttissue: Blood"}]}, {"GSM2352415": [{"title": "SUBJ.1165, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1165;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 60.9561643835616;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 21;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.3;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.207;\ttissue: Blood"}]}, {"GSM2352416": [{"title": "SUBJ.0298, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0298;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: asian;\tSex: Female;\tage_at_baseline: 24.517808219178;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 145;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.895;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.052;\ttissue: Blood"}]}, {"GSM2352417": [{"title": "SUBJ.0046, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0046;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 49.3780821917808;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 89;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.98;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.278;\ttissue: Blood"}]}, {"GSM2352418": [{"title": "SUBJ.0784, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0784;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 43.6383561643835;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 60;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.733;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.118;\ttissue: Blood"}]}, {"GSM2352419": [{"title": "SUBJ.0904, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0904;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 28.5890410958904;\tregion: us_can;\tsledai_at_baseline: 13;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 100;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.725;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.057;\ttissue: Blood"}]}, {"GSM2352420": [{"title": "SUBJ.1786, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1786;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 47.1808219178082;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 22;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.15;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.186;\ttissue: Blood"}]}, {"GSM2352421": [{"title": "SUBJ.1729, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1729;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 54.5479452054794;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.47;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.215;\ttissue: Blood"}]}, {"GSM2352422": [{"title": "SUBJ.0920, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0920;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 42.983606557377;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.495;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.076;\ttissue: Blood"}]}, {"GSM2352423": [{"title": "SUBJ.1262, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1262;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 29.8493150684931;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 215;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.858;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.102;\ttissue: Blood"}]}, {"GSM2352424": [{"title": "SUBJ.1049, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1049;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: multiple;\tSex: Female;\tage_at_baseline: 41.3808219178082;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 63;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.672;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.111;\ttissue: Blood"}]}, {"GSM2352425": [{"title": "SUBJ.1821, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1821;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 36.2328767123287;\tregion: rest_world;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 18;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.12;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.103;\ttissue: Blood"}]}, {"GSM2352426": [{"title": "SUBJ.0032, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0032;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 38.3616438356164;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 110;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.24;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.213;\ttissue: Blood"}]}, {"GSM2352427": [{"title": "SUBJ.1437, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1437;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 34.0301369863013;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.882;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.092;\ttissue: Blood"}]}, {"GSM2352428": [{"title": "SUBJ.0462, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0462;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 47.958904109589;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 14;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.38;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.191;\ttissue: Blood"}]}, {"GSM2352429": [{"title": "SUBJ.1026, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1026;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 49.8142076502732;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 46;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.54;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.174;\ttissue: Blood"}]}, {"GSM2352430": [{"title": "SUBJ.0696, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0696;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 33.4301369863013;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 16;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.23;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.159;\ttissue: Blood"}]}, {"GSM2352431": [{"title": "SUBJ.1434, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1434;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 34.9479452054794;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 23;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.82;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.122;\ttissue: Blood"}]}, {"GSM2352432": [{"title": "SUBJ.0600, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0600;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 24.8465753424657;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.542;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.06;\ttissue: Blood"}]}, {"GSM2352433": [{"title": "SUBJ.0943, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0943;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 50.5397260273972;\tregion: rest_world;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 12;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.22;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.145;\ttissue: Blood"}]}, {"GSM2352434": [{"title": "SUBJ.0892, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0892;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 33.5835616438356;\tregion: us_can;\tsledai_at_baseline: 21;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 10;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.81;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.186;\ttissue: Blood"}]}, {"GSM2352435": [{"title": "SUBJ.1757, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1757;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 59.7049180327868;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.38;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.216;\ttissue: Blood"}]}, {"GSM2352436": [{"title": "SUBJ.1767, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1767;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 39.117808219178;\tregion: mex_ca_sa;\tsledai_at_baseline: 13;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.854;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.148;\ttissue: Blood"}]}, {"GSM2352437": [{"title": "SUBJ.0684, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0684;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 27.3890410958904;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.15;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.166;\ttissue: Blood"}]}, {"GSM2352438": [{"title": "SUBJ.1056, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1056;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 50.6438356164383;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.951;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.23;\ttissue: Blood"}]}, {"GSM2352439": [{"title": "SUBJ.0767, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0767;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 60.7013698630137;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 143;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.13;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.122;\ttissue: Blood"}]}, {"GSM2352440": [{"title": "SUBJ.0213, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0213;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 40.9808219178082;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.07;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.109;\ttissue: Blood"}]}, {"GSM2352441": [{"title": "SUBJ.1776, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1776;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Male;\tage_at_baseline: 40.6693989071038;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.5;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.306;\ttissue: Blood"}]}, {"GSM2352442": [{"title": "SUBJ.0810, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0810;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 49.6958904109589;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.11;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.218;\ttissue: Blood"}]}, {"GSM2352443": [{"title": "SUBJ.1491, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1491;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 52.2602739726027;\tregion: mex_ca_sa;\tsledai_at_baseline: 7;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 11;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.28;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.24;\ttissue: Blood"}]}, {"GSM2352444": [{"title": "SUBJ.1832, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1832;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 55.3342465753424;\tregion: us_can;\tsledai_at_baseline: 17;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 90;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.828;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.195;\ttissue: Blood"}]}, {"GSM2352445": [{"title": "SUBJ.0148, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0148;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 46.372602739726;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 15;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.59;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.336;\ttissue: Blood"}]}, {"GSM2352446": [{"title": "SUBJ.1371, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1371;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 33.6054794520548;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.697;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.191;\ttissue: Blood"}]}, {"GSM2352447": [{"title": "SUBJ.0660, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0660;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 51.9699453551912;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.45;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.249;\ttissue: Blood"}]}, {"GSM2352448": [{"title": "SUBJ.0946, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0946;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 59.4273972602739;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.11;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.232;\ttissue: Blood"}]}, {"GSM2352449": [{"title": "SUBJ.1551, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1551;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 43.6602739726027;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 207;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.07;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.091;\ttissue: Blood"}]}, {"GSM2352450": [{"title": "SUBJ.1182, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1182;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 23.9534246575342;\tregion: rest_world;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.706;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.178;\ttissue: Blood"}]}, {"GSM2352451": [{"title": "SUBJ.0204, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0204;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 46.2958904109589;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 50;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.06;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.103;\ttissue: Blood"}]}, {"GSM2352452": [{"title": "SUBJ.0030, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0030;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 43.8410958904109;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 227;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.3;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.155;\ttissue: Blood"}]}, {"GSM2352453": [{"title": "SUBJ.0411, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0411;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 43.5068493150685;\tregion: rest_world;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 143;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.222;\ttissue: Blood"}]}, {"GSM2352454": [{"title": "SUBJ.0632, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0632;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 34.8575342465753;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 33;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.16;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.151;\ttissue: Blood"}]}, {"GSM2352455": [{"title": "SUBJ.1762, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1762;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 61.8383561643835;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 69;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.24;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.295;\ttissue: Blood"}]}, {"GSM2352456": [{"title": "SUBJ.0361, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0361;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 63.4027397260274;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 246;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.641;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.091;\ttissue: Blood"}]}, {"GSM2352457": [{"title": "SUBJ.0358, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0358;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 32.7377049180327;\tregion: mex_ca_sa;\tsledai_at_baseline: 21;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.662;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.061;\ttissue: Blood"}]}, {"GSM2352458": [{"title": "SUBJ.1643, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1643;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 69.9153005464481;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.06;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.248;\ttissue: Blood"}]}, {"GSM2352459": [{"title": "SUBJ.0058, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0058;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 53.9479452054794;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.57;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.307;\ttissue: Blood"}]}, {"GSM2352460": [{"title": "SUBJ.0270, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0270;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 59.0876712328767;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 68;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.937;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.127;\ttissue: Blood"}]}, {"GSM2352461": [{"title": "SUBJ.0748, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0748;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 26.1808219178082;\tregion: rest_world;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 181;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.32;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.4;\ttissue: Blood"}]}, {"GSM2352462": [{"title": "SUBJ.1313, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1313;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 39.4109589041095;\tregion: us_can;\tsledai_at_baseline: 15;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 66;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.774;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.072;\ttissue: Blood"}]}, {"GSM2352463": [{"title": "SUBJ.1775, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1775;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 32.6547945205479;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 16;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.62;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.278;\ttissue: Blood"}]}, {"GSM2352464": [{"title": "SUBJ.1238, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1238;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: asian;\tSex: Female;\tage_at_baseline: 26.9726775956284;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 39;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.34;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.177;\ttissue: Blood"}]}, {"GSM2352465": [{"title": "SUBJ.1019, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1019;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 28.9616438356164;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 66;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.738;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.14;\ttissue: Blood"}]}, {"GSM2352466": [{"title": "SUBJ.1012, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1012;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 36.1945205479452;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.16;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.238;\ttissue: Blood"}]}, {"GSM2352467": [{"title": "SUBJ.1006, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1006;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Male;\tage_at_baseline: 23.879781420765;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.47;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.288;\ttissue: Blood"}]}, {"GSM2352468": [{"title": "SUBJ.0713, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0713;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 43.5397260273972;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.39;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.301;\ttissue: Blood"}]}, {"GSM2352469": [{"title": "SUBJ.1267, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1267;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 21.9095890410958;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 187;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.754;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.138;\ttissue: Blood"}]}, {"GSM2352470": [{"title": "SUBJ.0099, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0099;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 48.0602739726027;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 49;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.367;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.063;\ttissue: Blood"}]}, {"GSM2352471": [{"title": "SUBJ.0512, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0512;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 39.2630136986301;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.854;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.168;\ttissue: Blood"}]}, {"GSM2352472": [{"title": "SUBJ.1547, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1547;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 39.3753424657534;\tregion: mex_ca_sa;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 70;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.21;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.181;\ttissue: Blood"}]}, {"GSM2352473": [{"title": "SUBJ.1567, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1567;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 40.2575342465753;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.21;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.241;\ttissue: Blood"}]}, {"GSM2352474": [{"title": "SUBJ.0947, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0947;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 42.811475409836;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 124;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.252;\ttissue: Blood"}]}, {"GSM2352475": [{"title": "SUBJ.1600, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1600;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 48.6693989071038;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 20;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.42;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.326;\ttissue: Blood"}]}, {"GSM2352476": [{"title": "SUBJ.0249, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0249;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 35.9095890410958;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 23;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.747;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.096;\ttissue: Blood"}]}, {"GSM2352477": [{"title": "SUBJ.0078, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0078;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 51.5287671232876;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.17;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.219;\ttissue: Blood"}]}, {"GSM2352478": [{"title": "SUBJ.1296, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1296;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 48.0465753424657;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 102;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.777;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.061;\ttissue: Blood"}]}, {"GSM2352479": [{"title": "SUBJ.0253, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0253;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 34.1369863013698;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.82;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.161;\ttissue: Blood"}]}, {"GSM2352480": [{"title": "SUBJ.1509, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1509;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 44.3561643835616;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.568;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.091;\ttissue: Blood"}]}, {"GSM2352481": [{"title": "SUBJ.0447, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0447;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 20.9232876712328;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.652;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.079;\ttissue: Blood"}]}, {"GSM2352482": [{"title": "SUBJ.0123, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0123;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 29.7568306010929;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 173;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.01;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.174;\ttissue: Blood"}]}, {"GSM2352483": [{"title": "SUBJ.1186, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1186;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 34.2027397260274;\tregion: rest_world;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.933;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.21;\ttissue: Blood"}]}, {"GSM2352484": [{"title": "SUBJ.1585, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1585;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 64.4767123287671;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 42;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.36;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.28;\ttissue: Blood"}]}, {"GSM2352485": [{"title": "SUBJ.1433, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1433;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 43.0739726027397;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.911;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.073;\ttissue: Blood"}]}, {"GSM2352486": [{"title": "SUBJ.1279, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1279;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 45.9344262295082;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.926;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.215;\ttissue: Blood"}]}, {"GSM2352487": [{"title": "SUBJ.0603, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0603;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 23.9672131147541;\tregion: europe;\tsledai_at_baseline: 7;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 47;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.191;\ttissue: Blood"}]}, {"GSM2352488": [{"title": "SUBJ.0800, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0800;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 42.8715846994535;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 69;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2352489": [{"title": "SUBJ.1497, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1497;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 49.0849315068493;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 129;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.13;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.112;\ttissue: Blood"}]}, {"GSM2352490": [{"title": "SUBJ.1209, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1209;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 50.3808219178082;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.47;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.304;\ttissue: Blood"}]}, {"GSM2352491": [{"title": "SUBJ.0672, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0672;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 50.2575342465753;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 7;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.06;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.127;\ttissue: Blood"}]}, {"GSM2352492": [{"title": "SUBJ.0045, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0045;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 39.0328767123287;\tregion: rest_world;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.33;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.157;\ttissue: Blood"}]}, {"GSM2352493": [{"title": "SUBJ.1343, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1343;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 30.8082191780821;\tregion: rest_world;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.683;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.086;\ttissue: Blood"}]}, {"GSM2352494": [{"title": "SUBJ.0215, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0215;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 60.0575342465753;\tregion: us_can;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 7;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.24;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.207;\ttissue: Blood"}]}, {"GSM2352495": [{"title": "SUBJ.1045, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1045;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 40.4739726027397;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 148;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.18;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.145;\ttissue: Blood"}]}, {"GSM2352496": [{"title": "SUBJ.1095, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1095;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 44.4438356164383;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.48;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.21;\ttissue: Blood"}]}, {"GSM2352497": [{"title": "SUBJ.0953, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0953;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: multiple;\tSex: Female;\tage_at_baseline: 34.2164383561643;\tregion: rest_world;\tsledai_at_baseline: 13;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 133;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.15;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.127;\ttissue: Blood"}]}, {"GSM2352498": [{"title": "SUBJ.1475, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1475;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 37.8743169398907;\tregion: europe;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.958;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.143;\ttissue: Blood"}]}, {"GSM2352499": [{"title": "SUBJ.1421, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1421;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 31.9262295081967;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.21;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.187;\ttissue: Blood"}]}, {"GSM2352500": [{"title": "SUBJ.1605, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1605;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 39.6301369863013;\tregion: us_can;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 107;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.16;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.242;\ttissue: Blood"}]}, {"GSM2352501": [{"title": "SUBJ.0124, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0124;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 33.3369863013698;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 42;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.834;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.171;\ttissue: Blood"}]}, {"GSM2352502": [{"title": "SUBJ.0463, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0463;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 30.2767123287671;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.6;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.337;\ttissue: Blood"}]}, {"GSM2352503": [{"title": "SUBJ.0396, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0396;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 43.4273972602739;\tregion: rest_world;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 78;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.211;\ttissue: Blood"}]}, {"GSM2352504": [{"title": "SUBJ.1462, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1462;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: asian;\tSex: Female;\tage_at_baseline: 31.2602739726027;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 153;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.511;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.175;\ttissue: Blood"}]}, {"GSM2352505": [{"title": "SUBJ.0665, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0665;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 51.2;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.555;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.063;\ttissue: Blood"}]}, {"GSM2352506": [{"title": "SUBJ.0594, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0594;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 33.8961748633879;\tregion: europe;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 52;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.01;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.229;\ttissue: Blood"}]}, {"GSM2352507": [{"title": "SUBJ.1010, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1010;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 46.6027397260274;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.685;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.083;\ttissue: Blood"}]}, {"GSM2352508": [{"title": "SUBJ.0685, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0685;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 44.1260273972602;\tregion: rest_world;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.225;\ttissue: Blood"}]}, {"GSM2352509": [{"title": "SUBJ.0575, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0575;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 47.2027397260274;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.09;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.187;\ttissue: Blood"}]}, {"GSM2352510": [{"title": "SUBJ.0724, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0724;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 51.8876712328767;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.939;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.151;\ttissue: Blood"}]}, {"GSM2352511": [{"title": "SUBJ.1300, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1300;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 37.545205479452;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 20;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.069;\ttissue: Blood"}]}, {"GSM2352512": [{"title": "SUBJ.1698, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1698;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 51.372602739726;\tregion: europe;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.39;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.247;\ttissue: Blood"}]}, {"GSM2352513": [{"title": "SUBJ.0352, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0352;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 48.9644808743169;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.67;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.387;\ttissue: Blood"}]}, {"GSM2352514": [{"title": "SUBJ.0629, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0629;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 51.931506849315;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 16;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.39;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.478;\ttissue: Blood"}]}, {"GSM2352515": [{"title": "SUBJ.1811, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1811;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 61.5972602739726;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 167;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.08;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.182;\ttissue: Blood"}]}, {"GSM2352516": [{"title": "SUBJ.0569, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0569;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 40.2821917808219;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 23;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.796;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.078;\ttissue: Blood"}]}, {"GSM2352517": [{"title": "SUBJ.0475, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0475;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 27.8547945205479;\tregion: mex_ca_sa;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 150;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.03;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.098;\ttissue: Blood"}]}, {"GSM2352518": [{"title": "SUBJ.0944, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0944;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 48.0438356164383;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 39;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.07;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.14;\ttissue: Blood"}]}, {"GSM2352519": [{"title": "SUBJ.0958, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0958;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 58.0520547945205;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 187;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.16;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.184;\ttissue: Blood"}]}, {"GSM2352520": [{"title": "SUBJ.0856, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0856;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: multiple;\tSex: Female;\tage_at_baseline: 52.5260273972602;\tregion: rest_world;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.18;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.236;\ttissue: Blood"}]}, {"GSM2352521": [{"title": "SUBJ.1620, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1620;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 34.9617486338797;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 132;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.762;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.062;\ttissue: Blood"}]}, {"GSM2352522": [{"title": "SUBJ.1761, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1761;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 36.8931506849315;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.5;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.442;\ttissue: Blood"}]}, {"GSM2352523": [{"title": "SUBJ.0483, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0483;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Male;\tage_at_baseline: 20.4438356164383;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 193;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.599;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.076;\ttissue: Blood"}]}, {"GSM2352524": [{"title": "SUBJ.1691, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1691;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 36.0794520547945;\tregion: rest_world;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 197;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.683;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.091;\ttissue: Blood"}]}, {"GSM2352525": [{"title": "SUBJ.1145, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1145;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 33.4849315068493;\tregion: rest_world;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.796;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.15;\ttissue: Blood"}]}, {"GSM2352526": [{"title": "SUBJ.1076, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1076;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 64.972602739726;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.15;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.116;\ttissue: Blood"}]}, {"GSM2352527": [{"title": "SUBJ.1245, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1245;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 58.7616438356164;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.887;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.162;\ttissue: Blood"}]}, {"GSM2352528": [{"title": "SUBJ.0146, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0146;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 62.6109589041096;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 10;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.33;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.212;\ttissue: Blood"}]}, {"GSM2352529": [{"title": "SUBJ.1435, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1435;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 51.1945205479452;\tregion: us_can;\tsledai_at_baseline: 28;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 141;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.777;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.101;\ttissue: Blood"}]}, {"GSM2352530": [{"title": "SUBJ.1368, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1368;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 41.8743169398907;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.879;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.129;\ttissue: Blood"}]}, {"GSM2352531": [{"title": "SUBJ.0657, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0657;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 28.7342465753424;\tregion: rest_world;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 258;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.814;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.151;\ttissue: Blood"}]}, {"GSM2352532": [{"title": "SUBJ.1149, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1149;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 21.0246575342465;\tregion: mex_ca_sa;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.644;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.079;\ttissue: Blood"}]}, {"GSM2352533": [{"title": "SUBJ.0738, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0738;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 22.7349726775956;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 189;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.679;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.09;\ttissue: Blood"}]}, {"GSM2352534": [{"title": "SUBJ.1675, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1675;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 53.3424657534246;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 30;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.68;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.226;\ttissue: Blood"}]}, {"GSM2352535": [{"title": "SUBJ.1528, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1528;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 28.358904109589;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.06;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.215;\ttissue: Blood"}]}, {"GSM2352536": [{"title": "SUBJ.0752, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0752;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 40.9041095890411;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 225;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.14;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.144;\ttissue: Blood"}]}, {"GSM2352537": [{"title": "SUBJ.1460, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1460;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 45.4109589041095;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.811;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.098;\ttissue: Blood"}]}, {"GSM2352538": [{"title": "SUBJ.1456, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1456;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 36.3041095890411;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 261;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.789;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.147;\ttissue: Blood"}]}, {"GSM2352539": [{"title": "SUBJ.0243, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0243;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Male;\tage_at_baseline: 24.0684931506849;\tregion: us_can;\tsledai_at_baseline: 22;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 179;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.847;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.121;\ttissue: Blood"}]}, {"GSM2352540": [{"title": "SUBJ.1309, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1309;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 52.7808219178082;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 20;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.38;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.341;\ttissue: Blood"}]}, {"GSM2352541": [{"title": "SUBJ.1349, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1349;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 28.4849315068493;\tregion: rest_world;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 7;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.774;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.155;\ttissue: Blood"}]}, {"GSM2352542": [{"title": "SUBJ.0251, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0251;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 32.5342465753424;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 39;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.816;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.134;\ttissue: Blood"}]}, {"GSM2352543": [{"title": "SUBJ.0646, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0646;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 20.3671232876712;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 11;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.73;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.148;\ttissue: Blood"}]}, {"GSM2352544": [{"title": "SUBJ.0059, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0059;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 53.6164383561643;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.492;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2352545": [{"title": "SUBJ.0588, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0588;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: multiple;\tSex: Female;\tage_at_baseline: 55.8657534246575;\tregion: rest_world;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 13;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.11;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.091;\ttissue: Blood"}]}, {"GSM2352546": [{"title": "SUBJ.0077, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0077;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 53.9287671232876;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.8;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.464;\ttissue: Blood"}]}, {"GSM2352547": [{"title": "SUBJ.0586, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0586;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 23.2767123287671;\tregion: rest_world;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.691;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.14;\ttissue: Blood"}]}, {"GSM2352548": [{"title": "SUBJ.1739, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1739;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 66.8849315068493;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.4;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.404;\ttissue: Blood"}]}, {"GSM2352549": [{"title": "SUBJ.0819, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0819;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 40.6054794520548;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 85;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.863;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.1;\ttissue: Blood"}]}, {"GSM2352550": [{"title": "SUBJ.1027, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1027;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 21.4136986301369;\tregion: europe;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.978;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.128;\ttissue: Blood"}]}, {"GSM2352551": [{"title": "SUBJ.1493, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1493;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 51.8794520547945;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.13;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.141;\ttissue: Blood"}]}, {"GSM2352552": [{"title": "SUBJ.0335, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0335;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 27;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.12;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.234;\ttissue: Blood"}]}, {"GSM2352553": [{"title": "SUBJ.0974, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0974;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 48.0794520547945;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 182;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.04;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.135;\ttissue: Blood"}]}, {"GSM2352554": [{"title": "SUBJ.1709, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1709;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 40.2767123287671;\tregion: us_can;\tsledai_at_baseline: 22;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 7;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.881;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2352555": [{"title": "SUBJ.1752, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1752;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 34.0465753424657;\tregion: rest_world;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 125;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.04;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.213;\ttissue: Blood"}]}, {"GSM2352556": [{"title": "SUBJ.1192, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1192;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 51.9644808743169;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.43;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.261;\ttissue: Blood"}]}, {"GSM2352557": [{"title": "SUBJ.0392, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0392;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 28.531506849315;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 39;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.23;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.272;\ttissue: Blood"}]}, {"GSM2352558": [{"title": "SUBJ.1530, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1530;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.8739726027397;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.713;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.058;\ttissue: Blood"}]}, {"GSM2352559": [{"title": "SUBJ.1718, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1718;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 32.8520547945205;\tregion: mex_ca_sa;\tsledai_at_baseline: 13;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 242;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.546;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.132;\ttissue: Blood"}]}, {"GSM2352560": [{"title": "SUBJ.0216, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0216;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 52.8907103825136;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 47;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.12;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.138;\ttissue: Blood"}]}, {"GSM2352561": [{"title": "SUBJ.0193, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0193;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 39.1041095890411;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 46;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.889;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.095;\ttissue: Blood"}]}, {"GSM2352562": [{"title": "SUBJ.0918, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0918;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 49.4273972602739;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 102;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.964;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.149;\ttissue: Blood"}]}, {"GSM2352563": [{"title": "SUBJ.0150, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0150;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 33.3506849315068;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.2;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.168;\ttissue: Blood"}]}, {"GSM2352564": [{"title": "SUBJ.1176, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1176;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 33.0027397260274;\tregion: mex_ca_sa;\tsledai_at_baseline: 27;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.73;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.122;\ttissue: Blood"}]}, {"GSM2352565": [{"title": "SUBJ.1002, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1002;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Male;\tage_at_baseline: 35.8767123287671;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.708;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.064;\ttissue: Blood"}]}, {"GSM2352566": [{"title": "SUBJ.1193, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1193;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 32.545205479452;\tregion: mex_ca_sa;\tsledai_at_baseline: 13;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.583;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2352567": [{"title": "SUBJ.0926, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0926;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 38.4191780821917;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 126;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.833;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.167;\ttissue: Blood"}]}, {"GSM2352568": [{"title": "SUBJ.1350, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1350;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 38.7213114754098;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.482;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.068;\ttissue: Blood"}]}, {"GSM2352569": [{"title": "SUBJ.1065, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1065;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 27.0438356164383;\tregion: rest_world;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 58;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.65;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.07;\ttissue: Blood"}]}, {"GSM2352570": [{"title": "SUBJ.1484, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1484;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 55.1123287671233;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.61;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.237;\ttissue: Blood"}]}, {"GSM2352571": [{"title": "SUBJ.1066, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1066;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 46.7814207650273;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 55;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.845;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.106;\ttissue: Blood"}]}, {"GSM2352572": [{"title": "SUBJ.1539, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1539;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 54.558904109589;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.907;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.163;\ttissue: Blood"}]}, {"GSM2352573": [{"title": "SUBJ.0556, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0556;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 55.4109589041096;\tregion: rest_world;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 24;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.05;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.265;\ttissue: Blood"}]}, {"GSM2352574": [{"title": "SUBJ.0607, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0607;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 38.7540983606557;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.957;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.184;\ttissue: Blood"}]}, {"GSM2352575": [{"title": "SUBJ.0451, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0451;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 28.6438356164383;\tregion: us_can;\tsledai_at_baseline: 7;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 24;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.26;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.291;\ttissue: Blood"}]}, {"GSM2352576": [{"title": "SUBJ.1078, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1078;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 36.6639344262295;\tregion: mex_ca_sa;\tsledai_at_baseline: 22;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.894;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.107;\ttissue: Blood"}]}, {"GSM2352577": [{"title": "SUBJ.0718, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0718;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 57.6438356164383;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 32;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.04;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.258;\ttissue: Blood"}]}, {"GSM2352578": [{"title": "SUBJ.1163, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1163;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 40.0438356164383;\tregion: rest_world;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 82;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.16;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.218;\ttissue: Blood"}]}, {"GSM2352579": [{"title": "SUBJ.1137, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1137;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 52.9863387978142;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 36;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.955;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.199;\ttissue: Blood"}]}, {"GSM2352580": [{"title": "SUBJ.1040, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1040;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 57.6767123287671;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.37;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.177;\ttissue: Blood"}]}, {"GSM2352581": [{"title": "SUBJ.1325, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1325;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 45.7534246575342;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.03;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.308;\ttissue: Blood"}]}, {"GSM2352582": [{"title": "SUBJ.0139, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0139;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 22.6438356164383;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 24;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.071;\ttissue: Blood"}]}, {"GSM2352583": [{"title": "SUBJ.1294, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1294;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 36.8169398907103;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 114;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.798;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.144;\ttissue: Blood"}]}, {"GSM2352584": [{"title": "SUBJ.0372, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0372;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 57.3917808219178;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.36;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.268;\ttissue: Blood"}]}, {"GSM2352585": [{"title": "SUBJ.0980, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0980;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 29.5561643835616;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 7;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.01;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.12;\ttissue: Blood"}]}, {"GSM2352586": [{"title": "SUBJ.1805, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1805;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 38.4136986301369;\tregion: mex_ca_sa;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.523;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.077;\ttissue: Blood"}]}, {"GSM2352587": [{"title": "SUBJ.1542, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1542;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 30.0383561643835;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.09;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.25;\ttissue: Blood"}]}, {"GSM2352588": [{"title": "SUBJ.0202, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0202;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Male;\tage_at_baseline: 35.7506849315068;\tregion: mex_ca_sa;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 169;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.03;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.283;\ttissue: Blood"}]}, {"GSM2352589": [{"title": "SUBJ.0408, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0408;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 48.2684931506849;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.45;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.402;\ttissue: Blood"}]}, {"GSM2352590": [{"title": "SUBJ.1649, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1649;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 51.1424657534246;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.52;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.196;\ttissue: Blood"}]}, {"GSM2352591": [{"title": "SUBJ.0975, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0975;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 46.0438356164383;\tregion: europe;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 50;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.903;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.251;\ttissue: Blood"}]}, {"GSM2352592": [{"title": "SUBJ.1185, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1185;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 35.9232876712328;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 147;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.32;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.2;\ttissue: Blood"}]}, {"GSM2352593": [{"title": "SUBJ.0427, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0427;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.9506849315068;\tregion: europe;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.575;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2352594": [{"title": "SUBJ.1440, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1440;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 39.8551912568306;\tregion: europe;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.11;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.21;\ttissue: Blood"}]}, {"GSM2352595": [{"title": "SUBJ.1647, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1647;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 54.3287671232876;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 7;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.948;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.16;\ttissue: Blood"}]}, {"GSM2352596": [{"title": "SUBJ.1035, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1035;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 29.3041095890411;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 234;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.777;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.109;\ttissue: Blood"}]}, {"GSM2352597": [{"title": "SUBJ.0266, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0266;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 32.8579234972677;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 13;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.07;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.182;\ttissue: Blood"}]}, {"GSM2352598": [{"title": "SUBJ.0826, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0826;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 24.172602739726;\tregion: rest_world;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 204;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.848;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.108;\ttissue: Blood"}]}, {"GSM2352599": [{"title": "SUBJ.0778, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0778;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: multiple;\tSex: Female;\tage_at_baseline: 46.7643835616438;\tregion: us_can;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.01;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.103;\ttissue: Blood"}]}, {"GSM2352600": [{"title": "SUBJ.0716, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0716;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 39.5506849315068;\tregion: europe;\tsledai_at_baseline: 24;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 35;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.164;\ttissue: Blood"}]}, {"GSM2352601": [{"title": "SUBJ.0902, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0902;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 24.0876712328767;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 52;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.678;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.115;\ttissue: Blood"}]}, {"GSM2352602": [{"title": "SUBJ.0700, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0700;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 49.4383561643835;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 11;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.22;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.259;\ttissue: Blood"}]}, {"GSM2352603": [{"title": "SUBJ.0829, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0829;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 36.1232876712328;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 52;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.742;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.088;\ttissue: Blood"}]}, {"GSM2352604": [{"title": "SUBJ.1226, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1226;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 30.2849315068493;\tregion: us_can;\tsledai_at_baseline: 13;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.966;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.084;\ttissue: Blood"}]}, {"GSM2352605": [{"title": "SUBJ.1516, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1516;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 22.7205479452054;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 147;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.29;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.158;\ttissue: Blood"}]}, {"GSM2352606": [{"title": "SUBJ.0546, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0546;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 50.7404371584699;\tregion: mex_ca_sa;\tsledai_at_baseline: 26;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.871;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.07;\ttissue: Blood"}]}, {"GSM2352607": [{"title": "SUBJ.1194, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1194;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 49.4109589041096;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.25;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.162;\ttissue: Blood"}]}, {"GSM2352608": [{"title": "SUBJ.0205, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0205;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 48.0520547945205;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.29;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.292;\ttissue: Blood"}]}, {"GSM2352609": [{"title": "SUBJ.0136, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0136;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 44.7424657534246;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 7;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.59;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.36;\ttissue: Blood"}]}, {"GSM2352610": [{"title": "SUBJ.0998, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0998;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 39.5095890410959;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 84;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.843;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.073;\ttissue: Blood"}]}, {"GSM2352611": [{"title": "SUBJ.1229, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1229;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 43.4082191780821;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 119;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.05;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.234;\ttissue: Blood"}]}, {"GSM2352612": [{"title": "SUBJ.1657, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1657;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 34.2520547945205;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 48;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.985;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.172;\ttissue: Blood"}]}, {"GSM2352613": [{"title": "SUBJ.1758, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1758;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 52.1397260273972;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 265;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.03;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.284;\ttissue: Blood"}]}, {"GSM2352614": [{"title": "SUBJ.1276, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1276;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 23.8273972602739;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 34;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.27;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.103;\ttissue: Blood"}]}, {"GSM2352615": [{"title": "SUBJ.1244, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1244;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 21.9506849315068;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.52;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.201;\ttissue: Blood"}]}, {"GSM2352616": [{"title": "SUBJ.0635, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0635;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 62.2602739726027;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.64;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.29;\ttissue: Blood"}]}, {"GSM2352617": [{"title": "SUBJ.1650, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1650;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 41.1232876712328;\tregion: mex_ca_sa;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 75;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.13;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.339;\ttissue: Blood"}]}, {"GSM2352618": [{"title": "SUBJ.1688, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1688;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 43.6602739726027;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.57;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.266;\ttissue: Blood"}]}, {"GSM2352619": [{"title": "SUBJ.0167, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0167;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 45.531506849315;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 97;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.989;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.296;\ttissue: Blood"}]}, {"GSM2352620": [{"title": "SUBJ.1532, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1532;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: multiple;\tSex: Female;\tage_at_baseline: 21.0520547945205;\tregion: rest_world;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 10;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.12;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.257;\ttissue: Blood"}]}, {"GSM2352621": [{"title": "SUBJ.1818, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1818;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 68.9561643835616;\tregion: us_can;\tsledai_at_baseline: 23;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 175;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.391;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.097;\ttissue: Blood"}]}, {"GSM2352622": [{"title": "SUBJ.0957, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0957;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 25.8497267759562;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 93;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.868;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.151;\ttissue: Blood"}]}, {"GSM2352623": [{"title": "SUBJ.0848, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0848;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 66.6164383561643;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): H;\tc3_at_baseline (g/l): 2.09;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.249;\ttissue: Blood"}]}, {"GSM2352624": [{"title": "SUBJ.1659, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1659;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 47.5260273972602;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 12;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.816;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.055;\ttissue: Blood"}]}, {"GSM2352625": [{"title": "SUBJ.0156, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0156;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.7950819672131;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.872;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.174;\ttissue: Blood"}]}, {"GSM2352626": [{"title": "SUBJ.1674, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1674;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: multiple;\tSex: Female;\tage_at_baseline: 31.9780821917808;\tregion: rest_world;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.65;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.566;\ttissue: Blood"}]}, {"GSM2352627": [{"title": "SUBJ.0776, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0776;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 30.9095890410958;\tregion: mex_ca_sa;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 150;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.11;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.276;\ttissue: Blood"}]}, {"GSM2352628": [{"title": "SUBJ.1034, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1034;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 51.5479452054794;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 23;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.856;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.085;\ttissue: Blood"}]}, {"GSM2352629": [{"title": "SUBJ.0656, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0656;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 28.9508196721311;\tregion: rest_world;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 124;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.817;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.159;\ttissue: Blood"}]}, {"GSM2352630": [{"title": "SUBJ.0628, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0628;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Male;\tage_at_baseline: 49.1232876712328;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.34;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.383;\ttissue: Blood"}]}, {"GSM2352631": [{"title": "SUBJ.0743, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0743;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 30.8497267759562;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 96;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.149;\ttissue: Blood"}]}, {"GSM2352632": [{"title": "SUBJ.0839, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0839;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 33.9945205479452;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 192;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.461;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.072;\ttissue: Blood"}]}, {"GSM2352633": [{"title": "SUBJ.1103, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1103;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 32.5479452054794;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.48;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.289;\ttissue: Blood"}]}, {"GSM2352634": [{"title": "SUBJ.1777, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1777;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 44.145205479452;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 137;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.994;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.118;\ttissue: Blood"}]}, {"GSM2352635": [{"title": "SUBJ.0085, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0085;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 32.3342465753424;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.75;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.321;\ttissue: Blood"}]}, {"GSM2352636": [{"title": "SUBJ.0956, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0956;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 57.2876712328767;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 128;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.4;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.26;\ttissue: Blood"}]}, {"GSM2352637": [{"title": "SUBJ.0650, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0650;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 49.8715846994535;\tregion: us_can;\tsledai_at_baseline: 23;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.746;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.066;\ttissue: Blood"}]}, {"GSM2352638": [{"title": "SUBJ.0508, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0508;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 60.9232876712328;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 109;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.12;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.223;\ttissue: Blood"}]}, {"GSM2352639": [{"title": "SUBJ.1362, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1362;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 33.7479452054794;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.678;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.06;\ttissue: Blood"}]}, {"GSM2352640": [{"title": "SUBJ.1277, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1277;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 52.4219178082191;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 20;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.19;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.164;\ttissue: Blood"}]}, {"GSM2352641": [{"title": "SUBJ.1707, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1707;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 25.7786885245901;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.998;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.185;\ttissue: Blood"}]}, {"GSM2352642": [{"title": "SUBJ.0328, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0328;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 47.5479452054794;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.01;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.233;\ttissue: Blood"}]}, {"GSM2352643": [{"title": "SUBJ.1405, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1405;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 45.9890410958904;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 47;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.903;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.159;\ttissue: Blood"}]}, {"GSM2352644": [{"title": "SUBJ.1455, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1455;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 71.9453551912568;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.63;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.362;\ttissue: Blood"}]}, {"GSM2352645": [{"title": "SUBJ.0194, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0194;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 52.7917808219178;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 10;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.35;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.266;\ttissue: Blood"}]}, {"GSM2352646": [{"title": "SUBJ.1829, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1829;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 36.5698630136986;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.32;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.352;\ttissue: Blood"}]}, {"GSM2352647": [{"title": "SUBJ.0596, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0596;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 54.3534246575342;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.13;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.228;\ttissue: Blood"}]}, {"GSM2352648": [{"title": "SUBJ.0103, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0103;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 39.2602739726027;\tregion: us_can;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 179;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.23;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.159;\ttissue: Blood"}]}, {"GSM2352649": [{"title": "SUBJ.1438, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1438;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 35.2849315068493;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.58;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.07;\ttissue: Blood"}]}, {"GSM2352650": [{"title": "SUBJ.1310, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1310;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 36.1205479452054;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.06;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.26;\ttissue: Blood"}]}, {"GSM2352651": [{"title": "SUBJ.1555, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1555;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 64.0328767123287;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 15;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.47;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.248;\ttissue: Blood"}]}, {"GSM2352652": [{"title": "SUBJ.1646, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1646;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 53.372602739726;\tregion: europe;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.838;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.206;\ttissue: Blood"}]}, {"GSM2352653": [{"title": "SUBJ.1417, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1417;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 46.5780821917808;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.756;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.104;\ttissue: Blood"}]}, {"GSM2352654": [{"title": "SUBJ.1597, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1597;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 35.6958904109589;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 17;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.844;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.053;\ttissue: Blood"}]}, {"GSM2352655": [{"title": "SUBJ.0912, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0912;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Male;\tage_at_baseline: 27.7950819672131;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.01;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.125;\ttissue: Blood"}]}, {"GSM2352656": [{"title": "SUBJ.1291, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1291;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 30.7123287671232;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.53;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.083;\ttissue: Blood"}]}, {"GSM2352657": [{"title": "SUBJ.0567, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0567;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 34.6684931506849;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.822;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.118;\ttissue: Blood"}]}, {"GSM2352658": [{"title": "SUBJ.1558, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1558;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 36.8876712328767;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.12;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.213;\ttissue: Blood"}]}, {"GSM2352659": [{"title": "SUBJ.0717, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0717;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 32.717808219178;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 53;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.853;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.264;\ttissue: Blood"}]}, {"GSM2352660": [{"title": "SUBJ.0911, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0911;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 47.8688524590164;\tregion: europe;\tsledai_at_baseline: 17;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 259;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.12;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.065;\ttissue: Blood"}]}, {"GSM2352661": [{"title": "SUBJ.0728, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0728;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 43.4438356164383;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 10;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.894;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.187;\ttissue: Blood"}]}, {"GSM2352662": [{"title": "SUBJ.0675, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0675;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 20.8876712328767;\tregion: rest_world;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 22;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.972;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.24;\ttissue: Blood"}]}, {"GSM2352663": [{"title": "SUBJ.0676, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0676;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 47.9287671232876;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 145;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.287;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2352664": [{"title": "SUBJ.1651, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1651;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 50.2027397260274;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.674;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.135;\ttissue: Blood"}]}, {"GSM2352665": [{"title": "SUBJ.0075, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0075;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 37.545205479452;\tregion: mex_ca_sa;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 64;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.37;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.308;\ttissue: Blood"}]}, {"GSM2352666": [{"title": "SUBJ.0516, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0516;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 43.0958904109589;\tregion: rest_world;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 50;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.912;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.119;\ttissue: Blood"}]}, {"GSM2352667": [{"title": "SUBJ.0223, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0223;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 51.2;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 132;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.06;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.113;\ttissue: Blood"}]}, {"GSM2352668": [{"title": "SUBJ.1340, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1340;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 47.8547945205479;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.831;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.108;\ttissue: Blood"}]}, {"GSM2352669": [{"title": "SUBJ.0927, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0927;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 24.1013698630137;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 182;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.677;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.103;\ttissue: Blood"}]}, {"GSM2352670": [{"title": "SUBJ.0489, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0489;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 43.8958904109589;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 41;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.814;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.241;\ttissue: Blood"}]}, {"GSM2352671": [{"title": "SUBJ.1115, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1115;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 36.0465753424657;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.36;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.305;\ttissue: Blood"}]}, {"GSM2352672": [{"title": "SUBJ.1100, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1100;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 49.2027397260274;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.56;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.28;\ttissue: Blood"}]}, {"GSM2352673": [{"title": "SUBJ.0322, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0322;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 46.4383561643835;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.01;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.186;\ttissue: Blood"}]}, {"GSM2352674": [{"title": "SUBJ.1632, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1632;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 36.0273972602739;\tregion: rest_world;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.697;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.259;\ttissue: Blood"}]}, {"GSM2352675": [{"title": "SUBJ.0433, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0433;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 34.3205479452054;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.39;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.264;\ttissue: Blood"}]}, {"GSM2352676": [{"title": "SUBJ.1041, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1041;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: multiple;\tSex: Female;\tage_at_baseline: 39.3041095890411;\tregion: rest_world;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 174;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.04;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.284;\ttissue: Blood"}]}, {"GSM2352677": [{"title": "SUBJ.0368, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0368;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 42.9808219178082;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 29;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.54;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.25;\ttissue: Blood"}]}, {"GSM2352678": [{"title": "SUBJ.0280, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0280;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 28.8743169398907;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.783;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.066;\ttissue: Blood"}]}, {"GSM2352679": [{"title": "SUBJ.0419, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0419;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 38.317808219178;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 41;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): H;\tc3_at_baseline (g/l): 1.84;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.439;\ttissue: Blood"}]}, {"GSM2352680": [{"title": "SUBJ.0553, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0553;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 55.0465753424657;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 211;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.971;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.095;\ttissue: Blood"}]}, {"GSM2352681": [{"title": "SUBJ.0854, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0854;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 29.2657534246575;\tregion: us_can;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 65;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.798;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.063;\ttissue: Blood"}]}, {"GSM2352682": [{"title": "SUBJ.1560, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1560;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 40.7890410958904;\tregion: us_can;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.488;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.098;\ttissue: Blood"}]}, {"GSM2352683": [{"title": "SUBJ.1008, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1008;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: multiple;\tSex: Female;\tage_at_baseline: 17.6739726027397;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 142;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.712;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.079;\ttissue: Blood"}]}, {"GSM2352684": [{"title": "SUBJ.0333, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0333;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 37.4493150684931;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.44;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.278;\ttissue: Blood"}]}, {"GSM2352685": [{"title": "SUBJ.0459, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0459;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 34.172602739726;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 65;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.16;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.25;\ttissue: Blood"}]}, {"GSM2352686": [{"title": "SUBJ.0455, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0455;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 56.5890410958904;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.77;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.317;\ttissue: Blood"}]}, {"GSM2352687": [{"title": "SUBJ.0597, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0597;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 36.117808219178;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.17;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.293;\ttissue: Blood"}]}, {"GSM2352688": [{"title": "SUBJ.0987, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0987;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 38.4657534246575;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.355;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.054;\ttissue: Blood"}]}, {"GSM2352689": [{"title": "SUBJ.0387, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0387;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.6;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.512;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.053;\ttissue: Blood"}]}, {"GSM2352690": [{"title": "SUBJ.0931, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0931;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 33.1890410958904;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.45;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.243;\ttissue: Blood"}]}, {"GSM2352691": [{"title": "SUBJ.1314, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.1314;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 35.2219178082191;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 176;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.854;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.245;\ttissue: Blood"}]}, {"GSM2352692": [{"title": "SUBJ.0850, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from sle subject"}, {"characteristics_ch1": "subject_id: SUBJ.0850;\ttime: baseline;\tgroup: SLE;\tbatch: ILLUMINATE-1;\trace: asian;\tSex: Female;\tage_at_baseline: 57.6054794520548;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.17;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.406;\ttissue: Blood"}]}, {"GSM2352693": [{"title": "SUBJ.1720, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1720;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 49.6438356164383;\tregion: us_can;\tsledai_at_baseline: 4;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 99;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.918;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2352694": [{"title": "SUBJ.1720, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1720;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 49.6438356164383;\tregion: us_can;\tsledai_at_baseline: 4;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 99;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.918;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2352695": [{"title": "SUBJ.1720, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1720;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 49.6438356164383;\tregion: us_can;\tsledai_at_baseline: 4;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 99;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.918;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2352696": [{"title": "SUBJ.0003, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0003;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 45.3534246575342;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 18;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.28;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.253;\ttissue: Blood"}]}, {"GSM2352697": [{"title": "SUBJ.0003, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0003;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 45.3534246575342;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 18;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.28;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.253;\ttissue: Blood"}]}, {"GSM2352698": [{"title": "SUBJ.0003, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0003;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 45.3534246575342;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 18;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.28;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.253;\ttissue: Blood"}]}, {"GSM2352699": [{"title": "SUBJ.0065, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0065;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 52.7185792349726;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.897;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.159;\ttissue: Blood"}]}, {"GSM2352700": [{"title": "SUBJ.0065, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0065;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 52.7185792349726;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.897;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.159;\ttissue: Blood"}]}, {"GSM2352701": [{"title": "SUBJ.1587, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1587;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 36.8438356164383;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 104;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.836;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.104;\ttissue: Blood"}]}, {"GSM2352702": [{"title": "SUBJ.1587, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1587;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 36.8438356164383;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 104;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.836;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.104;\ttissue: Blood"}]}, {"GSM2352703": [{"title": "SUBJ.1587, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1587;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 36.8438356164383;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 104;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.836;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.104;\ttissue: Blood"}]}, {"GSM2352704": [{"title": "SUBJ.1028, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1028;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 46.8551912568306;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 38;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.231;\ttissue: Blood"}]}, {"GSM2352705": [{"title": "SUBJ.1028, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1028;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 46.8551912568306;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 38;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.231;\ttissue: Blood"}]}, {"GSM2352706": [{"title": "SUBJ.1028, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1028;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 46.8551912568306;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 38;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.231;\ttissue: Blood"}]}, {"GSM2352707": [{"title": "SUBJ.0901, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0901;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 62.7978142076502;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 143;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.11;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.232;\ttissue: Blood"}]}, {"GSM2352708": [{"title": "SUBJ.0901, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0901;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 62.7978142076502;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 143;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.11;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.232;\ttissue: Blood"}]}, {"GSM2352709": [{"title": "SUBJ.0901, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0901;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 62.7978142076502;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 143;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.11;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.232;\ttissue: Blood"}]}, {"GSM2352710": [{"title": "SUBJ.1544, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1544;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 30.811475409836;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.958;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.059;\ttissue: Blood"}]}, {"GSM2352711": [{"title": "SUBJ.1544, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1544;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 30.811475409836;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.958;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.059;\ttissue: Blood"}]}, {"GSM2352712": [{"title": "SUBJ.1544, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1544;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 30.811475409836;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.958;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.059;\ttissue: Blood"}]}, {"GSM2352713": [{"title": "SUBJ.0200, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0200;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 32.8715846994535;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 36;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.18;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.251;\ttissue: Blood"}]}, {"GSM2352714": [{"title": "SUBJ.0200, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0200;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 32.8715846994535;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 36;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.18;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.251;\ttissue: Blood"}]}, {"GSM2352715": [{"title": "SUBJ.0200, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0200;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 32.8715846994535;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 36;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.18;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.251;\ttissue: Blood"}]}, {"GSM2352716": [{"title": "SUBJ.0032, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0032;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 38.3616438356164;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 110;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.24;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.213;\ttissue: Blood"}]}, {"GSM2352717": [{"title": "SUBJ.0032, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0032;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 38.3616438356164;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 110;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.24;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.213;\ttissue: Blood"}]}, {"GSM2352718": [{"title": "SUBJ.0032, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0032;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 38.3616438356164;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 110;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.24;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.213;\ttissue: Blood"}]}, {"GSM2352719": [{"title": "SUBJ.1545, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1545;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 42.9644808743169;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.58;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.087;\ttissue: Blood"}]}, {"GSM2352720": [{"title": "SUBJ.1545, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1545;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 42.9644808743169;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.58;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.087;\ttissue: Blood"}]}, {"GSM2352721": [{"title": "SUBJ.1833, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1833;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 58.9369863013698;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 37;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.64;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.269;\ttissue: Blood"}]}, {"GSM2352722": [{"title": "SUBJ.1833, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1833;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 58.9369863013698;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 37;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.64;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.269;\ttissue: Blood"}]}, {"GSM2352723": [{"title": "SUBJ.1833, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1833;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 58.9369863013698;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 37;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.64;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.269;\ttissue: Blood"}]}, {"GSM2352724": [{"title": "SUBJ.1631, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1631;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.9342465753424;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 38;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.36;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.266;\ttissue: Blood"}]}, {"GSM2352725": [{"title": "SUBJ.1631, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1631;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.9342465753424;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 38;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.36;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.266;\ttissue: Blood"}]}, {"GSM2352726": [{"title": "SUBJ.1631, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1631;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.9342465753424;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 38;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.36;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.266;\ttissue: Blood"}]}, {"GSM2352727": [{"title": "SUBJ.1827, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1827;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 23.4136986301369;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 119;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.93;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.148;\ttissue: Blood"}]}, {"GSM2352728": [{"title": "SUBJ.1827, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1827;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 23.4136986301369;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 119;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.93;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.148;\ttissue: Blood"}]}, {"GSM2352729": [{"title": "SUBJ.1827, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1827;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 23.4136986301369;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 119;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.93;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.148;\ttissue: Blood"}]}, {"GSM2352730": [{"title": "SUBJ.0445, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0445;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 26.8986301369863;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 7;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.908;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.159;\ttissue: Blood"}]}, {"GSM2352731": [{"title": "SUBJ.0445, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0445;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 26.8986301369863;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 7;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.908;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.159;\ttissue: Blood"}]}, {"GSM2352732": [{"title": "SUBJ.0445, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0445;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 26.8986301369863;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 7;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.908;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.159;\ttissue: Blood"}]}, {"GSM2352733": [{"title": "SUBJ.0385, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0385;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 58.0684931506849;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 96;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.55;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.219;\ttissue: Blood"}]}, {"GSM2352734": [{"title": "SUBJ.0385, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0385;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 58.0684931506849;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 96;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.55;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.219;\ttissue: Blood"}]}, {"GSM2352735": [{"title": "SUBJ.0385, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0385;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 58.0684931506849;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 96;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.55;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.219;\ttissue: Blood"}]}, {"GSM2352736": [{"title": "SUBJ.1128, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1128;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 36.8191780821917;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.45;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.273;\ttissue: Blood"}]}, {"GSM2352737": [{"title": "SUBJ.1128, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1128;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 36.8191780821917;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.45;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.273;\ttissue: Blood"}]}, {"GSM2352738": [{"title": "SUBJ.1128, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1128;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 36.8191780821917;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.45;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.273;\ttissue: Blood"}]}, {"GSM2352739": [{"title": "SUBJ.0423, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0423;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Male;\tage_at_baseline: 31.931506849315;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.14;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.42;\ttissue: Blood"}]}, {"GSM2352740": [{"title": "SUBJ.0423, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0423;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Male;\tage_at_baseline: 31.931506849315;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.14;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.42;\ttissue: Blood"}]}, {"GSM2352741": [{"title": "SUBJ.0423, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0423;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Male;\tage_at_baseline: 31.931506849315;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.14;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.42;\ttissue: Blood"}]}, {"GSM2352742": [{"title": "SUBJ.1266, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1266;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 44.3369863013698;\tregion: us_can;\tsledai_at_baseline: 22;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 35;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.636;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.106;\ttissue: Blood"}]}, {"GSM2352743": [{"title": "SUBJ.1266, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1266;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 44.3369863013698;\tregion: us_can;\tsledai_at_baseline: 22;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 35;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.636;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.106;\ttissue: Blood"}]}, {"GSM2352744": [{"title": "SUBJ.1266, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1266;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 44.3369863013698;\tregion: us_can;\tsledai_at_baseline: 22;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 35;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.636;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.106;\ttissue: Blood"}]}, {"GSM2352745": [{"title": "SUBJ.1191, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1191;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 65.7267759562841;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.24;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.257;\ttissue: Blood"}]}, {"GSM2352746": [{"title": "SUBJ.1191, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1191;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 65.7267759562841;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.24;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.257;\ttissue: Blood"}]}, {"GSM2352747": [{"title": "SUBJ.1191, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1191;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 65.7267759562841;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.24;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.257;\ttissue: Blood"}]}, {"GSM2352748": [{"title": "SUBJ.1462, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1462;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: asian;\tSex: Female;\tage_at_baseline: 31.2602739726027;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 153;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.511;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.175;\ttissue: Blood"}]}, {"GSM2352749": [{"title": "SUBJ.1462, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1462;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: asian;\tSex: Female;\tage_at_baseline: 31.2602739726027;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 153;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.511;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.175;\ttissue: Blood"}]}, {"GSM2352750": [{"title": "SUBJ.1462, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1462;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: asian;\tSex: Female;\tage_at_baseline: 31.2602739726027;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 153;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.511;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.175;\ttissue: Blood"}]}, {"GSM2352751": [{"title": "SUBJ.1813, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1813;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 28.8169398907103;\tregion: europe;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.32;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.331;\ttissue: Blood"}]}, {"GSM2352752": [{"title": "SUBJ.1813, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1813;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 28.8169398907103;\tregion: europe;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.32;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.331;\ttissue: Blood"}]}, {"GSM2352753": [{"title": "SUBJ.1813, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1813;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 28.8169398907103;\tregion: europe;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.32;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.331;\ttissue: Blood"}]}, {"GSM2352754": [{"title": "SUBJ.0421, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0421;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 44.7021857923497;\tregion: europe;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.877;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.204;\ttissue: Blood"}]}, {"GSM2352755": [{"title": "SUBJ.0421, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0421;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 44.7021857923497;\tregion: europe;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.877;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.204;\ttissue: Blood"}]}, {"GSM2352756": [{"title": "SUBJ.0421, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0421;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 44.7021857923497;\tregion: europe;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.877;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.204;\ttissue: Blood"}]}, {"GSM2352757": [{"title": "SUBJ.0394, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0394;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 62.6994535519125;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.988;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.211;\ttissue: Blood"}]}, {"GSM2352758": [{"title": "SUBJ.0394, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0394;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 62.6994535519125;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.988;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.211;\ttissue: Blood"}]}, {"GSM2352759": [{"title": "SUBJ.0394, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0394;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 62.6994535519125;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.988;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.211;\ttissue: Blood"}]}, {"GSM2352760": [{"title": "SUBJ.1551, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1551;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 43.6602739726027;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 207;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.07;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.091;\ttissue: Blood"}]}, {"GSM2352761": [{"title": "SUBJ.1551, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1551;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 43.6602739726027;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 207;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.07;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.091;\ttissue: Blood"}]}, {"GSM2352762": [{"title": "SUBJ.1551, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1551;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 43.6602739726027;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 207;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.07;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.091;\ttissue: Blood"}]}, {"GSM2352763": [{"title": "SUBJ.1099, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1099;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 42.9424657534246;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 98;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.2;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.228;\ttissue: Blood"}]}, {"GSM2352764": [{"title": "SUBJ.1099, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1099;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 42.9424657534246;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 98;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.2;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.228;\ttissue: Blood"}]}, {"GSM2352765": [{"title": "SUBJ.1099, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1099;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 42.9424657534246;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 98;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.2;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.228;\ttissue: Blood"}]}, {"GSM2352766": [{"title": "SUBJ.0765, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0765;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 27.7568306010929;\tregion: europe;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 143;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.129;\ttissue: Blood"}]}, {"GSM2352767": [{"title": "SUBJ.0765, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0765;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 27.7568306010929;\tregion: europe;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 143;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.129;\ttissue: Blood"}]}, {"GSM2352768": [{"title": "SUBJ.0765, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0765;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 27.7568306010929;\tregion: europe;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 143;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.129;\ttissue: Blood"}]}, {"GSM2352769": [{"title": "SUBJ.0285, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0285;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Male;\tage_at_baseline: 38.8739726027397;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 89;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.099;\ttissue: Blood"}]}, {"GSM2352770": [{"title": "SUBJ.0285, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0285;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Male;\tage_at_baseline: 38.8739726027397;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 89;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.099;\ttissue: Blood"}]}, {"GSM2352771": [{"title": "SUBJ.0285, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0285;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Male;\tage_at_baseline: 38.8739726027397;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 89;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.099;\ttissue: Blood"}]}, {"GSM2352772": [{"title": "SUBJ.0800, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0800;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 42.8715846994535;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 69;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2352773": [{"title": "SUBJ.0800, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0800;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 42.8715846994535;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 69;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2352774": [{"title": "SUBJ.0800, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0800;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 42.8715846994535;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 69;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): --;\tc3_at_baseline (g/l): --;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): --;\tc4_at_baseline (g/l): --;\ttissue: Blood"}]}, {"GSM2352775": [{"title": "SUBJ.0001, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0001;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 22.7671232876712;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 233;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.961;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.098;\ttissue: Blood"}]}, {"GSM2352776": [{"title": "SUBJ.0001, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0001;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 22.7671232876712;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 233;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.961;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.098;\ttissue: Blood"}]}, {"GSM2352777": [{"title": "SUBJ.0001, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0001;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 22.7671232876712;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 233;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.961;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.098;\ttissue: Blood"}]}, {"GSM2352778": [{"title": "SUBJ.1024, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1024;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 42.4767123287671;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 147;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.797;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.146;\ttissue: Blood"}]}, {"GSM2352779": [{"title": "SUBJ.1024, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1024;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 42.4767123287671;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 147;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.797;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.146;\ttissue: Blood"}]}, {"GSM2352780": [{"title": "SUBJ.1024, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1024;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 42.4767123287671;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 147;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.797;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.146;\ttissue: Blood"}]}, {"GSM2352781": [{"title": "SUBJ.0476, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0476;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 43.5835616438356;\tregion: us_can;\tsledai_at_baseline: 15;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.751;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.052;\ttissue: Blood"}]}, {"GSM2352782": [{"title": "SUBJ.0476, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0476;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 43.5835616438356;\tregion: us_can;\tsledai_at_baseline: 15;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.751;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.052;\ttissue: Blood"}]}, {"GSM2352783": [{"title": "SUBJ.0476, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0476;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 43.5835616438356;\tregion: us_can;\tsledai_at_baseline: 15;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.751;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.052;\ttissue: Blood"}]}, {"GSM2352784": [{"title": "SUBJ.1467, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1467;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 41.1643835616438;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.171;\ttissue: Blood"}]}, {"GSM2352785": [{"title": "SUBJ.1467, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1467;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 41.1643835616438;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.171;\ttissue: Blood"}]}, {"GSM2352786": [{"title": "SUBJ.1467, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1467;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 41.1643835616438;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.171;\ttissue: Blood"}]}, {"GSM2352787": [{"title": "SUBJ.0265, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0265;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 40.972602739726;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 16;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.04;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.145;\ttissue: Blood"}]}, {"GSM2352788": [{"title": "SUBJ.0265, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0265;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 40.972602739726;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 16;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.04;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.145;\ttissue: Blood"}]}, {"GSM2352789": [{"title": "SUBJ.0265, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0265;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 40.972602739726;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 16;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.04;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.145;\ttissue: Blood"}]}, {"GSM2352790": [{"title": "SUBJ.0090, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0090;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 37.7732240437158;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 57;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.735;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.062;\ttissue: Blood"}]}, {"GSM2352791": [{"title": "SUBJ.0090, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0090;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 37.7732240437158;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 57;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.735;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.062;\ttissue: Blood"}]}, {"GSM2352792": [{"title": "SUBJ.0090, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0090;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 37.7732240437158;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 57;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.735;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.062;\ttissue: Blood"}]}, {"GSM2352793": [{"title": "SUBJ.0365, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0365;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 67.8524590163934;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 39;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): H;\tc3_at_baseline (g/l): 1.88;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.333;\ttissue: Blood"}]}, {"GSM2352794": [{"title": "SUBJ.0365, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0365;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 67.8524590163934;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 39;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): H;\tc3_at_baseline (g/l): 1.88;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.333;\ttissue: Blood"}]}, {"GSM2352795": [{"title": "SUBJ.0365, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0365;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 67.8524590163934;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 39;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): H;\tc3_at_baseline (g/l): 1.88;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.333;\ttissue: Blood"}]}, {"GSM2352796": [{"title": "SUBJ.1797, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1797;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 35.7732240437158;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 22;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.04;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.137;\ttissue: Blood"}]}, {"GSM2352797": [{"title": "SUBJ.1797, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1797;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 35.7732240437158;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 22;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.04;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.137;\ttissue: Blood"}]}, {"GSM2352798": [{"title": "SUBJ.1797, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1797;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 35.7732240437158;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 22;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.04;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.137;\ttissue: Blood"}]}, {"GSM2352799": [{"title": "SUBJ.0741, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0741;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 55.2109589041096;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): H;\tc3_at_baseline (g/l): 1.84;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.157;\ttissue: Blood"}]}, {"GSM2352800": [{"title": "SUBJ.0741, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0741;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 55.2109589041096;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): H;\tc3_at_baseline (g/l): 1.84;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.157;\ttissue: Blood"}]}, {"GSM2352801": [{"title": "SUBJ.0741, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0741;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 55.2109589041096;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): H;\tc3_at_baseline (g/l): 1.84;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.157;\ttissue: Blood"}]}, {"GSM2352802": [{"title": "SUBJ.1705, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1705;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 35.7568306010929;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.934;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.086;\ttissue: Blood"}]}, {"GSM2352803": [{"title": "SUBJ.1705, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1705;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 35.7568306010929;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.934;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.086;\ttissue: Blood"}]}, {"GSM2352804": [{"title": "SUBJ.1705, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1705;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 35.7568306010929;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.934;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.086;\ttissue: Blood"}]}, {"GSM2352805": [{"title": "SUBJ.1795, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1795;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 50.9753424657534;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.18;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.281;\ttissue: Blood"}]}, {"GSM2352806": [{"title": "SUBJ.1795, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1795;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 50.9753424657534;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.18;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.281;\ttissue: Blood"}]}, {"GSM2352807": [{"title": "SUBJ.1795, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1795;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 50.9753424657534;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.18;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.281;\ttissue: Blood"}]}, {"GSM2352808": [{"title": "SUBJ.0858, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0858;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 33.8767123287671;\tregion: us_can;\tsledai_at_baseline: 15;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.848;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.133;\ttissue: Blood"}]}, {"GSM2352809": [{"title": "SUBJ.0858, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0858;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 33.8767123287671;\tregion: us_can;\tsledai_at_baseline: 15;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.848;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.133;\ttissue: Blood"}]}, {"GSM2352810": [{"title": "SUBJ.0858, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0858;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 33.8767123287671;\tregion: us_can;\tsledai_at_baseline: 15;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.848;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.133;\ttissue: Blood"}]}, {"GSM2352811": [{"title": "SUBJ.0513, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0513;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 47.9616438356164;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 131;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.31;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.368;\ttissue: Blood"}]}, {"GSM2352812": [{"title": "SUBJ.0513, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0513;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 47.9616438356164;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 131;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.31;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.368;\ttissue: Blood"}]}, {"GSM2352813": [{"title": "SUBJ.0513, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0513;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 47.9616438356164;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 131;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.31;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.368;\ttissue: Blood"}]}, {"GSM2352814": [{"title": "SUBJ.1749, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1749;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 55.6493150684931;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 13;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.33;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.197;\ttissue: Blood"}]}, {"GSM2352815": [{"title": "SUBJ.1749, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1749;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 55.6493150684931;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 13;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.33;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.197;\ttissue: Blood"}]}, {"GSM2352816": [{"title": "SUBJ.1749, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1749;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 55.6493150684931;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 13;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.33;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.197;\ttissue: Blood"}]}, {"GSM2352817": [{"title": "SUBJ.0359, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0359;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 38.8169398907103;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.05;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.284;\ttissue: Blood"}]}, {"GSM2352818": [{"title": "SUBJ.0359, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0359;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 38.8169398907103;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.05;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.284;\ttissue: Blood"}]}, {"GSM2352819": [{"title": "SUBJ.0359, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0359;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 38.8169398907103;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.05;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.284;\ttissue: Blood"}]}, {"GSM2352820": [{"title": "SUBJ.1258, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1258;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 54.7972602739726;\tregion: us_can;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 188;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.918;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.199;\ttissue: Blood"}]}, {"GSM2352821": [{"title": "SUBJ.1258, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1258;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 54.7972602739726;\tregion: us_can;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 188;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.918;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.199;\ttissue: Blood"}]}, {"GSM2352822": [{"title": "SUBJ.1258, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1258;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 54.7972602739726;\tregion: us_can;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 188;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.918;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.199;\ttissue: Blood"}]}, {"GSM2352823": [{"title": "SUBJ.1677, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1677;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 51.0904109589041;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 46;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.6;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.178;\ttissue: Blood"}]}, {"GSM2352824": [{"title": "SUBJ.1677, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1677;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 51.0904109589041;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 46;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.6;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.178;\ttissue: Blood"}]}, {"GSM2352825": [{"title": "SUBJ.1677, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1677;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 51.0904109589041;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 46;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.6;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.178;\ttissue: Blood"}]}, {"GSM2352826": [{"title": "SUBJ.1663, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1663;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Male;\tage_at_baseline: 33.75956284153;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.13;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.212;\ttissue: Blood"}]}, {"GSM2352827": [{"title": "SUBJ.1663, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1663;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Male;\tage_at_baseline: 33.75956284153;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.13;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.212;\ttissue: Blood"}]}, {"GSM2352828": [{"title": "SUBJ.1663, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1663;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Male;\tage_at_baseline: 33.75956284153;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.13;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.212;\ttissue: Blood"}]}, {"GSM2352829": [{"title": "SUBJ.0251, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0251;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 32.5342465753424;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 39;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.816;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.134;\ttissue: Blood"}]}, {"GSM2352830": [{"title": "SUBJ.0251, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0251;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 32.5342465753424;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 39;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.816;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.134;\ttissue: Blood"}]}, {"GSM2352831": [{"title": "SUBJ.0251, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0251;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 32.5342465753424;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 39;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.816;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.134;\ttissue: Blood"}]}, {"GSM2352832": [{"title": "SUBJ.1741, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1741;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.8879781420765;\tregion: mex_ca_sa;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 254;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.695;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.095;\ttissue: Blood"}]}, {"GSM2352833": [{"title": "SUBJ.1741, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1741;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.8879781420765;\tregion: mex_ca_sa;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 254;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.695;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.095;\ttissue: Blood"}]}, {"GSM2352834": [{"title": "SUBJ.1741, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1741;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.8879781420765;\tregion: mex_ca_sa;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 254;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.695;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.095;\ttissue: Blood"}]}, {"GSM2352835": [{"title": "SUBJ.1119, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1119;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 25.8142076502732;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.22;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.219;\ttissue: Blood"}]}, {"GSM2352836": [{"title": "SUBJ.1119, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1119;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 25.8142076502732;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.22;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.219;\ttissue: Blood"}]}, {"GSM2352837": [{"title": "SUBJ.1119, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1119;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 25.8142076502732;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.22;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.219;\ttissue: Blood"}]}, {"GSM2352838": [{"title": "SUBJ.0739, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0739;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 52.6054794520548;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 166;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.12;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.467;\ttissue: Blood"}]}, {"GSM2352839": [{"title": "SUBJ.0739, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0739;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 52.6054794520548;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 166;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.12;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.467;\ttissue: Blood"}]}, {"GSM2352840": [{"title": "SUBJ.0739, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0739;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 52.6054794520548;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 166;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.12;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.467;\ttissue: Blood"}]}, {"GSM2352841": [{"title": "SUBJ.0559, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0559;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 71.6939890710382;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.23;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.228;\ttissue: Blood"}]}, {"GSM2352842": [{"title": "SUBJ.0559, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0559;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 71.6939890710382;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.23;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.228;\ttissue: Blood"}]}, {"GSM2352843": [{"title": "SUBJ.0559, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0559;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 71.6939890710382;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.23;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.228;\ttissue: Blood"}]}, {"GSM2352844": [{"title": "SUBJ.0237, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0237;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 24.7021857923497;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 62;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.821;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.149;\ttissue: Blood"}]}, {"GSM2352845": [{"title": "SUBJ.0237, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0237;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 24.7021857923497;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 62;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.821;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.149;\ttissue: Blood"}]}, {"GSM2352846": [{"title": "SUBJ.0237, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0237;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 24.7021857923497;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 62;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.821;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.149;\ttissue: Blood"}]}, {"GSM2352847": [{"title": "SUBJ.0350, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0350;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 28.2630136986301;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.43;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.136;\ttissue: Blood"}]}, {"GSM2352848": [{"title": "SUBJ.0350, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0350;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 28.2630136986301;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.43;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.136;\ttissue: Blood"}]}, {"GSM2352849": [{"title": "SUBJ.0350, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0350;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 28.2630136986301;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.43;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.136;\ttissue: Blood"}]}, {"GSM2352850": [{"title": "SUBJ.1154, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1154;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 47.2191780821917;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 31;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): H;\tc3_at_baseline (g/l): 1.96;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.424;\ttissue: Blood"}]}, {"GSM2352851": [{"title": "SUBJ.1154, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1154;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 47.2191780821917;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 31;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): H;\tc3_at_baseline (g/l): 1.96;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.424;\ttissue: Blood"}]}, {"GSM2352852": [{"title": "SUBJ.1533, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1533;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 33.6027397260274;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.08;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.196;\ttissue: Blood"}]}, {"GSM2352853": [{"title": "SUBJ.1533, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1533;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 33.6027397260274;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.08;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.196;\ttissue: Blood"}]}, {"GSM2352854": [{"title": "SUBJ.1533, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1533;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 33.6027397260274;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.08;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.196;\ttissue: Blood"}]}, {"GSM2352855": [{"title": "SUBJ.1091, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1091;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 58.131506849315;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 180;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.03;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.17;\ttissue: Blood"}]}, {"GSM2352856": [{"title": "SUBJ.1091, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1091;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 58.131506849315;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 180;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.03;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.17;\ttissue: Blood"}]}, {"GSM2352857": [{"title": "SUBJ.1091, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1091;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 58.131506849315;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 180;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.03;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.17;\ttissue: Blood"}]}, {"GSM2352858": [{"title": "SUBJ.1268, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1268;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 59.4301369863013;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 119;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.83;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.088;\ttissue: Blood"}]}, {"GSM2352859": [{"title": "SUBJ.1268, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1268;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 59.4301369863013;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 119;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.83;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.088;\ttissue: Blood"}]}, {"GSM2352860": [{"title": "SUBJ.1268, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1268;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 59.4301369863013;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 119;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.83;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.088;\ttissue: Blood"}]}, {"GSM2352861": [{"title": "SUBJ.0046, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0046;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 49.3780821917808;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 89;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.98;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.278;\ttissue: Blood"}]}, {"GSM2352862": [{"title": "SUBJ.0046, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0046;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 49.3780821917808;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 89;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.98;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.278;\ttissue: Blood"}]}, {"GSM2352863": [{"title": "SUBJ.0046, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0046;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 49.3780821917808;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 89;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.98;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.278;\ttissue: Blood"}]}, {"GSM2352864": [{"title": "SUBJ.1454, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1454;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Male;\tage_at_baseline: 51.6410958904109;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.01;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.101;\ttissue: Blood"}]}, {"GSM2352865": [{"title": "SUBJ.1454, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1454;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Male;\tage_at_baseline: 51.6410958904109;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.01;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.101;\ttissue: Blood"}]}, {"GSM2352866": [{"title": "SUBJ.1454, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1454;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Male;\tage_at_baseline: 51.6410958904109;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.01;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.101;\ttissue: Blood"}]}, {"GSM2352867": [{"title": "SUBJ.0338, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0338;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 40.8743169398907;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 18;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.06;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.119;\ttissue: Blood"}]}, {"GSM2352868": [{"title": "SUBJ.0338, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0338;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 40.8743169398907;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 18;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.06;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.119;\ttissue: Blood"}]}, {"GSM2352869": [{"title": "SUBJ.0338, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0338;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 40.8743169398907;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 18;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.06;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.119;\ttissue: Blood"}]}, {"GSM2352870": [{"title": "SUBJ.1452, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1452;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 26.7732240437158;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 16;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.763;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.104;\ttissue: Blood"}]}, {"GSM2352871": [{"title": "SUBJ.1452, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1452;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 26.7732240437158;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 16;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.763;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.104;\ttissue: Blood"}]}, {"GSM2352872": [{"title": "SUBJ.1452, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1452;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 26.7732240437158;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 16;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.763;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.104;\ttissue: Blood"}]}, {"GSM2352873": [{"title": "SUBJ.0317, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0317;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 45.4191780821917;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.855;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.128;\ttissue: Blood"}]}, {"GSM2352874": [{"title": "SUBJ.0317, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0317;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 45.4191780821917;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.855;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.128;\ttissue: Blood"}]}, {"GSM2352875": [{"title": "SUBJ.0317, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0317;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 45.4191780821917;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.855;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.128;\ttissue: Blood"}]}, {"GSM2352876": [{"title": "SUBJ.0540, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0540;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 39.6684931506849;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.836;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.132;\ttissue: Blood"}]}, {"GSM2352877": [{"title": "SUBJ.0540, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0540;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 39.6684931506849;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.836;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.132;\ttissue: Blood"}]}, {"GSM2352878": [{"title": "SUBJ.0540, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0540;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 39.6684931506849;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.836;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.132;\ttissue: Blood"}]}, {"GSM2352879": [{"title": "SUBJ.0517, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0517;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 29.6465753424657;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.12;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.14;\ttissue: Blood"}]}, {"GSM2352880": [{"title": "SUBJ.0517, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0517;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 29.6465753424657;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.12;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.14;\ttissue: Blood"}]}, {"GSM2352881": [{"title": "SUBJ.0517, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0517;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 29.6465753424657;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.12;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.14;\ttissue: Blood"}]}, {"GSM2352882": [{"title": "SUBJ.1754, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1754;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 52.7568306010929;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.17;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.194;\ttissue: Blood"}]}, {"GSM2352883": [{"title": "SUBJ.1754, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1754;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 52.7568306010929;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.17;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.194;\ttissue: Blood"}]}, {"GSM2352884": [{"title": "SUBJ.1754, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1754;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 52.7568306010929;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.17;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.194;\ttissue: Blood"}]}, {"GSM2352885": [{"title": "SUBJ.1244, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1244;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 21.9506849315068;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.52;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.201;\ttissue: Blood"}]}, {"GSM2352886": [{"title": "SUBJ.1244, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1244;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 21.9506849315068;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.52;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.201;\ttissue: Blood"}]}, {"GSM2352887": [{"title": "SUBJ.1244, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1244;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 21.9506849315068;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.52;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.201;\ttissue: Blood"}]}, {"GSM2352888": [{"title": "SUBJ.0174, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0174;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 65.7095890410959;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.08;\ttissue: Blood"}]}, {"GSM2352889": [{"title": "SUBJ.0174, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0174;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 65.7095890410959;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.08;\ttissue: Blood"}]}, {"GSM2352890": [{"title": "SUBJ.0174, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0174;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 65.7095890410959;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.08;\ttissue: Blood"}]}, {"GSM2352891": [{"title": "SUBJ.1501, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1501;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 54.2082191780822;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 177;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.46;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.226;\ttissue: Blood"}]}, {"GSM2352892": [{"title": "SUBJ.1501, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1501;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 54.2082191780822;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 177;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.46;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.226;\ttissue: Blood"}]}, {"GSM2352893": [{"title": "SUBJ.1501, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1501;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 54.2082191780822;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 177;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.46;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.226;\ttissue: Blood"}]}, {"GSM2352894": [{"title": "SUBJ.0484, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0484;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 38.3424657534246;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 132;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.29;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.259;\ttissue: Blood"}]}, {"GSM2352895": [{"title": "SUBJ.0484, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0484;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 38.3424657534246;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 132;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.29;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.259;\ttissue: Blood"}]}, {"GSM2352896": [{"title": "SUBJ.0484, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0484;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 38.3424657534246;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 132;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.29;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.259;\ttissue: Blood"}]}, {"GSM2352897": [{"title": "SUBJ.0036, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0036;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.5671232876712;\tregion: us_can;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 50;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.627;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.117;\ttissue: Blood"}]}, {"GSM2352898": [{"title": "SUBJ.0036, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0036;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.5671232876712;\tregion: us_can;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 50;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.627;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.117;\ttissue: Blood"}]}, {"GSM2352899": [{"title": "SUBJ.0036, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0036;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.5671232876712;\tregion: us_can;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 50;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.627;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.117;\ttissue: Blood"}]}, {"GSM2352900": [{"title": "SUBJ.0168, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0168;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 46.2;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.04;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.203;\ttissue: Blood"}]}, {"GSM2352901": [{"title": "SUBJ.0168, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0168;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 46.2;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.04;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.203;\ttissue: Blood"}]}, {"GSM2352902": [{"title": "SUBJ.0007, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0007;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 39.8082191780821;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.79;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.743;\ttissue: Blood"}]}, {"GSM2352903": [{"title": "SUBJ.0007, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0007;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 39.8082191780821;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.79;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.743;\ttissue: Blood"}]}, {"GSM2352904": [{"title": "SUBJ.0007, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0007;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 39.8082191780821;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.79;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.743;\ttissue: Blood"}]}, {"GSM2352905": [{"title": "SUBJ.0113, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0113;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 37.8551912568306;\tregion: mex_ca_sa;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.741;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.216;\ttissue: Blood"}]}, {"GSM2352906": [{"title": "SUBJ.0113, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0113;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 37.8551912568306;\tregion: mex_ca_sa;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.741;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.216;\ttissue: Blood"}]}, {"GSM2352907": [{"title": "SUBJ.0113, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0113;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 37.8551912568306;\tregion: mex_ca_sa;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.741;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.216;\ttissue: Blood"}]}, {"GSM2352908": [{"title": "SUBJ.0889, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0889;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 43.9672131147541;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.23;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.201;\ttissue: Blood"}]}, {"GSM2352909": [{"title": "SUBJ.0889, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0889;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 43.9672131147541;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.23;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.201;\ttissue: Blood"}]}, {"GSM2352910": [{"title": "SUBJ.0889, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0889;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 43.9672131147541;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.23;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.201;\ttissue: Blood"}]}, {"GSM2352911": [{"title": "SUBJ.1814, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1814;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 29.572602739726;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.618;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.086;\ttissue: Blood"}]}, {"GSM2352912": [{"title": "SUBJ.1814, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1814;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 29.572602739726;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.618;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.086;\ttissue: Blood"}]}, {"GSM2352913": [{"title": "SUBJ.1814, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1814;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 29.572602739726;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.618;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.086;\ttissue: Blood"}]}, {"GSM2352914": [{"title": "SUBJ.0881, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0881;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 64.6639344262295;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 112;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.12;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.188;\ttissue: Blood"}]}, {"GSM2352915": [{"title": "SUBJ.0881, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0881;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 64.6639344262295;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 112;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.12;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.188;\ttissue: Blood"}]}, {"GSM2352916": [{"title": "SUBJ.0881, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0881;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 64.6639344262295;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 112;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.12;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.188;\ttissue: Blood"}]}, {"GSM2352917": [{"title": "SUBJ.1087, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1087;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 47.6639344262295;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 57;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.275;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2352918": [{"title": "SUBJ.1087, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1087;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 47.6639344262295;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 57;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.275;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2352919": [{"title": "SUBJ.1087, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1087;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 47.6639344262295;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 57;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.275;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2352920": [{"title": "SUBJ.1152, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1152;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 67.9945205479452;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.22;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.431;\ttissue: Blood"}]}, {"GSM2352921": [{"title": "SUBJ.1152, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1152;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 67.9945205479452;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.22;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.431;\ttissue: Blood"}]}, {"GSM2352922": [{"title": "SUBJ.1152, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1152;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 67.9945205479452;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.22;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.431;\ttissue: Blood"}]}, {"GSM2352923": [{"title": "SUBJ.0538, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0538;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.4520547945205;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.32;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.239;\ttissue: Blood"}]}, {"GSM2352924": [{"title": "SUBJ.0538, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0538;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.4520547945205;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.32;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.239;\ttissue: Blood"}]}, {"GSM2352925": [{"title": "SUBJ.0532, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0532;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 31.8934426229508;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 54;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.07;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.128;\ttissue: Blood"}]}, {"GSM2352926": [{"title": "SUBJ.0532, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0532;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 31.8934426229508;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 54;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.07;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.128;\ttissue: Blood"}]}, {"GSM2352927": [{"title": "SUBJ.0532, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0532;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 31.8934426229508;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 54;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.07;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.128;\ttissue: Blood"}]}, {"GSM2352928": [{"title": "SUBJ.0301, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0301;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 43.7841530054644;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.633;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.194;\ttissue: Blood"}]}, {"GSM2352929": [{"title": "SUBJ.0301, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0301;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 43.7841530054644;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.633;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.194;\ttissue: Blood"}]}, {"GSM2352930": [{"title": "SUBJ.0301, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0301;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 43.7841530054644;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.633;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.194;\ttissue: Blood"}]}, {"GSM2352931": [{"title": "SUBJ.0216, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0216;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 52.8907103825136;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 47;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.12;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.138;\ttissue: Blood"}]}, {"GSM2352932": [{"title": "SUBJ.0216, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0216;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 52.8907103825136;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 47;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.12;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.138;\ttissue: Blood"}]}, {"GSM2352933": [{"title": "SUBJ.0216, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0216;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 52.8907103825136;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 47;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.12;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.138;\ttissue: Blood"}]}, {"GSM2352934": [{"title": "SUBJ.1332, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1332;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 50.9753424657534;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.101;\ttissue: Blood"}]}, {"GSM2352935": [{"title": "SUBJ.1332, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1332;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 50.9753424657534;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.101;\ttissue: Blood"}]}, {"GSM2352936": [{"title": "SUBJ.1332, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1332;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 50.9753424657534;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.101;\ttissue: Blood"}]}, {"GSM2352937": [{"title": "SUBJ.1199, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1199;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 25.3616438356164;\tregion: europe;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.611;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.07;\ttissue: Blood"}]}, {"GSM2352938": [{"title": "SUBJ.1199, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1199;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 25.3616438356164;\tregion: europe;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.611;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.07;\ttissue: Blood"}]}, {"GSM2352939": [{"title": "SUBJ.1199, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1199;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 25.3616438356164;\tregion: europe;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.611;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.07;\ttissue: Blood"}]}, {"GSM2352940": [{"title": "SUBJ.0002, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0002;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 26.545205479452;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 70;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.931;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.115;\ttissue: Blood"}]}, {"GSM2352941": [{"title": "SUBJ.0002, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0002;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 26.545205479452;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 70;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.931;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.115;\ttissue: Blood"}]}, {"GSM2352942": [{"title": "SUBJ.0002, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0002;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 26.545205479452;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 70;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.931;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.115;\ttissue: Blood"}]}, {"GSM2352943": [{"title": "SUBJ.0541, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0541;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 45.9780821917808;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 71;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): H;\tc3_at_baseline (g/l): 1.86;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.326;\ttissue: Blood"}]}, {"GSM2352944": [{"title": "SUBJ.0541, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0541;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 45.9780821917808;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 71;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): H;\tc3_at_baseline (g/l): 1.86;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.326;\ttissue: Blood"}]}, {"GSM2352945": [{"title": "SUBJ.1738, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1738;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 61.358904109589;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.909;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2352946": [{"title": "SUBJ.1738, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1738;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 61.358904109589;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.909;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2352947": [{"title": "SUBJ.1738, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1738;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 61.358904109589;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.909;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2352948": [{"title": "SUBJ.1029, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1029;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 62.531506849315;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 44;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.52;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.239;\ttissue: Blood"}]}, {"GSM2352949": [{"title": "SUBJ.1029, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1029;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 62.531506849315;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 44;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.52;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.239;\ttissue: Blood"}]}, {"GSM2352950": [{"title": "SUBJ.1029, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1029;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 62.531506849315;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 44;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.52;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.239;\ttissue: Blood"}]}, {"GSM2352951": [{"title": "SUBJ.0177, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0177;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 35.7643835616438;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 23;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.65;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.183;\ttissue: Blood"}]}, {"GSM2352952": [{"title": "SUBJ.0177, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0177;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 35.7643835616438;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 23;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.65;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.183;\ttissue: Blood"}]}, {"GSM2352953": [{"title": "SUBJ.0177, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0177;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 35.7643835616438;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 23;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.65;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.183;\ttissue: Blood"}]}, {"GSM2352954": [{"title": "SUBJ.0526, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0526;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 49.7568306010929;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 14;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.991;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.16;\ttissue: Blood"}]}, {"GSM2352955": [{"title": "SUBJ.0526, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0526;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 49.7568306010929;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 14;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.991;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.16;\ttissue: Blood"}]}, {"GSM2352956": [{"title": "SUBJ.0526, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0526;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 49.7568306010929;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 14;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.991;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.16;\ttissue: Blood"}]}, {"GSM2352957": [{"title": "SUBJ.0505, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0505;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 65.1479452054794;\tregion: us_can;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.27;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.297;\ttissue: Blood"}]}, {"GSM2352958": [{"title": "SUBJ.0505, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0505;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 65.1479452054794;\tregion: us_can;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.27;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.297;\ttissue: Blood"}]}, {"GSM2352959": [{"title": "SUBJ.0505, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0505;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 65.1479452054794;\tregion: us_can;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.27;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.297;\ttissue: Blood"}]}, {"GSM2352960": [{"title": "SUBJ.0182, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0182;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 55.7479452054794;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 13;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.57;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.357;\ttissue: Blood"}]}, {"GSM2352961": [{"title": "SUBJ.0182, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0182;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 55.7479452054794;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 13;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.57;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.357;\ttissue: Blood"}]}, {"GSM2352962": [{"title": "SUBJ.0182, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0182;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 55.7479452054794;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 13;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.57;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.357;\ttissue: Blood"}]}, {"GSM2352963": [{"title": "SUBJ.1062, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1062;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 37.9125683060109;\tregion: mex_ca_sa;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 24;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.803;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.209;\ttissue: Blood"}]}, {"GSM2352964": [{"title": "SUBJ.1062, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1062;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 37.9125683060109;\tregion: mex_ca_sa;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 24;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.803;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.209;\ttissue: Blood"}]}, {"GSM2352965": [{"title": "SUBJ.1062, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1062;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 37.9125683060109;\tregion: mex_ca_sa;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 24;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.803;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.209;\ttissue: Blood"}]}, {"GSM2352966": [{"title": "SUBJ.0186, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0186;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 71.6136986301369;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.2;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.06;\ttissue: Blood"}]}, {"GSM2352967": [{"title": "SUBJ.0186, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0186;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 71.6136986301369;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.2;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.06;\ttissue: Blood"}]}, {"GSM2352968": [{"title": "SUBJ.0186, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0186;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 71.6136986301369;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.2;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.06;\ttissue: Blood"}]}, {"GSM2352969": [{"title": "SUBJ.1221, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1221;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 51.8219178082191;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.36;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.163;\ttissue: Blood"}]}, {"GSM2352970": [{"title": "SUBJ.1221, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1221;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 51.8219178082191;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.36;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.163;\ttissue: Blood"}]}, {"GSM2352971": [{"title": "SUBJ.1221, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1221;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 51.8219178082191;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.36;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.163;\ttissue: Blood"}]}, {"GSM2352972": [{"title": "SUBJ.1778, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1778;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 44.7841530054644;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 147;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.3;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.393;\ttissue: Blood"}]}, {"GSM2352973": [{"title": "SUBJ.1778, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1778;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 44.7841530054644;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 147;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.3;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.393;\ttissue: Blood"}]}, {"GSM2352974": [{"title": "SUBJ.1778, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1778;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 44.7841530054644;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 147;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.3;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.393;\ttissue: Blood"}]}, {"GSM2352975": [{"title": "SUBJ.0049, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0049;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 29.7978142076502;\tregion: europe;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.473;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2352976": [{"title": "SUBJ.0049, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0049;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 29.7978142076502;\tregion: europe;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.473;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2352977": [{"title": "SUBJ.0049, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0049;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 29.7978142076502;\tregion: europe;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.473;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2352978": [{"title": "SUBJ.1248, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1248;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 48.8524590163934;\tregion: us_can;\tsledai_at_baseline: 7;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.21;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.15;\ttissue: Blood"}]}, {"GSM2352979": [{"title": "SUBJ.1248, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1248;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 48.8524590163934;\tregion: us_can;\tsledai_at_baseline: 7;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.21;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.15;\ttissue: Blood"}]}, {"GSM2352980": [{"title": "SUBJ.1248, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1248;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 48.8524590163934;\tregion: us_can;\tsledai_at_baseline: 7;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.21;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.15;\ttissue: Blood"}]}, {"GSM2352981": [{"title": "SUBJ.0874, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0874;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 46.2767123287671;\tregion: us_can;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.39;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.305;\ttissue: Blood"}]}, {"GSM2352982": [{"title": "SUBJ.0874, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0874;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 46.2767123287671;\tregion: us_can;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.39;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.305;\ttissue: Blood"}]}, {"GSM2352983": [{"title": "SUBJ.0874, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0874;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 46.2767123287671;\tregion: us_can;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.39;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.305;\ttissue: Blood"}]}, {"GSM2352984": [{"title": "SUBJ.1257, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1257;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 63.8770491803278;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 147;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.221;\ttissue: Blood"}]}, {"GSM2352985": [{"title": "SUBJ.1257, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1257;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 63.8770491803278;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 147;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.221;\ttissue: Blood"}]}, {"GSM2352986": [{"title": "SUBJ.1257, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1257;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 63.8770491803278;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 147;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.221;\ttissue: Blood"}]}, {"GSM2352987": [{"title": "SUBJ.0158, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0158;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 46.9397260273972;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.32;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.153;\ttissue: Blood"}]}, {"GSM2352988": [{"title": "SUBJ.0158, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0158;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 46.9397260273972;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.32;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.153;\ttissue: Blood"}]}, {"GSM2352989": [{"title": "SUBJ.0158, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0158;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 46.9397260273972;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.32;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.153;\ttissue: Blood"}]}, {"GSM2352990": [{"title": "SUBJ.1496, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1496;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 46.7185792349726;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 125;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.902;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.101;\ttissue: Blood"}]}, {"GSM2352991": [{"title": "SUBJ.1496, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1496;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 46.7185792349726;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 125;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.902;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.101;\ttissue: Blood"}]}, {"GSM2352992": [{"title": "SUBJ.1496, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1496;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 46.7185792349726;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 125;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.902;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.101;\ttissue: Blood"}]}, {"GSM2352993": [{"title": "SUBJ.1135, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1135;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 48.0438356164383;\tregion: europe;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 148;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.76;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.067;\ttissue: Blood"}]}, {"GSM2352994": [{"title": "SUBJ.1135, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1135;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 48.0438356164383;\tregion: europe;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 148;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.76;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.067;\ttissue: Blood"}]}, {"GSM2352995": [{"title": "SUBJ.1135, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1135;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 48.0438356164383;\tregion: europe;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 148;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.76;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.067;\ttissue: Blood"}]}, {"GSM2352996": [{"title": "SUBJ.1639, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1639;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 18.8931506849315;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 51;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.04;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.216;\ttissue: Blood"}]}, {"GSM2352997": [{"title": "SUBJ.1639, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1639;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 18.8931506849315;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 51;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.04;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.216;\ttissue: Blood"}]}, {"GSM2352998": [{"title": "SUBJ.1639, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1639;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 18.8931506849315;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 51;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.04;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.216;\ttissue: Blood"}]}, {"GSM2352999": [{"title": "SUBJ.1459, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1459;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 42.6602739726027;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.7;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.287;\ttissue: Blood"}]}, {"GSM2353000": [{"title": "SUBJ.1459, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1459;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 42.6602739726027;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.7;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.287;\ttissue: Blood"}]}, {"GSM2353001": [{"title": "SUBJ.1459, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1459;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 42.6602739726027;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.7;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.287;\ttissue: Blood"}]}, {"GSM2353002": [{"title": "SUBJ.0127, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0127;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 45.7814207650273;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 102;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.796;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.186;\ttissue: Blood"}]}, {"GSM2353003": [{"title": "SUBJ.0127, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0127;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 45.7814207650273;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 102;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.796;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.186;\ttissue: Blood"}]}, {"GSM2353004": [{"title": "SUBJ.0127, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0127;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 45.7814207650273;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 102;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.796;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.186;\ttissue: Blood"}]}, {"GSM2353005": [{"title": "SUBJ.1105, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1105;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 50.9453551912568;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 110;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.589;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.088;\ttissue: Blood"}]}, {"GSM2353006": [{"title": "SUBJ.1105, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1105;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 50.9453551912568;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 110;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.589;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.088;\ttissue: Blood"}]}, {"GSM2353007": [{"title": "SUBJ.1105, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1105;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 50.9453551912568;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 110;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.589;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.088;\ttissue: Blood"}]}, {"GSM2353008": [{"title": "SUBJ.1107, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1107;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: multiple;\tSex: Female;\tage_at_baseline: 35.8054794520548;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 57;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.11;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.208;\ttissue: Blood"}]}, {"GSM2353009": [{"title": "SUBJ.1107, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1107;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: multiple;\tSex: Female;\tage_at_baseline: 35.8054794520548;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 57;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.11;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.208;\ttissue: Blood"}]}, {"GSM2353010": [{"title": "SUBJ.1107, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1107;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: multiple;\tSex: Female;\tage_at_baseline: 35.8054794520548;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 57;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.11;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.208;\ttissue: Blood"}]}, {"GSM2353011": [{"title": "SUBJ.0592, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0592;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 46.5506849315068;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.782;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.162;\ttissue: Blood"}]}, {"GSM2353012": [{"title": "SUBJ.0592, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0592;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 46.5506849315068;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.782;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.162;\ttissue: Blood"}]}, {"GSM2353013": [{"title": "SUBJ.0592, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0592;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 46.5506849315068;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.782;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.162;\ttissue: Blood"}]}, {"GSM2353014": [{"title": "SUBJ.1701, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1701;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 62.6830601092896;\tregion: europe;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 12;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.39;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.155;\ttissue: Blood"}]}, {"GSM2353015": [{"title": "SUBJ.1701, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1701;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 62.6830601092896;\tregion: europe;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 12;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.39;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.155;\ttissue: Blood"}]}, {"GSM2353016": [{"title": "SUBJ.1701, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1701;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 62.6830601092896;\tregion: europe;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 12;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.39;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.155;\ttissue: Blood"}]}, {"GSM2353017": [{"title": "SUBJ.1334, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1334;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 40.8551912568306;\tregion: europe;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.802;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.103;\ttissue: Blood"}]}, {"GSM2353018": [{"title": "SUBJ.1334, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1334;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 40.8551912568306;\tregion: europe;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.802;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.103;\ttissue: Blood"}]}, {"GSM2353019": [{"title": "SUBJ.1334, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1334;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 40.8551912568306;\tregion: europe;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.802;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.103;\ttissue: Blood"}]}, {"GSM2353020": [{"title": "SUBJ.0025, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0025;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 38.7923497267759;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 17;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.801;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.078;\ttissue: Blood"}]}, {"GSM2353021": [{"title": "SUBJ.0025, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0025;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 38.7923497267759;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 17;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.801;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.078;\ttissue: Blood"}]}, {"GSM2353022": [{"title": "SUBJ.0025, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0025;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 38.7923497267759;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 17;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.801;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.078;\ttissue: Blood"}]}, {"GSM2353023": [{"title": "SUBJ.1782, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1782;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 42.7213114754098;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 37;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.728;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.062;\ttissue: Blood"}]}, {"GSM2353024": [{"title": "SUBJ.1782, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1782;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 42.7213114754098;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 37;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.728;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.062;\ttissue: Blood"}]}, {"GSM2353025": [{"title": "SUBJ.1782, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1782;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 42.7213114754098;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 37;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.728;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.062;\ttissue: Blood"}]}, {"GSM2353026": [{"title": "SUBJ.1397, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1397;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 39.8547945205479;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 23;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.71;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.151;\ttissue: Blood"}]}, {"GSM2353027": [{"title": "SUBJ.1397, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1397;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 39.8547945205479;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 23;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.71;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.151;\ttissue: Blood"}]}, {"GSM2353028": [{"title": "SUBJ.1397, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1397;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 39.8547945205479;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 23;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.71;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.151;\ttissue: Blood"}]}, {"GSM2353029": [{"title": "SUBJ.0972, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0972;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 36.3616438356164;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.739;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.086;\ttissue: Blood"}]}, {"GSM2353030": [{"title": "SUBJ.0972, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0972;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 36.3616438356164;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.739;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.086;\ttissue: Blood"}]}, {"GSM2353031": [{"title": "SUBJ.0972, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0972;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 36.3616438356164;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.739;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.086;\ttissue: Blood"}]}, {"GSM2353032": [{"title": "SUBJ.0973, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0973;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 44.2986301369863;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.947;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.163;\ttissue: Blood"}]}, {"GSM2353033": [{"title": "SUBJ.0973, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0973;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 44.2986301369863;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.947;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.163;\ttissue: Blood"}]}, {"GSM2353034": [{"title": "SUBJ.0973, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0973;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 44.2986301369863;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.947;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.163;\ttissue: Blood"}]}, {"GSM2353035": [{"title": "SUBJ.1139, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1139;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 48.5150684931507;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 13;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.13;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.366;\ttissue: Blood"}]}, {"GSM2353036": [{"title": "SUBJ.1139, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1139;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 48.5150684931507;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 13;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.13;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.366;\ttissue: Blood"}]}, {"GSM2353037": [{"title": "SUBJ.1139, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1139;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 48.5150684931507;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 13;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.13;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.366;\ttissue: Blood"}]}, {"GSM2353038": [{"title": "SUBJ.1480, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1480;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 52.6520547945205;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 64;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.2;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.166;\ttissue: Blood"}]}, {"GSM2353039": [{"title": "SUBJ.1480, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1480;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 52.6520547945205;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 64;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.2;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.166;\ttissue: Blood"}]}, {"GSM2353040": [{"title": "SUBJ.1480, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1480;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 52.6520547945205;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 64;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.2;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.166;\ttissue: Blood"}]}, {"GSM2353041": [{"title": "SUBJ.0801, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0801;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 33.9071038251366;\tregion: europe;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.701;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.145;\ttissue: Blood"}]}, {"GSM2353042": [{"title": "SUBJ.0801, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0801;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 33.9071038251366;\tregion: europe;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.701;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.145;\ttissue: Blood"}]}, {"GSM2353043": [{"title": "SUBJ.0801, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0801;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 33.9071038251366;\tregion: europe;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.701;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.145;\ttissue: Blood"}]}, {"GSM2353044": [{"title": "SUBJ.1206, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1206;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 42.0273972602739;\tregion: us_can;\tsledai_at_baseline: 13;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 254;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.777;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.164;\ttissue: Blood"}]}, {"GSM2353045": [{"title": "SUBJ.1206, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1206;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 42.0273972602739;\tregion: us_can;\tsledai_at_baseline: 13;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 254;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.777;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.164;\ttissue: Blood"}]}, {"GSM2353046": [{"title": "SUBJ.1206, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1206;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 42.0273972602739;\tregion: us_can;\tsledai_at_baseline: 13;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 254;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.777;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.164;\ttissue: Blood"}]}, {"GSM2353047": [{"title": "SUBJ.1655, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1655;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 25.8770491803278;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.842;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.108;\ttissue: Blood"}]}, {"GSM2353048": [{"title": "SUBJ.1655, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1655;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 25.8770491803278;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.842;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.108;\ttissue: Blood"}]}, {"GSM2353049": [{"title": "SUBJ.1655, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1655;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 25.8770491803278;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.842;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.108;\ttissue: Blood"}]}, {"GSM2353050": [{"title": "SUBJ.0141, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0141;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 35.9672131147541;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 130;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.25;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.115;\ttissue: Blood"}]}, {"GSM2353051": [{"title": "SUBJ.0141, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0141;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 35.9672131147541;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 130;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.25;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.115;\ttissue: Blood"}]}, {"GSM2353052": [{"title": "SUBJ.0141, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0141;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 35.9672131147541;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 130;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.25;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.115;\ttissue: Blood"}]}, {"GSM2353053": [{"title": "SUBJ.1085, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1085;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 27.572602739726;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.31;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.243;\ttissue: Blood"}]}, {"GSM2353054": [{"title": "SUBJ.1085, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1085;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 27.572602739726;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.31;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.243;\ttissue: Blood"}]}, {"GSM2353055": [{"title": "SUBJ.1085, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1085;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 27.572602739726;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.31;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.243;\ttissue: Blood"}]}, {"GSM2353056": [{"title": "SUBJ.0104, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0104;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 53.9397260273972;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.25;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.142;\ttissue: Blood"}]}, {"GSM2353057": [{"title": "SUBJ.0104, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0104;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 53.9397260273972;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.25;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.142;\ttissue: Blood"}]}, {"GSM2353058": [{"title": "SUBJ.0104, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0104;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 53.9397260273972;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.25;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.142;\ttissue: Blood"}]}, {"GSM2353059": [{"title": "SUBJ.1562, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1562;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 44.4383561643835;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 15;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.44;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.203;\ttissue: Blood"}]}, {"GSM2353060": [{"title": "SUBJ.1562, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1562;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 44.4383561643835;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 15;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.44;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.203;\ttissue: Blood"}]}, {"GSM2353061": [{"title": "SUBJ.1265, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1265;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 51.5260273972602;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 60;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.532;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2353062": [{"title": "SUBJ.1265, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1265;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 51.5260273972602;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 60;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.532;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2353063": [{"title": "SUBJ.1265, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1265;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 51.5260273972602;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 60;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.532;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2353064": [{"title": "SUBJ.1009, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1009;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 32.9890410958904;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.46;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.195;\ttissue: Blood"}]}, {"GSM2353065": [{"title": "SUBJ.1009, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1009;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 32.9890410958904;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.46;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.195;\ttissue: Blood"}]}, {"GSM2353066": [{"title": "SUBJ.1009, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1009;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 32.9890410958904;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.46;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.195;\ttissue: Blood"}]}, {"GSM2353067": [{"title": "SUBJ.0175, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0175;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 40.5506849315068;\tregion: mex_ca_sa;\tsledai_at_baseline: 13;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.678;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.106;\ttissue: Blood"}]}, {"GSM2353068": [{"title": "SUBJ.0175, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0175;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 40.5506849315068;\tregion: mex_ca_sa;\tsledai_at_baseline: 13;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.678;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.106;\ttissue: Blood"}]}, {"GSM2353069": [{"title": "SUBJ.0175, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0175;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 40.5506849315068;\tregion: mex_ca_sa;\tsledai_at_baseline: 13;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.678;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.106;\ttissue: Blood"}]}, {"GSM2353070": [{"title": "SUBJ.0156, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0156;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.7950819672131;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.872;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.174;\ttissue: Blood"}]}, {"GSM2353071": [{"title": "SUBJ.0156, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0156;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.7950819672131;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.872;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.174;\ttissue: Blood"}]}, {"GSM2353072": [{"title": "SUBJ.0156, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0156;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.7950819672131;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.872;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.174;\ttissue: Blood"}]}, {"GSM2353073": [{"title": "SUBJ.1321, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1321;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 40.9342465753424;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.11;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.141;\ttissue: Blood"}]}, {"GSM2353074": [{"title": "SUBJ.1321, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1321;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 40.9342465753424;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.11;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.141;\ttissue: Blood"}]}, {"GSM2353075": [{"title": "SUBJ.1321, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1321;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 40.9342465753424;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.11;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.141;\ttissue: Blood"}]}, {"GSM2353076": [{"title": "SUBJ.1766, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1766;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 86.6967213114754;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 11;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.206;\ttissue: Blood"}]}, {"GSM2353077": [{"title": "SUBJ.1766, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1766;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 86.6967213114754;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 11;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.206;\ttissue: Blood"}]}, {"GSM2353078": [{"title": "SUBJ.1766, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1766;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 86.6967213114754;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 11;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.206;\ttissue: Blood"}]}, {"GSM2353079": [{"title": "SUBJ.0934, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0934;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 55.6657534246575;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.35;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.307;\ttissue: Blood"}]}, {"GSM2353080": [{"title": "SUBJ.0934, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0934;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 55.6657534246575;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.35;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.307;\ttissue: Blood"}]}, {"GSM2353081": [{"title": "SUBJ.0934, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0934;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 55.6657534246575;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.35;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.307;\ttissue: Blood"}]}, {"GSM2353082": [{"title": "SUBJ.0957, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0957;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 25.8497267759562;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 93;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.868;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.151;\ttissue: Blood"}]}, {"GSM2353083": [{"title": "SUBJ.0957, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0957;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 25.8497267759562;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 93;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.868;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.151;\ttissue: Blood"}]}, {"GSM2353084": [{"title": "SUBJ.0957, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0957;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 25.8497267759562;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 93;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.868;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.151;\ttissue: Blood"}]}, {"GSM2353085": [{"title": "SUBJ.1374, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1374;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 43.5506849315068;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 7;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.66;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.242;\ttissue: Blood"}]}, {"GSM2353086": [{"title": "SUBJ.1374, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1374;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 43.5506849315068;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 7;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.66;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.242;\ttissue: Blood"}]}, {"GSM2353087": [{"title": "SUBJ.1374, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1374;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 43.5506849315068;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 7;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.66;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.242;\ttissue: Blood"}]}, {"GSM2353088": [{"title": "SUBJ.0370, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0370;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 48.2602739726027;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 20;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.896;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.135;\ttissue: Blood"}]}, {"GSM2353089": [{"title": "SUBJ.0370, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0370;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 48.2602739726027;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 20;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.896;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.135;\ttissue: Blood"}]}, {"GSM2353090": [{"title": "SUBJ.0370, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0370;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 48.2602739726027;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 20;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.896;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.135;\ttissue: Blood"}]}, {"GSM2353091": [{"title": "SUBJ.0344, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0344;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 65.811475409836;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.134;\ttissue: Blood"}]}, {"GSM2353092": [{"title": "SUBJ.0344, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0344;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 65.811475409836;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.134;\ttissue: Blood"}]}, {"GSM2353093": [{"title": "SUBJ.0344, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0344;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 65.811475409836;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.134;\ttissue: Blood"}]}, {"GSM2353094": [{"title": "SUBJ.0725, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0725;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 27.0109589041095;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 176;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.956;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.099;\ttissue: Blood"}]}, {"GSM2353095": [{"title": "SUBJ.0725, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0725;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 27.0109589041095;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 176;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.956;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.099;\ttissue: Blood"}]}, {"GSM2353096": [{"title": "SUBJ.0725, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0725;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 27.0109589041095;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 176;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.956;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.099;\ttissue: Blood"}]}, {"GSM2353097": [{"title": "SUBJ.0009, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0009;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 43.0849315068493;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 106;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.971;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.183;\ttissue: Blood"}]}, {"GSM2353098": [{"title": "SUBJ.0009, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0009;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 43.0849315068493;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 106;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.971;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.183;\ttissue: Blood"}]}, {"GSM2353099": [{"title": "SUBJ.0009, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0009;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 43.0849315068493;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 106;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.971;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.183;\ttissue: Blood"}]}, {"GSM2353100": [{"title": "SUBJ.1377, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1377;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 45.9098360655737;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 11;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.953;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.232;\ttissue: Blood"}]}, {"GSM2353101": [{"title": "SUBJ.1377, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1377;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 45.9098360655737;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 11;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.953;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.232;\ttissue: Blood"}]}, {"GSM2353102": [{"title": "SUBJ.1377, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1377;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 45.9098360655737;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 11;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.953;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.232;\ttissue: Blood"}]}, {"GSM2353103": [{"title": "SUBJ.0661, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0661;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 48.8383561643835;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 22;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.66;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.079;\ttissue: Blood"}]}, {"GSM2353104": [{"title": "SUBJ.0661, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0661;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 48.8383561643835;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 22;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.66;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.079;\ttissue: Blood"}]}, {"GSM2353105": [{"title": "SUBJ.0661, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0661;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 48.8383561643835;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 22;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.66;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.079;\ttissue: Blood"}]}, {"GSM2353106": [{"title": "SUBJ.1414, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1414;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 34.6219178082191;\tregion: us_can;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): H;\tc3_at_baseline (g/l): 1.84;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.375;\ttissue: Blood"}]}, {"GSM2353107": [{"title": "SUBJ.1414, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1414;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 34.6219178082191;\tregion: us_can;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): H;\tc3_at_baseline (g/l): 1.84;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.375;\ttissue: Blood"}]}, {"GSM2353108": [{"title": "SUBJ.1414, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1414;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 34.6219178082191;\tregion: us_can;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): H;\tc3_at_baseline (g/l): 1.84;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.375;\ttissue: Blood"}]}, {"GSM2353109": [{"title": "SUBJ.0134, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0134;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 55.8465753424657;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.26;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.268;\ttissue: Blood"}]}, {"GSM2353110": [{"title": "SUBJ.0134, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0134;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 55.8465753424657;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.26;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.268;\ttissue: Blood"}]}, {"GSM2353111": [{"title": "SUBJ.0134, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0134;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 55.8465753424657;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.26;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.268;\ttissue: Blood"}]}, {"GSM2353112": [{"title": "SUBJ.0371, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0371;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 57.6666666666666;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.962;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.253;\ttissue: Blood"}]}, {"GSM2353113": [{"title": "SUBJ.0371, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0371;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 57.6666666666666;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.962;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.253;\ttissue: Blood"}]}, {"GSM2353114": [{"title": "SUBJ.0371, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0371;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 57.6666666666666;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.962;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.253;\ttissue: Blood"}]}, {"GSM2353115": [{"title": "SUBJ.1051, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1051;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 45.775956284153;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 13;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.24;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.148;\ttissue: Blood"}]}, {"GSM2353116": [{"title": "SUBJ.1051, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1051;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 45.775956284153;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 13;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.24;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.148;\ttissue: Blood"}]}, {"GSM2353117": [{"title": "SUBJ.1051, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1051;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 45.775956284153;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 13;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.24;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.148;\ttissue: Blood"}]}, {"GSM2353118": [{"title": "SUBJ.1440, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1440;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 39.8551912568306;\tregion: europe;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.11;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.21;\ttissue: Blood"}]}, {"GSM2353119": [{"title": "SUBJ.1440, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1440;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 39.8551912568306;\tregion: europe;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.11;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.21;\ttissue: Blood"}]}, {"GSM2353120": [{"title": "SUBJ.1440, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1440;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 39.8551912568306;\tregion: europe;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.11;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.21;\ttissue: Blood"}]}, {"GSM2353121": [{"title": "SUBJ.1236, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1236;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 49.7732240437158;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 114;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.07;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.183;\ttissue: Blood"}]}, {"GSM2353122": [{"title": "SUBJ.1236, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1236;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 49.7732240437158;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 114;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.07;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.183;\ttissue: Blood"}]}, {"GSM2353123": [{"title": "SUBJ.1236, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1236;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 49.7732240437158;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 114;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.07;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.183;\ttissue: Blood"}]}, {"GSM2353124": [{"title": "SUBJ.1689, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1689;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 36.9726775956284;\tregion: us_can;\tsledai_at_baseline: 7;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 117;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.958;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.148;\ttissue: Blood"}]}, {"GSM2353125": [{"title": "SUBJ.1689, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1689;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 36.9726775956284;\tregion: us_can;\tsledai_at_baseline: 7;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 117;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.958;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.148;\ttissue: Blood"}]}, {"GSM2353126": [{"title": "SUBJ.1689, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1689;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 36.9726775956284;\tregion: us_can;\tsledai_at_baseline: 7;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 117;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.958;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.148;\ttissue: Blood"}]}, {"GSM2353127": [{"title": "SUBJ.0899, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0899;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 38.1068493150685;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 13;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.61;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.475;\ttissue: Blood"}]}, {"GSM2353128": [{"title": "SUBJ.0899, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0899;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 38.1068493150685;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 13;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.61;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.475;\ttissue: Blood"}]}, {"GSM2353129": [{"title": "SUBJ.0899, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0899;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 38.1068493150685;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 13;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.61;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.475;\ttissue: Blood"}]}, {"GSM2353130": [{"title": "SUBJ.1308, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1308;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 34.4109589041095;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 66;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.896;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.124;\ttissue: Blood"}]}, {"GSM2353131": [{"title": "SUBJ.1308, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1308;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 34.4109589041095;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 66;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.896;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.124;\ttissue: Blood"}]}, {"GSM2353132": [{"title": "SUBJ.1308, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1308;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 34.4109589041095;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 66;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.896;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.124;\ttissue: Blood"}]}, {"GSM2353133": [{"title": "SUBJ.0252, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0252;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 59.8438356164383;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 61;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.29;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.283;\ttissue: Blood"}]}, {"GSM2353134": [{"title": "SUBJ.0252, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0252;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 59.8438356164383;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 61;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.29;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.283;\ttissue: Blood"}]}, {"GSM2353135": [{"title": "SUBJ.0252, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0252;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 59.8438356164383;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 61;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.29;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.283;\ttissue: Blood"}]}, {"GSM2353136": [{"title": "SUBJ.0694, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0694;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 33.7786885245901;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.729;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.084;\ttissue: Blood"}]}, {"GSM2353137": [{"title": "SUBJ.0694, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0694;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 33.7786885245901;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.729;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.084;\ttissue: Blood"}]}, {"GSM2353138": [{"title": "SUBJ.0810, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0810;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 49.6958904109589;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.11;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.218;\ttissue: Blood"}]}, {"GSM2353139": [{"title": "SUBJ.0810, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0810;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 49.6958904109589;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.11;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.218;\ttissue: Blood"}]}, {"GSM2353140": [{"title": "SUBJ.0810, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0810;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 49.6958904109589;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.11;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.218;\ttissue: Blood"}]}, {"GSM2353141": [{"title": "SUBJ.0806, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0806;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 46.8958904109589;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 38;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.97;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.337;\ttissue: Blood"}]}, {"GSM2353142": [{"title": "SUBJ.0806, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0806;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 46.8958904109589;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 38;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.97;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.337;\ttissue: Blood"}]}, {"GSM2353143": [{"title": "SUBJ.0806, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0806;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 46.8958904109589;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 38;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.97;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.337;\ttissue: Blood"}]}, {"GSM2353144": [{"title": "SUBJ.0947, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0947;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 42.811475409836;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 124;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.252;\ttissue: Blood"}]}, {"GSM2353145": [{"title": "SUBJ.0947, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0947;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 42.811475409836;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 124;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.252;\ttissue: Blood"}]}, {"GSM2353146": [{"title": "SUBJ.0947, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0947;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 42.811475409836;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 124;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.252;\ttissue: Blood"}]}, {"GSM2353147": [{"title": "SUBJ.0063, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0063;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 42.8497267759562;\tregion: europe;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 50;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.772;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.203;\ttissue: Blood"}]}, {"GSM2353148": [{"title": "SUBJ.0063, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0063;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 42.8497267759562;\tregion: europe;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 50;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.772;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.203;\ttissue: Blood"}]}, {"GSM2353149": [{"title": "SUBJ.0063, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0063;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 42.8497267759562;\tregion: europe;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 50;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.772;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.203;\ttissue: Blood"}]}, {"GSM2353150": [{"title": "SUBJ.1121, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1121;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 48.6054794520548;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 120;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.15;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.235;\ttissue: Blood"}]}, {"GSM2353151": [{"title": "SUBJ.1121, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1121;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 48.6054794520548;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 120;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.15;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.235;\ttissue: Blood"}]}, {"GSM2353152": [{"title": "SUBJ.1121, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1121;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 48.6054794520548;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 120;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.15;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.235;\ttissue: Blood"}]}, {"GSM2353153": [{"title": "SUBJ.1419, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1419;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 46.972602739726;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 15;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): H;\tc3_at_baseline (g/l): 1.98;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.392;\ttissue: Blood"}]}, {"GSM2353154": [{"title": "SUBJ.1419, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1419;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 46.972602739726;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 15;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): H;\tc3_at_baseline (g/l): 1.98;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.392;\ttissue: Blood"}]}, {"GSM2353155": [{"title": "SUBJ.0931, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0931;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 33.1890410958904;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.45;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.243;\ttissue: Blood"}]}, {"GSM2353156": [{"title": "SUBJ.0931, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0931;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 33.1890410958904;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.45;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.243;\ttissue: Blood"}]}, {"GSM2353157": [{"title": "SUBJ.0931, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0931;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 33.1890410958904;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.45;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.243;\ttissue: Blood"}]}, {"GSM2353158": [{"title": "SUBJ.0640, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0640;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 45.0931506849315;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 61;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.685;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.1;\ttissue: Blood"}]}, {"GSM2353159": [{"title": "SUBJ.0640, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0640;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 45.0931506849315;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 61;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.685;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.1;\ttissue: Blood"}]}, {"GSM2353160": [{"title": "SUBJ.0640, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0640;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 45.0931506849315;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 61;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.685;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.1;\ttissue: Blood"}]}, {"GSM2353161": [{"title": "SUBJ.1277, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1277;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 52.4219178082191;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 20;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.19;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.164;\ttissue: Blood"}]}, {"GSM2353162": [{"title": "SUBJ.1277, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1277;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 52.4219178082191;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 20;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.19;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.164;\ttissue: Blood"}]}, {"GSM2353163": [{"title": "SUBJ.1277, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1277;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 52.4219178082191;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 20;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.19;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.164;\ttissue: Blood"}]}, {"GSM2353164": [{"title": "SUBJ.1282, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1282;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.9945355191256;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 14;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.74;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.409;\ttissue: Blood"}]}, {"GSM2353165": [{"title": "SUBJ.1282, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1282;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.9945355191256;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 14;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.74;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.409;\ttissue: Blood"}]}, {"GSM2353166": [{"title": "SUBJ.1282, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1282;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.9945355191256;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 14;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.74;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.409;\ttissue: Blood"}]}, {"GSM2353167": [{"title": "SUBJ.1254, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1254;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 53.5506849315068;\tregion: europe;\tsledai_at_baseline: 24;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 37;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.08;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.234;\ttissue: Blood"}]}, {"GSM2353168": [{"title": "SUBJ.1254, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1254;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 53.5506849315068;\tregion: europe;\tsledai_at_baseline: 24;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 37;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.08;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.234;\ttissue: Blood"}]}, {"GSM2353169": [{"title": "SUBJ.0310, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0310;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 30.6803278688524;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.17;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.169;\ttissue: Blood"}]}, {"GSM2353170": [{"title": "SUBJ.0310, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0310;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 30.6803278688524;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.17;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.169;\ttissue: Blood"}]}, {"GSM2353171": [{"title": "SUBJ.0310, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0310;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 30.6803278688524;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.17;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.169;\ttissue: Blood"}]}, {"GSM2353172": [{"title": "SUBJ.0260, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0260;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 62.2383561643835;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.12;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.246;\ttissue: Blood"}]}, {"GSM2353173": [{"title": "SUBJ.0920, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0920;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 42.983606557377;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.495;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.076;\ttissue: Blood"}]}, {"GSM2353174": [{"title": "SUBJ.0920, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0920;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 42.983606557377;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.495;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.076;\ttissue: Blood"}]}, {"GSM2353175": [{"title": "SUBJ.0920, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0920;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 42.983606557377;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.495;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.076;\ttissue: Blood"}]}, {"GSM2353176": [{"title": "SUBJ.1299, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1299;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 53.0739726027397;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 251;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.83;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.103;\ttissue: Blood"}]}, {"GSM2353177": [{"title": "SUBJ.1299, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1299;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 53.0739726027397;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 251;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.83;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.103;\ttissue: Blood"}]}, {"GSM2353178": [{"title": "SUBJ.1299, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1299;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 53.0739726027397;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 251;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.83;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.103;\ttissue: Blood"}]}, {"GSM2353179": [{"title": "SUBJ.0454, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0454;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 30.6994535519125;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 150;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.521;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.123;\ttissue: Blood"}]}, {"GSM2353180": [{"title": "SUBJ.0454, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0454;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 30.6994535519125;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 150;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.521;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.123;\ttissue: Blood"}]}, {"GSM2353181": [{"title": "SUBJ.0454, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0454;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 30.6994535519125;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 150;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.521;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.123;\ttissue: Blood"}]}, {"GSM2353182": [{"title": "SUBJ.0603, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0603;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 23.9672131147541;\tregion: europe;\tsledai_at_baseline: 7;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 47;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.191;\ttissue: Blood"}]}, {"GSM2353183": [{"title": "SUBJ.0603, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0603;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 23.9672131147541;\tregion: europe;\tsledai_at_baseline: 7;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 47;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.191;\ttissue: Blood"}]}, {"GSM2353184": [{"title": "SUBJ.0603, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0603;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 23.9672131147541;\tregion: europe;\tsledai_at_baseline: 7;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 47;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.191;\ttissue: Blood"}]}, {"GSM2353185": [{"title": "SUBJ.0015, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0015;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 59.9534246575342;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.802;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.147;\ttissue: Blood"}]}, {"GSM2353186": [{"title": "SUBJ.0015, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0015;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 59.9534246575342;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.802;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.147;\ttissue: Blood"}]}, {"GSM2353187": [{"title": "SUBJ.0015, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0015;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 59.9534246575342;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.802;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.147;\ttissue: Blood"}]}, {"GSM2353188": [{"title": "SUBJ.1160, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1160;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 64.7835616438356;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.33;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.21;\ttissue: Blood"}]}, {"GSM2353189": [{"title": "SUBJ.1160, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1160;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 64.7835616438356;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.33;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.21;\ttissue: Blood"}]}, {"GSM2353190": [{"title": "SUBJ.1160, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1160;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 64.7835616438356;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.33;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.21;\ttissue: Blood"}]}, {"GSM2353191": [{"title": "SUBJ.0833, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0833;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 40.131506849315;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.809;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.404;\ttissue: Blood"}]}, {"GSM2353192": [{"title": "SUBJ.0833, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0833;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 40.131506849315;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.809;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.404;\ttissue: Blood"}]}, {"GSM2353193": [{"title": "SUBJ.0833, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0833;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 40.131506849315;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.809;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.404;\ttissue: Blood"}]}, {"GSM2353194": [{"title": "SUBJ.0254, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0254;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 47.2027397260274;\tregion: us_can;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 129;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.12;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.155;\ttissue: Blood"}]}, {"GSM2353195": [{"title": "SUBJ.0254, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0254;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 47.2027397260274;\tregion: us_can;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 129;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.12;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.155;\ttissue: Blood"}]}, {"GSM2353196": [{"title": "SUBJ.0254, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0254;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 47.2027397260274;\tregion: us_can;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 129;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.12;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.155;\ttissue: Blood"}]}, {"GSM2353197": [{"title": "SUBJ.0299, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0299;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 26.6602739726027;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 127;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.898;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.158;\ttissue: Blood"}]}, {"GSM2353198": [{"title": "SUBJ.0299, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0299;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 26.6602739726027;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 127;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.898;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.158;\ttissue: Blood"}]}, {"GSM2353199": [{"title": "SUBJ.0299, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0299;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 26.6602739726027;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 127;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.898;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.158;\ttissue: Blood"}]}, {"GSM2353200": [{"title": "SUBJ.0203, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0203;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 34.4520547945205;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.14;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.187;\ttissue: Blood"}]}, {"GSM2353201": [{"title": "SUBJ.0203, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0203;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 34.4520547945205;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.14;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.187;\ttissue: Blood"}]}, {"GSM2353202": [{"title": "SUBJ.0203, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0203;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 34.4520547945205;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.14;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.187;\ttissue: Blood"}]}, {"GSM2353203": [{"title": "SUBJ.0999, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0999;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 45.6821917808219;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.7;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.4;\ttissue: Blood"}]}, {"GSM2353204": [{"title": "SUBJ.0999, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0999;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 45.6821917808219;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.7;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.4;\ttissue: Blood"}]}, {"GSM2353205": [{"title": "SUBJ.0999, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0999;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 45.6821917808219;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.7;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.4;\ttissue: Blood"}]}, {"GSM2353206": [{"title": "SUBJ.1492, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1492;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.6191780821917;\tregion: europe;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.15;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.159;\ttissue: Blood"}]}, {"GSM2353207": [{"title": "SUBJ.1492, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1492;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.6191780821917;\tregion: europe;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.15;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.159;\ttissue: Blood"}]}, {"GSM2353208": [{"title": "SUBJ.1492, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1492;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.6191780821917;\tregion: europe;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.15;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.159;\ttissue: Blood"}]}, {"GSM2353209": [{"title": "SUBJ.0579, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0579;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 39.6639344262295;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 197;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.823;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.13;\ttissue: Blood"}]}, {"GSM2353210": [{"title": "SUBJ.0579, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0579;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 39.6639344262295;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 197;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.823;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.13;\ttissue: Blood"}]}, {"GSM2353211": [{"title": "SUBJ.0579, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0579;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 39.6639344262295;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 197;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.823;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.13;\ttissue: Blood"}]}, {"GSM2353212": [{"title": "SUBJ.1686, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1686;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 37.7978142076502;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.673;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.112;\ttissue: Blood"}]}, {"GSM2353213": [{"title": "SUBJ.1686, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1686;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 37.7978142076502;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.673;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.112;\ttissue: Blood"}]}, {"GSM2353214": [{"title": "SUBJ.1686, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1686;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 37.7978142076502;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.673;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.112;\ttissue: Blood"}]}, {"GSM2353215": [{"title": "SUBJ.1773, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1773;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 62.5917808219178;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.06;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.16;\ttissue: Blood"}]}, {"GSM2353216": [{"title": "SUBJ.1773, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1773;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 62.5917808219178;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.06;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.16;\ttissue: Blood"}]}, {"GSM2353217": [{"title": "SUBJ.1773, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1773;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 62.5917808219178;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.06;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.16;\ttissue: Blood"}]}, {"GSM2353218": [{"title": "SUBJ.0489, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0489;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 43.8958904109589;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 41;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.814;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.241;\ttissue: Blood"}]}, {"GSM2353219": [{"title": "SUBJ.0489, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0489;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 43.8958904109589;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 41;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.814;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.241;\ttissue: Blood"}]}, {"GSM2353220": [{"title": "SUBJ.0489, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0489;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 43.8958904109589;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 41;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.814;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.241;\ttissue: Blood"}]}, {"GSM2353221": [{"title": "SUBJ.0897, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0897;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 25.3780821917808;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.09;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.362;\ttissue: Blood"}]}, {"GSM2353222": [{"title": "SUBJ.0897, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0897;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 25.3780821917808;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.09;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.362;\ttissue: Blood"}]}, {"GSM2353223": [{"title": "SUBJ.0897, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0897;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 25.3780821917808;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.09;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.362;\ttissue: Blood"}]}, {"GSM2353224": [{"title": "SUBJ.0688, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0688;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 31.9480874316939;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 63;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.36;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.258;\ttissue: Blood"}]}, {"GSM2353225": [{"title": "SUBJ.0688, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0688;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 31.9480874316939;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 63;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.36;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.258;\ttissue: Blood"}]}, {"GSM2353226": [{"title": "SUBJ.0688, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0688;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 31.9480874316939;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 63;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.36;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.258;\ttissue: Blood"}]}, {"GSM2353227": [{"title": "SUBJ.0645, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0645;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 42.9071038251366;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.816;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2353228": [{"title": "SUBJ.0645, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0645;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 42.9071038251366;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.816;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2353229": [{"title": "SUBJ.1612, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1612;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 36.8333333333333;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.81;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.162;\ttissue: Blood"}]}, {"GSM2353230": [{"title": "SUBJ.1612, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1612;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 36.8333333333333;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.81;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.162;\ttissue: Blood"}]}, {"GSM2353231": [{"title": "SUBJ.1612, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1612;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 36.8333333333333;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.81;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.162;\ttissue: Blood"}]}, {"GSM2353232": [{"title": "SUBJ.0061, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0061;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: asian;\tSex: Female;\tage_at_baseline: 61.0328767123287;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 47;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.24;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.286;\ttissue: Blood"}]}, {"GSM2353233": [{"title": "SUBJ.0061, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0061;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: asian;\tSex: Female;\tage_at_baseline: 61.0328767123287;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 47;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.24;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.286;\ttissue: Blood"}]}, {"GSM2353234": [{"title": "SUBJ.0061, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0061;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: asian;\tSex: Female;\tage_at_baseline: 61.0328767123287;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 47;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.24;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.286;\ttissue: Blood"}]}, {"GSM2353235": [{"title": "SUBJ.1111, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1111;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.5616438356164;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 38;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.36;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.213;\ttissue: Blood"}]}, {"GSM2353236": [{"title": "SUBJ.1111, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1111;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.5616438356164;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 38;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.36;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.213;\ttissue: Blood"}]}, {"GSM2353237": [{"title": "SUBJ.1111, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1111;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.5616438356164;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 38;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.36;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.213;\ttissue: Blood"}]}, {"GSM2353238": [{"title": "SUBJ.1203, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1203;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 18.7377049180327;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.775;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.088;\ttissue: Blood"}]}, {"GSM2353239": [{"title": "SUBJ.1203, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1203;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 18.7377049180327;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.775;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.088;\ttissue: Blood"}]}, {"GSM2353240": [{"title": "SUBJ.1203, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1203;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 18.7377049180327;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.775;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.088;\ttissue: Blood"}]}, {"GSM2353241": [{"title": "SUBJ.1421, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1421;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 31.9262295081967;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.21;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.187;\ttissue: Blood"}]}, {"GSM2353242": [{"title": "SUBJ.1421, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1421;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 31.9262295081967;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.21;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.187;\ttissue: Blood"}]}, {"GSM2353243": [{"title": "SUBJ.1421, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1421;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 31.9262295081967;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.21;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.187;\ttissue: Blood"}]}, {"GSM2353244": [{"title": "SUBJ.0885, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0885;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: multiple;\tSex: Female;\tage_at_baseline: 19.4328767123287;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 190;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.03;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.191;\ttissue: Blood"}]}, {"GSM2353245": [{"title": "SUBJ.0885, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0885;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: multiple;\tSex: Female;\tage_at_baseline: 19.4328767123287;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 190;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.03;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.191;\ttissue: Blood"}]}, {"GSM2353246": [{"title": "SUBJ.0885, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0885;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: multiple;\tSex: Female;\tage_at_baseline: 19.4328767123287;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 190;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.03;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.191;\ttissue: Blood"}]}, {"GSM2353247": [{"title": "SUBJ.1340, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1340;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 47.8547945205479;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.831;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.108;\ttissue: Blood"}]}, {"GSM2353248": [{"title": "SUBJ.1340, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1340;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 47.8547945205479;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.831;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.108;\ttissue: Blood"}]}, {"GSM2353249": [{"title": "SUBJ.1340, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1340;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 47.8547945205479;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.831;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.108;\ttissue: Blood"}]}, {"GSM2353250": [{"title": "SUBJ.0792, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0792;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 37.8989071038251;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 100;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.847;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.21;\ttissue: Blood"}]}, {"GSM2353251": [{"title": "SUBJ.0792, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0792;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 37.8989071038251;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 100;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.847;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.21;\ttissue: Blood"}]}, {"GSM2353252": [{"title": "SUBJ.0792, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0792;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 37.8989071038251;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 100;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.847;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.21;\ttissue: Blood"}]}, {"GSM2353253": [{"title": "SUBJ.0821, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0821;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 53.2082191780822;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 11;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.663;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.104;\ttissue: Blood"}]}, {"GSM2353254": [{"title": "SUBJ.0821, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0821;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 53.2082191780822;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 11;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.663;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.104;\ttissue: Blood"}]}, {"GSM2353255": [{"title": "SUBJ.0821, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0821;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 53.2082191780822;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 11;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.663;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.104;\ttissue: Blood"}]}, {"GSM2353256": [{"title": "SUBJ.0428, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0428;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 39.2767123287671;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 184;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.63;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.074;\ttissue: Blood"}]}, {"GSM2353257": [{"title": "SUBJ.0428, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0428;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 39.2767123287671;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 184;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.63;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.074;\ttissue: Blood"}]}, {"GSM2353258": [{"title": "SUBJ.0428, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0428;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 39.2767123287671;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 184;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.63;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.074;\ttissue: Blood"}]}, {"GSM2353259": [{"title": "SUBJ.0720, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0720;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 25.9753424657534;\tregion: us_can;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 111;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.706;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.158;\ttissue: Blood"}]}, {"GSM2353260": [{"title": "SUBJ.0720, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0720;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 25.9753424657534;\tregion: us_can;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 111;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.706;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.158;\ttissue: Blood"}]}, {"GSM2353261": [{"title": "SUBJ.0720, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0720;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 25.9753424657534;\tregion: us_can;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 111;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.706;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.158;\ttissue: Blood"}]}, {"GSM2353262": [{"title": "SUBJ.0133, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0133;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 29.3397260273972;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.759;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.243;\ttissue: Blood"}]}, {"GSM2353263": [{"title": "SUBJ.0133, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0133;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 29.3397260273972;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.759;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.243;\ttissue: Blood"}]}, {"GSM2353264": [{"title": "SUBJ.0133, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0133;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 29.3397260273972;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.759;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.243;\ttissue: Blood"}]}, {"GSM2353265": [{"title": "SUBJ.1294, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1294;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 36.8169398907103;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 114;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.798;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.144;\ttissue: Blood"}]}, {"GSM2353266": [{"title": "SUBJ.1294, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1294;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 36.8169398907103;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 114;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.798;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.144;\ttissue: Blood"}]}, {"GSM2353267": [{"title": "SUBJ.1294, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1294;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 36.8169398907103;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 114;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.798;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.144;\ttissue: Blood"}]}, {"GSM2353268": [{"title": "SUBJ.0292, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0292;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 20.8821917808219;\tregion: us_can;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.27;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.221;\ttissue: Blood"}]}, {"GSM2353269": [{"title": "SUBJ.0292, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0292;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 20.8821917808219;\tregion: us_can;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.27;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.221;\ttissue: Blood"}]}, {"GSM2353270": [{"title": "SUBJ.0292, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0292;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 20.8821917808219;\tregion: us_can;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.27;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.221;\ttissue: Blood"}]}, {"GSM2353271": [{"title": "SUBJ.1084, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1084;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 46.3534246575342;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.26;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.264;\ttissue: Blood"}]}, {"GSM2353272": [{"title": "SUBJ.1084, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1084;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 46.3534246575342;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.26;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.264;\ttissue: Blood"}]}, {"GSM2353273": [{"title": "SUBJ.1084, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1084;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 46.3534246575342;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.26;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.264;\ttissue: Blood"}]}, {"GSM2353274": [{"title": "SUBJ.0364, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0364;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 20.3917808219178;\tregion: us_can;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.03;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.088;\ttissue: Blood"}]}, {"GSM2353275": [{"title": "SUBJ.0364, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0364;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 20.3917808219178;\tregion: us_can;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.03;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.088;\ttissue: Blood"}]}, {"GSM2353276": [{"title": "SUBJ.0364, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0364;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 20.3917808219178;\tregion: us_can;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.03;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.088;\ttissue: Blood"}]}, {"GSM2353277": [{"title": "SUBJ.1687, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1687;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 45.724043715847;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.4;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.231;\ttissue: Blood"}]}, {"GSM2353278": [{"title": "SUBJ.1687, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1687;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 45.724043715847;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.4;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.231;\ttissue: Blood"}]}, {"GSM2353279": [{"title": "SUBJ.1687, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1687;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 45.724043715847;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.4;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.231;\ttissue: Blood"}]}, {"GSM2353280": [{"title": "SUBJ.1222, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1222;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 66.7622950819672;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 18;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.967;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.189;\ttissue: Blood"}]}, {"GSM2353281": [{"title": "SUBJ.1222, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1222;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 66.7622950819672;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 18;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.967;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.189;\ttissue: Blood"}]}, {"GSM2353282": [{"title": "SUBJ.1222, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1222;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 66.7622950819672;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 18;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.967;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.189;\ttissue: Blood"}]}, {"GSM2353283": [{"title": "SUBJ.1806, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1806;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 51.7404371584699;\tregion: us_can;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 24;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.17;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.171;\ttissue: Blood"}]}, {"GSM2353284": [{"title": "SUBJ.1806, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1806;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 51.7404371584699;\tregion: us_can;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 24;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.17;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.171;\ttissue: Blood"}]}, {"GSM2353285": [{"title": "SUBJ.1806, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1806;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 51.7404371584699;\tregion: us_can;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 24;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.17;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.171;\ttissue: Blood"}]}, {"GSM2353286": [{"title": "SUBJ.1543, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1543;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 47.6082191780822;\tregion: us_can;\tsledai_at_baseline: 13;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 74;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.03;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.38;\ttissue: Blood"}]}, {"GSM2353287": [{"title": "SUBJ.1543, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1543;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 47.6082191780822;\tregion: us_can;\tsledai_at_baseline: 13;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 74;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.03;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.38;\ttissue: Blood"}]}, {"GSM2353288": [{"title": "SUBJ.1543, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1543;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 47.6082191780822;\tregion: us_can;\tsledai_at_baseline: 13;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 74;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.03;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.38;\ttissue: Blood"}]}, {"GSM2353289": [{"title": "SUBJ.0660, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0660;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 51.9699453551912;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.45;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.249;\ttissue: Blood"}]}, {"GSM2353290": [{"title": "SUBJ.0660, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0660;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 51.9699453551912;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.45;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.249;\ttissue: Blood"}]}, {"GSM2353291": [{"title": "SUBJ.0660, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0660;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 51.9699453551912;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.45;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.249;\ttissue: Blood"}]}, {"GSM2353292": [{"title": "SUBJ.0056, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0056;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 28.1616438356164;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 97;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.01;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.163;\ttissue: Blood"}]}, {"GSM2353293": [{"title": "SUBJ.0056, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0056;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 28.1616438356164;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 97;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.01;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.163;\ttissue: Blood"}]}, {"GSM2353294": [{"title": "SUBJ.0056, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0056;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 28.1616438356164;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 97;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.01;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.163;\ttissue: Blood"}]}, {"GSM2353295": [{"title": "SUBJ.0528, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0528;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 58.7232876712328;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.84;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2353296": [{"title": "SUBJ.0528, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0528;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 58.7232876712328;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.84;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2353297": [{"title": "SUBJ.0528, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0528;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 58.7232876712328;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.84;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2353298": [{"title": "SUBJ.1522, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1522;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 35.775956284153;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.05;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.171;\ttissue: Blood"}]}, {"GSM2353299": [{"title": "SUBJ.1522, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1522;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 35.775956284153;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.05;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.171;\ttissue: Blood"}]}, {"GSM2353300": [{"title": "SUBJ.1522, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1522;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 35.775956284153;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.05;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.171;\ttissue: Blood"}]}, {"GSM2353301": [{"title": "SUBJ.0233, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0233;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 46.8164383561643;\tregion: us_can;\tsledai_at_baseline: 23;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.478;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2353302": [{"title": "SUBJ.0233, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0233;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 46.8164383561643;\tregion: us_can;\tsledai_at_baseline: 23;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.478;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2353303": [{"title": "SUBJ.0233, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0233;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 46.8164383561643;\tregion: us_can;\tsledai_at_baseline: 23;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.478;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2353304": [{"title": "SUBJ.0942, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0942;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 31.1698630136986;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 39;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.75;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.341;\ttissue: Blood"}]}, {"GSM2353305": [{"title": "SUBJ.0942, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0942;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 31.1698630136986;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 39;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.75;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.341;\ttissue: Blood"}]}, {"GSM2353306": [{"title": "SUBJ.0942, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0942;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 31.1698630136986;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 39;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.75;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.341;\ttissue: Blood"}]}, {"GSM2353307": [{"title": "SUBJ.1081, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1081;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 69.4575342465753;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.15;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.158;\ttissue: Blood"}]}, {"GSM2353308": [{"title": "SUBJ.1081, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1081;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 69.4575342465753;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.15;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.158;\ttissue: Blood"}]}, {"GSM2353309": [{"title": "SUBJ.1081, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1081;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 69.4575342465753;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.15;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.158;\ttissue: Blood"}]}, {"GSM2353310": [{"title": "SUBJ.1565, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1565;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 42.8054794520548;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 25;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.943;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.214;\ttissue: Blood"}]}, {"GSM2353311": [{"title": "SUBJ.1565, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1565;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 42.8054794520548;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 25;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.943;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.214;\ttissue: Blood"}]}, {"GSM2353312": [{"title": "SUBJ.1565, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1565;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 42.8054794520548;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 25;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.943;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.214;\ttissue: Blood"}]}, {"GSM2353313": [{"title": "SUBJ.1278, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1278;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 50.9125683060109;\tregion: mex_ca_sa;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 15;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.707;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.135;\ttissue: Blood"}]}, {"GSM2353314": [{"title": "SUBJ.1278, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1278;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 50.9125683060109;\tregion: mex_ca_sa;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 15;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.707;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.135;\ttissue: Blood"}]}, {"GSM2353315": [{"title": "SUBJ.1278, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1278;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 50.9125683060109;\tregion: mex_ca_sa;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 15;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.707;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.135;\ttissue: Blood"}]}, {"GSM2353316": [{"title": "SUBJ.1274, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1274;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 43.8602739726027;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.22;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.224;\ttissue: Blood"}]}, {"GSM2353317": [{"title": "SUBJ.1274, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1274;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 43.8602739726027;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.22;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.224;\ttissue: Blood"}]}, {"GSM2353318": [{"title": "SUBJ.1274, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1274;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 43.8602739726027;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.22;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.224;\ttissue: Blood"}]}, {"GSM2353319": [{"title": "SUBJ.1598, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1598;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 31.9205479452054;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.066;\ttissue: Blood"}]}, {"GSM2353320": [{"title": "SUBJ.1598, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1598;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 31.9205479452054;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.066;\ttissue: Blood"}]}, {"GSM2353321": [{"title": "SUBJ.1598, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1598;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 31.9205479452054;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.066;\ttissue: Blood"}]}, {"GSM2353322": [{"title": "SUBJ.1762, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1762;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 61.8383561643835;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 69;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.24;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.295;\ttissue: Blood"}]}, {"GSM2353323": [{"title": "SUBJ.1762, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1762;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 61.8383561643835;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 69;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.24;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.295;\ttissue: Blood"}]}, {"GSM2353324": [{"title": "SUBJ.1762, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1762;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 61.8383561643835;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 69;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.24;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.295;\ttissue: Blood"}]}, {"GSM2353325": [{"title": "SUBJ.0582, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0582;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 33.9071038251366;\tregion: mex_ca_sa;\tsledai_at_baseline: 15;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.558;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.06;\ttissue: Blood"}]}, {"GSM2353326": [{"title": "SUBJ.0582, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0582;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 33.9071038251366;\tregion: mex_ca_sa;\tsledai_at_baseline: 15;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.558;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.06;\ttissue: Blood"}]}, {"GSM2353327": [{"title": "SUBJ.0482, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0482;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 37.0164383561643;\tregion: us_can;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 127;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.851;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.227;\ttissue: Blood"}]}, {"GSM2353328": [{"title": "SUBJ.0482, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0482;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 37.0164383561643;\tregion: us_can;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 127;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.851;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.227;\ttissue: Blood"}]}, {"GSM2353329": [{"title": "SUBJ.0482, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0482;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 37.0164383561643;\tregion: us_can;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 127;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.851;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.227;\ttissue: Blood"}]}, {"GSM2353330": [{"title": "SUBJ.0948, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0948;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 49.517808219178;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.242;\ttissue: Blood"}]}, {"GSM2353331": [{"title": "SUBJ.0948, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0948;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 49.517808219178;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.242;\ttissue: Blood"}]}, {"GSM2353332": [{"title": "SUBJ.1513, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1513;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 32.9780821917808;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.45;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.239;\ttissue: Blood"}]}, {"GSM2353333": [{"title": "SUBJ.1513, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1513;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 32.9780821917808;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.45;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.239;\ttissue: Blood"}]}, {"GSM2353334": [{"title": "SUBJ.1513, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1513;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 32.9780821917808;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.45;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.239;\ttissue: Blood"}]}, {"GSM2353335": [{"title": "SUBJ.0598, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0598;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 32.8306010928961;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.44;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.28;\ttissue: Blood"}]}, {"GSM2353336": [{"title": "SUBJ.0598, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0598;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 32.8306010928961;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.44;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.28;\ttissue: Blood"}]}, {"GSM2353337": [{"title": "SUBJ.0598, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0598;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 32.8306010928961;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.44;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.28;\ttissue: Blood"}]}, {"GSM2353338": [{"title": "SUBJ.1138, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1138;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 50.2301369863013;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): H;\tc3_at_baseline (g/l): 2.29;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.519;\ttissue: Blood"}]}, {"GSM2353339": [{"title": "SUBJ.1138, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1138;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 50.2301369863013;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): H;\tc3_at_baseline (g/l): 2.29;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.519;\ttissue: Blood"}]}, {"GSM2353340": [{"title": "SUBJ.1138, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1138;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 50.2301369863013;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): H;\tc3_at_baseline (g/l): 2.29;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.519;\ttissue: Blood"}]}, {"GSM2353341": [{"title": "SUBJ.0390, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0390;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 56.1479452054794;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.15;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.264;\ttissue: Blood"}]}, {"GSM2353342": [{"title": "SUBJ.0390, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0390;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 56.1479452054794;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.15;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.264;\ttissue: Blood"}]}, {"GSM2353343": [{"title": "SUBJ.0390, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0390;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 56.1479452054794;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.15;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.264;\ttissue: Blood"}]}, {"GSM2353344": [{"title": "SUBJ.0607, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0607;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 38.7540983606557;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.957;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.184;\ttissue: Blood"}]}, {"GSM2353345": [{"title": "SUBJ.0607, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0607;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 38.7540983606557;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.957;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.184;\ttissue: Blood"}]}, {"GSM2353346": [{"title": "SUBJ.0607, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0607;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 38.7540983606557;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.957;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.184;\ttissue: Blood"}]}, {"GSM2353347": [{"title": "SUBJ.0259, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0259;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 23.7540983606557;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 54;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.886;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.114;\ttissue: Blood"}]}, {"GSM2353348": [{"title": "SUBJ.0259, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0259;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 23.7540983606557;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 54;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.886;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.114;\ttissue: Blood"}]}, {"GSM2353349": [{"title": "SUBJ.1271, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1271;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 45.0383561643835;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 117;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.15;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.291;\ttissue: Blood"}]}, {"GSM2353350": [{"title": "SUBJ.1271, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1271;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 45.0383561643835;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 117;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.15;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.291;\ttissue: Blood"}]}, {"GSM2353351": [{"title": "SUBJ.1271, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1271;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 45.0383561643835;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 117;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.15;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.291;\ttissue: Blood"}]}, {"GSM2353352": [{"title": "SUBJ.1602, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1602;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 60.2986301369863;\tregion: europe;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.39;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.25;\ttissue: Blood"}]}, {"GSM2353353": [{"title": "SUBJ.1602, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1602;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 60.2986301369863;\tregion: europe;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.39;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.25;\ttissue: Blood"}]}, {"GSM2353354": [{"title": "SUBJ.1602, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1602;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 60.2986301369863;\tregion: europe;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.39;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.25;\ttissue: Blood"}]}, {"GSM2353355": [{"title": "SUBJ.1259, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1259;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 43.9754098360655;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.957;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.191;\ttissue: Blood"}]}, {"GSM2353356": [{"title": "SUBJ.1259, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1259;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 43.9754098360655;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.957;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.191;\ttissue: Blood"}]}, {"GSM2353357": [{"title": "SUBJ.1259, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1259;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 43.9754098360655;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.957;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.191;\ttissue: Blood"}]}, {"GSM2353358": [{"title": "SUBJ.0629, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0629;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 51.931506849315;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 16;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.39;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.478;\ttissue: Blood"}]}, {"GSM2353359": [{"title": "SUBJ.0629, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0629;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 51.931506849315;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 16;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.39;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.478;\ttissue: Blood"}]}, {"GSM2353360": [{"title": "SUBJ.0629, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0629;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 51.931506849315;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 16;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.39;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.478;\ttissue: Blood"}]}, {"GSM2353361": [{"title": "SUBJ.1006, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1006;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Male;\tage_at_baseline: 23.879781420765;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.47;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.288;\ttissue: Blood"}]}, {"GSM2353362": [{"title": "SUBJ.1006, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1006;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Male;\tage_at_baseline: 23.879781420765;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.47;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.288;\ttissue: Blood"}]}, {"GSM2353363": [{"title": "SUBJ.1006, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1006;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Male;\tage_at_baseline: 23.879781420765;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.47;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.288;\ttissue: Blood"}]}, {"GSM2353364": [{"title": "SUBJ.0198, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0198;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 52.9013698630137;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.998;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.181;\ttissue: Blood"}]}, {"GSM2353365": [{"title": "SUBJ.0198, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0198;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 52.9013698630137;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.998;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.181;\ttissue: Blood"}]}, {"GSM2353366": [{"title": "SUBJ.0198, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0198;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 52.9013698630137;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.998;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.181;\ttissue: Blood"}]}, {"GSM2353367": [{"title": "SUBJ.0028, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0028;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 53.6830601092896;\tregion: us_can;\tsledai_at_baseline: 7;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 53;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.13;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.305;\ttissue: Blood"}]}, {"GSM2353368": [{"title": "SUBJ.0028, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0028;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 53.6830601092896;\tregion: us_can;\tsledai_at_baseline: 7;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 53;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.13;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.305;\ttissue: Blood"}]}, {"GSM2353369": [{"title": "SUBJ.0028, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0028;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 53.6830601092896;\tregion: us_can;\tsledai_at_baseline: 7;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 53;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.13;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.305;\ttissue: Blood"}]}, {"GSM2353370": [{"title": "SUBJ.1724, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1724;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 51.8383561643835;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 52;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.44;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.278;\ttissue: Blood"}]}, {"GSM2353371": [{"title": "SUBJ.1724, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1724;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 51.8383561643835;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 52;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.44;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.278;\ttissue: Blood"}]}, {"GSM2353372": [{"title": "SUBJ.1724, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1724;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 51.8383561643835;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 52;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.44;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.278;\ttissue: Blood"}]}, {"GSM2353373": [{"title": "SUBJ.0743, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0743;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 30.8497267759562;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 96;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.149;\ttissue: Blood"}]}, {"GSM2353374": [{"title": "SUBJ.0743, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0743;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 30.8497267759562;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 96;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.149;\ttissue: Blood"}]}, {"GSM2353375": [{"title": "SUBJ.0743, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0743;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 30.8497267759562;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 96;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.149;\ttissue: Blood"}]}, {"GSM2353376": [{"title": "SUBJ.1083, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1083;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 38.7978142076502;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.74;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.155;\ttissue: Blood"}]}, {"GSM2353377": [{"title": "SUBJ.1083, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1083;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 38.7978142076502;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.74;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.155;\ttissue: Blood"}]}, {"GSM2353378": [{"title": "SUBJ.1083, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1083;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 38.7978142076502;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.74;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.155;\ttissue: Blood"}]}, {"GSM2353379": [{"title": "SUBJ.0839, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0839;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 33.9945205479452;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 192;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.461;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.072;\ttissue: Blood"}]}, {"GSM2353380": [{"title": "SUBJ.0839, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0839;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 33.9945205479452;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 192;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.461;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.072;\ttissue: Blood"}]}, {"GSM2353381": [{"title": "SUBJ.0839, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0839;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 33.9945205479452;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 192;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.461;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.072;\ttissue: Blood"}]}, {"GSM2353382": [{"title": "SUBJ.0742, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0742;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 37.8767123287671;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.858;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.15;\ttissue: Blood"}]}, {"GSM2353383": [{"title": "SUBJ.0742, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0742;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 37.8767123287671;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.858;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.15;\ttissue: Blood"}]}, {"GSM2353384": [{"title": "SUBJ.0742, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0742;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 37.8767123287671;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.858;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.15;\ttissue: Blood"}]}, {"GSM2353385": [{"title": "SUBJ.1784, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1784;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 47.7972602739726;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.46;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.311;\ttissue: Blood"}]}, {"GSM2353386": [{"title": "SUBJ.1784, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1784;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 47.7972602739726;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.46;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.311;\ttissue: Blood"}]}, {"GSM2353387": [{"title": "SUBJ.1784, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1784;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 47.7972602739726;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.46;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.311;\ttissue: Blood"}]}, {"GSM2353388": [{"title": "SUBJ.0117, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0117;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 24.7808219178082;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 57;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.862;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.071;\ttissue: Blood"}]}, {"GSM2353389": [{"title": "SUBJ.0117, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0117;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 24.7808219178082;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 57;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.862;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.071;\ttissue: Blood"}]}, {"GSM2353390": [{"title": "SUBJ.0117, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0117;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 24.7808219178082;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 57;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.862;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.071;\ttissue: Blood"}]}, {"GSM2353391": [{"title": "SUBJ.1369, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1369;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 51.5150684931507;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 11;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.5;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.255;\ttissue: Blood"}]}, {"GSM2353392": [{"title": "SUBJ.1369, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1369;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 51.5150684931507;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 11;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.5;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.255;\ttissue: Blood"}]}, {"GSM2353393": [{"title": "SUBJ.1369, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1369;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 51.5150684931507;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 11;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.5;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.255;\ttissue: Blood"}]}, {"GSM2353394": [{"title": "SUBJ.1449, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1449;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 28.811475409836;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.09;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.095;\ttissue: Blood"}]}, {"GSM2353395": [{"title": "SUBJ.1449, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1449;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 28.811475409836;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.09;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.095;\ttissue: Blood"}]}, {"GSM2353396": [{"title": "SUBJ.1449, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1449;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 28.811475409836;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.09;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.095;\ttissue: Blood"}]}, {"GSM2353397": [{"title": "SUBJ.0930, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0930;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 51.8551912568306;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 70;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.98;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.192;\ttissue: Blood"}]}, {"GSM2353398": [{"title": "SUBJ.0930, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0930;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 51.8551912568306;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 70;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.98;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.192;\ttissue: Blood"}]}, {"GSM2353399": [{"title": "SUBJ.0930, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0930;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 51.8551912568306;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 70;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.98;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.192;\ttissue: Blood"}]}, {"GSM2353400": [{"title": "SUBJ.1391, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1391;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 59.9808219178082;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 31;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.811;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.068;\ttissue: Blood"}]}, {"GSM2353401": [{"title": "SUBJ.1391, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1391;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 59.9808219178082;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 31;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.811;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.068;\ttissue: Blood"}]}, {"GSM2353402": [{"title": "SUBJ.1391, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1391;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 59.9808219178082;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 31;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.811;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.068;\ttissue: Blood"}]}, {"GSM2353403": [{"title": "SUBJ.0626, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0626;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 42.3808219178082;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 48;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.22;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.343;\ttissue: Blood"}]}, {"GSM2353404": [{"title": "SUBJ.0626, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0626;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 42.3808219178082;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 48;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.22;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.343;\ttissue: Blood"}]}, {"GSM2353405": [{"title": "SUBJ.0626, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0626;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 42.3808219178082;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 48;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.22;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.343;\ttissue: Blood"}]}, {"GSM2353406": [{"title": "SUBJ.1603, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1603;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 34.1287671232876;\tregion: us_can;\tsledai_at_baseline: 19;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 18;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.782;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.087;\ttissue: Blood"}]}, {"GSM2353407": [{"title": "SUBJ.1603, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1603;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 34.1287671232876;\tregion: us_can;\tsledai_at_baseline: 19;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 18;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.782;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.087;\ttissue: Blood"}]}, {"GSM2353408": [{"title": "SUBJ.1603, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1603;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 34.1287671232876;\tregion: us_can;\tsledai_at_baseline: 19;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 18;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.782;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.087;\ttissue: Blood"}]}, {"GSM2353409": [{"title": "SUBJ.0619, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0619;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 18.4109589041095;\tregion: mex_ca_sa;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 90;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.14;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.216;\ttissue: Blood"}]}, {"GSM2353410": [{"title": "SUBJ.0619, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0619;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 18.4109589041095;\tregion: mex_ca_sa;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 90;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.14;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.216;\ttissue: Blood"}]}, {"GSM2353411": [{"title": "SUBJ.0619, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0619;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 18.4109589041095;\tregion: mex_ca_sa;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 90;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.14;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.216;\ttissue: Blood"}]}, {"GSM2353412": [{"title": "SUBJ.0666, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0666;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 24.8142076502732;\tregion: europe;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.664;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.124;\ttissue: Blood"}]}, {"GSM2353413": [{"title": "SUBJ.0666, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0666;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 24.8142076502732;\tregion: europe;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.664;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.124;\ttissue: Blood"}]}, {"GSM2353414": [{"title": "SUBJ.0666, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0666;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 24.8142076502732;\tregion: europe;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.664;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.124;\ttissue: Blood"}]}, {"GSM2353415": [{"title": "SUBJ.1710, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1710;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 40.0767123287671;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.7;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.405;\ttissue: Blood"}]}, {"GSM2353416": [{"title": "SUBJ.1710, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1710;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 40.0767123287671;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.7;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.405;\ttissue: Blood"}]}, {"GSM2353417": [{"title": "SUBJ.1710, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1710;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 40.0767123287671;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.7;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.405;\ttissue: Blood"}]}, {"GSM2353418": [{"title": "SUBJ.0986, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0986;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 34.7404371584699;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.39;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.294;\ttissue: Blood"}]}, {"GSM2353419": [{"title": "SUBJ.0986, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0986;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 34.7404371584699;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.39;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.294;\ttissue: Blood"}]}, {"GSM2353420": [{"title": "SUBJ.0986, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0986;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 34.7404371584699;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.39;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.294;\ttissue: Blood"}]}, {"GSM2353421": [{"title": "SUBJ.1122, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1122;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 40.2602739726027;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.06;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.248;\ttissue: Blood"}]}, {"GSM2353422": [{"title": "SUBJ.1122, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1122;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 40.2602739726027;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.06;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.248;\ttissue: Blood"}]}, {"GSM2353423": [{"title": "SUBJ.1122, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1122;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 40.2602739726027;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.06;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.248;\ttissue: Blood"}]}, {"GSM2353424": [{"title": "SUBJ.1493, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1493;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 51.8794520547945;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.13;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.141;\ttissue: Blood"}]}, {"GSM2353425": [{"title": "SUBJ.1493, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1493;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 51.8794520547945;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.13;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.141;\ttissue: Blood"}]}, {"GSM2353426": [{"title": "SUBJ.1493, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1493;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 51.8794520547945;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.13;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.141;\ttissue: Blood"}]}, {"GSM2353427": [{"title": "SUBJ.0363, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0363;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 46.9561643835616;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.6;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.307;\ttissue: Blood"}]}, {"GSM2353428": [{"title": "SUBJ.0363, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0363;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 46.9561643835616;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.6;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.307;\ttissue: Blood"}]}, {"GSM2353429": [{"title": "SUBJ.0363, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0363;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 46.9561643835616;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.6;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.307;\ttissue: Blood"}]}, {"GSM2353430": [{"title": "SUBJ.0230, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0230;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 38.4191780821917;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.998;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.305;\ttissue: Blood"}]}, {"GSM2353431": [{"title": "SUBJ.0230, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0230;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 38.4191780821917;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.998;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.305;\ttissue: Blood"}]}, {"GSM2353432": [{"title": "SUBJ.0230, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0230;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 38.4191780821917;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.998;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.305;\ttissue: Blood"}]}, {"GSM2353433": [{"title": "SUBJ.0331, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0331;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 34.7616438356164;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 15;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.906;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.169;\ttissue: Blood"}]}, {"GSM2353434": [{"title": "SUBJ.0331, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0331;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 34.7616438356164;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 15;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.906;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.169;\ttissue: Blood"}]}, {"GSM2353435": [{"title": "SUBJ.0331, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0331;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 34.7616438356164;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 15;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.906;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.169;\ttissue: Blood"}]}, {"GSM2353436": [{"title": "SUBJ.0273, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0273;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 52.9071038251366;\tregion: europe;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 162;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.8;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.211;\ttissue: Blood"}]}, {"GSM2353437": [{"title": "SUBJ.0273, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0273;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 52.9071038251366;\tregion: europe;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 162;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.8;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.211;\ttissue: Blood"}]}, {"GSM2353438": [{"title": "SUBJ.0273, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0273;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 52.9071038251366;\tregion: europe;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 162;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.8;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.211;\ttissue: Blood"}]}, {"GSM2353439": [{"title": "SUBJ.1573, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1573;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 20.2;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 180;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.622;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.134;\ttissue: Blood"}]}, {"GSM2353440": [{"title": "SUBJ.1573, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1573;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 20.2;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 180;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.622;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.134;\ttissue: Blood"}]}, {"GSM2353441": [{"title": "SUBJ.1573, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1573;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 20.2;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 180;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.622;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.134;\ttissue: Blood"}]}, {"GSM2353442": [{"title": "SUBJ.0272, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0272;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 58.6602739726027;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.11;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.238;\ttissue: Blood"}]}, {"GSM2353443": [{"title": "SUBJ.0272, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0272;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 58.6602739726027;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.11;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.238;\ttissue: Blood"}]}, {"GSM2353444": [{"title": "SUBJ.0272, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0272;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 58.6602739726027;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.11;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.238;\ttissue: Blood"}]}, {"GSM2353445": [{"title": "SUBJ.0689, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0689;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 27.5534246575342;\tregion: europe;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 199;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.759;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.064;\ttissue: Blood"}]}, {"GSM2353446": [{"title": "SUBJ.0689, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0689;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 27.5534246575342;\tregion: europe;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 199;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.759;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.064;\ttissue: Blood"}]}, {"GSM2353447": [{"title": "SUBJ.0689, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0689;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 27.5534246575342;\tregion: europe;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 199;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.759;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.064;\ttissue: Blood"}]}, {"GSM2353448": [{"title": "SUBJ.0703, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0703;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 37.8360655737704;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 12;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.41;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.283;\ttissue: Blood"}]}, {"GSM2353449": [{"title": "SUBJ.0703, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0703;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 37.8360655737704;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 12;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.41;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.283;\ttissue: Blood"}]}, {"GSM2353450": [{"title": "SUBJ.0703, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0703;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 37.8360655737704;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 12;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.41;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.283;\ttissue: Blood"}]}, {"GSM2353451": [{"title": "SUBJ.0493, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0493;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 20.7506849315068;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.689;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.068;\ttissue: Blood"}]}, {"GSM2353452": [{"title": "SUBJ.0493, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0493;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 20.7506849315068;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.689;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.068;\ttissue: Blood"}]}, {"GSM2353453": [{"title": "SUBJ.0493, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0493;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 20.7506849315068;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.689;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.068;\ttissue: Blood"}]}, {"GSM2353454": [{"title": "SUBJ.0060, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0060;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 41.6775956284153;\tregion: mex_ca_sa;\tsledai_at_baseline: 7;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 23;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.27;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.232;\ttissue: Blood"}]}, {"GSM2353455": [{"title": "SUBJ.0060, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0060;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 41.6775956284153;\tregion: mex_ca_sa;\tsledai_at_baseline: 7;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 23;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.27;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.232;\ttissue: Blood"}]}, {"GSM2353456": [{"title": "SUBJ.0060, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0060;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 41.6775956284153;\tregion: mex_ca_sa;\tsledai_at_baseline: 7;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 23;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.27;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.232;\ttissue: Blood"}]}, {"GSM2353457": [{"title": "SUBJ.0735, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0735;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 31.8032786885245;\tregion: europe;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 39;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.807;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.176;\ttissue: Blood"}]}, {"GSM2353458": [{"title": "SUBJ.0735, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0735;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 31.8032786885245;\tregion: europe;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 39;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.807;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.176;\ttissue: Blood"}]}, {"GSM2353459": [{"title": "SUBJ.0735, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0735;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 31.8032786885245;\tregion: europe;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 39;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.807;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.176;\ttissue: Blood"}]}, {"GSM2353460": [{"title": "SUBJ.0157, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0157;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 52.8356164383561;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.24;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.207;\ttissue: Blood"}]}, {"GSM2353461": [{"title": "SUBJ.0157, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0157;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 52.8356164383561;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.24;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.207;\ttissue: Blood"}]}, {"GSM2353462": [{"title": "SUBJ.0166, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0166;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 23.6639344262295;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 53;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.581;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2353463": [{"title": "SUBJ.0166, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0166;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 23.6639344262295;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 53;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.581;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2353464": [{"title": "SUBJ.0166, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0166;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 23.6639344262295;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 53;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.581;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2353465": [{"title": "SUBJ.0377, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0377;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 34.1041095890411;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 172;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.748;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.102;\ttissue: Blood"}]}, {"GSM2353466": [{"title": "SUBJ.0377, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0377;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 34.1041095890411;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 172;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.748;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.102;\ttissue: Blood"}]}, {"GSM2353467": [{"title": "SUBJ.0377, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0377;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 34.1041095890411;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 172;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.748;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.102;\ttissue: Blood"}]}, {"GSM2353468": [{"title": "SUBJ.1742, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1742;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 37.6438356164383;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.93;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.145;\ttissue: Blood"}]}, {"GSM2353469": [{"title": "SUBJ.1742, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1742;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 37.6438356164383;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.93;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.145;\ttissue: Blood"}]}, {"GSM2353470": [{"title": "SUBJ.1742, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1742;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 37.6438356164383;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.93;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.145;\ttissue: Blood"}]}, {"GSM2353471": [{"title": "SUBJ.0231, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0231;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 24.6602739726027;\tregion: us_can;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 102;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.19;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.24;\ttissue: Blood"}]}, {"GSM2353472": [{"title": "SUBJ.0231, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0231;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 24.6602739726027;\tregion: us_can;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 102;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.19;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.24;\ttissue: Blood"}]}, {"GSM2353473": [{"title": "SUBJ.0231, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0231;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 24.6602739726027;\tregion: us_can;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 102;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.19;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.24;\ttissue: Blood"}]}, {"GSM2353474": [{"title": "SUBJ.0465, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0465;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 53.131506849315;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 144;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.853;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.153;\ttissue: Blood"}]}, {"GSM2353475": [{"title": "SUBJ.0465, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0465;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 53.131506849315;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 144;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.853;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.153;\ttissue: Blood"}]}, {"GSM2353476": [{"title": "SUBJ.0465, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0465;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 53.131506849315;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 144;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.853;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.153;\ttissue: Blood"}]}, {"GSM2353477": [{"title": "SUBJ.0509, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0509;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: multiple;\tSex: Female;\tage_at_baseline: 30.4684931506849;\tregion: mex_ca_sa;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 32;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.076;\ttissue: Blood"}]}, {"GSM2353478": [{"title": "SUBJ.0509, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0509;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: multiple;\tSex: Female;\tage_at_baseline: 30.4684931506849;\tregion: mex_ca_sa;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 32;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.076;\ttissue: Blood"}]}, {"GSM2353479": [{"title": "SUBJ.0509, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0509;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: multiple;\tSex: Female;\tage_at_baseline: 30.4684931506849;\tregion: mex_ca_sa;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 32;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.076;\ttissue: Blood"}]}, {"GSM2353480": [{"title": "SUBJ.1238, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1238;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: asian;\tSex: Female;\tage_at_baseline: 26.9726775956284;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 39;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.34;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.177;\ttissue: Blood"}]}, {"GSM2353481": [{"title": "SUBJ.1238, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1238;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: asian;\tSex: Female;\tage_at_baseline: 26.9726775956284;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 39;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.34;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.177;\ttissue: Blood"}]}, {"GSM2353482": [{"title": "SUBJ.1238, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1238;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: asian;\tSex: Female;\tage_at_baseline: 26.9726775956284;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 39;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.34;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.177;\ttissue: Blood"}]}, {"GSM2353483": [{"title": "SUBJ.0474, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0474;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 37.9344262295082;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 10;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.13;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.205;\ttissue: Blood"}]}, {"GSM2353484": [{"title": "SUBJ.0474, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0474;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 37.9344262295082;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 10;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.13;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.205;\ttissue: Blood"}]}, {"GSM2353485": [{"title": "SUBJ.0474, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0474;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 37.9344262295082;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 10;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.13;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.205;\ttissue: Blood"}]}, {"GSM2353486": [{"title": "SUBJ.1610, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1610;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.7021857923497;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 147;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.816;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.18;\ttissue: Blood"}]}, {"GSM2353487": [{"title": "SUBJ.1610, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1610;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.7021857923497;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 147;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.816;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.18;\ttissue: Blood"}]}, {"GSM2353488": [{"title": "SUBJ.1610, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1610;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.7021857923497;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 147;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.816;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.18;\ttissue: Blood"}]}, {"GSM2353489": [{"title": "SUBJ.1239, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1239;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 48.0547945205479;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 97;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.691;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.163;\ttissue: Blood"}]}, {"GSM2353490": [{"title": "SUBJ.1239, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1239;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 48.0547945205479;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 97;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.691;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.163;\ttissue: Blood"}]}, {"GSM2353491": [{"title": "SUBJ.1239, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1239;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 48.0547945205479;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 97;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.691;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.163;\ttissue: Blood"}]}, {"GSM2353492": [{"title": "SUBJ.0455, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0455;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 56.5890410958904;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.77;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.317;\ttissue: Blood"}]}, {"GSM2353493": [{"title": "SUBJ.0455, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0455;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 56.5890410958904;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.77;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.317;\ttissue: Blood"}]}, {"GSM2353494": [{"title": "SUBJ.1389, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1389;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 20.4712328767123;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.505;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2353495": [{"title": "SUBJ.1389, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1389;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 20.4712328767123;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.505;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2353496": [{"title": "SUBJ.1389, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1389;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 20.4712328767123;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.505;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2353497": [{"title": "SUBJ.0911, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0911;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 47.8688524590164;\tregion: europe;\tsledai_at_baseline: 17;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 259;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.12;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.065;\ttissue: Blood"}]}, {"GSM2353498": [{"title": "SUBJ.0911, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0911;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 47.8688524590164;\tregion: europe;\tsledai_at_baseline: 17;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 259;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.12;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.065;\ttissue: Blood"}]}, {"GSM2353499": [{"title": "SUBJ.0911, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0911;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 47.8688524590164;\tregion: europe;\tsledai_at_baseline: 17;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 259;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.12;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.065;\ttissue: Blood"}]}, {"GSM2353500": [{"title": "SUBJ.1341, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1341;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 26.186301369863;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 75;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.143;\ttissue: Blood"}]}, {"GSM2353501": [{"title": "SUBJ.1341, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1341;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 26.186301369863;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 75;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.143;\ttissue: Blood"}]}, {"GSM2353502": [{"title": "SUBJ.1341, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1341;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 26.186301369863;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 75;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.143;\ttissue: Blood"}]}, {"GSM2353503": [{"title": "SUBJ.1475, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1475;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 37.8743169398907;\tregion: europe;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.958;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.143;\ttissue: Blood"}]}, {"GSM2353504": [{"title": "SUBJ.1475, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1475;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 37.8743169398907;\tregion: europe;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.958;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.143;\ttissue: Blood"}]}, {"GSM2353505": [{"title": "SUBJ.1475, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1475;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 37.8743169398907;\tregion: europe;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.958;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.143;\ttissue: Blood"}]}, {"GSM2353506": [{"title": "SUBJ.1010, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1010;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 46.6027397260274;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.685;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.083;\ttissue: Blood"}]}, {"GSM2353507": [{"title": "SUBJ.1010, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1010;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 46.6027397260274;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.685;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.083;\ttissue: Blood"}]}, {"GSM2353508": [{"title": "SUBJ.1010, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1010;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 46.6027397260274;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.685;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.083;\ttissue: Blood"}]}, {"GSM2353509": [{"title": "SUBJ.1785, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1785;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 40.6273972602739;\tregion: europe;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.948;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.16;\ttissue: Blood"}]}, {"GSM2353510": [{"title": "SUBJ.1785, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1785;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 40.6273972602739;\tregion: europe;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.948;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.16;\ttissue: Blood"}]}, {"GSM2353511": [{"title": "SUBJ.1785, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1785;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 40.6273972602739;\tregion: europe;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.948;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.16;\ttissue: Blood"}]}, {"GSM2353512": [{"title": "SUBJ.0913, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0913;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 52.9699453551912;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 174;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.91;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.115;\ttissue: Blood"}]}, {"GSM2353513": [{"title": "SUBJ.0913, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0913;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 52.9699453551912;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 174;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.91;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.115;\ttissue: Blood"}]}, {"GSM2353514": [{"title": "SUBJ.0913, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0913;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 52.9699453551912;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 174;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.91;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.115;\ttissue: Blood"}]}, {"GSM2353515": [{"title": "SUBJ.1554, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1554;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 47.6639344262295;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.854;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2353516": [{"title": "SUBJ.1554, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1554;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 47.6639344262295;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.854;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2353517": [{"title": "SUBJ.1554, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1554;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 47.6639344262295;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.854;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2353518": [{"title": "SUBJ.0599, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0599;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 53.5698630136986;\tregion: us_can;\tsledai_at_baseline: 13;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 40;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.38;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.362;\ttissue: Blood"}]}, {"GSM2353519": [{"title": "SUBJ.0599, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0599;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 53.5698630136986;\tregion: us_can;\tsledai_at_baseline: 13;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 40;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.38;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.362;\ttissue: Blood"}]}, {"GSM2353520": [{"title": "SUBJ.0599, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0599;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 53.5698630136986;\tregion: us_can;\tsledai_at_baseline: 13;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 40;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.38;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.362;\ttissue: Blood"}]}, {"GSM2353521": [{"title": "SUBJ.1416, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1416;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 46.2410958904109;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 11;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.37;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.263;\ttissue: Blood"}]}, {"GSM2353522": [{"title": "SUBJ.1416, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1416;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 46.2410958904109;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 11;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.37;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.263;\ttissue: Blood"}]}, {"GSM2353523": [{"title": "SUBJ.1416, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1416;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 46.2410958904109;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 11;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.37;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.263;\ttissue: Blood"}]}, {"GSM2353524": [{"title": "SUBJ.0342, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0342;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 47.7732240437158;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 17;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.06;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.139;\ttissue: Blood"}]}, {"GSM2353525": [{"title": "SUBJ.0342, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0342;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 47.7732240437158;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 17;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.06;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.139;\ttissue: Blood"}]}, {"GSM2353526": [{"title": "SUBJ.0342, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0342;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 47.7732240437158;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 17;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.06;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.139;\ttissue: Blood"}]}, {"GSM2353527": [{"title": "SUBJ.1422, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1422;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 54.2054794520548;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.25;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.216;\ttissue: Blood"}]}, {"GSM2353528": [{"title": "SUBJ.1422, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1422;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 54.2054794520548;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.25;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.216;\ttissue: Blood"}]}, {"GSM2353529": [{"title": "SUBJ.1422, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1422;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 54.2054794520548;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.25;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.216;\ttissue: Blood"}]}, {"GSM2353530": [{"title": "SUBJ.0929, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0929;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 42.7732240437158;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 211;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.896;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.109;\ttissue: Blood"}]}, {"GSM2353531": [{"title": "SUBJ.0929, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0929;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 42.7732240437158;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 211;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.896;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.109;\ttissue: Blood"}]}, {"GSM2353532": [{"title": "SUBJ.0929, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0929;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 42.7732240437158;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 211;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.896;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.109;\ttissue: Blood"}]}, {"GSM2353533": [{"title": "SUBJ.1168, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1168;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 46.5287671232876;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 19;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.04;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.235;\ttissue: Blood"}]}, {"GSM2353534": [{"title": "SUBJ.1168, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1168;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 46.5287671232876;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 19;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.04;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.235;\ttissue: Blood"}]}, {"GSM2353535": [{"title": "SUBJ.1168, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1168;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 46.5287671232876;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 19;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.04;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.235;\ttissue: Blood"}]}, {"GSM2353536": [{"title": "SUBJ.1472, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1472;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 25.8876712328767;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 168;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.14;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.165;\ttissue: Blood"}]}, {"GSM2353537": [{"title": "SUBJ.1472, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1472;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 25.8876712328767;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 168;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.14;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.165;\ttissue: Blood"}]}, {"GSM2353538": [{"title": "SUBJ.1472, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1472;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 25.8876712328767;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 168;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.14;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.165;\ttissue: Blood"}]}, {"GSM2353539": [{"title": "SUBJ.1082, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1082;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 32.8524590163934;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 148;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.747;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.168;\ttissue: Blood"}]}, {"GSM2353540": [{"title": "SUBJ.1082, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1082;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 32.8524590163934;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 148;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.747;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.168;\ttissue: Blood"}]}, {"GSM2353541": [{"title": "SUBJ.1082, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1082;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 32.8524590163934;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 148;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.747;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.168;\ttissue: Blood"}]}, {"GSM2353542": [{"title": "SUBJ.0523, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0523;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 33.6493150684931;\tregion: us_can;\tsledai_at_baseline: 24;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.324;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.089;\ttissue: Blood"}]}, {"GSM2353543": [{"title": "SUBJ.0523, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0523;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 33.6493150684931;\tregion: us_can;\tsledai_at_baseline: 24;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.324;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.089;\ttissue: Blood"}]}, {"GSM2353544": [{"title": "SUBJ.0523, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0523;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 33.6493150684931;\tregion: us_can;\tsledai_at_baseline: 24;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.324;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.089;\ttissue: Blood"}]}, {"GSM2353545": [{"title": "SUBJ.0351, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0351;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Male;\tage_at_baseline: 33.8688524590164;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 67;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.831;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.21;\ttissue: Blood"}]}, {"GSM2353546": [{"title": "SUBJ.0351, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0351;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Male;\tage_at_baseline: 33.8688524590164;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 67;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.831;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.21;\ttissue: Blood"}]}, {"GSM2353547": [{"title": "SUBJ.0351, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0351;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Male;\tage_at_baseline: 33.8688524590164;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 67;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.831;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.21;\ttissue: Blood"}]}, {"GSM2353548": [{"title": "SUBJ.0450, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0450;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 43.6639344262295;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 7;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.26;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.221;\ttissue: Blood"}]}, {"GSM2353549": [{"title": "SUBJ.0450, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0450;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 43.6639344262295;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 7;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.26;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.221;\ttissue: Blood"}]}, {"GSM2353550": [{"title": "SUBJ.0450, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0450;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 43.6639344262295;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 7;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.26;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.221;\ttissue: Blood"}]}, {"GSM2353551": [{"title": "SUBJ.0356, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0356;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 40.7814207650273;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 55;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.95;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.142;\ttissue: Blood"}]}, {"GSM2353552": [{"title": "SUBJ.0356, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0356;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 40.7814207650273;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 55;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.95;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.142;\ttissue: Blood"}]}, {"GSM2353553": [{"title": "SUBJ.0356, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0356;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 40.7814207650273;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 55;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.95;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.142;\ttissue: Blood"}]}, {"GSM2353554": [{"title": "SUBJ.0878, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0878;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 43.4575342465753;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.953;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.113;\ttissue: Blood"}]}, {"GSM2353555": [{"title": "SUBJ.0878, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0878;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 43.4575342465753;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.953;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.113;\ttissue: Blood"}]}, {"GSM2353556": [{"title": "SUBJ.0878, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0878;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 43.4575342465753;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.953;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.113;\ttissue: Blood"}]}, {"GSM2353557": [{"title": "SUBJ.0438, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0438;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 22.9506849315068;\tregion: us_can;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.04;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.16;\ttissue: Blood"}]}, {"GSM2353558": [{"title": "SUBJ.0438, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0438;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 22.9506849315068;\tregion: us_can;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.04;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.16;\ttissue: Blood"}]}, {"GSM2353559": [{"title": "SUBJ.0438, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0438;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 22.9506849315068;\tregion: us_can;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.04;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.16;\ttissue: Blood"}]}, {"GSM2353560": [{"title": "SUBJ.1368, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1368;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 41.8743169398907;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.879;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.129;\ttissue: Blood"}]}, {"GSM2353561": [{"title": "SUBJ.1368, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1368;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 41.8743169398907;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.879;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.129;\ttissue: Blood"}]}, {"GSM2353562": [{"title": "SUBJ.1368, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1368;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 41.8743169398907;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.879;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.129;\ttissue: Blood"}]}, {"GSM2353563": [{"title": "SUBJ.1180, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1180;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 40.9643835616438;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.01;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.275;\ttissue: Blood"}]}, {"GSM2353564": [{"title": "SUBJ.1180, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1180;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 40.9643835616438;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.01;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.275;\ttissue: Blood"}]}, {"GSM2353565": [{"title": "SUBJ.1180, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1180;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 40.9643835616438;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.01;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.275;\ttissue: Blood"}]}, {"GSM2353566": [{"title": "SUBJ.0908, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0908;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 30.5643835616438;\tregion: mex_ca_sa;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 13;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.25;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.168;\ttissue: Blood"}]}, {"GSM2353567": [{"title": "SUBJ.0908, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0908;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 30.5643835616438;\tregion: mex_ca_sa;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 13;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.25;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.168;\ttissue: Blood"}]}, {"GSM2353568": [{"title": "SUBJ.0908, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0908;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 30.5643835616438;\tregion: mex_ca_sa;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 13;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.25;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.168;\ttissue: Blood"}]}, {"GSM2353569": [{"title": "SUBJ.0288, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0288;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 21.7349726775956;\tregion: mex_ca_sa;\tsledai_at_baseline: 24;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.09;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.131;\ttissue: Blood"}]}, {"GSM2353570": [{"title": "SUBJ.0288, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0288;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 21.7349726775956;\tregion: mex_ca_sa;\tsledai_at_baseline: 24;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.09;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.131;\ttissue: Blood"}]}, {"GSM2353571": [{"title": "SUBJ.0047, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0047;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 60.0657534246575;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.39;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.163;\ttissue: Blood"}]}, {"GSM2353572": [{"title": "SUBJ.0047, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0047;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 60.0657534246575;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.39;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.163;\ttissue: Blood"}]}, {"GSM2353573": [{"title": "SUBJ.0047, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0047;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 60.0657534246575;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.39;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.163;\ttissue: Blood"}]}, {"GSM2353574": [{"title": "SUBJ.0147, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0147;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 50.9753424657534;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 217;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.77;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.077;\ttissue: Blood"}]}, {"GSM2353575": [{"title": "SUBJ.0147, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0147;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 50.9753424657534;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 217;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.77;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.077;\ttissue: Blood"}]}, {"GSM2353576": [{"title": "SUBJ.0147, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0147;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 50.9753424657534;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 217;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.77;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.077;\ttissue: Blood"}]}, {"GSM2353577": [{"title": "SUBJ.0726, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0726;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.8715846994535;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.862;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.138;\ttissue: Blood"}]}, {"GSM2353578": [{"title": "SUBJ.0726, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0726;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.8715846994535;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.862;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.138;\ttissue: Blood"}]}, {"GSM2353579": [{"title": "SUBJ.0726, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0726;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 41.8715846994535;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.862;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.138;\ttissue: Blood"}]}, {"GSM2353580": [{"title": "SUBJ.1779, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1779;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 60.2684931506849;\tregion: us_can;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.16;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.229;\ttissue: Blood"}]}, {"GSM2353581": [{"title": "SUBJ.1779, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1779;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 60.2684931506849;\tregion: us_can;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.16;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.229;\ttissue: Blood"}]}, {"GSM2353582": [{"title": "SUBJ.1779, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1779;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 60.2684931506849;\tregion: us_can;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.16;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.229;\ttissue: Blood"}]}, {"GSM2353583": [{"title": "SUBJ.1824, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1824;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 39.3561643835616;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 20;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.05;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.149;\ttissue: Blood"}]}, {"GSM2353584": [{"title": "SUBJ.1824, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1824;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 39.3561643835616;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 20;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.05;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.149;\ttissue: Blood"}]}, {"GSM2353585": [{"title": "SUBJ.1824, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1824;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 39.3561643835616;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 20;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.05;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.149;\ttissue: Blood"}]}, {"GSM2353586": [{"title": "SUBJ.1509, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1509;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 44.3561643835616;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.568;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.091;\ttissue: Blood"}]}, {"GSM2353587": [{"title": "SUBJ.1509, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1509;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 44.3561643835616;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.568;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.091;\ttissue: Blood"}]}, {"GSM2353588": [{"title": "SUBJ.1509, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1509;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Female;\tage_at_baseline: 44.3561643835616;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.568;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.091;\ttissue: Blood"}]}, {"GSM2353589": [{"title": "SUBJ.1011, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1011;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 56.0356164383561;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 17;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.16;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.37;\ttissue: Blood"}]}, {"GSM2353590": [{"title": "SUBJ.1011, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1011;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 56.0356164383561;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 17;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.16;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.37;\ttissue: Blood"}]}, {"GSM2353591": [{"title": "SUBJ.1011, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1011;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 56.0356164383561;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 17;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.16;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.37;\ttissue: Blood"}]}, {"GSM2353592": [{"title": "SUBJ.1510, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1510;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 34.3424657534246;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.999;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.054;\ttissue: Blood"}]}, {"GSM2353593": [{"title": "SUBJ.1510, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1510;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 34.3424657534246;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.999;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.054;\ttissue: Blood"}]}, {"GSM2353594": [{"title": "SUBJ.1510, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1510;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 34.3424657534246;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.999;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.054;\ttissue: Blood"}]}, {"GSM2353595": [{"title": "SUBJ.0322, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0322;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 46.4383561643835;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.01;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.186;\ttissue: Blood"}]}, {"GSM2353596": [{"title": "SUBJ.0322, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0322;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 46.4383561643835;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.01;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.186;\ttissue: Blood"}]}, {"GSM2353597": [{"title": "SUBJ.0322, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0322;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-1;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 46.4383561643835;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): --;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.01;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.186;\ttissue: Blood"}]}, {"GSM2353598": [{"title": "SUBJ.1645, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1645;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 48.3616438356164;\tregion: europe;\tsledai_at_baseline: 13;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 12;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.09;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.188;\ttissue: Blood"}]}, {"GSM2353599": [{"title": "SUBJ.1645, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1645;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 48.3616438356164;\tregion: europe;\tsledai_at_baseline: 13;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 12;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.09;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.188;\ttissue: Blood"}]}, {"GSM2353600": [{"title": "SUBJ.1645, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1645;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-1;\trace: white;\tSex: Male;\tage_at_baseline: 48.3616438356164;\tregion: europe;\tsledai_at_baseline: 13;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 12;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.09;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.188;\ttissue: Blood"}]}, {"GSM2353601": [{"title": "SUBJ.0998, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0998;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 39.5095890410959;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 84;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.843;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.073;\ttissue: Blood"}]}, {"GSM2353602": [{"title": "SUBJ.0998, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0998;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 39.5095890410959;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 84;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.843;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.073;\ttissue: Blood"}]}, {"GSM2353603": [{"title": "SUBJ.0998, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0998;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 39.5095890410959;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 84;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.843;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.073;\ttissue: Blood"}]}, {"GSM2353604": [{"title": "SUBJ.0112, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0112;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 41.7267759562841;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 106;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.07;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.136;\ttissue: Blood"}]}, {"GSM2353605": [{"title": "SUBJ.0112, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0112;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 41.7267759562841;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 106;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.07;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.136;\ttissue: Blood"}]}, {"GSM2353606": [{"title": "SUBJ.0112, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0112;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 41.7267759562841;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 106;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.07;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.136;\ttissue: Blood"}]}, {"GSM2353607": [{"title": "SUBJ.0984, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0984;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 23.8579234972677;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 49;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.997;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.096;\ttissue: Blood"}]}, {"GSM2353608": [{"title": "SUBJ.0984, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0984;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 23.8579234972677;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 49;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.997;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.096;\ttissue: Blood"}]}, {"GSM2353609": [{"title": "SUBJ.0984, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0984;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 23.8579234972677;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 49;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.997;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.096;\ttissue: Blood"}]}, {"GSM2353610": [{"title": "SUBJ.0775, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0775;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 24.4712328767123;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.639;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.064;\ttissue: Blood"}]}, {"GSM2353611": [{"title": "SUBJ.0775, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0775;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 24.4712328767123;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.639;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.064;\ttissue: Blood"}]}, {"GSM2353612": [{"title": "SUBJ.0775, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0775;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 24.4712328767123;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.639;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.064;\ttissue: Blood"}]}, {"GSM2353613": [{"title": "SUBJ.1564, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1564;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 42.3260273972602;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.73;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.129;\ttissue: Blood"}]}, {"GSM2353614": [{"title": "SUBJ.1564, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1564;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 42.3260273972602;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.73;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.129;\ttissue: Blood"}]}, {"GSM2353615": [{"title": "SUBJ.1564, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1564;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 42.3260273972602;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.73;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.129;\ttissue: Blood"}]}, {"GSM2353616": [{"title": "SUBJ.1486, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1486;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 24.9098360655737;\tregion: mex_ca_sa;\tsledai_at_baseline: 13;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.286;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2353617": [{"title": "SUBJ.1486, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1486;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 24.9098360655737;\tregion: mex_ca_sa;\tsledai_at_baseline: 13;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.286;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2353618": [{"title": "SUBJ.0453, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0453;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 44.5753424657534;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.58;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.243;\ttissue: Blood"}]}, {"GSM2353619": [{"title": "SUBJ.0453, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0453;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 44.5753424657534;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.58;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.243;\ttissue: Blood"}]}, {"GSM2353620": [{"title": "SUBJ.0453, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0453;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 44.5753424657534;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.58;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.243;\ttissue: Blood"}]}, {"GSM2353621": [{"title": "SUBJ.1812, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1812;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 41.5123287671232;\tregion: europe;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 16;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.995;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.192;\ttissue: Blood"}]}, {"GSM2353622": [{"title": "SUBJ.1812, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1812;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 41.5123287671232;\tregion: europe;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 16;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.995;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.192;\ttissue: Blood"}]}, {"GSM2353623": [{"title": "SUBJ.1812, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1812;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 41.5123287671232;\tregion: europe;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 16;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.995;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.192;\ttissue: Blood"}]}, {"GSM2353624": [{"title": "SUBJ.1320, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1320;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 55.4712328767123;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): H;\tc3_at_baseline (g/l): 1.9;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.399;\ttissue: Blood"}]}, {"GSM2353625": [{"title": "SUBJ.1320, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1320;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 55.4712328767123;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): H;\tc3_at_baseline (g/l): 1.9;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.399;\ttissue: Blood"}]}, {"GSM2353626": [{"title": "SUBJ.1320, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1320;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 55.4712328767123;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): H;\tc3_at_baseline (g/l): 1.9;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.399;\ttissue: Blood"}]}, {"GSM2353627": [{"title": "SUBJ.0382, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0382;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 53.2246575342465;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.19;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.078;\ttissue: Blood"}]}, {"GSM2353628": [{"title": "SUBJ.0382, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0382;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 53.2246575342465;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.19;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.078;\ttissue: Blood"}]}, {"GSM2353629": [{"title": "SUBJ.0382, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0382;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 53.2246575342465;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.19;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.078;\ttissue: Blood"}]}, {"GSM2353630": [{"title": "SUBJ.1273, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1273;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 30.9013698630137;\tregion: us_can;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.19;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.136;\ttissue: Blood"}]}, {"GSM2353631": [{"title": "SUBJ.1273, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1273;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 30.9013698630137;\tregion: us_can;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.19;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.136;\ttissue: Blood"}]}, {"GSM2353632": [{"title": "SUBJ.1273, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1273;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 30.9013698630137;\tregion: us_can;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.19;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.136;\ttissue: Blood"}]}, {"GSM2353633": [{"title": "SUBJ.1195, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1195;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 35.0931506849315;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 77;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.712;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.158;\ttissue: Blood"}]}, {"GSM2353634": [{"title": "SUBJ.1195, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1195;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 35.0931506849315;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 77;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.712;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.158;\ttissue: Blood"}]}, {"GSM2353635": [{"title": "SUBJ.1195, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1195;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 35.0931506849315;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 77;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.712;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.158;\ttissue: Blood"}]}, {"GSM2353636": [{"title": "SUBJ.1540, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1540;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 55.7698630136986;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.826;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2353637": [{"title": "SUBJ.1540, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1540;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 55.7698630136986;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.826;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2353638": [{"title": "SUBJ.1292, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1292;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 62.0301369863013;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 46;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.37;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.163;\ttissue: Blood"}]}, {"GSM2353639": [{"title": "SUBJ.1292, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1292;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 62.0301369863013;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 46;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.37;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.163;\ttissue: Blood"}]}, {"GSM2353640": [{"title": "SUBJ.1292, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1292;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 62.0301369863013;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 46;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.37;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.163;\ttissue: Blood"}]}, {"GSM2353641": [{"title": "SUBJ.0813, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0813;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 44.1917808219178;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 13;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.834;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.18;\ttissue: Blood"}]}, {"GSM2353642": [{"title": "SUBJ.0813, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0813;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 44.1917808219178;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 13;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.834;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.18;\ttissue: Blood"}]}, {"GSM2353643": [{"title": "SUBJ.0813, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0813;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 44.1917808219178;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 13;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.834;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.18;\ttissue: Blood"}]}, {"GSM2353644": [{"title": "SUBJ.1479, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1479;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 36.7049180327868;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 33;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.642;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.117;\ttissue: Blood"}]}, {"GSM2353645": [{"title": "SUBJ.1479, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1479;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 36.7049180327868;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 33;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.642;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.117;\ttissue: Blood"}]}, {"GSM2353646": [{"title": "SUBJ.1479, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1479;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 36.7049180327868;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 33;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.642;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.117;\ttissue: Blood"}]}, {"GSM2353647": [{"title": "SUBJ.1228, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1228;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: multiple;\tSex: Female;\tage_at_baseline: 33.9972602739726;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 17;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.01;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.272;\ttissue: Blood"}]}, {"GSM2353648": [{"title": "SUBJ.1228, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1228;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: multiple;\tSex: Female;\tage_at_baseline: 33.9972602739726;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 17;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.01;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.272;\ttissue: Blood"}]}, {"GSM2353649": [{"title": "SUBJ.1228, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1228;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: multiple;\tSex: Female;\tage_at_baseline: 33.9972602739726;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 17;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.01;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.272;\ttissue: Blood"}]}, {"GSM2353650": [{"title": "SUBJ.1298, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1298;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 57.531506849315;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.33;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.183;\ttissue: Blood"}]}, {"GSM2353651": [{"title": "SUBJ.1298, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1298;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 57.531506849315;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.33;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.183;\ttissue: Blood"}]}, {"GSM2353652": [{"title": "SUBJ.0774, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0774;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 41.2109589041095;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.916;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.1;\ttissue: Blood"}]}, {"GSM2353653": [{"title": "SUBJ.0774, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0774;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 41.2109589041095;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.916;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.1;\ttissue: Blood"}]}, {"GSM2353654": [{"title": "SUBJ.0774, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0774;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 41.2109589041095;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.916;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.1;\ttissue: Blood"}]}, {"GSM2353655": [{"title": "SUBJ.1520, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1520;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 54.4383561643835;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.07;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.185;\ttissue: Blood"}]}, {"GSM2353656": [{"title": "SUBJ.1520, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1520;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 54.4383561643835;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.07;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.185;\ttissue: Blood"}]}, {"GSM2353657": [{"title": "SUBJ.1520, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1520;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 54.4383561643835;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.07;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.185;\ttissue: Blood"}]}, {"GSM2353658": [{"title": "SUBJ.1706, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1706;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 39.1671232876712;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.51;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.112;\ttissue: Blood"}]}, {"GSM2353659": [{"title": "SUBJ.1706, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1706;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 39.1671232876712;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.51;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.112;\ttissue: Blood"}]}, {"GSM2353660": [{"title": "SUBJ.1706, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1706;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 39.1671232876712;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.51;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.112;\ttissue: Blood"}]}, {"GSM2353661": [{"title": "SUBJ.1383, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1383;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 62.7978142076502;\tregion: rest_world;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.786;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.136;\ttissue: Blood"}]}, {"GSM2353662": [{"title": "SUBJ.1383, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1383;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 62.7978142076502;\tregion: rest_world;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.786;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.136;\ttissue: Blood"}]}, {"GSM2353663": [{"title": "SUBJ.0332, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0332;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 65.6136986301369;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.68;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.149;\ttissue: Blood"}]}, {"GSM2353664": [{"title": "SUBJ.0332, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0332;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 65.6136986301369;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.68;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.149;\ttissue: Blood"}]}, {"GSM2353665": [{"title": "SUBJ.0332, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0332;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 65.6136986301369;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.68;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.149;\ttissue: Blood"}]}, {"GSM2353666": [{"title": "SUBJ.0520, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0520;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 50.9041095890411;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.26;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.222;\ttissue: Blood"}]}, {"GSM2353667": [{"title": "SUBJ.0520, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0520;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 50.9041095890411;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 8;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.26;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.222;\ttissue: Blood"}]}, {"GSM2353668": [{"title": "SUBJ.1123, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1123;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 29.0301369863013;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.928;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.179;\ttissue: Blood"}]}, {"GSM2353669": [{"title": "SUBJ.1123, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1123;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 29.0301369863013;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.928;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.179;\ttissue: Blood"}]}, {"GSM2353670": [{"title": "SUBJ.1123, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1123;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 29.0301369863013;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.928;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.179;\ttissue: Blood"}]}, {"GSM2353671": [{"title": "SUBJ.0555, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0555;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 63.8360655737705;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 119;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.18;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.299;\ttissue: Blood"}]}, {"GSM2353672": [{"title": "SUBJ.0555, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0555;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 63.8360655737705;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 119;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.18;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.299;\ttissue: Blood"}]}, {"GSM2353673": [{"title": "SUBJ.0555, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0555;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 63.8360655737705;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 119;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.18;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.299;\ttissue: Blood"}]}, {"GSM2353674": [{"title": "SUBJ.1042, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1042;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 54.9945205479452;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 65;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.27;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.099;\ttissue: Blood"}]}, {"GSM2353675": [{"title": "SUBJ.1042, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1042;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 54.9945205479452;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 65;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.27;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.099;\ttissue: Blood"}]}, {"GSM2353676": [{"title": "SUBJ.1042, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1042;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 54.9945205479452;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 65;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.27;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.099;\ttissue: Blood"}]}, {"GSM2353677": [{"title": "SUBJ.0245, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0245;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 28.9369863013698;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 10;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.35;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.226;\ttissue: Blood"}]}, {"GSM2353678": [{"title": "SUBJ.0245, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0245;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 28.9369863013698;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 10;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.35;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.226;\ttissue: Blood"}]}, {"GSM2353679": [{"title": "SUBJ.1428, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1428;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 47.8657534246575;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.07;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.157;\ttissue: Blood"}]}, {"GSM2353680": [{"title": "SUBJ.1428, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1428;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 47.8657534246575;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.07;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.157;\ttissue: Blood"}]}, {"GSM2353681": [{"title": "SUBJ.1428, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1428;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 47.8657534246575;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.07;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.157;\ttissue: Blood"}]}, {"GSM2353682": [{"title": "SUBJ.0941, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0941;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 46.0767123287671;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.21;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.269;\ttissue: Blood"}]}, {"GSM2353683": [{"title": "SUBJ.0941, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0941;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 46.0767123287671;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.21;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.269;\ttissue: Blood"}]}, {"GSM2353684": [{"title": "SUBJ.0941, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0941;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 46.0767123287671;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.21;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.269;\ttissue: Blood"}]}, {"GSM2353685": [{"title": "SUBJ.0089, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0089;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 57.9644808743169;\tregion: mex_ca_sa;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 73;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.801;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.107;\ttissue: Blood"}]}, {"GSM2353686": [{"title": "SUBJ.0089, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0089;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 57.9644808743169;\tregion: mex_ca_sa;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 73;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.801;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.107;\ttissue: Blood"}]}, {"GSM2353687": [{"title": "SUBJ.0089, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0089;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 57.9644808743169;\tregion: mex_ca_sa;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 73;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.801;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.107;\ttissue: Blood"}]}, {"GSM2353688": [{"title": "SUBJ.1753, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1753;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 57.0904109589041;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 149;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.03;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.185;\ttissue: Blood"}]}, {"GSM2353689": [{"title": "SUBJ.1753, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1753;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 57.0904109589041;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 149;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.03;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.185;\ttissue: Blood"}]}, {"GSM2353690": [{"title": "SUBJ.1753, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1753;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 57.0904109589041;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 149;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.03;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.185;\ttissue: Blood"}]}, {"GSM2353691": [{"title": "SUBJ.0204, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0204;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 46.2958904109589;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 50;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.06;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.103;\ttissue: Blood"}]}, {"GSM2353692": [{"title": "SUBJ.0204, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0204;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 46.2958904109589;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 50;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.06;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.103;\ttissue: Blood"}]}, {"GSM2353693": [{"title": "SUBJ.0204, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0204;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 46.2958904109589;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 50;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.06;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.103;\ttissue: Blood"}]}, {"GSM2353694": [{"title": "SUBJ.0670, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0670;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 30.8142076502732;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 150;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.821;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.093;\ttissue: Blood"}]}, {"GSM2353695": [{"title": "SUBJ.0670, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0670;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 30.8142076502732;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 150;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.821;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.093;\ttissue: Blood"}]}, {"GSM2353696": [{"title": "SUBJ.0670, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0670;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 30.8142076502732;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 150;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.821;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.093;\ttissue: Blood"}]}, {"GSM2353697": [{"title": "SUBJ.0107, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0107;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 25.7232876712328;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.899;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.106;\ttissue: Blood"}]}, {"GSM2353698": [{"title": "SUBJ.0107, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0107;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 25.7232876712328;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.899;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.106;\ttissue: Blood"}]}, {"GSM2353699": [{"title": "SUBJ.0107, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0107;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 25.7232876712328;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.899;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.106;\ttissue: Blood"}]}, {"GSM2353700": [{"title": "SUBJ.1048, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1048;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 62.8551912568306;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 76;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.188;\ttissue: Blood"}]}, {"GSM2353701": [{"title": "SUBJ.1048, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1048;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 62.8551912568306;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 76;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.188;\ttissue: Blood"}]}, {"GSM2353702": [{"title": "SUBJ.1048, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1048;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 62.8551912568306;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 76;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.188;\ttissue: Blood"}]}, {"GSM2353703": [{"title": "SUBJ.1641, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1641;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 52.0876712328767;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.834;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.191;\ttissue: Blood"}]}, {"GSM2353704": [{"title": "SUBJ.1641, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1641;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 52.0876712328767;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.834;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.191;\ttissue: Blood"}]}, {"GSM2353705": [{"title": "SUBJ.1641, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1641;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 52.0876712328767;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.834;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.191;\ttissue: Blood"}]}, {"GSM2353706": [{"title": "SUBJ.1167, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1167;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 50.9698630136986;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 166;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.25;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.338;\ttissue: Blood"}]}, {"GSM2353707": [{"title": "SUBJ.1167, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1167;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 50.9698630136986;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 166;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.25;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.338;\ttissue: Blood"}]}, {"GSM2353708": [{"title": "SUBJ.1167, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1167;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 50.9698630136986;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 166;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.25;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.338;\ttissue: Blood"}]}, {"GSM2353709": [{"title": "SUBJ.0380, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0380;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 38.9150684931506;\tregion: us_can;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 227;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.14;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.235;\ttissue: Blood"}]}, {"GSM2353710": [{"title": "SUBJ.0380, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0380;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 38.9150684931506;\tregion: us_can;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 227;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.14;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.235;\ttissue: Blood"}]}, {"GSM2353711": [{"title": "SUBJ.0380, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0380;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 38.9150684931506;\tregion: us_can;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 227;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.14;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.235;\ttissue: Blood"}]}, {"GSM2353712": [{"title": "SUBJ.0562, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0562;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 38.2191780821917;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.74;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.316;\ttissue: Blood"}]}, {"GSM2353713": [{"title": "SUBJ.0562, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0562;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 38.2191780821917;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.74;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.316;\ttissue: Blood"}]}, {"GSM2353714": [{"title": "SUBJ.1621, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1621;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 56.8465753424657;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.36;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.351;\ttissue: Blood"}]}, {"GSM2353715": [{"title": "SUBJ.1621, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1621;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 56.8465753424657;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.36;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.351;\ttissue: Blood"}]}, {"GSM2353716": [{"title": "SUBJ.1621, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1621;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 56.8465753424657;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.36;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.351;\ttissue: Blood"}]}, {"GSM2353717": [{"title": "SUBJ.1285, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1285;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 67.2876712328767;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 24;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.2;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.27;\ttissue: Blood"}]}, {"GSM2353718": [{"title": "SUBJ.1285, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1285;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 67.2876712328767;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 24;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.2;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.27;\ttissue: Blood"}]}, {"GSM2353719": [{"title": "SUBJ.1285, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1285;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 67.2876712328767;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 24;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.2;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.27;\ttissue: Blood"}]}, {"GSM2353720": [{"title": "SUBJ.0213, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0213;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 40.9808219178082;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.07;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.109;\ttissue: Blood"}]}, {"GSM2353721": [{"title": "SUBJ.0213, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0213;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 40.9808219178082;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.07;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.109;\ttissue: Blood"}]}, {"GSM2353722": [{"title": "SUBJ.0213, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0213;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 40.9808219178082;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.07;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.109;\ttissue: Blood"}]}, {"GSM2353723": [{"title": "SUBJ.0393, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0393;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 38.7349726775956;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 99;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.723;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.234;\ttissue: Blood"}]}, {"GSM2353724": [{"title": "SUBJ.0393, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0393;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 38.7349726775956;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 99;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.723;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.234;\ttissue: Blood"}]}, {"GSM2353725": [{"title": "SUBJ.1436, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1436;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 41.0054794520548;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 111;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.851;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.102;\ttissue: Blood"}]}, {"GSM2353726": [{"title": "SUBJ.1436, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1436;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 41.0054794520548;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 111;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.851;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.102;\ttissue: Blood"}]}, {"GSM2353727": [{"title": "SUBJ.1436, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1436;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 41.0054794520548;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 111;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.851;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.102;\ttissue: Blood"}]}, {"GSM2353728": [{"title": "SUBJ.0225, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0225;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 49.2438356164383;\tregion: us_can;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.803;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.189;\ttissue: Blood"}]}, {"GSM2353729": [{"title": "SUBJ.0225, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0225;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 49.2438356164383;\tregion: us_can;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.803;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.189;\ttissue: Blood"}]}, {"GSM2353730": [{"title": "SUBJ.0225, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0225;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 49.2438356164383;\tregion: us_can;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.803;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.189;\ttissue: Blood"}]}, {"GSM2353731": [{"title": "SUBJ.1399, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1399;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 34.4109589041095;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.705;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.13;\ttissue: Blood"}]}, {"GSM2353732": [{"title": "SUBJ.1399, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1399;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 34.4109589041095;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.705;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.13;\ttissue: Blood"}]}, {"GSM2353733": [{"title": "SUBJ.1399, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1399;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 34.4109589041095;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.705;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.13;\ttissue: Blood"}]}, {"GSM2353734": [{"title": "SUBJ.0057, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0057;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 45.8169398907103;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.65;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2353735": [{"title": "SUBJ.0057, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0057;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 45.8169398907103;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.65;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2353736": [{"title": "SUBJ.0057, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0057;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 45.8169398907103;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.65;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2353737": [{"title": "SUBJ.0552, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0552;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 31.972602739726;\tregion: us_can;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.883;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.132;\ttissue: Blood"}]}, {"GSM2353738": [{"title": "SUBJ.0552, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0552;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 31.972602739726;\tregion: us_can;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.883;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.132;\ttissue: Blood"}]}, {"GSM2353739": [{"title": "SUBJ.0552, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0552;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 31.972602739726;\tregion: us_can;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.883;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.132;\ttissue: Blood"}]}, {"GSM2353740": [{"title": "SUBJ.0690, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0690;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 63.1917808219178;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.42;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.282;\ttissue: Blood"}]}, {"GSM2353741": [{"title": "SUBJ.0690, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0690;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 63.1917808219178;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.42;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.282;\ttissue: Blood"}]}, {"GSM2353742": [{"title": "SUBJ.0266, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0266;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 32.8579234972677;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 13;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.07;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.182;\ttissue: Blood"}]}, {"GSM2353743": [{"title": "SUBJ.0266, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0266;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 32.8579234972677;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 13;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.07;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.182;\ttissue: Blood"}]}, {"GSM2353744": [{"title": "SUBJ.0266, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0266;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 32.8579234972677;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 13;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.07;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.182;\ttissue: Blood"}]}, {"GSM2353745": [{"title": "SUBJ.0756, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0756;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 40.3561643835616;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 20;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.182;\ttissue: Blood"}]}, {"GSM2353746": [{"title": "SUBJ.0756, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0756;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 40.3561643835616;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 20;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.182;\ttissue: Blood"}]}, {"GSM2353747": [{"title": "SUBJ.0756, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0756;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 40.3561643835616;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 20;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.182;\ttissue: Blood"}]}, {"GSM2353748": [{"title": "SUBJ.1652, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1652;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 38.972602739726;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 89;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.664;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.08;\ttissue: Blood"}]}, {"GSM2353749": [{"title": "SUBJ.1652, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1652;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 38.972602739726;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 89;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.664;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.08;\ttissue: Blood"}]}, {"GSM2353750": [{"title": "SUBJ.1652, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1652;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 38.972602739726;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 89;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.664;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.08;\ttissue: Blood"}]}, {"GSM2353751": [{"title": "SUBJ.0313, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0313;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 42.2438356164383;\tregion: europe;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.32;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.293;\ttissue: Blood"}]}, {"GSM2353752": [{"title": "SUBJ.0313, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0313;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 42.2438356164383;\tregion: europe;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.32;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.293;\ttissue: Blood"}]}, {"GSM2353753": [{"title": "SUBJ.0313, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0313;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 42.2438356164383;\tregion: europe;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.32;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.293;\ttissue: Blood"}]}, {"GSM2353754": [{"title": "SUBJ.0695, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0695;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 42.3917808219178;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 128;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.01;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.191;\ttissue: Blood"}]}, {"GSM2353755": [{"title": "SUBJ.0695, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0695;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 42.3917808219178;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 128;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.01;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.191;\ttissue: Blood"}]}, {"GSM2353756": [{"title": "SUBJ.0695, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0695;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 42.3917808219178;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 128;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.01;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.191;\ttissue: Blood"}]}, {"GSM2353757": [{"title": "SUBJ.1441, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1441;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 64.8383561643835;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.873;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2353758": [{"title": "SUBJ.1441, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1441;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 64.8383561643835;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.873;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2353759": [{"title": "SUBJ.1441, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1441;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 64.8383561643835;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.873;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2353760": [{"title": "SUBJ.1381, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1381;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 45.4602739726027;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.24;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.237;\ttissue: Blood"}]}, {"GSM2353761": [{"title": "SUBJ.1381, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1381;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 45.4602739726027;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.24;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.237;\ttissue: Blood"}]}, {"GSM2353762": [{"title": "SUBJ.1381, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1381;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 45.4602739726027;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.24;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.237;\ttissue: Blood"}]}, {"GSM2353763": [{"title": "SUBJ.0979, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0979;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 40.8958904109589;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 52;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.169;\ttissue: Blood"}]}, {"GSM2353764": [{"title": "SUBJ.0979, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0979;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 40.8958904109589;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 52;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.169;\ttissue: Blood"}]}, {"GSM2353765": [{"title": "SUBJ.0979, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0979;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 40.8958904109589;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 52;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.02;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.169;\ttissue: Blood"}]}, {"GSM2353766": [{"title": "SUBJ.0440, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0440;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 22.8958904109589;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 49;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.234;\ttissue: Blood"}]}, {"GSM2353767": [{"title": "SUBJ.0440, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0440;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 22.8958904109589;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 49;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.234;\ttissue: Blood"}]}, {"GSM2353768": [{"title": "SUBJ.0284, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0284;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 54.2027397260274;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.896;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.106;\ttissue: Blood"}]}, {"GSM2353769": [{"title": "SUBJ.0284, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0284;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 54.2027397260274;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.896;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.106;\ttissue: Blood"}]}, {"GSM2353770": [{"title": "SUBJ.0284, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0284;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 54.2027397260274;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.896;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.106;\ttissue: Blood"}]}, {"GSM2353771": [{"title": "SUBJ.1438, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1438;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 35.2849315068493;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.58;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.07;\ttissue: Blood"}]}, {"GSM2353772": [{"title": "SUBJ.1438, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1438;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 35.2849315068493;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.58;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.07;\ttissue: Blood"}]}, {"GSM2353773": [{"title": "SUBJ.1438, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1438;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 35.2849315068493;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.58;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.07;\ttissue: Blood"}]}, {"GSM2353774": [{"title": "SUBJ.0663, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0663;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 62.2767123287671;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.959;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2353775": [{"title": "SUBJ.0663, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0663;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 62.2767123287671;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.959;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2353776": [{"title": "SUBJ.0663, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0663;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 62.2767123287671;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.959;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2353777": [{"title": "SUBJ.1776, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1776;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Male;\tage_at_baseline: 40.6693989071038;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.5;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.306;\ttissue: Blood"}]}, {"GSM2353778": [{"title": "SUBJ.1776, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1776;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Male;\tage_at_baseline: 40.6693989071038;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.5;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.306;\ttissue: Blood"}]}, {"GSM2353779": [{"title": "SUBJ.1776, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1776;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Male;\tage_at_baseline: 40.6693989071038;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.5;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.306;\ttissue: Blood"}]}, {"GSM2353780": [{"title": "SUBJ.0496, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0496;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 59.0767123287671;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.958;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.165;\ttissue: Blood"}]}, {"GSM2353781": [{"title": "SUBJ.0496, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0496;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 59.0767123287671;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.958;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.165;\ttissue: Blood"}]}, {"GSM2353782": [{"title": "SUBJ.0496, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0496;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 59.0767123287671;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.958;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.165;\ttissue: Blood"}]}, {"GSM2353783": [{"title": "SUBJ.1250, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1250;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 44.4547945205479;\tregion: us_can;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.619;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.187;\ttissue: Blood"}]}, {"GSM2353784": [{"title": "SUBJ.1250, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1250;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 44.4547945205479;\tregion: us_can;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.619;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.187;\ttissue: Blood"}]}, {"GSM2353785": [{"title": "SUBJ.1250, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1250;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 44.4547945205479;\tregion: us_can;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.619;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.187;\ttissue: Blood"}]}, {"GSM2353786": [{"title": "SUBJ.1483, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1483;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 43.2054794520548;\tregion: us_can;\tsledai_at_baseline: 26;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): H;\tc3_at_baseline (g/l): 1.89;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.09;\ttissue: Blood"}]}, {"GSM2353787": [{"title": "SUBJ.1483, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1483;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 43.2054794520548;\tregion: us_can;\tsledai_at_baseline: 26;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): H;\tc3_at_baseline (g/l): 1.89;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.09;\ttissue: Blood"}]}, {"GSM2353788": [{"title": "SUBJ.1483, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1483;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 43.2054794520548;\tregion: us_can;\tsledai_at_baseline: 26;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): H;\tc3_at_baseline (g/l): 1.89;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.09;\ttissue: Blood"}]}, {"GSM2353789": [{"title": "SUBJ.0658, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0658;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 37.9753424657534;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.802;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.096;\ttissue: Blood"}]}, {"GSM2353790": [{"title": "SUBJ.0658, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0658;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 37.9753424657534;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.802;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.096;\ttissue: Blood"}]}, {"GSM2353791": [{"title": "SUBJ.0658, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0658;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 37.9753424657534;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.802;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.096;\ttissue: Blood"}]}, {"GSM2353792": [{"title": "SUBJ.1049, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1049;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: multiple;\tSex: Female;\tage_at_baseline: 41.3808219178082;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 63;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.672;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.111;\ttissue: Blood"}]}, {"GSM2353793": [{"title": "SUBJ.1049, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1049;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: multiple;\tSex: Female;\tage_at_baseline: 41.3808219178082;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 63;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.672;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.111;\ttissue: Blood"}]}, {"GSM2353794": [{"title": "SUBJ.1049, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1049;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: multiple;\tSex: Female;\tage_at_baseline: 41.3808219178082;\tregion: mex_ca_sa;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 63;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.672;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.111;\ttissue: Blood"}]}, {"GSM2353795": [{"title": "SUBJ.0441, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0441;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 19.9561643835616;\tregion: us_can;\tsledai_at_baseline: 7;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 211;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.626;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.077;\ttissue: Blood"}]}, {"GSM2353796": [{"title": "SUBJ.0441, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0441;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 19.9561643835616;\tregion: us_can;\tsledai_at_baseline: 7;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 211;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.626;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.077;\ttissue: Blood"}]}, {"GSM2353797": [{"title": "SUBJ.0441, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0441;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 19.9561643835616;\tregion: us_can;\tsledai_at_baseline: 7;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 211;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.626;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.077;\ttissue: Blood"}]}, {"GSM2353798": [{"title": "SUBJ.0349, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0349;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 38.1041095890411;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 111;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.2;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.135;\ttissue: Blood"}]}, {"GSM2353799": [{"title": "SUBJ.0349, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0349;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 38.1041095890411;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 111;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.2;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.135;\ttissue: Blood"}]}, {"GSM2353800": [{"title": "SUBJ.0349, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0349;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 38.1041095890411;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 111;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.2;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.135;\ttissue: Blood"}]}, {"GSM2353801": [{"title": "SUBJ.1382, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1382;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 32.5287671232876;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 144;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.4;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.189;\ttissue: Blood"}]}, {"GSM2353802": [{"title": "SUBJ.1382, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1382;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 32.5287671232876;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 144;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.4;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.189;\ttissue: Blood"}]}, {"GSM2353803": [{"title": "SUBJ.1382, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1382;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 32.5287671232876;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 144;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.4;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.189;\ttissue: Blood"}]}, {"GSM2353804": [{"title": "SUBJ.1300, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1300;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 37.545205479452;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 20;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.069;\ttissue: Blood"}]}, {"GSM2353805": [{"title": "SUBJ.1300, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1300;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 37.545205479452;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 20;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.069;\ttissue: Blood"}]}, {"GSM2353806": [{"title": "SUBJ.1300, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1300;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 37.545205479452;\tregion: mex_ca_sa;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 20;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.069;\ttissue: Blood"}]}, {"GSM2353807": [{"title": "SUBJ.1175, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1175;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 28.4301369863013;\tregion: mex_ca_sa;\tsledai_at_baseline: 15;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.733;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.112;\ttissue: Blood"}]}, {"GSM2353808": [{"title": "SUBJ.1175, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1175;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 28.4301369863013;\tregion: mex_ca_sa;\tsledai_at_baseline: 15;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.733;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.112;\ttissue: Blood"}]}, {"GSM2353809": [{"title": "SUBJ.1175, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1175;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 28.4301369863013;\tregion: mex_ca_sa;\tsledai_at_baseline: 15;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.733;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.112;\ttissue: Blood"}]}, {"GSM2353810": [{"title": "SUBJ.0041, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0041;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 67.2246575342465;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 31;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.45;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.355;\ttissue: Blood"}]}, {"GSM2353811": [{"title": "SUBJ.0041, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0041;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 67.2246575342465;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 31;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.45;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.355;\ttissue: Blood"}]}, {"GSM2353812": [{"title": "SUBJ.0698, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0698;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 52.5506849315068;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.608;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.059;\ttissue: Blood"}]}, {"GSM2353813": [{"title": "SUBJ.0698, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0698;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 52.5506849315068;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.608;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.059;\ttissue: Blood"}]}, {"GSM2353814": [{"title": "SUBJ.0698, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0698;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 52.5506849315068;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.608;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.059;\ttissue: Blood"}]}, {"GSM2353815": [{"title": "SUBJ.0420, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0420;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 43.9232876712328;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.11;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.151;\ttissue: Blood"}]}, {"GSM2353816": [{"title": "SUBJ.0420, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0420;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 43.9232876712328;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.11;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.151;\ttissue: Blood"}]}, {"GSM2353817": [{"title": "SUBJ.0420, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0420;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 43.9232876712328;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.11;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.151;\ttissue: Blood"}]}, {"GSM2353818": [{"title": "SUBJ.0546, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0546;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 50.7404371584699;\tregion: mex_ca_sa;\tsledai_at_baseline: 26;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.871;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.07;\ttissue: Blood"}]}, {"GSM2353819": [{"title": "SUBJ.0546, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0546;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 50.7404371584699;\tregion: mex_ca_sa;\tsledai_at_baseline: 26;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.871;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.07;\ttissue: Blood"}]}, {"GSM2353820": [{"title": "SUBJ.0546, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0546;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 50.7404371584699;\tregion: mex_ca_sa;\tsledai_at_baseline: 26;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.871;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.07;\ttissue: Blood"}]}, {"GSM2353821": [{"title": "SUBJ.1674, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1674;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: multiple;\tSex: Female;\tage_at_baseline: 31.9780821917808;\tregion: rest_world;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.65;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.566;\ttissue: Blood"}]}, {"GSM2353822": [{"title": "SUBJ.1674, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1674;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: multiple;\tSex: Female;\tage_at_baseline: 31.9780821917808;\tregion: rest_world;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.65;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.566;\ttissue: Blood"}]}, {"GSM2353823": [{"title": "SUBJ.1674, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1674;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: multiple;\tSex: Female;\tage_at_baseline: 31.9780821917808;\tregion: rest_world;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.65;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): H;\tc4_at_baseline (g/l): 0.566;\ttissue: Blood"}]}, {"GSM2353824": [{"title": "SUBJ.0535, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0535;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 52.7349726775956;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 7;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.955;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.156;\ttissue: Blood"}]}, {"GSM2353825": [{"title": "SUBJ.0535, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0535;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 52.7349726775956;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 7;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.955;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.156;\ttissue: Blood"}]}, {"GSM2353826": [{"title": "SUBJ.0535, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0535;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 52.7349726775956;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 7;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.955;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.156;\ttissue: Blood"}]}, {"GSM2353827": [{"title": "SUBJ.0601, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0601;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 55.9698630136986;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.6;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.274;\ttissue: Blood"}]}, {"GSM2353828": [{"title": "SUBJ.0228, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0228;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 53.5479452054794;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 102;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.21;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.094;\ttissue: Blood"}]}, {"GSM2353829": [{"title": "SUBJ.0228, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0228;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 53.5479452054794;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 102;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.21;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.094;\ttissue: Blood"}]}, {"GSM2353830": [{"title": "SUBJ.0228, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0228;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 53.5479452054794;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 102;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.21;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.094;\ttissue: Blood"}]}, {"GSM2353831": [{"title": "SUBJ.0674, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0674;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 46.6109589041095;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.818;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.161;\ttissue: Blood"}]}, {"GSM2353832": [{"title": "SUBJ.0674, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0674;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 46.6109589041095;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.818;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.161;\ttissue: Blood"}]}, {"GSM2353833": [{"title": "SUBJ.0674, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0674;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 46.6109589041095;\tregion: us_can;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.818;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.161;\ttissue: Blood"}]}, {"GSM2353834": [{"title": "SUBJ.0818, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0818;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 63.1150684931507;\tregion: us_can;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.899;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.187;\ttissue: Blood"}]}, {"GSM2353835": [{"title": "SUBJ.0818, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0818;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 63.1150684931507;\tregion: us_can;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.899;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.187;\ttissue: Blood"}]}, {"GSM2353836": [{"title": "SUBJ.0824, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0824;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 52.8465753424657;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 141;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.2;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.193;\ttissue: Blood"}]}, {"GSM2353837": [{"title": "SUBJ.0824, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0824;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 52.8465753424657;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 141;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.2;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.193;\ttissue: Blood"}]}, {"GSM2353838": [{"title": "SUBJ.0824, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0824;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 52.8465753424657;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 141;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.2;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.193;\ttissue: Blood"}]}, {"GSM2353839": [{"title": "SUBJ.0413, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0413;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 43.2465753424657;\tregion: rest_world;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.918;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2353840": [{"title": "SUBJ.0413, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0413;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 43.2465753424657;\tregion: rest_world;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.918;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2353841": [{"title": "SUBJ.0413, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0413;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 43.2465753424657;\tregion: rest_world;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.918;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2353842": [{"title": "SUBJ.0892, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0892;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 33.5835616438356;\tregion: us_can;\tsledai_at_baseline: 21;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 10;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.81;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.186;\ttissue: Blood"}]}, {"GSM2353843": [{"title": "SUBJ.0892, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0892;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 33.5835616438356;\tregion: us_can;\tsledai_at_baseline: 21;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 10;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.81;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.186;\ttissue: Blood"}]}, {"GSM2353844": [{"title": "SUBJ.0859, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0859;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: multiple;\tSex: Female;\tage_at_baseline: 44.8770491803278;\tregion: mex_ca_sa;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.17;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.245;\ttissue: Blood"}]}, {"GSM2353845": [{"title": "SUBJ.0859, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0859;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: multiple;\tSex: Female;\tage_at_baseline: 44.8770491803278;\tregion: mex_ca_sa;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.17;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.245;\ttissue: Blood"}]}, {"GSM2353846": [{"title": "SUBJ.0859, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0859;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: multiple;\tSex: Female;\tage_at_baseline: 44.8770491803278;\tregion: mex_ca_sa;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.17;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.245;\ttissue: Blood"}]}, {"GSM2353847": [{"title": "SUBJ.1760, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1760;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 19.5890410958904;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.32;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.15;\ttissue: Blood"}]}, {"GSM2353848": [{"title": "SUBJ.1760, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1760;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 19.5890410958904;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.32;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.15;\ttissue: Blood"}]}, {"GSM2353849": [{"title": "SUBJ.1760, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1760;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 19.5890410958904;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.32;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.15;\ttissue: Blood"}]}, {"GSM2353850": [{"title": "SUBJ.0656, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0656;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 28.9508196721311;\tregion: rest_world;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 124;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.817;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.159;\ttissue: Blood"}]}, {"GSM2353851": [{"title": "SUBJ.0656, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0656;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 28.9508196721311;\tregion: rest_world;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 124;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.817;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.159;\ttissue: Blood"}]}, {"GSM2353852": [{"title": "SUBJ.0656, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0656;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 28.9508196721311;\tregion: rest_world;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 124;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.817;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.159;\ttissue: Blood"}]}, {"GSM2353853": [{"title": "SUBJ.1794, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1794;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 26.2438356164383;\tregion: rest_world;\tsledai_at_baseline: 15;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 144;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.838;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.133;\ttissue: Blood"}]}, {"GSM2353854": [{"title": "SUBJ.1794, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1794;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 26.2438356164383;\tregion: rest_world;\tsledai_at_baseline: 15;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 144;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.838;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.133;\ttissue: Blood"}]}, {"GSM2353855": [{"title": "SUBJ.1794, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1794;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 26.2438356164383;\tregion: rest_world;\tsledai_at_baseline: 15;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 144;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.838;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.133;\ttissue: Blood"}]}, {"GSM2353856": [{"title": "SUBJ.0062, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0062;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 42.3643835616438;\tregion: europe;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.856;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.179;\ttissue: Blood"}]}, {"GSM2353857": [{"title": "SUBJ.0062, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0062;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 42.3643835616438;\tregion: europe;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.856;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.179;\ttissue: Blood"}]}, {"GSM2353858": [{"title": "SUBJ.0062, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0062;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 42.3643835616438;\tregion: europe;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.856;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.179;\ttissue: Blood"}]}, {"GSM2353859": [{"title": "SUBJ.0631, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0631;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 21.8770491803278;\tregion: mex_ca_sa;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 72;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.961;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.196;\ttissue: Blood"}]}, {"GSM2353860": [{"title": "SUBJ.0631, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0631;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 21.8770491803278;\tregion: mex_ca_sa;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 72;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.961;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.196;\ttissue: Blood"}]}, {"GSM2353861": [{"title": "SUBJ.0631, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0631;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 21.8770491803278;\tregion: mex_ca_sa;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 72;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.961;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.196;\ttissue: Blood"}]}, {"GSM2353862": [{"title": "SUBJ.1768, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1768;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 18.7377049180327;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 127;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.861;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.104;\ttissue: Blood"}]}, {"GSM2353863": [{"title": "SUBJ.1768, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1768;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 18.7377049180327;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 127;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.861;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.104;\ttissue: Blood"}]}, {"GSM2353864": [{"title": "SUBJ.1768, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1768;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 18.7377049180327;\tregion: mex_ca_sa;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 127;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.861;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.104;\ttissue: Blood"}]}, {"GSM2353865": [{"title": "SUBJ.0300, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0300;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 46.7808219178082;\tregion: us_can;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.68;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.206;\ttissue: Blood"}]}, {"GSM2353866": [{"title": "SUBJ.0300, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0300;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 46.7808219178082;\tregion: us_can;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.68;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.206;\ttissue: Blood"}]}, {"GSM2353867": [{"title": "SUBJ.0300, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0300;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 46.7808219178082;\tregion: us_can;\tsledai_at_baseline: 18;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.68;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.206;\ttissue: Blood"}]}, {"GSM2353868": [{"title": "SUBJ.0840, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0840;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 57.4767123287671;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 7;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.17;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.231;\ttissue: Blood"}]}, {"GSM2353869": [{"title": "SUBJ.1566, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1566;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 52.7950819672131;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.21;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.201;\ttissue: Blood"}]}, {"GSM2353870": [{"title": "SUBJ.1566, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1566;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 52.7950819672131;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.21;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.201;\ttissue: Blood"}]}, {"GSM2353871": [{"title": "SUBJ.1566, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1566;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 52.7950819672131;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.21;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.201;\ttissue: Blood"}]}, {"GSM2353872": [{"title": "SUBJ.0883, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0883;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 26.5260273972602;\tregion: europe;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.39;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2353873": [{"title": "SUBJ.0883, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0883;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 26.5260273972602;\tregion: europe;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.39;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2353874": [{"title": "SUBJ.0883, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0883;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 26.5260273972602;\tregion: europe;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.39;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.025;\ttissue: Blood"}]}, {"GSM2353875": [{"title": "SUBJ.1649, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1649;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 51.1424657534246;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.52;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.196;\ttissue: Blood"}]}, {"GSM2353876": [{"title": "SUBJ.1649, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1649;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 51.1424657534246;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.52;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.196;\ttissue: Blood"}]}, {"GSM2353877": [{"title": "SUBJ.1649, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1649;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 51.1424657534246;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.52;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.196;\ttissue: Blood"}]}, {"GSM2353878": [{"title": "SUBJ.0490, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0490;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 52.7431693989071;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.8;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.257;\ttissue: Blood"}]}, {"GSM2353879": [{"title": "SUBJ.0490, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0490;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 52.7431693989071;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.8;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.257;\ttissue: Blood"}]}, {"GSM2353880": [{"title": "SUBJ.0490, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0490;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 52.7431693989071;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.8;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.257;\ttissue: Blood"}]}, {"GSM2353881": [{"title": "SUBJ.1693, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1693;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 73.531506849315;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 141;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.23;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.202;\ttissue: Blood"}]}, {"GSM2353882": [{"title": "SUBJ.1693, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1693;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 73.531506849315;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 141;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.23;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.202;\ttissue: Blood"}]}, {"GSM2353883": [{"title": "SUBJ.1693, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1693;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 73.531506849315;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 141;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.23;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.202;\ttissue: Blood"}]}, {"GSM2353884": [{"title": "SUBJ.0938, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0938;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 37.6748633879781;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.924;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.152;\ttissue: Blood"}]}, {"GSM2353885": [{"title": "SUBJ.0938, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0938;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 37.6748633879781;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.924;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.152;\ttissue: Blood"}]}, {"GSM2353886": [{"title": "SUBJ.0938, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0938;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 37.6748633879781;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.924;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.152;\ttissue: Blood"}]}, {"GSM2353887": [{"title": "SUBJ.1319, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1319;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 30.8715846994535;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 62;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.758;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.157;\ttissue: Blood"}]}, {"GSM2353888": [{"title": "SUBJ.1319, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1319;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 30.8715846994535;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 62;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.758;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.157;\ttissue: Blood"}]}, {"GSM2353889": [{"title": "SUBJ.1319, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1319;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 30.8715846994535;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 62;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.758;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.157;\ttissue: Blood"}]}, {"GSM2353890": [{"title": "SUBJ.1582, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1582;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 25.7622950819672;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 147;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.806;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.12;\ttissue: Blood"}]}, {"GSM2353891": [{"title": "SUBJ.1582, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1582;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 25.7622950819672;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 147;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.806;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.12;\ttissue: Blood"}]}, {"GSM2353892": [{"title": "SUBJ.1582, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1582;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 25.7622950819672;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 147;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.806;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.12;\ttissue: Blood"}]}, {"GSM2353893": [{"title": "SUBJ.0217, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0217;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 71.9890410958904;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 24;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.04;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.16;\ttissue: Blood"}]}, {"GSM2353894": [{"title": "SUBJ.0217, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0217;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 71.9890410958904;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 24;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.04;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.16;\ttissue: Blood"}]}, {"GSM2353895": [{"title": "SUBJ.0217, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0217;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 71.9890410958904;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 24;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.04;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.16;\ttissue: Blood"}]}, {"GSM2353896": [{"title": "SUBJ.0997, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0997;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 41.7322404371584;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 241;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.584;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.051;\ttissue: Blood"}]}, {"GSM2353897": [{"title": "SUBJ.0997, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0997;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 41.7322404371584;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 241;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.584;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.051;\ttissue: Blood"}]}, {"GSM2353898": [{"title": "SUBJ.0997, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0997;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 41.7322404371584;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 241;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.584;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.051;\ttissue: Blood"}]}, {"GSM2353899": [{"title": "SUBJ.1722, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1722;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: asian;\tSex: Female;\tage_at_baseline: 31.8333333333333;\tregion: us_can;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 135;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.878;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.222;\ttissue: Blood"}]}, {"GSM2353900": [{"title": "SUBJ.1722, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1722;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: asian;\tSex: Female;\tage_at_baseline: 31.8333333333333;\tregion: us_can;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 135;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.878;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.222;\ttissue: Blood"}]}, {"GSM2353901": [{"title": "SUBJ.1722, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1722;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: asian;\tSex: Female;\tage_at_baseline: 31.8333333333333;\tregion: us_can;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 135;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.878;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.222;\ttissue: Blood"}]}, {"GSM2353902": [{"title": "SUBJ.0172, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0172;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 55.4712328767123;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 54;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.25;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.186;\ttissue: Blood"}]}, {"GSM2353903": [{"title": "SUBJ.0172, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0172;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 55.4712328767123;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 54;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.25;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.186;\ttissue: Blood"}]}, {"GSM2353904": [{"title": "SUBJ.0172, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0172;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 55.4712328767123;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 54;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.25;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.186;\ttissue: Blood"}]}, {"GSM2353905": [{"title": "SUBJ.0433, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0433;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 34.3205479452054;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.39;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.264;\ttissue: Blood"}]}, {"GSM2353906": [{"title": "SUBJ.0433, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0433;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 34.3205479452054;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.39;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.264;\ttissue: Blood"}]}, {"GSM2353907": [{"title": "SUBJ.0433, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0433;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 34.3205479452054;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.39;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.264;\ttissue: Blood"}]}, {"GSM2353908": [{"title": "SUBJ.1194, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1194;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 49.4109589041096;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.25;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.162;\ttissue: Blood"}]}, {"GSM2353909": [{"title": "SUBJ.1194, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1194;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 49.4109589041096;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.25;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.162;\ttissue: Blood"}]}, {"GSM2353910": [{"title": "SUBJ.1194, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1194;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 49.4109589041096;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.25;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.162;\ttissue: Blood"}]}, {"GSM2353911": [{"title": "SUBJ.1323, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1323;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 49.5561643835616;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 16;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.85;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.069;\ttissue: Blood"}]}, {"GSM2353912": [{"title": "SUBJ.1323, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1323;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 49.5561643835616;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 16;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.85;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.069;\ttissue: Blood"}]}, {"GSM2353913": [{"title": "SUBJ.1323, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1323;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 49.5561643835616;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 16;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.85;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.069;\ttissue: Blood"}]}, {"GSM2353914": [{"title": "SUBJ.1570, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1570;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 40.4876712328767;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.845;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.119;\ttissue: Blood"}]}, {"GSM2353915": [{"title": "SUBJ.1570, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1570;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 40.4876712328767;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.845;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.119;\ttissue: Blood"}]}, {"GSM2353916": [{"title": "SUBJ.1570, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1570;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 40.4876712328767;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.845;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.119;\ttissue: Blood"}]}, {"GSM2353917": [{"title": "SUBJ.0846, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0846;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 49.7158469945355;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 19;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.2;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.139;\ttissue: Blood"}]}, {"GSM2353918": [{"title": "SUBJ.0846, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0846;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 49.7158469945355;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 19;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.2;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.139;\ttissue: Blood"}]}, {"GSM2353919": [{"title": "SUBJ.0846, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0846;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: amer_ind_ak_native;\tSex: Female;\tage_at_baseline: 49.7158469945355;\tregion: mex_ca_sa;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 19;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.2;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.139;\ttissue: Blood"}]}, {"GSM2353920": [{"title": "SUBJ.0576, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0576;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 39.9754098360655;\tregion: rest_world;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.86;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.102;\ttissue: Blood"}]}, {"GSM2353921": [{"title": "SUBJ.0576, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0576;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 39.9754098360655;\tregion: rest_world;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.86;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.102;\ttissue: Blood"}]}, {"GSM2353922": [{"title": "SUBJ.0951, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0951;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 36.372602739726;\tregion: europe;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.814;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.104;\ttissue: Blood"}]}, {"GSM2353923": [{"title": "SUBJ.0951, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0951;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 36.372602739726;\tregion: europe;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.814;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.104;\ttissue: Blood"}]}, {"GSM2353924": [{"title": "SUBJ.0951, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0951;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 36.372602739726;\tregion: europe;\tsledai_at_baseline: 14;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.814;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.104;\ttissue: Blood"}]}, {"GSM2353925": [{"title": "SUBJ.0289, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0289;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 34.6082191780822;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 34;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.118;\ttissue: Blood"}]}, {"GSM2353926": [{"title": "SUBJ.0289, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0289;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 34.6082191780822;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 34;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.118;\ttissue: Blood"}]}, {"GSM2353927": [{"title": "SUBJ.0289, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0289;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 34.6082191780822;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 34;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.118;\ttissue: Blood"}]}, {"GSM2353928": [{"title": "SUBJ.0274, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0274;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 59.4712328767123;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.69;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.26;\ttissue: Blood"}]}, {"GSM2353929": [{"title": "SUBJ.0274, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0274;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 59.4712328767123;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.69;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.26;\ttissue: Blood"}]}, {"GSM2353930": [{"title": "SUBJ.0274, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0274;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 59.4712328767123;\tregion: europe;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.69;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.26;\ttissue: Blood"}]}, {"GSM2353931": [{"title": "SUBJ.0604, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0604;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 35.9289617486338;\tregion: rest_world;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 15;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.964;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.068;\ttissue: Blood"}]}, {"GSM2353932": [{"title": "SUBJ.0604, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0604;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 35.9289617486338;\tregion: rest_world;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 15;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.964;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.068;\ttissue: Blood"}]}, {"GSM2353933": [{"title": "SUBJ.1410, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1410;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 51.0383561643835;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.21;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.261;\ttissue: Blood"}]}, {"GSM2353934": [{"title": "SUBJ.1410, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1410;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 51.0383561643835;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.21;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.261;\ttissue: Blood"}]}, {"GSM2353935": [{"title": "SUBJ.1675, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1675;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 53.3424657534246;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 30;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.68;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.226;\ttissue: Blood"}]}, {"GSM2353936": [{"title": "SUBJ.1675, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1675;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 53.3424657534246;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 30;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.68;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.226;\ttissue: Blood"}]}, {"GSM2353937": [{"title": "SUBJ.0865, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0865;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: multiple;\tSex: Female;\tage_at_baseline: 50.3534246575342;\tregion: rest_world;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 147;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.906;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.119;\ttissue: Blood"}]}, {"GSM2353938": [{"title": "SUBJ.0865, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0865;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: multiple;\tSex: Female;\tage_at_baseline: 50.3534246575342;\tregion: rest_world;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 147;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.906;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.119;\ttissue: Blood"}]}, {"GSM2353939": [{"title": "SUBJ.0865, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0865;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: multiple;\tSex: Female;\tage_at_baseline: 50.3534246575342;\tregion: rest_world;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 147;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.906;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.119;\ttissue: Blood"}]}, {"GSM2353940": [{"title": "SUBJ.0325, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0325;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 41.0547945205479;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.32;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.181;\ttissue: Blood"}]}, {"GSM2353941": [{"title": "SUBJ.0325, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0325;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 41.0547945205479;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.32;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.181;\ttissue: Blood"}]}, {"GSM2353942": [{"title": "SUBJ.0325, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0325;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 41.0547945205479;\tregion: us_can;\tsledai_at_baseline: 12;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.32;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.181;\ttissue: Blood"}]}, {"GSM2353943": [{"title": "SUBJ.0877, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0877;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 27.8169398907103;\tregion: rest_world;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 11;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.12;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.152;\ttissue: Blood"}]}, {"GSM2353944": [{"title": "SUBJ.0877, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0877;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 27.8169398907103;\tregion: rest_world;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 11;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.12;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.152;\ttissue: Blood"}]}, {"GSM2353945": [{"title": "SUBJ.0877, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0877;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 27.8169398907103;\tregion: rest_world;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 11;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.12;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.152;\ttissue: Blood"}]}, {"GSM2353946": [{"title": "SUBJ.0829, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0829;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 36.1232876712328;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 52;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.742;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.088;\ttissue: Blood"}]}, {"GSM2353947": [{"title": "SUBJ.0829, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0829;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 36.1232876712328;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 52;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.742;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.088;\ttissue: Blood"}]}, {"GSM2353948": [{"title": "SUBJ.0829, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0829;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 36.1232876712328;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 52;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.742;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.088;\ttissue: Blood"}]}, {"GSM2353949": [{"title": "SUBJ.1166, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1166;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 40.1260273972602;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.21;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.102;\ttissue: Blood"}]}, {"GSM2353950": [{"title": "SUBJ.1166, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1166;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 40.1260273972602;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.21;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.102;\ttissue: Blood"}]}, {"GSM2353951": [{"title": "SUBJ.1166, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1166;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 40.1260273972602;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.21;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.102;\ttissue: Blood"}]}, {"GSM2353952": [{"title": "SUBJ.1405, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1405;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 45.9890410958904;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 47;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.903;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.159;\ttissue: Blood"}]}, {"GSM2353953": [{"title": "SUBJ.1405, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1405;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 45.9890410958904;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 47;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.903;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.159;\ttissue: Blood"}]}, {"GSM2353954": [{"title": "SUBJ.0050, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0050;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 41.7786885245901;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.803;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.131;\ttissue: Blood"}]}, {"GSM2353955": [{"title": "SUBJ.0050, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0050;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 41.7786885245901;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.803;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.131;\ttissue: Blood"}]}, {"GSM2353956": [{"title": "SUBJ.0050, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0050;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 41.7786885245901;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.803;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.131;\ttissue: Blood"}]}, {"GSM2353957": [{"title": "SUBJ.0109, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0109;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 46.0931506849315;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 143;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.964;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.186;\ttissue: Blood"}]}, {"GSM2353958": [{"title": "SUBJ.0109, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0109;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 46.0931506849315;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 143;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.964;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.186;\ttissue: Blood"}]}, {"GSM2353959": [{"title": "SUBJ.0109, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0109;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 46.0931506849315;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 143;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.964;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.186;\ttissue: Blood"}]}, {"GSM2353960": [{"title": "SUBJ.0437, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0437;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 55.9698630136986;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 38;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.721;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.102;\ttissue: Blood"}]}, {"GSM2353961": [{"title": "SUBJ.0437, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0437;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 55.9698630136986;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 38;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.721;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.102;\ttissue: Blood"}]}, {"GSM2353962": [{"title": "SUBJ.0437, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0437;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 55.9698630136986;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 38;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.721;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.102;\ttissue: Blood"}]}, {"GSM2353963": [{"title": "SUBJ.1670, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1670;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 21.2821917808219;\tregion: mex_ca_sa;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 230;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.818;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.098;\ttissue: Blood"}]}, {"GSM2353964": [{"title": "SUBJ.1670, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1670;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 21.2821917808219;\tregion: mex_ca_sa;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 230;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.818;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.098;\ttissue: Blood"}]}, {"GSM2353965": [{"title": "SUBJ.1670, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1670;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 21.2821917808219;\tregion: mex_ca_sa;\tsledai_at_baseline: 20;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 230;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.818;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.098;\ttissue: Blood"}]}, {"GSM2353966": [{"title": "SUBJ.0369, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0369;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 28.531506849315;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 50;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.946;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.194;\ttissue: Blood"}]}, {"GSM2353967": [{"title": "SUBJ.0369, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0369;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 28.531506849315;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 50;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.946;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.194;\ttissue: Blood"}]}, {"GSM2353968": [{"title": "SUBJ.0369, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0369;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 28.531506849315;\tregion: europe;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 50;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 0.946;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.194;\ttissue: Blood"}]}, {"GSM2353969": [{"title": "SUBJ.1653, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1653;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 57.5643835616438;\tregion: rest_world;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.37;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.253;\ttissue: Blood"}]}, {"GSM2353970": [{"title": "SUBJ.1653, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1653;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 57.5643835616438;\tregion: rest_world;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.37;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.253;\ttissue: Blood"}]}, {"GSM2353971": [{"title": "SUBJ.1653, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1653;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 57.5643835616438;\tregion: rest_world;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.37;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.253;\ttissue: Blood"}]}, {"GSM2353972": [{"title": "SUBJ.1534, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1534;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 40.811475409836;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 7;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.07;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.232;\ttissue: Blood"}]}, {"GSM2353973": [{"title": "SUBJ.1534, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1534;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 40.811475409836;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 7;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.07;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.232;\ttissue: Blood"}]}, {"GSM2353974": [{"title": "SUBJ.1534, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1534;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 40.811475409836;\tregion: europe;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 7;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.07;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.232;\ttissue: Blood"}]}, {"GSM2353975": [{"title": "SUBJ.1735, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1735;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 34.5123287671232;\tregion: europe;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.894;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.112;\ttissue: Blood"}]}, {"GSM2353976": [{"title": "SUBJ.1735, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1735;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 34.5123287671232;\tregion: europe;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.894;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.112;\ttissue: Blood"}]}, {"GSM2353977": [{"title": "SUBJ.1735, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1735;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 34.5123287671232;\tregion: europe;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 9;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.894;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.112;\ttissue: Blood"}]}, {"GSM2353978": [{"title": "SUBJ.1759, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1759;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 56.9508196721311;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 43;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.27;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.303;\ttissue: Blood"}]}, {"GSM2353979": [{"title": "SUBJ.1759, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1759;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 56.9508196721311;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 43;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.27;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.303;\ttissue: Blood"}]}, {"GSM2353980": [{"title": "SUBJ.1759, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1759;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 56.9508196721311;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 43;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.27;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.303;\ttissue: Blood"}]}, {"GSM2353981": [{"title": "SUBJ.0215, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0215;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 60.0575342465753;\tregion: us_can;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 7;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.24;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.207;\ttissue: Blood"}]}, {"GSM2353982": [{"title": "SUBJ.0215, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0215;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 60.0575342465753;\tregion: us_can;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 7;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.24;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.207;\ttissue: Blood"}]}, {"GSM2353983": [{"title": "SUBJ.0215, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0215;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: afr_amer;\tSex: Female;\tage_at_baseline: 60.0575342465753;\tregion: us_can;\tsledai_at_baseline: 16;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 7;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.24;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.207;\ttissue: Blood"}]}, {"GSM2353984": [{"title": "SUBJ.0038, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0038;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 60.9616438356164;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.08;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.239;\ttissue: Blood"}]}, {"GSM2353985": [{"title": "SUBJ.0038, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0038;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 60.9616438356164;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.08;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.239;\ttissue: Blood"}]}, {"GSM2353986": [{"title": "SUBJ.0038, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0038;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 60.9616438356164;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.08;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.239;\ttissue: Blood"}]}, {"GSM2353987": [{"title": "SUBJ.1100, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1100;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 49.2027397260274;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.56;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.28;\ttissue: Blood"}]}, {"GSM2353988": [{"title": "SUBJ.1100, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1100;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 49.2027397260274;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.56;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.28;\ttissue: Blood"}]}, {"GSM2353989": [{"title": "SUBJ.1100, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1100;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 49.2027397260274;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 6;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.56;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.28;\ttissue: Blood"}]}, {"GSM2353990": [{"title": "SUBJ.1600, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1600;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 48.6693989071038;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 20;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.42;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.326;\ttissue: Blood"}]}, {"GSM2353991": [{"title": "SUBJ.1600, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1600;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 48.6693989071038;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 20;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.42;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.326;\ttissue: Blood"}]}, {"GSM2353992": [{"title": "SUBJ.1600, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1600;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 48.6693989071038;\tregion: us_can;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 20;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.42;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.326;\ttissue: Blood"}]}, {"GSM2353993": [{"title": "SUBJ.1695, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1695;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 47.9698630136986;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.56;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.272;\ttissue: Blood"}]}, {"GSM2353994": [{"title": "SUBJ.1695, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1695;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 47.9698630136986;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.56;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.272;\ttissue: Blood"}]}, {"GSM2353995": [{"title": "SUBJ.1695, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1695;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 47.9698630136986;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.56;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.272;\ttissue: Blood"}]}, {"GSM2353996": [{"title": "SUBJ.0759, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0759;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 30.0273972602739;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 122;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.25;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.174;\ttissue: Blood"}]}, {"GSM2353997": [{"title": "SUBJ.0759, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0759;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 30.0273972602739;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 122;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.25;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.174;\ttissue: Blood"}]}, {"GSM2353998": [{"title": "SUBJ.0759, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0759;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Male;\tage_at_baseline: 30.0273972602739;\tregion: mex_ca_sa;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 122;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.25;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.174;\ttissue: Blood"}]}, {"GSM2353999": [{"title": "SUBJ.1242, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1242;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 36.9890410958904;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.562;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.079;\ttissue: Blood"}]}, {"GSM2354000": [{"title": "SUBJ.1242, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1242;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 36.9890410958904;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.562;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.079;\ttissue: Blood"}]}, {"GSM2354001": [{"title": "SUBJ.1242, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1242;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 36.9890410958904;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 297;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.562;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.079;\ttissue: Blood"}]}, {"GSM2354002": [{"title": "SUBJ.1201, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1201;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 50.7698630136986;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.47;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.284;\ttissue: Blood"}]}, {"GSM2354003": [{"title": "SUBJ.1201, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1201;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 50.7698630136986;\tregion: us_can;\tsledai_at_baseline: 6;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.47;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.284;\ttissue: Blood"}]}, {"GSM2354004": [{"title": "SUBJ.1354, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1354;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 34.5506849315068;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 109;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.44;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.166;\ttissue: Blood"}]}, {"GSM2354005": [{"title": "SUBJ.1354, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1354;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 34.5506849315068;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 109;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.44;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.166;\ttissue: Blood"}]}, {"GSM2354006": [{"title": "SUBJ.1354, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with Placebo treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1354;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): Placebo;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 34.5506849315068;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 109;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.44;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.166;\ttissue: Blood"}]}, {"GSM2354007": [{"title": "SUBJ.0819, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0819;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 40.6054794520548;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 85;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.863;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.1;\ttissue: Blood"}]}, {"GSM2354008": [{"title": "SUBJ.0819, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0819;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 40.6054794520548;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 85;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.863;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.1;\ttissue: Blood"}]}, {"GSM2354009": [{"title": "SUBJ.0819, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0819;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 40.6054794520548;\tregion: europe;\tsledai_at_baseline: 10;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 85;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.863;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.1;\ttissue: Blood"}]}, {"GSM2354010": [{"title": "SUBJ.1595, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1595;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 35.8661202185792;\tregion: europe;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 87;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.52;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.181;\ttissue: Blood"}]}, {"GSM2354011": [{"title": "SUBJ.1595, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1595;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 35.8661202185792;\tregion: europe;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 87;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.52;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.181;\ttissue: Blood"}]}, {"GSM2354012": [{"title": "SUBJ.1595, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q2W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1595;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q2W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 35.8661202185792;\tregion: europe;\tsledai_at_baseline: 9;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Positive;\tantidsdna_at_baseline (iu): 87;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): N;\tc3_at_baseline (g/l): 1.52;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.181;\ttissue: Blood"}]}, {"GSM2354013": [{"title": "SUBJ.0638, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.0638;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 52.186301369863;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.695;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.18;\ttissue: Blood"}]}, {"GSM2354014": [{"title": "SUBJ.0638, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0638;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 52.186301369863;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.695;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.18;\ttissue: Blood"}]}, {"GSM2354015": [{"title": "SUBJ.0638, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.0638;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 52.186301369863;\tregion: us_can;\tsledai_at_baseline: 8;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.695;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): N;\tc4_at_baseline (g/l): 0.18;\ttissue: Blood"}]}, {"GSM2354016": [{"title": "SUBJ.1560, SLE, baseline"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at baseline"}, {"characteristics_ch1": "subject_id: SUBJ.1560;\ttime: baseline;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 40.7890410958904;\tregion: us_can;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.488;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.098;\ttissue: Blood"}]}, {"GSM2354017": [{"title": "SUBJ.1560, SLE, week16"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week16 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1560;\ttime: week16;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 40.7890410958904;\tregion: us_can;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.488;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.098;\ttissue: Blood"}]}, {"GSM2354018": [{"title": "SUBJ.1560, SLE, week52"}, {"type": "RNA"}, {"source_name_ch1": "Blood sample from SLE subject at week52 with LY 120 mg Q4W treatment"}, {"characteristics_ch1": "subject_id: SUBJ.1560;\ttime: week52;\tgroup: Systemic lupus erythematosus (SLE);\ttreatment (q2w=once in 2 weeks; q4w=once in 4 weeks): LY 120 mg Q4W;\tbatch: ILLUMINATE-2;\trace: white;\tSex: Female;\tage_at_baseline: 40.7890410958904;\tregion: us_can;\tsledai_at_baseline: 11;\tadna_at_baseline (anti-dsdna level: Negative < 30 IU; Positive  \u2265 30 IU): Negative;\tantidsdna_at_baseline (iu): 3;\tc3base (low < 0.9 g/l; normal >= 0.9 g/l; h = high): L;\tc3_at_baseline (g/l): 0.488;\tc4base (low < 0.1 g/l; normal >= 0.1 g/l; h = high): L;\tc4_at_baseline (g/l): 0.098;\ttissue: Blood"}]}, {"GSM2395321": [{"title": "Tumor OCT Curl Rep1"}, {"type": "RNA"}, {"source_name_ch1": "PDAC tumor_STS cohort"}, {"characteristics_ch1": "cohort: median survival of >3 month and <1 year postsurgery; short term survivors (STS);\ttissue: human pancreatic ductal adenocarcinoma (PDAC) tumor"}]}, {"GSM2395322": [{"title": "Tumor OCT Curl Rep2"}, {"type": "RNA"}, {"source_name_ch1": "PDAC tumor_STS cohort"}, {"characteristics_ch1": "cohort: median survival of >3 month and <1 year postsurgery; short term survivors (STS);\ttissue: human pancreatic ductal adenocarcinoma (PDAC) tumor"}]}, {"GSM2395323": [{"title": "Tumor OCT Curl Rep3"}, {"type": "RNA"}, {"source_name_ch1": "PDAC tumor_STS cohort"}, {"characteristics_ch1": "cohort: median survival of >3 month and <1 year postsurgery; short term survivors (STS);\ttissue: human pancreatic ductal adenocarcinoma (PDAC) tumor"}]}, {"GSM2395324": [{"title": "Tumor OCT Curl Rep4"}, {"type": "RNA"}, {"source_name_ch1": "PDAC tumor_STS cohort"}, {"characteristics_ch1": "cohort: median survival of >3 month and <1 year postsurgery; short term survivors (STS);\ttissue: human pancreatic ductal adenocarcinoma (PDAC) tumor"}]}, {"GSM2395325": [{"title": "Tumor OCT Curl Rep5"}, {"type": "RNA"}, {"source_name_ch1": "PDAC tumor_STS cohort"}, {"characteristics_ch1": "cohort: median survival of >3 month and <1 year postsurgery; short term survivors (STS);\ttissue: human pancreatic ductal adenocarcinoma (PDAC) tumor"}]}, {"GSM2395326": [{"title": "Tumor OCT Curl Rep6"}, {"type": "RNA"}, {"source_name_ch1": "PDAC tumor_STS cohort"}, {"characteristics_ch1": "cohort: median survival of >3 month and <1 year postsurgery; short term survivors (STS);\ttissue: human pancreatic ductal adenocarcinoma (PDAC) tumor"}]}, {"GSM2395327": [{"title": "Tumor OCT Curl Rep7"}, {"type": "RNA"}, {"source_name_ch1": "PDAC tumor_STS cohort"}, {"characteristics_ch1": "cohort: median survival of >3 month and <1 year postsurgery; short term survivors (STS);\ttissue: human pancreatic ductal adenocarcinoma (PDAC) tumor"}]}, {"GSM2395328": [{"title": "Tumor OCT Curl Rep8"}, {"type": "RNA"}, {"source_name_ch1": "PDAC tumor_STS cohort"}, {"characteristics_ch1": "cohort: median survival of >3 month and <1 year postsurgery; short term survivors (STS);\ttissue: human pancreatic ductal adenocarcinoma (PDAC) tumor"}]}, {"GSM2395329": [{"title": "Tumor OCT Curl Rep9"}, {"type": "RNA"}, {"source_name_ch1": "PDAC tumor_STS cohort"}, {"characteristics_ch1": "cohort: median survival of >3 month and <1 year postsurgery; short term survivors (STS);\ttissue: human pancreatic ductal adenocarcinoma (PDAC) tumor"}]}, {"GSM2395330": [{"title": "Tumor OCT Curl Rep10"}, {"type": "RNA"}, {"source_name_ch1": "PDAC tumor_STS cohort"}, {"characteristics_ch1": "cohort: median survival of >3 month and <1 year postsurgery; short term survivors (STS);\ttissue: human pancreatic ductal adenocarcinoma (PDAC) tumor"}]}, {"GSM2395331": [{"title": "Tumor OCT Curl Rep11"}, {"type": "RNA"}, {"source_name_ch1": "PDAC tumor_STS cohort"}, {"characteristics_ch1": "cohort: median survival of >3 month and <1 year postsurgery; short term survivors (STS);\ttissue: human pancreatic ductal adenocarcinoma (PDAC) tumor"}]}, {"GSM2395332": [{"title": "Tumor OCT Curl Rep12"}, {"type": "RNA"}, {"source_name_ch1": "PDAC tumor_STS cohort"}, {"characteristics_ch1": "cohort: median survival of >3 month and <1 year postsurgery; short term survivors (STS);\ttissue: human pancreatic ductal adenocarcinoma (PDAC) tumor"}]}, {"GSM2395333": [{"title": "Tumor OCT Curl Rep13"}, {"type": "RNA"}, {"source_name_ch1": "PDAC tumor_STS cohort"}, {"characteristics_ch1": "cohort: median survival of >3 month and <1 year postsurgery; short term survivors (STS);\ttissue: human pancreatic ductal adenocarcinoma (PDAC) tumor"}]}, {"GSM2395334": [{"title": "Tumor OCT Curl Rep14"}, {"type": "RNA"}, {"source_name_ch1": "PDAC tumor_STS cohort"}, {"characteristics_ch1": "cohort: median survival of >3 month and <1 year postsurgery; short term survivors (STS);\ttissue: human pancreatic ductal adenocarcinoma (PDAC) tumor"}]}, {"GSM2395335": [{"title": "Tumor OCT Curl Rep15"}, {"type": "RNA"}, {"source_name_ch1": "PDAC tumor_STS cohort"}, {"characteristics_ch1": "cohort: median survival of >3 month and <1 year postsurgery; short term survivors (STS);\ttissue: human pancreatic ductal adenocarcinoma (PDAC) tumor"}]}, {"GSM2395336": [{"title": "Tumor OCT Curl Rep16"}, {"type": "RNA"}, {"source_name_ch1": "PDAC tumor_LTS cohort"}, {"characteristics_ch1": "cohort: overall survival of >3 years postsurgery; long term survivors (LTS);\ttissue: human pancreatic ductal adenocarcinoma (PDAC) tumor"}]}, {"GSM2395337": [{"title": "Tumor OCT Curl Rep17"}, {"type": "RNA"}, {"source_name_ch1": "PDAC tumor_LTS cohort"}, {"characteristics_ch1": "cohort: overall survival of >3 years postsurgery; long term survivors (LTS);\ttissue: human pancreatic ductal adenocarcinoma (PDAC) tumor"}]}, {"GSM2395338": [{"title": "Tumor OCT Curl Rep18"}, {"type": "RNA"}, {"source_name_ch1": "PDAC tumor_LTS cohort"}, {"characteristics_ch1": "cohort: overall survival of >3 years postsurgery; long term survivors (LTS);\ttissue: human pancreatic ductal adenocarcinoma (PDAC) tumor"}]}, {"GSM2395339": [{"title": "Tumor OCT Curl Rep19"}, {"type": "RNA"}, {"source_name_ch1": "PDAC tumor_LTS cohort"}, {"characteristics_ch1": "cohort: overall survival of >3 years postsurgery; long term survivors (LTS);\ttissue: human pancreatic ductal adenocarcinoma (PDAC) tumor"}]}, {"GSM2395340": [{"title": "Tumor OCT Curl Rep20"}, {"type": "RNA"}, {"source_name_ch1": "PDAC tumor_LTS cohort"}, {"characteristics_ch1": "cohort: overall survival of >3 years postsurgery; long term survivors (LTS);\ttissue: human pancreatic ductal adenocarcinoma (PDAC) tumor"}]}, {"GSM2395341": [{"title": "Tumor OCT Curl Rep21"}, {"type": "RNA"}, {"source_name_ch1": "PDAC tumor_LTS cohort"}, {"characteristics_ch1": "cohort: overall survival of >3 years postsurgery; long term survivors (LTS);\ttissue: human pancreatic ductal adenocarcinoma (PDAC) tumor"}]}, {"GSM2395342": [{"title": "Tumor OCT Curl Rep22"}, {"type": "RNA"}, {"source_name_ch1": "PDAC tumor_LTS cohort"}, {"characteristics_ch1": "cohort: overall survival of >3 years postsurgery; long term survivors (LTS);\ttissue: human pancreatic ductal adenocarcinoma (PDAC) tumor"}]}, {"GSM2395343": [{"title": "Tumor OCT Curl Rep23"}, {"type": "RNA"}, {"source_name_ch1": "PDAC tumor_LTS cohort"}, {"characteristics_ch1": "cohort: overall survival of >3 years postsurgery; long term survivors (LTS);\ttissue: human pancreatic ductal adenocarcinoma (PDAC) tumor"}]}, {"GSM2395344": [{"title": "Tumor OCT Curl Rep24"}, {"type": "RNA"}, {"source_name_ch1": "PDAC tumor_LTS cohort"}, {"characteristics_ch1": "cohort: overall survival of >3 years postsurgery; long term survivors (LTS);\ttissue: human pancreatic ductal adenocarcinoma (PDAC) tumor"}]}, {"GSM2395345": [{"title": "Tumor OCT Curl Rep25"}, {"type": "RNA"}, {"source_name_ch1": "PDAC tumor_LTS cohort"}, {"characteristics_ch1": "cohort: overall survival of >3 years postsurgery; long term survivors (LTS);\ttissue: human pancreatic ductal adenocarcinoma (PDAC) tumor"}]}, {"GSM2395346": [{"title": "Tumor OCT Curl Rep26"}, {"type": "RNA"}, {"source_name_ch1": "PDAC tumor_LTS cohort"}, {"characteristics_ch1": "cohort: overall survival of >3 years postsurgery; long term survivors (LTS);\ttissue: human pancreatic ductal adenocarcinoma (PDAC) tumor"}]}, {"GSM2395347": [{"title": "Tumor OCT Curl Rep27"}, {"type": "RNA"}, {"source_name_ch1": "PDAC tumor_LTS cohort"}, {"characteristics_ch1": "cohort: overall survival of >3 years postsurgery; long term survivors (LTS);\ttissue: human pancreatic ductal adenocarcinoma (PDAC) tumor"}]}, {"GSM2395348": [{"title": "Tumor OCT Curl Rep28"}, {"type": "RNA"}, {"source_name_ch1": "PDAC tumor_LTS cohort"}, {"characteristics_ch1": "cohort: overall survival of >3 years postsurgery; long term survivors (LTS);\ttissue: human pancreatic ductal adenocarcinoma (PDAC) tumor"}]}, {"GSM2395349": [{"title": "Tumor OCT Curl Rep29"}, {"type": "RNA"}, {"source_name_ch1": "PDAC tumor_LTS cohort"}, {"characteristics_ch1": "cohort: overall survival of >3 years postsurgery; long term survivors (LTS);\ttissue: human pancreatic ductal adenocarcinoma (PDAC) tumor"}]}, {"GSM2395350": [{"title": "Tumor OCT Curl Rep30"}, {"type": "RNA"}, {"source_name_ch1": "PDAC tumor_LTS cohort"}, {"characteristics_ch1": "cohort: overall survival of >3 years postsurgery; long term survivors (LTS);\ttissue: human pancreatic ductal adenocarcinoma (PDAC) tumor"}]}, {"GSM1868934": [{"title": "RCM1"}, {"type": "RNA"}, {"source_name_ch1": "liver"}, {"characteristics_ch1": "tissue type: colorectal cancer liver metastasis"}]}, {"GSM1868935": [{"title": "RCM4"}, {"type": "RNA"}, {"source_name_ch1": "liver"}, {"characteristics_ch1": "tissue type: colorectal cancer liver metastasis"}]}, {"GSM1868936": [{"title": "RCM5"}, {"type": "RNA"}, {"source_name_ch1": "liver"}, {"characteristics_ch1": "tissue type: colorectal cancer liver metastasis"}]}, {"GSM1868937": [{"title": "RCM6"}, {"type": "RNA"}, {"source_name_ch1": "liver"}, {"characteristics_ch1": "tissue type: colorectal cancer liver metastasis"}]}, {"GSM1868938": [{"title": "RCM7"}, {"type": "RNA"}, {"source_name_ch1": "liver"}, {"characteristics_ch1": "tissue type: colorectal cancer liver metastasis"}]}, {"GSM1868939": [{"title": "RCM8"}, {"type": "RNA"}, {"source_name_ch1": "liver"}, {"characteristics_ch1": "tissue type: colorectal cancer liver metastasis"}]}, {"GSM1868940": [{"title": "RCM9"}, {"type": "RNA"}, {"source_name_ch1": "liver"}, {"characteristics_ch1": "tissue type: colorectal cancer liver metastasis"}]}, {"GSM1868941": [{"title": "RCM10"}, {"type": "RNA"}, {"source_name_ch1": "liver"}, {"characteristics_ch1": "tissue type: colorectal cancer liver metastasis"}]}, {"GSM1868942": [{"title": "RCM11"}, {"type": "RNA"}, {"source_name_ch1": "liver"}, {"characteristics_ch1": "tissue type: colorectal cancer liver metastasis"}]}, {"GSM1868943": [{"title": "RPC1"}, {"type": "RNA"}, {"source_name_ch1": "colon"}, {"characteristics_ch1": "tissue type: primary colorectal cancer liver metastasis"}]}, {"GSM1868944": [{"title": "RPC2"}, {"type": "RNA"}, {"source_name_ch1": "colon"}, {"characteristics_ch1": "tissue type: primary colorectal cancer liver metastasis"}]}, {"GSM1868945": [{"title": "RPC4"}, {"type": "RNA"}, {"source_name_ch1": "colon"}, {"characteristics_ch1": "tissue type: primary colorectal cancer liver metastasis"}]}, {"GSM1868946": [{"title": "RPC6"}, {"type": "RNA"}, {"source_name_ch1": "colon"}, {"characteristics_ch1": "tissue type: primary colorectal cancer liver metastasis"}]}, {"GSM1868947": [{"title": "RPC7"}, {"type": "RNA"}, {"source_name_ch1": "colon"}, {"characteristics_ch1": "tissue type: primary colorectal cancer liver metastasis"}]}, {"GSM1868948": [{"title": "RPC8"}, {"type": "RNA"}, {"source_name_ch1": "colon"}, {"characteristics_ch1": "tissue type: primary colorectal cancer liver metastasis"}]}, {"GSM1868949": [{"title": "RPC9"}, {"type": "RNA"}, {"source_name_ch1": "colon"}, {"characteristics_ch1": "tissue type: primary colorectal cancer liver metastasis"}]}, {"GSM1868950": [{"title": "RPC10"}, {"type": "RNA"}, {"source_name_ch1": "colon"}, {"characteristics_ch1": "tissue type: primary colorectal cancer liver metastasis"}]}, {"GSM1868951": [{"title": "RPC11"}, {"type": "RNA"}, {"source_name_ch1": "colon"}, {"characteristics_ch1": "tissue type: primary colorectal cancer liver metastasis"}]}, {"GSM1868952": [{"title": "Rt1"}, {"type": "RNA"}, {"source_name_ch1": "colon"}, {"characteristics_ch1": "tissue type: primary colorectal cancer without liver metastasis"}]}, {"GSM1868953": [{"title": "Rt2"}, {"type": "RNA"}, {"source_name_ch1": "colon"}, {"characteristics_ch1": "tissue type: primary colorectal cancer without liver metastasis"}]}, {"GSM1868954": [{"title": "Rt3"}, {"type": "RNA"}, {"source_name_ch1": "colon"}, {"characteristics_ch1": "tissue type: primary colorectal cancer without liver metastasis"}]}, {"GSM1868955": [{"title": "Rt4"}, {"type": "RNA"}, {"source_name_ch1": "colon"}, {"characteristics_ch1": "tissue type: primary colorectal cancer without liver metastasis"}]}, {"GSM1868956": [{"title": "Rt5"}, {"type": "RNA"}, {"source_name_ch1": "colon"}, {"characteristics_ch1": "tissue type: primary colorectal cancer without liver metastasis"}]}, {"GSM1868957": [{"title": "Rt6"}, {"type": "RNA"}, {"source_name_ch1": "colon"}, {"characteristics_ch1": "tissue type: primary colorectal cancer without liver metastasis"}]}, {"GSM1868958": [{"title": "Rt8"}, {"type": "RNA"}, {"source_name_ch1": "colon"}, {"characteristics_ch1": "tissue type: primary colorectal cancer without liver metastasis"}]}, {"GSM1868959": [{"title": "Rt9"}, {"type": "RNA"}, {"source_name_ch1": "colon"}, {"characteristics_ch1": "tissue type: primary colorectal cancer without liver metastasis"}]}, {"GSM1868960": [{"title": "Rt10"}, {"type": "RNA"}, {"source_name_ch1": "colon"}, {"characteristics_ch1": "tissue type: primary colorectal cancer without liver metastasis"}]}, {"GSM1868961": [{"title": "Rt11"}, {"type": "RNA"}, {"source_name_ch1": "colon"}, {"characteristics_ch1": "tissue type: primary colorectal cancer without liver metastasis"}]}, {"GSM2407025": [{"title": "control-1 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Control MDA-MB-231 cells"}, {"characteristics_ch1": "cell line: MDA-MB-231 cells"}]}, {"GSM2407026": [{"title": "control-2 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Control MDA-MB-231 cells"}, {"characteristics_ch1": "cell line: MDA-MB-231 cells"}]}, {"GSM2407027": [{"title": "control-3 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Control MDA-MB-231 cells"}, {"characteristics_ch1": "cell line: MDA-MB-231 cells"}]}, {"GSM2407028": [{"title": "PTX-1 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-231 cells with paclitaxel treatment"}, {"characteristics_ch1": "cell line: MDA-MB-231 cells"}]}, {"GSM2407029": [{"title": "PTX-2 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-231 cells with paclitaxel treatment"}, {"characteristics_ch1": "cell line: MDA-MB-231 cells"}]}, {"GSM2407030": [{"title": "PTX-3 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-231 cells with paclitaxel treatment"}, {"characteristics_ch1": "cell line: MDA-MB-231 cells"}]}, {"GSM2407031": [{"title": "231T-1 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-231 cells with TRA2A overexpression"}, {"characteristics_ch1": "cell line: MDA-MB-231 cells"}]}, {"GSM2407032": [{"title": "231T-2 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-231 cells with TRA2A overexpression"}, {"characteristics_ch1": "cell line: MDA-MB-231 cells"}]}, {"GSM2407033": [{"title": "231T-3 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-231 cells with TRA2A overexpression"}, {"characteristics_ch1": "cell line: MDA-MB-231 cells"}]}, {"GSM2417554": [{"title": "NSG_CD127-7-, biological rep 1"}, {"type": "RNA"}, {"source_name_ch1": "NSG mice engrafted with neonatal UCB CD34+ HPCs (NSG)"}, {"characteristics_ch1": "tissue: Bone marrow;\tcell type: Early Lymphoid Progenitors (ELPs)"}]}, {"GSM2417555": [{"title": "NSG_CD127-7-, biological rep 2"}, {"type": "RNA"}, {"source_name_ch1": "NSG mice engrafted with neonatal UCB CD34+ HPCs (NSG)"}, {"characteristics_ch1": "tissue: Bone marrow;\tcell type: Early Lymphoid Progenitors (ELPs)"}]}, {"GSM2417556": [{"title": "NSG_CD127-7+"}, {"type": "RNA"}, {"source_name_ch1": "NSG mice engrafted with neonatal UCB CD34+ HPCs (NSG)"}, {"characteristics_ch1": "tissue: Bone marrow;\tcell type: Early Lymphoid Progenitors (ELPs)"}]}, {"GSM2417557": [{"title": "NSG_CD127+7-, biological rep 1"}, {"type": "RNA"}, {"source_name_ch1": "NSG mice engrafted with neonatal UCB CD34+ HPCs (NSG)"}, {"characteristics_ch1": "tissue: Bone marrow;\tcell type: Early Lymphoid Progenitors (ELPs)"}]}, {"GSM2417558": [{"title": "NSG_CD127+7-, biological rep 2"}, {"type": "RNA"}, {"source_name_ch1": "NSG mice engrafted with neonatal UCB CD34+ HPCs (NSG)"}, {"characteristics_ch1": "tissue: Bone marrow;\tcell type: Early Lymphoid Progenitors (ELPs)"}]}, {"GSM2417559": [{"title": "NSG_CD127+7+, biological rep 1"}, {"type": "RNA"}, {"source_name_ch1": "NSG mice engrafted with neonatal UCB CD34+ HPCs (NSG)"}, {"characteristics_ch1": "tissue: Bone marrow;\tcell type: Early Lymphoid Progenitors (ELPs)"}]}, {"GSM2417560": [{"title": "NSG_CD127+7+, biological rep 2"}, {"type": "RNA"}, {"source_name_ch1": "NSG mice engrafted with neonatal UCB CD34+ HPCs (NSG)"}, {"characteristics_ch1": "tissue: Bone marrow;\tcell type: Early Lymphoid Progenitors (ELPs)"}]}, {"GSM2417561": [{"title": "NSG_LMDP, biological rep 1."}, {"type": "RNA"}, {"source_name_ch1": "NSG mice engrafted with neonatal UCB CD34+ HPCs (NSG)"}, {"characteristics_ch1": "tissue: Bone marrow;\tcell type: Lymphoid-Mono-Dendritic Progenitors (LMDPs)"}]}, {"GSM2417562": [{"title": "NSG_LMDP, biological rep 2"}, {"type": "RNA"}, {"source_name_ch1": "NSG mice engrafted with neonatal UCB CD34+ HPCs (NSG)"}, {"characteristics_ch1": "tissue: Bone marrow;\tcell type: Lymphoid-Mono-Dendritic Progenitors (LMDPs)"}]}, {"GSM2417563": [{"title": "PRIM_CD127-7-"}, {"type": "RNA"}, {"source_name_ch1": "Primary fetal donor (PRIM)"}, {"characteristics_ch1": "tissue: Bone marrow;\tcell type: Early Lymphoid Progenitors (ELPs)"}]}, {"GSM2417564": [{"title": "PRIM_CD127-7+"}, {"type": "RNA"}, {"source_name_ch1": "Primary fetal donor (PRIM)"}, {"characteristics_ch1": "tissue: Bone marrow;\tcell type: Early Lymphoid Progenitors (ELPs)"}]}, {"GSM2417565": [{"title": "PRIM_CD127+7-"}, {"type": "RNA"}, {"source_name_ch1": "Primary fetal donor (PRIM)"}, {"characteristics_ch1": "tissue: Bone marrow;\tcell type: Early Lymphoid Progenitors (ELPs)"}]}, {"GSM2417566": [{"title": "PRIM_CD127+7+"}, {"type": "RNA"}, {"source_name_ch1": "Primary fetal donor (PRIM)"}, {"characteristics_ch1": "tissue: Bone marrow;\tcell type: Early Lymphoid Progenitors (ELPs)"}]}, {"GSM2417567": [{"title": "PRIM_LMDP"}, {"type": "RNA"}, {"source_name_ch1": "Primary fetal donor (PRIM)"}, {"characteristics_ch1": "tissue: Bone marrow;\tcell type: Lymphoid-Mono-Dendritic Progenitors (LMDPs)"}]}, {"GSM2368489": [{"title": "Malignant glioma clone U3017MG-C56"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3017MG-C56"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3017MG-C56"}]}, {"GSM2368490": [{"title": "Malignant glioma clone U3017MG-C64"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3017MG-C64"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3017MG-C64"}]}, {"GSM2368491": [{"title": "Malignant glioma clone U3017MG-C70"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3017MG-C70"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3017MG-C70"}]}, {"GSM2368492": [{"title": "Malignant glioma clone U3017MG-C80"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3017MG-C80"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3017MG-C80"}]}, {"GSM2368493": [{"title": "Malignant glioma clone U3017MG-C88"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3017MG-C88"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3017MG-C88"}]}, {"GSM2368494": [{"title": "Malignant glioma clone U3017MG-C89"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3017MG-C89"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3017MG-C89"}]}, {"GSM2368495": [{"title": "Malignant glioma clone U3017MG-C92"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3017MG-C92"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3017MG-C92"}]}, {"GSM2368496": [{"title": "Malignant glioma clone U3017MG-C97"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3017MG-C97"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3017MG-C97"}]}, {"GSM2368497": [{"title": "Malignant glioma clone U3017MG-C99"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3017MG-C99"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3017MG-C99"}]}, {"GSM2368498": [{"title": "Malignant glioma clone U3017MG-C1"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3017MG-C1"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3017MG-C1"}]}, {"GSM2368499": [{"title": "Malignant glioma clone U3017MG-C20"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3017MG-C20"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3017MG-C20"}]}, {"GSM2368500": [{"title": "Malignant glioma clone U3017MG-C28"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3017MG-C28"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3017MG-C28"}]}, {"GSM2368501": [{"title": "Malignant glioma clone U3017MG-C29"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3017MG-C29"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3017MG-C29"}]}, {"GSM2368502": [{"title": "Malignant glioma clone U3017MG-C33"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3017MG-C33"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3017MG-C33"}]}, {"GSM2368503": [{"title": "Malignant glioma clone U3017MG-C3"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3017MG-C3"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3017MG-C3"}]}, {"GSM2368504": [{"title": "Malignant glioma clone U3017MG-C43"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3017MG-C43"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3017MG-C43"}]}, {"GSM2368505": [{"title": "Malignant glioma clone U3017MG-C48"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3017MG-C48"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3017MG-C48"}]}, {"GSM2368506": [{"title": "Malignant glioma clone U3017MG-C4"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3017MG-C4"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3017MG-C4"}]}, {"GSM2368507": [{"title": "Malignant glioma clone U3017MG-C53"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3017MG-C53"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3017MG-C53"}]}, {"GSM2368508": [{"title": "Malignant glioma clone U3017MG-C5"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3017MG-C5"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3017MG-C5"}]}, {"GSM2368509": [{"title": "Malignant glioma cell line U3017MG"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma cell line U3017MG"}, {"characteristics_ch1": "cell type: Malignant glioma cell line;\tcell line: U3017MG"}]}, {"GSM2368510": [{"title": "Malignant glioma clone U3065MG-C106"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3065MG-C106"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3065MG-C106"}]}, {"GSM2368511": [{"title": "Malignant glioma clone U3065MG-C113"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3065MG-C113"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3065MG-C113"}]}, {"GSM2368512": [{"title": "Malignant glioma clone U3065MG-C161"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3065MG-C161"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3065MG-C161"}]}, {"GSM2368513": [{"title": "Malignant glioma clone U3065MG-C179"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3065MG-C179"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3065MG-C179"}]}, {"GSM2368514": [{"title": "Malignant glioma clone U3065MG-C239"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3065MG-C239"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3065MG-C239"}]}, {"GSM2368515": [{"title": "Malignant glioma clone U3065MG-C271"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3065MG-C271"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3065MG-C271"}]}, {"GSM2368516": [{"title": "Malignant glioma clone U3065MG-C28"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3065MG-C28"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3065MG-C28"}]}, {"GSM2368517": [{"title": "Malignant glioma clone U3065MG-C349"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3065MG-C349"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3065MG-C349"}]}, {"GSM2368518": [{"title": "Malignant glioma clone U3065MG-C34"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3065MG-C34"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3065MG-C34"}]}, {"GSM2368519": [{"title": "Malignant glioma clone U3065MG-C466"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3065MG-C466"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3065MG-C466"}]}, {"GSM2368520": [{"title": "Malignant glioma clone U3065MG-C46"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3065MG-C46"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3065MG-C46"}]}, {"GSM2368521": [{"title": "Malignant glioma clone U3065MG-C475"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3065MG-C475"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3065MG-C475"}]}, {"GSM2368522": [{"title": "Malignant glioma clone U3065MG-C482"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3065MG-C482"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3065MG-C482"}]}, {"GSM2368523": [{"title": "Malignant glioma clone U3065MG-C494"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3065MG-C494"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3065MG-C494"}]}, {"GSM2368524": [{"title": "Malignant glioma clone U3065MG-C60"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3065MG-C60"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3065MG-C60"}]}, {"GSM2368525": [{"title": "Malignant glioma clone U3065MG-C78"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3065MG-C78"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3065MG-C78"}]}, {"GSM2368526": [{"title": "Malignant glioma clone U3065MG-C80"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3065MG-C80"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3065MG-C80"}]}, {"GSM2368527": [{"title": "Malignant glioma clone U3065MG-C90"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3065MG-C90"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3065MG-C90"}]}, {"GSM2368528": [{"title": "Malignant glioma clone U3065MG-C94"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3065MG-C94"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3065MG-C94"}]}, {"GSM2368529": [{"title": "Malignant glioma clone U3065MG-C95"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3065MG-C95"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3065MG-C95"}]}, {"GSM2368530": [{"title": "Malignant glioma cell line U3065MG"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma cell line U3065MG"}, {"characteristics_ch1": "cell type: Malignant glioma cell line;\tcell line: U3065MG"}]}, {"GSM2368531": [{"title": "Malignant glioma clone U3065MG-C46-repl1"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3065MG-C46"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3065MG-C46"}]}, {"GSM2368532": [{"title": "Malignant glioma clone U3065MG-C475-repl1"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3065MG-C475"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3065MG-C475"}]}, {"GSM2368533": [{"title": "Malignant glioma cell line U3065MG-repl1"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma cell line U3065MG"}, {"characteristics_ch1": "cell type: Malignant glioma cell line;\tcell line: U3065MG"}]}, {"GSM2368534": [{"title": "Malignant glioma clone U3118MG-C130"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3118MG-C130"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3118MG-C130"}]}, {"GSM2368535": [{"title": "Malignant glioma clone U3118MG-C150"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3118MG-C150"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3118MG-C150"}]}, {"GSM2368536": [{"title": "Malignant glioma clone U3118MG-C180"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3118MG-C180"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3118MG-C180"}]}, {"GSM2368537": [{"title": "Malignant glioma clone U3118MG-C182"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3118MG-C182"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3118MG-C182"}]}, {"GSM2368538": [{"title": "Malignant glioma clone U3118MG-C192"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3118MG-C192"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3118MG-C192"}]}, {"GSM2368539": [{"title": "Malignant glioma clone U3118MG-C200"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3118MG-C200"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3118MG-C200"}]}, {"GSM2368540": [{"title": "Malignant glioma clone U3118MG-C219"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3118MG-C219"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3118MG-C219"}]}, {"GSM2368541": [{"title": "Malignant glioma clone U3118MG-C220"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3118MG-C220"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3118MG-C220"}]}, {"GSM2368542": [{"title": "Malignant glioma clone U3118MG-C223"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3118MG-C223"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3118MG-C223"}]}, {"GSM2368543": [{"title": "Malignant glioma clone U3118MG-C228"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3118MG-C228"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3118MG-C228"}]}, {"GSM2368544": [{"title": "Malignant glioma clone U3118MG-C266"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3118MG-C266"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3118MG-C266"}]}, {"GSM2368545": [{"title": "Malignant glioma clone U3118MG-C29"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3118MG-C29"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3118MG-C29"}]}, {"GSM2368546": [{"title": "Malignant glioma clone U3118MG-C335"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3118MG-C335"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3118MG-C335"}]}, {"GSM2368547": [{"title": "Malignant glioma clone U3118MG-C348"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3118MG-C348"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3118MG-C348"}]}, {"GSM2368548": [{"title": "Malignant glioma clone U3118MG-C358"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3118MG-C358"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3118MG-C358"}]}, {"GSM2368549": [{"title": "Malignant glioma clone U3118MG-C38"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3118MG-C38"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3118MG-C38"}]}, {"GSM2368550": [{"title": "Malignant glioma clone U3118MG-C410"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3118MG-C410"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3118MG-C410"}]}, {"GSM2368551": [{"title": "Malignant glioma clone U3118MG-C424"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3118MG-C424"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3118MG-C424"}]}, {"GSM2368552": [{"title": "Malignant glioma clone U3118MG-C440"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3118MG-C440"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3118MG-C440"}]}, {"GSM2368553": [{"title": "Malignant glioma clone U3118MG-C508"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3118MG-C508"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3118MG-C508"}]}, {"GSM2368554": [{"title": "Malignant glioma clone U3118MG-C553"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3118MG-C553"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3118MG-C553"}]}, {"GSM2368555": [{"title": "Malignant glioma clone U3118MG-C688"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3118MG-C688"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3118MG-C688"}]}, {"GSM2368556": [{"title": "Malignant glioma clone U3118MG-C694"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3118MG-C694"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3118MG-C694"}]}, {"GSM2368557": [{"title": "Malignant glioma clone U3118MG-C696"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3118MG-C696"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3118MG-C696"}]}, {"GSM2368558": [{"title": "Malignant glioma clone U3118MG-C736"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3118MG-C736"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3118MG-C736"}]}, {"GSM2368559": [{"title": "Malignant glioma clone U3118MG-C81"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3118MG-C81"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3118MG-C81"}]}, {"GSM2368560": [{"title": "Malignant glioma clone U3118MG-C849"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3118MG-C849"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3118MG-C849"}]}, {"GSM2368561": [{"title": "Malignant glioma clone U3118MG-C861"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3118MG-C861"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3118MG-C861"}]}, {"GSM2368562": [{"title": "Malignant glioma clone U3118MG-C895"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3118MG-C895"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3118MG-C895"}]}, {"GSM2368563": [{"title": "Malignant glioma clone U3118MG-C89"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3118MG-C89"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3118MG-C89"}]}, {"GSM2368564": [{"title": "Malignant glioma clone U3118MG-C906"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3118MG-C906"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3118MG-C906"}]}, {"GSM2368565": [{"title": "Malignant glioma clone U3118MG-C92"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3118MG-C92"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3118MG-C92"}]}, {"GSM2368566": [{"title": "Malignant glioma cell line U3118MG"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma cell line U3118MG"}, {"characteristics_ch1": "cell type: Malignant glioma cell line;\tcell line: U3118MG"}]}, {"GSM2368567": [{"title": "Malignant glioma cell line U3118MG-repl1"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma cell line U3118MG"}, {"characteristics_ch1": "cell type: Malignant glioma cell line;\tcell line: U3118MG"}]}, {"GSM2368568": [{"title": "Malignant glioma cell line U3118MG-repl2"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma cell line U3118MG"}, {"characteristics_ch1": "cell type: Malignant glioma cell line;\tcell line: U3118MG2"}]}, {"GSM2368569": [{"title": "Malignant glioma clone U3118MG-C200-repl1"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3118MG-C200"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3118MG-C200"}]}, {"GSM2368570": [{"title": "Malignant glioma clone U3118MG-C220-repl1"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3118MG-C220"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3118MG-C220"}]}, {"GSM2368571": [{"title": "Malignant glioma clone U3118MG-C38-repl1"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3118MG-C38"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3118MG-C38"}]}, {"GSM2368572": [{"title": "Malignant glioma clone U3118MG-C410-repl1"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3118MG-C410"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3118MG-C410"}]}, {"GSM2368573": [{"title": "Malignant glioma clone U3118MG-C508-repl1"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3118MG-C508"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3118MG-C508"}]}, {"GSM2368574": [{"title": "Malignant glioma clone U3118MG-C688-repl1"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3118MG-C688"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3118MG-C688"}]}, {"GSM2368575": [{"title": "Malignant glioma clone U3118MG-C736-repl1"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3118MG-C736"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3118MG-C736"}]}, {"GSM2368576": [{"title": "Malignant glioma clone U3118MG-C81-repl1"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3118MG-C81"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3118MG-C81"}]}, {"GSM2368577": [{"title": "Malignant glioma clone U3118MG-C849-repl1"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3118MG-C849"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3118MG-C849"}]}, {"GSM2368578": [{"title": "Malignant glioma clone U3118MG-C92-repl1"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3118MG-C92"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3118MG-C92"}]}, {"GSM2368579": [{"title": "Malignant glioma clone U3121MG-C109"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3121MG-C109"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3121MG-C109"}]}, {"GSM2368580": [{"title": "Malignant glioma clone U3121MG-C133"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3121MG-C133"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3121MG-C133"}]}, {"GSM2368581": [{"title": "Malignant glioma clone U3121MG-C187"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3121MG-C187"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3121MG-C187"}]}, {"GSM2368582": [{"title": "Malignant glioma clone U3121MG-C203"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3121MG-C203"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3121MG-C203"}]}, {"GSM2368583": [{"title": "Malignant glioma clone U3121MG-C207"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3121MG-C207"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3121MG-C207"}]}, {"GSM2368584": [{"title": "Malignant glioma clone U3121MG-C227"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3121MG-C227"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3121MG-C227"}]}, {"GSM2368585": [{"title": "Malignant glioma cell line U3121MG"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma cell line U3121MG"}, {"characteristics_ch1": "cell type: Malignant glioma cell line;\tcell line: U3121MG"}]}, {"GSM2368586": [{"title": "Malignant glioma clone U3117MG-C22"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3117MG-C22"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3117MG-C22"}]}, {"GSM2368587": [{"title": "Malignant glioma clone U3117MG-C40"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3117MG-C40"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3117MG-C40"}]}, {"GSM2368588": [{"title": "Malignant glioma clone U3117MG-C48"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3117MG-C48"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3117MG-C48"}]}, {"GSM2368589": [{"title": "Malignant glioma clone U3117MG-C75"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3117MG-C75"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3117MG-C75"}]}, {"GSM2368590": [{"title": "Malignant glioma clone U3117MG-C86"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3117MG-C86"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3117MG-C86"}]}, {"GSM2368591": [{"title": "Malignant glioma clone U3117MG-C173"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3117MG-C173"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3117MG-C173"}]}, {"GSM2368592": [{"title": "Malignant glioma clone U3117MG-C174"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3117MG-C174"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3117MG-C174"}]}, {"GSM2368593": [{"title": "Malignant glioma clone U3117MG-C232"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3117MG-C232"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3117MG-C232"}]}, {"GSM2368594": [{"title": "Malignant glioma clone U3117MG-C262"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3117MG-C262"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3117MG-C262"}]}, {"GSM2368595": [{"title": "Malignant glioma clone U3117MG-C264"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3117MG-C264"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3117MG-C264"}]}, {"GSM2368596": [{"title": "Malignant glioma clone U3117MG-C274"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3117MG-C274"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3117MG-C274"}]}, {"GSM2368597": [{"title": "Malignant glioma clone U3117MG-C283"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3117MG-C283"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3117MG-C283"}]}, {"GSM2368598": [{"title": "Malignant glioma clone U3117MG-C333"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3117MG-C333"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3117MG-C333"}]}, {"GSM2368599": [{"title": "Malignant glioma clone U3117MG-C351"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3117MG-C351"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3117MG-C351"}]}, {"GSM2368600": [{"title": "Malignant glioma clone U3117MG-C492"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3117MG-C492"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3117MG-C492"}]}, {"GSM2368601": [{"title": "Malignant glioma clone U3117MG-C534"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3117MG-C534"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3117MG-C534"}]}, {"GSM2368602": [{"title": "Malignant glioma clone U3117MG-C563"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3117MG-C563"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3117MG-C563"}]}, {"GSM2368603": [{"title": "Malignant glioma clone U3117MG-C568"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3117MG-C568"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3117MG-C568"}]}, {"GSM2368604": [{"title": "Malignant glioma clone U3117MG-C585"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3117MG-C585"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3117MG-C585"}]}, {"GSM2368605": [{"title": "Malignant glioma clone U3117MG-C596"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3117MG-C596"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3117MG-C596"}]}, {"GSM2368606": [{"title": "Malignant glioma clone U3117MG-C612"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3117MG-C612"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3117MG-C612"}]}, {"GSM2368607": [{"title": "Malignant glioma cell line U3117MG"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma cell line U3117MG"}, {"characteristics_ch1": "cell type: Malignant glioma cell line;\tcell line: U3117MG"}]}, {"GSM2368608": [{"title": "Malignant glioma clone U3117MG-C174-repl1"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3117MG-C174"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3117MG-C174"}]}, {"GSM2368609": [{"title": "Malignant glioma clone U3117MG-C22-repl1"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3117MG-C22"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3117MG-C22"}]}, {"GSM2368610": [{"title": "Malignant glioma clone U3117MG-C232-repl1"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3117MG-C232"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3117MG-C232"}]}, {"GSM2368611": [{"title": "Malignant glioma clone U3117MG-C333-repl1"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3117MG-C333"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3117MG-C333"}]}, {"GSM2368612": [{"title": "Malignant glioma clone U3117MG-C48-repl1"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3117MG-C48"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3117MG-C48"}]}, {"GSM2368613": [{"title": "Malignant glioma clone U3117MG-C534-repl1"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3117MG-C534"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3117MG-C534"}]}, {"GSM2368614": [{"title": "Malignant glioma clone U3117MG-C568-repl1"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3117MG-C568"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3117MG-C568"}]}, {"GSM2368615": [{"title": "Malignant glioma clone U3117MG-C585-repl1"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3117MG-C585"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3117MG-C585"}]}, {"GSM2368616": [{"title": "Malignant glioma clone U3117MG-C612-repl1"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3117MG-C612"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3117MG-C612"}]}, {"GSM2368617": [{"title": "Malignant glioma clone U3117MG-C75-repl1"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3117MG-C75"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3117MG-C75"}]}, {"GSM2368618": [{"title": "Malignant glioma clone U3167MG-C116"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3167MG-C116"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3167MG-C116"}]}, {"GSM2368619": [{"title": "Malignant glioma clone U3167MG-C141"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3167MG-C141"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3167MG-C141"}]}, {"GSM2368620": [{"title": "Malignant glioma clone U3167MG-C157"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3167MG-C157"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3167MG-C157"}]}, {"GSM2368621": [{"title": "Malignant glioma clone U3167MG-C173"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3167MG-C173"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3167MG-C173"}]}, {"GSM2368622": [{"title": "Malignant glioma clone U3167MG-C390"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3167MG-C390"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3167MG-C390"}]}, {"GSM2368623": [{"title": "Malignant glioma clone U3167MG-C398"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3167MG-C398"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3167MG-C398"}]}, {"GSM2368624": [{"title": "Malignant glioma clone U3167MG-C442"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3167MG-C442"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3167MG-C442"}]}, {"GSM2368625": [{"title": "Malignant glioma clone U3167MG-C449"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3167MG-C449"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3167MG-C449"}]}, {"GSM2368626": [{"title": "Malignant glioma clone U3167MG-C500"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3167MG-C500"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3167MG-C500"}]}, {"GSM2368627": [{"title": "Malignant glioma clone U3167MG-C510"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3167MG-C510"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3167MG-C510"}]}, {"GSM2368628": [{"title": "Malignant glioma clone U3167MG-C670"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3167MG-C670"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3167MG-C670"}]}, {"GSM2368629": [{"title": "Malignant glioma clone U3167MG-C709"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3167MG-C709"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3167MG-C709"}]}, {"GSM2368630": [{"title": "Malignant glioma clone U3167MG-C723"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3167MG-C723"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3167MG-C723"}]}, {"GSM2368631": [{"title": "Malignant glioma clone U3167MG-C778"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3167MG-C778"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3167MG-C778"}]}, {"GSM2368632": [{"title": "Malignant glioma clone U3167MG-C827"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3167MG-C827"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3167MG-C827"}]}, {"GSM2368633": [{"title": "Malignant glioma clone U3167MG-C836"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma clone U3167MG-C836"}, {"characteristics_ch1": "cell type: Malignant glioma clone;\tcell line: U3167MG-C836"}]}, {"GSM2368634": [{"title": "Malignant glioma cell line U3167MG"}, {"type": "RNA"}, {"source_name_ch1": "Malignant glioma cell line U3167MG"}, {"characteristics_ch1": "cell type: Malignant glioma cell line;\tcell line: U3167MG"}]}, {"GSM2433237": [{"title": "DMSO, polysome, biological replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "DMSO, polysome"}, {"characteristics_ch1": "cell line: SUM149"}]}, {"GSM2433238": [{"title": "DMSO, polysome, biological replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "DMSO, polysome"}, {"characteristics_ch1": "cell line: SUM149"}]}, {"GSM2433239": [{"title": "DMSO, polysome, biological replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "DMSO, polysome"}, {"characteristics_ch1": "cell line: SUM149"}]}, {"GSM2433240": [{"title": "IR, polysome, biological replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "IR, polysome"}, {"characteristics_ch1": "cell line: SUM149"}]}, {"GSM2433241": [{"title": "IR, polysome, biological replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "IR, polysome"}, {"characteristics_ch1": "cell line: SUM149"}]}, {"GSM2433242": [{"title": "IR, polysome, biological replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "IR, polysome"}, {"characteristics_ch1": "cell line: SUM149"}]}, {"GSM2433243": [{"title": "IR, total, biological replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "IR, total"}, {"characteristics_ch1": "cell line: SUM149"}]}, {"GSM2433244": [{"title": "IR, total, biological replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "IR, total"}, {"characteristics_ch1": "cell line: SUM149"}]}, {"GSM2433245": [{"title": "IR, total, biological replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "IR, total"}, {"characteristics_ch1": "cell line: SUM149"}]}, {"GSM2433246": [{"title": "DMSO, total, biological replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "DMSO, total"}, {"characteristics_ch1": "cell line: SUM149"}]}, {"GSM2433247": [{"title": "DMSO, total, biological replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "DMSO, total"}, {"characteristics_ch1": "cell line: SUM149"}]}, {"GSM2433248": [{"title": "DMSO, total, biological replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "DMSO, total"}, {"characteristics_ch1": "cell line: SUM149"}]}, {"GSM2433249": [{"title": "PP242, polysome, biological replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "PP242, polysome"}, {"characteristics_ch1": "cell line: SUM149"}]}, {"GSM2433250": [{"title": "PP242, polysome, biological replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "PP242, polysome"}, {"characteristics_ch1": "cell line: SUM149"}]}, {"GSM2433251": [{"title": "PP242, polysome, biological replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "PP242, polysome"}, {"characteristics_ch1": "cell line: SUM149"}]}, {"GSM2433252": [{"title": "PP242 + IR, polysome, biological replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "PP242 + IR, polysome"}, {"characteristics_ch1": "cell line: SUM149"}]}, {"GSM2433253": [{"title": "PP242 + IR, polysome, biological replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "PP242 + IR, polysome"}, {"characteristics_ch1": "cell line: SUM149"}]}, {"GSM2433254": [{"title": "PP242 + IR, polysome, biological replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "PP242 + IR, polysome"}, {"characteristics_ch1": "cell line: SUM149"}]}, {"GSM2433255": [{"title": "PP242 + IR, total, biological replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "PP242 + IR, total"}, {"characteristics_ch1": "cell line: SUM149"}]}, {"GSM2433256": [{"title": "PP242 + IR, total, biological replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "PP242 + IR, total"}, {"characteristics_ch1": "cell line: SUM149"}]}, {"GSM2433257": [{"title": "PP242, total,  biological replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "PP242, total"}, {"characteristics_ch1": "cell line: SUM149"}]}, {"GSM2433258": [{"title": "PP242, total,  biological replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "PP242, total"}, {"characteristics_ch1": "cell line: SUM149"}]}, {"GSM2433259": [{"title": "PP242, total,  biological replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "PP242, total"}, {"characteristics_ch1": "cell line: SUM149"}]}, {"GSM2433260": [{"title": "RAD001, polysome, biological replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "RAD001, polysome"}, {"characteristics_ch1": "cell line: SUM149"}]}, {"GSM2433261": [{"title": "RAD001, polysome, biological replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "RAD001, polysome"}, {"characteristics_ch1": "cell line: SUM149"}]}, {"GSM2433262": [{"title": "RAD001, polysome, biological replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "RAD001, polysome"}, {"characteristics_ch1": "cell line: SUM149"}]}, {"GSM2433263": [{"title": "RAD001 + IR, polysome, biological replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "RAD001 + IR, polysome"}, {"characteristics_ch1": "cell line: SUM149"}]}, {"GSM2433264": [{"title": "RAD001 + IR, polysome, biological replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "RAD001 + IR, polysome"}, {"characteristics_ch1": "cell line: SUM149"}]}, {"GSM2433265": [{"title": "RAD001 + IR, polysome, biological replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "RAD001 + IR, polysome"}, {"characteristics_ch1": "cell line: SUM149"}]}, {"GSM2433266": [{"title": "RAD001 + IR, total, biological replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "RAD001 + IR, total"}, {"characteristics_ch1": "cell line: SUM149"}]}, {"GSM2433267": [{"title": "RAD001 + IR, total, biological replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "RAD001 + IR, total"}, {"characteristics_ch1": "cell line: SUM149"}]}, {"GSM2433268": [{"title": "RAD001 + IR, total, biological replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "RAD001 + IR, total"}, {"characteristics_ch1": "cell line: SUM149"}]}, {"GSM2433269": [{"title": "RAD001, total, biological replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "RAD001, total"}, {"characteristics_ch1": "cell line: SUM149"}]}, {"GSM2433270": [{"title": "RAD001, total, biological replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "RAD001, total"}, {"characteristics_ch1": "cell line: SUM149"}]}, {"GSM2433271": [{"title": "RAD001, total, biological replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "RAD001, total"}, {"characteristics_ch1": "cell line: SUM149"}]}, {"GSM2437565": [{"title": "769-P_control_rep1"}, {"type": "RNA"}, {"source_name_ch1": "Human ccRCC cell line 769-P transfected with plv-EGFP empty vector"}, {"characteristics_ch1": "tissue: clear-cell renal cell carcinoma;\tcell line: 769-P;\ttumor: Non-metastatic"}]}, {"GSM2437566": [{"title": "769-P_plvFOXK2_rep1"}, {"type": "RNA"}, {"source_name_ch1": "Human ccRCC cell line 769-P transfected with pLV-EGFP-FOXK2"}, {"characteristics_ch1": "tissue: clear-cell renal cell carcinoma;\tcell line: 769-P;\ttumor: Non-metastatic"}]}, {"GSM1547708": [{"title": "PBMCs_healthy_control_1"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_healthy_control"}, {"characteristics_ch1": "disease status: healthy;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547709": [{"title": "PBMCs_healthy_control_2"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_healthy_control"}, {"characteristics_ch1": "disease status: healthy;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547710": [{"title": "PBMCs_healthy_control_3"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_healthy_control"}, {"characteristics_ch1": "disease status: healthy;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547711": [{"title": "PBMCs_healthy_control_4"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_healthy_control"}, {"characteristics_ch1": "disease status: healthy;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547712": [{"title": "PBMCs_healthy_control_5"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_healthy_control"}, {"characteristics_ch1": "disease status: healthy;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547713": [{"title": "PBMCs_healthy_control_6"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_healthy_control"}, {"characteristics_ch1": "disease status: healthy;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547714": [{"title": "PBMCs_healthy_control_7"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_healthy_control"}, {"characteristics_ch1": "disease status: healthy;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547715": [{"title": "PBMCs_healthy_control_8"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_healthy_control"}, {"characteristics_ch1": "disease status: healthy;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547716": [{"title": "PBMCs_healthy_control_9"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_healthy_control"}, {"characteristics_ch1": "disease status: healthy;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547717": [{"title": "PBMCs_healthy_control_10"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_healthy_control"}, {"characteristics_ch1": "disease status: healthy;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547718": [{"title": "PBMCs_healthy_control_11"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_healthy_control"}, {"characteristics_ch1": "disease status: healthy;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547719": [{"title": "PBMCs_healthy_control_12"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_healthy_control"}, {"characteristics_ch1": "disease status: healthy;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547720": [{"title": "PBMCs_healthy_control_13"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_healthy_control"}, {"characteristics_ch1": "disease status: healthy;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547721": [{"title": "PBMCs_healthy_control_14"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_healthy_control"}, {"characteristics_ch1": "disease status: healthy;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547722": [{"title": "PBMCs_healthy_control_15"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_healthy_control"}, {"characteristics_ch1": "disease status: healthy;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547723": [{"title": "PBMCs_healthy_control_16"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_healthy_control"}, {"characteristics_ch1": "disease status: healthy;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547724": [{"title": "PBMCs_healthy_control_17"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_healthy_control"}, {"characteristics_ch1": "disease status: healthy;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547725": [{"title": "PBMCs_healthy_control_18"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_healthy_control"}, {"characteristics_ch1": "disease status: healthy;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547726": [{"title": "PBMCs_healthy_control_19"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_healthy_control"}, {"characteristics_ch1": "disease status: healthy;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547727": [{"title": "PBMCs_healthy_control_20"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_healthy_control"}, {"characteristics_ch1": "disease status: healthy;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547728": [{"title": "PBMCs_healthy_control_21"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_healthy_control"}, {"characteristics_ch1": "disease status: healthy;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547729": [{"title": "PBMCs_healthy_control_22"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_healthy_control"}, {"characteristics_ch1": "disease status: healthy;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547730": [{"title": "PBMCs_healthy_control_23"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_healthy_control"}, {"characteristics_ch1": "disease status: healthy;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547731": [{"title": "PBMCs_healthy_control_24"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_healthy_control"}, {"characteristics_ch1": "disease status: healthy;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547732": [{"title": "PBMCs_healthy_control_25"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_healthy_control"}, {"characteristics_ch1": "disease status: healthy;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547733": [{"title": "PBMCs_healthy_control_26"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_healthy_control"}, {"characteristics_ch1": "disease status: healthy;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547734": [{"title": "PBMCs_healthy_control_27"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_healthy_control"}, {"characteristics_ch1": "disease status: healthy;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547735": [{"title": "PBMCs_healthy_control_28"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_healthy_control"}, {"characteristics_ch1": "disease status: healthy;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547736": [{"title": "PBMCs_healthy_control_29"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_healthy_control"}, {"characteristics_ch1": "disease status: healthy;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547737": [{"title": "PBMCs_healthy_control_30"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_healthy_control"}, {"characteristics_ch1": "disease status: healthy;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547738": [{"title": "PBMCs_healthy_control_31"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_healthy_control"}, {"characteristics_ch1": "disease status: healthy;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547739": [{"title": "PBMCs_healthy_control_32"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_healthy_control"}, {"characteristics_ch1": "disease status: healthy;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547740": [{"title": "IBS_1"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_IBS"}, {"characteristics_ch1": "disease status: IBS;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547741": [{"title": "IBS_2"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_IBS"}, {"characteristics_ch1": "disease status: IBS;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547742": [{"title": "IBS_3"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_IBS"}, {"characteristics_ch1": "disease status: IBS;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547743": [{"title": "IBS_4"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_IBS"}, {"characteristics_ch1": "disease status: IBS;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547744": [{"title": "IBS_5"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_IBS"}, {"characteristics_ch1": "disease status: IBS;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547745": [{"title": "IBS_6"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_IBS"}, {"characteristics_ch1": "disease status: IBS;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547746": [{"title": "IBS_7"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_IBS"}, {"characteristics_ch1": "disease status: IBS;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547747": [{"title": "IBS_8"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_IBS"}, {"characteristics_ch1": "disease status: IBS;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547748": [{"title": "IBS_9"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_IBS"}, {"characteristics_ch1": "disease status: IBS;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547749": [{"title": "IBS_10"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_IBS"}, {"characteristics_ch1": "disease status: IBS;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547750": [{"title": "IBS_11"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_IBS"}, {"characteristics_ch1": "disease status: IBS;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547751": [{"title": "IBS_12"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_IBS"}, {"characteristics_ch1": "disease status: IBS;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547752": [{"title": "IBS_13"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_IBS"}, {"characteristics_ch1": "disease status: IBS;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547753": [{"title": "IBS_14"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_IBS"}, {"characteristics_ch1": "disease status: IBS;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547754": [{"title": "IBS_15"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_IBS"}, {"characteristics_ch1": "disease status: IBS;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547755": [{"title": "IBS_16"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_IBS"}, {"characteristics_ch1": "disease status: IBS;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547756": [{"title": "IBS_17"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_IBS"}, {"characteristics_ch1": "disease status: IBS;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547757": [{"title": "IBS_18"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_IBS"}, {"characteristics_ch1": "disease status: IBS;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547758": [{"title": "IBS_19"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_IBS"}, {"characteristics_ch1": "disease status: IBS;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547759": [{"title": "IBS_20"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_IBS"}, {"characteristics_ch1": "disease status: IBS;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547760": [{"title": "IBS_21"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_IBS"}, {"characteristics_ch1": "disease status: IBS;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547761": [{"title": "IBS_22"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_IBS"}, {"characteristics_ch1": "disease status: IBS;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547762": [{"title": "IBS_23"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_IBS"}, {"characteristics_ch1": "disease status: IBS;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547763": [{"title": "IBS_24"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_IBS"}, {"characteristics_ch1": "disease status: IBS;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547764": [{"title": "IBS_25"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_IBS"}, {"characteristics_ch1": "disease status: IBS;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547765": [{"title": "IBS_26"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_IBS"}, {"characteristics_ch1": "disease status: IBS;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547766": [{"title": "IBS_27"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_IBS"}, {"characteristics_ch1": "disease status: IBS;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547767": [{"title": "IBS_28"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_IBS"}, {"characteristics_ch1": "disease status: IBS;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547768": [{"title": "IBS_29"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_IBS"}, {"characteristics_ch1": "disease status: IBS;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547769": [{"title": "IBS_30"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_IBS"}, {"characteristics_ch1": "disease status: IBS;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547770": [{"title": "IBS_31"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_IBS"}, {"characteristics_ch1": "disease status: IBS;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547771": [{"title": "IBS_32"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_IBS"}, {"characteristics_ch1": "disease status: IBS;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547772": [{"title": "IBS_33"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_IBS"}, {"characteristics_ch1": "disease status: IBS;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547773": [{"title": "IBS_34"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_IBS"}, {"characteristics_ch1": "disease status: IBS;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1547774": [{"title": "IBS_35"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs_IBS"}, {"characteristics_ch1": "disease status: IBS;\ttissue: blood;\tcell type: peripheral blood mononuclear cells"}]}, {"GSM1891682": [{"title": "patient AA1, tumoral sample1, single array"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: colon adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: sigmoid colon;\tgender: male;\tpatient age: 69;\ttumor stage: tumor stage 4"}]}, {"GSM1891683": [{"title": "patient 11, tumoral sample1,  single array"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: colon adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: left colon;\tgender: female;\tpatient age: 75;\ttumor stage: tumor stage 3"}]}, {"GSM1891684": [{"title": "patient 13, tumoral sample1, array 1"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: colon adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: transverse colon;\tgender: male;\tpatient age: 46;\ttumor stage: tumor stage 3"}]}, {"GSM1891685": [{"title": "patient 13, tumoral sample1, array 2"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: colon adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: transverse colon;\tgender: male;\tpatient age: 46;\ttumor stage: tumor stage 3"}]}, {"GSM1891686": [{"title": "patient 15, tumoral sample1, array 1"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: colon adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: right colon;\tgender: male;\tpatient age: 62;\ttumor stage: tumor stage 3"}]}, {"GSM1891687": [{"title": "patient 15, tumoral sample1, array 2"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: colon adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: right colon;\tgender: male;\tpatient age: 62;\ttumor stage: tumor stage 3"}]}, {"GSM1891688": [{"title": "patient 17, tumoral sample1, single array"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: colon adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: sigmoid colon;\tgender: male;\tpatient age: 66;\ttumor stage: tumor stage 2"}]}, {"GSM1891689": [{"title": "patient 19, tumoral sample1, single array"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: colon adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: right colon;\tgender: male;\tpatient age: 38;\ttumor stage: tumor stage 2"}]}, {"GSM1891690": [{"title": "patient 23, tumoral sample1, array 1"}, {"type": "RNA"}, {"source_name_ch1": "rectal adenocarcinoma"}, {"characteristics_ch1": "tissue: rectal adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: rectum;\tgender: female;\tpatient age: 74;\ttumor stage: tumor stage 4"}]}, {"GSM1891691": [{"title": "patient 23, tumoral sample1, array 2"}, {"type": "RNA"}, {"source_name_ch1": "rectal adenocarcinoma"}, {"characteristics_ch1": "tissue: rectal adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: rectum;\tgender: female;\tpatient age: 74;\ttumor stage: tumor stage 4"}]}, {"GSM1891692": [{"title": "patient 29, tumoral sample1, array 1"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: colon adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: left colon;\tgender: male;\tpatient age: 42;\ttumor stage: tumor stage 4"}]}, {"GSM1891693": [{"title": "patient 29, tumoral sample1, array 2"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: colon adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: left colon;\tgender: male;\tpatient age: 42;\ttumor stage: tumor stage 4"}]}, {"GSM1891694": [{"title": "patient 31, tumoral sample1,  single array"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: colon adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: right colon;\tgender: male;\tpatient age: 75;\ttumor stage: tumor stage 4"}]}, {"GSM1891695": [{"title": "patient 37, tumoral sample1, single array"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: colon adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: left colon;\tgender: female;\tpatient age: 48;\ttumor stage: tumor stage 3"}]}, {"GSM1891696": [{"title": "patient 37, tumoral sample2, array 1"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: colon adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: left colon;\tgender: female;\tpatient age: 48;\ttumor stage: tumor stage 3"}]}, {"GSM1891697": [{"title": "patient 37, tumoral sample2, array 2"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: colon adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: left colon;\tgender: female;\tpatient age: 48;\ttumor stage: tumor stage 3"}]}, {"GSM1891698": [{"title": "patient 37, tumoral sample3, array 1"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: colon adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: transverse colon;\tgender: female;\tpatient age: 48;\ttumor stage: tumor stage 3"}]}, {"GSM1891699": [{"title": "patient 37, tumoral sample3, array 2"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: colon adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: transverse colon;\tgender: female;\tpatient age: 48;\ttumor stage: tumor stage 3"}]}, {"GSM1891700": [{"title": "patient 41, tumoral sample1, array 1"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: colon adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: right colon;\tgender: male;\tpatient age: 81;\ttumor stage: tumor stage 3"}]}, {"GSM1891701": [{"title": "patient 41, tumoral sample1, array 2"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: colon adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: right colon;\tgender: male;\tpatient age: 81;\ttumor stage: tumor stage 3"}]}, {"GSM1891702": [{"title": "patient 43, tumoral sample1,  single array"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: colon adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: right colon;\tgender: male;\tpatient age: 33;\ttumor stage: tumor stage 4"}]}, {"GSM1891703": [{"title": "patient 47, tumoral sample1, array 1"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: colon adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: left colon;\tgender: male;\tpatient age: 77;\ttumor stage: tumor stage 2"}]}, {"GSM1891704": [{"title": "patient 47, tumoral sample1, array 2"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: colon adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: left colon;\tgender: male;\tpatient age: 77;\ttumor stage: tumor stage 2"}]}, {"GSM1891705": [{"title": "patient 49, tumoral sample1, array 1"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: colon adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: left colon;\tgender: male;\tpatient age: 84;\ttumor stage: tumor stage 2"}]}, {"GSM1891706": [{"title": "patient 49, tumoral sample1, array 2"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: colon adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: left colon;\tgender: male;\tpatient age: 84;\ttumor stage: tumor stage 2"}]}, {"GSM1891707": [{"title": "patient 59, tumoral sample2, array 1"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: colon adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: right colon;\tgender: male;\tpatient age: 90;\ttumor stage: tumor stage 3"}]}, {"GSM1891708": [{"title": "patient 59, tumoral sample2, array 2"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: colon adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: right colon;\tgender: male;\tpatient age: 90;\ttumor stage: tumor stage 3"}]}, {"GSM1891709": [{"title": "patient 63, tumoral sample1, array 1"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: colon adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: sigmoid colon;\tgender: female;\tpatient age: 88;\ttumor stage: tumor stage 2"}]}, {"GSM1891710": [{"title": "patient 63, tumoral sample1, array 2"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: colon adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: sigmoid colon;\tgender: female;\tpatient age: 88;\ttumor stage: tumor stage 2"}]}, {"GSM1891711": [{"title": "patient 65, tumoral sample1, array 1"}, {"type": "RNA"}, {"source_name_ch1": "rectal adenocarcinoma"}, {"characteristics_ch1": "tissue: rectal adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: rectum;\tgender: male;\tpatient age: 71;\ttumor stage: tumor stage 2"}]}, {"GSM1891712": [{"title": "patient 65, tumoral sample1, array 2"}, {"type": "RNA"}, {"source_name_ch1": "rectal adenocarcinoma"}, {"characteristics_ch1": "tissue: rectal adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: rectum;\tgender: male;\tpatient age: 71;\ttumor stage: tumor stage 2"}]}, {"GSM1891713": [{"title": "patient 65, tumoral sample2, array 1"}, {"type": "RNA"}, {"source_name_ch1": "rectal adenocarcinoma"}, {"characteristics_ch1": "tissue: rectal adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: rectum;\tgender: male;\tpatient age: 71;\ttumor stage: tumor stage 2"}]}, {"GSM1891714": [{"title": "patient 65, tumoral sample2, array 2"}, {"type": "RNA"}, {"source_name_ch1": "rectal adenocarcinoma"}, {"characteristics_ch1": "tissue: rectal adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: rectum;\tgender: male;\tpatient age: 71;\ttumor stage: tumor stage 2"}]}, {"GSM1891715": [{"title": "patient 69, tumoral sample1,  single array 1"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: colon adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: left colon;\tgender: female;\tpatient age: 50;\ttumor stage: tumor stage 2"}]}, {"GSM1891716": [{"title": "patient 69, tumoral sample2,  single array 2"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: colon adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: left colon;\tgender: female;\tpatient age: 50;\ttumor stage: tumor stage 2"}]}, {"GSM1891717": [{"title": "patient 71, tumoral sample1,  single array"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: colon adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: right colon;\tgender: male;\tpatient age: 71;\ttumor stage: tumor stage 2"}]}, {"GSM1891718": [{"title": "patient 71, tumoral sample2,  single array"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: colon adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: right colon;\tgender: male;\tpatient age: 71;\ttumor stage: tumor stage 2"}]}, {"GSM1891719": [{"title": "patient 73, tumoral sample1,  single array"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: colon adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: right colon;\tgender: male;\tpatient age: 69;\ttumor stage: tumor stage 3"}]}, {"GSM1891720": [{"title": "patient 75, tumoral sample1, array 1"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: colon adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: right colon;\tgender: female;\tpatient age: 68;\ttumor stage: tumor stage 2"}]}, {"GSM1891721": [{"title": "patient 75, tumoral sample1, array 2"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: colon adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: right colon;\tgender: female;\tpatient age: 68;\ttumor stage: tumor stage 2"}]}, {"GSM1891722": [{"title": "patient 75, tumoral sample2, array 1"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: colon adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: right colon;\tgender: female;\tpatient age: 68;\ttumor stage: tumor stage 2"}]}, {"GSM1891723": [{"title": "patient 75, tumoral sample2, array 2"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: colon adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: right colon;\tgender: female;\tpatient age: 68;\ttumor stage: tumor stage 2"}]}, {"GSM1891724": [{"title": "patient 77, tumoral sample1,  single array"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: colon adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: right colon;\tgender: male;\tpatient age: 79;\ttumor stage: tumor stage 3"}]}, {"GSM1891725": [{"title": "patient 77, tumoral sample2,  single array"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: colon adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: right colon;\tgender: male;\tpatient age: 79;\ttumor stage: tumor stage 3"}]}, {"GSM1891726": [{"title": "patient 79, tumoral sample1,  single array"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: colon adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: right colon;\tgender: female;\tpatient age: 84;\ttumor stage: tumor stage 3"}]}, {"GSM1891727": [{"title": "patient 79, tumoral sample2,  single array"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: colon adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: right colon;\tgender: female;\tpatient age: 84;\ttumor stage: tumor stage 3"}]}, {"GSM1891728": [{"title": "patient 85, tumoral sample1, array 1"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: colon adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: right colon;\tgender: female;\tpatient age: 81;\ttumor stage: tumor stage 3"}]}, {"GSM1891729": [{"title": "patient 85, tumoral sample1, array 2"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: colon adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: right colon;\tgender: female;\tpatient age: 81;\ttumor stage: tumor stage 3"}]}, {"GSM1891730": [{"title": "patient 85, tumoral sample2, array 1"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: colon adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: right colon;\tgender: female;\tpatient age: 81;\ttumor stage: tumor stage 3"}]}, {"GSM1891731": [{"title": "patient 85, tumoral sample2, array 2"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: colon adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: right colon;\tgender: female;\tpatient age: 81;\ttumor stage: tumor stage 3"}]}, {"GSM1891732": [{"title": "patient 91, tumoral sample1, single array"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: colon adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: right colon;\tgender: male;\tpatient age: 73;\ttumor stage: tumor stage 3"}]}, {"GSM1891733": [{"title": "patient 93, tumoral sample1,  single array"}, {"type": "RNA"}, {"source_name_ch1": "rectal adenocarcinoma"}, {"characteristics_ch1": "tissue: rectal adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: rectum;\tgender: female;\tpatient age: 50;\ttumor stage: tumor stage 3"}]}, {"GSM1891734": [{"title": "patient 93, tumoral sample2, single array"}, {"type": "RNA"}, {"source_name_ch1": "rectal adenocarcinoma"}, {"characteristics_ch1": "tissue: rectal adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: rectum;\tgender: female;\tpatient age: 50;\ttumor stage: tumor stage 3"}]}, {"GSM1891735": [{"title": "patient 97, tumoral sample2, array 1"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: colon adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: sigmoid colon;\tgender: male;\tpatient age: 73;\ttumor stage: tumor stage 2"}]}, {"GSM1891736": [{"title": "patient 97, tumoral sample2, array 2"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: colon adenocarcinoma;\ttissue preparation: frozen sample;\tanatomical site: sigmoid colon;\tgender: male;\tpatient age: 73;\ttumor stage: tumor stage 2"}]}, {"GSM1891737": [{"title": "patient AA1, normal colonic mucosa,  single array"}, {"type": "RNA"}, {"source_name_ch1": "normal colonic mucosa"}, {"characteristics_ch1": "tissue: normal colonic mucosa;\ttissue preparation: frozen sample;\tanatomical site: sigmoid colon;\tgender: male;\tpatient age: 69;\ttumor stage: normal colonic mucosa"}]}, {"GSM1891738": [{"title": "patient 13, normal colonic mucosa, array 1"}, {"type": "RNA"}, {"source_name_ch1": "normal colonic mucosa"}, {"characteristics_ch1": "tissue: normal colonic mucosa;\ttissue preparation: frozen sample;\tanatomical site: transverse colon;\tgender: male;\tpatient age: 46;\ttumor stage: normal colonic mucosa"}]}, {"GSM1891739": [{"title": "patient 13, normal colonic mucosa, array 2"}, {"type": "RNA"}, {"source_name_ch1": "normal colonic mucosa"}, {"characteristics_ch1": "tissue: normal colonic mucosa;\ttissue preparation: frozen sample;\tanatomical site: transverse colon;\tgender: male;\tpatient age: 46;\ttumor stage: normal colonic mucosa"}]}, {"GSM1891740": [{"title": "patient 19, normal colonic mucosa, array 1"}, {"type": "RNA"}, {"source_name_ch1": "normal colonic mucosa"}, {"characteristics_ch1": "tissue: normal colonic mucosa;\ttissue preparation: frozen sample;\tanatomical site: right colon;\tgender: male;\tpatient age: 38;\ttumor stage: normal colonic mucosa"}]}, {"GSM1891741": [{"title": "patient 19, normal colonic mucosa, array 2"}, {"type": "RNA"}, {"source_name_ch1": "normal colonic mucosa"}, {"characteristics_ch1": "tissue: normal colonic mucosa;\ttissue preparation: frozen sample;\tanatomical site: right colon;\tgender: male;\tpatient age: 38;\ttumor stage: normal colonic mucosa"}]}, {"GSM1891742": [{"title": "patient 31, normal colonic mucosa,  single array"}, {"type": "RNA"}, {"source_name_ch1": "normal colonic mucosa"}, {"characteristics_ch1": "tissue: normal colonic mucosa;\ttissue preparation: frozen sample;\tanatomical site: right colon;\tgender: male;\tpatient age: 75;\ttumor stage: normal colonic mucosa"}]}, {"GSM1891743": [{"title": "patient 37, normal colonic mucosa, array 1"}, {"type": "RNA"}, {"source_name_ch1": "normal colonic mucosa"}, {"characteristics_ch1": "tissue: normal colonic mucosa;\ttissue preparation: frozen sample;\tanatomical site: left colon;\tgender: male;\tpatient age: 48;\ttumor stage: normal colonic mucosa"}]}, {"GSM1891744": [{"title": "patient 37, normal colonic mucosa, array 2"}, {"type": "RNA"}, {"source_name_ch1": "normal colonic mucosa"}, {"characteristics_ch1": "tissue: normal colonic mucosa;\ttissue preparation: frozen sample;\tanatomical site: left colon;\tgender: male;\tpatient age: 48;\ttumor stage: normal colonic mucosa"}]}, {"GSM1891745": [{"title": "patient 43, normal colonic mucosa,  single array"}, {"type": "RNA"}, {"source_name_ch1": "normal colonic mucosa"}, {"characteristics_ch1": "tissue: normal colonic mucosa;\ttissue preparation: frozen sample;\tanatomical site: right colon;\tgender: male;\tpatient age: 33;\ttumor stage: normal colonic mucosa"}]}, {"GSM1891746": [{"title": "patient 47, normal colonic mucosa, array 1"}, {"type": "RNA"}, {"source_name_ch1": "normal colonic mucosa"}, {"characteristics_ch1": "tissue: normal colonic mucosa;\ttissue preparation: frozen sample;\tanatomical site: left colon;\tgender: male;\tpatient age: 77;\ttumor stage: normal colonic mucosa"}]}, {"GSM1891747": [{"title": "patient 47, normal colonic mucosa, array 2"}, {"type": "RNA"}, {"source_name_ch1": "normal colonic mucosa"}, {"characteristics_ch1": "tissue: normal colonic mucosa;\ttissue preparation: frozen sample;\tanatomical site: left colon;\tgender: male;\tpatient age: 77;\ttumor stage: normal colonic mucosa"}]}, {"GSM1891748": [{"title": "patient 49, normal colonic mucosa, array 1"}, {"type": "RNA"}, {"source_name_ch1": "normal colonic mucosa"}, {"characteristics_ch1": "tissue: normal colonic mucosa;\ttissue preparation: frozen sample;\tanatomical site: left colon;\tgender: male;\tpatient age: 84;\ttumor stage: normal colonic mucosa"}]}, {"GSM1891749": [{"title": "patient 49, normal colonic mucosa, array 2"}, {"type": "RNA"}, {"source_name_ch1": "normal colonic mucosa"}, {"characteristics_ch1": "tissue: normal colonic mucosa;\ttissue preparation: frozen sample;\tanatomical site: left colon;\tgender: male;\tpatient age: 84;\ttumor stage: normal colonic mucosa"}]}, {"GSM1891750": [{"title": "patient 59, normal colonic mucosa, array 1"}, {"type": "RNA"}, {"source_name_ch1": "normal colonic mucosa"}, {"characteristics_ch1": "tissue: normal colonic mucosa;\ttissue preparation: frozen sample;\tanatomical site: right colon;\tgender: male;\tpatient age: 90;\ttumor stage: normal colonic mucosa"}]}, {"GSM1891751": [{"title": "patient 59, normal colonic mucosa, array 2"}, {"type": "RNA"}, {"source_name_ch1": "normal colonic mucosa"}, {"characteristics_ch1": "tissue: normal colonic mucosa;\ttissue preparation: frozen sample;\tanatomical site: right colon;\tgender: male;\tpatient age: 90;\ttumor stage: normal colonic mucosa"}]}, {"GSM1891752": [{"title": "patient 63, normal colonic mucosa, array 1"}, {"type": "RNA"}, {"source_name_ch1": "normal colonic mucosa"}, {"characteristics_ch1": "tissue: normal colonic mucosa;\ttissue preparation: frozen sample;\tanatomical site: sigmoid colon;\tgender: female;\tpatient age: 88;\ttumor stage: normal colonic mucosa"}]}, {"GSM1891753": [{"title": "patient 63, normal colonic mucosa, array 2"}, {"type": "RNA"}, {"source_name_ch1": "normal colonic mucosa"}, {"characteristics_ch1": "tissue: normal colonic mucosa;\ttissue preparation: frozen sample;\tanatomical site: sigmoid colon;\tgender: female;\tpatient age: 88;\ttumor stage: normal colonic mucosa"}]}, {"GSM1891754": [{"title": "patient 65, normal colonic mucosa, array 1"}, {"type": "RNA"}, {"source_name_ch1": "normal colonic mucosa"}, {"characteristics_ch1": "tissue: normal colonic mucosa;\ttissue preparation: frozen sample;\tanatomical site: rectum;\tgender: male;\tpatient age: 71;\ttumor stage: normal colonic mucosa"}]}, {"GSM1891755": [{"title": "patient 65,normal colonic mucosa, array 2"}, {"type": "RNA"}, {"source_name_ch1": "normal colonic mucosa"}, {"characteristics_ch1": "tissue: normal colonic mucosa;\ttissue preparation: frozen sample;\tanatomical site: rectum;\tgender: male;\tpatient age: 71;\ttumor stage: normal colonic mucosa"}]}, {"GSM1891756": [{"title": "patient 71, normal sample,  single array"}, {"type": "RNA"}, {"source_name_ch1": "normal colonic mucosa"}, {"characteristics_ch1": "tissue: normal colonic mucosa;\ttissue preparation: frozen sample;\tanatomical site: right colon;\tgender: male;\tpatient age: 71;\ttumor stage: normal colonic mucosa"}]}, {"GSM1891757": [{"title": "patient 73, normal sample, array 1"}, {"type": "RNA"}, {"source_name_ch1": "normal colonic mucosa"}, {"characteristics_ch1": "tissue: normal colonic mucosa;\ttissue preparation: frozen sample;\tanatomical site: right colon;\tgender: male;\tpatient age: 69;\ttumor stage: normal colonic mucosa"}]}, {"GSM1891758": [{"title": "patient 73, normal sample, array 2"}, {"type": "RNA"}, {"source_name_ch1": "normal colonic mucosa"}, {"characteristics_ch1": "tissue: normal colonic mucosa;\ttissue preparation: frozen sample;\tanatomical site: right colon;\tgender: male;\tpatient age: 69;\ttumor stage: normal colonic mucosa"}]}, {"GSM1891759": [{"title": "patient 75, normal sample, array 1"}, {"type": "RNA"}, {"source_name_ch1": "normal colonic mucosa"}, {"characteristics_ch1": "tissue: normal colonic mucosa;\ttissue preparation: frozen sample;\tanatomical site: right colon;\tgender: female;\tpatient age: 68;\ttumor stage: normal colonic mucosa"}]}, {"GSM1891760": [{"title": "patient 75, normal sample, array 2"}, {"type": "RNA"}, {"source_name_ch1": "normal colonic mucosa"}, {"characteristics_ch1": "tissue: normal colonic mucosa;\ttissue preparation: frozen sample;\tanatomical site: right colon;\tgender: female;\tpatient age: 68;\ttumor stage: normal colonic mucosa"}]}, {"GSM1891761": [{"title": "patient 77, normal sample, single array"}, {"type": "RNA"}, {"source_name_ch1": "normal colonic mucosa"}, {"characteristics_ch1": "tissue: normal colonic mucosa;\ttissue preparation: frozen sample;\tanatomical site: right colon;\tgender: male;\tpatient age: 79;\ttumor stage: normal colonic mucosa"}]}, {"GSM1891762": [{"title": "patient 79, normal sample,  single array"}, {"type": "RNA"}, {"source_name_ch1": "normal colonic mucosa"}, {"characteristics_ch1": "tissue: normal colonic mucosa;\ttissue preparation: frozen sample;\tanatomical site: right colon;\tgender: female;\tpatient age: 84;\ttumor stage: normal colonic mucosa"}]}, {"GSM1891763": [{"title": "patient 91, normal sample,  single array"}, {"type": "RNA"}, {"source_name_ch1": "normal colonic mucosa"}, {"characteristics_ch1": "tissue: normal colonic mucosa;\ttissue preparation: frozen sample;\tanatomical site: right colon;\tgender: male;\tpatient age: 73;\ttumor stage: normal colonic mucosa"}]}, {"GSM1891764": [{"title": "patient 93, normal sample, array 1"}, {"type": "RNA"}, {"source_name_ch1": "normal colonic mucosa"}, {"characteristics_ch1": "tissue: normal colonic mucosa;\ttissue preparation: frozen sample;\tanatomical site: rectum;\tgender: female;\tpatient age: 50;\ttumor stage: normal colonic mucosa"}]}, {"GSM1891765": [{"title": "patient 93, normal sample, array 2"}, {"type": "RNA"}, {"source_name_ch1": "normal colonic mucosa"}, {"characteristics_ch1": "tissue: normal colonic mucosa;\ttissue preparation: frozen sample;\tanatomical site: rectum;\tgender: female;\tpatient age: 50;\ttumor stage: normal colonic mucosa"}]}, {"GSM1891766": [{"title": "patient 97, normal sample, array 1"}, {"type": "RNA"}, {"source_name_ch1": "normal colonic mucosa"}, {"characteristics_ch1": "tissue: normal colonic mucosa;\ttissue preparation: frozen sample;\tanatomical site: sigmoid colon;\tgender: male;\tpatient age: 73;\ttumor stage: normal colonic mucosa"}]}, {"GSM1891767": [{"title": "patient 97, normal sample, array 2"}, {"type": "RNA"}, {"source_name_ch1": "normal colonic mucosa"}, {"characteristics_ch1": "tissue: normal colonic mucosa;\ttissue preparation: frozen sample;\tanatomical site: sigmoid colon;\tgender: male;\tpatient age: 73;\ttumor stage: normal colonic mucosa"}]}, {"GSM1891768": [{"title": "Caco-2 colorectal adenocarcinoma cell line, array 1"}, {"type": "RNA"}, {"source_name_ch1": "colorectal adenocarcinoma cell line"}, {"characteristics_ch1": "cell line: Caco-2;\ttissue: colorectal adenocarcinoma cell line;\ttissue preparation: confluent cell cultures;\tanatomical site: colon;\tgender: male;\tpatient age: 72;\ttumor stage: colorectal adenocarcinoma cell line"}]}, {"GSM1891769": [{"title": "Caco-2 colorectal adenocarcinoma cell line, array 2"}, {"type": "RNA"}, {"source_name_ch1": "colorectal adenocarcinoma cell line"}, {"characteristics_ch1": "cell line: Caco-2;\ttissue: colorectal adenocarcinoma cell line;\ttissue preparation: confluent cell cultures;\tanatomical site: colon;\tgender: male;\tpatient age: 72;\ttumor stage: colorectal adenocarcinoma cell line"}]}, {"GSM1891770": [{"title": "HT29 colorectal adenocarcinoma cell line, array 1"}, {"type": "RNA"}, {"source_name_ch1": "colorectal adenocarcinoma cell line"}, {"characteristics_ch1": "cell line: HT29;\ttissue: colorectal adenocarcinoma cell line;\ttissue preparation: confluent cell cultures;\tanatomical site: colon;\tgender: female;\tpatient age: 44;\ttumor stage: colorectal adenocarcinoma cell line"}]}, {"GSM1891771": [{"title": "HT29 colorectal adenocarcinoma cell line, array 2"}, {"type": "RNA"}, {"source_name_ch1": "colorectal adenocarcinoma cell line"}, {"characteristics_ch1": "cell line: HT29;\ttissue: colorectal adenocarcinoma cell line;\ttissue preparation: confluent cell cultures;\tanatomical site: colon;\tgender: female;\tpatient age: 44;\ttumor stage: colorectal adenocarcinoma cell line"}]}, {"GSM1891772": [{"title": "HCT116 colorectal adenocarcinoma cell line, array 1"}, {"type": "RNA"}, {"source_name_ch1": "colorectal carcinoma cell line"}, {"characteristics_ch1": "cell line: HCT116;\ttissue: colorectal carcinoma cell line;\ttissue preparation: confluent cell cultures;\tanatomical site: colon;\tgender: male;\tpatient age: adult;\ttumor stage: colorectal adenocarcinoma cell line"}]}, {"GSM1891773": [{"title": "HCT116 colorectal adenocarcinoma cell line, array 2"}, {"type": "RNA"}, {"source_name_ch1": "colorectal carcinoma cell line"}, {"characteristics_ch1": "cell line: HCT116;\ttissue: colorectal carcinoma cell line;\ttissue preparation: confluent cell cultures;\tanatomical site: colon;\tgender: male;\tpatient age: adult;\ttumor stage: colorectal adenocarcinoma cell line"}]}, {"GSM2027432": [{"title": "Control replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "lung carcinoma cells"}, {"characteristics_ch1": "cell line: A549"}]}, {"GSM2027433": [{"title": "Control replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "lung carcinoma cells"}, {"characteristics_ch1": "cell line: A549"}]}, {"GSM2027434": [{"title": "Control replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "lung carcinoma cells"}, {"characteristics_ch1": "cell line: A549"}]}, {"GSM2027435": [{"title": "ER stress control replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "lung carcinoma cells"}, {"characteristics_ch1": "cell line: A549"}]}, {"GSM2027436": [{"title": "ER stress control replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "lung carcinoma cells"}, {"characteristics_ch1": "cell line: A549"}]}, {"GSM2027437": [{"title": "ER stress control replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "lung carcinoma cells"}, {"characteristics_ch1": "cell line: A549"}]}, {"GSM2027438": [{"title": "ES stress TUSC3 Knock-out replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "lung carcinoma cells"}, {"characteristics_ch1": "cell line: A549"}]}, {"GSM2027439": [{"title": "ES stress TUSC3 Knock-out replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "lung carcinoma cells"}, {"characteristics_ch1": "cell line: A549"}]}, {"GSM2027440": [{"title": "ES stress TUSC3 Knock-out replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "lung carcinoma cells"}, {"characteristics_ch1": "cell line: A549"}]}, {"GSM2027441": [{"title": "TUSC3 Knock-out replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "lung carcinoma cells"}, {"characteristics_ch1": "cell line: A549"}]}, {"GSM2027442": [{"title": "TUSC3 Knock-out replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "lung carcinoma cells"}, {"characteristics_ch1": "cell line: A549"}]}, {"GSM2027443": [{"title": "TUSC3 Knock-out replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "lung carcinoma cells"}, {"characteristics_ch1": "cell line: A549"}]}, {"GSM2128264": [{"title": "H_PMN_C_30_1"}, {"type": "RNA"}, {"source_name_ch1": "Human neutrophils treated with DMSO (-ve control) for 30 mins"}, {"characteristics_ch1": "tissue: Peripheral Blood neutrophils;\tgender: male;\tdiagnosis: Healthy donor;\tage: Adult (20-40 years)"}]}, {"GSM2128265": [{"title": "H_PMN_C_30_2"}, {"type": "RNA"}, {"source_name_ch1": "Human neutrophils treated with DMSO (-ve control) for 30 mins"}, {"characteristics_ch1": "tissue: Peripheral Blood neutrophils;\tgender: male;\tdiagnosis: Healthy donor;\tage: Adult (20-40 years)"}]}, {"GSM2128266": [{"title": "H_PMN_C_30_3"}, {"type": "RNA"}, {"source_name_ch1": "Human neutrophils treated with DMSO (-ve control) for 30 mins"}, {"characteristics_ch1": "tissue: Peripheral Blood neutrophils;\tgender: male;\tdiagnosis: Healthy donor;\tage: Adult (20-40 years)"}]}, {"GSM2128267": [{"title": "H_PMN_C_60_1"}, {"type": "RNA"}, {"source_name_ch1": "Human neutrophils treated with DMSO (-ve control) for 60 mins"}, {"characteristics_ch1": "tissue: Peripheral Blood neutrophils;\tgender: male;\tdiagnosis: Healthy donor;\tage: Adult (20-40 years)"}]}, {"GSM2128268": [{"title": "H_PMN_C_60_2"}, {"type": "RNA"}, {"source_name_ch1": "Human neutrophils treated with DMSO (-ve control) for 60 mins"}, {"characteristics_ch1": "tissue: Peripheral Blood neutrophils;\tgender: male;\tdiagnosis: Healthy donor;\tage: Adult (20-40 years)"}]}, {"GSM2128269": [{"title": "H_PMN_C_60_3"}, {"type": "RNA"}, {"source_name_ch1": "Human neutrophils treated with DMSO (-ve control) for 60 mins"}, {"characteristics_ch1": "tissue: Peripheral Blood neutrophils;\tgender: male;\tdiagnosis: Healthy donor;\tage: Adult (20-40 years)"}]}, {"GSM2128271": [{"title": "H_PMN_P_30_1"}, {"type": "RNA"}, {"source_name_ch1": "Human neutrophils treated with PMA (25 nM) for 30 mins"}, {"characteristics_ch1": "tissue: Peripheral Blood neutrophils;\tgender: male;\tdiagnosis: Healthy donor;\tage: Adult (20-40 years)"}]}, {"GSM2128273": [{"title": "H_PMN_P_30_2"}, {"type": "RNA"}, {"source_name_ch1": "Human neutrophils treated with PMA (25 nM) for 30 mins"}, {"characteristics_ch1": "tissue: Peripheral Blood neutrophils;\tgender: male;\tdiagnosis: Healthy donor;\tage: Adult (20-40 years)"}]}, {"GSM2128274": [{"title": "H_PMN_P_30_3"}, {"type": "RNA"}, {"source_name_ch1": "Human neutrophils treated with PMA (25 nM) for 30 mins"}, {"characteristics_ch1": "tissue: Peripheral Blood neutrophils;\tgender: male;\tdiagnosis: Healthy donor;\tage: Adult (20-40 years)"}]}, {"GSM2128276": [{"title": "H_PMN_P_60_1"}, {"type": "RNA"}, {"source_name_ch1": "Human neutrophils treated with PMA (25 nM) for 60 mins"}, {"characteristics_ch1": "tissue: Peripheral Blood neutrophils;\tgender: male;\tdiagnosis: Healthy donor;\tage: Adult (20-40 years)"}]}, {"GSM2128279": [{"title": "H_PMN_P_60_2"}, {"type": "RNA"}, {"source_name_ch1": "Human neutrophils treated with PMA (25 nM) for 60 mins"}, {"characteristics_ch1": "tissue: Peripheral Blood neutrophils;\tgender: male;\tdiagnosis: Healthy donor;\tage: Adult (20-40 years)"}]}, {"GSM2128281": [{"title": "H_PMN_P_60_3"}, {"type": "RNA"}, {"source_name_ch1": "Human neutrophils treated with PMA (25 nM) for 60 mins"}, {"characteristics_ch1": "tissue: Peripheral Blood neutrophils;\tgender: male;\tdiagnosis: Healthy donor;\tage: Adult (20-40 years)"}]}, {"GSM2128283": [{"title": "H_PMN_A23187_30_1"}, {"type": "RNA"}, {"source_name_ch1": "Human neutrophils treated with A23187 (4 uM) for 30 mins"}, {"characteristics_ch1": "tissue: Peripheral Blood neutrophils;\tgender: male;\tdiagnosis: Healthy donor;\tage: Adult (20-40 years)"}]}, {"GSM2128285": [{"title": "H_PMN_A23187_30_2"}, {"type": "RNA"}, {"source_name_ch1": "Human neutrophils treated with A23187 (4 uM) for 30 mins"}, {"characteristics_ch1": "tissue: Peripheral Blood neutrophils;\tgender: male;\tdiagnosis: Healthy donor;\tage: Adult (20-40 years)"}]}, {"GSM2128288": [{"title": "H_PMN_A23187_30_3"}, {"type": "RNA"}, {"source_name_ch1": "Human neutrophils treated with A23187 (4 uM) for 30 mins"}, {"characteristics_ch1": "tissue: Peripheral Blood neutrophils;\tgender: male;\tdiagnosis: Healthy donor;\tage: Adult (20-40 years)"}]}, {"GSM2128290": [{"title": "H_PMN_A23187_60_1"}, {"type": "RNA"}, {"source_name_ch1": "Human neutrophils treated with A23187 (4 uM) for 60 mins"}, {"characteristics_ch1": "tissue: Peripheral Blood neutrophils;\tgender: male;\tdiagnosis: Healthy donor;\tage: Adult (20-40 years)"}]}, {"GSM2128292": [{"title": "H_PMN_A23187_60_2"}, {"type": "RNA"}, {"source_name_ch1": "Human neutrophils treated with A23187 (4 uM) for 60 mins"}, {"characteristics_ch1": "tissue: Peripheral Blood neutrophils;\tgender: male;\tdiagnosis: Healthy donor;\tage: Adult (20-40 years)"}]}, {"GSM2128294": [{"title": "H_PMN_A23187_60_3"}, {"type": "RNA"}, {"source_name_ch1": "Human neutrophils treated with A23187 (4 uM) for 60 mins"}, {"characteristics_ch1": "tissue: Peripheral Blood neutrophils;\tgender: male;\tdiagnosis: Healthy donor;\tage: Adult (20-40 years)"}]}, {"GSM2390107": [{"title": "Main Lacrimal Gland1 right"}, {"type": "RNA"}, {"source_name_ch1": "Main Lacrimal gland"}, {"characteristics_ch1": "tissue: Main Lacrimal gland"}]}, {"GSM2390108": [{"title": "Main Lacrimal Gland1 left"}, {"type": "RNA"}, {"source_name_ch1": "Main Lacrimal gland"}, {"characteristics_ch1": "tissue: Main Lacrimal gland"}]}, {"GSM2390109": [{"title": "Main Lacrimal Gland2 right"}, {"type": "RNA"}, {"source_name_ch1": "Main Lacrimal gland"}, {"characteristics_ch1": "tissue: Main Lacrimal gland"}]}, {"GSM2390110": [{"title": "Main Lacrimal Gland 2 left"}, {"type": "RNA"}, {"source_name_ch1": "Main Lacrimal gland"}, {"characteristics_ch1": "tissue: Main Lacrimal gland"}]}, {"GSM2390113": [{"title": "Main Lacrimal Gland 3a"}, {"type": "RNA"}, {"source_name_ch1": "Main Lacrimal gland"}, {"characteristics_ch1": "tissue: Main Lacrimal gland"}]}, {"GSM2390114": [{"title": "Main Lacrimal Gland 3b"}, {"type": "RNA"}, {"source_name_ch1": "Main Lacrimal gland"}, {"characteristics_ch1": "tissue: Main Lacrimal gland"}]}, {"GSM2226215": [{"title": "prostate_tumour_CPCG0236"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0236"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226216": [{"title": "prostate_tumour_CPCG0246"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0246"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226217": [{"title": "prostate_tumour_CPCG0248"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0248"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226218": [{"title": "prostate_tumour_CPCG0249"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0249"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226219": [{"title": "prostate_tumour_CPCG0250"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0250"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226220": [{"title": "prostate_tumour_CPCG0255"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0255"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226221": [{"title": "prostate_tumour_CPCG0258"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0258"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226222": [{"title": "prostate_tumour_CPCG0260"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0260"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226223": [{"title": "prostate_tumour_CPCG0262"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0262"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226224": [{"title": "prostate_tumour_CPCG0263"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0263"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226225": [{"title": "prostate_tumour_CPCG0265"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0265"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226226": [{"title": "prostate_tumour_CPCG0267"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0267"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226227": [{"title": "prostate_tumour_CPCG0269"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0269"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226228": [{"title": "prostate_tumour_CPCG0324"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0324"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226229": [{"title": "prostate_tumour_CPCG0331"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0331"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226230": [{"title": "prostate_tumour_CPCG0336"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0336"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226231": [{"title": "prostate_tumour_CPCG0339"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0339"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226232": [{"title": "prostate_tumour_CPCG0340"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0340"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226233": [{"title": "prostate_tumour_CPCG0341"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0341"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226234": [{"title": "prostate_tumour_CPCG0342"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0342"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226235": [{"title": "prostate_tumour_CPCG0344"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0344"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226236": [{"title": "prostate_tumour_CPCG0348"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0348"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226237": [{"title": "prostate_tumour_CPCG0350"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0350"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226238": [{"title": "prostate_tumour_CPCG0352"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0352"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226239": [{"title": "prostate_tumour_CPCG0353"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0353"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226240": [{"title": "prostate_tumour_CPCG0354"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0354"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226241": [{"title": "prostate_tumour_CPCG0355"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0355"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226242": [{"title": "prostate_tumour_CPCG0356"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0356"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226243": [{"title": "prostate_tumour_CPCG0357"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0357"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226244": [{"title": "prostate_tumour_CPCG0358"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0358"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226245": [{"title": "prostate_tumour_CPCG0362"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0362"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226246": [{"title": "prostate_tumour_CPCG0363"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0363"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226247": [{"title": "prostate_tumour_CPCG0364"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0364"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226248": [{"title": "prostate_tumour_CPCG0365"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0365"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226249": [{"title": "prostate_tumour_CPCG0366"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0366"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226250": [{"title": "prostate_tumour_CPCG0371"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0371"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226251": [{"title": "prostate_tumour_CPCG0372"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0372"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226252": [{"title": "prostate_tumour_CPCG0373"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0373"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226253": [{"title": "prostate_tumour_CPCG0375"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0375"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226254": [{"title": "prostate_tumour_CPCG0378"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0378"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226255": [{"title": "prostate_tumour_CPCG0381"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0381"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226256": [{"title": "prostate_tumour_CPCG0387"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0387"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226257": [{"title": "prostate_tumour_CPCG0391"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0391"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226258": [{"title": "prostate_tumour_CPCG0401"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0401"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226259": [{"title": "prostate_tumour_CPCG0407"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0407"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226260": [{"title": "prostate_tumour_CPCG0409"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0409"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226261": [{"title": "prostate_tumour_CPCG0410"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0410"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226262": [{"title": "prostate_tumour_CPCG0411"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0411"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226263": [{"title": "prostate_tumour_CPCG0412"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0412"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226264": [{"title": "prostate_tumour_CPCG0413"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0413"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226265": [{"title": "prostate_tumour_CPCG0414"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0414"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226266": [{"title": "prostate_tumour_CPCG0241"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0241"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226267": [{"title": "prostate_tumour_CPCG0266"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0266"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226268": [{"title": "prostate_tumour_CPCG0334"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0334"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226269": [{"title": "prostate_tumour_CPCG0346"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0346"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2226270": [{"title": "prostate_tumour_CPCG0361"}, {"type": "RNA"}, {"source_name_ch1": "prostate_tumour_CPCG0361"}, {"characteristics_ch1": "tissue: prostate tumor"}]}, {"GSM2451429": [{"title": "BEAS-2B cells as control, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "BEAS-2B cells"}, {"characteristics_ch1": "cell type: bronchial epithelial cells;\ttreatment: DMEM"}]}, {"GSM2451430": [{"title": "BEAS-2B cells as control, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "BEAS-2B cells"}, {"characteristics_ch1": "cell type: bronchial epithelial cells;\ttreatment: DMEM"}]}, {"GSM2451431": [{"title": "BEAS-2B cells as control, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "BEAS-2B cells"}, {"characteristics_ch1": "cell type: bronchial epithelial cells;\ttreatment: DMEM"}]}, {"GSM2451432": [{"title": "BEAS-2B cells treated with PM2.5, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "BEAS-2B cells"}, {"characteristics_ch1": "cell type: bronchial epithelial cells;\ttreatment: PM2.5 suspended in DMEM"}]}, {"GSM2451433": [{"title": "BEAS-2B cells treated with PM2.5, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "BEAS-2B cells"}, {"characteristics_ch1": "cell type: bronchial epithelial cells;\ttreatment: PM2.5 suspended in DMEM"}]}, {"GSM2451434": [{"title": "BEAS-2B cells treated with PM2.5, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "BEAS-2B cells"}, {"characteristics_ch1": "cell type: bronchial epithelial cells;\ttreatment: PM2.5 suspended in DMEM"}]}, {"GSM2100559": [{"title": "#4 AX4684 (SX00838CF8)"}, {"type": "RNA"}, {"source_name_ch1": "Thin melanoma, FFPE"}, {"characteristics_ch1": "outcome: Poor;\tdiagnosis: Thin melanoma"}]}, {"GSM2100560": [{"title": "#5 AX5487 (SX0083CDAE)"}, {"type": "RNA"}, {"source_name_ch1": "Thin melanoma, FFPE"}, {"characteristics_ch1": "outcome: Poor;\tdiagnosis: Thin melanoma"}]}, {"GSM2100561": [{"title": "#6 AX4170 (SX0083CBF0)"}, {"type": "RNA"}, {"source_name_ch1": "Thin melanoma, FFPE"}, {"characteristics_ch1": "outcome: Poor;\tdiagnosis: Thin melanoma"}]}, {"GSM2100562": [{"title": "#7 AX4171 (SX0083CBEF)"}, {"type": "RNA"}, {"source_name_ch1": "Thin melanoma, FFPE"}, {"characteristics_ch1": "outcome: Poor;\tdiagnosis: Thin melanoma"}]}, {"GSM2100563": [{"title": "#8 AX4182 (SX0083CA7D)"}, {"type": "RNA"}, {"source_name_ch1": "Thin melanoma, FFPE"}, {"characteristics_ch1": "outcome: Poor;\tdiagnosis: Thin melanoma"}]}, {"GSM2100564": [{"title": "#9 AX4169 (SX0083CA65)"}, {"type": "RNA"}, {"source_name_ch1": "Thin melanoma, FFPE"}, {"characteristics_ch1": "outcome: Poor;\tdiagnosis: Thin melanoma"}]}, {"GSM2100565": [{"title": "#10 AX5332 (SX0083C937)"}, {"type": "RNA"}, {"source_name_ch1": "Thin melanoma, FFPE"}, {"characteristics_ch1": "outcome: Poor;\tdiagnosis: Thin melanoma"}]}, {"GSM2100566": [{"title": "#11 AX4704 (SX0083C938)"}, {"type": "RNA"}, {"source_name_ch1": "Thin melanoma, FFPE"}, {"characteristics_ch1": "outcome: Poor;\tdiagnosis: Thin melanoma"}]}, {"GSM2100567": [{"title": "#18 AX4803 (SX0083CF5F)"}, {"type": "RNA"}, {"source_name_ch1": "Thin melanoma, FFPE"}, {"characteristics_ch1": "outcome: Poor;\tdiagnosis: Thin melanoma"}]}, {"GSM2100568": [{"title": "#1 AX4958 (SX0083BC56)"}, {"type": "RNA"}, {"source_name_ch1": "Thin melanoma, FFPE"}, {"characteristics_ch1": "outcome: Good;\tdiagnosis: Thin melanoma"}]}, {"GSM2100569": [{"title": "#2 AX4966 (SX0083AC63)"}, {"type": "RNA"}, {"source_name_ch1": "Thin melanoma, FFPE"}, {"characteristics_ch1": "outcome: Good;\tdiagnosis: Thin melanoma"}]}, {"GSM2100570": [{"title": "#3 AX4957 (SX00837F71)"}, {"type": "RNA"}, {"source_name_ch1": "Thin melanoma, FFPE"}, {"characteristics_ch1": "outcome: Good;\tdiagnosis: Thin melanoma"}]}, {"GSM2100571": [{"title": "#12 AX4963 (SX0083C0FD)"}, {"type": "RNA"}, {"source_name_ch1": "Thin melanoma, FFPE"}, {"characteristics_ch1": "outcome: Good;\tdiagnosis: Thin melanoma"}]}, {"GSM2100572": [{"title": "#13 AX4959 (SX0083D77)"}, {"type": "RNA"}, {"source_name_ch1": "Thin melanoma, FFPE"}, {"characteristics_ch1": "outcome: Good;\tdiagnosis: Thin melanoma"}]}, {"GSM2100573": [{"title": "#14 AX4961 (SX0083533)"}, {"type": "RNA"}, {"source_name_ch1": "Thin melanoma, FFPE"}, {"characteristics_ch1": "outcome: Good;\tdiagnosis: Thin melanoma"}]}, {"GSM2100574": [{"title": "#15 AX4960 (SX0083C797)"}, {"type": "RNA"}, {"source_name_ch1": "Thin melanoma, FFPE"}, {"characteristics_ch1": "outcome: Good;\tdiagnosis: Thin melanoma"}]}, {"GSM2100575": [{"title": "#16 AX4962 (SX0083CF95)"}, {"type": "RNA"}, {"source_name_ch1": "Thin melanoma, FFPE"}, {"characteristics_ch1": "outcome: Good;\tdiagnosis: Thin melanoma"}]}, {"GSM2100576": [{"title": "#17 AX4965 (SX00837F70)"}, {"type": "RNA"}, {"source_name_ch1": "Thin melanoma, FFPE"}, {"characteristics_ch1": "outcome: Good;\tdiagnosis: Thin melanoma"}]}, {"GSM2100577": [{"title": "#19 AX4964 (SX0083B9D6)"}, {"type": "RNA"}, {"source_name_ch1": "Thin melanoma, FFPE"}, {"characteristics_ch1": "outcome: Good;\tdiagnosis: Thin melanoma"}]}, {"GSM2422430": [{"title": "U3002 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422431": [{"title": "U3005 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422432": [{"title": "U3008 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422433": [{"title": "U3009 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422434": [{"title": "U3013 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422435": [{"title": "U3017 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422436": [{"title": "U3020 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422437": [{"title": "U3021 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422438": [{"title": "U3024 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422439": [{"title": "U3027 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422440": [{"title": "U3028 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422441": [{"title": "U3029 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422442": [{"title": "U3031 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422443": [{"title": "U3033 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422444": [{"title": "U3034 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422445": [{"title": "U3035 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422446": [{"title": "U3037 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422447": [{"title": "U3039 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422448": [{"title": "U3042 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422449": [{"title": "U3046 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422450": [{"title": "U3047 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422451": [{"title": "U3048 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422452": [{"title": "U3051 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422453": [{"title": "U3053 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422454": [{"title": "U3056 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422455": [{"title": "U3060 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422456": [{"title": "U3062 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422457": [{"title": "U3065 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422458": [{"title": "U3068 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422459": [{"title": "U3071 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422460": [{"title": "U3073 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422461": [{"title": "U3078 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422462": [{"title": "U3082 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422463": [{"title": "U3084 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422464": [{"title": "U3085 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422465": [{"title": "U3086 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422466": [{"title": "U3088 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422467": [{"title": "U3093 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422468": [{"title": "U3101 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422469": [{"title": "U3102 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422470": [{"title": "U3104 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422471": [{"title": "U3110 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422472": [{"title": "U3117 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422473": [{"title": "U3118 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422474": [{"title": "U3121 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422475": [{"title": "U3123 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422476": [{"title": "U3129 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422477": [{"title": "U3137 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422478": [{"title": "U3140 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422479": [{"title": "U3146 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422480": [{"title": "U3155 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422481": [{"title": "U3164 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422482": [{"title": "U3167 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422483": [{"title": "U3169 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422484": [{"title": "U3172 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422485": [{"title": "U3173 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422486": [{"title": "U3175 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422487": [{"title": "U3180 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422488": [{"title": "U3189 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422489": [{"title": "U3198 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2422490": [{"title": "U3202 cell line"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "cell type: Glioma stem cells"}]}, {"GSM2461407": [{"title": "OPM2_CNT"}, {"type": "RNA"}, {"source_name_ch1": "MM OPM2 Cell Line"}, {"characteristics_ch1": "agent: none;\tcell line: OPM2;\tcell type: Myeloma cells"}]}, {"GSM2461408": [{"title": "OPM2_TR_48h"}, {"type": "RNA"}, {"source_name_ch1": "MM OPM2 Cell Line"}, {"characteristics_ch1": "agent: KPT-9274;\tcell line: OPM2;\tcell type: Myeloma cells"}]}, {"GSM2461409": [{"title": "KMS11_CNT"}, {"type": "RNA"}, {"source_name_ch1": "MM KMS11 Cell Line"}, {"characteristics_ch1": "agent: none;\tcell line: KMS11;\tcell type: Myeloma cells"}]}, {"GSM2461410": [{"title": "KMS11_TR_48h"}, {"type": "RNA"}, {"source_name_ch1": "MM KMS11 Cell Line"}, {"characteristics_ch1": "agent: KPT-9274;\tcell line: KMS11;\tcell type: Myeloma cells"}]}, {"GSM2256452": [{"title": "Glioblastoma_RIW"}, {"type": "RNA"}, {"source_name_ch1": "flash-frozen globlastoma pathological sample"}, {"characteristics_ch1": "tissue: glioblastoma tumor tissue;\ttumor stage: WHO IV;\tgender: M;\tpatient age: 61"}]}, {"GSM2256453": [{"title": "Glioblastoma_TRM"}, {"type": "RNA"}, {"source_name_ch1": "flash-frozen globlastoma pathological sample"}, {"characteristics_ch1": "tissue: glioblastoma tumor tissue;\ttumor stage: WHO IV;\tgender: n.d.;\tpatient age: n.d."}]}, {"GSM2256454": [{"title": "Glioblastoma_UNY"}, {"type": "RNA"}, {"source_name_ch1": "flash-frozen globlastoma pathological sample"}, {"characteristics_ch1": "tissue: glioblastoma tumor tissue;\ttumor stage: WHO IV;\tgender: F;\tpatient age: 69"}]}, {"GSM2256455": [{"title": "Glioblastoma_W31"}, {"type": "RNA"}, {"source_name_ch1": "flash-frozen globlastoma pathological sample"}, {"characteristics_ch1": "tissue: glioblastoma tumor tissue;\ttumor stage: WHO IV;\tgender: F;\tpatient age: 65"}]}, {"GSM2256456": [{"title": "Glioblastoma_VVN"}, {"type": "RNA"}, {"source_name_ch1": "flash-frozen globlastoma pathological sample"}, {"characteristics_ch1": "tissue: glioblastoma tumor tissue;\ttumor stage: WHO IV;\tgender: M;\tpatient age: 61"}]}, {"GSM2256457": [{"title": "Glioblastoma_YXL"}, {"type": "RNA"}, {"source_name_ch1": "flash-frozen globlastoma pathological sample"}, {"characteristics_ch1": "tissue: glioblastoma tumor tissue;\ttumor stage: WHO IV;\tgender: F;\tpatient age: 56"}]}, {"GSM2256458": [{"title": "Glioblastoma_3HQ"}, {"type": "RNA"}, {"source_name_ch1": "flash-frozen globlastoma pathological sample"}, {"characteristics_ch1": "tissue: glioblastoma tumor tissue;\ttumor stage: WHO IV;\tgender: F;\tpatient age: 69"}]}, {"GSM2256459": [{"title": "Glioblastoma_CB2"}, {"type": "RNA"}, {"source_name_ch1": "flash-frozen globlastoma pathological sample"}, {"characteristics_ch1": "tissue: glioblastoma tumor tissue;\ttumor stage: WHO IV;\tgender: M;\tpatient age: 65"}]}, {"GSM2256460": [{"title": "Glioblastoma_H5M"}, {"type": "RNA"}, {"source_name_ch1": "flash-frozen globlastoma pathological sample"}, {"characteristics_ch1": "tissue: glioblastoma tumor tissue;\ttumor stage: WHO IV;\tgender: M;\tpatient age: 59"}]}, {"GSM2256461": [{"title": "Glioblastoma_LNA"}, {"type": "RNA"}, {"source_name_ch1": "flash-frozen globlastoma pathological sample"}, {"characteristics_ch1": "tissue: glioblastoma tumor tissue;\ttumor stage: WHO IV;\tgender: M;\tpatient age: 61"}]}, {"GSM2256462": [{"title": "Glioblastoma_PBH"}, {"type": "RNA"}, {"source_name_ch1": "flash-frozen globlastoma pathological sample"}, {"characteristics_ch1": "tissue: glioblastoma tumor tissue;\ttumor stage: WHO IV;\tgender: F;\tpatient age: 69"}]}, {"GSM2256463": [{"title": "Glioblastoma_R7K"}, {"type": "RNA"}, {"source_name_ch1": "flash-frozen globlastoma pathological sample"}, {"characteristics_ch1": "tissue: glioblastoma tumor tissue;\ttumor stage: WHO IV;\tgender: F;\tpatient age: 70"}]}, {"GSM1669237": [{"title": "U937_Control_rep1"}, {"type": "RNA"}, {"source_name_ch1": "Control,acute myeloid leukemia cell line U937"}, {"characteristics_ch1": "cell type: acute myeloid leukemia;\tcell line: U937"}]}, {"GSM1669238": [{"title": "U937_TWIST-1_rep1"}, {"type": "RNA"}, {"source_name_ch1": "TWIST-1,acute myeloid leukemia cell line U937"}, {"characteristics_ch1": "cell type: acute myeloid leukemia;\tcell line: U937"}]}, {"GSM1818003": [{"title": "Control 1"}, {"type": "RNA"}, {"source_name_ch1": "subcutanous tumor from HCT116 mouse xenograft"}, {"characteristics_ch1": "tissue: HCT116 mouse xenograft;\thost: mouse"}]}, {"GSM1818004": [{"title": "Control 2"}, {"type": "RNA"}, {"source_name_ch1": "subcutanous tumor from HCT116 mouse xenograft"}, {"characteristics_ch1": "tissue: HCT116 mouse xenograft;\thost: mouse"}]}, {"GSM1818005": [{"title": "Control 3"}, {"type": "RNA"}, {"source_name_ch1": "subcutanous tumor from HCT116 mouse xenograft"}, {"characteristics_ch1": "tissue: HCT116 mouse xenograft;\thost: mouse"}]}, {"GSM1818006": [{"title": "Control 4"}, {"type": "RNA"}, {"source_name_ch1": "subcutanous tumor from HCT116 mouse xenograft"}, {"characteristics_ch1": "tissue: HCT116 mouse xenograft;\thost: mouse"}]}, {"GSM1818007": [{"title": "Control 5"}, {"type": "RNA"}, {"source_name_ch1": "subcutanous tumor from HCT116 mouse xenograft"}, {"characteristics_ch1": "tissue: HCT116 mouse xenograft;\thost: mouse"}]}, {"GSM1818008": [{"title": "Control 6"}, {"type": "RNA"}, {"source_name_ch1": "subcutanous tumor from HCT116 mouse xenograft"}, {"characteristics_ch1": "tissue: HCT116 mouse xenograft;\thost: mouse"}]}, {"GSM1818009": [{"title": "Control 7"}, {"type": "RNA"}, {"source_name_ch1": "subcutanous tumor from HCT116 mouse xenograft"}, {"characteristics_ch1": "tissue: HCT116 mouse xenograft;\thost: mouse"}]}, {"GSM1818010": [{"title": "Control 8"}, {"type": "RNA"}, {"source_name_ch1": "subcutanous tumor from HCT116 mouse xenograft"}, {"characteristics_ch1": "tissue: HCT116 mouse xenograft;\thost: mouse"}]}, {"GSM1818011": [{"title": "Treatment 1"}, {"type": "RNA"}, {"source_name_ch1": "subcutanous tumor from HCT116 mouse xenograft"}, {"characteristics_ch1": "tissue: HCT116 mouse xenograft;\thost: mouse"}]}, {"GSM1818012": [{"title": "Treatment 2"}, {"type": "RNA"}, {"source_name_ch1": "subcutanous tumor from HCT116 mouse xenograft"}, {"characteristics_ch1": "tissue: HCT116 mouse xenograft;\thost: mouse"}]}, {"GSM1818013": [{"title": "Treatment 3"}, {"type": "RNA"}, {"source_name_ch1": "subcutanous tumor from HCT116 mouse xenograft"}, {"characteristics_ch1": "tissue: HCT116 mouse xenograft;\thost: mouse"}]}, {"GSM1818014": [{"title": "Treatment 4"}, {"type": "RNA"}, {"source_name_ch1": "subcutanous tumor from HCT116 mouse xenograft"}, {"characteristics_ch1": "tissue: HCT116 mouse xenograft;\thost: mouse"}]}, {"GSM1818015": [{"title": "Treatment 5"}, {"type": "RNA"}, {"source_name_ch1": "subcutanous tumor from HCT116 mouse xenograft"}, {"characteristics_ch1": "tissue: HCT116 mouse xenograft;\thost: mouse"}]}, {"GSM1818016": [{"title": "Treatment 6"}, {"type": "RNA"}, {"source_name_ch1": "subcutanous tumor from HCT116 mouse xenograft"}, {"characteristics_ch1": "tissue: HCT116 mouse xenograft;\thost: mouse"}]}, {"GSM1818017": [{"title": "Treatment 7"}, {"type": "RNA"}, {"source_name_ch1": "subcutanous tumor from HCT116 mouse xenograft"}, {"characteristics_ch1": "tissue: HCT116 mouse xenograft;\thost: mouse"}]}, {"GSM1818018": [{"title": "Treatment 8"}, {"type": "RNA"}, {"source_name_ch1": "subcutanous tumor from HCT116 mouse xenograft"}, {"characteristics_ch1": "tissue: HCT116 mouse xenograft;\thost: mouse"}]}, {"GSM1976573": [{"title": "Bladder cancer 3"}, {"type": "RNA"}, {"source_name_ch1": "bladder cancer"}, {"characteristics_ch1": "tissue: bladder;\tdisease state: bladder cancer"}]}, {"GSM1976574": [{"title": "Bladder cancer 4"}, {"type": "RNA"}, {"source_name_ch1": "bladder cancer"}, {"characteristics_ch1": "tissue: bladder;\tdisease state: bladder cancer"}]}, {"GSM1976575": [{"title": "Bladder cancer 5"}, {"type": "RNA"}, {"source_name_ch1": "bladder cancer"}, {"characteristics_ch1": "tissue: bladder;\tdisease state: bladder cancer"}]}, {"GSM1976577": [{"title": "Normal bladder 2"}, {"type": "RNA"}, {"source_name_ch1": "normal bladder"}, {"characteristics_ch1": "tissue: bladder;\tdisease state: healthy"}]}, {"GSM1976579": [{"title": "Normal bladder 4"}, {"type": "RNA"}, {"source_name_ch1": "normal bladder"}, {"characteristics_ch1": "tissue: bladder;\tdisease state: healthy"}]}, {"GSM1976580": [{"title": "Normal bladder 5"}, {"type": "RNA"}, {"source_name_ch1": "normal bladder"}, {"characteristics_ch1": "tissue: bladder;\tdisease state: healthy"}]}, {"GSM1830151": [{"title": "4A - baseline for subject 4"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis baseline"}, {"characteristics_ch1": "tissue: vastus lateralis;\tsubject id: 4"}]}, {"GSM1830152": [{"title": "6A - baseline for subject 6"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis baseline"}, {"characteristics_ch1": "tissue: vastus lateralis;\tsubject id: 6"}]}, {"GSM1830153": [{"title": "7A - baseline for subject 7"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis baseline"}, {"characteristics_ch1": "tissue: vastus lateralis;\tsubject id: 7"}]}, {"GSM1830154": [{"title": "4B - post supplementation for subject 4"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis after supplementation"}, {"characteristics_ch1": "tissue: vastus lateralis;\tsubject id: 4"}]}, {"GSM1830155": [{"title": "6B - post supplementation for subject 6"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis after supplementation"}, {"characteristics_ch1": "tissue: vastus lateralis;\tsubject id: 6"}]}, {"GSM1830156": [{"title": "7B - post supplementation for subject 7"}, {"type": "RNA"}, {"source_name_ch1": "vastus lateralis after supplementation"}, {"characteristics_ch1": "tissue: vastus lateralis;\tsubject id: 7"}]}, {"GSM2265483": [{"title": "MCF-7_BPAF_rep1"}, {"type": "RNA"}, {"source_name_ch1": "Breast cancer\u00a0cell line"}, {"characteristics_ch1": "cell line: MCF-7;\texposure time: 48h;\texperimental group: Bisphenol AF;\ttreatment: Bisphenol AF;\tconcentration (nm): 80"}]}, {"GSM2265484": [{"title": "MCF-7_BPAF_rep2"}, {"type": "RNA"}, {"source_name_ch1": "Breast cancer\u00a0cell line"}, {"characteristics_ch1": "cell line: MCF-7;\texposure time: 48h;\texperimental group: Bisphenol AF;\ttreatment: Bisphenol AF;\tconcentration (nm): 80"}]}, {"GSM2265485": [{"title": "MCF-7_BPAF_rep3"}, {"type": "RNA"}, {"source_name_ch1": "Breast cancer\u00a0cell line"}, {"characteristics_ch1": "cell line: MCF-7;\texposure time: 48h;\texperimental group: Bisphenol AF;\ttreatment: Bisphenol AF;\tconcentration (nm): 80"}]}, {"GSM2265486": [{"title": "MCF-7_BPAP_rep1"}, {"type": "RNA"}, {"source_name_ch1": "Breast cancer\u00a0cell line"}, {"characteristics_ch1": "cell line: MCF-7;\texposure time: 48h;\texperimental group: Bisphenol AP;\ttreatment: Bisphenol AP;\tconcentration (nm): 1000"}]}, {"GSM2265487": [{"title": "MCF-7_BPAP_rep2"}, {"type": "RNA"}, {"source_name_ch1": "Breast cancer\u00a0cell line"}, {"characteristics_ch1": "cell line: MCF-7;\texposure time: 48h;\texperimental group: Bisphenol AP;\ttreatment: Bisphenol AP;\tconcentration (nm): 1000"}]}, {"GSM2265488": [{"title": "MCF-7_BPAP_rep3"}, {"type": "RNA"}, {"source_name_ch1": "Breast cancer\u00a0cell line"}, {"characteristics_ch1": "cell line: MCF-7;\texposure time: 48h;\texperimental group: Bisphenol AP;\ttreatment: Bisphenol AP;\tconcentration (nm): 1000"}]}, {"GSM2265489": [{"title": "MCF-7_BPA_rep1"}, {"type": "RNA"}, {"source_name_ch1": "Breast cancer\u00a0cell line"}, {"characteristics_ch1": "cell line: MCF-7;\texposure time: 48h;\texperimental group: Bisphenol A;\ttreatment: Bisphenol A;\tconcentration (nm): 400"}]}, {"GSM2265490": [{"title": "MCF-7_BPA_rep2"}, {"type": "RNA"}, {"source_name_ch1": "Breast cancer\u00a0cell line"}, {"characteristics_ch1": "cell line: MCF-7;\texposure time: 48h;\texperimental group: Bisphenol A;\ttreatment: Bisphenol A;\tconcentration (nm): 400"}]}, {"GSM2265491": [{"title": "MCF-7_BPA_rep3"}, {"type": "RNA"}, {"source_name_ch1": "Breast cancer\u00a0cell line"}, {"characteristics_ch1": "cell line: MCF-7;\texposure time: 48h;\texperimental group: Bisphenol A;\ttreatment: Bisphenol A;\tconcentration (nm): 400"}]}, {"GSM2265492": [{"title": "MCF-7_BPB_rep1"}, {"type": "RNA"}, {"source_name_ch1": "Breast cancer\u00a0cell line"}, {"characteristics_ch1": "cell line: MCF-7;\texposure time: 48h;\texperimental group: Bisphenol B;\ttreatment: Bisphenol B;\tconcentration (nm): 300"}]}, {"GSM2265493": [{"title": "MCF-7_BPB_rep2"}, {"type": "RNA"}, {"source_name_ch1": "Breast cancer\u00a0cell line"}, {"characteristics_ch1": "cell line: MCF-7;\texposure time: 48h;\texperimental group: Bisphenol B;\ttreatment: Bisphenol B;\tconcentration (nm): 300"}]}, {"GSM2265494": [{"title": "MCF-7_BPB_rep3"}, {"type": "RNA"}, {"source_name_ch1": "Breast cancer\u00a0cell line"}, {"characteristics_ch1": "cell line: MCF-7;\texposure time: 48h;\texperimental group: Bisphenol B;\ttreatment: Bisphenol B;\tconcentration (nm): 300"}]}, {"GSM2265495": [{"title": "MCF-7_BPF_rep1"}, {"type": "RNA"}, {"source_name_ch1": "Breast cancer\u00a0cell line"}, {"characteristics_ch1": "cell line: MCF-7;\texposure time: 48h;\texperimental group: Bisphenol F;\ttreatment: Bisphenol F;\tconcentration (nm): 1000"}]}, {"GSM2265496": [{"title": "MCF-7_BPF_rep2"}, {"type": "RNA"}, {"source_name_ch1": "Breast cancer\u00a0cell line"}, {"characteristics_ch1": "cell line: MCF-7;\texposure time: 48h;\texperimental group: Bisphenol F;\ttreatment: Bisphenol F;\tconcentration (nm): 1000"}]}, {"GSM2265497": [{"title": "MCF-7_BPF_rep3"}, {"type": "RNA"}, {"source_name_ch1": "Breast cancer\u00a0cell line"}, {"characteristics_ch1": "cell line: MCF-7;\texposure time: 48h;\texperimental group: Bisphenol F;\ttreatment: Bisphenol F;\tconcentration (nm): 1000"}]}, {"GSM2265498": [{"title": "MCF-7_BPZ_rep1"}, {"type": "RNA"}, {"source_name_ch1": "Breast cancer\u00a0cell line"}, {"characteristics_ch1": "cell line: MCF-7;\texposure time: 48h;\texperimental group: Bisphenol Z;\ttreatment: Bisphenol Z;\tconcentration (nm): 400"}]}, {"GSM2265499": [{"title": "MCF-7_BPZ_rep2"}, {"type": "RNA"}, {"source_name_ch1": "Breast cancer\u00a0cell line"}, {"characteristics_ch1": "cell line: MCF-7;\texposure time: 48h;\texperimental group: Bisphenol Z;\ttreatment: Bisphenol Z;\tconcentration (nm): 400"}]}, {"GSM2265500": [{"title": "MCF-7_BPZ_rep3"}, {"type": "RNA"}, {"source_name_ch1": "Breast cancer\u00a0cell line"}, {"characteristics_ch1": "cell line: MCF-7;\texposure time: 48h;\texperimental group: Bisphenol Z;\ttreatment: Bisphenol Z;\tconcentration (nm): 400"}]}, {"GSM2265501": [{"title": "MCF-7_BPS_rep1"}, {"type": "RNA"}, {"source_name_ch1": "Breast cancer\u00a0cell line"}, {"characteristics_ch1": "cell line: MCF-7;\texposure time: 48h;\texperimental group: Bisphenol S;\ttreatment: Bisphenol S;\tconcentration (nm): 1500"}]}, {"GSM2265502": [{"title": "MCF-7_BPS_rep2"}, {"type": "RNA"}, {"source_name_ch1": "Breast cancer\u00a0cell line"}, {"characteristics_ch1": "cell line: MCF-7;\texposure time: 48h;\texperimental group: Bisphenol S;\ttreatment: Bisphenol S;\tconcentration (nm): 1500"}]}, {"GSM2265503": [{"title": "MCF-7_BPS_rep3"}, {"type": "RNA"}, {"source_name_ch1": "Breast cancer\u00a0cell line"}, {"characteristics_ch1": "cell line: MCF-7;\texposure time: 48h;\texperimental group: Bisphenol S;\ttreatment: Bisphenol S;\tconcentration (nm): 1500"}]}, {"GSM2265504": [{"title": "MCF-7_E2_1nM_rep1"}, {"type": "RNA"}, {"source_name_ch1": "Breast cancer\u00a0cell line"}, {"characteristics_ch1": "cell line: MCF-7;\texposure time: 48h;\texperimental group: E2_1nM;\ttreatment: Estradiol;\tconcentration (nm): 1"}]}, {"GSM2265505": [{"title": "MCF-7_E2_1nM_rep2"}, {"type": "RNA"}, {"source_name_ch1": "Breast cancer\u00a0cell line"}, {"characteristics_ch1": "cell line: MCF-7;\texposure time: 48h;\texperimental group: E2_1nM;\ttreatment: Estradiol;\tconcentration (nm): 1"}]}, {"GSM2265506": [{"title": "MCF-7_E2_1nM_rep3"}, {"type": "RNA"}, {"source_name_ch1": "Breast cancer\u00a0cell line"}, {"characteristics_ch1": "cell line: MCF-7;\texposure time: 48h;\texperimental group: E2_1nM;\ttreatment: Estradiol;\tconcentration (nm): 1"}]}, {"GSM2265507": [{"title": "MCF-7_E2_100pM_rep1"}, {"type": "RNA"}, {"source_name_ch1": "Breast cancer\u00a0cell line"}, {"characteristics_ch1": "cell line: MCF-7;\texposure time: 48h;\texperimental group: E2_100pM;\ttreatment: Estradiol;\tconcentration (nm): 0.1"}]}, {"GSM2265508": [{"title": "MCF-7_E2_100pM_rep2"}, {"type": "RNA"}, {"source_name_ch1": "Breast cancer\u00a0cell line"}, {"characteristics_ch1": "cell line: MCF-7;\texposure time: 48h;\texperimental group: E2_100pM;\ttreatment: Estradiol;\tconcentration (nm): 0.1"}]}, {"GSM2265509": [{"title": "MCF-7_E2_100pM_rep3"}, {"type": "RNA"}, {"source_name_ch1": "Breast cancer\u00a0cell line"}, {"characteristics_ch1": "cell line: MCF-7;\texposure time: 48h;\texperimental group: E2_100pM;\ttreatment: Estradiol;\tconcentration (nm): 0.1"}]}, {"GSM2265510": [{"title": "MCF-7_E2_10pM_rep1"}, {"type": "RNA"}, {"source_name_ch1": "Breast cancer\u00a0cell line"}, {"characteristics_ch1": "cell line: MCF-7;\texposure time: 48h;\texperimental group: E2_10pM;\ttreatment: Estradiol;\tconcentration (nm): 0.01"}]}, {"GSM2265511": [{"title": "MCF-7_E2_10pM_rep2"}, {"type": "RNA"}, {"source_name_ch1": "Breast cancer\u00a0cell line"}, {"characteristics_ch1": "cell line: MCF-7;\texposure time: 48h;\texperimental group: E2_10pM;\ttreatment: Estradiol;\tconcentration (nm): 0.01"}]}, {"GSM2265512": [{"title": "MCF-7_E2_10pM_rep3"}, {"type": "RNA"}, {"source_name_ch1": "Breast cancer\u00a0cell line"}, {"characteristics_ch1": "cell line: MCF-7;\texposure time: 48h;\texperimental group: E2_10pM;\ttreatment: Estradiol;\tconcentration (nm): 0.01"}]}, {"GSM2265513": [{"title": "MCF-7_Neg_rep1"}, {"type": "RNA"}, {"source_name_ch1": "Breast cancer\u00a0cell line"}, {"characteristics_ch1": "cell line: MCF-7;\texposure time: 48h;\texperimental group: Control;\ttreatment: Control;\tconcentration (nm): 0"}]}, {"GSM2265514": [{"title": "MCF-7_Neg_rep2"}, {"type": "RNA"}, {"source_name_ch1": "Breast cancer\u00a0cell line"}, {"characteristics_ch1": "cell line: MCF-7;\texposure time: 48h;\texperimental group: Control;\ttreatment: Control;\tconcentration (nm): 0"}]}, {"GSM2265515": [{"title": "MCF-7_Neg_rep3"}, {"type": "RNA"}, {"source_name_ch1": "Breast cancer\u00a0cell line"}, {"characteristics_ch1": "cell line: MCF-7;\texposure time: 48h;\texperimental group: Control;\ttreatment: Control;\tconcentration (nm): 0"}]}, {"GSM2405930": [{"title": "Tumour_28"}, {"type": "RNA"}, {"source_name_ch1": "Tumour"}, {"characteristics_ch1": "tissue: ameloblastoma"}]}, {"GSM2405931": [{"title": "Tumour_23"}, {"type": "RNA"}, {"source_name_ch1": "Tumour"}, {"characteristics_ch1": "tissue: ameloblastoma"}]}, {"GSM2405932": [{"title": "Tumour_24"}, {"type": "RNA"}, {"source_name_ch1": "Tumour"}, {"characteristics_ch1": "tissue: ameloblastoma"}]}, {"GSM2405933": [{"title": "Tumour_34"}, {"type": "RNA"}, {"source_name_ch1": "Tumour"}, {"characteristics_ch1": "tissue: ameloblastoma"}]}, {"GSM2405934": [{"title": "Tumour_41"}, {"type": "RNA"}, {"source_name_ch1": "Tumour"}, {"characteristics_ch1": "tissue: ameloblastoma"}]}, {"GSM2405935": [{"title": "Tumour_71"}, {"type": "RNA"}, {"source_name_ch1": "Tumour"}, {"characteristics_ch1": "tissue: ameloblastoma"}]}, {"GSM2405936": [{"title": "Control_15"}, {"type": "RNA"}, {"source_name_ch1": "Non-tumour control"}, {"characteristics_ch1": "tissue: control"}]}, {"GSM2405937": [{"title": "Control_16"}, {"type": "RNA"}, {"source_name_ch1": "Non-tumour control"}, {"characteristics_ch1": "tissue: control"}]}, {"GSM2405938": [{"title": "Control_C6"}, {"type": "RNA"}, {"source_name_ch1": "Non-tumour control"}, {"characteristics_ch1": "tissue: control"}]}, {"GSM2405939": [{"title": "Control_C7"}, {"type": "RNA"}, {"source_name_ch1": "Non-tumour control"}, {"characteristics_ch1": "tissue: control"}]}, {"GSM2011223": [{"title": "Sorted mesenchymal hGBM23 specimen, WNT5A+ tech Rep 1"}, {"type": "RNA"}, {"source_name_ch1": "GBM#23, WNT5A+ sorted"}, {"characteristics_ch1": "tissue: brain;\tcell type: glioblastoma"}]}, {"GSM2011224": [{"title": "Sorted mesenchymal hGBM23 specimen, WNT5A+ tech Rep 2"}, {"type": "RNA"}, {"source_name_ch1": "GBM#23, WNT5A+ sorted"}, {"characteristics_ch1": "tissue: brain;\tcell type: glioblastoma"}]}, {"GSM2011225": [{"title": "Sorted mesenchymal hGBM23 specimen, WNT5A- tech Rep 1"}, {"type": "RNA"}, {"source_name_ch1": "GBM#23, WNT5A- sorted"}, {"characteristics_ch1": "tissue: brain;\tcell type: glioblastoma"}]}, {"GSM2011226": [{"title": "Sorted mesenchymal hGBM23 specimen, WNT5A- tech Rep 2"}, {"type": "RNA"}, {"source_name_ch1": "GBM#23, WNT5A- sorted"}, {"characteristics_ch1": "tissue: brain;\tcell type: glioblastoma"}]}, {"GSM2011227": [{"title": "Unsorted mesenchymal hGBM23 specimen, tech Rep 1"}, {"type": "RNA"}, {"source_name_ch1": "GBM#23, unsorted"}, {"characteristics_ch1": "tissue: brain;\tcell type: glioblastoma"}]}, {"GSM2011228": [{"title": "Unsorted mesenchymal hGBM23 specimen, tech Rep 2"}, {"type": "RNA"}, {"source_name_ch1": "GBM#23, unsorted"}, {"characteristics_ch1": "tissue: brain;\tcell type: glioblastoma"}]}, {"GSM2011229": [{"title": "Sorted mesenchymal hGBM36 specimen, WNT5A+ tech Rep 1"}, {"type": "RNA"}, {"source_name_ch1": "GBM#36, WNT5A+ sorted"}, {"characteristics_ch1": "tissue: brain;\tcell type: glioblastoma"}]}, {"GSM2011230": [{"title": "Sorted mesenchymal hGBM36 specimen, WNT5A+ tech Rep 2"}, {"type": "RNA"}, {"source_name_ch1": "GBM#36, WNT5A+ sorted"}, {"characteristics_ch1": "tissue: brain;\tcell type: glioblastoma"}]}, {"GSM2011231": [{"title": "Sorted mesenchymal hGBM36 specimen, WNT5A- tech Rep 1"}, {"type": "RNA"}, {"source_name_ch1": "GBM#36, WNT5A- sorted"}, {"characteristics_ch1": "tissue: brain;\tcell type: glioblastoma"}]}, {"GSM2011232": [{"title": "Sorted mesenchymal hGBM36 specimen, WNT5A- tech Rep 2"}, {"type": "RNA"}, {"source_name_ch1": "GBM#36, WNT5A- sorted"}, {"characteristics_ch1": "tissue: brain;\tcell type: glioblastoma"}]}, {"GSM2011233": [{"title": "Unsorted mesenchymal hGBM36 specimen, tech Rep 1"}, {"type": "RNA"}, {"source_name_ch1": "GBM#36, unsorted"}, {"characteristics_ch1": "tissue: brain;\tcell type: glioblastoma"}]}, {"GSM2011234": [{"title": "Unsorted mesenchymal hGBM36 specimen, tech Rep 2"}, {"type": "RNA"}, {"source_name_ch1": "GBM#36, unsorted"}, {"characteristics_ch1": "tissue: brain;\tcell type: glioblastoma"}]}, {"GSM2108281": [{"title": "NPC 1.1"}, {"type": "RNA"}, {"source_name_ch1": "Neural progenitor cells"}, {"characteristics_ch1": "cell type: Neural progenitor cells"}]}, {"GSM2108282": [{"title": "NPC 1.2"}, {"type": "RNA"}, {"source_name_ch1": "Neural progenitor cells"}, {"characteristics_ch1": "cell type: Neural progenitor cells"}]}, {"GSM2108283": [{"title": "NPC 1.3"}, {"type": "RNA"}, {"source_name_ch1": "Neural progenitor cells"}, {"characteristics_ch1": "cell type: Neural progenitor cells"}]}, {"GSM2108284": [{"title": "NPC 2.1"}, {"type": "RNA"}, {"source_name_ch1": "Neural progenitor cells"}, {"characteristics_ch1": "cell type: Neural progenitor cells"}]}, {"GSM2108285": [{"title": "NPC 2.2"}, {"type": "RNA"}, {"source_name_ch1": "Neural progenitor cells"}, {"characteristics_ch1": "cell type: Neural progenitor cells"}]}, {"GSM2108286": [{"title": "NPC 2.3"}, {"type": "RNA"}, {"source_name_ch1": "Neural progenitor cells"}, {"characteristics_ch1": "cell type: Neural progenitor cells"}]}, {"GSM2108287": [{"title": "NPC 3.1"}, {"type": "RNA"}, {"source_name_ch1": "Neural progenitor cells"}, {"characteristics_ch1": "cell type: Neural progenitor cells"}]}, {"GSM2108288": [{"title": "NPC 3.2"}, {"type": "RNA"}, {"source_name_ch1": "Neural progenitor cells"}, {"characteristics_ch1": "cell type: Neural progenitor cells"}]}, {"GSM2108289": [{"title": "NPC 4.1"}, {"type": "RNA"}, {"source_name_ch1": "Neural progenitor cells"}, {"characteristics_ch1": "cell type: Neural progenitor cells"}]}, {"GSM2108290": [{"title": "NPC 4.2"}, {"type": "RNA"}, {"source_name_ch1": "Neural progenitor cells"}, {"characteristics_ch1": "cell type: Neural progenitor cells"}]}, {"GSM2108291": [{"title": "iOL 1.1"}, {"type": "RNA"}, {"source_name_ch1": "transduced oligodendrocytes with concentrated SON lentiviral particle"}, {"characteristics_ch1": "cell type: transduced oligodendrocytes with concentrated SON lentiviral particle"}]}, {"GSM2108292": [{"title": "iOL 1.2"}, {"type": "RNA"}, {"source_name_ch1": "transduced oligodendrocytes with concentrated SON lentiviral particle"}, {"characteristics_ch1": "cell type: transduced oligodendrocytes with concentrated SON lentiviral particle"}]}, {"GSM2108293": [{"title": "iOL 1.3"}, {"type": "RNA"}, {"source_name_ch1": "transduced oligodendrocytes with concentrated SON lentiviral particle"}, {"characteristics_ch1": "cell type: transduced oligodendrocytes with concentrated SON lentiviral particle"}]}, {"GSM2108294": [{"title": "iOL 2.1"}, {"type": "RNA"}, {"source_name_ch1": "transduced oligodendrocytes with concentrated SON lentiviral particle"}, {"characteristics_ch1": "cell type: transduced oligodendrocytes with concentrated SON lentiviral particle"}]}, {"GSM2108295": [{"title": "iOL 2.2"}, {"type": "RNA"}, {"source_name_ch1": "transduced oligodendrocytes with concentrated SON lentiviral particle"}, {"characteristics_ch1": "cell type: transduced oligodendrocytes with concentrated SON lentiviral particle"}]}, {"GSM2108296": [{"title": "iOL 2.3"}, {"type": "RNA"}, {"source_name_ch1": "transduced oligodendrocytes with concentrated SON lentiviral particle"}, {"characteristics_ch1": "cell type: transduced oligodendrocytes with concentrated SON lentiviral particle"}]}, {"GSM2108297": [{"title": "iOL 3.1"}, {"type": "RNA"}, {"source_name_ch1": "transduced oligodendrocytes with concentrated SON lentiviral particle"}, {"characteristics_ch1": "cell type: transduced oligodendrocytes with concentrated SON lentiviral particle"}]}, {"GSM2108298": [{"title": "iOL 3.2"}, {"type": "RNA"}, {"source_name_ch1": "transduced oligodendrocytes with concentrated SON lentiviral particle"}, {"characteristics_ch1": "cell type: transduced oligodendrocytes with concentrated SON lentiviral particle"}]}, {"GSM2108299": [{"title": "iOL 4.1"}, {"type": "RNA"}, {"source_name_ch1": "transduced oligodendrocytes with concentrated SON lentiviral particle"}, {"characteristics_ch1": "cell type: transduced oligodendrocytes with concentrated SON lentiviral particle"}]}, {"GSM2108300": [{"title": "iOL 4.2"}, {"type": "RNA"}, {"source_name_ch1": "transduced oligodendrocytes with concentrated SON lentiviral particle"}, {"characteristics_ch1": "cell type: transduced oligodendrocytes with concentrated SON lentiviral particle"}]}, {"GSM2136511": [{"title": "PC3 cells negative control 1"}, {"type": "RNA"}, {"source_name_ch1": "Human prostate cancer cell line"}, {"characteristics_ch1": "cell line: PC3;\ttransfection: negative control"}]}, {"GSM2136512": [{"title": "PC3 cells negative control 2"}, {"type": "RNA"}, {"source_name_ch1": "Human prostate cancer cell line"}, {"characteristics_ch1": "cell line: PC3;\ttransfection: negative control"}]}, {"GSM2136513": [{"title": "PC3 cells negative control 3"}, {"type": "RNA"}, {"source_name_ch1": "Human prostate cancer cell line"}, {"characteristics_ch1": "cell line: PC3;\ttransfection: negative control"}]}, {"GSM2136514": [{"title": "PC3 cells miR-130a transfected 1"}, {"type": "RNA"}, {"source_name_ch1": "Human prostate cancer cell line"}, {"characteristics_ch1": "cell line: PC3;\ttransfection: miR-130a"}]}, {"GSM2136515": [{"title": "PC3 cells miR-130a transfected 2"}, {"type": "RNA"}, {"source_name_ch1": "Human prostate cancer cell line"}, {"characteristics_ch1": "cell line: PC3;\ttransfection: miR-130a"}]}, {"GSM2136516": [{"title": "PC3 cells miR-130a transfected 3"}, {"type": "RNA"}, {"source_name_ch1": "Human prostate cancer cell line"}, {"characteristics_ch1": "cell line: PC3;\ttransfection: miR-130a"}]}, {"GSM2342200": [{"title": "H1299  DMSO 1"}, {"type": "RNA"}, {"source_name_ch1": "H1299 cell line"}, {"characteristics_ch1": "cell line: H1299;\ttreatment: DMSO"}]}, {"GSM2342201": [{"title": "H1299  DMSO 2"}, {"type": "RNA"}, {"source_name_ch1": "H1299 cell line"}, {"characteristics_ch1": "cell line: H1299;\ttreatment: DMSO"}]}, {"GSM2342202": [{"title": "H1299  DMSO 3"}, {"type": "RNA"}, {"source_name_ch1": "H1299 cell line"}, {"characteristics_ch1": "cell line: H1299;\ttreatment: DMSO"}]}, {"GSM2342203": [{"title": "H1299  PD 1"}, {"type": "RNA"}, {"source_name_ch1": "H1299 cell line"}, {"characteristics_ch1": "cell line: H1299;\ttreatment: DMSO containing  PD 0332991 ( 500 nM)"}]}, {"GSM2342204": [{"title": "H1299  PD 2"}, {"type": "RNA"}, {"source_name_ch1": "H1299 cell line"}, {"characteristics_ch1": "cell line: H1299;\ttreatment: DMSO containing  PD 0332991 ( 500 nM)"}]}, {"GSM2342205": [{"title": "H1299  PD 3"}, {"type": "RNA"}, {"source_name_ch1": "H1299 cell line"}, {"characteristics_ch1": "cell line: H1299;\ttreatment: DMSO containing  PD 0332991 ( 500 nM)"}]}, {"GSM2342250": [{"title": "PC3-ML DMSO 1"}, {"type": "RNA"}, {"source_name_ch1": "PC3-ML cell line"}, {"characteristics_ch1": "cell line: PC3-ML;\ttreatment: DMSO"}]}, {"GSM2342251": [{"title": "PC3-ML DMSO 2"}, {"type": "RNA"}, {"source_name_ch1": "PC3-ML cell line"}, {"characteristics_ch1": "cell line: PC3-ML;\ttreatment: DMSO"}]}, {"GSM2342252": [{"title": "PC3-ML DMSO 3"}, {"type": "RNA"}, {"source_name_ch1": "PC3-ML cell line"}, {"characteristics_ch1": "cell line: PC3-ML;\ttreatment: DMSO"}]}, {"GSM2342253": [{"title": "PC3-ML PD 1"}, {"type": "RNA"}, {"source_name_ch1": "PC3-ML cell line"}, {"characteristics_ch1": "cell line: PC3-ML;\ttreatment: DMSO containing  PD 0332991( 500 nM)  for 24 hours"}]}, {"GSM2342254": [{"title": "PC3-ML PD 2"}, {"type": "RNA"}, {"source_name_ch1": "PC3-ML cell line"}, {"characteristics_ch1": "cell line: PC3-ML;\ttreatment: DMSO containing  PD 0332991( 500 nM)  for 24 hours"}]}, {"GSM2342255": [{"title": "PC3-ML PD 3"}, {"type": "RNA"}, {"source_name_ch1": "PC3-ML cell line"}, {"characteristics_ch1": "cell line: PC3-ML;\ttreatment: DMSO containing  PD 0332991( 500 nM)  for 24 hours"}]}, {"GSM2413391": [{"title": "Normal (NT) Replicate 1 [gene level]"}, {"type": "RNA"}, {"source_name_ch1": "Normal BEAS-2B cells"}, {"characteristics_ch1": "cell line: BEAS-2B;\tcell type: lung epithelial cell line"}]}, {"GSM2413392": [{"title": "Normal (NT) Replicate 2 [gene level]"}, {"type": "RNA"}, {"source_name_ch1": "Normal BEAS-2B cells"}, {"characteristics_ch1": "cell line: BEAS-2B;\tcell type: lung epithelial cell line"}]}, {"GSM2413393": [{"title": "Inorganic arsenic-transformed (iAs-T) Replicate 1 [gene level]"}, {"type": "RNA"}, {"source_name_ch1": "iAs-transformed BEAS-2B cells"}, {"characteristics_ch1": "cell line: BEAS-2B;\tcell type: lung epithelial cell line;\ttreatment: inorganic sodium arsenite"}]}, {"GSM2413394": [{"title": "Inorganic arsenic-transformed (iAs-T) Replicate 2 [gene level]"}, {"type": "RNA"}, {"source_name_ch1": "iAs-transformed BEAS-2B cells"}, {"characteristics_ch1": "cell line: BEAS-2B;\tcell type: lung epithelial cell line;\ttreatment: inorganic sodium arsenite"}]}, {"GSM2515576": [{"title": "treated with PM2.5, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "AC16, PM2.5"}, {"characteristics_ch1": "cell line: AC16;\tcell type: myocardial cell line;\ttreatment: PM2.5 for 24h"}]}, {"GSM2515577": [{"title": "treated with PM2.5, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "AC16, PM2.5"}, {"characteristics_ch1": "cell line: AC16;\tcell type: myocardial cell line;\ttreatment: PM2.5 for 24h"}]}, {"GSM2515578": [{"title": "treated with PM2.5, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "AC16, PM2.5"}, {"characteristics_ch1": "cell line: AC16;\tcell type: myocardial cell line;\ttreatment: PM2.5 for 24h"}]}, {"GSM2515579": [{"title": "control, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "AC16, control"}, {"characteristics_ch1": "cell line: AC16;\tcell type: myocardial cell line;\ttreatment: control"}]}, {"GSM2515580": [{"title": "control, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "AC16, control"}, {"characteristics_ch1": "cell line: AC16;\tcell type: myocardial cell line;\ttreatment: control"}]}, {"GSM2515581": [{"title": "control, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "AC16, control"}, {"characteristics_ch1": "cell line: AC16;\tcell type: myocardial cell line;\ttreatment: control"}]}, {"GSM2536404": [{"title": "HC1 CD19high"}, {"type": "RNA"}, {"source_name_ch1": "B cells"}, {"characteristics_ch1": "tissue: peripheral blood;\tcell type: CD19hi B cells"}]}, {"GSM2536405": [{"title": "HC1 CD19low"}, {"type": "RNA"}, {"source_name_ch1": "B cells"}, {"characteristics_ch1": "tissue: peripheral blood;\tcell type: CD19lo B cells"}]}, {"GSM2536406": [{"title": "HC2+3 CD19high"}, {"type": "RNA"}, {"source_name_ch1": "B cells"}, {"characteristics_ch1": "tissue: peripheral blood;\tcell type: CD19hi B cells"}]}, {"GSM2536407": [{"title": "HC2+3 CD19low"}, {"type": "RNA"}, {"source_name_ch1": "B cells"}, {"characteristics_ch1": "tissue: peripheral blood;\tcell type: CD19lo B cells"}]}, {"GSM2255445": [{"title": "patient 67, tumoral sample2, array 1"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: frozen sample;\tanatomical site: right colon;\tgender: female;\tpatient age: 86;\ttumor stage: tumor stage 2"}]}, {"GSM2255446": [{"title": "patient 69, tumoral sample1, array 1"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: frozen sample;\tanatomical site: left colon;\tgender: female;\tpatient age: 50;\ttumor stage: tumor stage 2"}]}, {"GSM2255447": [{"title": "patient 69, tumoral sample2, array 1"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: frozen sample;\tanatomical site: left colon;\tgender: female;\tpatient age: 50;\ttumor stage: tumor stage 2"}]}, {"GSM2255448": [{"title": "patient 83, tumoral sample1, array 1"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: frozen sample;\tanatomical site: right colon;\tgender: female;\tpatient age: 76;\ttumor stage: tumor stage 3"}]}, {"GSM2255449": [{"title": "patient 87, tumoral sample1, array 1"}, {"type": "RNA"}, {"source_name_ch1": "rectal adenocarcinoma"}, {"characteristics_ch1": "tissue: frozen sample;\tanatomical site: rectum;\tgender: female;\tpatient age: 79;\ttumor stage: tumor stage 2"}]}, {"GSM2255450": [{"title": "patient 87, tumoral sample2, array 1"}, {"type": "RNA"}, {"source_name_ch1": "rectal adenocarcinoma"}, {"characteristics_ch1": "tissue: frozen sample;\tanatomical site: rectum;\tgender: female;\tpatient age: 79;\ttumor stage: tumor stage 2"}]}, {"GSM2255451": [{"title": "patient 89, tumoral sample2, array 1"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: frozen sample;\tanatomical site: right colon;\tgender: female;\tpatient age: 69;\ttumor stage: tumor stage 2"}]}, {"GSM2255452": [{"title": "patient 95, tumoral sample1, array 1"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: frozen sample;\tanatomical site: sigmoid colon;\tgender: male;\tpatient age: 73;\ttumor stage: tumor stage 3"}]}, {"GSM2255453": [{"title": "patient 95, tumoral sample2, array 1"}, {"type": "RNA"}, {"source_name_ch1": "colon adenocarcinoma"}, {"characteristics_ch1": "tissue: frozen sample;\tanatomical site: sigmoid colon;\tgender: male;\tpatient age: 73;\ttumor stage: tumor stage 3"}]}, {"GSM2255454": [{"title": "patient 67, normal colonic mucosa, array 1"}, {"type": "RNA"}, {"source_name_ch1": "normal colonic mucosa"}, {"characteristics_ch1": "tissue: frozen sample;\tanatomical site: right colon;\tgender: female;\tpatient age: 86;\ttumor stage: normal colonic mucosa"}]}, {"GSM2255455": [{"title": "patient 69, normal colonic mucosa, array 1"}, {"type": "RNA"}, {"source_name_ch1": "normal colonic mucosa"}, {"characteristics_ch1": "tissue: frozen sample;\tanatomical site: left colon;\tgender: female;\tpatient age: 50;\ttumor stage: normal colonic mucosa"}]}, {"GSM2255456": [{"title": "patient 83, normal colonic mucosa, array 1"}, {"type": "RNA"}, {"source_name_ch1": "normal colonic mucosa"}, {"characteristics_ch1": "tissue: frozen sample;\tanatomical site: right colon;\tgender: female;\tpatient age: 76;\ttumor stage: normal colonic mucosa"}]}, {"GSM2255457": [{"title": "patient 87, normal colonic mucosa, array 1"}, {"type": "RNA"}, {"source_name_ch1": "normal colonic mucosa"}, {"characteristics_ch1": "tissue: frozen sample;\tanatomical site: rectum;\tgender: female;\tpatient age: 79;\ttumor stage: normal colonic mucosa"}]}, {"GSM2255458": [{"title": "patient 89, normal colonic mucosa, array 1"}, {"type": "RNA"}, {"source_name_ch1": "normal colonic mucosa"}, {"characteristics_ch1": "tissue: frozen sample;\tanatomical site: right colon;\tgender: female;\tpatient age: 69;\ttumor stage: normal colonic mucosa"}]}, {"GSM2255459": [{"title": "patient 95, normal colonic mucosa, array 1"}, {"type": "RNA"}, {"source_name_ch1": "normal colonic mucosa"}, {"characteristics_ch1": "tissue: frozen sample;\tanatomical site: sigmoid colon;\tgender: male;\tpatient age: 73;\ttumor stage: normal colonic mucosa"}]}, {"GSM2449163": [{"title": "FTC236 control, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "FTC236, control"}, {"characteristics_ch1": "cell line: FTC236;\tcell type: Thyroid cancer cell line;\tgenotype/variation: control"}]}, {"GSM2449164": [{"title": "FTC236 control, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "FTC236, control"}, {"characteristics_ch1": "cell line: FTC236;\tcell type: Thyroid cancer cell line;\tgenotype/variation: control"}]}, {"GSM2449165": [{"title": "FTC236 control, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "FTC236, control"}, {"characteristics_ch1": "cell line: FTC236;\tcell type: Thyroid cancer cell line;\tgenotype/variation: control"}]}, {"GSM2449166": [{"title": "FTC236 shRCAN1-4, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "FTC236, shRCN"}, {"characteristics_ch1": "cell line: FTC236;\tcell type: Thyroid cancer cell line;\tgenotype/variation: RCAN1-4 knockdown"}]}, {"GSM2449167": [{"title": "FTC236 shRCAN1-4, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "FTC236, shRCN"}, {"characteristics_ch1": "cell line: FTC236;\tcell type: Thyroid cancer cell line;\tgenotype/variation: RCAN1-4 knockdown"}]}, {"GSM2449168": [{"title": "FTC236 shRCAN1-4, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "FTC236, shRCN"}, {"characteristics_ch1": "cell line: FTC236;\tcell type: Thyroid cancer cell line;\tgenotype/variation: RCAN1-4 knockdown"}]}, {"GSM2449169": [{"title": "Hth74 control, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "Hth74, control"}, {"characteristics_ch1": "cell line: Hth74;\tcell type: Thyroid cancer cell line;\tgenotype/variation: control"}]}, {"GSM2449170": [{"title": "Hth74 control, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "Hth74, control"}, {"characteristics_ch1": "cell line: Hth74;\tcell type: Thyroid cancer cell line;\tgenotype/variation: control"}]}, {"GSM2449171": [{"title": "Hth74 control, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "Hth74, control"}, {"characteristics_ch1": "cell line: Hth74;\tcell type: Thyroid cancer cell line;\tgenotype/variation: control"}]}, {"GSM2449172": [{"title": "Hth74 shRCAN1-4, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "Hth74, shRCN"}, {"characteristics_ch1": "cell line: Hth74;\tcell type: Thyroid cancer cell line;\tgenotype/variation: RCAN1-4 knockdown"}]}, {"GSM2449173": [{"title": "Hth74 shRCAN1-4, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "Hth74, shRCN"}, {"characteristics_ch1": "cell line: Hth74;\tcell type: Thyroid cancer cell line;\tgenotype/variation: RCAN1-4 knockdown"}]}, {"GSM2449174": [{"title": "Hth74 shRCAN1-4, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "Hth74, shRCN"}, {"characteristics_ch1": "cell line: Hth74;\tcell type: Thyroid cancer cell line;\tgenotype/variation: RCAN1-4 knockdown"}]}, {"GSM1356480": [{"title": "DPN treatment in spheres, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "DPN treatment in spheres"}, {"characteristics_ch1": "cell line: MCF7;\tphenotype: spheres;\tcell state: cancer stem cell state;\ttreated with: 10nM DPN for 48hrs"}]}, {"GSM1356481": [{"title": "DPN treatment in spheres, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "DPN treatment in spheres"}, {"characteristics_ch1": "cell line: MCF7;\tphenotype: spheres;\tcell state: cancer stem cell state;\ttreated with: 10nM DPN for 48hrs"}]}, {"GSM1356482": [{"title": "DPN treatment in spheres, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "DPN treatment in spheres"}, {"characteristics_ch1": "cell line: MCF7;\tphenotype: spheres;\tcell state: cancer stem cell state;\ttreated with: 10nM DPN for 48hrs"}]}, {"GSM1356483": [{"title": "DPN/PHTPP treatment in spheres, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "DPN/PHTPP treatment in spheres"}, {"characteristics_ch1": "cell line: MCF7;\tphenotype: spheres;\tcell state: cancer stem cell state;\ttreated with: 10nM DPN/PHTPP for 48hrs"}]}, {"GSM1356484": [{"title": "DPN/PHTPP treatment in spheres, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "DPN/PHTPP treatment in spheres"}, {"characteristics_ch1": "cell line: MCF7;\tphenotype: spheres;\tcell state: cancer stem cell state;\ttreated with: 10nM DPN/PHTPP for 48hrs"}]}, {"GSM1356485": [{"title": "DPN/PHTPP treatment in spheres, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "DPN/PHTPP treatment in spheres"}, {"characteristics_ch1": "cell line: MCF7;\tphenotype: spheres;\tcell state: cancer stem cell state;\ttreated with: 10nM DPN/PHTPP for 48hrs"}]}, {"GSM1356486": [{"title": "Ctrl in spheres, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "Ctrl in spheres"}, {"characteristics_ch1": "cell line: MCF7;\tphenotype: spheres;\tcell state: cancer stem cell state;\ttreated with: none (control)"}]}, {"GSM1356487": [{"title": "Ctrl in spheres, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "Ctrl in spheres"}, {"characteristics_ch1": "cell line: MCF7;\tphenotype: spheres;\tcell state: cancer stem cell state;\ttreated with: none (control)"}]}, {"GSM1356488": [{"title": "Ctrl in spheres, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "Ctrl in spheres"}, {"characteristics_ch1": "cell line: MCF7;\tphenotype: spheres;\tcell state: cancer stem cell state;\ttreated with: none (control)"}]}, {"GSM1356489": [{"title": "Ctrl in spheres, biological rep4"}, {"type": "RNA"}, {"source_name_ch1": "Ctrl in spheres"}, {"characteristics_ch1": "cell line: MCF7;\tphenotype: spheres;\tcell state: cancer stem cell state"}]}, {"GSM1356490": [{"title": "Ctrl in adherent culture, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "Ctrl in adherent culture"}, {"characteristics_ch1": "cell line: MCF7;\tphenotype: adherent monolayer cells;\tcell state: differentiated state;\ttreated with: none (control)"}]}, {"GSM1356491": [{"title": "Ctrl in adherent culture, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "Ctrl in adherent culture"}, {"characteristics_ch1": "cell line: MCF7;\tphenotype: adherent monolayer cells;\tcell state: differentiated state;\ttreated with: none (control)"}]}, {"GSM1356492": [{"title": "Ctrl in adherent culture, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "Ctrl in adherent culture"}, {"characteristics_ch1": "cell line: MCF7;\tphenotype: adherent monolayer cells;\tcell state: differentiated state;\ttreated with: none (control)"}]}, {"GSM1356493": [{"title": "DPN treatment in adherent culture, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "DPN treatment in adherent culture"}, {"characteristics_ch1": "cell line: MCF7;\tphenotype: adherent monolayer cells;\tcell state: differentiated state;\ttreated with: 10nM DPN for 48hrs"}]}, {"GSM1356494": [{"title": "DPN treatment in adherent culture, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "DPN treatment in adherent culture"}, {"characteristics_ch1": "cell line: MCF7;\tphenotype: adherent monolayer cells;\tcell state: differentiated state;\ttreated with: 10nM DPN for 48hrs"}]}, {"GSM1356495": [{"title": "DPN treatment in adherent culture, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "DPN treatment in adherent culture"}, {"characteristics_ch1": "cell line: MCF7;\tphenotype: adherent monolayer cells;\tcell state: differentiated state;\ttreated with: 10nM DPN for 48hrs"}]}, {"GSM2109078": [{"title": "colorectal cancer sample AUS2_291"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2109079": [{"title": "colorectal cancer sample AUS2_299"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2109080": [{"title": "colorectal cancer sample AUS2_315"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2109081": [{"title": "colorectal cancer sample AUS2_318"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2109082": [{"title": "colorectal cancer sample AUS2_322"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2109083": [{"title": "colorectal cancer sample AUS2_327"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2109084": [{"title": "colorectal cancer sample AUS2_338"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2109085": [{"title": "colorectal cancer sample AUS2_344"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2109086": [{"title": "colorectal cancer sample AUS2_354"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2109087": [{"title": "colorectal cancer sample AUS2_362"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2109088": [{"title": "colorectal cancer sample AUS2_366"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2109089": [{"title": "colorectal cancer sample AUS2_374"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2109090": [{"title": "colorectal cancer sample AUS2_375"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2109091": [{"title": "colorectal cancer sample AUS2_385"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2109092": [{"title": "colorectal cancer sample AUS2_388"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2109093": [{"title": "colorectal cancer sample AUS2_400"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2109094": [{"title": "colorectal cancer sample AUS2_410"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2109095": [{"title": "colorectal cancer sample AUS2_421"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2109096": [{"title": "colorectal cancer sample AUS2_422"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2109097": [{"title": "colorectal cancer sample AUS2_427"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2109098": [{"title": "colorectal cancer sample AUS2_434"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2109099": [{"title": "colorectal cancer sample AUS2_436"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2109100": [{"title": "colorectal cancer sample AUS2_439"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2109101": [{"title": "colorectal cancer sample AUS2_444"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2334667": [{"title": "colorectal cancer sample AUS2_446"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2334668": [{"title": "colorectal cancer sample AUS2_448"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2334669": [{"title": "colorectal cancer sample AUS2_473"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2334670": [{"title": "colorectal cancer sample AUS2_488"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2334671": [{"title": "colorectal cancer sample AUS2_491"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2334672": [{"title": "colorectal cancer sample AUS2_496"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2334673": [{"title": "colorectal cancer sample AUS2_546"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2334674": [{"title": "colorectal cancer sample AUS2_548"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2334675": [{"title": "colorectal cancer sample AUS2_550"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2334676": [{"title": "colorectal cancer sample AUS2_553"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2255604": [{"title": "human myotubes, aldosterone treated, biological rep 1"}, {"type": "RNA"}, {"source_name_ch1": "normal primary human myotubes"}, {"characteristics_ch1": "Sex: male;\tcell type: myotubes"}]}, {"GSM2255605": [{"title": "human myotubes, aldosterone treated, biological rep 2"}, {"type": "RNA"}, {"source_name_ch1": "normal primary human myotubes"}, {"characteristics_ch1": "Sex: male;\tcell type: myotubes"}]}, {"GSM2255606": [{"title": "human myotubes, aldosterone treated, biological rep 3"}, {"type": "RNA"}, {"source_name_ch1": "normal primary human myotubes"}, {"characteristics_ch1": "Sex: male;\tcell type: myotubes"}]}, {"GSM2255607": [{"title": "human myotubes, spironolactone treated, biological rep 1"}, {"type": "RNA"}, {"source_name_ch1": "normal primary human myotubes"}, {"characteristics_ch1": "Sex: male;\tcell type: myotubes"}]}, {"GSM2255608": [{"title": "human myotubes, spironolactone treated, biological rep 2"}, {"type": "RNA"}, {"source_name_ch1": "normal primary human myotubes"}, {"characteristics_ch1": "Sex: male;\tcell type: myotubes"}]}, {"GSM2255609": [{"title": "human myotubes, spironolactone treated, biological rep 3"}, {"type": "RNA"}, {"source_name_ch1": "normal primary human myotubes"}, {"characteristics_ch1": "Sex: male;\tcell type: myotubes"}]}, {"GSM2255610": [{"title": "human myotubes, untreated/vehicle-treated, biological rep 1"}, {"type": "RNA"}, {"source_name_ch1": "normal primary human myotubes"}, {"characteristics_ch1": "Sex: male;\tcell type: myotubes"}]}, {"GSM2255611": [{"title": "human myotubes, untreated/vehicle-treated, biological rep 2"}, {"type": "RNA"}, {"source_name_ch1": "normal primary human myotubes"}, {"characteristics_ch1": "Sex: male;\tcell type: myotubes"}]}, {"GSM2255612": [{"title": "human myotubes, untreated/vehicle-treated, biological rep 3"}, {"type": "RNA"}, {"source_name_ch1": "normal primary human myotubes"}, {"characteristics_ch1": "Sex: male;\tcell type: myotubes"}]}, {"GSM2255613": [{"title": "human myotubes, eplerenone treated, biological rep 1"}, {"type": "RNA"}, {"source_name_ch1": "normal primary human myotubes"}, {"characteristics_ch1": "Sex: male;\tcell type: myotubes"}]}, {"GSM2255614": [{"title": "human myotubes, eplerenone treated, biological rep 2"}, {"type": "RNA"}, {"source_name_ch1": "normal primary human myotubes"}, {"characteristics_ch1": "Sex: male;\tcell type: myotubes"}]}, {"GSM2255615": [{"title": "human myotubes, eplerenone treated, biological rep 3"}, {"type": "RNA"}, {"source_name_ch1": "normal primary human myotubes"}, {"characteristics_ch1": "Sex: male;\tcell type: myotubes"}]}, {"GSM2255616": [{"title": "human myotubes, mifepristone treated, biological rep 1"}, {"type": "RNA"}, {"source_name_ch1": "normal primary human myotubes"}, {"characteristics_ch1": "Sex: male;\tcell type: myotubes"}]}, {"GSM2255617": [{"title": "human myotubes, mifepristone treated, biological rep 2"}, {"type": "RNA"}, {"source_name_ch1": "normal primary human myotubes"}, {"characteristics_ch1": "Sex: male;\tcell type: myotubes"}]}, {"GSM2255618": [{"title": "human myotubes, mifepristone treated, biological rep 3"}, {"type": "RNA"}, {"source_name_ch1": "normal primary human myotubes"}, {"characteristics_ch1": "Sex: male;\tcell type: myotubes"}]}, {"GSM2255619": [{"title": "human myotubes, prednisolone treated, biological rep 1"}, {"type": "RNA"}, {"source_name_ch1": "normal primary human myotubes"}, {"characteristics_ch1": "Sex: male;\tcell type: myotubes"}]}, {"GSM2255620": [{"title": "human myotubes, prednisolone treated, biological rep 2"}, {"type": "RNA"}, {"source_name_ch1": "normal primary human myotubes"}, {"characteristics_ch1": "Sex: male;\tcell type: myotubes"}]}, {"GSM2255621": [{"title": "human myotubes, prednisolone treated, biological rep 3"}, {"type": "RNA"}, {"source_name_ch1": "normal primary human myotubes"}, {"characteristics_ch1": "Sex: male;\tcell type: myotubes"}]}, {"GSM2255622": [{"title": "human myotubes, aldosterone treated, biological rep 1a"}, {"type": "RNA"}, {"source_name_ch1": "normal primary human myotubes"}, {"characteristics_ch1": "Sex: male;\tcell type: myotubes"}]}, {"GSM2255623": [{"title": "human myotubes, aldosterone treated, biological rep 2a"}, {"type": "RNA"}, {"source_name_ch1": "normal primary human myotubes"}, {"characteristics_ch1": "Sex: male;\tcell type: myotubes"}]}, {"GSM2255624": [{"title": "human myotubes, aldosterone treated, biological rep 3a"}, {"type": "RNA"}, {"source_name_ch1": "normal primary human myotubes"}, {"characteristics_ch1": "Sex: male;\tcell type: myotubes"}]}, {"GSM2255625": [{"title": "human myotubes, spironolactone plus aldosterone treated, biological rep 1"}, {"type": "RNA"}, {"source_name_ch1": "normal primary human myotubes"}, {"characteristics_ch1": "Sex: male;\tcell type: myotubes"}]}, {"GSM2255626": [{"title": "human myotubes, spironolactone plus aldosterone treated, biological rep 2"}, {"type": "RNA"}, {"source_name_ch1": "normal primary human myotubes"}, {"characteristics_ch1": "Sex: male;\tcell type: myotubes"}]}, {"GSM2255627": [{"title": "human myotubes, spironolactone plus aldosterone treated, biological rep 3"}, {"type": "RNA"}, {"source_name_ch1": "normal primary human myotubes"}, {"characteristics_ch1": "Sex: male;\tcell type: myotubes"}]}, {"GSM2255628": [{"title": "human myotubes, eplerenone plus aldosterone treated, biological rep 1"}, {"type": "RNA"}, {"source_name_ch1": "normal primary human myotubes"}, {"characteristics_ch1": "Sex: male;\tcell type: myotubes"}]}, {"GSM2255629": [{"title": "human myotubes, eplerenone plus aldosterone treated, biological rep 2"}, {"type": "RNA"}, {"source_name_ch1": "normal primary human myotubes"}, {"characteristics_ch1": "Sex: male;\tcell type: myotubes"}]}, {"GSM2255630": [{"title": "human myotubes, eplerenone plus aldosterone treated, biological rep 3"}, {"type": "RNA"}, {"source_name_ch1": "normal primary human myotubes"}, {"characteristics_ch1": "Sex: male;\tcell type: myotubes"}]}, {"GSM2255631": [{"title": "human myotubes, mifepristone plus aldosterone treated, biological rep 1"}, {"type": "RNA"}, {"source_name_ch1": "normal primary human myotubes"}, {"characteristics_ch1": "Sex: male;\tcell type: myotubes"}]}, {"GSM2255632": [{"title": "human myotubes, mifepristone plus aldosterone treated, biological rep 2"}, {"type": "RNA"}, {"source_name_ch1": "normal primary human myotubes"}, {"characteristics_ch1": "Sex: male;\tcell type: myotubes"}]}, {"GSM2255633": [{"title": "human myotubes, mifepristone plus aldosterone treated, biological rep 3"}, {"type": "RNA"}, {"source_name_ch1": "normal primary human myotubes"}, {"characteristics_ch1": "Sex: male;\tcell type: myotubes"}]}, {"GSM2466140": [{"title": "PH_RNA_5_pharmacyclics_20140611"}, {"type": "RNA"}, {"source_name_ch1": "parental TMD8 cells"}, {"characteristics_ch1": "sample group: parental TMD8 cells"}]}, {"GSM2466141": [{"title": "PH_RNA_6_pharmacyclics_20140611"}, {"type": "RNA"}, {"source_name_ch1": "parental TMD8 cells"}, {"characteristics_ch1": "sample group: parental TMD8 cells"}]}, {"GSM2466142": [{"title": "PH_RNA_7_pharmacyclics_20140611"}, {"type": "RNA"}, {"source_name_ch1": "ibrutinib-resistant TMD8 cells"}, {"characteristics_ch1": "sample group: ibrutinib-resistant TMD8 cells"}]}, {"GSM2466143": [{"title": "PH_RNA_8_pharmacyclics_20140611"}, {"type": "RNA"}, {"source_name_ch1": "ibrutinib-resistant TMD8 cells"}, {"characteristics_ch1": "sample group: ibrutinib-resistant TMD8 cells"}]}, {"GSM2062765": [{"title": "individual 6"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062766": [{"title": "individual 7"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062767": [{"title": "individual 8"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062768": [{"title": "individual 10"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062769": [{"title": "individual 12"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062770": [{"title": "individual 13"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062771": [{"title": "individual 14"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062772": [{"title": "individual 15"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062773": [{"title": "individual 16"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062774": [{"title": "individual 19"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062775": [{"title": "individual 20"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062776": [{"title": "individual 21"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062777": [{"title": "individual 22"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062778": [{"title": "individual 23"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062779": [{"title": "individual 26"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062780": [{"title": "individual 27"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062781": [{"title": "individual 29"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062782": [{"title": "individual 30"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062783": [{"title": "individual 31"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062784": [{"title": "individual 32"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062785": [{"title": "individual 33"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062786": [{"title": "individual 36"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062787": [{"title": "individual 37"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062788": [{"title": "individual 38"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062789": [{"title": "individual 41"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062790": [{"title": "individual 42"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062791": [{"title": "individual 43"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062792": [{"title": "individual 44"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062793": [{"title": "individual 45"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062794": [{"title": "individual 50"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062795": [{"title": "individual 52"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062796": [{"title": "individual 53"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062797": [{"title": "individual 54"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062798": [{"title": "individual 55"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062799": [{"title": "individual 56"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062800": [{"title": "individual 57"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062801": [{"title": "individual 58"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062802": [{"title": "individual 59"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062803": [{"title": "individual 60"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062804": [{"title": "individual 65"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062805": [{"title": "individual 66"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062806": [{"title": "individual 67"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062807": [{"title": "individual 69"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062808": [{"title": "individual 70"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062809": [{"title": "individual 71"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062810": [{"title": "individual 72"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062811": [{"title": "individual 73"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062812": [{"title": "individual 74"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062813": [{"title": "individual 75"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062814": [{"title": "individual 76"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062815": [{"title": "individual 77"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062816": [{"title": "individual 78"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062817": [{"title": "individual 79"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062818": [{"title": "individual 80"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062819": [{"title": "individual 81"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062820": [{"title": "individual 82"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062821": [{"title": "individual 83"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062822": [{"title": "individual 84"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062823": [{"title": "individual 85"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062824": [{"title": "individual 86"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062825": [{"title": "individual 87"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062826": [{"title": "individual 90"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062827": [{"title": "individual 91"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062828": [{"title": "individual 92"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062829": [{"title": "individual 93"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062830": [{"title": "individual 94"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062831": [{"title": "individual 96"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062832": [{"title": "individual 98"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062833": [{"title": "individual 99"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062834": [{"title": "individual 100"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062835": [{"title": "individual 101"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062836": [{"title": "individual 102"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062837": [{"title": "individual 104"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062838": [{"title": "individual 107"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062839": [{"title": "individual 108"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062840": [{"title": "individual 109"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062841": [{"title": "individual 110"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062842": [{"title": "individual 111"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062843": [{"title": "individual 112"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062844": [{"title": "individual 113"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062845": [{"title": "individual 114"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062846": [{"title": "individual 115"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062847": [{"title": "individual 116"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062848": [{"title": "individual 117"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062849": [{"title": "individual 118"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062850": [{"title": "individual 119"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062851": [{"title": "individual 120"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062852": [{"title": "individual 121"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062853": [{"title": "individual 122"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062854": [{"title": "individual 123"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062855": [{"title": "individual 124"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062856": [{"title": "individual 125"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062857": [{"title": "individual 126"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062858": [{"title": "individual 127"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062859": [{"title": "individual 128"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062860": [{"title": "individual 129"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062861": [{"title": "individual 130"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062862": [{"title": "individual 131"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062863": [{"title": "individual 133"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062864": [{"title": "individual 134"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062865": [{"title": "individual 135"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062866": [{"title": "individual 136"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062867": [{"title": "individual 137"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062868": [{"title": "individual 138"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062869": [{"title": "individual 139"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062870": [{"title": "individual 140"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062871": [{"title": "individual 141"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062872": [{"title": "individual 142"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062873": [{"title": "individual 143"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062874": [{"title": "individual 144"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062875": [{"title": "individual 145"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062876": [{"title": "individual 146"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062877": [{"title": "individual 147"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062878": [{"title": "individual 148"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062879": [{"title": "individual 149"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062880": [{"title": "individual 150"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062881": [{"title": "individual 151"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062882": [{"title": "individual 152"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062883": [{"title": "individual 153"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062884": [{"title": "individual 154"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062885": [{"title": "individual 155"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062886": [{"title": "individual 156"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062887": [{"title": "individual 167"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062888": [{"title": "individual 178"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062889": [{"title": "individual 179"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062890": [{"title": "individual 180"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062891": [{"title": "individual 181"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062892": [{"title": "individual 184"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062893": [{"title": "individual 185"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062894": [{"title": "individual 186"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062895": [{"title": "individual 188"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062896": [{"title": "individual 190"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062897": [{"title": "individual 193"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062898": [{"title": "individual 194"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062899": [{"title": "individual 195"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062900": [{"title": "individual 198"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062901": [{"title": "individual 199"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062902": [{"title": "individual 200"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062903": [{"title": "individual 205"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062904": [{"title": "individual 207"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062905": [{"title": "individual 208"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062906": [{"title": "individual 209"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062907": [{"title": "individual 211"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062908": [{"title": "individual 212"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062909": [{"title": "individual 216"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062910": [{"title": "individual 218"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062911": [{"title": "individual 220"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062912": [{"title": "individual 221"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062913": [{"title": "individual 222"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062914": [{"title": "individual 223"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062915": [{"title": "individual 224"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062916": [{"title": "individual 225"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062917": [{"title": "individual 226"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062918": [{"title": "individual 227"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062919": [{"title": "individual 228"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062920": [{"title": "individual 229"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062921": [{"title": "individual 231"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062922": [{"title": "individual 232"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062923": [{"title": "individual 233"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062924": [{"title": "individual 234"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062925": [{"title": "individual 235"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062926": [{"title": "individual 236"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062927": [{"title": "individual 237"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062928": [{"title": "individual 238"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062929": [{"title": "individual 239"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062930": [{"title": "individual 240"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062931": [{"title": "individual 241"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062932": [{"title": "individual 242"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062933": [{"title": "individual 243"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062934": [{"title": "individual 244"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062935": [{"title": "individual 247"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062936": [{"title": "individual 249"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062937": [{"title": "individual 250"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062938": [{"title": "individual 251"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062939": [{"title": "individual 252"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062940": [{"title": "individual 254"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062941": [{"title": "individual 255"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062942": [{"title": "individual 257"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062943": [{"title": "individual 259"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062944": [{"title": "individual 261"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062945": [{"title": "individual 262"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062946": [{"title": "individual 266"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062947": [{"title": "individual 267"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062948": [{"title": "individual 268"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062949": [{"title": "individual 270"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062950": [{"title": "individual 271"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062951": [{"title": "individual 272"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062952": [{"title": "individual 273"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062953": [{"title": "individual 274"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062954": [{"title": "individual 275"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062955": [{"title": "individual 276"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062956": [{"title": "individual 277"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062957": [{"title": "individual 278"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062958": [{"title": "individual 279"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062959": [{"title": "individual 280"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062960": [{"title": "individual 281"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062961": [{"title": "individual 282"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062962": [{"title": "individual 283"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062963": [{"title": "individual 284"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062964": [{"title": "individual 285"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062965": [{"title": "individual 286"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062966": [{"title": "individual 287"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062967": [{"title": "individual 288"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062968": [{"title": "individual 289"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062969": [{"title": "individual 290"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062970": [{"title": "individual 291"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062971": [{"title": "individual 292"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062972": [{"title": "individual 293"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062973": [{"title": "individual 294"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062974": [{"title": "individual 296"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062975": [{"title": "individual 297"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062976": [{"title": "individual 298"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062977": [{"title": "individual 299"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2062978": [{"title": "individual 300"}, {"type": "RNA"}, {"source_name_ch1": "dorsal root ganglion"}, {"characteristics_ch1": "tissue: dorsal root ganglion"}]}, {"GSM2628001": [{"title": "HEK293T_with Riboflavin"}, {"type": "RNA"}, {"source_name_ch1": "HEK293T, with Riboflavin"}, {"characteristics_ch1": "cell line: HEK293T"}]}, {"GSM2628002": [{"title": "HEK293T_without Riboflavin"}, {"type": "RNA"}, {"source_name_ch1": "HEK293T, without Riboflavin"}, {"characteristics_ch1": "cell line: HEK293T"}]}, {"GSM2634065": [{"title": "Neuroblastoma cells at C0, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "SH-SY5Y without OA"}, {"characteristics_ch1": "cell line: SH-SY5Y;\tcell type: Human neuroblastoma line;\ttreated with: none (untreated; C0)"}]}, {"GSM2634066": [{"title": "Neuroblastoma cells at C0, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "SH-SY5Y without OA"}, {"characteristics_ch1": "cell line: SH-SY5Y;\tcell type: Human neuroblastoma line;\ttreated with: none (untreated; C0)"}]}, {"GSM2634067": [{"title": "Neuroblastoma cells at C0, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "SH-SY5Y without OA"}, {"characteristics_ch1": "cell line: SH-SY5Y;\tcell type: Human neuroblastoma line;\ttreated with: none (untreated; C0)"}]}, {"GSM2634068": [{"title": "Neuroblastoma cells at C1, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "SH-SY5Y treated with 20 nM OA for 12 h"}, {"characteristics_ch1": "cell line: SH-SY5Y;\tcell type: Human neuroblastoma line;\ttreated with: 20 nM Okadaic acid (OA) for 12h (C1)"}]}, {"GSM2634069": [{"title": "Neuroblastoma cells at C1, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "SH-SY5Y treated with 20 nM OA for 12 h"}, {"characteristics_ch1": "cell line: SH-SY5Y;\tcell type: Human neuroblastoma line;\ttreated with: 20 nM Okadaic acid (OA) for 12h (C1)"}]}, {"GSM2634070": [{"title": "Neuroblastoma cells at C1, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "SH-SY5Y treated with 20 nM OA for 12 h"}, {"characteristics_ch1": "cell line: SH-SY5Y;\tcell type: Human neuroblastoma line;\ttreated with: 20 nM Okadaic acid (OA) for 12h (C1)"}]}, {"GSM2634071": [{"title": "Neuroblastoma cells at C2, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "SH-SY5Y treated with 60 nM OA for 12 h"}, {"characteristics_ch1": "cell line: SH-SY5Y;\tcell type: Human neuroblastoma line;\ttreated with: 20 nM Okadaic acid (OA) for 12h (C2)"}]}, {"GSM2634072": [{"title": "Neuroblastoma cells at C2, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "SH-SY5Y treated with 60 nM OA for 12 h"}, {"characteristics_ch1": "cell line: SH-SY5Y;\tcell type: Human neuroblastoma line;\ttreated with: 20 nM Okadaic acid (OA) for 12h (C2)"}]}, {"GSM2634073": [{"title": "Neuroblastoma cells at C2, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "SH-SY5Y treated with 60 nM OA for 12 h"}, {"characteristics_ch1": "cell line: SH-SY5Y;\tcell type: Human neuroblastoma line;\ttreated with: 20 nM Okadaic acid (OA) for 12h (C2)"}]}, {"GSM2643403": [{"title": "No BCBM biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "BrPt1 blood"}, {"characteristics_ch1": "gender: female;\tprimary tumor subtype: TNBC"}]}, {"GSM2643404": [{"title": "No BCBM biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "BrPt2 blood"}, {"characteristics_ch1": "gender: female;\tprimary tumor subtype: ER-/PR-/HER2+"}]}, {"GSM2643405": [{"title": "No BCBM biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "BrPt3 blood"}, {"characteristics_ch1": "gender: female;\tprimary tumor subtype: TNBC"}]}, {"GSM2643406": [{"title": "No BCBM biological rep4"}, {"type": "RNA"}, {"source_name_ch1": "BrPt4 blood"}, {"characteristics_ch1": "gender: female;\tprimary tumor subtype: ER+/PR-/HER2-"}]}, {"GSM2643407": [{"title": "No BCBM biological rep5"}, {"type": "RNA"}, {"source_name_ch1": "BrPt5 blood"}, {"characteristics_ch1": "gender: female;\tprimary tumor subtype: TNBC"}]}, {"GSM2643408": [{"title": "BCBM biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "BrPt6 blood"}, {"characteristics_ch1": "gender: female;\tprimary tumor subtype: ER+/PR+/HER2-"}]}, {"GSM2643409": [{"title": "BCBM biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "BrPt7 blood"}, {"characteristics_ch1": "gender: female;\tprimary tumor subtype: ER+/PR-/HER2-"}]}, {"GSM2643410": [{"title": "BCBM biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "BrPt8 blood"}, {"characteristics_ch1": "gender: female;\tprimary tumor subtype: ER+/PR-/HER2-"}]}, {"GSM2643411": [{"title": "BCBM biological rep4"}, {"type": "RNA"}, {"source_name_ch1": "BrPt9 blood"}, {"characteristics_ch1": "gender: female;\tprimary tumor subtype: ER+/PR+/HER2-"}]}, {"GSM2643412": [{"title": "BCBM biological rep5"}, {"type": "RNA"}, {"source_name_ch1": "BrPt10 blood"}, {"characteristics_ch1": "gender: female;\tprimary tumor subtype: TNBC"}]}, {"GSM1979367": [{"title": "HCC Tumor Tissue LCS_501A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_501"}]}, {"GSM1979368": [{"title": "HCC Non-Tumor Tissue LCS_501B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_501"}]}, {"GSM1979369": [{"title": "HCC Tumor Tissue LCS_502A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_502"}]}, {"GSM1979370": [{"title": "HCC Non-Tumor Tissue LCS_502B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_502"}]}, {"GSM1979371": [{"title": "HCC Tumor Tissue LCS_503A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_503"}]}, {"GSM1979372": [{"title": "HCC Non-Tumor Tissue LCS_503B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_503"}]}, {"GSM1979373": [{"title": "HCC Tumor Tissue LCS_504A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_504"}]}, {"GSM1979374": [{"title": "HCC Non-Tumor Tissue LCS_504B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_504"}]}, {"GSM1979375": [{"title": "HCC Tumor Tissue LCS_505A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_505"}]}, {"GSM1979376": [{"title": "HCC Non-Tumor Tissue LCS_505B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_505"}]}, {"GSM1979377": [{"title": "HCC Tumor Tissue LCS_506A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_506"}]}, {"GSM1979378": [{"title": "HCC Non-Tumor Tissue LCS_506B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_506"}]}, {"GSM1979379": [{"title": "HCC Tumor Tissue LCS_507A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_507"}]}, {"GSM1979380": [{"title": "HCC Non-Tumor Tissue LCS_507B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_507"}]}, {"GSM1979381": [{"title": "HCC Tumor Tissue LCS_508A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_508"}]}, {"GSM1979382": [{"title": "HCC Non-Tumor Tissue LCS_508B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_508"}]}, {"GSM1979383": [{"title": "HCC Tumor Tissue LCS_509A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_509"}]}, {"GSM1979384": [{"title": "HCC Non-Tumor Tissue LCS_509B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_509"}]}, {"GSM1979385": [{"title": "HCC Tumor Tissue LCS_510A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_510"}]}, {"GSM1979386": [{"title": "HCC Non-Tumor Tissue LCS_510B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_510"}]}, {"GSM1979387": [{"title": "HCC Tumor Tissue LCS_511A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_511"}]}, {"GSM1979388": [{"title": "HCC Non-Tumor Tissue LCS_511B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_511"}]}, {"GSM1979389": [{"title": "HCC Tumor Tissue LCS_512A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_512"}]}, {"GSM1979390": [{"title": "HCC Non-Tumor Tissue LCS_512B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_512"}]}, {"GSM1979391": [{"title": "HCC Tumor Tissue LCS_513A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_513"}]}, {"GSM1979392": [{"title": "HCC Non-Tumor Tissue LCS_513B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_513"}]}, {"GSM1979393": [{"title": "HCC Tumor Tissue LCS_514A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_514"}]}, {"GSM1979394": [{"title": "HCC Non-Tumor Tissue LCS_514B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_514"}]}, {"GSM1979395": [{"title": "HCC Tumor Tissue LCS_515A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_515"}]}, {"GSM1979396": [{"title": "HCC Non-Tumor Tissue LCS_515B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_515"}]}, {"GSM1979397": [{"title": "HCC Tumor Tissue LCS_516A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_516"}]}, {"GSM1979398": [{"title": "HCC Non-Tumor Tissue LCS_516B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_516"}]}, {"GSM1979399": [{"title": "HCC Tumor Tissue LCS_517A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_517"}]}, {"GSM1979400": [{"title": "HCC Non-Tumor Tissue LCS_517B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_517"}]}, {"GSM1979401": [{"title": "HCC Tumor Tissue LCS_518A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_518"}]}, {"GSM1979402": [{"title": "HCC Non-Tumor Tissue LCS_518B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_518"}]}, {"GSM1979403": [{"title": "HCC Tumor Tissue LCS_519A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_519"}]}, {"GSM1979404": [{"title": "HCC Non-Tumor Tissue LCS_519B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_519"}]}, {"GSM1979405": [{"title": "HCC Tumor Tissue LCS_520A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_520"}]}, {"GSM1979406": [{"title": "HCC Non-Tumor Tissue LCS_520B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_520"}]}, {"GSM1979407": [{"title": "HCC Tumor Tissue LCS_523A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_523"}]}, {"GSM1979408": [{"title": "HCC Tumor Tissue LCS_524A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_524"}]}, {"GSM1979409": [{"title": "HCC Non-Tumor Tissue LCS_524B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_524"}]}, {"GSM1979410": [{"title": "HCC Tumor Tissue LCS_525A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_525"}]}, {"GSM1979411": [{"title": "HCC Non-Tumor Tissue LCS_525B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_525"}]}, {"GSM1979412": [{"title": "HCC Tumor Tissue LCS_527A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_527"}]}, {"GSM1979413": [{"title": "HCC Non-Tumor Tissue LCS_527B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_527"}]}, {"GSM1979414": [{"title": "HCC Tumor Tissue LCS_528A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_528"}]}, {"GSM1979415": [{"title": "HCC Non-Tumor Tissue LCS_528B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_528"}]}, {"GSM1979416": [{"title": "HCC Tumor Tissue LCS_529A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_529"}]}, {"GSM1979417": [{"title": "HCC Non-Tumor Tissue LCS_529B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_529"}]}, {"GSM1979418": [{"title": "HCC Tumor Tissue LCS_530A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_530"}]}, {"GSM1979419": [{"title": "HCC Non-Tumor Tissue LCS_530B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_530"}]}, {"GSM1979420": [{"title": "HCC Tumor Tissue LCS_531A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_531"}]}, {"GSM1979421": [{"title": "HCC Tumor Tissue LCS_532A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_532"}]}, {"GSM1979422": [{"title": "HCC Non-Tumor Tissue LCS_532B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_532"}]}, {"GSM1979423": [{"title": "HCC Tumor Tissue LCS_533A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_533"}]}, {"GSM1979424": [{"title": "HCC Non-Tumor Tissue LCS_533B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_533"}]}, {"GSM1979425": [{"title": "HCC Tumor Tissue LCS_534A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_534"}]}, {"GSM1979426": [{"title": "HCC Non-Tumor Tissue LCS_534B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_534"}]}, {"GSM1979427": [{"title": "HCC Tumor Tissue LCS_535A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_535"}]}, {"GSM1979428": [{"title": "HCC Non-Tumor Tissue LCS_535B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_535"}]}, {"GSM1979429": [{"title": "HCC Tumor Tissue LCS_536A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_536"}]}, {"GSM1979430": [{"title": "HCC Non-Tumor Tissue LCS_536B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_536"}]}, {"GSM1979431": [{"title": "HCC Tumor Tissue LCS_537A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_537"}]}, {"GSM1979432": [{"title": "HCC Non-Tumor Tissue LCS_537B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_537"}]}, {"GSM1979433": [{"title": "HCC Tumor Tissue LCS_538A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_538"}]}, {"GSM1979434": [{"title": "HCC Non-Tumor Tissue LCS_538B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_538"}]}, {"GSM1979435": [{"title": "HCC Tumor Tissue LCS_539A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_539"}]}, {"GSM1979436": [{"title": "HCC Non-Tumor Tissue LCS_539B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_539"}]}, {"GSM1979437": [{"title": "HCC Tumor Tissue LCS_540A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_540"}]}, {"GSM1979438": [{"title": "HCC Non-Tumor Tissue LCS_540B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_540"}]}, {"GSM1979439": [{"title": "HCC Tumor Tissue LCS_541A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_541"}]}, {"GSM1979440": [{"title": "HCC Non-Tumor Tissue LCS_541B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_541"}]}, {"GSM1979441": [{"title": "HCC Tumor Tissue LCS_542A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_542"}]}, {"GSM1979442": [{"title": "HCC Non-Tumor Tissue LCS_542B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_542"}]}, {"GSM1979443": [{"title": "HCC Tumor Tissue LCS_543A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_543"}]}, {"GSM1979444": [{"title": "HCC Non-Tumor Tissue LCS_543B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_543"}]}, {"GSM1979445": [{"title": "HCC Tumor Tissue LCS_544A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_544"}]}, {"GSM1979446": [{"title": "HCC Non-Tumor Tissue LCS_544B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_544"}]}, {"GSM1979447": [{"title": "HCC Tumor Tissue LCS_545A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_545"}]}, {"GSM1979448": [{"title": "HCC Non-Tumor Tissue LCS_545B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_545"}]}, {"GSM1979449": [{"title": "HCC Tumor Tissue LCS_546A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_546"}]}, {"GSM1979450": [{"title": "HCC Non-Tumor Tissue LCS_546B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_546"}]}, {"GSM1979451": [{"title": "HCC Tumor Tissue LCS_547A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_547"}]}, {"GSM1979452": [{"title": "HCC Non-Tumor Tissue LCS_547B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_547"}]}, {"GSM1979453": [{"title": "HCC Tumor Tissue LCS_548A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_548"}]}, {"GSM1979454": [{"title": "HCC Non-Tumor Tissue LCS_548B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_548"}]}, {"GSM1979455": [{"title": "HCC Tumor Tissue LCS_549A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_549"}]}, {"GSM1979456": [{"title": "HCC Non-Tumor Tissue LCS_549B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_549"}]}, {"GSM1979457": [{"title": "HCC Tumor Tissue LCS_550A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_550"}]}, {"GSM1979458": [{"title": "HCC Non-Tumor Tissue LCS_550B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_550"}]}, {"GSM1979459": [{"title": "HCC Tumor Tissue LCS_551A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_551"}]}, {"GSM1979460": [{"title": "HCC Non-Tumor Tissue LCS_551B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_551"}]}, {"GSM1979461": [{"title": "HCC Tumor Tissue LCS_552A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_552"}]}, {"GSM1979462": [{"title": "HCC Non-Tumor Tissue LCS_552B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_552"}]}, {"GSM1979463": [{"title": "HCC Tumor Tissue LCS_553A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_553"}]}, {"GSM1979464": [{"title": "HCC Non-Tumor Tissue LCS_553B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_553"}]}, {"GSM1979465": [{"title": "HCC Tumor Tissue LCS_557A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_557"}]}, {"GSM1979466": [{"title": "HCC Non-Tumor Tissue LCS_557B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_557"}]}, {"GSM1979467": [{"title": "HCC Tumor Tissue LCS_558A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_558"}]}, {"GSM1979468": [{"title": "HCC Non-Tumor Tissue LCS_558B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_558"}]}, {"GSM1979469": [{"title": "HCC Tumor Tissue LCS_559A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_559"}]}, {"GSM1979470": [{"title": "HCC Non-Tumor Tissue LCS_559B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_559"}]}, {"GSM1979471": [{"title": "HCC Tumor Tissue LCS_560A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_560"}]}, {"GSM1979472": [{"title": "HCC Non-Tumor Tissue LCS_560B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_560"}]}, {"GSM1979473": [{"title": "HCC Tumor Tissue LCS_562A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_562"}]}, {"GSM1979474": [{"title": "HCC Non-Tumor Tissue LCS_562B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_562"}]}, {"GSM1979475": [{"title": "HCC Tumor Tissue LCS_563A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_563"}]}, {"GSM1979476": [{"title": "HCC Non-Tumor Tissue LCS_563B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_563"}]}, {"GSM1979477": [{"title": "HCC Tumor Tissue LCS_564A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_564"}]}, {"GSM1979478": [{"title": "HCC Non-Tumor Tissue LCS_564B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_564"}]}, {"GSM1979479": [{"title": "HCC Tumor Tissue LCS_565A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_565"}]}, {"GSM1979480": [{"title": "HCC Non-Tumor Tissue LCS_565B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_565"}]}, {"GSM1979481": [{"title": "HCC Tumor Tissue LCS_566A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_566"}]}, {"GSM1979482": [{"title": "HCC Non-Tumor Tissue LCS_566B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_566"}]}, {"GSM1979483": [{"title": "HCC Tumor Tissue LCS_567A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_567"}]}, {"GSM1979484": [{"title": "HCC Non-Tumor Tissue LCS_567B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_567"}]}, {"GSM1979485": [{"title": "HCC Tumor Tissue LCS_568A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Hepatocellular carcinoma (HCC);\tindividual: LCS_568"}]}, {"GSM1979486": [{"title": "CCA Tumor Tissue LCS_570A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_570"}]}, {"GSM1979487": [{"title": "CCA Non-Tumor Tissue LCS_570B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_570"}]}, {"GSM1979488": [{"title": "CCA Tumor Tissue LCS_571A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_571"}]}, {"GSM1979489": [{"title": "CCA Non-Tumor Tissue LCS_571B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_571"}]}, {"GSM1979490": [{"title": "CCA Tumor Tissue LCS_572A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_572"}]}, {"GSM1979491": [{"title": "CCA Non-Tumor Tissue LCS_572B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_572"}]}, {"GSM1979492": [{"title": "CCA Tumor Tissue LCS_573A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_573"}]}, {"GSM1979493": [{"title": "CCA Non-Tumor Tissue LCS_573B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_573"}]}, {"GSM1979494": [{"title": "CCA Tumor Tissue LCS_574A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_574"}]}, {"GSM1979495": [{"title": "CCA Non-Tumor Tissue LCS_574B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_574"}]}, {"GSM1979496": [{"title": "CCA Tumor Tissue LCS_575A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_575"}]}, {"GSM1979497": [{"title": "CCA Non-Tumor Tissue LCS_575B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_575"}]}, {"GSM1979498": [{"title": "CCA Non-Tumor Tissue LCS_576B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_576"}]}, {"GSM1979499": [{"title": "CCA Tumor Tissue LCS_577A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_577"}]}, {"GSM1979500": [{"title": "CCA Non-Tumor Tissue LCS_577B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_577"}]}, {"GSM1979501": [{"title": "CCA Tumor Tissue LCS_578A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_578"}]}, {"GSM1979502": [{"title": "CCA Non-Tumor Tissue LCS_578B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_578"}]}, {"GSM1979503": [{"title": "CCA Tumor Tissue LCS_579A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_579"}]}, {"GSM1979504": [{"title": "CCA Non-Tumor Tissue LCS_579B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_579"}]}, {"GSM1979505": [{"title": "CCA Tumor Tissue LCS_580A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_580"}]}, {"GSM1979506": [{"title": "CCA Non-Tumor Tissue LCS_580B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_580"}]}, {"GSM1979507": [{"title": "CCA Tumor Tissue LCS_581A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_581"}]}, {"GSM1979508": [{"title": "CCA Non-Tumor Tissue LCS_581B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_581"}]}, {"GSM1979509": [{"title": "CCA Tumor Tissue LCS_583A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_583"}]}, {"GSM1979510": [{"title": "CCA Non-Tumor Tissue LCS_583B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_583"}]}, {"GSM1979511": [{"title": "HCC Tumor Tissue LCS_584A"}, {"type": "RNA"}, {"source_name_ch1": "HCC Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_584"}]}, {"GSM1979512": [{"title": "HCC Non-Tumor Tissue LCS_584B"}, {"type": "RNA"}, {"source_name_ch1": "HCC Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_584"}]}, {"GSM1979513": [{"title": "CCA Tumor Tissue LCS_585A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_585"}]}, {"GSM1979514": [{"title": "CCA Non-Tumor Tissue LCS_585B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_585"}]}, {"GSM1979515": [{"title": "CCA Tumor Tissue LCS_586A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_586"}]}, {"GSM1979516": [{"title": "CCA Non-Tumor Tissue LCS_586B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_586"}]}, {"GSM1979517": [{"title": "CCA Tumor Tissue LCS_587A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_587"}]}, {"GSM1979518": [{"title": "CCA Non-Tumor Tissue LCS_587B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_587"}]}, {"GSM1979519": [{"title": "CCA Tumor Tissue LCS_590A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_590"}]}, {"GSM1979520": [{"title": "CCA Non-Tumor Tissue LCS_590B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_590"}]}, {"GSM1979521": [{"title": "CCA Tumor Tissue LCS_591A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_591"}]}, {"GSM1979522": [{"title": "CCA Non-Tumor Tissue LCS_591B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_591"}]}, {"GSM1979523": [{"title": "CCA Tumor Tissue LCS_592A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_592"}]}, {"GSM1979524": [{"title": "CCA Non-Tumor Tissue LCS_592B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_592"}]}, {"GSM1979525": [{"title": "CCA Tumor Tissue LCS_594A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_594"}]}, {"GSM1979526": [{"title": "CCA Non-Tumor Tissue LCS_594B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_594"}]}, {"GSM1979527": [{"title": "CCA Tumor Tissue LCS_595A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_595"}]}, {"GSM1979528": [{"title": "CCA Non-Tumor Tissue LCS_595B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_595"}]}, {"GSM1979529": [{"title": "CCA Tumor Tissue LCS_596A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_596"}]}, {"GSM1979530": [{"title": "CCA Non-Tumor Tissue LCS_596B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_596"}]}, {"GSM1979531": [{"title": "CCA Tumor Tissue LCS_597A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_597"}]}, {"GSM1979532": [{"title": "CCA Non-Tumor Tissue LCS_597B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_597"}]}, {"GSM1979533": [{"title": "CCA Tumor Tissue LCS_598A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_598"}]}, {"GSM1979534": [{"title": "CCA Non-Tumor Tissue LCS_598B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_598"}]}, {"GSM1979535": [{"title": "CCA Tumor Tissue LCS_599A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_599"}]}, {"GSM1979536": [{"title": "CCA Non-Tumor Tissue LCS_599B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_599"}]}, {"GSM1979537": [{"title": "CCA Tumor Tissue LCS_600A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_600"}]}, {"GSM1979538": [{"title": "CCA Tumor Tissue LCS_601A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_601"}]}, {"GSM1979539": [{"title": "CCA Non-Tumor Tissue LCS_601B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_601"}]}, {"GSM1979540": [{"title": "CCA Tumor Tissue LCS_602A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_602"}]}, {"GSM1979541": [{"title": "CCA Non-Tumor Tissue LCS_602B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_602"}]}, {"GSM1979542": [{"title": "CCA Tumor Tissue LCS_603A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_603"}]}, {"GSM1979543": [{"title": "CCA Non-Tumor Tissue LCS_603B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_603"}]}, {"GSM1979544": [{"title": "CCA Tumor Tissue LCS_604A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_604"}]}, {"GSM1979545": [{"title": "CCA Non-Tumor Tissue LCS_604B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_604"}]}, {"GSM1979546": [{"title": "CCA Tumor Tissue LCS_606A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_606"}]}, {"GSM1979547": [{"title": "CCA Non-Tumor Tissue LCS_606B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_606"}]}, {"GSM1979548": [{"title": "CCA Tumor Tissue LCS_608A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_608"}]}, {"GSM1979549": [{"title": "CCA Non-Tumor Tissue LCS_608B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_608"}]}, {"GSM1979550": [{"title": "CCA Tumor Tissue LCS_609A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_609"}]}, {"GSM1979551": [{"title": "CCA Non-Tumor Tissue LCS_609B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_609"}]}, {"GSM1979552": [{"title": "CCA Tumor Tissue LCS_610A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_610"}]}, {"GSM1979553": [{"title": "CCA Non-Tumor Tissue LCS_610B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_610"}]}, {"GSM1979554": [{"title": "CCA Tumor Tissue LCS_612A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_612"}]}, {"GSM1979555": [{"title": "CCA Non-Tumor Tissue LCS_612B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_612"}]}, {"GSM1979556": [{"title": "CCA Tumor Tissue LCS_613A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_613"}]}, {"GSM1979557": [{"title": "CCA Non-Tumor Tissue LCS_613B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_613"}]}, {"GSM1979558": [{"title": "CCA Tumor Tissue LCS_614A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_614"}]}, {"GSM1979559": [{"title": "CCA Non-Tumor Tissue LCS_614B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_614"}]}, {"GSM1979560": [{"title": "CCA Tumor Tissue LCS_615A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_615"}]}, {"GSM1979561": [{"title": "CCA Non-Tumor Tissue LCS_615B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_615"}]}, {"GSM1979562": [{"title": "CCA Tumor Tissue LCS_616A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_616"}]}, {"GSM1979563": [{"title": "CCA Non-Tumor Tissue LCS_616B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_616"}]}, {"GSM1979564": [{"title": "CCA Tumor Tissue LCS_618A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_618"}]}, {"GSM1979565": [{"title": "CCA Non-Tumor Tissue LCS_618B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_618"}]}, {"GSM1979566": [{"title": "CCA Non-Tumor Tissue LCS_619B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_619"}]}, {"GSM1979567": [{"title": "CCA Tumor Tissue LCS_620A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_620"}]}, {"GSM1979568": [{"title": "CCA Non-Tumor Tissue LCS_620B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_620"}]}, {"GSM1979569": [{"title": "CCA Tumor Tissue LCS_621A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_621"}]}, {"GSM1979570": [{"title": "CCA Non-Tumor Tissue LCS_621B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_621"}]}, {"GSM1979571": [{"title": "CCA Tumor Tissue LCS_623A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_623"}]}, {"GSM1979572": [{"title": "CCA Non-Tumor Tissue LCS_623B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_623"}]}, {"GSM1979573": [{"title": "CCA Tumor Tissue LCS_624A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_624"}]}, {"GSM1979574": [{"title": "CCA Non-Tumor Tissue LCS_624B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_624"}]}, {"GSM1979575": [{"title": "CCA Tumor Tissue LCS_625A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_625"}]}, {"GSM1979576": [{"title": "CCA Non-Tumor Tissue LCS_625B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_625"}]}, {"GSM1979577": [{"title": "CCA Tumor Tissue LCS_626A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_626"}]}, {"GSM1979578": [{"title": "CCA Non-Tumor Tissue LCS_626B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_626"}]}, {"GSM1979579": [{"title": "CCA Tumor Tissue LCS_627A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_627"}]}, {"GSM1979580": [{"title": "CCA Non-Tumor Tissue LCS_627B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_627"}]}, {"GSM1979581": [{"title": "CCA Tumor Tissue LCS_628A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_628"}]}, {"GSM1979582": [{"title": "CCA Non-Tumor Tissue LCS_628B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_628"}]}, {"GSM1979583": [{"title": "CCA Tumor Tissue LCS_630A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_630"}]}, {"GSM1979584": [{"title": "CCA Non-Tumor Tissue LCS_630B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_630"}]}, {"GSM1979585": [{"title": "CCA Tumor Tissue LCS_631A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_631"}]}, {"GSM1979586": [{"title": "CCA Non-Tumor Tissue LCS_631B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_631"}]}, {"GSM1979587": [{"title": "CCA Tumor Tissue LCS_633A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_633"}]}, {"GSM1979588": [{"title": "CCA Non-Tumor Tissue LCS_633B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_633"}]}, {"GSM1979589": [{"title": "CCA Tumor Tissue LCS_634A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_634"}]}, {"GSM1979590": [{"title": "CCA Non-Tumor Tissue LCS_634B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_634"}]}, {"GSM1979591": [{"title": "CCA Tumor Tissue LCS_635A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_635"}]}, {"GSM1979592": [{"title": "CCA Non-Tumor Tissue LCS_635B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_635"}]}, {"GSM1979593": [{"title": "CCA Tumor Tissue LCS_636A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_636"}]}, {"GSM1979594": [{"title": "CCA Non-Tumor Tissue LCS_636B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_636"}]}, {"GSM1979595": [{"title": "CCA Tumor Tissue LCS_637A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_637"}]}, {"GSM1979596": [{"title": "CCA Non-Tumor Tissue LCS_637B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_637"}]}, {"GSM1979597": [{"title": "CCA Tumor Tissue LCS_638A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_638"}]}, {"GSM1979598": [{"title": "CCA Non-Tumor Tissue LCS_638B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_638"}]}, {"GSM1979599": [{"title": "CCA Tumor Tissue LCS_639A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_639"}]}, {"GSM1979600": [{"title": "CCA Non-Tumor Tissue LCS_639B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_639"}]}, {"GSM1979601": [{"title": "CCA Tumor Tissue LCS_640A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_640"}]}, {"GSM1979602": [{"title": "CCA Non-Tumor Tissue LCS_640B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_640"}]}, {"GSM1979603": [{"title": "CCA Tumor Tissue LCS_641A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_641"}]}, {"GSM1979604": [{"title": "CCA Non-Tumor Tissue LCS_641B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_641"}]}, {"GSM1979605": [{"title": "CCA Tumor Tissue LCS_642A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_642"}]}, {"GSM1979606": [{"title": "CCA Non-Tumor Tissue LCS_642B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_642"}]}, {"GSM1979607": [{"title": "CCA Tumor Tissue LCS_643A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_643"}]}, {"GSM1979608": [{"title": "CCA Non-Tumor Tissue LCS_643B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_643"}]}, {"GSM1979609": [{"title": "CCA Tumor Tissue LCS_644A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_644"}]}, {"GSM1979610": [{"title": "CCA Non-Tumor Tissue LCS_644B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_644"}]}, {"GSM1979611": [{"title": "CCA Tumor Tissue LCS_645A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_645"}]}, {"GSM1979612": [{"title": "CCA Non-Tumor Tissue LCS_645B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_645"}]}, {"GSM1979613": [{"title": "CCA Tumor Tissue LCS_646A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_646"}]}, {"GSM1979614": [{"title": "CCA Non-Tumor Tissue LCS_646B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_646"}]}, {"GSM1979615": [{"title": "CCA Tumor Tissue LCS_648A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_648"}]}, {"GSM1979616": [{"title": "CCA Non-Tumor Tissue LCS_648B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_648"}]}, {"GSM1979617": [{"title": "CCA Tumor Tissue LCS_649A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_649"}]}, {"GSM1979618": [{"title": "CCA Non-Tumor Tissue LCS_649B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_649"}]}, {"GSM1979619": [{"title": "CCA Tumor Tissue LCS_650A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_650"}]}, {"GSM1979620": [{"title": "CCA Non-Tumor Tissue LCS_650B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_650"}]}, {"GSM1979621": [{"title": "CCA Tumor Tissue LCS_651A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_651"}]}, {"GSM1979622": [{"title": "CCA Non-Tumor Tissue LCS_651B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_651"}]}, {"GSM1979623": [{"title": "CCA Tumor Tissue LCS_652A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_652"}]}, {"GSM1979624": [{"title": "CCA Non-Tumor Tissue LCS_652B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_652"}]}, {"GSM1979625": [{"title": "CCA Tumor Tissue LCS_653A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_653"}]}, {"GSM1979626": [{"title": "CCA Non-Tumor Tissue LCS_653B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_653"}]}, {"GSM1979627": [{"title": "CCA Tumor Tissue LCS_654A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_654"}]}, {"GSM1979628": [{"title": "CCA Non-Tumor Tissue LCS_654B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_654"}]}, {"GSM1979629": [{"title": "CCA Tumor Tissue LCS_657A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_657"}]}, {"GSM1979630": [{"title": "CCA Non-Tumor Tissue LCS_657B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_657"}]}, {"GSM1979631": [{"title": "CCA Tumor Tissue LCS_658A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_658"}]}, {"GSM1979632": [{"title": "CCA Non-Tumor Tissue LCS_658B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_658"}]}, {"GSM1979633": [{"title": "CCA Tumor Tissue LCS_664A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_664"}]}, {"GSM1979634": [{"title": "CCA Non-Tumor Tissue LCS_664B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_664"}]}, {"GSM1979635": [{"title": "CCA Tumor Tissue LCS_667A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_667"}]}, {"GSM1979636": [{"title": "CCA Non-Tumor Tissue LCS_667B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_667"}]}, {"GSM1979637": [{"title": "CCA Tumor Tissue LCS_668A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_668"}]}, {"GSM1979638": [{"title": "CCA Non-Tumor Tissue LCS_668B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_668"}]}, {"GSM1979639": [{"title": "CCA Tumor Tissue LCS_669A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_669"}]}, {"GSM1979640": [{"title": "CCA Non-Tumor Tissue LCS_669B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_669"}]}, {"GSM1979641": [{"title": "CCA Tumor Tissue LCS_670A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_670"}]}, {"GSM1979642": [{"title": "CCA Non-Tumor Tissue LCS_670B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_670"}]}, {"GSM1979643": [{"title": "CCA Tumor Tissue LCS_671A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_671"}]}, {"GSM1979644": [{"title": "CCA Non-Tumor Tissue LCS_671B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_671"}]}, {"GSM1979645": [{"title": "CCA Tumor Tissue LCS_674A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_674"}]}, {"GSM1979646": [{"title": "CCA Non-Tumor Tissue LCS_674B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_674"}]}, {"GSM1979647": [{"title": "CCA Tumor Tissue LCS_675A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_675"}]}, {"GSM1979648": [{"title": "CCA Non-Tumor Tissue LCS_675B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_675"}]}, {"GSM1979649": [{"title": "CCA Tumor Tissue LCS_677A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_677"}]}, {"GSM1979650": [{"title": "CCA Non-Tumor Tissue LCS_677B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_677"}]}, {"GSM1979651": [{"title": "CCA Tumor Tissue LCS_678A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_678"}]}, {"GSM1979652": [{"title": "CCA Non-Tumor Tissue LCS_678B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_678"}]}, {"GSM1979653": [{"title": "CCA Tumor Tissue LCS_679A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_679"}]}, {"GSM1979654": [{"title": "CCA Non-Tumor Tissue LCS_679B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_679"}]}, {"GSM1979655": [{"title": "CCA Tumor Tissue LCS_680A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_680"}]}, {"GSM1979656": [{"title": "CCA Non-Tumor Tissue LCS_680B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_680"}]}, {"GSM1979657": [{"title": "CCA Tumor Tissue LCS_681A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_681"}]}, {"GSM1979658": [{"title": "CCA Non-Tumor Tissue LCS_681B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_681"}]}, {"GSM1979659": [{"title": "CCA Tumor Tissue LCS_682A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_682"}]}, {"GSM1979660": [{"title": "CCA Non-Tumor Tissue LCS_682B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_682"}]}, {"GSM1979661": [{"title": "CCA Tumor Tissue LCS_683A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_683"}]}, {"GSM1979662": [{"title": "CCA Non-Tumor Tissue LCS_683B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_683"}]}, {"GSM1979663": [{"title": "CCA Tumor Tissue LCS_684A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_684"}]}, {"GSM1979664": [{"title": "CCA Non-Tumor Tissue LCS_684B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_684"}]}, {"GSM1979665": [{"title": "CCA Tumor Tissue LCS_685A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_685"}]}, {"GSM1979666": [{"title": "CCA Non-Tumor Tissue LCS_685B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_685"}]}, {"GSM1979667": [{"title": "CCA Tumor Tissue LCS_687A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_687"}]}, {"GSM1979668": [{"title": "CCA Non-Tumor Tissue LCS_687B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_687"}]}, {"GSM1979669": [{"title": "CCA Tumor Tissue LCS_688A"}, {"type": "RNA"}, {"source_name_ch1": "CCA Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_688"}]}, {"GSM1979670": [{"title": "CCA Non-Tumor Tissue LCS_688B"}, {"type": "RNA"}, {"source_name_ch1": "CCA Non-Tumor Tissue"}, {"characteristics_ch1": "tissue: Liver Non-Tumor Tissue;\tdisease state: Cholangiocarcinoma (CCA);\tindividual: LCS_688"}]}, {"GSM2460234": [{"title": "GNAQ mutant 92-1"}, {"type": "RNA"}, {"source_name_ch1": "tissue culture cell line"}, {"characteristics_ch1": "genotype: GNAQ mutant"}]}, {"GSM2460235": [{"title": "GNAQ mutant omm1.3"}, {"type": "RNA"}, {"source_name_ch1": "tissue culture cell line"}, {"characteristics_ch1": "genotype: GNAQ mutant"}]}, {"GSM2460236": [{"title": "GNAQ mutant mel202"}, {"type": "RNA"}, {"source_name_ch1": "tissue culture cell line"}, {"characteristics_ch1": "genotype: GNAQ mutant"}]}, {"GSM2460237": [{"title": "GNA11 mutant omm-gn11"}, {"type": "RNA"}, {"source_name_ch1": "tissue culture cell line"}, {"characteristics_ch1": "genotype: GNA11 mutant"}]}, {"GSM2460238": [{"title": "GNA11 mutant upmd-1"}, {"type": "RNA"}, {"source_name_ch1": "tissue culture cell line"}, {"characteristics_ch1": "genotype: GNA11 mutant"}]}, {"GSM2460239": [{"title": "Nras mutant sk-mel-2"}, {"type": "RNA"}, {"source_name_ch1": "tissue culture cell line"}, {"characteristics_ch1": "genotype: Nras mutant"}]}, {"GSM2460240": [{"title": "Nras mutant mm415"}, {"type": "RNA"}, {"source_name_ch1": "tissue culture cell line"}, {"characteristics_ch1": "genotype: Nras mutant"}]}, {"GSM2460241": [{"title": "Nras mutant mm485"}, {"type": "RNA"}, {"source_name_ch1": "tissue culture cell line"}, {"characteristics_ch1": "genotype: Nras mutant"}]}, {"GSM2460242": [{"title": "Braf mutant mum2c"}, {"type": "RNA"}, {"source_name_ch1": "tissue culture cell line"}, {"characteristics_ch1": "genotype: Braf mutant"}]}, {"GSM2460243": [{"title": "Braf mutant sk-mel-5"}, {"type": "RNA"}, {"source_name_ch1": "tissue culture cell line"}, {"characteristics_ch1": "genotype: Braf mutant"}]}, {"GSM2683175": [{"title": "Study patient 37"}, {"type": "RNA"}, {"source_name_ch1": "CD*+ T cell-enriched peripheral blood mononuclear cells, TOL"}, {"characteristics_ch1": "cell type: CD8+ T cell-enriched peripheral blood mononuclear cells;\tsulfonamide antibiotics sensitivity: Tolerant (TOL)"}]}, {"GSM2683176": [{"title": "Study patient 45"}, {"type": "RNA"}, {"source_name_ch1": "CD*+ T cell-enriched peripheral blood mononuclear cells, TOL"}, {"characteristics_ch1": "cell type: CD8+ T cell-enriched peripheral blood mononuclear cells;\tsulfonamide antibiotics sensitivity: Tolerant (TOL)"}]}, {"GSM2683177": [{"title": "Study patient 51"}, {"type": "RNA"}, {"source_name_ch1": "CD*+ T cell-enriched peripheral blood mononuclear cells, TOL"}, {"characteristics_ch1": "cell type: CD8+ T cell-enriched peripheral blood mononuclear cells;\tsulfonamide antibiotics sensitivity: Tolerant (TOL)"}]}, {"GSM2683178": [{"title": "Study patient 113"}, {"type": "RNA"}, {"source_name_ch1": "CD*+ T cell-enriched peripheral blood mononuclear cells, TOL"}, {"characteristics_ch1": "cell type: CD8+ T cell-enriched peripheral blood mononuclear cells;\tsulfonamide antibiotics sensitivity: Tolerant (TOL)"}]}, {"GSM2683179": [{"title": "Study patient 120"}, {"type": "RNA"}, {"source_name_ch1": "CD*+ T cell-enriched peripheral blood mononuclear cells, HS"}, {"characteristics_ch1": "cell type: CD8+ T cell-enriched peripheral blood mononuclear cells;\tsulfonamide antibiotics sensitivity: Hypersensitive (HS)"}]}, {"GSM2683180": [{"title": "Study patient 130"}, {"type": "RNA"}, {"source_name_ch1": "CD*+ T cell-enriched peripheral blood mononuclear cells, HS"}, {"characteristics_ch1": "cell type: CD8+ T cell-enriched peripheral blood mononuclear cells;\tsulfonamide antibiotics sensitivity: Hypersensitive (HS)"}]}, {"GSM2683181": [{"title": "Study patient 216"}, {"type": "RNA"}, {"source_name_ch1": "CD*+ T cell-enriched peripheral blood mononuclear cells, HS"}, {"characteristics_ch1": "cell type: CD8+ T cell-enriched peripheral blood mononuclear cells;\tsulfonamide antibiotics sensitivity: Hypersensitive (HS)"}]}, {"GSM2683182": [{"title": "Study patient 219"}, {"type": "RNA"}, {"source_name_ch1": "CD*+ T cell-enriched peripheral blood mononuclear cells, TOL"}, {"characteristics_ch1": "cell type: CD8+ T cell-enriched peripheral blood mononuclear cells;\tsulfonamide antibiotics sensitivity: Tolerant (TOL)"}]}, {"GSM2683183": [{"title": "Study patient 221"}, {"type": "RNA"}, {"source_name_ch1": "CD*+ T cell-enriched peripheral blood mononuclear cells, TOL"}, {"characteristics_ch1": "cell type: CD8+ T cell-enriched peripheral blood mononuclear cells;\tsulfonamide antibiotics sensitivity: Tolerant (TOL)"}]}, {"GSM2683184": [{"title": "Study patient 226"}, {"type": "RNA"}, {"source_name_ch1": "CD*+ T cell-enriched peripheral blood mononuclear cells, HS"}, {"characteristics_ch1": "cell type: CD8+ T cell-enriched peripheral blood mononuclear cells;\tsulfonamide antibiotics sensitivity: Hypersensitive (HS)"}]}, {"GSM2683185": [{"title": "Study patient 232"}, {"type": "RNA"}, {"source_name_ch1": "CD*+ T cell-enriched peripheral blood mononuclear cells, HS"}, {"characteristics_ch1": "cell type: CD8+ T cell-enriched peripheral blood mononuclear cells;\tsulfonamide antibiotics sensitivity: Hypersensitive (HS)"}]}, {"GSM2683186": [{"title": "Study patient 246"}, {"type": "RNA"}, {"source_name_ch1": "CD*+ T cell-enriched peripheral blood mononuclear cells, HS"}, {"characteristics_ch1": "cell type: CD8+ T cell-enriched peripheral blood mononuclear cells;\tsulfonamide antibiotics sensitivity: Hypersensitive (HS)"}]}, {"GSM2683187": [{"title": "Study patient 294"}, {"type": "RNA"}, {"source_name_ch1": "CD*+ T cell-enriched peripheral blood mononuclear cells, HS"}, {"characteristics_ch1": "cell type: CD8+ T cell-enriched peripheral blood mononuclear cells;\tsulfonamide antibiotics sensitivity: Hypersensitive (HS)"}]}, {"GSM2683188": [{"title": "Study patient 300"}, {"type": "RNA"}, {"source_name_ch1": "CD*+ T cell-enriched peripheral blood mononuclear cells, HS"}, {"characteristics_ch1": "cell type: CD8+ T cell-enriched peripheral blood mononuclear cells;\tsulfonamide antibiotics sensitivity: Hypersensitive (HS)"}]}, {"GSM2683189": [{"title": "Study patient B"}, {"type": "RNA"}, {"source_name_ch1": "CD*+ T cell-enriched peripheral blood mononuclear cells, HS"}, {"characteristics_ch1": "cell type: CD8+ T cell-enriched peripheral blood mononuclear cells;\tsulfonamide antibiotics sensitivity: Hypersensitive (HS)"}]}, {"GSM2683190": [{"title": "Study patient C"}, {"type": "RNA"}, {"source_name_ch1": "CD*+ T cell-enriched peripheral blood mononuclear cells, TOL"}, {"characteristics_ch1": "cell type: CD8+ T cell-enriched peripheral blood mononuclear cells;\tsulfonamide antibiotics sensitivity: Tolerant (TOL)"}]}, {"GSM2683191": [{"title": "Study patient F"}, {"type": "RNA"}, {"source_name_ch1": "CD*+ T cell-enriched peripheral blood mononuclear cells, HS"}, {"characteristics_ch1": "cell type: CD8+ T cell-enriched peripheral blood mononuclear cells;\tsulfonamide antibiotics sensitivity: Hypersensitive (HS)"}]}, {"GSM2683192": [{"title": "Study patient G"}, {"type": "RNA"}, {"source_name_ch1": "CD*+ T cell-enriched peripheral blood mononuclear cells, TOL"}, {"characteristics_ch1": "cell type: CD8+ T cell-enriched peripheral blood mononuclear cells;\tsulfonamide antibiotics sensitivity: Tolerant (TOL)"}]}, {"GSM2683193": [{"title": "Study patient H"}, {"type": "RNA"}, {"source_name_ch1": "CD*+ T cell-enriched peripheral blood mononuclear cells, TOL"}, {"characteristics_ch1": "cell type: CD8+ T cell-enriched peripheral blood mononuclear cells;\tsulfonamide antibiotics sensitivity: Tolerant (TOL)"}]}, {"GSM2683194": [{"title": "Study patient J"}, {"type": "RNA"}, {"source_name_ch1": "CD*+ T cell-enriched peripheral blood mononuclear cells, TOL"}, {"characteristics_ch1": "cell type: CD8+ T cell-enriched peripheral blood mononuclear cells;\tsulfonamide antibiotics sensitivity: Tolerant (TOL)"}]}, {"GSM2686007": [{"title": "HBEC3_p53_KRAS_SnailOE_high_mobility"}, {"type": "RNA"}, {"source_name_ch1": "HBEC3 p53 KRAS SNAIL OE, high mobility subpopulation"}, {"characteristics_ch1": "cell type: Human bronchial epithelial cells immortalized with hTERT and hCDK4;\tcell mobility: high mobility subpopulation;\tpatient age: 65;\tpatient gender: Female;\tpatient smoking status: Smoker;\tpatient diagnosis: No lung cancer as cells isolated from large airway;\tp53-shrna,kras v12: yes;\tsnail oe: yes"}]}, {"GSM2686008": [{"title": "HBEC3_p53_KRAS_SnailOE_unselected"}, {"type": "RNA"}, {"source_name_ch1": "HBEC3 p53 KRAS SNAIL OE, unselected population"}, {"characteristics_ch1": "cell type: Human bronchial epithelial cells immortalized with hTERT and hCDK4;\tcell mobility: unselected population;\tpatient age: 65;\tpatient gender: Female;\tpatient smoking status: Smoker;\tpatient diagnosis: No lung cancer as cells isolated from large airway;\tp53-shrna,kras v12: yes;\tsnail oe: yes"}]}, {"GSM2686009": [{"title": "HBEC3_p53_KRAS_high_mobility"}, {"type": "RNA"}, {"source_name_ch1": "HBEC3 p53 KRAS, high mobility subpopulation"}, {"characteristics_ch1": "cell type: Human bronchial epithelial cells immortalized with hTERT and hCDK4;\tcell mobility: high mobility subpopulation;\tpatient age: 65;\tpatient gender: Female;\tpatient smoking status: Smoker;\tpatient diagnosis: No lung cancer as cells isolated from large airway;\tp53-shrna,kras v12: yes;\tsnail oe: no"}]}, {"GSM2686010": [{"title": "HBEC3_p53_KRAS_unselected"}, {"type": "RNA"}, {"source_name_ch1": "HBEC3 p53 KRAS, unselected population"}, {"characteristics_ch1": "cell type: Human bronchial epithelial cells immortalized with hTERT and hCDK4;\tcell mobility: unselected population;\tpatient age: 65;\tpatient gender: Female;\tpatient smoking status: Smoker;\tpatient diagnosis: No lung cancer as cells isolated from large airway;\tp53-shrna,kras v12: yes;\tsnail oe: no"}]}, {"GSM2686011": [{"title": "HBEC3_SnailOE_high_mobility"}, {"type": "RNA"}, {"source_name_ch1": "HBEC3 SNAIL OE, high mobility subpopulation"}, {"characteristics_ch1": "cell type: Human bronchial epithelial cells immortalized with hTERT and hCDK4;\tcell mobility: high mobility subpopulation;\tpatient age: 65;\tpatient gender: Female;\tpatient smoking status: Smoker;\tpatient diagnosis: No lung cancer as cells isolated from large airway;\tp53-shrna,kras v12: no;\tsnail oe: yes"}]}, {"GSM2686012": [{"title": "HBEC3_SnailOE_unselected"}, {"type": "RNA"}, {"source_name_ch1": "HBEC3 SNAIL OE, unselected population"}, {"characteristics_ch1": "cell type: Human bronchial epithelial cells immortalized with hTERT and hCDK4;\tcell mobility: unselected population;\tpatient age: 65;\tpatient gender: Female;\tpatient smoking status: Smoker;\tpatient diagnosis: No lung cancer as cells isolated from large airway;\tp53-shrna,kras v12: no;\tsnail oe: yes"}]}, {"GSM2686013": [{"title": "HBEC3_high_mobility"}, {"type": "RNA"}, {"source_name_ch1": "HBEC3, high mobility subpopulation"}, {"characteristics_ch1": "cell type: Human bronchial epithelial cells immortalized with hTERT and hCDK4;\tcell mobility: high mobility subpopulation;\tpatient age: 65;\tpatient gender: Female;\tpatient smoking status: Smoker;\tpatient diagnosis: No lung cancer as cells isolated from large airway;\tp53-shrna,kras v12: no;\tsnail oe: no"}]}, {"GSM2686014": [{"title": "HBEC3_unselected"}, {"type": "RNA"}, {"source_name_ch1": "HBEC3, unselected population"}, {"characteristics_ch1": "cell type: Human bronchial epithelial cells immortalized with hTERT and hCDK4;\tcell mobility: unselected population;\tpatient age: 65;\tpatient gender: Female;\tpatient smoking status: Smoker;\tpatient diagnosis: No lung cancer as cells isolated from large airway;\tp53-shrna,kras v12: no;\tsnail oe: no"}]}, {"GSM2686015": [{"title": "HBEC4_SnailOE_high_mobility"}, {"type": "RNA"}, {"source_name_ch1": "HBEC4 SNAIL OE, high mobility subpopulation"}, {"characteristics_ch1": "cell type: Human bronchial epithelial cells immortalized with hTERT and hCDK4;\tcell mobility: high mobility subpopulation;\tpatient age: 71;\tpatient gender: Female;\tpatient smoking status: Smoker;\tpatient diagnosis: With lung cancer as cells isolated from large airway;\tp53-shrna,kras v12: no;\tsnail oe: yes"}]}, {"GSM2686016": [{"title": "HBEC4_SnailOE_unselected"}, {"type": "RNA"}, {"source_name_ch1": "HBEC4 SNAIL OE, unselected population"}, {"characteristics_ch1": "cell type: Human bronchial epithelial cells immortalized with hTERT and hCDK4;\tcell mobility: unselected population;\tpatient age: 71;\tpatient gender: Female;\tpatient smoking status: Smoker;\tpatient diagnosis: With lung cancer as cells isolated from large airway;\tp53-shrna,kras v12: no;\tsnail oe: yes"}]}, {"GSM2686017": [{"title": "HBEC4_high_mobility"}, {"type": "RNA"}, {"source_name_ch1": "HBEC4, high mobility subpopulation"}, {"characteristics_ch1": "cell type: Human bronchial epithelial cells immortalized with hTERT and hCDK4;\tcell mobility: high mobility subpopulation;\tpatient age: 71;\tpatient gender: Female;\tpatient smoking status: Smoker;\tpatient diagnosis: With lung cancer as cells isolated from large airway;\tp53-shrna,kras v12: no;\tsnail oe: no"}]}, {"GSM2686018": [{"title": "HBEC4_unselected"}, {"type": "RNA"}, {"source_name_ch1": "HBEC4, unselected population"}, {"characteristics_ch1": "cell type: Human bronchial epithelial cells immortalized with hTERT and hCDK4;\tcell mobility: unselected population;\tpatient age: 71;\tpatient gender: Female;\tpatient smoking status: Smoker;\tpatient diagnosis: With lung cancer as cells isolated from large airway;\tp53-shrna,kras v12: no;\tsnail oe: no"}]}, {"GSM2549989": [{"title": "colorectal cancer cell line, CaCo2"}, {"type": "RNA"}, {"source_name_ch1": "ATCC(Supplier ID HTB-37)"}, {"characteristics_ch1": "cell line: CaCo2;\tsample type: colorectal cancer cell line"}]}, {"GSM2549990": [{"title": "colorectal cancer cell line, CL-11"}, {"type": "RNA"}, {"source_name_ch1": "DSMZ(Supplier ID ACC 467)"}, {"characteristics_ch1": "cell line: CL-11;\tsample type: colorectal cancer cell line"}]}, {"GSM2549991": [{"title": "colorectal cancer cell line, CL-34"}, {"type": "RNA"}, {"source_name_ch1": "DSMZ(Supplier ID ACC 520)"}, {"characteristics_ch1": "cell line: CL-34;\tsample type: colorectal cancer cell line"}]}, {"GSM2549992": [{"title": "colorectal cancer cell line, CL-40"}, {"type": "RNA"}, {"source_name_ch1": "DSMZ(Supplier ID ACC 535)"}, {"characteristics_ch1": "cell line: CL-40;\tsample type: colorectal cancer cell line"}]}, {"GSM2549993": [{"title": "colorectal cancer cell line, Co115"}, {"type": "RNA"}, {"source_name_ch1": "Received from INSERM, R. Hamelin, Paris"}, {"characteristics_ch1": "cell line: Co115;\tsample type: colorectal cancer cell line"}]}, {"GSM2549994": [{"title": "colorectal cancer cell line, Colo205"}, {"type": "RNA"}, {"source_name_ch1": "ATCC(Supplier ID CCL-222)"}, {"characteristics_ch1": "cell line: Colo205;\tsample type: colorectal cancer cell line"}]}, {"GSM2549995": [{"title": "colorectal cancer cell line, Colo320"}, {"type": "RNA"}, {"source_name_ch1": "DSMZ(Supplier ID ACC 144)"}, {"characteristics_ch1": "cell line: Colo320;\tsample type: colorectal cancer cell line"}]}, {"GSM2549996": [{"title": "colorectal cancer cell line, Colo678"}, {"type": "RNA"}, {"source_name_ch1": "DSMZ(Supplier ID ACC 194)"}, {"characteristics_ch1": "cell line: Colo678;\tsample type: colorectal cancer cell line"}]}, {"GSM2549997": [{"title": "colorectal cancer cell line, DLD-1"}, {"type": "RNA"}, {"source_name_ch1": "ATCC(Supplier ID CCL-221)"}, {"characteristics_ch1": "cell line: DLD-1;\tsample type: colorectal cancer cell line"}]}, {"GSM2549998": [{"title": "colorectal cancer cell line, EB"}, {"type": "RNA"}, {"source_name_ch1": "Received from INSERM, R. Hamelin, Paris"}, {"characteristics_ch1": "cell line: EB;\tsample type: colorectal cancer cell line"}]}, {"GSM2549999": [{"title": "colorectal cancer cell line, FRI"}, {"type": "RNA"}, {"source_name_ch1": "Received from INSERM, R. Hamelin, Paris"}, {"characteristics_ch1": "cell line: FRI;\tsample type: colorectal cancer cell line"}]}, {"GSM2550000": [{"title": "colorectal cancer cell line, HCC2998"}, {"type": "RNA"}, {"source_name_ch1": "NCI60(Supplier ID )"}, {"characteristics_ch1": "cell line: HCC2998;\tsample type: colorectal cancer cell line"}]}, {"GSM2550001": [{"title": "colorectal cancer cell line, HCT116"}, {"type": "RNA"}, {"source_name_ch1": "ATCC(Supplier ID CCL-247)"}, {"characteristics_ch1": "cell line: HCT116;\tsample type: colorectal cancer cell line"}]}, {"GSM2550002": [{"title": "colorectal cancer cell line, HCT15"}, {"type": "RNA"}, {"source_name_ch1": "ATCC(Supplier ID CCL-225)"}, {"characteristics_ch1": "cell line: HCT15;\tsample type: colorectal cancer cell line"}]}, {"GSM2550003": [{"title": "colorectal cancer cell line, HT29"}, {"type": "RNA"}, {"source_name_ch1": "ATCC(Supplier ID HTB-38)"}, {"characteristics_ch1": "cell line: HT29;\tsample type: colorectal cancer cell line"}]}, {"GSM2550004": [{"title": "colorectal cancer cell line, IS1"}, {"type": "RNA"}, {"source_name_ch1": "Received from INSERM, R. Hamelin, Paris"}, {"characteristics_ch1": "cell line: IS1;\tsample type: colorectal cancer cell line"}]}, {"GSM2550005": [{"title": "colorectal cancer cell line, IS3"}, {"type": "RNA"}, {"source_name_ch1": "Received from INSERM, R. Hamelin, Paris"}, {"characteristics_ch1": "cell line: IS3;\tsample type: colorectal cancer cell line"}]}, {"GSM2550006": [{"title": "colorectal cancer cell line, KM12"}, {"type": "RNA"}, {"source_name_ch1": "NCI60(Supplier ID )"}, {"characteristics_ch1": "cell line: KM12;\tsample type: colorectal cancer cell line"}]}, {"GSM2550007": [{"title": "colorectal cancer cell line, LoVo"}, {"type": "RNA"}, {"source_name_ch1": "ATCC(Supplier ID CCL-229)"}, {"characteristics_ch1": "cell line: LoVo;\tsample type: colorectal cancer cell line"}]}, {"GSM2550008": [{"title": "colorectal cancer cell line, LS1034"}, {"type": "RNA"}, {"source_name_ch1": "ATCC(Supplier ID CRL-2158)"}, {"characteristics_ch1": "cell line: LS1034;\tsample type: colorectal cancer cell line"}]}, {"GSM2550009": [{"title": "colorectal cancer cell line, LS174T"}, {"type": "RNA"}, {"source_name_ch1": "ATCC(Supplier ID CL-188)"}, {"characteristics_ch1": "cell line: LS174T;\tsample type: colorectal cancer cell line"}]}, {"GSM2550010": [{"title": "colorectal cancer cell line, NCI-H508"}, {"type": "RNA"}, {"source_name_ch1": "ATCC(Supplier ID CCL-253)"}, {"characteristics_ch1": "cell line: NCI-H508;\tsample type: colorectal cancer cell line"}]}, {"GSM2550011": [{"title": "colorectal cancer cell line, RKO"}, {"type": "RNA"}, {"source_name_ch1": "ATCC(Supplier ID CRL-2577)"}, {"characteristics_ch1": "cell line: RKO;\tsample type: colorectal cancer cell line"}]}, {"GSM2550012": [{"title": "colorectal cancer cell line, SW1116"}, {"type": "RNA"}, {"source_name_ch1": "ECACC(Supplier ID 87071006)"}, {"characteristics_ch1": "cell line: SW1116;\tsample type: colorectal cancer cell line"}]}, {"GSM2550013": [{"title": "colorectal cancer cell line, SW1463"}, {"type": "RNA"}, {"source_name_ch1": "ATCC(Supplier ID CCL-234)"}, {"characteristics_ch1": "cell line: SW1463;\tsample type: colorectal cancer cell line"}]}, {"GSM2550014": [{"title": "colorectal cancer cell line, SW403"}, {"type": "RNA"}, {"source_name_ch1": "ECACC(Supplier ID 87071008)"}, {"characteristics_ch1": "cell line: SW403;\tsample type: colorectal cancer cell line"}]}, {"GSM2550015": [{"title": "colorectal cancer cell line, SW48"}, {"type": "RNA"}, {"source_name_ch1": "ATCC(Supplier ID CCL-231)"}, {"characteristics_ch1": "cell line: SW48;\tsample type: colorectal cancer cell line"}]}, {"GSM2550016": [{"title": "colorectal cancer cell line, SW480"}, {"type": "RNA"}, {"source_name_ch1": "ECACC(Supplier ID 87092801)"}, {"characteristics_ch1": "cell line: SW480;\tsample type: colorectal cancer cell line"}]}, {"GSM2550017": [{"title": "colorectal cancer cell line, SW620"}, {"type": "RNA"}, {"source_name_ch1": "ECACC(Supplier ID 87051203)"}, {"characteristics_ch1": "cell line: SW620;\tsample type: colorectal cancer cell line"}]}, {"GSM2550018": [{"title": "colorectal cancer cell line, SW837"}, {"type": "RNA"}, {"source_name_ch1": "ATCC(Supplier ID CCL-235)"}, {"characteristics_ch1": "cell line: SW837;\tsample type: colorectal cancer cell line"}]}, {"GSM2550019": [{"title": "colorectal cancer cell line, SW948"}, {"type": "RNA"}, {"source_name_ch1": "ECACC(Supplier ID 91030714)"}, {"characteristics_ch1": "cell line: SW948;\tsample type: colorectal cancer cell line"}]}, {"GSM2550020": [{"title": "colorectal cancer cell line, TC71"}, {"type": "RNA"}, {"source_name_ch1": "Received from INSERM, R. Hamelin, Paris"}, {"characteristics_ch1": "cell line: TC71;\tsample type: colorectal cancer cell line"}]}, {"GSM2550021": [{"title": "colorectal cancer cell line, V9P"}, {"type": "RNA"}, {"source_name_ch1": "Received from INSERM, R. Hamelin, Paris"}, {"characteristics_ch1": "cell line: V9P;\tsample type: colorectal cancer cell line"}]}, {"GSM2550022": [{"title": "colorectal cancer cell line, WiDr"}, {"type": "RNA"}, {"source_name_ch1": "ATCC(Supplier ID CCL-218)"}, {"characteristics_ch1": "cell line: WiDr;\tsample type: colorectal cancer cell line"}]}, {"GSM2311226": [{"title": "siMatrin3_gene1"}, {"type": "RNA"}, {"source_name_ch1": "SH-SY5Y, Matrin3-siRNA replicate1,Gene level"}, {"characteristics_ch1": "cell line: SH-SY5Y;\ttreatment: Matrin3 siRNA"}]}, {"GSM2311227": [{"title": "siControl_gene1"}, {"type": "RNA"}, {"source_name_ch1": "SH-SY5Y, NC-siRNA replicate1,Gene level"}, {"characteristics_ch1": "cell line: SH-SY5Y;\ttreatment: Negative control siRNA"}]}, {"GSM2311228": [{"title": "siMatrin3_gene2"}, {"type": "RNA"}, {"source_name_ch1": "SH-SY5Y, Matrin3-siRNA replicate2,Gene level"}, {"characteristics_ch1": "cell line: SH-SY5Y;\ttreatment: Matrin3 siRNA"}]}, {"GSM2311229": [{"title": "siControl_gene2"}, {"type": "RNA"}, {"source_name_ch1": "SH-SY5Y, NC-siRNA replicate2,Gene level"}, {"characteristics_ch1": "cell line: SH-SY5Y;\ttreatment: Negative control siRNA"}]}, {"GSM2311230": [{"title": "siMatrin3_gene3"}, {"type": "RNA"}, {"source_name_ch1": "SH-SY5Y, Matrin3-siRNA replicate3,Gene level"}, {"characteristics_ch1": "cell line: SH-SY5Y;\ttreatment: Matrin3 siRNA"}]}, {"GSM2311231": [{"title": "siControl_gene3"}, {"type": "RNA"}, {"source_name_ch1": "SH-SY5Y, NC-siRNA replicate3,Gene level"}, {"characteristics_ch1": "cell line: SH-SY5Y;\ttreatment: Negative control siRNA"}]}, {"GSM2702982": [{"title": "sorted human ILCreg cells"}, {"type": "RNA"}, {"source_name_ch1": "human normal intestinal tissues from resected small intestines"}, {"characteristics_ch1": "tissue: normal intestinal tissues from resected small intestines;\tcell type: ILCreg cell"}]}, {"GSM2642924": [{"title": "OCIMY5/NS"}, {"type": "RNA"}, {"source_name_ch1": "patient-derived multiple myeloma cell line"}, {"characteristics_ch1": "cell line: OCIMY5;\tcell type: multiple myeloma cell line;\tgrna: non-specific"}]}, {"GSM2642925": [{"title": "OCIMY5/FAM46C gRNA #1"}, {"type": "RNA"}, {"source_name_ch1": "patient-derived multiple myeloma cell line"}, {"characteristics_ch1": "cell line: OCIMY5;\tcell type: multiple myeloma cell line;\tgrna: FAM46C #1"}]}, {"GSM2642926": [{"title": "OCIMY5/FAM46C gRNA #6"}, {"type": "RNA"}, {"source_name_ch1": "patient-derived multiple myeloma cell line"}, {"characteristics_ch1": "cell line: OCIMY5;\tcell type: multiple myeloma cell line;\tgrna: FAM46C #6"}]}, {"GSM2716205": [{"title": "MCF7 cells not treated with TGF-\u03b2, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "MCF7 cells not treated with TGF-\u03b2 for 4 days"}, {"characteristics_ch1": "cell type: Breast cancer cell line"}]}, {"GSM2716206": [{"title": "MCF7 cells not treated with TGF-\u03b2, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "MCF7 cells not treated with TGF-\u03b2 for 4 days"}, {"characteristics_ch1": "cell type: Breast cancer cell line"}]}, {"GSM2716207": [{"title": "MCF7 cells not treated with TGF-\u03b2, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "MCF7 cells not treated with TGF-\u03b2 for 4 days"}, {"characteristics_ch1": "cell type: Breast cancer cell line"}]}, {"GSM2716208": [{"title": "MCF7 cells treated with TGF-\u03b2, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "MCF7 cells treated with TGF-\u03b2 for 4 days"}, {"characteristics_ch1": "cell type: Breast cancer cell line"}]}, {"GSM2716209": [{"title": "MCF7 cells treated with TGF-\u03b2, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "MCF7 cells treated with TGF-\u03b2 for 4 days"}, {"characteristics_ch1": "cell type: Breast cancer cell line"}]}, {"GSM2716210": [{"title": "MCF7 cells treated with TGF-\u03b2, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "MCF7 cells treated with TGF-\u03b2 for 4 days"}, {"characteristics_ch1": "cell type: Breast cancer cell line"}]}, {"GSM2677728": [{"title": "OC-mRNA-1"}, {"type": "RNA"}, {"source_name_ch1": "LCM-derived cells from snap-frozen tissues of cancer epithelium"}, {"characteristics_ch1": "cell type: LCM-derived;\ttissue: Ovarian Cancer Epithelium;\tStage: III c;\tgrade: 2/3;\tage: 71"}]}, {"GSM2677729": [{"title": "OC-mRNA-2"}, {"type": "RNA"}, {"source_name_ch1": "LCM-derived cells from snap-frozen tissues of cancer epithelium"}, {"characteristics_ch1": "cell type: LCM-derived;\ttissue: Ovarian Cancer Epithelium;\tStage: III c;\tgrade: 2/3;\tage: 71"}]}, {"GSM2677730": [{"title": "OC-mRNA-3"}, {"type": "RNA"}, {"source_name_ch1": "LCM-derived cells from snap-frozen tissues of cancer epithelium"}, {"characteristics_ch1": "cell type: LCM-derived;\ttissue: Ovarian Cancer Epithelium;\tStage: III c;\tgrade: 2/3;\tage: 71"}]}, {"GSM2677731": [{"title": "OM-mRNA-1"}, {"type": "RNA"}, {"source_name_ch1": "LCM-derived cells from snap-frozen tissues of cancer epithelium"}, {"characteristics_ch1": "cell type: LCM-derived;\ttissue: Metastatic ovarian cancer to omentum;\tStage: III c;\tgrade: 2/3;\tage: 71"}]}, {"GSM2677732": [{"title": "OM-mRNA-2"}, {"type": "RNA"}, {"source_name_ch1": "LCM-derived cells from snap-frozen tissues of cancer epithelium"}, {"characteristics_ch1": "cell type: LCM-derived;\ttissue: Metastatic ovarian cancer to omentum;\tStage: III c;\tgrade: 2/3;\tage: 71"}]}, {"GSM2677733": [{"title": "OM-mRNA-3"}, {"type": "RNA"}, {"source_name_ch1": "LCM-derived cells from snap-frozen tissues of cancer epithelium"}, {"characteristics_ch1": "cell type: LCM-derived;\ttissue: Metastatic ovarian cancer to omentum;\tStage: III c;\tgrade: 2/3;\tage: 71"}]}, {"GSM2723637": [{"title": "Human_normal_P1"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 37;\trace: black;\tbmi: 39.93"}]}, {"GSM2723638": [{"title": "Human_normal_P2"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 31;\trace: black;\tbmi: 33.45"}]}, {"GSM2723639": [{"title": "Human_normal_P4"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 30;\trace: black;\tbmi: 31.01"}]}, {"GSM2723640": [{"title": "Human_normal_P5"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 55;\trace: white;\tbmi: 27.25"}]}, {"GSM2723641": [{"title": "Human_normal_P6"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 41;\trace: white;\tbmi: 26.14"}]}, {"GSM2723642": [{"title": "Human_normal_P7"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 18;\trace: white;\tbmi: 26.52"}]}, {"GSM2723643": [{"title": "Human_normal_P8"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 31;\trace: black;\tbmi: 28.66"}]}, {"GSM2723644": [{"title": "Human_normal_P9"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 33;\trace: white;\tbmi: 31.00"}]}, {"GSM2723645": [{"title": "Human_normal_P10"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 36;\trace: black;\tbmi: 35.02"}]}, {"GSM2723646": [{"title": "Human_normal_P11"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 26;\trace: white;\tbmi: 30.89"}]}, {"GSM2723647": [{"title": "Human_normal_P12"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 53;\trace: white;\tbmi: 26.79"}]}, {"GSM2723648": [{"title": "Human_normal_P15"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 40;\trace: white;\tbmi: 24.80"}]}, {"GSM2723649": [{"title": "Human_normal_P16"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 48;\trace: white;\tbmi: 21.45"}]}, {"GSM2723650": [{"title": "Human_normal_P17"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 29;\trace: black;\tbmi: 30.66"}]}, {"GSM2723651": [{"title": "Human_normal_P18"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 30;\trace: black;\tbmi: 34.21"}]}, {"GSM2723652": [{"title": "Human_normal_P19"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 37;\trace: black;\tbmi: 37.76"}]}, {"GSM2723653": [{"title": "Human_normal_P20"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 55;\trace: white;\tbmi: 25.82"}]}, {"GSM2723654": [{"title": "Human_normal_P21"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 42;\trace: black;\tbmi: 31.61"}]}, {"GSM2723655": [{"title": "Human_normal_P24"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 19;\trace: white;\tbmi: 39.85"}]}, {"GSM2723656": [{"title": "Human_normal_P25"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 46;\trace: white;\tbmi: 28.90"}]}, {"GSM2723657": [{"title": "Human_normal_P26"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 51;\trace: white;\tbmi: 29.70"}]}, {"GSM2723658": [{"title": "Human_normal_P27"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 36;\trace: white;\tbmi: 28.91"}]}, {"GSM2723659": [{"title": "Human_normal_P28"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 35;\trace: white;\tbmi: 25.51"}]}, {"GSM2723660": [{"title": "Human_normal_P30"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 27;\trace: white;\tbmi: 42.76"}]}, {"GSM2723661": [{"title": "Human_normal_P31"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 31;\trace: black;\tbmi: 35.42"}]}, {"GSM2723662": [{"title": "Human_normal_P33"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 55;\trace: white;\tbmi: 21.08"}]}, {"GSM2723663": [{"title": "Human_normal_P34"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 35;\trace: black;\tbmi: 33.28"}]}, {"GSM2723664": [{"title": "Human_normal_P35"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 42;\trace: white;\tbmi: 23.17"}]}, {"GSM2723665": [{"title": "Human_normal_P36"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 45;\trace: black;\tbmi: 24.80"}]}, {"GSM2723666": [{"title": "Human_normal_P37"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 35;\trace: black;\tbmi: 31.01"}]}, {"GSM2723667": [{"title": "Human_normal_P39"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 48;\trace: white;\tbmi: 28.34"}]}, {"GSM2723668": [{"title": "Human_normal_P40"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 53;\trace: white;\tbmi: 25.40"}]}, {"GSM2723669": [{"title": "Human_normal_P41"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 23;\trace: white;\tbmi: 24.20"}]}, {"GSM2723670": [{"title": "Human_normal_P42"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 25;\trace: white;\tbmi: 36.02"}]}, {"GSM2723671": [{"title": "Human_normal_P43"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 27;\trace: black;\tbmi: 25.69"}]}, {"GSM2723672": [{"title": "Human_normal_P44"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 29;\trace: white;\tbmi: 29.95"}]}, {"GSM2723673": [{"title": "Human_normal_P45"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 44;\trace: white;\tbmi: 23.99"}]}, {"GSM2723674": [{"title": "Human_normal_P46"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 25;\trace: black;\tbmi: 33.45"}]}, {"GSM2723675": [{"title": "Human_normal_P49"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 48;\trace: white;\tbmi: 31.31"}]}, {"GSM2723676": [{"title": "Human_normal_P50"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 33;\trace: white;\tbmi: 38.26"}]}, {"GSM2723677": [{"title": "Human_normal_P51"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 51;\trace: white;\tbmi: 23.69"}]}, {"GSM2723678": [{"title": "Human_normal_P52"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 37;\trace: white;\tbmi: 20.59"}]}, {"GSM2723679": [{"title": "Human_normal_P55"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 28;\trace: black;\tbmi: 39.30"}]}, {"GSM2723680": [{"title": "Human_normal_P56"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 54;\trace: white;\tbmi: 28.90"}]}, {"GSM2723681": [{"title": "Human_normal_P57"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 43;\trace: white;\tbmi: 25.74"}]}, {"GSM2723682": [{"title": "Human_normal_P58"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 58;\trace: white;\tbmi: 29.45"}]}, {"GSM2723683": [{"title": "Human_normal_P59"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 20;\trace: white;\tbmi: 23.69"}]}, {"GSM2723684": [{"title": "Human_normal_P60"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 39;\trace: white;\tbmi: 21.77"}]}, {"GSM2723685": [{"title": "Human_normal_P61"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 41;\trace: white;\tbmi: 28.89"}]}, {"GSM2723686": [{"title": "Human_normal_P62"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 24;\trace: white;\tbmi: 22.96"}]}, {"GSM2723687": [{"title": "Human_normal_P65"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 62;\trace: white;\tbmi: 30.23"}]}, {"GSM2723688": [{"title": "Human_normal_P66"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 33;\trace: white;\tbmi: 21.25"}]}, {"GSM2723689": [{"title": "Human_normal_P67"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 56;\trace: white;\tbmi: 23.43"}]}, {"GSM2723690": [{"title": "Human_normal_P68"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 22;\trace: white;\tbmi: 29.05"}]}, {"GSM2723691": [{"title": "Human_normal_P69"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 50;\trace: white;\tbmi: 27.44"}]}, {"GSM2723692": [{"title": "Human_normal_P70"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 48;\trace: black;\tbmi: 25.74"}]}, {"GSM2723693": [{"title": "Human_normal_P71"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 38;\trace: white;\tbmi: 45.48"}]}, {"GSM2723694": [{"title": "Human_normal_P72"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 55;\trace: black;\tbmi: 31.74"}]}, {"GSM2723695": [{"title": "Human_normal_P73"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 19;\trace: white;\tbmi: 24.69"}]}, {"GSM2723696": [{"title": "Human_normal_P74"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 54;\trace: white;\tbmi: 25.29"}]}, {"GSM2723697": [{"title": "Human_normal_P76"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 36;\trace: black;\tbmi: 29.05"}]}, {"GSM2723698": [{"title": "Human_normal_P78"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 39;\trace: white;\tbmi: 23.08"}]}, {"GSM2723699": [{"title": "Human_normal_P81"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 56;\trace: white;\tbmi: 44.12"}]}, {"GSM2723700": [{"title": "Human_normal_P82"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 60;\trace: white;\tbmi: 27.29"}]}, {"GSM2723701": [{"title": "Human_normal_P83"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 41;\trace: white;\tbmi: 22.96"}]}, {"GSM2723702": [{"title": "Human_normal_P85"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 48;\trace: black;\tbmi: 34.33"}]}, {"GSM2723703": [{"title": "Human_normal_P87"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 40;\trace: white;\tbmi: 41.60"}]}, {"GSM2723704": [{"title": "Human_normal_P88"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 23;\trace: other;\tbmi: 21.25"}]}, {"GSM2723705": [{"title": "Human_normal_P90"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 40;\trace: white;\tbmi: 25.24"}]}, {"GSM2723706": [{"title": "Human_normal_P91"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 24;\trace: white;\tbmi: 20.80"}]}, {"GSM2723707": [{"title": "Human_normal_P93"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 28;\trace: white;\tbmi: 24.89"}]}, {"GSM2723708": [{"title": "Human_normal_P94"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 20;\trace: white;\tbmi: 25.84"}]}, {"GSM2723709": [{"title": "Human_normal_P95"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 29;\trace: white;\tbmi: 25.85"}]}, {"GSM2723710": [{"title": "Human_normal_P96"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 21;\trace: white;\tbmi: 25.29"}]}, {"GSM2723711": [{"title": "Human_normal_P100"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 31;\trace: black;\tbmi: 39.22"}]}, {"GSM2723712": [{"title": "Human_normal_P101"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 39;\trace: black;\tbmi: 29.18"}]}, {"GSM2723713": [{"title": "Human_normal_P103"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 22;\trace: black;\tbmi: 41.97"}]}, {"GSM2723714": [{"title": "Human_normal_P104"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 37;\trace: white;\tbmi: 25.79"}]}, {"GSM2723715": [{"title": "Human_normal_P105"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 26;\trace: white;\tbmi: 23.67"}]}, {"GSM2723716": [{"title": "Human_normal_P106"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 38;\trace: black;\tbmi: 31.30"}]}, {"GSM2723717": [{"title": "Human_normal_P107"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 33;\trace: black;\tbmi: 32.12"}]}, {"GSM2723718": [{"title": "Human_normal_P108"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 32;\trace: other;\tbmi: 34.06"}]}, {"GSM2723719": [{"title": "Human_normal_P109"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 17;\trace: white;\tbmi: 22.59"}]}, {"GSM2723720": [{"title": "Human_normal_P111"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 28;\trace: white;\tbmi: 33.65"}]}, {"GSM2723721": [{"title": "Human_normal_P113"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 52;\trace: white;\tbmi: 28.83"}]}, {"GSM2723722": [{"title": "Human_normal_P114"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 40;\trace: other;\tbmi: 27.67"}]}, {"GSM2723723": [{"title": "Human_normal_P115"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 18;\trace: white;\tbmi: 22.71"}]}, {"GSM2723724": [{"title": "Human_normal_P116"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 47;\trace: white;\tbmi: 21.58"}]}, {"GSM2723725": [{"title": "Human_normal_P117"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 35;\trace: white;\tbmi: 34.33"}]}, {"GSM2723726": [{"title": "Human_normal_P119"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 50;\trace: white;\tbmi: 36.27"}]}, {"GSM2723727": [{"title": "Human_normal_P120"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 45;\trace: black;\tbmi: 43.26"}]}, {"GSM2723728": [{"title": "Human_normal_P121"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 49;\trace: black;\tbmi: 28.24"}]}, {"GSM2723729": [{"title": "Human_normal_P123"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 41;\trace: black;\tbmi: 39.93"}]}, {"GSM2723730": [{"title": "Human_normal_P124"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 22;\trace: white;\tbmi: 23.96"}]}, {"GSM2723731": [{"title": "Human_normal_P125"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 50;\trace: white;\tbmi: 27.45"}]}, {"GSM2723732": [{"title": "Human_normal_P126"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 45;\trace: white;\tbmi: 26.52"}]}, {"GSM2723733": [{"title": "Human_normal_P127"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 31;\trace: black;\tbmi: 32.69"}]}, {"GSM2723734": [{"title": "Human_normal_P130"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 52;\trace: white;\tbmi: 26.92"}]}, {"GSM2723735": [{"title": "Human_normal_P131"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 43;\trace: white;\tbmi: 25.70"}]}, {"GSM2723736": [{"title": "Human_normal_P138"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 44;\trace: white;\tbmi: 21.25"}]}, {"GSM2723737": [{"title": "Human_normal_P139"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 47;\trace: white;\tbmi: 28.52"}]}, {"GSM2723738": [{"title": "Human_normal_P140"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 21;\trace: white;\tbmi: 29.95"}]}, {"GSM2723739": [{"title": "Human_normal_P155"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 23;\trace: white;\tbmi: 28.24"}]}, {"GSM2723740": [{"title": "Human_normal_P156"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 25;\trace: white;\tbmi: 20.78"}]}, {"GSM2723741": [{"title": "Human_normal_P157"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 25;\trace: black;\tbmi: 28.13"}]}, {"GSM2723742": [{"title": "Human_normal_P158"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 25;\trace: white;\tbmi: 30.23"}]}, {"GSM2723743": [{"title": "Human_normal_P159"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 50;\trace: white;\tbmi: 23.63"}]}, {"GSM2723744": [{"title": "Human_normal_P161"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 49;\trace: white;\tbmi: 32.19"}]}, {"GSM2723745": [{"title": "Human_normal_P162"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 76;\trace: white;\tbmi: 37.70"}]}, {"GSM2723746": [{"title": "Human_normal_P163"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 34;\trace: black;\tbmi: 33.65"}]}, {"GSM2723747": [{"title": "Human_normal_P165"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 35;\trace: white;\tbmi: 36.31"}]}, {"GSM2723748": [{"title": "Human_normal_P166"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 25;\trace: black;\tbmi: 33.20"}]}, {"GSM2723749": [{"title": "Human_normal_P167"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 64;\trace: white;\tbmi: 30.22"}]}, {"GSM2723750": [{"title": "Human_normal_P168"}, {"type": "RNA"}, {"source_name_ch1": "Epithelial cells from normal breast tissue"}, {"characteristics_ch1": "age: 47;\trace: white;\tbmi: 26.63"}]}, {"GSM2340947": [{"title": "MSC_donor1_P2_HPL [Affymetrix]"}, {"type": "RNA"}, {"source_name_ch1": "mesenchymal stromal cells in HPL for 2 passages"}, {"characteristics_ch1": "donor: donor 1;\tgender: male;\tgroup: HPL;\tage: 59;\tcell type: mesenchymal stromal cells;\tpassage: passage 2"}]}, {"GSM2340948": [{"title": "MSC_donor1_P2_FCS [Affymetrix]"}, {"type": "RNA"}, {"source_name_ch1": "mesenchymal stromal cells in FCS for 2 passages"}, {"characteristics_ch1": "donor: donor 1;\tgender: male;\tgroup: FCS;\tage: 59;\tcell type: mesenchymal stromal cells;\tpassage: passage 2"}]}, {"GSM2340949": [{"title": "MSC_donor2_P2_HPL [Affymetrix]"}, {"type": "RNA"}, {"source_name_ch1": "mesenchymal stromal cells in HPL for 2 passages"}, {"characteristics_ch1": "donor: donor 2;\tgender: male;\tgroup: HPL;\tage: 56;\tcell type: mesenchymal stromal cells;\tpassage: passage 2"}]}, {"GSM2340950": [{"title": "MSC_donor2_P2_FCS [Affymetrix]"}, {"type": "RNA"}, {"source_name_ch1": "mesenchymal stromal cells in FCS for 2 passages"}, {"characteristics_ch1": "donor: donor 2;\tgender: male;\tgroup: FCS;\tage: 56;\tcell type: mesenchymal stromal cells;\tpassage: passage 2"}]}, {"GSM2340951": [{"title": "MSC_donor3_P2_HPL [Affymetrix]"}, {"type": "RNA"}, {"source_name_ch1": "mesenchymal stromal cells in HPL for 2 passages"}, {"characteristics_ch1": "donor: donor 3;\tgender: male;\tgroup: HPL;\tage: 54;\tcell type: mesenchymal stromal cells;\tpassage: passage 2"}]}, {"GSM2340952": [{"title": "MSC_donor3_P2_FCS [Affymetrix]"}, {"type": "RNA"}, {"source_name_ch1": "mesenchymal stromal cells in FCS for 2 passages"}, {"characteristics_ch1": "donor: donor 3;\tgender: male;\tgroup: FCS;\tage: 54;\tcell type: mesenchymal stromal cells;\tpassage: passage 2"}]}, {"GSM2340953": [{"title": "MSC_donor4_P2_HPL [Affymetrix]"}, {"type": "RNA"}, {"source_name_ch1": "mesenchymal stromal cells in HPL for 2 passages"}, {"characteristics_ch1": "donor: donor 4;\tgender: male;\tgroup: HPL;\tage: 66;\tcell type: mesenchymal stromal cells;\tpassage: passage 2"}]}, {"GSM2340954": [{"title": "MSC_donor4_P2_FCS [Affymetrix]"}, {"type": "RNA"}, {"source_name_ch1": "mesenchymal stromal cells in FCS for 2 passages"}, {"characteristics_ch1": "donor: donor 4;\tgender: male;\tgroup: FCS;\tage: 66;\tcell type: mesenchymal stromal cells;\tpassage: passage 2"}]}, {"GSM2340955": [{"title": "MSC_donor5_P2_HPL [Affymetrix]"}, {"type": "RNA"}, {"source_name_ch1": "mesenchymal stromal cells in HPL for 2 passages"}, {"characteristics_ch1": "donor: donor 5;\tgender: female;\tgroup: HPL;\tage: 82;\tcell type: mesenchymal stromal cells;\tpassage: passage 2"}]}, {"GSM2340956": [{"title": "MSC_donor5_P2_FCS [Affymetrix]"}, {"type": "RNA"}, {"source_name_ch1": "mesenchymal stromal cells in FCS for 2 passages"}, {"characteristics_ch1": "donor: donor 5;\tgender: female;\tgroup: FCS;\tage: 82;\tcell type: mesenchymal stromal cells;\tpassage: passage 2"}]}, {"GSM2340957": [{"title": "MSC_donor6_P2_HPL [Affymetrix]"}, {"type": "RNA"}, {"source_name_ch1": "mesenchymal stromal cells in HPL for 2 passages"}, {"characteristics_ch1": "donor: donor 6;\tgender: female;\tgroup: HPL;\tage: 80;\tcell type: mesenchymal stromal cells;\tpassage: passage 2"}]}, {"GSM2340958": [{"title": "MSC_donor6_P2_FCS [Affymetrix]"}, {"type": "RNA"}, {"source_name_ch1": "mesenchymal stromal cells in FCS for 2 passages"}, {"characteristics_ch1": "donor: donor 6;\tgender: female;\tgroup: FCS;\tage: 80;\tcell type: mesenchymal stromal cells;\tpassage: passage 2"}]}, {"GSM2471787": [{"title": "Jurkat at 1g ground control, rep1"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471788": [{"title": "Jurkat at 1g ground control rep2"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471789": [{"title": "Jurkat at 1g ground control rep3"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471790": [{"title": "Jurkat at 1g ground control rep4"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471791": [{"title": "Jurkat at 1g ground control rep5"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471792": [{"title": "Jurkat at 1g ground control rep6"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471793": [{"title": "Jurkat at 1g flight, rep1"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471794": [{"title": "Jurkat at 1g flight, rep2"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471795": [{"title": "Jurkat at 1g flight, rep3"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471796": [{"title": "Jurkat at 1g flight, rep4"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471797": [{"title": "Jurkat at 1g flight, rep5"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471798": [{"title": "Jurkat at 1g flight, rep6"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471799": [{"title": "Jurkat at 1.8g flight, rep1"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471800": [{"title": "Jurkat at 1.8g flight, rep2"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471801": [{"title": "Jurkat at 1.8g flight, rep3"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471802": [{"title": "Jurkat at 1.8g flight, rep4"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471803": [{"title": "Jurkat at 1.8g flight, rep5"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471804": [{"title": "Jurkat at 1.8g flight, rep6"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471805": [{"title": "Jurkat at 0g flight, rep1"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471806": [{"title": "Jurkat at 0g flight, rep2"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471807": [{"title": "Jurkat at 0g flight, rep3"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471808": [{"title": "Jurkat at 0g flight, rep4"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471809": [{"title": "Jurkat at 0g flight, rep5"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471810": [{"title": "Jurkat at 0g flight, rep6"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471811": [{"title": "Jurkat at 1g in-flight, rep1"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471812": [{"title": "Jurkat at 1g in-flight, rep2"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471813": [{"title": "Jurkat at 1g in-flight, rep3"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471814": [{"title": "Jurkat at 1g in-flight, rep4"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471815": [{"title": "Jurkat at 1g in-flight, rep5"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471816": [{"title": "Jurkat at 1g in-flight, rep6"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471817": [{"title": "Jurkat at 1g in-flight, rep7"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471818": [{"title": "Jurkat at 1g in-flight, rep8"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471819": [{"title": "Jurkat at 1g in-flight, rep9"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471820": [{"title": "Jurkat at baseline, rep1"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471821": [{"title": "Jurkat at baseline, rep2"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471822": [{"title": "Jurkat at baseline, rep3"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471823": [{"title": "Jurkat at baseline, rep4"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471824": [{"title": "Jurkat at baseline, rep5"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471825": [{"title": "Jurkat at baseline, rep6"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471826": [{"title": "Jurkat at baseline, rep7"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471827": [{"title": "Jurkat at \u00b5g, rep1"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471828": [{"title": "Jurkat at \u00b5g, rep2"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471829": [{"title": "Jurkat at \u00b5g, rep3"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471830": [{"title": "Jurkat at \u00b5g, rep4"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471831": [{"title": "Jurkat at \u00b5g, rep5"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471832": [{"title": "Jurkat at \u00b5g, rep6"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471833": [{"title": "Jurkat at \u00b5g, rep7"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471834": [{"title": "Jurkat at \u00b5g, rep8"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471835": [{"title": "Jurkat at \u00b5g, rep9"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471836": [{"title": "Jurkat at 1g ground control, rep1 (2)"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471837": [{"title": "Jurkat at 1g ground control, rep2 (2)"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471838": [{"title": "Jurkat at 1g ground control, rep3 (2)"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471839": [{"title": "Jurkat at 1g ground control, rep4 (2)"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471840": [{"title": "Jurkat at 1g ground control, rep5 (2)"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471841": [{"title": "Jurkat at 1g ground control, rep6 (2)"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471842": [{"title": "Jurkat at 1g ground control, rep7 (2)"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471843": [{"title": "Jurkat at cell culture control, rep1"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471844": [{"title": "Jurkat at cell culture control, rep2"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471845": [{"title": "Jurkat at cell culture control, rep3"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471846": [{"title": "Jurkat at cell culture control, rep4"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471847": [{"title": "Jurkat at cell culture control, rep5"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471848": [{"title": "Jurkat at cell culture control, rep6"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2471849": [{"title": "Jurkat at cell culture control, rep7"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2741331": [{"title": "Caco-2 cells F. nucleatum 24h,rep1"}, {"type": "RNA"}, {"source_name_ch1": "Caco-2 cells F. nucleatum 24h"}, {"characteristics_ch1": "cell line: Caco-2;\tcell type: Human colorectal adenocarcinoma"}]}, {"GSM2741332": [{"title": "Caco-2 cells F. nucleatum 24h,rep2"}, {"type": "RNA"}, {"source_name_ch1": "Caco-2 cells F. nucleatum 24h"}, {"characteristics_ch1": "cell line: Caco-2;\tcell type: Human colorectal adenocarcinoma"}]}, {"GSM2741333": [{"title": "Caco-2 cells F. nucleatum 24h,rep3"}, {"type": "RNA"}, {"source_name_ch1": "Caco-2 cells F. nucleatum 24h"}, {"characteristics_ch1": "cell line: Caco-2;\tcell type: Human colorectal adenocarcinoma"}]}, {"GSM2741334": [{"title": "Caco-2 cells F. nucleatum 24h,rep4"}, {"type": "RNA"}, {"source_name_ch1": "Caco-2 cells F. nucleatum 24h"}, {"characteristics_ch1": "cell line: Caco-2;\tcell type: Human colorectal adenocarcinoma"}]}, {"GSM2741335": [{"title": "Caco-2 cells F. nucleatum 24h,rep5"}, {"type": "RNA"}, {"source_name_ch1": "Caco-2 cells F. nucleatum 24h"}, {"characteristics_ch1": "cell line: Caco-2;\tcell type: Human colorectal adenocarcinoma"}]}, {"GSM2741336": [{"title": "Caco-2 cells non-infected 24h,rep1"}, {"type": "RNA"}, {"source_name_ch1": "Caco-2 cells non-infected 24h"}, {"characteristics_ch1": "cell line: Caco-2;\tcell type: Human colorectal adenocarcinoma"}]}, {"GSM2741337": [{"title": "Caco-2 cells non-infected 24h,rep2"}, {"type": "RNA"}, {"source_name_ch1": "Caco-2 cells non-infected 24h"}, {"characteristics_ch1": "cell line: Caco-2;\tcell type: Human colorectal adenocarcinoma"}]}, {"GSM2741338": [{"title": "Caco-2 cells non-infected 24h,rep3"}, {"type": "RNA"}, {"source_name_ch1": "Caco-2 cells non-infected 24h"}, {"characteristics_ch1": "cell line: Caco-2;\tcell type: Human colorectal adenocarcinoma"}]}, {"GSM2741339": [{"title": "Caco-2 cells non-infected 24h,rep4"}, {"type": "RNA"}, {"source_name_ch1": "Caco-2 cells non-infected 24h"}, {"characteristics_ch1": "cell line: Caco-2;\tcell type: Human colorectal adenocarcinoma"}]}, {"GSM2741340": [{"title": "Caco-2 cells non-infected 24h,rep5"}, {"type": "RNA"}, {"source_name_ch1": "Caco-2 cells non-infected 24h"}, {"characteristics_ch1": "cell line: Caco-2;\tcell type: Human colorectal adenocarcinoma"}]}, {"GSM2367520": [{"title": "SKOV3.ip_negative control 1"}, {"type": "RNA"}, {"source_name_ch1": "SKOV3.ip_control"}, {"characteristics_ch1": "cell line: SKOV3.ip;\tcell type: epithelial ovarian cancer cells;\ttransfected with: 50nM negative control siRNA;\ttime point: 24h after transfection"}]}, {"GSM2367521": [{"title": "SKOV3.ip_negative control 2"}, {"type": "RNA"}, {"source_name_ch1": "SKOV3.ip_control"}, {"characteristics_ch1": "cell line: SKOV3.ip;\tcell type: epithelial ovarian cancer cells;\ttransfected with: 50nM negative control siRNA;\ttime point: 24h after transfection"}]}, {"GSM2367522": [{"title": "SKOV3.ip_negative control 3"}, {"type": "RNA"}, {"source_name_ch1": "SKOV3.ip_control"}, {"characteristics_ch1": "cell line: SKOV3.ip;\tcell type: epithelial ovarian cancer cells;\ttransfected with: 50nM negative control siRNA;\ttime point: 24h after transfection"}]}, {"GSM2367523": [{"title": "SKOV3.ip_RAD51-AS1 knockdown 1"}, {"type": "RNA"}, {"source_name_ch1": "SKOV3.ip_RAD51-AS1 knockdown"}, {"characteristics_ch1": "cell line: SKOV3.ip;\tcell type: epithelial ovarian cancer cells;\ttransfected with: 50nM RAD51-AS1-ASOs;\ttime point: 24h after transfection"}]}, {"GSM2367524": [{"title": "SKOV3.ip_RAD51-AS1 knockdown 2"}, {"type": "RNA"}, {"source_name_ch1": "SKOV3.ip_RAD51-AS1 knockdown"}, {"characteristics_ch1": "cell line: SKOV3.ip;\tcell type: epithelial ovarian cancer cells;\ttransfected with: 50nM RAD51-AS1-ASOs;\ttime point: 24h after transfection"}]}, {"GSM2367525": [{"title": "SKOV3.ip_RAD51-AS1 knockdown 3"}, {"type": "RNA"}, {"source_name_ch1": "SKOV3.ip_RAD51-AS1 knockdown"}, {"characteristics_ch1": "cell line: SKOV3.ip;\tcell type: epithelial ovarian cancer cells;\ttransfected with: 50nM RAD51-AS1-ASOs;\ttime point: 24h after transfection"}]}, {"GSM1949698": [{"title": "shNon-target, 1"}, {"type": "RNA"}, {"source_name_ch1": "GBM patient derived GSCs"}, {"characteristics_ch1": "cell type: glioma sphere cells;\tcell line: GBM;\ttransfection: pLKO 1.0- shNon-targeting vector"}]}, {"GSM1949699": [{"title": "shMLK4, 1"}, {"type": "RNA"}, {"source_name_ch1": "GBM patient derived GSCs"}, {"characteristics_ch1": "cell type: glioma sphere cells;\tcell line: GBM;\ttransfection: pLKO1.0 shMLK4_1"}]}, {"GSM1949700": [{"title": "shNon-target, 2"}, {"type": "RNA"}, {"source_name_ch1": "GBM patient derived GSCs"}, {"characteristics_ch1": "cell type: glioma sphere cells;\tcell line: GBM;\ttransfection: pLKO 1.0- shNon-targeting vector"}]}, {"GSM1949701": [{"title": "shMLK4, 2"}, {"type": "RNA"}, {"source_name_ch1": "GBM patient derived GSCs"}, {"characteristics_ch1": "cell type: glioma sphere cells;\tcell line: GBM;\ttransfection: pLKO1.0 shMLK4_1"}]}, {"GSM1949702": [{"title": "shNon-target, 3"}, {"type": "RNA"}, {"source_name_ch1": "GBM patient derived GSCs"}, {"characteristics_ch1": "cell type: glioma sphere cells;\tcell line: GBM;\ttransfection: pLKO 1.0- shNon-targeting vector"}]}, {"GSM1949703": [{"title": "shMLK4, 3"}, {"type": "RNA"}, {"source_name_ch1": "GBM patient derived GSCs"}, {"characteristics_ch1": "cell type: glioma sphere cells;\tcell line: GBM;\ttransfection: pLKO1.0 shMLK4_1"}]}, {"GSM2305989": [{"title": "Atrial Fibrillation_left ventricle_86"}, {"type": "RNA"}, {"source_name_ch1": "Human heart tissue"}, {"characteristics_ch1": "tissue: Heart;\tgender: Female;\tage: 76;\tcondition: Hight ejection fraction"}]}, {"GSM2305990": [{"title": "Atrial Fibrillation_left ventricle_88"}, {"type": "RNA"}, {"source_name_ch1": "Human heart tissue"}, {"characteristics_ch1": "tissue: Heart;\tgender: male;\tage: 67;\tcondition: Low ejection fraction"}]}, {"GSM2305991": [{"title": "Atrial Fibrillation_left ventricle_89"}, {"type": "RNA"}, {"source_name_ch1": "Human heart tissue"}, {"characteristics_ch1": "tissue: Heart;\tgender: Female;\tage: 46;\tcondition: Hight ejection fraction"}]}, {"GSM2305992": [{"title": "Atrial Fibrillation_left ventricle_90"}, {"type": "RNA"}, {"source_name_ch1": "Human heart tissue"}, {"characteristics_ch1": "tissue: Heart;\tgender: Female;\tage: 62;\tcondition: Low ejection fraction"}]}, {"GSM2305993": [{"title": "Atrial Fibrillation_left ventricle_91"}, {"type": "RNA"}, {"source_name_ch1": "Human heart tissue"}, {"characteristics_ch1": "tissue: Heart;\tgender: male;\tage: 59;\tcondition: Low ejection fraction"}]}, {"GSM2305994": [{"title": "Atrial Fibrillation_left ventricle_92"}, {"type": "RNA"}, {"source_name_ch1": "Human heart tissue"}, {"characteristics_ch1": "tissue: Heart;\tgender: Female;\tage: 76;\tcondition: Low ejection fraction"}]}, {"GSM2305995": [{"title": "Atrial Fibrillation_left ventricle_93"}, {"type": "RNA"}, {"source_name_ch1": "Human heart tissue"}, {"characteristics_ch1": "tissue: Heart;\tgender: Female;\tage: 44;\tcondition: Low ejection fraction"}]}, {"GSM2305996": [{"title": "Atrial Fibrillation_left ventricle_94"}, {"type": "RNA"}, {"source_name_ch1": "Human heart tissue"}, {"characteristics_ch1": "tissue: Heart;\tgender: male;\tage: 79;\tcondition: Hight ejection fraction"}]}, {"GSM2305997": [{"title": "Atrial Fibrillation_left ventricle_95"}, {"type": "RNA"}, {"source_name_ch1": "Human heart tissue"}, {"characteristics_ch1": "tissue: Heart;\tgender: male;\tage: 42;\tcondition: Low ejection fraction"}]}, {"GSM2305998": [{"title": "Atrial Fibrillation_left ventricle_97"}, {"type": "RNA"}, {"source_name_ch1": "Human heart tissue"}, {"characteristics_ch1": "tissue: Heart;\tgender: male;\tage: 56;\tcondition: Low ejection fraction"}]}, {"GSM2305999": [{"title": "Atrial Fibrillation_left ventricle_98"}, {"type": "RNA"}, {"source_name_ch1": "Human heart tissue"}, {"characteristics_ch1": "tissue: Heart;\tgender: male;\tage: 42;\tcondition: Low ejection fraction"}]}, {"GSM2306000": [{"title": "Atrial Fibrillation_left ventricle_99"}, {"type": "RNA"}, {"source_name_ch1": "Human heart tissue"}, {"characteristics_ch1": "tissue: Heart;\tgender: male;\tage: 59;\tcondition: Low ejection fraction"}]}, {"GSM2306001": [{"title": "Atrial Fibrillation_left ventricle_101"}, {"type": "RNA"}, {"source_name_ch1": "Human heart tissue"}, {"characteristics_ch1": "tissue: Heart;\tgender: Female;\tage: 63;\tcondition: Low ejection fraction"}]}, {"GSM2306002": [{"title": "Atrial Fibrillation_left ventricle_102"}, {"type": "RNA"}, {"source_name_ch1": "Human heart tissue"}, {"characteristics_ch1": "tissue: Heart;\tgender: Female;\tage: 58;\tcondition: Hight ejection fraction"}]}, {"GSM2306003": [{"title": "Atrial Fibrillation_left ventricle_103"}, {"type": "RNA"}, {"source_name_ch1": "Human heart tissue"}, {"characteristics_ch1": "tissue: Heart;\tgender: male;\tage: 65;\tcondition: Hight ejection fraction"}]}, {"GSM2306004": [{"title": "Atrial Fibrillation_left ventricle_107"}, {"type": "RNA"}, {"source_name_ch1": "Human heart tissue"}, {"characteristics_ch1": "tissue: Heart;\tgender: male;\tage: 66;\tcondition: Low ejection fraction"}]}, {"GSM2306005": [{"title": "Atrial Fibrillation_left ventricle_109"}, {"type": "RNA"}, {"source_name_ch1": "Human heart tissue"}, {"characteristics_ch1": "tissue: Heart;\tgender: Female;\tage: 68;\tcondition: Hight ejection fraction"}]}, {"GSM2306006": [{"title": "Atrial Fibrillation_left ventricle_110"}, {"type": "RNA"}, {"source_name_ch1": "Human heart tissue"}, {"characteristics_ch1": "tissue: Heart;\tgender: male;\tage: 67;\tcondition: Hight ejection fraction"}]}, {"GSM2306007": [{"title": "Atrial Fibrillation_left ventricle_111"}, {"type": "RNA"}, {"source_name_ch1": "Human heart tissue"}, {"characteristics_ch1": "tissue: Heart;\tgender: male;\tage: 62;\tcondition: Low ejection fraction"}]}, {"GSM2306008": [{"title": "Atrial Fibrillation_left ventricle_112"}, {"type": "RNA"}, {"source_name_ch1": "Human heart tissue"}, {"characteristics_ch1": "tissue: Heart;\tgender: Female;\tage: 48;\tcondition: Hight ejection fraction"}]}, {"GSM2306009": [{"title": "Atrial Fibrillation_left ventricle_113"}, {"type": "RNA"}, {"source_name_ch1": "Human heart tissue"}, {"characteristics_ch1": "tissue: Heart;\tgender: male;\tage: 82;\tcondition: Hight ejection fraction"}]}, {"GSM2306010": [{"title": "Atrial Fibrillation_left ventricle_116"}, {"type": "RNA"}, {"source_name_ch1": "Human heart tissue"}, {"characteristics_ch1": "tissue: Heart;\tgender: Female;\tage: 69;\tcondition: Hight ejection fraction"}]}, {"GSM2325104": [{"title": "Age 33-35 at donation + low ovarian reserve Sample 1 [D1.1]"}, {"type": "RNA"}, {"source_name_ch1": "Mature MII oocytes"}, {"characteristics_ch1": "age: Age 33-35 at donation;\tovarian reserve: low ovarian reserve"}]}, {"GSM2325105": [{"title": "Age 33-35 at donation + low ovarian reserve Sample 1 [D2.1]"}, {"type": "RNA"}, {"source_name_ch1": "Mature MII oocytes"}, {"characteristics_ch1": "age: Age 33-35 at donation;\tovarian reserve: low ovarian reserve"}]}, {"GSM2325106": [{"title": "Age 33-35 at donation + low ovarian reserve Sample 1 [D3.1]"}, {"type": "RNA"}, {"source_name_ch1": "Mature MII oocytes"}, {"characteristics_ch1": "age: Age 33-35 at donation;\tovarian reserve: low ovarian reserve"}]}, {"GSM2325107": [{"title": "Age 33-35 at donation + low ovarian reserve Sample 1 [D4.1]"}, {"type": "RNA"}, {"source_name_ch1": "Mature MII oocytes"}, {"characteristics_ch1": "age: Age 33-35 at donation;\tovarian reserve: low ovarian reserve"}]}, {"GSM2325108": [{"title": "Age 33-35 at donation + low ovarian reserve Sample 1 [D5.1]"}, {"type": "RNA"}, {"source_name_ch1": "Mature MII oocytes"}, {"characteristics_ch1": "age: Age 33-35 at donation;\tovarian reserve: low ovarian reserve"}]}, {"GSM2325109": [{"title": "Age 33-35 at donation + low ovarian reserve Sample 1 [D6.1]"}, {"type": "RNA"}, {"source_name_ch1": "Mature MII oocytes"}, {"characteristics_ch1": "age: Age 33-35 at donation;\tovarian reserve: low ovarian reserve"}]}, {"GSM2325110": [{"title": "Age 33-35 at donation + low ovarian reserve Sample 1 [D7.1]"}, {"type": "RNA"}, {"source_name_ch1": "Mature MII oocytes"}, {"characteristics_ch1": "age: Age 33-35 at donation;\tovarian reserve: low ovarian reserve"}]}, {"GSM2325111": [{"title": "Age 33-35 at donation + low ovarian reserve Sample 1 [D8.1]"}, {"type": "RNA"}, {"source_name_ch1": "Mature MII oocytes"}, {"characteristics_ch1": "age: Age 33-35 at donation;\tovarian reserve: low ovarian reserve"}]}, {"GSM2325112": [{"title": "Age 33-35 at donation + low ovarian reserve Sample 1 [D9.1]"}, {"type": "RNA"}, {"source_name_ch1": "Mature MII oocytes"}, {"characteristics_ch1": "age: Age 33-35 at donation;\tovarian reserve: low ovarian reserve"}]}, {"GSM2325113": [{"title": "Age 20-22 at donation + low ovarian reserve Sample 1 [D11.1]"}, {"type": "RNA"}, {"source_name_ch1": "Mature MII oocytes"}, {"characteristics_ch1": "age: Age 20-22 at donation;\tovarian reserve: low ovarian reserve"}]}, {"GSM2325114": [{"title": "Age 20-22 at donation + low ovarian reserve Sample 1 [D12.1]"}, {"type": "RNA"}, {"source_name_ch1": "Mature MII oocytes"}, {"characteristics_ch1": "age: Age 20-22 at donation;\tovarian reserve: low ovarian reserve"}]}, {"GSM2325115": [{"title": "Age 20-22 at donation + low ovarian reserve Sample 1 [D13.1]"}, {"type": "RNA"}, {"source_name_ch1": "Mature MII oocytes"}, {"characteristics_ch1": "age: Age 20-22 at donation;\tovarian reserve: low ovarian reserve"}]}, {"GSM2325116": [{"title": "Age 20-22 at donation + low ovarian reserve Sample 1 [D13.2]"}, {"type": "RNA"}, {"source_name_ch1": "Mature MII oocytes"}, {"characteristics_ch1": "age: Age 20-22 at donation;\tovarian reserve: low ovarian reserve"}]}, {"GSM2325117": [{"title": "Age 20-22 at donation + low ovarian reserve Sample 1 [D14.1]"}, {"type": "RNA"}, {"source_name_ch1": "Mature MII oocytes"}, {"characteristics_ch1": "age: Age 20-22 at donation;\tovarian reserve: low ovarian reserve"}]}, {"GSM2325118": [{"title": "Age 20-22 at donation + low ovarian reserve Sample 1 [D14.2]"}, {"type": "RNA"}, {"source_name_ch1": "Mature MII oocytes"}, {"characteristics_ch1": "age: Age 20-22 at donation;\tovarian reserve: low ovarian reserve"}]}, {"GSM2325119": [{"title": "Age 20-22 at donation + low ovarian reserve Sample 1 [D15.1]"}, {"type": "RNA"}, {"source_name_ch1": "Mature MII oocytes"}, {"characteristics_ch1": "age: Age 20-22 at donation;\tovarian reserve: low ovarian reserve"}]}, {"GSM2325120": [{"title": "Age 20-22 at donation + low ovarian reserve Sample 1 [D15.2]"}, {"type": "RNA"}, {"source_name_ch1": "Mature MII oocytes"}, {"characteristics_ch1": "age: Age 20-22 at donation;\tovarian reserve: low ovarian reserve"}]}, {"GSM2325121": [{"title": "Age 20-22 at donation + high ovarian reserve Sample 1 [D16.1]"}, {"type": "RNA"}, {"source_name_ch1": "Mature MII oocytes"}, {"characteristics_ch1": "age: Age 20-22 at donation;\tovarian reserve: high ovarian reserve"}]}, {"GSM2325122": [{"title": "Age 20-22 at donation + high ovarian reserve Sample 1 [D17.1]"}, {"type": "RNA"}, {"source_name_ch1": "Mature MII oocytes"}, {"characteristics_ch1": "age: Age 20-22 at donation;\tovarian reserve: high ovarian reserve"}]}, {"GSM2325123": [{"title": "Age 20-22 at donation + high ovarian reserve Sample 1 [D17.2]"}, {"type": "RNA"}, {"source_name_ch1": "Mature MII oocytes"}, {"characteristics_ch1": "age: Age 20-22 at donation;\tovarian reserve: high ovarian reserve"}]}, {"GSM2325124": [{"title": "Age 20-22 at donation + high ovarian reserve Sample 1 [D18.1]"}, {"type": "RNA"}, {"source_name_ch1": "Mature MII oocytes"}, {"characteristics_ch1": "age: Age 20-22 at donation;\tovarian reserve: high ovarian reserve"}]}, {"GSM2325125": [{"title": "Age 20-22 at donation + high ovarian reserve Sample 1 [D19.1]"}, {"type": "RNA"}, {"source_name_ch1": "Mature MII oocytes"}, {"characteristics_ch1": "age: Age 20-22 at donation;\tovarian reserve: high ovarian reserve"}]}, {"GSM2325126": [{"title": "Age 20-22 at donation + high ovarian reserve Sample 1 [D20.1]"}, {"type": "RNA"}, {"source_name_ch1": "Mature MII oocytes"}, {"characteristics_ch1": "age: Age 20-22 at donation;\tovarian reserve: high ovarian reserve"}]}, {"GSM2325127": [{"title": "Age 20-22 at donation + high ovarian reserve Sample 1 [D21.1]"}, {"type": "RNA"}, {"source_name_ch1": "Mature MII oocytes"}, {"characteristics_ch1": "age: Age 20-22 at donation;\tovarian reserve: high ovarian reserve"}]}, {"GSM2325128": [{"title": "Age 20-22 at donation + high ovarian reserve Sample 1 [D22.1]"}, {"type": "RNA"}, {"source_name_ch1": "Mature MII oocytes"}, {"characteristics_ch1": "age: Age 20-22 at donation;\tovarian reserve: high ovarian reserve"}]}, {"GSM2325129": [{"title": "Age 20-22 at donation + high ovarian reserve Sample 1 [D23.1]"}, {"type": "RNA"}, {"source_name_ch1": "Mature MII oocytes"}, {"characteristics_ch1": "age: Age 20-22 at donation;\tovarian reserve: high ovarian reserve"}]}, {"GSM2325130": [{"title": "Age 33-35 at donation + high ovarian reserve Sample 1 [D24.1]"}, {"type": "RNA"}, {"source_name_ch1": "Mature MII oocytes"}, {"characteristics_ch1": "age: Age 33-35 at donation;\tovarian reserve: high ovarian reserve"}]}, {"GSM2325131": [{"title": "Age 33-35 at donation + high ovarian reserve Sample 1 [D25.1]"}, {"type": "RNA"}, {"source_name_ch1": "Mature MII oocytes"}, {"characteristics_ch1": "age: Age 33-35 at donation;\tovarian reserve: high ovarian reserve"}]}, {"GSM2325132": [{"title": "Age 33-35 at donation + high ovarian reserve Sample 1 [D26.1]"}, {"type": "RNA"}, {"source_name_ch1": "Mature MII oocytes"}, {"characteristics_ch1": "age: Age 33-35 at donation;\tovarian reserve: high ovarian reserve"}]}, {"GSM2325133": [{"title": "Age 33-35 at donation + high ovarian reserve Sample 1 [D26.2]"}, {"type": "RNA"}, {"source_name_ch1": "Mature MII oocytes"}, {"characteristics_ch1": "age: Age 33-35 at donation;\tovarian reserve: high ovarian reserve"}]}, {"GSM2325134": [{"title": "Age 33-35 at donation + high ovarian reserve Sample 1 [D27.1]"}, {"type": "RNA"}, {"source_name_ch1": "Mature MII oocytes"}, {"characteristics_ch1": "age: Age 33-35 at donation;\tovarian reserve: high ovarian reserve"}]}, {"GSM2325135": [{"title": "Age 33-35 at donation + high ovarian reserve Sample 1 [D28.1]"}, {"type": "RNA"}, {"source_name_ch1": "Mature MII oocytes"}, {"characteristics_ch1": "age: Age 33-35 at donation;\tovarian reserve: high ovarian reserve"}]}, {"GSM2325136": [{"title": "Age 33-35 at donation + high ovarian reserve Sample 1 [D29.1]"}, {"type": "RNA"}, {"source_name_ch1": "Mature MII oocytes"}, {"characteristics_ch1": "age: Age 33-35 at donation;\tovarian reserve: high ovarian reserve"}]}, {"GSM2325137": [{"title": "Age 33-35 at donation + high ovarian reserve Sample 1 [D30.1]"}, {"type": "RNA"}, {"source_name_ch1": "Mature MII oocytes"}, {"characteristics_ch1": "age: Age 33-35 at donation;\tovarian reserve: high ovarian reserve"}]}, {"GSM2325138": [{"title": "Age 33-35 at donation + high ovarian reserve Sample 1 [D30.2]"}, {"type": "RNA"}, {"source_name_ch1": "Mature MII oocytes"}, {"characteristics_ch1": "age: Age 33-35 at donation;\tovarian reserve: high ovarian reserve"}]}, {"GSM1871890": [{"title": "HepG2"}, {"type": "RNA"}, {"source_name_ch1": "cell line"}, {"characteristics_ch1": "cell line: HepG2;\ttissue: liver;\thbv status: Negative"}]}, {"GSM1871891": [{"title": "Huh7"}, {"type": "RNA"}, {"source_name_ch1": "cell line"}, {"characteristics_ch1": "cell line: Huh7;\ttissue: liver;\thbv status: Negative"}]}, {"GSM1871892": [{"title": "Hep3B"}, {"type": "RNA"}, {"source_name_ch1": "cell line"}, {"characteristics_ch1": "cell line: Hep3B;\ttissue: liver;\thbv status: Positive"}]}, {"GSM1871893": [{"title": "PLC/PRF/5"}, {"type": "RNA"}, {"source_name_ch1": "cell line"}, {"characteristics_ch1": "cell line: PLC/PRF/5;\ttissue: liver;\thbv status: Positive"}]}, {"GSM1871894": [{"title": "Caco-2"}, {"type": "RNA"}, {"source_name_ch1": "cell line"}, {"characteristics_ch1": "cell line: Caco-2;\ttissue: Colon;\thbv status: Negative"}]}, {"GSM1871895": [{"title": "Kato III"}, {"type": "RNA"}, {"source_name_ch1": "cell line"}, {"characteristics_ch1": "cell line: Kato III;\ttissue: Stomach;\thbv status: Negative"}]}, {"GSM1871896": [{"title": "AGS"}, {"type": "RNA"}, {"source_name_ch1": "cell line"}, {"characteristics_ch1": "cell line: AGS;\ttissue: Stomach;\thbv status: Negative"}]}, {"GSM1871897": [{"title": "A549"}, {"type": "RNA"}, {"source_name_ch1": "cell line"}, {"characteristics_ch1": "cell line: A549;\ttissue: Lung;\thbv status: Negative"}]}, {"GSM1871898": [{"title": "5637"}, {"type": "RNA"}, {"source_name_ch1": "cell line"}, {"characteristics_ch1": "cell line: 5637;\ttissue: Bladder;\thbv status: Negative"}]}, {"GSM1871899": [{"title": "T24"}, {"type": "RNA"}, {"source_name_ch1": "cell line"}, {"characteristics_ch1": "cell line: T24;\ttissue: Bladder;\thbv status: Negative"}]}, {"GSM1871900": [{"title": "PC-3"}, {"type": "RNA"}, {"source_name_ch1": "cell line"}, {"characteristics_ch1": "cell line: PC-3;\ttissue: Prostate;\thbv status: Negative"}]}, {"GSM1871901": [{"title": "Saos-2"}, {"type": "RNA"}, {"source_name_ch1": "cell line"}, {"characteristics_ch1": "cell line: Saos-2;\ttissue: Bone;\thbv status: Negative"}]}, {"GSM1871902": [{"title": "COLO316"}, {"type": "RNA"}, {"source_name_ch1": "cell line"}, {"characteristics_ch1": "cell line: COLO316;\ttissue: Ovary;\thbv status: Negative"}]}, {"GSM1871903": [{"title": "FS-04"}, {"type": "RNA"}, {"source_name_ch1": "cell line"}, {"characteristics_ch1": "cell line: FS-04;\ttissue: Skin;\thbv status: Negative"}]}, {"GSM2677530": [{"title": "patient1"}, {"type": "RNA"}, {"source_name_ch1": "asymptomatic_Dengue patient_PBMCs"}, {"characteristics_ch1": "disease state: asymptomatic;\tSex: M;\tage: 9;\tviral load: 26700;\tcell type: peripheral blood mononuclear cells (PBMCs);\tscanner: 2;\tscan date: 2014-05-22"}]}, {"GSM2677531": [{"title": "patient2"}, {"type": "RNA"}, {"source_name_ch1": "asymptomatic_Dengue patient_PBMCs"}, {"characteristics_ch1": "disease state: asymptomatic;\tSex: F;\tage: 4;\tviral load: 9530;\tcell type: peripheral blood mononuclear cells (PBMCs);\tscanner: 8;\tscan date: 2014-06-20"}]}, {"GSM2677532": [{"title": "patient3"}, {"type": "RNA"}, {"source_name_ch1": "DFDHF_Dengue patient_PBMCs"}, {"characteristics_ch1": "disease state: dengue fever (DF)/dengue hemorrhagic fever (DHF);\tSex: F;\tage: 10;\tviral load: 3780;\tcell type: peripheral blood mononuclear cells (PBMCs);\tscanner: 8;\tscan date: 2014-07-08"}]}, {"GSM2677533": [{"title": "patient4"}, {"type": "RNA"}, {"source_name_ch1": "asymptomatic_Dengue patient_PBMCs"}, {"characteristics_ch1": "disease state: asymptomatic;\tSex: M;\tage: 6;\tviral load: 246;\tcell type: peripheral blood mononuclear cells (PBMCs);\tscanner: 2;\tscan date: 2014-06-06"}]}, {"GSM2677534": [{"title": "patient5"}, {"type": "RNA"}, {"source_name_ch1": "DSS_Dengue patient_PBMCs"}, {"characteristics_ch1": "disease state: dengue shock syndrome (DSS);\tSex: F;\tage: 6;\tviral load: 21300;\tcell type: peripheral blood mononuclear cells (PBMCs);\tscanner: 8;\tscan date: 2014-07-08"}]}, {"GSM2677535": [{"title": "patient6"}, {"type": "RNA"}, {"source_name_ch1": "asymptomatic_Dengue patient_PBMCs"}, {"characteristics_ch1": "disease state: asymptomatic;\tSex: F;\tage: 5;\tviral load: 21200;\tcell type: peripheral blood mononuclear cells (PBMCs);\tscanner: 2;\tscan date: 2014-05-22"}]}, {"GSM2677536": [{"title": "patient7"}, {"type": "RNA"}, {"source_name_ch1": "DSS_Dengue patient_PBMCs"}, {"characteristics_ch1": "disease state: dengue shock syndrome (DSS);\tSex: M;\tage: 12;\tviral load: 61800;\tcell type: peripheral blood mononuclear cells (PBMCs);\tscanner: 8;\tscan date: 2014-07-08"}]}, {"GSM2677537": [{"title": "patient8"}, {"type": "RNA"}, {"source_name_ch1": "asymptomatic_Dengue patient_PBMCs"}, {"characteristics_ch1": "disease state: asymptomatic;\tSex: M;\tage: 5;\tviral load: 778;\tcell type: peripheral blood mononuclear cells (PBMCs);\tscanner: 2;\tscan date: 2014-05-22"}]}, {"GSM2677538": [{"title": "patient9"}, {"type": "RNA"}, {"source_name_ch1": "asymptomatic_Dengue patient_PBMCs"}, {"characteristics_ch1": "disease state: asymptomatic;\tSex: F;\tage: 15;\tviral load: 40300;\tcell type: peripheral blood mononuclear cells (PBMCs);\tscanner: 2;\tscan date: 2014-06-04"}]}, {"GSM2677539": [{"title": "patient10"}, {"type": "RNA"}, {"source_name_ch1": "DFDHF_Dengue patient_PBMCs"}, {"characteristics_ch1": "disease state: dengue fever (DF)/dengue hemorrhagic fever (DHF);\tSex: M;\tage: 4;\tviral load: 134000;\tcell type: peripheral blood mononuclear cells (PBMCs);\tscanner: 2;\tscan date: 2014-06-04"}]}, {"GSM2677540": [{"title": "patient11"}, {"type": "RNA"}, {"source_name_ch1": "DFDHF_Dengue patient_PBMCs"}, {"characteristics_ch1": "disease state: dengue fever (DF)/dengue hemorrhagic fever (DHF);\tSex: F;\tage: 4;\tviral load: 24000;\tcell type: peripheral blood mononuclear cells (PBMCs);\tscanner: 8;\tscan date: 2014-05-16"}]}, {"GSM2677541": [{"title": "patient12"}, {"type": "RNA"}, {"source_name_ch1": "DFDHF_Dengue patient_PBMCs"}, {"characteristics_ch1": "disease state: dengue fever (DF)/dengue hemorrhagic fever (DHF);\tSex: F;\tage: 3;\tviral load: 4140;\tcell type: peripheral blood mononuclear cells (PBMCs);\tscanner: 8;\tscan date: 2014-06-04"}]}, {"GSM2677542": [{"title": "patient13"}, {"type": "RNA"}, {"source_name_ch1": "DSS_Dengue patient_PBMCs"}, {"characteristics_ch1": "disease state: dengue shock syndrome (DSS);\tSex: M;\tage: 6;\tviral load: 102000;\tcell type: peripheral blood mononuclear cells (PBMCs);\tscanner: 8;\tscan date: 2014-06-12"}]}, {"GSM2677543": [{"title": "patient14"}, {"type": "RNA"}, {"source_name_ch1": "DSS_Dengue patient_PBMCs"}, {"characteristics_ch1": "disease state: dengue shock syndrome (DSS);\tSex: F;\tage: 9;\tviral load: 387000;\tcell type: peripheral blood mononuclear cells (PBMCs);\tscanner: 8;\tscan date: 2014-06-12"}]}, {"GSM2677544": [{"title": "patient15"}, {"type": "RNA"}, {"source_name_ch1": "DSS_Dengue patient_PBMCs"}, {"characteristics_ch1": "disease state: dengue shock syndrome (DSS);\tSex: F;\tage: 8;\tviral load: 335000;\tcell type: peripheral blood mononuclear cells (PBMCs);\tscanner: 8;\tscan date: 2014-06-06"}]}, {"GSM2677545": [{"title": "patient20"}, {"type": "RNA"}, {"source_name_ch1": "DFDHF_Dengue patient_PBMCs"}, {"characteristics_ch1": "disease state: dengue fever (DF)/dengue hemorrhagic fever (DHF);\tSex: M;\tage: 12;\tviral load: 2300;\tcell type: peripheral blood mononuclear cells (PBMCs);\tscanner: 8;\tscan date: 2014-06-12"}]}, {"GSM2677546": [{"title": "patient21"}, {"type": "RNA"}, {"source_name_ch1": "DSS_Dengue patient_PBMCs"}, {"characteristics_ch1": "disease state: dengue shock syndrome (DSS);\tSex: M;\tage: 9;\tviral load: 359000;\tcell type: peripheral blood mononuclear cells (PBMCs);\tscanner: 8;\tscan date: 2014-06-12"}]}, {"GSM2677547": [{"title": "patient22"}, {"type": "RNA"}, {"source_name_ch1": "DFDHF_Dengue patient_PBMCs"}, {"characteristics_ch1": "disease state: dengue fever (DF)/dengue hemorrhagic fever (DHF);\tSex: M;\tage: 8;\tviral load: 11500;\tcell type: peripheral blood mononuclear cells (PBMCs);\tscanner: 8;\tscan date: 2014-06-12"}]}, {"GSM2677548": [{"title": "patient23"}, {"type": "RNA"}, {"source_name_ch1": "DSS_Dengue patient_PBMCs"}, {"characteristics_ch1": "disease state: dengue shock syndrome (DSS);\tSex: F;\tage: 8;\tviral load: 14200;\tcell type: peripheral blood mononuclear cells (PBMCs);\tscanner: 8;\tscan date: 2014-06-18"}]}, {"GSM2677549": [{"title": "patient25"}, {"type": "RNA"}, {"source_name_ch1": "DSS_Dengue patient_PBMCs"}, {"characteristics_ch1": "disease state: dengue shock syndrome (DSS);\tSex: M;\tage: 7;\tviral load: 127000;\tcell type: peripheral blood mononuclear cells (PBMCs);\tscanner: 8;\tscan date: 2014-06-12"}]}, {"GSM2677550": [{"title": "patient26"}, {"type": "RNA"}, {"source_name_ch1": "DFDHF_Dengue patient_PBMCs"}, {"characteristics_ch1": "disease state: dengue fever (DF)/dengue hemorrhagic fever (DHF);\tSex: F;\tage: 4;\tviral load: 440000;\tcell type: peripheral blood mononuclear cells (PBMCs);\tscanner: 2;\tscan date: 2014-06-04"}]}, {"GSM2677551": [{"title": "patient28"}, {"type": "RNA"}, {"source_name_ch1": "DSS_Dengue patient_PBMCs"}, {"characteristics_ch1": "disease state: dengue shock syndrome (DSS);\tSex: F;\tage: 4;\tviral load: 39000;\tcell type: peripheral blood mononuclear cells (PBMCs);\tscanner: 8;\tscan date: 2014-06-04"}]}, {"GSM2677552": [{"title": "patient29"}, {"type": "RNA"}, {"source_name_ch1": "DSS_Dengue patient_PBMCs"}, {"characteristics_ch1": "disease state: dengue shock syndrome (DSS);\tSex: F;\tage: 12;\tviral load: 6810;\tcell type: peripheral blood mononuclear cells (PBMCs);\tscanner: 2;\tscan date: 2014-06-04"}]}, {"GSM2677553": [{"title": "patient30"}, {"type": "RNA"}, {"source_name_ch1": "DFDHF_Dengue patient_PBMCs"}, {"characteristics_ch1": "disease state: dengue fever (DF)/dengue hemorrhagic fever (DHF);\tSex: M;\tage: 13;\tviral load: 160000;\tcell type: peripheral blood mononuclear cells (PBMCs);\tscanner: 8;\tscan date: 2014-06-12"}]}, {"GSM2677554": [{"title": "patient32"}, {"type": "RNA"}, {"source_name_ch1": "DSS_Dengue patient_PBMCs"}, {"characteristics_ch1": "disease state: dengue shock syndrome (DSS);\tSex: F;\tage: 10;\tviral load: 179000;\tcell type: peripheral blood mononuclear cells (PBMCs);\tscanner: 2;\tscan date: 2014-05-22"}]}, {"GSM2677555": [{"title": "patient33"}, {"type": "RNA"}, {"source_name_ch1": "DFDHF_Dengue patient_PBMCs"}, {"characteristics_ch1": "disease state: dengue fever (DF)/dengue hemorrhagic fever (DHF);\tSex: M;\tage: 12;\tviral load: 26900;\tcell type: peripheral blood mononuclear cells (PBMCs);\tscanner: 2;\tscan date: 2014-05-22"}]}, {"GSM2677556": [{"title": "patient34"}, {"type": "RNA"}, {"source_name_ch1": "DFDHF_Dengue patient_PBMCs"}, {"characteristics_ch1": "disease state: dengue fever (DF)/dengue hemorrhagic fever (DHF);\tSex: M;\tage: 8;\tviral load: 45800;\tcell type: peripheral blood mononuclear cells (PBMCs);\tscanner: 8;\tscan date: 2014-05-22"}]}, {"GSM2677557": [{"title": "patient35"}, {"type": "RNA"}, {"source_name_ch1": "DFDHF_Dengue patient_PBMCs"}, {"characteristics_ch1": "disease state: dengue fever (DF)/dengue hemorrhagic fever (DHF);\tSex: F;\tage: 6;\tviral load: 1470;\tcell type: peripheral blood mononuclear cells (PBMCs);\tscanner: 8;\tscan date: 2014-06-06"}]}, {"GSM2677558": [{"title": "patient38"}, {"type": "RNA"}, {"source_name_ch1": "DFDHF_Dengue patient_PBMCs"}, {"characteristics_ch1": "disease state: dengue fever (DF)/dengue hemorrhagic fever (DHF);\tSex: F;\tage: 5;\tviral load: 306000;\tcell type: peripheral blood mononuclear cells (PBMCs);\tscanner: 8;\tscan date: 2014-05-22"}]}, {"GSM2677559": [{"title": "patient41"}, {"type": "RNA"}, {"source_name_ch1": "DFDHF_Dengue patient_PBMCs"}, {"characteristics_ch1": "disease state: dengue fever (DF)/dengue hemorrhagic fever (DHF);\tSex: F;\tage: 9;\tviral load: 5960;\tcell type: peripheral blood mononuclear cells (PBMCs);\tscanner: 2;\tscan date: 2014-06-12"}]}, {"GSM2677560": [{"title": "patient42"}, {"type": "RNA"}, {"source_name_ch1": "DFDHF_Dengue patient_PBMCs"}, {"characteristics_ch1": "disease state: dengue fever (DF)/dengue hemorrhagic fever (DHF);\tSex: F;\tage: 5;\tviral load: 3520;\tcell type: peripheral blood mononuclear cells (PBMCs);\tscanner: 8;\tscan date: 2014-06-04"}]}, {"GSM2677561": [{"title": "patient43"}, {"type": "RNA"}, {"source_name_ch1": "asymptomatic_Dengue patient_PBMCs"}, {"characteristics_ch1": "disease state: asymptomatic;\tSex: F;\tage: 11;\tviral load: 167;\tcell type: peripheral blood mononuclear cells (PBMCs);\tscanner: 8;\tscan date: 2014-06-18"}]}, {"GSM2677562": [{"title": "patient44"}, {"type": "RNA"}, {"source_name_ch1": "asymptomatic_Dengue patient_PBMCs"}, {"characteristics_ch1": "disease state: asymptomatic;\tSex: F;\tage: 10;\tviral load: 625000;\tcell type: peripheral blood mononuclear cells (PBMCs);\tscanner: 2;\tscan date: 2014-06-04"}]}, {"GSM2132158": [{"title": "CD45-/CD34+/CD31- cells from non-obese human adipose SVF JL01_P6_1"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: Progenitor;\tfacs markers: CD45-/CD34+/CD31-;\tweight status: Non-obese;\tpatient number: 1;\tSex: Female"}]}, {"GSM2132159": [{"title": "CD45-/CD34+/CD31- cells from non-obese human adipose SVF JL02_P6_2"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: Progenitor;\tfacs markers: CD45-/CD34+/CD31-;\tweight status: Non-obese;\tpatient number: 2;\tSex: Female"}]}, {"GSM2132160": [{"title": "CD45-/CD34+/CD31- cells from non-obese human adipose SVF JL03_P6_3"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: Progenitor;\tfacs markers: CD45-/CD34+/CD31-;\tweight status: Non-obese;\tpatient number: 3;\tSex: Female"}]}, {"GSM2132161": [{"title": "CD45-/CD34+/CD31- cells from non-obese human adipose SVF JL04_P6_4"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: Progenitor;\tfacs markers: CD45-/CD34+/CD31-;\tweight status: Non-obese;\tpatient number: 4;\tSex: Female"}]}, {"GSM2132162": [{"title": "CD45-/CD34+/CD31- cells from non-obese human adipose SVF JL05_P6_5"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: Progenitor;\tfacs markers: CD45-/CD34+/CD31-;\tweight status: Non-obese;\tpatient number: 5;\tSex: Female"}]}, {"GSM2132163": [{"title": "CD45-/CD34+/CD31- cells from non-obese human adipose SVF JL06_P6_6"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: Progenitor;\tfacs markers: CD45-/CD34+/CD31-;\tweight status: Non-obese;\tpatient number: 6;\tSex: Female"}]}, {"GSM2132164": [{"title": "CD45-/CD34+/CD31- cells from non-obese human adipose SVF JL07_P6_7"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: Progenitor;\tfacs markers: CD45-/CD34+/CD31-;\tweight status: Non-obese;\tpatient number: 7;\tSex: Female"}]}, {"GSM2132165": [{"title": "CD45-/CD34+/CD31- cells from non-obese human adipose SVF JL08_P6_8"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: Progenitor;\tfacs markers: CD45-/CD34+/CD31-;\tweight status: Non-obese;\tpatient number: 8;\tSex: Female"}]}, {"GSM2132166": [{"title": "CD45-/CD34+/CD31- cells from non-obese human adipose SVF JL09_P6_9"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: Progenitor;\tfacs markers: CD45-/CD34+/CD31-;\tweight status: Non-obese;\tpatient number: 9;\tSex: Female"}]}, {"GSM2132167": [{"title": "CD45-/CD34+/CD31- cells from non-obese human adipose SVF JL10_P6_10"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: Progenitor;\tfacs markers: CD45-/CD34+/CD31-;\tweight status: Non-obese;\tpatient number: 10;\tSex: Female"}]}, {"GSM2132168": [{"title": "CD45-/CD34+/CD31- cells from obese human adipose SVF JL11_P6_11"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: Progenitor;\tfacs markers: CD45-/CD34+/CD31-;\tweight status: Obese;\tpatient number: 11;\tSex: Female"}]}, {"GSM2132169": [{"title": "CD45-/CD34+/CD31- cells from obese human adipose SVF JL12_P6_12"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: Progenitor;\tfacs markers: CD45-/CD34+/CD31-;\tweight status: Obese;\tpatient number: 12;\tSex: Female"}]}, {"GSM2132170": [{"title": "CD45-/CD34+/CD31- cells from obese human adipose SVF JL13_P6_13"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: Progenitor;\tfacs markers: CD45-/CD34+/CD31-;\tweight status: Obese;\tpatient number: 13;\tSex: Female"}]}, {"GSM2132171": [{"title": "CD45-/CD34+/CD31- cells from obese human adipose SVF JL14_P6_14"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: Progenitor;\tfacs markers: CD45-/CD34+/CD31-;\tweight status: Obese;\tpatient number: 14;\tSex: Female"}]}, {"GSM2132172": [{"title": "CD45-/CD34+/CD31- cells from obese human adipose SVF JL15_P6_15"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: Progenitor;\tfacs markers: CD45-/CD34+/CD31-;\tweight status: Obese;\tpatient number: 15;\tSex: Female"}]}, {"GSM2132173": [{"title": "CD45-/CD34+/CD31- cells from obese human adipose SVF JL16_P6_16"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: Progenitor;\tfacs markers: CD45-/CD34+/CD31-;\tweight status: Obese;\tpatient number: 16;\tSex: Male"}]}, {"GSM2132174": [{"title": "CD45-/CD34+/CD31- cells from obese human adipose SVF JL17_P6_17"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: Progenitor;\tfacs markers: CD45-/CD34+/CD31-;\tweight status: Obese;\tpatient number: 17;\tSex: Female"}]}, {"GSM2132175": [{"title": "CD45-/CD34+/CD31- cells from obese human adipose SVF JL18_P6_18"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: Progenitor;\tfacs markers: CD45-/CD34+/CD31-;\tweight status: Obese;\tpatient number: 18;\tSex: Male"}]}, {"GSM2132176": [{"title": "CD45-/CD34+/CD31- cells from obese human adipose SVF JL19_P6_19"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: Progenitor;\tfacs markers: CD45-/CD34+/CD31-;\tweight status: Obese;\tpatient number: 19;\tSex: Female"}]}, {"GSM2132177": [{"title": "CD45+/CD14+ cells from non-obese human adipose SVF JL20_P8_1"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: Monocyte/Macrophage;\tfacs markers: CD45+/CD14+;\tweight status: Non-obese;\tpatient number: 1;\tSex: Female"}]}, {"GSM2132178": [{"title": "CD45+/CD14+ cells from non-obese human adipose SVF JL21_P8_2"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: Monocyte/Macrophage;\tfacs markers: CD45+/CD14+;\tweight status: Non-obese;\tpatient number: 2;\tSex: Female"}]}, {"GSM2132179": [{"title": "CD45+/CD14+ cells from non-obese human adipose SVF JL22_P8_3"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: Monocyte/Macrophage;\tfacs markers: CD45+/CD14+;\tweight status: Non-obese;\tpatient number: 3;\tSex: Female"}]}, {"GSM2132180": [{"title": "CD45+/CD14+ cells from non-obese human adipose SVF JL23_P8_4"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: Monocyte/Macrophage;\tfacs markers: CD45+/CD14+;\tweight status: Non-obese;\tpatient number: 4;\tSex: Female"}]}, {"GSM2132181": [{"title": "CD45+/CD14+ cells from non-obese human adipose SVF JL24_P8_5"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: Monocyte/Macrophage;\tfacs markers: CD45+/CD14+;\tweight status: Non-obese;\tpatient number: 5;\tSex: Female"}]}, {"GSM2132182": [{"title": "CD45+/CD14+ cells from non-obese human adipose SVF JL25_P8_6"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: Monocyte/Macrophage;\tfacs markers: CD45+/CD14+;\tweight status: Non-obese;\tpatient number: 6;\tSex: Female"}]}, {"GSM2132183": [{"title": "CD45+/CD14- cells from non-obese human adipose SVF JL26_P9_1"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: Leukocyte;\tfacs markers: CD45+/CD14-;\tweight status: Non-obese;\tpatient number: 1;\tSex: Female"}]}, {"GSM2132184": [{"title": "CD45+/CD14- cells from non-obese human adipose SVF JL27_P9_2"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: Leukocyte;\tfacs markers: CD45+/CD14-;\tweight status: Non-obese;\tpatient number: 2;\tSex: Female"}]}, {"GSM2132185": [{"title": "CD45+/CD14- cells from non-obese human adipose SVF JL28_P9_3"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: Leukocyte;\tfacs markers: CD45+/CD14-;\tweight status: Non-obese;\tpatient number: 3;\tSex: Female"}]}, {"GSM2132186": [{"title": "CD45+/CD14- cells from non-obese human adipose SVF JL29_P9_4"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: Leukocyte;\tfacs markers: CD45+/CD14-;\tweight status: Non-obese;\tpatient number: 4;\tSex: Female"}]}, {"GSM2132187": [{"title": "CD45+/CD14- cells from non-obese human adipose SVF JL30_P9_5"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: Leukocyte;\tfacs markers: CD45+/CD14-;\tweight status: Non-obese;\tpatient number: 5;\tSex: Female"}]}, {"GSM2132188": [{"title": "CD45+/CD14- cells from non-obese human adipose SVF JL31_P9_6"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: Leukocyte;\tfacs markers: CD45+/CD14-;\tweight status: Non-obese;\tpatient number: 6;\tSex: Female"}]}, {"GSM2132189": [{"title": "SVF cells from non-obese human adipose tissue JL32_SVF_1"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: SVF;\tfacs markers: Collagenase pellet;\tweight status: Non-obese;\tpatient number: 1;\tSex: Female"}]}, {"GSM2132190": [{"title": "SVF cells from non-obese human adipose tissue JL33_SVF_2"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: SVF;\tfacs markers: Collagenase pellet;\tweight status: Non-obese;\tpatient number: 2;\tSex: Female"}]}, {"GSM2132191": [{"title": "SVF cells from non-obese human adipose tissue JL34_SVF_3"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: SVF;\tfacs markers: Collagenase pellet;\tweight status: Non-obese;\tpatient number: 3;\tSex: Female"}]}, {"GSM2132192": [{"title": "SVF cells from non-obese human adipose tissue JL35_SVF_4"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: SVF;\tfacs markers: Collagenase pellet;\tweight status: Non-obese;\tpatient number: 4;\tSex: Female"}]}, {"GSM2132193": [{"title": "SVF cells from non-obese human adipose tissue JL36_SVF_5"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: SVF;\tfacs markers: Collagenase pellet;\tweight status: Non-obese;\tpatient number: 5;\tSex: Female"}]}, {"GSM2132194": [{"title": "SVF cells from non-obese human adipose tissue JL37_SVF_6"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: SVF;\tfacs markers: Collagenase pellet;\tweight status: Non-obese;\tpatient number: 6;\tSex: Female"}]}, {"GSM2132195": [{"title": "Adipocytes from non-obese human adipose tissue JL38_M_1"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: Adipocyte;\tfacs markers: Collagenase float;\tweight status: Non-obese;\tpatient number: 1;\tSex: Female"}]}, {"GSM2132196": [{"title": "Adipocytes from non-obese human adipose tissue JL39_M_2"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: Adipocyte;\tfacs markers: Collagenase float;\tweight status: Non-obese;\tpatient number: 2;\tSex: Female"}]}, {"GSM2132197": [{"title": "Adipocytes from non-obese human adipose tissue JL40_M_3"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: Adipocyte;\tfacs markers: Collagenase float;\tweight status: Non-obese;\tpatient number: 3;\tSex: Female"}]}, {"GSM2132198": [{"title": "Adipocytes from non-obese human adipose tissue JL41_M_4"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: Adipocyte;\tfacs markers: Collagenase float;\tweight status: Non-obese;\tpatient number: 4;\tSex: Female"}]}, {"GSM2132199": [{"title": "Adipocytes from non-obese human adipose tissue JL42_M_5"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: Adipocyte;\tfacs markers: Collagenase float;\tweight status: Non-obese;\tpatient number: 5;\tSex: Female"}]}, {"GSM2132200": [{"title": "Adipocytes from non-obese human adipose tissue JL43_M_6"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: Adipocyte;\tfacs markers: Collagenase float;\tweight status: Non-obese;\tpatient number: 6;\tSex: Female"}]}, {"GSM2252288": [{"title": "HFC6 PI flat undifferentiated cells"}, {"type": "RNA"}, {"source_name_ch1": "Fibroblasts obtained from foreskin"}, {"characteristics_ch1": "donor: Human Fibroblasts donor A;\tcell type: induced Pluripotent Stem Cells (iPSCs);\tseeded on: non-structured polyimide (PI flat) substrate;\tdifferentiation status: undifferentiated cells"}]}, {"GSM2252289": [{"title": "HFC6 PI 650 undifferentiated cells"}, {"type": "RNA"}, {"source_name_ch1": "Fibroblasts obtained from foreskin"}, {"characteristics_ch1": "donor: Human Fibroblasts donor A;\tcell type: induced Pluripotent Stem Cells (iPSCs);\tseeded on: nanogrooved polyimide (PI 650) substrate;\tdifferentiation status: undifferentiated cells"}]}, {"GSM2252290": [{"title": "HFC6 PI flat differentiated cells"}, {"type": "RNA"}, {"source_name_ch1": "Fibroblasts obtained from foreskin"}, {"characteristics_ch1": "donor: Human Fibroblasts donor A;\tcell type: induced Pluripotent Stem Cells (iPSCs);\tseeded on: non-structured polyimide (PI flat) substrate;\tdifferentiation status: differentiated cells"}]}, {"GSM2252291": [{"title": "HFC6 PI 650 differentiated cells"}, {"type": "RNA"}, {"source_name_ch1": "Fibroblasts obtained from foreskin"}, {"characteristics_ch1": "donor: Human Fibroblasts donor A;\tcell type: induced Pluripotent Stem Cells (iPSCs);\tseeded on: nanogrooved polyimide (PI 650) substrate;\tdifferentiation status: differentiated cells"}]}, {"GSM2252292": [{"title": "BM102C2 PI flat undifferentiated cells"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow derived Mesenchymal Stem Cells"}, {"characteristics_ch1": "donor: Bone marrow donor 102;\tcell type: induced Pluripotent Stem Cells (iPSCs);\tseeded on: non-structured polyimide (PI flat) substrate;\tdifferentiation status: undifferentiated cells"}]}, {"GSM2252293": [{"title": "BM102C2 PI 650 undifferentiated cells"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow derived Mesenchymal Stem Cells"}, {"characteristics_ch1": "donor: Bone marrow donor 102;\tcell type: induced Pluripotent Stem Cells (iPSCs);\tseeded on: nanogrooved polyimide (PI 650) substrate;\tdifferentiation status: undifferentiated cells"}]}, {"GSM2252294": [{"title": "BM102C2 PI flat differentiated cells"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow derived Mesenchymal Stem Cells"}, {"characteristics_ch1": "donor: Bone marrow donor 102;\tcell type: induced Pluripotent Stem Cells (iPSCs);\tseeded on: non-structured polyimide (PI flat) substrate;\tdifferentiation status: differentiated cells"}]}, {"GSM2252295": [{"title": "BM102C2 PI 650 differentiated cells"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow derived Mesenchymal Stem Cells"}, {"characteristics_ch1": "donor: Bone marrow donor 102;\tcell type: induced Pluripotent Stem Cells (iPSCs);\tseeded on: nanogrooved polyimide (PI 650) substrate;\tdifferentiation status: differentiated cells"}]}, {"GSM2252296": [{"title": "BM104C3 PI flat undifferentiated cells"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow derived Mesenchymal Stem Cells"}, {"characteristics_ch1": "donor: Bone marrow donor 104;\tcell type: induced Pluripotent Stem Cells (iPSCs);\tseeded on: non-structured polyimide (PI flat) substrate;\tdifferentiation status: undifferentiated cells"}]}, {"GSM2252297": [{"title": "BM104C3 PI 650 undifferentiated cells"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow derived Mesenchymal Stem Cells"}, {"characteristics_ch1": "donor: Bone marrow donor 104;\tcell type: induced Pluripotent Stem Cells (iPSCs);\tseeded on: nanogrooved polyimide (PI 650) substrate;\tdifferentiation status: undifferentiated cells"}]}, {"GSM2252298": [{"title": "BM104C3 PI flat differentiated cells"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow derived Mesenchymal Stem Cells"}, {"characteristics_ch1": "donor: Bone marrow donor 104;\tcell type: induced Pluripotent Stem Cells (iPSCs);\tseeded on: non-structured polyimide (PI flat) substrate;\tdifferentiation status: differentiated cells"}]}, {"GSM2252299": [{"title": "BM104C3 PI 650 differentiated cells"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow derived Mesenchymal Stem Cells"}, {"characteristics_ch1": "donor: Bone marrow donor 104;\tcell type: induced Pluripotent Stem Cells (iPSCs);\tseeded on: nanogrooved polyimide (PI 650) substrate;\tdifferentiation status: differentiated cells"}]}, {"GSM2587057": [{"title": "Adipocytes from non-obese human adipose tissue [JL44_M_8]"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: Adipocyte;\tfacs markers: Collagenase float;\tweight status: Non-obese;\tpatient number: 8"}]}, {"GSM2587058": [{"title": "Adipocytes from obese human adipose tissue [JL45_M_11]"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: Adipocyte;\tfacs markers: Collagenase float;\tweight status: Obese;\tpatient number: 11"}]}, {"GSM2587059": [{"title": "Adipocytes from obese human adipose tissue [JL46_M_12]"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: Adipocyte;\tfacs markers: Collagenase float;\tweight status: Obese;\tpatient number: 12"}]}, {"GSM2587060": [{"title": "Adipocytes from obese human adipose tissue [JL47_M_13]"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: Adipocyte;\tfacs markers: Collagenase float;\tweight status: Obese;\tpatient number: 13"}]}, {"GSM2587061": [{"title": "Adipocytes from obese human adipose tissue [JL48_M_14]"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: Adipocyte;\tfacs markers: Collagenase float;\tweight status: Obese;\tpatient number: 14"}]}, {"GSM2587062": [{"title": "Adipocytes from obese human adipose tissue [JL49_M_15]"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: Adipocyte;\tfacs markers: Collagenase float;\tweight status: Obese;\tpatient number: 15"}]}, {"GSM2587063": [{"title": "Adipocytes from obese human adipose tissue [JL50_M_16]"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: Adipocyte;\tfacs markers: Collagenase float;\tweight status: Obese;\tpatient number: 16"}]}, {"GSM2587064": [{"title": "Adipocytes from obese human adipose tissue [JL51_M_17]"}, {"type": "RNA"}, {"source_name_ch1": "Subcutaneous white adipose tissue"}, {"characteristics_ch1": "cell type: Adipocyte;\tfacs markers: Collagenase float;\tweight status: Obese;\tpatient number: 17"}]}, {"GSM2786992": [{"title": "KMS11minus_1"}, {"type": "RNA"}, {"source_name_ch1": "MM KMS11 Cell Line"}, {"characteristics_ch1": "cell type: Multiple myeloma cell line KMS11"}]}, {"GSM2786993": [{"title": "KMS11minus_2"}, {"type": "RNA"}, {"source_name_ch1": "MM KMS11 Cell Line"}, {"characteristics_ch1": "cell type: Multiple myeloma cell line KMS11"}]}, {"GSM2786994": [{"title": "KMS11plus2_5uM_1"}, {"type": "RNA"}, {"source_name_ch1": "MM KMS11 Cell Line"}, {"characteristics_ch1": "cell type: Multiple myeloma cell line KMS11 with EPZ025666 treatment"}]}, {"GSM2786995": [{"title": "KMS11plus2_5uM_2"}, {"type": "RNA"}, {"source_name_ch1": "MM KMS11 Cell Line"}, {"characteristics_ch1": "cell type: Multiple myeloma cell line KMS11 with EPZ025666 treatment"}]}, {"GSM2787196": [{"title": "Thymus sample 1, Grade 1-4"}, {"type": "RNA"}, {"source_name_ch1": "myasthenia gravis thymus"}, {"characteristics_ch1": "tissue: Thymus;\tgrade: Grade 1-4;\tmorphology: Germinal Center"}]}, {"GSM2787197": [{"title": "Thymus sample 2, Grade 1-4"}, {"type": "RNA"}, {"source_name_ch1": "myasthenia gravis thymus"}, {"characteristics_ch1": "tissue: Thymus;\tgrade: Grade 1-4;\tmorphology: Germinal Center"}]}, {"GSM2787198": [{"title": "Thymus sample 3, Grade 1-4"}, {"type": "RNA"}, {"source_name_ch1": "myasthenia gravis thymus"}, {"characteristics_ch1": "tissue: Thymus;\tgrade: Grade 1-4;\tmorphology: Germinal Center"}]}, {"GSM2787199": [{"title": "Thymus sample 4, Grade 1-4"}, {"type": "RNA"}, {"source_name_ch1": "myasthenia gravis thymus"}, {"characteristics_ch1": "tissue: Thymus;\tgrade: Grade 1-4;\tmorphology: Germinal Center"}]}, {"GSM2787200": [{"title": "Thymus sample 6, Grade 0"}, {"type": "RNA"}, {"source_name_ch1": "myasthenia gravis thymus"}, {"characteristics_ch1": "tissue: Thymus;\tgrade: Grade 0;\tmorphology: No Germinal Center"}]}, {"GSM2787201": [{"title": "Thymus sample 7, Grade 0"}, {"type": "RNA"}, {"source_name_ch1": "myasthenia gravis thymus"}, {"characteristics_ch1": "tissue: Thymus;\tgrade: Grade 0;\tmorphology: No Germinal Center"}]}, {"GSM2787202": [{"title": "Thymus sample 8, Grade 1-4"}, {"type": "RNA"}, {"source_name_ch1": "myasthenia gravis thymus"}, {"characteristics_ch1": "tissue: Thymus;\tgrade: Grade 1-4;\tmorphology: Germinal Center"}]}, {"GSM2787203": [{"title": "Thymus sample 9, Grade 0"}, {"type": "RNA"}, {"source_name_ch1": "myasthenia gravis thymus"}, {"characteristics_ch1": "tissue: Thymus;\tgrade: Grade 0;\tmorphology: No Germinal Center"}]}, {"GSM2787204": [{"title": "Thymus sample 10, Grade 0"}, {"type": "RNA"}, {"source_name_ch1": "myasthenia gravis thymus"}, {"characteristics_ch1": "tissue: Thymus;\tgrade: Grade 0;\tmorphology: No Germinal Center"}]}, {"GSM2787205": [{"title": "Thymus sample 11, Grade 0"}, {"type": "RNA"}, {"source_name_ch1": "myasthenia gravis thymus"}, {"characteristics_ch1": "tissue: Thymus;\tgrade: Grade 0;\tmorphology: No Germinal Center"}]}, {"GSM2787206": [{"title": "Thymus sample 12, Grade 1-4"}, {"type": "RNA"}, {"source_name_ch1": "myasthenia gravis thymus"}, {"characteristics_ch1": "tissue: Thymus;\tgrade: Grade 1-4;\tmorphology: Germinal Center"}]}, {"GSM2787207": [{"title": "Thymus sample 13, Grade 0"}, {"type": "RNA"}, {"source_name_ch1": "myasthenia gravis thymus"}, {"characteristics_ch1": "tissue: Thymus;\tgrade: Grade 0;\tmorphology: No Germinal Center"}]}, {"GSM2787208": [{"title": "Thymus sample 14, Grade 1-4"}, {"type": "RNA"}, {"source_name_ch1": "myasthenia gravis thymus"}, {"characteristics_ch1": "tissue: Thymus;\tgrade: Grade 1-4;\tmorphology: Germinal Center"}]}, {"GSM2140556": [{"title": "CONTROL_1"}, {"type": "RNA"}, {"source_name_ch1": "MCF7"}, {"characteristics_ch1": "source: Luminal"}]}, {"GSM2140557": [{"title": "CONTROL_2"}, {"type": "RNA"}, {"source_name_ch1": "MCF7"}, {"characteristics_ch1": "source: Luminal"}]}, {"GSM2140558": [{"title": "BORIS_1"}, {"type": "RNA"}, {"source_name_ch1": "MCF7"}, {"characteristics_ch1": "source: Luminal"}]}, {"GSM2140559": [{"title": "BORIS_2"}, {"type": "RNA"}, {"source_name_ch1": "MCF7"}, {"characteristics_ch1": "source: Luminal"}]}, {"GSM2671180": [{"title": "cont1"}, {"type": "RNA"}, {"source_name_ch1": "Human choriocarcinoma cell line"}, {"characteristics_ch1": "cell line: BeWo;\tcell type: choriocarcinoma cell line;\ttreatment: none"}]}, {"GSM2671181": [{"title": "cont2"}, {"type": "RNA"}, {"source_name_ch1": "Human choriocarcinoma cell line"}, {"characteristics_ch1": "cell line: BeWo;\tcell type: choriocarcinoma cell line;\ttreatment: none"}]}, {"GSM2671182": [{"title": "cont3"}, {"type": "RNA"}, {"source_name_ch1": "Human choriocarcinoma cell line"}, {"characteristics_ch1": "cell line: BeWo;\tcell type: choriocarcinoma cell line;\ttreatment: none"}]}, {"GSM2671183": [{"title": "epac1"}, {"type": "RNA"}, {"source_name_ch1": "Human choriocarcinoma cell line"}, {"characteristics_ch1": "cell line: BeWo;\tcell type: choriocarcinoma cell line;\ttreatment: 8-(4-chlorophenyltio)-2'-O-methyl cAMP"}]}, {"GSM2671184": [{"title": "epac2"}, {"type": "RNA"}, {"source_name_ch1": "Human choriocarcinoma cell line"}, {"characteristics_ch1": "cell line: BeWo;\tcell type: choriocarcinoma cell line;\ttreatment: 8-(4-chlorophenyltio)-2'-O-methyl cAMP"}]}, {"GSM2671185": [{"title": "epac3"}, {"type": "RNA"}, {"source_name_ch1": "Human choriocarcinoma cell line"}, {"characteristics_ch1": "cell line: BeWo;\tcell type: choriocarcinoma cell line;\ttreatment: 8-(4-chlorophenyltio)-2'-O-methyl cAMP"}]}, {"GSM2671186": [{"title": "pka1"}, {"type": "RNA"}, {"source_name_ch1": "Human choriocarcinoma cell line"}, {"characteristics_ch1": "cell line: BeWo;\tcell type: choriocarcinoma cell line;\ttreatment: N6-phenyl-cAMP"}]}, {"GSM2671187": [{"title": "pka2"}, {"type": "RNA"}, {"source_name_ch1": "Human choriocarcinoma cell line"}, {"characteristics_ch1": "cell line: BeWo;\tcell type: choriocarcinoma cell line;\ttreatment: N6-phenyl-cAMP"}]}, {"GSM2671188": [{"title": "pka3"}, {"type": "RNA"}, {"source_name_ch1": "Human choriocarcinoma cell line"}, {"characteristics_ch1": "cell line: BeWo;\tcell type: choriocarcinoma cell line;\ttreatment: N6-phenyl-cAMP"}]}, {"GSM2795553": [{"title": "1_Human LAM_shGFP_DMSO [gene expression]"}, {"type": "RNA"}, {"source_name_ch1": "human LAM_shGFP_DMSO"}, {"characteristics_ch1": "Sex: female;\tcell line: LAM 621-101;\tcell type: Lymphangioleiomyomatosis cell line;\tgenotype/variation: stably expressing shRNA targeting GFP (pLKO-puro-shGFP);\ttreated with: DMSO (vehicle control) for 24hrs"}]}, {"GSM2795554": [{"title": "2_Human LAM_shGFP_DMSO [gene expression]"}, {"type": "RNA"}, {"source_name_ch1": "human LAM_shGFP_DMSO"}, {"characteristics_ch1": "Sex: female;\tcell line: LAM 621-101;\tcell type: Lymphangioleiomyomatosis cell line;\tgenotype/variation: stably expressing shRNA targeting GFP (pLKO-puro-shGFP);\ttreated with: DMSO (vehicle control) for 24hrs"}]}, {"GSM2795555": [{"title": "3_Human LAM_shGFP_DMSO [gene expression]"}, {"type": "RNA"}, {"source_name_ch1": "human LAM_shGFP_DMSO"}, {"characteristics_ch1": "Sex: female;\tcell line: LAM 621-101;\tcell type: Lymphangioleiomyomatosis cell line;\tgenotype/variation: stably expressing shRNA targeting GFP (pLKO-puro-shGFP);\ttreated with: DMSO (vehicle control) for 24hrs"}]}, {"GSM2795556": [{"title": "4_Human LAM_shGFP_rapamycin [gene expression]"}, {"type": "RNA"}, {"source_name_ch1": "human LAM_shGFP_rapamycin"}, {"characteristics_ch1": "Sex: female;\tcell line: LAM 621-101;\tcell type: Lymphangioleiomyomatosis cell line;\tgenotype/variation: stably expressing shRNA targeting GFP (pLKO-puro-shGFP);\ttreated with: 100 nM rapamycin for 24 hr"}]}, {"GSM2795557": [{"title": "5_Human LAM_shGFP_rapamycin [gene expression]"}, {"type": "RNA"}, {"source_name_ch1": "human LAM_shGFP_rapamycin"}, {"characteristics_ch1": "Sex: female;\tcell line: LAM 621-101;\tcell type: Lymphangioleiomyomatosis cell line;\tgenotype/variation: stably expressing shRNA targeting GFP (pLKO-puro-shGFP);\ttreated with: 100 nM rapamycin for 24 hr"}]}, {"GSM2795558": [{"title": "6_Human LAM_shGFP_rapamycin [gene expression]"}, {"type": "RNA"}, {"source_name_ch1": "human LAM_shGFP_rapamycin"}, {"characteristics_ch1": "Sex: female;\tcell line: LAM 621-101;\tcell type: Lymphangioleiomyomatosis cell line;\tgenotype/variation: stably expressing shRNA targeting GFP (pLKO-puro-shGFP);\ttreated with: 100 nM rapamycin for 24 hr"}]}, {"GSM2795559": [{"title": "7_Human LAM_shSRPK2_DMSO [gene expression]"}, {"type": "RNA"}, {"source_name_ch1": "human LAM_shSRPK2_DMSO"}, {"characteristics_ch1": "Sex: female;\tcell line: LAM 621-101;\tcell type: Lymphangioleiomyomatosis cell line;\tgenotype/variation: stably expressing shRNA targeting SRPK2 (pLKO-puro-shSRPK2);\ttreated with: DMSO (vehicle control) for 24hrs"}]}, {"GSM2795560": [{"title": "8_Human LAM_shSRPK2_DMSO [gene expression]"}, {"type": "RNA"}, {"source_name_ch1": "human LAM_shSRPK2_DMSO"}, {"characteristics_ch1": "Sex: female;\tcell line: LAM 621-101;\tcell type: Lymphangioleiomyomatosis cell line;\tgenotype/variation: stably expressing shRNA targeting SRPK2 (pLKO-puro-shSRPK2);\ttreated with: DMSO (vehicle control) for 24hrs"}]}, {"GSM2795561": [{"title": "9_Human LAM_shSRPK2_DMSO [gene expression]"}, {"type": "RNA"}, {"source_name_ch1": "human LAM_shSRPK2_DMSO"}, {"characteristics_ch1": "Sex: female;\tcell line: LAM 621-101;\tcell type: Lymphangioleiomyomatosis cell line;\tgenotype/variation: stably expressing shRNA targeting SRPK2 (pLKO-puro-shSRPK2);\ttreated with: DMSO (vehicle control) for 24hrs"}]}, {"GSM2510289": [{"title": "Parental cell lines"}, {"type": "RNA"}, {"source_name_ch1": "Parental NCI-N87 cells"}, {"characteristics_ch1": "cell type: gastric carcinoma cell;\tcell line: NCI-N87"}]}, {"GSM2510290": [{"title": "TDM-1 resistant cell lines"}, {"type": "RNA"}, {"source_name_ch1": "TDM-1 resistant cell lines"}, {"characteristics_ch1": "cell type: gastric carcinoma cell;\tcell line: NCI-N87"}]}, {"GSM2828279": [{"title": "231_shNC"}, {"type": "RNA"}, {"source_name_ch1": "231 cells, stably transfected with pLKO.1 vector"}, {"characteristics_ch1": "cell line: MDA-MB-231;\tgenotype: control"}]}, {"GSM2828280": [{"title": "231_shSREBP1"}, {"type": "RNA"}, {"source_name_ch1": "231 cells, stably transfected with pLKO.1-shSREBP vector"}, {"characteristics_ch1": "cell line: MDA-MB-231;\tgenotype: SREBP1 KD"}]}, {"GSM2375323": [{"title": "Finite ccRCC line, UT13 of P3"}, {"type": "RNA"}, {"source_name_ch1": "Finite ccRCC line, UT13 of P3"}, {"characteristics_ch1": "gender: male;\ttissue: clear cell renal cell carcinoma;\ttumor stage: I;\tpassage number in vitro: 7"}]}, {"GSM2375324": [{"title": "Finite ccRCC line, UT27 of P3"}, {"type": "RNA"}, {"source_name_ch1": "Finite ccRCC line, UT27 of P3"}, {"characteristics_ch1": "gender: female;\ttissue: clear cell renal cell carcinoma;\ttumor stage: I-II;\tpassage number in vitro: 11"}]}, {"GSM2375325": [{"title": "Finite ccRCC line, UT37 of P2"}, {"type": "RNA"}, {"source_name_ch1": "Finite ccRCC line, UT37 of P2"}, {"characteristics_ch1": "gender: male;\ttissue: clear cell renal cell carcinoma;\ttumor stage: II;\tpassage number in vitro: 4"}]}, {"GSM2375326": [{"title": "Finite ccRCC line, UT41 of P2"}, {"type": "RNA"}, {"source_name_ch1": "Finite ccRCC line, UT41 of P2"}, {"characteristics_ch1": "gender: female;\ttissue: clear cell renal cell carcinoma;\ttumor stage: III;\tpassage number in vitro: 5"}]}, {"GSM2375327": [{"title": "Finite ccRCC line, UT54 of P3"}, {"type": "RNA"}, {"source_name_ch1": "Finite ccRCC line, UT54 of P3"}, {"characteristics_ch1": "gender: male;\ttissue: clear cell renal cell carcinoma;\ttumor stage: II;\tpassage number in vitro: 6"}]}, {"GSM2375328": [{"title": "Stable ccRCC line, UT14 of P2"}, {"type": "RNA"}, {"source_name_ch1": "Stable ccRCC line, UT14 of P2"}, {"characteristics_ch1": "gender: male;\ttissue: clear cell renal cell carcinoma;\ttumor stage: II;\tpassage number in vitro: 42"}]}, {"GSM2375329": [{"title": "Stable ccRCC line, UT14 of P18"}, {"type": "RNA"}, {"source_name_ch1": "Stable ccRCC line, UT14 of P18"}, {"characteristics_ch1": "gender: male;\ttissue: clear cell renal cell carcinoma;\ttumor stage: II;\tpassage number in vitro: 42"}]}, {"GSM2375330": [{"title": "Stable ccRCC line, UT14 of P38"}, {"type": "RNA"}, {"source_name_ch1": "Stable ccRCC line, UT14 of P38"}, {"characteristics_ch1": "gender: male;\ttissue: clear cell renal cell carcinoma;\ttumor stage: II;\tpassage number in vitro: 42"}]}, {"GSM2375331": [{"title": "Stable ccRCC line, UT16 of P2"}, {"type": "RNA"}, {"source_name_ch1": "Stable ccRCC line, UT16 of P2"}, {"characteristics_ch1": "gender: female;\ttissue: clear cell renal cell carcinoma;\ttumor stage: I;\tpassage number in vitro: 40"}]}, {"GSM2375332": [{"title": "Stable ccRCC line, UT33a of P3"}, {"type": "RNA"}, {"source_name_ch1": "Stable ccRCC line, UT33a of P3"}, {"characteristics_ch1": "gender: female;\ttissue: clear cell renal cell carcinoma;\ttumor stage: I-II;\tpassage number in vitro: 40"}]}, {"GSM2375333": [{"title": "Stable ccRCC line, UT48 of P2"}, {"type": "RNA"}, {"source_name_ch1": "Stable ccRCC line, UT48 of P2"}, {"characteristics_ch1": "gender: male;\ttissue: clear cell renal cell carcinoma;\ttumor stage: III;\tpassage number in vitro: 40"}]}, {"GSM2375334": [{"title": "Stable ccRCC line, UT56 of P1"}, {"type": "RNA"}, {"source_name_ch1": "Stable ccRCC line, UT56 of P1"}, {"characteristics_ch1": "gender: male;\ttissue: clear cell renal cell carcinoma;\ttumor stage: II;\tpassage number in vitro: 26"}]}, {"GSM2858677": [{"title": "1V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858678": [{"title": "2"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes + carboplatin;\tpathological complete response: no"}]}, {"GSM2858679": [{"title": "2V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858680": [{"title": "3"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: yes"}]}, {"GSM2858681": [{"title": "3V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858682": [{"title": "4"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes + carboplatin;\tpathological complete response: yes"}]}, {"GSM2858683": [{"title": "4V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: yes"}]}, {"GSM2858684": [{"title": "5"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858685": [{"title": "5V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858686": [{"title": "6"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes + carboplatin;\tpathological complete response: no"}]}, {"GSM2858687": [{"title": "6V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858688": [{"title": "7A"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes + carboplatin;\tpathological complete response: no"}]}, {"GSM2858689": [{"title": "7V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858690": [{"title": "8"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes + carboplatin;\tpathological complete response: yes"}]}, {"GSM2858691": [{"title": "8V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858692": [{"title": "9"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes + carboplatin;\tpathological complete response: no"}]}, {"GSM2858693": [{"title": "9V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858694": [{"title": "10"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes + carboplatin;\tpathological complete response: no"}]}, {"GSM2858695": [{"title": "10V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858696": [{"title": "11"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858697": [{"title": "11V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: yes"}]}, {"GSM2858698": [{"title": "12V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858699": [{"title": "13"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes + carboplatin;\tpathological complete response: no"}]}, {"GSM2858700": [{"title": "14"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858701": [{"title": "15"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes + carboplatin;\tpathological complete response: no"}]}, {"GSM2858702": [{"title": "16"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: yes"}]}, {"GSM2858703": [{"title": "16V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858704": [{"title": "17V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: yes"}]}, {"GSM2858705": [{"title": "18"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes + carboplatin;\tpathological complete response: no"}]}, {"GSM2858706": [{"title": "18V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: yes"}]}, {"GSM2858707": [{"title": "19"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes + carboplatin;\tpathological complete response: yes"}]}, {"GSM2858708": [{"title": "19V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858709": [{"title": "20V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858710": [{"title": "21V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858711": [{"title": "22A"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes + carboplatin;\tpathological complete response: yes"}]}, {"GSM2858712": [{"title": "22V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: yes"}]}, {"GSM2858713": [{"title": "23"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes + carboplatin;\tpathological complete response: no"}]}, {"GSM2858714": [{"title": "23V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858715": [{"title": "24"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858716": [{"title": "25"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes + carboplatin;\tpathological complete response: yes"}]}, {"GSM2858717": [{"title": "25V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858718": [{"title": "26"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes + carboplatin;\tpathological complete response: yes"}]}, {"GSM2858719": [{"title": "26V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: yes"}]}, {"GSM2858720": [{"title": "27"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858721": [{"title": "27V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858722": [{"title": "28B"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: yes"}]}, {"GSM2858723": [{"title": "28V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858724": [{"title": "29V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858725": [{"title": "30"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858726": [{"title": "30V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes + carboplatin;\tpathological complete response: no"}]}, {"GSM2858727": [{"title": "31"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes + carboplatin;\tpathological complete response: no"}]}, {"GSM2858728": [{"title": "31V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: yes"}]}, {"GSM2858729": [{"title": "32"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes + carboplatin;\tpathological complete response: yes"}]}, {"GSM2858730": [{"title": "32V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: yes"}]}, {"GSM2858731": [{"title": "33"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: yes"}]}, {"GSM2858732": [{"title": "33V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: yes"}]}, {"GSM2858733": [{"title": "34"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858734": [{"title": "34V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: yes"}]}, {"GSM2858735": [{"title": "35"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: yes"}]}, {"GSM2858736": [{"title": "35V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: yes"}]}, {"GSM2858737": [{"title": "36B"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858738": [{"title": "36V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858739": [{"title": "37"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes + carboplatin;\tpathological complete response: no"}]}, {"GSM2858740": [{"title": "38"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858741": [{"title": "38V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858742": [{"title": "39"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes + carboplatin;\tpathological complete response: no"}]}, {"GSM2858743": [{"title": "39V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: yes"}]}, {"GSM2858744": [{"title": "40"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: yes"}]}, {"GSM2858745": [{"title": "40V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858746": [{"title": "42"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes + carboplatin;\tpathological complete response: no"}]}, {"GSM2858747": [{"title": "42V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858748": [{"title": "43"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes + carboplatin;\tpathological complete response: no"}]}, {"GSM2858749": [{"title": "45"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes + carboplatin;\tpathological complete response: no"}]}, {"GSM2858750": [{"title": "46"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858751": [{"title": "46V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858752": [{"title": "48"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: yes"}]}, {"GSM2858753": [{"title": "48V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858754": [{"title": "49PNVV"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: yes"}]}, {"GSM2858755": [{"title": "49V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858756": [{"title": "52V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858757": [{"title": "54PNVV"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: yes"}]}, {"GSM2858758": [{"title": "54V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858759": [{"title": "55V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858760": [{"title": "56V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes + carboplatin;\tpathological complete response: yes"}]}, {"GSM2858761": [{"title": "57V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes + carboplatin;\tpathological complete response: no"}]}, {"GSM2858762": [{"title": "58V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: yes"}]}, {"GSM2858763": [{"title": "59V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858764": [{"title": "60V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858765": [{"title": "62HVV"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: yes"}]}, {"GSM2858766": [{"title": "62V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes + carboplatin;\tpathological complete response: no"}]}, {"GSM2858767": [{"title": "63V"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes + carboplatin;\tpathological complete response: no"}]}, {"GSM2858768": [{"title": "68HNVV"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858769": [{"title": "138PNJ"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858770": [{"title": "160PNJ"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: yes"}]}, {"GSM2858771": [{"title": "173PNJ"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858772": [{"title": "176PNJ"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes + carboplatin;\tpathological complete response: yes"}]}, {"GSM2858773": [{"title": "178PNJ"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: yes"}]}, {"GSM2858774": [{"title": "179PNJ"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858775": [{"title": "180PNJ"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: yes"}]}, {"GSM2858776": [{"title": "182PNJ"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858777": [{"title": "184PNJ"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: yes"}]}, {"GSM2858778": [{"title": "185PNJ"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: yes"}]}, {"GSM2858779": [{"title": "186PNJ"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858780": [{"title": "187PNJ"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes + carboplatin;\tpathological complete response: no"}]}, {"GSM2858781": [{"title": "190PNJ"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858782": [{"title": "191PNJ"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858783": [{"title": "192PNJ"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858784": [{"title": "193PNJ"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: yes"}]}, {"GSM2858785": [{"title": "194PNJ"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: yes"}]}, {"GSM2858786": [{"title": "195PNJ"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858787": [{"title": "197PNJ"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: no"}]}, {"GSM2858788": [{"title": "198PNJ"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: yes"}]}, {"GSM2858789": [{"title": "199PNJ"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes + carboplatin;\tpathological complete response: yes"}]}, {"GSM2858790": [{"title": "200PNJ"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: yes"}]}, {"GSM2858791": [{"title": "201PNJ"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: yes"}]}, {"GSM2858792": [{"title": "202PNJ"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes + carboplatin;\tpathological complete response: no"}]}, {"GSM2858793": [{"title": "203PNJ"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: yes"}]}, {"GSM2858794": [{"title": "206PNJ"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: yes"}]}, {"GSM2858795": [{"title": "207PNJ"}, {"type": "RNA"}, {"source_name_ch1": "Total RNA from pretreatment biopsies of a triple negative breast cancer patient"}, {"characteristics_ch1": "tissue: breast cancer;\ttreatment: Anthracyclines and/or taxanes;\tpathological complete response: yes"}]}, {"GSM2863293": [{"title": "LCH sorted CD207+, DMSO treated, biological paired sample 1"}, {"type": "RNA"}, {"source_name_ch1": "Langerhans Cell Histiocytosis Lesion - Sorted CD207+ Cells"}, {"characteristics_ch1": "tissue: Langerhans cell histiocytosis lesion;\tcell type: CD207+;\tagent: DMSO"}]}, {"GSM2863294": [{"title": "LCH sorted CD207+, BRAFi treated, biological paired sample 1"}, {"type": "RNA"}, {"source_name_ch1": "Langerhans Cell Histiocytosis Lesion - Sorted CD207+ Cells"}, {"characteristics_ch1": "tissue: Langerhans cell histiocytosis lesion;\tcell type: CD207+;\tagent: BRAFi"}]}, {"GSM2863295": [{"title": "LCH sorted CD207+, MEKi treated, biological paired sample 1"}, {"type": "RNA"}, {"source_name_ch1": "Langerhans Cell Histiocytosis Lesion - Sorted CD207+ Cells"}, {"characteristics_ch1": "tissue: Langerhans cell histiocytosis lesion;\tcell type: CD207+;\tagent: MEKi"}]}, {"GSM2863296": [{"title": "LCH sorted CD207+, DMSO treated, biological paired sample 2"}, {"type": "RNA"}, {"source_name_ch1": "Langerhans Cell Histiocytosis Lesion - Sorted CD207+ Cells"}, {"characteristics_ch1": "tissue: Langerhans cell histiocytosis lesion;\tcell type: CD207+;\tagent: DMSO"}]}, {"GSM2863297": [{"title": "LCH sorted CD207+, BRAFi treated, biological paired sample 2"}, {"type": "RNA"}, {"source_name_ch1": "Langerhans Cell Histiocytosis Lesion - Sorted CD207+ Cells"}, {"characteristics_ch1": "tissue: Langerhans cell histiocytosis lesion;\tcell type: CD207+;\tagent: BRAFi"}]}, {"GSM2863298": [{"title": "LCH sorted CD207+, MEKi treated, biological paired sample 2"}, {"type": "RNA"}, {"source_name_ch1": "Langerhans Cell Histiocytosis Lesion - Sorted CD207+ Cells"}, {"characteristics_ch1": "tissue: Langerhans cell histiocytosis lesion;\tcell type: CD207+;\tagent: MEKi"}]}, {"GSM2863299": [{"title": "LCH sorted CD207+, DMSO treated, biological paired sample 3"}, {"type": "RNA"}, {"source_name_ch1": "Langerhans Cell Histiocytosis Lesion - Sorted CD207+ Cells"}, {"characteristics_ch1": "tissue: Langerhans cell histiocytosis lesion;\tcell type: CD207+;\tagent: DMSO"}]}, {"GSM2863300": [{"title": "LCH sorted CD207+, BRAFi treated, biological paired sample 3"}, {"type": "RNA"}, {"source_name_ch1": "Langerhans Cell Histiocytosis Lesion - Sorted CD207+ Cells"}, {"characteristics_ch1": "tissue: Langerhans cell histiocytosis lesion;\tcell type: CD207+;\tagent: BRAFi"}]}, {"GSM2863301": [{"title": "LCH sorted CD207+, MEKi treated, biological paired sample 3"}, {"type": "RNA"}, {"source_name_ch1": "Langerhans Cell Histiocytosis Lesion - Sorted CD207+ Cells"}, {"characteristics_ch1": "tissue: Langerhans cell histiocytosis lesion;\tcell type: CD207+;\tagent: MEKi"}]}, {"GSM2863302": [{"title": "LCH sorted CD207+, DMSO treated, biological paired sample 4"}, {"type": "RNA"}, {"source_name_ch1": "Langerhans Cell Histiocytosis Lesion - Sorted CD207+ Cells"}, {"characteristics_ch1": "tissue: Langerhans cell histiocytosis lesion;\tcell type: CD207+;\tagent: DMSO"}]}, {"GSM2863303": [{"title": "LCH sorted CD207+, BRAFi treated, biological paired sample 4"}, {"type": "RNA"}, {"source_name_ch1": "Langerhans Cell Histiocytosis Lesion - Sorted CD207+ Cells"}, {"characteristics_ch1": "tissue: Langerhans cell histiocytosis lesion;\tcell type: CD207+;\tagent: BRAFi"}]}, {"GSM2863304": [{"title": "LCH sorted CD207+, MEKi treated, biological paired sample 4"}, {"type": "RNA"}, {"source_name_ch1": "Langerhans Cell Histiocytosis Lesion - Sorted CD207+ Cells"}, {"characteristics_ch1": "tissue: Langerhans cell histiocytosis lesion;\tcell type: CD207+;\tagent: MEKi"}]}, {"GSM2279022": [{"title": "Acute EBV 15VC1799"}, {"type": "RNA"}, {"source_name_ch1": "peripheral blood cells"}, {"characteristics_ch1": "gender: M;\tage: 27 m;\ttissue: peripheral blood mononuclear cells;\tdiagnosis: acute infectious mononucleosis (AIM)"}]}, {"GSM2279023": [{"title": "Acute EBV 15VC1803"}, {"type": "RNA"}, {"source_name_ch1": "peripheral blood cells"}, {"characteristics_ch1": "gender: F;\tage: 18 m;\ttissue: peripheral blood mononuclear cells;\tdiagnosis: acute infectious mononucleosis (AIM)"}]}, {"GSM2279024": [{"title": "Acute EBV 15VC2293"}, {"type": "RNA"}, {"source_name_ch1": "peripheral blood cells"}, {"characteristics_ch1": "gender: M;\tage: 4 y;\ttissue: peripheral blood mononuclear cells;\tdiagnosis: acute infectious mononucleosis (AIM)"}]}, {"GSM2279025": [{"title": "Chronic EBV 15VC2295"}, {"type": "RNA"}, {"source_name_ch1": "peripheral blood cells"}, {"characteristics_ch1": "gender: F;\tage: 3 y;\ttissue: peripheral blood mononuclear cells;\tdiagnosis: chronic active EBV infection (CAEBV)"}]}, {"GSM2279026": [{"title": "Acute EBV 15VC2386"}, {"type": "RNA"}, {"source_name_ch1": "peripheral blood cells"}, {"characteristics_ch1": "gender: F;\tage: 3 y;\ttissue: peripheral blood mononuclear cells;\tdiagnosis: acute infectious mononucleosis (AIM)"}]}, {"GSM2279027": [{"title": "Chronic EBV 15VC2407"}, {"type": "RNA"}, {"source_name_ch1": "peripheral blood cells"}, {"characteristics_ch1": "gender: M;\tage: 9 y;\ttissue: peripheral blood mononuclear cells;\tdiagnosis: chronic active EBV infection (CAEBV)"}]}, {"GSM2279028": [{"title": "Chronic EBV 15VC2414"}, {"type": "RNA"}, {"source_name_ch1": "peripheral blood cells"}, {"characteristics_ch1": "gender: M;\tage: 15 y;\ttissue: peripheral blood mononuclear cells;\tdiagnosis: chronic active EBV infection (CAEBV)"}]}, {"GSM2279029": [{"title": "Chronic EBV 15VC2656"}, {"type": "RNA"}, {"source_name_ch1": "peripheral blood cells"}, {"characteristics_ch1": "gender: F;\tage: 2 y;\ttissue: peripheral blood mononuclear cells;\tdiagnosis: chronic active EBV infection (CAEBV)"}]}, {"GSM2279030": [{"title": "Chronic EBV 15VC3454"}, {"type": "RNA"}, {"source_name_ch1": "peripheral blood cells"}, {"characteristics_ch1": "gender: M;\tage: 12 y;\ttissue: peripheral blood mononuclear cells;\tdiagnosis: chronic active EBV infection (CAEBV)"}]}, {"GSM2279031": [{"title": "Healthy Control C13"}, {"type": "RNA"}, {"source_name_ch1": "peripheral blood cells"}, {"characteristics_ch1": "gender: M;\tage: 1 y;\ttissue: peripheral blood mononuclear cells;\tdiagnosis: healthy"}]}, {"GSM2279032": [{"title": "Healthy Control C15"}, {"type": "RNA"}, {"source_name_ch1": "peripheral blood cells"}, {"characteristics_ch1": "gender: F;\tage: 3 y;\ttissue: peripheral blood mononuclear cells;\tdiagnosis: healthy"}]}, {"GSM2279033": [{"title": "Healthy Control C21"}, {"type": "RNA"}, {"source_name_ch1": "peripheral blood cells"}, {"characteristics_ch1": "gender: F;\tage: 1 y;\ttissue: peripheral blood mononuclear cells;\tdiagnosis: healthy"}]}, {"GSM2279034": [{"title": "Healthy Control C22"}, {"type": "RNA"}, {"source_name_ch1": "peripheral blood cells"}, {"characteristics_ch1": "gender: M;\tage: 3 y;\ttissue: peripheral blood mononuclear cells;\tdiagnosis: healthy"}]}, {"GSM2279035": [{"title": "Healthy Control C23"}, {"type": "RNA"}, {"source_name_ch1": "peripheral blood cells"}, {"characteristics_ch1": "gender: M;\tage: 3 y;\ttissue: peripheral blood mononuclear cells;\tdiagnosis: healthy"}]}, {"GSM2279036": [{"title": "Healthy Control C24"}, {"type": "RNA"}, {"source_name_ch1": "peripheral blood cells"}, {"characteristics_ch1": "gender: F;\tage: 4 y;\ttissue: peripheral blood mononuclear cells;\tdiagnosis: healthy"}]}, {"GSM2279037": [{"title": "Acute EBV ED483"}, {"type": "RNA"}, {"source_name_ch1": "peripheral blood cells"}, {"characteristics_ch1": "gender: M;\tage: 24 m;\ttissue: peripheral blood mononuclear cells;\tdiagnosis: acute infectious mononucleosis (AIM)"}]}, {"GSM2279038": [{"title": "Acute EBV ED490"}, {"type": "RNA"}, {"source_name_ch1": "peripheral blood cells"}, {"characteristics_ch1": "gender: M;\tage: 12 m;\ttissue: peripheral blood mononuclear cells;\tdiagnosis: acute infectious mononucleosis (AIM)"}]}, {"GSM2723911": [{"title": "HaCaT cells_DMSO_3 h_rep1"}, {"type": "RNA"}, {"source_name_ch1": "Human keratinocyte cells"}, {"characteristics_ch1": "treatment: 0.3% DMSO for 3 h;\tcells: Human keratinocyte cells"}]}, {"GSM2723912": [{"title": "HaCaT cells_DMSO_3 h_rep2"}, {"type": "RNA"}, {"source_name_ch1": "Human keratinocyte cells"}, {"characteristics_ch1": "treatment: 0.3% DMSO for 3 h;\tcells: Human keratinocyte cells"}]}, {"GSM2723913": [{"title": "HaCaT cells_30 \u03bcM apratyramide_3 h_rep1"}, {"type": "RNA"}, {"source_name_ch1": "Human keratinocyte cells"}, {"characteristics_ch1": "treatment: 30 \u03bcM apratyramide for 3 h;\tcells: Human keratinocyte cells"}]}, {"GSM2723914": [{"title": "HaCaT cells_30 \u03bcM apratyramide_3 h_rep2"}, {"type": "RNA"}, {"source_name_ch1": "Human keratinocyte cells"}, {"characteristics_ch1": "treatment: 30 \u03bcM apratyramide for 3 h;\tcells: Human keratinocyte cells"}]}, {"GSM2723915": [{"title": "HaCaT cells_DMSO_12 h_rep1"}, {"type": "RNA"}, {"source_name_ch1": "Human keratinocyte cells"}, {"characteristics_ch1": "treatment: 0.3% DMSO for 12 h;\tcells: Human keratinocyte cells"}]}, {"GSM2723916": [{"title": "HaCaT cells_DMSO_12 h_rep2"}, {"type": "RNA"}, {"source_name_ch1": "Human keratinocyte cells"}, {"characteristics_ch1": "treatment: 0.3% DMSO for 12 h;\tcells: Human keratinocyte cells"}]}, {"GSM2723917": [{"title": "HaCaT cells_30 \u03bcM apratyramide_12 h_rep1"}, {"type": "RNA"}, {"source_name_ch1": "Human keratinocyte cells"}, {"characteristics_ch1": "treatment: 30 \u03bcM apratyramide for 12 h;\tcells: Human keratinocyte cells"}]}, {"GSM2723918": [{"title": "HaCaT cells_30 \u03bcM apratyramide_12 h_rep2"}, {"type": "RNA"}, {"source_name_ch1": "Human keratinocyte cells"}, {"characteristics_ch1": "treatment: 30 \u03bcM apratyramide for 12 h;\tcells: Human keratinocyte cells"}]}, {"GSM2387237": [{"title": "Human Dermal Adult Fibroblasts, transfected with control inhibitor-1"}, {"type": "RNA"}, {"source_name_ch1": "primary cells, abdominal skin, ATCC"}, {"characteristics_ch1": "tissue: fibroblast;\tSex: female;\ttransfection: control inhibitor"}]}, {"GSM2387238": [{"title": "Human Dermal Adult Fibroblasts, transfected with control inhibitor-2"}, {"type": "RNA"}, {"source_name_ch1": "primary cells, abdominal skin, ATCC"}, {"characteristics_ch1": "tissue: fibroblast;\tSex: female;\ttransfection: control inhibitor"}]}, {"GSM2387239": [{"title": "Human Dermal Adult Fibroblasts, transfected with control inhibitor-3"}, {"type": "RNA"}, {"source_name_ch1": "primary cells, abdominal skin, ATCC"}, {"characteristics_ch1": "tissue: fibroblast;\tSex: female;\ttransfection: control inhibitor"}]}, {"GSM2387240": [{"title": "Human Dermal Adult Fibroblasts, transfected with miR-200b inhibitor-1"}, {"type": "RNA"}, {"source_name_ch1": "primary cells, abdominal skin, ATCC"}, {"characteristics_ch1": "tissue: fibroblast;\tSex: female;\ttransfection: miR-200b inhibitor"}]}, {"GSM2387241": [{"title": "Human Dermal Adult Fibroblasts, transfected with miR-200b inhibitor-2"}, {"type": "RNA"}, {"source_name_ch1": "primary cells, abdominal skin, ATCC"}, {"characteristics_ch1": "tissue: fibroblast;\tSex: female;\ttransfection: miR-200b inhibitor"}]}, {"GSM2387242": [{"title": "Human Dermal Adult Fibroblasts, transfected with miR-200b inhibitor-3"}, {"type": "RNA"}, {"source_name_ch1": "primary cells, abdominal skin, ATCC"}, {"characteristics_ch1": "tissue: fibroblast;\tSex: female;\ttransfection: miR-200b inhibitor"}]}, {"GSM2387243": [{"title": "Human Dermal Microvascular Endothelial Cells-1"}, {"type": "RNA"}, {"source_name_ch1": "Immortalized primary cells, foreskin, CDC"}, {"characteristics_ch1": "tissue: endothelial;\tSex: female;\ttransfection: untransfected"}]}, {"GSM2387244": [{"title": "Human Dermal Microvascular Endothelial Cells-2"}, {"type": "RNA"}, {"source_name_ch1": "Immortalized primary cells, foreskin, CDC"}, {"characteristics_ch1": "tissue: endothelial;\tSex: female;\ttransfection: untransfected"}]}, {"GSM2387245": [{"title": "Human Dermal Microvascular Endothelial Cells-3"}, {"type": "RNA"}, {"source_name_ch1": "Immortalized primary cells, foreskin, CDC"}, {"characteristics_ch1": "tissue: endothelial;\tSex: female;\ttransfection: untransfected"}]}, {"GSM2534821": [{"title": "colorectal cancer sample AUS2_355"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534822": [{"title": "colorectal cancer sample AUS2_356"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534823": [{"title": "colorectal cancer sample AUS2_358"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534824": [{"title": "colorectal cancer sample AUS2_359"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534825": [{"title": "colorectal cancer sample AUS2_363"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534826": [{"title": "colorectal cancer sample AUS2_365"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534827": [{"title": "colorectal cancer sample AUS2_369"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534828": [{"title": "colorectal cancer sample AUS2_371"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534829": [{"title": "colorectal cancer sample AUS2_383"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534830": [{"title": "colorectal cancer sample AUS2_391"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534831": [{"title": "colorectal cancer sample AUS2_395"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534832": [{"title": "colorectal cancer sample AUS2_316"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534833": [{"title": "colorectal cancer sample AUS2_403"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534834": [{"title": "colorectal cancer sample AUS2_404"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534835": [{"title": "colorectal cancer sample AUS2_406"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534836": [{"title": "colorectal cancer sample AUS2_407"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534837": [{"title": "colorectal cancer sample AUS2_408"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534838": [{"title": "colorectal cancer sample AUS2_409"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534839": [{"title": "colorectal cancer sample AUS2_414"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534840": [{"title": "colorectal cancer sample AUS2_415"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534841": [{"title": "colorectal cancer sample AUS2_416"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534842": [{"title": "colorectal cancer sample AUS2_417"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534843": [{"title": "colorectal cancer sample AUS2_431"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534844": [{"title": "colorectal cancer sample AUS2_432"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534845": [{"title": "colorectal cancer sample AUS2_442"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534846": [{"title": "colorectal cancer sample AUS2_311"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534847": [{"title": "colorectal cancer sample AUS2_337"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534848": [{"title": "colorectal cancer sample AUS2_347"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534849": [{"title": "colorectal cancer sample AUS2_349"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534850": [{"title": "colorectal cancer sample AUS2_350"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534851": [{"title": "colorectal cancer sample AUS2_351"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534852": [{"title": "colorectal cancer sample AUS2_361"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534853": [{"title": "colorectal cancer sample AUS2_364"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534854": [{"title": "colorectal cancer sample AUS2_368"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534855": [{"title": "colorectal cancer sample AUS2_382"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534856": [{"title": "colorectal cancer sample AUS2_387"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534857": [{"title": "colorectal cancer sample AUS2_389"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534858": [{"title": "colorectal cancer sample AUS2_392"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534859": [{"title": "colorectal cancer sample AUS2_397"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534860": [{"title": "colorectal cancer sample AUS2_398"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534861": [{"title": "colorectal cancer sample AUS2_399"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534862": [{"title": "colorectal cancer sample AUS2_401"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534863": [{"title": "colorectal cancer sample AUS2_402"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534864": [{"title": "colorectal cancer sample AUS2_405"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534865": [{"title": "colorectal cancer sample AUS2_418"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534866": [{"title": "colorectal cancer sample AUS2_419"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534867": [{"title": "colorectal cancer sample AUS2_423"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534868": [{"title": "colorectal cancer sample AUS2_426"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534869": [{"title": "colorectal cancer sample AUS2_429"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534870": [{"title": "colorectal cancer sample AUS2_433"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534871": [{"title": "colorectal cancer sample AUS2_435"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534872": [{"title": "colorectal cancer sample AUS2_443"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534873": [{"title": "colorectal cancer sample AUS2_445"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534874": [{"title": "colorectal cancer sample AUS2_447"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534875": [{"title": "colorectal cancer sample AUS2_450"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534876": [{"title": "colorectal cancer sample AUS2_451"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534877": [{"title": "colorectal cancer sample AUS2_452"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534878": [{"title": "colorectal cancer sample AUS2_456"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534879": [{"title": "colorectal cancer sample AUS2_458"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534880": [{"title": "colorectal cancer sample AUS2_460"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534881": [{"title": "colorectal cancer sample AUS2_462"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534882": [{"title": "colorectal cancer sample AUS2_463"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534883": [{"title": "colorectal cancer sample AUS2_465"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534884": [{"title": "colorectal cancer sample AUS2_466"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534885": [{"title": "colorectal cancer sample AUS2_467"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534886": [{"title": "colorectal cancer sample AUS2_468"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534887": [{"title": "colorectal cancer sample AUS2_470"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534888": [{"title": "colorectal cancer sample AUS2_471"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534889": [{"title": "colorectal cancer sample AUS2_472"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534890": [{"title": "colorectal cancer sample AUS2_474"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534891": [{"title": "colorectal cancer sample AUS2_476"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534892": [{"title": "colorectal cancer sample AUS2_477"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534893": [{"title": "colorectal cancer sample AUS2_478"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534894": [{"title": "colorectal cancer sample AUS2_479"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534895": [{"title": "colorectal cancer sample AUS2_480"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534896": [{"title": "colorectal cancer sample AUS2_481"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534897": [{"title": "colorectal cancer sample AUS2_482"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534898": [{"title": "colorectal cancer sample AUS2_484"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534899": [{"title": "colorectal cancer sample AUS2_485"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534900": [{"title": "colorectal cancer sample AUS2_487"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534901": [{"title": "colorectal cancer sample AUS2_489"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534902": [{"title": "colorectal cancer sample AUS2_490"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534903": [{"title": "colorectal cancer sample AUS2_493"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534904": [{"title": "colorectal cancer sample AUS2_494"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534905": [{"title": "colorectal cancer sample AUS2_497"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534906": [{"title": "colorectal cancer sample AUS2_499"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534907": [{"title": "colorectal cancer sample AUS2_500"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534908": [{"title": "colorectal cancer sample AUS2_501"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534909": [{"title": "colorectal cancer sample AUS2_503"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534910": [{"title": "colorectal cancer sample AUS2_504"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534911": [{"title": "colorectal cancer sample AUS2_505"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534912": [{"title": "colorectal cancer sample AUS2_506"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534913": [{"title": "colorectal cancer sample AUS2_507"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534914": [{"title": "colorectal cancer sample AUS2_534"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534915": [{"title": "colorectal cancer sample AUS2_535"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534916": [{"title": "colorectal cancer sample AUS2_539"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534917": [{"title": "colorectal cancer sample AUS2_540"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534918": [{"title": "colorectal cancer sample AUS2_541"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534919": [{"title": "colorectal cancer sample AUS2_542"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534920": [{"title": "colorectal cancer sample AUS2_543"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534921": [{"title": "colorectal cancer sample AUS2_544"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534922": [{"title": "colorectal cancer sample AUS2_545"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534923": [{"title": "colorectal cancer sample AUS2_547"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534924": [{"title": "colorectal cancer sample AUS2_549"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534925": [{"title": "colorectal cancer sample AUS2_551"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534926": [{"title": "colorectal cancer sample AUS2_552"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534927": [{"title": "colorectal cancer sample AUS2_554"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534928": [{"title": "colorectal cancer sample AUS2_555"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534929": [{"title": "colorectal cancer sample AUS2_556"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534930": [{"title": "colorectal cancer sample AUS2_557"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534931": [{"title": "colorectal cancer sample AUS2_558"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534932": [{"title": "colorectal cancer sample AUS2_560"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534933": [{"title": "colorectal cancer sample AUS2_561"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534934": [{"title": "colorectal cancer sample AUS2_562"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534935": [{"title": "colorectal cancer sample AUS2_564"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534936": [{"title": "colorectal cancer sample AUS2_565"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534937": [{"title": "colorectal cancer sample AUS2_566"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534938": [{"title": "colorectal cancer sample AUS2_459"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534939": [{"title": "colorectal cancer sample AUS2_469"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534940": [{"title": "colorectal cancer sample AUS2_563"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534941": [{"title": "colorectal cancer sample AUS2_529"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534942": [{"title": "colorectal cancer sample AUS2_277"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534943": [{"title": "colorectal cancer sample AUS2_278"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534944": [{"title": "colorectal cancer sample AUS2_280"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534945": [{"title": "colorectal cancer sample AUS2_282"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534946": [{"title": "colorectal cancer sample AUS2_283"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534947": [{"title": "colorectal cancer sample AUS2_285"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534948": [{"title": "colorectal cancer sample AUS2_286"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534949": [{"title": "colorectal cancer sample AUS2_288"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534950": [{"title": "colorectal cancer sample AUS2_292"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534951": [{"title": "colorectal cancer sample AUS2_293"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534952": [{"title": "colorectal cancer sample AUS2_294"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534953": [{"title": "colorectal cancer sample AUS2_295"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534954": [{"title": "colorectal cancer sample AUS2_296"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534955": [{"title": "colorectal cancer sample AUS2_297"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534956": [{"title": "colorectal cancer sample AUS2_306"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534957": [{"title": "colorectal cancer sample AUS2_307"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534958": [{"title": "colorectal cancer sample AUS2_308"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534959": [{"title": "colorectal cancer sample AUS2_309"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534960": [{"title": "colorectal cancer sample AUS2_310"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534961": [{"title": "colorectal cancer sample AUS2_312"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534962": [{"title": "colorectal cancer sample AUS2_313"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534963": [{"title": "colorectal cancer sample AUS2_317"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534964": [{"title": "colorectal cancer sample AUS2_319"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534965": [{"title": "colorectal cancer sample AUS2_320"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534966": [{"title": "colorectal cancer sample AUS2_321"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534967": [{"title": "colorectal cancer sample AUS2_324"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534968": [{"title": "colorectal cancer sample AUS2_325"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534969": [{"title": "colorectal cancer sample AUS2_326"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534970": [{"title": "colorectal cancer sample AUS2_328"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534971": [{"title": "colorectal cancer sample AUS2_329"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534972": [{"title": "colorectal cancer sample AUS2_330"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534973": [{"title": "colorectal cancer sample AUS2_331"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534974": [{"title": "colorectal cancer sample AUS2_334"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534975": [{"title": "colorectal cancer sample AUS2_301"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534976": [{"title": "colorectal cancer sample AUS2_336"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534977": [{"title": "colorectal cancer sample AUS2_340"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534978": [{"title": "colorectal cancer sample AUS2_348"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534979": [{"title": "colorectal cancer sample AUS2_357"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534980": [{"title": "colorectal cancer sample AUS2_367"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534981": [{"title": "colorectal cancer sample AUS2_376"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534982": [{"title": "colorectal cancer sample AUS2_378"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534983": [{"title": "colorectal cancer sample AUS2_379"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534984": [{"title": "colorectal cancer sample AUS2_380"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534985": [{"title": "colorectal cancer sample AUS2_393"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534986": [{"title": "colorectal cancer sample AUS2_411"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534987": [{"title": "colorectal cancer sample AUS2_412"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534988": [{"title": "colorectal cancer sample AUS2_413"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534989": [{"title": "colorectal cancer sample AUS2_420"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534990": [{"title": "colorectal cancer sample AUS2_425"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534991": [{"title": "colorectal cancer sample AUS2_430"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534992": [{"title": "colorectal cancer sample AUS2_346"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534993": [{"title": "colorectal cancer sample AUS2_352"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2534994": [{"title": "colorectal cancer sample AUS2_353"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer patient"}, {"characteristics_ch1": "tissue: colorectal cancer biopsy"}]}, {"GSM2777312": [{"title": "HeLa_PPIH77_gene_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HeLa, PPIH77, rep1"}, {"characteristics_ch1": "cell line: HeLa;\tgenotype/variation: PPIH knockdown"}]}, {"GSM2777313": [{"title": "HeLa_PPIH77_gene_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HeLa, PPIH77, rep2"}, {"characteristics_ch1": "cell line: HeLa;\tgenotype/variation: PPIH knockdown"}]}, {"GSM2777314": [{"title": "HeLa_PPIH77_gene_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HeLa, PPIH77, rep3"}, {"characteristics_ch1": "cell line: HeLa;\tgenotype/variation: PPIH knockdown"}]}, {"GSM2777315": [{"title": "HeLa_SCR_gene_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HeLa, SCR, rep1"}, {"characteristics_ch1": "cell line: HeLa;\tgenotype/variation: SCR control"}]}, {"GSM2777316": [{"title": "HeLa_SCR_gene_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HeLa, SCR, rep2"}, {"characteristics_ch1": "cell line: HeLa;\tgenotype/variation: SCR control"}]}, {"GSM2777317": [{"title": "HeLa_SCR_gene_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HeLa, SCR, rep3"}, {"characteristics_ch1": "cell line: HeLa;\tgenotype/variation: SCR control"}]}, {"GSM2862114": [{"title": "Caski-NC"}, {"type": "RNA"}, {"source_name_ch1": "NCK1-AS1 negative control cells"}, {"characteristics_ch1": "cell type: cervical cancer cell"}]}, {"GSM2862115": [{"title": "Caski-shAS1"}, {"type": "RNA"}, {"source_name_ch1": "NCK1-AS1 knockdown CaSki cells"}, {"characteristics_ch1": "cell type: cervical cancer cell"}]}, {"GSM2942398": [{"title": "MCF7 wile type cells, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "MCF7 wile type cells"}, {"characteristics_ch1": "cell line: MCF7;\tcell type: Breast cancer cell line;\tgenotype/variation: wild type"}]}, {"GSM2942399": [{"title": "MCF7 wile type cells, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "MCF7 wile type cells"}, {"characteristics_ch1": "cell line: MCF7;\tcell type: Breast cancer cell line;\tgenotype/variation: wild type"}]}, {"GSM2942400": [{"title": "MCF7 wile type cells, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "MCF7 wile type cells"}, {"characteristics_ch1": "cell line: MCF7;\tcell type: Breast cancer cell line;\tgenotype/variation: wild type"}]}, {"GSM2942401": [{"title": "MCF7C463A/WT cells, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "MCF7C463A/WT cells"}, {"characteristics_ch1": "cell line: MCF7;\tcell type: Breast cancer cell line;\tgenotype/variation: MDMX C463A mutation"}]}, {"GSM2942402": [{"title": "MCF7C463A/WT cells, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "MCF7C463A/WT cells"}, {"characteristics_ch1": "cell line: MCF7;\tcell type: Breast cancer cell line;\tgenotype/variation: MDMX C463A mutation"}]}, {"GSM2942403": [{"title": "MCF7C463A/WT cells, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "MCF7C463A/WT cells"}, {"characteristics_ch1": "cell line: MCF7;\tcell type: Breast cancer cell line;\tgenotype/variation: MDMX C463A mutation"}]}, {"GSM2967397": [{"title": "PBMC at baseline, ID 01"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 before dosing with panobinostat"}, {"characteristics_ch1": "drug dosing: Baseline;\tgender: Male"}]}, {"GSM2967398": [{"title": "PBMC at Visit 4, ID 01"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 after three doses (20 mg oral) panobinostat"}, {"characteristics_ch1": "drug dosing: After 3 doses;\tgender: Male"}]}, {"GSM2967399": [{"title": "PBMC at Visit 12, ID 01"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 4 weeks after total of 8 weeks of panobinostat dosing"}, {"characteristics_ch1": "drug dosing: 4 week follow-up;\tgender: Male"}]}, {"GSM2967400": [{"title": "PBMC at Visit 13, ID 01"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 6 months after total of 8 weeks of panobinostat dosing"}, {"characteristics_ch1": "drug dosing: 6 month follow-up;\tgender: Male"}]}, {"GSM2967401": [{"title": "PBMC at baseline, ID 02"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 before dosing with panobinostat"}, {"characteristics_ch1": "drug dosing: Baseline;\tgender: Male"}]}, {"GSM2967402": [{"title": "PBMC at Visit 4, ID 02"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 after three doses (20 mg oral) panobinostat"}, {"characteristics_ch1": "drug dosing: After 3 doses;\tgender: Male"}]}, {"GSM2967403": [{"title": "PBMC at Visit 12, ID 02"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 4 weeks after total of 8 weeks of panobinostat dosing"}, {"characteristics_ch1": "drug dosing: 4 week follow-up;\tgender: Male"}]}, {"GSM2967404": [{"title": "PBMC at Visit 13, ID 02"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 6 months after total of 8 weeks of panobinostat dosing"}, {"characteristics_ch1": "drug dosing: 6 month follow-up;\tgender: Male"}]}, {"GSM2967405": [{"title": "PBMC at baseline, ID 04"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 before dosing with panobinostat"}, {"characteristics_ch1": "drug dosing: Baseline;\tgender: Male"}]}, {"GSM2967406": [{"title": "PBMC at Visit 4, ID 04"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 after three doses (20 mg oral) panobinostat"}, {"characteristics_ch1": "drug dosing: After 3 doses;\tgender: Male"}]}, {"GSM2967407": [{"title": "PBMC at Visit 12, ID 04"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 4 weeks after total of 8 weeks of panobinostat dosing"}, {"characteristics_ch1": "drug dosing: 4 week follow-up;\tgender: Male"}]}, {"GSM2967408": [{"title": "PBMC at Visit 13, ID 04"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 6 months after total of 8 weeks of panobinostat dosing"}, {"characteristics_ch1": "drug dosing: 6 month follow-up;\tgender: Male"}]}, {"GSM2967409": [{"title": "PBMC at baseline, ID 05"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 before dosing with panobinostat"}, {"characteristics_ch1": "drug dosing: Baseline;\tgender: Male"}]}, {"GSM2967410": [{"title": "PBMC at Visit 4, ID 05"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 after three doses (20 mg oral) panobinostat"}, {"characteristics_ch1": "drug dosing: After 3 doses;\tgender: Male"}]}, {"GSM2967411": [{"title": "PBMC at Visit 12, ID 05"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 4 weeks after total of 8 weeks of panobinostat dosing"}, {"characteristics_ch1": "drug dosing: 4 week follow-up;\tgender: Male"}]}, {"GSM2967412": [{"title": "PBMC at Visit 13, ID 05"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 6 months after total of 8 weeks of panobinostat dosing"}, {"characteristics_ch1": "drug dosing: 6 month follow-up;\tgender: Male"}]}, {"GSM2967413": [{"title": "PBMC at baseline, ID 06"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 before dosing with panobinostat"}, {"characteristics_ch1": "drug dosing: Baseline;\tgender: Male"}]}, {"GSM2967414": [{"title": "PBMC at Visit 4, ID 06"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 after three doses (20 mg oral) panobinostat"}, {"characteristics_ch1": "drug dosing: After 3 doses;\tgender: Male"}]}, {"GSM2967415": [{"title": "PBMC at Visit 12, ID 06"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 4 weeks after total of 8 weeks of panobinostat dosing"}, {"characteristics_ch1": "drug dosing: 4 week follow-up;\tgender: Male"}]}, {"GSM2967416": [{"title": "PBMC at Visit 13, ID 06"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 6 months after total of 8 weeks of panobinostat dosing"}, {"characteristics_ch1": "drug dosing: 6 month follow-up;\tgender: Male"}]}, {"GSM2967417": [{"title": "PBMC at baseline, ID 07"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 before dosing with panobinostat"}, {"characteristics_ch1": "drug dosing: Baseline;\tgender: Male"}]}, {"GSM2967418": [{"title": "PBMC at Visit 4, ID 07"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 after three doses (20 mg oral) panobinostat"}, {"characteristics_ch1": "drug dosing: After 3 doses;\tgender: Male"}]}, {"GSM2967419": [{"title": "PBMC at Visit 12, ID 07"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 4 weeks after total of 8 weeks of panobinostat dosing"}, {"characteristics_ch1": "drug dosing: 4 week follow-up;\tgender: Male"}]}, {"GSM2967420": [{"title": "PBMC at Visit 13, ID 07"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 6 months after total of 8 weeks of panobinostat dosing"}, {"characteristics_ch1": "drug dosing: 6 month follow-up;\tgender: Male"}]}, {"GSM2967421": [{"title": "PBMC at baseline, ID 08"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 before dosing with panobinostat"}, {"characteristics_ch1": "drug dosing: Baseline;\tgender: Male"}]}, {"GSM2967422": [{"title": "PBMC at Visit 4, ID 08"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 after three doses (20 mg oral) panobinostat"}, {"characteristics_ch1": "drug dosing: After 3 doses;\tgender: Male"}]}, {"GSM2967423": [{"title": "PBMC at Visit 12, ID 08"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 4 weeks after total of 8 weeks of panobinostat dosing"}, {"characteristics_ch1": "drug dosing: 4 week follow-up;\tgender: Male"}]}, {"GSM2967424": [{"title": "PBMC at Visit 13, ID 08"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 6 months after total of 8 weeks of panobinostat dosing"}, {"characteristics_ch1": "drug dosing: 6 month follow-up;\tgender: Male"}]}, {"GSM2967425": [{"title": "PBMC at baseline, ID 09"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 before dosing with panobinostat"}, {"characteristics_ch1": "drug dosing: Baseline;\tgender: Male"}]}, {"GSM2967426": [{"title": "PBMC at Visit 4, ID 09"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 after three doses (20 mg oral) panobinostat"}, {"characteristics_ch1": "drug dosing: After 3 doses;\tgender: Male"}]}, {"GSM2967427": [{"title": "PBMC at Visit 12, ID 09"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 4 weeks after total of 8 weeks of panobinostat dosing"}, {"characteristics_ch1": "drug dosing: 4 week follow-up;\tgender: Male"}]}, {"GSM2967428": [{"title": "PBMC at Visit 13, ID 09"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 6 months after total of 8 weeks of panobinostat dosing"}, {"characteristics_ch1": "drug dosing: 6 month follow-up;\tgender: Male"}]}, {"GSM2967429": [{"title": "PBMC at baseline, ID 10"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 before dosing with panobinostat"}, {"characteristics_ch1": "drug dosing: Baseline;\tgender: Male"}]}, {"GSM2967430": [{"title": "PBMC at Visit 4, ID 10"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 after three doses (20 mg oral) panobinostat"}, {"characteristics_ch1": "drug dosing: After 3 doses;\tgender: Male"}]}, {"GSM2967431": [{"title": "PBMC at Visit 12, ID 10"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 4 weeks after total of 8 weeks of panobinostat dosing"}, {"characteristics_ch1": "drug dosing: 4 week follow-up;\tgender: Male"}]}, {"GSM2967432": [{"title": "PBMC at Visit 13, ID 10"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 6 months after total of 8 weeks of panobinostat dosing"}, {"characteristics_ch1": "drug dosing: 6 month follow-up;\tgender: Male"}]}, {"GSM2967433": [{"title": "PBMC at baseline, ID 12"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 before dosing with panobinostat"}, {"characteristics_ch1": "drug dosing: Baseline;\tgender: Male"}]}, {"GSM2967434": [{"title": "PBMC at Visit 4, ID 12"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 after three doses (20 mg oral) panobinostat"}, {"characteristics_ch1": "drug dosing: After 3 doses;\tgender: Male"}]}, {"GSM2967435": [{"title": "PBMC at Visit 12, ID 12"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 4 weeks after total of 8 weeks of panobinostat dosing"}, {"characteristics_ch1": "drug dosing: 4 week follow-up;\tgender: Male"}]}, {"GSM2967436": [{"title": "PBMC at Visit 13, ID 12"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 6 months after total of 8 weeks of panobinostat dosing"}, {"characteristics_ch1": "drug dosing: 6 month follow-up;\tgender: Male"}]}, {"GSM2967437": [{"title": "PBMC at baseline, ID 14"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 before dosing with panobinostat"}, {"characteristics_ch1": "drug dosing: Baseline;\tgender: Male"}]}, {"GSM2967438": [{"title": "PBMC at Visit 4, ID 14"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 after three doses (20 mg oral) panobinostat"}, {"characteristics_ch1": "drug dosing: After 3 doses;\tgender: Male"}]}, {"GSM2967439": [{"title": "PBMC at Visit 12, ID 14"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 4 weeks after total of 8 weeks of panobinostat dosing"}, {"characteristics_ch1": "drug dosing: 4 week follow-up;\tgender: Male"}]}, {"GSM2967440": [{"title": "PBMC at Visit 13, ID 14"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 6 months after total of 8 weeks of panobinostat dosing"}, {"characteristics_ch1": "drug dosing: 6 month follow-up;\tgender: Male"}]}, {"GSM2967441": [{"title": "PBMC at baseline, ID 15"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 before dosing with panobinostat"}, {"characteristics_ch1": "drug dosing: Baseline;\tgender: Male"}]}, {"GSM2967442": [{"title": "PBMC at Visit 4, ID 15"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 after three doses (20 mg oral) panobinostat"}, {"characteristics_ch1": "drug dosing: After 3 doses;\tgender: Male"}]}, {"GSM2967443": [{"title": "PBMC at Visit 12, ID 15"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 4 weeks after total of 8 weeks of panobinostat dosing"}, {"characteristics_ch1": "drug dosing: 4 week follow-up;\tgender: Male"}]}, {"GSM2967444": [{"title": "PBMC at Visit 13, ID 15"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 6 months after total of 8 weeks of panobinostat dosing"}, {"characteristics_ch1": "drug dosing: 6 month follow-up;\tgender: Male"}]}, {"GSM2967445": [{"title": "PBMC at baseline, ID 17"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 before dosing with panobinostat"}, {"characteristics_ch1": "drug dosing: Baseline;\tgender: Male"}]}, {"GSM2967446": [{"title": "PBMC at Visit 4, ID 17"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 after three doses (20 mg oral) panobinostat"}, {"characteristics_ch1": "drug dosing: After 3 doses;\tgender: Male"}]}, {"GSM2967447": [{"title": "PBMC at Visit 12, ID 17"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 4 weeks after total of 8 weeks of panobinostat dosing"}, {"characteristics_ch1": "drug dosing: 4 week follow-up;\tgender: Male"}]}, {"GSM2967448": [{"title": "PBMC at Visit 13, ID 17"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 6 months after total of 8 weeks of panobinostat dosing"}, {"characteristics_ch1": "drug dosing: 6 month follow-up;\tgender: Male"}]}, {"GSM2967449": [{"title": "PBMC at baseline, ID 18"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 before dosing with panobinostat"}, {"characteristics_ch1": "drug dosing: Baseline;\tgender: Male"}]}, {"GSM2967450": [{"title": "PBMC at Visit 4, ID 18"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 after three doses (20 mg oral) panobinostat"}, {"characteristics_ch1": "drug dosing: After 3 doses;\tgender: Male"}]}, {"GSM2967451": [{"title": "PBMC at Visit 12, ID 18"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 4 weeks after total of 8 weeks of panobinostat dosing"}, {"characteristics_ch1": "drug dosing: 4 week follow-up;\tgender: Male"}]}, {"GSM2967452": [{"title": "PBMC at Visit 13, ID 18"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 6 months after total of 8 weeks of panobinostat dosing"}, {"characteristics_ch1": "drug dosing: 6 month follow-up;\tgender: Male"}]}, {"GSM2967453": [{"title": "PBMC at baseline, ID 19"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 before dosing with panobinostat"}, {"characteristics_ch1": "drug dosing: Baseline;\tgender: Male"}]}, {"GSM2967454": [{"title": "PBMC at Visit 4, ID 19"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 after three doses (20 mg oral) panobinostat"}, {"characteristics_ch1": "drug dosing: After 3 doses;\tgender: Male"}]}, {"GSM2967455": [{"title": "PBMC at Visit 12, ID 19"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 4 weeks after total of 8 weeks of panobinostat dosing"}, {"characteristics_ch1": "drug dosing: 4 week follow-up;\tgender: Male"}]}, {"GSM2967456": [{"title": "PBMC at Visit 13, ID 19"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs from humans infected with HIV-1 6 months after total of 8 weeks of panobinostat dosing"}, {"characteristics_ch1": "drug dosing: 6 month follow-up;\tgender: Male"}]}, {"GSM2988840": [{"title": "MSCs, AIS group A01"}, {"type": "RNA"}, {"source_name_ch1": "mesenchymal stem cells from AIS patient"}, {"characteristics_ch1": "tissue: mesenchymal stem cells;\tage: Patients age less than 18;\tdisease state: AIS"}]}, {"GSM2988841": [{"title": "MSCs, AIS group A02"}, {"type": "RNA"}, {"source_name_ch1": "mesenchymal stem cells from AIS patient"}, {"characteristics_ch1": "tissue: mesenchymal stem cells;\tage: Patients age less than 18;\tdisease state: AIS"}]}, {"GSM2988842": [{"title": "MSCs, AIS group A03"}, {"type": "RNA"}, {"source_name_ch1": "mesenchymal stem cells from AIS patient"}, {"characteristics_ch1": "tissue: mesenchymal stem cells;\tage: Patients age less than 18;\tdisease state: AIS"}]}, {"GSM2988843": [{"title": "MSCs, AIS group A04"}, {"type": "RNA"}, {"source_name_ch1": "mesenchymal stem cells from AIS patient"}, {"characteristics_ch1": "tissue: mesenchymal stem cells;\tage: Patients age less than 18;\tdisease state: AIS"}]}, {"GSM2988844": [{"title": "MSCs, AIS group A05"}, {"type": "RNA"}, {"source_name_ch1": "mesenchymal stem cells from AIS patient"}, {"characteristics_ch1": "tissue: mesenchymal stem cells;\tage: Patients age less than 18;\tdisease state: AIS"}]}, {"GSM2988845": [{"title": "MSCs, AIS group A06"}, {"type": "RNA"}, {"source_name_ch1": "mesenchymal stem cells from AIS patient"}, {"characteristics_ch1": "tissue: mesenchymal stem cells;\tage: Patients age less than 18;\tdisease state: AIS"}]}, {"GSM2988846": [{"title": "MSCs, AIS group A07"}, {"type": "RNA"}, {"source_name_ch1": "mesenchymal stem cells from AIS patient"}, {"characteristics_ch1": "tissue: mesenchymal stem cells;\tage: Patients age less than 18;\tdisease state: AIS"}]}, {"GSM2988847": [{"title": "MSCs, AIS group A08"}, {"type": "RNA"}, {"source_name_ch1": "mesenchymal stem cells from AIS patient"}, {"characteristics_ch1": "tissue: mesenchymal stem cells;\tage: Patients age less than 18;\tdisease state: AIS"}]}, {"GSM2988848": [{"title": "MSCs, AIS group A09"}, {"type": "RNA"}, {"source_name_ch1": "mesenchymal stem cells from AIS patient"}, {"characteristics_ch1": "tissue: mesenchymal stem cells;\tage: Patients age less than 18;\tdisease state: AIS"}]}, {"GSM2988849": [{"title": "MSCs, AIS group A10"}, {"type": "RNA"}, {"source_name_ch1": "mesenchymal stem cells from AIS patient"}, {"characteristics_ch1": "tissue: mesenchymal stem cells;\tage: Patients age less than 18;\tdisease state: AIS"}]}, {"GSM2988850": [{"title": "MSCs, AIS group A11"}, {"type": "RNA"}, {"source_name_ch1": "mesenchymal stem cells from AIS patient"}, {"characteristics_ch1": "tissue: mesenchymal stem cells;\tage: Patients age less than 18;\tdisease state: AIS"}]}, {"GSM2988851": [{"title": "MSCs, AIS group A12"}, {"type": "RNA"}, {"source_name_ch1": "mesenchymal stem cells from AIS patient"}, {"characteristics_ch1": "tissue: mesenchymal stem cells;\tage: Patients age less than 18;\tdisease state: AIS"}]}, {"GSM2988852": [{"title": "MSCs, Control group C01"}, {"type": "RNA"}, {"source_name_ch1": "mesenchymal stem cells from Healthy donors"}, {"characteristics_ch1": "tissue: mesenchymal stem cells;\tage: Donors age less than 18;\tdisease state: healthy"}]}, {"GSM2988853": [{"title": "MSCs, Control group C02"}, {"type": "RNA"}, {"source_name_ch1": "mesenchymal stem cells from Healthy donors"}, {"characteristics_ch1": "tissue: mesenchymal stem cells;\tage: Donors age less than 18;\tdisease state: healthy"}]}, {"GSM2988854": [{"title": "MSCs, Control group C03"}, {"type": "RNA"}, {"source_name_ch1": "mesenchymal stem cells from Healthy donors"}, {"characteristics_ch1": "tissue: mesenchymal stem cells;\tage: Donors age less than 18;\tdisease state: healthy"}]}, {"GSM2988855": [{"title": "MSCs, Control group C04"}, {"type": "RNA"}, {"source_name_ch1": "mesenchymal stem cells from Healthy donors"}, {"characteristics_ch1": "tissue: mesenchymal stem cells;\tage: Donors age less than 18;\tdisease state: healthy"}]}, {"GSM2988856": [{"title": "MSCs, Control group C05"}, {"type": "RNA"}, {"source_name_ch1": "mesenchymal stem cells from Healthy donors"}, {"characteristics_ch1": "tissue: mesenchymal stem cells;\tage: Donors age less than 18;\tdisease state: healthy"}]}, {"GSM2455254": [{"title": "DMSO_replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "TC71 Ewing Sarcoma cell line"}, {"characteristics_ch1": "agent: DMSO"}]}, {"GSM2455255": [{"title": "DMSO_replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "TC71 Ewing Sarcoma cell line"}, {"characteristics_ch1": "agent: DMSO"}]}, {"GSM2455256": [{"title": "DMSO_replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "TC71 Ewing Sarcoma cell line"}, {"characteristics_ch1": "agent: DMSO"}]}, {"GSM2455257": [{"title": "BEZ235_replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "TC71 Ewing Sarcoma cell line"}, {"characteristics_ch1": "agent: BEZ235"}]}, {"GSM2455258": [{"title": "BEZ235_replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "TC71 Ewing Sarcoma cell line"}, {"characteristics_ch1": "agent: BEZ235"}]}, {"GSM2455259": [{"title": "BEZ235_replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "TC71 Ewing Sarcoma cell line"}, {"characteristics_ch1": "agent: BEZ235"}]}, {"GSM2550665": [{"title": "MDS0060"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 66.7;\tgender: Male"}]}, {"GSM2550666": [{"title": "MDS0114"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 52.3;\tgender: Male"}]}, {"GSM2550667": [{"title": "MDS0129"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 71.0;\tgender: Male"}]}, {"GSM2550669": [{"title": "MDS0152"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 38.8;\tgender: Male"}]}, {"GSM2550671": [{"title": "MDS0154"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 42.4;\tgender: Female"}]}, {"GSM2550672": [{"title": "MDS0203"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 18.5;\tgender: Female"}]}, {"GSM2550674": [{"title": "MDS0213"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 41.2;\tgender: Male"}]}, {"GSM2550675": [{"title": "MDS0267"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 78.7;\tgender: Male"}]}, {"GSM2550677": [{"title": "MDS0273"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 60.7;\tgender: Male"}]}, {"GSM2550679": [{"title": "MDS0298"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 57.2;\tgender: Male"}]}, {"GSM2550680": [{"title": "MDS0303"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 58.8;\tgender: Male"}]}, {"GSM2550681": [{"title": "MDS0305"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 57.3;\tgender: Male"}]}, {"GSM2550683": [{"title": "MDS0307"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 74.7;\tgender: Male"}]}, {"GSM2550685": [{"title": "MDS0312"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 77.8;\tgender: Male"}]}, {"GSM2550686": [{"title": "MDS0353"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 30.9;\tgender: Female"}]}, {"GSM2550688": [{"title": "MDS0365"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 71.2;\tgender: Male"}]}, {"GSM2550690": [{"title": "MDS0373"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 83.6;\tgender: Male"}]}, {"GSM2550691": [{"title": "MDS0376"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 47.1;\tgender: Male"}]}, {"GSM2550692": [{"title": "MDS0380"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 80.4;\tgender: Male"}]}, {"GSM2550694": [{"title": "MDS0381"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 78.3;\tgender: Male"}]}, {"GSM2550695": [{"title": "MDS0388"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 63.3;\tgender: Male"}]}, {"GSM2550697": [{"title": "MDS0389"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 74.5;\tgender: Male"}]}, {"GSM2550699": [{"title": "MDS0391"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 79.9;\tgender: Male"}]}, {"GSM2550700": [{"title": "MDS0394"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 67.3;\tgender: Female"}]}, {"GSM2550702": [{"title": "MDS0395"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 51.4;\tgender: Female"}]}, {"GSM2550703": [{"title": "MDS0504"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 50.0;\tgender: Male"}]}, {"GSM2550705": [{"title": "MDS0512"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 65.5;\tgender: Male"}]}, {"GSM2550707": [{"title": "MDS0514"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 60.1;\tgender: Female"}]}, {"GSM2550708": [{"title": "MDS0515"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 53.8;\tgender: Male"}]}, {"GSM2550710": [{"title": "MDS0519"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 59.4;\tgender: Male"}]}, {"GSM2550712": [{"title": "MDS0520"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 59.2;\tgender: Male"}]}, {"GSM2550713": [{"title": "MDS0523"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 40.9;\tgender: Male"}]}, {"GSM2550715": [{"title": "MDS0525"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 61.2;\tgender: Male"}]}, {"GSM2550718": [{"title": "MDS0527"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 39.8;\tgender: Female"}]}, {"GSM2550720": [{"title": "MDS0530"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 72.4;\tgender: Male"}]}, {"GSM2550723": [{"title": "MDS0537"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 71.9;\tgender: Male"}]}, {"GSM2550725": [{"title": "MDS0539"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 67.5;\tgender: Female"}]}, {"GSM2550728": [{"title": "MDS0540"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 52.8;\tgender: Male"}]}, {"GSM2550731": [{"title": "MDS0549"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 55.5;\tgender: Female"}]}, {"GSM2550733": [{"title": "MDS0557"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 68.0;\tgender: Male"}]}, {"GSM2550734": [{"title": "MDS0560"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 85.5;\tgender: Male"}]}, {"GSM2550735": [{"title": "MDS0565"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 77.3;\tgender: Male"}]}, {"GSM2550736": [{"title": "MDS0570"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 73.6;\tgender: Male"}]}, {"GSM2550737": [{"title": "MDS0589"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 70.7;\tgender: Male"}]}, {"GSM2550738": [{"title": "MDS0592"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 84.9;\tgender: Female"}]}, {"GSM2550739": [{"title": "MDS0600"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 71.9;\tgender: Male"}]}, {"GSM2550740": [{"title": "MDS0612"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 84.6;\tgender: Male"}]}, {"GSM2550741": [{"title": "MDS0624"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 29.0;\tgender: Female"}]}, {"GSM2550742": [{"title": "MDS0625"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 27.2;\tgender: Male"}]}, {"GSM2550743": [{"title": "MDS0626"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 84.3;\tgender: Male"}]}, {"GSM2550744": [{"title": "MDS0637"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 46.1;\tgender: Female"}]}, {"GSM2550745": [{"title": "MDS0650"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 85.7;\tgender: Male"}]}, {"GSM2550746": [{"title": "MDS0653"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 75.3;\tgender: Male"}]}, {"GSM2550747": [{"title": "MDS0661"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 87.9;\tgender: Male"}]}, {"GSM2550748": [{"title": "MDS0662"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 89.2;\tgender: Male"}]}, {"GSM2550749": [{"title": "MDS0665"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 65.8;\tgender: Male"}]}, {"GSM2550750": [{"title": "MDS0672"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 76.8;\tgender: Male"}]}, {"GSM2550751": [{"title": "MDS0674"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 69.5;\tgender: Female"}]}, {"GSM2550752": [{"title": "MDS0683"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 48.1;\tgender: Male"}]}, {"GSM2550753": [{"title": "MDS0686"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 79.9;\tgender: Male"}]}, {"GSM2550754": [{"title": "MDS0693"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 57.6;\tgender: Female"}]}, {"GSM2550755": [{"title": "MDS0699"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 67.8;\tgender: Male"}]}, {"GSM2550756": [{"title": "MDS0708"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 49.9;\tgender: Male"}]}, {"GSM2550757": [{"title": "MDS0711"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 61.0;\tgender: Female"}]}, {"GSM2550758": [{"title": "MDS0719"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 69.7;\tgender: Female"}]}, {"GSM2550759": [{"title": "MDS0724"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 77.9;\tgender: Male"}]}, {"GSM2550760": [{"title": "MDS0740"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 40.0;\tgender: Female"}]}, {"GSM2550761": [{"title": "MDS0742"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 50.1;\tgender: Male"}]}, {"GSM2550762": [{"title": "MDS0757"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 80.0;\tgender: Female"}]}, {"GSM2550763": [{"title": "MDS0759"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 46.4;\tgender: Male"}]}, {"GSM2550764": [{"title": "MDS0764"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 58.2;\tgender: Male"}]}, {"GSM2550765": [{"title": "MDS0765"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 80.4;\tgender: Female"}]}, {"GSM2550766": [{"title": "MDS0766"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 81.4;\tgender: Male"}]}, {"GSM2550767": [{"title": "MDS0770"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 85.9;\tgender: Male"}]}, {"GSM2550768": [{"title": "MDS0771"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 74.7;\tgender: Male"}]}, {"GSM2550769": [{"title": "MDS0777"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 48.6;\tgender: Female"}]}, {"GSM2550770": [{"title": "MDS0781"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 66.6;\tgender: Female"}]}, {"GSM2550771": [{"title": "MDS0782"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 45.5;\tgender: Male"}]}, {"GSM2550772": [{"title": "MDS0784"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 54.4;\tgender: Female"}]}, {"GSM2550773": [{"title": "MDS0786"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 80.8;\tgender: Female"}]}, {"GSM2550774": [{"title": "MDS0787"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 62.3;\tgender: Female"}]}, {"GSM2550775": [{"title": "MDS0788"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 69.6;\tgender: Female"}]}, {"GSM2550776": [{"title": "MDS0792"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 58.3;\tgender: Male"}]}, {"GSM2550777": [{"title": "MDS0795"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 74.9;\tgender: Male"}]}, {"GSM2550778": [{"title": "MDS0801"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 62.9;\tgender: Male"}]}, {"GSM2550779": [{"title": "MDS0810"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 80.6;\tgender: Male"}]}, {"GSM2550780": [{"title": "MDS0817"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 74.7;\tgender: Male"}]}, {"GSM2550781": [{"title": "MDS0821"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 71.7;\tgender: Male"}]}, {"GSM2550782": [{"title": "MDS0823"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 51.6;\tgender: Male"}]}, {"GSM2550783": [{"title": "MDS0824"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 75.9;\tgender: Female"}]}, {"GSM2550784": [{"title": "MDS0826"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 64.1;\tgender: Male"}]}, {"GSM2550785": [{"title": "MDS0829"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 66.1;\tgender: Male"}]}, {"GSM2550786": [{"title": "MDS0833"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 69.9;\tgender: Male"}]}, {"GSM2550787": [{"title": "MDS0836"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 85.2;\tgender: Male"}]}, {"GSM2550788": [{"title": "MDS0844"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 27.5;\tgender: Male"}]}, {"GSM2550789": [{"title": "MDS0846"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 77.7;\tgender: Female"}]}, {"GSM2550790": [{"title": "MDS0849"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 69.3;\tgender: Male"}]}, {"GSM2550791": [{"title": "MDS0858"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 82.5;\tgender: Male"}]}, {"GSM2550792": [{"title": "MDS0860"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 76.4;\tgender: Male"}]}, {"GSM2550793": [{"title": "MDS0864"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 71.1;\tgender: Female"}]}, {"GSM2550794": [{"title": "MDS0866"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 79.9;\tgender: Male"}]}, {"GSM2550795": [{"title": "MDS0868"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 72.7;\tgender: Male"}]}, {"GSM2550796": [{"title": "MDS0870"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 60.5;\tgender: Male"}]}, {"GSM2550797": [{"title": "MDS0873"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 80.7;\tgender: Male"}]}, {"GSM2550798": [{"title": "MDS0875"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 81.5;\tgender: Male"}]}, {"GSM2550799": [{"title": "MDS0879"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 54.7;\tgender: Male"}]}, {"GSM2550800": [{"title": "MDS0882"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 36.8;\tgender: Male"}]}, {"GSM2550801": [{"title": "MDS0884"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 75.5;\tgender: Male"}]}, {"GSM2550802": [{"title": "MDS0903"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 43.7;\tgender: Female"}]}, {"GSM2550803": [{"title": "MDS0911"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 73.2;\tgender: Female"}]}, {"GSM2550804": [{"title": "MDS0920"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 83.0;\tgender: Female"}]}, {"GSM2550805": [{"title": "MDS0921"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 24.6;\tgender: Female"}]}, {"GSM2550806": [{"title": "MDS0924"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 78.1;\tgender: Male"}]}, {"GSM2550807": [{"title": "MDS0926"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 28.3;\tgender: Male"}]}, {"GSM2550808": [{"title": "MDS0941"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 73.0;\tgender: Male"}]}, {"GSM2550809": [{"title": "MDS0944"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 55.4;\tgender: Male"}]}, {"GSM2550810": [{"title": "MDS0945"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 71.2;\tgender: Female"}]}, {"GSM2550811": [{"title": "MDS0949"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 44.8;\tgender: Female"}]}, {"GSM2550812": [{"title": "MDS0952"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 70.9;\tgender: Female"}]}, {"GSM2550813": [{"title": "MDS0953"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 64.8;\tgender: Female"}]}, {"GSM2550814": [{"title": "MDS0954"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 69.6;\tgender: Male"}]}, {"GSM2550815": [{"title": "MDS0955"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 71.6;\tgender: Male"}]}, {"GSM2550816": [{"title": "MDS0957"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 50.5;\tgender: Female"}]}, {"GSM2550817": [{"title": "MDS0959"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 78.2;\tgender: Male"}]}, {"GSM2550818": [{"title": "MDS0961"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 87.0;\tgender: Male"}]}, {"GSM2550819": [{"title": "MDS0962"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 69.5;\tgender: Male"}]}, {"GSM2550820": [{"title": "MDS0967"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 77.4;\tgender: Female"}]}, {"GSM2550821": [{"title": "MDS0969"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 75.4;\tgender: Female"}]}, {"GSM2550822": [{"title": "MDS0971"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 58.1;\tgender: Male"}]}, {"GSM2550823": [{"title": "MDS0976"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 29.5;\tgender: Male"}]}, {"GSM2550824": [{"title": "MDS0979"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 71.1;\tgender: Male"}]}, {"GSM2550825": [{"title": "MDS0980"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 63.6;\tgender: Female"}]}, {"GSM2550826": [{"title": "MDS0981"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 61.7;\tgender: Female"}]}, {"GSM2550827": [{"title": "MDS0985"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 25.9;\tgender: Male"}]}, {"GSM2550828": [{"title": "MDS0993"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 85.4;\tgender: Male"}]}, {"GSM2550829": [{"title": "MDS1000"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 86.2;\tgender: Male"}]}, {"GSM2550830": [{"title": "MDS1001"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 94.5;\tgender: Male"}]}, {"GSM2550831": [{"title": "MDS1002"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 74.9;\tgender: Male"}]}, {"GSM2550832": [{"title": "MDS1005"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 82.7;\tgender: Male"}]}, {"GSM2550833": [{"title": "MDS1007"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 81.5;\tgender: Female"}]}, {"GSM2550834": [{"title": "MDS1008"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 83.6;\tgender: Female"}]}, {"GSM2550835": [{"title": "MDS1014"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 29.4;\tgender: Male"}]}, {"GSM2550836": [{"title": "MDS1016"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 64.3;\tgender: Male"}]}, {"GSM2550837": [{"title": "MDS1017"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 51.0;\tgender: Male"}]}, {"GSM2550838": [{"title": "MDS1018"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 85.2;\tgender: Female"}]}, {"GSM2550839": [{"title": "MDS1020"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 54.4;\tgender: Male"}]}, {"GSM2550840": [{"title": "MDS1021"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 55.2;\tgender: Male"}]}, {"GSM2550841": [{"title": "MDS1025"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 69.6;\tgender: Male"}]}, {"GSM2550842": [{"title": "MDS1026"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 78.0;\tgender: Male"}]}, {"GSM2550843": [{"title": "MDS1027"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 50.0;\tgender: Female"}]}, {"GSM2550844": [{"title": "MDS1029"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 40.6;\tgender: Female"}]}, {"GSM2550845": [{"title": "MDS1035"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 68.0;\tgender: Male"}]}, {"GSM2550846": [{"title": "MDS1036"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 41.8;\tgender: Female"}]}, {"GSM2550847": [{"title": "MDS1039"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 77.2;\tgender: Female"}]}, {"GSM2550848": [{"title": "MDS1040"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 72.7;\tgender: Male"}]}, {"GSM2550849": [{"title": "MDS1044"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 51.6;\tgender: Male"}]}, {"GSM2550850": [{"title": "MDS1045"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 72.8;\tgender: Female"}]}, {"GSM2550851": [{"title": "MDS1046"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 66.7;\tgender: Male"}]}, {"GSM2550852": [{"title": "MDS1047"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 75.2;\tgender: Female"}]}, {"GSM2550853": [{"title": "MDS1048"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 43.4;\tgender: Male"}]}, {"GSM2550854": [{"title": "MDS1049"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 53.8;\tgender: Male"}]}, {"GSM2550855": [{"title": "MDS1052"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 74.2;\tgender: Male"}]}, {"GSM2550856": [{"title": "MDS1053"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 37.2;\tgender: Female"}]}, {"GSM2550857": [{"title": "MDS1056"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 80.3;\tgender: Male"}]}, {"GSM2550858": [{"title": "MDS1057"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 83.3;\tgender: Male"}]}, {"GSM2550859": [{"title": "MDS1059"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 69.7;\tgender: Male"}]}, {"GSM2550860": [{"title": "MDS1063"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 67.8;\tgender: Female"}]}, {"GSM2550861": [{"title": "MDS1070"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 89.2;\tgender: Male"}]}, {"GSM2550862": [{"title": "MDS1073"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 71.2;\tgender: Female"}]}, {"GSM2550863": [{"title": "MDS1075"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 30.3;\tgender: Male"}]}, {"GSM2550864": [{"title": "MDS1079"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 48.2;\tgender: Female"}]}, {"GSM2550865": [{"title": "MDS1083"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 74.8;\tgender: Male"}]}, {"GSM2550866": [{"title": "MDS1087"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 55.7;\tgender: Male"}]}, {"GSM2550867": [{"title": "MDS1161"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 20.6;\tgender: Female"}]}, {"GSM2550868": [{"title": "MDS1163"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 62.0;\tgender: Male"}]}, {"GSM2550869": [{"title": "MDS1166"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: training;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 52.8;\tgender: Male"}]}, {"GSM2550870": [{"title": "MDS1240"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: validation;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 66.9;\tgender: Female"}]}, {"GSM2550871": [{"title": "MDS1243"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: validation;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 34.5;\tgender: Female"}]}, {"GSM2550872": [{"title": "MDS1246"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: validation;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 75.2;\tgender: Male"}]}, {"GSM2550873": [{"title": "MDS1248"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: validation;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 79.2;\tgender: Male"}]}, {"GSM2550874": [{"title": "MDS1254"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: validation;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 68.3;\tgender: Female"}]}, {"GSM2550875": [{"title": "MDS1257"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: validation;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 45.5;\tgender: Female"}]}, {"GSM2550876": [{"title": "MDS1259"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: validation;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 68.4;\tgender: Male"}]}, {"GSM2550877": [{"title": "MDS1261"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: validation;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 76.2;\tgender: Male"}]}, {"GSM2550878": [{"title": "MDS1263"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: validation;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 63.4;\tgender: Male"}]}, {"GSM2550879": [{"title": "MDS1265"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: validation;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 59.6;\tgender: Female"}]}, {"GSM2550880": [{"title": "MDS1266"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: validation;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 66.8;\tgender: Female"}]}, {"GSM2550881": [{"title": "MDS1267"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: validation;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 56.7;\tgender: Male"}]}, {"GSM2550882": [{"title": "MDS1269"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: validation;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 66.6;\tgender: Male"}]}, {"GSM2550883": [{"title": "MDS1270"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: validation;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 80.6;\tgender: Male"}]}, {"GSM2550884": [{"title": "MDS1271"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: validation;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 48.5;\tgender: Male"}]}, {"GSM2550885": [{"title": "MDS1277"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: validation;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 59.8;\tgender: Male"}]}, {"GSM2550886": [{"title": "MDS1278"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: validation;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 70.6;\tgender: Male"}]}, {"GSM2550887": [{"title": "MDS1280"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: validation;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 74.9;\tgender: Male"}]}, {"GSM2550888": [{"title": "MDS1281"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: validation;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 53.7;\tgender: Male"}]}, {"GSM2550889": [{"title": "MDS1284"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: validation;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 72.1;\tgender: Male"}]}, {"GSM2550890": [{"title": "MDS1285"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: validation;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 78.2;\tgender: Male"}]}, {"GSM2550891": [{"title": "MDS1286"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: validation;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 57.5;\tgender: Female"}]}, {"GSM2550892": [{"title": "MDS1288"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: validation;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 54.4;\tgender: Female"}]}, {"GSM2550893": [{"title": "MDS1291"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: validation;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 39.9;\tgender: Male"}]}, {"GSM2550894": [{"title": "MDS1292"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: validation;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 84.8;\tgender: Female"}]}, {"GSM2550895": [{"title": "MDS1293"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: validation;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 76.4;\tgender: Female"}]}, {"GSM2550896": [{"title": "MDS1294"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: validation;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 69.3;\tgender: Female"}]}, {"GSM2550897": [{"title": "MDS1300"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: validation;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 91.8;\tgender: Male"}]}, {"GSM2550898": [{"title": "MDS1301"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: validation;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 68.9;\tgender: Male"}]}, {"GSM2550899": [{"title": "MDS1302"}, {"type": "RNA"}, {"source_name_ch1": "Bone marrow"}, {"characteristics_ch1": "cohort: validation;\tdisease state: MDS;\ttissue: Bone marrow;\tcondition: Pre-treatment;\tage: 81.6;\tgender: Female"}]}, {"GSM2991342": [{"title": "unstim NK cells, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "unstimulated NK cells donor 1"}, {"characteristics_ch1": "individual: donor 1;\tcell type: NK cells;\tphenotype: CD56dimCD16dim/neg NK cells;\ttreatment: Unstimulated"}]}, {"GSM2991343": [{"title": "K562 stim NK cells, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "NK cells stimulated with K562 targets donor 1"}, {"characteristics_ch1": "individual: donor 1;\tcell type: NK cells;\tphenotype: CD56dimCD16dim/neg NK cells;\ttreatment: K562"}]}, {"GSM2991344": [{"title": "ADCC stim NK cells, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "NK cells stimulated with CEM.NKR.CCR5 targets donor 1"}, {"characteristics_ch1": "individual: donor 1;\tcell type: NK cells;\tphenotype: CD56dimCD16dim/neg NK cells;\ttreatment: ADCC"}]}, {"GSM2991345": [{"title": "Cytokine stim NK cells, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "NK cells stimulated with IL-12 and IL-18 donor 1"}, {"characteristics_ch1": "individual: donor 1;\tcell type: NK cells;\tphenotype: CD56dimCD16dim/neg NK cells;\ttreatment: Cytokine"}]}, {"GSM2991346": [{"title": "unstim NK cells, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "unstimulated NK cells donor 2"}, {"characteristics_ch1": "individual: donor 2;\tcell type: NK cells;\tphenotype: CD56dimCD16dim/neg NK cells;\ttreatment: Unstimulated"}]}, {"GSM2991347": [{"title": "K562 stim NK cells, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "NK cells stimulated with K562 targets donor 2"}, {"characteristics_ch1": "individual: donor 2;\tcell type: NK cells;\tphenotype: CD56dimCD16dim/neg NK cells;\ttreatment: K562"}]}, {"GSM2991348": [{"title": "ADCC stim NK cells, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "NK cells stimulated with CEM.NKR.CCR5 targets donor 2"}, {"characteristics_ch1": "individual: donor 2;\tcell type: NK cells;\tphenotype: CD56dimCD16dim/neg NK cells;\ttreatment: ADCC"}]}, {"GSM2991349": [{"title": "Cytokine stim NK cells, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "NK cells stimulated with IL-12 and IL-18 donor 2"}, {"characteristics_ch1": "individual: donor 2;\tcell type: NK cells;\tphenotype: CD56dimCD16dim/neg NK cells;\ttreatment: Cytokine"}]}, {"GSM2991350": [{"title": "unstim NK cells, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "unstimulated NK cells donor 3"}, {"characteristics_ch1": "individual: donor 3;\tcell type: NK cells;\tphenotype: CD56dimCD16dim/neg NK cells;\ttreatment: Unstimulated"}]}, {"GSM2991351": [{"title": "K562 stim NK cells, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "NK cells stimulated with K562 targets donor 3"}, {"characteristics_ch1": "individual: donor 3;\tcell type: NK cells;\tphenotype: CD56dimCD16dim/neg NK cells;\ttreatment: K562"}]}, {"GSM2991352": [{"title": "ADCC stim NK cells, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "NK cells stimulated with CEM.NKR.CCR5 targets donor 3"}, {"characteristics_ch1": "individual: donor 3;\tcell type: NK cells;\tphenotype: CD56dimCD16dim/neg NK cells;\ttreatment: ADCC"}]}, {"GSM2991353": [{"title": "Cytokine stim NK cells, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "NK cells stimulated with IL-12 and IL-18 donor 3"}, {"characteristics_ch1": "individual: donor 3;\tcell type: NK cells;\tphenotype: CD56dimCD16dim/neg NK cells;\ttreatment: Cytokine"}]}, {"GSM2991354": [{"title": "unstim NK cells, biological rep4"}, {"type": "RNA"}, {"source_name_ch1": "unstimulated NK cells donor 4"}, {"characteristics_ch1": "individual: donor 4;\tcell type: NK cells;\tphenotype: CD56dimCD16dim/neg NK cells;\ttreatment: Unstimulated"}]}, {"GSM2991355": [{"title": "K562 stim NK cells, biological rep4"}, {"type": "RNA"}, {"source_name_ch1": "NK cells stimulated with K562 targets donor 4"}, {"characteristics_ch1": "individual: donor 4;\tcell type: NK cells;\tphenotype: CD56dimCD16dim/neg NK cells;\ttreatment: K562"}]}, {"GSM2991356": [{"title": "ADCC stim NK cells, biological rep4"}, {"type": "RNA"}, {"source_name_ch1": "NK cells stimulated with CEM.NKR.CCR5 targets donor 4"}, {"characteristics_ch1": "individual: donor 4;\tcell type: NK cells;\tphenotype: CD56dimCD16dim/neg NK cells;\ttreatment: ADCC"}]}, {"GSM2991357": [{"title": "Cytokine stim NK cells, biological rep4"}, {"type": "RNA"}, {"source_name_ch1": "NK cells stimulated with IL-12 and IL-18 donor 4"}, {"characteristics_ch1": "individual: donor 4;\tcell type: NK cells;\tphenotype: CD56dimCD16dim/neg NK cells;\ttreatment: Cytokine"}]}, {"GSM2991358": [{"title": "unstim NK cells, biological rep5"}, {"type": "RNA"}, {"source_name_ch1": "unstimulated NK cells donor 5"}, {"characteristics_ch1": "individual: donor 5;\tcell type: NK cells;\tphenotype: CD56dimCD16dim/neg NK cells;\ttreatment: Unstimulated"}]}, {"GSM2991359": [{"title": "K562 stim NK cells, biological rep5"}, {"type": "RNA"}, {"source_name_ch1": "NK cells stimulated with K562 targets donor 5"}, {"characteristics_ch1": "individual: donor 5;\tcell type: NK cells;\tphenotype: CD56dimCD16dim/neg NK cells;\ttreatment: K562"}]}, {"GSM2991360": [{"title": "ADCC stim NK cells, biological rep5"}, {"type": "RNA"}, {"source_name_ch1": "NK cells stimulated with CEM.NKR.CCR5 targets donor 5"}, {"characteristics_ch1": "individual: donor 5;\tcell type: NK cells;\tphenotype: CD56dimCD16dim/neg NK cells;\ttreatment: ADCC"}]}, {"GSM2991361": [{"title": "Cytokine stim NK cells, biological rep5"}, {"type": "RNA"}, {"source_name_ch1": "NK cells stimulated with IL-12 and IL-18 donor 5"}, {"characteristics_ch1": "individual: donor 5;\tcell type: NK cells;\tphenotype: CD56dimCD16dim/neg NK cells;\ttreatment: Cytokine"}]}, {"GSM2991362": [{"title": "unstim NK cells, biological rep6"}, {"type": "RNA"}, {"source_name_ch1": "unstimulated NK cells donor 6"}, {"characteristics_ch1": "individual: donor 6;\tcell type: NK cells;\tphenotype: CD56dimCD16dim/neg NK cells;\ttreatment: Unstimulated"}]}, {"GSM2991363": [{"title": "K562 stim NK cells, biological rep6"}, {"type": "RNA"}, {"source_name_ch1": "NK cells stimulated with K562 targets donor 6"}, {"characteristics_ch1": "individual: donor 6;\tcell type: NK cells;\tphenotype: CD56dimCD16dim/neg NK cells;\ttreatment: K562"}]}, {"GSM2991364": [{"title": "ADCC stim NK cells, biological rep6"}, {"type": "RNA"}, {"source_name_ch1": "NK cells stimulated with CEM.NKR.CCR5 targets donor 6"}, {"characteristics_ch1": "individual: donor 6;\tcell type: NK cells;\tphenotype: CD56dimCD16dim/neg NK cells;\ttreatment: ADCC"}]}, {"GSM2991365": [{"title": "Cytokine stim NK cells, biological rep6"}, {"type": "RNA"}, {"source_name_ch1": "NK cells stimulated with IL-12 and IL-18 donor 6"}, {"characteristics_ch1": "individual: donor 6;\tcell type: NK cells;\tphenotype: CD56dimCD16dim/neg NK cells;\ttreatment: Cytokine"}]}, {"GSM2515567": [{"title": "Bel-7402_DMSO_rep1"}, {"type": "RNA"}, {"source_name_ch1": "Bel-7402 cell line treated with 0.1%  DMSO for 24h"}, {"characteristics_ch1": "cell line: Bel-7402;\ttissue: Hepatocellular carcinoma"}]}, {"GSM2515568": [{"title": "Bel-7402_DMSO_rep2"}, {"type": "RNA"}, {"source_name_ch1": "Bel-7402 cell line treated with 0.1%  DMSO for 24h"}, {"characteristics_ch1": "cell line: Bel-7402;\ttissue: Hepatocellular carcinoma"}]}, {"GSM2515569": [{"title": "Bel-7402_DMSO_rep3"}, {"type": "RNA"}, {"source_name_ch1": "Bel-7402 cell line treated with 0.1%  DMSO for 24h"}, {"characteristics_ch1": "cell line: Bel-7402;\ttissue: Hepatocellular carcinoma"}]}, {"GSM2515570": [{"title": "Bel-7402_Baicalein_40uM_rep1"}, {"type": "RNA"}, {"source_name_ch1": "Bel-7402 cell line treated with 40 uM  baicalein for 24h"}, {"characteristics_ch1": "cell line: Bel-7402;\ttissue: Hepatocellular carcinoma"}]}, {"GSM2515571": [{"title": "Bel-7402_Baicalein_40uM_rep2"}, {"type": "RNA"}, {"source_name_ch1": "Bel-7402 cell line treated with 40 uM  baicalein for 24h"}, {"characteristics_ch1": "cell line: Bel-7402;\ttissue: Hepatocellular carcinoma"}]}, {"GSM2515572": [{"title": "Bel-7402_Baicalein_40uM_rep3"}, {"type": "RNA"}, {"source_name_ch1": "Bel-7402 cell line treated with 40 uM  baicalein for 24h"}, {"characteristics_ch1": "cell line: Bel-7402;\ttissue: Hepatocellular carcinoma"}]}, {"GSM2515573": [{"title": "Bel-7402_Baicalein_80uM_rep1"}, {"type": "RNA"}, {"source_name_ch1": "Bel-7402 cell line treated with 80 uM  baicalein for 24h"}, {"characteristics_ch1": "cell line: Bel-7402;\ttissue: Hepatocellular carcinoma"}]}, {"GSM2515574": [{"title": "Bel-7402_Baicalein_80uM_rep2"}, {"type": "RNA"}, {"source_name_ch1": "Bel-7402 cell line treated with 80 uM  baicalein for 24h"}, {"characteristics_ch1": "cell line: Bel-7402;\ttissue: Hepatocellular carcinoma"}]}, {"GSM2515575": [{"title": "Bel-7402_Baicalein_80uM_rep3"}, {"type": "RNA"}, {"source_name_ch1": "Bel-7402 cell line treated with 80 uM  baicalein for 24h"}, {"characteristics_ch1": "cell line: Bel-7402;\ttissue: Hepatocellular carcinoma"}]}, {"GSM2858343": [{"title": "DI1"}, {"type": "RNA"}, {"source_name_ch1": "Human Tarsal Conjunctiva"}, {"characteristics_ch1": "gender: male;\tage: 6 years old;\tphenotype: ocular Chlamydia trachomatis (Ct) infection and trachomatous inflammation-follicular (TF);\ttissue: conjunctiva"}]}, {"GSM2858344": [{"title": "DI2"}, {"type": "RNA"}, {"source_name_ch1": "Human Tarsal Conjunctiva"}, {"characteristics_ch1": "gender: male;\tage: 7 years old;\tphenotype: ocular Chlamydia trachomatis (Ct) infection and trachomatous inflammation-follicular (TF);\ttissue: conjunctiva"}]}, {"GSM2858345": [{"title": "DI3"}, {"type": "RNA"}, {"source_name_ch1": "Human Tarsal Conjunctiva"}, {"characteristics_ch1": "gender: male;\tage: 9 years old;\tphenotype: ocular Chlamydia trachomatis (Ct) infection and trachomatous inflammation-follicular (TF);\ttissue: conjunctiva"}]}, {"GSM2858346": [{"title": "DI4"}, {"type": "RNA"}, {"source_name_ch1": "Human Tarsal Conjunctiva"}, {"characteristics_ch1": "gender: male;\tage: 3 years old;\tphenotype: ocular Chlamydia trachomatis (Ct) infection and trachomatous inflammation-follicular (TF);\ttissue: conjunctiva"}]}, {"GSM2858347": [{"title": "DI5"}, {"type": "RNA"}, {"source_name_ch1": "Human Tarsal Conjunctiva"}, {"characteristics_ch1": "gender: male;\tage: 6 years old;\tphenotype: ocular Chlamydia trachomatis (Ct) infection and trachomatous inflammation-follicular (TF);\ttissue: conjunctiva"}]}, {"GSM2858348": [{"title": "DI6"}, {"type": "RNA"}, {"source_name_ch1": "Human Tarsal Conjunctiva"}, {"characteristics_ch1": "gender: female;\tage: 4 years old;\tphenotype: ocular Chlamydia trachomatis (Ct) infection and trachomatous inflammation-follicular (TF);\ttissue: conjunctiva"}]}, {"GSM2858349": [{"title": "D1"}, {"type": "RNA"}, {"source_name_ch1": "Human Tarsal Conjunctiva"}, {"characteristics_ch1": "gender: male;\tage: 9 years old;\tphenotype: trachomatous inflammation-follicular (TF) and no Ct;\ttissue: conjunctiva"}]}, {"GSM2858350": [{"title": "D2"}, {"type": "RNA"}, {"source_name_ch1": "Human Tarsal Conjunctiva"}, {"characteristics_ch1": "gender: female;\tage: 4 years old;\tphenotype: trachomatous inflammation-follicular (TF) and no Ct;\ttissue: conjunctiva"}]}, {"GSM2858351": [{"title": "D3"}, {"type": "RNA"}, {"source_name_ch1": "Human Tarsal Conjunctiva"}, {"characteristics_ch1": "gender: male;\tage: 9 years old;\tphenotype: trachomatous inflammation-follicular (TF) and no Ct;\ttissue: conjunctiva"}]}, {"GSM2858352": [{"title": "D4"}, {"type": "RNA"}, {"source_name_ch1": "Human Tarsal Conjunctiva"}, {"characteristics_ch1": "gender: female;\tage: 6 years old;\tphenotype: trachomatous inflammation-follicular (TF) and no Ct;\ttissue: conjunctiva"}]}, {"GSM2858353": [{"title": "D5"}, {"type": "RNA"}, {"source_name_ch1": "Human Tarsal Conjunctiva"}, {"characteristics_ch1": "gender: female;\tage: 6 years old;\tphenotype: trachomatous inflammation-follicular (TF) and no Ct;\ttissue: conjunctiva"}]}, {"GSM2858354": [{"title": "D6"}, {"type": "RNA"}, {"source_name_ch1": "Human Tarsal Conjunctiva"}, {"characteristics_ch1": "gender: male;\tage: 9 years old;\tphenotype: trachomatous inflammation-follicular (TF) and no Ct;\ttissue: conjunctiva"}]}, {"GSM2858355": [{"title": "D7"}, {"type": "RNA"}, {"source_name_ch1": "Human Tarsal Conjunctiva"}, {"characteristics_ch1": "gender: female;\tage: 9 years old;\tphenotype: trachomatous inflammation-follicular (TF) and no Ct;\ttissue: conjunctiva"}]}, {"GSM2858356": [{"title": "N1"}, {"type": "RNA"}, {"source_name_ch1": "Human Tarsal Conjunctiva"}, {"characteristics_ch1": "gender: female;\tage: 7 years old;\tphenotype: no TF or Ct;\ttissue: conjunctiva"}]}, {"GSM2858357": [{"title": "N2"}, {"type": "RNA"}, {"source_name_ch1": "Human Tarsal Conjunctiva"}, {"characteristics_ch1": "gender: male;\tage: 6 years old;\tphenotype: no TF or Ct;\ttissue: conjunctiva"}]}, {"GSM2858358": [{"title": "N3"}, {"type": "RNA"}, {"source_name_ch1": "Human Tarsal Conjunctiva"}, {"characteristics_ch1": "gender: male;\tage: 2 years old;\tphenotype: no TF or Ct;\ttissue: conjunctiva"}]}, {"GSM2858359": [{"title": "N4"}, {"type": "RNA"}, {"source_name_ch1": "Human Tarsal Conjunctiva"}, {"characteristics_ch1": "gender: female;\tage: 5 years old;\tphenotype: no TF or Ct;\ttissue: conjunctiva"}]}, {"GSM2858360": [{"title": "N5"}, {"type": "RNA"}, {"source_name_ch1": "Human Tarsal Conjunctiva"}, {"characteristics_ch1": "gender: female;\tage: 3 years old;\tphenotype: no TF or Ct;\ttissue: conjunctiva"}]}, {"GSM2858361": [{"title": "N6"}, {"type": "RNA"}, {"source_name_ch1": "Human Tarsal Conjunctiva"}, {"characteristics_ch1": "gender: female;\tage: 5 years old;\tphenotype: no TF or Ct;\ttissue: conjunctiva"}]}, {"GSM2858362": [{"title": "N7"}, {"type": "RNA"}, {"source_name_ch1": "Human Tarsal Conjunctiva"}, {"characteristics_ch1": "gender: male;\tage: 3 years old;\tphenotype: no TF or Ct;\ttissue: conjunctiva"}]}, {"GSM2699159": [{"title": "Jurkat at 1g baseline, rep1"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2699160": [{"title": "Jurkat at 1g baseline,rep2"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2699161": [{"title": "Jurkat at 1g baseline, rep3"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2699162": [{"title": "Jurkat at 1g baseline, rep4"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2699163": [{"title": "Jurkat at 1g baseline, rep5"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2699164": [{"title": "Jurkat at 1g baseline, rep6"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2699165": [{"title": "Jurkat at 1g baseline rep7"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2699166": [{"title": "Jurkat at 1g ground control rep1"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2699167": [{"title": "Jurkat at 1g  ground control  rep2"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2699168": [{"title": "Jurkat at 1g  ground control  rep3"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2699169": [{"title": "Jurkat at 1g  ground control  rep4"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2699170": [{"title": "Jurkat at 1g  ground control  rep5"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2699171": [{"title": "Jurkat at 1g  ground control  rep6"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2699172": [{"title": "Jurkat at sim ug, rep2"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2699173": [{"title": "Jurkat at sim ug, rep3"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2699174": [{"title": "Jurkat at sim ug, rep4"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2699175": [{"title": "Jurkat at sim ug, rep5"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2699176": [{"title": "Jurkat at sim ug, rep6"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2699177": [{"title": "Jurkat at sim ug, rep7"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2699178": [{"title": "Jurkat at 9g, rep1"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2699179": [{"title": "Jurkat at 9g, rep2"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2699180": [{"title": "Jurkat at 9g,  rep3"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2699181": [{"title": "Jurkat at 9g, rep4"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2699182": [{"title": "Jurkat at 9g, rep5"}, {"type": "RNA"}, {"source_name_ch1": "Jurkat cells (ATCC Clone E6-1, TIB152\u2122)"}, {"characteristics_ch1": "cell line: Jurkat T cells"}]}, {"GSM2928435": [{"title": "DLD-1\u0394\u03b1-Cat_3D_96h_rep1"}, {"type": "RNA"}, {"source_name_ch1": "DLD-1 subpopulations, cultivated for 96h in collagen type I"}, {"characteristics_ch1": "cell line: subclone derived from DLD-1 cell line"}]}, {"GSM2928436": [{"title": "DLD-1\u03b1-Cat_3D_96h_rep1"}, {"type": "RNA"}, {"source_name_ch1": "DLD-1 subpopulations, cultivated for 96h in collagen type I"}, {"characteristics_ch1": "cell line: subclone derived from DLD-1 cell line"}]}, {"GSM2928437": [{"title": "DLD-1\u0394\u03b1-Cat_3D_96h_rep2"}, {"type": "RNA"}, {"source_name_ch1": "DLD-1 subpopulations, cultivated for 96h in collagen type I"}, {"characteristics_ch1": "cell line: subclone derived from DLD-1 cell line"}]}, {"GSM2928438": [{"title": "DLD-1\u03b1-Cat_3D_96h_rep2"}, {"type": "RNA"}, {"source_name_ch1": "DLD-1 subpopulations, cultivated for 96h in collagen type I"}, {"characteristics_ch1": "cell line: subclone derived from DLD-1 cell line"}]}, {"GSM2928439": [{"title": "DLD-1\u0394\u03b1-Cat_3D_96h_rep3"}, {"type": "RNA"}, {"source_name_ch1": "DLD-1 subpopulations, cultivated for 96h in collagen type I"}, {"characteristics_ch1": "cell line: subclone derived from DLD-1 cell line"}]}, {"GSM2928440": [{"title": "DLD-1\u03b1-Cat_3D_96h_rep3"}, {"type": "RNA"}, {"source_name_ch1": "DLD-1 subpopulations, cultivated for 96h in collagen type I"}, {"characteristics_ch1": "cell line: subclone derived from DLD-1 cell line"}]}, {"GSM2526260": [{"title": "B2"}, {"type": "RNA"}, {"source_name_ch1": "primary tumor"}, {"characteristics_ch1": "tissue: head and neck squamous cell carcinoma"}]}, {"GSM2526261": [{"title": "B15"}, {"type": "RNA"}, {"source_name_ch1": "primary tumor"}, {"characteristics_ch1": "tissue: head and neck squamous cell carcinoma"}]}, {"GSM2526262": [{"title": "B91"}, {"type": "RNA"}, {"source_name_ch1": "primary tumor"}, {"characteristics_ch1": "tissue: head and neck squamous cell carcinoma"}]}, {"GSM2526263": [{"title": "B16"}, {"type": "RNA"}, {"source_name_ch1": "primary tumor"}, {"characteristics_ch1": "tissue: head and neck squamous cell carcinoma"}]}, {"GSM2526264": [{"title": "B17"}, {"type": "RNA"}, {"source_name_ch1": "primary tumor"}, {"characteristics_ch1": "tissue: head and neck squamous cell carcinoma"}]}, {"GSM2526265": [{"title": "B90"}, {"type": "RNA"}, {"source_name_ch1": "primary tumor"}, {"characteristics_ch1": "tissue: head and neck squamous cell carcinoma"}]}, {"GSM2526266": [{"title": "B22"}, {"type": "RNA"}, {"source_name_ch1": "primary tumor"}, {"characteristics_ch1": "tissue: head and neck squamous cell carcinoma"}]}, {"GSM2526267": [{"title": "B44"}, {"type": "RNA"}, {"source_name_ch1": "primary tumor"}, {"characteristics_ch1": "tissue: head and neck squamous cell carcinoma"}]}, {"GSM2526268": [{"title": "B55"}, {"type": "RNA"}, {"source_name_ch1": "primary tumor"}, {"characteristics_ch1": "tissue: head and neck squamous cell carcinoma"}]}, {"GSM2526269": [{"title": "B26"}, {"type": "RNA"}, {"source_name_ch1": "primary tumor"}, {"characteristics_ch1": "tissue: head and neck squamous cell carcinoma"}]}, {"GSM2526270": [{"title": "B27"}, {"type": "RNA"}, {"source_name_ch1": "primary tumor"}, {"characteristics_ch1": "tissue: head and neck squamous cell carcinoma"}]}, {"GSM2526271": [{"title": "B28"}, {"type": "RNA"}, {"source_name_ch1": "primary tumor"}, {"characteristics_ch1": "tissue: head and neck squamous cell carcinoma"}]}, {"GSM2526272": [{"title": "B81"}, {"type": "RNA"}, {"source_name_ch1": "primary tumor"}, {"characteristics_ch1": "tissue: head and neck squamous cell carcinoma"}]}, {"GSM2526273": [{"title": "B30"}, {"type": "RNA"}, {"source_name_ch1": "primary tumor"}, {"characteristics_ch1": "tissue: head and neck squamous cell carcinoma"}]}, {"GSM2526274": [{"title": "B32"}, {"type": "RNA"}, {"source_name_ch1": "primary tumor"}, {"characteristics_ch1": "tissue: head and neck squamous cell carcinoma"}]}, {"GSM2526275": [{"title": "B42"}, {"type": "RNA"}, {"source_name_ch1": "primary tumor"}, {"characteristics_ch1": "tissue: head and neck squamous cell carcinoma"}]}, {"GSM2526276": [{"title": "B35"}, {"type": "RNA"}, {"source_name_ch1": "primary tumor"}, {"characteristics_ch1": "tissue: head and neck squamous cell carcinoma"}]}, {"GSM2526277": [{"title": "B97"}, {"type": "RNA"}, {"source_name_ch1": "primary tumor"}, {"characteristics_ch1": "tissue: head and neck squamous cell carcinoma"}]}, {"GSM2526278": [{"title": "B52"}, {"type": "RNA"}, {"source_name_ch1": "primary tumor"}, {"characteristics_ch1": "tissue: head and neck squamous cell carcinoma"}]}, {"GSM2526279": [{"title": "B98"}, {"type": "RNA"}, {"source_name_ch1": "primary tumor"}, {"characteristics_ch1": "tissue: head and neck squamous cell carcinoma"}]}, {"GSM2526280": [{"title": "B100"}, {"type": "RNA"}, {"source_name_ch1": "primary tumor"}, {"characteristics_ch1": "tissue: head and neck squamous cell carcinoma"}]}, {"GSM2526281": [{"title": "B103"}, {"type": "RNA"}, {"source_name_ch1": "primary tumor"}, {"characteristics_ch1": "tissue: head and neck squamous cell carcinoma"}]}, {"GSM2526282": [{"title": "B63"}, {"type": "RNA"}, {"source_name_ch1": "primary tumor"}, {"characteristics_ch1": "tissue: head and neck squamous cell carcinoma"}]}, {"GSM2526283": [{"title": "B82"}, {"type": "RNA"}, {"source_name_ch1": "primary tumor"}, {"characteristics_ch1": "tissue: head and neck squamous cell carcinoma"}]}, {"GSM2526284": [{"title": "B96"}, {"type": "RNA"}, {"source_name_ch1": "primary tumor"}, {"characteristics_ch1": "tissue: head and neck squamous cell carcinoma"}]}, {"GSM2526285": [{"title": "B4"}, {"type": "RNA"}, {"source_name_ch1": "primary tumor"}, {"characteristics_ch1": "tissue: head and neck squamous cell carcinoma"}]}, {"GSM2526286": [{"title": "B62"}, {"type": "RNA"}, {"source_name_ch1": "primary tumor"}, {"characteristics_ch1": "tissue: head and neck squamous cell carcinoma"}]}, {"GSM2526287": [{"title": "B99"}, {"type": "RNA"}, {"source_name_ch1": "primary tumor"}, {"characteristics_ch1": "tissue: head and neck squamous cell carcinoma"}]}, {"GSM2526288": [{"title": "B75"}, {"type": "RNA"}, {"source_name_ch1": "primary tumor"}, {"characteristics_ch1": "tissue: head and neck squamous cell carcinoma"}]}, {"GSM2526289": [{"title": "B12/14"}, {"type": "RNA"}, {"source_name_ch1": "primary tumor"}, {"characteristics_ch1": "tissue: head and neck squamous cell carcinoma"}]}, {"GSM2526290": [{"title": "B88"}, {"type": "RNA"}, {"source_name_ch1": "primary tumor"}, {"characteristics_ch1": "tissue: head and neck squamous cell carcinoma"}]}, {"GSM2856043": [{"title": "KG-10"}, {"type": "RNA"}, {"source_name_ch1": "HCC-cell line, Zerumbone treated"}, {"characteristics_ch1": "tissue: Hepatocellular carcinoma (HCC);\tcell line: MHCC-LM3"}]}, {"GSM2856044": [{"title": "KG-7"}, {"type": "RNA"}, {"source_name_ch1": "HCC-cell line, DMSO"}, {"characteristics_ch1": "tissue: Hepatocellular carcinoma (HCC);\tcell line: MHCC-LM3"}]}, {"GSM2856045": [{"title": "KG-8"}, {"type": "RNA"}, {"source_name_ch1": "HCC-cell line, DMSO"}, {"characteristics_ch1": "tissue: Hepatocellular carcinoma (HCC);\tcell line: MHCC-LM3"}]}, {"GSM2856046": [{"title": "KG-9"}, {"type": "RNA"}, {"source_name_ch1": "HCC-cell line, Zerumbone treated"}, {"characteristics_ch1": "tissue: Hepatocellular carcinoma (HCC);\tcell line: MHCC-LM3"}]}, {"GSM2581980": [{"title": "MRC5_si-Ctrl_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MRC5-CAFs transfected with si-Ctrl for 72 hr replicate 1"}, {"characteristics_ch1": "cell type: CAFs"}]}, {"GSM2581981": [{"title": "MRC5_si-Ctrl_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MRC5-CAFs transfected with si-Ctrl for 72 hr replicate 2"}, {"characteristics_ch1": "cell type: CAFs"}]}, {"GSM2581982": [{"title": "MRC5_si-Ctrl_rep3"}, {"type": "RNA"}, {"source_name_ch1": "MRC5-CAFs transfected with si-Ctrl for 72 hr replicate 3"}, {"characteristics_ch1": "cell type: CAFs"}]}, {"GSM2581983": [{"title": "MRC5_si-Dicer1_rep1"}, {"type": "RNA"}, {"source_name_ch1": "MRC5-CAFs transfected with si-Dicer1 for 72 hr replicate 1"}, {"characteristics_ch1": "cell type: CAFs"}]}, {"GSM2581984": [{"title": "MRC5_si-Dicer1_rep2"}, {"type": "RNA"}, {"source_name_ch1": "MRC5-CAFs transfected with si-Dicer1 for 72 hr replicate 2"}, {"characteristics_ch1": "cell type: CAFs"}]}, {"GSM2581985": [{"title": "MRC5_si-Dicer1_rep3"}, {"type": "RNA"}, {"source_name_ch1": "MRC5-CAFs transfected with si-Dicer1 for 72 hr replicate 3"}, {"characteristics_ch1": "cell type: CAFs"}]}, {"GSM2178651": [{"title": "H3118 shCtl, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "human mucoepidermoid carcinoma cell line derived from parotid, scrambled shRNA control"}, {"characteristics_ch1": "cell line: H3118;\tcell type: mucoepidermoid carcinoma cell line;\tshRNA: scrambled control"}]}, {"GSM2178652": [{"title": "H3118 shLnc473 4A, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "human mucoepidermoid carcinoma cell line derived from parotid, LINC00473 knock-down"}, {"characteristics_ch1": "cell line: H3118;\tcell type: mucoepidermoid carcinoma cell line;\tshRNA: LINC00473"}]}, {"GSM2178653": [{"title": "H3118 shCtl, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "human mucoepidermoid carcinoma cell line derived from parotid, scrambled shRNA control"}, {"characteristics_ch1": "cell line: H3118;\tcell type: mucoepidermoid carcinoma cell line;\tshRNA: scrambled control"}]}, {"GSM2178654": [{"title": "H3118 shLnc473 4A, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "human mucoepidermoid carcinoma cell line derived from parotid, LINC00473 knock-down"}, {"characteristics_ch1": "cell line: H3118;\tcell type: mucoepidermoid carcinoma cell line;\tshRNA: LINC00473"}]}, {"GSM2946848": [{"title": "Patient A  Vehicle (-)"}, {"type": "RNA"}, {"source_name_ch1": "B-Chronic Lymphocytic Leukemia (CLL) cells"}, {"characteristics_ch1": "patient id: A;\tcell type: Primary B-CLL cells"}]}, {"GSM2946849": [{"title": "Pat. A CpG+"}, {"type": "RNA"}, {"source_name_ch1": "B-Chronic Lymphocytic Leukemia (CLL) cells"}, {"characteristics_ch1": "patient id: A;\tcell type: Primary B-CLL cells"}]}, {"GSM2946850": [{"title": "Pat. A PLX05 / CpG+"}, {"type": "RNA"}, {"source_name_ch1": "B-Chronic Lymphocytic Leukemia (CLL) cells"}, {"characteristics_ch1": "patient id: A;\tcell type: Primary B-CLL cells"}]}, {"GSM2946851": [{"title": "Patient B  Vehicle (-)"}, {"type": "RNA"}, {"source_name_ch1": "B-Chronic Lymphocytic Leukemia (CLL) cells"}, {"characteristics_ch1": "patient id: B;\tcell type: Primary B-CLL cells"}]}, {"GSM2946852": [{"title": "Pat. B CpG+"}, {"type": "RNA"}, {"source_name_ch1": "B-Chronic Lymphocytic Leukemia (CLL) cells"}, {"characteristics_ch1": "patient id: B;\tcell type: Primary B-CLL cells"}]}, {"GSM2946853": [{"title": "Pat. B PLX05 / CpG+"}, {"type": "RNA"}, {"source_name_ch1": "B-Chronic Lymphocytic Leukemia (CLL) cells"}, {"characteristics_ch1": "patient id: B;\tcell type: Primary B-CLL cells"}]}, {"GSM2946854": [{"title": "Patient C  Vehicle (-)"}, {"type": "RNA"}, {"source_name_ch1": "B-Chronic Lymphocytic Leukemia (CLL) cells"}, {"characteristics_ch1": "patient id: C;\tcell type: Primary B-CLL cells"}]}, {"GSM2946855": [{"title": "Pat. C CpG+"}, {"type": "RNA"}, {"source_name_ch1": "B-Chronic Lymphocytic Leukemia (CLL) cells"}, {"characteristics_ch1": "patient id: C;\tcell type: Primary B-CLL cells"}]}, {"GSM2946856": [{"title": "Pat. C PLX05 / CpG+"}, {"type": "RNA"}, {"source_name_ch1": "B-Chronic Lymphocytic Leukemia (CLL) cells"}, {"characteristics_ch1": "patient id: C;\tcell type: Primary B-CLL cells"}]}, {"GSM2724470": [{"title": "prostate tumor control patient1"}, {"type": "RNA"}, {"source_name_ch1": "prostate, tumor, untreated"}, {"characteristics_ch1": "tissue: prostate;\ttreatment group: untreated"}]}, {"GSM2724471": [{"title": "prostate tumor control patient2"}, {"type": "RNA"}, {"source_name_ch1": "prostate, tumor, untreated"}, {"characteristics_ch1": "tissue: prostate;\ttreatment group: untreated"}]}, {"GSM2724472": [{"title": "prostate tumor control patient3"}, {"type": "RNA"}, {"source_name_ch1": "prostate, tumor, untreated"}, {"characteristics_ch1": "tissue: prostate;\ttreatment group: untreated"}]}, {"GSM2724473": [{"title": "prostate tumor treated patient 518_focus-c12"}, {"type": "RNA"}, {"source_name_ch1": "prostate, tumor, treated"}, {"characteristics_ch1": "tissue: prostate;\ttreatment group: treated"}]}, {"GSM2724474": [{"title": "prostate tumor treated patient 523_focus-q"}, {"type": "RNA"}, {"source_name_ch1": "prostate, tumor, treated"}, {"characteristics_ch1": "tissue: prostate;\ttreatment group: treated"}]}, {"GSM2724475": [{"title": "prostate tumor treated patient 004_focus-a10"}, {"type": "RNA"}, {"source_name_ch1": "prostate, tumor, treated"}, {"characteristics_ch1": "tissue: prostate;\ttreatment group: treated"}]}, {"GSM2724476": [{"title": "prostate tumor treated patient 510_focus-c13"}, {"type": "RNA"}, {"source_name_ch1": "prostate, tumor, treated"}, {"characteristics_ch1": "tissue: prostate;\ttreatment group: treated"}]}, {"GSM2724477": [{"title": "prostate tumor treated patient 506_focus-c15"}, {"type": "RNA"}, {"source_name_ch1": "prostate, tumor, treated"}, {"characteristics_ch1": "tissue: prostate;\ttreatment group: treated"}]}, {"GSM2724478": [{"title": "prostate tumor treated patient 501_focus-c20"}, {"type": "RNA"}, {"source_name_ch1": "prostate, tumor, treated"}, {"characteristics_ch1": "tissue: prostate;\ttreatment group: treated"}]}, {"GSM2724479": [{"title": "prostate tumor treated patient 501_focus-c16"}, {"type": "RNA"}, {"source_name_ch1": "prostate, tumor, treated"}, {"characteristics_ch1": "tissue: prostate;\ttreatment group: treated"}]}, {"GSM2724480": [{"title": "prostate tumor treated patient 516_focus-c12"}, {"type": "RNA"}, {"source_name_ch1": "prostate, tumor, treated"}, {"characteristics_ch1": "tissue: prostate;\ttreatment group: treated"}]}, {"GSM2724481": [{"title": "prostate tumor treated patient 003_focus-c12f1"}, {"type": "RNA"}, {"source_name_ch1": "prostate, tumor, treated"}, {"characteristics_ch1": "tissue: prostate;\ttreatment group: treated"}]}, {"GSM2724482": [{"title": "prostate tumor treated patient 523_focus-s"}, {"type": "RNA"}, {"source_name_ch1": "prostate, tumor, treated"}, {"characteristics_ch1": "tissue: prostate;\ttreatment group: treated"}]}, {"GSM2724483": [{"title": "prostate tumor treated patient 004_focus-a14"}, {"type": "RNA"}, {"source_name_ch1": "prostate, tumor, treated"}, {"characteristics_ch1": "tissue: prostate;\ttreatment group: treated"}]}, {"GSM2724484": [{"title": "prostate tumor treated patient 003_focus-c12f2"}, {"type": "RNA"}, {"source_name_ch1": "prostate, tumor, treated"}, {"characteristics_ch1": "tissue: prostate;\ttreatment group: treated"}]}, {"GSM2724485": [{"title": "prostate tumor treated patient 006_focus-c21"}, {"type": "RNA"}, {"source_name_ch1": "prostate, tumor, treated"}, {"characteristics_ch1": "tissue: prostate;\ttreatment group: treated"}]}, {"GSM2724486": [{"title": "prostate tumor treated patient 505_focus-c20"}, {"type": "RNA"}, {"source_name_ch1": "prostate, tumor, treated"}, {"characteristics_ch1": "tissue: prostate;\ttreatment group: treated"}]}, {"GSM2724487": [{"title": "prostate tumor treated patient 507_focus-c16"}, {"type": "RNA"}, {"source_name_ch1": "prostate, tumor, treated"}, {"characteristics_ch1": "tissue: prostate;\ttreatment group: treated"}]}, {"GSM2724488": [{"title": "prostate tumor treated patient 516_focus-c7"}, {"type": "RNA"}, {"source_name_ch1": "prostate, tumor, treated"}, {"characteristics_ch1": "tissue: prostate;\ttreatment group: treated"}]}, {"GSM2724489": [{"title": "prostate tumor treated patient 513_focus-d15"}, {"type": "RNA"}, {"source_name_ch1": "prostate, tumor, treated"}, {"characteristics_ch1": "tissue: prostate;\ttreatment group: treated"}]}, {"GSM2724490": [{"title": "prostate tumor treated patient 513_focus-d16"}, {"type": "RNA"}, {"source_name_ch1": "prostate, tumor, treated"}, {"characteristics_ch1": "tissue: prostate;\ttreatment group: treated"}]}, {"GSM2724491": [{"title": "prostate tumor treated patient 007_focus-c20"}, {"type": "RNA"}, {"source_name_ch1": "prostate, tumor, treated"}, {"characteristics_ch1": "tissue: prostate;\ttreatment group: treated"}]}, {"GSM2834531": [{"title": "A549_Mock A"}, {"type": "RNA"}, {"source_name_ch1": "A549 cells, mock infected, replicate A"}, {"characteristics_ch1": "cell line: A549;\tagent: mock"}]}, {"GSM2834532": [{"title": "A549_Mock B"}, {"type": "RNA"}, {"source_name_ch1": "A549 cells, mock infected, replicate B"}, {"characteristics_ch1": "cell line: A549;\tagent: mock"}]}, {"GSM2834533": [{"title": "A549_Mock C"}, {"type": "RNA"}, {"source_name_ch1": "A549 cells, mock infected, replicate C"}, {"characteristics_ch1": "cell line: A549;\tagent: mock"}]}, {"GSM2834534": [{"title": "A549_Virus A"}, {"type": "RNA"}, {"source_name_ch1": "A549 cells, H1N1 virus infected, replicate A"}, {"characteristics_ch1": "cell line: A549;\tagent: H1N1/A/Puerto Rico/8/34"}]}, {"GSM2834535": [{"title": "A549_Virus B"}, {"type": "RNA"}, {"source_name_ch1": "A549 cells, H1N1 virus infected, replicate B"}, {"characteristics_ch1": "cell line: A549;\tagent: H1N1/A/Puerto Rico/8/34"}]}, {"GSM2834536": [{"title": "A549_Virus C"}, {"type": "RNA"}, {"source_name_ch1": "A549 cells, H1N1 virus infected, replicate C"}, {"characteristics_ch1": "cell line: A549;\tagent: H1N1/A/Puerto Rico/8/34"}]}, {"GSM2834537": [{"title": "A549-KO3_Mock A"}, {"type": "RNA"}, {"source_name_ch1": "A549-KO3 cells, mock infected, replicate A"}, {"characteristics_ch1": "cell line: A549-KO3;\tagent: mock"}]}, {"GSM2834538": [{"title": "A549-KO3_Mock B"}, {"type": "RNA"}, {"source_name_ch1": "A549-KO3 cells, mock infected, replicate B"}, {"characteristics_ch1": "cell line: A549-KO3;\tagent: mock"}]}, {"GSM2834539": [{"title": "A549-KO3_Mock C"}, {"type": "RNA"}, {"source_name_ch1": "A549-KO3 cells, mock infected, replicate C"}, {"characteristics_ch1": "cell line: A549-KO3;\tagent: mock"}]}, {"GSM2834540": [{"title": "A549-KO3_Virus A"}, {"type": "RNA"}, {"source_name_ch1": "A549-KO3 cells, H1N1 virus infected, replicate A"}, {"characteristics_ch1": "cell line: A549-KO3;\tagent: H1N1/A/Puerto Rico/8/34"}]}, {"GSM2834541": [{"title": "A549-KO3_Virus B"}, {"type": "RNA"}, {"source_name_ch1": "A549-KO3 cells, H1N1 virus infected, replicate B"}, {"characteristics_ch1": "cell line: A549-KO3;\tagent: H1N1/A/Puerto Rico/8/34"}]}, {"GSM2834542": [{"title": "A549-KO3_Virus C"}, {"type": "RNA"}, {"source_name_ch1": "A549-KO3 cells, H1N1 virus infected, replicate C"}, {"characteristics_ch1": "cell line: A549-KO3;\tagent: H1N1/A/Puerto Rico/8/34"}]}, {"GSM2862786": [{"title": "MCF10A-rep1"}, {"type": "RNA"}, {"source_name_ch1": "75-80% confluent MCF10A cells"}, {"characteristics_ch1": "cell line: MCF10A;\tcell type: human mammary epithelial cells"}]}, {"GSM2862787": [{"title": "MCF10A-rep2"}, {"type": "RNA"}, {"source_name_ch1": "75-80% confluent MCF10A cells"}, {"characteristics_ch1": "cell line: MCF10A;\tcell type: human mammary epithelial cells"}]}, {"GSM2862788": [{"title": "MCF10A-rep3"}, {"type": "RNA"}, {"source_name_ch1": "75-80% confluent MCF10A cells"}, {"characteristics_ch1": "cell line: MCF10A;\tcell type: human mammary epithelial cells"}]}, {"GSM2862789": [{"title": "UFH-001-rep1"}, {"type": "RNA"}, {"source_name_ch1": "75-80% confluent UFH-001 cells"}, {"characteristics_ch1": "cell line: UFH-001;\tcell type: metastatic breast cancer cell line"}]}, {"GSM2862790": [{"title": "UFH-001-rep2"}, {"type": "RNA"}, {"source_name_ch1": "75-80% confluent UFH-001 cells"}, {"characteristics_ch1": "cell line: UFH-001;\tcell type: metastatic breast cancer cell line"}]}, {"GSM2862791": [{"title": "UFH-001-rep3"}, {"type": "RNA"}, {"source_name_ch1": "75-80% confluent UFH-001 cells"}, {"characteristics_ch1": "cell line: UFH-001;\tcell type: metastatic breast cancer cell line"}]}, {"GSM2869312": [{"title": "fHSC_ biological rep 1"}, {"type": "RNA"}, {"source_name_ch1": "Fresh umbilical cord blood"}, {"characteristics_ch1": "blood fraction/population: MNC fraction;\tcell type: fHSC"}]}, {"GSM2869313": [{"title": "fHSC_ biological rep 2"}, {"type": "RNA"}, {"source_name_ch1": "Fresh umbilical cord blood"}, {"characteristics_ch1": "blood fraction/population: MNC fraction;\tcell type: fHSC"}]}, {"GSM2869314": [{"title": "fHSC_ biological rep 3"}, {"type": "RNA"}, {"source_name_ch1": "Fresh umbilical cord blood"}, {"characteristics_ch1": "blood fraction/population: MNC fraction;\tcell type: fHSC"}]}, {"GSM2869315": [{"title": "ivHSC_biological rep 1"}, {"type": "RNA"}, {"source_name_ch1": "Fresh umbilical cord blood"}, {"characteristics_ch1": "blood fraction/population: fHSC population;\tcell type: ivHSC"}]}, {"GSM2869316": [{"title": "ivHSC_biological rep 2"}, {"type": "RNA"}, {"source_name_ch1": "Fresh umbilical cord blood"}, {"characteristics_ch1": "blood fraction/population: fHSC population;\tcell type: ivHSC"}]}, {"GSM2869317": [{"title": "fMPC_biological rep 1"}, {"type": "RNA"}, {"source_name_ch1": "Fresh umbilical cord blood"}, {"characteristics_ch1": "blood fraction/population: MNC fraction;\tcell type: fMPC"}]}, {"GSM2869318": [{"title": "fMPC_biological rep 2"}, {"type": "RNA"}, {"source_name_ch1": "Fresh umbilical cord blood"}, {"characteristics_ch1": "blood fraction/population: MNC fraction;\tcell type: fMPC"}]}, {"GSM2869319": [{"title": "fMPC_biological rep 3"}, {"type": "RNA"}, {"source_name_ch1": "Fresh umbilical cord blood"}, {"characteristics_ch1": "blood fraction/population: MNC fraction;\tcell type: fMPC"}]}, {"GSM2869320": [{"title": "fMPC_biological rep 4"}, {"type": "RNA"}, {"source_name_ch1": "Fresh umbilical cord blood"}, {"characteristics_ch1": "blood fraction/population: MNC fraction;\tcell type: fMPC"}]}, {"GSM2869321": [{"title": "ivMPC_biological rep 1"}, {"type": "RNA"}, {"source_name_ch1": "Fresh umbilical cord blood"}, {"characteristics_ch1": "blood fraction/population: fHSC population;\tcell type: ivMPC"}]}, {"GSM2869322": [{"title": "ivMPC_biological rep 2"}, {"type": "RNA"}, {"source_name_ch1": "Fresh umbilical cord blood"}, {"characteristics_ch1": "blood fraction/population: fHSC population;\tcell type: ivMPC"}]}, {"GSM2869323": [{"title": "ivMPC_biological rep 3"}, {"type": "RNA"}, {"source_name_ch1": "Fresh umbilical cord blood"}, {"characteristics_ch1": "blood fraction/population: fHSC population;\tcell type: ivMPC"}]}, {"GSM2869324": [{"title": "fEPC_biological rep 1"}, {"type": "RNA"}, {"source_name_ch1": "Fresh umbilical cord blood"}, {"characteristics_ch1": "blood fraction/population: MNC fraction;\tcell type: fEPC"}]}, {"GSM2869325": [{"title": "fEPC_biological rep 2"}, {"type": "RNA"}, {"source_name_ch1": "Fresh umbilical cord blood"}, {"characteristics_ch1": "blood fraction/population: MNC fraction;\tcell type: fEPC"}]}, {"GSM2869326": [{"title": "fEPC_biological rep 3"}, {"type": "RNA"}, {"source_name_ch1": "Fresh umbilical cord blood"}, {"characteristics_ch1": "blood fraction/population: MNC fraction;\tcell type: fEPC"}]}, {"GSM2869327": [{"title": "fEPC_biological rep 4"}, {"type": "RNA"}, {"source_name_ch1": "Fresh umbilical cord blood"}, {"characteristics_ch1": "blood fraction/population: MNC fraction;\tcell type: fEPC"}]}, {"GSM2869328": [{"title": "ivEPC1 biological rep 1"}, {"type": "RNA"}, {"source_name_ch1": "Fresh umbilical cord blood"}, {"characteristics_ch1": "blood fraction/population: fHSC population;\tcell type: ivEPC"}]}, {"GSM2869329": [{"title": "ivEPC1 biological rep 2"}, {"type": "RNA"}, {"source_name_ch1": "Fresh umbilical cord blood"}, {"characteristics_ch1": "blood fraction/population: fHSC population;\tcell type: ivEPC"}]}, {"GSM2869330": [{"title": "ivEPC1 biological rep 3"}, {"type": "RNA"}, {"source_name_ch1": "Fresh umbilical cord blood"}, {"characteristics_ch1": "blood fraction/population: fHSC population;\tcell type: ivEPC"}]}, {"GSM2454209": [{"title": "239"}, {"type": "RNA"}, {"source_name_ch1": "TAG2 Bladder Tumour"}, {"characteristics_ch1": "tumour stage: TaG2;\tage: 59;\tgender: M;\trecurrence free survival (months): 183;\tevent: Last follow up;\tsmoker: Current;\tgenomic subtype: 1"}]}, {"GSM2454210": [{"title": "494"}, {"type": "RNA"}, {"source_name_ch1": "TAG2 Bladder Tumour"}, {"characteristics_ch1": "tumour stage: TaG2;\tage: 68;\tgender: F;\trecurrence free survival (months): 165;\tevent: Last follow up;\tsmoker: Ex;\tgenomic subtype: 1"}]}, {"GSM2454211": [{"title": "578"}, {"type": "RNA"}, {"source_name_ch1": "TAG2 Bladder Tumour"}, {"characteristics_ch1": "tumour stage: TaG2;\tage: 66;\tgender: M;\trecurrence free survival (months): 66;\tevent: Recurrence;\tsmoker: Current;\tgenomic subtype: 1"}]}, {"GSM2454212": [{"title": "672"}, {"type": "RNA"}, {"source_name_ch1": "TAG2 Bladder Tumour"}, {"characteristics_ch1": "tumour stage: TaG2;\tage: 40;\tgender: F;\trecurrence free survival (months): 158;\tevent: Last follow up;\tsmoker: Current;\tgenomic subtype: 1"}]}, {"GSM2454213": [{"title": "675"}, {"type": "RNA"}, {"source_name_ch1": "TAG2 Bladder Tumour"}, {"characteristics_ch1": "tumour stage: TaG2;\tage: 58;\tgender: M;\trecurrence free survival (months): 43;\tevent: Death;\tsmoker: Current;\tgenomic subtype: 2"}]}, {"GSM2454214": [{"title": "811"}, {"type": "RNA"}, {"source_name_ch1": "TAG2 Bladder Tumour"}, {"characteristics_ch1": "tumour stage: TaG2;\tage: 73;\tgender: F;\trecurrence free survival (months): 10;\tevent: Recurrence;\tsmoker: Ex;\tgenomic subtype: 1"}]}, {"GSM2454215": [{"title": "865"}, {"type": "RNA"}, {"source_name_ch1": "TAG2 Bladder Tumour"}, {"characteristics_ch1": "tumour stage: TaG2;\tage: 63;\tgender: F;\trecurrence free survival (months): 10;\tevent: Recurrence;\tsmoker: Current;\tgenomic subtype: 1"}]}, {"GSM2454216": [{"title": "894"}, {"type": "RNA"}, {"source_name_ch1": "TAG2 Bladder Tumour"}, {"characteristics_ch1": "tumour stage: TaG2;\tage: 77;\tgender: F;\trecurrence free survival (months): 27;\tevent: Recurrence;\tsmoker: Never;\tgenomic subtype: 1"}]}, {"GSM2454217": [{"title": "933"}, {"type": "RNA"}, {"source_name_ch1": "TAG2 Bladder Tumour"}, {"characteristics_ch1": "tumour stage: TaG2;\tage: 74;\tgender: F;\trecurrence free survival (months): 12;\tevent: Recurrence;\tsmoker: Ex;\tgenomic subtype: 1"}]}, {"GSM2454218": [{"title": "934"}, {"type": "RNA"}, {"source_name_ch1": "TAG2 Bladder Tumour"}, {"characteristics_ch1": "tumour stage: TaG2;\tage: 54;\tgender: F;\trecurrence free survival (months): 12;\tevent: Recurrence;\tsmoker: Current;\tgenomic subtype: 2"}]}, {"GSM2454219": [{"title": "1017"}, {"type": "RNA"}, {"source_name_ch1": "TAG2 Bladder Tumour"}, {"characteristics_ch1": "tumour stage: TaG2;\tage: 79;\tgender: M;\trecurrence free survival (months): 67;\tevent: Recurrence;\tsmoker: Ex;\tgenomic subtype: 1"}]}, {"GSM2454220": [{"title": "1038"}, {"type": "RNA"}, {"source_name_ch1": "TAG2 Bladder Tumour"}, {"characteristics_ch1": "tumour stage: TaG2;\tage: 59;\tgender: M;\trecurrence free survival (months): 144;\tevent: Last follow up;\tsmoker: Current;\tgenomic subtype: 1"}]}, {"GSM2454221": [{"title": "1058"}, {"type": "RNA"}, {"source_name_ch1": "TAG2 Bladder Tumour"}, {"characteristics_ch1": "tumour stage: TaG2;\tage: 73;\tgender: M;\trecurrence free survival (months): 141;\tevent: Last follow up;\tsmoker: Ex;\tgenomic subtype: 1"}]}, {"GSM2454222": [{"title": "1063"}, {"type": "RNA"}, {"source_name_ch1": "TAG2 Bladder Tumour"}, {"characteristics_ch1": "tumour stage: TaG2;\tage: 78;\tgender: M;\trecurrence free survival (months): 7;\tevent: Recurrence;\tsmoker: Never;\tgenomic subtype: 2"}]}, {"GSM2454223": [{"title": "1117"}, {"type": "RNA"}, {"source_name_ch1": "TAG2 Bladder Tumour"}, {"characteristics_ch1": "tumour stage: TaG2;\tage: 60;\tgender: M;\trecurrence free survival (months): 7;\tevent: Recurrence;\tsmoker: Ex;\tgenomic subtype: 1"}]}, {"GSM2454224": [{"title": "1142"}, {"type": "RNA"}, {"source_name_ch1": "TAG2 Bladder Tumour"}, {"characteristics_ch1": "tumour stage: TaG2;\tage: 58;\tgender: M;\trecurrence free survival (months): 18;\tevent: Recurrence;\tsmoker: Ex;\tgenomic subtype: 1"}]}, {"GSM2454225": [{"title": "1144"}, {"type": "RNA"}, {"source_name_ch1": "TAG2 Bladder Tumour"}, {"characteristics_ch1": "tumour stage: TaG2;\tage: 76;\tgender: M;\trecurrence free survival (months): 135;\tevent: Last follow up;\tsmoker: Never;\tgenomic subtype: 1"}]}, {"GSM2454226": [{"title": "1167"}, {"type": "RNA"}, {"source_name_ch1": "TAG2 Bladder Tumour"}, {"characteristics_ch1": "tumour stage: TaG2;\tage: 77;\tgender: F;\trecurrence free survival (months): 110;\tevent: Death;\tsmoker: Current;\tgenomic subtype: 1"}]}, {"GSM2454227": [{"title": "1177"}, {"type": "RNA"}, {"source_name_ch1": "TAG2 Bladder Tumour"}, {"characteristics_ch1": "tumour stage: TaG2;\tage: 47;\tgender: M;\trecurrence free survival (months): 24;\tevent: Recurrence;\tsmoker: Current;\tgenomic subtype: 1"}]}, {"GSM2454228": [{"title": "1213"}, {"type": "RNA"}, {"source_name_ch1": "TAG2 Bladder Tumour"}, {"characteristics_ch1": "tumour stage: TaG2;\tage: 81;\tgender: F;\trecurrence free survival (months): 36;\tevent: Death;\tsmoker: Ex;\tgenomic subtype: 2"}]}, {"GSM2454229": [{"title": "1214"}, {"type": "RNA"}, {"source_name_ch1": "TAG2 Bladder Tumour"}, {"characteristics_ch1": "tumour stage: TaG2;\tage: 67;\tgender: F;\trecurrence free survival (months): 132;\tevent: Last follow up;\tsmoker: Current;\tgenomic subtype: 1"}]}, {"GSM2454230": [{"title": "1273"}, {"type": "RNA"}, {"source_name_ch1": "TAG2 Bladder Tumour"}, {"characteristics_ch1": "tumour stage: TaG2;\tage: 70;\tgender: F;\trecurrence free survival (months): 12;\tevent: Recurrence;\tsmoker: Never;\tgenomic subtype: 1"}]}, {"GSM2454231": [{"title": "1283"}, {"type": "RNA"}, {"source_name_ch1": "TAG2 Bladder Tumour"}, {"characteristics_ch1": "tumour stage: TaG2;\tage: 59;\tgender: M;\trecurrence free survival (months): 14;\tevent: Recurrence;\tsmoker: Ex;\tgenomic subtype: 2"}]}, {"GSM2454232": [{"title": "1305"}, {"type": "RNA"}, {"source_name_ch1": "TAG2 Bladder Tumour"}, {"characteristics_ch1": "tumour stage: TaG2;\tage: 86;\tgender: M;\trecurrence free survival (months): 39;\tevent: Death;\tsmoker: Ex;\tgenomic subtype: 2"}]}, {"GSM2454233": [{"title": "1307"}, {"type": "RNA"}, {"source_name_ch1": "TAG2 Bladder Tumour"}, {"characteristics_ch1": "tumour stage: TaG2;\tage: 74;\tgender: M;\trecurrence free survival (months): 45;\tevent: Death;\tsmoker: Ex;\tgenomic subtype: 2"}]}, {"GSM2454234": [{"title": "1313"}, {"type": "RNA"}, {"source_name_ch1": "TAG2 Bladder Tumour"}, {"characteristics_ch1": "tumour stage: TaG2;\tage: 54;\tgender: M;\trecurrence free survival (months): 16;\tevent: Recurrence;\tsmoker: Current;\tgenomic subtype: 2"}]}, {"GSM2454235": [{"title": "1335"}, {"type": "RNA"}, {"source_name_ch1": "TAG2 Bladder Tumour"}, {"characteristics_ch1": "tumour stage: TaG2;\tage: 67;\tgender: F;\trecurrence free survival (months): 22;\tevent: Recurrence;\tsmoker: Never;\tgenomic subtype: 2"}]}, {"GSM2454236": [{"title": "1361"}, {"type": "RNA"}, {"source_name_ch1": "TAG2 Bladder Tumour"}, {"characteristics_ch1": "tumour stage: TaG2;\tage: 82;\tgender: M;\trecurrence free survival (months): 34;\tevent: Recurrence;\tsmoker: Current;\tgenomic subtype: 1"}]}, {"GSM2454237": [{"title": "1385"}, {"type": "RNA"}, {"source_name_ch1": "TAG2 Bladder Tumour"}, {"characteristics_ch1": "tumour stage: TaG2;\tage: 59;\tgender: F;\trecurrence free survival (months): 118;\tevent: Last follow up;\tsmoker: Never;\tgenomic subtype: 1"}]}, {"GSM2454238": [{"title": "1387"}, {"type": "RNA"}, {"source_name_ch1": "TAG2 Bladder Tumour"}, {"characteristics_ch1": "tumour stage: TaG2;\tage: 74;\tgender: F;\trecurrence free survival (months): 20;\tevent: Recurrence;\tsmoker: Ex;\tgenomic subtype: 2"}]}, {"GSM2454239": [{"title": "1436"}, {"type": "RNA"}, {"source_name_ch1": "TAG2 Bladder Tumour"}, {"characteristics_ch1": "tumour stage: TaG2;\tage: 86;\tgender: M;\trecurrence free survival (months): 106;\tevent: Death;\tsmoker: Current;\tgenomic subtype: 1"}]}, {"GSM2454240": [{"title": "1440"}, {"type": "RNA"}, {"source_name_ch1": "TAG2 Bladder Tumour"}, {"characteristics_ch1": "tumour stage: TaG2;\tage: 67;\tgender: M;\trecurrence free survival (months): 67;\tevent: Death;\tsmoker: Ex;\tgenomic subtype: 1"}]}, {"GSM2454241": [{"title": "1453"}, {"type": "RNA"}, {"source_name_ch1": "TAG2 Bladder Tumour"}, {"characteristics_ch1": "tumour stage: TaG2;\tage: 88;\tgender: M;\trecurrence free survival (months): 18;\tevent: Recurrence;\tsmoker: Ex;\tgenomic subtype: 2"}]}, {"GSM2454242": [{"title": "1467"}, {"type": "RNA"}, {"source_name_ch1": "TAG2 Bladder Tumour"}, {"characteristics_ch1": "tumour stage: TaG2;\tage: 84;\tgender: M;\trecurrence free survival (months): 14;\tevent: Recurrence;\tsmoker: Ex;\tgenomic subtype: 2"}]}, {"GSM2454243": [{"title": "1474"}, {"type": "RNA"}, {"source_name_ch1": "TAG2 Bladder Tumour"}, {"characteristics_ch1": "tumour stage: TaG2;\tage: 58;\tgender: F;\trecurrence free survival (months): 44;\tevent: Recurrence;\tsmoker: Never;\tgenomic subtype: 1"}]}, {"GSM2902594": [{"title": "bone marrow 1, biological rep 1"}, {"type": "RNA"}, {"source_name_ch1": "mesenchymal stem cells from bone marrow"}, {"characteristics_ch1": "tissue: bone marrow;\tcell type: mesenchymal stem cells"}]}, {"GSM2902595": [{"title": "bone marrow 2, biological rep 2"}, {"type": "RNA"}, {"source_name_ch1": "mesenchymal stem cells from bone marrow"}, {"characteristics_ch1": "tissue: bone marrow;\tcell type: mesenchymal stem cells"}]}, {"GSM2902596": [{"title": "bone marrow 2, biological rep 3"}, {"type": "RNA"}, {"source_name_ch1": "mesenchymal stem cells from bone marrow"}, {"characteristics_ch1": "tissue: bone marrow;\tcell type: mesenchymal stem cells"}]}, {"GSM2902597": [{"title": "bone marrow 2, biological rep 4"}, {"type": "RNA"}, {"source_name_ch1": "mesenchymal stem cells from bone marrow"}, {"characteristics_ch1": "tissue: bone marrow;\tcell type: mesenchymal stem cells"}]}, {"GSM2902598": [{"title": "bone marrow 2, biological rep 5"}, {"type": "RNA"}, {"source_name_ch1": "mesenchymal stem cells from bone marrow"}, {"characteristics_ch1": "tissue: bone marrow;\tcell type: mesenchymal stem cells"}]}, {"GSM2902599": [{"title": "adipose tissue 1, biological rep 1"}, {"type": "RNA"}, {"source_name_ch1": "mesenchymal stem cells from adipose tissue"}, {"characteristics_ch1": "tissue: adipose tissue;\tcell type: mesenchymal stem cells"}]}, {"GSM2902600": [{"title": "adipose tissue 2, biological rep 2"}, {"type": "RNA"}, {"source_name_ch1": "mesenchymal stem cells from adipose tissue"}, {"characteristics_ch1": "tissue: adipose tissue;\tcell type: mesenchymal stem cells"}]}, {"GSM2902601": [{"title": "adipose tissue 3, biological rep 3"}, {"type": "RNA"}, {"source_name_ch1": "mesenchymal stem cells from adipose tissue"}, {"characteristics_ch1": "tissue: adipose tissue;\tcell type: mesenchymal stem cells"}]}, {"GSM2902602": [{"title": "umbilical cord 1, biological rep 1"}, {"type": "RNA"}, {"source_name_ch1": "mesenchymal stem cells from umbilical cord"}, {"characteristics_ch1": "tissue: umbilical cord;\tcell type: mesenchymal stem cells"}]}, {"GSM2902603": [{"title": "umbilical cord 2, biological rep 2"}, {"type": "RNA"}, {"source_name_ch1": "mesenchymal stem cells from umbilical cord"}, {"characteristics_ch1": "tissue: umbilical cord;\tcell type: mesenchymal stem cells"}]}, {"GSM2902604": [{"title": "umbilical cord 3, biological rep 3"}, {"type": "RNA"}, {"source_name_ch1": "mesenchymal stem cells from umbilical cord"}, {"characteristics_ch1": "tissue: umbilical cord;\tcell type: mesenchymal stem cells"}]}, {"GSM2902605": [{"title": "umbilical cord 4, biological rep 4"}, {"type": "RNA"}, {"source_name_ch1": "mesenchymal stem cells from umbilical cord"}, {"characteristics_ch1": "tissue: umbilical cord;\tcell type: mesenchymal stem cells"}]}, {"GSM2902606": [{"title": "placenta 1. biological rep 1"}, {"type": "RNA"}, {"source_name_ch1": "mesenchymal stem cells from placenta"}, {"characteristics_ch1": "tissue: placenta;\tcell type: mesenchymal stem cells"}]}, {"GSM2902607": [{"title": "placenta 2, biological rep 2"}, {"type": "RNA"}, {"source_name_ch1": "mesenchymal stem cells from placenta"}, {"characteristics_ch1": "tissue: placenta;\tcell type: mesenchymal stem cells"}]}, {"GSM2902608": [{"title": "placenta 3, biological rep 3"}, {"type": "RNA"}, {"source_name_ch1": "mesenchymal stem cells from placenta"}, {"characteristics_ch1": "tissue: placenta;\tcell type: mesenchymal stem cells"}]}, {"GSM2902609": [{"title": "Dermal fibroblast 1, biological rep 1"}, {"type": "RNA"}, {"source_name_ch1": "fibroblast from dermis"}, {"characteristics_ch1": "tissue: foreskin dermis;\tcell type: fibroblast"}]}, {"GSM2902610": [{"title": "Dermal fibroblast 2, biological rep 2"}, {"type": "RNA"}, {"source_name_ch1": "fibroblast from dermis"}, {"characteristics_ch1": "tissue: foreskin dermis;\tcell type: fibroblast"}]}, {"GSM2902611": [{"title": "Dermal fibroblast 3, biological rep 3"}, {"type": "RNA"}, {"source_name_ch1": "fibroblast from dermis"}, {"characteristics_ch1": "tissue: foreskin dermis;\tcell type: fibroblast"}]}, {"GSM1716642": [{"title": "CS-1_untreated_rep1"}, {"type": "RNA"}, {"source_name_ch1": "Grade III human chondrosarcoma"}, {"characteristics_ch1": "cell line: CS-1;\ttreatment: untreated"}]}, {"GSM1716643": [{"title": "CS-1_untreated_rep2"}, {"type": "RNA"}, {"source_name_ch1": "Grade III human chondrosarcoma"}, {"characteristics_ch1": "cell line: CS-1;\ttreatment: untreated"}]}, {"GSM1716644": [{"title": "CS-1_untreated_rep3"}, {"type": "RNA"}, {"source_name_ch1": "Grade III human chondrosarcoma"}, {"characteristics_ch1": "cell line: CS-1;\ttreatment: untreated"}]}, {"GSM1716645": [{"title": "CS-1_control lentivector_rep1"}, {"type": "RNA"}, {"source_name_ch1": "Grade III human chondrosarcoma"}, {"characteristics_ch1": "cell line: CS-1;\ttreatment: control lentivector"}]}, {"GSM1716646": [{"title": "CS-1_control lentivector_rep2"}, {"type": "RNA"}, {"source_name_ch1": "Grade III human chondrosarcoma"}, {"characteristics_ch1": "cell line: CS-1;\ttreatment: control lentivector"}]}, {"GSM1716647": [{"title": "CS-1_control lentivector_rep3"}, {"type": "RNA"}, {"source_name_ch1": "Grade III human chondrosarcoma"}, {"characteristics_ch1": "cell line: CS-1;\ttreatment: control lentivector"}]}, {"GSM1716648": [{"title": "CS-1_anti-miR-181a lentivector_rep1"}, {"type": "RNA"}, {"source_name_ch1": "Grade III human chondrosarcoma"}, {"characteristics_ch1": "cell line: CS-1;\ttreatment: anti-miR-181a lentivector"}]}, {"GSM1716649": [{"title": "CS-1_anti-miR-181a lentivector_rep2"}, {"type": "RNA"}, {"source_name_ch1": "Grade III human chondrosarcoma"}, {"characteristics_ch1": "cell line: CS-1;\ttreatment: anti-miR-181a lentivector"}]}, {"GSM1716650": [{"title": "CS-1_anti-miR-181a lentivector_rep3"}, {"type": "RNA"}, {"source_name_ch1": "Grade III human chondrosarcoma"}, {"characteristics_ch1": "cell line: CS-1;\ttreatment: anti-miR-181a lentivector"}]}, {"GSM1939651": [{"title": "T CD8 DP from cHL 1 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Ex-vivo Tfh"}, {"characteristics_ch1": "pathology: Classical Hodgkin Lymphoma;\ttreatment: Untreated;\tcell type: CXCR5+ ICOS+ CD8+ T cells"}]}, {"GSM1939652": [{"title": "T CD8 DP from cHL 2 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Ex-vivo Tfh"}, {"characteristics_ch1": "pathology: Classical Hodgkin Lymphoma;\ttreatment: Untreated;\tcell type: CXCR5+ ICOS+ CD8+ T cells"}]}, {"GSM1939653": [{"title": "T CD8 DP from cHL 3 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Ex-vivo Tfh"}, {"characteristics_ch1": "pathology: Classical Hodgkin Lymphoma;\ttreatment: Untreated;\tcell type: CXCR5+ ICOS+ CD8+ T cells"}]}, {"GSM1939654": [{"title": "T CD8 DN from cHL 1 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Ex-vivo Tfh"}, {"characteristics_ch1": "pathology: Classical Hodgkin Lymphoma;\ttreatment: Untreated;\tcell type: CXCR5- ICOS- CD8+ T cells"}]}, {"GSM1939655": [{"title": "T CD8 DN from cHL 2 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Ex-vivo Tfh"}, {"characteristics_ch1": "pathology: Classical Hodgkin Lymphoma;\ttreatment: Untreated;\tcell type: CXCR5- ICOS- CD8+ T cells"}]}, {"GSM1939656": [{"title": "T CD8 DN from cHL 3 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Ex-vivo Tfh"}, {"characteristics_ch1": "pathology: Classical Hodgkin Lymphoma;\ttreatment: Untreated;\tcell type: CXCR5- ICOS- CD8+ T cells"}]}, {"GSM2893469": [{"title": "Normal never_06"}, {"type": "RNA"}, {"source_name_ch1": "Brachial plexus"}, {"characteristics_ch1": "disease state: control;\ttissue: normal control vestibular nerve;\tgender: M;\tage: 20"}]}, {"GSM2893470": [{"title": "Normal never_08"}, {"type": "RNA"}, {"source_name_ch1": "Brachial plexus"}, {"characteristics_ch1": "disease state: control;\ttissue: normal control vestibular nerve;\tgender: F;\tage: 61"}]}, {"GSM2893471": [{"title": "Normal never_09"}, {"type": "RNA"}, {"source_name_ch1": "Brachial plexus"}, {"characteristics_ch1": "disease state: control;\ttissue: normal control vestibular nerve;\tgender: M;\tage: 52"}]}, {"GSM2893472": [{"title": "Normal never_10"}, {"type": "RNA"}, {"source_name_ch1": "Brachial plexus"}, {"characteristics_ch1": "disease state: control;\ttissue: normal control vestibular nerve;\tgender: F;\tage: 40"}]}, {"GSM2893473": [{"title": "Sporadic Vestibular Schwannoma_01"}, {"type": "RNA"}, {"source_name_ch1": "Vestibular Schwannoma"}, {"characteristics_ch1": "disease state: Vestibular Schwannoma;\ttissue: VS;\tgender: M;\tage: 34"}]}, {"GSM2893474": [{"title": "Sporadic Vestibular Schwannoma_02"}, {"type": "RNA"}, {"source_name_ch1": "Vestibular Schwannoma"}, {"characteristics_ch1": "disease state: Vestibular Schwannoma;\ttissue: VS;\tgender: M;\tage: 51"}]}, {"GSM2893475": [{"title": "Sporadic Vestibular Schwannoma_03"}, {"type": "RNA"}, {"source_name_ch1": "Vestibular Schwannoma"}, {"characteristics_ch1": "disease state: Vestibular Schwannoma;\ttissue: VS;\tgender: F;\tage: 44"}]}, {"GSM2893476": [{"title": "Sporadic Vestibular Schwannoma_04"}, {"type": "RNA"}, {"source_name_ch1": "Vestibular Schwannoma"}, {"characteristics_ch1": "disease state: Vestibular Schwannoma;\ttissue: VS;\tgender: M;\tage: 48"}]}, {"GSM2893477": [{"title": "Sporadic Vestibular Schwannoma_05"}, {"type": "RNA"}, {"source_name_ch1": "Vestibular Schwannoma"}, {"characteristics_ch1": "disease state: Vestibular Schwannoma;\ttissue: VS;\tgender: M;\tage: 48"}]}, {"GSM2893478": [{"title": "Sporadic Vestibular Schwannoma_06"}, {"type": "RNA"}, {"source_name_ch1": "Vestibular Schwannoma"}, {"characteristics_ch1": "disease state: Vestibular Schwannoma;\ttissue: VS;\tgender: M;\tage: 21"}]}, {"GSM2893479": [{"title": "Sporadic Vestibular Schwannoma_07"}, {"type": "RNA"}, {"source_name_ch1": "Vestibular Schwannoma"}, {"characteristics_ch1": "disease state: Vestibular Schwannoma;\ttissue: VS;\tgender: F;\tage: 33"}]}, {"GSM2893480": [{"title": "Sporadic Vestibular Schwannoma_08"}, {"type": "RNA"}, {"source_name_ch1": "Vestibular Schwannoma"}, {"characteristics_ch1": "disease state: Vestibular Schwannoma;\ttissue: VS;\tgender: M;\tage: 45"}]}, {"GSM2893481": [{"title": "Sporadic Vestibular Schwannoma_09"}, {"type": "RNA"}, {"source_name_ch1": "Vestibular Schwannoma"}, {"characteristics_ch1": "disease state: Vestibular Schwannoma;\ttissue: VS;\tgender: M;\tage: 48"}]}, {"GSM2893482": [{"title": "Sporadic Vestibular Schwannoma_10"}, {"type": "RNA"}, {"source_name_ch1": "Vestibular Schwannoma"}, {"characteristics_ch1": "disease state: Vestibular Schwannoma;\ttissue: VS;\tgender: M;\tage: 55"}]}, {"GSM2902750": [{"title": "NF2-associated Vestibular Schwannoma_08"}, {"type": "RNA"}, {"source_name_ch1": "Vestibular Schwannoma"}, {"characteristics_ch1": "disease state: NF2-associated VS;\tgender: M;\tage at onset of nf2 symptoms: 37;\tage at diagnosis: 39;\ttissue: VS"}]}, {"GSM2902751": [{"title": "NF2-associated Vestibular Schwannoma_09"}, {"type": "RNA"}, {"source_name_ch1": "Vestibular Schwannoma"}, {"characteristics_ch1": "disease state: NF2-associated VS;\tgender: F;\tage at onset of nf2 symptoms: 22;\tage at diagnosis: 23;\ttissue: VS"}]}, {"GSM2902752": [{"title": "NF2-associated Vestibular Schwannoma_10"}, {"type": "RNA"}, {"source_name_ch1": "Vestibular Schwannoma"}, {"characteristics_ch1": "disease state: NF2-associated VS;\tgender: F;\tage at onset of nf2 symptoms: 14;\tage at diagnosis: 16;\ttissue: VS"}]}, {"GSM2902753": [{"title": "NF2-associated Vestibular Schwannoma_11"}, {"type": "RNA"}, {"source_name_ch1": "Vestibular Schwannoma"}, {"characteristics_ch1": "disease state: NF2-associated VS;\tgender: M;\tage at onset of nf2 symptoms: 10;\tage at diagnosis: 15;\ttissue: VS"}]}, {"GSM2902754": [{"title": "NF2-associated Vestibular Schwannoma_14"}, {"type": "RNA"}, {"source_name_ch1": "Vestibular Schwannoma"}, {"characteristics_ch1": "disease state: NF2-associated VS;\tgender: M;\tage at onset of nf2 symptoms: 14;\tage at diagnosis: 19;\ttissue: VS"}]}, {"GSM2902755": [{"title": "NF2-associated Vestibular Schwannoma_15"}, {"type": "RNA"}, {"source_name_ch1": "Vestibular Schwannoma"}, {"characteristics_ch1": "disease state: NF2-associated VS;\tgender: M;\tage at onset of nf2 symptoms: 35;\tage at diagnosis: 35;\ttissue: VS"}]}, {"GSM2902756": [{"title": "NF2-associated Vestibular Schwannoma_16"}, {"type": "RNA"}, {"source_name_ch1": "Vestibular Schwannoma"}, {"characteristics_ch1": "disease state: NF2-associated VS;\tgender: M;\tage at onset of nf2 symptoms: 18;\tage at diagnosis: 19;\ttissue: VS"}]}, {"GSM2902757": [{"title": "NF2-associated Vestibular Schwannoma_17"}, {"type": "RNA"}, {"source_name_ch1": "Vestibular Schwannoma"}, {"characteristics_ch1": "disease state: NF2-associated VS;\tgender: M;\tage at onset of nf2 symptoms: 15;\tage at diagnosis: 25;\ttissue: VS"}]}, {"GSM2902758": [{"title": "NF2-associated Vestibular Schwannoma_19"}, {"type": "RNA"}, {"source_name_ch1": "Vestibular Schwannoma"}, {"characteristics_ch1": "disease state: NF2-associated VS;\tgender: M;\tage at onset of nf2 symptoms: 16;\tage at diagnosis: 17;\ttissue: VS"}]}, {"GSM2902759": [{"title": "NF2-associated Vestibular Schwannoma_20"}, {"type": "RNA"}, {"source_name_ch1": "Vestibular Schwannoma"}, {"characteristics_ch1": "disease state: NF2-associated VS;\tgender: M;\tage at onset of nf2 symptoms: 23;\tage at diagnosis: 34;\ttissue: VS"}]}, {"GSM2902760": [{"title": "NF2-associated Vestibular Schwannoma_21"}, {"type": "RNA"}, {"source_name_ch1": "Vestibular Schwannoma"}, {"characteristics_ch1": "disease state: NF2-associated VS;\tgender: M;\tage at onset of nf2 symptoms: 6;\tage at diagnosis: 7;\ttissue: VS"}]}, {"GSM2902761": [{"title": "NF2-associated Vestibular Schwannoma_22"}, {"type": "RNA"}, {"source_name_ch1": "Vestibular Schwannoma"}, {"characteristics_ch1": "disease state: NF2-associated VS;\tgender: F;\tage at onset of nf2 symptoms: 32;\tage at diagnosis: 52;\ttissue: VS"}]}, {"GSM2902762": [{"title": "NF2-associated Vestibular Schwannoma_24"}, {"type": "RNA"}, {"source_name_ch1": "Vestibular Schwannoma"}, {"characteristics_ch1": "disease state: NF2-associated VS;\tgender: F;\tage at onset of nf2 symptoms: 25;\tage at diagnosis: 35;\ttissue: VS"}]}, {"GSM2902763": [{"title": "NF2-associated Vestibular Schwannoma_25"}, {"type": "RNA"}, {"source_name_ch1": "Vestibular Schwannoma"}, {"characteristics_ch1": "disease state: NF2-associated VS;\tgender: F;\tage at onset of nf2 symptoms: 16;\tage at diagnosis: 19;\ttissue: VS"}]}, {"GSM2902764": [{"title": "NF2-associated Vestibular Schwannoma_27"}, {"type": "RNA"}, {"source_name_ch1": "Vestibular Schwannoma"}, {"characteristics_ch1": "disease state: NF2-associated VS;\tgender: M;\tage at onset of nf2 symptoms: 16;\tage at diagnosis: 35;\ttissue: VS"}]}, {"GSM2902765": [{"title": "NF2-associated Vestibular Schwannoma_28"}, {"type": "RNA"}, {"source_name_ch1": "Vestibular Schwannoma"}, {"characteristics_ch1": "disease state: NF2-associated VS;\tgender: M;\tage at onset of nf2 symptoms: 9;\tage at diagnosis: 10;\ttissue: VS"}]}, {"GSM2902766": [{"title": "NF2-associated Vestibular Schwannoma_29"}, {"type": "RNA"}, {"source_name_ch1": "Vestibular Schwannoma"}, {"characteristics_ch1": "disease state: NF2-associated VS;\tgender: F;\tage at onset of nf2 symptoms: 6;\tage at diagnosis: 8;\ttissue: VS"}]}, {"GSM1939639": [{"title": "Memory  T CD4 from TONS 1 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Ex-vivo memory CD4 T cells"}, {"characteristics_ch1": "pathology: Tonsillectomy;\ttreatment: Untreated"}]}, {"GSM1939640": [{"title": "Memory T CD4 from TONS 2 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Ex-vivo memory CD4 T cells"}, {"characteristics_ch1": "pathology: Tonsillectomy;\ttreatment: Untreated"}]}, {"GSM1939641": [{"title": "Memory  T CD4 from TONS 3 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Ex-vivo memory CD4 T cells"}, {"characteristics_ch1": "pathology: Tonsillectomy;\ttreatment: Untreated"}]}, {"GSM1939642": [{"title": "Tfh from TONS 1 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Ex-vivo Tfh cells"}, {"characteristics_ch1": "pathology: Tonsillectomy;\ttreatment: Untreated"}]}, {"GSM1939643": [{"title": "Tfh from TONS 2 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Ex-vivo Tfh cells"}, {"characteristics_ch1": "pathology: Tonsillectomy;\ttreatment: Untreated"}]}, {"GSM1939644": [{"title": "Tfh from TONS 3 [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "Ex-vivo Tfh cells"}, {"characteristics_ch1": "pathology: Tonsillectomy;\ttreatment: Untreated"}]}, {"GSM2957702": [{"title": "MCF-7 2D, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "MCF-7 monolayer cells harvested at day 3"}, {"characteristics_ch1": "tissue: Breast Epithelial Adenocarcinoma;\tcell line: MCF-7;\tage: 69;\tculture method: 2D monolayer"}]}, {"GSM2957703": [{"title": "MCF-7 2D, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "MCF-7 monolayer cells harvested at day 3"}, {"characteristics_ch1": "tissue: Breast Epithelial Adenocarcinoma;\tcell line: MCF-7;\tage: 69;\tculture method: 2D monolayer"}]}, {"GSM2957704": [{"title": "MCF-7 2D, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "MCF-7 monolayer cells harvested at day 3"}, {"characteristics_ch1": "tissue: Breast Epithelial Adenocarcinoma;\tcell line: MCF-7;\tage: 69;\tculture method: 2D monolayer"}]}, {"GSM2957705": [{"title": "MCF-7 3D Ultra-Low Attachment, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "MCF-7 spheroids grown in Ultra-low attachment 96-well plates harvested at day 3"}, {"characteristics_ch1": "tissue: Breast Epithelial Adenocarcinoma;\tcell line: MCF-7;\tage: 69;\tculture method: 3D ultra-low attachment"}]}, {"GSM2957706": [{"title": "MCF-7 3D Ultra-Low Attachment, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "MCF-7 spheroids grown in Ultra-low attachment 96-well plates harvested at day 3"}, {"characteristics_ch1": "tissue: Breast Epithelial Adenocarcinoma;\tcell line: MCF-7;\tage: 69;\tculture method: 3D ultra-low attachment"}]}, {"GSM2957707": [{"title": "MCF-7 3D Ultra-Low Attachment, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "MCF-7 spheroids grown in Ultra-low attachment 96-well plates harvested at day 3"}, {"characteristics_ch1": "tissue: Breast Epithelial Adenocarcinoma;\tcell line: MCF-7;\tage: 69;\tculture method: 3D ultra-low attachment"}]}, {"GSM2957708": [{"title": "MCF-7 3D PolyHema, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "MCF-7 spheroids grown in PolyHema coated 96-well plates harvested at day 3"}, {"characteristics_ch1": "tissue: Breast Epithelial Adenocarcinoma;\tcell line: MCF-7;\tage: 69;\tculture method: 3D polyhema"}]}, {"GSM2957709": [{"title": "MCF-7 3D PolyHema, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "MCF-7 spheroids grown in PolyHema coated 96-well plates harvested at day 3"}, {"characteristics_ch1": "tissue: Breast Epithelial Adenocarcinoma;\tcell line: MCF-7;\tage: 69;\tculture method: 3D polyhema"}]}, {"GSM2957710": [{"title": "MCF-7 3D PolyHema, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "MCF-7 spheroids grown in PolyHema coated 96-well plates harvested at day 3"}, {"characteristics_ch1": "tissue: Breast Epithelial Adenocarcinoma;\tcell line: MCF-7;\tage: 69;\tculture method: 3D polyhema"}]}, {"GSM2957711": [{"title": "MCF-7 3D Methylcellulose, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "MCF-7 spheroids grown in 96-well plates with methylcellulose harvested at day 3"}, {"characteristics_ch1": "tissue: Breast Epithelial Adenocarcinoma;\tcell line: MCF-7;\tage: 69;\tculture method: 3D methylcellulose"}]}, {"GSM2957712": [{"title": "MCF-7 3D Methylcellulose, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "MCF-7 spheroids grown in 96-well plates with methylcellulose harvested at day 3"}, {"characteristics_ch1": "tissue: Breast Epithelial Adenocarcinoma;\tcell line: MCF-7;\tage: 69;\tculture method: 3D methylcellulose"}]}, {"GSM2957713": [{"title": "MCF-7 3D Methylcellulose, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "MCF-7 spheroids grown in 96-well plates with methylcellulose harvested at day 3"}, {"characteristics_ch1": "tissue: Breast Epithelial Adenocarcinoma;\tcell line: MCF-7;\tage: 69;\tculture method: 3D methylcellulose"}]}, {"GSM2544275": [{"title": "Human glomeruli DN 01"}, {"type": "RNA"}, {"source_name_ch1": "diabetic nephropathy"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: female"}]}, {"GSM2544276": [{"title": "Human glomeruli DN 02"}, {"type": "RNA"}, {"source_name_ch1": "diabetic nephropathy"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: male"}]}, {"GSM2544277": [{"title": "Human glomeruli DN 03"}, {"type": "RNA"}, {"source_name_ch1": "diabetic nephropathy"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: male"}]}, {"GSM2544278": [{"title": "Human glomeruli DN 04"}, {"type": "RNA"}, {"source_name_ch1": "diabetic nephropathy"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: female"}]}, {"GSM2544279": [{"title": "Human glomeruli DN 05"}, {"type": "RNA"}, {"source_name_ch1": "diabetic nephropathy"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: male"}]}, {"GSM2544280": [{"title": "Human glomeruli DN 06"}, {"type": "RNA"}, {"source_name_ch1": "diabetic nephropathy"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: male"}]}, {"GSM2544281": [{"title": "Human glomeruli DN 07"}, {"type": "RNA"}, {"source_name_ch1": "diabetic nephropathy"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: female"}]}, {"GSM2544282": [{"title": "Human glomeruli DN 08"}, {"type": "RNA"}, {"source_name_ch1": "diabetic nephropathy"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: male"}]}, {"GSM2544283": [{"title": "Human glomeruli DN 09"}, {"type": "RNA"}, {"source_name_ch1": "diabetic nephropathy"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: female"}]}, {"GSM2544284": [{"title": "Human glomeruli DN 10"}, {"type": "RNA"}, {"source_name_ch1": "diabetic nephropathy"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: female"}]}, {"GSM2544285": [{"title": "Human glomeruli DN 11"}, {"type": "RNA"}, {"source_name_ch1": "diabetic nephropathy"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: male"}]}, {"GSM2544286": [{"title": "Human glomeruli DN 12"}, {"type": "RNA"}, {"source_name_ch1": "diabetic nephropathy"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: female"}]}, {"GSM2544287": [{"title": "Human glomeruli DN 13"}, {"type": "RNA"}, {"source_name_ch1": "diabetic nephropathy"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: male"}]}, {"GSM2544288": [{"title": "Human glomeruli DN 14"}, {"type": "RNA"}, {"source_name_ch1": "diabetic nephropathy"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: male"}]}, {"GSM2544289": [{"title": "Human glomeruli DN 15"}, {"type": "RNA"}, {"source_name_ch1": "diabetic nephropathy"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: male"}]}, {"GSM2544290": [{"title": "Human glomeruli DN 16"}, {"type": "RNA"}, {"source_name_ch1": "diabetic nephropathy"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: female"}]}, {"GSM2544291": [{"title": "Human glomeruli DN 17"}, {"type": "RNA"}, {"source_name_ch1": "diabetic nephropathy"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: female"}]}, {"GSM2544292": [{"title": "Human glomeruli DN 18"}, {"type": "RNA"}, {"source_name_ch1": "diabetic nephropathy"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: male"}]}, {"GSM2544293": [{"title": "Human glomeruli DN 19"}, {"type": "RNA"}, {"source_name_ch1": "diabetic nephropathy"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: female"}]}, {"GSM2544294": [{"title": "Human glomeruli DN 20"}, {"type": "RNA"}, {"source_name_ch1": "diabetic nephropathy"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: male"}]}, {"GSM2544295": [{"title": "Human glomeruli DN 21"}, {"type": "RNA"}, {"source_name_ch1": "diabetic nephropathy"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: male"}]}, {"GSM2544296": [{"title": "Human glomeruli DN 22"}, {"type": "RNA"}, {"source_name_ch1": "diabetic nephropathy"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: male"}]}, {"GSM2544297": [{"title": "Human glomeruli DN 23"}, {"type": "RNA"}, {"source_name_ch1": "diabetic nephropathy"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: male"}]}, {"GSM2544298": [{"title": "Human glomeruli DN 24"}, {"type": "RNA"}, {"source_name_ch1": "diabetic nephropathy"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: male"}]}, {"GSM2544299": [{"title": "Human glomeruli DN 25"}, {"type": "RNA"}, {"source_name_ch1": "diabetic nephropathy"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: female"}]}, {"GSM2544300": [{"title": "Human glomeruli DN 26"}, {"type": "RNA"}, {"source_name_ch1": "diabetic nephropathy"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: male"}]}, {"GSM2544301": [{"title": "Human glomeruli DN 27"}, {"type": "RNA"}, {"source_name_ch1": "diabetic nephropathy"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: male"}]}, {"GSM2544302": [{"title": "Human glomeruli DN 28"}, {"type": "RNA"}, {"source_name_ch1": "diabetic nephropathy"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: male"}]}, {"GSM2544303": [{"title": "Human glomeruli DN 29"}, {"type": "RNA"}, {"source_name_ch1": "diabetic nephropathy"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: male"}]}, {"GSM2544304": [{"title": "Human glomeruli DN 30"}, {"type": "RNA"}, {"source_name_ch1": "diabetic nephropathy"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: male"}]}, {"GSM2544305": [{"title": "Human glomeruli DN 31"}, {"type": "RNA"}, {"source_name_ch1": "diabetic nephropathy"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: male"}]}, {"GSM2544306": [{"title": "Human glomeruli DN 32"}, {"type": "RNA"}, {"source_name_ch1": "diabetic nephropathy"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: male"}]}, {"GSM2544307": [{"title": "Human glomeruli DN 33"}, {"type": "RNA"}, {"source_name_ch1": "diabetic nephropathy"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: male"}]}, {"GSM2544308": [{"title": "Human glomeruli DN 34"}, {"type": "RNA"}, {"source_name_ch1": "diabetic nephropathy"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: male"}]}, {"GSM2544309": [{"title": "Human glomeruli DN 35"}, {"type": "RNA"}, {"source_name_ch1": "diabetic nephropathy"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: male"}]}, {"GSM2544310": [{"title": "Human glomeruli DN 36"}, {"type": "RNA"}, {"source_name_ch1": "diabetic nephropathy"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: female"}]}, {"GSM2544311": [{"title": "Human glomeruli DN 37"}, {"type": "RNA"}, {"source_name_ch1": "diabetic nephropathy"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: male"}]}, {"GSM2544312": [{"title": "Human glomeruli DN 38"}, {"type": "RNA"}, {"source_name_ch1": "diabetic nephropathy"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: female"}]}, {"GSM2544313": [{"title": "Human glomeruli DN 39"}, {"type": "RNA"}, {"source_name_ch1": "diabetic nephropathy"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: male"}]}, {"GSM2544314": [{"title": "Human glomeruli DN 40"}, {"type": "RNA"}, {"source_name_ch1": "diabetic nephropathy"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: male"}]}, {"GSM2544315": [{"title": "Human glomeruli DN 41"}, {"type": "RNA"}, {"source_name_ch1": "diabetic nephropathy"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: male"}]}, {"GSM2544316": [{"title": "Human glomeruli Control 01"}, {"type": "RNA"}, {"source_name_ch1": "unaffected portion of tumor nephrectomies"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: male"}]}, {"GSM2544317": [{"title": "Human glomeruli Control 02"}, {"type": "RNA"}, {"source_name_ch1": "unaffected portion of tumor nephrectomies"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: male"}]}, {"GSM2544318": [{"title": "Human glomeruli Control 03"}, {"type": "RNA"}, {"source_name_ch1": "unaffected portion of tumor nephrectomies"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: male"}]}, {"GSM2544319": [{"title": "Human glomeruli Control 04"}, {"type": "RNA"}, {"source_name_ch1": "unaffected portion of tumor nephrectomies"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: female"}]}, {"GSM2544320": [{"title": "Human glomeruli Control 05"}, {"type": "RNA"}, {"source_name_ch1": "unaffected portion of tumor nephrectomies"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: female"}]}, {"GSM2544321": [{"title": "Human glomeruli Control 06"}, {"type": "RNA"}, {"source_name_ch1": "unaffected portion of tumor nephrectomies"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: male"}]}, {"GSM2544322": [{"title": "Human glomeruli Control 07"}, {"type": "RNA"}, {"source_name_ch1": "unaffected portion of tumor nephrectomies"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: male"}]}, {"GSM2544323": [{"title": "Human glomeruli Control 08"}, {"type": "RNA"}, {"source_name_ch1": "unaffected portion of tumor nephrectomies"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: male"}]}, {"GSM2544324": [{"title": "Human glomeruli Control 09"}, {"type": "RNA"}, {"source_name_ch1": "unaffected portion of tumor nephrectomies"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: male"}]}, {"GSM2544325": [{"title": "Human glomeruli Control 10"}, {"type": "RNA"}, {"source_name_ch1": "unaffected portion of tumor nephrectomies"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: male"}]}, {"GSM2544326": [{"title": "Human glomeruli Control 11"}, {"type": "RNA"}, {"source_name_ch1": "unaffected portion of tumor nephrectomies"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: female"}]}, {"GSM2544327": [{"title": "Human glomeruli Control 12"}, {"type": "RNA"}, {"source_name_ch1": "unaffected portion of tumor nephrectomies"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: male"}]}, {"GSM2544328": [{"title": "Human glomeruli Control 13"}, {"type": "RNA"}, {"source_name_ch1": "unaffected portion of tumor nephrectomies"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: female"}]}, {"GSM2544329": [{"title": "Human glomeruli Control 14"}, {"type": "RNA"}, {"source_name_ch1": "unaffected portion of tumor nephrectomies"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: male"}]}, {"GSM2544330": [{"title": "Human glomeruli Control 15"}, {"type": "RNA"}, {"source_name_ch1": "unaffected portion of tumor nephrectomies"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: male"}]}, {"GSM2544331": [{"title": "Human glomeruli Control 16"}, {"type": "RNA"}, {"source_name_ch1": "unaffected portion of tumor nephrectomies"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: female"}]}, {"GSM2544332": [{"title": "Human glomeruli Control 17"}, {"type": "RNA"}, {"source_name_ch1": "unaffected portion of tumor nephrectomies"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: male"}]}, {"GSM2544333": [{"title": "Human glomeruli Control 18"}, {"type": "RNA"}, {"source_name_ch1": "unaffected portion of tumor nephrectomies"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: male"}]}, {"GSM2544334": [{"title": "Human glomeruli Control 19"}, {"type": "RNA"}, {"source_name_ch1": "unaffected portion of tumor nephrectomies"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: female"}]}, {"GSM2544335": [{"title": "Human glomeruli Control 20"}, {"type": "RNA"}, {"source_name_ch1": "unaffected portion of tumor nephrectomies"}, {"characteristics_ch1": "tissue: glomeruli;\tSex: male"}]}, {"GSM2809077": [{"title": "MCF10A_WT"}, {"type": "RNA"}, {"source_name_ch1": "cultured cells, wt"}, {"characteristics_ch1": "cell line: MCF10A;\tgenotype: wild type"}]}, {"GSM2809078": [{"title": "MCF10A_ERAS"}, {"type": "RNA"}, {"source_name_ch1": "cultured cells, ERAS expressing"}, {"characteristics_ch1": "cell line: MCF10A;\tgenotype: ERAS-expressing"}]}, {"GSM2610066": [{"title": "SAMPLE 1: NPB CD1c"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood"}, {"characteristics_ch1": "cell type: CD1c"}]}, {"GSM2610067": [{"title": "SAMPLE 2: NPB CD141high"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood"}, {"characteristics_ch1": "cell type: CD141high"}]}, {"GSM2610068": [{"title": "SAMPLE 3: NPB SlanDC"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood"}, {"characteristics_ch1": "cell type: SlanDC"}]}, {"GSM2610069": [{"title": "SAMPLE 4: NPB CD1c"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood"}, {"characteristics_ch1": "cell type: CD1c"}]}, {"GSM2610070": [{"title": "SAMPLE 5: NPB CD141high"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood"}, {"characteristics_ch1": "cell type: CD141high"}]}, {"GSM2610071": [{"title": "SAMPLE 6: NPB SlanDC"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood"}, {"characteristics_ch1": "cell type: SlanDC"}]}, {"GSM2610072": [{"title": "SAMPLE 7: NPB CD1c"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood"}, {"characteristics_ch1": "cell type: CD1c"}]}, {"GSM2610073": [{"title": "SAMPLE 8: NPB CD141high"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood"}, {"characteristics_ch1": "cell type: CD141high"}]}, {"GSM2610074": [{"title": "SAMPLE 9: NPB SlanDC"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood"}, {"characteristics_ch1": "cell type: SlanDC"}]}, {"GSM2610075": [{"title": "SAMPLE 10: NPB CD1c"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood"}, {"characteristics_ch1": "cell type: CD1c"}]}, {"GSM2610076": [{"title": "SAMPLE 11: NPB CD141high"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood"}, {"characteristics_ch1": "cell type: CD141high"}]}, {"GSM2610077": [{"title": "SAMPLE 12: NPB SlanDC"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood"}, {"characteristics_ch1": "cell type: SlanDC"}]}, {"GSM1527868": [{"title": "LNCaP, untreated [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "androgen-sensitive human prostate adenocarcinoma (LNCaP)"}, {"characteristics_ch1": "cell line: LNCaP"}]}, {"GSM1527869": [{"title": "PrEC, untreated [gene-level]"}, {"type": "RNA"}, {"source_name_ch1": "normal prostate epithelial cells (PrEC)"}, {"characteristics_ch1": "cell line: PrEC"}]}, {"GSM1704481": [{"title": "Normal Differentiated Mesodermal Cells (NDMCs) type 1, biological rep1 [gene]"}, {"type": "RNA"}, {"source_name_ch1": "Normal Differentiated Mesodermal Cells type 1 (NDMC1), biological rep1"}, {"characteristics_ch1": "cell type: NDMC1;\tID: 13;\tgender: Female"}]}, {"GSM1704482": [{"title": "Normal Differentiated Mesodermal Cells (NDMCs) type 2, biological rep1 [gene]"}, {"type": "RNA"}, {"source_name_ch1": "Normal Differentiated Mesodermal Cells type 2 (NDMC2), biological rep1"}, {"characteristics_ch1": "cell type: NDMC2;\tID: 13;\tgender: Female"}]}, {"GSM1704483": [{"title": "Normal Differentiated Mesodermal Cells (NDMCs) type 1, biological rep2 [gene]"}, {"type": "RNA"}, {"source_name_ch1": "Normal Differentiated Mesodermal Cells type 1 (NDMC1), biological rep2"}, {"characteristics_ch1": "cell type: NDMC1;\tID: 18;\tgender: Female"}]}, {"GSM1704484": [{"title": "Normal Differentiated Mesodermal Cells (NDMCs) type 2, biological rep2 [gene]"}, {"type": "RNA"}, {"source_name_ch1": "Normal Differentiated Mesodermal Cells type 2 (NDMC2), biological rep2"}, {"characteristics_ch1": "cell type: NDMC2;\tID: 18;\tgender: Female"}]}, {"GSM1704485": [{"title": "Normal Differentiated Mesodermal Cells (NDMCs) type 1, biological rep3 [gene]"}, {"type": "RNA"}, {"source_name_ch1": "Normal Differentiated Mesodermal Cells type 1 (NDMC1), biological rep3"}, {"characteristics_ch1": "cell type: NDMC1;\tID: 23;\tgender: Female"}]}, {"GSM1704486": [{"title": "Normal Differentiated Mesodermal Cells (NDMCs) type 2, biological rep3 [gene]"}, {"type": "RNA"}, {"source_name_ch1": "Normal Differentiated Mesodermal Cells type 2 (NDMC2), biological rep3"}, {"characteristics_ch1": "cell type: NDMC2;\tID: 23;\tgender: Female"}]}, {"GSM2310628": [{"title": "B3"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: M;\tpopulation: Italy Caucasian"}]}, {"GSM2310629": [{"title": "B16"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: UNS;\tpopulation: Italy Caucasian"}]}, {"GSM2310630": [{"title": "B22"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: UNS;\tpopulation: Italy Caucasian"}]}, {"GSM2310631": [{"title": "B43"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: IM;\tpopulation: Italy Caucasian"}]}, {"GSM2310632": [{"title": "B63"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: UNS;\tpopulation: Italy Caucasian"}]}, {"GSM2310633": [{"title": "B89"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: BL1;\tpopulation: Italy Caucasian"}]}, {"GSM2310634": [{"title": "B91"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: BL1;\tpopulation: Italy Caucasian"}]}, {"GSM2310635": [{"title": "BP44"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: UNS;\tpopulation: Italy Caucasian"}]}, {"GSM2310636": [{"title": "BP45"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: M;\tpopulation: Italy Caucasian"}]}, {"GSM2310637": [{"title": "BP46"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: BL1;\tpopulation: Italy Caucasian"}]}, {"GSM2310638": [{"title": "BP48"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: LAR;\tpopulation: Italy Caucasian"}]}, {"GSM2310639": [{"title": "BP49"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: IM;\tpopulation: Italy Caucasian"}]}, {"GSM2310640": [{"title": "BP50"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: IM;\tpopulation: Italy Caucasian"}]}, {"GSM2310641": [{"title": "BP51"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: LAR;\tpopulation: Italy Caucasian"}]}, {"GSM2310642": [{"title": "BP52"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: BL1;\tpopulation: Italy Caucasian"}]}, {"GSM2310643": [{"title": "BP53"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: BL2;\tpopulation: Italy Caucasian"}]}, {"GSM2310644": [{"title": "BP54"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: IM;\tpopulation: Italy Caucasian"}]}, {"GSM2310645": [{"title": "BP55"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: IM;\tpopulation: Italy Caucasian"}]}, {"GSM2310646": [{"title": "BP56"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: M;\tpopulation: Italy Caucasian"}]}, {"GSM2310647": [{"title": "BP57"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: MSL;\tpopulation: Italy Caucasian"}]}, {"GSM2310648": [{"title": "BP58"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: NA;\tpopulation: Italy Caucasian"}]}, {"GSM2310649": [{"title": "BP60"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: LAR;\tpopulation: Italy Caucasian"}]}, {"GSM2310650": [{"title": "BP61"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: UNS;\tpopulation: Italy Caucasian"}]}, {"GSM2310651": [{"title": "BP62"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: LAR;\tpopulation: Italy Caucasian"}]}, {"GSM2310652": [{"title": "BP63"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: BL2;\tpopulation: Italy Caucasian"}]}, {"GSM2310653": [{"title": "BP65"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: MSL;\tpopulation: Italy Caucasian"}]}, {"GSM2310654": [{"title": "BP66"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: LAR;\tpopulation: Italy Caucasian"}]}, {"GSM2310655": [{"title": "BP69"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: IM;\tpopulation: Italy Caucasian"}]}, {"GSM2310656": [{"title": "BP70"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: BL1;\tpopulation: Italy Caucasian"}]}, {"GSM2310657": [{"title": "BP71"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: BL1;\tpopulation: Italy Caucasian"}]}, {"GSM2310658": [{"title": "BP72"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: BL1;\tpopulation: Italy Caucasian"}]}, {"GSM2310659": [{"title": "BP73"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: IM;\tpopulation: Italy Caucasian"}]}, {"GSM2310660": [{"title": "BP75"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: UNS;\tpopulation: Italy Caucasian"}]}, {"GSM2310661": [{"title": "BP77"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: M;\tpopulation: Italy Caucasian"}]}, {"GSM2310662": [{"title": "BP78"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: BL2;\tpopulation: Italy Caucasian"}]}, {"GSM2310663": [{"title": "BP79"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: M;\tpopulation: Italy Caucasian"}]}, {"GSM2310664": [{"title": "BP80"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: LAR;\tpopulation: Italy Caucasian"}]}, {"GSM2310665": [{"title": "BP81"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: IM;\tpopulation: Italy Caucasian"}]}, {"GSM2310666": [{"title": "BP82"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: IM;\tpopulation: Italy Caucasian"}]}, {"GSM2310667": [{"title": "BP83"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: IM;\tpopulation: Italy Caucasian"}]}, {"GSM2310668": [{"title": "BP85"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: NA;\tpopulation: Italy Caucasian"}]}, {"GSM2310669": [{"title": "BP86"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: MSL;\tpopulation: Italy Caucasian"}]}, {"GSM2310670": [{"title": "BP87"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: BL1;\tpopulation: Italy Caucasian"}]}, {"GSM2310671": [{"title": "BP88"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: UNS;\tpopulation: Italy Caucasian"}]}, {"GSM2310672": [{"title": "BP90"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: M;\tpopulation: Italy Caucasian"}]}, {"GSM2310673": [{"title": "BP92"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: IM;\tpopulation: Italy Caucasian"}]}, {"GSM2310674": [{"title": "BP94"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: M;\tpopulation: Italy Caucasian"}]}, {"GSM2310675": [{"title": "BP95"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: LAR;\tpopulation: Italy Caucasian"}]}, {"GSM2310676": [{"title": "BP96"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: M;\tpopulation: Italy Caucasian"}]}, {"GSM2310677": [{"title": "BP97"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: IM;\tpopulation: Italy Caucasian"}]}, {"GSM2310678": [{"title": "BP98"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: BL2;\tpopulation: Italy Caucasian"}]}, {"GSM2310679": [{"title": "BP99"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: BL1;\tpopulation: Italy Caucasian"}]}, {"GSM2310680": [{"title": "BQ00"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: BL1;\tpopulation: Italy Caucasian"}]}, {"GSM2310681": [{"title": "BQ01"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: BL2;\tpopulation: Italy Caucasian"}]}, {"GSM2310682": [{"title": "BQ02"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: MSL;\tpopulation: Italy Caucasian"}]}, {"GSM2310683": [{"title": "BQ03"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: BL1;\tpopulation: Italy Caucasian"}]}, {"GSM2310684": [{"title": "BQ05"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: M;\tpopulation: Italy Caucasian"}]}, {"GSM2310685": [{"title": "BQ06"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: M;\tpopulation: Italy Caucasian"}]}, {"GSM2310686": [{"title": "BQ07"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: UNS;\tpopulation: Italy Caucasian"}]}, {"GSM2310687": [{"title": "BQ08"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: IM;\tpopulation: Italy Caucasian"}]}, {"GSM2310688": [{"title": "BQ09"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: MSL;\tpopulation: Italy Caucasian"}]}, {"GSM2310689": [{"title": "BQ10"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: M;\tpopulation: Italy Caucasian"}]}, {"GSM2310690": [{"title": "BQ12"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: BL1;\tpopulation: Italy Caucasian"}]}, {"GSM2310691": [{"title": "BQ14"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: M;\tpopulation: Italy Caucasian"}]}, {"GSM2310692": [{"title": "BQ15"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: IM;\tpopulation: Italy Caucasian"}]}, {"GSM2310693": [{"title": "BQ16"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: BL2;\tpopulation: Italy Caucasian"}]}, {"GSM2310694": [{"title": "BQ17"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: UNS;\tpopulation: Italy Caucasian"}]}, {"GSM2310695": [{"title": "BQ19"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: IM;\tpopulation: Italy Caucasian"}]}, {"GSM2310696": [{"title": "BQ21"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: MSL;\tpopulation: Italy Caucasian"}]}, {"GSM2310697": [{"title": "BQ22"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: M;\tpopulation: Italy Caucasian"}]}, {"GSM2310698": [{"title": "BQ24"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: IM;\tpopulation: Italy Caucasian"}]}, {"GSM2310699": [{"title": "BQ25"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: M;\tpopulation: Italy Caucasian"}]}, {"GSM2310700": [{"title": "BQ26"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: UNS;\tpopulation: Italy Caucasian"}]}, {"GSM2310701": [{"title": "BQ27"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: IM;\tpopulation: Italy Caucasian"}]}, {"GSM2310702": [{"title": "BQ28"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: M;\tpopulation: Italy Caucasian"}]}, {"GSM2310703": [{"title": "BQ29"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: LAR;\tpopulation: Italy Caucasian"}]}, {"GSM2310704": [{"title": "BQ30"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: M;\tpopulation: Italy Caucasian"}]}, {"GSM2310705": [{"title": "BQ33"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: BL1;\tpopulation: Italy Caucasian"}]}, {"GSM2310706": [{"title": "BQ34"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: BL1;\tpopulation: Italy Caucasian"}]}, {"GSM2310707": [{"title": "BQ35"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: M;\tpopulation: Italy Caucasian"}]}, {"GSM2310708": [{"title": "BQ36"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: IM;\tpopulation: Italy Caucasian"}]}, {"GSM2310709": [{"title": "BQ38"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: IM;\tpopulation: Italy Caucasian"}]}, {"GSM2310710": [{"title": "BQ39"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: IM;\tpopulation: Italy Caucasian"}]}, {"GSM2310711": [{"title": "BQ42"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: LAR;\tpopulation: Italy Caucasian"}]}, {"GSM2310712": [{"title": "BQ43"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: IM;\tpopulation: Italy Caucasian"}]}, {"GSM2310713": [{"title": "BQ44"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: BL2;\tpopulation: Italy Caucasian"}]}, {"GSM2310714": [{"title": "BQ47B"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: MSL;\tpopulation: Italy Caucasian"}]}, {"GSM2310715": [{"title": "BQ48"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: LAR;\tpopulation: Italy Caucasian"}]}, {"GSM2310716": [{"title": "BQ49"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: UNS;\tpopulation: Italy Caucasian"}]}, {"GSM2310717": [{"title": "BQ51"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: MSL;\tpopulation: Italy Caucasian"}]}, {"GSM2310718": [{"title": "BQ52"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: BL2;\tpopulation: Italy Caucasian"}]}, {"GSM2310719": [{"title": "BQ53"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: BL2;\tpopulation: Italy Caucasian"}]}, {"GSM2310720": [{"title": "BQ55"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: BL1;\tpopulation: Italy Caucasian"}]}, {"GSM2310721": [{"title": "BQ56"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: M;\tpopulation: Italy Caucasian"}]}, {"GSM2310722": [{"title": "BQ58"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: LAR;\tpopulation: Italy Caucasian"}]}, {"GSM2310723": [{"title": "BQ59"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: LAR;\tpopulation: Italy Caucasian"}]}, {"GSM2310724": [{"title": "BQ60"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: M;\tpopulation: Italy Caucasian"}]}, {"GSM2310725": [{"title": "BQ62"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: M;\tpopulation: Italy Caucasian"}]}, {"GSM2310726": [{"title": "BQ63"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: UNS;\tpopulation: Italy Caucasian"}]}, {"GSM2310727": [{"title": "BQ66"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: LAR;\tpopulation: Italy Caucasian"}]}, {"GSM2310728": [{"title": "DTN6"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: NA;\tpopulation: Mexico Hispanic"}]}, {"GSM2310729": [{"title": "TN01"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: M;\tpopulation: Mexico Hispanic"}]}, {"GSM2310730": [{"title": "TN3"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: NA;\tpopulation: Mexico Hispanic"}]}, {"GSM2310731": [{"title": "TN04"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: LAR;\tpopulation: Mexico Hispanic"}]}, {"GSM2310732": [{"title": "TN5"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: NA;\tpopulation: Mexico Hispanic"}]}, {"GSM2310733": [{"title": "TN7"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: NA;\tpopulation: Mexico Hispanic"}]}, {"GSM2310734": [{"title": "TN8"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: NA;\tpopulation: Mexico Hispanic"}]}, {"GSM2310735": [{"title": "TN09"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: UNS;\tpopulation: Mexico Hispanic"}]}, {"GSM2310736": [{"title": "TN10"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: BL1;\tpopulation: Mexico Hispanic"}]}, {"GSM2310737": [{"title": "TN11"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: UNS;\tpopulation: Mexico Hispanic"}]}, {"GSM2310738": [{"title": "TN13"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: IM;\tpopulation: Mexico Hispanic"}]}, {"GSM2310739": [{"title": "TN14"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: M;\tpopulation: Mexico Hispanic"}]}, {"GSM2310740": [{"title": "TN16"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: IM;\tpopulation: Mexico Hispanic"}]}, {"GSM2310741": [{"title": "TN17"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: BL1;\tpopulation: Mexico Hispanic"}]}, {"GSM2310742": [{"title": "TN18"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: UNS;\tpopulation: Mexico Hispanic"}]}, {"GSM2310743": [{"title": "TN19"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: UNS;\tpopulation: Mexico Hispanic"}]}, {"GSM2310744": [{"title": "TN20"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: M;\tpopulation: Mexico Hispanic"}]}, {"GSM2310745": [{"title": "TN22"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: UNS;\tpopulation: Mexico Hispanic"}]}, {"GSM2310746": [{"title": "TN23"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: IM;\tpopulation: Mexico Hispanic"}]}, {"GSM2310747": [{"title": "TN24"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: IM;\tpopulation: Mexico Hispanic"}]}, {"GSM2310748": [{"title": "TN26"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: IM;\tpopulation: Mexico Hispanic"}]}, {"GSM2310749": [{"title": "TN29"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: UNS;\tpopulation: Mexico Hispanic"}]}, {"GSM2310750": [{"title": "TN30"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: BL2;\tpopulation: Mexico Hispanic"}]}, {"GSM2310751": [{"title": "TN32"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: MSL;\tpopulation: Mexico Hispanic"}]}, {"GSM2310752": [{"title": "TN36"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: LAR;\tpopulation: Mexico Hispanic"}]}, {"GSM2310753": [{"title": "TN38"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: IM;\tpopulation: Mexico Hispanic"}]}, {"GSM2310754": [{"title": "TN39"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: MSL;\tpopulation: Mexico Hispanic"}]}, {"GSM2310755": [{"title": "TN40"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: BL2;\tpopulation: Mexico Hispanic"}]}, {"GSM2310756": [{"title": "TN42"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: M;\tpopulation: Mexico Hispanic"}]}, {"GSM2310757": [{"title": "TN45"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: NA;\tpopulation: Mexico Hispanic"}]}, {"GSM2310758": [{"title": "TN47"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: UNS;\tpopulation: Mexico Hispanic"}]}, {"GSM2310759": [{"title": "TN48"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: IM;\tpopulation: Mexico Hispanic"}]}, {"GSM2310760": [{"title": "TN49"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: M;\tpopulation: Mexico Hispanic"}]}, {"GSM2310761": [{"title": "TN50"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: LAR;\tpopulation: Mexico Hispanic"}]}, {"GSM2310762": [{"title": "TN51"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: IM;\tpopulation: Mexico Hispanic"}]}, {"GSM2310763": [{"title": "TN52"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: M;\tpopulation: Mexico Hispanic"}]}, {"GSM2310764": [{"title": "TN53"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: M;\tpopulation: Mexico Hispanic"}]}, {"GSM2310765": [{"title": "TN54"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: M;\tpopulation: Mexico Hispanic"}]}, {"GSM2310766": [{"title": "TN55"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: M;\tpopulation: Mexico Hispanic"}]}, {"GSM2310767": [{"title": "TN56"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: M;\tpopulation: Mexico Hispanic"}]}, {"GSM2310768": [{"title": "TN58"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: IM;\tpopulation: Mexico Hispanic"}]}, {"GSM2310769": [{"title": "TN60"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: LAR;\tpopulation: Mexico Hispanic"}]}, {"GSM2310770": [{"title": "TN61"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: MSL;\tpopulation: Mexico Hispanic"}]}, {"GSM2310771": [{"title": "TN63"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: BL1;\tpopulation: Mexico Hispanic"}]}, {"GSM2310772": [{"title": "TN65"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: M;\tpopulation: Mexico Hispanic"}]}, {"GSM2310773": [{"title": "TN66"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: UNS;\tpopulation: Mexico Hispanic"}]}, {"GSM2310774": [{"title": "TN68"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: BL1;\tpopulation: Mexico Hispanic"}]}, {"GSM2310775": [{"title": "TN70"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: IM;\tpopulation: Mexico Hispanic"}]}, {"GSM2310776": [{"title": "TN73"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: M;\tpopulation: Mexico Hispanic"}]}, {"GSM2310777": [{"title": "TN75"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: IM;\tpopulation: Mexico Hispanic"}]}, {"GSM2310778": [{"title": "TN76"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: UNS;\tpopulation: Mexico Hispanic"}]}, {"GSM2310779": [{"title": "TN78"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: LAR;\tpopulation: Mexico Hispanic"}]}, {"GSM2310780": [{"title": "TN79"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: M;\tpopulation: Mexico Hispanic"}]}, {"GSM2310781": [{"title": "TN80"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: BL1;\tpopulation: Mexico Hispanic"}]}, {"GSM2310782": [{"title": "TN81"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: M;\tpopulation: Mexico Hispanic"}]}, {"GSM2310783": [{"title": "TN83"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: IM;\tpopulation: Mexico Hispanic"}]}, {"GSM2310784": [{"title": "TN85"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: LAR;\tpopulation: Mexico Hispanic"}]}, {"GSM2310785": [{"title": "TN162"}, {"type": "RNA"}, {"source_name_ch1": "FFPE breast cancer tumor"}, {"characteristics_ch1": "tissue: Triple negative breast cancer;\tlehmann subtype: BL1;\tpopulation: Mexico Hispanic"}]}, {"GSM2825137": [{"title": "DMEM-1"}, {"type": "RNA"}, {"source_name_ch1": "culture in DMEM for 4 h"}, {"characteristics_ch1": "cell line: HEp-2;\tcell type: human laryngeal carcinoma"}]}, {"GSM2825138": [{"title": "DMEM-2"}, {"type": "RNA"}, {"source_name_ch1": "culture in DMEM for 4 h"}, {"characteristics_ch1": "cell line: HEp-2;\tcell type: human laryngeal carcinoma"}]}, {"GSM2825139": [{"title": "EBSS-1"}, {"type": "RNA"}, {"source_name_ch1": "culture in EBSS for 4 h"}, {"characteristics_ch1": "cell line: HEp-2;\tcell type: human laryngeal carcinoma"}]}, {"GSM2825140": [{"title": "EBSS-2"}, {"type": "RNA"}, {"source_name_ch1": "culture in EBSS for 4 h"}, {"characteristics_ch1": "cell line: HEp-2;\tcell type: human laryngeal carcinoma"}]}, {"GSM2825141": [{"title": "EBSS+His-1"}, {"type": "RNA"}, {"source_name_ch1": "culture in EBSS+histidine for 4 h"}, {"characteristics_ch1": "cell line: HEp-2;\tcell type: human laryngeal carcinoma"}]}, {"GSM2825142": [{"title": "EBSS+His-2"}, {"type": "RNA"}, {"source_name_ch1": "culture in EBSS+histidine for 4 h"}, {"characteristics_ch1": "cell line: HEp-2;\tcell type: human laryngeal carcinoma"}]}, {"GSM2588749": [{"title": "Individual__SKOV3_1_Rep 1"}, {"type": "RNA"}, {"source_name_ch1": "SKOV3 cells that could not form spheroids with CAFs after 4 h"}, {"characteristics_ch1": "cell line: SKOV3;\tcell type: tumor cells"}]}, {"GSM2588750": [{"title": "Individual__SKOV3_2_Rep 2"}, {"type": "RNA"}, {"source_name_ch1": "SKOV3 cells that could not form spheroids with CAFs after 4 h"}, {"characteristics_ch1": "cell line: SKOV3;\tcell type: tumor cells"}]}, {"GSM2588751": [{"title": "Individual__SKOV3_3_Rep 3"}, {"type": "RNA"}, {"source_name_ch1": "SKOV3 cells that could not form spheroids with CAFs after 4 h"}, {"characteristics_ch1": "cell line: SKOV3;\tcell type: tumor cells"}]}, {"GSM2588752": [{"title": "Spheroid_SKOV3_1_Rep 1"}, {"type": "RNA"}, {"source_name_ch1": "SKOV3 cells that could form spheroids with CAFs after 4 h"}, {"characteristics_ch1": "cell line: SKOV3;\tcell type: tumor cells"}]}, {"GSM2588753": [{"title": "Spheroid_SKOV3_2_Rep 2"}, {"type": "RNA"}, {"source_name_ch1": "SKOV3 cells that could form spheroids with CAFs after 4 h"}, {"characteristics_ch1": "cell line: SKOV3;\tcell type: tumor cells"}]}, {"GSM2588754": [{"title": "Spheroid_SKOV3_3_Rep 3"}, {"type": "RNA"}, {"source_name_ch1": "SKOV3 cells that could form spheroids with CAFs after 4 h"}, {"characteristics_ch1": "cell line: SKOV3;\tcell type: tumor cells"}]}, {"GSM2588755": [{"title": "Spheroid_SKOV3_4_Rep 4"}, {"type": "RNA"}, {"source_name_ch1": "SKOV3 cells that could form spheroids with CAFs after 4 h"}, {"characteristics_ch1": "cell line: SKOV3;\tcell type: tumor cells"}]}, {"GSM2804187": [{"title": "NHDF_control (set3)"}, {"type": "RNA"}, {"source_name_ch1": "NHDF unsynchronised"}, {"characteristics_ch1": "tissue: Primary human fibroblasts (NHDF);\tage: early passage NHDF"}]}, {"GSM2804188": [{"title": "NHDF_t=0 (set3)"}, {"type": "RNA"}, {"source_name_ch1": "NHDF quiescent"}, {"characteristics_ch1": "tissue: Primary human fibroblasts (NHDF);\tage: early passage NHDF"}]}, {"GSM2804189": [{"title": "NHDF_t=1 (set3)"}, {"type": "RNA"}, {"source_name_ch1": "NHDF early proliferation"}, {"characteristics_ch1": "tissue: Primary human fibroblasts (NHDF);\tage: early passage NHDF"}]}, {"GSM2804190": [{"title": "NHDF_t=2 (set3)"}, {"type": "RNA"}, {"source_name_ch1": "NHDF early proliferation"}, {"characteristics_ch1": "tissue: Primary human fibroblasts (NHDF);\tage: early passage NHDF"}]}, {"GSM2804191": [{"title": "NHDF_t=4 (set3)"}, {"type": "RNA"}, {"source_name_ch1": "NHDF early proliferation"}, {"characteristics_ch1": "tissue: Primary human fibroblasts (NHDF);\tage: early passage NHDF"}]}, {"GSM2804192": [{"title": "NHDF_t=6 (set3)"}, {"type": "RNA"}, {"source_name_ch1": "NHDF mid proliferation"}, {"characteristics_ch1": "tissue: Primary human fibroblasts (NHDF);\tage: early passage NHDF"}]}, {"GSM2804193": [{"title": "NHDF_t=8 (set3)"}, {"type": "RNA"}, {"source_name_ch1": "NHDF mid proliferation"}, {"characteristics_ch1": "tissue: Primary human fibroblasts (NHDF);\tage: early passage NHDF"}]}, {"GSM2804194": [{"title": "NHDF_t=10 (set3)"}, {"type": "RNA"}, {"source_name_ch1": "NHDF mid proliferation"}, {"characteristics_ch1": "tissue: Primary human fibroblasts (NHDF);\tage: early passage NHDF"}]}, {"GSM2804195": [{"title": "NHDF_t=12 (set3)"}, {"type": "RNA"}, {"source_name_ch1": "NHDF mid proliferation"}, {"characteristics_ch1": "tissue: Primary human fibroblasts (NHDF);\tage: early passage NHDF"}]}, {"GSM2804196": [{"title": "NHDF_t=13 (set3)"}, {"type": "RNA"}, {"source_name_ch1": "NHDF mid proliferation"}, {"characteristics_ch1": "tissue: Primary human fibroblasts (NHDF);\tage: early passage NHDF"}]}, {"GSM2804197": [{"title": "NHDF_t=14 (set3)"}, {"type": "RNA"}, {"source_name_ch1": "NHDF late proliferation"}, {"characteristics_ch1": "tissue: Primary human fibroblasts (NHDF);\tage: early passage NHDF"}]}, {"GSM2804198": [{"title": "NHDF_t=15 (set3)"}, {"type": "RNA"}, {"source_name_ch1": "NHDF late proliferation"}, {"characteristics_ch1": "tissue: Primary human fibroblasts (NHDF);\tage: early passage NHDF"}]}, {"GSM2804199": [{"title": "NHDF_t=16 (set3)"}, {"type": "RNA"}, {"source_name_ch1": "NHDF late proliferation"}, {"characteristics_ch1": "tissue: Primary human fibroblasts (NHDF);\tage: early passage NHDF"}]}, {"GSM2804200": [{"title": "NHDF_t=17 (set3)"}, {"type": "RNA"}, {"source_name_ch1": "NHDF late proliferation"}, {"characteristics_ch1": "tissue: Primary human fibroblasts (NHDF);\tage: early passage NHDF"}]}, {"GSM2804201": [{"title": "NHDF_t=18 (set3)"}, {"type": "RNA"}, {"source_name_ch1": "NHDF late proliferation"}, {"characteristics_ch1": "tissue: Primary human fibroblasts (NHDF);\tage: early passage NHDF"}]}, {"GSM2804202": [{"title": "NHDF_t=19 (set3)"}, {"type": "RNA"}, {"source_name_ch1": "NHDF late proliferation"}, {"characteristics_ch1": "tissue: Primary human fibroblasts (NHDF);\tage: early passage NHDF"}]}, {"GSM2804203": [{"title": "NHDF_t=20 (set3)"}, {"type": "RNA"}, {"source_name_ch1": "NHDF late proliferation"}, {"characteristics_ch1": "tissue: Primary human fibroblasts (NHDF);\tage: early passage NHDF"}]}, {"GSM2804204": [{"title": "NHDF_t=21 (set3)"}, {"type": "RNA"}, {"source_name_ch1": "NHDF late proliferation"}, {"characteristics_ch1": "tissue: Primary human fibroblasts (NHDF);\tage: early passage NHDF"}]}, {"GSM2804205": [{"title": "NHDF_t=22 (set3)"}, {"type": "RNA"}, {"source_name_ch1": "NHDF late proliferation"}, {"characteristics_ch1": "tissue: Primary human fibroblasts (NHDF);\tage: early passage NHDF"}]}, {"GSM2804206": [{"title": "NHDF_t=23 (set3)"}, {"type": "RNA"}, {"source_name_ch1": "NHDF late proliferation"}, {"characteristics_ch1": "tissue: Primary human fibroblasts (NHDF);\tage: early passage NHDF"}]}, {"GSM2804207": [{"title": "NHDF_t=24 (set3)"}, {"type": "RNA"}, {"source_name_ch1": "NHDF late proliferation"}, {"characteristics_ch1": "tissue: Primary human fibroblasts (NHDF);\tage: early passage NHDF"}]}, {"GSM2804208": [{"title": "NHDF_t=26 (set3)"}, {"type": "RNA"}, {"source_name_ch1": "NHDF late proliferation"}, {"characteristics_ch1": "tissue: Primary human fibroblasts (NHDF);\tage: early passage NHDF"}]}, {"GSM2804209": [{"title": "NHDF_t=28 (set3)"}, {"type": "RNA"}, {"source_name_ch1": "NHDF late proliferation"}, {"characteristics_ch1": "tissue: Primary human fibroblasts (NHDF);\tage: early passage NHDF"}]}, {"GSM2808487": [{"title": "dendritic cells transfected with negative control - donor 1"}, {"type": "RNA"}, {"source_name_ch1": "healthy donor 1"}, {"characteristics_ch1": "cell type: Dendritic cells;\ttransfection: negative control"}]}, {"GSM2808488": [{"title": "dendritic cells transfected with miR-29b mimics - donor 1"}, {"type": "RNA"}, {"source_name_ch1": "healthy donor 1"}, {"characteristics_ch1": "cell type: Dendritic cells;\ttransfection: miR-29b mimic"}]}, {"GSM2808489": [{"title": "dendritic cells transfected with negative control - donor 2"}, {"type": "RNA"}, {"source_name_ch1": "healthy donor 2"}, {"characteristics_ch1": "cell type: Dendritic cells;\ttransfection: negative control"}]}, {"GSM2808490": [{"title": "dendritic cells transfected with miR-29b mimics - donor 2"}, {"type": "RNA"}, {"source_name_ch1": "healthy donor 2"}, {"characteristics_ch1": "cell type: Dendritic cells;\ttransfection: miR-29b mimic"}]}, {"GSM2808491": [{"title": "dendritic cells transfected with negative control - donor 3"}, {"type": "RNA"}, {"source_name_ch1": "healthy donor 3"}, {"characteristics_ch1": "cell type: Dendritic cells;\ttransfection: negative control"}]}, {"GSM2808492": [{"title": "dendritic cells transfected with miR-29b mimics - donor 3"}, {"type": "RNA"}, {"source_name_ch1": "healthy donor 3"}, {"characteristics_ch1": "cell type: Dendritic cells;\ttransfection: miR-29b mimic"}]}, {"GSM2971841": [{"title": "U3082MG cells transduced with shLGR5"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "tissue: primary glioblastoma;\tcell type: Glioblastoma stem-like cells;\tlentiviral vector: shLGR5"}]}, {"GSM2971842": [{"title": "U3082MG cells transduced with shNT"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "tissue: primary glioblastoma;\tcell type: Glioblastoma stem-like cells;\tlentiviral vector: shNT"}]}, {"GSM2971843": [{"title": "U3117MG cells transduced with shLGR5"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "tissue: primary glioblastoma;\tcell type: Glioblastoma stem-like cells;\tlentiviral vector: shLGR5"}]}, {"GSM2971844": [{"title": "U3117MG cells transduced with shNT"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "tissue: primary glioblastoma;\tcell type: Glioblastoma stem-like cells;\tlentiviral vector: shNT"}]}, {"GSM2971845": [{"title": "U3118MG cells transduced with shLGR5"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "tissue: primary glioblastoma;\tcell type: Glioblastoma stem-like cells;\tlentiviral vector: shLGR5"}]}, {"GSM2971846": [{"title": "U3118MG cells transduced with shNT"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "tissue: primary glioblastoma;\tcell type: Glioblastoma stem-like cells;\tlentiviral vector: shNT"}]}, {"GSM2825656": [{"title": "J82C1"}, {"type": "RNA"}, {"source_name_ch1": "J82 cell line control"}, {"characteristics_ch1": "cell line: J82;\tcell type: Bladder cell line;\ttreated with: PBS (control)"}]}, {"GSM2825657": [{"title": "J82C2"}, {"type": "RNA"}, {"source_name_ch1": "J82 cell line control"}, {"characteristics_ch1": "cell line: J82;\tcell type: Bladder cell line;\ttreated with: PBS (control)"}]}, {"GSM2825658": [{"title": "J82C3"}, {"type": "RNA"}, {"source_name_ch1": "J82 cell line control"}, {"characteristics_ch1": "cell line: J82;\tcell type: Bladder cell line;\ttreated with: PBS (control)"}]}, {"GSM2825659": [{"title": "J82PB1"}, {"type": "RNA"}, {"source_name_ch1": "J82 cell line treated with palbociclib (IC50)"}, {"characteristics_ch1": "cell line: J82;\tcell type: Bladder cell line;\ttreated with: palbociclib (IC50)"}]}, {"GSM2825660": [{"title": "J82PB2"}, {"type": "RNA"}, {"source_name_ch1": "J82 cell line treated with palbociclib (IC50)"}, {"characteristics_ch1": "cell line: J82;\tcell type: Bladder cell line;\ttreated with: palbociclib (IC50)"}]}, {"GSM2825661": [{"title": "J82PB3"}, {"type": "RNA"}, {"source_name_ch1": "J82 cell line treated with palbociclib (IC50)"}, {"characteristics_ch1": "cell line: J82;\tcell type: Bladder cell line;\ttreated with: palbociclib (IC50)"}]}, {"GSM2825662": [{"title": "RT112C1"}, {"type": "RNA"}, {"source_name_ch1": "RT112 cell line control"}, {"characteristics_ch1": "cell line: RT112;\tcell type: Bladder cell line;\ttreated with: PBS (control)"}]}, {"GSM2825663": [{"title": "RT112C2"}, {"type": "RNA"}, {"source_name_ch1": "RT112 cell line control"}, {"characteristics_ch1": "cell line: RT112;\tcell type: Bladder cell line;\ttreated with: PBS (control)"}]}, {"GSM2825664": [{"title": "RT112C3"}, {"type": "RNA"}, {"source_name_ch1": "RT112 cell line control"}, {"characteristics_ch1": "cell line: RT112;\tcell type: Bladder cell line;\ttreated with: PBS (control)"}]}, {"GSM2825665": [{"title": "RT112PB1"}, {"type": "RNA"}, {"source_name_ch1": "RT112 cell line treated with palbociclib (IC50)"}, {"characteristics_ch1": "cell line: RT112;\tcell type: Bladder cell line;\ttreated with: palbociclib (IC50)"}]}, {"GSM2825666": [{"title": "RT112PB2"}, {"type": "RNA"}, {"source_name_ch1": "RT112 cell line treated with palbociclib (IC50)"}, {"characteristics_ch1": "cell line: RT112;\tcell type: Bladder cell line;\ttreated with: palbociclib (IC50)"}]}, {"GSM2825667": [{"title": "RT112PB3"}, {"type": "RNA"}, {"source_name_ch1": "RT112 cell line treated with palbociclib (IC50)"}, {"characteristics_ch1": "cell line: RT112;\tcell type: Bladder cell line;\ttreated with: palbociclib (IC50)"}]}, {"GSM2825668": [{"title": "5637C1"}, {"type": "RNA"}, {"source_name_ch1": "5637 cell line control"}, {"characteristics_ch1": "cell line: 5637;\tcell type: Bladder cell line;\ttreated with: PBS (control)"}]}, {"GSM2825669": [{"title": "5637C2"}, {"type": "RNA"}, {"source_name_ch1": "5637 cell line control"}, {"characteristics_ch1": "cell line: 5637;\tcell type: Bladder cell line;\ttreated with: PBS (control)"}]}, {"GSM2825670": [{"title": "5637C3"}, {"type": "RNA"}, {"source_name_ch1": "5637 cell line control"}, {"characteristics_ch1": "cell line: 5637;\tcell type: Bladder cell line;\ttreated with: PBS (control)"}]}, {"GSM2825671": [{"title": "5637PB1"}, {"type": "RNA"}, {"source_name_ch1": "5637 cell line treated with palbociclib (IC50)"}, {"characteristics_ch1": "cell line: 5637;\tcell type: Bladder cell line;\ttreated with: palbociclib (IC50)"}]}, {"GSM2825672": [{"title": "5637PB2"}, {"type": "RNA"}, {"source_name_ch1": "5637 cell line treated with palbociclib (IC50)"}, {"characteristics_ch1": "cell line: 5637;\tcell type: Bladder cell line;\ttreated with: palbociclib (IC50)"}]}, {"GSM2825673": [{"title": "5637PB3"}, {"type": "RNA"}, {"source_name_ch1": "5637 cell line treated with palbociclib (IC50)"}, {"characteristics_ch1": "cell line: 5637;\tcell type: Bladder cell line;\ttreated with: palbociclib (IC50)"}]}, {"GSM2940281": [{"title": "pooled healthy control 1"}, {"type": "RNA"}, {"source_name_ch1": "pooled sample"}, {"characteristics_ch1": "disease state: control;\tcell type: white blood cell"}]}, {"GSM2940282": [{"title": "pooled healthy control 2"}, {"type": "RNA"}, {"source_name_ch1": "pooled sample"}, {"characteristics_ch1": "disease state: control;\tcell type: white blood cell"}]}, {"GSM2940283": [{"title": "pooled healthy control 3"}, {"type": "RNA"}, {"source_name_ch1": "pooled sample"}, {"characteristics_ch1": "disease state: control;\tcell type: white blood cell"}]}, {"GSM2940284": [{"title": "pooled KD patient at acute phase 1"}, {"type": "RNA"}, {"source_name_ch1": "pooled sample"}, {"characteristics_ch1": "disease state: acute-phase KD;\tcell type: white blood cell"}]}, {"GSM2940285": [{"title": "pooled KD patient at acute phase 2"}, {"type": "RNA"}, {"source_name_ch1": "pooled sample"}, {"characteristics_ch1": "disease state: acute-phase KD;\tcell type: white blood cell"}]}, {"GSM2940286": [{"title": "pooled KD patient at acute phase 3"}, {"type": "RNA"}, {"source_name_ch1": "pooled sample"}, {"characteristics_ch1": "disease state: acute-phase KD;\tcell type: white blood cell"}]}, {"GSM2940287": [{"title": "pooled KD patient at convalescent phase 1"}, {"type": "RNA"}, {"source_name_ch1": "pooled sample"}, {"characteristics_ch1": "disease state: convalescent-phase KD;\tcell type: white blood cell"}]}, {"GSM2940288": [{"title": "pooled KD patient at convalescent phase 2"}, {"type": "RNA"}, {"source_name_ch1": "pooled sample"}, {"characteristics_ch1": "disease state: convalescent-phase KD;\tcell type: white blood cell"}]}, {"GSM2940289": [{"title": "pooled KD patient at convalescent phase 3"}, {"type": "RNA"}, {"source_name_ch1": "pooled sample"}, {"characteristics_ch1": "disease state: convalescent-phase KD;\tcell type: white blood cell"}]}, {"GSM2863206": [{"title": "A549 shCtl, biological rep1 (WA1)"}, {"type": "RNA"}, {"source_name_ch1": "human lung carcinoma epithelial cells, vector control"}, {"characteristics_ch1": "cell line: A549 cells;\tgenotype/variation: vector knock-down control"}]}, {"GSM2863207": [{"title": "A549 shINSL4 A, biological rep1 (WA2)"}, {"type": "RNA"}, {"source_name_ch1": "human lung carcinoma epithelial cells, INSL4 knock-down"}, {"characteristics_ch1": "cell line: A549 cells;\tgenotype/variation: INSL4 knock-down"}]}, {"GSM2863208": [{"title": "A549 shCtl, biological rep2 (WB1)"}, {"type": "RNA"}, {"source_name_ch1": "human lung carcinoma epithelial cells, vector control"}, {"characteristics_ch1": "cell line: A549 cells;\tgenotype/variation: vector knock-down control"}]}, {"GSM2863209": [{"title": "A549 shINSL4 A, biological rep2 (WB2)"}, {"type": "RNA"}, {"source_name_ch1": "human lung carcinoma epithelial cells, INSL4 knock-down"}, {"characteristics_ch1": "cell line: A549 cells;\tgenotype/variation: INSL4 knock-down"}]}, {"GSM1634615": [{"title": "G190-12 amygdala"}, {"type": "RNA"}, {"source_name_ch1": "amygdala of suicide victim"}, {"characteristics_ch1": "group: suicide victim;\tindividual: G190-12;\tbrain region: amygdala;\trin: 6.6;\thybridiziation date: 2013-11-28"}]}, {"GSM1634616": [{"title": "G206-12 amygdala"}, {"type": "RNA"}, {"source_name_ch1": "amygdala of suicide victim"}, {"characteristics_ch1": "group: suicide victim;\tindividual: G206-12;\tbrain region: amygdala;\trin: 5.6;\thybridiziation date: 2014-01-12"}]}, {"GSM1634617": [{"title": "G190-12 hippocampus"}, {"type": "RNA"}, {"source_name_ch1": "hippocampus of suicide victim"}, {"characteristics_ch1": "group: suicide victim;\tindividual: G190-12;\tbrain region: hippocampus;\trin: 5.6;\thybridiziation date: 2013-11-28"}]}, {"GSM1634618": [{"title": "G206-12 hippocampus"}, {"type": "RNA"}, {"source_name_ch1": "hippocampus of suicide victim"}, {"characteristics_ch1": "group: suicide victim;\tindividual: G206-12;\tbrain region: hippocampus;\trin: 7.4;\thybridiziation date: 2014-01-12"}]}, {"GSM1634619": [{"title": "G190-12 thalamus"}, {"type": "RNA"}, {"source_name_ch1": "thalamus of suicide victim"}, {"characteristics_ch1": "group: suicide victim;\tindividual: G190-12;\tbrain region: thalamus;\trin: 6.3;\thybridiziation date: 2013-11-28"}]}, {"GSM1634620": [{"title": "G206-12 thalamus"}, {"type": "RNA"}, {"source_name_ch1": "thalamus of suicide victim"}, {"characteristics_ch1": "group: suicide victim;\tindividual: G206-12;\tbrain region: thalamus;\trin: 6.9;\thybridiziation date: 2014-01-12"}]}, {"GSM1634621": [{"title": "G131-12 prefrontal cortex"}, {"type": "RNA"}, {"source_name_ch1": "prefrontal cortex of control person"}, {"characteristics_ch1": "group: control person;\tindividual: G131-12;\tbrain region: prefrontal cortex;\trin: 6.9;\thybridiziation date: 2013-11-28"}]}, {"GSM1634622": [{"title": "G534-13 prefrontal cortex"}, {"type": "RNA"}, {"source_name_ch1": "prefrontal cortex of suicide victim"}, {"characteristics_ch1": "group: suicide victim;\tindividual: G534-13;\tbrain region: prefrontal cortex;\trin: 7.5;\thybridiziation date: 2014-01-12"}]}, {"GSM1634623": [{"title": "G131-12 amygdala"}, {"type": "RNA"}, {"source_name_ch1": "amygdala of control person"}, {"characteristics_ch1": "group: control person;\tindividual: G131-12;\tbrain region: amygdala;\trin: 6;\thybridiziation date: 2013-11-28"}]}, {"GSM1634624": [{"title": "G534-13 amygdala"}, {"type": "RNA"}, {"source_name_ch1": "amygdala of suicide victim"}, {"characteristics_ch1": "group: suicide victim;\tindividual: G534-13;\tbrain region: amygdala;\trin: 7.3;\thybridiziation date: 2014-01-12"}]}, {"GSM1634625": [{"title": "G131-12 hippocampus"}, {"type": "RNA"}, {"source_name_ch1": "hippocampus of control person"}, {"characteristics_ch1": "group: control person;\tindividual: G131-12;\tbrain region: hippocampus;\trin: 7.2;\thybridiziation date: 2013-11-28"}]}, {"GSM1634626": [{"title": "G534-13 hippocampus"}, {"type": "RNA"}, {"source_name_ch1": "hippocampus of suicide victim"}, {"characteristics_ch1": "group: suicide victim;\tindividual: G534-13;\tbrain region: hippocampus;\trin: 7.6;\thybridiziation date: 2014-01-12"}]}, {"GSM1634627": [{"title": "G131-12 thalamus"}, {"type": "RNA"}, {"source_name_ch1": "thalamus of control person"}, {"characteristics_ch1": "group: control person;\tindividual: G131-12;\tbrain region: thalamus;\trin: 6.3;\thybridiziation date: 2013-11-28"}]}, {"GSM1634628": [{"title": "G534-13 thalamus"}, {"type": "RNA"}, {"source_name_ch1": "thalamus of suicide victim"}, {"characteristics_ch1": "group: suicide victim;\tindividual: G534-13;\tbrain region: thalamus;\trin: 7.2;\thybridiziation date: 2014-01-12"}]}, {"GSM1634629": [{"title": "G44-12 prefrontal cortex"}, {"type": "RNA"}, {"source_name_ch1": "prefrontal cortex of suicide victim"}, {"characteristics_ch1": "group: suicide victim;\tindividual: G44-12;\tbrain region: prefrontal cortex;\trin: 7.9;\thybridiziation date: 2013-11-28"}]}, {"GSM1634630": [{"title": "G599-12 prefrontal cortex"}, {"type": "RNA"}, {"source_name_ch1": "prefrontal cortex of suicide victim"}, {"characteristics_ch1": "group: suicide victim;\tindividual: G599-12;\tbrain region: prefrontal cortex;\trin: 7.6;\thybridiziation date: 2014-01-17"}]}, {"GSM1634631": [{"title": "G44-12 amygdala"}, {"type": "RNA"}, {"source_name_ch1": "amygdala of suicide victim"}, {"characteristics_ch1": "group: suicide victim;\tindividual: G44-12;\tbrain region: amygdala;\trin: 6.9;\thybridiziation date: 2013-11-28"}]}, {"GSM1634632": [{"title": "G599-12 amygdala"}, {"type": "RNA"}, {"source_name_ch1": "amygdala of suicide victim"}, {"characteristics_ch1": "group: suicide victim;\tindividual: G599-12;\tbrain region: amygdala;\trin: 7.7;\thybridiziation date: 2014-01-17"}]}, {"GSM1634633": [{"title": "G44-12 hippocampus"}, {"type": "RNA"}, {"source_name_ch1": "hippocampus of suicide victim"}, {"characteristics_ch1": "group: suicide victim;\tindividual: G44-12;\tbrain region: hippocampus;\trin: 7.5;\thybridiziation date: 2013-11-28"}]}, {"GSM1634634": [{"title": "G599-12 hippocampus"}, {"type": "RNA"}, {"source_name_ch1": "hippocampus of suicide victim"}, {"characteristics_ch1": "group: suicide victim;\tindividual: G599-12;\tbrain region: hippocampus;\trin: 7.8;\thybridiziation date: 2014-01-17"}]}, {"GSM1634635": [{"title": "G109-12 prefrontal cortex"}, {"type": "RNA"}, {"source_name_ch1": "prefrontal cortex of suicide victim"}, {"characteristics_ch1": "group: suicide victim;\tindividual: G109-12;\tbrain region: prefrontal cortex;\trin: 7;\thybridiziation date: 2014-01-12"}]}, {"GSM1634636": [{"title": "G44-13 prefrontal cortex"}, {"type": "RNA"}, {"source_name_ch1": "prefrontal cortex of suicide victim"}, {"characteristics_ch1": "group: suicide victim;\tindividual: G44-13;\tbrain region: prefrontal cortex;\trin: 7.7;\thybridiziation date: 2013-11-28"}]}, {"GSM1634637": [{"title": "G44-12 thalamus"}, {"type": "RNA"}, {"source_name_ch1": "thalamus of suicide victim"}, {"characteristics_ch1": "group: suicide victim;\tindividual: G44-12;\tbrain region: thalamus;\trin: 7;\thybridiziation date: 2013-11-28"}]}, {"GSM1634638": [{"title": "G599-12 thalamus"}, {"type": "RNA"}, {"source_name_ch1": "thalamus of suicide victim"}, {"characteristics_ch1": "group: suicide victim;\tindividual: G599-12;\tbrain region: thalamus;\trin: 7.1;\thybridiziation date: 2014-01-17"}]}, {"GSM1634639": [{"title": "G44-13 prefrontal cortex technical replicate"}, {"type": "RNA"}, {"source_name_ch1": "prefrontal cortex of suicide victim"}, {"characteristics_ch1": "group: suicide victim;\tindividual: G44-13;\tbrain region: prefrontal cortex;\trin: 8.2;\thybridiziation date: 2014-01-17"}]}, {"GSM1634640": [{"title": "G597-12 prefrontal cortex"}, {"type": "RNA"}, {"source_name_ch1": "prefrontal cortex of control person"}, {"characteristics_ch1": "group: control person;\tindividual: G597-12;\tbrain region: prefrontal cortex;\trin: 7.2;\thybridiziation date: 2013-12-03"}]}, {"GSM1634641": [{"title": "G44-13 amygdala technical replicate"}, {"type": "RNA"}, {"source_name_ch1": "amygdala of suicide victim"}, {"characteristics_ch1": "group: suicide victim;\tindividual: G44-13;\tbrain region: amygdala;\trin: 7.5;\thybridiziation date: 2014-01-17"}]}, {"GSM1634642": [{"title": "G597-12 amygdala"}, {"type": "RNA"}, {"source_name_ch1": "amygdala of control person"}, {"characteristics_ch1": "group: control person;\tindividual: G597-12;\tbrain region: amygdala;\trin: 5.5;\thybridiziation date: 2013-12-03"}]}, {"GSM1634643": [{"title": "G44-13 hippocampus technical replicate"}, {"type": "RNA"}, {"source_name_ch1": "hippocampus of suicide victim"}, {"characteristics_ch1": "group: suicide victim;\tindividual: G44-13;\tbrain region: hippocampus;\trin: 8.1;\thybridiziation date: 2014-01-17"}]}, {"GSM1634644": [{"title": "G597-12 hippocampus"}, {"type": "RNA"}, {"source_name_ch1": "hippocampus of control person"}, {"characteristics_ch1": "group: control person;\tindividual: G597-12;\tbrain region: hippocampus;\trin: 6.8;\thybridiziation date: 2013-12-03"}]}, {"GSM1634645": [{"title": "G44-13 thalamus technical replicate"}, {"type": "RNA"}, {"source_name_ch1": "thalamus of suicide victim"}, {"characteristics_ch1": "group: suicide victim;\tindividual: G44-13;\tbrain region: thalamus;\trin: 8.1;\thybridiziation date: 2014-01-17"}]}, {"GSM1634646": [{"title": "G597-12 thalamus"}, {"type": "RNA"}, {"source_name_ch1": "thalamus of control person"}, {"characteristics_ch1": "group: control person;\tindividual: G597-12;\tbrain region: thalamus;\trin: 6;\thybridiziation date: 2013-12-03"}]}, {"GSM1634647": [{"title": "G131-12 prefrontal cortex technical replicate"}, {"type": "RNA"}, {"source_name_ch1": "prefrontal cortex of control person"}, {"characteristics_ch1": "group: control person;\tindividual: G131-12;\tbrain region: prefrontal cortex;\trin: 6.9;\thybridiziation date: 2014-01-17"}]}, {"GSM1634648": [{"title": "G51-12 prefrontal cortex"}, {"type": "RNA"}, {"source_name_ch1": "prefrontal cortex of control person"}, {"characteristics_ch1": "group: control person;\tindividual: G51-12;\tbrain region: prefrontal cortex;\trin: 7.1;\thybridiziation date: 2013-12-03"}]}, {"GSM1634649": [{"title": "G131-12 amygdala technical replicate"}, {"type": "RNA"}, {"source_name_ch1": "amygdala of control person"}, {"characteristics_ch1": "group: control person;\tindividual: G131-12;\tbrain region: amygdala;\trin: 6;\thybridiziation date: 2014-01-17"}]}, {"GSM1634650": [{"title": "G51-12 amygdala"}, {"type": "RNA"}, {"source_name_ch1": "amygdala of control person"}, {"characteristics_ch1": "group: control person;\tindividual: G51-12;\tbrain region: amygdala;\trin: 5.7;\thybridiziation date: 2013-12-03"}]}, {"GSM1634651": [{"title": "G131-12 hippocampus technical replicate"}, {"type": "RNA"}, {"source_name_ch1": "hippocampus of control person"}, {"characteristics_ch1": "group: control person;\tindividual: G131-12;\tbrain region: hippocampus;\trin: 7.2;\thybridiziation date: 2014-01-17"}]}, {"GSM1634652": [{"title": "G51-12 hippocampus"}, {"type": "RNA"}, {"source_name_ch1": "hippocampus of control person"}, {"characteristics_ch1": "group: control person;\tindividual: G51-12;\tbrain region: hippocampus;\trin: 6.3;\thybridiziation date: 2013-12-03"}]}, {"GSM1634653": [{"title": "G131-12 thalamus technical replicate"}, {"type": "RNA"}, {"source_name_ch1": "thalamus of control person"}, {"characteristics_ch1": "group: control person;\tindividual: G131-12;\tbrain region: thalamus;\trin: 6.3;\thybridiziation date: 2014-01-17"}]}, {"GSM1634654": [{"title": "G51-12 thalamus"}, {"type": "RNA"}, {"source_name_ch1": "thalamus of control person"}, {"characteristics_ch1": "group: control person;\tindividual: G51-12;\tbrain region: thalamus;\trin: 7.1;\thybridiziation date: 2013-12-03"}]}, {"GSM1634655": [{"title": "G123-12 prefrontal cortex"}, {"type": "RNA"}, {"source_name_ch1": "prefrontal cortex of suicide victim"}, {"characteristics_ch1": "group: suicide victim;\tindividual: G123-12;\tbrain region: prefrontal cortex;\trin: 7.3;\thybridiziation date: 2013-12-03"}]}, {"GSM1634656": [{"title": "G109-12 amygdala"}, {"type": "RNA"}, {"source_name_ch1": "amygdala of suicide victim"}, {"characteristics_ch1": "group: suicide victim;\tindividual: G109-12;\tbrain region: amygdala;\trin: 7.5;\thybridiziation date: 2014-01-12"}]}, {"GSM1634657": [{"title": "G44-13 amygdala"}, {"type": "RNA"}, {"source_name_ch1": "amygdala of suicide victim"}, {"characteristics_ch1": "group: suicide victim;\tindividual: G44-13;\tbrain region: amygdala;\trin: 7.3;\thybridiziation date: 2013-11-28"}]}, {"GSM1634658": [{"title": "G123-12 amygdala"}, {"type": "RNA"}, {"source_name_ch1": "amygdala of suicide victim"}, {"characteristics_ch1": "group: suicide victim;\tindividual: G123-12;\tbrain region: amygdala;\trin: 5.7;\thybridiziation date: 2013-12-03"}]}, {"GSM1634659": [{"title": "G123-12 hippocampus"}, {"type": "RNA"}, {"source_name_ch1": "hippocampus of suicide victim"}, {"characteristics_ch1": "group: suicide victim;\tindividual: G123-12;\tbrain region: hippocampus;\trin: 5.6;\thybridiziation date: 2013-12-03"}]}, {"GSM1634660": [{"title": "G123-12 thalamus"}, {"type": "RNA"}, {"source_name_ch1": "thalamus of suicide victim"}, {"characteristics_ch1": "group: suicide victim;\tindividual: G123-12;\tbrain region: thalamus;\trin: 5.8;\thybridiziation date: 2013-12-03"}]}, {"GSM1634661": [{"title": "G193-12 prefrontal cortex"}, {"type": "RNA"}, {"source_name_ch1": "prefrontal cortex of control person"}, {"characteristics_ch1": "group: control person;\tindividual: G193-12;\tbrain region: prefrontal cortex;\trin: 5.9;\thybridiziation date: 2013-12-03"}]}, {"GSM1634662": [{"title": "G193-12 amygdala"}, {"type": "RNA"}, {"source_name_ch1": "amygdala of control person"}, {"characteristics_ch1": "group: control person;\tindividual: G193-12;\tbrain region: amygdala;\trin: 5.5;\thybridiziation date: 2013-12-03"}]}, {"GSM1634663": [{"title": "G193-12 hippocampus"}, {"type": "RNA"}, {"source_name_ch1": "hippocampus of control person"}, {"characteristics_ch1": "group: control person;\tindividual: G193-12;\tbrain region: hippocampus;\trin: 6.6;\thybridiziation date: 2013-12-03"}]}, {"GSM1634664": [{"title": "G193-12 thalamus"}, {"type": "RNA"}, {"source_name_ch1": "thalamus of control person"}, {"characteristics_ch1": "group: control person;\tindividual: G193-12;\tbrain region: thalamus;\trin: 6.3;\thybridiziation date: 2013-12-03"}]}, {"GSM1634665": [{"title": "G41-12 prefrontal cortex"}, {"type": "RNA"}, {"source_name_ch1": "prefrontal cortex of suicide victim"}, {"characteristics_ch1": "group: suicide victim;\tindividual: G41-12;\tbrain region: prefrontal cortex;\trin: 6.6;\thybridiziation date: 2013-12-03"}]}, {"GSM1634666": [{"title": "G41-12 amygdala"}, {"type": "RNA"}, {"source_name_ch1": "amygdala of suicide victim"}, {"characteristics_ch1": "group: suicide victim;\tindividual: G41-12;\tbrain region: amygdala;\trin: 4.3;\thybridiziation date: 2013-12-03"}]}, {"GSM1634667": [{"title": "G41-12 hippocampus"}, {"type": "RNA"}, {"source_name_ch1": "hippocampus of suicide victim"}, {"characteristics_ch1": "group: suicide victim;\tindividual: G41-12;\tbrain region: hippocampus;\trin: 6;\thybridiziation date: 2013-12-03"}]}, {"GSM1634668": [{"title": "G44-13 hippocampus"}, {"type": "RNA"}, {"source_name_ch1": "hippocampus of suicide victim"}, {"characteristics_ch1": "group: suicide victim;\tindividual: G44-13;\tbrain region: hippocampus;\trin: 8.4;\thybridiziation date: 2013-11-28"}]}, {"GSM1634669": [{"title": "G41-12 thalamus"}, {"type": "RNA"}, {"source_name_ch1": "thalamus of suicide victim"}, {"characteristics_ch1": "group: suicide victim;\tindividual: G41-12;\tbrain region: thalamus;\trin: 5.7;\thybridiziation date: 2013-12-03"}]}, {"GSM1634670": [{"title": "G109-12 thalamus"}, {"type": "RNA"}, {"source_name_ch1": "thalamus of suicide victim"}, {"characteristics_ch1": "group: suicide victim;\tindividual: G109-12;\tbrain region: thalamus;\trin: 6.9;\thybridiziation date: 2014-01-12"}]}, {"GSM1634671": [{"title": "G44-13 thalamus"}, {"type": "RNA"}, {"source_name_ch1": "thalamus of suicide victim"}, {"characteristics_ch1": "group: suicide victim;\tindividual: G44-13;\tbrain region: thalamus;\trin: 7.7;\thybridiziation date: 2013-11-28"}]}, {"GSM1634672": [{"title": "G138-12 prefrontal cortex"}, {"type": "RNA"}, {"source_name_ch1": "prefrontal cortex of control person"}, {"characteristics_ch1": "group: control person;\tindividual: G138-12;\tbrain region: prefrontal cortex;\trin: 8.3;\thybridiziation date: 2014-01-12"}]}, {"GSM1634673": [{"title": "G192-12 prefrontal cortex"}, {"type": "RNA"}, {"source_name_ch1": "prefrontal cortex of control person"}, {"characteristics_ch1": "group: control person;\tindividual: G192-12;\tbrain region: prefrontal cortex;\trin: 8.1;\thybridiziation date: 2013-11-28"}]}, {"GSM1634674": [{"title": "G138-12 amygdala"}, {"type": "RNA"}, {"source_name_ch1": "amygdala of control person"}, {"characteristics_ch1": "group: control person;\tindividual: G138-12;\tbrain region: amygdala;\trin: 7.9;\thybridiziation date: 2014-01-12"}]}, {"GSM1634675": [{"title": "G192-12 amygdala"}, {"type": "RNA"}, {"source_name_ch1": "amygdala of control person"}, {"characteristics_ch1": "group: control person;\tindividual: G192-12;\tbrain region: amygdala;\trin: 6.6;\thybridiziation date: 2013-11-28"}]}, {"GSM1634676": [{"title": "G138-12 hippocampus"}, {"type": "RNA"}, {"source_name_ch1": "hippocampus of control person"}, {"characteristics_ch1": "group: control person;\tindividual: G138-12;\tbrain region: hippocampus;\trin: 7.4;\thybridiziation date: 2014-01-12"}]}, {"GSM1634677": [{"title": "G192-12 hippocampus"}, {"type": "RNA"}, {"source_name_ch1": "hippocampus of control person"}, {"characteristics_ch1": "group: control person;\tindividual: G192-12;\tbrain region: hippocampus;\trin: 7.5;\thybridiziation date: 2013-11-28"}]}, {"GSM1634678": [{"title": "G138-12 thalamus"}, {"type": "RNA"}, {"source_name_ch1": "thalamus of control person"}, {"characteristics_ch1": "group: control person;\tindividual: G138-12;\tbrain region: thalamus;\trin: 7.6;\thybridiziation date: 2014-01-12"}]}, {"GSM1634679": [{"title": "G192-12 thalamus"}, {"type": "RNA"}, {"source_name_ch1": "thalamus of control person"}, {"characteristics_ch1": "group: control person;\tindividual: G192-12;\tbrain region: thalamus;\trin: 7.1;\thybridiziation date: 2013-11-28"}]}, {"GSM1634680": [{"title": "G190-12 prefrontal cortex"}, {"type": "RNA"}, {"source_name_ch1": "prefrontal cortex of suicide victim"}, {"characteristics_ch1": "group: suicide victim;\tindividual: G190-12;\tbrain region: prefrontal cortex;\trin: 7.9;\thybridiziation date: 2013-11-28"}]}, {"GSM1634681": [{"title": "G206-12 prefrontal cortex"}, {"type": "RNA"}, {"source_name_ch1": "prefrontal cortex of suicide victim"}, {"characteristics_ch1": "group: suicide victim;\tindividual: G206-12;\tbrain region: prefrontal cortex;\trin: 6.7;\thybridiziation date: 2014-01-12"}]}, {"GSM1708244": [{"title": "CemSS + APoBEC3G #1"}, {"type": "RNA"}, {"source_name_ch1": "CemSS T cells stably overexpressing APOBEC3G"}, {"characteristics_ch1": "group: overexpression;\trin: 10;\thybridization date: 2015-04-14;\tcell line: CemSS;\tcell type: T cells"}]}, {"GSM1708245": [{"title": "CemSS - APoBEC3G #1"}, {"type": "RNA"}, {"source_name_ch1": "CemSS T cells stably transduced with control construct"}, {"characteristics_ch1": "group: control;\trin: 10;\thybridization date: 2015-04-14;\tcell line: CemSS;\tcell type: T cells"}]}, {"GSM1708246": [{"title": "CemSS + APoBEC3G #2"}, {"type": "RNA"}, {"source_name_ch1": "CemSS T cells stably overexpressing APOBEC3G"}, {"characteristics_ch1": "group: overexpression;\trin: 10;\thybridization date: 2015-04-14;\tcell line: CemSS;\tcell type: T cells"}]}, {"GSM1708247": [{"title": "CemSS - APoBEC3G #2"}, {"type": "RNA"}, {"source_name_ch1": "CemSS T cells stably transduced with control construct"}, {"characteristics_ch1": "group: control;\trin: 10;\thybridization date: 2015-04-14;\tcell line: CemSS;\tcell type: T cells"}]}, {"GSM1708248": [{"title": "CemSS + APoBEC3G #3"}, {"type": "RNA"}, {"source_name_ch1": "CemSS T cells stably overexpressing APOBEC3G"}, {"characteristics_ch1": "group: overexpression;\trin: 10;\thybridization date: 2015-04-14;\tcell line: CemSS;\tcell type: T cells"}]}, {"GSM1708249": [{"title": "CemSS - APoBEC3G #3"}, {"type": "RNA"}, {"source_name_ch1": "CemSS T cells stably transduced with control construct"}, {"characteristics_ch1": "group: control;\trin: 10;\thybridization date: 2015-04-14;\tcell line: CemSS;\tcell type: T cells"}]}, {"GSM2983043": [{"title": "endometrium NPAEC1"}, {"type": "RNA"}, {"source_name_ch1": "Endometrial biopsy"}, {"characteristics_ch1": "tissue: Endometrium"}]}, {"GSM2983044": [{"title": "endometrium NPAEC2"}, {"type": "RNA"}, {"source_name_ch1": "Endometrial biopsy"}, {"characteristics_ch1": "tissue: Endometrium"}]}, {"GSM2983045": [{"title": "endometrium NPAEC3"}, {"type": "RNA"}, {"source_name_ch1": "Endometrial biopsy"}, {"characteristics_ch1": "tissue: Endometrium"}]}, {"GSM2983046": [{"title": "endometrium NPAEC4"}, {"type": "RNA"}, {"source_name_ch1": "Endometrial biopsy"}, {"characteristics_ch1": "tissue: Endometrium"}]}, {"GSM2983047": [{"title": "endometrium PAEC-1"}, {"type": "RNA"}, {"source_name_ch1": "Endometrial biopsy"}, {"characteristics_ch1": "tissue: Endometrium"}]}, {"GSM2983048": [{"title": "endometrium PAEC-2"}, {"type": "RNA"}, {"source_name_ch1": "Endometrial biopsy"}, {"characteristics_ch1": "tissue: Endometrium"}]}, {"GSM2983049": [{"title": "endometrium PAEC-3"}, {"type": "RNA"}, {"source_name_ch1": "Endometrial biopsy"}, {"characteristics_ch1": "tissue: Endometrium"}]}, {"GSM2983050": [{"title": "endometrium PAEC-4"}, {"type": "RNA"}, {"source_name_ch1": "Endometrial biopsy"}, {"characteristics_ch1": "tissue: Endometrium"}]}, {"GSM2983051": [{"title": "endometrium PAEC-5"}, {"type": "RNA"}, {"source_name_ch1": "Endometrial biopsy"}, {"characteristics_ch1": "tissue: Endometrium"}]}, {"GSM2983052": [{"title": "endometrium PAEC-6"}, {"type": "RNA"}, {"source_name_ch1": "Endometrial biopsy"}, {"characteristics_ch1": "tissue: Endometrium"}]}, {"GSM2983053": [{"title": "endometrium PAEC-7"}, {"type": "RNA"}, {"source_name_ch1": "Endometrial biopsy"}, {"characteristics_ch1": "tissue: Endometrium"}]}, {"GSM2781547": [{"title": "BH13811-3_Zhengchang-1"}, {"type": "RNA"}, {"source_name_ch1": "Normal HUVECs"}, {"characteristics_ch1": "cell type: HUVEC;\tcondition: normal"}]}, {"GSM2781548": [{"title": "BH13811-3_Zhengchang-2"}, {"type": "RNA"}, {"source_name_ch1": "Normal HUVECs"}, {"characteristics_ch1": "cell type: HUVEC;\tcondition: normal"}]}, {"GSM2781549": [{"title": "BH13811-3_Zhengchang-3"}, {"type": "RNA"}, {"source_name_ch1": "Normal HUVECs"}, {"characteristics_ch1": "cell type: HUVEC;\tcondition: normal"}]}, {"GSM2781550": [{"title": "BH13811-2_Mouxing-1"}, {"type": "RNA"}, {"source_name_ch1": "HUVECs undergoing hypoxia/reoxygenation-induced injury"}, {"characteristics_ch1": "cell type: HUVEC;\tcondition: undergoing hypoxia/reoxygenation-induced injury"}]}, {"GSM2781551": [{"title": "BH13811-3_Muxing-2"}, {"type": "RNA"}, {"source_name_ch1": "HUVECs undergoing hypoxia/reoxygenation-induced injury"}, {"characteristics_ch1": "cell type: HUVEC;\tcondition: undergoing hypoxia/reoxygenation-induced injury"}]}, {"GSM2781552": [{"title": "BH13811-3_Muxing-3"}, {"type": "RNA"}, {"source_name_ch1": "HUVECs undergoing hypoxia/reoxygenation-induced injury"}, {"characteristics_ch1": "cell type: HUVEC;\tcondition: undergoing hypoxia/reoxygenation-induced injury"}]}, {"GSM2781553": [{"title": "BH13811-2_Yao-1"}, {"type": "RNA"}, {"source_name_ch1": "HUVECs undergoing hypoxia/reoxygenation-induced injury and Inulin-type oligosaccharides administration"}, {"characteristics_ch1": "cell type: HUVEC;\tcondition: undergoing hypoxia/reoxygenation-induced injury and Inulin-type oligosaccharides administration"}]}, {"GSM2781554": [{"title": "BH13811-3_Yao-2"}, {"type": "RNA"}, {"source_name_ch1": "HUVECs undergoing hypoxia/reoxygenation-induced injury and Inulin-type oligosaccharides administration"}, {"characteristics_ch1": "cell type: HUVEC;\tcondition: undergoing hypoxia/reoxygenation-induced injury and Inulin-type oligosaccharides administration"}]}, {"GSM2781555": [{"title": "BH13811-3_Yao-3"}, {"type": "RNA"}, {"source_name_ch1": "HUVECs undergoing hypoxia/reoxygenation-induced injury and Inulin-type oligosaccharides administration"}, {"characteristics_ch1": "cell type: HUVEC;\tcondition: undergoing hypoxia/reoxygenation-induced injury and Inulin-type oligosaccharides administration"}]}, {"GSM2743767": [{"title": "Skin_3004/014 V2 (V)_rep1"}, {"type": "RNA"}, {"source_name_ch1": "Skin biopsy (lesional, baseline), patient with moderate to severe plaque type psoriasis"}, {"characteristics_ch1": "tissue: Skin;\tdisease state: Plaque-type psoriasis patient;\tskin type: psoriasis plaque"}]}, {"GSM2743768": [{"title": "Skin_3004/014 V9 (V)_rep1"}, {"type": "RNA"}, {"source_name_ch1": "Skin biopsy (lesional, 16 wk secukinumab), patient with moderate to severe plaque type psoriasis"}, {"characteristics_ch1": "tissue: Skin;\tdisease state: Plaque-type psoriasis patient;\tskin type: psoriasis plaque"}]}, {"GSM2743769": [{"title": "Skin_3004/014 V14 (V)_rep1"}, {"type": "RNA"}, {"source_name_ch1": "Skin biopsy (lesional, 16 wk secukinumab + 16 wk secukinumab), patient with moderate to severe plaque type psoriasis"}, {"characteristics_ch1": "tissue: Skin;\tdisease state: Plaque-type psoriasis patient;\tskin type: psoriasis plaque"}]}, {"GSM2743770": [{"title": "Skin_3004/014 V2 non-les. (V)_rep1"}, {"type": "RNA"}, {"source_name_ch1": "Skin biopsy (non-lesional, baseline), patient with moderate to severe plaque type psoriasis"}, {"characteristics_ch1": "tissue: Skin;\tdisease state: Plaque-type psoriasis patient;\tskin type: non-affected skin"}]}, {"GSM2743771": [{"title": "Skin_3004/012 V2 (V)_rep2"}, {"type": "RNA"}, {"source_name_ch1": "Skin biopsy (lesional, baseline), patient with moderate to severe plaque type psoriasis"}, {"characteristics_ch1": "tissue: Skin;\tdisease state: Plaque-type psoriasis patient;\tskin type: psoriasis plaque"}]}, {"GSM2743772": [{"title": "Skin_3004/012 V9 (V)_rep2"}, {"type": "RNA"}, {"source_name_ch1": "Skin biopsy (lesional, 16 wk secukinumab), patient with moderate to severe plaque type psoriasis"}, {"characteristics_ch1": "tissue: Skin;\tdisease state: Plaque-type psoriasis patient;\tskin type: psoriasis plaque"}]}, {"GSM2743773": [{"title": "Skin_3004/012 V14 (V)_rep2"}, {"type": "RNA"}, {"source_name_ch1": "Skin biopsy (lesional, 16 wk secukinumab + 16 wk secukinumab), patient with moderate to severe plaque type psoriasis"}, {"characteristics_ch1": "tissue: Skin;\tdisease state: Plaque-type psoriasis patient;\tskin type: psoriasis plaque"}]}, {"GSM2743774": [{"title": "Skin_3004/012 V2 non-les. (V)_rep2"}, {"type": "RNA"}, {"source_name_ch1": "Skin biopsy (non-lesional, baseline), patient with moderate to severe plaque type psoriasis"}, {"characteristics_ch1": "tissue: Skin;\tdisease state: Plaque-type psoriasis patient;\tskin type: non-affected skin"}]}, {"GSM2743775": [{"title": "Skin_3009/001 V2 (P)_rep1"}, {"type": "RNA"}, {"source_name_ch1": "Skin biopsy (lesional, baseline), patient with moderate to severe plaque type psoriasis"}, {"characteristics_ch1": "tissue: Skin;\tdisease state: Plaque-type psoriasis patient;\tskin type: psoriasis plaque"}]}, {"GSM2743776": [{"title": "Skin_3009/001 V9 (P)_rep1"}, {"type": "RNA"}, {"source_name_ch1": "Skin biopsy (lesional, 16 wk secukinumab), patient with moderate to severe plaque type psoriasis"}, {"characteristics_ch1": "tissue: Skin;\tdisease state: Plaque-type psoriasis patient;\tskin type: psoriasis plaque"}]}, {"GSM2743777": [{"title": "Skin_3009/001 V14 (P)_rep1"}, {"type": "RNA"}, {"source_name_ch1": "Skin biopsy (lesional, 16 wk secukinumab + 16 wk placebo), patient with moderate to severe plaque type psoriasis"}, {"characteristics_ch1": "tissue: Skin;\tdisease state: Plaque-type psoriasis patient;\tskin type: psoriasis plaque"}]}, {"GSM2743778": [{"title": "Skin_3009/001 V2 non-les. (P)_rep1"}, {"type": "RNA"}, {"source_name_ch1": "Skin biopsy (non-lesional, baseline), patient with moderate to severe plaque type psoriasis"}, {"characteristics_ch1": "tissue: Skin;\tdisease state: Plaque-type psoriasis patient;\tskin type: non-affected skin"}]}, {"GSM2743779": [{"title": "Skin_3025/005 V2 (P)_rep2"}, {"type": "RNA"}, {"source_name_ch1": "Skin biopsy (lesional, baseline), patient with moderate to severe plaque type psoriasis"}, {"characteristics_ch1": "tissue: Skin;\tdisease state: Plaque-type psoriasis patient;\tskin type: psoriasis plaque"}]}, {"GSM2743780": [{"title": "Skin_3025/005 V9 (P)_rep2"}, {"type": "RNA"}, {"source_name_ch1": "Skin biopsy (lesional, 16 wk secukinumab), patient with moderate to severe plaque type psoriasis"}, {"characteristics_ch1": "tissue: Skin;\tdisease state: Plaque-type psoriasis patient;\tskin type: psoriasis plaque"}]}, {"GSM2743781": [{"title": "Skin_3025/005 V14 (P)_rep2"}, {"type": "RNA"}, {"source_name_ch1": "Skin biopsy (lesional, 16 wk secukinumab + 16 wk placebo), patient with moderate to severe plaque type psoriasis"}, {"characteristics_ch1": "tissue: Skin;\tdisease state: Plaque-type psoriasis patient;\tskin type: psoriasis plaque"}]}, {"GSM2743782": [{"title": "Skin_3025/005 V2 non-les. (P)_rep2"}, {"type": "RNA"}, {"source_name_ch1": "Skin biopsy (non-lesional, baseline), patient with moderate to severe plaque type psoriasis"}, {"characteristics_ch1": "tissue: Skin;\tdisease state: Plaque-type psoriasis patient;\tskin type: non-affected skin"}]}, {"GSM2743783": [{"title": "Skin_3009/004 V2 (V)_rep3"}, {"type": "RNA"}, {"source_name_ch1": "Skin biopsy (lesional, baseline), patient with moderate to severe plaque type psoriasis"}, {"characteristics_ch1": "tissue: Skin;\tdisease state: Plaque-type psoriasis patient;\tskin type: psoriasis plaque"}]}, {"GSM2743784": [{"title": "Skin_3009/004 V9 (V)_rep3"}, {"type": "RNA"}, {"source_name_ch1": "Skin biopsy (lesional, 16 wk secukinumab), patient with moderate to severe plaque type psoriasis"}, {"characteristics_ch1": "tissue: Skin;\tdisease state: Plaque-type psoriasis patient;\tskin type: psoriasis plaque"}]}, {"GSM2743785": [{"title": "Skin_3009/004 V14 (V)_rep3"}, {"type": "RNA"}, {"source_name_ch1": "Skin biopsy (lesional, 16 wk secukinumab + 16 wk secukinumab), patient with moderate to severe plaque type psoriasis"}, {"characteristics_ch1": "tissue: Skin;\tdisease state: Plaque-type psoriasis patient;\tskin type: psoriasis plaque"}]}, {"GSM2743786": [{"title": "Skin_3009/004 V2 non-les. (V)_rep3"}, {"type": "RNA"}, {"source_name_ch1": "Skin biopsy (non-lesional, baseline), patient with moderate to severe plaque type psoriasis"}, {"characteristics_ch1": "tissue: Skin;\tdisease state: Plaque-type psoriasis patient;\tskin type: non-affected skin"}]}, {"GSM2743787": [{"title": "Skin_3010/005 V2 (V)_rep4"}, {"type": "RNA"}, {"source_name_ch1": "Skin biopsy (lesional, baseline), patient with moderate to severe plaque type psoriasis"}, {"characteristics_ch1": "tissue: Skin;\tdisease state: Plaque-type psoriasis patient;\tskin type: psoriasis plaque"}]}, {"GSM2743788": [{"title": "Skin_3010/005 V9 (V)_rep4"}, {"type": "RNA"}, {"source_name_ch1": "Skin biopsy (lesional, 16 wk secukinumab), patient with moderate to severe plaque type psoriasis"}, {"characteristics_ch1": "tissue: Skin;\tdisease state: Plaque-type psoriasis patient;\tskin type: psoriasis plaque"}]}, {"GSM2743789": [{"title": "Skin_3010/005 V14 (V)_rep4"}, {"type": "RNA"}, {"source_name_ch1": "Skin biopsy (lesional, 16 wk secukinumab + 16 wk secukinumab), patient with moderate to severe plaque type psoriasis"}, {"characteristics_ch1": "tissue: Skin;\tdisease state: Plaque-type psoriasis patient;\tskin type: psoriasis plaque"}]}, {"GSM2743790": [{"title": "Skin_3010/005 V2 non-les. (V)_rep4"}, {"type": "RNA"}, {"source_name_ch1": "Skin biopsy (non-lesional, baseline), patient with moderate to severe plaque type psoriasis"}, {"characteristics_ch1": "tissue: Skin;\tdisease state: Plaque-type psoriasis patient;\tskin type: non-affected skin"}]}, {"GSM2743791": [{"title": "Skin_3013/010 V2 (P)_rep3"}, {"type": "RNA"}, {"source_name_ch1": "Skin biopsy (lesional, baseline), patient with moderate to severe plaque type psoriasis"}, {"characteristics_ch1": "tissue: Skin;\tdisease state: Plaque-type psoriasis patient;\tskin type: psoriasis plaque"}]}, {"GSM2743792": [{"title": "Skin_3013/010 V9 (P)_rep3"}, {"type": "RNA"}, {"source_name_ch1": "Skin biopsy (lesional, 16 wk secukinumab), patient with moderate to severe plaque type psoriasis"}, {"characteristics_ch1": "tissue: Skin;\tdisease state: Plaque-type psoriasis patient;\tskin type: psoriasis plaque"}]}, {"GSM2743793": [{"title": "Skin_3013/010 V14 (P)_rep3"}, {"type": "RNA"}, {"source_name_ch1": "Skin biopsy (lesional, 16 wk secukinumab + 16 wk placebo), patient with moderate to severe plaque type psoriasis"}, {"characteristics_ch1": "tissue: Skin;\tdisease state: Plaque-type psoriasis patient;\tskin type: psoriasis plaque"}]}, {"GSM2743794": [{"title": "Skin_3013/010 V2 non-les. (P)_rep3"}, {"type": "RNA"}, {"source_name_ch1": "Skin biopsy (non-lesional, baseline), patient with moderate to severe plaque type psoriasis"}, {"characteristics_ch1": "tissue: Skin;\tdisease state: Plaque-type psoriasis patient;\tskin type: non-affected skin"}]}, {"GSM2743795": [{"title": "Skin_3013/008 V2 (P)_rep4"}, {"type": "RNA"}, {"source_name_ch1": "Skin biopsy (lesional, baseline), patient with moderate to severe plaque type psoriasis"}, {"characteristics_ch1": "tissue: Skin;\tdisease state: Plaque-type psoriasis patient;\tskin type: psoriasis plaque"}]}, {"GSM2743796": [{"title": "Skin_3013/008 V9 (P)_rep4"}, {"type": "RNA"}, {"source_name_ch1": "Skin biopsy (lesional, 16 wk secukinumab), patient with moderate to severe plaque type psoriasis"}, {"characteristics_ch1": "tissue: Skin;\tdisease state: Plaque-type psoriasis patient;\tskin type: psoriasis plaque"}]}, {"GSM2743797": [{"title": "Skin_3013/008 V14 (P)_rep4"}, {"type": "RNA"}, {"source_name_ch1": "Skin biopsy (lesional, 16 wk secukinumab + 16 wk placebo), patient with moderate to severe plaque type psoriasis"}, {"characteristics_ch1": "tissue: Skin;\tdisease state: Plaque-type psoriasis patient;\tskin type: psoriasis plaque"}]}, {"GSM2743798": [{"title": "Skin_3013/008 V2 non-les. (P)_rep4"}, {"type": "RNA"}, {"source_name_ch1": "Skin biopsy (non-lesional, baseline), patient with moderate to severe plaque type psoriasis"}, {"characteristics_ch1": "tissue: Skin;\tdisease state: Plaque-type psoriasis patient;\tskin type: non-affected skin"}]}, {"GSM2743799": [{"title": "Skin_3001/004 V2 (P)_rep5"}, {"type": "RNA"}, {"source_name_ch1": "Skin biopsy (lesional, baseline), patient with moderate to severe plaque type psoriasis"}, {"characteristics_ch1": "tissue: Skin;\tdisease state: Plaque-type psoriasis patient;\tskin type: psoriasis plaque"}]}, {"GSM2743800": [{"title": "Skin_3001/004 V9 (P)_rep5"}, {"type": "RNA"}, {"source_name_ch1": "Skin biopsy (lesional, 16 wk secukinumab), patient with moderate to severe plaque type psoriasis"}, {"characteristics_ch1": "tissue: Skin;\tdisease state: Plaque-type psoriasis patient;\tskin type: psoriasis plaque"}]}, {"GSM2743801": [{"title": "Skin_3001/004 V14 (P)_rep5"}, {"type": "RNA"}, {"source_name_ch1": "Skin biopsy (lesional, 16 wk secukinumab + 16 wk placebo), patient with moderate to severe plaque type psoriasis"}, {"characteristics_ch1": "tissue: Skin;\tdisease state: Plaque-type psoriasis patient;\tskin type: psoriasis plaque"}]}, {"GSM2743802": [{"title": "Skin_3001/004 V2 non-les. (P)_rep5"}, {"type": "RNA"}, {"source_name_ch1": "Skin biopsy (non-lesional, baseline), patient with moderate to severe plaque type psoriasis"}, {"characteristics_ch1": "tissue: Skin;\tdisease state: Plaque-type psoriasis patient;\tskin type: non-affected skin"}]}, {"GSM2743803": [{"title": "Skin_3009/005 V2 (V)_rep5"}, {"type": "RNA"}, {"source_name_ch1": "Skin biopsy (lesional, baseline), patient with moderate to severe plaque type psoriasis"}, {"characteristics_ch1": "tissue: Skin;\tdisease state: Plaque-type psoriasis patient;\tskin type: psoriasis plaque"}]}, {"GSM2743804": [{"title": "Skin_3009/005 V9 (V)_rep5"}, {"type": "RNA"}, {"source_name_ch1": "Skin biopsy (lesional, 16 wk secukinumab), patient with moderate to severe plaque type psoriasis"}, {"characteristics_ch1": "tissue: Skin;\tdisease state: Plaque-type psoriasis patient;\tskin type: psoriasis plaque"}]}, {"GSM2743805": [{"title": "Skin_3009/005 V14 (V)_rep5"}, {"type": "RNA"}, {"source_name_ch1": "Skin biopsy (lesional, 16 wk secukinumab + 16 wk secukinumab), patient with moderate to severe plaque type psoriasis"}, {"characteristics_ch1": "tissue: Skin;\tdisease state: Plaque-type psoriasis patient;\tskin type: psoriasis plaque"}]}, {"GSM2743806": [{"title": "Skin_3009/005 V2 non-les. (V)_rep5"}, {"type": "RNA"}, {"source_name_ch1": "Skin biopsy (non-lesional, baseline), patient with moderate to severe plaque type psoriasis"}, {"characteristics_ch1": "tissue: Skin;\tdisease state: Plaque-type psoriasis patient;\tskin type: non-affected skin"}]}, {"GSM2704114": [{"title": "CR559251"}, {"type": "RNA"}, {"source_name_ch1": "RNA (5 \u00b5g); Colon: left; Adenocarcinoma of colon"}, {"characteristics_ch1": "tissue: Primary CRC total RNA;\tsite: Colon: left;\tage: 36;\tgender: Male;\tgrade: AJCC G2: Moderately differentiated;\tStage: IV;\tt: T3;\tn: N1;\tm: M1"}]}, {"GSM2704115": [{"title": "CR559521"}, {"type": "RNA"}, {"source_name_ch1": "RNA (5 \u00b5g); Rectum; Adenocarcinoma of rectum"}, {"characteristics_ch1": "tissue: Primary CRC total RNA;\tsite: Rectum;\tage: 75;\tgender: Male;\tgrade: AJCC G2: Moderately differentiated;\tStage: IIA;\tt: T3;\tn: N0;\tm: MX"}]}, {"GSM2704116": [{"title": "CR560026"}, {"type": "RNA"}, {"source_name_ch1": "RNA (5 \u00b5g); Colon: right; Adenocarcinoma of colon"}, {"characteristics_ch1": "tissue: Primary CRC total RNA;\tsite: Colon: right;\tage: 72;\tgender: Male;\tgrade: AJCC G1: Well differentiated;\tStage: IV;\tt: T3;\tn: N0;\tm: M1"}]}, {"GSM2704117": [{"title": "CR560080"}, {"type": "RNA"}, {"source_name_ch1": "RNA (5 \u00b5g); Colon: right; Adenocarcinoma of colon"}, {"characteristics_ch1": "tissue: Primary CRC total RNA;\tsite: Colon: right;\tage: 76;\tgender: Male;\tgrade: AJCC G1: Well differentiated;\tStage: I;\tt: T2;\tn: N0;\tm: MX"}]}, {"GSM2704118": [{"title": "CR560126"}, {"type": "RNA"}, {"source_name_ch1": "RNA (5 \u00b5g); Colon: rectosigmoid; Adenocarcinoma of colon"}, {"characteristics_ch1": "tissue: Primary CRC total RNA;\tsite: Colon: rectosigmoid;\tage: 38;\tgender: Male;\tgrade: AJCC G2: Moderately differentiated;\tStage: IIIC;\tt: T3;\tn: N2;\tm: MX"}]}, {"GSM2704119": [{"title": "CR560367"}, {"type": "RNA"}, {"source_name_ch1": "RNA (5 \u00b5g); Cecum; Adenocarcinoma of colon"}, {"characteristics_ch1": "tissue: Primary CRC total RNA;\tsite: Cecum;\tage: 89;\tgender: Female;\tgrade: AJCC G3: Poorly differentiated;\tStage: IIIB;\tt: T3;\tn: N1;\tm: MX"}]}, {"GSM2704120": [{"title": "CR560403"}, {"type": "RNA"}, {"source_name_ch1": "RNA (5 \u00b5g); Colon: sigmoid; Adenocarcinoma of colon"}, {"characteristics_ch1": "tissue: Primary CRC total RNA;\tsite: Colon: sigmoid;\tage: 75;\tgender: Male;\tgrade: AJCC G2: Moderately differentiated;\tStage: IIB;\tt: T4;\tn: N0;\tm: MX"}]}, {"GSM2704121": [{"title": "CR560476"}, {"type": "RNA"}, {"source_name_ch1": "RNA (5 \u00b5g); Cecum; Adenocarcinoma of colon"}, {"characteristics_ch1": "tissue: Primary CRC total RNA;\tsite: Cecum;\tage: 60;\tgender: Female;\tgrade: AJCC G2: Moderately differentiated;\tStage: IIIB;\tt: T3;\tn: N1;\tm: MX"}]}, {"GSM2704122": [{"title": "CR560523"}, {"type": "RNA"}, {"source_name_ch1": "RNA (5 \u00b5g); Colon: right; Adenocarcinoma of colon"}, {"characteristics_ch1": "tissue: Primary CRC total RNA;\tsite: Colon: right;\tage: 76;\tgender: Female;\tgrade: AJCC G1: Well differentiated;\tStage: IIIC;\tt: T3;\tn: N2;\tm: MX"}]}, {"GSM2704123": [{"title": "CR560527"}, {"type": "RNA"}, {"source_name_ch1": "RNA (5 \u00b5g); Colon: left; Adenocarcinoma of colon"}, {"characteristics_ch1": "tissue: Primary CRC total RNA;\tsite: Colon: left;\tage: 64;\tgender: Male;\tgrade: AJCC G1: Well differentiated;\tStage: IIIC;\tt: T4;\tn: N2;\tm: MX"}]}, {"GSM2704124": [{"title": "CR560590"}, {"type": "RNA"}, {"source_name_ch1": "RNA (5 \u00b5g); Cecum; Adenocarcinoma of colon"}, {"characteristics_ch1": "tissue: Primary CRC total RNA;\tsite: Cecum;\tage: 60;\tgender: Female;\tgrade: AJCC G1: Well differentiated;\tStage: IIIC;\tt: T4;\tn: N2;\tm: MX"}]}, {"GSM2704125": [{"title": "CR560603"}, {"type": "RNA"}, {"source_name_ch1": "RNA (5 \u00b5g); Colon: transverse; Adenocarcinoma of colon"}, {"characteristics_ch1": "tissue: Primary CRC total RNA;\tsite: Colon: transverse;\tage: 70;\tgender: Female;\tgrade: AJCC G2: Moderately differentiated;\tStage: IIA;\tt: T3;\tn: N0;\tm: MX"}]}, {"GSM2704126": [{"title": "CR560671"}, {"type": "RNA"}, {"source_name_ch1": "RNA (5 \u00b5g); Colon: right; Adenocarcinoma of colon"}, {"characteristics_ch1": "tissue: Primary CRC total RNA;\tsite: Colon: right;\tage: 72;\tgender: Female;\tgrade: AJCC G2: Moderately differentiated;\tStage: I;\tt: T2;\tn: N0;\tm: MX"}]}, {"GSM2704127": [{"title": "CR560798"}, {"type": "RNA"}, {"source_name_ch1": "RNA (5 \u00b5g); Colon; Adenocarcinoma of colon, metastatic"}, {"characteristics_ch1": "tissue: Liver metastasis CRC total RNA;\tsite: Liver;\tage: 72;\tgender: Male;\tgrade: AJCC G2: Moderately differentiated;\tStage: IV;\tt: TX;\tn: NX;\tm: M1"}]}, {"GSM2704128": [{"title": "CR560973"}, {"type": "RNA"}, {"source_name_ch1": "RNA (5 \u00b5g); Cecum; Adenocarcinoma of colon"}, {"characteristics_ch1": "tissue: Primary CRC total RNA;\tsite: Cecum;\tage: 42;\tgender: Female;\tgrade: AJCC G1: Well differentiated;\tStage: IIIB;\tt: T3;\tn: N1;\tm: MX"}]}, {"GSM2704129": [{"title": "CR561060"}, {"type": "RNA"}, {"source_name_ch1": "RNA (5 \u00b5g): NA"}, {"characteristics_ch1": "tissue: Total RNA;\tsite: NA;\tage: NA;\tgender: NA;\tgrade: NA;\tStage: NA;\tt: NA;\tn: NA;\tm: NA"}]}, {"GSM2704130": [{"title": "CR561163"}, {"type": "RNA"}, {"source_name_ch1": "RNA (5 \u00b5g); Colon: right; Adenocarcinoma of colon, mucinous"}, {"characteristics_ch1": "tissue: Primary CRC total RNA;\tsite: Colon: right;\tage: 69;\tgender: Female;\tgrade: Not Reported;\tStage: IIA;\tt: T3;\tn: N0;\tm: MX"}]}, {"GSM2985443": [{"title": "CON"}, {"type": "RNA"}, {"source_name_ch1": "Negative control ASO-treated CF patients-derived CFBE41o- cells"}, {"characteristics_ch1": "cell line: CFBE41o-;\tcell type: CF bronchial epithelial cell line;\ttreatment: Control ASO"}]}, {"GSM2985444": [{"title": "linc-SUMF1-2 knockdown"}, {"type": "RNA"}, {"source_name_ch1": "Linc-SUMF1-2 ASO-treated CF patients-derived CFBE41o- cells"}, {"characteristics_ch1": "cell line: CFBE41o-;\tcell type: CF bronchial epithelial cell line;\ttreatment: Linc-SUMF1-2 ASO"}]}, {"GSM2985445": [{"title": "16HBE14o-"}, {"type": "RNA"}, {"source_name_ch1": "Normal 16HBE14o- cells"}, {"characteristics_ch1": "cell line: 16HBE14o-;\tcell type: Normal bronchial epithelial cell line"}]}, {"GSM2985446": [{"title": "CFBE41o-"}, {"type": "RNA"}, {"source_name_ch1": "CF patients-derived CFBE41o- cells"}, {"characteristics_ch1": "cell line: CFBE41o-;\tcell type: CF bronchial epithelial cell line"}]}, {"GSM2985447": [{"title": "WT-CFTR-CFBE41o-"}, {"type": "RNA"}, {"source_name_ch1": "WT-CFTR-rescued CFBE41o- cells"}, {"characteristics_ch1": "cell line: CFBE41o-;\tcell type: CF bronchial epithelial cell line;\ttreatment: WT-CFTR-rescue"}]}, {"GSM2478340": [{"title": "GCS11782,NB4 cells no ZYH005, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "NB4 cells no ZYH005"}, {"characteristics_ch1": "cell line: Acute promyelocytic leukemia (APL) cell line NB4;\tagent: control"}]}, {"GSM2478341": [{"title": "GCS11783,NB4 cells no ZYH005, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "NB4 cells no ZYH005"}, {"characteristics_ch1": "cell line: Acute promyelocytic leukemia (APL) cell line NB4;\tagent: control"}]}, {"GSM2478342": [{"title": "GCS11784,NB4 cells no ZYH005, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "NB4 cells no ZYH005"}, {"characteristics_ch1": "cell line: Acute promyelocytic leukemia (APL) cell line NB4;\tagent: control"}]}, {"GSM2478343": [{"title": "GCS11788,NB4 cells with ZYH005, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "NB4 cells with ZYH005"}, {"characteristics_ch1": "cell line: Acute promyelocytic leukemia (APL) cell line NB4;\tagent: ZYH005"}]}, {"GSM2478344": [{"title": "GCS11789,NB4 cells with ZYH005, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "NB4 cells with ZYH005"}, {"characteristics_ch1": "cell line: Acute promyelocytic leukemia (APL) cell line NB4;\tagent: ZYH005"}]}, {"GSM2478345": [{"title": "GCS11790,NB4 cells with ZYH005, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "NB4 cells with ZYH005"}, {"characteristics_ch1": "cell line: Acute promyelocytic leukemia (APL) cell line NB4;\tagent: ZYH005"}]}, {"GSM3024087": [{"title": "EDN, 1"}, {"type": "RNA"}, {"source_name_ch1": "early diabetic nephropathy"}, {"characteristics_ch1": "tissue: Kidney Cortical Tissue;\tdisease: early diabetic nephropathy"}]}, {"GSM3024088": [{"title": "EDN, 2"}, {"type": "RNA"}, {"source_name_ch1": "early diabetic nephropathy"}, {"characteristics_ch1": "tissue: Kidney Cortical Tissue;\tdisease: early diabetic nephropathy"}]}, {"GSM3024089": [{"title": "EDN, 3"}, {"type": "RNA"}, {"source_name_ch1": "early diabetic nephropathy"}, {"characteristics_ch1": "tissue: Kidney Cortical Tissue;\tdisease: early diabetic nephropathy"}]}, {"GSM3024090": [{"title": "EDN, 4"}, {"type": "RNA"}, {"source_name_ch1": "early diabetic nephropathy"}, {"characteristics_ch1": "tissue: Kidney Cortical Tissue;\tdisease: early diabetic nephropathy"}]}, {"GSM3024091": [{"title": "Non-diabetic Control, 1"}, {"type": "RNA"}, {"source_name_ch1": "Non-diabetic Control"}, {"characteristics_ch1": "tissue: Kidney Cortical Tissue;\tdisease: Control"}]}, {"GSM3024092": [{"title": "Non-diabetic Control, 2"}, {"type": "RNA"}, {"source_name_ch1": "Non-diabetic Control"}, {"characteristics_ch1": "tissue: Kidney Cortical Tissue;\tdisease: Control"}]}, {"GSM3024093": [{"title": "Non-diabetic Control, 3"}, {"type": "RNA"}, {"source_name_ch1": "Non-diabetic Control"}, {"characteristics_ch1": "tissue: Kidney Cortical Tissue;\tdisease: Control"}]}, {"GSM3024094": [{"title": "Non-diabetic Control, 4"}, {"type": "RNA"}, {"source_name_ch1": "Non-diabetic Control"}, {"characteristics_ch1": "tissue: Kidney Cortical Tissue;\tdisease: Control"}]}, {"GSM3024184": [{"title": "case1_duodenum_normal_rep1"}, {"type": "RNA"}, {"source_name_ch1": "normal tissue from duodenal cancer patient(Case 1)"}, {"characteristics_ch1": "tissue: normal"}]}, {"GSM3024185": [{"title": "case1_duodenum_adenoma_rep1"}, {"type": "RNA"}, {"source_name_ch1": "adenoma tissue from duodenal cancer patient(Case 1)"}, {"characteristics_ch1": "tissue: adenoma"}]}, {"GSM3024186": [{"title": "case1_duodenum_cancer_rep1"}, {"type": "RNA"}, {"source_name_ch1": "cancer tissue from duodenal cancer patient(Case 1)"}, {"characteristics_ch1": "tissue: adenocarcinoma"}]}, {"GSM3024187": [{"title": "case2_duodenum_normal_rep1"}, {"type": "RNA"}, {"source_name_ch1": "normal tissue from duodenal cancer patient(Case 2)"}, {"characteristics_ch1": "tissue: normal"}]}, {"GSM3024188": [{"title": "case2_duodenum_adenoma_rep1"}, {"type": "RNA"}, {"source_name_ch1": "adenoma tissue from duodenal cancer patient(Case 2)"}, {"characteristics_ch1": "tissue: adenoma"}]}, {"GSM3024189": [{"title": "case2_duodenum_cancer_rep1"}, {"type": "RNA"}, {"source_name_ch1": "cancer tissue from duodenal cancer patient(Case 2)"}, {"characteristics_ch1": "tissue: adenocarcinoma"}]}, {"GSM3024190": [{"title": "case3_duodenum_normal_rep1"}, {"type": "RNA"}, {"source_name_ch1": "normal tissue from duodenal cancer patient(Case 3)"}, {"characteristics_ch1": "tissue: normal"}]}, {"GSM3024191": [{"title": "case3_duodenum_adenoma_rep1"}, {"type": "RNA"}, {"source_name_ch1": "adenoma tissue from duodenal cancer patient(Case 3)"}, {"characteristics_ch1": "tissue: adenoma"}]}, {"GSM3024192": [{"title": "case3_duodenum_cancer_rep1"}, {"type": "RNA"}, {"source_name_ch1": "cancer tissue from duodenal cancer patient(Case 3)"}, {"characteristics_ch1": "tissue: adenocarcinoma"}]}, {"GSM3024193": [{"title": "case4_duodenum_normal_rep1"}, {"type": "RNA"}, {"source_name_ch1": "normal tissue from duodenal cancer patient(Case 4)"}, {"characteristics_ch1": "tissue: normal"}]}, {"GSM3024194": [{"title": "case4_duodenum_adenoma_rep1"}, {"type": "RNA"}, {"source_name_ch1": "adenoma tissue from duodenal cancer patient(Case 4)"}, {"characteristics_ch1": "tissue: adenoma"}]}, {"GSM3024195": [{"title": "case4_duodenum_cancer_rep1"}, {"type": "RNA"}, {"source_name_ch1": "cancer tissue from duodenal cancer patient(Case 4)"}, {"characteristics_ch1": "tissue: adenocarcinoma"}]}, {"GSM3024196": [{"title": "case5_duodenum_normal_rep1"}, {"type": "RNA"}, {"source_name_ch1": "normal tissue from duodenal cancer patient(Case 5)"}, {"characteristics_ch1": "tissue: normal"}]}, {"GSM3024197": [{"title": "case5_duodenum_adenoma_rep1"}, {"type": "RNA"}, {"source_name_ch1": "adenoma tissue from duodenal cancer patient(Case 5)"}, {"characteristics_ch1": "tissue: adenoma"}]}, {"GSM3024198": [{"title": "case5_duodenum_cancer_rep1"}, {"type": "RNA"}, {"source_name_ch1": "cancer tissue from duodenal cancer patient(Case 5)"}, {"characteristics_ch1": "tissue: adenocarcinoma"}]}, {"GSM3024199": [{"title": "case6_duodenum_normal_rep1"}, {"type": "RNA"}, {"source_name_ch1": "normal tissue from duodenal cancer patient(Case 6)"}, {"characteristics_ch1": "tissue: normal"}]}, {"GSM3024200": [{"title": "case6_duodenum_adenoma_rep1"}, {"type": "RNA"}, {"source_name_ch1": "adenoma tissue from duodenal cancer patient(Case 6)"}, {"characteristics_ch1": "tissue: adenoma"}]}, {"GSM3024201": [{"title": "case6_duodenum_cancer_rep1"}, {"type": "RNA"}, {"source_name_ch1": "cancer tissue from duodenal cancer patient(Case 6)"}, {"characteristics_ch1": "tissue: adenocarcinoma"}]}, {"GSM3024202": [{"title": "case7_duodenum_normal_rep1"}, {"type": "RNA"}, {"source_name_ch1": "normal tissue from duodenal cancer patient(Case 7)"}, {"characteristics_ch1": "tissue: normal"}]}, {"GSM3024203": [{"title": "case7_duodenum_adenoma_rep1"}, {"type": "RNA"}, {"source_name_ch1": "adenoma tissue from duodenal cancer patient(Case 7)"}, {"characteristics_ch1": "tissue: adenoma"}]}, {"GSM3024204": [{"title": "case7_duodenum_cancer_rep1"}, {"type": "RNA"}, {"source_name_ch1": "cancer tissue from duodenal cancer patient(Case 7)"}, {"characteristics_ch1": "tissue: adenocarcinoma"}]}, {"GSM3024205": [{"title": "case8_duodenum_normal_rep1"}, {"type": "RNA"}, {"source_name_ch1": "normal tissue from duodenal cancer patient(Case 8)"}, {"characteristics_ch1": "tissue: normal"}]}, {"GSM3024206": [{"title": "case8_duodenum_adenoma_rep1"}, {"type": "RNA"}, {"source_name_ch1": "adenoma tissue from duodenal cancer patient(Case 8)"}, {"characteristics_ch1": "tissue: adenoma"}]}, {"GSM3024207": [{"title": "case8_duodenum_cancer_rep1"}, {"type": "RNA"}, {"source_name_ch1": "cancer tissue from duodenal cancer patient(Case 8)"}, {"characteristics_ch1": "tissue: adenocarcinoma"}]}, {"GSM3024208": [{"title": "case9_duodenum_normal_rep1"}, {"type": "RNA"}, {"source_name_ch1": "normal tissue from duodenal cancer patient(Case 9)"}, {"characteristics_ch1": "tissue: normal"}]}, {"GSM3024209": [{"title": "case9_duodenum_adenoma_rep1"}, {"type": "RNA"}, {"source_name_ch1": "adenoma tissue from duodenal cancer patient(Case 9)"}, {"characteristics_ch1": "tissue: adenoma"}]}, {"GSM3024210": [{"title": "case9_duodenum_cancer_rep1"}, {"type": "RNA"}, {"source_name_ch1": "cancer tissue from duodenal cancer patient(Case 9)"}, {"characteristics_ch1": "tissue: adenocarcinoma"}]}, {"GSM3024211": [{"title": "case10_duodenum_normal_rep1"}, {"type": "RNA"}, {"source_name_ch1": "normal tissue from duodenal cancer patient(Case 10)"}, {"characteristics_ch1": "tissue: normal"}]}, {"GSM3024212": [{"title": "case10_duodenum_adenoma_rep1"}, {"type": "RNA"}, {"source_name_ch1": "adenoma tissue from duodenal cancer patient(Case 10)"}, {"characteristics_ch1": "tissue: adenoma"}]}, {"GSM3024213": [{"title": "case10_duodenum_cancer_rep1"}, {"type": "RNA"}, {"source_name_ch1": "cancer tissue from duodenal cancer patient(Case 10)"}, {"characteristics_ch1": "tissue: adenocarcinoma"}]}, {"GSM3024214": [{"title": "case11_duodenum_normal_rep1"}, {"type": "RNA"}, {"source_name_ch1": "normal tissue from duodenal cancer patient(Case 11)"}, {"characteristics_ch1": "tissue: normal"}]}, {"GSM3024215": [{"title": "case11_duodenum_adenoma_rep1"}, {"type": "RNA"}, {"source_name_ch1": "adenoma tissue from duodenal cancer patient(Case 11)"}, {"characteristics_ch1": "tissue: adenoma"}]}, {"GSM3024216": [{"title": "case11_duodenum_cancer_rep1"}, {"type": "RNA"}, {"source_name_ch1": "cancer tissue from duodenal cancer patient(Case 11)"}, {"characteristics_ch1": "tissue: adenocarcinoma"}]}, {"GSM3024217": [{"title": "case12_duodenum_normal_rep1"}, {"type": "RNA"}, {"source_name_ch1": "normal tissue from duodenal cancer patient(Case 12)"}, {"characteristics_ch1": "tissue: normal"}]}, {"GSM3024218": [{"title": "case12_duodenum_adenoma_rep1"}, {"type": "RNA"}, {"source_name_ch1": "adenoma tissue from duodenal cancer patient(Case 12)"}, {"characteristics_ch1": "tissue: adenoma"}]}, {"GSM3024219": [{"title": "case12_duodenum_cancer_rep1"}, {"type": "RNA"}, {"source_name_ch1": "cancer tissue from duodenal cancer patient(Case 12)"}, {"characteristics_ch1": "tissue: adenocarcinoma"}]}, {"GSM3024220": [{"title": "control1_duodenum_adenoma_rep1"}, {"type": "RNA"}, {"source_name_ch1": "adenoma tissue from duodenal polyposis patient(Control 1)"}, {"characteristics_ch1": "tissue: adenoma"}]}, {"GSM3024221": [{"title": "control2_duodenum_adenoma_rep1"}, {"type": "RNA"}, {"source_name_ch1": "adenoma tissue from duodenal polyposis patient(Control 2)"}, {"characteristics_ch1": "tissue: adenoma"}]}, {"GSM3024222": [{"title": "control3_duodenum_adenoma_rep1"}, {"type": "RNA"}, {"source_name_ch1": "adenoma tissue from duodenal polyposis patient(Control 3)"}, {"characteristics_ch1": "tissue: adenoma"}]}, {"GSM3024223": [{"title": "control4_duodenum_adenoma_rep1"}, {"type": "RNA"}, {"source_name_ch1": "adenoma tissue from duodenal polyposis patient(Control 4)"}, {"characteristics_ch1": "tissue: adenoma"}]}, {"GSM3024224": [{"title": "control5_duodenum_adenoma_rep1"}, {"type": "RNA"}, {"source_name_ch1": "adenoma tissue from duodenal polyposis patient(Control 5)"}, {"characteristics_ch1": "tissue: adenoma"}]}, {"GSM3024225": [{"title": "control6_duodenum_adenoma_rep1"}, {"type": "RNA"}, {"source_name_ch1": "adenoma tissue from duodenal polyposis patient(Control 6)"}, {"characteristics_ch1": "tissue: adenoma"}]}, {"GSM3024226": [{"title": "control7_duodenum_adenoma_rep1"}, {"type": "RNA"}, {"source_name_ch1": "adenoma tissue from duodenal polyposis patient(Control 7)"}, {"characteristics_ch1": "tissue: adenoma"}]}, {"GSM3024227": [{"title": "control8_duodenum_adenoma_rep1"}, {"type": "RNA"}, {"source_name_ch1": "adenoma tissue from duodenal polyposis patient(Control 8)"}, {"characteristics_ch1": "tissue: adenoma"}]}, {"GSM3024228": [{"title": "control9_duodenum_adenoma_rep1"}, {"type": "RNA"}, {"source_name_ch1": "adenoma tissue from duodenal polyposis patient(Control 9)"}, {"characteristics_ch1": "tissue: adenoma"}]}, {"GSM3024229": [{"title": "control10_duodenum_adenoma_rep1"}, {"type": "RNA"}, {"source_name_ch1": "adenoma tissue from duodenal polyposis patient(Control 10)"}, {"characteristics_ch1": "tissue: adenoma"}]}, {"GSM3024230": [{"title": "control11_duodenum_adenoma_rep1"}, {"type": "RNA"}, {"source_name_ch1": "adenoma tissue from duodenal polyposis patient(Control 11)"}, {"characteristics_ch1": "tissue: adenoma"}]}, {"GSM3024231": [{"title": "control12_duodenum_adenoma_rep1"}, {"type": "RNA"}, {"source_name_ch1": "adenoma tissue from duodenal polyposis patient(Control 12)"}, {"characteristics_ch1": "tissue: adenoma"}]}, {"GSM3034037": [{"title": "1Ma: muscle RNA_baseline_1"}, {"type": "RNA"}, {"source_name_ch1": "muscle, pretraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 27;\theight: 1.81;\tbody weight: 84.8;\ttissue: vastus lateralis (leg muscle);\tvo2peak (l/min): 4.127;\tvo2peak (ml/min/kg): 48.7"}]}, {"GSM3034038": [{"title": "2Ma: muscle RNA_baseline_2"}, {"type": "RNA"}, {"source_name_ch1": "muscle, pretraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 19;\theight: 1.91;\tbody weight: 100.6;\ttissue: vastus lateralis (leg muscle);\tvo2peak (l/min): 5.230;\tvo2peak (ml/min/kg): 52.0"}]}, {"GSM3034039": [{"title": "6Ma: muscle RNA_baseline_6"}, {"type": "RNA"}, {"source_name_ch1": "muscle, pretraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 30;\theight: 1.79;\tbody weight: 71.7;\ttissue: vastus lateralis (leg muscle);\tvo2peak (l/min): 3.568;\tvo2peak (ml/min/kg): 49.8"}]}, {"GSM3034040": [{"title": "8Ma: muscle RNA_baseline_8"}, {"type": "RNA"}, {"source_name_ch1": "muscle, pretraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 21;\theight: 1.90;\tbody weight: 70.3;\ttissue: vastus lateralis (leg muscle);\tvo2peak (l/min): 3.843;\tvo2peak (ml/min/kg): 54.7"}]}, {"GSM3034041": [{"title": "9Ma: muscle RNA_baseline_9"}, {"type": "RNA"}, {"source_name_ch1": "muscle, pretraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 27;\theight: 1.81;\tbody weight: 95.8;\ttissue: vastus lateralis (leg muscle);\tvo2peak (l/min): 4.559;\tvo2peak (ml/min/kg): 47.6"}]}, {"GSM3034042": [{"title": "10Ma: muscle RNA_baseline_10"}, {"type": "RNA"}, {"source_name_ch1": "muscle, pretraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 29;\theight: 1.65;\tbody weight: 72.6;\ttissue: vastus lateralis (leg muscle);\tvo2peak (l/min): 3.144;\tvo2peak (ml/min/kg): 43.3"}]}, {"GSM3034043": [{"title": "12Ma: muscle RNA_baseline_12"}, {"type": "RNA"}, {"source_name_ch1": "muscle, pretraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 28;\theight: 1.77;\tbody weight: 85.1;\ttissue: vastus lateralis (leg muscle);\tvo2peak (l/min): 4.379;\tvo2peak (ml/min/kg): 51.5"}]}, {"GSM3034044": [{"title": "13Ma: muscle RNA_baseline_13"}, {"type": "RNA"}, {"source_name_ch1": "muscle, pretraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 28;\theight: 1.64;\tbody weight: 56.9;\ttissue: vastus lateralis (leg muscle);\tvo2peak (l/min): 3.249;\tvo2peak (ml/min/kg): 57.1"}]}, {"GSM3034045": [{"title": "14Ma: muscle RNA_baseline_14"}, {"type": "RNA"}, {"source_name_ch1": "muscle, pretraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 28;\theight: 1.73;\tbody weight: 89.0;\ttissue: vastus lateralis (leg muscle);\tvo2peak (l/min): 3.802;\tvo2peak (ml/min/kg): 42.7"}]}, {"GSM3034046": [{"title": "16Ma: muscle RNA_baseline_16"}, {"type": "RNA"}, {"source_name_ch1": "muscle, pretraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 30;\theight: 1.74;\tbody weight: 76.8;\ttissue: vastus lateralis (leg muscle);\tvo2peak (l/min): 3.691;\tvo2peak (ml/min/kg): 48.1"}]}, {"GSM3034047": [{"title": "18Ma: muscle RNA_baseline_18"}, {"type": "RNA"}, {"source_name_ch1": "muscle, pretraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 29;\theight: 1.68;\tbody weight: 67.4;\ttissue: vastus lateralis (leg muscle);\tvo2peak (l/min): 3.069;\tvo2peak (ml/min/kg): 45.5"}]}, {"GSM3034048": [{"title": "19Ma: muscle RNA_baseline_19"}, {"type": "RNA"}, {"source_name_ch1": "muscle, pretraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 25;\theight: 1.67;\tbody weight: 65.4;\ttissue: vastus lateralis (leg muscle);\tvo2peak (l/min): 3.152;\tvo2peak (ml/min/kg): 48.2"}]}, {"GSM3034049": [{"title": "20Ma: muscle RNA_baseline_20"}, {"type": "RNA"}, {"source_name_ch1": "muscle, pretraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 19;\theight: 1.69;\tbody weight: 70.4;\ttissue: vastus lateralis (leg muscle);\tvo2peak (l/min): 3.487;\tvo2peak (ml/min/kg): 49.5"}]}, {"GSM3034050": [{"title": "1Mb: muscle RNA_posttraining_1"}, {"type": "RNA"}, {"source_name_ch1": "muscle, posttraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 27;\theight: 1.81;\tbody weight: 84.8;\ttissue: vastus lateralis (leg muscle);\tvo2peak (l/min): 4.571;\tvo2peak (ml/min/kg): 56.7"}]}, {"GSM3034051": [{"title": "2Mb: muscle RNA_posttraining_2"}, {"type": "RNA"}, {"source_name_ch1": "muscle, posttraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 19;\theight: 1.91;\tbody weight: 100.6;\ttissue: vastus lateralis (leg muscle);\tvo2peak (l/min): 5.328;\tvo2peak (ml/min/kg): 56.9"}]}, {"GSM3034052": [{"title": "6Mb: muscle RNA_posttraining_6"}, {"type": "RNA"}, {"source_name_ch1": "muscle, posttraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 30;\theight: 1.79;\tbody weight: 71.7;\ttissue: vastus lateralis (leg muscle);\tvo2peak (l/min): 3.849;\tvo2peak (ml/min/kg): 55.2"}]}, {"GSM3034053": [{"title": "8Mb: muscle RNA_posttraining_8"}, {"type": "RNA"}, {"source_name_ch1": "muscle, posttraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 21;\theight: 1.90;\tbody weight: 70.3;\ttissue: vastus lateralis (leg muscle);\tvo2peak (l/min): 4.390;\tvo2peak (ml/min/kg): 61.3"}]}, {"GSM3034054": [{"title": "9Mb: muscle RNA_posttraining_9"}, {"type": "RNA"}, {"source_name_ch1": "muscle, posttraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 27;\theight: 1.81;\tbody weight: 95.8;\ttissue: vastus lateralis (leg muscle);\tvo2peak (l/min): 5.191;\tvo2peak (ml/min/kg): 56.5"}]}, {"GSM3034055": [{"title": "10Mb: muscle RNA_posttraining_10"}, {"type": "RNA"}, {"source_name_ch1": "muscle, posttraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 29;\theight: 1.65;\tbody weight: 72.6;\ttissue: vastus lateralis (leg muscle);\tvo2peak (l/min): 3.791;\tvo2peak (ml/min/kg): 51.5"}]}, {"GSM3034056": [{"title": "12Mb: muscle RNA_posttraining_12"}, {"type": "RNA"}, {"source_name_ch1": "muscle, posttraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 28;\theight: 1.77;\tbody weight: 85.1;\ttissue: vastus lateralis (leg muscle);\tvo2peak (l/min): 5.271;\tvo2peak (ml/min/kg): 60.0"}]}, {"GSM3034057": [{"title": "13Mb: muscle RNA_posttraining_13"}, {"type": "RNA"}, {"source_name_ch1": "muscle, posttraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 28;\theight: 1.64;\tbody weight: 56.9;\ttissue: vastus lateralis (leg muscle);\tvo2peak (l/min): 3.778;\tvo2peak (ml/min/kg): 67.7"}]}, {"GSM3034058": [{"title": "14Mb: muscle RNA_posttraining_14"}, {"type": "RNA"}, {"source_name_ch1": "muscle, posttraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 28;\theight: 1.73;\tbody weight: 89.0;\ttissue: vastus lateralis (leg muscle);\tvo2peak (l/min): 4.073;\tvo2peak (ml/min/kg): 45.5"}]}, {"GSM3034059": [{"title": "16Mb: muscle RNA_posttraining_16"}, {"type": "RNA"}, {"source_name_ch1": "muscle, posttraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 30;\theight: 1.74;\tbody weight: 76.8;\ttissue: vastus lateralis (leg muscle);\tvo2peak (l/min): 4.473;\tvo2peak (ml/min/kg): 59.2"}]}, {"GSM3034060": [{"title": "18Mb: muscle RNA_posttraining_18"}, {"type": "RNA"}, {"source_name_ch1": "muscle, posttraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 29;\theight: 1.68;\tbody weight: 67.4;\ttissue: vastus lateralis (leg muscle);\tvo2peak (l/min): 3.644;\tvo2peak (ml/min/kg): 56.1"}]}, {"GSM3034061": [{"title": "19Mb: muscle RNA_posttraining_19"}, {"type": "RNA"}, {"source_name_ch1": "muscle, posttraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 25;\theight: 1.67;\tbody weight: 65.4;\ttissue: vastus lateralis (leg muscle);\tvo2peak (l/min): 3.509;\tvo2peak (ml/min/kg): 52.1"}]}, {"GSM3034062": [{"title": "20Mb: muscle RNA_posttraining_20"}, {"type": "RNA"}, {"source_name_ch1": "muscle, posttraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 19;\theight: 1.69;\tbody weight: 70.4;\ttissue: vastus lateralis (leg muscle);\tvo2peak (l/min): 4.089;\tvo2peak (ml/min/kg): 56.0"}]}, {"GSM3034063": [{"title": "1Pa: PBMC RNA_baseline_1"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs, pretraining, resting state"}, {"characteristics_ch1": "tissue: peripheral blood mononuclear cells (PBMCs);\tgender: male;\tage: 27;\theight: 1.81;\tbody weight: 84.8;\tvo2peak (l/min): 4.127;\tvo2peak (ml/min/kg): 48.7"}]}, {"GSM3034064": [{"title": "2Pa: PBMC RNA_baseline_2"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs, pretraining, resting state"}, {"characteristics_ch1": "tissue: peripheral blood mononuclear cells (PBMCs);\tgender: male;\tage: 19;\theight: 1.91;\tbody weight: 100.6;\tvo2peak (l/min): 5.230;\tvo2peak (ml/min/kg): 52.0"}]}, {"GSM3034065": [{"title": "3Pa: PBMC RNA_baseline_3"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs, pretraining, resting state"}, {"characteristics_ch1": "tissue: peripheral blood mononuclear cells (PBMCs);\tgender: male;\tage: 21;\theight: 1.77;\tbody weight: 80.0;\tvo2peak (l/min): 3.968;\tvo2peak (ml/min/kg): 49.6"}]}, {"GSM3034066": [{"title": "6Pa: PBMC RNA_baseline_4"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs, pretraining, resting state"}, {"characteristics_ch1": "tissue: peripheral blood mononuclear cells (PBMCs);\tgender: male;\tage: 30;\theight: 1.79;\tbody weight: 71.7;\tvo2peak (l/min): 3.568;\tvo2peak (ml/min/kg): 49.8"}]}, {"GSM3034067": [{"title": "7Pa: PBMC RNA_baseline_5"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs, pretraining, resting state"}, {"characteristics_ch1": "tissue: peripheral blood mononuclear cells (PBMCs);\tgender: male;\tage: 22;\theight: 1.78;\tbody weight: 66.9;\tvo2peak (l/min): 3.280;\tvo2peak (ml/min/kg): 49.0"}]}, {"GSM3034068": [{"title": "8Pa: PBMC RNA_baseline_6"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs, pretraining, resting state"}, {"characteristics_ch1": "tissue: peripheral blood mononuclear cells (PBMCs);\tgender: male;\tage: 21;\theight: 1.90;\tbody weight: 70.3;\tvo2peak (l/min): 3.843;\tvo2peak (ml/min/kg): 54.7"}]}, {"GSM3034069": [{"title": "9Pa: PBMC RNA_baseline_7"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs, pretraining, resting state"}, {"characteristics_ch1": "tissue: peripheral blood mononuclear cells (PBMCs);\tgender: male;\tage: 27;\theight: 1.81;\tbody weight: 95.8;\tvo2peak (l/min): 4.559;\tvo2peak (ml/min/kg): 47.6"}]}, {"GSM3034070": [{"title": "10Pa: PBMC RNA_baseline_8"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs, pretraining, resting state"}, {"characteristics_ch1": "tissue: peripheral blood mononuclear cells (PBMCs);\tgender: male;\tage: 29;\theight: 1.65;\tbody weight: 72.6;\tvo2peak (l/min): 3.144;\tvo2peak (ml/min/kg): 43.3"}]}, {"GSM3034071": [{"title": "12Pa: PBMC RNA_baseline_9"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs, pretraining, resting state"}, {"characteristics_ch1": "tissue: peripheral blood mononuclear cells (PBMCs);\tgender: male;\tage: 28;\theight: 1.77;\tbody weight: 85.1;\tvo2peak (l/min): 4.379;\tvo2peak (ml/min/kg): 51.5"}]}, {"GSM3034072": [{"title": "13Pa: PBMC RNA_baseline_10"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs, pretraining, resting state"}, {"characteristics_ch1": "tissue: peripheral blood mononuclear cells (PBMCs);\tgender: male;\tage: 28;\theight: 1.64;\tbody weight: 56.9;\tvo2peak (l/min): 3.249;\tvo2peak (ml/min/kg): 57.1"}]}, {"GSM3034073": [{"title": "14Pa: PBMC RNA_baseline_11"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs, pretraining, resting state"}, {"characteristics_ch1": "tissue: peripheral blood mononuclear cells (PBMCs);\tgender: male;\tage: 28;\theight: 1.73;\tbody weight: 89.0;\tvo2peak (l/min): 3.802;\tvo2peak (ml/min/kg): 42.7"}]}, {"GSM3034074": [{"title": "15Pa: PBMC RNA_baseline_12"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs, pretraining, resting state"}, {"characteristics_ch1": "tissue: peripheral blood mononuclear cells (PBMCs);\tgender: male;\tage: 27;\theight: 1.68;\tbody weight: 55.3;\tvo2peak (l/min): 2.870;\tvo2peak (ml/min/kg): 51.9"}]}, {"GSM3034075": [{"title": "16Pa: PBMC RNA_baseline_13"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs, pretraining, resting state"}, {"characteristics_ch1": "tissue: peripheral blood mononuclear cells (PBMCs);\tgender: male;\tage: 30;\theight: 1.74;\tbody weight: 76.8;\tvo2peak (l/min): 3.691;\tvo2peak (ml/min/kg): 48.1"}]}, {"GSM3034076": [{"title": "17Pa: PBMC RNA_baseline_14"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs, pretraining, resting state"}, {"characteristics_ch1": "tissue: peripheral blood mononuclear cells (PBMCs);\tgender: male;\tage: 22;\theight: 1.84;\tbody weight: 95.5;\tvo2peak (l/min): 4.925;\tvo2peak (ml/min/kg): 51.6"}]}, {"GSM3034077": [{"title": "18Pa: PBMC RNA_baseline_15"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs, pretraining, resting state"}, {"characteristics_ch1": "tissue: peripheral blood mononuclear cells (PBMCs);\tgender: male;\tage: 29;\theight: 1.68;\tbody weight: 67.4;\tvo2peak (l/min): 3.069;\tvo2peak (ml/min/kg): 45.5"}]}, {"GSM3034078": [{"title": "19Pa: PBMC RNA_baseline_16"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs, pretraining, resting state"}, {"characteristics_ch1": "tissue: peripheral blood mononuclear cells (PBMCs);\tgender: male;\tage: 25;\theight: 1.67;\tbody weight: 65.4;\tvo2peak (l/min): 3.152;\tvo2peak (ml/min/kg): 48.2"}]}, {"GSM3034079": [{"title": "1Pb: PBMC RNA_posttraining_1"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs, pretraining, resting state"}, {"characteristics_ch1": "tissue: peripheral blood mononuclear cells (PBMCs);\tgender: male;\tage: 27;\theight: 1.81;\tbody weight: 80.6;\tvo2peak (l/min): 4.571;\tvo2peak (ml/min/kg): 56.7"}]}, {"GSM3034080": [{"title": "2Pb: PBMC RNA_posttraining_2"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs, pretraining, resting state"}, {"characteristics_ch1": "tissue: peripheral blood mononuclear cells (PBMCs);\tgender: male;\tage: 19;\theight: 1.91;\tbody weight: 93.6;\tvo2peak (l/min): 5.328;\tvo2peak (ml/min/kg): 56.9"}]}, {"GSM3034081": [{"title": "3Pb: PBMC RNA_posttraining_3"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs, pretraining, resting state"}, {"characteristics_ch1": "tissue: peripheral blood mononuclear cells (PBMCs);\tgender: male;\tage: 21;\theight: 1.77;\tbody weight: 83.0;\tvo2peak (l/min): 4.045;\tvo2peak (ml/min/kg): 48.7"}]}, {"GSM3034082": [{"title": "6Pb: PBMC RNA_posttraining_4"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs, pretraining, resting state"}, {"characteristics_ch1": "tissue: peripheral blood mononuclear cells (PBMCs);\tgender: male;\tage: 30;\theight: 1.79;\tbody weight: 69.7;\tvo2peak (l/min): 3.849;\tvo2peak (ml/min/kg): 55.2"}]}, {"GSM3034083": [{"title": "7Pb: PBMC RNA_posttraining_5"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs, pretraining, resting state"}, {"characteristics_ch1": "tissue: peripheral blood mononuclear cells (PBMCs);\tgender: male;\tage: 22;\theight: 1.78;\tbody weight: 66.3;\tvo2peak (l/min): 4.060;\tvo2peak (ml/min/kg): 61.2"}]}, {"GSM3034084": [{"title": "8Pb: PBMC RNA_posttraining_6"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs, pretraining, resting state"}, {"characteristics_ch1": "tissue: peripheral blood mononuclear cells (PBMCs);\tgender: male;\tage: 21;\theight: 1.90;\tbody weight: 71.6;\tvo2peak (l/min): 4.390;\tvo2peak (ml/min/kg): 61.3"}]}, {"GSM3034085": [{"title": "9Pb: PBMC RNA_posttraining_7"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs, posttraining, resting state"}, {"characteristics_ch1": "tissue: peripheral blood mononuclear cells (PBMCs);\tgender: male;\tage: 27;\theight: 1.81;\tbody weight: 91.9;\tvo2peak (l/min): 5.191;\tvo2peak (ml/min/kg): 56.5"}]}, {"GSM3034086": [{"title": "10Pb: PBMC RNA_posttraining_8"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs, posttraining, resting state"}, {"characteristics_ch1": "tissue: peripheral blood mononuclear cells (PBMCs);\tgender: male;\tage: 29;\theight: 1.65;\tbody weight: 73.6;\tvo2peak (l/min): 3.791;\tvo2peak (ml/min/kg): 51.5"}]}, {"GSM3034087": [{"title": "12Pb: PBMC RNA_posttraining_9"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs, posttraining, resting state"}, {"characteristics_ch1": "tissue: peripheral blood mononuclear cells (PBMCs);\tgender: male;\tage: 28;\theight: 1.77;\tbody weight: 87.8;\tvo2peak (l/min): 5.271;\tvo2peak (ml/min/kg): 60.0"}]}, {"GSM3034088": [{"title": "13Pb: PBMC RNA_posttraining_10"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs, posttraining, resting state"}, {"characteristics_ch1": "tissue: peripheral blood mononuclear cells (PBMCs);\tgender: male;\tage: 28;\theight: 1.64;\tbody weight: 55.8;\tvo2peak (l/min): 3.778;\tvo2peak (ml/min/kg): 67.7"}]}, {"GSM3034089": [{"title": "14Pb: PBMC RNA_posttraining_11"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs, posttraining, resting state"}, {"characteristics_ch1": "tissue: peripheral blood mononuclear cells (PBMCs);\tgender: male;\tage: 28;\theight: 1.73;\tbody weight: 89.6;\tvo2peak (l/min): 4.073;\tvo2peak (ml/min/kg): 45.5"}]}, {"GSM3034090": [{"title": "15Pb: PBMC RNA_posttraining_12"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs, posttraining, resting state"}, {"characteristics_ch1": "tissue: peripheral blood mononuclear cells (PBMCs);\tgender: male;\tage: 27;\theight: 1.68;\tbody weight: 56.4;\tvo2peak (l/min): 3.444;\tvo2peak (ml/min/kg): 61.1"}]}, {"GSM3034091": [{"title": "16Pb: PBMC RNA_posttraining_13"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs, posttraining, resting state"}, {"characteristics_ch1": "tissue: peripheral blood mononuclear cells (PBMCs);\tgender: male;\tage: 30;\theight: 1.74;\tbody weight: 75.6;\tvo2peak (l/min): 4.473;\tvo2peak (ml/min/kg): 59.2"}]}, {"GSM3034092": [{"title": "17Pb: PBMC RNA_posttraining_14"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs, posttraining, resting state"}, {"characteristics_ch1": "tissue: peripheral blood mononuclear cells (PBMCs);\tgender: male;\tage: 22;\theight: 1.84;\tbody weight: 92.3;\tvo2peak (l/min): 5.068;\tvo2peak (ml/min/kg): 54.9"}]}, {"GSM3034093": [{"title": "18Pb: PBMC RNA_posttraining_15"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs, posttraining, resting state"}, {"characteristics_ch1": "tissue: peripheral blood mononuclear cells (PBMCs);\tgender: male;\tage: 29;\theight: 1.68;\tbody weight: 64.9;\tvo2peak (l/min): 3.644;\tvo2peak (ml/min/kg): 56.1"}]}, {"GSM3034094": [{"title": "19Pb: PBMC RNA_posttraining_16"}, {"type": "RNA"}, {"source_name_ch1": "PBMCs, posttraining, resting state"}, {"characteristics_ch1": "tissue: peripheral blood mononuclear cells (PBMCs);\tgender: male;\tage: 25;\theight: 1.67;\tbody weight: 67.3;\tvo2peak (l/min): 3.509;\tvo2peak (ml/min/kg): 52.1"}]}, {"GSM3034095": [{"title": "21Ta: total blood RNA_baseline_21"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, pretraining, resting state"}, {"characteristics_ch1": "tissue: total blood (leukocytes);\tgender: male;\tage: 27;\theight: 1.66;\tbody weight: 84.0"}]}, {"GSM3034096": [{"title": "22Ta: total blood RNA_baseline_22"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, pretraining, resting state"}, {"characteristics_ch1": "tissue: total blood (leukocytes);\tgender: male;\tage: 27;\theight: 1.87;\tbody weight: 95.0"}]}, {"GSM3034097": [{"title": "23Ta: total blood RNA_baseline_23"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, pretraining, resting state"}, {"characteristics_ch1": "tissue: total blood (leukocytes);\tgender: male;\tage: 30;\theight: 1.78;\tbody weight: 88.0"}]}, {"GSM3034098": [{"title": "24Ta: total blood RNA_baseline_24"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, pretraining, resting state"}, {"characteristics_ch1": "tissue: total blood (leukocytes);\tgender: male;\tage: 23;\theight: 1.75;\tbody weight: 89.4"}]}, {"GSM3034099": [{"title": "25Ta: total blood RNA_baseline_25"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, pretraining, resting state"}, {"characteristics_ch1": "tissue: total blood (leukocytes);\tgender: male;\tage: 23;\theight: 2.09;\tbody weight: 107.0"}]}, {"GSM3034100": [{"title": "26Ta: total blood RNA_baseline_26"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, pretraining, resting state"}, {"characteristics_ch1": "tissue: total blood (leukocytes);\tgender: male;\tage: 30;\theight: 1.87;\tbody weight: 79.3"}]}, {"GSM3034101": [{"title": "27Ta: total blood RNA_baseline_27"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, pretraining, resting state"}, {"characteristics_ch1": "tissue: total blood (leukocytes);\tgender: male;\tage: 22;\theight: 1.84;\tbody weight: 74.3"}]}, {"GSM3034102": [{"title": "28Ta: total blood RNA_baseline_28"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, pretraining, resting state"}, {"characteristics_ch1": "tissue: total blood (leukocytes);\tgender: male;\tage: --;\theight: --;\tbody weight: --"}]}, {"GSM3034103": [{"title": "29Ta: total blood RNA_baseline_29"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, pretraining, resting state"}, {"characteristics_ch1": "tissue: total blood (leukocytes);\tgender: male;\tage: 29;\theight: 1.71;\tbody weight: 93.1"}]}, {"GSM3034104": [{"title": "30Ta: total blood RNA_baseline_30"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, pretraining, resting state"}, {"characteristics_ch1": "tissue: total blood (leukocytes);\tgender: male;\tage: 29;\theight: 1.8;\tbody weight: 76.0"}]}, {"GSM3034105": [{"title": "31Ta: total blood RNA_baseline_31"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, pretraining, resting state"}, {"characteristics_ch1": "tissue: total blood (leukocytes);\tgender: male;\tage: 25;\theight: 1.71;\tbody weight: 75.0"}]}, {"GSM3034106": [{"title": "32Ta: total blood RNA_baseline_32"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, pretraining, resting state"}, {"characteristics_ch1": "tissue: total blood (leukocytes);\tgender: male;\tage: 26;\theight: 1.83;\tbody weight: 97.0"}]}, {"GSM3034107": [{"title": "33Ta: total blood RNA_baseline_33"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, pretraining, resting state"}, {"characteristics_ch1": "tissue: total blood (leukocytes);\tgender: male;\tage: 23;\theight: 1.78;\tbody weight: 71.0"}]}, {"GSM3034108": [{"title": "34Ta: total blood RNA_baseline_34"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, pretraining, resting state"}, {"characteristics_ch1": "tissue: total blood (leukocytes);\tgender: male;\tage: 28;\theight: 1.78;\tbody weight: 88.2"}]}, {"GSM3034109": [{"title": "35Ta: total blood RNA_baseline_35"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, pretraining, resting state"}, {"characteristics_ch1": "tissue: total blood (leukocytes);\tgender: male;\tage: 28;\theight: 1.72;\tbody weight: 62.0"}]}, {"GSM3034110": [{"title": "36Ta: total blood RNA_baseline_36"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, pretraining, resting state"}, {"characteristics_ch1": "tissue: total blood (leukocytes);\tgender: male;\tage: 27;\theight: 1.75;\tbody weight: 86.0"}]}, {"GSM3034111": [{"title": "37Ta: total blood RNA_baseline_37"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, pretraining, resting state"}, {"characteristics_ch1": "tissue: total blood (leukocytes);\tgender: male;\tage: 30;\theight: --;\tbody weight: --"}]}, {"GSM3034112": [{"title": "38Ta: total blood RNA_baseline_38"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, pretraining, resting state"}, {"characteristics_ch1": "tissue: total blood (leukocytes);\tgender: male;\tage: 28;\theight: 1.79;\tbody weight: 88.7"}]}, {"GSM3034113": [{"title": "39Ta: total blood RNA_baseline_39"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, pretraining, resting state"}, {"characteristics_ch1": "tissue: total blood (leukocytes);\tgender: male;\tage: 19;\theight: 1.8;\tbody weight: 94.4"}]}, {"GSM3034114": [{"title": "40Ta: total blood RNA_baseline_40"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, pretraining, resting state"}, {"characteristics_ch1": "tissue: total blood (leukocytes);\tgender: male;\tage: 30;\theight: 1.77;\tbody weight: 89.4"}]}, {"GSM3034115": [{"title": "41Ta: total blood RNA_baseline_41"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, pretraining, resting state"}, {"characteristics_ch1": "tissue: total blood (leukocytes);\tgender: male;\tage: 27;\theight: 1.71;\tbody weight: 71.4"}]}, {"GSM3034116": [{"title": "42Ta: total blood RNA_baseline_42"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, pretraining, resting state"}, {"characteristics_ch1": "tissue: total blood (leukocytes);\tgender: male;\tage: 26;\theight: 1.75;\tbody weight: 67.0"}]}, {"GSM3034117": [{"title": "21Tb: total blood RNA_posttraining_21"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, posttraining, resting state"}, {"characteristics_ch1": "tissue: total blood (leukocytes);\tgender: male;\tage: 27;\theight: --;\tbody weight: 83"}]}, {"GSM3034118": [{"title": "22Tb: total blood RNA_posttraining_22"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, posttraining, resting state"}, {"characteristics_ch1": "tissue: total blood (leukocytes);\tgender: male;\tage: 27;\theight: --;\tbody weight: 91.1"}]}, {"GSM3034119": [{"title": "23Tb: total blood RNA_posttraining_23"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, posttraining, resting state"}, {"characteristics_ch1": "tissue: total blood (leukocytes);\tgender: male;\tage: 30;\theight: --;\tbody weight: 81.8"}]}, {"GSM3034120": [{"title": "24Tb: total blood RNA_posttraining_24"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, posttraining, resting state"}, {"characteristics_ch1": "tissue: total blood (leukocytes);\tgender: male;\tage: 23;\theight: --;\tbody weight: 81.8"}]}, {"GSM3034121": [{"title": "25Tb: total blood RNA_posttraining_25"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, posttraining, resting state"}, {"characteristics_ch1": "tissue: total blood (leukocytes);\tgender: male;\tage: 23;\theight: --;\tbody weight: 101.8"}]}, {"GSM3034122": [{"title": "26Tb: total blood RNA_posttraining_26"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, posttraining, resting state"}, {"characteristics_ch1": "tissue: total blood (leukocytes);\tgender: male;\tage: 30;\theight: --;\tbody weight: 79.5"}]}, {"GSM3034123": [{"title": "27Tb: total blood RNA_posttraining_27"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, posttraining, resting state"}, {"characteristics_ch1": "tissue: total blood (leukocytes);\tgender: male;\tage: 22;\theight: --;\tbody weight: 71.1"}]}, {"GSM3034124": [{"title": "28Tb: total blood RNA_posttraining_28"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, posttraining, resting state"}, {"characteristics_ch1": "tissue: total blood (leukocytes);\tgender: male;\tage: --;\theight: --;\tbody weight: --"}]}, {"GSM3034125": [{"title": "29Tb: total blood RNA_posttraining_29"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, posttraining, resting state"}, {"characteristics_ch1": "tissue: total blood (leukocytes);\tgender: male;\tage: 29;\theight: --;\tbody weight: 89"}]}, {"GSM3034126": [{"title": "30Tb: total blood RNA_posttraining_30"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, posttraining, resting state"}, {"characteristics_ch1": "tissue: total blood (leukocytes);\tgender: male;\tage: 29;\theight: --;\tbody weight: 72.1"}]}, {"GSM3034127": [{"title": "31Tb: total blood RNA_posttraining_31"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, posttraining, resting state"}, {"characteristics_ch1": "tissue: total blood (leukocytes);\tgender: male;\tage: 25;\theight: --;\tbody weight: 70.2"}]}, {"GSM3034128": [{"title": "32Tb: total blood RNA_posttraining_32"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, posttraining, resting state"}, {"characteristics_ch1": "tissue: total blood (leukocytes);\tgender: male;\tage: 26;\theight: --;\tbody weight: 93.1"}]}, {"GSM3034129": [{"title": "33Tb: total blood RNA_posttraining_33"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, posttraining, resting state"}, {"characteristics_ch1": "tissue: total blood (leukocytes);\tgender: male;\tage: 23;\theight: --;\tbody weight: 68.5"}]}, {"GSM3034130": [{"title": "34Tb: total blood RNA_posttraining_34"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, posttraining, resting state"}, {"characteristics_ch1": "tissue: total blood (leukocytes);\tgender: male;\tage: 28;\theight: --;\tbody weight: 86.8"}]}, {"GSM3034131": [{"title": "35Tb: total blood RNA_posttraining_35"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, posttraining, resting state"}, {"characteristics_ch1": "tissue: total blood (leukocytes);\tgender: male;\tage: 28;\theight: --;\tbody weight: 62.2"}]}, {"GSM3034132": [{"title": "36Tb: total blood RNA_posttraining_36"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, posttraining, resting state"}, {"characteristics_ch1": "tissue: total blood (leukocytes);\tgender: male;\tage: 27;\theight: --;\tbody weight: 85.9"}]}, {"GSM3034133": [{"title": "37Tb: total blood RNA_posttraining_37"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, posttraining, resting state"}, {"characteristics_ch1": "tissue: total blood (leukocytes);\tgender: male;\tage: 30;\theight: --;\tbody weight: 88.1"}]}, {"GSM3034134": [{"title": "38Tb: total blood RNA_posttraining_38"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, posttraining, resting state"}, {"characteristics_ch1": "tissue: total blood (leukocytes);\tgender: male;\tage: 28;\theight: --;\tbody weight: 84.7"}]}, {"GSM3034135": [{"title": "39Tb: total blood RNA_posttraining_39"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, posttraining, resting state"}, {"characteristics_ch1": "tissue: total blood (leukocytes);\tgender: male;\tage: 19;\theight: --;\tbody weight: 91.7"}]}, {"GSM3034136": [{"title": "40Tb: total blood RNA_posttraining_40"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, posttraining, resting state"}, {"characteristics_ch1": "tissue: total blood (leukocytes);\tgender: male;\tage: 30;\theight: --;\tbody weight: 81.9"}]}, {"GSM3034137": [{"title": "41Tb: total blood RNA_posttraining_41"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, posttraining, resting state"}, {"characteristics_ch1": "tissue: total blood (leukocytes);\tgender: male;\tage: 27;\theight: --;\tbody weight: 69.7"}]}, {"GSM3034138": [{"title": "42Tb: total blood RNA_posttraining_42"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, posttraining, resting state"}, {"characteristics_ch1": "tissue: total blood (leukocytes);\tgender: male;\tage: 26;\theight: --;\tbody weight: 69.1"}]}, {"GSM3034139": [{"title": "1Ta: total blood RNA_baseline_1"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, pretraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 27;\theight: 1.81;\tbody weight: 84.8;\ttissue: total blood (leukocytes);\tvo2peak (l/min): 4.127;\tvo2peak (ml/min/kg): 48.7"}]}, {"GSM3034140": [{"title": "2Ta: total blood RNA_baseline_2"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, pretraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 19;\theight: 1.91;\tbody weight: 100.6;\ttissue: total blood (leukocytes);\tvo2peak (l/min): 5.230;\tvo2peak (ml/min/kg): 52.0"}]}, {"GSM3034141": [{"title": "3Ta: total blood RNA_baseline_3"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, pretraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 21;\theight: 1.77;\tbody weight: 80.0;\ttissue: total blood (leukocytes);\tvo2peak (l/min): 3.968;\tvo2peak (ml/min/kg): 49.6"}]}, {"GSM3034142": [{"title": "4Ta: total blood RNA_baseline_4"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, pretraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 28;\theight: 1.68;\tbody weight: 57.1;\ttissue: total blood (leukocytes);\tvo2peak (l/min): 3.003;\tvo2peak (ml/min/kg): 52.6"}]}, {"GSM3034143": [{"title": "5Ta: total blood RNA_baseline_5"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, pretraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 25;\theight: 1.70;\tbody weight: 79.9;\ttissue: total blood (leukocytes);\tvo2peak (l/min): 3.409;\tvo2peak (ml/min/kg): 42.7"}]}, {"GSM3034144": [{"title": "6Ta: total blood RNA_baseline_6"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, pretraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 30;\theight: 1.79;\tbody weight: 71.7;\ttissue: total blood (leukocytes);\tvo2peak (l/min): 3.568;\tvo2peak (ml/min/kg): 49.8"}]}, {"GSM3034145": [{"title": "7Ta: total blood RNA_baseline_7"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, pretraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 22;\theight: 1.78;\tbody weight: 66.9;\ttissue: total blood (leukocytes);\tvo2peak (l/min): 3.280;\tvo2peak (ml/min/kg): 49.0"}]}, {"GSM3034146": [{"title": "8Ta: total blood RNA_baseline_8"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, pretraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 21;\theight: 1.90;\tbody weight: 70.3;\ttissue: total blood (leukocytes);\tvo2peak (l/min): 3.843;\tvo2peak (ml/min/kg): 54.7"}]}, {"GSM3034147": [{"title": "9Ta: total blood RNA_baseline_9"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, pretraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 27;\theight: 1.81;\tbody weight: 95.8;\ttissue: total blood (leukocytes);\tvo2peak (l/min): 4.559;\tvo2peak (ml/min/kg): 47.6"}]}, {"GSM3034148": [{"title": "10Ta: total blood RNA_baseline_10"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, pretraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 29;\theight: 1.65;\tbody weight: 72.6;\ttissue: total blood (leukocytes);\tvo2peak (l/min): 3.144;\tvo2peak (ml/min/kg): 43.3"}]}, {"GSM3034149": [{"title": "11Ta: total blood RNA_baseline_11"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, pretraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 29;\theight: 1.72;\tbody weight: 77.6;\ttissue: total blood (leukocytes);\tvo2peak (l/min): 3.616;\tvo2peak (ml/min/kg): 46.6"}]}, {"GSM3034150": [{"title": "12Ta: total blood RNA_baseline_12"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, pretraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 28;\theight: 1.77;\tbody weight: 85.1;\ttissue: total blood (leukocytes);\tvo2peak (l/min): 4.379;\tvo2peak (ml/min/kg): 51.5"}]}, {"GSM3034151": [{"title": "13Ta: total blood RNA_baseline_13"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, pretraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 28;\theight: 1.64;\tbody weight: 56.9;\ttissue: total blood (leukocytes);\tvo2peak (l/min): 3.249;\tvo2peak (ml/min/kg): 57.1"}]}, {"GSM3034152": [{"title": "14Ta: total blood RNA_baseline_14"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, pretraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 28;\theight: 1.73;\tbody weight: 89.0;\ttissue: total blood (leukocytes);\tvo2peak (l/min): 3.802;\tvo2peak (ml/min/kg): 42.7"}]}, {"GSM3034153": [{"title": "15Ta: total blood RNA_baseline_15"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, pretraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 27;\theight: 1.68;\tbody weight: 55.3;\ttissue: total blood (leukocytes);\tvo2peak (l/min): 2.870;\tvo2peak (ml/min/kg): 51.9"}]}, {"GSM3034154": [{"title": "16Ta: total blood RNA_baseline_16"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, pretraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 30;\theight: 1.74;\tbody weight: 76.8;\ttissue: total blood (leukocytes);\tvo2peak (l/min): 3.691;\tvo2peak (ml/min/kg): 48.1"}]}, {"GSM3034155": [{"title": "17Ta: total blood RNA_baseline_17"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, pretraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 22;\theight: 1.84;\tbody weight: 95.5;\ttissue: total blood (leukocytes);\tvo2peak (l/min): 4.925;\tvo2peak (ml/min/kg): 51.6"}]}, {"GSM3034156": [{"title": "18Ta: total blood RNA_baseline_18"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, pretraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 29;\theight: 1.68;\tbody weight: 67.4;\ttissue: total blood (leukocytes);\tvo2peak (l/min): 3.069;\tvo2peak (ml/min/kg): 45.5"}]}, {"GSM3034157": [{"title": "19Ta: total blood RNA_baseline_19"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, pretraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 25;\theight: 1.67;\tbody weight: 65.4;\ttissue: total blood (leukocytes);\tvo2peak (l/min): 3.152;\tvo2peak (ml/min/kg): 48.2"}]}, {"GSM3034158": [{"title": "20Ta: total blood RNA_baseline_20"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, pretraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 19;\theight: 1.69;\tbody weight: 70.4;\ttissue: total blood (leukocytes);\tvo2peak (l/min): 3.487;\tvo2peak (ml/min/kg): 49.5"}]}, {"GSM3034159": [{"title": "1Tb: total blood RNA_posttraining_1"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, posttraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 27;\theight: 1.81;\tbody weight: 84.8;\ttissue: total blood (leukocytes);\tvo2peak (l/min): 4.571;\tvo2peak (ml/min/kg): 56.7"}]}, {"GSM3034160": [{"title": "2Tb: total blood RNA_posttraining_2"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, posttraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 19;\theight: 1.91;\tbody weight: 100.6;\ttissue: total blood (leukocytes);\tvo2peak (l/min): 5.328;\tvo2peak (ml/min/kg): 56.9"}]}, {"GSM3034161": [{"title": "3Tb: total blood RNA_posttraining_3"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, posttraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 21;\theight: 1.77;\tbody weight: 80.0;\ttissue: total blood (leukocytes);\tvo2peak (l/min): 4.045;\tvo2peak (ml/min/kg): 48.7"}]}, {"GSM3034162": [{"title": "4Tb: total blood RNA_posttraining_4"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, posttraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 28;\theight: 1.68;\tbody weight: 57.1;\ttissue: total blood (leukocytes);\tvo2peak (l/min): 3.728;\tvo2peak (ml/min/kg): 63.0"}]}, {"GSM3034163": [{"title": "5Tb: total blood RNA_posttraining_5"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, posttraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 25;\theight: 1.70;\tbody weight: 79.9;\ttissue: total blood (leukocytes);\tvo2peak (l/min): 4.208;\tvo2peak (ml/min/kg): 54.2"}]}, {"GSM3034164": [{"title": "6Tb: total blood RNA_posttraining_6"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, posttraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 30;\theight: 1.79;\tbody weight: 71.7;\ttissue: total blood (leukocytes);\tvo2peak (l/min): 3.849;\tvo2peak (ml/min/kg): 55.2"}]}, {"GSM3034165": [{"title": "7Tb: total blood RNA_posttraining_7"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, posttraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 22;\theight: 1.78;\tbody weight: 66.9;\ttissue: total blood (leukocytes);\tvo2peak (l/min): 4.060;\tvo2peak (ml/min/kg): 61.2"}]}, {"GSM3034166": [{"title": "8Tb: total blood RNA_posttraining_8"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, posttraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 21;\theight: 1.90;\tbody weight: 70.3;\ttissue: total blood (leukocytes);\tvo2peak (l/min): 4.390;\tvo2peak (ml/min/kg): 61.3"}]}, {"GSM3034167": [{"title": "9Tb: total blood RNA_posttraining_9"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, posttraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 27;\theight: 1.81;\tbody weight: 95.8;\ttissue: total blood (leukocytes);\tvo2peak (l/min): 5.191;\tvo2peak (ml/min/kg): 56.5"}]}, {"GSM3034168": [{"title": "10Tb: total blood RNA_posttraining_10"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, posttraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 29;\theight: 1.65;\tbody weight: 72.6;\ttissue: total blood (leukocytes);\tvo2peak (l/min): 3.791;\tvo2peak (ml/min/kg): 51.5"}]}, {"GSM3034169": [{"title": "11Tb: total blood RNA_posttraining_11"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, posttraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 29;\theight: 1.72;\tbody weight: 77.6;\ttissue: total blood (leukocytes);\tvo2peak (l/min): 4.234;\tvo2peak (ml/min/kg): 54.7"}]}, {"GSM3034170": [{"title": "12Tb: total blood RNA_posttraining_12"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, posttraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 28;\theight: 1.77;\tbody weight: 85.1;\ttissue: total blood (leukocytes);\tvo2peak (l/min): 5.271;\tvo2peak (ml/min/kg): 60.0"}]}, {"GSM3034171": [{"title": "13Tb: total blood RNA_posttraining_13"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, posttraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 28;\theight: 1.64;\tbody weight: 56.9;\ttissue: total blood (leukocytes);\tvo2peak (l/min): 3.778;\tvo2peak (ml/min/kg): 67.7"}]}, {"GSM3034172": [{"title": "14Tb: total blood RNA_posttraining_14"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, posttraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 28;\theight: 1.73;\tbody weight: 89.0;\ttissue: total blood (leukocytes);\tvo2peak (l/min): 4.073;\tvo2peak (ml/min/kg): 45.5"}]}, {"GSM3034173": [{"title": "15Tb: total blood RNA_posttraining_15"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, posttraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 27;\theight: 1.68;\tbody weight: 55.3;\ttissue: total blood (leukocytes);\tvo2peak (l/min): 3.444;\tvo2peak (ml/min/kg): 61.1"}]}, {"GSM3034174": [{"title": "16Tb: total blood RNA_posttraining_16"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, posttraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 30;\theight: 1.74;\tbody weight: 76.8;\ttissue: total blood (leukocytes);\tvo2peak (l/min): 4.473;\tvo2peak (ml/min/kg): 59.2"}]}, {"GSM3034175": [{"title": "17Tb: total blood RNA_posttraining_17"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, posttraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 22;\theight: 1.84;\tbody weight: 95.5;\ttissue: total blood (leukocytes);\tvo2peak (l/min): 5.068;\tvo2peak (ml/min/kg): 54.9"}]}, {"GSM3034176": [{"title": "18Tb: total blood RNA_posttraining_18"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, posttraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 29;\theight: 1.68;\tbody weight: 67.4;\ttissue: total blood (leukocytes);\tvo2peak (l/min): 3.644;\tvo2peak (ml/min/kg): 56.1"}]}, {"GSM3034177": [{"title": "19Tb: total blood RNA_posttraining_19"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, posttraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 25;\theight: 1.67;\tbody weight: 65.4;\ttissue: total blood (leukocytes);\tvo2peak (l/min): 3.509;\tvo2peak (ml/min/kg): 52.1"}]}, {"GSM3034178": [{"title": "20Tb: total blood RNA_posttraining_20"}, {"type": "RNA"}, {"source_name_ch1": "PAX gene blood, posttraining, resting state"}, {"characteristics_ch1": "gender: male;\tage: 19;\theight: 1.69;\tbody weight: 70.4;\ttissue: total blood (leukocytes);\tvo2peak (l/min): 4.089;\tvo2peak (ml/min/kg): 56.0"}]}, {"GSM3034536": [{"title": "Peruvian NTL, Patient 093"}, {"type": "RNA"}, {"source_name_ch1": "NTL tissues with clear cell foci"}, {"characteristics_ch1": "subject status: Peruvian patients with hepatocellular carcinoma (HCC);\tsubject id: Patient 093;\ttissue: Non-tumoral liver (NTL) tissue;\tclear cell foci: Positive"}]}, {"GSM3034537": [{"title": "Peruvian NTL, Patient 099"}, {"type": "RNA"}, {"source_name_ch1": "NTL tissues without clear cell foci"}, {"characteristics_ch1": "subject status: Peruvian patients with hepatocellular carcinoma (HCC);\tsubject id: Patient 099;\ttissue: Non-tumoral liver (NTL) tissue;\tclear cell foci: Negative"}]}, {"GSM3034538": [{"title": "Peruvian NTL, Patient 101"}, {"type": "RNA"}, {"source_name_ch1": "NTL tissues with clear cell foci"}, {"characteristics_ch1": "subject status: Peruvian patients with hepatocellular carcinoma (HCC);\tsubject id: Patient 101;\ttissue: Non-tumoral liver (NTL) tissue;\tclear cell foci: Positive"}]}, {"GSM3034539": [{"title": "Peruvian NTL, Patient 104"}, {"type": "RNA"}, {"source_name_ch1": "NTL tissues without clear cell foci"}, {"characteristics_ch1": "subject status: Peruvian patients with hepatocellular carcinoma (HCC);\tsubject id: Patient 104;\ttissue: Non-tumoral liver (NTL) tissue;\tclear cell foci: Negative"}]}, {"GSM3034540": [{"title": "Peruvian NTL, Patient 106"}, {"type": "RNA"}, {"source_name_ch1": "NTL tissues without clear cell foci"}, {"characteristics_ch1": "subject status: Peruvian patients with hepatocellular carcinoma (HCC);\tsubject id: Patient 106;\ttissue: Non-tumoral liver (NTL) tissue;\tclear cell foci: Negative"}]}, {"GSM3034541": [{"title": "Peruvian NTL, Patient 109"}, {"type": "RNA"}, {"source_name_ch1": "NTL tissues with clear cell foci"}, {"characteristics_ch1": "subject status: Peruvian patients with hepatocellular carcinoma (HCC);\tsubject id: Patient 109;\ttissue: Non-tumoral liver (NTL) tissue;\tclear cell foci: Positive"}]}, {"GSM3034542": [{"title": "Peruvian NTL, Patient 120"}, {"type": "RNA"}, {"source_name_ch1": "NTL tissues with clear cell foci"}, {"characteristics_ch1": "subject status: Peruvian patients with hepatocellular carcinoma (HCC);\tsubject id: Patient 120;\ttissue: Non-tumoral liver (NTL) tissue;\tclear cell foci: Positive"}]}, {"GSM3034543": [{"title": "Peruvian NTL, Patient 179"}, {"type": "RNA"}, {"source_name_ch1": "NTL tissues with clear cell foci"}, {"characteristics_ch1": "subject status: Peruvian patients with hepatocellular carcinoma (HCC);\tsubject id: Patient 179;\ttissue: Non-tumoral liver (NTL) tissue;\tclear cell foci: Positive"}]}, {"GSM3034544": [{"title": "Peruvian NTL, Patient 180"}, {"type": "RNA"}, {"source_name_ch1": "NTL tissues with clear cell foci"}, {"characteristics_ch1": "subject status: Peruvian patients with hepatocellular carcinoma (HCC);\tsubject id: Patient 180;\ttissue: Non-tumoral liver (NTL) tissue;\tclear cell foci: Positive"}]}, {"GSM3058115": [{"title": "RH30 vector, replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "RH30 cells, vector"}, {"characteristics_ch1": "cell line: RH30;\tcell type: Rhabdomyosarcoma"}]}, {"GSM3058116": [{"title": "RH30 vector, replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "RH30 cells, vector"}, {"characteristics_ch1": "cell line: RH30;\tcell type: Rhabdomyosarcoma"}]}, {"GSM3058117": [{"title": "RH30 vector, replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "RH30 cells, vector"}, {"characteristics_ch1": "cell line: RH30;\tcell type: Rhabdomyosarcoma"}]}, {"GSM3058118": [{"title": "RH30 SR, replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "RH30 cells, SR"}, {"characteristics_ch1": "cell line: RH30;\tcell type: Rhabdomyosarcoma"}]}, {"GSM3058119": [{"title": "RH30 SR, replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "RH30 cells, SR"}, {"characteristics_ch1": "cell line: RH30;\tcell type: Rhabdomyosarcoma"}]}, {"GSM3058120": [{"title": "RH30 SR, replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "RH30 cells, SR"}, {"characteristics_ch1": "cell line: RH30;\tcell type: Rhabdomyosarcoma"}]}, {"GSM3083163": [{"title": "PB CD1c (1)"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood"}, {"characteristics_ch1": "tissue: PB;\tcell type: DC;\tcell population: CD1c"}]}, {"GSM3083164": [{"title": "PB CD141high (2)"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood"}, {"characteristics_ch1": "tissue: PB;\tcell type: DC;\tcell population: CD141high"}]}, {"GSM3083165": [{"title": "PB Slan DC (3)"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood"}, {"characteristics_ch1": "tissue: PB;\tcell type: DC;\tcell population: SlanDC"}]}, {"GSM3083166": [{"title": "PB CD1c (4)"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood"}, {"characteristics_ch1": "tissue: PB;\tcell type: DC;\tcell population: CD1c"}]}, {"GSM3083167": [{"title": "PB CD141 high (5)"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood"}, {"characteristics_ch1": "tissue: PB;\tcell type: DC;\tcell population: CD141high"}]}, {"GSM3083168": [{"title": "PB Slan DC (6)"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood"}, {"characteristics_ch1": "tissue: PB;\tcell type: DC;\tcell population: SlanDC"}]}, {"GSM3083169": [{"title": "PB CD1c (7)"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood"}, {"characteristics_ch1": "tissue: PB;\tcell type: DC;\tcell population: CD1c"}]}, {"GSM3083170": [{"title": "PB CD141 high (8)"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood"}, {"characteristics_ch1": "tissue: PB;\tcell type: DC;\tcell population: CD141high"}]}, {"GSM3083171": [{"title": "PB Slan DC (9)"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood"}, {"characteristics_ch1": "tissue: PB;\tcell type: DC;\tcell population: SlanDC"}]}, {"GSM3083172": [{"title": "PB CD1c (10)"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood"}, {"characteristics_ch1": "tissue: PB;\tcell type: DC;\tcell population: CD1c"}]}, {"GSM3083173": [{"title": "PB CD141 high (11)"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood"}, {"characteristics_ch1": "tissue: PB;\tcell type: DC;\tcell population: CD141high"}]}, {"GSM3083174": [{"title": "PB Slan DC (12)"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood"}, {"characteristics_ch1": "tissue: PB;\tcell type: DC;\tcell population: SlanDC"}]}, {"GSM3083175": [{"title": "BM CD141 high (13)"}, {"type": "RNA"}, {"source_name_ch1": "Bone Marrow"}, {"characteristics_ch1": "tissue: BM;\tcell type: DC;\tcell population: CD141high"}]}, {"GSM3083176": [{"title": "BM CD1c (14)"}, {"type": "RNA"}, {"source_name_ch1": "Bone Marrow"}, {"characteristics_ch1": "tissue: BM;\tcell type: DC;\tcell population: CD1c"}]}, {"GSM3083177": [{"title": "BM Slan DC (15)"}, {"type": "RNA"}, {"source_name_ch1": "Bone Marrow"}, {"characteristics_ch1": "tissue: BM;\tcell type: DC;\tcell population: SlanDC"}]}, {"GSM3083178": [{"title": "BM CD1c (17)"}, {"type": "RNA"}, {"source_name_ch1": "Bone Marrow"}, {"characteristics_ch1": "tissue: BM;\tcell type: DC;\tcell population: CD1c"}]}, {"GSM3083179": [{"title": "BM CD141 high (18)"}, {"type": "RNA"}, {"source_name_ch1": "Bone Marrow"}, {"characteristics_ch1": "tissue: BM;\tcell type: DC;\tcell population: CD141high"}]}, {"GSM3083180": [{"title": "BM Slan DC (19)"}, {"type": "RNA"}, {"source_name_ch1": "Bone Marrow"}, {"characteristics_ch1": "tissue: BM;\tcell type: DC;\tcell population: SlanDC"}]}, {"GSM3083181": [{"title": "BM Slan DC (21)"}, {"type": "RNA"}, {"source_name_ch1": "Bone Marrow"}, {"characteristics_ch1": "tissue: BM;\tcell type: DC;\tcell population: SlanDC"}]}, {"GSM3083182": [{"title": "BM CD141 high (22)"}, {"type": "RNA"}, {"source_name_ch1": "Bone Marrow"}, {"characteristics_ch1": "tissue: BM;\tcell type: DC;\tcell population: CD141high"}]}, {"GSM3083183": [{"title": "BM CD1c (24)"}, {"type": "RNA"}, {"source_name_ch1": "Bone Marrow"}, {"characteristics_ch1": "tissue: BM;\tcell type: DC;\tcell population: CD1c"}]}, {"GSM3083184": [{"title": "BM Slan DC (26)"}, {"type": "RNA"}, {"source_name_ch1": "Bone Marrow"}, {"characteristics_ch1": "tissue: BM;\tcell type: DC;\tcell population: SlanDC"}]}, {"GSM3083185": [{"title": "BM CD1c (27)"}, {"type": "RNA"}, {"source_name_ch1": "Bone Marrow"}, {"characteristics_ch1": "tissue: BM;\tcell type: DC;\tcell population: CD1c"}]}, {"GSM3083186": [{"title": "BM CD141 high (28)"}, {"type": "RNA"}, {"source_name_ch1": "Bone Marrow"}, {"characteristics_ch1": "tissue: BM;\tcell type: DC;\tcell population: CD141high"}]}, {"GSM3098116": [{"title": "GSC20_shNT"}, {"type": "RNA"}, {"source_name_ch1": "GSC_shNT"}, {"characteristics_ch1": "cell line: GSC20;\tcell type: Glioma stem cells (GSCs);\tgenotype/variation: shNT"}]}, {"GSM3098117": [{"title": "GSC20_shCD109"}, {"type": "RNA"}, {"source_name_ch1": "GSC_shCD109"}, {"characteristics_ch1": "cell line: GSC20;\tcell type: Glioma stem cells (GSCs);\tgenotype/variation: shCD109"}]}, {"GSM3098118": [{"title": "GSC185_shNT"}, {"type": "RNA"}, {"source_name_ch1": "GSC_shNT"}, {"characteristics_ch1": "cell line: GSC185;\tcell type: Glioma stem cells (GSCs);\tgenotype/variation: shNT"}]}, {"GSM3098119": [{"title": "GSC185_shCD109"}, {"type": "RNA"}, {"source_name_ch1": "GSC_shCD109"}, {"characteristics_ch1": "cell line: GSC185;\tcell type: Glioma stem cells (GSCs);\tgenotype/variation: shCD109"}]}, {"GSM3103247": [{"title": "shControl 1_Rep_1"}, {"type": "RNA"}, {"source_name_ch1": "HNC cells H157"}, {"characteristics_ch1": "genotype/variation: PAK2 Control"}]}, {"GSM3103248": [{"title": "shControl 2_Rep_2"}, {"type": "RNA"}, {"source_name_ch1": "HNC cells H157"}, {"characteristics_ch1": "genotype/variation: PAK2 Control"}]}, {"GSM3103249": [{"title": "shPAK2 1_Rep_1"}, {"type": "RNA"}, {"source_name_ch1": "HNC cells H157"}, {"characteristics_ch1": "genotype/variation: PAK2 knockdown"}]}, {"GSM3103250": [{"title": "shPAK2 2_Rep_2"}, {"type": "RNA"}, {"source_name_ch1": "HNC cells H157"}, {"characteristics_ch1": "genotype/variation: PAK2 knockdown"}]}, {"GSM3120075": [{"title": "Sample_10"}, {"type": "RNA"}, {"source_name_ch1": "Maternal Blood"}, {"characteristics_ch1": "individual: mi548;\tgroup: TIL [Term in Labor (with labor)];\tgestational age: 26"}]}, {"GSM3120076": [{"title": "Sample_11"}, {"type": "RNA"}, {"source_name_ch1": "Maternal Blood"}, {"characteristics_ch1": "individual: mi548;\tgroup: TIL [Term in Labor (with labor)];\tgestational age: 34.7"}]}, {"GSM3120077": [{"title": "Sample_12"}, {"type": "RNA"}, {"source_name_ch1": "Maternal Blood"}, {"characteristics_ch1": "individual: mi548;\tgroup: TIL [Term in Labor (with labor)];\tgestational age: 40"}]}, {"GSM3120078": [{"title": "Sample_13"}, {"type": "RNA"}, {"source_name_ch1": "Maternal Blood"}, {"characteristics_ch1": "individual: mi334;\tgroup: TIL [Term in Labor (with labor)];\tgestational age: 18.9"}]}, {"GSM3120079": [{"title": "Sample_14"}, {"type": "RNA"}, {"source_name_ch1": "Maternal Blood"}, {"characteristics_ch1": "individual: mi334;\tgroup: TIL [Term in Labor (with labor)];\tgestational age: 33.9"}]}, {"GSM3120080": [{"title": "Sample_15"}, {"type": "RNA"}, {"source_name_ch1": "Maternal Blood"}, {"characteristics_ch1": "individual: mi334;\tgroup: TIL [Term in Labor (with labor)];\tgestational age: 40"}]}, {"GSM3120081": [{"title": "Sample_18"}, {"type": "RNA"}, {"source_name_ch1": "Maternal Blood"}, {"characteristics_ch1": "individual: mi751;\tgroup: TNL [Term not in labor (without labor)];\tgestational age: 38.9"}]}, {"GSM3120082": [{"title": "Sample_19"}, {"type": "RNA"}, {"source_name_ch1": "Maternal Blood"}, {"characteristics_ch1": "individual: mi708;\tgroup: TNL [Term not in labor (without labor)];\tgestational age: 19.9"}]}, {"GSM3120083": [{"title": "Sample_20"}, {"type": "RNA"}, {"source_name_ch1": "Maternal Blood"}, {"characteristics_ch1": "individual: mi708;\tgroup: TNL [Term not in labor (without labor)];\tgestational age: 29.9"}]}, {"GSM3120084": [{"title": "Sample_21"}, {"type": "RNA"}, {"source_name_ch1": "Maternal Blood"}, {"characteristics_ch1": "individual: mi708;\tgroup: TNL [Term not in labor (without labor)];\tgestational age: 37.3"}]}, {"GSM3120085": [{"title": "Sample_22"}, {"type": "RNA"}, {"source_name_ch1": "Maternal Blood"}, {"characteristics_ch1": "individual: mi323;\tgroup: TNL [Term not in labor (without labor)];\tgestational age: 12.7"}]}, {"GSM3120086": [{"title": "Sample_23"}, {"type": "RNA"}, {"source_name_ch1": "Maternal Blood"}, {"characteristics_ch1": "individual: mi323;\tgroup: TNL [Term not in labor (without labor)];\tgestational age: 25.7"}]}, {"GSM3120087": [{"title": "Sample_24"}, {"type": "RNA"}, {"source_name_ch1": "Maternal Blood"}, {"characteristics_ch1": "individual: mi323;\tgroup: TNL [Term not in labor (without labor)];\tgestational age: 38.7"}]}, {"GSM3120088": [{"title": "Sample_25"}, {"type": "RNA"}, {"source_name_ch1": "Maternal Blood"}, {"characteristics_ch1": "individual: mi695;\tgroup: TNL [Term not in labor (without labor)];\tgestational age: 25.3"}]}, {"GSM3120089": [{"title": "Sample_26"}, {"type": "RNA"}, {"source_name_ch1": "Maternal Blood"}, {"characteristics_ch1": "individual: mi695;\tgroup: TNL [Term not in labor (without labor)];\tgestational age: 34.7"}]}, {"GSM3120090": [{"title": "Sample_27"}, {"type": "RNA"}, {"source_name_ch1": "Maternal Blood"}, {"characteristics_ch1": "individual: mi695;\tgroup: TNL [Term not in labor (without labor)];\tgestational age: 39"}]}, {"GSM3120091": [{"title": "Sample_28"}, {"type": "RNA"}, {"source_name_ch1": "Maternal Blood"}, {"characteristics_ch1": "individual: mi424;\tgroup: TNL [Term not in labor (without labor)];\tgestational age: 19.9"}]}, {"GSM3120092": [{"title": "Sample_29"}, {"type": "RNA"}, {"source_name_ch1": "Maternal Blood"}, {"characteristics_ch1": "individual: mi424;\tgroup: TNL [Term not in labor (without labor)];\tgestational age: 35.1"}]}, {"GSM3120093": [{"title": "Sample_30"}, {"type": "RNA"}, {"source_name_ch1": "Maternal Blood"}, {"characteristics_ch1": "individual: mi424;\tgroup: TNL [Term not in labor (without labor)];\tgestational age: 39.1"}]}, {"GSM3120094": [{"title": "Sample_31"}, {"type": "RNA"}, {"source_name_ch1": "Maternal Blood"}, {"characteristics_ch1": "individual: mi134;\tgroup: TIL [Term in Labor (with labor)];\tgestational age: 39.7"}]}, {"GSM3120095": [{"title": "Sample_32"}, {"type": "RNA"}, {"source_name_ch1": "Maternal Blood"}, {"characteristics_ch1": "individual: mi417;\tgroup: TIL [Term in Labor (with labor)];\tgestational age: 40"}]}, {"GSM3120096": [{"title": "Sample_34"}, {"type": "RNA"}, {"source_name_ch1": "Maternal Blood"}, {"characteristics_ch1": "individual: mi379;\tgroup: TIL [Term in Labor (with labor)];\tgestational age: 38.6"}]}, {"GSM3120097": [{"title": "Sample_36"}, {"type": "RNA"}, {"source_name_ch1": "Maternal Blood"}, {"characteristics_ch1": "individual: mi270;\tgroup: TNL [Term not in labor (without labor)];\tgestational age: 39"}]}, {"GSM3120098": [{"title": "Sample_37"}, {"type": "RNA"}, {"source_name_ch1": "Maternal Blood"}, {"characteristics_ch1": "individual: mi306;\tgroup: TNL [Term not in labor (without labor)];\tgestational age: 38.7"}]}, {"GSM3120099": [{"title": "Sample_38"}, {"type": "RNA"}, {"source_name_ch1": "Maternal Blood"}, {"characteristics_ch1": "individual: mi411;\tgroup: TNL [Term not in labor (without labor)];\tgestational age: 39.3"}]}, {"GSM3120100": [{"title": "Sample_3"}, {"type": "RNA"}, {"source_name_ch1": "Maternal Blood"}, {"characteristics_ch1": "individual: mi609;\tgroup: TIL [Term in Labor (with labor)];\tgestational age: 40.3"}]}, {"GSM3120101": [{"title": "Sample_4"}, {"type": "RNA"}, {"source_name_ch1": "Maternal Blood"}, {"characteristics_ch1": "individual: mi686;\tgroup: TIL [Term in Labor (with labor)];\tgestational age: 18.6"}]}, {"GSM3120102": [{"title": "Sample_5"}, {"type": "RNA"}, {"source_name_ch1": "Maternal Blood"}, {"characteristics_ch1": "individual: mi686;\tgroup: TIL [Term in Labor (with labor)];\tgestational age: 30.6"}]}, {"GSM3120103": [{"title": "Sample_6"}, {"type": "RNA"}, {"source_name_ch1": "Maternal Blood"}, {"characteristics_ch1": "individual: mi686;\tgroup: TIL [Term in Labor (with labor)];\tgestational age: 40.1"}]}, {"GSM3120104": [{"title": "Sample_7"}, {"type": "RNA"}, {"source_name_ch1": "Maternal Blood"}, {"characteristics_ch1": "individual: mi058;\tgroup: TIL [Term in Labor (with labor)];\tgestational age: 12.1"}]}, {"GSM3120105": [{"title": "Sample_8"}, {"type": "RNA"}, {"source_name_ch1": "Maternal Blood"}, {"characteristics_ch1": "individual: mi058;\tgroup: TIL [Term in Labor (with labor)];\tgestational age: 26.1"}]}, {"GSM3120106": [{"title": "Sample_9"}, {"type": "RNA"}, {"source_name_ch1": "Maternal Blood"}, {"characteristics_ch1": "individual: mi058;\tgroup: TIL [Term in Labor (with labor)];\tgestational age: 39.3"}]}, {"GSM3120594": [{"title": "patients 1,2 (pooled) 1 month"}, {"type": "RNA"}, {"source_name_ch1": "Jejunum_1 month after RYGB"}, {"characteristics_ch1": "patients status: Obese patients undergoing RYGB surgery;\tpatients id: patients 1,2 (pooled);\ttime point: 1 month after RYGB;\ttissue: jejunum"}]}, {"GSM3120595": [{"title": "patients 1,2 (pooled) baseline"}, {"type": "RNA"}, {"source_name_ch1": "Jejunum_during RYGB"}, {"characteristics_ch1": "patients status: Obese patients undergoing RYGB surgery;\tpatients id: patients 1,2 (pooled);\ttime point: during RYGB;\ttissue: jejunum"}]}, {"GSM3120596": [{"title": "patients 3,4 (pooled) 1 month"}, {"type": "RNA"}, {"source_name_ch1": "Jejunum_1 month after RYGB"}, {"characteristics_ch1": "patients status: Obese patients undergoing RYGB surgery;\tpatients id: patients 3,4 (pooled);\ttime point: 1 month after RYGB;\ttissue: jejunum"}]}, {"GSM3120597": [{"title": "patients 3,4 (pooled) baseline"}, {"type": "RNA"}, {"source_name_ch1": "Jejunum_during RYGB"}, {"characteristics_ch1": "patients status: Obese patients undergoing RYGB surgery;\tpatients id: patients 3,4 (pooled);\ttime point: during RYGB;\ttissue: jejunum"}]}, {"GSM3120598": [{"title": "patients 5,6 (pooled) 1 month"}, {"type": "RNA"}, {"source_name_ch1": "Jejunum_1 month after RYGB"}, {"characteristics_ch1": "patients status: Obese patients undergoing RYGB surgery;\tpatients id: patients 5,6 (pooled);\ttime point: 1 month after RYGB;\ttissue: jejunum"}]}, {"GSM3120599": [{"title": "patients 5,6 (pooled) baseline"}, {"type": "RNA"}, {"source_name_ch1": "Jejunum_during RYGB"}, {"characteristics_ch1": "patients status: Obese patients undergoing RYGB surgery;\tpatients id: patients 5,6 (pooled);\ttime point: during RYGB;\ttissue: jejunum"}]}, {"GSM3120600": [{"title": "patients 7,8 (pooled) 1 month"}, {"type": "RNA"}, {"source_name_ch1": "Jejunum_1 month after RYGB"}, {"characteristics_ch1": "patients status: Obese patients undergoing RYGB surgery;\tpatients id: patients 7,8 (pooled);\ttime point: 1 month after RYGB;\ttissue: jejunum"}]}, {"GSM3120601": [{"title": "patients 7,8 (pooled) baseline"}, {"type": "RNA"}, {"source_name_ch1": "Jejunum_during RYGB"}, {"characteristics_ch1": "patients status: Obese patients undergoing RYGB surgery;\tpatients id: patients 7,8 (pooled);\ttime point: during RYGB;\ttissue: jejunum"}]}, {"GSM3120602": [{"title": "patients 9,10 (pooled) 1 month"}, {"type": "RNA"}, {"source_name_ch1": "Jejunum_1 month after RYGB"}, {"characteristics_ch1": "patients status: Obese patients undergoing RYGB surgery;\tpatients id: patients 9,10 (pooled);\ttime point: 1 month after RYGB;\ttissue: jejunum"}]}, {"GSM3120603": [{"title": "patients 9,10 (pooled) baseline"}, {"type": "RNA"}, {"source_name_ch1": "Jejunum_during RYGB"}, {"characteristics_ch1": "patients status: Obese patients undergoing RYGB surgery;\tpatients id: patients 9,10 (pooled);\ttime point: during RYGB;\ttissue: jejunum"}]}, {"GSM3141461": [{"title": "Normal, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "granulosa cells from normal patients"}, {"characteristics_ch1": "cell type: granulosa cells;\tSex: female;\tdiagnosis: healthy control"}]}, {"GSM3141462": [{"title": "Normal, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "granulosa cells from normal patients"}, {"characteristics_ch1": "cell type: granulosa cells;\tSex: female;\tdiagnosis: healthy control"}]}, {"GSM3141463": [{"title": "Normal, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "granulosa cells from normal patients"}, {"characteristics_ch1": "cell type: granulosa cells;\tSex: female;\tdiagnosis: healthy control"}]}, {"GSM3141464": [{"title": "PCOS, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "granulosa cells from PCOS patients"}, {"characteristics_ch1": "cell type: granulosa cells;\tSex: female;\tdiagnosis: Polycystic Ovary Syndrome (PCOS)"}]}, {"GSM3141465": [{"title": "PCOS, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "granulosa cells from PCOS patients"}, {"characteristics_ch1": "cell type: granulosa cells;\tSex: female;\tdiagnosis: Polycystic Ovary Syndrome (PCOS)"}]}, {"GSM3141466": [{"title": "PCOS, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "granulosa cells from PCOS patients"}, {"characteristics_ch1": "cell type: granulosa cells;\tSex: female;\tdiagnosis: Polycystic Ovary Syndrome (PCOS)"}]}, {"GSM3141904": [{"title": "HepG2 sh-Vector-1"}, {"type": "RNA"}, {"source_name_ch1": "HepG2 pLKO-Vector stable cell lines treated with 5-Fu for 48h"}, {"characteristics_ch1": "cell line: HepG2;\tgene expression: normal"}]}, {"GSM3141905": [{"title": "HepG2 sh-Vector-2"}, {"type": "RNA"}, {"source_name_ch1": "HepG2 pLKO-Vector stable cell lines treated with 5-Fu for 48h"}, {"characteristics_ch1": "cell line: HepG2;\tgene expression: normal"}]}, {"GSM3141906": [{"title": "HepG2 sh-Vector-3"}, {"type": "RNA"}, {"source_name_ch1": "HepG2 pLKO-Vector stable cell lines treated with 5-Fu for 48h"}, {"characteristics_ch1": "cell line: HepG2;\tgene expression: normal"}]}, {"GSM3141907": [{"title": "HepG2 shSND1-#1-1"}, {"type": "RNA"}, {"source_name_ch1": "HepG2 pLKO-shSND1-#1 stable cell lines treated with 5-Fu for 48h"}, {"characteristics_ch1": "cell line: HepG2;\tgene expression: SND1 knockdown"}]}, {"GSM3141908": [{"title": "HepG2 shSND1-#1-2"}, {"type": "RNA"}, {"source_name_ch1": "HepG2 pLKO-shSND1-#1 stable cell lines treated with 5-Fu for 48h"}, {"characteristics_ch1": "cell line: HepG2;\tgene expression: SND1 knockdown"}]}, {"GSM3141909": [{"title": "HepG2 shSND1-#1-3"}, {"type": "RNA"}, {"source_name_ch1": "HepG2 pLKO-shSND1-#1 stable cell lines treated with 5-Fu for 48h"}, {"characteristics_ch1": "cell line: HepG2;\tgene expression: SND1 knockdown"}]}, {"GSM3143287": [{"title": "U2OS-PLKO.1 DMSO R2"}, {"type": "RNA"}, {"source_name_ch1": "U2OS cells"}, {"characteristics_ch1": "cell line: U2OS cells;\tagent: DMSO"}]}, {"GSM3143288": [{"title": "U2OS-PLKO.1 DMSO R3"}, {"type": "RNA"}, {"source_name_ch1": "U2OS cells"}, {"characteristics_ch1": "cell line: U2OS cells;\tagent: DMSO"}]}, {"GSM3143289": [{"title": "U2OS-PLKO.1 NOC 48h R2"}, {"type": "RNA"}, {"source_name_ch1": "U2OS cells"}, {"characteristics_ch1": "cell line: U2OS cells;\tagent: nocodazole"}]}, {"GSM3143290": [{"title": "U2OS-PLKO.1 NOC 48h R3"}, {"type": "RNA"}, {"source_name_ch1": "U2OS cells"}, {"characteristics_ch1": "cell line: U2OS cells;\tagent: nocodazole"}]}, {"GSM3167527": [{"title": "4014_para-carcinoma"}, {"type": "RNA"}, {"source_name_ch1": "para-carcinoma"}, {"characteristics_ch1": "disease state: luminal (ER+) breast cancer;\ttissue: breast;\tgender: female"}]}, {"GSM3167528": [{"title": "4014_carcinoma"}, {"type": "RNA"}, {"source_name_ch1": "carcinoma"}, {"characteristics_ch1": "disease state: luminal (ER+) breast cancer;\ttissue: breast;\tgender: female"}]}, {"GSM3167529": [{"title": "4133_para-carcinoma"}, {"type": "RNA"}, {"source_name_ch1": "para-carcinoma"}, {"characteristics_ch1": "disease state: luminal (ER+) breast cancer;\ttissue: breast;\tgender: female"}]}, {"GSM3167530": [{"title": "4133_carcinoma"}, {"type": "RNA"}, {"source_name_ch1": "carcinoma"}, {"characteristics_ch1": "disease state: luminal (ER+) breast cancer;\ttissue: breast;\tgender: female"}]}, {"GSM3167531": [{"title": "4171_para-carcinoma"}, {"type": "RNA"}, {"source_name_ch1": "para-carcinoma"}, {"characteristics_ch1": "disease state: luminal (ER+) breast cancer;\ttissue: breast;\tgender: female"}]}, {"GSM3167532": [{"title": "4171_carcinoma"}, {"type": "RNA"}, {"source_name_ch1": "carcinoma"}, {"characteristics_ch1": "disease state: luminal (ER+) breast cancer;\ttissue: breast;\tgender: female"}]}, {"GSM3167533": [{"title": "4185_para-carcinoma"}, {"type": "RNA"}, {"source_name_ch1": "para-carcinoma"}, {"characteristics_ch1": "disease state: luminal (ER+) breast cancer;\ttissue: breast;\tgender: female"}]}, {"GSM3167534": [{"title": "4185_carcinoma"}, {"type": "RNA"}, {"source_name_ch1": "carcinoma"}, {"characteristics_ch1": "disease state: luminal (ER+) breast cancer;\ttissue: breast;\tgender: female"}]}, {"GSM3167535": [{"title": "4198_para-carcinoma"}, {"type": "RNA"}, {"source_name_ch1": "para-carcinoma"}, {"characteristics_ch1": "disease state: luminal (ER+) breast cancer;\ttissue: breast;\tgender: female"}]}, {"GSM3167536": [{"title": "4198_carcinoma"}, {"type": "RNA"}, {"source_name_ch1": "carcinoma"}, {"characteristics_ch1": "disease state: luminal (ER+) breast cancer;\ttissue: breast;\tgender: female"}]}, {"GSM3167537": [{"title": "4230_para-carcinoma"}, {"type": "RNA"}, {"source_name_ch1": "para-carcinoma"}, {"characteristics_ch1": "disease state: luminal (ER+) breast cancer;\ttissue: breast;\tgender: female"}]}, {"GSM3167538": [{"title": "4230_carcinoma"}, {"type": "RNA"}, {"source_name_ch1": "carcinoma"}, {"characteristics_ch1": "disease state: luminal (ER+) breast cancer;\ttissue: breast;\tgender: female"}]}, {"GSM3167539": [{"title": "4232_para-carcinoma"}, {"type": "RNA"}, {"source_name_ch1": "para-carcinoma"}, {"characteristics_ch1": "disease state: luminal (ER+) breast cancer;\ttissue: breast;\tgender: female"}]}, {"GSM3167540": [{"title": "4232_carcinoma"}, {"type": "RNA"}, {"source_name_ch1": "carcinoma"}, {"characteristics_ch1": "disease state: luminal (ER+) breast cancer;\ttissue: breast;\tgender: female"}]}, {"GSM3167541": [{"title": "4235_para-carcinoma"}, {"type": "RNA"}, {"source_name_ch1": "para-carcinoma"}, {"characteristics_ch1": "disease state: luminal (ER+) breast cancer;\ttissue: breast;\tgender: female"}]}, {"GSM3167542": [{"title": "4235_carcinoma"}, {"type": "RNA"}, {"source_name_ch1": "carcinoma"}, {"characteristics_ch1": "disease state: luminal (ER+) breast cancer;\ttissue: breast;\tgender: female"}]}, {"GSM3167543": [{"title": "4288_para-carcinoma"}, {"type": "RNA"}, {"source_name_ch1": "para-carcinoma"}, {"characteristics_ch1": "disease state: luminal (ER+) breast cancer;\ttissue: breast;\tgender: female"}]}, {"GSM3167544": [{"title": "4288_carcinoma"}, {"type": "RNA"}, {"source_name_ch1": "carcinoma"}, {"characteristics_ch1": "disease state: luminal (ER+) breast cancer;\ttissue: breast;\tgender: female"}]}, {"GSM3167545": [{"title": "4290_para-carcinoma"}, {"type": "RNA"}, {"source_name_ch1": "para-carcinoma"}, {"characteristics_ch1": "disease state: luminal (ER+) breast cancer;\ttissue: breast;\tgender: female"}]}, {"GSM3167546": [{"title": "4290_carcinoma"}, {"type": "RNA"}, {"source_name_ch1": "carcinoma"}, {"characteristics_ch1": "disease state: luminal (ER+) breast cancer;\ttissue: breast;\tgender: female"}]}, {"GSM3167547": [{"title": "4315_para-carcinoma"}, {"type": "RNA"}, {"source_name_ch1": "para-carcinoma"}, {"characteristics_ch1": "disease state: luminal (ER+) breast cancer;\ttissue: breast;\tgender: female"}]}, {"GSM3167548": [{"title": "4315_carcinoma"}, {"type": "RNA"}, {"source_name_ch1": "carcinoma"}, {"characteristics_ch1": "disease state: luminal (ER+) breast cancer;\ttissue: breast;\tgender: female"}]}, {"GSM3167549": [{"title": "4383_para-carcinoma"}, {"type": "RNA"}, {"source_name_ch1": "para-carcinoma"}, {"characteristics_ch1": "disease state: luminal (ER+) breast cancer;\ttissue: breast;\tgender: female"}]}, {"GSM3167550": [{"title": "4383_carcinoma"}, {"type": "RNA"}, {"source_name_ch1": "carcinoma"}, {"characteristics_ch1": "disease state: luminal (ER+) breast cancer;\ttissue: breast;\tgender: female"}]}, {"GSM3167551": [{"title": "4411_para-carcinoma"}, {"type": "RNA"}, {"source_name_ch1": "para-carcinoma"}, {"characteristics_ch1": "disease state: luminal (ER+) breast cancer;\ttissue: breast;\tgender: female"}]}, {"GSM3167552": [{"title": "4411_carcinoma"}, {"type": "RNA"}, {"source_name_ch1": "carcinoma"}, {"characteristics_ch1": "disease state: luminal (ER+) breast cancer;\ttissue: breast;\tgender: female"}]}, {"GSM3167553": [{"title": "4473_para-carcinoma"}, {"type": "RNA"}, {"source_name_ch1": "para-carcinoma"}, {"characteristics_ch1": "disease state: luminal (ER+) breast cancer;\ttissue: breast;\tgender: female"}]}, {"GSM3167554": [{"title": "4473_carcinoma"}, {"type": "RNA"}, {"source_name_ch1": "carcinoma"}, {"characteristics_ch1": "disease state: luminal (ER+) breast cancer;\ttissue: breast;\tgender: female"}]}, {"GSM3167555": [{"title": "4486_para-carcinoma"}, {"type": "RNA"}, {"source_name_ch1": "para-carcinoma"}, {"characteristics_ch1": "disease state: luminal (ER+) breast cancer;\ttissue: breast;\tgender: female"}]}, {"GSM3167556": [{"title": "4486_carcinoma"}, {"type": "RNA"}, {"source_name_ch1": "carcinoma"}, {"characteristics_ch1": "disease state: luminal (ER+) breast cancer;\ttissue: breast;\tgender: female"}]}, {"GSM3167557": [{"title": "4493_para-carcinoma"}, {"type": "RNA"}, {"source_name_ch1": "para-carcinoma"}, {"characteristics_ch1": "disease state: luminal (ER+) breast cancer;\ttissue: breast;\tgender: female"}]}, {"GSM3167558": [{"title": "4493_carcinoma"}, {"type": "RNA"}, {"source_name_ch1": "carcinoma"}, {"characteristics_ch1": "disease state: luminal (ER+) breast cancer;\ttissue: breast;\tgender: female"}]}, {"GSM3167559": [{"title": "4511_para-carcinoma"}, {"type": "RNA"}, {"source_name_ch1": "para-carcinoma"}, {"characteristics_ch1": "disease state: luminal (ER+) breast cancer;\ttissue: breast;\tgender: female"}]}, {"GSM3167560": [{"title": "4511_carcinoma"}, {"type": "RNA"}, {"source_name_ch1": "carcinoma"}, {"characteristics_ch1": "disease state: luminal (ER+) breast cancer;\ttissue: breast;\tgender: female"}]}, {"GSM3167561": [{"title": "4514_para-carcinoma"}, {"type": "RNA"}, {"source_name_ch1": "para-carcinoma"}, {"characteristics_ch1": "disease state: luminal (ER+) breast cancer;\ttissue: breast;\tgender: female"}]}, {"GSM3167562": [{"title": "4514_carcinoma"}, {"type": "RNA"}, {"source_name_ch1": "carcinoma"}, {"characteristics_ch1": "disease state: luminal (ER+) breast cancer;\ttissue: breast;\tgender: female"}]}, {"GSM3167563": [{"title": "4618_para-carcinoma"}, {"type": "RNA"}, {"source_name_ch1": "para-carcinoma"}, {"characteristics_ch1": "disease state: luminal (ER+) breast cancer;\ttissue: breast;\tgender: female"}]}, {"GSM3167564": [{"title": "4618_carcinoma"}, {"type": "RNA"}, {"source_name_ch1": "carcinoma"}, {"characteristics_ch1": "disease state: luminal (ER+) breast cancer;\ttissue: breast;\tgender: female"}]}, {"GSM3167565": [{"title": "4632_para-carcinoma"}, {"type": "RNA"}, {"source_name_ch1": "para-carcinoma"}, {"characteristics_ch1": "disease state: luminal (ER+) breast cancer;\ttissue: breast;\tgender: female"}]}, {"GSM3167566": [{"title": "4632_carcinoma"}, {"type": "RNA"}, {"source_name_ch1": "carcinoma"}, {"characteristics_ch1": "disease state: luminal (ER+) breast cancer;\ttissue: breast;\tgender: female"}]}, {"GSM3167567": [{"title": "4640_para-carcinoma"}, {"type": "RNA"}, {"source_name_ch1": "para-carcinoma"}, {"characteristics_ch1": "disease state: luminal (ER+) breast cancer;\ttissue: breast;\tgender: female"}]}, {"GSM3167568": [{"title": "4640_carcinoma"}, {"type": "RNA"}, {"source_name_ch1": "carcinoma"}, {"characteristics_ch1": "disease state: luminal (ER+) breast cancer;\ttissue: breast;\tgender: female"}]}, {"GSM3181773": [{"title": "RT112-CM272-1"}, {"type": "RNA"}, {"source_name_ch1": "RT112 cell line treated with CM272 (IC50) replicate 1"}, {"characteristics_ch1": "cell line: RT112;\ttreatment: CM272 (IC50)"}]}, {"GSM3181774": [{"title": "RT112-CM272-2"}, {"type": "RNA"}, {"source_name_ch1": "RT112 cell line treated with CM272 (IC50) replicate 2"}, {"characteristics_ch1": "cell line: RT112;\ttreatment: CM272 (IC50)"}]}, {"GSM3181775": [{"title": "RT112-CM272-3"}, {"type": "RNA"}, {"source_name_ch1": "RT112 cell line treated with CM272 (IC50) replicate 3"}, {"characteristics_ch1": "cell line: RT112;\ttreatment: CM272 (IC50)"}]}, {"GSM3181776": [{"title": "RT112 C1"}, {"type": "RNA"}, {"source_name_ch1": "RT112 cell line control 1"}, {"characteristics_ch1": "cell line: RT112;\ttreatment: none"}]}, {"GSM3181777": [{"title": "RT112 C2"}, {"type": "RNA"}, {"source_name_ch1": "RT112 cell line control 2"}, {"characteristics_ch1": "cell line: RT112;\ttreatment: none"}]}, {"GSM3181778": [{"title": "RT112 C3"}, {"type": "RNA"}, {"source_name_ch1": "RT112 cell line control 3"}, {"characteristics_ch1": "cell line: RT112;\ttreatment: none"}]}, {"GSM3181779": [{"title": "5637-CM272-1"}, {"type": "RNA"}, {"source_name_ch1": "5637 cell line treated with CM272 (IC50) replicate 1"}, {"characteristics_ch1": "cell line: 5637;\ttreatment: CM272 (IC50)"}]}, {"GSM3181780": [{"title": "5637-CM272-2"}, {"type": "RNA"}, {"source_name_ch1": "5637 cell line treated with CM272 (IC50) replicate 2"}, {"characteristics_ch1": "cell line: 5637;\ttreatment: CM272 (IC50)"}]}, {"GSM3181781": [{"title": "5637-CM272-3"}, {"type": "RNA"}, {"source_name_ch1": "5637 cell line treated with CM272 (IC50) replicate 3"}, {"characteristics_ch1": "cell line: 5637;\ttreatment: CM272 (IC50)"}]}, {"GSM3181782": [{"title": "5637 C1"}, {"type": "RNA"}, {"source_name_ch1": "5637 cell line control 1"}, {"characteristics_ch1": "cell line: 5637;\ttreatment: none"}]}, {"GSM3181783": [{"title": "5637 C2"}, {"type": "RNA"}, {"source_name_ch1": "5637 cell line control 2"}, {"characteristics_ch1": "cell line: 5637;\ttreatment: none"}]}, {"GSM3181784": [{"title": "5637 C3"}, {"type": "RNA"}, {"source_name_ch1": "5637 cell line control 3"}, {"characteristics_ch1": "cell line: 5637;\ttreatment: none"}]}, {"GSM3192079": [{"title": "s13: NTC-DMSO#1"}, {"type": "RNA"}, {"source_name_ch1": "DMSO"}, {"characteristics_ch1": "cell line: HCC4006;\ttissue: Lung cancer cell line"}]}, {"GSM3192080": [{"title": "s14: NTC-DMSO#2"}, {"type": "RNA"}, {"source_name_ch1": "DMSO"}, {"characteristics_ch1": "cell line: HCC4006;\ttissue: Lung cancer cell line"}]}, {"GSM3192081": [{"title": "s15: NTC-DMSO#3"}, {"type": "RNA"}, {"source_name_ch1": "DMSO"}, {"characteristics_ch1": "cell line: HCC4006;\ttissue: Lung cancer cell line"}]}, {"GSM3192082": [{"title": "s22: Notch1-sIRNA-Erlotinib#1"}, {"type": "RNA"}, {"source_name_ch1": "Notch1 KO + Erlotinib"}, {"characteristics_ch1": "cell line: HCC4006;\ttissue: Lung cancer cell line"}]}, {"GSM3192083": [{"title": "s23: Notch1-sIRNA-Erlotinib#2"}, {"type": "RNA"}, {"source_name_ch1": "Notch1 KO + Erlotinib"}, {"characteristics_ch1": "cell line: HCC4006;\ttissue: Lung cancer cell line"}]}, {"GSM3192084": [{"title": "s24: Notch1-sIRNA-Erlotinib#3"}, {"type": "RNA"}, {"source_name_ch1": "Notch1 KO + Erlotinib"}, {"characteristics_ch1": "cell line: HCC4006;\ttissue: Lung cancer cell line"}]}, {"GSM3192085": [{"title": "s25: Notch3-sIRNA-Erlotinib#4"}, {"type": "RNA"}, {"source_name_ch1": "Notch3 KO + Erlotinib"}, {"characteristics_ch1": "cell line: HCC4006;\ttissue: Lung cancer cell line"}]}, {"GSM3192086": [{"title": "s26: Notch3-sIRNA-Erlotinib#5"}, {"type": "RNA"}, {"source_name_ch1": "Notch3 KO + Erlotinib"}, {"characteristics_ch1": "cell line: HCC4006;\ttissue: Lung cancer cell line"}]}, {"GSM3192087": [{"title": "s27: Notch3-sIRNA-Erlotinib#6"}, {"type": "RNA"}, {"source_name_ch1": "Notch3 KO + Erlotinib"}, {"characteristics_ch1": "cell line: HCC4006;\ttissue: Lung cancer cell line"}]}, {"GSM3192088": [{"title": "s31: NTC-Erlotinib#1"}, {"type": "RNA"}, {"source_name_ch1": "Erlotinib"}, {"characteristics_ch1": "cell line: HCC4006;\ttissue: Lung cancer cell line"}]}, {"GSM3192089": [{"title": "s32: NTC-Erlotinib#2"}, {"type": "RNA"}, {"source_name_ch1": "Erlotinib"}, {"characteristics_ch1": "cell line: HCC4006;\ttissue: Lung cancer cell line"}]}, {"GSM3192090": [{"title": "s33: NTC-Erlotinib#3"}, {"type": "RNA"}, {"source_name_ch1": "Erlotinib"}, {"characteristics_ch1": "cell line: HCC4006;\ttissue: Lung cancer cell line"}]}, {"GSM3192091": [{"title": "s4: Notch1-sIRNA-DMSO#1"}, {"type": "RNA"}, {"source_name_ch1": "Notch1 KO"}, {"characteristics_ch1": "cell line: HCC4006;\ttissue: Lung cancer cell line"}]}, {"GSM3192092": [{"title": "s5: Notch1-sIRNA-DMSO#2"}, {"type": "RNA"}, {"source_name_ch1": "Notch1 KO"}, {"characteristics_ch1": "cell line: HCC4006;\ttissue: Lung cancer cell line"}]}, {"GSM3192093": [{"title": "s6: Notch1-sIRNA-DMSO#3"}, {"type": "RNA"}, {"source_name_ch1": "Notch1 KO"}, {"characteristics_ch1": "cell line: HCC4006;\ttissue: Lung cancer cell line"}]}, {"GSM3192094": [{"title": "s7: Notch3-sIRNA-DMSO#1"}, {"type": "RNA"}, {"source_name_ch1": "Notch3 KO"}, {"characteristics_ch1": "cell line: HCC4006;\ttissue: Lung cancer cell line"}]}, {"GSM3192095": [{"title": "s8: Notch3-sIRNA-DMSO#2"}, {"type": "RNA"}, {"source_name_ch1": "Notch3 KO"}, {"characteristics_ch1": "cell line: HCC4006;\ttissue: Lung cancer cell line"}]}, {"GSM3192096": [{"title": "s9: Notch3-sIRNA-DMSO#3"}, {"type": "RNA"}, {"source_name_ch1": "Notch3 KO"}, {"characteristics_ch1": "cell line: HCC4006;\ttissue: Lung cancer cell line"}]}, {"GSM3207052": [{"title": "U3020MG cells transduced with oeCTL"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "patient-derived cell line: U3020MG;\tcell type: Glioblastoma stem-like cells;\tlentiviral vector: oeCTL"}]}, {"GSM3207053": [{"title": "U3020MG cells transduced with oeLGR5"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "patient-derived cell line: U3020MG;\tcell type: Glioblastoma stem-like cells;\tlentiviral vector: oeLGR5"}]}, {"GSM3207054": [{"title": "U3060MG cells transduced with oeCTL"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "patient-derived cell line: U3060MG;\tcell type: Glioblastoma stem-like cells;\tlentiviral vector: oeCTL"}]}, {"GSM3207055": [{"title": "U3060MG cells transduced with oeLGR5"}, {"type": "RNA"}, {"source_name_ch1": "Primary human GBM"}, {"characteristics_ch1": "patient-derived cell line: U3060MG;\tcell type: Glioblastoma stem-like cells;\tlentiviral vector: oeLGR5"}]}, {"GSM3271219": [{"title": "Mock irradiated Human HaCaT cells, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "Human keratinocyte HaCaT cells"}, {"characteristics_ch1": "cell line: HaCaT;\tcell type: keratinocyte cell line;\ttreatment: mock irradiation"}]}, {"GSM3271220": [{"title": "20 Gy X-ray irradiated Human HaCaT cells, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "Human keratinocyte HaCaT cells"}, {"characteristics_ch1": "cell line: HaCaT;\tcell type: keratinocyte cell line;\ttreatment: 20 Gy X-ray irradiation"}]}, {"GSM3271221": [{"title": "Mock irradiated Human HaCaT cells, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "Human keratinocyte HaCaT cells"}, {"characteristics_ch1": "cell line: HaCaT;\tcell type: keratinocyte cell line;\ttreatment: mock irradiation"}]}, {"GSM3271222": [{"title": "20 Gy X-ray irradiated Human HaCaT cells, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "Human keratinocyte HaCaT cells"}, {"characteristics_ch1": "cell line: HaCaT;\tcell type: keratinocyte cell line;\ttreatment: 20 Gy X-ray irradiation"}]}, {"GSM3271223": [{"title": "Mock irradiated Human HaCaT cells, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "Human keratinocyte HaCaT cells"}, {"characteristics_ch1": "cell line: HaCaT;\tcell type: keratinocyte cell line;\ttreatment: mock irradiation"}]}, {"GSM3271224": [{"title": "20 Gy X-ray irradiated Human HaCaT cells, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "Human keratinocyte HaCaT cells"}, {"characteristics_ch1": "cell line: HaCaT;\tcell type: keratinocyte cell line;\ttreatment: 20 Gy X-ray irradiation"}]}, {"GSM3272154": [{"title": "HEK293T_139CWC27_gene_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HEK293T, 139CWC27, rep1"}, {"characteristics_ch1": "cell line: HEK293T"}]}, {"GSM3272155": [{"title": "HEK293T_139CWC27_gene_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HEK293T, 139CWC27, rep2"}, {"characteristics_ch1": "cell line: HEK293T"}]}, {"GSM3272156": [{"title": "HEK293T_139CWC27_gene_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HEK293T, 139CWC27, rep3"}, {"characteristics_ch1": "cell line: HEK293T"}]}, {"GSM3272157": [{"title": "HEK293T_SCR_gene_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HEK293T, SCR, rep1"}, {"characteristics_ch1": "cell line: HEK293T;\tgenotype/variation: SCR control"}]}, {"GSM3272158": [{"title": "HEK293T_SCR_gene_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HEK293T, SCR, rep2"}, {"characteristics_ch1": "cell line: HEK293T;\tgenotype/variation: SCR control"}]}, {"GSM3272159": [{"title": "HEK293T_SCR_gene_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HEK293T, SCR, rep3"}, {"characteristics_ch1": "cell line: HEK293T;\tgenotype/variation: SCR control"}]}, {"GSM3273019": [{"title": "HEK293T_368PPIE_gene_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HEK293T, 368PPIE, rep1"}, {"characteristics_ch1": "cell line: HEK293T"}]}, {"GSM3273020": [{"title": "HEK293T_368PPIE_gene_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HEK293T, 368PPIE, rep2"}, {"characteristics_ch1": "cell line: HEK293T"}]}, {"GSM3273021": [{"title": "HEK293T_368PPIE_gene_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HEK293T, 368PPIE, rep3"}, {"characteristics_ch1": "cell line: HEK293T"}]}, {"GSM3289380": [{"title": "HEK293T_368PPIG_gene_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HEK293T, 368PPIG, rep1"}, {"characteristics_ch1": "cell line: HEK293T"}]}, {"GSM3289381": [{"title": "HEK293T_368PPIG_gene_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HEK293T, 368PPIG, rep2"}, {"characteristics_ch1": "cell line: HEK293T"}]}, {"GSM3289382": [{"title": "HEK293T_368PPIG_gene_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HEK293T, 368PPIG, rep3"}, {"characteristics_ch1": "cell line: HEK293T"}]}, {"GSM3290751": [{"title": "HEK293T 368PPIL3 gene rep1"}, {"type": "RNA"}, {"source_name_ch1": "HEK293T, 185PPIL3, rep1"}, {"characteristics_ch1": "cell line: HEK293T;\tgenotype/variation: PPIL3 knockdown"}]}, {"GSM3290752": [{"title": "HEK293T 368PPIL3 gene rep2"}, {"type": "RNA"}, {"source_name_ch1": "HEK293T, 185PPIL3, rep2"}, {"characteristics_ch1": "cell line: HEK293T;\tgenotype/variation: PPIL3 knockdown"}]}, {"GSM3290753": [{"title": "HEK293T 368PPIL3 gene rep3"}, {"type": "RNA"}, {"source_name_ch1": "HEK293T, 185PPIL3, rep3"}, {"characteristics_ch1": "cell line: HEK293T;\tgenotype/variation: PPIL3 knockdown"}]}, {"GSM3293563": [{"title": "HEK293T_475PPIL2_gene_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HEK293T, 475PPIL2, rep1"}, {"characteristics_ch1": "cell line: HEK293T;\tgenotype/variation: PPIL2 knockdown"}]}, {"GSM3293564": [{"title": "HEK293T_475PPIL2_gene_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HEK293T, 475PPIL2, rep2"}, {"characteristics_ch1": "cell line: HEK293T;\tgenotype/variation: PPIL2 knockdown"}]}, {"GSM3293565": [{"title": "HEK293T_475PPIL2_gene_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HEK293T, 475PPIL2, rep3"}, {"characteristics_ch1": "cell line: HEK293T;\tgenotype/variation: PPIL2 knockdown"}]}, {"GSM3293566": [{"title": "HEK293T_5191SCR_gene_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HEK293T, SCR, rep1"}, {"characteristics_ch1": "cell line: HEK293T;\tgenotype/variation: SCR control"}]}, {"GSM3293567": [{"title": "HEK293T_5191SCR_gene_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HEK293T, SCR, rep2"}, {"characteristics_ch1": "cell line: HEK293T;\tgenotype/variation: SCR control"}]}, {"GSM3293568": [{"title": "HEK293T_5191SCR_gene_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HEK293T, SCR, rep3"}, {"characteristics_ch1": "cell line: HEK293T;\tgenotype/variation: SCR control"}]}, {"GSM3293592": [{"title": "HEK293T_165PPWD1_gene_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HEK293T, 165PPWD1, rep1"}, {"characteristics_ch1": "cell line: HEK293T;\tgenotype/variation: PPWD1 knockdown"}]}, {"GSM3293593": [{"title": "HEK293T_165PPWD1_gene_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HEK293T, 165PPWD1, rep2"}, {"characteristics_ch1": "cell line: HEK293T;\tgenotype/variation: PPWD1 knockdown"}]}, {"GSM3293594": [{"title": "HEK293T_165PPWD1_gene_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HEK293T, 165PPWD1, rep3"}, {"characteristics_ch1": "cell line: HEK293T;\tgenotype/variation: PPWD1 knockdown"}]}, {"GSM3293617": [{"title": "HEK293T_470PPIL1_gene_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HEK293T, 470PPIL1, rep1"}, {"characteristics_ch1": "cell line: HEK293T;\tgenotype/variation: PPIL1 knockdown"}]}, {"GSM3293618": [{"title": "HEK293T_470PPIL1_gene_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HEK293T, 470PPIL1, rep2"}, {"characteristics_ch1": "cell line: HEK293T;\tgenotype/variation: PPIL1 knockdown"}]}, {"GSM3293619": [{"title": "HEK293T_470PPIL1_gene_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HEK293T, 470PPIL1, rep3"}, {"characteristics_ch1": "cell line: HEK293T;\tgenotype/variation: PPIL1 knockdown"}]}, {"GSM3293639": [{"title": "HEK293T_755+769PRPF4_gene_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HEK293T, 755+769PRPF4, rep1"}, {"characteristics_ch1": "cell line: HEK293T;\tgenotype/variation: PRPF4 knockdown"}]}, {"GSM3293640": [{"title": "HEK293T_755+769PRPF4_gene_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HEK293T, 755+769PRPF4, rep2"}, {"characteristics_ch1": "cell line: HEK293T;\tgenotype/variation: PRPF4 knockdown"}]}, {"GSM3293641": [{"title": "HEK293T_755+769PRPF4_gene_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HEK293T, 755+769PRPF4, rep3"}, {"characteristics_ch1": "cell line: HEK293T;\tgenotype/variation: PRPF4 knockdown"}]}, {"GSM3293642": [{"title": "HEK293T_5104SCR_gene_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HEK293T, SCR, rep1"}, {"characteristics_ch1": "cell line: HEK293T;\tgenotype/variation: SCR control"}]}, {"GSM3293643": [{"title": "HEK293T_5104SCR_gene_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HEK293T, SCR, rep2"}, {"characteristics_ch1": "cell line: HEK293T;\tgenotype/variation: SCR control"}]}, {"GSM3293644": [{"title": "HEK293T_5104SCR_gene_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HEK293T, SCR, rep3"}, {"characteristics_ch1": "cell line: HEK293T;\tgenotype/variation: SCR control"}]}, {"GSM3293709": [{"title": "HEK293T_560+198ZNF830_gene_rep1"}, {"type": "RNA"}, {"source_name_ch1": "HEK293T, 560+198ZNF830, rep1"}, {"characteristics_ch1": "cell line: HEK293T;\tgenotype/variation: ZNF830 knockdown"}]}, {"GSM3293710": [{"title": "HEK293T_560+198ZNF830_gene_rep2"}, {"type": "RNA"}, {"source_name_ch1": "HEK293T, 560+198ZNF830, rep2"}, {"characteristics_ch1": "cell line: HEK293T;\tgenotype/variation: ZNF830 knockdown"}]}, {"GSM3293711": [{"title": "HEK293T_560+198ZNF830_gene_rep3"}, {"type": "RNA"}, {"source_name_ch1": "HEK293T, 560+198ZNF830, rep3"}, {"characteristics_ch1": "cell line: HEK293T;\tgenotype/variation: ZNF830 knockdown"}]}, {"GSM3308597": [{"title": "A498 DGAT1/2 shRNA xenograft, control chow, 5 days, biol repl 1"}, {"type": "RNA"}, {"source_name_ch1": "A498 DGAT1/2 shRNA tumor from mouse treated with control chow"}, {"characteristics_ch1": "tissue: A498 xenograft tumor;\tcell type: Clear cell renal cell carcinoma (ccRCC);\ttreatment: vehicle;\tgenotype/variation: wildtype"}]}, {"GSM3308598": [{"title": "A498 DGAT1/2 shRNA xenograft, control chow, 5 days, biol repl 2"}, {"type": "RNA"}, {"source_name_ch1": "A498 DGAT1/2 shRNA tumor from mouse treated with control chow"}, {"characteristics_ch1": "tissue: A498 xenograft tumor;\tcell type: Clear cell renal cell carcinoma (ccRCC);\ttreatment: vehicle;\tgenotype/variation: wildtype"}]}, {"GSM3308599": [{"title": "A498 DGAT1/2 shRNA xenograft, control chow, 5 days, biol repl 3"}, {"type": "RNA"}, {"source_name_ch1": "A498 DGAT1/2 shRNA tumor from mouse treated with control chow"}, {"characteristics_ch1": "tissue: A498 xenograft tumor;\tcell type: Clear cell renal cell carcinoma (ccRCC);\ttreatment: vehicle;\tgenotype/variation: wildtype"}]}, {"GSM3308600": [{"title": "A498 DGAT1/2 shRNA xenograft, control chow, 5 days, biol repl 4"}, {"type": "RNA"}, {"source_name_ch1": "A498 DGAT1/2 shRNA tumor from mouse treated with control chow"}, {"characteristics_ch1": "tissue: A498 xenograft tumor;\tcell type: Clear cell renal cell carcinoma (ccRCC);\ttreatment: vehicle;\tgenotype/variation: wildtype"}]}, {"GSM3308601": [{"title": "A498 DGAT1/2 shRNA xenograft, 200mg/kg doxycycline chow, 5 days, biol repl 1"}, {"type": "RNA"}, {"source_name_ch1": "A498 DGAT1/2 shRNA tumor from mouse treated with 200mg/kg doxycycline chow"}, {"characteristics_ch1": "tissue: A498 xenograft tumor;\tcell type: Clear cell renal cell carcinoma (ccRCC);\ttreatment: doxycycline;\tgenotype/variation: DGAT1/2 knockdown"}]}, {"GSM3308602": [{"title": "A498 DGAT1/2 shRNA xenograft, 200mg/kg doxycycline chow, 5 days, biol repl 2"}, {"type": "RNA"}, {"source_name_ch1": "A498 DGAT1/2 shRNA tumor from mouse treated with 200mg/kg doxycycline chow"}, {"characteristics_ch1": "tissue: A498 xenograft tumor;\tcell type: Clear cell renal cell carcinoma (ccRCC);\ttreatment: doxycycline;\tgenotype/variation: DGAT1/2 knockdown"}]}, {"GSM3308603": [{"title": "A498 DGAT1/2 shRNA xenograft, 200mg/kg doxycycline chow, 5 days, biol repl 3"}, {"type": "RNA"}, {"source_name_ch1": "A498 DGAT1/2 shRNA tumor from mouse treated with 200mg/kg doxycycline chow"}, {"characteristics_ch1": "tissue: A498 xenograft tumor;\tcell type: Clear cell renal cell carcinoma (ccRCC);\ttreatment: doxycycline;\tgenotype/variation: DGAT1/2 knockdown"}]}, {"GSM3308604": [{"title": "A498 DGAT1/2 shRNA xenograft, 200mg/kg doxycycline chow, 5 days, biol repl 4"}, {"type": "RNA"}, {"source_name_ch1": "A498 DGAT1/2 shRNA tumor from mouse treated with 200mg/kg doxycycline chow"}, {"characteristics_ch1": "tissue: A498 xenograft tumor;\tcell type: Clear cell renal cell carcinoma (ccRCC);\ttreatment: doxycycline;\tgenotype/variation: DGAT1/2 knockdown"}]}, {"GSM3308605": [{"title": "A498 DGAT1/2 shRNA cells, vehicle treatment, normoxia, biol repl 1"}, {"type": "RNA"}, {"source_name_ch1": "A498 expressing non-induced DGAT1/2 shRNA construct grown under serum deprivation and normoxia"}, {"characteristics_ch1": "treatment: vehicle;\tcell line: A498;\tcell type: Clear cell renal cell carcinoma (ccRCC);\tgenotype/variation: wildtype;\toxygen levels: normoxia"}]}, {"GSM3308606": [{"title": "A498 DGAT1/2 shRNA cells, vehicle treatment, normoxia, biol repl 2"}, {"type": "RNA"}, {"source_name_ch1": "A498 expressing non-induced DGAT1/2 shRNA construct grown under serum deprivation and normoxia"}, {"characteristics_ch1": "treatment: vehicle;\tcell line: A498;\tcell type: Clear cell renal cell carcinoma (ccRCC);\tgenotype/variation: wildtype;\toxygen levels: normoxia"}]}, {"GSM3308607": [{"title": "A498 DGAT1/2 shRNA cells, vehicle treatment, normoxia, biol repl 3"}, {"type": "RNA"}, {"source_name_ch1": "A498 expressing non-induced DGAT1/2 shRNA construct grown under serum deprivation and normoxia"}, {"characteristics_ch1": "treatment: vehicle;\tcell line: A498;\tcell type: Clear cell renal cell carcinoma (ccRCC);\tgenotype/variation: wildtype;\toxygen levels: normoxia"}]}, {"GSM3308608": [{"title": "A498 DGAT1/2 shRNA cells, vehicle treatment, normoxia, biol repl 4"}, {"type": "RNA"}, {"source_name_ch1": "A498 expressing non-induced DGAT1/2 shRNA construct grown under serum deprivation and normoxia"}, {"characteristics_ch1": "treatment: vehicle;\tcell line: A498;\tcell type: Clear cell renal cell carcinoma (ccRCC);\tgenotype/variation: wildtype;\toxygen levels: normoxia"}]}, {"GSM3308609": [{"title": "A498 DGAT1/2 shRNA cells, vehicle treatment, hypoxia, biol repl 1"}, {"type": "RNA"}, {"source_name_ch1": "A498 expressing non-induced DGAT1/2 shRNA construct grown under serum deprivation and hypoxia"}, {"characteristics_ch1": "treatment: vehicle;\tcell line: A498;\tcell type: Clear cell renal cell carcinoma (ccRCC);\tgenotype/variation: wildtype;\toxygen levels: hypoxia"}]}, {"GSM3308610": [{"title": "A498 DGAT1/2 shRNA cells, vehicle treatment, hypoxia, biol repl 2"}, {"type": "RNA"}, {"source_name_ch1": "A498 expressing non-induced DGAT1/2 shRNA construct grown under serum deprivation and hypoxia"}, {"characteristics_ch1": "treatment: vehicle;\tcell line: A498;\tcell type: Clear cell renal cell carcinoma (ccRCC);\tgenotype/variation: wildtype;\toxygen levels: hypoxia"}]}, {"GSM3308611": [{"title": "A498 DGAT1/2 shRNA cells, vehicle treatment, hypoxia, biol repl 3"}, {"type": "RNA"}, {"source_name_ch1": "A498 expressing non-induced DGAT1/2 shRNA construct grown under serum deprivation and hypoxia"}, {"characteristics_ch1": "treatment: vehicle;\tcell line: A498;\tcell type: Clear cell renal cell carcinoma (ccRCC);\tgenotype/variation: wildtype;\toxygen levels: hypoxia"}]}, {"GSM3308612": [{"title": "A498 DGAT1/2 shRNA cells, vehicle treatment, hypoxia, biol repl 4"}, {"type": "RNA"}, {"source_name_ch1": "A498 expressing non-induced DGAT1/2 shRNA construct grown under serum deprivation and hypoxia"}, {"characteristics_ch1": "treatment: vehicle;\tcell line: A498;\tcell type: Clear cell renal cell carcinoma (ccRCC);\tgenotype/variation: wildtype;\toxygen levels: hypoxia"}]}, {"GSM3308613": [{"title": "A498 DGAT1/2 shRNA cells, doxycycline treatment, normoxia, biol repl 1"}, {"type": "RNA"}, {"source_name_ch1": "A498 expressing induced DGAT1/2 shRNA construct grown under serum deprivation and normoxia"}, {"characteristics_ch1": "treatment: doxycycline;\tcell line: A498;\tcell type: Clear cell renal cell carcinoma (ccRCC);\tgenotype/variation: DGAT1/2 knockdown;\toxygen levels: normoxia"}]}, {"GSM3308614": [{"title": "A498 DGAT1/2 shRNA cells, doxycycline treatment, normoxia, biol repl 2"}, {"type": "RNA"}, {"source_name_ch1": "A498 expressing induced DGAT1/2 shRNA construct grown under serum deprivation and normoxia"}, {"characteristics_ch1": "treatment: doxycycline;\tcell line: A498;\tcell type: Clear cell renal cell carcinoma (ccRCC);\tgenotype/variation: DGAT1/2 knockdown;\toxygen levels: normoxia"}]}, {"GSM3308615": [{"title": "A498 DGAT1/2 shRNA cells, doxycycline treatment, normoxia, biol repl 3"}, {"type": "RNA"}, {"source_name_ch1": "A498 expressing induced DGAT1/2 shRNA construct grown under serum deprivation and normoxia"}, {"characteristics_ch1": "treatment: doxycycline;\tcell line: A498;\tcell type: Clear cell renal cell carcinoma (ccRCC);\tgenotype/variation: DGAT1/2 knockdown;\toxygen levels: normoxia"}]}, {"GSM3308616": [{"title": "A498 DGAT1/2 shRNA cells, doxycycline treatment, normoxia, biol repl 4"}, {"type": "RNA"}, {"source_name_ch1": "A498 expressing induced DGAT1/2 shRNA construct grown under serum deprivation and normoxia"}, {"characteristics_ch1": "treatment: doxycycline;\tcell line: A498;\tcell type: Clear cell renal cell carcinoma (ccRCC);\tgenotype/variation: DGAT1/2 knockdown;\toxygen levels: normoxia"}]}, {"GSM3308617": [{"title": "A498 DGAT1/2 shRNA cells, doxycycline treatment, hypoxia, biol repl 1"}, {"type": "RNA"}, {"source_name_ch1": "A498 expressing induced DGAT1/2 shRNA construct grown under serum deprivation and hypoxia"}, {"characteristics_ch1": "treatment: doxycycline;\tcell line: A498;\tcell type: Clear cell renal cell carcinoma (ccRCC);\tgenotype/variation: DGAT1/2 knockdown;\toxygen levels: hypoxia"}]}, {"GSM3308618": [{"title": "A498 DGAT1/2 shRNA cells, doxycycline treatment, hypoxia, biol repl 2"}, {"type": "RNA"}, {"source_name_ch1": "A498 expressing induced DGAT1/2 shRNA construct grown under serum deprivation and hypoxia"}, {"characteristics_ch1": "treatment: doxycycline;\tcell line: A498;\tcell type: Clear cell renal cell carcinoma (ccRCC);\tgenotype/variation: DGAT1/2 knockdown;\toxygen levels: hypoxia"}]}, {"GSM3308619": [{"title": "A498 DGAT1/2 shRNA cells, doxycycline treatment, hypoxia, biol repl 3"}, {"type": "RNA"}, {"source_name_ch1": "A498 expressing induced DGAT1/2 shRNA construct grown under serum deprivation and hypoxia"}, {"characteristics_ch1": "treatment: doxycycline;\tcell line: A498;\tcell type: Clear cell renal cell carcinoma (ccRCC);\tgenotype/variation: DGAT1/2 knockdown;\toxygen levels: hypoxia"}]}, {"GSM3308620": [{"title": "A498 DGAT1/2 shRNA cells, doxycycline treatment, hypoxia, biol repl 4"}, {"type": "RNA"}, {"source_name_ch1": "A498 expressing induced DGAT1/2 shRNA construct grown under serum deprivation and hypoxia"}, {"characteristics_ch1": "treatment: doxycycline;\tcell line: A498;\tcell type: Clear cell renal cell carcinoma (ccRCC);\tgenotype/variation: DGAT1/2 knockdown;\toxygen levels: hypoxia"}]}, {"GSM3321741": [{"title": "Human islets_control_rep1"}, {"type": "RNA"}, {"source_name_ch1": "pancreatic islets_control"}, {"characteristics_ch1": "gender: male;\tage: 59 years old;\ttissue: pancreatic islets"}]}, {"GSM3321742": [{"title": "Human islets_palmitate_4hours_rep1"}, {"type": "RNA"}, {"source_name_ch1": "pancreatic islets_4hours"}, {"characteristics_ch1": "gender: male;\tage: 59 years old;\ttissue: pancreatic islets"}]}, {"GSM3321743": [{"title": "Human islets_palmitate_12hours_rep1"}, {"type": "RNA"}, {"source_name_ch1": "pancreatic islets_12hours"}, {"characteristics_ch1": "gender: male;\tage: 59 years old;\ttissue: pancreatic islets"}]}, {"GSM3321744": [{"title": "Human islets_palmitate_1day_rep1"}, {"type": "RNA"}, {"source_name_ch1": "pancreatic islets_1day"}, {"characteristics_ch1": "gender: male;\tage: 59 years old;\ttissue: pancreatic islets"}]}, {"GSM3321745": [{"title": "Human islets_palmitate_2days_rep1"}, {"type": "RNA"}, {"source_name_ch1": "pancreatic islets_2days"}, {"characteristics_ch1": "gender: male;\tage: 59 years old;\ttissue: pancreatic islets"}]}, {"GSM3321746": [{"title": "Human islets_palmitate_7days_rep1"}, {"type": "RNA"}, {"source_name_ch1": "pancreatic islets_7days"}, {"characteristics_ch1": "gender: male;\tage: 59 years old;\ttissue: pancreatic islets"}]}, {"GSM3321747": [{"title": "Human islets_control_rep2"}, {"type": "RNA"}, {"source_name_ch1": "pancreatic islets_control"}, {"characteristics_ch1": "gender: female;\tage: 34 years old;\ttissue: pancreatic islets"}]}, {"GSM3321748": [{"title": "Human islets_palmitate_4hours_rep2"}, {"type": "RNA"}, {"source_name_ch1": "pancreatic islets_4hours"}, {"characteristics_ch1": "gender: female;\tage: 34 years old;\ttissue: pancreatic islets"}]}, {"GSM3321749": [{"title": "Human islets_palmitate_12hours_rep2"}, {"type": "RNA"}, {"source_name_ch1": "pancreatic islets_12hours"}, {"characteristics_ch1": "gender: female;\tage: 34 years old;\ttissue: pancreatic islets"}]}, {"GSM3321750": [{"title": "Human islets_palmitate_1day_rep2"}, {"type": "RNA"}, {"source_name_ch1": "pancreatic islets_1day"}, {"characteristics_ch1": "gender: female;\tage: 34 years old;\ttissue: pancreatic islets"}]}, {"GSM3321751": [{"title": "Human islets_palmitate_2days_rep2"}, {"type": "RNA"}, {"source_name_ch1": "pancreatic islets_2days"}, {"characteristics_ch1": "gender: female;\tage: 34 years old;\ttissue: pancreatic islets"}]}, {"GSM3321752": [{"title": "Human islets_palmitate_7days_rep2"}, {"type": "RNA"}, {"source_name_ch1": "pancreatic islets_7days"}, {"characteristics_ch1": "gender: female;\tage: 34 years old;\ttissue: pancreatic islets"}]}, {"GSM3321753": [{"title": "Human islets_control_rep3"}, {"type": "RNA"}, {"source_name_ch1": "pancreatic islets_control"}, {"characteristics_ch1": "gender: female;\tage: 39 years old;\ttissue: pancreatic islets"}]}, {"GSM3321754": [{"title": "Human islets_palmitate_4hours_rep3"}, {"type": "RNA"}, {"source_name_ch1": "pancreatic islets_4hours"}, {"characteristics_ch1": "gender: female;\tage: 39 years old;\ttissue: pancreatic islets"}]}, {"GSM3321755": [{"title": "Human islets_palmitate_12hours_rep3"}, {"type": "RNA"}, {"source_name_ch1": "pancreatic islets_12hours"}, {"characteristics_ch1": "gender: female;\tage: 39 years old;\ttissue: pancreatic islets"}]}, {"GSM3321756": [{"title": "Human islets_palmitate_1day_rep3"}, {"type": "RNA"}, {"source_name_ch1": "pancreatic islets_1day"}, {"characteristics_ch1": "gender: female;\tage: 39 years old;\ttissue: pancreatic islets"}]}, {"GSM3321757": [{"title": "Human islets_palmitate_2days_rep3"}, {"type": "RNA"}, {"source_name_ch1": "pancreatic islets_2days"}, {"characteristics_ch1": "gender: female;\tage: 39 years old;\ttissue: pancreatic islets"}]}, {"GSM3321758": [{"title": "Human islets_palmitate_7days_rep3"}, {"type": "RNA"}, {"source_name_ch1": "pancreatic islets_7days"}, {"characteristics_ch1": "gender: female;\tage: 39 years old;\ttissue: pancreatic islets"}]}, {"GSM3321759": [{"title": "Human islets_control_rep4"}, {"type": "RNA"}, {"source_name_ch1": "pancreatic islets_control"}, {"characteristics_ch1": "gender: male;\tage: 66 years old;\ttissue: pancreatic islets"}]}, {"GSM3321760": [{"title": "Human islets_palmitate_4hours_rep4"}, {"type": "RNA"}, {"source_name_ch1": "pancreatic islets_4hours"}, {"characteristics_ch1": "gender: male;\tage: 66 years old;\ttissue: pancreatic islets"}]}, {"GSM3321761": [{"title": "Human islets_palmitate_12hours_rep4"}, {"type": "RNA"}, {"source_name_ch1": "pancreatic islets_12hours"}, {"characteristics_ch1": "gender: male;\tage: 66 years old;\ttissue: pancreatic islets"}]}, {"GSM3321762": [{"title": "Human islets_palmitate_1day_rep4"}, {"type": "RNA"}, {"source_name_ch1": "pancreatic islets_1day"}, {"characteristics_ch1": "gender: male;\tage: 66 years old;\ttissue: pancreatic islets"}]}, {"GSM3321763": [{"title": "Human islets_palmitate_2days_rep4"}, {"type": "RNA"}, {"source_name_ch1": "pancreatic islets_2days"}, {"characteristics_ch1": "gender: male;\tage: 66 years old;\ttissue: pancreatic islets"}]}, {"GSM3321764": [{"title": "Human islets_palmitate_7days_rep4"}, {"type": "RNA"}, {"source_name_ch1": "pancreatic islets_7days"}, {"characteristics_ch1": "gender: male;\tage: 66 years old;\ttissue: pancreatic islets"}]}, {"GSM3321765": [{"title": "Human islets_control_rep5"}, {"type": "RNA"}, {"source_name_ch1": "pancreatic islets_control"}, {"characteristics_ch1": "gender: female;\tage: 48 years old;\ttissue: pancreatic islets"}]}, {"GSM3321766": [{"title": "Human islets_palmitate_4hours_rep5"}, {"type": "RNA"}, {"source_name_ch1": "pancreatic islets_4hours"}, {"characteristics_ch1": "gender: female;\tage: 48 years old;\ttissue: pancreatic islets"}]}, {"GSM3321767": [{"title": "Human islets_palmitate_12hours_rep5"}, {"type": "RNA"}, {"source_name_ch1": "pancreatic islets_12hours"}, {"characteristics_ch1": "gender: female;\tage: 48 years old;\ttissue: pancreatic islets"}]}, {"GSM3321768": [{"title": "Human islets_palmitate_1day_rep5"}, {"type": "RNA"}, {"source_name_ch1": "pancreatic islets_1day"}, {"characteristics_ch1": "gender: female;\tage: 48 years old;\ttissue: pancreatic islets"}]}, {"GSM3321769": [{"title": "Human islets_palmitate_2days_rep5"}, {"type": "RNA"}, {"source_name_ch1": "pancreatic islets_2days"}, {"characteristics_ch1": "gender: female;\tage: 48 years old;\ttissue: pancreatic islets"}]}, {"GSM3321770": [{"title": "Human islets_palmitate_7days_rep5"}, {"type": "RNA"}, {"source_name_ch1": "pancreatic islets_7days"}, {"characteristics_ch1": "gender: female;\tage: 48 years old;\ttissue: pancreatic islets"}]}, {"GSM3346417": [{"title": "CEL22681"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL22681"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF na\u00efve;\trutgeerts score: I0"}]}, {"GSM3346418": [{"title": "CEL22682"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL22682"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF exposed;\tcomposite score: 18"}]}, {"GSM3346419": [{"title": "CEL22684"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL22684"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: excluded from analysis"}]}, {"GSM3346420": [{"title": "CEL22688"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL22688"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF exposed;\tcomposite score: 17"}]}, {"GSM3346421": [{"title": "CEL22689"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL22689"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF exposed;\tcomposite score: 21"}]}, {"GSM3346422": [{"title": "CEL22690"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL22690"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF na\u00efve;\trutgeerts score: I3"}]}, {"GSM3346423": [{"title": "CEL22691"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL22691"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF na\u00efve;\trutgeerts score: I3"}]}, {"GSM3346424": [{"title": "CEL22692"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL22692"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF exposed;\tcomposite score: 14"}]}, {"GSM3346425": [{"title": "CEL22693"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL22693"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF exposed;\tcomposite score: 11"}]}, {"GSM3346426": [{"title": "CEL22849"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL22849"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF na\u00efve;\trutgeerts score: I2"}]}, {"GSM3346427": [{"title": "CEL22850"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL22850"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF na\u00efve;\trutgeerts score: I2"}]}, {"GSM3346428": [{"title": "CEL22851"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL22851"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF na\u00efve;\trutgeerts score: I4"}]}, {"GSM3346429": [{"title": "CEL22857"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL22857"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF exposed;\tcomposite score: 7"}]}, {"GSM3346430": [{"title": "CEL22858"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL22858"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF na\u00efve;\trutgeerts score: I0"}]}, {"GSM3346431": [{"title": "CEL22859"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL22859"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF exposed;\tcomposite score: 7"}]}, {"GSM3346432": [{"title": "CEL22860"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL22860"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF exposed;\tcomposite score: 9"}]}, {"GSM3346433": [{"title": "CEL22861"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL22861"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF exposed;\tcomposite score: 10"}]}, {"GSM3346434": [{"title": "CEL22862"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL22862"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: excluded from analysis"}]}, {"GSM3346435": [{"title": "CEL22863"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL22863"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF exposed;\tcomposite score: 13"}]}, {"GSM3346436": [{"title": "CEL22865"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL22865"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF exposed;\tcomposite score: 9"}]}, {"GSM3346437": [{"title": "CEL22866"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL22866"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF exposed;\tcomposite score: 11"}]}, {"GSM3346438": [{"title": "CEL23343"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL23343"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF na\u00efve;\trutgeerts score: I3"}]}, {"GSM3346439": [{"title": "CEL23345"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL23345"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF na\u00efve;\trutgeerts score: I0"}]}, {"GSM3346440": [{"title": "CEL23346"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL23346"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF na\u00efve;\trutgeerts score: I1"}]}, {"GSM3346441": [{"title": "CEL23348"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL23348"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF exposed;\tcomposite score: 16"}]}, {"GSM3346442": [{"title": "CEL23349"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL23349"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF exposed;\tcomposite score: 9"}]}, {"GSM3346443": [{"title": "CEL23352"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL23352"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF na\u00efve;\trutgeerts score: I2"}]}, {"GSM3346444": [{"title": "CEL23355"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL23355"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF na\u00efve;\trutgeerts score: I0"}]}, {"GSM3346445": [{"title": "CEL23356"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL23356"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF exposed;\tcomposite score: 11"}]}, {"GSM3346446": [{"title": "CEL23763"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL23763"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF na\u00efve;\trutgeerts score: I3"}]}, {"GSM3346447": [{"title": "CEL23768"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL23768"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF na\u00efve;\trutgeerts score: I2"}]}, {"GSM3346448": [{"title": "CEL23771"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL23771"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF exposed;\tcomposite score: 9"}]}, {"GSM3346449": [{"title": "CEL23773"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL23773"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF na\u00efve;\trutgeerts score: I2"}]}, {"GSM3346450": [{"title": "CEL24087"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL24087"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF exposed;\tcomposite score: 10"}]}, {"GSM3346451": [{"title": "CEL24089"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL24089"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF na\u00efve;\trutgeerts score: I3"}]}, {"GSM3346452": [{"title": "CEL24090"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL24090"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF na\u00efve;\trutgeerts score: I2"}]}, {"GSM3346453": [{"title": "CEL24092"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL24092"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF exposed;\tcomposite score: 6"}]}, {"GSM3346454": [{"title": "CEL24094"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL24094"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: excluded from analysis"}]}, {"GSM3346455": [{"title": "CEL24095"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL24095"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF exposed;\tcomposite score: 8"}]}, {"GSM3346456": [{"title": "CEL24097"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL24097"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF exposed;\tcomposite score: 10"}]}, {"GSM3346457": [{"title": "CEL24098"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL24098"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF na\u00efve;\trutgeerts score: I2"}]}, {"GSM3346458": [{"title": "CEL24099"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL24099"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: excluded from analysis"}]}, {"GSM3346459": [{"title": "CEL24105"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL24105"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: excluded from analysis"}]}, {"GSM3346460": [{"title": "CEL24106"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL24106"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF exposed;\tcomposite score: 8"}]}, {"GSM3346461": [{"title": "CEL24108"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL24108"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: excluded from analysis"}]}, {"GSM3346462": [{"title": "CEL24111"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL24111"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF na\u00efve;\trutgeerts score: I2"}]}, {"GSM3346463": [{"title": "CEL24113"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL24113"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF exposed;\tcomposite score: 13"}]}, {"GSM3346464": [{"title": "CEL24116"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL24116"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF exposed;\tcomposite score: 16"}]}, {"GSM3346465": [{"title": "CEL24393"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL24393"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF exposed;\tcomposite score: 13"}]}, {"GSM3346466": [{"title": "CEL24394"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL24394"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: excluded from analysis"}]}, {"GSM3346467": [{"title": "CEL24399"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL24399"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF exposed;\tcomposite score: 9"}]}, {"GSM3346468": [{"title": "CEL24401"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL24401"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF exposed;\tcomposite score: 12"}]}, {"GSM3346469": [{"title": "CEL24405"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL24405"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF na\u00efve;\trutgeerts score: I0"}]}, {"GSM3346470": [{"title": "CEL24890"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL24890"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF exposed;\tcomposite score: 8"}]}, {"GSM3346471": [{"title": "CEL24897"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL24897"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: excluded from analysis"}]}, {"GSM3346472": [{"title": "CEL24898"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL24898"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF na\u00efve;\trutgeerts score: I1"}]}, {"GSM3346473": [{"title": "CEL24899"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL24899"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: excluded from analysis"}]}, {"GSM3346474": [{"title": "CEL24900"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL24900"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF exposed;\tcomposite score: 12"}]}, {"GSM3346475": [{"title": "CEL24901"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL24901"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF exposed;\tcomposite score: 8"}]}, {"GSM3346476": [{"title": "CEL24902"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL24902"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF na\u00efve;\trutgeerts score: I0"}]}, {"GSM3346477": [{"title": "CEL24940"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL24940"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF exposed;\tcomposite score: 14"}]}, {"GSM3346478": [{"title": "CEL24944"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL24944"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: excluded from analysis"}]}, {"GSM3346479": [{"title": "CEL24945"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL24945"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: excluded from analysis"}]}, {"GSM3346480": [{"title": "CEL25217"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL25217"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF na\u00efve;\trutgeerts score: I3"}]}, {"GSM3346481": [{"title": "CEL25218"}, {"type": "RNA"}, {"source_name_ch1": "Homo sapien CEL25218"}, {"characteristics_ch1": "tissue: ileal mucosa;\tgroup: anti-TNF na\u00efve;\trutgeerts score: I1"}]}, {"GSM3359529": [{"title": "TB patient-1"}, {"type": "RNA"}, {"source_name_ch1": "TB patient_PBMCs"}, {"characteristics_ch1": "subject status: Pulmonary tuberculosis (TB) patient;\ttissue: whole blood;\tcell type: Peripheral blood mononuclear cells (PBMCs)"}]}, {"GSM3359530": [{"title": "TB patient-2"}, {"type": "RNA"}, {"source_name_ch1": "TB patient_PBMCs"}, {"characteristics_ch1": "subject status: Pulmonary tuberculosis (TB) patient;\ttissue: whole blood;\tcell type: Peripheral blood mononuclear cells (PBMCs)"}]}, {"GSM3359531": [{"title": "TB patient-3"}, {"type": "RNA"}, {"source_name_ch1": "TB patient_PBMCs"}, {"characteristics_ch1": "subject status: Pulmonary tuberculosis (TB) patient;\ttissue: whole blood;\tcell type: Peripheral blood mononuclear cells (PBMCs)"}]}, {"GSM3359532": [{"title": "TB patient-4"}, {"type": "RNA"}, {"source_name_ch1": "TB patient_PBMCs"}, {"characteristics_ch1": "subject status: Pulmonary tuberculosis (TB) patient;\ttissue: whole blood;\tcell type: Peripheral blood mononuclear cells (PBMCs)"}]}, {"GSM3359533": [{"title": "TB patient-5"}, {"type": "RNA"}, {"source_name_ch1": "TB patient_PBMCs"}, {"characteristics_ch1": "subject status: Pulmonary tuberculosis (TB) patient;\ttissue: whole blood;\tcell type: Peripheral blood mononuclear cells (PBMCs)"}]}, {"GSM3359534": [{"title": "TB patient-6"}, {"type": "RNA"}, {"source_name_ch1": "TB patient_PBMCs"}, {"characteristics_ch1": "subject status: Pulmonary tuberculosis (TB) patient;\ttissue: whole blood;\tcell type: Peripheral blood mononuclear cells (PBMCs)"}]}, {"GSM3359535": [{"title": "TB patient-7"}, {"type": "RNA"}, {"source_name_ch1": "TB patient_PBMCs"}, {"characteristics_ch1": "subject status: Pulmonary tuberculosis (TB) patient;\ttissue: whole blood;\tcell type: Peripheral blood mononuclear cells (PBMCs)"}]}, {"GSM3359536": [{"title": "Healthy individual-1"}, {"type": "RNA"}, {"source_name_ch1": "Healthy individual_PBMCs"}, {"characteristics_ch1": "subject status: Healthy individual;\ttissue: whole blood;\tcell type: Peripheral blood mononuclear cells (PBMCs)"}]}, {"GSM3359537": [{"title": "Healthy individual-2"}, {"type": "RNA"}, {"source_name_ch1": "Healthy individual_PBMCs"}, {"characteristics_ch1": "subject status: Healthy individual;\ttissue: whole blood;\tcell type: Peripheral blood mononuclear cells (PBMCs)"}]}, {"GSM3359538": [{"title": "Healthy individual-3"}, {"type": "RNA"}, {"source_name_ch1": "Healthy individual_PBMCs"}, {"characteristics_ch1": "subject status: Healthy individual;\ttissue: whole blood;\tcell type: Peripheral blood mononuclear cells (PBMCs)"}]}, {"GSM3359539": [{"title": "Healthy individual-4"}, {"type": "RNA"}, {"source_name_ch1": "Healthy individual_PBMCs"}, {"characteristics_ch1": "subject status: Healthy individual;\ttissue: whole blood;\tcell type: Peripheral blood mononuclear cells (PBMCs)"}]}, {"GSM3359540": [{"title": "Healthy individual-5"}, {"type": "RNA"}, {"source_name_ch1": "Healthy individual_PBMCs"}, {"characteristics_ch1": "subject status: Healthy individual;\ttissue: whole blood;\tcell type: Peripheral blood mononuclear cells (PBMCs)"}]}, {"GSM3369573": [{"title": "C1: OV2008-NC-sample 1"}, {"type": "RNA"}, {"source_name_ch1": "OV2008 cells transfected with NC miRNA-sample 1"}, {"characteristics_ch1": "cell type: ovarian cancer;\tcell line: OV2008"}]}, {"GSM3369574": [{"title": "C2: OV2008-NC-sample 2"}, {"type": "RNA"}, {"source_name_ch1": "OV2008 cells transfected with NC miRNA-sample 2"}, {"characteristics_ch1": "cell type: ovarian cancer;\tcell line: OV2008"}]}, {"GSM3369575": [{"title": "C3: OV2008-NC-sample 3"}, {"type": "RNA"}, {"source_name_ch1": "OV2008 cells transfected with NC miRNA-sample 3"}, {"characteristics_ch1": "cell type: ovarian cancer;\tcell line: OV2008"}]}, {"GSM3369576": [{"title": "M1: OV2008-miR328-sample 1"}, {"type": "RNA"}, {"source_name_ch1": "OV2008 cells transfected with miR328-M-sample 1"}, {"characteristics_ch1": "cell type: ovarian cancer;\tcell line: OV2008"}]}, {"GSM3369577": [{"title": "M2: OV2008-miR328-sample 2"}, {"type": "RNA"}, {"source_name_ch1": "OV2008 cells transfected with miR328-M-sample 2"}, {"characteristics_ch1": "cell type: ovarian cancer;\tcell line: OV2008"}]}, {"GSM3369578": [{"title": "M3: OV2008-miR328-sample 3"}, {"type": "RNA"}, {"source_name_ch1": "OV2008 cells transfected with miR328-M-sample 3"}, {"characteristics_ch1": "cell type: ovarian cancer;\tcell line: OV2008"}]}, {"GSM3389407": [{"title": "African American primary proximal tubule cells (K10015_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G0G0 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G0G0;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389408": [{"title": "African American primary proximal tubule cells (K10018_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G1G2 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G1G2;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389409": [{"title": "African American primary proximal tubule cells (K10023_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G0G0 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G0G0;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389410": [{"title": "African American primary proximal tubule cells (K10024_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G2G0 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G2G0;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389411": [{"title": "African American primary proximal tubule cells (K10032_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G1G0 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G1G0;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389412": [{"title": "African American primary proximal tubule cells (K10041_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G2G0 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G2G0;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389413": [{"title": "African American primary proximal tubule cells (K10047_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G1G0 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G1G0;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389414": [{"title": "African American primary proximal tubule cells (K10054_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G1G0 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G1G0;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389415": [{"title": "African American primary proximal tubule cells (K10056_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G0G0 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G0G0;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389416": [{"title": "African American primary proximal tubule cells (K10073_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G1G1 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G1G1;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389417": [{"title": "African American primary proximal tubule cells (K10075_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G0G0 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G0G0;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389418": [{"title": "African American primary proximal tubule cells (K10095_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G0G0 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G0G0;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389419": [{"title": "African American primary proximal tubule cells (K10097_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G2G0 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G2G0;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389420": [{"title": "African American primary proximal tubule cells (K10101_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G0G0 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G0G0;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389421": [{"title": "African American primary proximal tubule cells (K10102_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G0G0 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G0G0;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389422": [{"title": "African American primary proximal tubule cells (K10106_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G1G0 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G1G0;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389423": [{"title": "African American primary proximal tubule cells (K10107_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G2G0 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G2G0;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389424": [{"title": "African American primary proximal tubule cells (K10109_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G0G0 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G0G0;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389425": [{"title": "African American primary proximal tubule cells (K10110_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G0G0 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G0G0;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389426": [{"title": "African American primary proximal tubule cells (K10111_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G0G0 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G0G0;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389427": [{"title": "African American primary proximal tubule cells (K10113_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G2G0 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G2G0;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389428": [{"title": "African American primary proximal tubule cells (K10133_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G0G0 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G0G0;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389429": [{"title": "African American primary proximal tubule cells (K10141_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G2G0 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G2G0;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389430": [{"title": "African American primary proximal tubule cells (K10144_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G1G0 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G1G0;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389431": [{"title": "African American primary proximal tubule cells (K10148_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G0G0 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G0G0;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389432": [{"title": "African American primary proximal tubule cells (K10150_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G0G0 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G0G0;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389433": [{"title": "African American primary proximal tubule cells (K10156_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G2G0 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G2G0;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389434": [{"title": "African American primary proximal tubule cells (K10159_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G0G0 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G0G0;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389435": [{"title": "African American primary proximal tubule cells (K10160_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G0G0 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G0G0;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389436": [{"title": "African American primary proximal tubule cells (K10165_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G0G0 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G0G0;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389437": [{"title": "African American primary proximal tubule cells (K10169_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G1G0 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G1G0;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389438": [{"title": "African American primary proximal tubule cells (K10174_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G2G0 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G2G0;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389439": [{"title": "African American primary proximal tubule cells (K10176_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G1G0 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G1G0;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389440": [{"title": "African American primary proximal tubule cells (K10182_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G1G2 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G1G2;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389441": [{"title": "African American primary proximal tubule cells (K10188_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G0G0 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G0G0;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389442": [{"title": "African American primary proximal tubule cells (K10189_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G1G0 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G1G0;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389443": [{"title": "African American primary proximal tubule cells (K10199_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G1G0 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G1G0;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389444": [{"title": "African American primary proximal tubule cells (K10202_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G1G2 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G1G2;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389445": [{"title": "African American primary proximal tubule cells (K10203_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G1G1 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G1G1;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389446": [{"title": "African American primary proximal tubule cells (K10205_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G2G0 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G2G0;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389447": [{"title": "African American primary proximal tubule cells (K10210_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G0G0 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G0G0;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389448": [{"title": "African American primary proximal tubule cells (K10214_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G0G0 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G0G0;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389449": [{"title": "African American primary proximal tubule cells (K10217_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G0G0 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G0G0;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389450": [{"title": "African American primary proximal tubule cells (K10218_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G2G0 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G2G0;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389451": [{"title": "African American primary proximal tubule cells (K10219_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G0G0 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G0G0;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389452": [{"title": "African American primary proximal tubule cells (K10220_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G1G0 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G1G0;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389453": [{"title": "African American primary proximal tubule cells (K10221_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G1G0 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G1G0;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389454": [{"title": "African American primary proximal tubule cells (K10222_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G0G0 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G0G0;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389455": [{"title": "African American primary proximal tubule cells (K10223_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G2G0 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G2G0;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389456": [{"title": "African American primary proximal tubule cells (K10224_pre)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G2G0 pre-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G2G0;\ttime: pre-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389457": [{"title": "African American primary proximal tubule cells (K10015_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G0G0 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G0G0;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389458": [{"title": "African American primary proximal tubule cells (K10018_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G1G2 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G1G2;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389459": [{"title": "African American primary proximal tubule cells (K10023_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G0G0 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G0G0;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389460": [{"title": "African American primary proximal tubule cells (K10024_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G2G0 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G2G0;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389461": [{"title": "African American primary proximal tubule cells (K10032_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G1G0 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G1G0;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389462": [{"title": "African American primary proximal tubule cells (K10041_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G2G0 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G2G0;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389463": [{"title": "African American primary proximal tubule cells (K10047_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G1G0 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G1G0;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389464": [{"title": "African American primary proximal tubule cells (K10054_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G1G0 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G1G0;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389465": [{"title": "African American primary proximal tubule cells (K10056_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G0G0 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G0G0;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389466": [{"title": "African American primary proximal tubule cells (K10073_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G1G1 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G1G1;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389467": [{"title": "African American primary proximal tubule cells (K10075_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G0G0 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G0G0;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389468": [{"title": "African American primary proximal tubule cells (K10095_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G0G0 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G0G0;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389469": [{"title": "African American primary proximal tubule cells (K10097_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G2G0 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G2G0;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389470": [{"title": "African American primary proximal tubule cells (K10101_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G0G0 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G0G0;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389471": [{"title": "African American primary proximal tubule cells (K10102_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G0G0 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G0G0;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389472": [{"title": "African American primary proximal tubule cells (K10106_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G1G0 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G1G0;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389473": [{"title": "African American primary proximal tubule cells (K10107_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G2G0 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G2G0;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389474": [{"title": "African American primary proximal tubule cells (K10109_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G0G0 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G0G0;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389475": [{"title": "African American primary proximal tubule cells (K10110_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G0G0 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G0G0;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389476": [{"title": "African American primary proximal tubule cells (K10111_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G0G0 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G0G0;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389477": [{"title": "African American primary proximal tubule cells (K10113_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G2G0 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G2G0;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389478": [{"title": "African American primary proximal tubule cells (K10133_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G0G0 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G0G0;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389479": [{"title": "African American primary proximal tubule cells (K10141_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G2G0 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G2G0;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389480": [{"title": "African American primary proximal tubule cells (K10144_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G1G0 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G1G0;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389481": [{"title": "African American primary proximal tubule cells (K10148_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G0G0 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G0G0;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389482": [{"title": "African American primary proximal tubule cells (K10150_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G0G0 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G0G0;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389483": [{"title": "African American primary proximal tubule cells (K10156_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G2G0 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G2G0;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389484": [{"title": "African American primary proximal tubule cells (K10159_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G0G0 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G0G0;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389485": [{"title": "African American primary proximal tubule cells (K10160_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G0G0 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G0G0;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389486": [{"title": "African American primary proximal tubule cells (K10165_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G0G0 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G0G0;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389487": [{"title": "African American primary proximal tubule cells (K10169_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G1G0 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G1G0;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389488": [{"title": "African American primary proximal tubule cells (K10174_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G2G0 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G2G0;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389489": [{"title": "African American primary proximal tubule cells (K10176_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G1G0 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G1G0;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389490": [{"title": "African American primary proximal tubule cells (K10182_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G1G2 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G1G2;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389491": [{"title": "African American primary proximal tubule cells (K10188_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G0G0 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G0G0;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389492": [{"title": "African American primary proximal tubule cells (K10189_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G1G0 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G1G0;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389493": [{"title": "African American primary proximal tubule cells (K10199_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G1G0 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G1G0;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389494": [{"title": "African American primary proximal tubule cells (K10202_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G1G2 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G1G2;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389495": [{"title": "African American primary proximal tubule cells (K10203_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G1G1 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G1G1;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389496": [{"title": "African American primary proximal tubule cells (K10205_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G2G0 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G2G0;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389497": [{"title": "African American primary proximal tubule cells (K10210_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G0G0 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G0G0;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389498": [{"title": "African American primary proximal tubule cells (K10214_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G0G0 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G0G0;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389499": [{"title": "African American primary proximal tubule cells (K10217_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G0G0 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G0G0;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389500": [{"title": "African American primary proximal tubule cells (K10218_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G2G0 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G2G0;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389501": [{"title": "African American primary proximal tubule cells (K10219_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G0G0 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G0G0;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389502": [{"title": "African American primary proximal tubule cells (K10220_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G1G0 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G1G0;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389503": [{"title": "African American primary proximal tubule cells (K10221_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G1G0 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G1G0;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389504": [{"title": "African American primary proximal tubule cells (K10222_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G0G0 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G0G0;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389505": [{"title": "African American primary proximal tubule cells (K10223_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G2G0 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G2G0;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389506": [{"title": "African American primary proximal tubule cells (K10224_post)"}, {"type": "RNA"}, {"source_name_ch1": "APOL1 Genotype_G2G0 post-polyIC Stimulation"}, {"characteristics_ch1": "ethnicity: African American;\tgenotype: APOL1 Genotype G2G0;\ttime: post-polyIC Stimulation;\tcell type: primary proximal tubule cells"}]}, {"GSM3389631": [{"title": "143B-1: 143B cell cultured in Matrigel, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "143B cell cultured in Matrigel after 24 hours"}, {"characteristics_ch1": "cell line: 143B;\ttissue: osteosarcama cell line;\ttumor phenotype: vasculogenic mimicry"}]}, {"GSM3389632": [{"title": "143B-2: 143B cell cultured in Matrigel, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "143B cell cultured in Matrigel after 24 hours"}, {"characteristics_ch1": "cell line: 143B;\ttissue: osteosarcama cell line;\ttumor phenotype: vasculogenic mimicry"}]}, {"GSM3389633": [{"title": "143B-3: 143B cell cultured in Matrigel, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "143B cell cultured in Matrigel after 24 hours"}, {"characteristics_ch1": "cell line: 143B;\ttissue: osteosarcama cell line;\ttumor phenotype: vasculogenic mimicry"}]}, {"GSM3389634": [{"title": "HOS-1: HOS cell cultured in Matrigel, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "HOS cell cultured in Matrigel after 24 hours"}, {"characteristics_ch1": "cell line: HOS;\ttissue: osteosarcama cell line;\ttumor phenotype: non-vasculogenic mimicry"}]}, {"GSM3389635": [{"title": "HOS-2: HOS cell cultured in Matrigel, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "HOS cell cultured in Matrigel after 24 hours"}, {"characteristics_ch1": "cell line: HOS;\ttissue: osteosarcama cell line;\ttumor phenotype: non-vasculogenic mimicry"}]}, {"GSM3389636": [{"title": "HOS-3: HOS cell cultured in Matrigel, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "HOS cell cultured in Matrigel after 24 hours"}, {"characteristics_ch1": "cell line: HOS;\ttissue: osteosarcama cell line;\ttumor phenotype: non-vasculogenic mimicry"}]}, {"GSM3393952": [{"title": "Burkitt lymphoma patient_PP11019167"}, {"type": "RNA"}, {"source_name_ch1": "Patient n\u00b011P19167, frozen Burkitt lymphoma biopsy"}, {"characteristics_ch1": "tissue: Burkitt lymphoma biopsy (lymph node)"}]}, {"GSM3393953": [{"title": "Hodgkin lymphoma patient_PP12005647"}, {"type": "RNA"}, {"source_name_ch1": "Patient n\u00b012P5647, frozen HL biopsy"}, {"characteristics_ch1": "tissue: HL biopsy (lymph node)"}]}, {"GSM3393954": [{"title": "Hodgkin lymphoma patient_PP12005999"}, {"type": "RNA"}, {"source_name_ch1": "Patient n\u00b0 12P5999, frozen HL biopsy"}, {"characteristics_ch1": "tissue: HL biopsy (lymph node)"}]}, {"GSM3393955": [{"title": "Hodgkin lymphoma patient_PP12007177"}, {"type": "RNA"}, {"source_name_ch1": "Patient n\u00b0 12P7177, frozen HL biopsy"}, {"characteristics_ch1": "tissue: HL biopsy (lymph node)"}]}, {"GSM3393956": [{"title": "ABC DLBCL patient_PP12009422"}, {"type": "RNA"}, {"source_name_ch1": "Patient n\u00b012P9422, frozen ABC DLBCL biopsy"}, {"characteristics_ch1": "tissue: ABC DLBCL biopsy (lymph node)"}]}, {"GSM3393957": [{"title": "Peripheral T cell lymphoma patient_PP12013625"}, {"type": "RNA"}, {"source_name_ch1": "Patient n\u00b012P13625, frozen peripheral T cell lymphoma biopsy"}, {"characteristics_ch1": "tissue: Peripheral T cell lymphoma biopsy (lymph node)"}]}, {"GSM3393958": [{"title": "ABC DLBCL patient_PP12013729"}, {"type": "RNA"}, {"source_name_ch1": "Patient n\u00b012P13729, frozen ABC DLBCL biopsy"}, {"characteristics_ch1": "tissue: ABC DLBCL biopsy (lymph node)"}]}, {"GSM3393959": [{"title": "Mantle cell lymphoma patient_PP12016407"}, {"type": "RNA"}, {"source_name_ch1": "Patient n\u00b012P16407, frozen Mantle cell lymphoma biopsy"}, {"characteristics_ch1": "tissue: Mantle cell lymphoma biopsy (lymph node)"}]}, {"GSM3393960": [{"title": "GCB DLBCL patient_PP12019610"}, {"type": "RNA"}, {"source_name_ch1": "Patient n\u00b012P19610, frozen GCB DLBCL biopsy"}, {"characteristics_ch1": "tissue: GCB DLBCL biopsy (lymph node)"}]}, {"GSM3393961": [{"title": "Burkitt lymphoma patient_PP13004440"}, {"type": "RNA"}, {"source_name_ch1": "Patient n\u00b013P4440, frozen Burkitt lymphoma biopsy"}, {"characteristics_ch1": "tissue: Burkitt lymphoma biopsy (lymph node)"}]}, {"GSM3393962": [{"title": "Hodgkin lymphoma patient_PP13010349"}, {"type": "RNA"}, {"source_name_ch1": "Patient n\u00b013P10349, frozen HL biopsy"}, {"characteristics_ch1": "tissue: HL biopsy (lymph node)"}]}, {"GSM3393963": [{"title": "Mantle cell lymphoma patient_PP13021046"}, {"type": "RNA"}, {"source_name_ch1": "Patient n\u00b013P21046, frozen Mantle cell lymphoma biopsy"}, {"characteristics_ch1": "tissue: Mantle cell lymphoma biopsy (lymph node)"}]}, {"GSM3393964": [{"title": "Peripheral T cell lymphoma (NOS) patient_PP14006021"}, {"type": "RNA"}, {"source_name_ch1": "Patient n\u00b014P06021, frozen Peripheral T cell lymphoma (NOS) biopsy"}, {"characteristics_ch1": "tissue: Peripheral T cell lymphoma biopsy (lymph node)"}]}, {"GSM3393965": [{"title": "Follicular lymphoma patient_RR10002808"}, {"type": "RNA"}, {"source_name_ch1": "Patient n\u00b010R02808, frozen Follicular lymphoma biopsy"}, {"characteristics_ch1": "tissue: Follicular lymphoma biopsy (lymph node)"}]}, {"GSM3393966": [{"title": "ALK- anaplastic large cell lymphoma patient_RR11015469"}, {"type": "RNA"}, {"source_name_ch1": "Patient n\u00b011R15469, frozen ALK- anaplastic large cell lymphoma biopsy"}, {"characteristics_ch1": "tissue: ALK- anaplastic large cell lymphoma biopsy (lymph node)"}]}, {"GSM3393967": [{"title": "ALK+ anaplastic large cell lymphoma patient_RR11019637"}, {"type": "RNA"}, {"source_name_ch1": "Patient n\u00b011R19637, frozen ALK+ anaplastic large cell lymphoma biopsy"}, {"characteristics_ch1": "tissue: ALK+ anaplastic large cell lymphoma biopsy (lymph node)"}]}, {"GSM3393968": [{"title": "ABC DLBCL patient_RR12001665"}, {"type": "RNA"}, {"source_name_ch1": "Patient n\u00b012R1665, frozen ABC DLBCL biopsy"}, {"characteristics_ch1": "tissue: ABC DLBCL biopsy (lymph node)"}]}, {"GSM3393969": [{"title": "GCB DLBCL patient_RR12011145"}, {"type": "RNA"}, {"source_name_ch1": "Patient n\u00b012R11145, frozen GCB DLBCL biopsy"}, {"characteristics_ch1": "tissue: GCB DLBCL biopsy (lymph node)"}]}, {"GSM3393970": [{"title": "ABC DLBCL patient_RR13008462"}, {"type": "RNA"}, {"source_name_ch1": "Patient n\u00b013R8462, frozen ABC DLBCL biopsy"}, {"characteristics_ch1": "tissue: ABC DLBCL biopsy (lymph node)"}]}, {"GSM3393971": [{"title": "ABC DLBCL patient_RR13015923"}, {"type": "RNA"}, {"source_name_ch1": "Patient n\u00b013R15923, frozen ABC DLBCL biopsy"}, {"characteristics_ch1": "tissue: ABC DLBCL biopsy (lymph node)"}]}, {"GSM3393972": [{"title": "ABC DLBCL patient_RR13020351"}, {"type": "RNA"}, {"source_name_ch1": "Patient n\u00b013R20351, frozen ABC DLBCL biopsy"}, {"characteristics_ch1": "tissue: ABC DLBCL biopsy (lymph node)"}]}, {"GSM3393973": [{"title": "ABC DLBCL patient_14T024678"}, {"type": "RNA"}, {"source_name_ch1": "Patient n\u00b014T024678, frozen ABC DLBCL biopsy"}, {"characteristics_ch1": "tissue: ABC DLBCL biopsy (lymph node)"}]}, {"GSM3393974": [{"title": "Hodgkin lymphoma patient_14T027341"}, {"type": "RNA"}, {"source_name_ch1": "Patient n\u00b014T027341, frozen HL biopsy"}, {"characteristics_ch1": "tissue: HL biopsy (lymph node)"}]}, {"GSM3393975": [{"title": "GCB DLBCL patient_15T001992"}, {"type": "RNA"}, {"source_name_ch1": "Patient n\u00b015T001992, frozen GCB DLBCL biopsy"}, {"characteristics_ch1": "tissue: GCB DLBCL biopsy (lymph node)"}]}, {"GSM3393976": [{"title": "Follicular lymphoma patient_15T010556"}, {"type": "RNA"}, {"source_name_ch1": "Patient n\u00b015T010556, frozen Follicular lymphoma biopsy"}, {"characteristics_ch1": "tissue: Follicular lymphoma biopsy (lymph node)"}]}, {"GSM3393977": [{"title": "ABC DLBCL patient_15T011542"}, {"type": "RNA"}, {"source_name_ch1": "Patient n\u00b015T011542, frozen ABC DLBCL biopsy"}, {"characteristics_ch1": "tissue: ABC DLBCL biopsy (lymph node)"}]}, {"GSM3393978": [{"title": "GCB DLBCL patient_15T019328"}, {"type": "RNA"}, {"source_name_ch1": "Patient n\u00b015T019328, frozen GCB DLBCL biopsy"}, {"characteristics_ch1": "tissue: GCB DLBCL biopsy (lymph node)"}]}, {"GSM3393979": [{"title": "ABC DLBCL patient_RR14006050"}, {"type": "RNA"}, {"source_name_ch1": "Patient n\u00b014R6050, frozen ABC DLBCL biopsy"}, {"characteristics_ch1": "tissue: ABC DLBCL biopsy (lymph node)"}]}, {"GSM3393980": [{"title": "GCB DLBCL patient_RR13007950"}, {"type": "RNA"}, {"source_name_ch1": "Patient n\u00b013R7950, frozen GCB DLBCL biopsy"}, {"characteristics_ch1": "tissue: GCB DLBCL biopsy (lymph node)"}]}, {"GSM3393981": [{"title": "Follicular lymphoma patient_PP08004926"}, {"type": "RNA"}, {"source_name_ch1": "Patient n\u00b008P4926, frozen Follicular lymphoma biopsy"}, {"characteristics_ch1": "tissue: Follicular lymphoma biopsy (lymph node)"}]}, {"GSM3393982": [{"title": "ABC DLBCL patient_PP14007995"}, {"type": "RNA"}, {"source_name_ch1": "Patient n\u00b014P7995, frozen ABC DLBCL biopsy"}, {"characteristics_ch1": "tissue: ABC DLBCL biopsy (lymph node)"}]}, {"GSM3393983": [{"title": "Follicular lymphoma patient_RR09012575"}, {"type": "RNA"}, {"source_name_ch1": "Patient n\u00b009R12575, frozen Follicular lymphoma biopsy"}, {"characteristics_ch1": "tissue: Follicular lymphoma biopsy (lymph node)"}]}, {"GSM3393984": [{"title": "GCB DLBCL patient_RR12013196"}, {"type": "RNA"}, {"source_name_ch1": "Patient n\u00b012R13196, frozen GCB DLBCL biopsy"}, {"characteristics_ch1": "tissue: GCB DLBCL biopsy (lymph node)"}]}, {"GSM3393985": [{"title": "GCB DLBCL patient_PP12019020"}, {"type": "RNA"}, {"source_name_ch1": "Patient n\u00b012P19020, frozen GCB DLBCL biopsy"}, {"characteristics_ch1": "tissue: GCB DLBCL biopsy (lymph node)"}]}, {"GSM3393986": [{"title": "GCB DLBCL patient_RR14002195"}, {"type": "RNA"}, {"source_name_ch1": "Patient n\u00b014R2195, frozen GCB DLBCL biopsy"}, {"characteristics_ch1": "tissue: GCB DLBCL biopsy (lymph node)"}]}, {"GSM3393987": [{"title": "Hodgkin lymphoma patient_PP11015820"}, {"type": "RNA"}, {"source_name_ch1": "Patient n\u00b011P15820, frozen HL biopsy"}, {"characteristics_ch1": "tissue: HL biopsy (lymph node)"}]}, {"GSM3393988": [{"title": "GCB DLBCL patient_PP11018905"}, {"type": "RNA"}, {"source_name_ch1": "Patient n\u00b011P8905, frozen GCB DLBCL biopsy"}, {"characteristics_ch1": "tissue: GCB DLBCL biopsy (lymph node)"}]}, {"GSM3393989": [{"title": "Hodgkin lymphoma patient_PP13002041"}, {"type": "RNA"}, {"source_name_ch1": "Patient n\u00b013P2041, frozen HL biopsy"}, {"characteristics_ch1": "tissue: HL biopsy (lymph node)"}]}, {"GSM3393990": [{"title": "Hodgkin lymphoma patient_RR1108130"}, {"type": "RNA"}, {"source_name_ch1": "Patient n\u00b011R8130, frozen HL biopsy"}, {"characteristics_ch1": "tissue: HL biopsy (lymph node)"}]}, {"GSM3393991": [{"title": "Follicular lymphoma patient_PP08006619"}, {"type": "RNA"}, {"source_name_ch1": "Patient n\u00b008P6619, frozen Follicular lymphoma biopsy"}, {"characteristics_ch1": "tissue: Follicular lymphoma biopsy (lymph node)"}]}, {"GSM3398903": [{"title": "primary myelofibrosis, biological rep4"}, {"type": "RNA"}, {"source_name_ch1": "MPN patients"}, {"characteristics_ch1": "disease state: primary myelofibrosis;\tcell type: CD34+ PBMCs;\ttissue: peripheral blood;\tgenotype: CALR mut"}]}, {"GSM3398904": [{"title": "post-ET-myelofibrosis, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "MPN patients"}, {"characteristics_ch1": "disease state: post-ET-myelofibrosis;\tcell type: CD34+ BMMCs;\ttissue: bone marrow;\tgenotype: CALR mut"}]}, {"GSM3398905": [{"title": "pre-myelofibrosis, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "MPN patients"}, {"characteristics_ch1": "disease state: pre-myelofibrosis;\tcell type: CD34+ PBMCs;\ttissue: peripheral blood;\tgenotype: CALR mut"}]}, {"GSM3398906": [{"title": "essential thrombocythemia, biological rep4"}, {"type": "RNA"}, {"source_name_ch1": "MPN patients"}, {"characteristics_ch1": "disease state: essential thrombocythemia;\tcell type: CD34+ BMMCs;\ttissue: bone marrow;\tgenotype: CALR mut"}]}, {"GSM3398907": [{"title": "primary myelofibrosis, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "MPN patients"}, {"characteristics_ch1": "disease state: primary myelofibrosis;\tcell type: CD34+ PBMCs;\ttissue: peripheral blood;\tgenotype: JAK2V617F positive"}]}, {"GSM3398908": [{"title": "primary myelofibrosis, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "MPN patients"}, {"characteristics_ch1": "disease state: primary myelofibrosis;\tcell type: CD34+ BMMCs;\ttissue: bone marrow;\tgenotype: JAK2V617F positive"}]}, {"GSM3398909": [{"title": "primary myelofibrosis, biological rep5"}, {"type": "RNA"}, {"source_name_ch1": "MPN patients"}, {"characteristics_ch1": "disease state: primary myelofibrosis;\tcell type: CD34+ BMMCs;\ttissue: bone marrow;\tgenotype: JAK2V617F positive"}]}, {"GSM3398910": [{"title": "post-PV-myelofibrosis, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "MPN patients"}, {"characteristics_ch1": "disease state: post-PV-myelofibrosis;\tcell type: CD34+ BMMCs;\ttissue: bone marrow;\tgenotype: JAK2V617F positive"}]}, {"GSM3398911": [{"title": "primary myelofibrosis, biological rep10"}, {"type": "RNA"}, {"source_name_ch1": "MPN patients"}, {"characteristics_ch1": "disease state: primary myelofibrosis;\tcell type: CD34+ BMMCs;\ttissue: bone marrow;\tgenotype: JAK2V617F positive"}]}, {"GSM3398912": [{"title": "primary myelofibrosis, biological rep7"}, {"type": "RNA"}, {"source_name_ch1": "MPN patients"}, {"characteristics_ch1": "disease state: primary myelofibrosis;\tcell type: CD34+ BMMCs;\ttissue: bone marrow;\tgenotype: JAK2V617F positive"}]}, {"GSM3398913": [{"title": "essential thrombocythemia, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "MPN patients"}, {"characteristics_ch1": "disease state: essential thrombocythemia;\tcell type: CD34+ BMMCs;\ttissue: bone marrow;\tgenotype: JAK2V617F positive"}]}, {"GSM3400724": [{"title": "Scrambled control 1"}, {"type": "RNA"}, {"source_name_ch1": "RNA sample from neutrophil cells transfected with scrambled control"}, {"characteristics_ch1": "cell line: HL-60;\tcell type: neutrophil cell"}]}, {"GSM3400725": [{"title": "Scrambled control 2"}, {"type": "RNA"}, {"source_name_ch1": "RNA sample from neutrophil cells transfected with scrambled control"}, {"characteristics_ch1": "cell line: HL-60;\tcell type: neutrophil cell"}]}, {"GSM3400726": [{"title": "hsa-miR-182-5p mimic 1"}, {"type": "RNA"}, {"source_name_ch1": "RNA sample from neutrophil cells transfected with hsa-miR-182-5p mimic"}, {"characteristics_ch1": "cell line: HL-60;\tcell type: neutrophil cell"}]}, {"GSM3400727": [{"title": "hsa-miR-182-5p mimic 2"}, {"type": "RNA"}, {"source_name_ch1": "RNA sample from neutrophil cells transfected with hsa-miR-182-5p mimic"}, {"characteristics_ch1": "cell line: HL-60;\tcell type: neutrophil cell"}]}, {"GSM3402289": [{"title": "SKNMC siRNA control rep1"}, {"type": "RNA"}, {"source_name_ch1": "SKNMC cells transfected with control siRNA"}, {"characteristics_ch1": "cell line: Ewing Sarcoma cell line;\tgenotype: control"}]}, {"GSM3402290": [{"title": "SKNMC siRNA control rep2"}, {"type": "RNA"}, {"source_name_ch1": "SKNMC cells transfected with control siRNA"}, {"characteristics_ch1": "cell line: Ewing Sarcoma cell line;\tgenotype: control"}]}, {"GSM3402291": [{"title": "SKNMC siRNA control rep3"}, {"type": "RNA"}, {"source_name_ch1": "SKNMC cells transfected with control siRNA"}, {"characteristics_ch1": "cell line: Ewing Sarcoma cell line;\tgenotype: control"}]}, {"GSM3402292": [{"title": "SKNMC siRNA control rep4"}, {"type": "RNA"}, {"source_name_ch1": "SKNMC cells transfected with control siRNA"}, {"characteristics_ch1": "cell line: Ewing Sarcoma cell line;\tgenotype: control"}]}, {"GSM3402293": [{"title": "SKNMC siRNA YT rep1"}, {"type": "RNA"}, {"source_name_ch1": "SKNMC cells transfected with a mix of siRNA targeting both YAP1 and TAZ"}, {"characteristics_ch1": "cell line: Ewing Sarcoma cell line;\tgenotype: loss-of-YAP1/TAZ"}]}, {"GSM3402294": [{"title": "SKNMC siRNA YT rep2"}, {"type": "RNA"}, {"source_name_ch1": "SKNMC cells transfected with a mix of siRNA targeting both YAP1 and TAZ"}, {"characteristics_ch1": "cell line: Ewing Sarcoma cell line;\tgenotype: loss-of-YAP1/TAZ"}]}, {"GSM3402295": [{"title": "SKNMC siRNA YT rep3"}, {"type": "RNA"}, {"source_name_ch1": "SKNMC cells transfected with a mix of siRNA targeting both YAP1 and TAZ"}, {"characteristics_ch1": "cell line: Ewing Sarcoma cell line;\tgenotype: loss-of-YAP1/TAZ"}]}, {"GSM3402296": [{"title": "SKNMC siRNA YT rep4"}, {"type": "RNA"}, {"source_name_ch1": "SKNMC cells transfected with a mix of siRNA targeting both YAP1 and TAZ"}, {"characteristics_ch1": "cell line: Ewing Sarcoma cell line;\tgenotype: loss-of-YAP1/TAZ"}]}, {"GSM3402331": [{"title": "SUM159-Mir100-Ctrl"}, {"type": "RNA"}, {"source_name_ch1": "SUM159 transfected with doxy-induced-Mir100 overexpression plasmid treated without doxy for a week"}, {"characteristics_ch1": "cell type: breast cancer;\tcell line: SUM159;\ttransfection: control"}]}, {"GSM3402332": [{"title": "SUM159-Mir100-Doxy"}, {"type": "RNA"}, {"source_name_ch1": "SUM159 transfected with doxy-induced-Mir100 overexpression plasmid treated with doxy for a week"}, {"characteristics_ch1": "cell type: breast cancer;\tcell line: SUM159;\ttransfection: doxy-induced-Mir100 overexpression"}]}, {"GSM3402333": [{"title": "MDA-MB-231-Mir100-Ctrl"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-231 transfected with doxy-induced-Mir100 overexpression plasmid treated without doxy for a week"}, {"characteristics_ch1": "cell type: breast cancer;\tcell line: MDA-MB-231;\ttransfection: control"}]}, {"GSM3402334": [{"title": "MDA-MB-231-Mir100-Doxy"}, {"type": "RNA"}, {"source_name_ch1": "MDA-MB-231 transfected with doxy-induced-Mir100 overexpression plasmid treated with doxy for a week"}, {"characteristics_ch1": "cell type: breast cancer;\tcell line: MDA-MB-231;\ttransfection: doxy-induced-Mir100 overexpression"}]}, {"GSM3414971": [{"title": "negative control, 24 h post-transfection, replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "HeLa cells + control plasmid"}, {"characteristics_ch1": "cell line: HeLa;\tplasmid: negative control plasmid;\ttime point: 24 h"}]}, {"GSM3414972": [{"title": "negative control, 24 h post-transfection, replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "HeLa cells + control plasmid"}, {"characteristics_ch1": "cell line: HeLa;\tplasmid: negative control plasmid;\ttime point: 24 h"}]}, {"GSM3414973": [{"title": "negative control, 48 h post-transfection, replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "HeLa cells + control plasmid"}, {"characteristics_ch1": "cell line: HeLa;\tplasmid: negative control plasmid;\ttime point: 48 h"}]}, {"GSM3414974": [{"title": "negative control, 48 h post-transfection, replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "HeLa cells + control plasmid"}, {"characteristics_ch1": "cell line: HeLa;\tplasmid: negative control plasmid;\ttime point: 48 h"}]}, {"GSM3414975": [{"title": "miR-548ac overexpression, 24 h post-transfection, replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "HeLa cells + mir-548ac plasmid"}, {"characteristics_ch1": "cell line: HeLa;\tplasmid: mir-548ac expression plasmid;\ttime point: 24 h"}]}, {"GSM3414976": [{"title": "miR-548ac overexpression, 24 h post-transfection, replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "HeLa cells + mir-548ac plasmid"}, {"characteristics_ch1": "cell line: HeLa;\tplasmid: mir-548ac expression plasmid;\ttime point: 24 h"}]}, {"GSM3414977": [{"title": "miR-548ac overexpression, 24 h post-transfection, replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "HeLa cells + mir-548ac plasmid"}, {"characteristics_ch1": "cell line: HeLa;\tplasmid: mir-548ac expression plasmid;\ttime point: 24 h"}]}, {"GSM3414978": [{"title": "miR-548ac overexpression, 48 h post-transfection, replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "HeLa cells + mir-548ac plasmid"}, {"characteristics_ch1": "cell line: HeLa;\tplasmid: mir-548ac expression plasmid;\ttime point: 48 h"}]}, {"GSM3414979": [{"title": "miR-548ac overexpression, 48 h post-transfection, replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "HeLa cells + mir-548ac plasmid"}, {"characteristics_ch1": "cell line: HeLa;\tplasmid: mir-548ac expression plasmid;\ttime point: 48 h"}]}, {"GSM3414980": [{"title": "miR-548ac overexpression, 48 h post-transfection, replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "HeLa cells + mir-548ac plasmid"}, {"characteristics_ch1": "cell line: HeLa;\tplasmid: mir-548ac expression plasmid;\ttime point: 48 h"}]}, {"GSM3416984": [{"title": "CD19+ non stimulated"}, {"type": "RNA"}, {"source_name_ch1": "CD19+ non stimulated"}, {"characteristics_ch1": "cell type: CD19+ cells MACS purifed from PBMCs;\tagent: control"}]}, {"GSM3416985": [{"title": "CD19+ IL-12 stimulated"}, {"type": "RNA"}, {"source_name_ch1": "CD19+ IL-12 stimulated"}, {"characteristics_ch1": "cell type: CD19+ cells MACS purifed from PBMCs;\tagent: IL-12"}]}, {"GSM3416986": [{"title": "CD19+ IL-23 stimulated"}, {"type": "RNA"}, {"source_name_ch1": "CD19+ IL-23 stimulated"}, {"characteristics_ch1": "cell type: CD19+ cells MACS purifed from PBMCs;\tagent: IL-23"}]}, {"GSM3416987": [{"title": "CD8+ non stimulated"}, {"type": "RNA"}, {"source_name_ch1": "CD8+ non stimulated"}, {"characteristics_ch1": "cell type: CD8+ cells MACS purifed from PBMCs;\tagent: control"}]}, {"GSM3416988": [{"title": "CD8+ IL-12 stimulated"}, {"type": "RNA"}, {"source_name_ch1": "CD8+ IL-12 stimulated"}, {"characteristics_ch1": "cell type: CD8+ cells MACS purifed from PBMCs;\tagent: IL-12"}]}, {"GSM3416989": [{"title": "CD8+ IL-23 stimulated"}, {"type": "RNA"}, {"source_name_ch1": "CD8+ IL-23 stimulated"}, {"characteristics_ch1": "cell type: CD8+ cells MACS purifed from PBMCs;\tagent: IL-23"}]}, {"GSM3416990": [{"title": "CD4+ non stimulated"}, {"type": "RNA"}, {"source_name_ch1": "CD4+ non stimulated"}, {"characteristics_ch1": "cell type: CD4+ cells MACS purifed from PBMCs;\tagent: control"}]}, {"GSM3416991": [{"title": "CD4+ IL-12 stimulated"}, {"type": "RNA"}, {"source_name_ch1": "CD4+ IL-12 stimulated"}, {"characteristics_ch1": "cell type: CD4+ cells MACS purifed from PBMCs;\tagent: IL-12"}]}, {"GSM3416992": [{"title": "CD4+ IL-23 stimulated"}, {"type": "RNA"}, {"source_name_ch1": "CD4+ IL-23 stimulated"}, {"characteristics_ch1": "cell type: CD4+ cells MACS purifed from PBMCs;\tagent: IL-23"}]}, {"GSM3416993": [{"title": "gdTCR+ non stimulated"}, {"type": "RNA"}, {"source_name_ch1": "gdTCR+ non stimulated"}, {"characteristics_ch1": "cell type: gdTCR+ cells purified by sorting;\tagent: control"}]}, {"GSM3416994": [{"title": "gdTCR+ IL-12 stimulated"}, {"type": "RNA"}, {"source_name_ch1": "gdTCR+ IL-12 stimulated"}, {"characteristics_ch1": "cell type: gdTCR+ cells purified by sorting;\tagent: IL-12"}]}, {"GSM3416995": [{"title": "gdTCR+ IL-23 stimulated"}, {"type": "RNA"}, {"source_name_ch1": "gdTCR+ IL-23 stimulated"}, {"characteristics_ch1": "cell type: gdTCR+ cells purified by sorting;\tagent: IL-23"}]}, {"GSM3416996": [{"title": "CD56+ non stimulated"}, {"type": "RNA"}, {"source_name_ch1": "CD56+ non stimulated"}, {"characteristics_ch1": "cell type: CD56+ cells MACS purifed from PBMCs;\tagent: control"}]}, {"GSM3416997": [{"title": "CD56+ IL-12 stimulated"}, {"type": "RNA"}, {"source_name_ch1": "CD56+ IL-12 stimulated"}, {"characteristics_ch1": "cell type: CD56+ cells MACS purifed from PBMCs;\tagent: IL-12"}]}, {"GSM3416998": [{"title": "CD56+ IL-23 stimulated"}, {"type": "RNA"}, {"source_name_ch1": "CD56+ IL-23 stimulated"}, {"characteristics_ch1": "cell type: CD56+ cells MACS purifed from PBMCs;\tagent: IL-23"}]}, {"GSM3427858": [{"title": "Control_Tub1"}, {"type": "RNA"}, {"source_name_ch1": "renal tubular tissue"}, {"characteristics_ch1": "tissue: renal tubular tissue;\tdisease state: control"}]}, {"GSM3427859": [{"title": "Control_Tub2"}, {"type": "RNA"}, {"source_name_ch1": "renal tubular tissue"}, {"characteristics_ch1": "tissue: renal tubular tissue;\tdisease state: control"}]}, {"GSM3427860": [{"title": "Control_Tub3"}, {"type": "RNA"}, {"source_name_ch1": "renal tubular tissue"}, {"characteristics_ch1": "tissue: renal tubular tissue;\tdisease state: control"}]}, {"GSM3427861": [{"title": "Control_Tub4"}, {"type": "RNA"}, {"source_name_ch1": "renal tubular tissue"}, {"characteristics_ch1": "tissue: renal tubular tissue;\tdisease state: control"}]}, {"GSM3427862": [{"title": "Control_Tub5"}, {"type": "RNA"}, {"source_name_ch1": "renal tubular tissue"}, {"characteristics_ch1": "tissue: renal tubular tissue;\tdisease state: control"}]}, {"GSM3427863": [{"title": "FSGS_Tub1"}, {"type": "RNA"}, {"source_name_ch1": "renal tubular tissue"}, {"characteristics_ch1": "tissue: renal tubular tissue;\tdisease state: Focal segmental glomerulosclerosis (FSGS)"}]}, {"GSM3427864": [{"title": "FSGS_Tub2"}, {"type": "RNA"}, {"source_name_ch1": "renal tubular tissue"}, {"characteristics_ch1": "tissue: renal tubular tissue;\tdisease state: Focal segmental glomerulosclerosis (FSGS)"}]}, {"GSM3427865": [{"title": "FSGS_Tub3"}, {"type": "RNA"}, {"source_name_ch1": "renal tubular tissue"}, {"characteristics_ch1": "tissue: renal tubular tissue;\tdisease state: Focal segmental glomerulosclerosis (FSGS)"}]}, {"GSM3427866": [{"title": "FSGS_Tub4"}, {"type": "RNA"}, {"source_name_ch1": "renal tubular tissue"}, {"characteristics_ch1": "tissue: renal tubular tissue;\tdisease state: Focal segmental glomerulosclerosis (FSGS)"}]}, {"GSM3427867": [{"title": "FSGS_Tub5"}, {"type": "RNA"}, {"source_name_ch1": "renal tubular tissue"}, {"characteristics_ch1": "tissue: renal tubular tissue;\tdisease state: Focal segmental glomerulosclerosis (FSGS)"}]}, {"GSM3428207": [{"title": "Control_1"}, {"type": "RNA"}, {"source_name_ch1": "Renal glomerular tissue"}, {"characteristics_ch1": "tissue: glomeruli;\tdisease state: control"}]}, {"GSM3428208": [{"title": "Control_2"}, {"type": "RNA"}, {"source_name_ch1": "Renal glomerular tissue"}, {"characteristics_ch1": "tissue: glomeruli;\tdisease state: control"}]}, {"GSM3428209": [{"title": "Control_3"}, {"type": "RNA"}, {"source_name_ch1": "Renal glomerular tissue"}, {"characteristics_ch1": "tissue: glomeruli;\tdisease state: control"}]}, {"GSM3428210": [{"title": "Control_4"}, {"type": "RNA"}, {"source_name_ch1": "Renal glomerular tissue"}, {"characteristics_ch1": "tissue: glomeruli;\tdisease state: control"}]}, {"GSM3428211": [{"title": "Control_5"}, {"type": "RNA"}, {"source_name_ch1": "Renal glomerular tissue"}, {"characteristics_ch1": "tissue: glomeruli;\tdisease state: control"}]}, {"GSM3428212": [{"title": "FSGS_1"}, {"type": "RNA"}, {"source_name_ch1": "Renal glomerular tissue"}, {"characteristics_ch1": "tissue: glomeruli;\tdisease state: Focal segmental glomerulosclerosis (FSGS)"}]}, {"GSM3428213": [{"title": "FSGS_2"}, {"type": "RNA"}, {"source_name_ch1": "Renal glomerular tissue"}, {"characteristics_ch1": "tissue: glomeruli;\tdisease state: Focal segmental glomerulosclerosis (FSGS)"}]}, {"GSM3428214": [{"title": "FSGS_3"}, {"type": "RNA"}, {"source_name_ch1": "Renal glomerular tissue"}, {"characteristics_ch1": "tissue: glomeruli;\tdisease state: Focal segmental glomerulosclerosis (FSGS)"}]}, {"GSM3428215": [{"title": "FSGS_4"}, {"type": "RNA"}, {"source_name_ch1": "Renal glomerular tissue"}, {"characteristics_ch1": "tissue: glomeruli;\tdisease state: Focal segmental glomerulosclerosis (FSGS)"}]}, {"GSM3428216": [{"title": "FSGS_5"}, {"type": "RNA"}, {"source_name_ch1": "Renal glomerular tissue"}, {"characteristics_ch1": "tissue: glomeruli;\tdisease state: Focal segmental glomerulosclerosis (FSGS)"}]}, {"GSM3450542": [{"title": "BD patient blood sample in manic episode [422220-1]"}, {"type": "RNA"}, {"source_name_ch1": "Whold blood of BD patient in manic episode"}, {"characteristics_ch1": "subject status: bipolar disorder (BD) patients;\tgender: Female;\tage: 53;\tdisease status: manic episode;\ttissue: Whold blood"}]}, {"GSM3450543": [{"title": "BD patient blood sample in remission  [422220-2]"}, {"type": "RNA"}, {"source_name_ch1": "Whold blood of BD patient in remission"}, {"characteristics_ch1": "subject status: bipolar disorder (BD) patients;\tgender: Female;\tage: 53;\tdisease status: remission;\ttissue: Whold blood"}]}, {"GSM3450544": [{"title": "BD patient blood sample in manic episode [422520-1]"}, {"type": "RNA"}, {"source_name_ch1": "Whold blood of BD patient in manic episode"}, {"characteristics_ch1": "subject status: bipolar disorder (BD) patients;\tgender: Male;\tage: 53;\tdisease status: manic episode;\ttissue: Whold blood"}]}, {"GSM3450545": [{"title": "BD patient blood sample in remission  [422520-2]"}, {"type": "RNA"}, {"source_name_ch1": "Whold blood of BD patient in remission"}, {"characteristics_ch1": "subject status: bipolar disorder (BD) patients;\tgender: Male;\tage: 53;\tdisease status: remission;\ttissue: Whold blood"}]}, {"GSM3450546": [{"title": "BD patient blood sample in manic episode [422720-1]"}, {"type": "RNA"}, {"source_name_ch1": "Whold blood of BD patient in manic episode"}, {"characteristics_ch1": "subject status: bipolar disorder (BD) patients;\tgender: Female;\tage: 38;\tdisease status: manic episode;\ttissue: Whold blood"}]}, {"GSM3450547": [{"title": "BD patient blood sample in remission  [422720-2]"}, {"type": "RNA"}, {"source_name_ch1": "Whold blood of BD patient in remission"}, {"characteristics_ch1": "subject status: bipolar disorder (BD) patients;\tgender: Female;\tage: 38;\tdisease status: remission;\ttissue: Whold blood"}]}, {"GSM3450548": [{"title": "BD patient blood sample in manic episode [422820-1]"}, {"type": "RNA"}, {"source_name_ch1": "Whold blood of BD patient in manic episode"}, {"characteristics_ch1": "subject status: bipolar disorder (BD) patients;\tgender: Male;\tage: 33;\tdisease status: manic episode;\ttissue: Whold blood"}]}, {"GSM3450549": [{"title": "BD patient blood sample in remission  [422820-2]"}, {"type": "RNA"}, {"source_name_ch1": "Whold blood of BD patient in remission"}, {"characteristics_ch1": "subject status: bipolar disorder (BD) patients;\tgender: Male;\tage: 33;\tdisease status: remission;\ttissue: Whold blood"}]}, {"GSM3450550": [{"title": "BD patient blood sample in manic episode [423120-1]"}, {"type": "RNA"}, {"source_name_ch1": "Whold blood of BD patient in manic episode"}, {"characteristics_ch1": "subject status: bipolar disorder (BD) patients;\tgender: Female;\tage: 38;\tdisease status: manic episode;\ttissue: Whold blood"}]}, {"GSM3450551": [{"title": "BD patient blood sample in remission  [423120-2]"}, {"type": "RNA"}, {"source_name_ch1": "Whold blood of BD patient in remission"}, {"characteristics_ch1": "subject status: bipolar disorder (BD) patients;\tgender: Female;\tage: 38;\tdisease status: remission;\ttissue: Whold blood"}]}, {"GSM3450552": [{"title": "BD patient blood sample in manic episode [423820-1]"}, {"type": "RNA"}, {"source_name_ch1": "Whold blood of BD patient in manic episode"}, {"characteristics_ch1": "subject status: bipolar disorder (BD) patients;\tgender: Male;\tage: 56;\tdisease status: manic episode;\ttissue: Whold blood"}]}, {"GSM3450553": [{"title": "BD patient blood sample in remission  [423820-2]"}, {"type": "RNA"}, {"source_name_ch1": "Whold blood of BD patient in remission"}, {"characteristics_ch1": "subject status: bipolar disorder (BD) patients;\tgender: Male;\tage: 56;\tdisease status: remission;\ttissue: Whold blood"}]}, {"GSM3457347": [{"title": "Early stage of colorectal cancer tissues without F. nucleatum infection,rep1"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer tissues with F. nucleatum infection"}, {"characteristics_ch1": "tissue: Human colorectal adenocarcinoma"}]}, {"GSM3457348": [{"title": "Early stage of colorectal cancer tissues without F. nucleatum infection,rep2"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer tissues with F. nucleatum infection"}, {"characteristics_ch1": "tissue: Human colorectal adenocarcinoma"}]}, {"GSM3457349": [{"title": "Early stage of colorectal cancer tissues without F. nucleatum infection,rep3"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer tissues with F. nucleatum infection"}, {"characteristics_ch1": "tissue: Human colorectal adenocarcinoma"}]}, {"GSM3457350": [{"title": "Early stage of colorectal cancer tissues without F. nucleatum infection,rep4"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer tissues with F. nucleatum infection"}, {"characteristics_ch1": "tissue: Human colorectal adenocarcinoma"}]}, {"GSM3457351": [{"title": "Early stage of colorectal cancer tissues without F. nucleatum infection,rep5"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer tissues with F. nucleatum infection"}, {"characteristics_ch1": "tissue: Human colorectal adenocarcinoma"}]}, {"GSM3457352": [{"title": "Advanced stage of colorectal cancer tissues without F. nucleatum infection,rep1"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer tissues with F. nucleatum infection"}, {"characteristics_ch1": "tissue: Human colorectal adenocarcinoma"}]}, {"GSM3457353": [{"title": "Advanced stage of colorectal cancer tissues without F. nucleatum infection,rep2"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer tissues with F. nucleatum infection"}, {"characteristics_ch1": "tissue: Human colorectal adenocarcinoma"}]}, {"GSM3457354": [{"title": "Advanced stage of colorectal cancer tissues without F. nucleatum infection,rep3"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer tissues with F. nucleatum infection"}, {"characteristics_ch1": "tissue: Human colorectal adenocarcinoma"}]}, {"GSM3457355": [{"title": "Advanced stage of colorectal cancer tissues without F. nucleatum infection,rep4"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer tissues with F. nucleatum infection"}, {"characteristics_ch1": "tissue: Human colorectal adenocarcinoma"}]}, {"GSM3457356": [{"title": "Advanced stage of colorectal cancer tissues without F. nucleatum infection,rep5"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer tissues with F. nucleatum infection"}, {"characteristics_ch1": "tissue: Human colorectal adenocarcinoma"}]}, {"GSM3457357": [{"title": "Colorectal cancer tissues without F. nucleatum infection rep1"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer tissues without F. nucleatum infection"}, {"characteristics_ch1": "tissue: Human colorectal adenocarcinoma"}]}, {"GSM3457358": [{"title": "Colorectal cancer tissues without F. nucleatum infection rep2"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer tissues without F. nucleatum infection"}, {"characteristics_ch1": "tissue: Human colorectal adenocarcinoma"}]}, {"GSM3457359": [{"title": "Colorectal cancer tissues without F. nucleatum infection rep3"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer tissues without F. nucleatum infection"}, {"characteristics_ch1": "tissue: Human colorectal adenocarcinoma"}]}, {"GSM3457360": [{"title": "Colorectal cancer tissues without F. nucleatum infection rep4"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer tissues without F. nucleatum infection"}, {"characteristics_ch1": "tissue: Human colorectal adenocarcinoma"}]}, {"GSM3457361": [{"title": "Colorectal cancer tissues without F. nucleatum infection rep5"}, {"type": "RNA"}, {"source_name_ch1": "Colorectal cancer tissues without F. nucleatum infection"}, {"characteristics_ch1": "tissue: Human colorectal adenocarcinoma"}]}, {"GSM3457362": [{"title": "the adjacent normal tissues (Control) without F. nucleatum infection rep1"}, {"type": "RNA"}, {"source_name_ch1": "the adjacent normal tissues (Control) without F. nucleatum infection"}, {"characteristics_ch1": "tissue: Human colorectal tissues"}]}, {"GSM3457363": [{"title": "the adjacent normal tissues (Control) without F. nucleatum infection rep2"}, {"type": "RNA"}, {"source_name_ch1": "the adjacent normal tissues (Control) without F. nucleatum infection"}, {"characteristics_ch1": "tissue: Human colorectal tissues"}]}, {"GSM3457364": [{"title": "the adjacent normal tissues (Control) without F. nucleatum infection rep3"}, {"type": "RNA"}, {"source_name_ch1": "the adjacent normal tissues (Control) without F. nucleatum infection"}, {"characteristics_ch1": "tissue: Human colorectal tissues"}]}, {"GSM3457365": [{"title": "the adjacent normal tissues (Control) without F. nucleatum infection rep4"}, {"type": "RNA"}, {"source_name_ch1": "the adjacent normal tissues (Control) without F. nucleatum infection"}, {"characteristics_ch1": "tissue: Human colorectal tissues"}]}, {"GSM3457366": [{"title": "the adjacent normal tissues (Control) without F. nucleatum infection rep5"}, {"type": "RNA"}, {"source_name_ch1": "the adjacent normal tissues (Control) without F. nucleatum infection"}, {"characteristics_ch1": "tissue: Human colorectal tissues"}]}, {"GSM3457367": [{"title": "the adjacent normal tissues (Control) with F. nucleatum infection,rep1"}, {"type": "RNA"}, {"source_name_ch1": "the adjacent normal tissues (Control) with F. nucleatum infection"}, {"characteristics_ch1": "tissue: colorectal normal tissues"}]}, {"GSM3457368": [{"title": "the adjacent normal tissues (Control) with F. nucleatum infection,rep2"}, {"type": "RNA"}, {"source_name_ch1": "the adjacent normal tissues (Control) with F. nucleatum infection"}, {"characteristics_ch1": "tissue: colorectal normal tissues"}]}, {"GSM3457369": [{"title": "the adjacent normal tissues (Control) with F. nucleatum infection,rep3"}, {"type": "RNA"}, {"source_name_ch1": "the adjacent normal tissues (Control) with F. nucleatum infection"}, {"characteristics_ch1": "tissue: colorectal normal tissues"}]}, {"GSM3457370": [{"title": "the adjacent normal tissues (Control) with F. nucleatum infection,rep4"}, {"type": "RNA"}, {"source_name_ch1": "the adjacent normal tissues (Control) with F. nucleatum infection"}, {"characteristics_ch1": "tissue: colorectal normal tissues"}]}, {"GSM3457371": [{"title": "the adjacent normal tissues (Control) with F. nucleatum infection,rep5"}, {"type": "RNA"}, {"source_name_ch1": "the adjacent normal tissues (Control) with F. nucleatum infection"}, {"characteristics_ch1": "tissue: colorectal normal tissues"}]}, {"GSM3461590": [{"title": "Untreated HT29-MTX, Biological Replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "Untreated HT29-MTX cells"}, {"characteristics_ch1": "cell line: HT29-MTX-E12;\ttreatment: Untreated;\tincubation time: 3 h"}]}, {"GSM3461591": [{"title": "Untreated HT29-MTX, Biological Replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "Untreated HT29-MTX cells"}, {"characteristics_ch1": "cell line: HT29-MTX-E12;\ttreatment: Untreated;\tincubation time: 3 h"}]}, {"GSM3461592": [{"title": "Untreated HT29-MTX, Biological Replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "Untreated HT29-MTX cells"}, {"characteristics_ch1": "cell line: HT29-MTX-E12;\ttreatment: Untreated;\tincubation time: 3 h"}]}, {"GSM3461593": [{"title": "HT29-MTX + YCFA, Biological Replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "HT29-MTX cells treated with YCFA"}, {"characteristics_ch1": "cell line: HT29-MTX-E12;\ttreatment: Bacterial growth medium (YCFA);\tincubation time: 3 h"}]}, {"GSM3461594": [{"title": "HT29-MTX + YCFA, Biological Replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "HT29-MTX cells treated with YCFA"}, {"characteristics_ch1": "cell line: HT29-MTX-E12;\ttreatment: Bacterial growth medium (YCFA);\tincubation time: 3 h"}]}, {"GSM3461595": [{"title": "HT29-MTX + YCFA, Biological Replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "HT29-MTX cells treated with YCFA"}, {"characteristics_ch1": "cell line: HT29-MTX-E12;\ttreatment: Bacterial growth medium (YCFA);\tincubation time: 3 h"}]}, {"GSM3461596": [{"title": "HT29-MTX + MRx0518 live, Biological Replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "HT29-MTX cells treated with live MRx0518"}, {"characteristics_ch1": "cell line: HT29-MTX-E12;\ttreatment: Live MRx0518, MOI 100:1;\tincubation time: 3 h"}]}, {"GSM3461597": [{"title": "HT29-MTX + MRx0518 live, Biological Replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "HT29-MTX cells treated with live MRx0518"}, {"characteristics_ch1": "cell line: HT29-MTX-E12;\ttreatment: Live MRx0518, MOI 100:1;\tincubation time: 3 h"}]}, {"GSM3461598": [{"title": "HT29-MTX + MRx0518 live, Biological Replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "HT29-MTX cells treated with live MRx0518"}, {"characteristics_ch1": "cell line: HT29-MTX-E12;\ttreatment: Live MRx0518, MOI 100:1;\tincubation time: 3 h"}]}, {"GSM3461599": [{"title": "HT29-MTX + MRx0518 supernatant, Biological Replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "HT29-MTX cells treated with MRx0518 supernatant"}, {"characteristics_ch1": "cell line: HT29-MTX-E12;\ttreatment: MRx0518 Supernatant, MOI 100:1 equivalent;\tincubation time: 3 h"}]}, {"GSM3461600": [{"title": "HT29-MTX + MRx0518 supernatant, Biological Replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "HT29-MTX cells treated with MRx0518 supernatant"}, {"characteristics_ch1": "cell line: HT29-MTX-E12;\ttreatment: MRx0518 Supernatant, MOI 100:1 equivalent;\tincubation time: 3 h"}]}, {"GSM3461601": [{"title": "HT29-MTX + MRx0518 supernatant, Biological Replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "HT29-MTX cells treated with MRx0518 supernatant"}, {"characteristics_ch1": "cell line: HT29-MTX-E12;\ttreatment: MRx0518 Supernatant, MOI 100:1 equivalent;\tincubation time: 3 h"}]}, {"GSM3461602": [{"title": "HT29-MTX + MRx0518 heat-killed, Biological Replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "HT29-MTX cells treated with heat-killed MRx0518"}, {"characteristics_ch1": "cell line: HT29-MTX-E12;\ttreatment: Heat-killed MRx0518, MOI 100:1;\tincubation time: 3 h"}]}, {"GSM3461603": [{"title": "HT29-MTX + MRx0518 heat-killed, Biological Replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "HT29-MTX cells treated with heat-killed MRx0518"}, {"characteristics_ch1": "cell line: HT29-MTX-E12;\ttreatment: Heat-killed MRx0518, MOI 100:1;\tincubation time: 3 h"}]}, {"GSM3461604": [{"title": "HT29-MTX + MRx0518 heat-killed, Biological Replicate 3"}, {"type": "RNA"}, {"source_name_ch1": "HT29-MTX cells treated with heat-killed MRx0518"}, {"characteristics_ch1": "cell line: HT29-MTX-E12;\ttreatment: Heat-killed MRx0518, MOI 100:1;\tincubation time: 3 h"}]}, {"GSM3518827": [{"title": "M(IFN-\u03b3), 1"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood"}, {"characteristics_ch1": "cell type: macrophages;\tagent: M(IFN-gamma)"}]}, {"GSM3518828": [{"title": "M(IFN-\u03b3), 2"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood"}, {"characteristics_ch1": "cell type: macrophages;\tagent: M(IFN-gamma)"}]}, {"GSM3518829": [{"title": "M(IFN-\u03b3), 3"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood"}, {"characteristics_ch1": "cell type: macrophages;\tagent: M(IFN-gamma)"}]}, {"GSM3518830": [{"title": "M (IL-10), 1"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood"}, {"characteristics_ch1": "cell type: macrophages;\tagent: M (IL-10)"}]}, {"GSM3518831": [{"title": "M (IL-10), 2"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood"}, {"characteristics_ch1": "cell type: macrophages;\tagent: M (IL-10)"}]}, {"GSM3518832": [{"title": "M (IL-10), 3"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood"}, {"characteristics_ch1": "cell type: macrophages;\tagent: M (IL-10)"}]}, {"GSM3518833": [{"title": "M(IFN-\u03b3) + Rapamycin, 1"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood"}, {"characteristics_ch1": "cell type: macrophages;\tagent: M(IFN-gamma) + Rapamycin"}]}, {"GSM3518834": [{"title": "M(IFN-\u03b3) + Rapamycin, 2"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood"}, {"characteristics_ch1": "cell type: macrophages;\tagent: M(IFN-gamma) + Rapamycin"}]}, {"GSM3518835": [{"title": "M(IFN-\u03b3) + Rapamycin, 3"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood"}, {"characteristics_ch1": "cell type: macrophages;\tagent: M(IFN-gamma) + Rapamycin"}]}, {"GSM3518836": [{"title": "M (IL-10) + Rapamycin, 1"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood"}, {"characteristics_ch1": "cell type: macrophages;\tagent: M (IL-10) + Rapamycin"}]}, {"GSM3518837": [{"title": "M (IL-10) + Rapamycin, 2"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood"}, {"characteristics_ch1": "cell type: macrophages;\tagent: M (IL-10) + Rapamycin"}]}, {"GSM3518838": [{"title": "M (IL-10) + Rapamycin, 3"}, {"type": "RNA"}, {"source_name_ch1": "Peripheral blood"}, {"characteristics_ch1": "cell type: macrophages;\tagent: M (IL-10) + Rapamycin"}]}, {"GSM3520736": [{"title": "1_PBM"}, {"type": "RNA"}, {"source_name_ch1": "adult peripheral blood"}, {"characteristics_ch1": "tissue: adult peripheral blood;\tcell type: macrophages;\tagent: IFN-\u03b3"}]}, {"GSM3520737": [{"title": "2_PBM"}, {"type": "RNA"}, {"source_name_ch1": "adult peripheral blood"}, {"characteristics_ch1": "tissue: adult peripheral blood;\tcell type: macrophages;\tagent: IFN-\u03b3"}]}, {"GSM3520738": [{"title": "3_PBM"}, {"type": "RNA"}, {"source_name_ch1": "adult peripheral blood"}, {"characteristics_ch1": "tissue: adult peripheral blood;\tcell type: macrophages;\tagent: IFN-\u03b3"}]}, {"GSM3520739": [{"title": "1_adult"}, {"type": "RNA"}, {"source_name_ch1": "adult peripheral blood"}, {"characteristics_ch1": "tissue: adult peripheral blood;\tcell type: macrophages;\tagent: IL10"}]}, {"GSM3520740": [{"title": "2_adult"}, {"type": "RNA"}, {"source_name_ch1": "adult peripheral blood"}, {"characteristics_ch1": "tissue: adult peripheral blood;\tcell type: macrophages;\tagent: IL10"}]}, {"GSM3520741": [{"title": "3_adult"}, {"type": "RNA"}, {"source_name_ch1": "adult peripheral blood"}, {"characteristics_ch1": "tissue: adult peripheral blood;\tcell type: macrophages;\tagent: IL10"}]}, {"GSM3520742": [{"title": "1_CBM"}, {"type": "RNA"}, {"source_name_ch1": "cord blood"}, {"characteristics_ch1": "tissue: cord blood;\tcell type: macrophages;\tagent: IFN-\u03b3"}]}, {"GSM3520743": [{"title": "2_CBM"}, {"type": "RNA"}, {"source_name_ch1": "cord blood"}, {"characteristics_ch1": "tissue: cord blood;\tcell type: macrophages;\tagent: IFN-\u03b3"}]}, {"GSM3520744": [{"title": "3_CBM"}, {"type": "RNA"}, {"source_name_ch1": "cord blood"}, {"characteristics_ch1": "tissue: cord blood;\tcell type: macrophages;\tagent: IFN-\u03b3"}]}, {"GSM3520745": [{"title": "1_CB"}, {"type": "RNA"}, {"source_name_ch1": "cord blood"}, {"characteristics_ch1": "tissue: cord blood;\tcell type: macrophages;\tagent: IL10"}]}, {"GSM3520746": [{"title": "2_CB"}, {"type": "RNA"}, {"source_name_ch1": "cord blood"}, {"characteristics_ch1": "tissue: cord blood;\tcell type: macrophages;\tagent: IL10"}]}, {"GSM3520747": [{"title": "3_CB"}, {"type": "RNA"}, {"source_name_ch1": "cord blood"}, {"characteristics_ch1": "tissue: cord blood;\tcell type: macrophages;\tagent: IL10"}]}, {"GSM3559852": [{"title": "D319N ERK2, rep 1"}, {"type": "RNA"}, {"source_name_ch1": "MCF10A D319N ERK2"}, {"characteristics_ch1": "cell line: MCF10A;\tcell type: breast epithelial cells;\tgenotype/variation: expressing D319N ERK2"}]}, {"GSM3559853": [{"title": "D319N ERK2, rep 2"}, {"type": "RNA"}, {"source_name_ch1": "MCF10A D319N ERK2"}, {"characteristics_ch1": "cell line: MCF10A;\tcell type: breast epithelial cells;\tgenotype/variation: expressing D319N ERK2"}]}, {"GSM3559854": [{"title": "D319N ERK2, rep 3"}, {"type": "RNA"}, {"source_name_ch1": "MCF10A D319N ERK2"}, {"characteristics_ch1": "cell line: MCF10A;\tcell type: breast epithelial cells;\tgenotype/variation: expressing D319N ERK2"}]}, {"GSM3559855": [{"title": "Vec control, rep 1"}, {"type": "RNA"}, {"source_name_ch1": "MCF10A vec control"}, {"characteristics_ch1": "cell line: MCF10A;\tcell type: breast epithelial cells;\tgenotype/variation: expressing vector control"}]}, {"GSM3559856": [{"title": "Vec control, rep 2"}, {"type": "RNA"}, {"source_name_ch1": "MCF10A vec control"}, {"characteristics_ch1": "cell line: MCF10A;\tcell type: breast epithelial cells;\tgenotype/variation: expressing vector control"}]}, {"GSM3559857": [{"title": "Vec control, rep 3"}, {"type": "RNA"}, {"source_name_ch1": "MCF10A vec control"}, {"characteristics_ch1": "cell line: MCF10A;\tcell type: breast epithelial cells;\tgenotype/variation: expressing vector control"}]}, {"GSM3559858": [{"title": "Y261A ERK2, rep 1"}, {"type": "RNA"}, {"source_name_ch1": "MCF10A Y261A ERK2"}, {"characteristics_ch1": "cell line: MCF10A;\tcell type: breast epithelial cells;\tgenotype/variation: expressing Y261A ERK2"}]}, {"GSM3559859": [{"title": "Y261A ERK2, rep 2"}, {"type": "RNA"}, {"source_name_ch1": "MCF10A Y261A ERK2"}, {"characteristics_ch1": "cell line: MCF10A;\tcell type: breast epithelial cells;\tgenotype/variation: expressing Y261A ERK2"}]}, {"GSM3559860": [{"title": "Y261A ERK2, rep 3"}, {"type": "RNA"}, {"source_name_ch1": "MCF10A Y261A ERK2"}, {"characteristics_ch1": "cell line: MCF10A;\tcell type: breast epithelial cells;\tgenotype/variation: expressing Y261A ERK2"}]}, {"GSM3581796": [{"title": "Control_Tub_1"}, {"type": "RNA"}, {"source_name_ch1": "Control"}, {"characteristics_ch1": "tissue: renal tubulointerstitial tissue;\tdisease state: Control"}]}, {"GSM3581797": [{"title": "Control_Tub_2"}, {"type": "RNA"}, {"source_name_ch1": "Control"}, {"characteristics_ch1": "tissue: renal tubulointerstitial tissue;\tdisease state: Control"}]}, {"GSM3581798": [{"title": "Control_Tub_3"}, {"type": "RNA"}, {"source_name_ch1": "Control"}, {"characteristics_ch1": "tissue: renal tubulointerstitial tissue;\tdisease state: Control"}]}, {"GSM3581799": [{"title": "Control_Tub_4"}, {"type": "RNA"}, {"source_name_ch1": "Control"}, {"characteristics_ch1": "tissue: renal tubulointerstitial tissue;\tdisease state: Control"}]}, {"GSM3581800": [{"title": "Control_Tub_5"}, {"type": "RNA"}, {"source_name_ch1": "Control"}, {"characteristics_ch1": "tissue: renal tubulointerstitial tissue;\tdisease state: Control"}]}, {"GSM3581801": [{"title": "Control_Tub_6"}, {"type": "RNA"}, {"source_name_ch1": "Control"}, {"characteristics_ch1": "tissue: renal tubulointerstitial tissue;\tdisease state: Control"}]}, {"GSM3581802": [{"title": "Control_Tub_7"}, {"type": "RNA"}, {"source_name_ch1": "Control"}, {"characteristics_ch1": "tissue: renal tubulointerstitial tissue;\tdisease state: Control"}]}, {"GSM3581803": [{"title": "Control_Tub_8"}, {"type": "RNA"}, {"source_name_ch1": "Control"}, {"characteristics_ch1": "tissue: renal tubulointerstitial tissue;\tdisease state: Control"}]}, {"GSM3581804": [{"title": "FSGS_Tub_1"}, {"type": "RNA"}, {"source_name_ch1": "FSGS"}, {"characteristics_ch1": "tissue: renal tubulointerstitial tissue;\tdisease state: FSGS"}]}, {"GSM3581805": [{"title": "FSGS_Tub_2"}, {"type": "RNA"}, {"source_name_ch1": "FSGS"}, {"characteristics_ch1": "tissue: renal tubulointerstitial tissue;\tdisease state: FSGS"}]}, {"GSM3581806": [{"title": "FSGS_Tub_3"}, {"type": "RNA"}, {"source_name_ch1": "FSGS"}, {"characteristics_ch1": "tissue: renal tubulointerstitial tissue;\tdisease state: FSGS"}]}, {"GSM3581807": [{"title": "FSGS_Tub_4"}, {"type": "RNA"}, {"source_name_ch1": "FSGS"}, {"characteristics_ch1": "tissue: renal tubulointerstitial tissue;\tdisease state: FSGS"}]}, {"GSM3581808": [{"title": "FSGS_Tub_5"}, {"type": "RNA"}, {"source_name_ch1": "FSGS"}, {"characteristics_ch1": "tissue: renal tubulointerstitial tissue;\tdisease state: FSGS"}]}, {"GSM3581809": [{"title": "FSGS_Tub_6"}, {"type": "RNA"}, {"source_name_ch1": "FSGS"}, {"characteristics_ch1": "tissue: renal tubulointerstitial tissue;\tdisease state: FSGS"}]}, {"GSM3581810": [{"title": "FSGS_Tub_7"}, {"type": "RNA"}, {"source_name_ch1": "FSGS"}, {"characteristics_ch1": "tissue: renal tubulointerstitial tissue;\tdisease state: FSGS"}]}, {"GSM3581811": [{"title": "FSGS_Tub_8"}, {"type": "RNA"}, {"source_name_ch1": "FSGS"}, {"characteristics_ch1": "tissue: renal tubulointerstitial tissue;\tdisease state: FSGS"}]}, {"GSM3594212": [{"title": "hPDLs cells control 1"}, {"type": "RNA"}, {"source_name_ch1": "hPDLs cells"}, {"characteristics_ch1": "tissue: periodontal ligament cells;\ttreatment: Human IgG Fc fragment"}]}, {"GSM3594213": [{"title": "hPDLs cells control 2"}, {"type": "RNA"}, {"source_name_ch1": "hPDLs cells"}, {"characteristics_ch1": "tissue: periodontal ligament cells;\ttreatment: Human IgG Fc fragment"}]}, {"GSM3594214": [{"title": "hPDLs cells control 3"}, {"type": "RNA"}, {"source_name_ch1": "hPDLs cells"}, {"characteristics_ch1": "tissue: periodontal ligament cells;\ttreatment: Human IgG Fc fragment"}]}, {"GSM3594215": [{"title": "hPDLs cells control 4"}, {"type": "RNA"}, {"source_name_ch1": "hPDLs cells from"}, {"characteristics_ch1": "tissue: periodontal ligament cells;\ttreatment: Human IgG Fc fragment"}]}, {"GSM3594216": [{"title": "hPDLs cells control 5"}, {"type": "RNA"}, {"source_name_ch1": "hPDLs cells"}, {"characteristics_ch1": "tissue: periodontal ligament cells;\ttreatment: Human IgG Fc fragment"}]}, {"GSM3594217": [{"title": "Jagged1 treated hPDLs cells 1"}, {"type": "RNA"}, {"source_name_ch1": "Jagged1 treated hPDLs cells"}, {"characteristics_ch1": "tissue: periodontal ligament cells;\ttreatment: bovine serum albumin (10 mg/mL) for 2 h and Jagged1/Fc (10 nM) for 2 h"}]}, {"GSM3594218": [{"title": "Jagged1 treated hPDLs cells 2"}, {"type": "RNA"}, {"source_name_ch1": "Jagged1 treated hPDLs cells"}, {"characteristics_ch1": "tissue: periodontal ligament cells;\ttreatment: bovine serum albumin (10 mg/mL) for 2 h and Jagged1/Fc (10 nM) for 2 h"}]}, {"GSM3594219": [{"title": "Jagged1 treated hPDLs cells 3"}, {"type": "RNA"}, {"source_name_ch1": "Jagged1 treated hPDLs cells"}, {"characteristics_ch1": "tissue: periodontal ligament cells;\ttreatment: bovine serum albumin (10 mg/mL) for 2 h and Jagged1/Fc (10 nM) for 2 h"}]}, {"GSM3594220": [{"title": "Jagged1 treated hPDLs cells 4"}, {"type": "RNA"}, {"source_name_ch1": "Jagged1 treated hPDLs cells"}, {"characteristics_ch1": "tissue: periodontal ligament cells;\ttreatment: bovine serum albumin (10 mg/mL) for 2 h and Jagged1/Fc (10 nM) for 2 h"}]}, {"GSM3594221": [{"title": "Jagged1 treated hPDLs cells 5"}, {"type": "RNA"}, {"source_name_ch1": "Jagged1 treated hPDLs cells"}, {"characteristics_ch1": "tissue: periodontal ligament cells;\ttreatment: bovine serum albumin (10 mg/mL) for 2 h and Jagged1/Fc (10 nM) for 2 h"}]}, {"GSM2452044": [{"title": "DMSO_shCTCF1_Rep1_RNA"}, {"type": "RNA"}, {"source_name_ch1": "Immortalized prostate epithelial cells"}, {"characteristics_ch1": "tissue: Immortalized prostate epithelial cells;\ttreatment: No knockdown control, vehicle treated, 5 days"}]}, {"GSM2452045": [{"title": "DMSO_shCTCF1_Rep2_RNA"}, {"type": "RNA"}, {"source_name_ch1": "Immortalized prostate epithelial cells"}, {"characteristics_ch1": "tissue: Immortalized prostate epithelial cells;\ttreatment: No knockdown control, vehicle treated, 5 days"}]}, {"GSM2452046": [{"title": "DMSO_shCTCF1_Rep3_RNA"}, {"type": "RNA"}, {"source_name_ch1": "Immortalized prostate epithelial cells"}, {"characteristics_ch1": "tissue: Immortalized prostate epithelial cells;\ttreatment: No knockdown control, vehicle treated, 5 days"}]}, {"GSM2452047": [{"title": "Dox_shCTCF1_Rep1_RNA"}, {"type": "RNA"}, {"source_name_ch1": "Immortalized prostate epithelial cells"}, {"characteristics_ch1": "tissue: Immortalized prostate epithelial cells;\ttreatment: CTCF knockdown, doxycycline treated, 5 days"}]}, {"GSM2452048": [{"title": "Dox_shCTCF1_Rep2_RNA"}, {"type": "RNA"}, {"source_name_ch1": "Immortalized prostate epithelial cells"}, {"characteristics_ch1": "tissue: Immortalized prostate epithelial cells;\ttreatment: CTCF knockdown, doxycycline treated, 5 days"}]}, {"GSM2452049": [{"title": "Dox_shCTCF1_Rep3_RNA"}, {"type": "RNA"}, {"source_name_ch1": "Immortalized prostate epithelial cells"}, {"characteristics_ch1": "tissue: Immortalized prostate epithelial cells;\ttreatment: CTCF knockdown, doxycycline treated, 5 days"}]}, {"GSM2646622": [{"title": "stool_N1_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Female;\tage (yr): 62;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Testing"}]}, {"GSM2646623": [{"title": "stool_N2_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 41;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646624": [{"title": "stool_N3_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Female;\tage (yr): 49;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646625": [{"title": "stool_N4_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Female;\tage (yr): 49;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646626": [{"title": "stool_N5_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 50;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646627": [{"title": "stool_P1_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 54;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Testing"}]}, {"GSM2646628": [{"title": "stool_C1_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage I;\tSex: Female;\tage (yr): 53;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Testing"}]}, {"GSM2646629": [{"title": "stool_C2_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage III;\tSex: Male;\tage (yr): 47;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646630": [{"title": "stool_C3_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage III;\tSex: Male;\tage (yr): 47;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646631": [{"title": "stool_C4_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage IV;\tSex: Female;\tage (yr): 49;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646632": [{"title": "stool_P2_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 48;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646633": [{"title": "stool_P3_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 55;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646634": [{"title": "stool_N6_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 62;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Testing"}]}, {"GSM2646635": [{"title": "stool_P4_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 63;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646636": [{"title": "stool_P5_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 48;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646637": [{"title": "stool_C5_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage II;\tSex: Male;\tage (yr): 54;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646638": [{"title": "stool_C6_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage I;\tSex: Female;\tage (yr): 58;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Testing"}]}, {"GSM2646639": [{"title": "stool_C7_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage IV;\tSex: Female;\tage (yr): 55;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646640": [{"title": "stool_N7_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 53;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646641": [{"title": "stool_N8_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 54;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646642": [{"title": "stool_N9_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 58;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646643": [{"title": "stool_N10_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 62;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646644": [{"title": "stool_P6_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Female;\tage (yr): 60;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Testing"}]}, {"GSM2646645": [{"title": "stool_C8_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage I;\tSex: Female;\tage (yr): 54;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646646": [{"title": "stool_C9_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage III;\tSex: Female;\tage (yr): 53;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646647": [{"title": "stool_C10_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage III;\tSex: Male;\tage (yr): 52;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646648": [{"title": "stool_C11_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage III;\tSex: Female;\tage (yr): 56;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: Yes;\tset: Testing"}]}, {"GSM2646649": [{"title": "stool_N11_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Female;\tage (yr): 50;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Testing"}]}, {"GSM2646650": [{"title": "stool_N12_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Female;\tage (yr): 42;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646651": [{"title": "stool_N13_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 54;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646652": [{"title": "stool_P7_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 55;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646653": [{"title": "stool_P8_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Female;\tage (yr): 68;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646654": [{"title": "stool_P9_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Female;\tage (yr): 50;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646655": [{"title": "stool_P10_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Female;\tage (yr): 58;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646656": [{"title": "stool_N14_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 48;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646657": [{"title": "stool_N15_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Female;\tage (yr): 50;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646658": [{"title": "stool_N16_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 63;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Testing"}]}, {"GSM2646659": [{"title": "stool_N17_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 54;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646660": [{"title": "stool_P11_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 37;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Testing"}]}, {"GSM2646661": [{"title": "stool_P12_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Female;\tage (yr): 44;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646662": [{"title": "stool_P13_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 52;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646663": [{"title": "stool_P14_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 47;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646664": [{"title": "stool_P15_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Female;\tage (yr): 53;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646665": [{"title": "stool_P16_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Female;\tage (yr): 61;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Testing"}]}, {"GSM2646666": [{"title": "stool_P17_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 67;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646667": [{"title": "stool_N18_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 60;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646668": [{"title": "stool_N19_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 55;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646669": [{"title": "stool_N20_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 52;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646670": [{"title": "stool_N21_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 57;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Testing"}]}, {"GSM2646671": [{"title": "stool_N22_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Female;\tage (yr): 63;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646672": [{"title": "stool_N23_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 62;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646673": [{"title": "stool_N24_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 63;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646674": [{"title": "stool_N25_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Female;\tage (yr): 54;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646675": [{"title": "stool_N26_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 55;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Testing"}]}, {"GSM2646676": [{"title": "stool_N27_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 48;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646677": [{"title": "stool_C12_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage III;\tSex: Female;\tage (yr): 47;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646678": [{"title": "stool_P18_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 64;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646679": [{"title": "stool_C13_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage II;\tSex: Male;\tage (yr): 55;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646680": [{"title": "stool_C14_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage IV;\tSex: Male;\tage (yr): 58;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646681": [{"title": "stool_P19_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Female;\tage (yr): 47;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646682": [{"title": "stool_C15_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage I;\tSex: Male;\tage (yr): 61;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646683": [{"title": "stool_C16_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage I;\tSex: Male;\tage (yr): 65;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Testing"}]}, {"GSM2646684": [{"title": "stool_N28_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 63;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646685": [{"title": "stool_C17_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage IV;\tSex: Female;\tage (yr): 63;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: Yes;\tset: Training"}]}, {"GSM2646686": [{"title": "stool_N29_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Female;\tage (yr): 55;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646687": [{"title": "stool_N30_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Female;\tage (yr): 55;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646688": [{"title": "stool_N31_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 49;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646689": [{"title": "stool_N32_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Female;\tage (yr): 53;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Testing"}]}, {"GSM2646690": [{"title": "stool_N33_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Female;\tage (yr): 58;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646691": [{"title": "stool_N34_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 61;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646692": [{"title": "stool_N35_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 52;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646693": [{"title": "stool_P20_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Female;\tage (yr): 62;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646694": [{"title": "stool_P21_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 55;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646695": [{"title": "stool_P22_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 49;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Testing"}]}, {"GSM2646696": [{"title": "stool_P23_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Female;\tage (yr): 54;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646697": [{"title": "stool_P24_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 35;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646698": [{"title": "stool_N36_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Female;\tage (yr): 63;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646699": [{"title": "stool_P25_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 53;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646700": [{"title": "stool_P26_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Female;\tage (yr): 60;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646701": [{"title": "stool_N37_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Female;\tage (yr): 53;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Testing"}]}, {"GSM2646702": [{"title": "stool_N38_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Female;\tage (yr): 62;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646703": [{"title": "stool_N39_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 55;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646704": [{"title": "stool_N40_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 48;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646705": [{"title": "stool_N41_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 51;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646706": [{"title": "stool_N42_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Female;\tage (yr): 53;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Testing"}]}, {"GSM2646707": [{"title": "stool_N43_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 62;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646708": [{"title": "stool_N44_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 55;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646709": [{"title": "stool_C18_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage IV;\tSex: Female;\tage (yr): 55;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646710": [{"title": "stool_C19_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage IV;\tSex: Male;\tage (yr): 67;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646711": [{"title": "stool_C20_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage III;\tSex: Male;\tage (yr): 58;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646712": [{"title": "stool_C21_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage III;\tSex: Female;\tage (yr): 63;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646713": [{"title": "stool_C22_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage III;\tSex: Female;\tage (yr): 71;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Testing"}]}, {"GSM2646714": [{"title": "stool_C23_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage II;\tSex: Female;\tage (yr): 58;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646715": [{"title": "stool_C24_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage II;\tSex: Female;\tage (yr): 72;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646716": [{"title": "stool_C25_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage II;\tSex: Female;\tage (yr): 64;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646717": [{"title": "stool_C26_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage II;\tSex: Male;\tage (yr): 56;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646718": [{"title": "stool_C27_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage I;\tSex: Female;\tage (yr): 58;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Testing"}]}, {"GSM2646719": [{"title": "stool_C28_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage I;\tSex: Male;\tage (yr): 72;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646720": [{"title": "stool_C29_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage I;\tSex: Male;\tage (yr): 64;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646721": [{"title": "stool_C30_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage I;\tSex: Male;\tage (yr): 56;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646722": [{"title": "stool_N45_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 65;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646723": [{"title": "stool_N46_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Female;\tage (yr): 54;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646724": [{"title": "stool_N47_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Female;\tage (yr): 50;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646725": [{"title": "stool_C31_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage IV;\tSex: Male;\tage (yr): 54;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Testing"}]}, {"GSM2646726": [{"title": "stool_C32_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage IV;\tSex: Female;\tage (yr): 60;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646727": [{"title": "stool_C33_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage IV;\tSex: Male;\tage (yr): 70;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646728": [{"title": "stool_C34_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage III;\tSex: Male;\tage (yr): 55;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646729": [{"title": "stool_C35_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage III;\tSex: Male;\tage (yr): 49;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646730": [{"title": "stool_C36_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage III;\tSex: Male;\tage (yr): 65;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646731": [{"title": "stool_C37_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage II;\tSex: Male;\tage (yr): 66;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Testing"}]}, {"GSM2646732": [{"title": "stool_C38_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage II;\tSex: Male;\tage (yr): 69;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646733": [{"title": "stool_C39_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage II;\tSex: Female;\tage (yr): 51;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646734": [{"title": "stool_C40_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage II;\tSex: Male;\tage (yr): 54;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646735": [{"title": "stool_C41_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage I;\tSex: Male;\tage (yr): 66;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646736": [{"title": "stool_C42_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage I;\tSex: Male;\tage (yr): 69;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Testing"}]}, {"GSM2646737": [{"title": "stool_C43_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage I;\tSex: Male;\tage (yr): 73;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646738": [{"title": "stool_C44_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage I;\tSex: Male;\tage (yr): 75;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646739": [{"title": "stool_P27_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 45;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Testing"}]}, {"GSM2646740": [{"title": "stool_P28_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 57;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646741": [{"title": "stool_P29_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 63;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646742": [{"title": "stool_P30_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 61;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646743": [{"title": "stool_P31_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 55;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646744": [{"title": "stool_N48_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Female;\tage (yr): 60;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646745": [{"title": "stool_N49_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 64;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646746": [{"title": "stool_N50_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 52;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Testing"}]}, {"GSM2646747": [{"title": "stool_N51_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Female;\tage (yr): 46;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646748": [{"title": "stool_P32_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Female;\tage (yr): 49;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Testing"}]}, {"GSM2646749": [{"title": "stool_P33_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Female;\tage (yr): 57;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646750": [{"title": "stool_P34_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 62;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646751": [{"title": "stool_P35_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Female;\tage (yr): 70;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646752": [{"title": "stool_P36_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 65;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646753": [{"title": "stool_P37_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 58;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646754": [{"title": "stool_C45_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage IV;\tSex: Female;\tage (yr): 53;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646755": [{"title": "stool_C46_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage IV;\tSex: Female;\tage (yr): 47;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646756": [{"title": "stool_C47_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage IV;\tSex: Male;\tage (yr): 42;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Testing"}]}, {"GSM2646757": [{"title": "stool_C48_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage III;\tSex: Male;\tage (yr): 67;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646758": [{"title": "stool_C49_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage III;\tSex: Male;\tage (yr): 54;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646759": [{"title": "stool_C50_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage III;\tSex: Male;\tage (yr): 58;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646760": [{"title": "stool_C51_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage II;\tSex: Male;\tage (yr): 55;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646761": [{"title": "stool_C52_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage II;\tSex: Male;\tage (yr): 53;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646762": [{"title": "stool_C53_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage II;\tSex: Male;\tage (yr): 58;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Testing"}]}, {"GSM2646763": [{"title": "stool_C54_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage I;\tSex: Female;\tage (yr): 56;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646764": [{"title": "stool_C55_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage I;\tSex: Female;\tage (yr): 55;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646765": [{"title": "stool_C56_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage I;\tSex: Female;\tage (yr): 63;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646766": [{"title": "stool_P38_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Female;\tage (yr): 45;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Testing"}]}, {"GSM2646767": [{"title": "stool_P39_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 38;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646768": [{"title": "stool_N52_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 53;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646769": [{"title": "stool_N53_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Female;\tage (yr): 47;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Testing"}]}, {"GSM2646770": [{"title": "stool_N54_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 57;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646771": [{"title": "stool_N55_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 45;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646772": [{"title": "stool_P40_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Female;\tage (yr): 55;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646773": [{"title": "stool_P41_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Female;\tage (yr): 66;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646774": [{"title": "stool_P42_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Female;\tage (yr): 70;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646775": [{"title": "stool_P43_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Female;\tage (yr): 57;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Testing"}]}, {"GSM2646776": [{"title": "stool_P44_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 61;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646777": [{"title": "stool_P45_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Female;\tage (yr): 59;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646778": [{"title": "stool_P46_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Female;\tage (yr): 54;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646779": [{"title": "stool_P47_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Female;\tage (yr): 72;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646780": [{"title": "stool_P48_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 60;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Testing"}]}, {"GSM2646781": [{"title": "stool_C57_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage IV;\tSex: Male;\tage (yr): 67;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646782": [{"title": "stool_C58_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage IV;\tSex: Male;\tage (yr): 53;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Testing"}]}, {"GSM2646783": [{"title": "stool_C59_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage III;\tSex: Male;\tage (yr): 62;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646784": [{"title": "stool_C60_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage III;\tSex: Male;\tage (yr): 60;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646785": [{"title": "stool_C61_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage III;\tSex: Female;\tage (yr): 55;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646786": [{"title": "stool_C62_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage II;\tSex: Male;\tage (yr): 61;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646787": [{"title": "stool_C63_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage II;\tSex: Female;\tage (yr): 65;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Testing"}]}, {"GSM2646788": [{"title": "stool_C64_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage I;\tSex: Male;\tage (yr): 70;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646789": [{"title": "stool_C65_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage I;\tSex: Female;\tage (yr): 52;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646790": [{"title": "stool_C66_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage I;\tSex: Male;\tage (yr): 50;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646791": [{"title": "stool_N56_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Female;\tage (yr): 39;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646792": [{"title": "stool_N57_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Female;\tage (yr): 42;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646793": [{"title": "stool_N58_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 54;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646794": [{"title": "stool_N59_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Female;\tage (yr): 51;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Testing"}]}, {"GSM2646795": [{"title": "stool_N60_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 62;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646796": [{"title": "stool_P49_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 75;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646797": [{"title": "stool_P50_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 65;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646798": [{"title": "stool_P51_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Female;\tage (yr): 59;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646799": [{"title": "stool_P52_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 51;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646800": [{"title": "stool_P53_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 63;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646801": [{"title": "stool_P54_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 61;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Testing"}]}, {"GSM2646802": [{"title": "stool_P55_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Female;\tage (yr): 55;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646803": [{"title": "stool_P56_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 49;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646804": [{"title": "stool_C67_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage IV;\tSex: Male;\tage (yr): 58;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646805": [{"title": "stool_C68_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage II;\tSex: Female;\tage (yr): 64;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646806": [{"title": "stool_C69_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage I;\tSex: Male;\tage (yr): 63;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Testing"}]}, {"GSM2646807": [{"title": "stool_N61_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 43;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646808": [{"title": "stool_N62_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 47;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646809": [{"title": "stool_N63_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Female;\tage (yr): 34;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646810": [{"title": "stool_N64_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 57;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Testing"}]}, {"GSM2646811": [{"title": "stool_N65_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Female;\tage (yr): 55;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646812": [{"title": "stool_N66_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 51;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646813": [{"title": "stool_N67_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 62;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646814": [{"title": "stool_N68_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Female;\tage (yr): 48;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646815": [{"title": "stool_P57_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 47;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646816": [{"title": "stool_C70_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage II;\tSex: Female;\tage (yr): 54;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646817": [{"title": "stool_P58_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 57;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646818": [{"title": "stool_P59_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Female;\tage (yr): 62;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646819": [{"title": "stool_P60_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Female;\tage (yr): 70;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Testing"}]}, {"GSM2646820": [{"title": "stool_P61_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Female;\tage (yr): 65;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646821": [{"title": "stool_P62_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 47;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646822": [{"title": "stool_C71_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage IV;\tSex: Male;\tage (yr): 71;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646823": [{"title": "stool_C72_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage IV;\tSex: Male;\tage (yr): 55;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646824": [{"title": "stool_C73_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage IV;\tSex: Male;\tage (yr): 48;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646825": [{"title": "stool_C74_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage III;\tSex: Female;\tage (yr): 56;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646826": [{"title": "stool_C75_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage II;\tSex: Male;\tage (yr): 64;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Testing"}]}, {"GSM2646827": [{"title": "stool_C76_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage II;\tSex: Female;\tage (yr): 65;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646828": [{"title": "stool_C77_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage I;\tSex: Female;\tage (yr): 57;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646829": [{"title": "stool_C78_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage I;\tSex: Female;\tage (yr): 55;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646830": [{"title": "stool_N69_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 51;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Testing"}]}, {"GSM2646831": [{"title": "stool_N70_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 58;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646832": [{"title": "stool_N71_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Female;\tage (yr): 62;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646833": [{"title": "stool_N72_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 64;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646834": [{"title": "stool_N73_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 51;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646835": [{"title": "stool_N74_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Female;\tage (yr): 50;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Testing"}]}, {"GSM2646836": [{"title": "stool_N75_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 47;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646837": [{"title": "stool_N76_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Female;\tage (yr): 50;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646838": [{"title": "stool_P63_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 58;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646839": [{"title": "stool_P64_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 37;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Testing"}]}, {"GSM2646840": [{"title": "stool_N77_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 37;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646841": [{"title": "stool_N78_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Female;\tage (yr): 54;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646842": [{"title": "stool_N79_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 58;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Testing"}]}, {"GSM2646843": [{"title": "stool_N80_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 55;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646844": [{"title": "stool_P65_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Female;\tage (yr): 69;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646845": [{"title": "stool_P66_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 67;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646846": [{"title": "stool_P67_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 63;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646847": [{"title": "stool_P68_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Female;\tage (yr): 51;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646848": [{"title": "stool_C79_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage III;\tSex: Male;\tage (yr): 62;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Testing"}]}, {"GSM2646849": [{"title": "stool_C80_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage II;\tSex: Male;\tage (yr): 45;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646850": [{"title": "stool_N81_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Female;\tage (yr): 60;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646851": [{"title": "stool_N82_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 62;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646852": [{"title": "stool_N83_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 64;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646853": [{"title": "stool_N84_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Female;\tage (yr): 67;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646854": [{"title": "stool_P69_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Female;\tage (yr): 66;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646855": [{"title": "stool_P70_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Female;\tage (yr): 48;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Testing"}]}, {"GSM2646856": [{"title": "stool_P71_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Female;\tage (yr): 63;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646857": [{"title": "stool_P72_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Female;\tage (yr): 58;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646858": [{"title": "stool_C81_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage IV;\tSex: Female;\tage (yr): 62;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646859": [{"title": "stool_C82_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage III;\tSex: Male;\tage (yr): 64;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646860": [{"title": "stool_C83_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage II;\tSex: Male;\tage (yr): 57;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646861": [{"title": "stool_C84_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage I;\tSex: Female;\tage (yr): 44;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646862": [{"title": "stool_P73_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 43;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646863": [{"title": "stool_P74_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Female;\tage (yr): 65;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646864": [{"title": "stool_P75_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 67;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Testing"}]}, {"GSM2646865": [{"title": "stool_P76_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 54;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646866": [{"title": "stool_C85_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage IV;\tSex: Female;\tage (yr): 60;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Testing"}]}, {"GSM2646867": [{"title": "stool_C86_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage IV;\tSex: Male;\tage (yr): 46;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646868": [{"title": "stool_C87_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage IV;\tSex: Male;\tage (yr): 49;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646869": [{"title": "stool_C88_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage IV;\tSex: Male;\tage (yr): 67;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646870": [{"title": "stool_C89_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage IV;\tSex: Male;\tage (yr): 54;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646871": [{"title": "stool_C90_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage III;\tSex: Female;\tage (yr): 58;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Testing"}]}, {"GSM2646872": [{"title": "stool_C91_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage III;\tSex: Female;\tage (yr): 62;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646873": [{"title": "stool_C92_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage III;\tSex: Male;\tage (yr): 53;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646874": [{"title": "stool_C93_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage III;\tSex: Female;\tage (yr): 58;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646875": [{"title": "stool_C94_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage III;\tSex: Male;\tage (yr): 62;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646876": [{"title": "stool_C95_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage III;\tSex: Female;\tage (yr): 63;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Testing"}]}, {"GSM2646877": [{"title": "stool_C96_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage II;\tSex: Male;\tage (yr): 60;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646878": [{"title": "stool_N85_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Female;\tage (yr): 62;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Testing"}]}, {"GSM2646879": [{"title": "stool_N86_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 55;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646880": [{"title": "stool_N87_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 59;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646881": [{"title": "stool_N88_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Female;\tage (yr): 42;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646882": [{"title": "stool_N89_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Female;\tage (yr): 62;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646883": [{"title": "stool_N90_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 53;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Testing"}]}, {"GSM2646884": [{"title": "stool_N91_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 50;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646885": [{"title": "stool_N92_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 45;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646886": [{"title": "stool_C97_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage I;\tSex: Male;\tage (yr): 61;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646887": [{"title": "stool_C98_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage III;\tSex: Male;\tage (yr): 70;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646888": [{"title": "stool_C99_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage I;\tSex: Female;\tage (yr): 58;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646889": [{"title": "stool_N93_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Female;\tage (yr): 65;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646890": [{"title": "stool_N94_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 64;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646891": [{"title": "stool_N95_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 68;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Testing"}]}, {"GSM2646892": [{"title": "stool_N96_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 66;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646893": [{"title": "stool_N97_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 51;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646894": [{"title": "stool_N98_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 60;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646895": [{"title": "stool_N99_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 58;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646896": [{"title": "stool_N100_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Female;\tage (yr): 59;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Testing"}]}, {"GSM2646897": [{"title": "stool_P77_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 36;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646898": [{"title": "stool_P78_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Female;\tage (yr): 44;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646899": [{"title": "stool_P79_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 42;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646900": [{"title": "stool_P80_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 45;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Testing"}]}, {"GSM2646901": [{"title": "stool_P81_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 55;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646902": [{"title": "stool_C100_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage II;\tSex: Female;\tage (yr): 58;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646903": [{"title": "stool_N101_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Female;\tage (yr): 55;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646904": [{"title": "stool_P82_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Female;\tage (yr): 35;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646905": [{"title": "stool_P83_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 46;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646906": [{"title": "stool_P84_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 69;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646907": [{"title": "stool_P85_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 50;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646908": [{"title": "stool_P86_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 45;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Testing"}]}, {"GSM2646909": [{"title": "stool_P87_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Female;\tage (yr): 47;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646910": [{"title": "stool_P88_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Female;\tage (yr): 38;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646911": [{"title": "stool_P89_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 55;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646912": [{"title": "stool_P90_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 63;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646913": [{"title": "stool_P91_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 69;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Testing"}]}, {"GSM2646914": [{"title": "stool_C101_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage IV;\tSex: Male;\tage (yr): 58;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Testing"}]}, {"GSM2646915": [{"title": "stool_C102_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage III;\tSex: Male;\tage (yr): 50;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646916": [{"title": "stool_C103_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage II;\tSex: Female;\tage (yr): 40;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646917": [{"title": "stool_C104_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage I;\tSex: Female;\tage (yr): 56;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646918": [{"title": "stool_P92_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Female;\tage (yr): 50;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646919": [{"title": "stool_N102_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 50;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646920": [{"title": "stool_N103_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Female;\tage (yr): 43;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646921": [{"title": "stool_N104_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Female;\tage (yr): 62;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646922": [{"title": "stool_N105_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Female;\tage (yr): 67;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Testing"}]}, {"GSM2646923": [{"title": "stool_P93_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 56;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646924": [{"title": "stool_P94_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 35;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646925": [{"title": "stool_P95_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 68;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646926": [{"title": "stool_P96_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Female;\tage (yr): 49;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Testing"}]}, {"GSM2646927": [{"title": "stool_C105_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage I;\tSex: Male;\tage (yr): 59;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646928": [{"title": "stool_C106_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage IV;\tSex: Female;\tage (yr): 62;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Testing"}]}, {"GSM2646929": [{"title": "stool_C107_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage IV;\tSex: Female;\tage (yr): 63;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646930": [{"title": "stool_C108_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage III;\tSex: Female;\tage (yr): 58;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646931": [{"title": "stool_C109_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage III;\tSex: Male;\tage (yr): 72;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646932": [{"title": "stool_C110_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage III;\tSex: Male;\tage (yr): 64;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646933": [{"title": "stool_C111_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage I;\tSex: Male;\tage (yr): 54;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Testing"}]}, {"GSM2646934": [{"title": "stool_C112_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage III;\tSex: Male;\tage (yr): 69;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Testing"}]}, {"GSM2646935": [{"title": "stool_C113_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage I;\tSex: Male;\tage (yr): 62;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646936": [{"title": "stool_P97_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Female;\tage (yr): 69;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646937": [{"title": "stool_P98_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 39;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646938": [{"title": "stool_P99_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 52;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646939": [{"title": "stool_P100_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Female;\tage (yr): 61;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646940": [{"title": "stool_P101_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Female;\tage (yr): 63;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646941": [{"title": "stool_P102_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; precancerous adenoma on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Adenoma;\tSex: Male;\tage (yr): 45;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Testing"}]}, {"GSM2646942": [{"title": "stool_N106_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 58;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646943": [{"title": "stool_N107_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Female;\tage (yr): 49;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646944": [{"title": "stool_N108_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 40;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646945": [{"title": "stool_N109_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Male;\tage (yr): 51;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646946": [{"title": "stool_N110_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Female;\tage (yr): 61;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646947": [{"title": "stool_N111_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; no findings on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Normal;\tSex: Female;\tage (yr): 62;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Testing"}]}, {"GSM2646948": [{"title": "stool_C114_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage II;\tSex: Female;\tage (yr): 52;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646949": [{"title": "stool_C115_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage IV;\tSex: Male;\tage (yr): 62;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646950": [{"title": "stool_C116_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage IV;\tSex: Male;\tage (yr): 70;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Training"}]}, {"GSM2646951": [{"title": "stool_C117_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; cancer on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Stage I;\tSex: Male;\tage (yr): 61;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Training"}]}, {"GSM2646952": [{"title": "stool_B1_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; hyperplastic polyp on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Benign;\tSex: Female;\tage (yr): 50;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Not Used"}]}, {"GSM2646953": [{"title": "stool_B2_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; hyperplastic polyp on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Benign;\tSex: Female;\tage (yr): 55;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Not Used"}]}, {"GSM2646954": [{"title": "stool_B3_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; hyperplastic polyp on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Benign;\tSex: Male;\tage (yr): 53;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Not Used"}]}, {"GSM2646955": [{"title": "stool_B4_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; hyperplastic polyp on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Benign;\tSex: Female;\tage (yr): 57;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Not Used"}]}, {"GSM2646956": [{"title": "stool_B5_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; hyperplastic polyp on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Benign;\tSex: Male;\tage (yr): 52;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Not Used"}]}, {"GSM2646957": [{"title": "stool_B6_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; hyperplastic polyp on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Benign;\tSex: Male;\tage (yr): 62;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Not Used"}]}, {"GSM2646958": [{"title": "stool_B7_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; hyperplastic polyp on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Benign;\tSex: Female;\tage (yr): 51;\tethnicity: Caucasian/white;\tsmoking status: Yes;\tfamily history: No;\tset: Not Used"}]}, {"GSM2646959": [{"title": "stool_B8_rep0"}, {"type": "RNA"}, {"source_name_ch1": "Stool sample; hyperplastic polyp on colonoscopy"}, {"characteristics_ch1": "tissue: Stool;\tdisease status: Benign;\tSex: Male;\tage (yr): 62;\tethnicity: Caucasian/white;\tsmoking status: No;\tfamily history: No;\tset: Not Used"}]}, {"GSM2976632": [{"title": "Sample 1 Media"}, {"type": "RNA"}, {"source_name_ch1": "peripherial blood mononuclear cells"}, {"characteristics_ch1": "tissue: PBMC;\ttreatment: Control"}]}, {"GSM2976633": [{"title": "Sample 1 0.3 ug/ml WS-CM"}, {"type": "RNA"}, {"source_name_ch1": "peripherial blood mononuclear cells"}, {"characteristics_ch1": "tissue: PBMC;\ttreatment: 0.3 ug/ml equi-nicotine of WS-CM for 3 hours"}]}, {"GSM2976634": [{"title": "Sample 1 1.0 ug/ml WS-CM"}, {"type": "RNA"}, {"source_name_ch1": "peripherial blood mononuclear cells"}, {"characteristics_ch1": "tissue: PBMC;\ttreatment: 1 ug/ml equi-nicotine of WS-CM for 3 hours"}]}, {"GSM2976635": [{"title": "Sample 1 3.0 ug/ml WS-CM"}, {"type": "RNA"}, {"source_name_ch1": "peripherial blood mononuclear cells"}, {"characteristics_ch1": "tissue: PBMC;\ttreatment: PBMC sxposed to 3 ug/ml equi-nicotine of WS-CM for 3 hours"}]}, {"GSM2976636": [{"title": "Sample 1 100 ug/ml ST-PO4"}, {"type": "RNA"}, {"source_name_ch1": "peripherial blood mononuclear cells"}, {"characteristics_ch1": "tissue: PBMC;\ttreatment: 100 ug/ml equi-nicotine of STE for 3 hours"}]}, {"GSM2976637": [{"title": "Sample 2 Media"}, {"type": "RNA"}, {"source_name_ch1": "peripherial blood mononuclear cells"}, {"characteristics_ch1": "tissue: PBMC;\ttreatment: Control"}]}, {"GSM2976638": [{"title": "Sample 2 0.3 ug/ml WS-CM"}, {"type": "RNA"}, {"source_name_ch1": "peripherial blood mononuclear cells"}, {"characteristics_ch1": "tissue: PBMC;\ttreatment: 0.3 ug/ml equi-nicotine of WS-CM for 3 hours"}]}, {"GSM2976639": [{"title": "Sample 2 1.0 ug/ml WS-CM"}, {"type": "RNA"}, {"source_name_ch1": "peripherial blood mononuclear cells"}, {"characteristics_ch1": "tissue: PBMC;\ttreatment: 1 ug/ml equi-nicotine of WS-CM for 3 hours"}]}, {"GSM2976640": [{"title": "Sample 2 3.0 ug/ml WS-CM"}, {"type": "RNA"}, {"source_name_ch1": "peripherial blood mononuclear cells"}, {"characteristics_ch1": "tissue: PBMC;\ttreatment: PBMC sxposed to 3 ug/ml equi-nicotine of WS-CM for 3 hours"}]}, {"GSM2976641": [{"title": "Sample 2 100 ug/ml ST-PO4"}, {"type": "RNA"}, {"source_name_ch1": "peripherial blood mononuclear cells"}, {"characteristics_ch1": "tissue: PBMC;\ttreatment: 100 ug/ml equi-nicotine of STE for 3 hours"}]}, {"GSM2976642": [{"title": "Sample 3 Media"}, {"type": "RNA"}, {"source_name_ch1": "peripherial blood mononuclear cells"}, {"characteristics_ch1": "tissue: PBMC;\ttreatment: Control"}]}, {"GSM2976643": [{"title": "Sample 3 0.3 ug/ml WS-CM"}, {"type": "RNA"}, {"source_name_ch1": "peripherial blood mononuclear cells"}, {"characteristics_ch1": "tissue: PBMC;\ttreatment: 0.3 ug/ml equi-nicotine of WS-CM for 3 hours"}]}, {"GSM2976644": [{"title": "Sample 3 1.0 ug/ml WS-CM"}, {"type": "RNA"}, {"source_name_ch1": "peripherial blood mononuclear cells"}, {"characteristics_ch1": "tissue: PBMC;\ttreatment: 1 ug/ml equi-nicotine of WS-CM for 3 hours"}]}, {"GSM2976645": [{"title": "Sample 3 3.0 ug/ml WS-CM"}, {"type": "RNA"}, {"source_name_ch1": "peripherial blood mononuclear cells"}, {"characteristics_ch1": "tissue: PBMC;\ttreatment: PBMC sxposed to 3 ug/ml equi-nicotine of WS-CM for 3 hours"}]}, {"GSM2976646": [{"title": "Sample 3 100 ug/ml ST-PO4"}, {"type": "RNA"}, {"source_name_ch1": "peripherial blood mononuclear cells"}, {"characteristics_ch1": "tissue: PBMC;\ttreatment: 100 ug/ml equi-nicotine of STE for 3 hours"}]}, {"GSM2976647": [{"title": "Sample 4 Media"}, {"type": "RNA"}, {"source_name_ch1": "peripherial blood mononuclear cells"}, {"characteristics_ch1": "tissue: PBMC;\ttreatment: Control"}]}, {"GSM2976648": [{"title": "Sample 4 0.3 ug/ml WS-CM"}, {"type": "RNA"}, {"source_name_ch1": "peripherial blood mononuclear cells"}, {"characteristics_ch1": "tissue: PBMC;\ttreatment: 0.3 ug/ml equi-nicotine of WS-CM for 3 hours"}]}, {"GSM2976649": [{"title": "Sample 4 1.0 ug/ml WS-CM"}, {"type": "RNA"}, {"source_name_ch1": "peripherial blood mononuclear cells"}, {"characteristics_ch1": "tissue: PBMC;\ttreatment: 1 ug/ml equi-nicotine of WS-CM for 3 hours"}]}, {"GSM2976650": [{"title": "Sample 4 3.0 ug/ml WS-CM"}, {"type": "RNA"}, {"source_name_ch1": "peripherial blood mononuclear cells"}, {"characteristics_ch1": "tissue: PBMC;\ttreatment: PBMC sxposed to 3 ug/ml equi-nicotine of WS-CM for 3 hours"}]}, {"GSM2976651": [{"title": "Sample 4 100 ug/ml ST-PO4"}, {"type": "RNA"}, {"source_name_ch1": "peripherial blood mononuclear cells"}, {"characteristics_ch1": "tissue: PBMC;\ttreatment: 100 ug/ml equi-nicotine of STE for 3 hours"}]}, {"GSM3036125": [{"title": "responder to therapy 1"}, {"type": "RNA"}, {"source_name_ch1": "responder to therapy"}, {"characteristics_ch1": "disease state: bladder cancer;\ttreatment: pembrolizumab;\ttreatment response: responder to therapy;\ttissue: Bladder"}]}, {"GSM3036126": [{"title": "responder to therapy 2"}, {"type": "RNA"}, {"source_name_ch1": "responder to therapy"}, {"characteristics_ch1": "disease state: bladder cancer;\ttreatment: pembrolizumab;\ttreatment response: responder to therapy;\ttissue: Bladder"}]}, {"GSM3036127": [{"title": "responder to therapy 3"}, {"type": "RNA"}, {"source_name_ch1": "responder to therapy"}, {"characteristics_ch1": "disease state: bladder cancer;\ttreatment: pembrolizumab;\ttreatment response: responder to therapy;\ttissue: Bladder"}]}, {"GSM3036128": [{"title": "responder to therapy 4"}, {"type": "RNA"}, {"source_name_ch1": "responder to therapy"}, {"characteristics_ch1": "disease state: bladder cancer;\ttreatment: pembrolizumab;\ttreatment response: responder to therapy;\ttissue: Bladder"}]}, {"GSM3036129": [{"title": "responder to therapy 5"}, {"type": "RNA"}, {"source_name_ch1": "responder to therapy"}, {"characteristics_ch1": "disease state: bladder cancer;\ttreatment: pembrolizumab;\ttreatment response: responder to therapy;\ttissue: Bladder"}]}, {"GSM3036130": [{"title": "responder to therapy 6"}, {"type": "RNA"}, {"source_name_ch1": "responder to therapy"}, {"characteristics_ch1": "disease state: bladder cancer;\ttreatment: pembrolizumab;\ttreatment response: responder to therapy;\ttissue: Bladder"}]}, {"GSM3036131": [{"title": "progressor 7"}, {"type": "RNA"}, {"source_name_ch1": "progressor"}, {"characteristics_ch1": "disease state: bladder cancer;\ttreatment: pembrolizumab;\ttreatment response: progressor;\ttissue: Bladder"}]}, {"GSM3036132": [{"title": "progressor 8"}, {"type": "RNA"}, {"source_name_ch1": "progressor"}, {"characteristics_ch1": "disease state: bladder cancer;\ttreatment: pembrolizumab;\ttreatment response: progressor;\ttissue: Bladder"}]}, {"GSM3036133": [{"title": "progressor 9"}, {"type": "RNA"}, {"source_name_ch1": "progressor"}, {"characteristics_ch1": "disease state: bladder cancer;\ttreatment: pembrolizumab;\ttreatment response: progressor;\ttissue: Bladder"}]}, {"GSM3036134": [{"title": "progressor 10"}, {"type": "RNA"}, {"source_name_ch1": "progressor"}, {"characteristics_ch1": "disease state: bladder cancer;\ttreatment: pembrolizumab;\ttreatment response: progressor;\ttissue: Bladder"}]}, {"GSM3036135": [{"title": "progressor 11"}, {"type": "RNA"}, {"source_name_ch1": "progressor"}, {"characteristics_ch1": "disease state: bladder cancer;\ttreatment: pembrolizumab;\ttreatment response: progressor;\ttissue: Bladder"}]}, {"GSM3657736": [{"title": "BEAS-2B cells as control (dataset II), biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "BEAS-2B cells"}, {"characteristics_ch1": "cell type: bronchial epithelial cells"}]}, {"GSM3657737": [{"title": "BEAS-2B cells as control (dataset II), biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "BEAS-2B cells"}, {"characteristics_ch1": "cell type: bronchial epithelial cells"}]}, {"GSM3657738": [{"title": "BEAS-2B cells as control (dataset II), biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "BEAS-2B cells"}, {"characteristics_ch1": "cell type: bronchial epithelial cells"}]}, {"GSM3657739": [{"title": "BEAS-2B cells treated with 200 nm of silica nanoparticles, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "BEAS-2B cells"}, {"characteristics_ch1": "cell type: bronchial epithelial cells"}]}, {"GSM3657740": [{"title": "BEAS-2B cells treated with 200 nm of silica nanoparticles, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "BEAS-2B cells"}, {"characteristics_ch1": "cell type: bronchial epithelial cells"}]}, {"GSM3657741": [{"title": "BEAS-2B cells treated with 200 nm of silica nanoparticles, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "BEAS-2B cells"}, {"characteristics_ch1": "cell type: bronchial epithelial cells"}]}, {"GSM3657742": [{"title": "BEAS-2B cells treated with 60 nm of silica nanoparticles, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "BEAS-2B cells"}, {"characteristics_ch1": "cell type: bronchial epithelial cells"}]}, {"GSM3657743": [{"title": "BEAS-2B cells treated with 60 nm of silica nanoparticles, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "BEAS-2B cells"}, {"characteristics_ch1": "cell type: bronchial epithelial cells"}]}, {"GSM3657744": [{"title": "BEAS-2B cells treated with 60 nm of silica nanoparticles, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "BEAS-2B cells"}, {"characteristics_ch1": "cell type: bronchial epithelial cells"}]}, {"GSM3657745": [{"title": "BEAS-2B cells treated with 40 nm of silica nanoparticles, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "BEAS-2B cells"}, {"characteristics_ch1": "cell type: bronchial epithelial cells"}]}, {"GSM3657746": [{"title": "BEAS-2B cells treated with 40 nm of silica nanoparticles, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "BEAS-2B cells"}, {"characteristics_ch1": "cell type: bronchial epithelial cells"}]}, {"GSM3657747": [{"title": "BEAS-2B cells treated with 40 nm of silica nanoparticles, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "BEAS-2B cells"}, {"characteristics_ch1": "cell type: bronchial epithelial cells"}]}, {"GSM3440270": [{"title": "A549 shCont, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "A549 cells stably expressing lentiviral control shRNA"}, {"characteristics_ch1": "cell line: A549;\tshRNA: lentiviral control shRNA"}]}, {"GSM3440271": [{"title": "A549 shCont, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "A549 cells stably expressing lentiviral control shRNA"}, {"characteristics_ch1": "cell line: A549;\tshRNA: lentiviral control shRNA"}]}, {"GSM3440272": [{"title": "A549 shCont, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "A549 cells stably expressing lentiviral control shRNA"}, {"characteristics_ch1": "cell line: A549;\tshRNA: lentiviral control shRNA"}]}, {"GSM3440273": [{"title": "A549 shS100A4, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "A549 cells stably expressing lentiviral shRNA targeting S100A4"}, {"characteristics_ch1": "cell line: A549;\tshRNA: lentiviral shRNA targeting S100A4"}]}, {"GSM3440274": [{"title": "A549 shS100A4, biological rep2"}, {"type": "RNA"}, {"source_name_ch1": "A549 cells stably expressing lentiviral shRNA targeting S100A4"}, {"characteristics_ch1": "cell line: A549;\tshRNA: lentiviral shRNA targeting S100A4"}]}, {"GSM3440275": [{"title": "A549 shS100A4, biological rep3"}, {"type": "RNA"}, {"source_name_ch1": "A549 cells stably expressing lentiviral shRNA targeting S100A4"}, {"characteristics_ch1": "cell line: A549;\tshRNA: lentiviral shRNA targeting S100A4"}]}, {"GSM3582890": [{"title": "1 VPG, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "Vastus lateralis muscle, football players"}, {"characteristics_ch1": "tissue: Vastus lateralis muscle"}]}, {"GSM3582891": [{"title": "2 VPG, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "Vastus lateralis muscle, football players"}, {"characteristics_ch1": "tissue: Vastus lateralis muscle"}]}, {"GSM3582892": [{"title": "3 VPG, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "Vastus lateralis muscle, football players"}, {"characteristics_ch1": "tissue: Vastus lateralis muscle"}]}, {"GSM3582893": [{"title": "1 CG, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "Vastus lateralis muscle, untrained controls"}, {"characteristics_ch1": "tissue: Vastus lateralis muscle"}]}, {"GSM3582894": [{"title": "2 CG, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "Vastus lateralis muscle, untrained controls"}, {"characteristics_ch1": "tissue: Vastus lateralis muscle"}]}, {"GSM3582895": [{"title": "3 CG, biological rep1"}, {"type": "RNA"}, {"source_name_ch1": "Vastus lateralis muscle, untrained controls"}, {"characteristics_ch1": "tissue: Vastus lateralis muscle"}]}, {"GSM3142325": [{"title": "HCC1187 with shRNA-1 rep1"}, {"type": "RNA"}, {"source_name_ch1": "shRNA-1"}, {"characteristics_ch1": "treatment: RNA from HCC1187 transfected with shRNA-1 versus lnc-KLHDC7B"}]}, {"GSM3142326": [{"title": "HCC1187 with shRNA-1 rep2"}, {"type": "RNA"}, {"source_name_ch1": "shRNA-1"}, {"characteristics_ch1": "treatment: RNA from HCC1187 transfected with shRNA-1 versus lnc-KLHDC7B"}]}, {"GSM3142327": [{"title": "HCC1187 with shRNA-1 rep3"}, {"type": "RNA"}, {"source_name_ch1": "shRNA-1"}, {"characteristics_ch1": "treatment: RNA from HCC1187 transfected with shRNA-1 versus lnc-KLHDC7B"}]}, {"GSM3142328": [{"title": "HCC1187 with shRNA-NC (negative control) rep1"}, {"type": "RNA"}, {"source_name_ch1": "Negative Control"}, {"characteristics_ch1": "treatment: RNA from HCC1187 transfected with shRNA negative control"}]}, {"GSM3142329": [{"title": "HCC1187 with shRNA-NC (negative control) rep2"}, {"type": "RNA"}, {"source_name_ch1": "Negative Control"}, {"characteristics_ch1": "treatment: RNA from HCC1187 transfected with shRNA negative control"}]}, {"GSM3142330": [{"title": "HCC1187 with shRNA-NC (negative control) rep3"}, {"type": "RNA"}, {"source_name_ch1": "Negative Control"}, {"characteristics_ch1": "treatment: RNA from HCC1187 transfected with shRNA negative control"}]}, {"GSM3678176": [{"title": "Human cochlea"}, {"type": "RNA"}, {"source_name_ch1": "Healthy inner ear"}, {"characteristics_ch1": "tissue: basilar membrane, lateral wall, modiolus"}]}, {"GSM3660504": [{"title": "U266 control at time 24h biol replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "U266 MM cells untreated"}, {"characteristics_ch1": "cell line: U266;\tcell type: multiple myeloma (MM) cell line;\tcell type: plasma cells;\ttreatment: none (untreated)"}]}, {"GSM3660505": [{"title": "U266 control at time 24h biol replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "U266 MM cells untreated"}, {"characteristics_ch1": "cell line: U266;\tcell type: multiple myeloma (MM) cell line;\tcell type: plasma cells;\ttreatment: none (untreated)"}]}, {"GSM3660506": [{"title": "U266 treated at time 24h biol replicate 1"}, {"type": "RNA"}, {"source_name_ch1": "U266 MM cells treated with 2.5 nM of trabectedin"}, {"characteristics_ch1": "cell line: U266;\tcell type: multiple myeloma (MM) cell line;\tcell type: plasma cells;\ttreatment: 2.5 nM of trabectedin"}]}, {"GSM3660507": [{"title": "U266 treated at time 24h biol replicate 2"}, {"type": "RNA"}, {"source_name_ch1": "U266 MM cells treated with 2.5 nM of trabectedin"}, {"characteristics_ch1": "cell line: U266;\tcell type: multiple myeloma (MM) cell line;\tcell type: plasma cells;\ttreatment: 2.5 nM of trabectedin"}]}, {"GSM3271048": [{"title": "HSC-Ctrl CD34_C10"}, {"type": "RNA"}, {"source_name_ch1": "HSC-Ctrl"}, {"characteristics_ch1": "patient id: C10;\tgender: F"}]}, {"GSM3271049": [{"title": "HSC-Ctrl CD34_C11"}, {"type": "RNA"}, {"source_name_ch1": "HSC-Ctrl"}, {"characteristics_ch1": "patient id: C11;\tgender: F"}]}, {"GSM3271050": [{"title": "HSC-Ctrl CD34_C4"}, {"type": "RNA"}, {"source_name_ch1": "HSC-Ctrl"}, {"characteristics_ch1": "patient id: C4;\tgender: F"}]}, {"GSM3271051": [{"title": "HSC-Ctrl CD34_C6"}, {"type": "RNA"}, {"source_name_ch1": "HSC-Ctrl"}, {"characteristics_ch1": "patient id: C6;\tgender: M"}]}, {"GSM3271052": [{"title": "HSC-Ctrl CD34_C7"}, {"type": "RNA"}, {"source_name_ch1": "HSC-Ctrl"}, {"characteristics_ch1": "patient id: C7;\tgender: M"}]}, {"GSM3271053": [{"title": "HSC-Ctrl CD34_C8"}, {"type": "RNA"}, {"source_name_ch1": "HSC-Ctrl"}, {"characteristics_ch1": "patient id: C8;\tgender: M"}]}, {"GSM3271054": [{"title": "HSC-Ctrl CD34_C9"}, {"type": "RNA"}, {"source_name_ch1": "HSC-Ctrl"}, {"characteristics_ch1": "patient id: C9;\tgender: M"}]}, {"GSM3271055": [{"title": "LSC-Adverse CD34_P1"}, {"type": "RNA"}, {"source_name_ch1": "LSC-Adverse"}, {"characteristics_ch1": "patient id: AML-18;\tgender: F"}]}, {"GSM3271056": [{"title": "LSC-Adverse CD34_P10"}, {"type": "RNA"}, {"source_name_ch1": "LSC-Adverse"}, {"characteristics_ch1": "patient id: AML-19;\tgender: M"}]}, {"GSM3271057": [{"title": "LSC-Favorable CD34_P12"}, {"type": "RNA"}, {"source_name_ch1": "LSC-Favorable"}, {"characteristics_ch1": "patient id: AML-26;\tgender: M"}]}, {"GSM3271058": [{"title": "LSC-Favorable CD34_P13"}, {"type": "RNA"}, {"source_name_ch1": "LSC-Favorable"}, {"characteristics_ch1": "patient id: AML-14;\tgender: M"}]}, {"GSM3271059": [{"title": "LSC-Favorable CD34_P14"}, {"type": "RNA"}, {"source_name_ch1": "LSC-Favorable"}, {"characteristics_ch1": "patient id: AML-15;\tgender: M"}]}, {"GSM3271060": [{"title": "LSC-Favorable CD34_P15"}, {"type": "RNA"}, {"source_name_ch1": "LSC-Favorable"}, {"characteristics_ch1": "patient id: AML-8;\tgender: M"}]}, {"GSM3271061": [{"title": "LSC-Favorable CD34_P16"}, {"type": "RNA"}, {"source_name_ch1": "LSC-Favorable"}, {"characteristics_ch1": "patient id: AML-9;\tgender: F"}]}, {"GSM3271062": [{"title": "LSC-Favorable CD34_P17"}, {"type": "RNA"}, {"source_name_ch1": "LSC-Favorable"}, {"characteristics_ch1": "patient id: AML-10;\tgender: F"}]}, {"GSM3271063": [{"title": "LSC-Intermediate CD34_P18"}, {"type": "RNA"}, {"source_name_ch1": "LSC-Intermediate"}, {"characteristics_ch1": "patient id: AML-13;\tgender: M"}]}, {"GSM3271064": [{"title": "LSC-Adverse CD34_P19"}, {"type": "RNA"}, {"source_name_ch1": "LSC-Adverse"}, {"characteristics_ch1": "patient id: AML-2;\tgender: M"}]}, {"GSM3271065": [{"title": "LSC-Adverse CD34_P2"}, {"type": "RNA"}, {"source_name_ch1": "LSC-Adverse"}, {"characteristics_ch1": "patient id: AML-12;\tgender: M"}]}, {"GSM3271066": [{"title": "LSC-Intermediate CD34_P20"}, {"type": "RNA"}, {"source_name_ch1": "LSC-Intermediate"}, {"characteristics_ch1": "patient id: AML-17;\tgender: F"}]}, {"GSM3271067": [{"title": "LSC-Intermediate CD34_P21"}, {"type": "RNA"}, {"source_name_ch1": "LSC-Intermediate"}, {"characteristics_ch1": "patient id: AML-29;\tgender: F"}]}, {"GSM3271068": [{"title": "LSC-Intermediate CD34_P22"}, {"type": "RNA"}, {"source_name_ch1": "LSC-Intermediate"}, {"characteristics_ch1": "patient id: AML-20;\tgender: M"}]}, {"GSM3271069": [{"title": "LSC-Intermediate CD34_P23"}, {"type": "RNA"}, {"source_name_ch1": "LSC-Intermediate"}, {"characteristics_ch1": "patient id: AML-6;\tgender: F"}]}, {"GSM3271070": [{"title": "LSC-Intermediate CD34_P24"}, {"type": "RNA"}, {"source_name_ch1": "LSC-Intermediate"}, {"characteristics_ch1": "patient id: AML-21;\tgender: M"}]}, {"GSM3271071": [{"title": "LSC-Intermediate CD34_P28"}, {"type": "RNA"}, {"source_name_ch1": "LSC-Intermediate"}, {"characteristics_ch1": "patient id: AML-27;\tgender: F"}]}, {"GSM3271072": [{"title": "LSC-Adverse CD34_P3"}, {"type": "RNA"}, {"source_name_ch1": "LSC-Adverse"}, {"characteristics_ch1": "patient id: AML-22;\tgender: M"}]}, {"GSM3271073": [{"title": "LSC-Adverse CD34_P30"}, {"type": "RNA"}, {"source_name_ch1": "LSC-Adverse"}, {"characteristics_ch1": "patient id: AML-3;\tgender: F"}]}, {"GSM3271074": [{"title": "LSC-Favorable CD34_P31"}, {"type": "RNA"}, {"source_name_ch1": "LSC-Favorable"}, {"characteristics_ch1": "patient id: AML-11;\tgender: F"}]}, {"GSM3271075": [{"title": "LSC-Favorable CD34_P32"}, {"type": "RNA"}, {"source_name_ch1": "LSC-Favorable"}, {"characteristics_ch1": "patient id: AML-16;\tgender: F"}]}, {"GSM3271076": [{"title": "LSC-Intermediate CD34_P33"}, {"type": "RNA"}, {"source_name_ch1": "LSC-Intermediate"}, {"characteristics_ch1": "patient id: AML-30;\tgender: M"}]}, {"GSM3271077": [{"title": "LSC-Intermediate CD34_P4"}, {"type": "RNA"}, {"source_name_ch1": "LSC-Intermediate"}, {"characteristics_ch1": "patient id: AML-4;\tgender: M"}]}, {"GSM3271078": [{"title": "LSC-Adverse CD34_P5"}, {"type": "RNA"}, {"source_name_ch1": "LSC-Adverse"}, {"characteristics_ch1": "patient id: AML-1;\tgender: M"}]}, {"GSM3271079": [{"title": "LSC-Adverse CD34_P6"}, {"type": "RNA"}, {"source_name_ch1": "LSC-Adverse"}, {"characteristics_ch1": "patient id: AML-24;\tgender: F"}]}, {"GSM3271080": [{"title": "LSC-Intermediate CD34_P7"}, {"type": "RNA"}, {"source_name_ch1": "LSC-Intermediate"}, {"characteristics_ch1": "patient id: AML-5;\tgender: F"}]}, {"GSM3271081": [{"title": "LSC-Adverse CD34_P8"}, {"type": "RNA"}, {"source_name_ch1": "LSC-Adverse"}, {"characteristics_ch1": "patient id: AML-25;\tgender: M"}]}, {"GSM3271082": [{"title": "LSC-Adverse CD34_P9"}, {"type": "RNA"}, {"source_name_ch1": "LSC-Adverse"}, {"characteristics_ch1": "patient id: AML-28;\tgender: M"}]}, {"GSM3271083": [{"title": "HPC-Ctrl CD38_C10"}, {"type": "RNA"}, {"source_name_ch1": "HPC-Ctrl"}, {"characteristics_ch1": "patient id: C10;\tgender: F"}]}, {"GSM3271084": [{"title": "HPC-Ctrl CD38_C11"}, {"type": "RNA"}, {"source_name_ch1": "HPC-Ctrl"}, {"characteristics_ch1": "patient id: C11;\tgender: F"}]}, {"GSM3271085": [{"title": "HPC-Ctrl CD38_C4"}, {"type": "RNA"}, {"source_name_ch1": "HPC-Ctrl"}, {"characteristics_ch1": "patient id: C4;\tgender: F"}]}, {"GSM3271086": [{"title": "HPC-Ctrl CD38_C6"}, {"type": "RNA"}, {"source_name_ch1": "HPC-Ctrl"}, {"characteristics_ch1": "patient id: C6;\tgender: M"}]}, {"GSM3271087": [{"title": "HPC-Ctrl CD38_C7"}, {"type": "RNA"}, {"source_name_ch1": "HPC-Ctrl"}, {"characteristics_ch1": "patient id: C7;\tgender: M"}]}, {"GSM3271088": [{"title": "HPC-Ctrl CD38_C8"}, {"type": "RNA"}, {"source_name_ch1": "HPC-Ctrl"}, {"characteristics_ch1": "patient id: C8;\tgender: M"}]}, {"GSM3271089": [{"title": "HPC-Ctrl CD38_C9"}, {"type": "RNA"}, {"source_name_ch1": "HPC-Ctrl"}, {"characteristics_ch1": "patient id: C9;\tgender: M"}]}, {"GSM3271090": [{"title": "LPC-Adverse CD38_P1"}, {"type": "RNA"}, {"source_name_ch1": "LPC-Adverse"}, {"characteristics_ch1": "patient id: AML-18;\tgender: F"}]}, {"GSM3271091": [{"title": "LPC-Adverse CD38_P10"}, {"type": "RNA"}, {"source_name_ch1": "LPC-Adverse"}, {"characteristics_ch1": "patient id: AML-19;\tgender: M"}]}, {"GSM3271092": [{"title": "LPC-Favorable CD38_P11"}, {"type": "RNA"}, {"source_name_ch1": "LPC-Favorable"}, {"characteristics_ch1": "patient id: AML-7;\tgender: F"}]}, {"GSM3271093": [{"title": "LPC-Favorable CD38_P12"}, {"type": "RNA"}, {"source_name_ch1": "LPC-Favorable"}, {"characteristics_ch1": "patient id: AML-26;\tgender: M"}]}, {"GSM3271094": [{"title": "LPC-Favorable CD38_P13"}, {"type": "RNA"}, {"source_name_ch1": "LPC-Favorable"}, {"characteristics_ch1": "patient id: AML-14;\tgender: M"}]}, {"GSM3271095": [{"title": "LPC-Favorable CD38_P14"}, {"type": "RNA"}, {"source_name_ch1": "LPC-Favorable"}, {"characteristics_ch1": "patient id: AML-15;\tgender: M"}]}, {"GSM3271096": [{"title": "LPC-Favorable CD38_P15"}, {"type": "RNA"}, {"source_name_ch1": "LPC-Favorable"}, {"characteristics_ch1": "patient id: AML-8;\tgender: M"}]}, {"GSM3271097": [{"title": "LPC-Favorable CD38_P16"}, {"type": "RNA"}, {"source_name_ch1": "LPC-Favorable"}, {"characteristics_ch1": "patient id: AML-9;\tgender: F"}]}, {"GSM3271098": [{"title": "LPC-Favorable CD38_P17"}, {"type": "RNA"}, {"source_name_ch1": "LPC-Favorable"}, {"characteristics_ch1": "patient id: AML-10;\tgender: F"}]}, {"GSM3271099": [{"title": "LPC-Intermediate CD38_P18"}, {"type": "RNA"}, {"source_name_ch1": "LPC-Intermediate"}, {"characteristics_ch1": "patient id: AML-13;\tgender: M"}]}, {"GSM3271100": [{"title": "LPC-Adverse CD38_P19"}, {"type": "RNA"}, {"source_name_ch1": "LPC-Adverse"}, {"characteristics_ch1": "patient id: AML-2;\tgender: M"}]}, {"GSM3271101": [{"title": "LPC-Adverse CD38_P2"}, {"type": "RNA"}, {"source_name_ch1": "LPC-Adverse"}, {"characteristics_ch1": "patient id: AML-12;\tgender: M"}]}, {"GSM3271102": [{"title": "LPC-Intermediate CD38_P20"}, {"type": "RNA"}, {"source_name_ch1": "LPC-Intermediate"}, {"characteristics_ch1": "patient id: AML-17;\tgender: F"}]}, {"GSM3271103": [{"title": "LPC-Intermediate CD38_P21"}, {"type": "RNA"}, {"source_name_ch1": "LPC-Intermediate"}, {"characteristics_ch1": "patient id: AML-29;\tgender: F"}]}, {"GSM3271104": [{"title": "LPC-Intermediate CD38_P22"}, {"type": "RNA"}, {"source_name_ch1": "LPC-Intermediate"}, {"characteristics_ch1": "patient id: AML-20;\tgender: M"}]}, {"GSM3271105": [{"title": "LPC-Intermediate CD38_P23"}, {"type": "RNA"}, {"source_name_ch1": "LPC-Intermediate"}, {"characteristics_ch1": "patient id: AML-6;\tgender: F"}]}, {"GSM3271106": [{"title": "LPC-Intermediate CD38_P24"}, {"type": "RNA"}, {"source_name_ch1": "LPC-Intermediate"}, {"characteristics_ch1": "patient id: AML-21;\tgender: M"}]}, {"GSM3271107": [{"title": "LPC-Intermediate CD38_P28"}, {"type": "RNA"}, {"source_name_ch1": "LPC-Intermediate"}, {"characteristics_ch1": "patient id: AML-27;\tgender: F"}]}, {"GSM3271108": [{"title": "LPC-Intermediate CD38_P29"}, {"type": "RNA"}, {"source_name_ch1": "LPC-Intermediate"}, {"characteristics_ch1": "patient id: AML-23;\tgender: M"}]}, {"GSM3271109": [{"title": "LPC-Adverse CD38_P3"}, {"type": "RNA"}, {"source_name_ch1": "LPC-Adverse"}, {"characteristics_ch1": "patient id: AML-22;\tgender: M"}]}, {"GSM3271110": [{"title": "LPC-Adverse CD38_P30"}, {"type": "RNA"}, {"source_name_ch1": "LPC-Adverse"}, {"characteristics_ch1": "patient id: AML-3;\tgender: F"}]}, {"GSM3271111": [{"title": "LPC-Favorable CD38_P31"}, {"type": "RNA"}, {"source_name_ch1": "LPC-Favorable"}, {"characteristics_ch1": "patient id: AML-11;\tgender: F"}]}, {"GSM3271112": [{"title": "LPC-Favorable CD38_P32"}, {"type": "RNA"}, {"source_name_ch1": "LPC-Favorable"}, {"characteristics_ch1": "patient id: AML-16;\tgender: F"}]}, {"GSM3271113": [{"title": "LPC-Intermediate CD38_P33"}, {"type": "RNA"}, {"source_name_ch1": "LPC-Intermediate"}, {"characteristics_ch1": "patient id: AML-30;\tgender: M"}]}, {"GSM3271114": [{"title": "LPC-Intermediate CD38_P4"}, {"type": "RNA"}, {"source_name_ch1": "LPC-Intermediate"}, {"characteristics_ch1": "patient id: AML-4;\tgender: M"}]}, {"GSM3271115": [{"title": "LPC-Adverse CD38_P5"}, {"type": "RNA"}, {"source_name_ch1": "LPC-Adverse"}, {"characteristics_ch1": "patient id: AML-1;\tgender: M"}]}, {"GSM3271116": [{"title": "LPC-Adverse CD38_P6"}, {"type": "RNA"}, {"source_name_ch1": "LPC-Adverse"}, {"characteristics_ch1": "patient id: AML-24;\tgender: F"}]}, {"GSM3271117": [{"title": "LPC-Intermediate CD38_P7"}, {"type": "RNA"}, {"source_name_ch1": "LPC-Intermediate"}, {"characteristics_ch1": "patient id: AML-5;\tgender: F"}]}, {"GSM3271118": [{"title": "LPC-Adverse CD38_P8"}, {"type": "RNA"}, {"source_name_ch1": "LPC-Adverse"}, {"characteristics_ch1": "patient id: AML-25;\tgender: M"}]}, {"GSM3271119": [{"title": "LPC-Adverse CD38_P9"}, {"type": "RNA"}, {"source_name_ch1": "LPC-Adverse"}, {"characteristics_ch1": "patient id: AML-28;\tgender: M"}]}, {"GSM3271120": [{"title": "CD8-Ctrl CD8_C10"}, {"type": "RNA"}, {"source_name_ch1": "CD8-Ctrl"}, {"characteristics_ch1": "patient id: C10;\tgender: F"}]}, {"GSM3271121": [{"title": "CD8-Ctrl CD8_C11"}, {"type": "RNA"}, {"source_name_ch1": "CD8-Ctrl"}, {"characteristics_ch1": "patient id: C11;\tgender: F"}]}, {"GSM3271122": [{"title": "CD8-Ctrl CD8_C4"}, {"type": "RNA"}, {"source_name_ch1": "CD8-Ctrl"}, {"characteristics_ch1": "patient id: C4;\tgender: F"}]}, {"GSM3271123": [{"title": "CD8-Ctrl CD8_C6"}, {"type": "RNA"}, {"source_name_ch1": "CD8-Ctrl"}, {"characteristics_ch1": "patient id: C6;\tgender: M"}]}, {"GSM3271124": [{"title": "CD8-Ctrl CD8_C7"}, {"type": "RNA"}, {"source_name_ch1": "CD8-Ctrl"}, {"characteristics_ch1": "patient id: C7;\tgender: M"}]}, {"GSM3271125": [{"title": "CD8-Ctrl CD8_C8"}, {"type": "RNA"}, {"source_name_ch1": "CD8-Ctrl"}, {"characteristics_ch1": "patient id: C8;\tgender: M"}]}, {"GSM3271126": [{"title": "CD8-Ctrl CD8_C9"}, {"type": "RNA"}, {"source_name_ch1": "CD8-Ctrl"}, {"characteristics_ch1": "patient id: C9;\tgender: M"}]}, {"GSM3271127": [{"title": "CD8-Adverse CD8_P1"}, {"type": "RNA"}, {"source_name_ch1": "CD8-Adverse"}, {"characteristics_ch1": "patient id: AML-18;\tgender: F"}]}, {"GSM3271128": [{"title": "CD8-Adverse CD8_P10"}, {"type": "RNA"}, {"source_name_ch1": "CD8-Adverse"}, {"characteristics_ch1": "patient id: AML-19;\tgender: M"}]}, {"GSM3271129": [{"title": "CD8-Favorable CD8_P11"}, {"type": "RNA"}, {"source_name_ch1": "CD8-Favorable"}, {"characteristics_ch1": "patient id: AML-7;\tgender: F"}]}, {"GSM3271130": [{"title": "CD8-Favorable CD8_P12"}, {"type": "RNA"}, {"source_name_ch1": "CD8-Favorable"}, {"characteristics_ch1": "patient id: AML-26;\tgender: M"}]}, {"GSM3271131": [{"title": "CD8-Favorable CD8_P13"}, {"type": "RNA"}, {"source_name_ch1": "CD8-Favorable"}, {"characteristics_ch1": "patient id: AML-14;\tgender: M"}]}, {"GSM3271132": [{"title": "CD8-Favorable CD8_P14"}, {"type": "RNA"}, {"source_name_ch1": "CD8-Favorable"}, {"characteristics_ch1": "patient id: AML-15;\tgender: M"}]}, {"GSM3271133": [{"title": "CD8-Favorable CD8_P15"}, {"type": "RNA"}, {"source_name_ch1": "CD8-Favorable"}, {"characteristics_ch1": "patient id: AML-8;\tgender: M"}]}, {"GSM3271134": [{"title": "CD8-Favorable CD8_P16"}, {"type": "RNA"}, {"source_name_ch1": "CD8-Favorable"}, {"characteristics_ch1": "patient id: AML-9;\tgender: F"}]}, {"GSM3271135": [{"title": "CD8-Favorable CD8_P17"}, {"type": "RNA"}, {"source_name_ch1": "CD8-Favorable"}, {"characteristics_ch1": "patient id: AML-10;\tgender: F"}]}, {"GSM3271136": [{"title": "CD8-Intermediate CD8_P18"}, {"type": "RNA"}, {"source_name_ch1": "CD8-Intermediate"}, {"characteristics_ch1": "patient id: AML-13;\tgender: M"}]}, {"GSM3271137": [{"title": "CD8-Adverse CD8_P19"}, {"type": "RNA"}, {"source_name_ch1": "CD8-Adverse"}, {"characteristics_ch1": "patient id: AML-2;\tgender: M"}]}, {"GSM3271138": [{"title": "CD8-Adverse CD8_P2"}, {"type": "RNA"}, {"source_name_ch1": "CD8-Adverse"}, {"characteristics_ch1": "patient id: AML-12;\tgender: M"}]}, {"GSM3271139": [{"title": "CD8-Intermediate CD8_P20"}, {"type": "RNA"}, {"source_name_ch1": "CD8-Intermediate"}, {"characteristics_ch1": "patient id: AML-17;\tgender: F"}]}, {"GSM3271140": [{"title": "CD8-Intermediate CD8_P21"}, {"type": "RNA"}, {"source_name_ch1": "CD8-Intermediate"}, {"characteristics_ch1": "patient id: AML-29;\tgender: F"}]}, {"GSM3271141": [{"title": "CD8-Intermediate CD8_P22"}, {"type": "RNA"}, {"source_name_ch1": "CD8-Intermediate"}, {"characteristics_ch1": "patient id: AML-20;\tgender: M"}]}, {"GSM3271142": [{"title": "CD8-Intermediate CD8_P23"}, {"type": "RNA"}, {"source_name_ch1": "CD8-Intermediate"}, {"characteristics_ch1": "patient id: AML-6;\tgender: F"}]}, {"GSM3271143": [{"title": "CD8-Intermediate CD8_P24"}, {"type": "RNA"}, {"source_name_ch1": "CD8-Intermediate"}, {"characteristics_ch1": "patient id: AML-21;\tgender: M"}]}, {"GSM3271144": [{"title": "CD8-Intermediate CD8_P28"}, {"type": "RNA"}, {"source_name_ch1": "CD8-Intermediate"}, {"characteristics_ch1": "patient id: AML-27;\tgender: F"}]}, {"GSM3271145": [{"title": "CD8-Intermediate CD8_P29"}, {"type": "RNA"}, {"source_name_ch1": "CD8-Intermediate"}, {"characteristics_ch1": "patient id: AML-23;\tgender: M"}]}, {"GSM3271146": [{"title": "CD8-Adverse CD8_P3"}, {"type": "RNA"}, {"source_name_ch1": "CD8-Adverse"}, {"characteristics_ch1": "patient id: AML-22;\tgender: M"}]}, {"GSM3271147": [{"title": "CD8-Adverse CD8_P30"}, {"type": "RNA"}, {"source_name_ch1": "CD8-Adverse"}, {"characteristics_ch1": "patient id: AML-3;\tgender: F"}]}, {"GSM3271148": [{"title": "CD8-Favorable CD8_P31"}, {"type": "RNA"}, {"source_name_ch1": "CD8-Favorable"}, {"characteristics_ch1": "patient id: AML-11;\tgender: F"}]}, {"GSM3271149": [{"title": "CD8-Favorable CD8_P32"}, {"type": "RNA"}, {"source_name_ch1": "CD8-Favorable"}, {"characteristics_ch1": "patient id: AML-16;\tgender: F"}]}, {"GSM3271150": [{"title": "CD8-Intermediate CD8_P33"}, {"type": "RNA"}, {"source_name_ch1": "CD8-Intermediate"}, {"characteristics_ch1": "patient id: AML-30;\tgender: M"}]}, {"GSM3271151": [{"title": "CD8-Intermediate CD8_P4"}, {"type": "RNA"}, {"source_name_ch1": "CD8-Intermediate"}, {"characteristics_ch1": "patient id: AML-4;\tgender: M"}]}, {"GSM3271152": [{"title": "CD8-Adverse CD8_P5"}, {"type": "RNA"}, {"source_name_ch1": "CD8-Adverse"}, {"characteristics_ch1": "patient id: AML-1;\tgender: M"}]}, {"GSM3271153": [{"title": "CD8-Adverse CD8_P6"}, {"type": "RNA"}, {"source_name_ch1": "CD8-Adverse"}, {"characteristics_ch1": "patient id: AML-24;\tgender: F"}]}, {"GSM3271154": [{"title": "CD8-Intermediate CD8_P7"}, {"type": "RNA"}, {"source_name_ch1": "CD8-Intermediate"}, {"characteristics_ch1": "patient id: AML-5;\tgender: F"}]}, {"GSM3271155": [{"title": "CD8-Adverse CD8_P8"}, {"type": "RNA"}, {"source_name_ch1": "CD8-Adverse"}, {"characteristics_ch1": "patient id: AML-25;\tgender: M"}]}, {"GSM3271156": [{"title": "CD8-Adverse CD8_P9"}, {"type": "RNA"}, {"source_name_ch1": "CD8-Adverse"}, {"characteristics_ch1": "patient id: AML-28;\tgender: M"}]}, {"GSM3417169": [{"title": "Cord Blood_P15"}, {"type": "RNA"}, {"source_name_ch1": "Healthy Neonate"}, {"characteristics_ch1": "tissue: cord blood;\tcell type: Mononuclear Leukocytes"}]}, {"GSM3417170": [{"title": "Cord Blood_P17"}, {"type": "RNA"}, {"source_name_ch1": "Healthy Neonate"}, {"characteristics_ch1": "tissue: cord blood;\tcell type: Mononuclear Leukocytes"}]}, {"GSM3417171": [{"title": "Cord Blood_P21"}, {"type": "RNA"}, {"source_name_ch1": "Healthy Neonate"}, {"characteristics_ch1": "tissue: cord blood;\tcell type: Mononuclear Leukocytes"}]}, {"GSM3417172": [{"title": "Cord Blood_P24"}, {"type": "RNA"}, {"source_name_ch1": "Healthy Neonate"}, {"characteristics_ch1": "tissue: cord blood;\tcell type: Mononuclear Leukocytes"}]}, {"GSM3417173": [{"title": "Cord Blood_P30"}, {"type": "RNA"}, {"source_name_ch1": "Healthy Neonate"}, {"characteristics_ch1": "tissue: cord blood;\tcell type: Mononuclear Leukocytes"}]}, {"GSM3417174": [{"title": "Cord Blood_P12"}, {"type": "RNA"}, {"source_name_ch1": "Chorioamnionitis exposed neonate"}, {"characteristics_ch1": "tissue: cord blood;\tcell type: Mononuclear Leukocytes"}]}, {"GSM3417175": [{"title": "Cord Blood_P18"}, {"type": "RNA"}, {"source_name_ch1": "Chorioamnionitis exposed neonate"}, {"characteristics_ch1": "tissue: cord blood;\tcell type: Mononuclear Leukocytes"}]}, {"GSM3417176": [{"title": "Cord Blood_P20"}, {"type": "RNA"}, {"source_name_ch1": "Chorioamnionitis exposed neonate"}, {"characteristics_ch1": "tissue: cord blood;\tcell type: Mononuclear Leukocytes"}]}, {"GSM3417177": [{"title": "Cord Blood_P25"}, {"type": "RNA"}, {"source_name_ch1": "Chorioamnionitis exposed neonate"}, {"characteristics_ch1": "tissue: cord blood;\tcell type: Mononuclear Leukocytes"}]}, {"GSM3417178": [{"title": "Cord Blood_P29"}, {"type": "RNA"}, {"source_name_ch1": "Chorioamnionitis exposed neonate"}, {"characteristics_ch1": "tissue: cord blood;\tcell type: Mononuclear Leukocytes"}]}, {"GSM3699746": [{"title": "bladder tumour 66"}, {"type": "RNA"}, {"source_name_ch1": "fresh frozen bladder tumour tissue"}, {"characteristics_ch1": "tumour stage: Ta"}]}, {"GSM3699747": [{"title": "bladder tumour 103"}, {"type": "RNA"}, {"source_name_ch1": "fresh frozen bladder tumour tissue"}, {"characteristics_ch1": "tumour stage: Ta"}]}, {"GSM3699748": [{"title": "bladder tumour 390"}, {"type": "RNA"}, {"source_name_ch1": "fresh frozen bladder tumour tissue"}, {"characteristics_ch1": "tumour stage: Ta"}]}, {"GSM3699749": [{"title": "bladder tumour 419"}, {"type": "RNA"}, {"source_name_ch1": "fresh frozen bladder tumour tissue"}, {"characteristics_ch1": "tumour stage: Ta"}]}, {"GSM3699750": [{"title": "bladder tumour 437"}, {"type": "RNA"}, {"source_name_ch1": "fresh frozen bladder tumour tissue"}, {"characteristics_ch1": "tumour stage: Ta"}]}, {"GSM3699751": [{"title": "bladder tumour 705"}, {"type": "RNA"}, {"source_name_ch1": "fresh frozen bladder tumour tissue"}, {"characteristics_ch1": "tumour stage: Ta"}]}, {"GSM3699752": [{"title": "bladder tumour 787"}, {"type": "RNA"}, {"source_name_ch1": "fresh frozen bladder tumour tissue"}, {"characteristics_ch1": "tumour stage: Ta"}]}, {"GSM3699753": [{"title": "bladder tumour 1067"}, {"type": "RNA"}, {"source_name_ch1": "fresh frozen bladder tumour tissue"}, {"characteristics_ch1": "tumour stage: Ta"}]}, {"GSM3699754": [{"title": "bladder tumour 1083"}, {"type": "RNA"}, {"source_name_ch1": "fresh frozen bladder tumour tissue"}, {"characteristics_ch1": "tumour stage: Ta"}]}, {"GSM3699755": [{"title": "bladder tumour 1103"}, {"type": "RNA"}, {"source_name_ch1": "fresh frozen bladder tumour tissue"}, {"characteristics_ch1": "tumour stage: Ta"}]}, {"GSM3699756": [{"title": "bladder tumour 1181"}, {"type": "RNA"}, {"source_name_ch1": "fresh frozen bladder tumour tissue"}, {"characteristics_ch1": "tumour stage: Ta"}]}, {"GSM3699757": [{"title": "bladder tumour 1289"}, {"type": "RNA"}, {"source_name_ch1": "fresh frozen bladder tumour tissue"}, {"characteristics_ch1": "tumour stage: Ta"}]}, {"GSM3699758": [{"title": "bladder tumour 1390"}, {"type": "RNA"}, {"source_name_ch1": "fresh frozen bladder tumour tissue"}, {"characteristics_ch1": "tumour stage: Ta"}]}, {"GSM3699759": [{"title": "bladder tumour 1514"}, {"type": "RNA"}, {"source_name_ch1": "fresh frozen bladder tumour tissue"}, {"characteristics_ch1": "tumour stage: Ta"}]}, {"GSM3699760": [{"title": "bladder tumour 1566"}, {"type": "RNA"}, {"source_name_ch1": "fresh frozen bladder tumour tissue"}, {"characteristics_ch1": "tumour stage: Ta"}]}, {"GSM3699761": [{"title": "bladder tumour 1567"}, {"type": "RNA"}, {"source_name_ch1": "fresh frozen bladder tumour tissue"}, {"characteristics_ch1": "tumour stage: Ta"}]}, {"GSM3699762": [{"title": "bladder tumour 1719"}, {"type": "RNA"}, {"source_name_ch1": "fresh frozen bladder tumour tissue"}, {"characteristics_ch1": "tumour stage: Ta"}]}, {"GSM3699763": [{"title": "bladder tumour 1732"}, {"type": "RNA"}, {"source_name_ch1": "fresh frozen bladder tumour tissue"}, {"characteristics_ch1": "tumour stage: Ta"}]}, {"GSM3699764": [{"title": "bladder tumour 1798"}, {"type": "RNA"}, {"source_name_ch1": "fresh frozen bladder tumour tissue"}, {"characteristics_ch1": "tumour stage: Ta"}]}, {"GSM3699765": [{"title": "bladder tumour 1858"}, {"type": "RNA"}, {"source_name_ch1": "fresh frozen bladder tumour tissue"}, {"characteristics_ch1": "tumour stage: Ta"}]}, {"GSM3699766": [{"title": "bladder tumour 1930"}, {"type": "RNA"}, {"source_name_ch1": "fresh frozen bladder tumour tissue"}, {"characteristics_ch1": "tumour stage: Ta"}]}, {"GSM3699767": [{"title": "bladder tumour 1931"}, {"type": "RNA"}, {"source_name_ch1": "fresh frozen bladder tumour tissue"}, {"characteristics_ch1": "tumour stage: Ta"}]}, {"GSM3699768": [{"title": "bladder tumour 1932"}, {"type": "RNA"}, {"source_name_ch1": "fresh frozen bladder tumour tissue"}, {"characteristics_ch1": "tumour stage: Ta"}]}, {"GSM3699769": [{"title": "bladder tumour 1971"}, {"type": "RNA"}, {"source_name_ch1": "fresh frozen bladder tumour tissue"}, {"characteristics_ch1": "tumour stage: Ta"}]}, {"GSM3699770": [{"title": "bladder tumour 1992"}, {"type": "RNA"}, {"source_name_ch1": "fresh frozen bladder tumour tissue"}, {"characteristics_ch1": "tumour stage: Ta"}]}, {"GSM3699771": [{"title": "bladder tumour 2013"}, {"type": "RNA"}, {"source_name_ch1": "fresh frozen bladder tumour tissue"}, {"characteristics_ch1": "tumour stage: Ta"}]}, {"GSM3699772": [{"title": "bladder tumour 2032"}, {"type": "RNA"}, {"source_name_ch1": "fresh frozen bladder tumour tissue"}, {"characteristics_ch1": "tumour stage: Ta"}]}, {"GSM3699773": [{"title": "bladder tumour 2047"}, {"type": "RNA"}, {"source_name_ch1": "fresh frozen bladder tumour tissue"}, {"characteristics_ch1": "tumour stage: Ta"}]}, {"GSM3699774": [{"title": "bladder tumour 2055"}, {"type": "RNA"}, {"source_name_ch1": "fresh frozen bladder tumour tissue"}, {"characteristics_ch1": "tumour stage: Ta"}]}, {"GSM3699775": [{"title": "bladder tumour 2063"}, {"type": "RNA"}, {"source_name_ch1": "fresh frozen bladder tumour tissue"}, {"characteristics_ch1": "tumour stage: Ta"}]}, {"GSM3699776": [{"title": "bladder tumour 2065"}, {"type": "RNA"}, {"source_name_ch1": "fresh frozen bladder tumour tissue"}, {"characteristics_ch1": "tumour stage: Ta"}]}, {"GSM3699777": [{"title": "bladder tumour 2074"}, {"type": "RNA"}, {"source_name_ch1": "fresh frozen bladder tumour tissue"}, {"characteristics_ch1": "tumour stage: Ta"}]}, {"GSM3699778": [{"title": "bladder tumour 2082"}, {"type": "RNA"}, {"source_name_ch1": "fresh frozen bladder tumour tissue"}, {"characteristics_ch1": "tumour stage: Ta"}]}, {"GSM3699779": [{"title": "bladder tumour 2086"}, {"type": "RNA"}, {"source_name_ch1": "fresh frozen bladder tumour tissue"}, {"characteristics_ch1": "tumour stage: Ta"}]}, {"GSM3699780": [{"title": "bladder tumour 2100"}, {"type": "RNA"}, {"source_name_ch1": "fresh frozen bladder tumour tissue"}, {"characteristics_ch1": "tumour stage: Ta"}]}, {"GSM3699781": [{"title": "bladder tumour 2104"}, {"type": "RNA"}, {"source_name_ch1": "fresh frozen bladder tumour tissue"}, {"characteristics_ch1": "tumour stage: Ta"}]}, {"GSM3699782": [{"title": "bladder tumour 2118"}, {"type": "RNA"}, {"source_name_ch1": "fresh frozen bladder tumour tissue"}, {"characteristics_ch1": "tumour stage: Ta"}]}, {"GSM3699783": [{"title": "bladder tumour 2161"}, {"type": "RNA"}, {"source_name_ch1": "fresh frozen bladder tumour tissue"}, {"characteristics_ch1": "tumour stage: Ta"}]}, {"GSM3699784": [{"title": "bladder tumour 2220"}, {"type": "RNA"}, {"source_name_ch1": "fresh frozen bladder tumour tissue"}, {"characteristics_ch1": "tumour stage: Ta"}]}, {"GSM3699785": [{"title": "bladder tumour 2334"}, {"type": "RNA"}, {"source_name_ch1": "fresh frozen bladder tumour tissue"}, {"characteristics_ch1": "tumour stage: Ta"}]}, {"GSM3699786": [{"title": "bladder tumour 2338"}, {"type": "RNA"}, {"source_name_ch1": "fresh frozen bladder tumour tissue"}, {"characteristics_ch1": "tumour stage: Ta"}]}, {"GSM3699787": [{"title": "bladder tumour 2425"}, {"type": "RNA"}, {"source_name_ch1": "fresh frozen bladder tumour tissue"}, {"characteristics_ch1": "tumour stage: Ta"}]}, {"GSM3699788": [{"title": "bladder tumour 2452"}, {"type": "RNA"}, {"source_name_ch1": "fresh frozen bladder tumour tissue"}, {"characteristics_ch1": "tumour stage: Ta"}]}, {"GSM3699789": [{"title": "bladder tumour 2498"}, {"type": "RNA"}, {"source_name_ch1": "fresh frozen bladder tumour tissue"}, {"characteristics_ch1": "tumour stage: Ta"}]}, {"GSM3701655": [{"title": "donor 3 NS"}, {"type": "RNA"}, {"source_name_ch1": "Primary cell culture"}, {"characteristics_ch1": "cell type: Control lung fibroblasts;\tstimulation: non-stimulated 24 hours"}]}, {"GSM3701656": [{"title": "donor 3 TGF-b1"}, {"type": "RNA"}, {"source_name_ch1": "Primary cell culture"}, {"characteristics_ch1": "cell type: Control lung fibroblasts;\tstimulation: TGF-b1-stimulated 24 hours"}]}, {"GSM3701657": [{"title": "NL-59 NS"}, {"type": "RNA"}, {"source_name_ch1": "Primary cell culture"}, {"characteristics_ch1": "cell type: Control lung fibroblasts;\tstimulation: non-stimulated 24 hours"}]}, {"GSM3701658": [{"title": "NL59 TGF-b1"}, {"type": "RNA"}, {"source_name_ch1": "Primary cell culture"}, {"characteristics_ch1": "cell type: Control lung fibroblasts;\tstimulation: TGF-b1-stimulated 24 hours"}]}, {"GSM3701659": [{"title": "AG02603 NS"}, {"type": "RNA"}, {"source_name_ch1": "Primary cell culture"}, {"characteristics_ch1": "cell type: Control lung fibroblasts;\tstimulation: non-stimulated 24 hours"}]}, {"GSM3701660": [{"title": "AG02603 TGF-b1"}, {"type": "RNA"}, {"source_name_ch1": "Primary cell culture"}, {"characteristics_ch1": "cell type: Control lung fibroblasts;\tstimulation: TGF-b1-stimulated 24 hours"}]}, {"GSM3701661": [{"title": "AG02262 NS"}, {"type": "RNA"}, {"source_name_ch1": "Primary cell culture"}, {"characteristics_ch1": "cell type: Control lung fibroblasts;\tstimulation: non-stimulated 24 hours"}]}, {"GSM3701662": [{"title": "AG02262 TGF-b1"}, {"type": "RNA"}, {"source_name_ch1": "Primary cell culture"}, {"characteristics_ch1": "cell type: Control lung fibroblasts;\tstimulation: TGF-b1-stimulated 24 hours"}]}, {"GSM3701663": [{"title": "AG02258 NS"}, {"type": "RNA"}, {"source_name_ch1": "Primary cell culture"}, {"characteristics_ch1": "cell type: Control lung fibroblasts;\tstimulation: non-stimulated 24 hours"}]}, {"GSM3701664": [{"title": "AG02258 TGF-b1"}, {"type": "RNA"}, {"source_name_ch1": "Primary cell culture"}, {"characteristics_ch1": "cell type: Control lung fibroblasts;\tstimulation: TGF-b1-stimulated 24 hours"}]}, {"GSM3701665": [{"title": "IPF8 NS"}, {"type": "RNA"}, {"source_name_ch1": "Primary cell culture"}, {"characteristics_ch1": "cell type: IPF lung fibroblasts;\tstimulation: non-stimulated 24 hours"}]}, {"GSM3701666": [{"title": "IPF8 TGF-b1"}, {"type": "RNA"}, {"source_name_ch1": "Primary cell culture"}, {"characteristics_ch1": "cell type: IPF lung fibroblasts;\tstimulation: TGF-b1-stimulated 24 hours"}]}, {"GSM3701667": [{"title": "IPF32 NS"}, {"type": "RNA"}, {"source_name_ch1": "Primary cell culture"}, {"characteristics_ch1": "cell type: IPF lung fibroblasts;\tstimulation: non-stimulated 24 hours"}]}, {"GSM3701668": [{"title": "IPF32 TGF-b1"}, {"type": "RNA"}, {"source_name_ch1": "Primary cell culture"}, {"characteristics_ch1": "cell type: IPF lung fibroblasts;\tstimulation: TGF-b1-stimulated 24 hours"}]}, {"GSM3701669": [{"title": "IPF36 NS"}, {"type": "RNA"}, {"source_name_ch1": "Primary cell culture"}, {"characteristics_ch1": "cell type: IPF lung fibroblasts;\tstimulation: non-stimulated 24 hours"}]}, {"GSM3701670": [{"title": "IPF36 TGF-b1"}, {"type": "RNA"}, {"source_name_ch1": "Primary cell culture"}, {"characteristics_ch1": "cell type: IPF lung fibroblasts;\tstimulation: TGF-b1-stimulated 24 hours"}]}, {"GSM3701671": [{"title": "IPF38 NS"}, {"type": "RNA"}, {"source_name_ch1": "Primary cell culture"}, {"characteristics_ch1": "cell type: IPF lung fibroblasts;\tstimulation: non-stimulated 24 hours"}]}, {"GSM3701672": [{"title": "IPF38 TGF-b1"}, {"type": "RNA"}, {"source_name_ch1": "Primary cell culture"}, {"characteristics_ch1": "cell type: IPF lung fibroblasts;\tstimulation: TGF-b1-stimulated 24 hours"}]}, {"GSM3701673": [{"title": "IPF26 NS"}, {"type": "RNA"}, {"source_name_ch1": "Primary cell culture"}, {"characteristics_ch1": "cell type: IPF lung fibroblasts;\tstimulation: non-stimulated 24 hours"}]}, {"GSM3701674": [{"title": "IPF26 TGF-b1"}, {"type": "RNA"}, {"source_name_ch1": "Primary cell culture"}, {"characteristics_ch1": "cell type: IPF lung fibroblasts;\tstimulation: TGF-b1-stimulated 24 hours"}]}, {"GSM2575430": [{"title": "Cumulus cells ET-1 18H"}, {"type": "RNA"}, {"source_name_ch1": "ET-1 treated 18 hours"}, {"characteristics_ch1": "cell type: cumulus cells;\ttreatment: ET-1;\ttime: 18H"}]}, {"GSM2575431": [{"title": "Cumulus cells ET-1 0H"}, {"type": "RNA"}, {"source_name_ch1": "ET-1 treated 0 hours"}, {"characteristics_ch1": "cell type: cumulus cells;\ttreatment: control;\ttime: 0H"}]}]}